Citrus Sinensis ID: 040050

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-
Protein Sequence
MKKKLTWKSITLSCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPNETESSVYLRNGKETNSEEESGEKNG
Secondary Structure (PSIPRED)
cccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEcHHHHHHHHccccccccccccccccEEEEEEcccccccccccEEEEEEEccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccccccccccccccHHHHccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccEEccHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHcccccccccEEEEEEccccccccccEEEEEEEEccccccccHHHHHHHHHHHHccccccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHccccccccccccccEEEEEcccccHccHHHHHHccccHHHHHHHHHHHHHHHHHccccccHHHccccccHHHHHHHHHcccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mkkkltwksITLScykssmpesntnneqvdkqTSFQRLclsdvsnpssplsaddlsnsvigskLHVFTLAELRLITsnfsrsnllgeggfgpvykgfvdeklkpgleaqPVAVKaldldgtqgHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEymprgslhnqlfrsysaalpwsTRMKIALGAAKGLaflhgedkpviyrdfkasnilldsdytaklsdfglakdgpegeetHVITRVMgtqgyaapeyvmtghlttmSDVYSFGVVLLELLTgkramdntrlgREQSLAEWARPllkeprklerlidprlegqfpiKGAQKAAATAFKclshhprhrptmSYVVRVLDSLQdfqdsfvgpfvyvvpnetessvylrngketnseeesgekng
Flexible Loop (DISEMBL)
mkkkltwksitlscykssmpesntnnEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSlaewarpllkeprklerlidprLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPnetessvylrngketnseeesgekng
Low Complexity Region (SEG)
MKKKLTWKSITLSCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPNETESSVYLRNGKETNSEEESGEKNG
Disordered region (IsUnstruct)
********SITLSC********************************************VIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD****EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL*****LAEWARPLL******ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPNE************************
Disordered Region (DISOPRED)
*****************************************************************VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ*****************************************
Disordered Region (DISEMBL)
MKKKLTWKSITLSCYKS*************KQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPNETESSVYLRN***************
Disordered Region (DISPRO)
**KKLTWKSITLSCYKS********************************************SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF***************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKKKLTWKSITLSCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPNETESSVYLRNGKETNSEEESGEKNG
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	401	2.2.26 [Sep-21-2011]
Q9CAH1	450	Putative receptor-like pr	no	no	0.922	0.822	0.576	1e-124
Q8GXZ3	410	Serine/threonine-protein	no	no	0.817	0.8	0.625	1e-119
Q9LFP7	493	Probable receptor-like pr	no	no	0.947	0.770	0.559	1e-111
Q9FM85	408	Probable receptor-like pr	no	no	0.785	0.772	0.594	1e-107
Q9SRH7	490	Receptor-like serine/thre	no	no	0.802	0.657	0.618	1e-107
P46573	412	Protein kinase APK1B, chl	no	no	0.750	0.730	0.597	1e-102
Q06548	410	Protein kinase APK1A, chl	no	no	0.807	0.790	0.562	1e-100
P43293	389	Probable serine/threonine	no	no	0.743	0.766	0.580	4e-99
O49840	426	Protein kinase 2B, chloro	no	no	0.738	0.694	0.594	3e-98
O49839	426	Protein kinase 2A, chloro	no	no	0.738	0.694	0.588	1e-96

>sp|Q9CAH1|Y1725_ARATH Putative receptor-like protein kinase At1g72540 OS=Arabidopsis thaliana GN=At1g72540 PE=2 SV=1

 Score =  445 bits (1144), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 216/375 (57%), Positives = 283/375 (75%), Gaps = 5/375 (1%)

Query: 29  VDKQTSF-QRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGE 87
           + +QTS   R+ +SD SN  S +S +D SNS     +H+FT  EL+ IT  FS+ N LGE
Sbjct: 36  LSRQTSVPSRVYMSDFSN--STISLNDFSNSFF-INIHIFTYEELKTITQGFSKYNFLGE 92

Query: 88  GGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIG 147
           GGFG VYKGFVD+ LK GL+ QPVAVKAL  +G QGH+EW+AE+I LGQL+HPHLV L+G
Sbjct: 93  GGFGEVYKGFVDDSLKTGLKDQPVAVKALKREGGQGHREWLAEVIILGQLKHPHLVNLVG 152

Query: 148 YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIY 207
           YC E++ RLLVYEYM RG+L + LF+ Y  ALPW TR+KI LGAAKGL FLH ++KPVIY
Sbjct: 153 YCCEDDERLLVYEYMERGNLEDHLFQKYGGALPWLTRVKILLGAAKGLEFLHKQEKPVIY 212

Query: 208 RDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS 267
           RDFK SNILL SD+++KLSDFGLA DG E E+++    VMGT+GYAAPEY+  G+LTTMS
Sbjct: 213 RDFKPSNILLSSDFSSKLSDFGLATDGSEEEDSNFTKSVMGTEGYAAPEYISAGNLTTMS 272

Query: 268 DVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKG 327
           DV+SFGVVLLE+LT ++A++  R  R ++L EWARP+LK+P KLER+IDP LEG++ ++G
Sbjct: 273 DVFSFGVVLLEMLTARKAVEKYRAQRGRNLVEWARPMLKDPNKLERIIDPSLEGKYSVEG 332

Query: 328 AQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPNETESSVY-LRN 386
            +KAAA A++CLSH+P+ RPTM+ VV+ L+ + D +D   GPFVY+VP    S V+ ++ 
Sbjct: 333 IRKAAALAYQCLSHNPKSRPTMTTVVKTLEPILDLKDIQNGPFVYIVPVAGVSEVHEIKC 392

Query: 387 GKETNSEEESGEKNG 401
             +    +E  EK+ 
Sbjct: 393 KDDVKVVKEETEKDA 407

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  428 bits (1101), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 205/328 (62%), Positives = 257/328 (78%)

Query: 40  LSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVD 99
           +SD+S+PS+P   DD    +  +++  FTL EL  IT +F    +LGEGGFG VYKG++D
Sbjct: 30  VSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYID 89

Query: 100 EKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVY 159
           + L+ GL++ PVAVK L+ +G QGH+EW+ E+ FLGQLRHP+LVKLIGYC E+++RLLVY
Sbjct: 90  DNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY 149

Query: 160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS 219
           E+M RGSL N LFR  +A L WS RM IALGAAKGLAFLH  ++PVIYRDFK SNILLDS
Sbjct: 150 EFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDS 209

Query: 220 DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLEL 279
           DYTAKLSDFGLAK GP+G+ETHV TRVMGT GYAAPEYVMTGHLT  SDVYSFGVVLLE+
Sbjct: 210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEM 269

Query: 280 LTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCL 339
           LTG++++D TR  +EQ+L +WARP L + RKL ++IDPRLE Q+ ++ AQKA + A+ CL
Sbjct: 270 LTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCL 329

Query: 340 SHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
           S +P+ RP MS VV  L+ LQ   D+ +
Sbjct: 330 SQNPKARPLMSDVVETLEPLQCTGDALI 357

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  402 bits (1032), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 221/395 (55%), Positives = 268/395 (67%), Gaps = 15/395 (3%)

Query: 13  SCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSV-IGSKLHVFTLAE 71
           +C  ++M ES + NE+ + Q   Q    +  SN  S  S   +S  + I S L  FT  +
Sbjct: 76  NCTVTTM-ESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFND 134

Query: 72  LRLITSNFSRSNLLGEGGFGPVYKGFVDEK----LKPGLEAQPVAVKALDLDGTQGHKEW 127
           L+L T NF   +LLGEGGFG V+KG+++E     +KPG     VAVK L+ DG QGHKEW
Sbjct: 135 LKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT-GLTVAVKTLNPDGLQGHKEW 193

Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           +AEI FLG L HP+LVKL+GYC E++ RLLVYE+MPRGSL N LFR  S  LPWS RMKI
Sbjct: 194 LAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 252

Query: 188 ALGAAKGLAFLHGED-KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           ALGAAKGL+FLH E  KPVIYRDFK SNILLD+DY AKLSDFGLAKD P+  +THV TRV
Sbjct: 253 ALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRV 312

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           MGT GYAAPEYVMTGHLT+ SDVYSFGVVLLE+LTG+R+MD  R   E +L EWARP L 
Sbjct: 313 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLL 372

Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           + R+  RL+DPRLEG F IKGAQK    A +CLS  P+ RP MS VV  L  L   +D  
Sbjct: 373 DKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMA 432

Query: 367 VGPFVYVVPNETESSVYLRNGKETNSEEESGEKNG 401
              + +    +T  +  L+NG  +   +  G +NG
Sbjct: 433 SSSYYF----QTMQAERLKNG--SGRSQGFGSRNG 461

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  389 bits (999), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 189/318 (59%), Positives = 235/318 (73%), Gaps = 3/318 (0%)

Query: 46  PSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKL--K 103
           PS+P   +DL      + L  FT  EL+ ITSNF +  +LG GGFG VYKGF+ E L  +
Sbjct: 43  PSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQ 102

Query: 104 PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYM 162
              E  PVAVK  D D + QGH+EW+AE+IFLGQL HP+LVKLIGYC E+ +R+L+YEYM
Sbjct: 103 EVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYM 162

Query: 163 PRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT 222
            RGS+ N LF      L W+ RMKIA GAAKGLAFLH   KPVIYRDFK SNILLD DY 
Sbjct: 163 ARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYN 222

Query: 223 AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           AKLSDFGLAKDGP G+++HV TR+MGT GYAAPEY+MTGHLT  SDVYSFGVVLLELLTG
Sbjct: 223 AKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTG 282

Query: 283 KRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHH 342
           ++++D +R  REQ+L +WA PLLKE +K+  ++DP++  ++P+K  QKAA  A+ CL+ +
Sbjct: 283 RKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRN 342

Query: 343 PRHRPTMSYVVRVLDSLQ 360
           P+ RP M  +V  L+ LQ
Sbjct: 343 PKARPLMRDIVDSLEPLQ 360

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  387 bits (995), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 204/330 (61%), Positives = 239/330 (72%), Gaps = 8/330 (2%)

Query: 41  SDVSNPSSPLSADDLSNSV-IGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVD 99
           +  SN  S LS   +S  + I S L  F+  +L+L T NF   +LLGEGGFG V+KG+V+
Sbjct: 97  TTTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVE 156

Query: 100 EK----LKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR 155
           E     +KPG     VAVK L+ DG QGHKEW+AEI +LG L HP+LVKL+GYC E++ R
Sbjct: 157 ENGTAPVKPG-TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQR 215

Query: 156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED-KPVIYRDFKASN 214
           LLVYE+MPRGSL N LFR  S  LPWS RMKIALGAAKGL+FLH E  KPVIYRDFK SN
Sbjct: 216 LLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSN 274

Query: 215 ILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGV 274
           ILLD +Y AKLSDFGLAKD P+  +THV TRVMGT GYAAPEYVMTGHLT+ SDVYSFGV
Sbjct: 275 ILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 334

Query: 275 VLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAAT 334
           VLLE+LTG+R+MD  R   E +L EWARP L + R+  RL+DPRLEG F +KGAQK    
Sbjct: 335 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQL 394

Query: 335 AFKCLSHHPRHRPTMSYVVRVLDSLQDFQD 364
           A +CLS   + RP MS VV VL  L   +D
Sbjct: 395 AAQCLSRDSKIRPKMSEVVEVLKPLPHLKD 424

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  371 bits (952), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 184/308 (59%), Positives = 229/308 (74%), Gaps = 7/308 (2%)

Query: 64  LHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKL----KPGLEAQPVAVKALDLD 119
           L  FT AEL+  T NF   ++LGEGGFG V+KG++DE+     KPG     +AVK L+ D
Sbjct: 54  LKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPG-TGVVIAVKKLNQD 112

Query: 120 GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYSA 177
           G QGH+EW+AE+ +LGQ  HP+LVKLIGYC E+E+RLLVYE+MPRGSL N LFR  SY  
Sbjct: 113 GWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQ 172

Query: 178 ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 237
            L W+ R+K+ALGAAKGLAFLH  +  VIYRDFK SNILLDS+Y AKLSDFGLAKDGP G
Sbjct: 173 PLSWTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTG 232

Query: 238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
           +++HV TR+MGT GYAAPEY+ TGHLTT SDVYS+GVVLLE+L+G+RA+D  R   EQ L
Sbjct: 233 DKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKL 292

Query: 298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
            EWARPLL   RKL R+ID RL+ Q+ ++ A K A  A +CL+   + RP M+ VV  L+
Sbjct: 293 VEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLE 352

Query: 358 SLQDFQDS 365
            +Q   ++
Sbjct: 353 HIQTLNEA 360

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  364 bits (934), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 188/334 (56%), Positives = 235/334 (70%), Gaps = 10/334 (2%)

Query: 41  SDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDE 100
           S VS   SP +  ++  S     L  F+ AEL+  T NF   ++LGEGGFG V+KG++DE
Sbjct: 33  SSVSVRPSPRTEGEILQS---PNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDE 89

Query: 101 KL----KPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL 156
           K     +PG     +AVK L+ DG QGH+EW+AE+ +LGQ  H HLVKLIGYC E+E+RL
Sbjct: 90  KSLTASRPG-TGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRL 148

Query: 157 LVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASN 214
           LVYE+MPRGSL N LFR   Y   L W  R+K+ALGAAKGLAFLH  +  VIYRDFK SN
Sbjct: 149 LVYEFMPRGSLENHLFRRGLYFQPLSWKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSN 208

Query: 215 ILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGV 274
           ILLDS+Y AKLSDFGLAKDGP G+++HV TRVMGT GYAAPEY+ TGHLTT SDVYSFGV
Sbjct: 209 ILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGV 268

Query: 275 VLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAAT 334
           VLLELL+G+RA+D  R   E++L EWA+P L   RK+ R+ID RL+ Q+ ++ A K A  
Sbjct: 269 VLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATL 328

Query: 335 AFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVG 368
           + +CL+   + RP MS VV  L+ +Q    +  G
Sbjct: 329 SLRCLTTEIKLRPNMSEVVSHLEHIQSLNAAIGG 362

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  362 bits (928), Expect = 4e-99,   Method: Compositional matrix adjust.
 Identities = 177/305 (58%), Positives = 228/305 (74%), Gaps = 7/305 (2%)

Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKL----KPGLEAQPVAVKALD 117
           + L  F+L+EL+  T NF   +++GEGGFG V+KG++DE      KPG     +AVK L+
Sbjct: 51  ANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPG-TGIVIAVKRLN 109

Query: 118 LDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SY 175
            +G QGH+EW+AEI +LGQL HP+LVKLIGYC EEE+RLLVYE+M RGSL N LFR  ++
Sbjct: 110 QEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTF 169

Query: 176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
              L W+TR+++ALGAA+GLAFLH     VIYRDFKASNILLDS+Y AKLSDFGLA+DGP
Sbjct: 170 YQPLSWNTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGP 229

Query: 236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ 295
            G+ +HV TRVMGTQGYAAPEY+ TGHL+  SDVYSFGVVLLELL+G+RA+D  +   E 
Sbjct: 230 MGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEH 289

Query: 296 SLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV 355
           +L +WARP L   R+L R++DPRL+GQ+ +  A K A  A  C+S   + RPTM+ +V+ 
Sbjct: 290 NLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKT 349

Query: 356 LDSLQ 360
           ++ L 
Sbjct: 350 MEELH 354

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  358 bits (920), Expect = 3e-98,   Method: Compositional matrix adjust.
 Identities = 179/301 (59%), Positives = 221/301 (73%), Gaps = 5/301 (1%)

Query: 64  LHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKL----KPGLEAQPVAVKALDLD 119
           L  FT  EL+  T NF   +LLGEGGFG V+KG++D       KPG     VAVK L  +
Sbjct: 68  LKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPG-SGIVVAVKKLKTE 126

Query: 120 GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL 179
           G QGHKEW+ E+ +LGQL HP+LVKL+GYC E E RLLVYE+MP+GSL N LFR  +  L
Sbjct: 127 GYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPL 186

Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
            W+ RMK+A+GAAKGL FLH     VIYRDFKA+NILLD+++ +KLSDFGLAK GP G++
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDK 246

Query: 240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE 299
           THV T+VMGT GYAAPEYV TG LT  SDVYSFGVVLLELL+G+RA+D +++G EQSL +
Sbjct: 247 THVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVD 306

Query: 300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           WA P L + RKL R++D RL GQ+P KGA  AA+ A +CL+   + RP MS V+  LD L
Sbjct: 307 WATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQL 366

Query: 360 Q 360
           +
Sbjct: 367 E 367

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  353 bits (907), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 177/301 (58%), Positives = 218/301 (72%), Gaps = 5/301 (1%)

Query: 64  LHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDE----KLKPGLEAQPVAVKALDLD 119
           L  FT  EL+  T NF + NLLGEGGFG V+KG++D+      +PG     VAVK L  +
Sbjct: 71  LKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPG-SGIVVAVKQLKPE 129

Query: 120 GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL 179
           G QGHKEW+ E+ +LGQL HP+LV L+GYC E E RLLVYE+MP+GSL N LFR  +  L
Sbjct: 130 GFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPL 189

Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
            W+ RMK+A+GAAKGL FLH     VIYRDFKA+NILLD+D+ AKLSDFGLAK GP G+ 
Sbjct: 190 TWAIRMKVAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDN 249

Query: 240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE 299
           THV T+V+GT GYAAPEYV TG LT  SDVYSFGVVLLEL++G+RAMDN+  G E SL +
Sbjct: 250 THVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVD 309

Query: 300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           WA P L + RKL R++D +L GQ+P KGA  AA  A +CL+   + RP MS V+  L+ L
Sbjct: 310 WATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQL 369

Query: 360 Q 360
           +
Sbjct: 370 E 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	401
255550207	448	Protein kinase APK1A, chloroplast precur	0.935	0.837	0.788	1e-174
224092059	347	predicted protein [Populus trichocarpa]	0.865	1.0	0.821	1e-170
225429710	440	PREDICTED: serine/threonine-protein kina	0.970	0.884	0.729	1e-169
224068458	454	predicted protein [Populus trichocarpa]	0.987	0.872	0.689	1e-162
255550441	451	Protein kinase APK1B, chloroplast precur	0.935	0.831	0.717	1e-159
356552460	389	PREDICTED: serine/threonine-protein kina	0.930	0.958	0.721	1e-159
356518179	374	PREDICTED: serine/threonine-protein kina	0.907	0.973	0.736	1e-157
225444724	442	PREDICTED: serine/threonine-protein kina	0.937	0.850	0.714	1e-156
357437255	388	Protein kinase 2B [Medicago truncatula]	0.932	0.963	0.735	1e-155
356509845	380	PREDICTED: serine/threonine-protein kina	0.922	0.973	0.723	1e-154

>gi|255550207|ref|XP_002516154.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223544640|gb|EEF46156.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis]

 Score =  618 bits (1594), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 299/379 (78%), Positives = 330/379 (87%), Gaps = 4/379 (1%)

Query: 3   KKLTWKSITLSCYKSS-MPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIG 61
           KK TWK I LSCYK+  +PES     Q  K TSF+R  LS+VSNPSSPLS +DLSNS  G
Sbjct: 4   KKGTWKCIILSCYKTEPLPESEN---QALKHTSFRRRSLSEVSNPSSPLSIEDLSNSFAG 60

Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
            KLH+F  AELR IT +FSRSNLLGEGGFGPVYKGFVD+KL+PGL AQPVAVK+LDLDG 
Sbjct: 61  PKLHIFAFAELRTITQSFSRSNLLGEGGFGPVYKGFVDDKLRPGLAAQPVAVKSLDLDGL 120

Query: 122 QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
           QGHKEWMAEIIFLGQLRH HLVKLIGYC EE+ RLLVYEYMPRGSL NQLFR YSAALPW
Sbjct: 121 QGHKEWMAEIIFLGQLRHQHLVKLIGYCSEEDQRLLVYEYMPRGSLENQLFRRYSAALPW 180

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
           S RMKIALGAAKGLAFLH  D PVIYRDFK+SNILLDSDY AKLSDFGLAKDGP+GEETH
Sbjct: 181 SARMKIALGAAKGLAFLHETDPPVIYRDFKSSNILLDSDYIAKLSDFGLAKDGPDGEETH 240

Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA 301
           V TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVL+ELLTG+R+MD+TR GR+Q++ EWA
Sbjct: 241 VTTRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLIELLTGRRSMDDTRPGRDQNIVEWA 300

Query: 302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
           RPLLK+  KL+R+IDPRLEGQ+   GAQKAAA A+KCLSHHP+ RPTMSYVV+VL+SLQD
Sbjct: 301 RPLLKDLNKLDRIIDPRLEGQYSSSGAQKAAALAYKCLSHHPKPRPTMSYVVKVLESLQD 360

Query: 362 FQDSFVGPFVYVVPNETES 380
           F D+F+ PFVY+VPNE  S
Sbjct: 361 FDDTFLAPFVYIVPNENGS 379

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224092059|ref|XP_002309457.1| predicted protein [Populus trichocarpa] gi|222855433|gb|EEE92980.1| predicted protein [Populus trichocarpa]

 Score =  602 bits (1553), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 285/347 (82%), Positives = 314/347 (90%)

Query: 29  VDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEG 88
           + KQ SFQRL LSDVS+PS P   +D+SNS  GSKLH+FT +ELR+IT NFSRSNLLGEG
Sbjct: 1   ISKQGSFQRLSLSDVSDPSLPFCIEDISNSFSGSKLHIFTFSELRVITHNFSRSNLLGEG 60

Query: 89  GFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGY 148
           GFGPVYKGFVD+KL+PGL+AQPVAVK+LDLDG QGHKEWMAEIIFLGQLRH HLV+LIGY
Sbjct: 61  GFGPVYKGFVDDKLRPGLDAQPVAVKSLDLDGLQGHKEWMAEIIFLGQLRHSHLVRLIGY 120

Query: 149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYR 208
           C EE+ RLLVYEYMPRGSL NQLFR YSAALPWSTRMKIALGAAKGLAFLH  DKPVIYR
Sbjct: 121 CCEEDQRLLVYEYMPRGSLENQLFRRYSAALPWSTRMKIALGAAKGLAFLHESDKPVIYR 180

Query: 209 DFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSD 268
           DFK+SNILLDSDYTAKLSDFGLAKDGPEGEETHV TRVMGTQGYAAPEY+MTGHLTTMSD
Sbjct: 181 DFKSSNILLDSDYTAKLSDFGLAKDGPEGEETHVTTRVMGTQGYAAPEYIMTGHLTTMSD 240

Query: 269 VYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGA 328
           VYSFGVVLLELLTGKR+MDNTR GREQSL EWARPLLK+  KL+R++DPRLEGQ+  KGA
Sbjct: 241 VYSFGVVLLELLTGKRSMDNTRPGREQSLVEWARPLLKDASKLDRIMDPRLEGQYSTKGA 300

Query: 329 QKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVP 375
           QKAAA A+KCLSHHP+ RP MS+VV VL+SLQ F ++F+ PFVY+VP
Sbjct: 301 QKAAALAYKCLSHHPKPRPMMSHVVEVLESLQGFDETFIQPFVYIVP 347

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225429710|ref|XP_002280196.1| PREDICTED: serine/threonine-protein kinase At5g01020 [Vitis vinifera]

 Score =  600 bits (1547), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 288/395 (72%), Positives = 328/395 (83%), Gaps = 6/395 (1%)

Query: 1   MKKKLTWKSITLSCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVI 60
           M  K+TWK+I   CYK+  P + +  + V KQ SFQRL LSD+SNP SPLS DD+SNS+I
Sbjct: 1   MTLKITWKTIMPGCYKTETPIAESRKKPVLKQGSFQRLSLSDLSNPGSPLSVDDISNSLI 60

Query: 61  GSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG 120
           GS L+ FTLAELR IT NFS SNLLGEGGFGPVYKGF+DEKL+P L+AQPVAVK LDLDG
Sbjct: 61  GSNLYTFTLAELREITHNFSPSNLLGEGGFGPVYKGFIDEKLRPKLKAQPVAVKLLDLDG 120

Query: 121 TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP 180
            QGH+EW+AEIIFLGQLRHPHLVKLIGYC E+E+RLL+YEYM RGSL NQLFR YSAALP
Sbjct: 121 LQGHREWLAEIIFLGQLRHPHLVKLIGYCCEDEHRLLIYEYMARGSLENQLFRRYSAALP 180

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
           WS RMKI  GAAKGLAFLH  DKPVIYRDFKASNILLD DYTAKLSDFGLAKDGPEG+ET
Sbjct: 181 WSARMKILFGAAKGLAFLHEGDKPVIYRDFKASNILLDPDYTAKLSDFGLAKDGPEGDET 240

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW 300
           HV TR+MGT GYAAPEY+MTGHLTTMSDVYSFGVVLLE+++GKR+MD TR  REQ+L EW
Sbjct: 241 HVSTRIMGTHGYAAPEYIMTGHLTTMSDVYSFGVVLLEVISGKRSMDKTRPSREQNLVEW 300

Query: 301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
           ARP+LK+PRKL+R+ID RLEG F  KGAQKAA  A+KCLSH  + RP MS VV++L+ LQ
Sbjct: 301 ARPMLKDPRKLDRVIDSRLEGLFSTKGAQKAAELAYKCLSHQAKARPAMSDVVKILEPLQ 360

Query: 361 DFQDSFVGPFVYVVPNETESSVYLRNGKETNSEEE 395
           DF D+ + PFVYVVP E E       G E+ SE++
Sbjct: 361 DFDDTVISPFVYVVPAEGEV------GDESESEKD 389

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224068458|ref|XP_002326125.1| predicted protein [Populus trichocarpa] gi|222833318|gb|EEE71795.1| predicted protein [Populus trichocarpa]

 Score =  576 bits (1484), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 275/399 (68%), Positives = 327/399 (81%), Gaps = 3/399 (0%)

Query: 3   KKLTWKSITLSCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGS 62
           +K TW+S+  SC+K +    +   + V KQTSFQR+ +SD+SNPS+   ++DLS S+ GS
Sbjct: 4   EKTTWRSMVSSCFKPNEISPSKPKKIVTKQTSFQRISMSDLSNPST--LSEDLSISLAGS 61

Query: 63  KLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
            LHVFTL EL++IT NF+ SN LGEGGFGPV+KGF+D+KL+PGL+AQPVAVK LDLDG+Q
Sbjct: 62  NLHVFTLPELKVITQNFAASNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLDGSQ 121

Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
           GH+EW+AE+IFLGQLRHPHLVKLIGYC EEE+RLLVYEYMPRGSL NQLFR YS +LPWS
Sbjct: 122 GHREWLAEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPWS 181

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
            R KIA+GAAKGLAFLH  +KPVIYRDFKASNILLDSDYT KLSDFGLAKDGPEG +THV
Sbjct: 182 ARTKIAVGAAKGLAFLHESEKPVIYRDFKASNILLDSDYTPKLSDFGLAKDGPEGSDTHV 241

Query: 243 ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR 302
            TRVMGTQGYAAPEY+MTGHLT+ SDVYSFGVVLLELLTG+R++D +R  REQ+L EWAR
Sbjct: 242 STRVMGTQGYAAPEYIMTGHLTSRSDVYSFGVVLLELLTGRRSVDKSRPQREQNLVEWAR 301

Query: 303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF 362
           P+L +PRKL R++DPRLEGQ+   GA+KAA  A++CLSH P+HRPTMS VV  LD L+DF
Sbjct: 302 PMLNDPRKLGRIMDPRLEGQYSETGARKAAELAYQCLSHRPKHRPTMSIVVNTLDPLKDF 361

Query: 363 QDSFVGPFVYVVPNETESSVYLRNGKETNSEEESGEKNG 401
           +D  +GPFVY VP E       +   ET  +E   EKNG
Sbjct: 362 EDVPIGPFVYTVPTENLKEDDNKEC-ETKRDETKKEKNG 399

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255550441|ref|XP_002516271.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223544757|gb|EEF46273.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  568 bits (1464), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 272/379 (71%), Positives = 316/379 (83%), Gaps = 4/379 (1%)

Query: 4   KLTWKSITLSCYKSSMPES--NTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIG 61
           K  W S+  SC+K    +       ++V KQTSF RL LSD+SNPSS   ++DLS S+ G
Sbjct: 5   KAKWISMVSSCFKPLEQKRALKAPKKEVTKQTSFTRLSLSDLSNPSS--LSEDLSISLAG 62

Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S LHVFTLAEL++IT NFS SN LGEGGFGPV+KGF+D+KL+PGL+AQPVAVK LDLDG 
Sbjct: 63  SNLHVFTLAELKVITQNFSSSNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLDGL 122

Query: 122 QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
           QGH+EW+ E+IFLGQLRHPHLVKLIGYC EEE+RLLVYEYMPRGSL NQLFR YS +LPW
Sbjct: 123 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEEEHRLLVYEYMPRGSLENQLFRRYSVSLPW 182

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
           STRMKIALGAAKGLAFLH  +K VIYRDFKASNILLDSDY AKLSDFGLAKDGP+G +TH
Sbjct: 183 STRMKIALGAAKGLAFLHESEKSVIYRDFKASNILLDSDYNAKLSDFGLAKDGPQGSDTH 242

Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA 301
           V TRVMGTQGYAAPEY+MTGHLT MSDVYSFGVVLLELLTG+R++D +R  REQ LAEWA
Sbjct: 243 VSTRVMGTQGYAAPEYIMTGHLTAMSDVYSFGVVLLELLTGRRSVDKSRPQREQKLAEWA 302

Query: 302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
           RP+L +PRKL R++DPRLEGQ+   GA+KAAA A+ CLSH P+ RP MS VV+ L+S +D
Sbjct: 303 RPMLNDPRKLGRIMDPRLEGQYSETGARKAAALAYLCLSHRPKQRPIMSIVVKTLESFKD 362

Query: 362 FQDSFVGPFVYVVPNETES 380
           F+D  VGPFVY VP E+++
Sbjct: 363 FEDIPVGPFVYTVPTESDN 381

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552460|ref|XP_003544585.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  567 bits (1462), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 274/380 (72%), Positives = 319/380 (83%), Gaps = 7/380 (1%)

Query: 3   KKLTWKSITL--SCYK--SSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNS 58
           K+ TWKS+ L  SCYK   S+ ES    +QV KQ SFQRLCLSDVSN SS  + +D+S S
Sbjct: 7   KRNTWKSVILILSCYKVKCSLEESE---KQVLKQGSFQRLCLSDVSNSSSTQAIEDISIS 63

Query: 59  VIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL 118
             GSKL+ FTL ELR  T++FS SN+LGEGGFGPVYKGF+D+KL+ GL+AQ +AVK LDL
Sbjct: 64  FAGSKLYAFTLEELREATNSFSWSNMLGEGGFGPVYKGFLDDKLRSGLKAQTIAVKRLDL 123

Query: 119 DGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
           DG QGH+EW+AEIIFLGQLRHPHLVKLIGYC+E+E+RLL+YEYMPRGSL NQLFR YSAA
Sbjct: 124 DGLQGHREWLAEIIFLGQLRHPHLVKLIGYCYEDEHRLLMYEYMPRGSLENQLFRKYSAA 183

Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
           +PWSTRMKIALGAAKGL FLH  DKPVIYRDFKASNILLDSD+TAKLSDFGLAKDGPEGE
Sbjct: 184 MPWSTRMKIALGAAKGLTFLHEADKPVIYRDFKASNILLDSDFTAKLSDFGLAKDGPEGE 243

Query: 239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA 298
           +THV TR+MGTQGYAAPEY+MTGHLTT SDVYS+GVVLLELLTG+R +D ++    +SL 
Sbjct: 244 DTHVTTRIMGTQGYAAPEYIMTGHLTTKSDVYSYGVVLLELLTGRRVVDKSQSNGRKSLV 303

Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
           EWARPLL++ +K+  +ID RLEGQFP+KGA K A  AFKCLSHHP  RP+MS VV+VL+ 
Sbjct: 304 EWARPLLRDQKKVYSIIDRRLEGQFPMKGAMKVAMLAFKCLSHHPNARPSMSDVVKVLEP 363

Query: 359 LQDFQDSFVGPFVYVVPNET 378
           LQD+ D F+GPFVYV  +E 
Sbjct: 364 LQDYDDVFIGPFVYVAVSEN 383

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356518179|ref|XP_003527759.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  561 bits (1445), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 277/376 (73%), Positives = 311/376 (82%), Gaps = 12/376 (3%)

Query: 3   KKLTWKSITL--SCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSV- 59
           KK+TWKSI L  SC K       T+ +QV KQ SFQRLCLSD+S PSSP + +DLS S+ 
Sbjct: 4   KKITWKSIVLILSCNK-------TSEKQVLKQGSFQRLCLSDISIPSSPQAIEDLSISIS 56

Query: 60  -IGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL 118
            +G KLH FTL ELR  T NFS SN LGEGGFGPVYKGFVD+KL+PGL+AQP+AVK LDL
Sbjct: 57  LVGPKLHTFTLDELREATHNFSWSNFLGEGGFGPVYKGFVDDKLRPGLKAQPLAVKQLDL 116

Query: 119 DGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
           DG QGH+EW+AEIIFLGQLRHPHLVKLIGYC E+E+RLLVYEYM RGSL NQL R YSAA
Sbjct: 117 DGLQGHREWLAEIIFLGQLRHPHLVKLIGYCCEDEHRLLVYEYMARGSLENQLHRRYSAA 176

Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
           LPWSTRMKIALGAAKGLAFLH  DKPVIYRDFK SNILLDSDYTAKLSD GLAKDGPEGE
Sbjct: 177 LPWSTRMKIALGAAKGLAFLHEADKPVIYRDFKTSNILLDSDYTAKLSDLGLAKDGPEGE 236

Query: 239 ETHVITR-VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
            THV T  +MGT+GYAAPEY+M+GHL+T SDVYS+GVVLLELLTG+R +D     REQSL
Sbjct: 237 ATHVTTTCIMGTRGYAAPEYIMSGHLSTKSDVYSYGVVLLELLTGRRVVDKCGSNREQSL 296

Query: 298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
            EWARPLL++ RKL  +IDPRLEGQFP+KGA K AA  +KCLS HP  RP+MS VV++L+
Sbjct: 297 VEWARPLLRDQRKLHHIIDPRLEGQFPMKGALKVAALTYKCLSRHPNPRPSMSDVVKILE 356

Query: 358 SLQDFQDSFVGPFVYV 373
           SLQDF D  +GPFVYV
Sbjct: 357 SLQDFDDVIIGPFVYV 372

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225444724|ref|XP_002277991.1| PREDICTED: serine/threonine-protein kinase At5g01020 [Vitis vinifera] gi|297738561|emb|CBI27806.3| unnamed protein product [Vitis vinifera]

 Score =  556 bits (1434), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 270/378 (71%), Positives = 318/378 (84%), Gaps = 2/378 (0%)

Query: 3   KKLTWKSITLSCYKS-SMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIG 61
           KK+TW+S+  +CY S  M         V KQTSFQR+ +SD+SNP S LS +DLS S++G
Sbjct: 4   KKITWRSVFPACYGSEKMASKRRKAAVVAKQTSFQRISISDLSNPGSTLS-EDLSTSLMG 62

Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S LHVFTL EL++I  NFS +N +GEGGFGPV+KGF+D+KL+PGL+AQPVAVK LDL+G 
Sbjct: 63  SNLHVFTLTELKVICQNFSSNNFIGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLEGL 122

Query: 122 QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
           QGH+EW+ E+IFLGQLRHPHLVKLIGYC E+E+RLLVYEYMPRGSL NQLFR YS +LPW
Sbjct: 123 QGHREWLTEVIFLGQLRHPHLVKLIGYCCEDEHRLLVYEYMPRGSLENQLFRRYSVSLPW 182

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
           STRMKIALGAAKGLAFLH  +KPVIYRDFKASNILLDSD+T KLSDFGLAKDGPEG++TH
Sbjct: 183 STRMKIALGAAKGLAFLHEAEKPVIYRDFKASNILLDSDHTPKLSDFGLAKDGPEGDDTH 242

Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA 301
           V TRVMGTQGYAAPEY+MTGHLT MSDVYSFGVVLLELLTG+R++D TR  REQ+LAEWA
Sbjct: 243 VSTRVMGTQGYAAPEYIMTGHLTAMSDVYSFGVVLLELLTGRRSVDKTRPNREQNLAEWA 302

Query: 302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
           RP L + RKL R++DPRLEGQ+   GAQ AAA A++CLSH P+HRPTMS VV+ L+ LQD
Sbjct: 303 RPQLNDSRKLARIMDPRLEGQYSEAGAQSAAALAYQCLSHRPKHRPTMSTVVKTLEPLQD 362

Query: 362 FQDSFVGPFVYVVPNETE 379
           + +  VG FVY VP+E +
Sbjct: 363 YNEIPVGTFVYTVPSEND 380

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357437255|ref|XP_003588903.1| Protein kinase 2B [Medicago truncatula] gi|355477951|gb|AES59154.1| Protein kinase 2B [Medicago truncatula]

 Score =  555 bits (1429), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 278/378 (73%), Positives = 314/378 (83%), Gaps = 4/378 (1%)

Query: 3   KKLTWKS--ITLSCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVI 60
           KK+TWKS  + L+CYKS  P   +  + V KQ S QRLCLSD+SN SS  + +DLS S  
Sbjct: 5   KKITWKSMILILNCYKSKYPLEESE-KHVLKQGSLQRLCLSDISNSSSSQAIEDLSVSFA 63

Query: 61  GSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG 120
           GSKLH FTL EL+  T NFS SN+LGEGGFGPVYKGFVD+KL+ GL+AQ VAVK LDLDG
Sbjct: 64  GSKLHAFTLEELKEATHNFSWSNMLGEGGFGPVYKGFVDDKLRQGLKAQTVAVKCLDLDG 123

Query: 121 TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP 180
            QGH+EW+AEIIFLGQL HPHLVKLIGYC+E+E+RLLVYEYMPRGSL NQLFR YSA +P
Sbjct: 124 LQGHREWLAEIIFLGQLSHPHLVKLIGYCFEDEHRLLVYEYMPRGSLENQLFRRYSATMP 183

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
           WSTRMKIALGAAKGLAFLH  DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET
Sbjct: 184 WSTRMKIALGAAKGLAFLHEADKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 243

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAE 299
           HV TRVMGT GYAAPEY+MTGHLTT SDVYS+GVVLLELLTG+R +D ++   R ++L E
Sbjct: 244 HVTTRVMGTHGYAAPEYIMTGHLTTKSDVYSYGVVLLELLTGRRVVDKSSESSRGKNLVE 303

Query: 300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           WARP+L++ +KL R+ID RLEGQ+P KGA K A  AFKCLSHHP  RP MS VV+VL+ L
Sbjct: 304 WARPMLRDQKKLHRIIDRRLEGQYPTKGALKVAMLAFKCLSHHPNPRPFMSDVVKVLEPL 363

Query: 360 QDFQDSFVGPFVYVVPNE 377
           QDF D F+GPFVYV  NE
Sbjct: 364 QDFDDVFIGPFVYVAVNE 381

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356509845|ref|XP_003523655.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  551 bits (1420), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 272/376 (72%), Positives = 310/376 (82%), Gaps = 6/376 (1%)

Query: 3   KKLTWKSITL--SCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSV- 59
           KK+TWKSI L  SCYK+       + +QV KQ SFQRLCLSD+S PSSP + +DLS S+ 
Sbjct: 4   KKITWKSIVLILSCYKTQC-HLQDSEKQVLKQGSFQRLCLSDISIPSSPQAIEDLSISIS 62

Query: 60  -IGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL 118
            +G KL+ F L ELR  T NFS +N LGEGGFGPVYKGFVD+KL+ GL+AQPVAVK LDL
Sbjct: 63  LVGPKLYTFPLDELREATHNFSWNNFLGEGGFGPVYKGFVDDKLRLGLKAQPVAVKQLDL 122

Query: 119 DGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
           DG QGH+EW+AEIIFLGQLRHPHLVKLIGYC E+E RLLVYEYM RGSL NQL R YSAA
Sbjct: 123 DGLQGHREWLAEIIFLGQLRHPHLVKLIGYCCEDEDRLLVYEYMARGSLENQLHRRYSAA 182

Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
           LPWSTRMKIALGAA+GLAFLH  DKPVIYRDFK SNILLDSDY AKLSD GLAKDGPEGE
Sbjct: 183 LPWSTRMKIALGAARGLAFLHEADKPVIYRDFKTSNILLDSDYIAKLSDLGLAKDGPEGE 242

Query: 239 ETHVITR-VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
           +THV T  +MGT+GYAAPEY+M+GHL+T SDVYS+GVVLLELLTG+R +D  R  RE+SL
Sbjct: 243 DTHVTTTCIMGTRGYAAPEYIMSGHLSTKSDVYSYGVVLLELLTGRRVVDMCRPNRERSL 302

Query: 298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
            EWARPLL++ RKL  +IDPRLEGQFP+KGA K AA  +KCLSHHP  RP+MS VV++L+
Sbjct: 303 VEWARPLLRDQRKLYHIIDPRLEGQFPMKGALKVAALTYKCLSHHPNPRPSMSDVVKILE 362

Query: 358 SLQDFQDSFVGPFVYV 373
           SLQD  D  +GPFVYV
Sbjct: 363 SLQDLDDVIIGPFVYV 378

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	401
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.947	0.822	0.658	7.2e-139
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.897	0.849	0.709	8.5e-136
TAIR|locus:2157101	494	AT5G35580 [Arabidopsis thalian	0.917	0.744	0.628	1.1e-124
TAIR|locus:2030185	450	AT1G72540 [Arabidopsis thalian	0.982	0.875	0.551	3.1e-115
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.817	0.8	0.625	3.4e-109
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.880	0.832	0.578	2.7e-107
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.947	0.770	0.559	4.7e-103
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.877	0.718	0.579	4.4e-100
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.788	0.697	0.619	4.4e-100
TAIR|locus:2060167	442	AT2G07180 [Arabidopsis thalian	0.798	0.723	0.575	8.2e-99

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1359 (483.5 bits), Expect = 7.2e-139, P = 7.2e-139
 Identities = 254/386 (65%), Positives = 315/386 (81%)

Query:     1 MKKKLTWKSITLSCY------KSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADD 54
             +KKK++W+S+ + C        +S  +    N+ + KQ+SFQRL + D+SNPSS   ++D
Sbjct:     3 VKKKVSWRSLIVGCLGDPETLMASSKKPKRKNDVIKKQSSFQRLSILDMSNPSSNTLSED 62

Query:    55 LSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVK 114
             LS S+ GS LHVFTLAEL++IT +FS +N LGEGGFGPV+KGF+D+KL+PGL+AQPVAVK
Sbjct:    63 LSISLAGSDLHVFTLAELKVITQSFSSTNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVK 122

Query:   115 ALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS 174
              LDL+G QGH+EW+ E++FLGQL+H +LVKLIGYC EEE+R LVYE+MPRGSL NQLFR 
Sbjct:   123 LLDLEGLQGHREWLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRR 182

Query:   175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 234
             YSA+LPWSTRMKIA GAA GL FLH  + PVIYRDFKASNILLDSDYTAKLSDFGLAKDG
Sbjct:   183 YSASLPWSTRMKIAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 242

Query:   235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE 294
             PEG++THV TRVMGTQGYAAPEY+MTGHLT  SDVYSFGVVLLELLTG+R++D  R  RE
Sbjct:   243 PEGDDTHVSTRVMGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSSRE 302

Query:   295 QSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
             Q+L +WARP+L +PRKL R++DPRLEGQ+   GA+KAA  A++CLSH P++RP MS VV 
Sbjct:   303 QNLVDWARPMLNDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVS 362

Query:   355 VLDSLQDFQDSFVGPFVYVVPNETES 380
             +L+ L+D+ D  +G F Y VPN  ++
Sbjct:   363 ILNDLKDYNDIPMGTFTYTVPNTPDN 388

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1330 (473.2 bits), Expect = 8.5e-136, P = 8.5e-136
 Identities = 259/365 (70%), Positives = 303/365 (83%)

Query:     2 KKKLTWKSITLSCYKSSMPESNTNNEQ-VDK-QT--SFQRLCLSDVSNPSSPLSA-DDLS 56
             KKK +  S+ L CYK+         E+ V K +T  +F+RL LSD+S+PSSP+S  DDLS
Sbjct:     6 KKKTSLTSLFLGCYKAKNASKYEGGEKAVMKIRTCPAFKRLSLSDISDPSSPMSVMDDLS 65

Query:    57 NSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL 116
             +S    KL +FTL+ELR+IT NFSRSN+LGEGGFGPVYKGF+D+K+KPG+EAQPVAVKAL
Sbjct:    66 HSFTSQKLRLFTLSELRVITHNFSRSNMLGEGGFGPVYKGFIDDKVKPGIEAQPVAVKAL 125

Query:   117 DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS 176
             DL G QGH+EW+AEI+FLGQL + HLVKLIG+C EEE R+LVYEYMPRGSL NQLFR  S
Sbjct:   126 DLHGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEEEQRVLVYEYMPRGSLENQLFRRNS 185

Query:   177 AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 236
              A+ W  RMKIALGAAKGLAFLH  +KPVIYRDFK SNILLDSDY AKLSDFGLAKDGPE
Sbjct:   186 LAMAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKTSNILLDSDYNAKLSDFGLAKDGPE 245

Query:   237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS 296
             GE THV TRVMGTQGYAAPEY+MTGHLTTM+DVYSFGVVLLEL+TGKR+MDNTR  REQS
Sbjct:   246 GEHTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLLELITGKRSMDNTRTRREQS 305

Query:   297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
             L EWARP+L++ RKLER+IDPRL  Q   + AQ AA+ A+KCLS HP++RPTM  VV+VL
Sbjct:   306 LVEWARPMLRDQRKLERIIDPRLANQHKTEAAQVAASLAYKCLSQHPKYRPTMCEVVKVL 365

Query:   357 DSLQD 361
             +S+Q+
Sbjct:   366 ESIQE 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2157101 AT5G35580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1225 (436.3 bits), Expect = 1.1e-124, P = 1.1e-124
 Identities = 232/369 (62%), Positives = 289/369 (78%)

Query:    15 YKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRL 74
             Y     + +     + KQ SF  L + D+SNPSS   ++DLS S+ GS LHVFT AELR+
Sbjct:    12 YSPKKTKKDDGERVITKQKSFLGLSILDISNPSSTTLSEDLSISLAGSDLHVFTQAELRV 71

Query:    75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
             IT +FS SN LGEGGFGPV+KGF+D+KL+PGL+AQPVAVK LDLDG QGH+E+M E++ L
Sbjct:    72 ITQSFSSSNFLGEGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLDGLQGHREFMTEVMCL 131

Query:   135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
             G+L+HP+LVKLIGYC EE +RLLVYE+MPRGSL +QLFR  S  LPW+TR+ IA  AAKG
Sbjct:   132 GKLKHPNLVKLIGYCCEEAHRLLVYEFMPRGSLESQLFRRCSLPLPWTTRLNIAYEAAKG 191

Query:   195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
             L FLH  +KP+IYRDFKASNILLDSDYTAKLSDFGLAKDGP+G++THV TRVMGTQGYAA
Sbjct:   192 LQFLHEAEKPIIYRDFKASNILLDSDYTAKLSDFGLAKDGPQGDDTHVSTRVMGTQGYAA 251

Query:   255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
             PEY+MTGHLT  SDVYSFGVVLLELLTG++++D  R  R+++L EWARP+L + RKL R+
Sbjct:   252 PEYIMTGHLTAKSDVYSFGVVLLELLTGRKSVDIARSSRKETLVEWARPMLNDARKLGRI 311

Query:   315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF-VGPFVYV 373
             +DPRLE Q+   GA+KAA  A++CL + P+ RP +S VV VL  ++D++D   +G F Y 
Sbjct:   312 MDPRLEDQYSETGARKAATLAYQCLRYRPKTRPDISTVVSVLQDIKDYKDDIPIGIFTYT 371

Query:   374 VPNETESSV 382
             VP +    V
Sbjct:   372 VPTKPRREV 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2030185 AT1G72540 [Arabidopsis thaliana (taxid:3702)]

 Score = 1136 (405.0 bits), Expect = 3.1e-115, P = 3.1e-115
 Identities = 225/408 (55%), Positives = 298/408 (73%)

Query:     4 KLTWKSITL--SCYKSS-MPESNTNNEQVDK------QTSF-QRLCLSDVSNPSSPLSAD 53
             + +WK+I L  SC  ++   ++ T N   +K      QTS   R+ +SD SN  S +S +
Sbjct:     2 RFSWKNICLPISCINNTNQKKTTTTNPPKEKLLLLSRQTSVPSRVYMSDFSN--STISLN 59

Query:    54 DLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAV 113
             D SNS     +H+FT  EL+ IT  FS+ N LGEGGFG VYKGFVD+ LK GL+ QPVAV
Sbjct:    60 DFSNSFF-INIHIFTYEELKTITQGFSKYNFLGEGGFGEVYKGFVDDSLKTGLKDQPVAV 118

Query:   114 KALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR 173
             KAL  +G QGH+EW+AE+I LGQL+HPHLV L+GYC E++ RLLVYEYM RG+L + LF+
Sbjct:   119 KALKREGGQGHREWLAEVIILGQLKHPHLVNLVGYCCEDDERLLVYEYMERGNLEDHLFQ 178

Query:   174 SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 233
              Y  ALPW TR+KI LGAAKGL FLH ++KPVIYRDFK SNILL SD+++KLSDFGLA D
Sbjct:   179 KYGGALPWLTRVKILLGAAKGLEFLHKQEKPVIYRDFKPSNILLSSDFSSKLSDFGLATD 238

Query:   234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR 293
             G E E+++    VMGT+GYAAPEY+  G+LTTMSDV+SFGVVLLE+LT ++A++  R  R
Sbjct:   239 GSEEEDSNFTKSVMGTEGYAAPEYISAGNLTTMSDVFSFGVVLLEMLTARKAVEKYRAQR 298

Query:   294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
              ++L EWARP+LK+P KLER+IDP LEG++ ++G +KAAA A++CLSH+P+ RPTM+ VV
Sbjct:   299 GRNLVEWARPMLKDPNKLERIIDPSLEGKYSVEGIRKAAALAYQCLSHNPKSRPTMTTVV 358

Query:   354 RVLDSLQDFQDSFVGPFVYVVPNETESSVY-LRNGKETNSEEESGEKN 400
             + L+ + D +D   GPFVY+VP    S V+ ++   +    +E  EK+
Sbjct:   359 KTLEPILDLKDIQNGPFVYIVPVAGVSEVHEIKCKDDVKVVKEETEKD 406

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1079 (384.9 bits), Expect = 3.4e-109, P = 3.4e-109
 Identities = 205/328 (62%), Positives = 257/328 (78%)

Query:    40 LSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVD 99
             +SD+S+PS+P   DD    +  +++  FTL EL  IT +F    +LGEGGFG VYKG++D
Sbjct:    30 VSDLSDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYID 89

Query:   100 EKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVY 159
             + L+ GL++ PVAVK L+ +G QGH+EW+ E+ FLGQLRHP+LVKLIGYC E+++RLLVY
Sbjct:    90 DNLRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY 149

Query:   160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS 219
             E+M RGSL N LFR  +A L WS RM IALGAAKGLAFLH  ++PVIYRDFK SNILLDS
Sbjct:   150 EFMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDS 209

Query:   220 DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLEL 279
             DYTAKLSDFGLAK GP+G+ETHV TRVMGT GYAAPEYVMTGHLT  SDVYSFGVVLLE+
Sbjct:   210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEM 269

Query:   280 LTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCL 339
             LTG++++D TR  +EQ+L +WARP L + RKL ++IDPRLE Q+ ++ AQKA + A+ CL
Sbjct:   270 LTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCL 329

Query:   340 SHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
             S +P+ RP MS VV  L+ LQ   D+ +
Sbjct:   330 SQNPKARPLMSDVVETLEPLQCTGDALI 357

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
 Identities = 206/356 (57%), Positives = 270/356 (75%)

Query:    12 LSCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAE 71
             LS  + S  E + N+  +    SF+RL  +D+S  SS    +DL+ + +G+ L  F + E
Sbjct:    35 LSRCRPSRSEFSKNH--LGPLPSFRRLSFADLSRSSSARINEDLAQT-LGADLVDFQMCE 91

Query:    72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI 131
             L++IT +FS + LLGEGGFG VYKG+VD+ L+  L+AQPVAVK LD++G QGH+EW++E+
Sbjct:    92 LKMITQSFSGNYLLGEGGFGKVYKGYVDDYLRQSLKAQPVAVKLLDIEGLQGHREWLSEV 151

Query:   132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             IFLGQL+HP+LVKLIGYC EEE R+L+YE+MPRGSL N LFR  S +LPW+TR+KIA+ A
Sbjct:   152 IFLGQLKHPNLVKLIGYCCEEEERVLIYEFMPRGSLENHLFRRISLSLPWATRLKIAVAA 211

Query:   192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             AKGLAFLH  + P+IYRDFK SNILLDSD+TAKLSDFGLAK GPEG ++HV TRVMGT G
Sbjct:   212 AKGLAFLHDLESPIIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSKSHVTTRVMGTYG 271

Query:   252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL 311
             YAAPEYV TGHLTT SDVYS+GVVLLELLTG+RA + +R   +Q++ +W++P L   R+L
Sbjct:   272 YAAPEYVSTGHLTTKSDVYSYGVVLLELLTGRRATEKSRPKNQQNIIDWSKPYLTSSRRL 331

Query:   312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
               ++DPRL GQ+ +K A+  A  A +C+S +P+ RP M  VV  L+SL  ++D  V
Sbjct:   332 RCVMDPRLAGQYSVKAAKDTALLALQCVSPNPKDRPKMLAVVEALESLIHYKDMAV 387

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1021 (364.5 bits), Expect = 4.7e-103, P = 4.7e-103
 Identities = 221/395 (55%), Positives = 268/395 (67%)

Query:    13 SCYKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSV-IGSKLHVFTLAE 71
             +C  ++M ES + NE+ + Q   Q    +  SN  S  S   +S  + I S L  FT  +
Sbjct:    76 NCTVTTM-ESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFND 134

Query:    72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEK----LKPGLEAQPVAVKALDLDGTQGHKEW 127
             L+L T NF   +LLGEGGFG V+KG+++E     +KPG     VAVK L+ DG QGHKEW
Sbjct:   135 LKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT-GLTVAVKTLNPDGLQGHKEW 193

Query:   128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
             +AEI FLG L HP+LVKL+GYC E++ RLLVYE+MPRGSL N LFR  S  LPWS RMKI
Sbjct:   194 LAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKI 252

Query:   188 ALGAAKGLAFLHGED-KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             ALGAAKGL+FLH E  KPVIYRDFK SNILLD+DY AKLSDFGLAKD P+  +THV TRV
Sbjct:   253 ALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRV 312

Query:   247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
             MGT GYAAPEYVMTGHLT+ SDVYSFGVVLLE+LTG+R+MD  R   E +L EWARP L 
Sbjct:   313 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLL 372

Query:   307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
             + R+  RL+DPRLEG F IKGAQK    A +CLS  P+ RP MS VV  L  L   +D  
Sbjct:   373 DKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMA 432

Query:   367 VGPFVYVVPNETESSVYLRNGKETNSEEESGEKNG 401
                + +    +T  +  L+NG  +   +  G +NG
Sbjct:   433 SSSYYF----QTMQAERLKNG--SGRSQGFGSRNG 461

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
 Identities = 211/364 (57%), Positives = 252/364 (69%)

Query:    44 SNPSSPLSADDLSNSV-IGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEK- 101
             SN  S LS   +S  + I S L  F+  +L+L T NF   +LLGEGGFG V+KG+V+E  
Sbjct:   100 SNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 159

Query:   102 ---LKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV 158
                +KPG     VAVK L+ DG QGHKEW+AEI +LG L HP+LVKL+GYC E++ RLLV
Sbjct:   160 TAPVKPGT-GLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLV 218

Query:   159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED-KPVIYRDFKASNILL 217
             YE+MPRGSL N LFR  S  LPWS RMKIALGAAKGL+FLH E  KPVIYRDFK SNILL
Sbjct:   219 YEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILL 277

Query:   218 DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLL 277
             D +Y AKLSDFGLAKD P+  +THV TRVMGT GYAAPEYVMTGHLT+ SDVYSFGVVLL
Sbjct:   278 DGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 337

Query:   278 ELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFK 337
             E+LTG+R+MD  R   E +L EWARP L + R+  RL+DPRLEG F +KGAQK    A +
Sbjct:   338 EMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQ 397

Query:   338 CLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPNETESSVYLRNGKETNSEEESG 397
             CLS   + RP MS VV VL  L   +D     + +    +T  +  L+ G  + S    G
Sbjct:   398 CLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYF----QTMQAERLKAGSGSGSGRGFG 453

Query:   398 EKNG 401
              +NG
Sbjct:   454 SRNG 457

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 993 (354.6 bits), Expect = 4.4e-100, P = 4.4e-100
 Identities = 202/326 (61%), Positives = 242/326 (74%)

Query:    44 SNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEK-- 101
             S  S+PL + +L  S   SKL +F   +L+L T NF   +LLGEGGFG V+KG+++E   
Sbjct:    71 SGSSTPLMSGELKYS---SKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGT 127

Query:   102 --LKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVY 159
               +KPG     VAVK L+ DG QGHKEW+AEI FLG L HP LVKL+GYC EE+ RLLVY
Sbjct:   128 APVKPGT-GLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVY 186

Query:   160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE-DKPVIYRDFKASNILLD 218
             E+MPRGSL N LFR  +  LPWS RMKIALGAAKGLAFLH E +KPVIYRDFK SNILLD
Sbjct:   187 EFMPRGSLENHLFRR-TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 245

Query:   219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLE 278
              +Y AKLSDFGLAKD P+ +++HV TRVMGT GYAAPEYVMTGHLTT SDVYSFGVVLLE
Sbjct:   246 GEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLE 305

Query:   279 LLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKC 338
             +LTG+R++D +R   EQ+L EW RP L + ++  RL+DPRLEG + IKGAQKA   A +C
Sbjct:   306 ILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQC 365

Query:   339 LSHHPRHRPTMSYVVRVLDSLQDFQD 364
             L+   + RP MS VV  L  L + +D
Sbjct:   366 LNRDSKARPKMSEVVEALKPLPNLKD 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)]

 Score = 981 (350.4 bits), Expect = 8.2e-99, P = 8.2e-99
 Identities = 184/320 (57%), Positives = 237/320 (74%)

Query:    46 PSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPG 105
             P +P +  DL ++     + +FT  E+++ T  F    +LGEGGFG VYKG +DE ++ G
Sbjct:    57 PLAPKNIKDLQSNPGYENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVRVG 116

Query:   106 LEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRG 165
              ++  VA+K L+ +G QG +EW+AE+ +LGQL HP+LVKLIGYC E+++RLLVYEYM  G
Sbjct:   117 FKSTKVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAMG 176

Query:   166 SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL 225
             SL   LFR     L W+ RMKIAL AAKGLAFLHG ++ +IYRD K +NILLD  Y AKL
Sbjct:   177 SLEKHLFRRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNAKL 236

Query:   226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA 285
             SDFGLAKDGP G++THV TRVMGT GYAAPEYVMTGHLT+ SDVY FGV+LLE+L GKRA
Sbjct:   237 SDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKRA 296

Query:   286 MDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH 345
             MD +R  RE +L EWARPLL   +KL R+IDPR++GQ+  K   K A  A++CLS +P+ 
Sbjct:   297 MDKSRACREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPKG 356

Query:   346 RPTMSYVVRVLDSLQDFQDS 365
             RP M++VV VL++L+D  D+
Sbjct:   357 RPLMNHVVEVLETLKDDGDA 376

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	401
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-57
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-56
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-53
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-38
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-37
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-34
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-33
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-32
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-32
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-30
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-29
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-29
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-28
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-28
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-28
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-26
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-26
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-25
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	6e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-24
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-24
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-20
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-20
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	8e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-18
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-18
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-17
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-17
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-16
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-15
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	8e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-14
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-13
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-13
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-13
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	9e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-11
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	9e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  188 bits (480), Expect = 2e-57
 Identities = 94/280 (33%), Positives = 136/280 (48%), Gaps = 37/280 (13%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG VYKG +  K K G +   VAVK L  D + Q  +E++ E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGKL--KGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           KL+G C EEE   +V EYM  G L + L R     L  S  +  AL  A+G+ +L    K
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE--SK 121

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG---YAAPEYVMT 260
             I+RD  A N L+  +   K+SDFGL++D  + +      R  G +    + APE +  
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD----YYRKRGGKLPIRWMAPESLKE 177

Query: 261 GHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLAEWARPLLKEPRKLERLID 316
           G  T+ SDV+SFGV+L E+ T G++    M N  +             LK   +L +   
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV----------LEYLKNGYRLPQ--- 224

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
                  P     +      +C +  P  RPT S +V +L
Sbjct: 225 -------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  183 bits (468), Expect = 9e-56
 Identities = 94/282 (33%), Positives = 137/282 (48%), Gaps = 40/282 (14%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG VYKG +  K K   +   VAVK L  D + Q  +E++ E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGTL--KGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           KL+G C EEE  ++V EYMP G L + L ++    L  S  +  AL  A+G+ +L    K
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SK 122

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT-----RVMGTQGYAAPEYV 258
             I+RD  A N L+  +   K+SDFGL++D  + +   V       R M      APE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM------APESL 176

Query: 259 MTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLAEWARPLLKEPRKLERL 314
             G  T+ SDV+SFGV+L E+ T G+     M N  +             LK+  +L + 
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV----------LEYLKKGYRLPK- 225

Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
                    P     +      +C +  P  RPT S +V +L
Sbjct: 226 ---------PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  176 bits (450), Expect = 4e-53
 Identities = 87/292 (29%), Positives = 127/292 (43%), Gaps = 47/292 (16%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPH 141
             LGEG FG VYKG +  K     E   VAVK L  D + +  K+++ E   + +L HP+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTE---VAVKTLKEDASEEERKDFLKEARVMKKLGHPN 57

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLH-------NQLFRSYSAALPWSTRMKIALGAAKG 194
           +V+L+G C EEE   LV EYM  G L                + L     +  A+  AKG
Sbjct: 58  VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--- 251
           + +L    K  ++RD  A N L+  D   K+SDFGL++D  + +          T G   
Sbjct: 118 MEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKKTGGKLP 170

Query: 252 --YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GK---RAMDNTRLGREQSLAEWARPLL 305
             + APE +  G  T+ SDV+SFGV+L E+ T G      + N  +             L
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV----------LEYL 220

Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
           ++  +L +          P     +       C    P  RPT S +V  L+
Sbjct: 221 RKGYRLPK----------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  175 bits (446), Expect = 2e-52
 Identities = 88/292 (30%), Positives = 129/292 (44%), Gaps = 60/292 (20%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG VYKG +  K         VAVK L    + +  +E++ E   + +L HP++V
Sbjct: 7   LGEGAFGEVYKGTL--KGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +L+G C + E   +V EYMP G L + L R +   L     +++AL  AKG+ +L    K
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE--SK 121

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA-----APEYV 258
             ++RD  A N L+  +   K+SDFGL++D  E +            G       APE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGGGKLPIKWMAPESL 176

Query: 259 MTGHLTTMSDVYSFGVVLLELLTG--------------KRAMDNTRLGREQSLAEWARPL 304
             G  T+ SDV+SFGV+L E+ T               +   D  RL          RP 
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRL---------PRPE 227

Query: 305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
              P +L  L+                     +C ++ P  RPT S +V  L
Sbjct: 228 NC-PDELYELML--------------------QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  168 bits (428), Expect = 2e-50
 Identities = 72/198 (36%), Positives = 103/198 (52%), Gaps = 14/198 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPHLV 143
           LGEGGFG VY     +        + VA+K +  + +    E  + EI  L +L HP++V
Sbjct: 1   LGEGGFGTVYLARDKK------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           KL G   +E +  LV EY   GSL   L +     L     ++I L   +GL +LH    
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLK-DLLKENEGKLSEDEILRILLQILEGLEYLH--SN 111

Query: 204 PVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-TG 261
            +I+RD K  NILLDSD    KL+DFGL+K     +       ++GT  Y APE ++  G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKG 169

Query: 262 HLTTMSDVYSFGVVLLEL 279
           + +  SD++S GV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  152 bits (387), Expect = 7e-44
 Identities = 72/202 (35%), Positives = 99/202 (49%), Gaps = 14/202 (6%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPH 141
             LGEG FG VY        K G   + VA+K +     +  +E  + EI  L +L+HP+
Sbjct: 5   EKLGEGSFGKVYLA---RDKKTG---KLVAIKVIKKKKIKKDRERILREIKILKKLKHPN 58

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           +V+L     +E+   LV EY   G L + L +     L               L +LH  
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILSALEYLH-- 114

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG 261
            K +++RD K  NILLD D   KL+DFGLA+    GE+    T V GT  Y APE ++  
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYMAPEVLLGK 171

Query: 262 HLTTMSDVYSFGVVLLELLTGK 283
                 D++S GV+L ELLTGK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  147 bits (373), Expect = 8e-42
 Identities = 88/275 (32%), Positives = 123/275 (44%), Gaps = 32/275 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           LG G FG VYK    +        + VAVK L       +  +    EI  L +L HP++
Sbjct: 7   LGSGSFGTVYKA-KHKG-----TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V+LI    ++++  LV EY   G L + L R     L      KIAL   +GL +LH   
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLH--S 116

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE-GEETHVITRVMGTQGYAAPEYVMTG 261
             +I+RD K  NILLD +   K++DFGLAK   +            GT  Y APE ++ G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV---GTPWYMAPEVLLGG 173

Query: 262 -HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
                  DV+S GV+L ELLTGK                    +L + + + R++ P LE
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPLE 220

Query: 321 GQFPIKGAQKAAATAF--KCLSHHPRHRPTMSYVV 353
              P   +    A     KCL+  P  RPT   ++
Sbjct: 221 FDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (348), Expect = 4e-38
 Identities = 65/206 (31%), Positives = 104/206 (50%), Gaps = 14/206 (6%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           F     +G+GGFG VYK             + VA+K + L+  +  ++ + EI  L + +
Sbjct: 2   FEILEKIGKGGFGEVYKARHKR------TGKEVAIKVIKLESKEKKEKIINEIQILKKCK 55

Query: 139 HPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           HP++VK  G  + ++  L +V E+   GSL   L +S +  L  S    +     KGL +
Sbjct: 56  HPNIVKYYG-SYLKKDELWIVMEFCSGGSL-KDLLKSTNQTLTESQIAYVCKELLKGLEY 113

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
           LH     +I+RD KA+NILL SD   KL DFGL+    + +  + +   +GT  + APE 
Sbjct: 114 LH--SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEV 168

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGK 283
           +        +D++S G+  +EL  GK
Sbjct: 169 INGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  134 bits (341), Expect = 5e-37
 Identities = 71/222 (31%), Positives = 104/222 (46%), Gaps = 36/222 (16%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA---EIIFL 134
            ++R  LLG G FG VY          G     +AVK+++L G    +E  A   EI  L
Sbjct: 1   EWTRGELLGRGSFGSVYLALD---KDTGEL---MAVKSVELSG-DSEEELEALEREIRIL 53

Query: 135 GQLRHPHLVKLIGYCWEEE--YRLLVYEYMPRGSL----------HNQLFRSYSAALPWS 182
             L+HP++V+  G   +EE     +  EY+  GSL             + R Y       
Sbjct: 54  SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY------- 106

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
           TR  +     +GLA+LH     +++RD K +NIL+DSD   KL+DFG AK   + E    
Sbjct: 107 TRQIL-----EGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159

Query: 243 ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
              V GT  + APE +        +D++S G  ++E+ TGK 
Sbjct: 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 2e-34
 Identities = 72/208 (34%), Positives = 104/208 (50%), Gaps = 14/208 (6%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL--DGTQGHKEWMAEIIFLG 135
           N+   +L+G G FG VYKG     L+ G     VA+K + L     +  K  M EI  L 
Sbjct: 1   NYQLGDLIGRGAFGVVYKGL---NLETG---DFVAIKQISLEKIKEEALKSIMQEIDLLK 54

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
            L+HP++VK IG     +   ++ EY   GSL   + +      P S          +GL
Sbjct: 55  NLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGL 112

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+LH +   VI+RD KA+NIL   D   KL+DFG+A      + +     V+GT  + AP
Sbjct: 113 AYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAP 168

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           E +     +T SD++S G  ++ELLTG 
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  128 bits (323), Expect = 3e-34
 Identities = 71/210 (33%), Positives = 105/210 (50%), Gaps = 13/210 (6%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVD-EKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLG 135
           +      LGEG FG V     D      G +   VAVK+L+  G + H  ++  EI  L 
Sbjct: 5   HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQ---VAVKSLNHSGEEQHRSDFEREIEILR 61

Query: 136 QLRHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
            L H ++VK  G C +   R   L+ EY+P GSL + L + +   +     +  +    K
Sbjct: 62  TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICK 120

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT--RVMGTQG 251
           G+ +L    +  I+RD  A NIL++S+   K+SDFGLAK  PE ++ + +          
Sbjct: 121 GMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           Y APE + T   ++ SDV+SFGV L EL T
Sbjct: 179 Y-APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 2e-33
 Identities = 74/221 (33%), Positives = 111/221 (50%), Gaps = 24/221 (10%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPHL 142
            +G+G FG VYKG     LK   E   VAVK          K  ++ E   L Q  HP++
Sbjct: 2   KIGKGNFGDVYKG----VLKGNTE---VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI 54

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           VKLIG C +++   +V E +P GSL   L R     L     ++++L AA G+ +L  E 
Sbjct: 55  VKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYL--ES 111

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ----GYAAPEYV 258
           K  I+RD  A N L+  +   K+SDFG++++    EE  + T   G +     + APE +
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIKWTAPEAL 167

Query: 259 MTGHLTTMSDVYSFGVVLLELLTGK----RAMDNTRLGREQ 295
             G  T+ SDV+S+G++L E  +        M N +  RE+
Sbjct: 168 NYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-TRER 207

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 2e-32
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 16/202 (7%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            +G+G FG V  G            Q VAVK L  D T     ++AE   +  LRHP+LV
Sbjct: 13  TIGKGEFGDVMLGD--------YRGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLV 63

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +L+G   +     +V EYM +GSL + L     A +  + ++  AL   +G+ +L  E+K
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL--EEK 121

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             ++RD  A N+L+  D  AK+SDFGLAK+  +G+++  +  V  T    APE +     
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP-VKWT----APEALREKKF 176

Query: 264 TTMSDVYSFGVVLLELLTGKRA 285
           +T SDV+SFG++L E+ +  R 
Sbjct: 177 STKSDVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  121 bits (305), Expect = 6e-32
 Identities = 80/217 (36%), Positives = 106/217 (48%), Gaps = 27/217 (12%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPH 141
           N LG G FG VY+G   + L PG     VAVK L    T Q  KE++ E   +    HP+
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIALGAAKGLA 196
           +VKL+G C   E + ++ E M  G L + L      R     L     + I L  AKG  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 197 FLHGEDKPVIYRDFKASNILL-----DSDYTAKLSDFGLAKD-------GPEGEETHVIT 244
           +L  E    I+RD  A N L+     D+D   K+ DFGLA+D         EGE   +  
Sbjct: 121 YL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL-LPV 177

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           R M      APE ++ G  TT SDV+SFGV++ E+LT
Sbjct: 178 RWM------APESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  117 bits (294), Expect = 2e-30
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
             F+    LG G FG V++G    ++        VA+K L  D     +++  E+  L +
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRV-------RVAIKILKSDDLLKQQDFQKEVQALKR 58

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           LRH HL+ L   C   E   ++ E M +GSL   L       LP ++ + +A   A+G+A
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA---KDGPEGEETHVITRVMGTQGYA 253
           +L  E++  I+RD  A NIL+  D   K++DFGLA   K+         I        + 
Sbjct: 119 YL--EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-----PYKWT 171

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLT 281
           APE    G  +T SDV+SFG++L E+ T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  115 bits (289), Expect = 1e-29
 Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 53/299 (17%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW--MAEIIFL 134
           S  +   ++G G FG V +G +     PG +   VA+K L   G+   +    + E   +
Sbjct: 4   SYVTIEKVIGGGEFGEVCRGRL---KLPGKKEIDVAIKTLK-AGSSDKQRLDFLTEASIM 59

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           GQ  HP++++L G   +    +++ EYM  GSL ++  R           + +  G A G
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASG 118

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRVMGTQG- 251
           + +L   +   ++RD  A NIL++S+   K+SDFGL++  +  E   T        T+G 
Sbjct: 119 MKYL--SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT--------TKGG 168

Query: 252 -----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRA---MDNTRLGREQSLAEWAR 302
                + APE +     T+ SDV+SFG+V+ E+++ G+R    M N  +   +++ +  R
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV--IKAVEDGYR 226

Query: 303 --PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
             P +  P  L +L                       C       RPT S +V  LD +
Sbjct: 227 LPPPMDCPSALYQL--------------------MLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  114 bits (286), Expect = 4e-29
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 19/215 (8%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG V+ G     L+P  + + VAVK L +       K++  E   L   +H ++V
Sbjct: 13  LGEGAFGKVFLGEC-YHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS-------------AALPWSTRMKIALG 190
           K  G C E +  ++V+EYM  G L N+  RS+                L  S  ++IA+ 
Sbjct: 72  KFYGVCTEGDPPIMVFEYMEHGDL-NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            A G+ +L  +    ++RD    N L+  D   K+ DFG+++D    +   V    M   
Sbjct: 131 IASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR 284
            +  PE +M    TT SDV+SFGVVL E+ T GK+
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (288), Expect = 7e-29
 Identities = 85/280 (30%), Positives = 125/280 (44%), Gaps = 29/280 (10%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLGQLRHP 140
            LGEG FG VY            + + VA+K L        KE    + EI  L  L HP
Sbjct: 7   KLGEGSFGEVYLA---------RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 141 -HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFL 198
            ++VKL  +  +E    LV EY+  GSL + L        L  S  + I       L +L
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 199 HGEDKPVIYRDFKASNILLDSDYT-AKLSDFGLAK----DGPEGEETHVITRVMGTQGYA 253
           H   K +I+RD K  NILLD D    KL DFGLAK     G       + +  +GT GY 
Sbjct: 118 H--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 254 APEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
           APE ++     + ++ SD++S G+ L ELLTG    +        + ++  + +L+ P  
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPT- 232

Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
               +   L    P   ++ A+    K L+  P++R + S
Sbjct: 233 --PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270

Length = 384

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 2e-28
 Identities = 73/246 (29%), Positives = 113/246 (45%), Gaps = 31/246 (12%)

Query: 64  LHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQ--PVAVKAL-DLDG 120
           L +    EL  I        +LG G FG VYKG       P  E    PVA+K L +   
Sbjct: 1   LRILKETELEKI-------KVLGSGAFGTVYKGV----WIPEGEKVKIPVAIKVLREETS 49

Query: 121 TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL------HNQLFRS 174
            + +KE + E   +  + HPH+V+L+G C   +   L+ + MP G L      H     S
Sbjct: 50  PKANKEILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGS 108

Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 234
               L W  ++      AKG+++L  E+K +++RD  A N+L+ +    K++DFGLAK  
Sbjct: 109 QYL-LNWCVQI------AKGMSYL--EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159

Query: 235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGR 293
              E+ +          + A E ++    T  SDV+S+GV + EL+T G +  +      
Sbjct: 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Query: 294 EQSLAE 299
              L E
Sbjct: 220 IPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 2e-28
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 12/206 (5%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G     +  G     VA+K ++ + +   + E++ E   + +    H+V
Sbjct: 14  LGQGSFGMVYEGLAK-GVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--------FRSYSAALPWSTRMKIALGAAKGL 195
           +L+G     +  L+V E M +G L + L                     +++A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L    K  ++RD  A N ++  D T K+ DFG+ +D  E +      + +    + AP
Sbjct: 133 AYLA--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLT 281
           E +  G  TT SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  110 bits (278), Expect = 3e-28
 Identities = 84/274 (30%), Positives = 121/274 (44%), Gaps = 33/274 (12%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQLRHPHL 142
            LG+G FG V +G   E    G +  PVAVK L  D       +++ E   +  L H +L
Sbjct: 2   KLGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           ++L G        ++V E  P GSL ++L +        ST    A+  A G+ +L  E 
Sbjct: 59  IRLYGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL--ES 115

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ-----GYAAPEY 257
           K  I+RD  A NILL SD   K+ DFGL +  P+ E+ +    VM         + APE 
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY----VMEEHLKVPFAWCAPES 171

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE-PRKLERLID 316
           + T   +  SDV+ FGV L E+ T          G E         +LK+  ++ ERL  
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT---------YGEEPWAGLSGSQILKKIDKEGERLER 222

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
           P           Q       +C +H+P  RPT +
Sbjct: 223 PE-------ACPQDIYNVMLQCWAHNPADRPTFA 249

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  111 bits (278), Expect = 7e-28
 Identities = 70/228 (30%), Positives = 113/228 (49%), Gaps = 25/228 (10%)

Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHK 125
             L+ +R +         LGEG FG VYKG +       L A  VA+K L  +   +  +
Sbjct: 2   IPLSAVRFLEE-------LGEGAFGKVYKGEL-TGPNERLSATSVAIKTLKENAEPKVQQ 53

Query: 126 EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR------------ 173
           E+  E   +  L+HP++V L+G C +E+   +++EY+  G LH  L R            
Sbjct: 54  EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 174 --SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
             +  ++L  S  + IA+  A G+ +L       ++RD  A N L+    T K+SDFGL+
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLEL 279
           +D    +   V ++ +    +  PE ++ G  TT SD++SFGVVL E+
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 8e-27
 Identities = 70/200 (35%), Positives = 101/200 (50%), Gaps = 17/200 (8%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G  +           VAVK L   GT   + ++ E   + +LRH  LV+
Sbjct: 14  LGAGQFGEVWMGTWNGTT-------KVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQ 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L   C EEE   +V EYM +GSL + L       L     + +A   A+G+A+L  E + 
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL--ESRN 123

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMTG 261
            I+RD  A NIL+  +   K++DFGLA+     E+     R  G +    + APE    G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTAR-EGAKFPIKWTAPEAANYG 179

Query: 262 HLTTMSDVYSFGVVLLELLT 281
             T  SDV+SFG++L E++T
Sbjct: 180 RFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 73/211 (34%), Positives = 97/211 (45%), Gaps = 33/211 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM-AEIIFLGQLRHPHLV 143
           LG+G FG V    V +K    L A  V  K   +   +   E    E   L ++ HP +V
Sbjct: 1   LGKGSFGKVLL--VRKKDTGKLYAMKVLKKKKIIK--RKEVEHTLTERNILSRINHPFIV 56

Query: 144 KLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWSTRMKIALGAA 192
           KL  Y ++ E +L LV EY P G L + L +           Y+A        +I L   
Sbjct: 57  KLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA--------EIVLA-- 105

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
             L +LH     +IYRD K  NILLD+D   KL+DFGLAK+              GT  Y
Sbjct: 106 --LEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEY 159

Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            APE ++        D +S GV+L E+LTGK
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  105 bits (263), Expect = 7e-26
 Identities = 89/290 (30%), Positives = 126/290 (43%), Gaps = 35/290 (12%)

Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRH 139
           LGEG FG V    Y    D         + VAVK L  +  Q +   W  EI  L  L H
Sbjct: 12  LGEGHFGKVSLYCYDPANDGT------GEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65

Query: 140 PHLVKLIGYCWE--EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
            ++VK  G C E   +   L+ EY+P GSL + L +     L  +  +  A    +G+A+
Sbjct: 66  ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAY 122

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAP 255
           LH   +  I+RD  A N+LLD+D   K+ DFGLAK  PEG E + + R  G     + A 
Sbjct: 123 LHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV-REDGDSPVFWYAV 179

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLT------GKRAMDNTRLGREQSLAEWARPLLKEPR 309
           E +     +  SDV+SFGV L ELLT               +G +Q        L++   
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT-VVRLIELLE 238

Query: 310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           +  RL  P      P    Q+       C     + RPT   ++ +L  +
Sbjct: 239 RGMRL--PC-----PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 7e-26
 Identities = 83/285 (29%), Positives = 131/285 (45%), Gaps = 58/285 (20%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQL 137
           F+    +G+G FG VYK   D++       Q VA+K +DL+  +   E +  EI FL Q 
Sbjct: 3   FTLLECIGKGSFGEVYKAI-DKRTN-----QVVAIKVIDLEEAEDEIEDIQQEIQFLSQC 56

Query: 138 RHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           R P++ K  G  + +  +L ++ EY   GS  + L +     L  +    I      GL 
Sbjct: 57  RSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLD-LLKPGK--LDETYIAFILREVLLGLE 112

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYA 253
           +LH E K  I+RD KA+NILL  +   KL+DFG++     G+ T  +++    +GT  + 
Sbjct: 113 YLHEEGK--IHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWM 165

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER 313
           APE +        +D++S G+  +EL  G           E  L++        P ++  
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKG-----------EPPLSD------LHPMRVLF 208

Query: 314 LID----PRLEG-QFPIKGAQKAAATAFK-----CLSHHPRHRPT 348
           LI     P LEG +F         +  FK     CL+  P+ RP+
Sbjct: 209 LIPKNNPPSLEGNKF---------SKPFKDFVSLCLNKDPKERPS 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (260), Expect = 2e-25
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 22/213 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA---EIIF 133
           S+  R  +LG+G  G VYK       KP    +  A+K + +DG +  ++ +    + + 
Sbjct: 1   SDLERVKVLGQGSSGVVYKVR----HKP--TGKIYALKKIHVDGDEEFRKQLLRELKTLR 54

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
             +   P++VK  G  ++E    +V EYM  GSL +         +P      IA    K
Sbjct: 55  SCE--SPYVVKCYGAFYKEGEISIVLEYMDGGSLAD--LLKKVGKIPEPVLAYIARQILK 110

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQ 250
           GL +LH   + +I+RD K SN+L++S    K++DFG++K   +  +   T V     GT 
Sbjct: 111 GLDYLHT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTV 164

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            Y +PE +     +  +D++S G+ LLE   GK
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  104 bits (261), Expect = 2e-25
 Identities = 74/244 (30%), Positives = 115/244 (47%), Gaps = 38/244 (15%)

Query: 78  NFSRSNL-----LGEGGFGPVY-------KGFVDEKLKPGLEA-QP--VAVKALDLDGTQ 122
            F R  L     LGEG FG V+       + F ++       A  P  VAVK L  D + 
Sbjct: 1   EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60

Query: 123 -GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA--- 178
              ++++ E+  L +L  P++ +L+G C  +    ++ EYM  G L NQ  + + A    
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSG 119

Query: 179 -------LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                  L +ST + +A   A G+ +L  E    ++RD    N L+  +YT K++DFG++
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           ++    +   V  R      + A E V+ G  TT SDV++FGV L E+LT         L
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT---------L 228

Query: 292 GREQ 295
            REQ
Sbjct: 229 CREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 4e-25
 Identities = 68/198 (34%), Positives = 100/198 (50%), Gaps = 13/198 (6%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V++G  +          PVAVK L   GT   K+++AE   + +LRHP L++
Sbjct: 14  LGAGQFGEVWEGLWNN-------TTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQ 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L   C  EE   +V E M  GSL   L      AL     + +A   A G+A+L  E + 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL--EAQN 123

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE-ETHVITRVMGTQGYAAPEYVMTGHL 263
            I+RD  A N+L+  +   K++DFGLA+   E   E     +      + APE  +    
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRF 181

Query: 264 TTMSDVYSFGVVLLELLT 281
           +  SDV+SFG++L E++T
Sbjct: 182 SIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  107 bits (268), Expect = 5e-25
 Identities = 93/304 (30%), Positives = 143/304 (47%), Gaps = 40/304 (13%)

Query: 71  ELRLITSNFSRS-------------NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD 117
           EL+   S  S+S             N++  G  G  YKG   + +K G+  Q V  +  D
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKG---KSIKNGM--QFVVKEIND 725

Query: 118 LDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA 177
           ++         +EI  +G+L+HP++VKLIG C  E+   L++EY+   +L +++ R+ S 
Sbjct: 726 VNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-SEVLRNLS- 778

Query: 178 ALPWSTRMKIALGAAKGLAFLHGEDKP-VIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 236
              W  R KIA+G AK L FLH    P V+  +     I++D      L    L+  G  
Sbjct: 779 ---WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLL 832

Query: 237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS 296
             +T        +  Y APE   T  +T  SD+Y FG++L+ELLTGK   D    G   S
Sbjct: 833 CTDTKCFI----SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD-AEFGVHGS 887

Query: 297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQ--KAAATAFKCLSHHPRHRPTMSYVVR 354
           + EWAR    +   L+  IDP + G   +   +  +    A  C +  P  RP  + V++
Sbjct: 888 IVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946

Query: 355 VLDS 358
            L+S
Sbjct: 947 TLES 950

Length = 968

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  102 bits (255), Expect = 6e-25
 Identities = 87/288 (30%), Positives = 131/288 (45%), Gaps = 51/288 (17%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VA+K+L   G+   + ++AE   + QL+HP LV+
Sbjct: 14  LGAGQFGEVWMGYYNGHTK-------VAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVR 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E    ++ EYM  GSL + L       L  +  + +A   A+G+AF+  E K 
Sbjct: 66  LYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI--ERKN 122

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            I+RD +A+NIL+      K++DFGLA+   + E T         +G      + APE +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-------AREGAKFPIKWTAPEAI 175

Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---RKLERLI 315
             G  T  SDV+SFG++L E++T  R                  P +  P   + LER  
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRI---------------PYPGMTNPEVIQNLERGY 220

Query: 316 D-PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF 362
             PR     P    ++       C    P  RPT  Y+  VL+   DF
Sbjct: 221 RMPR-----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE---DF 260

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  102 bits (256), Expect = 6e-25
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 12/213 (5%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQ 136
           + +    LG G FG VY+G    +    +E   VAVK L    + Q   +++ E + + +
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVE-LQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY-SAALPWSTRMK----IALGA 191
             H ++V+LIG  +E   R ++ E M  G L + L  +      P S  MK     A   
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           AKG  +L  E+   I+RD  A N LL        AK++DFG+A+D           R M 
Sbjct: 126 AKGCKYL--EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAML 183

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
              +  PE  + G  T+ +DV+SFGV+L E+ +
Sbjct: 184 PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  101 bits (253), Expect = 1e-24
 Identities = 71/217 (32%), Positives = 107/217 (49%), Gaps = 41/217 (18%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVK--ALDLDGTQGH---KEWMAEIIFLGQLR 138
           LLG G FG VY+G   +           AVK  +L  DG  G    K+   EI  L +L+
Sbjct: 7   LLGSGSFGSVYEGLNLDD------GDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 139 HPHLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWS-----TRMKIALGAA 192
           HP++V+ +G   EE+  L ++ E +P GSL   L + Y  + P       TR  +     
Sbjct: 61  HPNIVQYLGTEREED-NLYIFLELVPGGSLAKLL-KKY-GSFPEPVIRLYTRQIL----- 112

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM----- 247
            GL +LH  D+  ++RD K +NIL+D++   KL+DFG+AK         V+         
Sbjct: 113 LGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFK 162

Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           G+  + APE +   G     +D++S G  +LE+ TGK
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  101 bits (253), Expect = 2e-24
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 9/198 (4%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPHL 142
            +GEG FG VY+G V    +   E   VAVK      +   +E ++ E   + Q  HPH+
Sbjct: 13  CIGEGQFGDVYQG-VYMSPEN--EKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           VKLIG    E    +V E  P G L + L +    +L  ++ +  +   +  LA+L    
Sbjct: 70  VKLIGVI-TENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLES-- 125

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
           K  ++RD  A N+L+ S    KL DFGL++   E E  +  ++      + APE +    
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRR 184

Query: 263 LTTMSDVYSFGVVLLELL 280
            T+ SDV+ FGV + E+L
Sbjct: 185 FTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  100 bits (250), Expect = 2e-24
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 18/201 (8%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG FG V +G   E        Q VAVK +  D T   + ++ E   + +L H +LV+
Sbjct: 14  IGEGEFGAVLQG---EYT-----GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVR 63

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L+G        + V E M +G+L N L     A +     ++ +L  A+G+ +L  E K 
Sbjct: 64  LLGVILHNGLYI-VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL--ESKK 120

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
           +++RD  A NIL+  D  AK+SDFGLA+ G  G +   +        + APE +     +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKWTAPEALKHKKFS 175

Query: 265 TMSDVYSFGVVLLELLTGKRA 285
           + SDV+S+GV+L E+ +  RA
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  100 bits (251), Expect = 2e-24
 Identities = 71/296 (23%), Positives = 119/296 (40%), Gaps = 65/296 (21%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEW-MAEIIFLG 135
            +     +G+G FG VY      +   G   +   +K +DL   ++  +E  + E+  L 
Sbjct: 1   KYEIIKQIGKGSFGKVYLV---RRKSDG---KLYVLKEIDLSNMSEKEREDALNEVKILK 54

Query: 136 QLRHPHLVKLIGYCWEEEYRLL-VYEYMPRGSLHNQLFRSYSAALPWS--TRMKIALGAA 192
           +L HP+++K     +EE+ +L  V EY   G L  ++ +      P+     +   +   
Sbjct: 55  KLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR-VMGTQG 251
             L +LH   + +++RD K  NI L S+   KL DFG++K       T  + + V+GT  
Sbjct: 114 LALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISK---VLSSTVDLAKTVVGTPY 168

Query: 252 YAAPE------YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
           Y +PE      Y         SD++S G VL EL T K   +        +L E A  +L
Sbjct: 169 YLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGE------NLLELALKIL 216

Query: 306 KEP---------RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYV 352
           K            +L  L+                       L   P  RP+++ +
Sbjct: 217 KGQYPPIPSQYSSELRNLVS--------------------SLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 99.7 bits (248), Expect = 4e-24
 Identities = 81/276 (29%), Positives = 130/276 (47%), Gaps = 28/276 (10%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHL 142
           LLG+G FG V+KG + +K        PVAVK    D  Q  K ++++E   L Q  HP++
Sbjct: 2   LLGKGNFGEVFKGTLKDK-------TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI 54

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           VKLIG C + +   +V E +P G   + L R     L     +K AL AA G+A+L  E 
Sbjct: 55  VKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYL--ES 111

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
           K  I+RD  A N L+  +   K+SDFG+++   +G  +    + +  + + APE +  G 
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGR 170

Query: 263 LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQ 322
            ++ SDV+S+G++L E                 SL     P +   +  E+ ++      
Sbjct: 171 YSSESDVWSYGILLWETF---------------SLGVCPYPGMTNQQAREQ-VEKGYRMS 214

Query: 323 FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
            P K          +C  + P +RP  S + + L +
Sbjct: 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 5e-24
 Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 18/203 (8%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           LG G FG V KG     L    +   VAVK L       G KE++ E   + QL HP +V
Sbjct: 3   LGHGNFGSVVKGVY---LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +LIG C + E  +LV E  P G L   L +     +P S   ++A   A G+A+L  E K
Sbjct: 60  RLIGVC-KGEPLMLVMELAPLGPLLKYL-KKRRE-IPVSDLKELAHQVAMGMAYL--ESK 114

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG-----YAAPEYV 258
             ++RD  A N+LL + + AK+SDFG+++    G + +  T    T G     + APE +
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPECI 170

Query: 259 MTGHLTTMSDVYSFGVVLLELLT 281
             G  ++ SDV+S+GV L E  +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.5 bits (245), Expect = 1e-23
 Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 36/284 (12%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           S  +    +G G FG V+ G+  EK K       VA+K +  +G    ++++ E   + +
Sbjct: 4   SELTLVQEIGSGQFGLVWLGYWLEKRK-------VAIKTIR-EGAMSEEDFIEEAQVMMK 55

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP LV+L G C E     LV+E+M  G L + L R+        T + + L   +G+A
Sbjct: 56  LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMA 114

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYA 253
           +L  E   VI+RD  A N L+  +   K+SDFG+ +   + +     T   GT+    ++
Sbjct: 115 YL--ESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWS 168

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE 312
           +PE       ++ SDV+SFGV++ E+ + GK   +N    R  S       +++      
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN----RSNS------EVVETINAGF 218

Query: 313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
           RL  PRL  Q   +  Q        C    P  RP+ S ++  L
Sbjct: 219 RLYKPRLASQSVYELMQ-------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 23/218 (10%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLGQ 136
                +LGEG FG V +G + +          VAVK + LD       +E+++E   +  
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQ---DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKD 57

Query: 137 LRHPHLVKLIGYCWEEEYR------LLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMK 186
             HP+++KLIG C+E          +++  +M  G LH+ L  S        LP  T +K
Sbjct: 58  FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE---ETHVI 243
             +  A G+ +L   ++  I+RD  A N +L  D T  ++DFGL+K    G+   +  + 
Sbjct: 118 FMVDIALGMEYL--SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
              M  + + A E +     T+ SDV++FGV + E+ T
Sbjct: 176 K--MPVK-WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 98.5 bits (245), Expect = 2e-23
 Identities = 68/215 (31%), Positives = 98/215 (45%), Gaps = 19/215 (8%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LGEG FG V+       L P  +   VAVKAL        +++  E   L  L+H H+V+
Sbjct: 13  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS--------------AALPWSTRMKIALG 190
             G C E    L+V+EYM  G L N+  RS+                 L     + IA  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            A G+ +L       ++RD    N L+      K+ DFG+++D    +   V  R M   
Sbjct: 131 IASGMVYLASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR 284
            +  PE ++    TT SD++SFGVVL E+ T GK+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 97.3 bits (242), Expect = 5e-23
 Identities = 70/249 (28%), Positives = 119/249 (47%), Gaps = 24/249 (9%)

Query: 76  TSNFSRSNLLGEGGFGPVYKGF---VDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEI 131
            +   +  LLG G FG V+KG      + +K      PVA+K + D  G Q  +E    +
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKI-----PVAIKTIQDRSGRQTFQEITDHM 60

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           + +G L H ++V+L+G C     +L V +  P GSL + + R +  +L     +   +  
Sbjct: 61  LAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQI 118

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           AKG+ +L  E+  +++R+  A NILL SD   +++DFG+A      ++ +  +       
Sbjct: 119 AKGMYYL--EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRK 310
           + A E ++ G  T  SDV+S+GV + E+++ G       R      L E          K
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE----------K 226

Query: 311 LERLIDPRL 319
            ERL  P++
Sbjct: 227 GERLAQPQI 235

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.0 bits (241), Expect = 5e-23
 Identities = 65/219 (29%), Positives = 117/219 (53%), Gaps = 25/219 (11%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLG 135
           S+ ++  ++G G FG V++G +     PG +   VA+K L    T+  + ++++E   +G
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILK---MPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMG 61

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           Q  H ++++L G   + +  +++ EYM  G+L ++  R +         + +  G A G+
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGM 120

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQG- 251
            +L   D   ++RD  A NIL++S+   K+SDFGL++   D PEG  T        T G 
Sbjct: 121 KYL--SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT--------TSGG 170

Query: 252 -----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR 284
                + APE +     T+ SDV+SFG+V+ E+++ G+R
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 96.8 bits (241), Expect = 7e-23
 Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 10/203 (4%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD-LDGTQGHKEWMAEIIFLGQLRHPH 141
            ++G+G FG VY G     +    +    AVK+L+ +   +  ++++ E I +    HP+
Sbjct: 1   RVIGKGHFGCVYHG---TLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 142 LVKLIGYCWEEE-YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           ++ L+G C   E   L+V  YM  G L N   RS +        +   L  AKG+ +L  
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRN-FIRSETHNPTVKDLIGFGLQVAKGMEYL-- 114

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEYV 258
             K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E +
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 259 MTGHLTTMSDVYSFGVVLLELLT 281
            T   TT SDV+SFGV+L EL+T
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 95.3 bits (238), Expect = 3e-22
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 58/225 (25%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW------MAEIIFLGQLR 138
           +GEG +G VYK       K G   + VA+K + ++    +++       + EI  L +LR
Sbjct: 7   IGEGTYGQVYKA---RNKKTG---ELVALKKIRME----NEKEGFPITAIREIKLLQKLR 56

Query: 139 HPHLVKLIGYCWEEE----YRLLVYEYMP---RGSLHNQLFRSYSAALPWSTRMKIALGA 191
           HP++V+L      +     Y  +V+EYM     G L +               +K     
Sbjct: 57  HPNIVRLKEIVTSKGKGSIY--MVFEYMDHDLTGLLDS-------------PEVKFTESQ 101

Query: 192 AK--------GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA----KDGPEGEE 239
            K        GL +LH     +++RD K SNIL+++D   KL+DFGLA    K       
Sbjct: 102 IKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159

Query: 240 THVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
             VIT       Y  PE ++         D++S G +L EL  GK
Sbjct: 160 NRVITL-----WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLV 143
           LG G  G V K       +P    + +AVK + L+      K+ + E+  L +   P++V
Sbjct: 9   LGAGNSGVVSKV----LHRP--TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
              G  +      +  EYM  GSL +++ +     +P     KIA+   KGL +LH E  
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH-EKH 120

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV-MGTQGYAAPEYVMTGH 262
            +I+RD K SNIL++S    KL DFG++     G+  + + +  +GT  Y APE +    
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERIQGND 175

Query: 263 LTTMSDVYSFGVVLLELLTGK 283
            +  SD++S G+ L+EL TG+
Sbjct: 176 YSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 26/207 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL----DGTQGHKEWMAEIIFLGQLRHP 140
           +GEG  G V+K    E        + VA+K + L     G     + + EI  L   +HP
Sbjct: 8   IGEGAHGIVFKAKDRET------GETVALKKVALRRLEGGIP--NQALREIKALQACQHP 59

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           ++VKL+         +LV EYMP   L   L R     LP +          KG+A++H 
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPEAQVKSYMRMLLKGVAYMHA 117

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLA---KDGPEGEETHVITRVMGTQGYAAPEY 257
               +++RD K +N+L+ +D   K++DFGLA    +      +H +     T+ Y APE 
Sbjct: 118 NG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV----ATRWYRAPE- 170

Query: 258 VMTG--HLTTMSDVYSFGVVLLELLTG 282
           ++ G        D+++ G +  ELL G
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.7 bits (233), Expect = 6e-22
 Identities = 74/275 (26%), Positives = 114/275 (41%), Gaps = 35/275 (12%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLG 135
           +F   N +G+G FG V+K  V  K     + +  A+K +DL     +  +E + E   L 
Sbjct: 1   DFEILNKIGKGSFGVVFK--VVRKA----DKRVYAMKQIDLSKMNRREREEAIDEARVLA 54

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +L   ++++      ++    +V EY   G LH  L       LP     +  +    GL
Sbjct: 55  KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A LH   K +++RD K+ N+ LD+    K+ D G+AK     + T+    ++GT  Y +P
Sbjct: 115 AHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSP 170

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E          SDV++ GVVL E  TGK   D    G                     LI
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--------------------ALI 210

Query: 316 DPRLEGQFPIKGAQKAAATA---FKCLSHHPRHRP 347
              + G FP      +   A    +CL+   R RP
Sbjct: 211 LKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.7 bits (235), Expect = 6e-22
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 24/218 (11%)

Query: 85  LGEGGFGPVYKGFVDE--KLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           LGEG FG V   F+ E   L P  +   VAVKAL        K++  E   L  L+H H+
Sbjct: 13  LGEGAFGKV---FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY---------------SAALPWSTRMKI 187
           VK  G C + +  ++V+EYM  G L N+  R++                  L  S  + I
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   A G+ +L  +    ++RD    N L+ ++   K+ DFG+++D    +   V    M
Sbjct: 129 ASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR 284
               +  PE +M    TT SDV+SFGV+L E+ T GK+
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 93.5 bits (232), Expect = 7e-22
 Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 18/201 (8%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G+G FG V  G              VAVK +  D T   + ++AE   + QLRH +LV+
Sbjct: 14  IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63

Query: 145 LIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           L+G   EE+  L +V EYM +GSL + L     + L     +K +L   + + +L   + 
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN- 122

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             ++RD  A N+L+  D  AK+SDFGL K+    ++T  +        + APE +     
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKF 176

Query: 264 TTMSDVYSFGVVLLELLTGKR 284
           +T SDV+SFG++L E+ +  R
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 93.7 bits (234), Expect = 9e-22
 Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 23/212 (10%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD----GTQGHKEWMAEIIFL 134
           + +   LGEG +G VYK   D+K       + VA+K + LD    G       + EI  L
Sbjct: 1   YEKLEKLGEGTYGVVYKAR-DKKTG-----EIVALKKIRLDNEEEGIP--STALREISLL 52

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
            +L+HP++VKL+     E    LV+EY     L           L  +    I     +G
Sbjct: 53  KELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKK-YLDKRPGPLSPNLIKSIMYQLLRG 110

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGY 252
           LA+ H     +++RD K  NIL++ D   KL+DFGLA+    P    TH +     T  Y
Sbjct: 111 LAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWY 164

Query: 253 AAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
            APE ++     + + D++S G +  E++TGK
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 34/275 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G    K+        VA+K +  +G     +++ E   + +L HP+LV+
Sbjct: 12  LGSGQFGVVHLGKWRGKID-------VAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQ 63

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G C ++    +V EYM  G L N L R     L     + +     + + +L  E   
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCEAMEYL--ESNG 120

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMTG 261
            I+RD  A N L+  D   K+SDFGLA+   + +     T   GT+    +A PE     
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYS 176

Query: 262 HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG 321
             ++ SDV+SFGV++ E+ +  + M   R    + +   +           RL  P+L  
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGK-MPYERFSNSEVVESVSAGY--------RLYRPKL-- 225

Query: 322 QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
                   +     + C    P  RP    ++  L
Sbjct: 226 -----APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 69/220 (31%), Positives = 113/220 (51%), Gaps = 27/220 (12%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEIIFL 134
           S      ++G G FG V  G    +LK PG    PVA+K L    T+  + ++++E   +
Sbjct: 4   SCIKIEKVIGAGEFGEVCSG----RLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIM 59

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           GQ  HP+++ L G   + +  ++V EYM  GSL +   R +         + +  G A G
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASG 118

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQG 251
           + +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        T+G
Sbjct: 119 MKYL--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT--------TRG 168

Query: 252 ------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR 284
                 + APE +     T+ SDV+S+G+V+ E+++ G+R
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 92.7 bits (230), Expect = 2e-21
 Identities = 60/215 (27%), Positives = 110/215 (51%), Gaps = 21/215 (9%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------QGHKEWMAEII 132
           +++  +LG+G +G VY G  ++        Q +AVK ++LD +      + +++   E+ 
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQ-------GQLIAVKQVELDTSNVLAAEKEYEKLQEEVD 54

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            L  L+H ++V+ +G C ++    +  E++P GS+ + L R     LP     K      
Sbjct: 55  LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQIL 112

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD----GPEGEETHVITRVMG 248
            G+A+LH  +  V++RD K +N++L  +   KL DFG A+     G  G  ++++  + G
Sbjct: 113 DGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  + APE +        SD++S G  + E+ TGK
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 68/214 (31%), Positives = 97/214 (45%), Gaps = 13/214 (6%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD-LDGTQGHKEWMAEII 132
           F RSNL     LG G FG V+        + G E   V VKAL          E+  E+ 
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGE-TLVLVKALQKTKDENLQSEFRRELD 60

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL-----PWSTRMKI 187
              +L H ++V+L+G C E E   ++ EY   G L   L  + S        P ST+ K+
Sbjct: 61  MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           AL     L   H  +   ++RD  A N L+ S    K+S   L+KD     E + +   +
Sbjct: 121 ALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNAL 179

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               + APE V     +T SDV+SFGV++ E+ T
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 63/214 (29%), Positives = 109/214 (50%), Gaps = 22/214 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLE-AQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHL 142
           LGE  FG +YKG +     PG++ AQ VA+K L D++  Q   E+  E   + +L HP++
Sbjct: 13  LGECAFGKIYKGHL---YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR---------------SYSAALPWSTRMKI 187
           V L+G   +E+   +++EY+ +G LH  L                 +  ++L     + I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A+  A G+ +L       +++D  A NIL+      K+SD GL+++    +   V  + +
Sbjct: 130 AIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               +  PE +M G  ++ SD++SFGVVL E+ +
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.9 bits (228), Expect = 3e-21
 Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 13/207 (6%)

Query: 84  LLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPH 141
           ++G G FG V +G    +LK PG     VA+K L    T +  +++++E   +GQ  HP+
Sbjct: 11  VIGAGEFGEVCRG----RLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L G   +    +++ E+M  G+L +   R           + +  G A G+ +L   
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--S 123

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYV 258
           +   ++RD  A NIL++S+   K+SDFGL++   +       T  +G +    + APE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 259 MTGHLTTMSDVYSFGVVLLELLT-GKR 284
                T+ SDV+S+G+V+ E+++ G+R
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 76/291 (26%), Positives = 129/291 (44%), Gaps = 50/291 (17%)

Query: 78  NFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGT--QGHKEWM------ 128
            + +  L+G+G +G VY    V          + +AVK ++L  T    H          
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTT-------GEMMAVKQVELPATIAGRHDSRQKDMVKA 54

Query: 129 --AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
             +EI  L  L H ++V+ +G+   EEY  +  EY+P GS+     R+Y        R  
Sbjct: 55  LRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSCLRTYGRFEEQLVRF- 112

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                 +GLA+LH   K +++RD KA N+L+D+D   K+SDFG++K   +  +      +
Sbjct: 113 FTEQVLEGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 247 MGTQGYAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNT-------RLGREQSL 297
            G+  + APE + +     +   D++S G V+LE+  G+R   +        +LG ++S 
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS- 229

Query: 298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
              A P+   P  +   + P             A      C + +P +RPT
Sbjct: 230 ---APPI---PPDVSMNLSP------------VALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.5 bits (227), Expect = 5e-21
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 16/208 (7%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 6   TDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKE 58

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYA 253
           +L  E K  I+RD  A N L+  ++  K++DFGL++      +T+  T   G +    + 
Sbjct: 119 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTY--TAHAGAKFPIKWT 172

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLT 281
           APE +     +  SDV++FGV+L E+ T
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 29/209 (13%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMA--EIIFLGQLRHPH 141
           +GEG +G VYK       +  L  + VA+K + L   ++G  +  A  EI  L +L HP+
Sbjct: 7   IGEGTYGVVYKA------RDKLTGEIVAIKKIKLRFESEGIPK-TALREIKLLKELNHPN 59

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHN--QLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           ++KL+     +    LV+E+M      +  +L +     LP S          +GLAF H
Sbjct: 60  IIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETH-VITRVMGTQGYAAPE 256
                +++RD K  N+L++++   KL+DFGLA+    P    TH V+TR      Y APE
Sbjct: 116 SHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPE 168

Query: 257 --YVMTGHLTTMSDVYSFGVVLLELLTGK 283
                 G+ T + D++S G +  ELL+ +
Sbjct: 169 LLLGDKGYSTPV-DIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 90.8 bits (226), Expect = 7e-21
 Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 13/200 (6%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LGEG +G VYK    E        Q VA+K + ++     +E + EI  L Q   P++V
Sbjct: 10  KLGEGSYGSVYKAIHKE------TGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIV 61

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G  ++     +V EY   GS+ + + +  +  L       I     KGL +LH    
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYLH--SN 118

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             I+RD KA NILL+ +  AKL+DFG++  G   +       V+GT  + APE +     
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 264 TTMSDVYSFGVVLLELLTGK 283
              +D++S G+  +E+  GK
Sbjct: 177 NNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 20/211 (9%)

Query: 85  LGEGGFGPVYKGFVDE--KLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           LGEG FG V   F+ E   L P  +   VAVK L        K++  E   L  L+H H+
Sbjct: 13  LGEGAFGKV---FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS------------AALPWSTRMKIALG 190
           VK  G C E +  ++V+EYM  G L N+  R++             A L  S  + IA  
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            A G+ +L  +    ++RD    N L+  +   K+ DFG+++D    +   V    M   
Sbjct: 129 IAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            +  PE +M    TT SDV+S GVVL E+ T
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 90.3 bits (225), Expect = 1e-20
 Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 34/223 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQL-RH 139
           ++GEG F  V       + +   E    A+K LD   L   +  K    E   L +L  H
Sbjct: 8   IIGEGSFSTVVLAK---EKETNKE---YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 140 PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           P ++KL  Y +++E  L  V EY P G L   + +  S      TR   A      L +L
Sbjct: 62  PGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE-ILLALEYL 118

Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD----GPEGEETHVITRVM------- 247
           H   K +I+RD K  NILLD D   K++DFG AK               T +        
Sbjct: 119 H--SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 248 -------GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
                  GT  Y +PE +        SD+++ G ++ ++LTGK
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 90.7 bits (225), Expect = 2e-20
 Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 36/224 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLV 143
           +G+G FG V++      L P      VAVK L  +       ++  E   + +  HP++V
Sbjct: 13  IGQGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR------------------- 184
           KL+G C   +   L++EYM  G L+  L      A    +                    
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 185 -MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-----DGPEGE 238
            + IA   A G+A+L   ++  ++RD    N L+  +   K++DFGL++     D  +  
Sbjct: 132 QLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 239 ETHVI-TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           E   I  R M       PE +     TT SDV+++GVVL E+ +
Sbjct: 190 ENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 32/223 (14%)

Query: 85  LGEGGFGPVYKGFVDE-KLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHPHL 142
           LGEG FG V K      K + G     VAVK L  + +    ++ ++E   L Q+ HPH+
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTT--VAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLH----------------------NQLFRSYSAALP 180
           +KL G C ++   LL+ EY   GSL                       + L      AL 
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
               +  A   ++G+ +L   +  +++RD  A N+L+      K+SDFGL++D    EE 
Sbjct: 126 MGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD--VYEED 181

Query: 241 HVITRVMG--TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
             + R  G     + A E +     TT SDV+SFGV+L E++T
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 24/215 (11%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EII 132
            + +   LGEG +  VYK   D++       + VA+K + L   +  K+ +      EI 
Sbjct: 1   RYEKGKKLGEGTYAVVYKA-RDKETG-----RIVAIKKIKLGERKEAKDGINFTALREIK 54

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            L +L+HP+++ L+     +    LV+E+M    L  ++ +  S  L  +      L   
Sbjct: 55  LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSYMLMTL 112

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETH-VITRVMGT 249
           +GL +LH     +++RD K +N+L+ SD   KL+DFGLA+    P  + TH V+TR    
Sbjct: 113 RGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW--- 167

Query: 250 QGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
             Y APE +    H     D++S G +  ELL   
Sbjct: 168 --YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 73/214 (34%), Positives = 108/214 (50%), Gaps = 20/214 (9%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMA---EII 132
           N+ R  LLG+G FG VY   +   +  G E   +AVK +  D       KE  A   EI 
Sbjct: 3   NWRRGKLLGQGAFGRVY---LCYDVDTGRE---LAVKQVPFDPDSPETKKEVNALECEIQ 56

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            L  L+H  +V+  G C  ++  L ++ EYMP GS+ +QL ++Y A     TR K     
Sbjct: 57  LLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTR-KYTRQI 113

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE-GEETHVITRVMGTQ 250
            +G+ +LH     +++RD K +NIL DS    KL DFG +K           +  V GT 
Sbjct: 114 LEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171

Query: 251 GYAAPEYVMTGH-LTTMSDVYSFGVVLLELLTGK 283
            + +PE V++G      +DV+S G  ++E+LT K
Sbjct: 172 YWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 14/199 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG  G VYK         G E   VA+K + L   Q  +  + EI+ +   +HP++V 
Sbjct: 27  IGEGASGEVYKA---TDRATGKE---VAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
                   +   +V EYM  GSL + +       +       +     +GL +LH   + 
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLHS--QN 136

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
           VI+RD K+ NILL  D + KL+DFG A    + +       V+GT  + APE V+     
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPE-VIKRKDY 193

Query: 265 TMS-DVYSFGVVLLELLTG 282
               D++S G++ +E+  G
Sbjct: 194 GPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 86/283 (30%), Positives = 127/283 (44%), Gaps = 48/283 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G  +   K       VAVK L   GT   + ++ E   + +LRH  LV+
Sbjct: 14  LGNGQFGEVWMGTWNGNTK-------VAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L      AL     + +A   A G+A++  E   
Sbjct: 66  LYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI--ERMN 122

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            I+RD +++NIL+      K++DFGLA+   + E T         QG      + APE  
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 175

Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           + G  T  SDV+SFG++L EL+T  R     M+N             R +L++  +  R+
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------------REVLEQVERGYRM 222

Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
             P      PI   +       +C    P  RPT  Y+   L+
Sbjct: 223 PCP---QDCPISLHE----LMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 23/203 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK L   GT   + ++ E   +  L+H  LV+
Sbjct: 14  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +EE   ++ EYM +GSL + L       +     +  +   A+G+A++  E K 
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKN 123

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            I+RD +A+N+L+      K++DFGLA+   + E T         +G      + APE +
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-------AREGAKFPIKWTAPEAI 176

Query: 259 MTGHLTTMSDVYSFGVVLLELLT 281
             G  T  SDV+SFG++L E++T
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 68/241 (28%), Positives = 124/241 (51%), Gaps = 26/241 (10%)

Query: 79  FSRSNL-----LGEGGFGPVY----KGFVD--EKLKPGLEAQP--VAVKALDLDGTQ-GH 124
           F R  L     LGEG FG V+    +G  +   +  P  + QP  VAVK L  D T+   
Sbjct: 2   FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR 61

Query: 125 KEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-------SYSA 177
            +++ EI  + +L++P++++L+G C  ++   ++ EYM  G L+  L +       +++ 
Sbjct: 62  NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHAN 121

Query: 178 ALPWSTR---MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 234
            +P  +    + +A+  A G+ +L   +   ++RD    N L+ + YT K++DFG++++ 
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVGNHYTIKIADFGMSRNL 179

Query: 235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE 294
             G+   +  R +    + A E ++ G  TT SDV++FGV L E+ T  +    + L  E
Sbjct: 180 YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239

Query: 295 Q 295
           Q
Sbjct: 240 Q 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 89.1 bits (221), Expect = 3e-20
 Identities = 64/217 (29%), Positives = 101/217 (46%), Gaps = 25/217 (11%)

Query: 81  RSNLLGEGGFGPVYKGF---------VDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI 131
           +  L+G G FG VY G          V +   P + A     K   LD          EI
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAR------EI 57

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             L +L+H ++V+ +G   + ++  +  EY+P GS+   L  +Y  A   +         
Sbjct: 58  ALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNY-GAFEETLVRNFVRQI 115

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR-----V 246
            KGL +LH     +I+RD K +NIL+D+    K+SDFG++K   E       T      +
Sbjct: 116 LKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSL 172

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            G+  + APE V     T  +D++S G +++E+LTGK
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 89.3 bits (221), Expect = 5e-20
 Identities = 65/217 (29%), Positives = 113/217 (52%), Gaps = 29/217 (13%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQL-RHP 140
           +++GEG FG V +  +    K GL+    A+K L +      H+++  E+  L +L  HP
Sbjct: 8   DVIGEGNFGQVIRAMIK---KDGLKMN-AAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS------------YSAALPWSTR--MK 186
           +++ L+G C    Y  +  EY P G+L + L +S            +  A   +++  ++
Sbjct: 64  NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A G+ +L   +K  I+RD  A N+L+  +  +K++DFGL++    GEE +V  + 
Sbjct: 124 FASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYV-KKT 176

Query: 247 MGTQG--YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           MG     + A E +     TT SDV+SFGV+L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 82/291 (28%), Positives = 115/291 (39%), Gaps = 59/291 (20%)

Query: 81  RSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDL-DGTQG-HKEWMAEIIFLGQL 137
           R N +G G FG VY    +D         + +AVK + + D      KE   E+  L  L
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDT-------GELMAVKEIRIQDNDPKTIKEIADEMKVLELL 56

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           +HP+LVK  G     E   +  EY   G+L   L   +   L         L   +GLA+
Sbjct: 57  KHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAY 114

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--------GPEGEETHVITRVMGT 249
           LH     +++RD K +NI LD +   KL DFG A          G E +         GT
Sbjct: 115 LH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL------AGT 166

Query: 250 QGYAAPEYV----MTGHLTTMSDVYSFGVVLLELLTGKR---AMDNTRLGREQSLAEWA- 301
             Y APE +      GH     D++S G V+LE+ TGKR    +DN          E+  
Sbjct: 167 PAYMAPEVITGGKGKGHGRAA-DIWSLGCVVLEMATGKRPWSELDN----------EFQI 215

Query: 302 --RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
                      +   +    EG+  +           +CL   P+ RPT S
Sbjct: 216 MFHVGAGHKPPIPDSLQLSPEGKDFLD----------RCLESDPKKRPTAS 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.6 bits (219), Expect = 6e-20
 Identities = 83/283 (29%), Positives = 123/283 (43%), Gaps = 48/283 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 14  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 66  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 122

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 175

Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE---QSLAEWARPLLKE-PRKLERL 314
           + G  T  SDV+SFG++L EL T  R      + RE   Q    +  P   E P  L  L
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235

Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
           +                     +C    P  RPT  Y+   L+
Sbjct: 236 M--------------------CQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 89.0 bits (220), Expect = 6e-20
 Identities = 70/215 (32%), Positives = 114/215 (53%), Gaps = 14/215 (6%)

Query: 72  LRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWM 128
           LR++  +   R  +LG G FG VYKG +V E     +   PVA+K L +  G + + E+M
Sbjct: 1   LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKI---PVAIKILNETTGPKANVEFM 57

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
            E + +  + HPHLV+L+G C     + LV + MP G L       +   +     +   
Sbjct: 58  DEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLL-DYVHEHKDNIGSQLLLNWC 115

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRV 246
           +  AKG+ +L  E++ +++RD  A N+L+ S    K++DFGLA+  +G E +E +     
Sbjct: 116 VQIAKGMMYL--EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGK 172

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           M  + + A E +     T  SDV+S+GV + EL+T
Sbjct: 173 MPIK-WMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.2 bits (219), Expect = 6e-20
 Identities = 60/181 (33%), Positives = 85/181 (46%), Gaps = 13/181 (7%)

Query: 111 VAVKALDLDGTQGH-KEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHN 169
           VA+K +DL+  Q    E   E+  + Q  HP++VK        +   LV  Y+  GSL +
Sbjct: 29  VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD 88

Query: 170 QLFRSYSAA-LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF 228
            +  SY    L  +    +     KGL +LH      I+RD KA NILL  D + K++DF
Sbjct: 89  IMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADF 146

Query: 229 G----LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH--LTTMSDVYSFGVVLLELLTG 282
           G    LA  G       V    +GT  + APE VM         +D++SFG+  +EL TG
Sbjct: 147 GVSASLADGG--DRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATG 203

Query: 283 K 283
            
Sbjct: 204 A 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 62/231 (26%), Positives = 116/231 (50%), Gaps = 22/231 (9%)

Query: 85  LGEGGFGPVY-------KGFVDEKLK---PGLEAQPVAVKALDLDGTQGHK-EWMAEIIF 133
           LGEG FG V+       + F+D+       G +   VAVK L  D  +  + +++ EI  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH---------NQLFRSYSAALPWSTR 184
           + +L+ P++++L+  C   +   ++ EYM  G L+             ++    + +ST 
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT 244
           + +A   A G+ +L   +   ++RD    N L+  +YT K++DFG++++   G+   +  
Sbjct: 133 IFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ 295
           R +    + + E ++ G  TT SDV++FGV L E+LT  +    ++L  EQ
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 27/222 (12%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++    +++GEG FG V K  +    K GL       +  +      H+++  E+  L +
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63

Query: 137 L-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS------------YSAALPWST 183
           L  HP+++ L+G C    Y  L  EY P G+L + L +S             S A   S+
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 184 RMKIALGA--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
           +  +   A  A+G+ +L    K  I+RD  A NIL+  +Y AK++DFGL++    G+E +
Sbjct: 124 QQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVY 177

Query: 242 VITRVMGTQG--YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           V  + MG     + A E +     TT SDV+S+GV+L E+++
Sbjct: 178 V-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 68/209 (32%), Positives = 99/209 (47%), Gaps = 24/209 (11%)

Query: 84  LLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH 139
            LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNT------GEVVAVKKLQHSTAEHLRDFEREIEILKSLQH 64

Query: 140 PHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
            ++VK  G C+    R   LV EY+P GSL + L + +   L     +  A    KG+ +
Sbjct: 65  DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEY 123

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG-----Y 252
           L    K  ++RD    NIL++S+   K+ DFGL K  P+ +E + +       G     +
Sbjct: 124 LGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVRE----PGESPIFW 177

Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            APE +     +  SDV+SFGVVL EL T
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 87.7 bits (217), Expect = 2e-19
 Identities = 72/252 (28%), Positives = 122/252 (48%), Gaps = 37/252 (14%)

Query: 78  NFSRSNL-----LGEGGFGPVYKGFVDEKLK-PGLE-------AQP--VAVKALDLDGTQ 122
            F R +L     LGEG FG V+   V      P L+        +P  VAVK L  D  +
Sbjct: 1   KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60

Query: 123 GHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY------ 175
             + +++ E+  L +L+ P++++L+G C +E+   ++ EYM  G L NQ   S+      
Sbjct: 61  NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKE 119

Query: 176 ---------SAALP---WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA 223
                    +  LP   +S+ + +AL  A G+ +L   +   ++RD    N L+  + T 
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENLTI 177

Query: 224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           K++DFG++++   G+   +  R +    + A E ++ G  TT SDV++FGV L E+L   
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237

Query: 284 RAMDNTRLGREQ 295
           +      L  EQ
Sbjct: 238 KEQPYGELTDEQ 249

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 81/300 (27%), Positives = 115/300 (38%), Gaps = 49/300 (16%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEII 132
           F R+NL     LG G FG V +       K     + VAVK L        +E  M+E+ 
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMK-VAVKMLKPTAHSSEREALMSELK 90

Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            +  L  H ++V L+G C      L++ EY   G L N L R   + L     +  +   
Sbjct: 91  IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           AKG+AFL    K  I+RD  A N+LL      K+ DFGLA+D            +M    
Sbjct: 151 AKGMAFL--ASKNCIHRDLAARNVLLTHGKIVKICDFGLARD------------IMNDSN 196

Query: 252 YA------------APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE 299
           Y             APE +     T  SDV+S+G++L E+                SL  
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF---------------SLGS 241

Query: 300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
              P +    K  +LI        P     +       C    P  RPT   +V+++   
Sbjct: 242 NPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 46/281 (16%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLG 135
           S + R  L+G G +G VY+G      K     + VA+K ++LD       +   E+  L 
Sbjct: 1   SLYQRLELIGRGAYGAVYRG------KHVPTGRVVALKIINLDTPDDDVSDIQREVALLS 54

Query: 136 QLRH---PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTR-----MK 186
           QLR    P++ K  G  + +  RL ++ EY   GS+     R+   A P + +     ++
Sbjct: 55  QLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSV-----RTLMKAGPIAEKYISVIIR 108

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             L A   L ++H     VI+RD KA+NIL+ +    KL DFG+A    +       +  
Sbjct: 109 EVLVA---LKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STF 161

Query: 247 MGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
           +GT  + APE +  G    T +D++S G+ + E+ TG     +    R   L   ++P  
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP-- 219

Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHR 346
                      PRLE     K  ++  A    CL   P+ R
Sbjct: 220 -----------PRLEDNGYSKLLREFVAA---CLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 83/280 (29%), Positives = 127/280 (45%), Gaps = 42/280 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   K       VA+K L   GT   + ++ E   + +LRH  LV 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-------VAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVP 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V E+M +GSL + L       L     + +A   A G+A++  E   
Sbjct: 66  LYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI--ERMN 122

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            I+RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 175

Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL+T  R      + RE         +L++  +  R+  P 
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---------VLEQVERGYRMPCP- 225

Query: 319 LEGQFPIKGAQKAAATAFK-CLSHHPRHRPTMSYVVRVLD 357
                  +G  ++     K C    P  RPT  Y+   L+
Sbjct: 226 -------QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 86.5 bits (214), Expect = 3e-19
 Identities = 75/277 (27%), Positives = 129/277 (46%), Gaps = 44/277 (15%)

Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG G FG V    ++G  D           VA+K +  +G+    E++ E   + +L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            LV+L G C ++    +V EYM  G L N L R +      S  +++     +G+A+L  
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYL-- 116

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEY 257
           E K  I+RD  A N L+D     K+SDFGL++   + E     T  +G++    ++ PE 
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEV 172

Query: 258 VMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID 316
           ++    ++ SDV++FGV++ E+ + GK   +  R    +++ + ++ L        RL  
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE--RFNNSETVEKVSQGL--------RLYR 222

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
           P L        ++K  A  + C       RPT   ++
Sbjct: 223 PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 46/291 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA-LDLDGTQG-HKEWMAEIIFLGQLRHPH 141
           ++GEG +G V K             + VA+K   + +  +   K  + E+  L QLRH +
Sbjct: 8   VVGEGAYGVVLKCRNKAT------GEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           +V L      +    LV+EY+ R  L  +L  +    LP            + +A+ H  
Sbjct: 62  IVNLKEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE----Y 257
           +  +I+RD K  NIL+      KL DFG A+       + +   V  T+ Y APE     
Sbjct: 120 N--IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGD 176

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG------KRAMDN-----TRLG----REQSLAEWAR 302
              G      DV++ G ++ ELL G         +D        LG      Q L     
Sbjct: 177 TNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQEL----- 228

Query: 303 PLLKEPRKL-ERLIDPR----LEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
                PR       +P     LE ++P K +  A      CL   P+ R T
Sbjct: 229 -FSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 86.3 bits (213), Expect = 3e-19
 Identities = 69/217 (31%), Positives = 113/217 (52%), Gaps = 29/217 (13%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           +++GEG FG V K  +    K GL     A+K +    ++  H+++  E+  L +L  HP
Sbjct: 1   DVIGEGNFGQVLKARIK---KDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 56

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS------------YSAALPWSTR--MK 186
           +++ L+G C    Y  L  EY P G+L + L +S             S A   S++  + 
Sbjct: 57  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A NIL+  +Y AK++DFGL++    G+E +V  + 
Sbjct: 117 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKT 169

Query: 247 MGTQG--YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           MG     + A E +     TT SDV+S+GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 12/206 (5%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G     +K   E + VA+K ++   +   + E++ E   + +    H+V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 144 KLIGYCWEEEYRLLVYEYMPRG-------SLHNQLFRSYSAALPWSTRM-KIALGAAKGL 195
           +L+G   + +  L++ E M RG       SL  ++  +   A P   +M ++A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+      ++RD  A N ++  D+T K+ DFG+ +D  E +      + +    + +P
Sbjct: 133 AYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLT 281
           E +  G  TT SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 60/203 (29%), Positives = 87/203 (42%), Gaps = 16/203 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+GGFG V    V    K        A K LD   L   +G +  + E   L ++    
Sbjct: 1   LGKGGFGEVCACQVKATGKM------YACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 142 LVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           +V L  Y +E +  L LV   M  G L   ++       P +  +  A     GL  LH 
Sbjct: 55  IVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
               ++YRD K  N+LLD     ++SD GLA +   G++     R  GT GY APE +  
Sbjct: 114 RR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK--GRA-GTPGYMAPEVLQG 168

Query: 261 GHLTTMSDVYSFGVVLLELLTGK 283
                  D ++ G  L E++ G+
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.4 bits (212), Expect = 5e-19
 Identities = 64/224 (28%), Positives = 91/224 (40%), Gaps = 15/224 (6%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F    ++G+G FG V    V ++    + A     K          +  + E   L +L
Sbjct: 1   HFELLRVIGKGAFGKVCI--VQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL 57

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSL--HNQLFRSYSAALPWSTRMKIALGAAKGL 195
            HP LV L     +EE   LV + +  G L  H      +S       +  I       L
Sbjct: 58  NHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE---QVKFWIC-EIVLAL 113

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
            +LH   K +I+RD K  NILLD      ++DF +A        T   T   GT GY AP
Sbjct: 114 EYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAP 168

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLA 298
           E +     +   D +S GV   E L GKR    ++R  R+Q  A
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 88.7 bits (220), Expect = 6e-19
 Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 18/191 (9%)

Query: 109 QPVAVKALDLDGTQGHKE---WMAEIIFLGQLRHPHLVKLI--GYCWEEEYRLLVYEYMP 163
             VA+K L  D  +   +   +  E     +L HP++V L+  G          V+EY+P
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVP 62

Query: 164 RGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL---DSD 220
             +L   L  +   ALP     ++ L     LA  H  ++ +++RD K  NI++      
Sbjct: 63  GRTLREVL--AADGALPAGETGRLMLQVLDALACAH--NQGIVHRDLKPQNIMVSQTGVR 118

Query: 221 YTAKLSDFGLAKDGPEGEETHV--ITR---VMGTQGYAAPEYVMTGHLTTMSDVYSFGVV 275
             AK+ DFG+    P   +  V  +TR   V+GT  Y APE +    +T  SD+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 276 LLELLTGKRAM 286
            LE LTG+R +
Sbjct: 179 FLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 85.8 bits (212), Expect = 8e-19
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 30/291 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYS----AALPWSTRMKIALGA--AKGL 195
           +L+G   + +  L+V E M  G L + L   R  +       P + +  I + A  A G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E +      + +    + AP
Sbjct: 133 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 235

Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P+ RPT   +V +L    D   SF
Sbjct: 236 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK--DDLHPSF 283

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 27/209 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQLRHPHLV 143
           LGEG  G V K     +LK        A+K +  D      K+ + E+      + P++V
Sbjct: 9   LGEGAGGSVTKC----RLKNT--GMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62

Query: 144 KLIGYCWEEEYRLL--VYEYMPRGSLHNQLFRSYSAALPWSTRM------KIALGAAKGL 195
           K  G   +E    +    EY   GSL       Y        R+      KIA    KGL
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSLD----SIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE-THVITRVMGTQGYAA 254
           ++LH   + +I+RD K SNILL      KL DFG++     GE    +     GT  Y A
Sbjct: 119 SYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMA 171

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE +     +  SDV+S G+ LLE+   +
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 24/204 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG VYK    +  + GL A   A K + ++  +  +++M EI  L + +HP++V 
Sbjct: 13  LGDGAFGKVYKA---QHKETGLFA---AAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L    + E    ++ E+   G+L + +       L       +     + L FLH     
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLH--SHK 123

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
           VI+RD KA NILL  D   KL+DFG+ AK+    ++       +GT  + APE V     
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF---IGTPYWMAPEVVAC--- 177

Query: 264 TTM--------SDVYSFGVVLLEL 279
            T         +D++S G+ L+EL
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 66/216 (30%), Positives = 115/216 (53%), Gaps = 16/216 (7%)

Query: 72  LRLIT-SNFSRSNLLGEGGFGPVYKGF---VDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           LR++  + F +  +LG G FG VYKG      EK+K      PVA+K L +    + +KE
Sbjct: 1   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI-----PVAIKELREATSPKANKE 55

Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L + + MP G L + + R +   +     + 
Sbjct: 56  ILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLN 113

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  E++ +++RD  A N+L+ +    K++DFGLAK  G + +E H    
Sbjct: 114 WCVQIAKGMNYL--EERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171

Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            +  + + A E ++    T  SDV+S+GV + EL+T
Sbjct: 172 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 13/205 (6%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPHL 142
           +LG G FG + +G +  KL P     PVA+  L    +   +  ++AE + LGQ  H ++
Sbjct: 12  ILGTGRFGELCRGCL--KL-PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI 68

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V+L G        ++V EYM  G+L +   R +   L     M +  G A G+ +L   +
Sbjct: 69  VRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL--SE 125

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPEYVMT 260
              +++   A  +L++SD   K+S F       E +   + T + G     +AAPE +  
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 261 GHLTTMSDVYSFGVVLLELLT-GKR 284
            H ++ SDV+SFG+V+ E+++ G+R
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 85  LGEGGFGPVYKGFVD-EKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHPHL 142
           LGEG FG V     D E    G   + VAVK+L  +    H  +   EI  L  L H ++
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTG---EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 143 VKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           VK  G C E+      L+ E++P GSL   L R+    +    ++K A+   KG+ +L  
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG- 126

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEYVM 259
             +  ++RD  A N+L++S++  K+ DFGL K     +E + +   + +  +  APE ++
Sbjct: 127 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
                  SDV+SFGV L ELLT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 34/279 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           +G G FG V+ G    +L+   +  PVAVK+  +        +++ E   L Q  HP++V
Sbjct: 3   IGRGNFGEVFSG----RLRA--DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +LIG C +++   +V E +  G     L R+    L     +++   AA G+ +L  E K
Sbjct: 57  RLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYL--ESK 113

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ----GYAAPEYVM 259
             I+RD  A N L+      K+SDFG++++    EE  V     G +     + APE + 
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSRE----EEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 260 TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
            G  ++ SDV+SFG++L E  +   A+    L  +Q+     R  +++  +L        
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS-LGAVPYANLSNQQT-----REAIEQGVRLP------- 216

Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P            +C  + P  RP+ S V + L S
Sbjct: 217 ---CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 71/222 (31%), Positives = 111/222 (50%), Gaps = 35/222 (15%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 1   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 54

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-- 193
           +L HP++VKL+     E    LV+E++      +Q  + +  A P S    I L   K  
Sbjct: 55  ELNHPNIVKLLDVIHTENKLYLVFEFL------HQDLKKFMDASPLS---GIPLPLIKSY 105

Query: 194 ------GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITR 245
                 GLAF H     V++RD K  N+L++++   KL+DFGLA+    P    TH +  
Sbjct: 106 LFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV- 162

Query: 246 VMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
              T  Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 163 ---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 83.1 bits (206), Expect = 4e-18
 Identities = 69/204 (33%), Positives = 94/204 (46%), Gaps = 20/204 (9%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGH----KEWMAEIIFLGQLRH 139
           LG GGFG V    V  K K    A     K   ++ G Q H    KE + E        H
Sbjct: 1   LGVGGFGRVEL--VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC------NH 52

Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           P +VKL     +++Y  ++ EY   G L   L R       ++ R  IA        +LH
Sbjct: 53  PFIVKLYRTFKDKKYIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIA-CVVLAFEYLH 110

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
             ++ +IYRD K  N+LLDS+   KL DFG AK    G++T       GT  Y APE ++
Sbjct: 111 --NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF---CGTPEYVAPEIIL 165

Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D +S G++L ELLTG+
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 83.2 bits (205), Expect = 6e-18
 Identities = 84/276 (30%), Positives = 124/276 (44%), Gaps = 41/276 (14%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQL 137
           F++   +G+G FG VYKG +D + K     + VA+K +DL+  +   E    EI  L Q 
Sbjct: 6   FTKLERIGKGSFGEVYKG-IDNRTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
             P++ +  G   +     ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 60  DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDY 116

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV-ITR--VMGTQGYAA 254
           LH E K  I+RD KA+N+LL      KL+DFG+A     G+ T   I R   +GT  + A
Sbjct: 117 LHSERK--IHRDIKAANVLLSEQGDVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMA 169

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +        +D++S G+  +EL  G+    +    R   L     P           
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP----------- 218

Query: 315 IDPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPT 348
             P LEGQ+  P K   +A      CL+  PR RPT
Sbjct: 219 --PTLEGQYSKPFKEFVEA------CLNKDPRFRPT 246

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 82.8 bits (204), Expect = 7e-18
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 22/227 (9%)

Query: 71  ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--HKEWM 128
           E+ L T  F     LGE  FG VYKG +     PG + Q VA+K L  D  +G   +E+ 
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGT-APGEQTQAVAIKTLK-DKAEGPLREEFK 56

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF--------------RS 174
            E +   +L+HP++V L+G   +E+   +++ Y     LH  L               ++
Sbjct: 57  HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 234
             + L  +  + I    A G+ FL      V+++D    N+L+      K+SD GL ++ 
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREV 174

Query: 235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
              +   ++   +    + +PE +M G  +  SD++S+GVVL E+ +
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.0 bits (206), Expect = 7e-18
 Identities = 70/224 (31%), Positives = 101/224 (45%), Gaps = 48/224 (21%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEIIF 133
            +F     LG G FG V    V  K   G   +  A+K L        K+    + E   
Sbjct: 1   DDFEFIKTLGTGSFGRVM--LVRHK-GSG---KYYALKILSKAKIVKLKQVEHVLNEKRI 54

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWS 182
           L  +RHP LV L G  ++++  L LV EY+P G L + L +S          Y+A     
Sbjct: 55  LQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA----- 108

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              ++ L     L +LH  D  ++YRD K  N+LLDSD   K++DFG AK         V
Sbjct: 109 ---QVVLA----LEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RV 151

Query: 243 ITRVM---GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTG 282
             R     GT  Y APE ++  G+     D ++ G+++ E+L G
Sbjct: 152 KGRTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.9 bits (202), Expect = 8e-18
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQLRHPHLV 143
           LG G FG V KG    + K       VA+K L  +  +    E M E   + QL +P++V
Sbjct: 3   LGSGNFGCVKKGVYKMRKK----QIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           ++IG C E E  +LV E    G L N+        +  S  +++    + G+ +L  E K
Sbjct: 59  RMIGVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYL--EGK 114

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTG 261
             ++RD  A N+LL + + AK+SDFGL+K     ++++   R  G     + APE +   
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 262 HLTTMSDVYSFGVVLLELLT 281
             ++ SDV+S+G+ + E  +
Sbjct: 174 KFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 36/214 (16%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---------DLDGTQGHKEWMAEIIFL 134
           +LG+G FG V    + E        +  AVK L         D++ T   K      +  
Sbjct: 2   VLGKGSFGKV---LLAELKGTD---ELYAVKVLKKDVILQDDDVECTMTEKR-----VLA 50

Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSL--HNQLFRSYSAALPWSTRMKIALGA 191
              +HP L +L   C++ + RL  V EY+  G L  H Q    +          +I LG 
Sbjct: 51  LAGKHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG- 108

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM-GTQ 250
              L FLH  ++ +IYRD K  N+LLDS+   K++DFG+ K+G  G  T   T    GT 
Sbjct: 109 ---LQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTP 160

Query: 251 GYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
            Y APE +++      + D ++ GV+L E+L G+
Sbjct: 161 DYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 21/205 (10%)

Query: 88  GGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH---KEWMAEIIFLGQLRHPHLVK 144
           G +G V+     +K   G      A+K +            + + E   L Q + P++VK
Sbjct: 4   GAYGRVFLA---KKKSTG---DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 145 LIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           L  Y ++ +  L LV EY+P G L + L  +   +L               L +LH    
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLAS-LLENV-GSLDEDVARIYIAEIVLALEYLHSNG- 113

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI------TRVMGTQGYAAPEY 257
            +I+RD K  NIL+DS+   KL+DFGL+K G    + ++        R++GT  Y APE 
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           ++    +   D +S G +L E L G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 33/272 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQLRHPHLV 143
           LG G  G V       K+K       +A K + +       K+ + E+  + + R P++V
Sbjct: 13  LGAGNGGSV------SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIV 66

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
              G    E    +  E+M  GSL +++++     +P     KIA+   +GL +L+   +
Sbjct: 67  SFYGAFLNENNICMCMEFMDCGSL-DRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHR 124

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV-MGTQGYAAPEYVMTGH 262
            +++RD K SNIL++S    KL DFG++     GE  + I    +GT  Y +PE +  G 
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGK 178

Query: 263 LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-----EWARPLLKEPRKLERLIDP 317
            T  SDV+S G+ ++EL  GK     + +  +         +  + +++EP        P
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------PP 231

Query: 318 RL-EGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
           RL    FP    +        CL   P  RPT
Sbjct: 232 RLPSSDFP----EDLRDFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 67/207 (32%), Positives = 96/207 (46%), Gaps = 34/207 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLGQLRHPH 141
           +G G FG VY  F  +        + VA+K +   G Q +++W   + E+ FL QLRHP+
Sbjct: 23  IGHGSFGAVY--FARDVRT----NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGS------LHNQLFRSYSAALPWSTRMKIALGAAKGL 195
            ++  G    E    LV EY   GS      +H +  +    A        I  GA +GL
Sbjct: 77  TIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIA-------AICHGALQGL 128

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+LH  ++  I+RD KA NILL    T KL+DFG A               +GT  + AP
Sbjct: 129 AYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS------FVGTPYWMAP 180

Query: 256 EYVMT---GHLTTMSDVYSFGVVLLEL 279
           E ++    G      DV+S G+  +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 28/216 (12%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEIIFL 134
           +F     LG+G +G VYK      +K   + Q  A+K +DL G+   KE    + EI  L
Sbjct: 1   DFKVLKKLGKGSYGSVYK------VKRLSDNQFYALKEVDL-GSMSQKEREDAVNEIRIL 53

Query: 135 GQLRHPHLVKLIGYCWEEEY----RL-LVYEYMPRGSLHNQLFRSYSAALPWSTRM--KI 187
             + HP+++      ++E +    +L +V EY P G L   + +          +   +I
Sbjct: 54  ASVNHPNII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            +   +GL  LH  ++ +++RD K++NILL ++   K+ D G++K   +      I    
Sbjct: 109 FIQLLRGLQALH--EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---- 162

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           GT  Y APE       +  SD++S G +L E+ T  
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 82.2 bits (204), Expect = 2e-17
 Identities = 75/233 (32%), Positives = 107/233 (45%), Gaps = 71/233 (30%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVK--------ALDLDGTQGHKEWMAEIIFLGQ 136
           LG+G +G V+K  +D + K     + VA+K        A D   T        EI+FL +
Sbjct: 15  LGKGAYGIVWKA-IDRRTK-----EVVALKKIFDAFRNATDAQRT------FREIMFLQE 62

Query: 137 LR-HPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHN-----------------QLFRSYS 176
           L  HP++VKL+     E  +   LV+EYM    LH                  QL ++  
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILEDVHKRYIMYQLLKA-- 119

Query: 177 AALPWSTRMKIALGAAKGLAFLH-GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--- 232
                             L ++H G    VI+RD K SNILL+SD   KL+DFGLA+   
Sbjct: 120 ------------------LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158

Query: 233 DGPEGEETHVITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
           +  E  E  V+T  + T+ Y APE ++ G    T   D++S G +L E+L GK
Sbjct: 159 ELEENPENPVLTDYVATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.3 bits (200), Expect = 2e-17
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQL 137
           F++   +G+G FG V+KG +D + +     Q VA+K +DL+  +   E    EI  L Q 
Sbjct: 6   FTKLERIGKGSFGEVFKG-IDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
             P++ K  G   +     ++ EY+  GS  + L          +T +K  L   KGL +
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDY 116

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA---KDGPEGEETHVITRVMGTQGYAA 254
           LH E K  I+RD KA+N+LL      KL+DFG+A    D      T V     GT  + A
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMA 169

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE +      + +D++S G+  +EL  G+
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 70/228 (30%), Positives = 99/228 (43%), Gaps = 32/228 (14%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
             R  L     LGEG FG V K        P  E   VAVK L  D T+  K+       
Sbjct: 9   LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPN-ETSTVAVKMLKDDATE--KDLSDLVSE 65

Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS------YSAALPW 181
           M  +  +G+  H +++ L+G C +E    +V EY   G+L + L          S   P 
Sbjct: 66  MEMMKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 182 STRMKI--------ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 233
                +        A   A+G+ FL    K  I+RD  A N+L+  D+  K++DFGLA+D
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181

Query: 234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               +     T       + APE +     T  SDV+SFGV+L E+ T
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 80.5 bits (198), Expect = 3e-17
 Identities = 69/212 (32%), Positives = 103/212 (48%), Gaps = 14/212 (6%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA---EIIFL 134
           N+ R  LLG+G FG VY  +    +  G E     V+  D +  +  KE  A   EI  L
Sbjct: 3   NWRRGKLLGQGAFGRVYLCY---DVDTGRELAAKQVQ-FDPESPETSKEVSALECEIQLL 58

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLV--YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
             L+H  +V+  G   +   + L    EYMP GS+ +QL ++Y A     TR K      
Sbjct: 59  KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTR-KYTRQIL 116

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV-ITRVMGTQG 251
           +G+++LH     +++RD K +NIL DS    KL DFG +K       +   I  V GT  
Sbjct: 117 EGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           + +PE +        +DV+S G  ++E+LT K
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 17/215 (7%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEIIFLGQ 136
           F+   +LG+G FG V +  +  K + G   Q VAVK L  D+  +   +E++ E   + +
Sbjct: 1   FTLGRMLGKGEFGSVREAQL--KSEDG-SFQKVAVKMLKADIFSSSDIEEFLREAACMKE 57

Query: 137 LRHPHLVKLIGYCWEEEYR------LLVYEYMPRGSLHNQLFRSYSA----ALPWSTRMK 186
             HP+++KLIG       +      +++  +M  G LH  L  S        LP  T ++
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             +  A G+ +L    K  I+RD  A N +L+ + T  ++DFGL+K    G+        
Sbjct: 118 FMIDIASGMEYL--SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + A E +     TT SDV++FGV + E++T
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 81/258 (31%), Positives = 119/258 (46%), Gaps = 35/258 (13%)

Query: 84  LLGEGGFGPVYK-GFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +LG+GG+G V++   V       + A  V  KA  +   +      AE   L  ++HP +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----YSAALPWSTRMKIALGAAKGLAF 197
           V LI Y ++   +L L+ EY+  G L   L R        A  + + + +AL        
Sbjct: 63  VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------- 114

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAPE 256
            H   + +IYRD K  NILLD+    KL+DFGL K+   EG  TH      GT  Y APE
Sbjct: 115 -HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPE 170

Query: 257 YVM-TGHLTTMSDVYSFGVVLLELLTG---------KRAMDNT---RLGREQSLAEWARP 303
            +M +GH   + D +S G ++ ++LTG         K+ +D     +L     L   AR 
Sbjct: 171 ILMRSGHGKAV-DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229

Query: 304 LLKEPRKLERLIDPRLEG 321
           LLK  + L+R    RL  
Sbjct: 230 LLK--KLLKRNPSSRLGA 245

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.8 bits (199), Expect = 5e-17
 Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLGQLRHPH 141
           +G G FG VY  F           + VAVK +   G Q +++W   + E+ FL QL+HP+
Sbjct: 29  IGHGSFGAVY--FATN----SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
            ++  G   +E    LV EY   GS  + L   +   L       I  GA +GLA+LH  
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT- 260
           +   I+RD KA NILL      KL+DFG A               +GT  + APE ++  
Sbjct: 141 NM--IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAM 192

Query: 261 --GHLTTMSDVYSFGVVLLELLTGKRAMDN 288
             G      DV+S G+  +EL   K  + N
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 7e-17
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 19/200 (9%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLV 143
           LG G  G VYK +        L  + +AVK + LD T +  K+ M+E+  L +   P+++
Sbjct: 9   LGHGNGGTVYKAYHL------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYII 62

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
              G  + E    +  E+M  GSL   ++R     +P     +IA+   KGL +L     
Sbjct: 63  GFYGAFFVENRISICTEFMDGGSL--DVYRK----IPEHVLGRIAVAVVKGLTYLWS--L 114

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            +++RD K SN+L+++    KL DFG++          +    +GT  Y APE +     
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQ----LVNSIAKTYVGTNAYMAPERISGEQY 170

Query: 264 TTMSDVYSFGVVLLELLTGK 283
              SDV+S G+  +EL  G+
Sbjct: 171 GIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.4 bits (195), Expect = 1e-16
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 43/283 (15%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           F++   +G+G FG V+KG +D + +     + VA+K +DL+  +   ++   EI  L Q 
Sbjct: 6   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
             P++ K  G   ++    ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDY 116

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
           LH E K  I+RD KA+N+LL      KL+DFG+A  G   +        +GT  + APE 
Sbjct: 117 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEV 172

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI-- 315
           +      + +D++S G+  +EL  G+                        P K+  LI  
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSEL-----------------HPMKVLFLIPK 215

Query: 316 --DPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
              P LEG +  P+K   +A      CL+  P  RPT   +++
Sbjct: 216 NNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 69/210 (32%), Positives = 92/210 (43%), Gaps = 33/210 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +GEG +G V+K    E        Q VA+K      D     K  + EI  L QL+HP+L
Sbjct: 9   IGEGSYGVVFKCRNRET------GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 143 VKLIGYCWEEEYRL-----LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           V LI     E +R      LV+EY     L+          +P     KI     + + F
Sbjct: 63  VNLI-----EVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTLQAVNF 115

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEET-HVITRVMGTQGYAA 254
            H  +   I+RD K  NIL+      KL DFG A+   GP  + T +V TR      Y A
Sbjct: 116 CHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRA 168

Query: 255 PEYVMTGHLT--TMSDVYSFGVVLLELLTG 282
           PE ++ G        DV++ G V  ELLTG
Sbjct: 169 PE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 23/217 (10%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPG-LEA--QPVAVKALDLDGTQGHKEWMAEIIFL 134
            + +   LG G F   Y+      +K G L A  Q   V+    +  +  +    EI  +
Sbjct: 1   EWLKGQQLGTGAFSSCYQA---RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLM 57

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
            +L HPH+++++G   E+ +  L  E+M  GS+ + L   Y  A   +  +       +G
Sbjct: 58  ARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKY-GAFKEAVIINYTEQLLRG 115

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGEETHVITR-------V 246
           L++LH  +  +I+RD K +N+L+DS     +++DFG A            T        +
Sbjct: 116 LSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAA-----ARLAAKGTGAGEFQGQL 168

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           +GT  + APE +         DV+S G V++E+ T K
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 12/208 (5%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-MAEIIFLGQ 136
           NF +   LGEG +  VYKG      +     + VA+K + LD  +G     + EI  + +
Sbjct: 1   NFKQLEKLGEGTYATVYKG------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKE 54

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L+H ++V+L      E   +LV+EYM +             AL  +T         KG+A
Sbjct: 55  LKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           F H  +  V++RD K  N+L++     KL+DFGLA+    G   +  +  + T  Y AP+
Sbjct: 115 FCH--ENRVLHRDLKPQNLLINKRGELKLADFGLAR--AFGIPVNTFSNEVVTLWYRAPD 170

Query: 257 YVMTGHLTTMS-DVYSFGVVLLELLTGK 283
            ++     + S D++S G ++ E++TG+
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 14/198 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEIIFLGQLRHPHL 142
           LG G FG V KG    K+K     + VAVK L  D +      E + E   + QL +P++
Sbjct: 3   LGSGNFGTVKKGMY--KMKKS--EKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI 58

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V++IG C E E  +LV E    G L+  L ++        T  ++    + G+ +L  E+
Sbjct: 59  VRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT--ELVHQVSMGMKYL--EE 113

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT--QGYAAPEYVMT 260
              ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +  
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 261 GHLTTMSDVYSFGVVLLE 278
              ++ SDV+SFGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 78.1 bits (192), Expect = 2e-16
 Identities = 81/277 (29%), Positives = 128/277 (46%), Gaps = 36/277 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+    ++  K       VAVK +   G+   + ++AE   +  L+H  LVK
Sbjct: 14  LGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E    ++ E+M +GSL + L     +  P    +  +   A+G+AF+  E + 
Sbjct: 66  LHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 122

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+ +    K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFT 181

Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
             SDV+SFG++L+E++T  R     M N          E  R L +  R       PR E
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSN---------PEVIRALERGYRM------PRPE 226

Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                   ++      +C  + P  RPT  Y+  VLD
Sbjct: 227 -----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 69/204 (33%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEIIFLG-QLRH 139
           +LG+G FG V   F+ E        Q  A+KAL  D      +    M E   L     H
Sbjct: 2   MLGKGSFGKV---FLAELKGTN---QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           P L  L      +E    V EY+  G L   +   +   LP +T    A     GL FLH
Sbjct: 56  PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLH 113

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
              K ++YRD K  NILLD+D   K++DFG+ K+   G+         GT  Y APE ++
Sbjct: 114 --SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILL 169

Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                T  D +SFGV+L E+L G+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 71/213 (33%), Positives = 103/213 (48%), Gaps = 16/213 (7%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA---EIIFL 134
           N+    LLG G FG VY  + D      L  + V     D D  +  KE  A   EI  L
Sbjct: 3   NWRLGKLLGRGAFGEVYLCY-DADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLL 58

Query: 135 GQLRHPHLVKLIGYCWE--EEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             LRH  +V+  G C    EE +L ++ EYMP GS+ +QL ++Y A     TR +     
Sbjct: 59  KNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTR-RYTRQI 115

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV-ITRVMGTQ 250
            +G+++LH     +++RD K +NIL DS    KL DFG +K       +   I  V GT 
Sbjct: 116 LQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            + +PE +        +DV+S    ++E+LT K
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 59/201 (29%), Positives = 92/201 (45%), Gaps = 20/201 (9%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G +G VYK      +  G   + VA+K + L+     +    EI  L + RHP++V 
Sbjct: 11  IGSGTYGDVYKARD---IATG---ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
             G     +   +V EY   GSL + +++     L       +     KGLA+LH   K 
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHETGK- 122

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAAPEYV--- 258
            I+RD K +NILL  D   KL+DFG++      + T  I +    +GT  + APE     
Sbjct: 123 -IHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAAVE 176

Query: 259 MTGHLTTMSDVYSFGVVLLEL 279
             G      D+++ G+  +EL
Sbjct: 177 RKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 76.8 bits (189), Expect = 5e-16
 Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 30/274 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G    ++K       VA+KA++ +G    ++++ E   + +L HP LV+
Sbjct: 12  LGSGQFGVVHLGKWRAQIK-------VAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G C +++   +V E+M  G L N L R     L     + +     +G+ +L  E   
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYL--ERNS 120

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD  A N L+ S    K+SDFG+ +   + E T         + ++ PE       +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK-WSPPEVFNFSKYS 179

Query: 265 TMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQF 323
           + SDV+SFGV++ E+ T GK   +       +S  E    +++   +  RL  P+L    
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEK------KSNYE----VVEMISRGFRLYRPKL---- 225

Query: 324 PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
               +       + C    P  RPT + ++R + 
Sbjct: 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 76.0 bits (187), Expect = 9e-16
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 18/219 (8%)

Query: 78  NFSRSNLLGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIF 133
            + +  ++G G FG V+  +   D+KL        V +K + ++     +   A  E   
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKL--------VIIKQIPVEQMTKDERLAAQNECQV 52

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           L  L HP++++      E++  ++V EY P G+L   + +  ++ L   T +   +    
Sbjct: 53  LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL- 111

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            LA  H   K +++RD K  NILLD      K+ DFG++K      ++   T V+GT  Y
Sbjct: 112 -LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCY 167

Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
            +PE          SD+++ G VL EL + KRA +   L
Sbjct: 168 ISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 80/245 (32%), Positives = 118/245 (48%), Gaps = 39/245 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--------DLDGTQGHKEWMAEIIFLG 135
           +LG+G FG V   F+  K+      Q  A+K L        D   T+  ++ +AE+    
Sbjct: 3   VLGQGSFGKV---FLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV---- 55

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
              HP +VKL  Y ++ E +L L+ +++  G L  +L +     +     +K  L A   
Sbjct: 56  --NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFYL-AELA 108

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           LA  H     +IYRD K  NILLD +   KL+DFGL+K+  + E+        GT  Y A
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMA 166

Query: 255 PEYV-MTGHLTTMSDVYSFGVVLLELLTG---------KRAMD---NTRLGREQSLAEWA 301
           PE V   GH T  +D +SFGV++ E+LTG         K  M      +LG  Q L+  A
Sbjct: 167 PEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEA 225

Query: 302 RPLLK 306
           + LL+
Sbjct: 226 QSLLR 230

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 24/204 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG VYK    +  + G  A   A K ++    +  +++M EI  L    HP++VK
Sbjct: 20  LGDGAFGKVYKA---KNKETGALA---AAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73

Query: 145 LIG-YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           L+G + W+ +  +++ E+ P G++ + +       L       I     + L +LH    
Sbjct: 74  LLGAFYWDGKLWIMI-EFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLH--SM 129

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAAPEYVMT 260
            +I+RD KA N+LL  D   KL+DFG++      +    + R    +GT  + APE VM 
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMC 184

Query: 261 GHLTTM-----SDVYSFGVVLLEL 279
             +        +D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 50/293 (17%)

Query: 70  AELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG 123
           A L+L+               +GEG  G V    +      G   + VAVK +DL   Q 
Sbjct: 6   AALQLVVDPGDPRSYLDNFVKIGEGSTGIVC---IATDKSTG---RQVAVKKMDLRKQQR 59

Query: 124 HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWST 183
            +    E++ +   +HP++V++       +   +V E++  G+L +         +   T
Sbjct: 60  RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD---------IVTHT 110

Query: 184 RMK------IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKD 233
           RM       + L   K L+FLH   + VI+RD K+ +ILL SD   KLSDFG    ++K+
Sbjct: 111 RMNEEQIATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168

Query: 234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR 293
            P  +       ++GT  + APE +      T  D++S G++++E++ G+    N     
Sbjct: 169 VPRRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN----- 217

Query: 294 EQSLAEWARPLLKEPRKLERL--IDPRLEG---QFPIKGAQKAAATAFKCLSH 341
           E  L    R     P KL+ L  + PRL     +  ++   +  ATA + L+H
Sbjct: 218 EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQ-RATAAELLNH 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 77/258 (29%), Positives = 119/258 (46%), Gaps = 36/258 (13%)

Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR I S       ++R   +G+G  G VY   +D         Q VA+K ++L   Q
Sbjct: 5   LEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTA-IDVAT-----GQEVAIKQMNLQ-QQ 57

Query: 123 GHKEWMA-EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
             KE +  EI+ + + +HP++V  +      +   +V EY+  GSL + +          
Sbjct: 58  PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-------- 109

Query: 182 STRMKIALGAA------KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDG 234
            T M     AA      + L FLH     VI+RD K+ NILL  D + KL+DFG  A+  
Sbjct: 110 -TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166

Query: 235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE 294
           PE  +    + ++GT  + APE V         D++S G++ +E++ G+    N    R 
Sbjct: 167 PEQSKR---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223

Query: 295 QSL-AEWARPLLKEPRKL 311
             L A    P L+ P KL
Sbjct: 224 LYLIATNGTPELQNPEKL 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 69/203 (33%), Positives = 91/203 (44%), Gaps = 18/203 (8%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAE-IIFLGQLRHP 140
           +G+G FG V         K   + +  AVK L        KE    MAE  + L  ++HP
Sbjct: 3   IGKGSFGKVLLA------KHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP 56

Query: 141 HLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
            LV L  Y ++   +L  V +Y+  G L   L R  S   P       A   A  L +LH
Sbjct: 57  FLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERS--FPEPRARFYAAEIASALGYLH 113

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
             +  +IYRD K  NILLDS     L+DFGL K+G E  +T   +   GT  Y APE + 
Sbjct: 114 SLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLR 169

Query: 260 TGHLTTMSDVYSFGVVLLELLTG 282
                   D +  G VL E+L G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.8 bits (184), Expect = 2e-15
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 16/218 (7%)

Query: 78  NFSRSNLLGEGGFGP--VYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIF 133
           ++    +LG+G FG   +Y+   D+ L        V  K ++L     +  ++ + EI+ 
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSL--------VVWKEVNLTRLSEKERRDALNEIVI 52

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           L  L+HP+++    +  ++   L+  EY   G+L++++ R           +        
Sbjct: 53  LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
            ++++H     +++RD K  NI L      KL DFG++K    G E  +   V+GT  Y 
Sbjct: 113 AVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYM 168

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           +PE          SD+++ G VL ELLT KR  D T  
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 22/210 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLGQLRHPH 141
           +G G FG VY        +    ++ VA+K +   G Q +++W   + E+ FL +LRHP+
Sbjct: 23  IGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
            ++  G    E    LV EY   GS  + L   +   L       +  GA +GLA+LH  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT- 260
           +  +I+RD KA NILL      KL DFG A               +GT  + APE ++  
Sbjct: 135 N--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAM 186

Query: 261 --GHLTTMSDVYSFGVVLLELLTGKRAMDN 288
             G      DV+S G+  +EL   K  + N
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.6 bits (187), Expect = 3e-15
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 52/226 (23%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL------DLDGTQGHKEWMAEIIFLGQ 136
             +G G +G V    VD++       + VA+K +       +D     K  + EI  L  
Sbjct: 6   KPIGSGAYGVVCSA-VDKRTG-----RKVAIKKISNVFDDLIDA----KRILREIKLLRH 55

Query: 137 LRHPHLVKLI-------GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           LRH +++ L+          + + Y  +V E M    LH ++ +S              L
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVY--IVTELME-TDLH-KVIKS-----------PQPL 100

Query: 190 GAA----------KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGE 238
                        +GL +LH  +  VI+RD K SNIL++S+   K+ DFGLA+   P+ +
Sbjct: 101 TDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158

Query: 239 ETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
           E   +T  + T+ Y APE +++    T   D++S G +  ELLT K
Sbjct: 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 68/224 (30%), Positives = 102/224 (45%), Gaps = 40/224 (17%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL----DGTQGHKEWMAEIIFLGQLRHP 140
           LGEG FG VYK     ++K G   + VA+K + +    DG       + EI  L +L+HP
Sbjct: 16  LGEGTFGEVYKA---RQIKTG---RVVALKKILMHNEKDGF--PITALREIKILKKLKHP 67

Query: 141 HLVKLIGYCWEE-----EYRLLVYEYMP------RGSLHNQLFRSYSAALPWSTRMKIAL 189
           ++V LI    E        R  VY   P       G L N   +     L  S      L
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQIKCYML 122

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---------DGPEGEET 240
              +G+ +LH  +  +++RD KA+NIL+D+    K++DFGLA+          G  G  T
Sbjct: 123 QLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Query: 241 HVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
              T ++ T+ Y  PE ++     TT  D++  G V  E+ T +
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 22/203 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG VYK    +  + G+ A   A K +D    +  +++M EI  L    HP++VK
Sbjct: 13  LGDGAFGKVYKA---QNKETGVLA---AAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L+   + E    ++ E+   G++ + +       L       +     + L +LH  +  
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLH--ENK 123

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAAPEYVMTG 261
           +I+RD KA NIL   D   KL+DFG++      + T  I R    +GT  + APE VM  
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 262 H-----LTTMSDVYSFGVVLLEL 279
                     +DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 25/223 (11%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIFLG 135
            +     +GEG FG +Y        K   +++   +K +DL      ++  +  E+I L 
Sbjct: 1   RYEIIKKIGEGSFGKIYLA------KAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLA 54

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR------SYSAALPWSTRMKIAL 189
           +++HP++V       E     +V EY   G L  ++ R      S    L W   ++I+L
Sbjct: 55  KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISL 112

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGEETHVITRVMG 248
           G        H  D+ +++RD K+ NI L  +   AKL DFG+A+     +   +    +G
Sbjct: 113 G------LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVG 164

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           T  Y +PE          +D++S G VL EL T K   +   L
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 61/203 (30%), Positives = 90/203 (44%), Gaps = 16/203 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+GGFG V    V          +  A K LD   L    G K  + E   L ++  P 
Sbjct: 1   LGKGGFGEVCAVQVKNT------GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 142 LVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           +V L  Y +E +  L LV   M  G L   ++      L     +  +     G+  LH 
Sbjct: 55  IVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
            D  ++YRD K  N+LLD     +LSD GLA +  +G+    IT+  GT GY APE +  
Sbjct: 114 MD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKE 168

Query: 261 GHLTTMSDVYSFGVVLLELLTGK 283
              +   D ++ G  + E++ G+
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 67/231 (29%), Positives = 107/231 (46%), Gaps = 55/231 (23%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EI 131
           + F + N +GEG +G VY+   D         + VA+K + +D     ++ +      EI
Sbjct: 7   TEFEKLNRIGEGTYGIVYRA-RDTTSG-----EIVALKKVRMDN---ERDGIPISSLREI 57

Query: 132 IFLGQLRHPHLVKL---------------IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS 176
             L  LRHP++V+L               + YC ++   LL  + MP             
Sbjct: 58  TLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT------------ 103

Query: 177 AALPWST-RMK-IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 234
              P+S  ++K + L   +GL +LH  +  +I+RD K SN+LL      K++DFGLA+  
Sbjct: 104 ---PFSESQVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR-- 156

Query: 235 PEGEETHVITRVMGTQGYAAPEYV--MTGHLTTMSDVYSFGVVLLELLTGK 283
             G     +T  + T  Y APE +   T + TT  D+++ G +L ELL  K
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 17/214 (7%)

Query: 74  LITSNFSRSNLLGEGGFGPVYKGFV---DEKLKPGLEAQPVAVKALDLDGT-QGHKEWMA 129
           L  +   +  +LG G FG VYKG      E +K      PVA+K L  + + + +KE + 
Sbjct: 4   LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKI-----PVAIKVLRENTSPKANKEILD 58

Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E   +  +  P++ +L+G C     +L V + MP G L + + R     +     +   +
Sbjct: 59  EAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYV-RENKDRIGSQDLLNWCV 116

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRVM 247
             AKG+++L  E+  +++RD  A N+L+ S    K++DFGLA+  D  E E      +V 
Sbjct: 117 QIAKGMSYL--EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV- 173

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               + A E ++    T  SDV+S+GV + EL+T
Sbjct: 174 -PIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAV--KALDLDGTQGHKEWMAEIIFL 134
            +  R   +G G FG V+   V +++     A  V    + + L   Q       E   L
Sbjct: 1   DDLERIKTVGTGTFGRVHL--VRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVL 55

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--A 192
            ++ HP +++L     ++ +  ++ EY+P G    +LF     +  +S    +   +   
Sbjct: 56  KEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG----ELFSYLRNSGRFSNSTGLFYASEIV 111

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM-GTQG 251
             L +LH   K ++YRD K  NILLD +   KL+DFG AK      +    T  + GT  
Sbjct: 112 CALEYLHS--KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPE 163

Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE +   GH   + D ++ G+++ E+L G 
Sbjct: 164 YLAPEVIQSKGHNKAV-DWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 22/216 (10%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLG 135
           F+    +G G FG VY        +     + VA+K +   G Q +++W   + E+ FL 
Sbjct: 27  FTDLREIGHGSFGAVYFA------RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +++HP+ ++  G    E    LV EY   GS  + L   +   L       I  GA +GL
Sbjct: 81  RIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGL 138

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+LH  +  +I+RD KA NILL      KL+DFG A               +GT  + AP
Sbjct: 139 AYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAP 190

Query: 256 EYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDN 288
           E ++    G      DV+S G+  +EL   K  + N
Sbjct: 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 77/286 (26%), Positives = 120/286 (41%), Gaps = 44/286 (15%)

Query: 85  LGEGGFGPVYKGFVDEK--LKPGLEAQPVAVKALDLDGTQGHKEWMA---EIIFLGQLRH 139
           LG+G F  +YKG +  +  L      Q V+V    L     H++ +A       + QL H
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG--SDHRDSLAFFETASLMSQLSH 60

Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
            HLVKL G C  +E  ++V EY+  G L   L       +    ++ +A   A  L +L 
Sbjct: 61  KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFL-HREKNNVSLHWKLDVAKQLASALHYL- 117

Query: 200 GEDKPVIYRDFKASNILL-----DSDYT--AKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            EDK +++ +    NIL+     +  Y    KLSD G+       EE     RV     +
Sbjct: 118 -EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-----RVERIP-W 170

Query: 253 AAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
            APE +  G   LT  +D +SFG  LLE+ +      +T      S +E          K
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL-----SSSE----------K 215

Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
                D   + + P+    + A    +C ++ P  RP+   ++R L
Sbjct: 216 ERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 30/221 (13%)

Query: 78  NFSRSNLLGEGGFGPVY----KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           +F+   +LG+G FG V     KG  DE     +  + V ++  D++ T      M E   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVIIQDDDVECT------MVEKRV 53

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKI 187
           L     P  +  +  C++   RL  V EY+  G L   +     F+   A          
Sbjct: 54  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-------Y 106

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   A GL FLH   K +IYRD K  N++LD++   K++DFG+ K+   G +T   TR  
Sbjct: 107 AAEIAIGLFFLH--SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTF 161

Query: 248 -GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
            GT  Y APE +         D ++FGV+L E+L G+   D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 27/213 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLV 143
           +G G FG V  G        G+    V VK L    T      ++ E+    +L HP+++
Sbjct: 3   IGNGWFGKVLLGEAHR----GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLF--RSYSAALPWS-TRMKIALGAAKGLAFLHG 200
           + +G C E    LLV E+ P G L N L   R   A +       ++A   A GL +LH 
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLA-----KDGPEGEETHVITRVMGTQGYAAP 255
            D   I+ D    N  L +D + K+ D+GLA     +D    ++ H +        + AP
Sbjct: 119 AD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-----PLRWLAP 171

Query: 256 EYV-------MTGHLTTMSDVYSFGVVLLELLT 281
           E V       +    T  S+++S GV + EL T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 73.4 bits (181), Expect = 8e-15
 Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 31/215 (14%)

Query: 85  LGEGGFGPVYKGFV----DEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AEIIFLGQLR 138
           +G+G FG V K  V    D K+        +  K +D       ++    +E+  L +L+
Sbjct: 8   IGKGSFGTVRK--VRRKSDGKI--------LVWKEIDYGNMTEKEKQQLVSEVNILRELK 57

Query: 139 HPHLVKLIGYCWEEEYRLL--VYEYMPRGSLHN--QLFRSYSAALPWSTRMKIALGAAKG 194
           HP++V+      +   + L  V EY   G L    Q  +     +      +I       
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 195 LAFLHGEDKP---VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE---ETHVITRVMG 248
           L   H    P   V++RD K +NI LD++   KL DFGLAK         +T+V     G
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----G 172

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y +PE +        SD++S G ++ EL    
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEIIFLGQLRHPH 141
           L+GEG +G V K       K     Q VA+K      D     K  M EI  L QLRH +
Sbjct: 8   LVGEGSYGMVMK------CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           LV LI     ++   LV+E++    L +     Y   L  S   K      +G+ F H  
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-- 259
           +  +I+RD K  NIL+      KL DFG A+      E  V T  + T+ Y APE ++  
Sbjct: 120 N--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGD 175

Query: 260 TGHLTTMSDVYSFGVVLLELLTG 282
           T +   + D+++ G ++ E+LTG
Sbjct: 176 TKYGRAV-DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 40/215 (18%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLGQLRHPHL 142
           +GEG +G VYK       +  L  + VA+K + L+   +G     + EI  L +L HP++
Sbjct: 7   IGEGTYGVVYKA------RDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 143 VKLIGYCWEEEYRLLVYEYM-----------PRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           V+L+     E    LV+E++           P   L   L +SY   L            
Sbjct: 61  VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL------------ 108

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRVMGT 249
            +G+A+ H     V++RD K  N+L+D +   KL+DFGLA+    P    TH +     T
Sbjct: 109 LQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----T 162

Query: 250 QGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
             Y APE ++     +T  D++S G +  E++  +
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 44/235 (18%)

Query: 79  FSRSNL-----LGEGGFGPVYK--GFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R  L     LGEG FG V +   +  +K +P  +   VAVK L  + T      +A++
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPD-QTVTVAVKMLKDNATDKD---LADL 64

Query: 132 IFLGQL-----RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--------------F 172
           I   +L     +H +++ L+G C +E    ++ EY  +G+L   L               
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124

Query: 173 RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK 232
           +     L +   +  A   A+G+ +L  E +  I+RD  A N+L+  D   K++DFGLA+
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182

Query: 233 DGPEGEETHVITRVMGTQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                   H I     T        + APE +     T  SDV+SFG+++ E+ T
Sbjct: 183 G------VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 25/215 (11%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIFLG 135
           ++++   +GEG +G VYKG      +     Q VA+K + L+  +      A  EI  L 
Sbjct: 1   DYTKIEKIGEGTYGVVYKG------RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLK 54

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA--- 192
           +L+HP++V L     +E    L++E++      +   + Y  +LP    M   L  +   
Sbjct: 55  ELQHPNIVCLQDVLMQESRLYLIFEFL------SMDLKKYLDSLPKGQYMDAELVKSYLY 108

Query: 193 ---KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
              +G+ F H   + V++RD K  N+L+D+    KL+DFGLA+    G    V T  + T
Sbjct: 109 QILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVT 164

Query: 250 QGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
             Y APE ++     +   D++S G +  E+ T K
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)

Query: 85  LGEGGFGPVYKGFVDEK---LKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHP 140
           LGEG FG V +G +++    LK  ++   +A+       T+   E +++E + + +  HP
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI------CTRSEMEDFLSEAVCMKEFDHP 60

Query: 141 HLVKLIGYCWEEEYR------LLVYEYMPRGSLHNQLFRSY----SAALPWSTRMKIALG 190
           ++++LIG C +          +++  +M  G LH+ L  S        LP    +K    
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            A G+ +L    K  I+RD  A N +L+ +    ++DFGL+K    G+            
Sbjct: 121 IASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            + A E +     TT SDV+SFGV + E+ T
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 75/241 (31%), Positives = 110/241 (45%), Gaps = 25/241 (10%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKL----KPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           NF    +LG G +G V   F+  K+       L A  V  KA  +   +  +    E   
Sbjct: 1   NFELLRVLGTGAYGKV---FLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQV 57

Query: 134 LGQLRH-PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           L  +R  P LV L  Y ++ + +L L+ +Y+  G L   L++         + +++ +  
Sbjct: 58  LEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVYIAE 113

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGT 249
              LA  H     +IYRD K  NILLDS+    L+DFGL+K+    E E  +      GT
Sbjct: 114 IV-LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GT 169

Query: 250 QGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
             Y APE +     GH     D +S GV+  ELLTG  A   T  G + S +E +R +LK
Sbjct: 170 IEYMAPEVIRGGSGGH-DKAVDWWSLGVLTFELLTG--ASPFTVDGEQNSQSEISRRILK 226

Query: 307 E 307
            
Sbjct: 227 S 227

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 25/283 (8%)

Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           + +LR I S       ++R   +G+G  G V+   +D         Q VA+K ++L    
Sbjct: 5   MEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTA-IDVAT-----GQEVAIKQINLQKQP 58

Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
             +  + EI+ + +L++P++V  +      +   +V EY+  GSL + +  +    +  +
Sbjct: 59  KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEA 115

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETH 241
               +     + L FLH     VI+RD K+ N+LL  D + KL+DFG  A+  PE  +  
Sbjct: 116 QIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR- 172

Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW 300
             + ++GT  + APE V         D++S G++ +E++ G+    N    R   L A  
Sbjct: 173 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230

Query: 301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHP 343
             P L+ P KL  +    L     +   ++ +A   K L  HP
Sbjct: 231 GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSA---KELLQHP 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 32/212 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---------DLDGTQGHKEWMAEIIFL 134
           +LG+G FG V     + K       +  A+KAL         D++ T   +  +A    L
Sbjct: 2   VLGKGSFGKVM--LAELKGT----NEFFAIKALKKDVVLEDDDVECTMVERRVLA----L 51

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL--HNQLFRSYSAALPWSTRMKIALGAA 192
               HP L  L      +E+   V EY+  G L  H Q    +  A       +I  G  
Sbjct: 52  AW-EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG-- 108

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
             L FLH   K +IYRD K  N+LLD D   K++DFG+ K+   GE     +   GT  Y
Sbjct: 109 --LQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162

Query: 253 AAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
            APE ++ G     S D +SFGV+L E+L G+
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 70/205 (34%), Positives = 98/205 (47%), Gaps = 18/205 (8%)

Query: 84  LLGEGGFGPVY----KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH 139
           +LG+G FG V     KG  DE     +  + V ++  D+D T   K     I+ L   +H
Sbjct: 2   VLGKGSFGKVMLAELKG-TDEVYAIKVLKKDVILQDDDVDCTMTEKR----ILALAA-KH 55

Query: 140 PHLVKLIGYCWEEEYRLL-VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           P L  L   C++ + RL  V EY+  G L  Q+ RS     P S      +  A  L FL
Sbjct: 56  PFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--LMFL 112

Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
           H     VIYRD K  NILLD++   KL+DFG+ K+G     T   T   GT  Y APE +
Sbjct: 113 HRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEIL 168

Query: 259 MTGHLTTMSDVYSFGVVLLELLTGK 283
                    D ++ GV++ E++ G+
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 28/220 (12%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMA---EI 131
           +N+    LLG+G FG VY  +  +        + +AVK +  D +  +  KE  A   EI
Sbjct: 2   TNWRLGKLLGQGAFGRVYLCYDADT------GRELAVKQVQFDPESPETSKEVNALECEI 55

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLL--VYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
             L  L H  +V+  G   +   R L    E+MP GS+ +QL +SY A     TR K   
Sbjct: 56  QLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTR-KYTR 113

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD------GPEGEETHVI 243
              +G+++LH     +++RD K +NIL DS    KL DFG +K          G     +
Sbjct: 114 QILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG-----M 166

Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V GT  + +PE +        +D++S G  ++E+LT K
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 46/155 (29%), Positives = 84/155 (54%), Gaps = 9/155 (5%)

Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+  L +   P++V   G  + +    +  E+M  GSL +Q+ +  +  +P +   KI++
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKK-AGRIPENILGKISI 106

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR-VMG 248
              +GL +L  + K +++RD K SNIL++S    KL DFG++     G+    +    +G
Sbjct: 107 AVLRGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVG 160

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T+ Y +PE +   H T  SD++S G+ L+E+  G+
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 71/205 (34%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAE-IIFLGQLRH 139
           ++G+G FG V         K   +    AVK L        KE    MAE  + L  L+H
Sbjct: 2   VIGKGSFGKVLLA------KRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH 55

Query: 140 PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKI-ALGAAKGLAF 197
           P LV L  Y ++   +L  V +Y+  G L   L R      P   R +  A   A  + +
Sbjct: 56  PFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARFYAAEVASAIGY 111

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
           LH  +  +IYRD K  NILLDS     L+DFGL K+G E EET   +   GT  Y APE 
Sbjct: 112 LHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEV 167

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           +         D +  G VL E+L G
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 70/213 (32%), Positives = 97/213 (45%), Gaps = 36/213 (16%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---------DLDGTQGHKEWMAEIIFL 134
           +LG+G FG V    + E        +  AVK L         D++ T   K     I+ L
Sbjct: 2   VLGKGSFGKVMLARLKE------SGRLYAVKVLKKDVILQDDDVECTMTEKR----ILSL 51

Query: 135 GQLRHPHLVKLIGYCWEEEYRLL-VYEYMPRGSL--HNQLFRSYSAALPWSTRMKI-ALG 190
            +  HP L +L   C++   RL  V E++  G L  H Q  R +  A     R +  A  
Sbjct: 52  AR-NHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAE 104

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGT 249
               L FLH  DK +IYRD K  N+LLD +   KL+DFG+ K+G   G+ T       GT
Sbjct: 105 ITSALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC---GT 159

Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             Y APE +         D ++ GV+L E+L G
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 5e-14
 Identities = 59/211 (27%), Positives = 85/211 (40%), Gaps = 40/211 (18%)

Query: 88  GGFGPVYKGFVDEKLKPGLEAQPVAVKAL---DLDGTQGHKEWMAE-IIFLGQLRHPHLV 143
           G FG VY        K        A+K L   D+          AE  I + Q   P++ 
Sbjct: 7   GAFGSVYLA------KKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 144 KLIGYCWEEEYRLLVYEYMPRGS----------LHNQLFRSYSAALPWSTRMKIALGAAK 193
           KL      ++Y  LV EY+  G           L     + Y A +              
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV------------VL 108

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K  N+L+D     KL+DFGL+++G E +      + +GT  Y 
Sbjct: 109 GVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYL 160

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
           APE ++      MSD +S G V+ E L G  
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.2 bits (174), Expect = 5e-14
 Identities = 64/289 (22%), Positives = 120/289 (41%), Gaps = 29/289 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---DLDGTQGHKEWMAEIIF 133
           +NF     +G G F  VY+          L+ +PVA+K +   ++   +  ++ + EI  
Sbjct: 2   ANFQIEKKIGRGQFSEVYRATCL------LDRKPVALKKVQIFEMMDAKARQDCVKEIDL 55

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALPWSTRMKIALGA 191
           L QL HP+++K +    E+    +V E    G L   +  F+     +P  T  K  +  
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
              +  +H   + V++RD K +N+ + +    KL D GL +      +T     ++GT  
Sbjct: 116 CSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPY 171

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL 311
           Y +PE +        SD++S G +L E+   +      ++            L    +K+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----------LFSLCQKI 220

Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
           E+   P L  +     ++K       C+   P  RP + YV ++   + 
Sbjct: 221 EQCDYPPLPTE---HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 68/219 (31%), Positives = 93/219 (42%), Gaps = 49/219 (22%)

Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEI-IFL-- 134
           LG G FG V    YK             +  A+KAL         E    M E  IF   
Sbjct: 7   LGRGHFGKVLLAEYKK----------TGELYAIKALKKGDIIARDEVESLMCEKRIFETA 56

Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSL----HNQLF-----RSYSAALPWSTR 184
              RHP LV L   C++ E  +  V EY   G L    H  +F       Y+A       
Sbjct: 57  NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC------ 109

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP-EGEETHVI 243
             + LG    L +LH  +  ++YRD K  N+LLD++   K++DFGL K+G   G+ T   
Sbjct: 110 --VVLG----LQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF 161

Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
               GT  + APE +     T   D +  GV++ E+L G
Sbjct: 162 C---GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 76/292 (26%), Positives = 121/292 (41%), Gaps = 39/292 (13%)

Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 84

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       + +                 + 
Sbjct: 85  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 145 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL 305
                + APE +     T  SDV+SFGV+L E+ T G        +       E    LL
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELFKLL 255

Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
           KE  ++++          P     +       C    P  RPT   +V  LD
Sbjct: 256 KEGHRMDK----------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 26/226 (11%)

Query: 79  FSRSNL-----LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAE 130
            SR+ L     LGEG FG V   +    +K KP  +   VAVK L  D T +   + ++E
Sbjct: 9   LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPN-KPVTVAVKMLKDDATDKDLSDLVSE 67

Query: 131 IIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS------- 182
           +  +  + +H +++ L+G C ++    ++ EY  +G+L   L       + +S       
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 183 -------TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
                    +  A   A+G+ +L    +  I+RD  A N+L+  D   K++DFGLA+D  
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185

Query: 236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
             +     T       + APE +     T  SDV+SFGV+L E+ T
Sbjct: 186 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 59/181 (32%), Positives = 89/181 (49%), Gaps = 31/181 (17%)

Query: 117 DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSL--HNQLFR 173
           D+D  Q  K      +F     HP LV L   C++ E RL  V E++  G L  H Q  R
Sbjct: 38  DIDWVQTEKH-----VFETASNHPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQR 91

Query: 174 SYSAALP------WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
                LP      +S  + +AL       FLH  ++ +IYRD K  N+LLD++   KL+D
Sbjct: 92  K----LPEEHARFYSAEISLALN------FLH--ERGIIYRDLKLDNVLLDAEGHIKLTD 139

Query: 228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGKRAM 286
           +G+ K+G    +T   +   GT  Y APE ++ G     S D ++ GV++ E++ G+   
Sbjct: 140 YGMCKEGIRPGDT--TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Query: 287 D 287
           D
Sbjct: 197 D 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 74/245 (30%), Positives = 99/245 (40%), Gaps = 58/245 (23%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLG 135
            +F    ++G G FG V+   V +K    + A  V  K+  +   Q  H    AE   L 
Sbjct: 1   DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILA 56

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS----------YSAALPWSTRM 185
               P +VKL     +EE+  LV EYMP G L N L R           Y A       +
Sbjct: 57  DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA------EL 110

Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET----- 240
            +AL +   L F+H        RD K  NIL+D+D   KL+DFGL K   + ++      
Sbjct: 111 VLALDSVHKLGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLN 162

Query: 241 -----------------HVITRVM-----GTQGYAAPEYVMTGH-LTTMSDVYSFGVVLL 277
                            H   RV      GT  Y APE V+ G       D +S GV+L 
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILY 221

Query: 278 ELLTG 282
           E+L G
Sbjct: 222 EMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 28/211 (13%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQ-PVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +LG+G +G VY           L  Q  +A+K +    ++  +    EI     L+H ++
Sbjct: 15  VLGKGTYGIVYAA-------RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI 67

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA--KGLAFLHG 200
           V+ +G   E  +  +  E +P GSL + L RS    L  + +  I       +GL +LH 
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH- 125

Query: 201 EDKPVIYRDFKASNILLDSDYTA--KLSDFG----LAKDGPEGEETHVITRVMGTQGYAA 254
            D  +++RD K  N+L+++ Y+   K+SDFG    LA   P  E         GT  Y A
Sbjct: 126 -DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINPCTET------FTGTLQYMA 177

Query: 255 PEYVMTGH--LTTMSDVYSFGVVLLELLTGK 283
           PE +  G       +D++S G  ++E+ TGK
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-----MAEIIFLGQL-R 138
           LG+G FG VY        + G   + VA+K +     +    W     + E+  L +L  
Sbjct: 7   LGDGTFGSVYLA---RNKETG---ELVAIKKM----KKKFYSWEECMNLREVKSLRKLNE 56

Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA-ALPWSTRMKIALGAAKGLAF 197
           HP++VKL     E +    V+EYM  G+L+ QL +         S    I     +GLA 
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYM-EGNLY-QLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 198 LH--GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           +H  G      +RD K  N+L+      K++DFGLA+   E       T  + T+ Y AP
Sbjct: 115 IHKHG----FFHRDLKPENLLVSGPEVVKIADFGLAR---EIRSRPPYTDYVSTRWYRAP 167

Query: 256 EYVMTGHLTTMS---DVYSFGVVLLELLTGK 283
           E ++    T+ S   D+++ G ++ EL T +
Sbjct: 168 EILL--RSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 29/284 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---DLDGTQGHKEWMAEIIF 133
           +NF     +G G F  VY+          L+  PVA+K +   DL   +   + + EI  
Sbjct: 2   ANFRIEKKIGRGQFSEVYRATCL------LDGVPVALKKVQIFDLMDAKARADCIKEIDL 55

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALPWSTRMKIALGA 191
           L QL HP+++K      E+    +V E    G L   +  F+     +P  T  K  +  
Sbjct: 56  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQL 115

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
              L  +H   + V++RD K +N+ + +    KL D GL +      +T     ++GT  
Sbjct: 116 CSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPY 171

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL 311
           Y +PE +        SD++S G +L E+     A+ +   G + +L           +K+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLC-------KKI 220

Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV 355
           E+   P L        +++       C++  P  RP ++YV  V
Sbjct: 221 EQCDYPPLPSD---HYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 81/307 (26%), Positives = 129/307 (42%), Gaps = 48/307 (15%)

Query: 79  FSRSNL-----LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAE 130
           FSR  L     LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E
Sbjct: 12  FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSE 70

Query: 131 IIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--------------FRSY 175
           +  +  + +H +++ L+G C ++    ++ EY  +G+L   L               R  
Sbjct: 71  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130

Query: 176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
              + +   +      A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D  
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ 295
             +     T       + APE +     T  SDV+SFGV++ E+ T         LG   
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT---------LGGSP 239

Query: 296 SLA---EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYV 352
                 E    LLKE  ++++          P     +       C    P HRPT   +
Sbjct: 240 YPGIPVEELFKLLKEGHRMDK----------PANCTNELYMMMRDCWHAIPSHRPTFKQL 289

Query: 353 VRVLDSL 359
           V  LD +
Sbjct: 290 VEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 70.1 bits (171), Expect = 2e-13
 Identities = 70/242 (28%), Positives = 108/242 (44%), Gaps = 27/242 (11%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-----DLDGTQGHKEWMAEIIFLGQLR 138
           ++G G +  V    V  K    + A  V  K L     D+D  Q  K      +F     
Sbjct: 2   VIGRGSYAKVL--LVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKH-----VFEQASS 54

Query: 139 HPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           +P LV L   C++   RL LV EY+  G L   + R     LP       A      L F
Sbjct: 55  NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNF 111

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
           LH  ++ +IYRD K  N+LLD+D   KL+D+G+ K+G    +T   +   GT  Y APE 
Sbjct: 112 LH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEI 167

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAM----DNTRLGREQSLAEWARPLLKEPRKLER 313
           +         D ++ GV++ E++ G+       DN  +  E  L +    +L++P ++ R
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ---VILEKPIRIPR 224

Query: 314 LI 315
            +
Sbjct: 225 FL 226

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.8 bits (170), Expect = 3e-13
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 22/251 (8%)

Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR I S       ++R   +G+G  G VY       +  G   Q VA++ ++L    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 59

Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
             +  + EI+ + + ++P++V  +      +   +V EY+  GSL + +  +    +   
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEG 116

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETH 241
               +     + L FLH     VI+RD K+ NILL  D + KL+DFG  A+  PE  +  
Sbjct: 117 QIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173

Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW 300
             + ++GT  + APE V         D++S G++ +E++ G+    N    R   L A  
Sbjct: 174 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231

Query: 301 ARPLLKEPRKL 311
             P L+ P KL
Sbjct: 232 GTPELQNPEKL 242

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 21/208 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G +G VYK       +P      +    L+LD ++ ++  M E+  L +   P++V 
Sbjct: 9   LGKGNYGSVYKVL----HRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYIVD 63

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA--LPWSTRMKIALGAAKGLAFLHGED 202
             G  + E    +  EYM  GSL ++L+    A   +P     +I     KGL FL  E+
Sbjct: 64  FYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK-EE 121

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV-MGTQGYAAPEYVMTG 261
             +I+RD K +N+L++ +   KL DFG++     G     + +  +G Q Y APE + +G
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 262 HL------TTMSDVYSFGVVLLELLTGK 283
                   T  SDV+S G+ +LE+  G+
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.0 bits (168), Expect = 4e-13
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 22/251 (8%)

Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR I S       ++R   +G+G  G VY       +  G   Q VA+K ++L    
Sbjct: 5   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAI---DIATG---QEVAIKQMNLQQQP 58

Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
             +  + EI+ + + ++P++V  +      +   +V EY+  GSL + +  +    +   
Sbjct: 59  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEG 115

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETH 241
               +     + L FLH     VI+RD K+ NILL  D + KL+DFG  A+  PE  +  
Sbjct: 116 QIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 172

Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW 300
             + ++GT  + APE V         D++S G++ +E++ G+    N    R   L A  
Sbjct: 173 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230

Query: 301 ARPLLKEPRKL 311
             P L+ P +L
Sbjct: 231 GTPELQNPERL 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 32/213 (15%)

Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVK----ALDLDGTQGHKEWMA---EIIFL 134
              +GEG +G VYK       +     + VA+K     L  +G       ++   EI  L
Sbjct: 4   LAEIGEGAYGTVYKA------RDLNTGRFVALKKVRVPLSEEGIP-----LSTLREIALL 52

Query: 135 GQLR---HPHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            QL    HP++V+L+  C     + E +L LV+E++ +  L   L +     LP  T   
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD 111

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           +     +G+ FLH     +++RD K  NIL+ SD   K++DFGLA+          +T V
Sbjct: 112 LMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSV 166

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLEL 279
           + T  Y APE ++     T  D++S G +  EL
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 76/240 (31%), Positives = 110/240 (45%), Gaps = 20/240 (8%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKP----GLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           NF    +LG G +G V   F+  K+       L A  V  KA  +   +  +    E   
Sbjct: 1   NFELLKVLGTGAYGKV---FLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           L  +R    +  + Y ++ + +L L+ +Y+  G L   L +           ++I  G  
Sbjct: 58  LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEI 114

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
             LA  H     +IYRD K  NILLDS+    L+DFGL+K+  E +E        GT  Y
Sbjct: 115 V-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEY 172

Query: 253 AAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK-EP 308
            AP+ V     GH   + D +S GV++ ELLTG  A   T  G + S AE +R +LK EP
Sbjct: 173 MAPDIVRGGDGGHDKAV-DWWSMGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKSEP 229

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 15/209 (7%)

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---DLDGTQGHKEWMAEII 132
             NF     +G+G F  VYK          L+ + VA+K +   ++   +  ++ + EI 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICL------LDGRVVALKKVQIFEMMDAKARQDCLKEID 54

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALPWSTRMKIALG 190
            L QL HP+++K +    E     +V E    G L   +  F+     +P  T  K  + 
Sbjct: 55  LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
               L  +H   K +++RD K +N+ + +    KL D GL +      +T     ++GT 
Sbjct: 115 LCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTP 170

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLEL 279
            Y +PE +        SD++S G +L E+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 67/209 (32%), Positives = 93/209 (44%), Gaps = 16/209 (7%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMA--EIIFLG 135
           F +  +LG+GGFG V    V          +  A K L+    +  K E MA  E   L 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT------GKMYACKKLEKKRIKKRKGESMALNEKQILE 55

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           ++    +V L  Y +E +  L LV   M  G L   ++    A       +  A     G
Sbjct: 56  KVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L  LH E   ++YRD K  NILLD     ++SD GLA   PEG+    I   +GT GY A
Sbjct: 115 LEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMA 169

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE V     T   D ++ G +L E++ G+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 54/172 (31%), Positives = 82/172 (47%), Gaps = 13/172 (7%)

Query: 117 DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL-VYEYMPRGSLHNQLFRSY 175
           D+D  Q  K      +F     HP LV L   C++ E RL  V EY+  G L   + R  
Sbjct: 38  DIDWVQTEKH-----VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQR 91

Query: 176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
              LP       +   +  L +LH  ++ +IYRD K  N+LLDS+   KL+D+G+ K+G 
Sbjct: 92  K--LPEEHARFYSAEISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147

Query: 236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
              +T   +   GT  Y APE +         D ++ GV++ E++ G+   D
Sbjct: 148 RPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 75/249 (30%), Positives = 112/249 (44%), Gaps = 22/249 (8%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKL----KPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           NF    +LG G +G V   F+  K+       L A  V  KA  +   +  +    E   
Sbjct: 1   NFELLKVLGTGAYGKV---FLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNV 57

Query: 134 LGQLRH-PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALG 190
           L  +R  P LV L  Y ++ E +L L+ +Y+  G +   L+ R   +       ++   G
Sbjct: 58  LEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSG 112

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
               LA  H     ++YRD K  NILLDS+    L+DFGL+K+    E+    +   GT 
Sbjct: 113 EII-LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTI 170

Query: 251 GYAAPEYV--MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP 308
            Y APE +    GH   + D +S G+++ ELLTG  A   T  G   + +E +R +LK  
Sbjct: 171 EYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTG--ASPFTLEGERNTQSEVSRRILKCD 227

Query: 309 RKLERLIDP 317
                 I P
Sbjct: 228 PPFPSFIGP 236

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 67.6 bits (165), Expect = 8e-13
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 35/282 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQ--PVAVKALDLDGTQGHKEWMAEII----FLGQLR 138
           LG+G F  ++KG +  ++    E     V +K LD    + H+ +          + QL 
Sbjct: 3   LGQGTFTKIFKG-IRREVGDYGELHKTEVLLKVLD----KSHRNYSESFFEAASMMSQLS 57

Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           H HLV   G C   +  ++V EY+  GSL   L ++ +  +  S ++++A   A  L FL
Sbjct: 58  HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFL 116

Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPE 256
             EDK + + +  A N+LL  +   K  +    K    G    V+ + +  +   +  PE
Sbjct: 117 --EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPE 174

Query: 257 YVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +    +L+  +D +SFG  L E+ +G           ++ L+      L   +KL+   
Sbjct: 175 CIENPQNLSLAADKWSFGTTLWEIFSGG----------DKPLS-----ALDSQKKLQ-FY 218

Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
           + R   Q P     + A    +C+ + P  RP+   ++R L+
Sbjct: 219 EDRH--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 78  NFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI 131
           +F + + LG G  G V+K      G +  +    LE +P A++           + + E+
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP-AIR----------NQIIREL 54

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             L +   P++V   G  + +    +  E+M  GSL   L ++    +P     K+++  
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAV 112

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            KGL +L  E   +++RD K SNIL++S    KL DFG++    +     +    +GT+ 
Sbjct: 113 IKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 167

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 20/216 (9%)

Query: 78  NFSRSNLLGEGGFGPVY----KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           +F+   +LG+G FG V     KG  DE     +  + V ++  D++ T      M E   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECT------MVEKRV 53

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           L     P  +  +  C++   RL  V EY+  G L   + +      P +  +  A   +
Sbjct: 54  LALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA--VFYAAEIS 111

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM-GTQG 251
            GL FLH   + +IYRD K  N++LDS+   K++DFG+ K   E     V TR   GT  
Sbjct: 112 VGLFFLH--RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPD 166

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           Y APE +         D +++GV+L E+L G+   D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 45/154 (29%), Positives = 82/154 (53%), Gaps = 7/154 (4%)

Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+  L +   P++V   G  + +    +  E+M  GSL +Q+ +  +  +P     K+++
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE-AKRIPEEILGKVSI 110

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
              +GLA+L  E   +++RD K SNIL++S    KL DFG++    +     +    +GT
Sbjct: 111 AVLRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGT 165

Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           + Y +PE +   H +  SD++S G+ L+EL  G+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 68/201 (33%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI-IFLGQLRHPHL 142
           ++G+G FG V       KL     A  V  K + L+  +  K  MAE  + L  ++HP L
Sbjct: 2   VIGKGSFGKVL--LAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFL 58

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           V L  Y ++   +L  V +++  G L   L R  S   P   R   A   A  L +LH  
Sbjct: 59  VGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-RARFYAA-EIASALGYLHSI 115

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG 261
           +  ++YRD K  NILLDS     L+DFGL K+G    +T   T   GT  Y APE +   
Sbjct: 116 N--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEVIRKQ 171

Query: 262 HLTTMSDVYSFGVVLLELLTG 282
                 D +  G VL E+L G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 66/214 (30%), Positives = 94/214 (43%), Gaps = 36/214 (16%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---------DLDGTQGHKEWMAEIIFL 134
           +LG+G FG V    +  K       +  AVKAL         D++ T   K  +A     
Sbjct: 2   VLGKGSFGKVLLAELKGK------GEYFAVKALKKDVVLIDDDVECTMVEKRVLAL---- 51

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL--HNQ---LFRSYSAALPWSTRMKIAL 189
               +P L  L      +E+   V E++  G L  H Q    F  Y A    +  +    
Sbjct: 52  -AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC--- 107

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
               GL FLH   K +IYRD K  N++LD D   K++DFG+ K+   G+     +   GT
Sbjct: 108 ----GLQFLH--SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGT 159

Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             Y APE +     T   D +SFGV+L E+L G+
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 70/276 (25%), Positives = 129/276 (46%), Gaps = 28/276 (10%)

Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEII 132
           R +  N+ +   +GEG  G V      EK       + VAVK +DL   Q  +    E++
Sbjct: 20  RSLLENYIK---IGEGSTGIVC--IAREKH----SGRQVAVKMMDLRKQQRRELLFNEVV 70

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            +   +H ++V++       E   ++ E++  G+L + + ++       +T  +  L A 
Sbjct: 71  IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA- 129

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEETHVITRVMG 248
             L +LH +   VI+RD K+ +ILL  D   KLSDFG    ++KD P+ +       ++G
Sbjct: 130 --LCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS------LVG 179

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA-MDNTRLGREQSLAEWARPLLKE 307
           T  + APE +      T  D++S G++++E++ G+     ++ +   + L +   P LK 
Sbjct: 180 TPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN 239

Query: 308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHP 343
             K+  ++   LE     +  ++A A     L  HP
Sbjct: 240 AHKISPVLRDFLERMLTREPQERATAQE---LLDHP 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPG--LEAQPVAVKALDLDGTQGHKE-----WMAEIIFLG- 135
            LG G FG VYK  V +K      L  + + V        +  ++      ++E+  +  
Sbjct: 7   HLGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYM---PRGSLHNQL---FRSYSAALPWSTRMKIAL 189
           QLRHP++V+      E +   +V + +   P G   N L    + ++    W+  +++ L
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                L +LH E K +++RD   +NI+L  D    ++DFGLAK   +  E+  +T V+GT
Sbjct: 125 A----LRYLHKE-KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESK-LTSVVGT 176

Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
             Y+ PE V        +DV++FG +L ++ T
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLG 135
           F +  +LG+GGFG V    V          +  A K L+   +   +G    + E   L 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT------GKMYACKRLEKKRIKKRKGESMALNEKQILE 55

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK- 193
           ++    +V L  Y +E +  L LV   M  G L    F  Y+   P     +    AA+ 
Sbjct: 56  KVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFEEERALFYAAEI 111

Query: 194 --GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             GL  LH E+   +YRD K  NILLD     ++SD GLA   PEGE    I   +GT G
Sbjct: 112 LCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVG 166

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE +     T   D +  G ++ E++ G+
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 77/302 (25%), Positives = 113/302 (37%), Gaps = 82/302 (27%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHL 142
           ++GEG +G VYK    +K       Q VA+K +D+   +  +E   E   L +   HP++
Sbjct: 13  VIGEGTYGKVYKA-RHKKTG-----QLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNI 65

Query: 143 VKLIG------------YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK---- 186
               G              W      LV E    GS+ + L +          R+K    
Sbjct: 66  ATFYGAFIKKNPPGNDDQLW------LVMELCGGGSVTD-LVKG---LRKKGKRLKEEWI 115

Query: 187 --IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHV 242
             I     +GLA+LH  +  VI+RD K  NILL  +   KL DFG++   D   G     
Sbjct: 116 AYILRETLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173

Query: 243 ITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGK---------RAMDN 288
           I    GT  + APE +             SDV+S G+  +EL  GK         RA+  
Sbjct: 174 I----GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-- 227

Query: 289 TRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
            ++ R         P LK P    +  +  +                 +CL  +   RP 
Sbjct: 228 FKIPRNPP------PTLKSPENWSKKFNDFIS----------------ECLIKNYEQRPF 265

Query: 349 MS 350
           M 
Sbjct: 266 ME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 65/204 (31%), Positives = 90/204 (44%), Gaps = 17/204 (8%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHL 142
           LLG+G FG V    V EK      A  +  K + +   +  H   + E   L   RHP L
Sbjct: 2   LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT--VTESRVLQNTRHPFL 57

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--AKGLAFLH 199
             L  Y ++   RL  V EY   G    +LF   S    ++       GA     L +LH
Sbjct: 58  TAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYGAEIVSALEYLH 112

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
             D  V+YRD K  N++LD D   K++DFGL K+G     T  +    GT  Y APE + 
Sbjct: 113 SRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 168

Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D +  GVV+ E++ G+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EIIFLGQLR- 138
           +GEG +G V+K      LK G   + VA+K + +   Q  +E M      E+  L  L  
Sbjct: 9   IGEGAYGKVFKA---RDLKNG--GRFVALKRVRV---QTGEEGMPLSTIREVAVLRHLET 60

Query: 139 --HPHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             HP++V+L   C     + E +L LV+E++ +  L   L +     +P  T   +    
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GL FLH     V++RD K  NIL+ S    KL+DFGLA+          +T V+ T  
Sbjct: 120 LRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLW 174

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE ++     T  D++S G +  E+   K
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 14/212 (6%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--HKEWMAEIIFLGQ 136
           + +   +GEG FG   K  + +  + G   +   +K +++        +E   E+  L  
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDG---KQYVIKEINISKMSPKEREESRKEVAVLSN 55

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP++V+      E     +V +Y   G L+ ++  +    + +     +       LA
Sbjct: 56  MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDWFVQICLA 113

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV-MGTQGYAAP 255
             H  D+ +++RD K+ NI L  D T KL DFG+A+       T  + R  +GT  Y +P
Sbjct: 114 LKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR---VLNSTVELARTCIGTPYYLSP 170

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           E          SD+++ G VL E+ T K A +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 57/231 (24%), Positives = 113/231 (48%), Gaps = 16/231 (6%)

Query: 108 AQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL 167
            + VAVK +DL   Q  +    E++ +    H ++V +       +   +V E++  G+L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 168 HNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
            + +  +       +T   + L   + L++LH +   VI+RD K+ +ILL SD   KLSD
Sbjct: 107 TDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSD 161

Query: 228 FG----LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           FG    ++K+ P+ +       ++GT  + APE +      T  D++S G++++E++ G+
Sbjct: 162 FGFCAQVSKEVPKRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Query: 284 RAMDNT-RLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAA 333
               N   L   + + +   P +K+  K+  ++   L+     + +Q+A A
Sbjct: 216 PPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATA 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 19/208 (9%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFL 134
           NF R+  LG G FG V       +  P     PVA+K  +       K+     +E   L
Sbjct: 33  NFIRT--LGTGSFGRVILATYKNEDFP-----PVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
             + HP  V L G   +E Y  LV E++  G     L R+      +   +     A   
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIV 141

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L F + +   ++YRD K  N+LLD D   K++DFG AK      +T   T + GT  Y A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTRTYT-LCGTPEYIA 196

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           PE ++       +D ++ G+ + E+L G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 20/216 (9%)

Query: 78  NFSRSNLLGEGGFGPVY----KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           +F+   +LG+G FG V     KG  DE     +  + V ++  D++ T      M E   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECT------MVEKRV 53

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           L     P  +  +  C++   RL  V EY+  G L  Q+ +      P +  +  A   A
Sbjct: 54  LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA--VFYAAEIA 111

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM-GTQG 251
            GL FLH   K +IYRD K  N++LDS+   K++DFG+ K   E     V T+   GT  
Sbjct: 112 IGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPD 166

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           Y APE +         D ++FGV+L E+L G+   +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 67/204 (32%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHL 142
           LLG+G FG V    V EK      A  +  K + +   +  H   + E   L   RHP L
Sbjct: 2   LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTENRVLQNSRHPFL 57

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--AKGLAFLH 199
             L  Y ++   RL  V EY   G    +LF   S    +S       GA     L +LH
Sbjct: 58  TAL-KYSFQTHDRLCFVMEYANGG----ELFFHLSRERVFSEDRARFYGAEIVSALDYLH 112

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            E K V+YRD K  N++LD D   K++DFGL K+G +   T  +    GT  Y APE + 
Sbjct: 113 SE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLE 169

Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D +  GVV+ E++ G+
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 33/93 (35%), Positives = 58/93 (62%), Gaps = 4/93 (4%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL+++   K+ DFGLA+   PE + T  +T  + T+ 
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T + D++S G +L E+L+ +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 72/212 (33%), Positives = 95/212 (44%), Gaps = 22/212 (10%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMA--EIIFLG 135
           F    +LG+GGFG V    V    K        A K L+    +  K E MA  E   L 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKM------YACKKLEKKRIKKRKGEAMALNEKQILE 55

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK- 193
           ++    +V L  Y +E +  L LV   M  G L    F  Y+   P     +    AA+ 
Sbjct: 56  KVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK---FHIYNMGNPGFDEERAVFYAAEI 111

Query: 194 --GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             GL  LH E   ++YRD K  NILLD     ++SD GLA + PEGE    I   +GT G
Sbjct: 112 TCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVG 166

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE V     T   D +  G ++ E++ GK
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 66/236 (27%), Positives = 99/236 (41%), Gaps = 49/236 (20%)

Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           + +LR+   +F    ++G G FG V    V  K       Q  A+K L        K  M
Sbjct: 35  ITKLRMKAEDFDVIKVIGRGAFGEVQ--LVRHKSS----KQVYAMKLLS-------KFEM 81

Query: 129 ---AEIIFLGQLRH-------PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
              ++  F  + R          +V+L     +++Y  +V EYMP G L N L  +Y   
Sbjct: 82  IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIP 140

Query: 179 LPWS----TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----L 230
             W+      + +AL A   + F+H        RD K  N+LLD     KL+DFG    +
Sbjct: 141 EKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKM 192

Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLTG 282
             +G    +T V     GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 193 DANGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 86  GEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA---EIIFLGQLRHPHL 142
           G G +G VYK     K K G + +  A+K    D  Q      +   EI  L +L+H ++
Sbjct: 9   GRGTYGRVYKA----KRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV 64

Query: 143 VKLIGYCWEEEYRL--LVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAAKGLAFL 198
           V L+    E   +   L+++Y          F   +  +     M   +      G+ +L
Sbjct: 65  VSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 199 HGEDKPVIYRDFKASNILLDSDY----TAKLSDFGLAK--DGPEGEETHVITRVMGTQGY 252
           H     V++RD K +NIL+  +       K+ D GLA+  + P      +   V+ T  Y
Sbjct: 125 H--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL-DPVVVTIWY 181

Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLT 281
            APE ++   H T   D+++ G +  ELLT
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 30/217 (13%)

Query: 82  SNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM-AEIIFLGQLRH 139
           S+LL EG FG ++ G  +DEK     + + V VK +    ++     +  E   L  L H
Sbjct: 11  SDLLQEGTFGRIFYGILIDEK---PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67

Query: 140 PHLVKLIGYCWEE-EYRLLVYEYMPRGSLHNQLF----RSYSAALP--WSTR--MKIALG 190
            +++ ++  C E+ E   ++Y YM  G+L  +LF    R   A  P   ST+  + +A+ 
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNL--KLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPE-----GEETHVIT 244
            A G+++LH   + VI++D  A N ++D +   K++D  L++D  P      G+  +   
Sbjct: 126 IACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           + M      A E ++    ++ SDV+SFGV+L EL+T
Sbjct: 184 KWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 70/224 (31%), Positives = 101/224 (45%), Gaps = 36/224 (16%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-----MAEIIF 133
           F     +GEG +G VYK       +     + VA+K + LD     KE      + EI  
Sbjct: 9   FDIIGQIGEGTYGQVYKA------RDKDTGELVALKKVRLDN---EKEGFPITAIREIKI 59

Query: 134 LGQLRHPHLVKL----------IGYCWEEEYRLLVYEYMPR---GSLHNQLFRSYSAALP 180
           L QL H ++V L          + +  ++    LV+EYM     G L + L   +S    
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-HFSEDHI 118

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
            S  MK  L   +GL + H   K  ++RD K SNILL++    KL+DFGLA+     E  
Sbjct: 119 KSF-MKQLL---EGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
               +V+ T  Y  PE ++       + DV+S G +L EL T K
Sbjct: 173 PYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 70/212 (33%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMA--EIIFLG 135
           F    +LG+GGFG V    V          +  A K L+    +  K E MA  E   L 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRAT------GKMYACKKLEKKRIKKRKGEAMALNEKRILE 55

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK- 193
           ++    +V L  Y +E +  L LV   M  G L    F  Y+   P     +    AA+ 
Sbjct: 56  KVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLK---FHIYNMGNPGFDEQRAIFYAAEL 111

Query: 194 --GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             GL  L  E   ++YRD K  NILLD     ++SD GLA   PEGE   V  RV GT G
Sbjct: 112 CCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVG 166

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE +     T   D +  G ++ E++ G+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 66/204 (32%), Positives = 89/204 (43%), Gaps = 17/204 (8%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHL 142
           LLG+G FG V    V EK      A  +  K + +   +  H   + E   L   RHP L
Sbjct: 2   LLGKGTFGKVI--LVREKATGKYYAMKILKKEVIIAKDEVAHT--LTESRVLQNTRHPFL 57

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--AKGLAFLH 199
             L  Y ++   RL  V EY   G L   L R    +     R     GA     L +LH
Sbjct: 58  TAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF---YGAEIVSALGYLH 112

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
             D  V+YRD K  N++LD D   K++DFGL K+G     T  +    GT  Y APE + 
Sbjct: 113 SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 168

Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D +  GVV+ E++ G+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 11/156 (7%)

Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
             E   L +L HP +V ++    +E     + E++  G    +LF     A  +   +  
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGG----ELFTHLRKAGRFPNDVAK 121

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
              A   LAF +   K +IYRD K  N+LLD+    K++DFG AK  P+   T     + 
Sbjct: 122 FYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LC 176

Query: 248 GTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTG 282
           GT  Y APE + + GH   + D ++ GV+L E + G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAV-DWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 10/93 (10%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H     +I+RD K SNI ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 181

Query: 253 AAPEYVMT--GHLTTMSDVYSFGVVLLELLTGK 283
            APE +M    H     D++S G ++ ELLTGK
Sbjct: 182 RAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 39/107 (36%), Positives = 54/107 (50%), Gaps = 18/107 (16%)

Query: 186 KIALGAAKGLAFL---HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ET 240
           K+ +   K L +L   HG    VI+RD K SNILLD+    KL DFG++     G   ++
Sbjct: 118 KMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGIS-----GRLVDS 168

Query: 241 HVITRVMGTQGYAAPEYV----MTGHLTTMSDVYSFGVVLLELLTGK 283
              TR  G   Y APE +            +DV+S G+ L+EL TG+
Sbjct: 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 64/204 (31%), Positives = 91/204 (44%), Gaps = 17/204 (8%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHL 142
           LLG+G FG V    V EK      A  +  K + +   +  H   + E   L   RHP L
Sbjct: 2   LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHT--LTESRVLKNTRHPFL 57

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--AKGLAFLH 199
             L  Y ++ + RL  V EY+  G    +LF   S    +S       GA     L +LH
Sbjct: 58  TSL-KYSFQTKDRLCFVMEYVNGG----ELFFHLSRERVFSEDRTRFYGAEIVSALDYLH 112

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
                ++YRD K  N++LD D   K++DFGL K+G     T  +    GT  Y APE + 
Sbjct: 113 --SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--MKTFCGTPEYLAPEVLE 168

Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D +  GVV+ E++ G+
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 12/116 (10%)

Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           KIA+   K L +LH     VI+RD K SN+L++ +   KL DFG++     G     + +
Sbjct: 107 KIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-----GYLVDSVAK 160

Query: 246 VM--GTQGYAAPEYV----MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ 295
            +  G + Y APE +            SDV+S G+ ++EL TG+   D+ +   +Q
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 15/203 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVK--ALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +GEG +G V+K    E        + VA+K   LD D        + EI  L +L+H ++
Sbjct: 8   IGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V+L      ++   LV+EY  +     + F S +  +             KGLAF H  +
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCDQDL--KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
             V++RD K  N+L++ +   KL+DFGLA+    G      +  + T  Y  P+ +    
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 263 LTTMS-DVYSFGVVLLELLTGKR 284
           L + S D++S G +  EL    R
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL +LH     +++RD K  N+L++S+   K+ DFGLA+     E  H+   V+ TQ Y
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170

Query: 253 AAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            APE +M + H T+  D++S G +  ELL  +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 66/207 (31%), Positives = 92/207 (44%), Gaps = 24/207 (11%)

Query: 84  LLGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEI-IFLGQL 137
           ++G+G FG V   +   +EK          AVK L        KE    M+E  + L  +
Sbjct: 2   VIGKGSFGKVLLARHKAEEKF--------YAVKVLQKKAILKKKEEKHIMSERNVLLKNV 53

Query: 138 RHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKI-ALGAAKGL 195
           +HP LV L  + ++   +L  V +Y+  G L   L R      P   R +  A   A  L
Sbjct: 54  KHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASAL 109

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
            +LH  +  ++YRD K  NILLDS     L+DFGL K+  E   T   +   GT  Y AP
Sbjct: 110 GYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAP 165

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTG 282
           E +         D +  G VL E+L G
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 61/269 (22%), Positives = 103/269 (38%), Gaps = 45/269 (16%)

Query: 93  VYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA----EIIFLGQLRHPHLVKLIGY 148
           +YKG  + K         V ++        GHK  +     EI  L ++   +++K+ G+
Sbjct: 36  IYKGIFNNK--------EVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGF 86

Query: 149 CWEEEYRL----LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED-K 203
             +    L    L+ EY  RG L   L       L + T++ +A+   KGL  L+    K
Sbjct: 87  IIDIVDDLPRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK 144

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT--G 261
           P  Y++  + + L+  +Y  K+   GL K        +V   V     Y + + +     
Sbjct: 145 P--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFS 197

Query: 262 HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG 321
             T   D+YS GVVL E+ TGK   +N       +  E    ++ +   L          
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIPFENL------TTKEIYDLIINKNNSL---------- 241

Query: 322 QFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
           + P+    +       C SH    RP + 
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIK 270

Length = 283

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 58/232 (25%), Positives = 115/232 (49%), Gaps = 36/232 (15%)

Query: 71  ELRLITSNFSRS--------NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           E ++I ++ +RS        N++G G FG VY+    +       ++ VA+K +  D   
Sbjct: 52  EEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDT------SEKVAIKKVLQDPQY 105

Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL--------LVYEYMPRGSLHNQL--F 172
            ++E +     +  L H +++ L  Y + E ++         +V E++P+ ++H  +  +
Sbjct: 106 KNRELL----IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHY 160

Query: 173 RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLA 231
              + ALP       +    + LA++H   K + +RD K  N+L+D + +T KL DFG A
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218

Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTG 282
           K+   G+ +      + ++ Y APE ++   + TT  D++S G ++ E++ G
Sbjct: 219 KNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 61.0 bits (148), Expect = 9e-11
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 29/182 (15%)

Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP------WSTRMKIALGAAK 193
           P++V L  Y   E+   LV ++   G L + +  S    +P      W+  M +AL A  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI--SKFLNIPEECVKRWAAEMVVALDA-- 100

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
               LH E   ++ RD   +NILLD     +L+ F    +  +  +   +  +     Y 
Sbjct: 101 ----LHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YC 149

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD--------NTRLGREQSLAEWARPLL 305
           APE       T   D +S G +L ELLTGK  ++        +T L   + ++E AR LL
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLL 209

Query: 306 KE 307
           ++
Sbjct: 210 QQ 211

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 59/234 (25%), Positives = 105/234 (44%), Gaps = 11/234 (4%)

Query: 111 VAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQ 170
           VAVK +DL   Q  +    E++ +   +H ++V++       +   +V E++  G+L + 
Sbjct: 48  VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 107

Query: 171 LFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
           +  +       +    + L   K L+ LH +   VI+RD K+ +ILL  D   KLSDFG 
Sbjct: 108 VTHTRMNEEQIAA---VCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGF 162

Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNT- 289
                  +E      ++GT  + APE +         D++S G++++E++ G+    N  
Sbjct: 163 CAQ--VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220

Query: 290 RLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHP 343
            L   + + +   P LK   K+   +   L+       AQ+A A     L  HP
Sbjct: 221 PLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE---LLKHP 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIFLGQLRHPHL 142
           +GEG +G VYK       +  +  + +A+K + L+         A  EI  L +++H ++
Sbjct: 10  IGEGTYGVVYKA------RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM-KIAL-GAAKGLAFLHG 200
           V+L      E+   LV+EY+    L  +     S     + R+ K  L    +G+A+ H 
Sbjct: 64  VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120

Query: 201 EDKPVIYRDFKASNILLD-SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
               V++RD K  N+L+D      KL+DFGLA+    G      T  + T  Y APE ++
Sbjct: 121 HR--VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEILL 176

Query: 260 -TGHLTTMSDVYSFGVVLLELLTGK 283
            + H +T  D++S G +  E++  K
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 22/209 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK--EWMAEIIFLGQLR---H 139
           +G G +G VYK         G     VA+K++ +   +       + E+  L +L    H
Sbjct: 8   IGVGAYGTVYKA---RDPHSG---HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 140 PHLVKLIGYCW-----EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           P++V+L+  C       E    LV+E++ +  L   L +     LP  T   +     +G
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L FLH     +++RD K  NIL+ S    KL+DFGLA+          +T V+ T  Y A
Sbjct: 121 LDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRA 175

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE ++     T  D++S G +  E+   K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 54/199 (27%), Positives = 82/199 (41%), Gaps = 34/199 (17%)

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           LA  H   K +I+RD K++NILL S+   KL DFG +K         V     GT  Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE       +  +D++S GV+L ELLT KR  D                       +E +
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------------------NMEEV 253

Query: 315 IDPRLEGQF---PIKGAQKAAATAFKCLSHHPRHRPTMS----------YVVRVLDSLQD 361
           +   L G++   P   + +        LS  P+ RP+ S          ++  +L+ +Q 
Sbjct: 254 MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQT 313

Query: 362 FQDSFVGPFVYVVPNETES 380
            Q  F GP    +  + + 
Sbjct: 314 -QPGFSGPLRDTISRQIQQ 331

Length = 496

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG--EETHVITRVMGTQG 251
           GL ++H  +  V++RD K  N+L+++D   K+ DFGLA+   E   E    +T  + T+ 
Sbjct: 117 GLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE +++    T + DV+S G +L ELL  K
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 29/226 (12%)

Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           + +LR+   ++    ++G G FG V    V  K    + A  +  K   +  +     W 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW----STR 184
              I +     P +V+L     ++ Y  +V EYMP G L N L  +Y     W    +  
Sbjct: 93  ERDI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 150

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEET 240
           + +AL A   + F+H        RD K  N+LLD     KL+DFG    + K+G    +T
Sbjct: 151 VVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202

Query: 241 HVITRVMGTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLTG 282
            V     GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 203 AV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 14/218 (6%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LGEG +  VYKG         +  Q VA+K + +   +G     + E   L  L+H ++V
Sbjct: 13  LGEGSYATVYKGI------SRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
            L      +E    V+EYM    L   + +      P++ R+       +GLA++HG+  
Sbjct: 67  LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQH- 123

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-TGH 262
            +++RD K  N+L+      KL+DFGLA+      +T+    V  T  Y  P+ ++    
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATD 180

Query: 263 LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW 300
            ++  D++  G + +E+L G+ A        EQ    W
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 42/103 (40%), Positives = 55/103 (53%), Gaps = 11/103 (10%)

Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI-- 243
           KIA+   K L +L  E K +I+RD K SNILLD +   KL DFG++     G+    I  
Sbjct: 111 KIAVATVKALNYLKEELK-IIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAK 164

Query: 244 TRVMGTQGYAAPEYVMTGHLT---TMSDVYSFGVVLLELLTGK 283
           TR  G + Y APE +           SDV+S G+ L E+ TGK
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 48/151 (31%), Positives = 68/151 (45%), Gaps = 18/151 (11%)

Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW----STRMKIALGAAKGL 195
           P +V+L     +++Y  +V EYMP G L N L  +Y     W    +  + +AL A   +
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
             +H        RD K  N+LLD     KL+DFG      E       T V GT  Y +P
Sbjct: 162 GLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISP 212

Query: 256 EYVMT----GHLTTMSDVYSFGVVLLELLTG 282
           E + +    G+     D +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 26/186 (13%)

Query: 109 QPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLI-GYCWEE-------EYRLLVYE 160
           + V VKA+    T G      EI  L  + H  ++ LI  Y W+        +Y+  ++ 
Sbjct: 120 KKVIVKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFT 174

Query: 161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD 220
           Y+ R           S  LP    + I     + LA+LHG  + +I+RD K  NI LD  
Sbjct: 175 YVDR-----------SGPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEP 221

Query: 221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL 280
             A L DFG A       +T       GT    +PE +        +D++S G+VL E+ 
Sbjct: 222 ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Query: 281 TGKRAM 286
                +
Sbjct: 282 VKNVTL 287

Length = 392

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 67/240 (27%), Positives = 89/240 (37%), Gaps = 50/240 (20%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL-----DGTQGHKEWMAEIIF 133
           F +  LLG+G  G V+   V  K       +  A+K LD                 EI  
Sbjct: 3   FKKIKLLGKGDVGRVF--LVRLKGT----GKLFALKVLDKKEMIKRNKVKRVLTEQEI-- 54

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           L  L HP L  L      E Y  LV +Y P G L   L R     L           AA+
Sbjct: 55  LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEV---ARFYAAE 111

Query: 194 ---GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--------------DGPE 236
               L +LH     ++YRD K  NILL       LSDF L+K               G  
Sbjct: 112 VLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSR 169

Query: 237 GEETHVITR-------------VMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
               + I                +GT+ Y APE V++G     + D ++ G++L E+L G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRH- 139
           ++G GGFG VY        +     +  A+K LD   +   QG    + E I L  +   
Sbjct: 1   IIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 54

Query: 140 --PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
             P +V  + Y +    +L  + + M  G LH  L    S    +S        A   L 
Sbjct: 55  DCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILG 109

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
             H  ++ V+YRD K +NILLD     ++SD GLA D  + ++ H     +GT GY APE
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA---SVGTHGYMAPE 165

Query: 257 YVMTG-HLTTMSDVYSFGVVLLELLTG 282
            +  G    + +D +S G +L +LL G
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 25/215 (11%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEII 132
           IT+ +     +G G FG V         +  L  Q VA+K +          K    E+ 
Sbjct: 8   ITNRYVDLQPVGMGAFGLVCSA------RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 133 FLGQLRHPHLVKLIG-YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIAL 189
            L  LRH +++ L   +    E    V E +    LH  L      + P   +       
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLL-----TSRPLEKQFIQYFLY 115

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
              +GL ++H     V++RD K SNIL++ +   K+ DFGLA+      +   +T  + T
Sbjct: 116 QILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLAR-----IQDPQMTGYVST 168

Query: 250 QGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           + Y APE ++T     +  D++S G +  E+L GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 76/246 (30%), Positives = 112/246 (45%), Gaps = 32/246 (13%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLV 143
           +G G FG V  G V+    P   AQ V VK L +    Q   +++ E      L+H +L+
Sbjct: 3   IGNGWFGKVILGEVNSGYTP---AQ-VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS----TRMKIALGAAKGLAFLH 199
           + +G C E    LLV E+ P G L   L RS   A   +    T  ++A   A GL  LH
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLH 117

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT--RVMGTQGYAAPEY 257
             +   I+ D    N LL +D T K+ D+GL+ +  + +E + +T  ++     + APE 
Sbjct: 118 KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 258 VMTGH-------LTTMSDVYSFGVVLLELLT-GKRAMDN-------TRLGREQSLAEWAR 302
           V   H        T  S+V+S GV + EL   G +   +       T   REQ L +  +
Sbjct: 174 VDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL-KLPK 232

Query: 303 PLLKEP 308
           P LK P
Sbjct: 233 PRLKLP 238

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 26/219 (11%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA--LDLDGTQGHKEWMAEIIFLG 135
            + +   +GEG +G VYK         G   + VA+K   L++D        + EI  L 
Sbjct: 2   AYEKLEKIGEGTYGKVYKA---RDKNTG---KLVALKKTRLEMDEEGIPPTALREISLLQ 55

Query: 136 QLRH-PHLVKLIGYCWEEEYR-----LLVYEYMPRG--SLHNQLFRSYSAALPWSTRMKI 187
            L    ++V+L+     EE        LV+EY+        +   R     LP  T    
Sbjct: 56  MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDG--PEGEETHVIT 244
                KG+A  H     V++RD K  N+L+D      K++D GL +    P    TH I 
Sbjct: 116 MYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 245 RVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTG 282
               T  Y APE ++   H +T  D++S G +  E+   
Sbjct: 174 ----TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 54/219 (24%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEII-------FLGQL 137
           +G+GG+G V   F+ +K   G   + VA+K +     +     + E+         L   
Sbjct: 9   VGQGGYGQV---FLAKKKDTG---EIVALKRM----KKSLLFKLNEVRHVLTERDILTTT 58

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMP----------RGSLHNQLFRSYSAALPWSTRMKI 187
           +   LVKL+    ++EY  L  EY+P           G L     R Y A       M  
Sbjct: 59  KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA------EMFE 112

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR-- 245
           A+ A   L ++H        RD K  N L+D+    KL+DFGL+K         ++T   
Sbjct: 113 AVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKG--------IVTYAN 156

Query: 246 -VMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            V+G+  Y APE V+ G     + D +S G +L E L G
Sbjct: 157 SVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRH- 139
           ++G GGFG VY        +     +  A+K LD   +   QG    + E I L  +   
Sbjct: 1   IIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 54

Query: 140 --PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
             P +V  + Y +    +L  + + M  G LH  L    S    +S +          L 
Sbjct: 55  DCPFIV-CMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILG 109

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
             H  ++ V+YRD K +NILLD     ++SD GLA D  + ++ H     +GT GY APE
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA---SVGTHGYMAPE 165

Query: 257 YVMTG-HLTTMSDVYSFGVVLLELLTG 282
            +  G    + +D +S G +L +LL G
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 27/204 (13%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G +G VYK      L  G   +  AVK + L+          EI  + + +H ++V 
Sbjct: 17  VGSGTYGDVYKA---RNLHTG---ELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL---GAAKGLAFLHGE 201
             G     E   +  EY   GSL +     Y    P S  ++IA       +GLA+LH +
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQD----IYHVTGPLS-ELQIAYVCRETLQGLAYLHSK 125

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAAPEYV 258
            K  ++RD K +NILL  +   KL+DFG+A      + T  I +    +GT  + APE  
Sbjct: 126 GK--MHRDIKGANILLTDNGDVKLADFGVA-----AKITATIAKRKSFIGTPYWMAPEVA 178

Query: 259 M---TGHLTTMSDVYSFGVVLLEL 279
                G    + D+++ G+  +EL
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 25/215 (11%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEW-MAEIIFL 134
           + F    ++GEG +G V K    E        + VA+K   D +  +  KE  + E+  L
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKET------KEIVAIKKFKDSEENEEVKETTLRELKML 54

Query: 135 GQLRHPHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIA 188
             L+  ++V+L     +E +R      LV+EY+ +  L  +L     +   P   R  I 
Sbjct: 55  RTLKQENIVEL-----KEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPEKVRSYI- 106

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
               K + + H  D  +++RD K  N+L+  +   KL DFG A++  EG   +  T  + 
Sbjct: 107 YQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVA 163

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T+ Y +PE ++        D++S G +L EL  G+
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 31/218 (14%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EII 132
            + + N + EG +G VY+   D+K       + VA+K L ++     KE        EI 
Sbjct: 6   EYEKLNRIEEGTYGVVYRA-RDKKTG-----EIVALKKLKMEK---EKEGFPITSLREIN 56

Query: 133 FLGQLRHPHLVKL----IGYCWEEEYRLLVYEYMPRG--SLHNQLFRSYSAALPWSTRMK 186
            L +L+HP++V +    +G   ++ Y  +V EY+     SL   + + +  +      M 
Sbjct: 57  ILLKLQHPNIVTVKEVVVGSNLDKIY--MVMEYVEHDLKSLMETMKQPFLQS-EVKCLML 113

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             L    G+A LH  D  +++RD K SN+LL++    K+ DFGLA+    G      T++
Sbjct: 114 QLL---SGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQL 166

Query: 247 MGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           + T  Y APE ++     +T  D++S G +  ELLT K
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 21/207 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+GGFG V      +    G   +  A K L+   L   +G++  M E   L ++ H  
Sbjct: 1   LGKGGFGEV---SACQMRATG---KLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSR 53

Query: 142 LVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFL 198
            +  + Y ++ +  L LV   M  G L   ++     +   P             GL  L
Sbjct: 54  FIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR-VMGTQGYAAPEY 257
           H   + +IYRD K  N+LLD+D   ++SD GLA +  +G+     T+   GT G+ APE 
Sbjct: 114 H--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK---TKGYAGTPGFMAPE- 167

Query: 258 VMTGHLTTMS-DVYSFGVVLLELLTGK 283
           ++ G     S D ++ GV L E++  +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 35/95 (36%), Positives = 54/95 (56%), Gaps = 11/95 (11%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE---THVITRVMGT 249
           +GL ++H  +  V++RD K SN+LL+++   K+ DFGLA+   E  +    +V+TR    
Sbjct: 119 RGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---- 172

Query: 250 QGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK 283
             Y APE ++     TT  DV+S G +  ELL  K
Sbjct: 173 -WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     +G G +G VYK      +  G   +  A+K + L+  +       EII +   
Sbjct: 10  DFELIQRIGSGTYGDVYKA---RNVNTG---ELAAIKVIKLEPGEDFAVVQQEIIMMKDC 63

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           +H ++V   G     +   +  E+   GSL  Q     +  L  S    ++    +GL +
Sbjct: 64  KHSNIVAYFGSYLRRDKLWICMEFCGGGSL--QDIYHVTGPLSESQIAYVSRETLQGLYY 121

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH + K  ++RD K +NILL  +   KL+DFG++      + T  I +    +GT  + A
Sbjct: 122 LHSKGK--MHRDIKGANILLTDNGHVKLADFGVS-----AQITATIAKRKSFIGTPYWMA 174

Query: 255 PEYVMT---GHLTTMSDVYSFGVVLLEL 279
           PE       G    + D+++ G+  +EL
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 131 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 183

Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 53/196 (27%), Positives = 82/196 (41%), Gaps = 2/196 (1%)

Query: 89  GFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGY 148
           G  P    FV    +     + V  K + L+  +      +E+  L    H  +VK    
Sbjct: 76  GRNPTTAAFV--ATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDD 133

Query: 149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYR 208
              ++  LL+ EY   G L+ Q+ +     LP+       L     LA      + +++R
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR 193

Query: 209 DFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSD 268
           D K++NI L      KL DFG +K   +     V +   GT  Y APE       +  +D
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKAD 253

Query: 269 VYSFGVVLLELLTGKR 284
           ++S GV+L ELLT  R
Sbjct: 254 MWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 42/230 (18%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-------------GTQG-HKEWM 128
             LGEG +G V K + D         + VA+K + +              G  G H   +
Sbjct: 15  AHLGEGTYGKVEKAY-DTLTG-----KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-- 186
            E+  + +++H +++ L+    E ++  LV + M      + L +     +  +      
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKC 123

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--------DGPEGE 238
           I L    GL  LH      ++RD   +NI ++S    K++DFGLA+        D    +
Sbjct: 124 ILLQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181

Query: 239 ETHVITRVMG----TQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           ET      M     T  Y APE +M       + D++S G +  ELLTGK
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 62/232 (26%), Positives = 106/232 (45%), Gaps = 35/232 (15%)

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            + Q+ H HL  + G C      ++V E++  G L +   R     +P + ++ +A   A
Sbjct: 69  LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLA 127

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLD----SDYTA---KLSDFGLAKDGPEGEETHVITR 245
             L++L  EDK +++ +  A NILL     ++ T+   KLSD G++      EE   + R
Sbjct: 128 SALSYL--EDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER--VER 183

Query: 246 VMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL 304
           +     + APE V  G  L+T +D +SFG  LLE+              E  L E     
Sbjct: 184 I----PWIAPECVPGGNSLSTAADKWSFGTTLLEIC----------FDGEVPLKE----- 224

Query: 305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
            + P + ER  + +   + P    ++ A    +CL++ P  RP+   ++R L
Sbjct: 225 -RTPSEKERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 49/168 (29%), Positives = 69/168 (41%), Gaps = 17/168 (10%)

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           AKG+ FL    +  I+RD  A NILL  +   K+ DFGLA+D  +  +            
Sbjct: 189 AKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL 311
           + APE +     T  SDV+SFGV+L E+                SL     P +K   + 
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKIDEEF 291

Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
            R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 292 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.4 bits (138), Expect = 3e-09
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 14/211 (6%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQ 136
           ++ +   LGEG +  VYKG      K  +  + VA+K + L   +G     + E   L  
Sbjct: 6   SYEKLEKLGEGSYATVYKG------KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG 59

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L+H ++V L      +E   LV+EY+    L   + +      P + ++ +     +GL+
Sbjct: 60  LKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-FQLLRGLS 117

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           ++H   + +++RD K  N+L+      KL+DFGLA+   +   +H  +  + T  Y  P+
Sbjct: 118 YIH--QRYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173

Query: 257 YVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
            ++ +   +T  D++  G + +E++ G  A 
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 49/182 (26%), Positives = 76/182 (41%), Gaps = 13/182 (7%)

Query: 111 VAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH 168
           VAVK ++LD    +  K    EII   QL+HP+++  +     +    +V   M  GS  
Sbjct: 28  VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87

Query: 169 NQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF 228
           + L   +   LP      I       L ++H +    I+R  KAS+ILL  D    LS  
Sbjct: 88  DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGL 145

Query: 229 ----GLAKDGPEGEETHVITR-VMGTQGYAAPEYV---MTGHLTTMSDVYSFGVVLLELL 280
                + K G      H   +  +    + +PE +   + G+    SD+YS G+   EL 
Sbjct: 146 RYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELA 204

Query: 281 TG 282
            G
Sbjct: 205 NG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 24/227 (10%)

Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLL--VYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           E   L QL+HP++V      WE E  LL  V  +   G L+++L       LP +  ++ 
Sbjct: 49  EAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            +  A  L +LH  +K +++RD K  N+ L      K+ D G+A+      +  + + ++
Sbjct: 108 FVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLI 163

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE 307
           GT  Y +PE          SDV++ G  + E+ T K A +   +    SL          
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NSL---------- 210

Query: 308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
              + R+I+ +L    P   + +        LS  P  RP++  ++R
Sbjct: 211 ---VYRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 49/171 (28%), Positives = 73/171 (42%), Gaps = 23/171 (13%)

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           A+G+ FL    +  I+RD  A NILL  +   K+ DFGLA+D  +  +            
Sbjct: 184 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGRE--QSLAEWARPLLKEP 308
           + APE +     TT SDV+SFGV+L E+ + G       ++  E  Q L +  R  ++ P
Sbjct: 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR--MRAP 299

Query: 309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                   P +                  C    P+ RPT S +V +L  L
Sbjct: 300 ----ENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 14/201 (6%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LGEG +  VYKG      +  L    VA+K + L+  +G     + E+  L  L+H ++V
Sbjct: 14  LGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
            L      E+   LV+EY+ +     Q       ++             +GL + H   +
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDKDL--KQYLDDCGNSINMHNVKLFLFQLLRGLNYCH--RR 123

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-TGH 262
            V++RD K  N+L++     KL+DFGLA+   +   T   +  + T  Y  P+ ++ +  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 263 LTTMSDVYSFGVVLLELLTGK 283
            +T  D++  G +  E+ TG+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.2 bits (136), Expect = 7e-09
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 28/195 (14%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIFL 134
           S + +   +G+G FG V+K       +     Q VA+K + ++  +      A  EI  L
Sbjct: 12  SKYEKLAKIGQGTFGEVFKA------RHKKTKQIVALKKVLMENEKEGFPITALREIKIL 65

Query: 135 GQLRHPHLVKLIGYCWEE-----EYR---LLVYEYMPR---GSLHNQLFRSYSAALPWST 183
             L+H ++V LI  C  +      Y+    LV+E+      G L N+  +   + +    
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI--KK 123

Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETH 241
            MK+ L    GL ++H     +++RD KA+NIL+  D   KL+DFGLA+     +  + +
Sbjct: 124 VMKMLL---NGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178

Query: 242 VITRVMGTQGYAAPE 256
             T  + T  Y  PE
Sbjct: 179 RYTNRVVTLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 40/214 (18%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LGEG +  V+KG      +  L    VA+K + L+  +G     + E+  L  L+H ++V
Sbjct: 14  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 144 KLIGYCWEEEYRLLVYEYMPRG------------SLHNQLFRSYSAALPWSTRMKIAL-G 190
            L      ++   LV+EY+ +             S+HN               +KI L  
Sbjct: 68  TLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN---------------VKIFLYQ 112

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
             +GLA+ H   + V++RD K  N+L++     KL+DFGLA+   +   T   +  + T 
Sbjct: 113 ILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTL 168

Query: 251 GYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            Y  P+ ++ +   +T  D++  G +  E+ +G+
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 8/98 (8%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRVMGTQ 250
           +GL ++H  +  VI+RD K SN+L++ D   ++ DFG+A+       E  + +T  + T+
Sbjct: 118 RGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 251 GYAAPE--YVMTGHLTTMSDVYSFGVVLLELLTGKRAM 286
            Y APE    +  + TT  D++S G +  E+L G+R +
Sbjct: 176 WYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 32/90 (35%), Positives = 44/90 (48%), Gaps = 5/90 (5%)

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           LA  H     ++YRD K  NILLD+     L DFGL+K      +        GT  Y A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLA 164

Query: 255 PEYVM--TGHLTTMSDVYSFGVVLLELLTG 282
           PE ++   G+ T   D +S GV++ E+  G
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 65/255 (25%), Positives = 109/255 (42%), Gaps = 50/255 (19%)

Query: 46  PSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPG 105
           P S  S+   S+S  GS              S   R N +G G  G VYK       +P 
Sbjct: 49  PPSSSSSSSSSSSASGSAPSA------AKSLSELERVNRIGSGAGGTVYK----VIHRP- 97

Query: 106 LEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLVKLIG-YCWEEEYRLLVYEYMP 163
              +  A+K +  +     +  +  EI  L  + HP++VK    +    E ++L+ E+M 
Sbjct: 98  -TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL-EFMD 155

Query: 164 RGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA 223
            GSL      +    L       +A     G+A+LH   + +++RD K SN+L++S    
Sbjct: 156 GGSLEGTHI-ADEQFLA-----DVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNV 207

Query: 224 KLSDFGLAKDGPEGEETHVITRVM-------GTQGYAAPEYVMT--------GHLTTMSD 268
           K++DFG+++         ++ + M       GT  Y +PE + T        G+     D
Sbjct: 208 KIADFGVSR---------ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY---AGD 255

Query: 269 VYSFGVVLLELLTGK 283
           ++S GV +LE   G+
Sbjct: 256 IWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            GL ++H     +I+RD K  N+ ++ D   K+ DFGLA+        +V+TR      Y
Sbjct: 128 CGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WY 180

Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ E+LTGK
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+        +V+TR      Y
Sbjct: 129 KGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WY 181

Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H T   D++S G ++ E+LTGK
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LGEG +  V+KG      +  L    VA+K + L+  +G     + E+  L  L+H ++V
Sbjct: 13  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLAFLHGED 202
            L      E    LV+EY+         +      L     +KI +    +GL++ H   
Sbjct: 67  TLHDIIHTERCLTLVFEYLDSDLKQ---YLDNCGNLMSMHNVKIFMFQLLRGLSYCH--K 121

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-TG 261
           + +++RD K  N+L++     KL+DFGLA+   +   T   +  + T  Y  P+ ++ + 
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 262 HLTTMSDVYSFGVVLLELLTGK 283
             +T  D++  G +L E+ TG+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 42/219 (19%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ------LR 138
           +G G FG V       ++        V VK  +L      KE   +  FL Q      L+
Sbjct: 3   IGNGWFGKVLLS----EIYTDTGVARVVVK--ELKANASSKE---QNEFLQQGDPYRILQ 53

Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR-------MKIALGA 191
           HP++++ +G C E    LLV+EY   G L     +SY +   W  R        ++A   
Sbjct: 54  HPNILQCLGQCVEAIPYLLVFEYCELGDL-----KSYLSQEQWHRRNSQLLLLQRMACEI 108

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG-EETHVIT--RVMG 248
           A G+  +H  +   ++ D    N  L SD T K+ D+G+   GP   +E ++ T      
Sbjct: 109 AAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCV 163

Query: 249 TQGYAAPEYV-------MTGHLTTMSDVYSFGVVLLELL 280
              + APE V       +T   T  S+V++ GV L EL 
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 37/220 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G  G V+   VD         + VAVK + L   Q  K  + EI  + +L H ++VK
Sbjct: 13  LGCGSNGLVFSA-VDSDCD-----KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 145 LIGYCWEEEYRL--------------LVYEYMP---RGSLHNQLFRSYSAALPWSTRMKI 187
           +          L              +V EYM       L         A L        
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-------F 119

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAK--DGPEGEETHVIT 244
                +GL ++H  +  V++RD K +N+ +++ D   K+ DFGLA+  D P       ++
Sbjct: 120 MYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVD-PHYSHKGYLS 176

Query: 245 RVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK 283
             + T+ Y +P  +++  + T   D+++ G +  E+LTGK
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 57/209 (27%), Positives = 84/209 (40%), Gaps = 27/209 (12%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPHL 142
           ++GEG FG      V          Q  A+K + L  +    E    E + L +++HP++
Sbjct: 7   VVGEGSFGRAL--LVQHVN----SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP------WSTRMKIALGAAKGLA 196
           V        + +  +V EY   G L  ++        P      W  +M         L 
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM--------CLG 112

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRVMGTQGYAA 254
             H  +K V++RD K+ NI L  +   KL DFG A+    P     +  T V GT  Y  
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP---GAYACTYV-GTPYYVP 168

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE          SD++S G +L EL T K
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 51/160 (31%), Positives = 70/160 (43%), Gaps = 16/160 (10%)

Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWS 182
           +AE   L Q+  P +V L       E   LV  ++  G L + L     F    A   ++
Sbjct: 41  LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARF-YT 99

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
             +  AL        LH  +  VIYRD K  NILLD      L DFGL K   + ++   
Sbjct: 100 AELLCALEN------LHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-- 149

Query: 243 ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
                GT  Y APE ++    T   D ++ GV+L E+LTG
Sbjct: 150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 48/201 (23%), Positives = 75/201 (37%), Gaps = 17/201 (8%)

Query: 159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
           Y+      + N L    S  L     +      A+G+ FL    K  ++RD  A N+LL 
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271

Query: 219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLE 278
                K+ DFGLA+D                  + APE +     TT+SDV+S+G++L E
Sbjct: 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331

Query: 279 LLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKC 338
           +                SL     P +         I        P    Q+      KC
Sbjct: 332 IF---------------SLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKC 376

Query: 339 LSHHPRHRPTMSYVVRVLDSL 359
            +  P  RP+  ++  +++SL
Sbjct: 377 WNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 16/97 (16%)

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           A+G+ FL    K  I+RD  A N+LL     AK+ DFGLA+D    +  +V+      +G
Sbjct: 222 AQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARD-IMNDSNYVV------KG 272

Query: 252 YA-------APEYVMTGHLTTMSDVYSFGVVLLELLT 281
            A       APE +     T  SDV+S+G++L E+ +
Sbjct: 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 27/228 (11%)

Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           L+ LR     F    ++G G +G VYKG     +K G   Q  A+K +D+   +  +E  
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKG---RHVKTG---QLAAIKVMDVTEDE-EEEIK 60

Query: 129 AEIIFLGQLRHPHLVKLIGYCW-------EEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
            EI  L +  H   +      +        ++   LV E+   GS+ + +  +   AL  
Sbjct: 61  LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEE 239
                I     +GLA LH     VI+RD K  N+LL  +   KL DFG++   D   G  
Sbjct: 121 DWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178

Query: 240 THVITRVMGTQGYAAPEYVMTGH-----LTTMSDVYSFGVVLLELLTG 282
              I    GT  + APE +             SD++S G+  +E+  G
Sbjct: 179 NTFI----GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 13/98 (13%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPEGEETHVI-TRVM 247
           + L ++H  +  V +RD K  NIL ++D   K+ DFGLA+    D P    T +  T  +
Sbjct: 114 RALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTP----TAIFWTDYV 167

Query: 248 GTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGK 283
            T+ Y APE   +     T   D++S G +  E+LTGK
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           AKG++FL    K  I+RD  A NILL      K+ DFGLA+D        V         
Sbjct: 224 AKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVK 281

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           + APE +     T  SDV+S+G++L E+ +
Sbjct: 282 WMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 16/97 (16%)

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPE----GEETHVIT 244
           A+G+ FL    +  I+RD  A NILL  +   K+ DFGLA+D    P+    G+    + 
Sbjct: 183 ARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                  + APE +     TT SDV+SFGV+L E+ +
Sbjct: 241 -------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 54/220 (24%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LGEG +  VYKG      +  L  Q VA+K + L+  +G     + E   L  L+H ++V
Sbjct: 13  LGEGSYATVYKG------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV 66

Query: 144 KLIGYCWEEEYRLLVYEYM-----------PRG-SLHN------QLFRSYSAALPWSTRM 185
            L      ++   LV+EY+             G S+HN      QL R            
Sbjct: 67  TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR------------ 114

Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL--AKDGPEGEETHVI 243
                   GLA+ H   + V++RD K  N+L+      KL+DFGL  AK  P    +   
Sbjct: 115 --------GLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP----SKTY 160

Query: 244 TRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTG 282
           +  + T  Y  P+ ++ +   +T  D++  G +  E+ TG
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 11/157 (7%)

Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLV---YEYMPRGSLHNQLFRSYSAALPWSTR-- 184
           EI+ LG+L H +++K+      E    ++   Y++     ++++ F      L   TR  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT 244
           MK  L A   + ++H  DK +I+RD K  NI L+ D    L DFG A    +  E     
Sbjct: 273 MKQLLCA---VEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYG 327

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            V GT    +PE +       ++D++S G++LL++L+
Sbjct: 328 WV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 42/229 (18%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DL-DGTQGHKEWMAEIIFLGQLRHP 140
           L+G+GG G VY  + D        ++ VA+K +  DL +     K ++ E      L HP
Sbjct: 9   LIGKGGMGEVYLAY-DPVC-----SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62

Query: 141 HLVKLIGYCWEEEYRLLVYEYMP--RGSLHNQLFRSY--SAALPWSTRMKIALGA----- 191
            +V +   C + +    VY  MP   G     L +S     +L      K ++GA     
Sbjct: 63  GIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 192 ---AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK------------DGPE 236
                 + ++H   K V++RD K  NILL       + D+G A             D  E
Sbjct: 120 HKICATIEYVH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 237 GEETH----VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               +    +  +++GT  Y APE ++    +  +D+Y+ GV+L ++LT
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 14/178 (7%)

Query: 103 KPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYM 162
           KPG +  PV +K     G +G    + E + L  + HP ++++           +V  + 
Sbjct: 87  KPG-QPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139

Query: 163 PRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT 222
               L+  L +  S  LP    + I     +GL +LH +   +I+RD K  NI ++    
Sbjct: 140 -SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQ 195

Query: 223 AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL 280
             + D G A+  P      +   + GT    APE +      + +D++S G+VL E+L
Sbjct: 196 VCIGDLGAAQ-FPVVAPAFL--GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 35/108 (32%), Positives = 57/108 (52%), Gaps = 6/108 (5%)

Query: 176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
           S AL +   +  +   A G+ FL    K  ++RD  A N+L+      K+ DFGLA+D  
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARD-- 288

Query: 236 EGEETHVITR--VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
              +++ I++        + APE +     TT+SDV+SFG++L E+ T
Sbjct: 289 IMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H     +I+RD K SN+ ++ D   ++ DFGLA+   +    +V TR      Y
Sbjct: 129 RGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181

Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELL GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 59/249 (23%), Positives = 89/249 (35%), Gaps = 57/249 (22%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLG 135
            +F    ++G G FG V    V +K    + A     K+  L+  Q  H    AE   L 
Sbjct: 1   DDFESIKVIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVR--AERDILA 56

Query: 136 QLRHPHLVKLIGYC--WEEEYRLLVYEYMPRGSLHNQLFR----SYSAALPWSTRMKIAL 189
           +  +P +VKL  Y    +E Y  L+ EY+P G +   L +    +      +     +A+
Sbjct: 57  EADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAI 114

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--------------DGP 235
            +   L ++H        RD K  N+LLD+    KLSDFGL                   
Sbjct: 115 DSIHKLGYIH--------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 236 EGEETHVITR----------------------VMGTQGYAAPEYVMTGHLTTMSDVYSFG 273
                                            +GT  Y APE  +        D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 274 VVLLELLTG 282
           V++ E+L G
Sbjct: 227 VIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 27/218 (12%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL- 137
           F    L+G G +G VYKG     +K G   Q  A+K +D+ G +  +E   EI  L +  
Sbjct: 8   FELVELVGNGTYGQVYKG---RHVKTG---QLAAIKVMDVTGDE-EEEIKQEINMLKKYS 60

Query: 138 RHPHLVKLIGYCWE------EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            H ++    G   +      ++   LV E+   GS+ + +  +    L       I    
Sbjct: 61  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 120

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRVMGT 249
            +GL+ LH     VI+RD K  N+LL  +   KL DFG++   D   G     I    GT
Sbjct: 121 LRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GT 174

Query: 250 QGYAAPEYVMTGH-----LTTMSDVYSFGVVLLELLTG 282
             + APE +             SD++S G+  +E+  G
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 58/232 (25%), Positives = 99/232 (42%), Gaps = 45/232 (19%)

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF---RSYSAALPWSTRMKIALGAA 192
           Q+ H H+V L G C  +   ++V E++  G L   LF   +S     PW  + K+A   A
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPW--KFKVAKQLA 115

Query: 193 KGLAFLHGEDKPVIYRDFKASNILL-----DSDYTA--KLSDFGLAKDGPEGEETHVITR 245
             L++L  EDK +++ +    NILL     D +     KLSD G+       +E   + R
Sbjct: 116 SALSYL--EDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC--VER 171

Query: 246 VMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLEL-LTGKRAM-DNTRLGREQSLAEWAR 302
           +     + APE V  + +L+  +D +SFG  L E+   G+  + D T   +E+       
Sbjct: 172 I----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCM 227

Query: 303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
            +    ++L  L+                      C+++ P  RP    ++R
Sbjct: 228 LVTPSCKELADLMT--------------------HCMNYDPNQRPFFRAIMR 259

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 35/210 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-----DLDGTQGHKEWMAEIIFLGQLR- 138
           +GEG F  V K    +  K G   +  A+K +      L+        + EI  L +L  
Sbjct: 7   IGEGTFSEVLKA---QSRKTG---KYYAIKCMKKHFKSLEQVNN----LREIQALRRLSP 56

Query: 139 HPHLVKLIGYCWEEEY-RL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           HP++++LI   ++ +  RL LV+E M   +L+ +L +     LP            K L 
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELM-DMNLY-ELIKGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK----DGPEGEETHVITRVMGTQGY 252
            +H     + +RD K  NIL+  D   KL+DFG  +      P        T  + T+ Y
Sbjct: 115 HMHR--NGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP-------YTEYISTRWY 164

Query: 253 AAPEYVMT-GHLTTMSDVYSFGVVLLELLT 281
            APE ++T G+     D+++ G V  E+L+
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 5/89 (5%)

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+         ++T  + T+ Y 
Sbjct: 135 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 24/214 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G +G VYK     K K G + +  A+K   ++GT        EI  L +L+HP+++ 
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIA 62

Query: 145 LIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAA------LPWSTRMKIALGAAKGLA 196
           L         R   L+++Y      H   F   S A      LP S    +      G+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYT----AKLSDFGLAK--DGPEGEETHVITRVMGTQ 250
           +LH     V++RD K +NIL+  +       K++D G A+  + P  +    +  V+ T 
Sbjct: 123 YLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL-KPLADLDPVVVTF 179

Query: 251 GYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            Y APE ++   H T   D+++ G +  ELLT +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG--EETHVITRVMGTQG 251
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+          +V+TR      
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----- 190

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE ++        D++S G ++ E++ G 
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 9/92 (9%)

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG--EETHVITRVMGTQG 251
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+          +V+TR      
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY----- 182

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE ++        D++S G ++ E++ G 
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 61/244 (25%), Positives = 95/244 (38%), Gaps = 52/244 (21%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQ 136
           +F    ++G G FG V    V +K    + A  +  KA  L+  Q GH    AE   L +
Sbjct: 2   DFESLKVIGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIR--AERDILVE 57

Query: 137 LRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFR----SYSAALPWSTRMKIALGA 191
                +VK+  Y ++++  L L+ E++P G +   L +    +      +     +A+ +
Sbjct: 58  ADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET----------- 240
              L F+H        RD K  N+LLDS    KLSDFGL     +   T           
Sbjct: 117 IHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168

Query: 241 ----------------------HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLE 278
                                  +    +GT  Y APE  M      + D +S GV++ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 279 LLTG 282
           +L G
Sbjct: 229 MLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 24/214 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G +G VYK     K K G + +  A+K   ++GT        EI  L +L+HP+++ 
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVIS 62

Query: 145 LIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAA------LPWSTRMKIALGAAKGLA 196
           L         R   L+++Y      H   F   S A      LP      +      G+ 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYT----AKLSDFGLAK--DGPEGEETHVITRVMGTQ 250
           +LH     V++RD K +NIL+  +       K++D G A+  + P  +    +  V+ T 
Sbjct: 123 YLHA--NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL-KPLADLDPVVVTF 179

Query: 251 GYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            Y APE ++   H T   D+++ G +  ELLT +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 62/244 (25%), Positives = 95/244 (38%), Gaps = 52/244 (21%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQ 136
           +F    ++G G FG V    V +K    + A  +  KA  L+  Q  H    AE   L +
Sbjct: 2   DFESLKVIGRGAFGEVR--LVQKKDTGHIYAMKILRKADMLEKEQVAHIR--AERDILVE 57

Query: 137 LRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFR----SYSAALPWSTRMKIALGA 191
                +VK+  Y ++++  L L+ E++P G +   L +    S  A   +     +A+ A
Sbjct: 58  ADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET----------- 240
              L F+H        RD K  N+LLD+    KLSDFGL     +   T           
Sbjct: 117 IHQLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168

Query: 241 ----------------------HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLE 278
                                  +    +GT  Y APE  M      + D +S GV++ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 279 LLTG 282
           +L G
Sbjct: 229 MLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 66/227 (29%), Positives = 98/227 (43%), Gaps = 38/227 (16%)

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
           T  +     +G+G +G VYK  V  K    L A  +     D+D     +E  AE   L 
Sbjct: 21  TDTWEIIETIGKGTYGKVYK--VTNKKDGSLAAVKILDPISDVD-----EEIEAEYNILQ 73

Query: 136 QL-RHPHLVKLIGYCWEEEYRL-----LVYEYMPRGSLHNQLFRSYSAALPWSTRMK--- 186
            L  HP++VK  G  ++ +  +     LV E    GS+  +L +     L    R+    
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVK---GLLICGQRLDEAM 129

Query: 187 ---IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
              I  GA  GL  LH  +  +I+RD K +NILL ++   KL DFG++      + T   
Sbjct: 130 ISYILYGALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVS-----AQLTSTR 182

Query: 244 TR---VMGTQGYAAPEYVMTGHLTTMS-----DVYSFGVVLLELLTG 282
            R    +GT  + APE +        S     DV+S G+  +EL  G
Sbjct: 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 27/249 (10%)

Query: 85  LGEGGFGPVY-----KGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLR 138
           LG+G FG VY     K   +E+LK   E   + V  L+ + T Q ++E  A++  L +L 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKE---IPVGELNPNETVQANQE--AQL--LSKLD 60

Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALPWSTRMKIALGAAKGLA 196
           HP +VK      E +   ++ EY     L  +L   +     L  +   +  +    G+ 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRVMGTQGYAA 254
           ++H   + +++RD KA NI L ++   K+ DFG+++   G       + T   GT  Y +
Sbjct: 121 YMH--QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG----SCDLATTFTGTPYYMS 173

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTR-LGREQSLAEWARPLLKE--PRKL 311
           PE +      + SD++S G +L E+     A +    L     + E   P L E   R+L
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL 233

Query: 312 ERLIDPRLE 320
             ++   L 
Sbjct: 234 NSIMQSMLN 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 39/225 (17%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA--LDLDGTQGHKEWMAEIIFLG 135
           +F   +L+G G FG V    V EK    + A  V  K+  L  +     +E   E   L 
Sbjct: 2   DFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEE---ERDILS 56

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIAL 189
               P + +L  Y ++++  L LV EY P G L + L R         A  +   + +A+
Sbjct: 57  ISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAI 115

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEETHVITR 245
            +   + ++H        RD K  N+L+D     KL+DFG    L  +        V ++
Sbjct: 116 HSVHQMGYVH--------RDIKPENVLIDRTGHIKLADFGSAARLTANK------MVNSK 161

Query: 246 V-MGTQGYAAPEY--VMTGHLTTMSDV----YSFGVVLLELLTGK 283
           + +GT  Y APE    M G       V    +S GV+  E++ G+
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 23/160 (14%)

Query: 139 HPHLVKLIGYCWEEEYRLL--VYEYMPRGSLHNQLFRSYSAALPWST-RMKIALGAAKGL 195
           +P +V +  +C  E  R L  V EY+  G     L      ALP    RM  A      L
Sbjct: 60  NPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVDMARMYFA-ETVLAL 114

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI-------TR--- 245
            +LH  +  +++RD K  N+L+ S    KL+DFGL+K G     T++        TR   
Sbjct: 115 EYLH--NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172

Query: 246 ---VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
              V GT  Y APE ++        D ++ G++L E L G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 48/201 (23%), Positives = 80/201 (39%), Gaps = 21/201 (10%)

Query: 90  FGPVYKGF----VDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKL 145
           F P  +GF    +D K       + V +KA    GT        E   L  + HP +++L
Sbjct: 100 FTPGAEGFAFACIDNKTC-----EHVVIKAGQRGGT------ATEAHILRAINHPSIIQL 148

Query: 146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPV 205
            G     ++  L+   +PR       + +    +     + I     + + +LH  +  +
Sbjct: 149 KGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLH--ENRI 203

Query: 206 IYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTT 265
           I+RD KA NI ++      L DFG A   P     +      GT    APE +       
Sbjct: 204 IHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAGTIATNAPELLARDPYGP 262

Query: 266 MSDVYSFGVVLLELLTGKRAM 286
             D++S G+VL E+ T   ++
Sbjct: 263 AVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 58/224 (25%)

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFR----SYSAALPWST 183
           AE   L +  +  +VKL  Y ++++  L  V +Y+P G + + L R        A  +  
Sbjct: 50  AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA 108

Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK----------- 232
            +  A+ +   + F+H        RD K  NIL+D D   KL+DFGL             
Sbjct: 109 ELTCAIESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160

Query: 233 -----------------DGPEGEETHVITR-------------VMGTQGYAAPEYVM-TG 261
                               +      + R             ++GT  Y APE ++ TG
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220

Query: 262 HLTTMSDVYSFGVVLLELLTGKRA-MDNTRLGREQSLAEWARPL 304
           + T + D +S GV+L E+L G+   + +T    +  +  W   L
Sbjct: 221 Y-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 79/289 (27%), Positives = 116/289 (40%), Gaps = 59/289 (20%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD----LDGTQGHKEWMAEIIFLGQLR-H 139
           +G+G +G V+K  V  K          AVK LD    +D     +E  AE   L  L  H
Sbjct: 26  IGKGTYGKVFK--VLNKK----NGSKAAVKILDPIHDID-----EEIEAEYNILKALSDH 74

Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK------IA 188
           P++VK  G  ++++ +      LV E    GS+   L + +   L    RM+      I 
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGF---LKRGERMEEPIIAYIL 130

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
             A  GL  LH      I+RD K +NILL ++   KL DFG++               +G
Sbjct: 131 HEALMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTSVG 186

Query: 249 TQGYAAPEYV-----MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW--A 301
           T  + APE +     +        DV+S G+  +EL  G           +  LA+    
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG-----------DPPLADLHPM 235

Query: 302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
           R L K PR      +P      P   + +      KCL+     RPT+S
Sbjct: 236 RALFKIPR------NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 63/260 (24%), Positives = 94/260 (36%), Gaps = 72/260 (27%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA----EIIF 133
           +F    ++G+G FG V    + +K   G   +  A+K L L      K+ +A    E   
Sbjct: 2   DFHTVKVIGKGAFGEVR---LVQKKDTG---KIYAMKTL-LKSEMFKKDQLAHVKAERDV 54

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA----- 188
           L +   P +V L     + +Y  L+ E++P G L   L + Y       TR  +A     
Sbjct: 55  LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLA 113

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL------------------ 230
           + A   L F+H        RD K  NIL+D     KLSDFGL                  
Sbjct: 114 IEAVHKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQ 165

Query: 231 ---AKDGPEGEETHVIT-------------------RVM-----GTQGYAAPEYVMTGH- 262
               K+  +   +  +                    R+M     GT  Y APE +     
Sbjct: 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQG 224

Query: 263 LTTMSDVYSFGVVLLELLTG 282
                D +S G ++ E L G
Sbjct: 225 YGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 57/204 (27%)

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR----SYSAALPWSTR 184
           AE   L +  +  +VKL     +++    V +Y+P G + + L R        A  +   
Sbjct: 50  AERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAE 109

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA------------- 231
           + +A+ +   + F+H        RD K  NIL+D D   KL+DFGL              
Sbjct: 110 LTLAIESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161

Query: 232 ------KDGPE-------------GEETHVITR-------------VMGTQGYAAPEYVM 259
                 +D  E             G+    + +             ++GT  Y APE ++
Sbjct: 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221

Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
               T + D +S GV+L E+L G+
Sbjct: 222 RKGYTQLCDWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 43.8 bits (103), Expect = 9e-05
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 23/188 (12%)

Query: 111 VAVKALDLDG-TQGH-KEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH 168
           V V+  DL+  T+ H K    E++     RHP+++          +  ++  +M  GS  
Sbjct: 28  VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSA- 86

Query: 169 NQLFRSY-----SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA 223
           N L ++Y     S AL  +    I  GA +GL +LH      I+R+ KAS+IL+  D   
Sbjct: 87  NSLLKTYFPEGMSEALIGN----ILFGALRGLNYLH--QNGYIHRNIKASHILISGDGLV 140

Query: 224 KLSD----FGLAKDGPEGEETHVITRV-MGTQGYAAPEYV---MTGHLTTMSDVYSFGVV 275
            LS     + L ++G + +  +   +       + +PE +   + G+    SD+YS G+ 
Sbjct: 141 SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGY-NVKSDIYSVGIT 199

Query: 276 LLELLTGK 283
             EL TG+
Sbjct: 200 ACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 42/149 (28%), Positives = 63/149 (42%), Gaps = 31/149 (20%)

Query: 151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALP------WSTRMKIALGAAKGLAFLHGEDKP 204
           +E    LV +Y   G L   L   +   LP      +   M +A+ +   L ++H     
Sbjct: 72  DENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH----- 125

Query: 205 VIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEETHVITRV-MGTQGYAAPEYVM 259
              RD K  N+LLD +   +L+DFG    L  DG       V + V +GT  Y +PE + 
Sbjct: 126 ---RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT------VQSNVAVGTPDYISPEILQ 176

Query: 260 -----TGHLTTMSDVYSFGVVLLELLTGK 283
                 G      D +S GV + E+L G+
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 42/176 (23%), Positives = 66/176 (37%), Gaps = 57/176 (32%)

Query: 157 LVYEYMPRGSLHNQLFR----SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKA 212
            V +Y+P G + + L R        A  +   +  A+ +   + F+H        RD K 
Sbjct: 78  FVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--------RDIKP 129

Query: 213 SNILLDSDYTAKLSDFGL--------------AKDGPE------------------GEET 240
            NIL+D D   KL+DFGL              + D                     G+  
Sbjct: 130 DNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRL 189

Query: 241 HVITR-------------VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             + R             ++GT  Y APE ++    T + D +S GV+L E+L G+
Sbjct: 190 KPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 41/148 (27%), Positives = 62/148 (41%), Gaps = 29/148 (19%)

Query: 151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALP------WSTRMKIALGAAKGLAFLHGEDKP 204
           +E Y  LV +Y   G L   L   +   LP      +   M +A+ +   L ++H     
Sbjct: 72  DENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH----- 125

Query: 205 VIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
              RD K  N+LLD +   +L+DFG    + +DG       V     GT  Y +PE +  
Sbjct: 126 ---RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-----GTPDYISPEILQA 177

Query: 261 -----GHLTTMSDVYSFGVVLLELLTGK 283
                G      D +S GV + E+L G+
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 30/157 (19%)

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALP------WSTRMKIALGAAKGL 195
           +  + Y +++E  L LV +Y   G L   L   +   LP      +   M IA+ +   L
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEETHVITRVMGTQG 251
            ++H        RD K  NIL+D +   +L+DFG    L +DG       V     GT  
Sbjct: 122 HYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-----GTPD 168

Query: 252 YAAPEYVMT-----GHLTTMSDVYSFGVVLLELLTGK 283
           Y +PE +       G      D +S GV + E+L G+
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 26/82 (31%), Positives = 39/82 (47%), Gaps = 2/82 (2%)

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           ++HGE   +I+RD K  N+L++      L DFG A        T     + GT    APE
Sbjct: 275 YIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE 332

Query: 257 YVMTGHLTTMSDVYSFGVVLLE 278
            +     T   D++S G+V+ E
Sbjct: 333 VLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	401
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.98
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PRK10345	210	hypothetical protein; Provisional	99.84
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
smart00090	237	RIO RIO-like kinase.	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
PRK14879	211	serine/threonine protein kinase; Provisional	99.78
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.5
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
KOG1243	690	consensus Protein kinase [General function predict	99.45
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.34
COG4248	637	Uncharacterized protein with protein kinase and he	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.3
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.86
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
PRK09902	216	hypothetical protein; Provisional	98.76
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.64
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.47
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.46
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.43
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.37
PF01636	239	APH: Phosphotransferase enzyme family This family	98.37
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.22
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.2
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.18
PLN02876	822	acyl-CoA dehydrogenase	98.14
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.94
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.91
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.91
PRK10593	297	hypothetical protein; Provisional	97.83
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.82
PRK05231	319	homoserine kinase; Provisional	97.79
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.76
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.73
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.69
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.6
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.57
PLN02236	344	choline kinase	97.32
KOG2270	520	consensus Serine/threonine protein kinase involved	97.22
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.15
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.03
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.89
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.88
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.88
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.77
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.76
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.75
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.69
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.62
PLN02756	418	S-methyl-5-thioribose kinase	96.43
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.39
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.3
PTZ00384	383	choline kinase; Provisional	96.27
PRK12396	409	5-methylribose kinase; Reviewed	95.91
PRK06148	1013	hypothetical protein; Provisional	95.83
PTZ00296	442	choline kinase; Provisional	95.65
PRK11768	325	serine/threonine protein kinase; Provisional	95.5
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	95.35
COG2334	331	Putative homoserine kinase type II (protein kinase	95.32

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=378.95  Aligned_cols=254  Identities=27%  Similarity=0.402  Sum_probs=213.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-e
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-Y  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~-~  154 (401)
                      ++.+.++.||+|..|+||++.++.      +++.+|+|++... .....+++.+|+++++..+||+||.+||.|..+. .
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKP------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcC------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            456677899999999999999887      7999999999654 3455678999999999999999999999999998 5


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      ++|+||||++|+|.+.+...  +.+++....+++.+|++||.|||.. ++||||||||.||||+..|.|||||||.+...
T Consensus       153 isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            99999999999999988765  7899999999999999999999952 55999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ...    ...++.||..|||||.+.+..|+.++||||||++++|+.+|+.||...... .....+...          .+
T Consensus       230 vnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~~~~~Ll~----------~I  294 (364)
T KOG0581|consen  230 VNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YLDIFELLC----------AI  294 (364)
T ss_pred             hhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CCCHHHHHH----------HH
Confidence            544    346788999999999999999999999999999999999999999765211 111111111          11


Q ss_pred             cCCcCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          315 IDPRLEGQFPIK-GAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ++ ...+.+|.. +++++++|+..||++||.+||++.+++++
T Consensus       295 v~-~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  295 VD-EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             hc-CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            11 111233443 78899999999999999999999999865

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-52  Score=381.31  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=210.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-------ccHHHHHHHHHHHhccCCCceeeEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-------QGHKEWMAEIIFLGQLRHPHLVKLIG  147 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnI~~~~~  147 (401)
                      ..+.|.+.+.||+|+||.|-+|+.+.      +++.||||++.....       .......+|+++|++|+|||||++++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d  243 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKK------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD  243 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcc------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence            56789999999999999999999887      799999999974321       12234568999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC---CcEE
Q 040050          148 YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD---YTAK  224 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~---~~vk  224 (401)
                      +|..++..||||||+.||+|++++..+  +.+.+.....++.|++.|+.|||+++  |+||||||+|||+..+   -.+|
T Consensus       244 ~f~~~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  244 FFEVPDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             eeecCCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEE
Confidence            999999999999999999999999876  78888899999999999999999655  9999999999999765   7899


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCC---CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL---TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      |+|||+|.....   ...+.+.||||.|.|||++.++.+   ..++|+|||||++|.+|+|.+||......         
T Consensus       320 ItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~---------  387 (475)
T KOG0615|consen  320 ITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD---------  387 (475)
T ss_pred             ecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC---------
Confidence            999999998754   345678999999999999986543   34789999999999999999999875322         


Q ss_pred             hhhhcCccchhhhcCCcC--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          302 RPLLKEPRKLERLIDPRL--EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            +.-.+++...+.  .+.....++++..+||.+||..||++||++.+++++
T Consensus       388 ------~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  388 ------PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ------ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                  111122222221  112234678999999999999999999999999865

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-52  Score=394.04  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=215.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .+|..+++||+|||+.||.+++..      +++.||+|++...   .......+.+|+++.+.|+|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            579999999999999999999866      6899999999753   3444567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ++|||+|+|..++|..++.+.  +.+++.+++.++.||+.||.|||+++  |||||||..|+|++++.+|||+|||+|..
T Consensus        92 nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeee
Confidence            999999999999999998754  89999999999999999999999655  99999999999999999999999999998


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......  ...+.||||.|.|||++.....+..+||||+||+||.||.|++||....      +.+....+..+      
T Consensus       168 le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~------  233 (592)
T KOG0575|consen  168 LEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLN------  233 (592)
T ss_pred             ecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhc------
Confidence            764432  2356799999999999999999999999999999999999999997642      22211111111      


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            .-.+|...+.++.+||.++|+.||.+|||+++|+..
T Consensus       234 ------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 ------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                  113455778899999999999999999999999875

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-50  Score=380.08  Aligned_cols=290  Identities=57%  Similarity=0.947  Sum_probs=251.0

Q ss_pred             CcccccHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce
Q 040050           63 KLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL  142 (401)
Q Consensus        63 ~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI  142 (401)
                      ....|+..++..++++|.-...||+|+||.||+|...+       +..||||.+.........+|.+|+.++.+++|||+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc
Confidence            56789999999999999999999999999999998876       47899998775543214569999999999999999


Q ss_pred             eeEEEEEEeCC-eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeccCCCCcEEEcCC
Q 040050          143 VKLIGYCWEEE-YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED-KPVIYRDFKASNILLDSD  220 (401)
Q Consensus       143 ~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~iiH~Dlkp~NIlv~~~  220 (401)
                      ++++|||.+.+ ..+||+||+++|+|.+++.......++|..+++|+.++|.||+|||... +.||||||||.|||+|++
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            99999999998 5999999999999999998753338899999999999999999999753 379999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeecc-ccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRV-MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      ...||+|||+|...... ... .... .||.+|+|||.+..+..+.++||||||+++.||++|+.+.+.........+..
T Consensus       214 ~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~  291 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVE  291 (361)
T ss_pred             CCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHH
Confidence            99999999999765441 111 1122 79999999999999999999999999999999999999998766555667999


Q ss_pred             HhhhhhcCccchhhhcCCcCC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          300 WARPLLKEPRKLERLIDPRLE-GQFPI-KGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      |..+.+... .+..++|+.+. ..++. .....+..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus       292 w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  292 WAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            998887775 78889999987 66664 5777899999999999999999999999999766554

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-51  Score=369.84  Aligned_cols=250  Identities=28%  Similarity=0.439  Sum_probs=207.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .++|.+.+.||.|+||+||+|++++      ++..||||.+...  .....+.+..|+.+|+.++|||||.+++++..++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            3789999999999999999999988      5789999999876  4455667889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC------CcEEEEe
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD------YTAKLSD  227 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~------~~vkL~D  227 (401)
                      .+|||||||.||+|.++|++.  +.+++..+..++.||+.||++||++  +||||||||+|||++..      -.+||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~--~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHEN--NIIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence            999999999999999999876  7999999999999999999999954  49999999999999764      5689999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ||+|+....+..   ..+.||+|.|||||++....|+.|+|+||+|+++|++++|++||.....      .+..... . 
T Consensus       159 FGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~------~eL~~~~-~-  227 (429)
T KOG0595|consen  159 FGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP------KELLLYI-K-  227 (429)
T ss_pred             cchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH------HHHHHHH-h-
Confidence            999998876543   4567999999999999999999999999999999999999999975421      1111100 0 


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV  353 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il  353 (401)
                             .........+...+..+.+++...++.+|..|.+..+-.
T Consensus       228 -------k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  228 -------KGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             -------ccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence                   011222233444455667788888888888887765543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-52  Score=361.33  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=210.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEE-EEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIG-YCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~-~~~~~~  153 (401)
                      .+|.+.+.||.|+||+||++.+..      ++..||.|.+...  .....+....|+.+|++|+||||+++++ .|.+++
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLL------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeecc------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            457788999999999999998877      7899999999854  2344567889999999999999999998 455555


Q ss_pred             e-EEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCC--eeeccCCCCcEEEcCCCcEEEEec
Q 040050          154 Y-RLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKP--VIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       154 ~-~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~--iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                      . ++||||+|.+|+|...++.  +..+.+++..+|+++.|++.||.++|+.-++  |+||||||.||+++.+|.|||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            4 8999999999999998864  4567899999999999999999999974344  999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |+++.+....  ......+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+      +.+....     
T Consensus       173 GL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~K-----  239 (375)
T KOG0591|consen  173 GLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKK-----  239 (375)
T ss_pred             hhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHH-----
Confidence            9999876543  23456899999999999999999999999999999999999999997642      2221111     


Q ss_pred             cchhhhcCCcCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFP-IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                            +...-.+..| ...+..+..+|..|+..||+.||+.-.++..+.
T Consensus       240 ------I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  240 ------IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             ------HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                  1111122234 567899999999999999999999554444433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-50  Score=366.26  Aligned_cols=243  Identities=29%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|++.++||+|+||.||.++..+      +++.+|+|+++..   .........+|..+|.+++||+|+.++..|++.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~d------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKD------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcc------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            4789999999999999999998876      7899999999744   334567788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ..+|+|++|+.||.|+..|++.  +.+++..+..++.+|+.||.|||+  +|||||||||+|||+|.+|+++|+|||+++
T Consensus        98 ~kLylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~--~gIiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHS--KGIIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHh--CCeeeccCCHHHeeecCCCcEEEeccccch
Confidence            9999999999999999999876  789999999999999999999995  559999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .......  ...++|||+.|||||++.+..|+.++|+||||+++|+|++|.+||...+.      ..+...+        
T Consensus       174 ~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I--------  237 (357)
T KOG0598|consen  174 EDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKI--------  237 (357)
T ss_pred             hcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHH--------
Confidence            6544332  23558999999999999999999999999999999999999999987532      1222221        


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP  347 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP  347 (401)
                        ...+ ....+...+.+.++++.++|..||++|.
T Consensus       238 --~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  238 --LKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --hcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              1111 1123334678999999999999999996

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=373.60  Aligned_cols=261  Identities=34%  Similarity=0.533  Sum_probs=215.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--cHHHHHHHHHHHhccCCCceeeEEEEEEeCC-
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~-  153 (401)
                      ....+.+.||.|+||+||+|.+..       ...||+|++......  ....|.+|+.+|.+++||||++++|++.+.. 
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g-------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRG-------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCC-------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            344555679999999999998875       223999999754322  2568999999999999999999999999988 


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEecCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAK  232 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~DfG~a~  232 (401)
                      .++|||||+++|+|.+++.......+++..++.++.+|+.||.|||+.++ ||||||||+|||++.++ ++||+|||+++
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccce
Confidence            79999999999999999987545799999999999999999999995444 99999999999999997 99999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccc--cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVM--TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ......  ...+...||+.|||||++.  ...|+.++||||||+++|||+||..||......                ..
T Consensus       193 ~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----------------~~  254 (362)
T KOG0192|consen  193 EKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----------------QV  254 (362)
T ss_pred             eecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----------------HH
Confidence            654322  2234468999999999999  669999999999999999999999999875321                11


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      ...+.....+..+|..++..+..++.+||+.||..||++.+++..|+.+..-.
T Consensus       255 ~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  255 ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence            11122233344455557889999999999999999999999999999986533

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-49  Score=367.92  Aligned_cols=254  Identities=26%  Similarity=0.343  Sum_probs=213.0

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYC  149 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~  149 (401)
                      .-..+|.+++.||.|+|++|++|+...      +++.||||++...   ..........|-++|.+| .||+|++++..|
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKA------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecC------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            345789999999999999999999887      7899999998632   222334566789999999 799999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      .++..+|+|+||+++|+|.++|.+.  +.+++..+..++.+|+.||.|||+  +|||||||||+|||++.+++++|+|||
T Consensus       144 QD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~--~GIIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  144 QDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHS--NGIIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             ecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHh--cCceeccCChhheeEcCCCcEEEeecc
Confidence            9999999999999999999999887  899999999999999999999995  559999999999999999999999999


Q ss_pred             CCCCCCCCCcc---------ee--eeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          230 LAKDGPEGEET---------HV--ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       230 ~a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                      .|..+......         ..  ...++||..|.+||++.....+..+|+|+||||+|.|+.|.+||...+.-      
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------  293 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------  293 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------
Confidence            99865432211         11  14589999999999999999999999999999999999999999775311      


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                -.+++++.-  .-.+|...++.+.+|+.++|..||.+|+|+++|-++
T Consensus       294 ----------liFqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  294 ----------LIFQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ----------HHHHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                      111222211  123455567899999999999999999999888775

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-48  Score=363.19  Aligned_cols=258  Identities=31%  Similarity=0.447  Sum_probs=218.1

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      .+.+.+.||+|.||.||+|.++.       ...||+|.+... .-....|.+|+++|++|+|+|||++++++..+..+||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-------~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-------STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-------CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            34556889999999999999986       457999998754 3445788899999999999999999999999889999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      |||||+.|+|.++|.......+.....+.++.|||+|++||++++  +|||||...||||+++..+||+|||+|+.....
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            999999999999999866788999999999999999999999655  999999999999999999999999999944332


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      . ........-+..|.|||.+..+.++.+||||||||+||||+| |+.||.+...                 ...-..++
T Consensus       357 ~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev~~~le  418 (468)
T KOG0197|consen  357 E-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEVLELLE  418 (468)
T ss_pred             c-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHHHHHHh
Confidence            2 222222223567999999999999999999999999999999 8888876521                 22233445


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      ...+-..|..++..+.+++..||+.+|++|||++.+...|+.+....
T Consensus       419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            55666678889999999999999999999999999999998876543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-48  Score=337.68  Aligned_cols=237  Identities=29%  Similarity=0.400  Sum_probs=207.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||.|+||.|.+++.+.      ++..+|+|++....   -...+...+|..+|+.+.||+++++++.+.+..
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKH------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEcc------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            578899999999999999998887      68999999987542   233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+||||||++||.|+.++++.  +.+++..+..++.||+.||+|||+.+  |++|||||+|||+|.+|.+||+|||.|..
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEE
Confidence            999999999999999999876  78999999999999999999999666  99999999999999999999999999997


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     ..+.||||.|+|||++..++|+.++|+|||||++|||+.|.+||...+..                ...++
T Consensus       194 v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~----------------~iY~K  252 (355)
T KOG0616|consen  194 VSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI----------------QIYEK  252 (355)
T ss_pred             ecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH----------------HHHHH
Confidence            5432     35679999999999999999999999999999999999999999875321                12233


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHR  346 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  346 (401)
                      ++...+  .+|...+.++++|+.++|+.|-.+|
T Consensus       253 I~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            333333  4677788899999999999999999

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-48  Score=354.32  Aligned_cols=263  Identities=32%  Similarity=0.444  Sum_probs=212.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--e
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE--Y  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~--~  154 (401)
                      .++..++.||+|+||+||++.+.+      ++...|||.+........+.+.+|+.+|++++|||||+++|......  .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKK------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             chhhhhccccCccceEEEEEEecC------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            567788999999999999999877      48899999987664333667899999999999999999999754444  6


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEEEEecCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD  233 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vkL~DfG~a~~  233 (401)
                      ++++|||+++|+|.+++.+..+ .+++..+..++.||++||+|||+  +|||||||||+|||++. ++.+||+|||++..
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs--~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS--KGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh--CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            8999999999999999987644 79999999999999999999995  55999999999999999 79999999999987


Q ss_pred             CCC-CCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          234 GPE-GEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       234 ~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ... ...........||+.|||||++.++ ....++|||||||++.||+||++||... ..    ..          ..+
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~----~~----------~~~  232 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE----EA----------EAL  232 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc----hH----------HHH
Confidence            653 1111222346799999999999963 3345999999999999999999999763 00    00          111


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      ..+......+.+|...+....+|+.+|+..||++||||.++++..--.+...
T Consensus       233 ~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  233 LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            1122222333667778899999999999999999999999998755544433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-47  Score=361.77  Aligned_cols=256  Identities=27%  Similarity=0.385  Sum_probs=212.1

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC----Cc-ccHHHHHHHHHHHhccC-CCceeeEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD----GT-QGHKEWMAEIIFLGQLR-HPHLVKLIG  147 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnI~~~~~  147 (401)
                      ...++|.+++.||+|+||.|+.|.+..      ++..||+|++...    .. .....+.+|+.+++.+. ||||+++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            345899999999999999999998877      6799999977643    11 23456668999999999 999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEE
Q 040050          148 YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLS  226 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~  226 (401)
                      ++.....+|+||||+.||+|++++...  +.+.+..+..++.|++.|++|||++  ||+||||||+|||++.+ +++||+
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~--gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR--GIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEecCCCCCEEEe
Confidence            999999999999999999999999874  7899999999999999999999965  49999999999999999 999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCC-CC-ccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH-LT-TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |||++....  .......+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||+....      ....+. 
T Consensus       164 DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~k-  234 (370)
T KOG0583|consen  164 DFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRK-  234 (370)
T ss_pred             ccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHH-
Confidence            999999763  1222356789999999999999877 86 789999999999999999999987321      111111 


Q ss_pred             hcCccchhhhcCCcCCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKG-AQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                               +....  -.+|... +.++..++.+||..||.+|+++.+|+ .-.-++
T Consensus       235 ---------i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~  279 (370)
T KOG0583|consen  235 ---------IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ  279 (370)
T ss_pred             ---------HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence                     11111  1234444 88999999999999999999999998 434444

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-47  Score=347.49  Aligned_cols=264  Identities=26%  Similarity=0.358  Sum_probs=215.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .+.|++...||.|..++||+|++..      .++.||||++..+... +...+.+|+..|+.++||||++++..|..+..
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIP------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecc------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            4789999999999999999999988      5799999999877543 35788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|+||+||.+|++.+.+.......+++..+..|+++++.||.|||.++  .||||||+.||||+.+|.|||+|||.+..+
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeee
Confidence            999999999999999999988889999999999999999999999555  999999999999999999999999998765


Q ss_pred             CCCCccee--eeccccccccccccccc--cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          235 PEGEETHV--ITRVMGTQGYAAPEYVM--TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       235 ~~~~~~~~--~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ........  +.++.||++|||||++.  ...|+.|+||||||+++.||.+|..||......  ..+   ...+...+..
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvL---l~tLqn~pp~  251 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVL---LLTLQNDPPT  251 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHH---HHHhcCCCCC
Confidence            54432222  24578999999999965  467999999999999999999999999875321  011   1111111111


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +.   ...+........+..++.++..||+.||.+|||++++++.
T Consensus       252 ~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 LL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            11   0111111122335589999999999999999999999865

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4e-48  Score=339.46  Aligned_cols=266  Identities=26%  Similarity=0.323  Sum_probs=208.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +.|+.+.++|+|+||.||++++++      +|+.||||++....  +...+-.++|+.+|++++|+|+|.++++|.....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk   75 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK   75 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence            468888999999999999998888      79999999986432  2234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +++|+|||+. ++.+.+.+. ..+++...+..++.|++.|+.|+|+++  +|||||||+||||+.+|.+||||||+|+..
T Consensus        76 lhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L  151 (396)
T KOG0593|consen   76 LHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTL  151 (396)
T ss_pred             eEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhh
Confidence            9999999966 554555543 468999999999999999999999777  999999999999999999999999999987


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH-Hhhhhh-------
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE-WARPLL-------  305 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~~-------  305 (401)
                      ...  ...++.++.|.+|+|||.+.| ..|+..+||||+||++.||++|.+.|.+....+.-.... ...+++       
T Consensus       152 ~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  152 SAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             cCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence            642  234577889999999999998 789999999999999999999999998764332211111 111111       


Q ss_pred             cCccchhhhcCCcC------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLERLIDPRL------EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........+.-|..      ...+ +..+.-+.+|+..||+.||.+|++.++++..
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            11111111111111      1112 3446689999999999999999999988754

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.1e-46  Score=353.70  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=204.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|+++++||+|+||.||+|+-+.      +|..+|+|+++..   ........+.|-.+|....+|+||+++..|.+.
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKD------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             cccchhheeeccccceeEEEEEEcc------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            3689999999999999999998776      7999999999754   234466788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      .++||||||++||++..+|.+.  +.|++..+..++.+++.|+..||+++  +|||||||+|+|||..|++||+|||++.
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~  289 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLST  289 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccc
Confidence            9999999999999999999876  89999999999999999999999655  9999999999999999999999999984


Q ss_pred             CCCC----------------------CCcc----ee-------------------eeccccccccccccccccCCCCccc
Q 040050          233 DGPE----------------------GEET----HV-------------------ITRVMGTQGYAAPEYVMTGHLTTMS  267 (401)
Q Consensus       233 ~~~~----------------------~~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~  267 (401)
                      -...                      ....    ..                   ....+|||.|||||++.+..|+..+
T Consensus       290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c  369 (550)
T KOG0605|consen  290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC  369 (550)
T ss_pred             hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence            1110                      0000    00                   0125799999999999999999999


Q ss_pred             cHHhHHHHHHHHHhCCCCCCCCcccc-cccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 040050          268 DVYSFGVVLLELLTGKRAMDNTRLGR-EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHR  346 (401)
Q Consensus       268 DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  346 (401)
                      |+||||||+||||.|.+||....+.. -..+..|...               +...-...++.++.+||.+||. ||.+|
T Consensus       370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            99999999999999999998753221 1112222111               1111122345899999999999 99999


Q ss_pred             CC---HHHHHH
Q 040050          347 PT---MSYVVR  354 (401)
Q Consensus       347 Pt---~~~il~  354 (401)
                      .-   ++||-+
T Consensus       434 LG~~G~~EIK~  444 (550)
T KOG0605|consen  434 LGSKGAEEIKK  444 (550)
T ss_pred             cCcccHHHHhc
Confidence            76   555543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-47  Score=359.47  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=215.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ..|.....||+|+.|.||.|....      +++.||||.+........+-+++|+.+|+..+|+|||.+++.|...+.+|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKIS------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhcchhhhccccccceeeeeecc------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            478889999999999999998776      57889999999887777788999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||++||+|.+.+...   .+++.++..|++++++||+|||  .+||+|||||.+|||++.+|.|||+|||++.....
T Consensus       347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH--~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH--ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH--hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999988663   5999999999999999999999  45599999999999999999999999999987766


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ....  -.+.+|||+|||||++..+.|+++.||||||++++||+-|.+||-..+.-..                +..+.+
T Consensus       422 ~~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA----------------lyLIa~  483 (550)
T KOG0578|consen  422 EQSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----------------LYLIAT  483 (550)
T ss_pred             ccCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH----------------HHHHhh
Confidence            5432  2456899999999999999999999999999999999999999976422111                111111


Q ss_pred             -CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          317 -PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       317 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       ....-..+..++..+++|+.+||+.||.+|+++.++|++
T Consensus       484 ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  484 NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence             111223456678999999999999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-47  Score=364.14  Aligned_cols=256  Identities=27%  Similarity=0.410  Sum_probs=218.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      +-|.+++.||.|+-|.|-+|++..      +|+.+|||++....   ......+.+|+-+|+.+.||||+++|+++.+..
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~   85 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAE------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ   85 (786)
T ss_pred             cceeccccccCCCCceehhhhccc------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc
Confidence            568899999999999999998887      89999999997541   223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ++|+|.||++||.|++++.++  +++++.++.++++||+.|+.|||..+  |+||||||+|+|++..+++||+|||+|..
T Consensus        86 ~lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen   86 HLYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             eEEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeec
Confidence            999999999999999999887  89999999999999999999999666  99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCC-ccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLT-TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      -..+.   ...+.||+|.|.|||++.|.+|+ .++||||+|||||.||+|+.||++.+.                    .
T Consensus       162 e~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------------------r  218 (786)
T KOG0588|consen  162 EVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------------------R  218 (786)
T ss_pred             ccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------------------H
Confidence            55543   34667999999999999999995 689999999999999999999985421                    1


Q ss_pred             hhcCCcCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhhcccC
Q 040050          313 RLIDPRLEG--QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV--LDSLQDFQDS  365 (401)
Q Consensus       313 ~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~--L~~l~~~~~~  365 (401)
                      .++..-..+  ++|..++.++++|+.+||..||++|.|+++|+++  |........+
T Consensus       219 ~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  219 VLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             HHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            111111111  3466778899999999999999999999999987  4444444443

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=354.78  Aligned_cols=268  Identities=24%  Similarity=0.354  Sum_probs=214.3

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc-HHHHHHHHHHHhccC-CCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQLR-HPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-hpnI~~~~~~~~~  151 (401)
                      .+.++|.+.+.||.|+||.||+|....      ++..||||.++..-... ..--++|+..|++|+ ||||+++.+++.+
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~------~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d   80 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKE------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD   80 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecC------CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc
Confidence            345789999999999999999998877      68889999987543222 223468999999998 9999999999999


Q ss_pred             CC-eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          152 EE-YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       152 ~~-~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      .+ .+|+||||| ..+|++++..+ +..+++..+..|+.||++||+|+|.++  +.|||+||+|||+.....|||+|||+
T Consensus        81 ~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   81 NDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             cCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccccc
Confidence            88 999999999 67999999877 789999999999999999999999655  99999999999999888999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc-HHHHhhhhhcC-
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-LAEWARPLLKE-  307 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~-  307 (401)
                      |+...+..   .++.++-|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++.|.+....++.. +.+........ 
T Consensus       157 ARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~  233 (538)
T KOG0661|consen  157 AREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS  233 (538)
T ss_pred             ccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence            99876544   357788999999999987 5788999999999999999999999998875433221 11111110000 


Q ss_pred             ---ccchhhhcC--------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 ---PRKLERLID--------PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ---~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ...+...+.        ..+...++ +.+.++.++|.+||..||.+||||.+++++
T Consensus       234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  234 WPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             chhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               011111111        11111122 378899999999999999999999999876

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.5e-46  Score=322.87  Aligned_cols=264  Identities=27%  Similarity=0.375  Sum_probs=210.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--cHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .+|...+.||+|.||.||+|++..      +++.||||+++.....  .....++|+..|+.++|+||+.++++|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            478888999999999999999887      7999999999866432  24578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +.||+||+ ..+|...+..+ .-.++...+..++.+++.||+|||++.  |+||||||+|+||+.+|.+||+|||+|+.+
T Consensus        76 l~lVfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   76 LSLVFEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             eEEEEEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhcc
Confidence            99999999 56998888654 467889999999999999999999655  999999999999999999999999999987


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc-Ccc---
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK-EPR---  309 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~---  309 (401)
                      ......  .+..+-|.+|+|||.+.| ..|+...|+||.||++.||+.|.+.|.+...-++  +....+.+-. .+.   
T Consensus       152 ~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP  227 (318)
T KOG0659|consen  152 GSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWP  227 (318)
T ss_pred             CCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCc
Confidence            765433  233477999999999986 6799999999999999999999998877543221  1111111110 000   


Q ss_pred             ---------chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 ---------KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                               .+.....+.... +-+.++.++.+|+.+||..||.+|+++.+++++
T Consensus       228 ~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  228 EMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                     111111111111 223456778999999999999999999999876

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-46  Score=354.10  Aligned_cols=248  Identities=31%  Similarity=0.447  Sum_probs=215.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|.+.+.||+|+||.||+|+.+.      +.+.||+|.+...+  ......+.+|++|++.++||||+.++++|+...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            468888999999999999997665      78899999997554  3446678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|+|.||+.| +|+.++...  +.++++.+..++.+++.||.|||++.  |+|||+||.|||++..|.+|+||||+|+..
T Consensus        76 ~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhc
Confidence            9999999965 999999764  89999999999999999999999766  999999999999999999999999999976


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..  .+.+.+...|||.|||||++.+++|+..+|+|||||++||+++|++||-..      ++.+.+..+..++.     
T Consensus       151 ~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d~v-----  217 (808)
T KOG0597|consen  151 ST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKDPV-----  217 (808)
T ss_pred             cc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcCCC-----
Confidence            55  455677889999999999999999999999999999999999999999643      34444444333322     


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             .+|...+..+..|+..+|.+||.+|.+..+++.+
T Consensus       218 -------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 -------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                   2355678899999999999999999999998764

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-47  Score=350.49  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=212.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..|+....||+|.||.||+|.+..      +++.||+|++..+.. ..+..+.+|+.+|..++++||.++|+.+..+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNK------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccchhccccccceeeeeeecc------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            467777999999999999999888      789999999988754 4467888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++||||.||++.+.+...  ..+.+..+..++++++.|+.|||.++  .+|||||+.||++..+|.|||+|||++....
T Consensus        87 wiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeee
Confidence            9999999999999999664  45588889999999999999999655  9999999999999999999999999998766


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ......  .+++|||.|||||++.+..|+.++||||||++++||++|.+|+...-+.                 ....++
T Consensus       163 ~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rvlflI  223 (467)
T KOG0201|consen  163 NTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RVLFLI  223 (467)
T ss_pred             chhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eEEEec
Confidence            543322  6689999999999999999999999999999999999999999764221                 111112


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .....+.+....+..+++|+..||..||+.||+|.+++++
T Consensus       224 pk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  224 PKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            2222222333567889999999999999999999999875

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-45  Score=351.10  Aligned_cols=268  Identities=28%  Similarity=0.421  Sum_probs=207.4

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      ..++|++.+.||+|+||.||+|.+... ....++..||+|++..... .....+.+|+.++..+ +||||+++++++...
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGI-DKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEecc-CCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            347899999999999999999976321 1123467899999874432 3345788999999999 899999999988764


Q ss_pred             C-eEEEEEEecCCCChhHHHhhhc--------------------------------------------------------
Q 040050          153 E-YRLLVYEYMPRGSLHNQLFRSY--------------------------------------------------------  175 (401)
Q Consensus       153 ~-~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------------  175 (401)
                      + .++++|||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence            4 5889999999999999986421                                                        


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccc
Q 040050          176 ----SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG  251 (401)
Q Consensus       176 ----~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~  251 (401)
                          ...+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++................+++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHH--CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                1347788899999999999999995  5599999999999999999999999999986533222212223446788


Q ss_pred             cccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHH
Q 040050          252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQK  330 (401)
Q Consensus       252 y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (401)
                      |+|||++.+..++.++|||||||++|+|++ |..||.......  .+..   . ...          ......+...+..
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~---~-~~~----------~~~~~~~~~~~~~  305 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ---R-LKD----------GTRMRAPENATPE  305 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH---H-Hhc----------CCCCCCCCCCCHH
Confidence            999999999999999999999999999997 999997643211  0111   0 000          0011123344678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          331 AAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       331 l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      +.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-46  Score=320.09  Aligned_cols=250  Identities=28%  Similarity=0.399  Sum_probs=216.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|++++.||+|.||.||+|+.++      ++-.||+|++...   ......++.+|++|...|+||||+++|++|.+.
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekk------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKK------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             hhhccccccccCCccccEeEeeecc------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            3789999999999999999998887      6789999998643   234457889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...|+++||..+|+|+..|.....+.+++.....++.|++.|+.|+|  .++||||||||+|+|++..|.+||+|||.+.
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            99999999999999999999777788999999999999999999999  6669999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..+...    -.+.|||..|.|||.+.+..++..+|+|++|++.||++.|.+||......                ....
T Consensus       173 ~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYk  232 (281)
T KOG0580|consen  173 HAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYK  232 (281)
T ss_pred             ecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHH
Confidence            755322    24578999999999999999999999999999999999999999765311                1122


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ++...  .-.+|..++..++++|.+|+..+|.+|.+..++++.
T Consensus       233 rI~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  233 RIRKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            22221  224566778899999999999999999999999875

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-46  Score=344.56  Aligned_cols=266  Identities=27%  Similarity=0.317  Sum_probs=208.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE-  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-  152 (401)
                      .+.|+.++.||+|+||.||+|++..      +++.||+|+++.+.  ........+||.||++|.||||+++.+...+. 
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~  189 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLE------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL  189 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecc------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence            3568888999999999999999887      79999999999775  44456778999999999999999999998876 


Q ss_pred             -CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          153 -EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       153 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                       ..+|||+|||+ -+|.-++.. ..-.+++.++..++.||+.||.|||  .+||+|||||..|||||.+|.+||+|||+|
T Consensus       190 ~~siYlVFeYMd-hDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH--~~gvlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  190 SGSIYLVFEYMD-HDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH--SRGVLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             CceEEEEEeccc-chhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh--hcCeeeccccccceEEcCCCCEEeccccce
Confidence             68999999995 488877754 2457999999999999999999999  455999999999999999999999999999


Q ss_pred             CCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc-
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR-  309 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  309 (401)
                      +.+...... .++..+-|.+|+|||++.| ..|+.+.|+||+||||.||++|++.|.+......   .+.+..+...|. 
T Consensus       266 r~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ---l~kIfklcGSP~e  341 (560)
T KOG0600|consen  266 RFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ---LHKIFKLCGSPTE  341 (560)
T ss_pred             eeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH---HHHHHHHhCCCCh
Confidence            976554332 3677788999999999997 5799999999999999999999999987543211   111111111110 


Q ss_pred             -chh--hhcC---CcCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 -KLE--RLID---PRLEGQFP-------IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 -~~~--~~~~---~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       .+.  ++..   ......+.       ...+....+|+..+|..||.+|.|+.++++.
T Consensus       342 ~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  342 DYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             hccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence             011  1100   00111111       1235578889999999999999999999764

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-46  Score=339.17  Aligned_cols=251  Identities=23%  Similarity=0.346  Sum_probs=212.6

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ...+|++.+.||+|+||.|-+|+...      .++.||||.++.+.   .++...+++|++||..|+||||+.+|++|..
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN  124 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHK------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN  124 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhcc------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC
Confidence            45789999999999999999998765      68999999998664   4445668899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+.+.|||||..+|.|++++.+.  +.+++.++..+++||+.|+.|+|.+.  ++|||||.+|||+|.++++||+|||++
T Consensus       125 kdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccchh
Confidence            99999999999999999999775  89999999999999999999999655  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ..+..+.   ...++||+|-|.+||+++|.+| ++.+|.||||++||.|+.|..||++.+..      ..++        
T Consensus       201 Nly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvr--------  263 (668)
T KOG0611|consen  201 NLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVR--------  263 (668)
T ss_pred             hhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHH--------
Confidence            8775544   3567899999999999999998 57899999999999999999999886311      1111        


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                        ++-.....   .+..+....-||++||-.||++|.|+.+|..++.
T Consensus       264 --QIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  264 --QISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             --Hhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence              11111111   1112345677999999999999999999998865

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-45  Score=353.24  Aligned_cols=245  Identities=27%  Similarity=0.428  Sum_probs=208.3

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccC-CCceeeEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLR-HPHLVKLIGYC  149 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~  149 (401)
                      ..-.+|.+.++||+|.||.|++|..+.      +++.+|||+++.+   ...+.+..+.|..|+.... ||+++.++..|
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f  438 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKG------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF  438 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcC------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence            344789999999999999999998887      6889999999865   3556778888999888775 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      .+.+++|+||||+.||++..+++   .+.+++..+..++..|+.||.|||.++  |||||||.+|||+|.+|++||+|||
T Consensus       439 QT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFG  513 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFG  513 (694)
T ss_pred             ccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccc
Confidence            99999999999999999544433   368999999999999999999999555  9999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      +++.......  ..+++||||.|||||++.+..|+.++|+|||||+|||||.|+.||.+.+.+   .+            
T Consensus       514 lcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e~------------  576 (694)
T KOG0694|consen  514 LCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---EV------------  576 (694)
T ss_pred             cccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---HH------------
Confidence            9987553222  457899999999999999999999999999999999999999999875321   11            


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  349 (401)
                       ...++..  ...+|..++.+...++.++|..+|++|.-+
T Consensus       577 -FdsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  577 -FDSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -HHHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence             1111111  224677889999999999999999999876

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-44  Score=329.25  Aligned_cols=256  Identities=26%  Similarity=0.327  Sum_probs=211.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .+.|++++.||.|.-|+||++....      ++..+|+|++....   .....+...|-+||..++||.++++|..|..+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRG------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecC------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            3567788999999999999998887      56899999997542   33345677799999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..|++||||+||+|+.+++++..+.+++..+..++.+|+.||+|||.++  ||+|||||+||||.++|+|-|+||.++.
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeeccccc
Confidence            99999999999999999999999999999999999999999999999655  9999999999999999999999999975


Q ss_pred             CCCC---------------------------------CCcc---------------------eeeecccccccccccccc
Q 040050          233 DGPE---------------------------------GEET---------------------HVITRVMGTQGYAAPEYV  258 (401)
Q Consensus       233 ~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~  258 (401)
                      ....                                 ....                     .....++||-.|+|||++
T Consensus       228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI  307 (459)
T KOG0610|consen  228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI  307 (459)
T ss_pred             cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence            3211                                 0000                     011236899999999999


Q ss_pred             ccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHh
Q 040050          259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKC  338 (401)
Q Consensus       259 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  338 (401)
                      .|...+.++|+|+|||++|||+.|..||.+.+.                ...+..++...+.-.-.+..+..+++||+++
T Consensus       308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~L  371 (459)
T KOG0610|consen  308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKL  371 (459)
T ss_pred             ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHH
Confidence            999999999999999999999999999987632                1223333333222222235678999999999


Q ss_pred             cccCCCCCCC----HHHHHHH
Q 040050          339 LSHHPRHRPT----MSYVVRV  355 (401)
Q Consensus       339 l~~dP~~RPt----~~~il~~  355 (401)
                      |.+||.+|..    +.||-++
T Consensus       372 LvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  372 LVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             hccChhhhhccccchHHhhcC
Confidence            9999999998    7777553

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-45  Score=345.23  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=217.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|..++++|+|+||.+++++++.      .+..+|+|.+.....  ........|+.++++++||||+.+.+.|..++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~------~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKS------DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhcc------CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            578999999999999999987776      577999999986643  233467889999999999999999999999887


Q ss_pred             -EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          155 -RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       155 -~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                       ++|||+||+||+|.+.|.++.+..++++.+..++.|++.|+.|||+  .+|+|||||+.|||++.++.|+|+|||+|+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~--~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE--NRVLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh--hhhhcccchhhhhhccccCceeecchhhhhh
Confidence             9999999999999999998877889999999999999999999995  4499999999999999999999999999998


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .....  .......||+.||+||++.+.+|+.++|||||||++|||++-+++|...+-      ..          -..+
T Consensus       156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m------~~----------Li~k  217 (426)
T KOG0589|consen  156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM------SE----------LILK  217 (426)
T ss_pred             cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch------HH----------HHHH
Confidence            76654  234567899999999999999999999999999999999999999976521      11          1111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +. .......|...+.+++.++..||+.+|..||++.+++..
T Consensus       218 i~-~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  218 IN-RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             Hh-hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            11 122335667778999999999999999999999999877

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=330.59  Aligned_cols=270  Identities=24%  Similarity=0.311  Sum_probs=211.7

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEec--CCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+..+|...+.||+|++|.|+.|.+..      +++.||||++.  .......++..+|+.+|+.++|+||+.+.+++..
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p   92 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKR------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP   92 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcC------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence            445677778999999999999999887      68999999987  4455567788999999999999999999999875


Q ss_pred             -----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          152 -----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       152 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                           -+.+|+|+|+| +.+|...+..+  +.++...+..++.|++.||+|+|+.+  |+||||||.|++++.+..+||+
T Consensus        93 ~~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   93 PSRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             ccccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEec
Confidence                 34689999999 77999988765  56999999999999999999999766  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||+|+..........++.++-|.+|+|||++. ...|+.+.||||+|||+.||++|++.|.+......-.+.....+..
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            999999875443344457788999999999886 5789999999999999999999999998764322111110000000


Q ss_pred             cCccchhhhc---------CCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLERLI---------DPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~~~~---------~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       .+..+..+.         .-......     -++..+...+|+.+||..||.+|+|++++++.
T Consensus       248 -~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  248 -SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             -CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence             000111110         00001111     12456789999999999999999999998754

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=334.67  Aligned_cols=266  Identities=26%  Similarity=0.328  Sum_probs=211.5

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--------------cccHHHHHHHHHHHhccC
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--------------TQGHKEWMAEIIFLGQLR  138 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~  138 (401)
                      ...-+.|++.+.||+|.||.|-+|++..      +++.||||++....              ....+...+|+.+|++++
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEV------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecC------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            3445789999999999999999998876      68999999995321              112357889999999999


Q ss_pred             CCceeeEEEEEEeC--CeEEEEEEecCCCChhHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcE
Q 040050          139 HPHLVKLIGYCWEE--EYRLLVYEYMPRGSLHNQLFRSYSAA-LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNI  215 (401)
Q Consensus       139 hpnI~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NI  215 (401)
                      |||||+++++..+.  +.+|||+|||..|.+...-   ..+. +.+.+++++++.++.||.|||.++  ||||||||.|+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNL  241 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNL  241 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhhe
Confidence            99999999999874  4799999999988875432   2244 899999999999999999999666  99999999999


Q ss_pred             EEcCCCcEEEEecCCCCCCCCCC---cceeeeccccccccccccccccCC----CCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          216 LLDSDYTAKLSDFGLAKDGPEGE---ETHVITRVMGTQGYAAPEYVMTGH----LTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       216 lv~~~~~vkL~DfG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                      |++.+|+|||+|||.+.....+.   .........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||..
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~  321 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD  321 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence            99999999999999998663331   112233468999999999998633    35689999999999999999999976


Q ss_pred             CcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          289 TRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                      ...      .+          ...+++...+.-.....+.+.+.+||.+||++||++|.++.+|..+..-.+.++.+
T Consensus       322 ~~~------~~----------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~  382 (576)
T KOG0585|consen  322 DFE------LE----------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP  382 (576)
T ss_pred             chH------HH----------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence            421      11          11223333332222234578999999999999999999999999888877777664

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=356.07  Aligned_cols=264  Identities=22%  Similarity=0.258  Sum_probs=218.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEE-EEe--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGY-CWE--  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~-~~~--  151 (401)
                      ..++++.++|.+|||+.||+|.+..      .+..||+|++-.......+.+.+|+++|+.|+ |+|||.+++. ...  
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVK------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecC------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            4578888999999999999998876      34899999998777777888999999999998 9999999993 321  


Q ss_pred             -C---CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          152 -E---EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       152 -~---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                       .   -.++|.||||.||.|-+++..+....|++.++++|+.++++|+++||....+|||||||-+||||+.+|.+||||
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence             1   246799999999999999987655679999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCcceee-------eccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccH
Q 040050          228 FGLAKDGPEGEETHVI-------TRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL  297 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  297 (401)
                      ||.+............       -...-|+.|+|||++.   +...++|+|||+|||+||-|+....||+...       
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------  262 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------  262 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc-------
Confidence            9999754332211000       0134689999999985   7789999999999999999999999998641       


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                                   -..|+.....-...+..+..+.+||..||+.||.+||++-++++.+.++..-+..
T Consensus       263 -------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  263 -------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             -------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence                         1223333333233356799999999999999999999999999999999766543

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.4e-44  Score=344.50  Aligned_cols=266  Identities=27%  Similarity=0.376  Sum_probs=208.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      .++|.+.+.||+|+||.||+|++..... ..+...||+|++..... .....+.+|+.+++.+ +|+||+++++++....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGK-EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCc-ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            4689999999999999999998654211 22456899999975432 2345688999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc----------------------------------------------------------
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY----------------------------------------------------------  175 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------  175 (401)
                      ..++||||+++|+|.+++....                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999986421                                                          


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeec
Q 040050          176 ----------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR  245 (401)
Q Consensus       176 ----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~  245 (401)
                                ...+++..++.++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++..............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~--~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      1247788899999999999999995  5599999999999999999999999999976544322222222


Q ss_pred             cccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCC
Q 040050          246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP  324 (401)
Q Consensus       246 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (401)
                      ..++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .+..              ..........+
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~--------------~~~~~~~~~~~  337 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK--------------MVKRGYQMSRP  337 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH--------------HHHcccCccCC
Confidence            345678999999998999999999999999999997 999997542211  0111              11111111122


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          325 IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       325 ~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      ...+.++.+++.+||+.||.+||++.++++.|+++-
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            233578999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-44  Score=336.42  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=203.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            468899999999999999998876      57899999986432   223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+++|.+++...  ..+++..+..++.|++.||+|||++  +|+||||||+||+++.+|.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            999999999999999998764  6789999999999999999999954  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     .....|++.|+|||++.+..++.++|||||||++|+|++|..||......      ......         
T Consensus       151 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i---------  210 (291)
T cd05612         151 LRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKI---------  210 (291)
T ss_pred             ccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH---------
Confidence            5332     12356999999999999999999999999999999999999999754211      111111         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                       ....  ..++...+..+.+++.+||+.||.+||+     +.++++.
T Consensus       211 -~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         211 -LAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -HhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             1111  1233344678899999999999999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-43  Score=330.53  Aligned_cols=253  Identities=25%  Similarity=0.353  Sum_probs=204.2

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .|.+.+.||+|+||.||+|.+..      +++.||+|.+....   ......+.+|+.+++.++|+||+++++++.+++.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEec------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence            37788999999999999998876      58899999986432   2223457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++|+|..++.......+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR--ERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            9999999999999988866544578999999999999999999995  45999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ........          
T Consensus       153 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~----------  217 (285)
T cd05631         153 PEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRV----------  217 (285)
T ss_pred             CCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHh----------
Confidence            4322   12345799999999999999999999999999999999999999976432110  00000000          


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                      .  .....++...+..+.+|+.+||+.||.+||+     ++++++.
T Consensus       218 ~--~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         218 K--EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             h--cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            0  0111233345678999999999999999997     7888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-43  Score=329.05  Aligned_cols=247  Identities=22%  Similarity=0.317  Sum_probs=201.4

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc---HHHHHHHHHHHhccCCCceeeEEEEEEe----CCeE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG---HKEWMAEIIFLGQLRHPHLVKLIGYCWE----EEYR  155 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnI~~~~~~~~~----~~~~  155 (401)
                      ..||+|++|.||+|.+.        ++.||+|.+.......   ...+.+|+.+|++++||||+++++++.+    ....
T Consensus        26 ~~i~~g~~~~v~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN--------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEEC--------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            67999999999999763        6789999987553322   4667799999999999999999999877    3478


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++|+|.+++...  ..+++...+.++.+++.||.|||+. .+++||||||+||+++.++.+||+|||++....
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKY-TNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhc-CCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            9999999999999999764  6789999999999999999999953 248899999999999999999999999987643


Q ss_pred             CCCcceeeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...     ....|+..|+|||++.+  ..++.++|||||||++|+|++|..||......      +.....         
T Consensus       175 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i---------  234 (283)
T PHA02988        175 SPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLI---------  234 (283)
T ss_pred             ccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHH---------
Confidence            321     23468899999999976  68999999999999999999999999764211      111111         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                       .........+..++..+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       235 -~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        235 -INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -HhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence             11111122333457789999999999999999999999999998865

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=309.74  Aligned_cols=265  Identities=25%  Similarity=0.306  Sum_probs=213.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~-  153 (401)
                      ..++|++.+.||+|||+-||++....      ++..+|+|++.+...++.+..++|++..++++|||+++++++...+. 
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLS------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccC------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            35799999999999999999997655      68899999999888888899999999999999999999998765433 


Q ss_pred             ----eEEEEEEecCCCChhHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          154 ----YRLLVYEYMPRGSLHNQLFRSY--SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       154 ----~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                          ..||+++|...|+|.+.+....  +..+++.+++.|+.+|++||.+||....++.||||||.||++.+.+.++|.|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence                4899999999999999997642  3478999999999999999999997777799999999999999999999999


Q ss_pred             cCCCCCCCCCCcce-------eeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccH
Q 040050          228 FGLAKDGPEGEETH-------VITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL  297 (401)
Q Consensus       228 fG~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  297 (401)
                      ||.++...-.-...       .......|..|+|||.+.   +...++++|||||||++|+|+.|..||+..-.      
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------  246 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------  246 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------
Confidence            99987543211100       011245788999999987   45678999999999999999999999975321      


Q ss_pred             HHHhhhhhcCccchhh-hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          298 AEWARPLLKEPRKLER-LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                               ..+.+.- +....+.-.-....++.+.+++.+||+.||.+||++.+++..++.+.
T Consensus       247 ---------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 ---------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                     1111111 11111111111226889999999999999999999999999988764

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.7e-44  Score=340.62  Aligned_cols=246  Identities=24%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++..++
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            678999999999999999998876      5789999998643   1233456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+.+++|.+++...  ..+++..+..++.|++.||.|||++  +|+||||||+|||++.++.+||+|||++..
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK--DIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            999999999999999998764  6789999999999999999999954  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .....     ....||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .....          .
T Consensus       168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~----------~  226 (329)
T PTZ00263        168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYE----------K  226 (329)
T ss_pred             cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHH----------H
Confidence            54322     235799999999999999999999999999999999999999965321      11111          1


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                      +....  ..++...+..+.+++.+||+.||.+||+     +.+++.+
T Consensus       227 i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        227 ILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11111  1123334667899999999999999997     6777755

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.6e-44  Score=338.57  Aligned_cols=243  Identities=27%  Similarity=0.368  Sum_probs=199.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKA------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            469999999999998876      5889999998743   2233456778999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCc
Q 040050          160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE  239 (401)
Q Consensus       160 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~  239 (401)
                      ||+.+++|.+++...  ..+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||++....... 
T Consensus        75 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~--~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  149 (323)
T cd05571          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC--DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence            999999999988764  6789999999999999999999954  59999999999999999999999999987532221 


Q ss_pred             ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ....   ...          ..  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~---~~~----------~~--  210 (323)
T cd05571         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---LIL----------ME--  210 (323)
T ss_pred             -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHH---HHH----------cC--
Confidence             1223457999999999999999999999999999999999999999654211   0111   000          00  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                      ...++...+..+.+++.+||+.||++||     ++.+++++
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            0123344577899999999999999999     79988764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-43  Score=342.05  Aligned_cols=265  Identities=28%  Similarity=0.365  Sum_probs=206.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      .++|++.+.||+|+||.||+|.+... ....++..||+|++.... ......+.+|+.++..+ +||||+++++++....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGL-FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecc-ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            35789999999999999999975421 112246789999987443 23345688999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc----------------------------------------------------------
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY----------------------------------------------------------  175 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------  175 (401)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999886421                                                          


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc
Q 040050          176 ---------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       176 ---------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~  240 (401)
                                     ...+++..++.++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++.........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS--KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           1247788899999999999999995  45999999999999999999999999999865443222


Q ss_pred             eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                      .......++..|+|||++.+..++.++|||||||++|+|++ |..||......  ..+....              ....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~--------------~~~~  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI--------------KEGY  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH--------------HhCc
Confidence            11222345678999999999999999999999999999998 88888654211  1111111              1111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ....+...+.++.+++.+||+.||++||++.++++.|++.
T Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1111222356899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.4e-43  Score=328.95  Aligned_cols=271  Identities=26%  Similarity=0.409  Sum_probs=206.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCC----------CCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceee
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLK----------PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVK  144 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~----------~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~  144 (401)
                      .++|.+.+.||+|+||.||+|.+.....          ....+..||+|.+..... .....+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999998654211          112445799999875432 23457889999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhHHHhhhc-----------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 040050          145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY-----------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIY  207 (401)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH  207 (401)
                      +++++.+.+..++||||+.+++|.+++....                 ...+++..++.++.||+.||.|||+.  +|+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--~ivH  161 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--NFVH  161 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--Cccc
Confidence            9999999999999999999999999886431                 12467888999999999999999954  5999


Q ss_pred             ccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh--CCCC
Q 040050          208 RDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT--GKRA  285 (401)
Q Consensus       208 ~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p  285 (401)
                      |||||+|||++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|+|++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986544433222333456789999999998899999999999999999987  4566


Q ss_pred             CCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          286 MDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       286 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                      |......   ...............       ......+..++..+.+++.+||+.||.+|||+.+|.+.|++
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQGR-------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhccc-------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            6543211   111111111110000       00011123346789999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=341.43  Aligned_cols=268  Identities=26%  Similarity=0.429  Sum_probs=215.3

Q ss_pred             cHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeE
Q 040050           68 TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKL  145 (401)
Q Consensus        68 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~  145 (401)
                      +..++.+..+.+.++..||+|.||+||+|.|..         .||||++..+..  +..+.|.+|+..+++-+|-||+-+
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLF  453 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLF  453 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeeccccc---------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheee
Confidence            345556667788899999999999999999876         699999987643  446789999999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      .|++..+.. .||+.+|+|-+|+.++.... ..+.+...+.|+.||++|+.|||  .++|||||||.+|||+.+++.|||
T Consensus       454 MG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH--AK~IIHrDLKSnNIFl~~~~kVkI  529 (678)
T KOG0193|consen  454 MGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH--AKNIIHRDLKSNNIFLHEDLKVKI  529 (678)
T ss_pred             ehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh--hhhhhhhhccccceEEccCCcEEE
Confidence            999999887 99999999999999997653 57889999999999999999999  566999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      +|||++................|...|||||++.   ..+|+..+||||||+++|||++|..||....  .++.+....+
T Consensus       530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dqIifmVGr  607 (678)
T KOG0193|consen  530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQIIFMVGR  607 (678)
T ss_pred             ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhheEEEecc
Confidence            9999987433322222233355888999999997   3578999999999999999999999998431  1111110000


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ..          +.+ .......+++.++.+|+..||..++++||.+.+|+..|+.+..
T Consensus       608 G~----------l~p-d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  608 GY----------LMP-DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cc----------cCc-cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            00          000 0112234567899999999999999999999999999888866

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-44  Score=338.69  Aligned_cols=254  Identities=22%  Similarity=0.279  Sum_probs=205.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+..|+.++..++||||+++++++....
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            468999999999999999999876      57899999986431   223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+++++|.+++...  ..+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            999999999999999999654  6789999999999999999999954  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...     ......||+.|+|||++.+..++.++|||||||++|+|++|..||........  ..    .......    
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~----~i~~~~~----  215 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WE----NLKYWKE----  215 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HH----HHHhccc----
Confidence            533     22345799999999999999999999999999999999999999976432110  00    0000000    


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+............+..+.+++.+||..+|.+||++.++++.
T Consensus       216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000000000012346789999999999999999999999876

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.8e-43  Score=327.23  Aligned_cols=262  Identities=31%  Similarity=0.495  Sum_probs=210.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|++.+.||+|+||.||+|....... ......||+|.+..... .....+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE-RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC-CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            578889999999999999998765321 23457899999875432 2345688999999999999999999999998899


Q ss_pred             EEEEEecCCCChhHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYS--------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      +++|||+++++|.+++.....              ..+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccccceEEEcCCC
Confidence            999999999999999975321              457889999999999999999995  4599999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHH
Q 040050          222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  300 (401)
                      .++|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......   .+.. 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~-  237 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIE-  237 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence            999999999976543332222334557889999999998899999999999999999998 99998754211   1111 


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                                   .+........+..++..+.+|+.+||+.||.+||++.+|++.|+.
T Consensus       238 -------------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         238 -------------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -------------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                         111111122344567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.9e-44  Score=319.07  Aligned_cols=264  Identities=25%  Similarity=0.312  Sum_probs=207.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc--HHHHHHHHHHHhccCCCceeeEEEEEEeC--
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--HKEWMAEIIFLGQLRHPHLVKLIGYCWEE--  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--  152 (401)
                      +.|+.+..|++|+||.||+|++..      +++.||+|+++.+....  .-.-++|+.+|.+++|||||.+..+....  
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~  149 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKK------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM  149 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCC------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence            468888999999999999998887      78999999998764322  33567999999999999999999988754  


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +.+|||||||+ -+|..++... .+++...++..+..|++.|++|||.+.  |+||||||.|+|++..|.+||+|||+|+
T Consensus       150 d~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  150 DKIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             ceeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhh
Confidence            46999999995 5898888654 368999999999999999999999555  9999999999999999999999999999


Q ss_pred             CCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc---
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---  308 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  308 (401)
                      ...+..  ..++..+-|.+|+|||++.| ..|+.+.|+||+|||+.||+++++.|.+....++  +..+. ..+..|   
T Consensus       226 ~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If-~llGtPte~  300 (419)
T KOG0663|consen  226 EYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIF-KLLGTPSEA  300 (419)
T ss_pred             hhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHH-HHhCCCccc
Confidence            876542  33566778999999999987 5799999999999999999999999987643221  11111 111110   


Q ss_pred             --------cch-----hhhcCCcCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 --------RKL-----ERLIDPRLEGQFPIK-GAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 --------~~~-----~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                              ...     ....-..++..++.. .++.-.+|+..+|..||++|.|+.+.++.
T Consensus       301 iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  301 IWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                    000     000011122223322 56788999999999999999999999865

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.6e-43  Score=350.55  Aligned_cols=254  Identities=23%  Similarity=0.276  Sum_probs=206.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ..|.+.+.||+|+||.||+|.....     .+..||+|.+..........+.+|+.+|+.++||||+++++++..++..|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~-----~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSD-----PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCC-----CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            3489999999999999999986551     25789999876655555566788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      |||||+++|+|.+++...  ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++...
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh--CCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            999999999999888542  23568899999999999999999995  45999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ......          +
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~----------~  283 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQ----------V  283 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH----------H
Confidence            443322233456799999999999999999999999999999999999999965321      111111          1


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .... ....+...+..+.+++.+||..||++||++.+++.
T Consensus       284 ~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        284 LYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HhCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1110 11223345678999999999999999999999875

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-43  Score=329.05  Aligned_cols=266  Identities=21%  Similarity=0.298  Sum_probs=202.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|.+.+.||+|+||.||+|++..      +++.||+|++....  ......+.+|+.+++.++||||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            478999999999999999998876      57899999987542  2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.++.+..+...  ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN--DIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999987766544322  35789999999999999999999954  5999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc-cHHHHhhh--------hh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-SLAEWARP--------LL  305 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~--------~~  305 (401)
                      ..... .......|++.|+|||++.+..++.++|||||||++|+|++|++||......... .......+        ..
T Consensus       151 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             ccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            43221 1223456899999999999988999999999999999999999999764321110 00000000        00


Q ss_pred             cCccchhhhcCCcC------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          306 KEPRKLERLIDPRL------EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       306 ~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ..+ .......+..      ...+....+..+.+|+.+||+.||++|||++++++
T Consensus       230 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         230 SNP-RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccc-hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000 0000000000      01111234678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.4e-43  Score=333.53  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=207.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||.||+|.+..      ++..||+|.+..... .....+.+|+++++.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            4789999999999999999998876      578999999876532 334578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.++|+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            99999999999999998764  5789999999999999999999952 24999999999999999999999999998765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhh-hhhcCccc---
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR-PLLKEPRK---  310 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~---  310 (401)
                      ....    .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......   .+..... +.......   
T Consensus       155 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~  227 (331)
T cd06649         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPH  227 (331)
T ss_pred             cccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCcc
Confidence            3321    23456999999999999999999999999999999999999999653211   1111100 00000000   


Q ss_pred             -----------------------------hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 -----------------------------LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 -----------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                                   ...+.............+.++.+|+.+||+.||++|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                         000000000000112346789999999999999999999999876

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-43  Score=318.03  Aligned_cols=265  Identities=25%  Similarity=0.334  Sum_probs=207.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPH-LVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-I~~~~~~~~~~~  153 (401)
                      ..|...+.||+|+||+||+|+...      +++.||+|+++....  .......+|+.+|+.++|+| |+.+++++...+
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~   84 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKR------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSN   84 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEec------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecc
Confidence            456667789999999999999887      689999999987644  24567889999999999999 999999999887


Q ss_pred             ------eEEEEEEecCCCChhHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          154 ------YRLLVYEYMPRGSLHNQLFRSYS--AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       154 ------~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                            .+++||||+ ..+|..++.....  ..++...+..++.||+.||+|||+++  |+||||||+||||+.+|.+||
T Consensus        85 ~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKl  161 (323)
T KOG0594|consen   85 NHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKL  161 (323)
T ss_pred             cccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEee
Confidence                  889999999 6799999976532  46888899999999999999999655  999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||+|+...-..  ..++..++|..|+|||++.|. .|+...||||+|||++||+++++.|.+....  ..+... ...
T Consensus       162 aDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~--~ql~~I-f~~  236 (323)
T KOG0594|consen  162 ADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI--DQLFRI-FRL  236 (323)
T ss_pred             eccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH--HHHHHH-HHH
Confidence            9999999654322  235677899999999999986 7999999999999999999999999876431  111111 111


Q ss_pred             hcCc--cchhhhc---C-----CcCC--CCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKEP--RKLERLI---D-----PRLE--GQFP---IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~--~~~~~~~---~-----~~~~--~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +..|  ..+....   +     +...  ..+.   +.......+++.+||+.+|.+|.++..++++
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111  1111110   0     0000  0000   1112478899999999999999999999875

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.8e-43  Score=321.61  Aligned_cols=260  Identities=23%  Similarity=0.384  Sum_probs=206.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|++.+.||+|+||.||+|.+...   ...+..||+|.++.... .....+.+|+.++++++||||+++++++.....
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLP---SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecC---CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            35788999999999999999986532   12467899999876533 234568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++... ...+++..++.++.|++.||+|||+  .+++||||||+||+++.++.++|+|||.+...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~--~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSE--MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            99999999999999988754 3578999999999999999999995  55999999999999999999999999987654


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...... ......++..|+|||.+.+..++.++|||||||++|++++ |..||......   ......            
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~------------  221 (266)
T cd05064         158 KSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAV------------  221 (266)
T ss_pred             cccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH------------
Confidence            222111 1112335678999999999999999999999999999875 99999754211   111110            


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                        ........+..++..+.+++.+||+.+|.+||++.+|++.|.++
T Consensus       222 --~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         222 --EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence              00111122344567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-44  Score=336.92  Aligned_cols=240  Identities=28%  Similarity=0.425  Sum_probs=204.9

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ++-||.|+.|.||+|+..        ++.||||+++.       .-..+|..|++|+||||+.+.|+|.....+||||||
T Consensus       129 LeWlGSGaQGAVF~Grl~--------netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--------NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             hhhhccCcccceeeeecc--------CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            466999999999999765        57899999862       223478999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      |..|.|...|...  ..++....+.+..+||.|+.|||.+.  |||||||.-||||..+..|||+|||-++.....   .
T Consensus       194 Ca~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S  266 (904)
T KOG4721|consen  194 CAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S  266 (904)
T ss_pred             cccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence            9999999999765  78999999999999999999999777  999999999999999999999999999865443   2


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG  321 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (401)
                      ....++||..|||||++.+.+.++|+|||||||+|||||||..||......                -.+...-...+..
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----------------AIIwGVGsNsL~L  330 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----------------AIIWGVGSNSLHL  330 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----------------eeEEeccCCcccc
Confidence            345689999999999999999999999999999999999999999754210                0011112233444


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          322 QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       322 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ..|..++..+.-|+++||+..|.+||++++|+.+|+-.
T Consensus       331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            56778889999999999999999999999999998744

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-43  Score=340.95  Aligned_cols=205  Identities=26%  Similarity=0.346  Sum_probs=180.2

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-C-----CceeeE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-H-----PHLVKL  145 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnI~~~  145 (401)
                      ...+..+|.+.++||+|+||.|.+|++..      +++.||||+++.. .....+...|+.+|..|+ |     -|+|++
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~------T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm  253 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHK------TGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRM  253 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecC------CCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence            34455689999999999999999999887      7999999999743 445567788999999997 4     389999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC--CcE
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD--YTA  223 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~--~~v  223 (401)
                      +++|...+++|||+|.+ +.+|++++..+...+++...+..++.||+.||.+||..+  |||+||||+|||+.+.  ..|
T Consensus       254 ~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  254 LDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             eeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCce
Confidence            99999999999999999 789999999888889999999999999999999999544  9999999999999653  479


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcc
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL  291 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  291 (401)
                      ||+|||+|+......     ..++-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+.
T Consensus       331 KVIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  331 KVIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             eEEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            999999999754432     256778899999999999999999999999999999999999987653

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-43  Score=332.61  Aligned_cols=241  Identities=28%  Similarity=0.346  Sum_probs=196.3

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.++++++||||+++++++...+..|+||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRD------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            7999999999998876      5789999998642   233345678899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.++|+|||++.......  .
T Consensus        75 ~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  148 (312)
T cd05585          75 INGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHK--FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D  148 (312)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence            9999999998764  678999999999999999999995  459999999999999999999999999987533221  1


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG  321 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (401)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ..........          .  .
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~----------~--~  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQE----------P--L  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcC----------C--C
Confidence            22446799999999999999999999999999999999999999975421      1111111111          1  1


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 040050          322 QFPIKGAQKAAATAFKCLSHHPRHRPT---MSYVVRV  355 (401)
Q Consensus       322 ~~~~~~~~~l~~li~~cl~~dP~~RPt---~~~il~~  355 (401)
                      .++...+..+.+++.+||..||.+||+   +.+++.+
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            233445678999999999999999985   5565543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-42  Score=337.39  Aligned_cols=266  Identities=26%  Similarity=0.400  Sum_probs=208.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~  153 (401)
                      .++|.+++.||+|+||.||+|.+... ........||+|++..... .....+.+|+.+++++. ||||+++++++....
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGL-SRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEccc-CCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            57899999999999999999987432 1122356799999875433 23457889999999996 999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc----------------------------------------------------------
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY----------------------------------------------------------  175 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------  175 (401)
                      ..||||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886421                                                          


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC
Q 040050          176 ------------------------------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS  219 (401)
Q Consensus       176 ------------------------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~  219 (401)
                                                          ...+++..++.++.|++.||.|||+  .+|+||||||+|||++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivH~dikp~Nill~~  272 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS--KNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCChHhEEEeC
Confidence                                                1247788889999999999999995  45999999999999999


Q ss_pred             CCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHH
Q 040050          220 DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLA  298 (401)
Q Consensus       220 ~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  298 (401)
                      ++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .+.
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence            99999999999976543322222223457788999999999999999999999999999997 889986532110  000


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      .              .+........+...+..+.+++.+||+.||++||++.++.+.|+.+.
T Consensus       351 ~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 N--------------KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H--------------HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            0              00011111223345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-42  Score=324.40  Aligned_cols=269  Identities=27%  Similarity=0.400  Sum_probs=213.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|.+.+.||+|+||.||+|.+... ........+++|.+..........+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNL-SPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeecc-CCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            4688889999999999999976431 112345679999987555545567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc
Q 040050          157 LVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT  222 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~  222 (401)
                      +||||+++++|.+++....              ...+++..++.++.|++.||+|||+  ++|+||||||+||+++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS--QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCc
Confidence            9999999999999996532              2347899999999999999999995  55999999999999999999


Q ss_pred             EEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHh
Q 040050          223 AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       223 vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  301 (401)
                      ++|+|||++................|+..|+|||++.+..++.++|||||||++|+|++ |..||.......   ..+. 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~-  237 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC-  237 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence            99999999976544332222233457889999999999999999999999999999998 999986542210   1110 


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                                  +. .......+...+..+.+++.+||+.+|.+||++.++++.|+++.....+
T Consensus       238 ------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~~  288 (291)
T cd05094         238 ------------IT-QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI  288 (291)
T ss_pred             ------------Hh-CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcCc
Confidence                        00 0011111223456899999999999999999999999999999765443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-43  Score=335.39  Aligned_cols=247  Identities=26%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+...     .+..||+|.+...   .......+.+|+.+++.++||||+++++++.+..
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNE-----DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECC-----CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            5799999999999999999986542     2368999988632   2233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS--LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            999999999999999999765  679999999999999999999995  4599999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      .....          
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~----------  239 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQK----------  239 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHH----------
Confidence            5332     13457999999999999989999999999999999999999999754211      00011          


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                      +....  ..++...+..+.+++.+||+.||.+|+     +++++++.
T Consensus       240 i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        240 ILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            11111  112334466789999999999999995     88888765

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.9e-43  Score=325.75  Aligned_cols=264  Identities=22%  Similarity=0.340  Sum_probs=201.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|.+.+.||.|+||.||+|++..      ++..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKL------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECC------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            579999999999999999998776      578999999875432 2345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+. ++|.+++... ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.+||+|||++....
T Consensus        79 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHK--RKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            99999996 5898888653 3467899999999999999999995  459999999999999999999999999987543


Q ss_pred             CCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh---------
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL---------  305 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------  305 (401)
                      ....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||........  +........         
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  230 (288)
T cd07871         155 VPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTEETWPG  230 (288)
T ss_pred             CCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhc
Confidence            3221  1234568999999999875 5689999999999999999999999976432211  111100000         


Q ss_pred             -cCccchhhhcCCcCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          306 -KEPRKLERLIDPRLEGQ----FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       306 -~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       ...........+.....    .....+.++.+|+.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             00001111111111000    01123567899999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-43  Score=328.54  Aligned_cols=251  Identities=22%  Similarity=0.354  Sum_probs=218.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.+-|.+.+.||+|.|..|-+|++.      ++|..||||++....-  -....++.|+..|+.++|||||++|++....
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHV------FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHV------FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhh------cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            3467889999999999999988554      5899999999975532  2345788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc-CCCcEEEEecCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD-SDYTAKLSDFGLA  231 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~-~~~~vkL~DfG~a  231 (401)
                      ..+|||+|+-++|+|+++|.+. ..++.+..+.+++.||+.|+.|+|+..  +|||||||+||.+- +-|-|||+|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecccc
Confidence            9999999999999999999875 468999999999999999999999666  99999999999875 4599999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCC-ccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT-TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ..+..+..   ..+.||+..|.|||++.|..|+ +++||||||||||-|++|++||...+                +.+.
T Consensus       167 Nkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN----------------DSET  227 (864)
T KOG4717|consen  167 NKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN----------------DSET  227 (864)
T ss_pred             ccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc----------------chhh
Confidence            98877653   4667999999999999999997 57999999999999999999997653                2345


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +..+++...  ..|..++.+.++||..||..||++|.+.++|...
T Consensus       228 LTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  228 LTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            555666544  5788999999999999999999999999999754

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.1e-43  Score=332.58  Aligned_cols=243  Identities=26%  Similarity=0.358  Sum_probs=198.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      +.||+|+||.||+|.+..      ++..||+|++...   .......+.+|+.+++.++||||+++++++......|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            469999999999998776      5889999998643   2233456778999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCc
Q 040050          160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE  239 (401)
Q Consensus       160 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~  239 (401)
                      ||+++++|..++...  ..+++..++.++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++........
T Consensus        75 E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  150 (323)
T cd05595          75 EYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence            999999999888654  5789999999999999999999954  599999999999999999999999999875322211


Q ss_pred             ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ...   .          .+.... 
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~---~----------~~~~~~-  211 (323)
T cd05595         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF---E----------LILMEE-  211 (323)
T ss_pred             --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHH---H----------HHhcCC-
Confidence              223457999999999999999999999999999999999999999654211   000   0          000000 


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                       ..++...+..+.+++.+||+.||.+||     ++.++++.
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence             122334567899999999999999998     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5e-43  Score=332.70  Aligned_cols=243  Identities=26%  Similarity=0.365  Sum_probs=199.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKA------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            469999999999998876      5889999998743   2233456788999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCc
Q 040050          160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE  239 (401)
Q Consensus       160 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~  239 (401)
                      ||+++++|..++...  ..+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||++....... 
T Consensus        75 Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-  149 (328)
T cd05593          75 EYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG--KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-  149 (328)
T ss_pred             eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence            999999999888654  6789999999999999999999954  59999999999999999999999999987532221 


Q ss_pred             ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|..||......      ........          .  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~----------~--  210 (328)
T cd05593         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILM----------E--  210 (328)
T ss_pred             -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhcc----------C--
Confidence             1223467999999999999999999999999999999999999999654211      11111100          0  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                      ...++...+..+.+++.+||+.||.+||     ++.++++.
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            1123334567899999999999999997     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-42  Score=319.51  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=208.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|.+.+.||.|+||.||+|.+.+      .+..||+|.+... ......+.+|+.+++.++||||+++++++..+...+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec------CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            568888999999999999999876      5788999998643 333567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|||+++++|.+++.......+++..++.++.|++.||+|||+  .+++||||||+||+++.++.+||+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999999976555678999999999999999999995  4599999999999999999999999999986544


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......      +.....           
T Consensus       157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~-----------  218 (263)
T cd05052         157 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELL-----------  218 (263)
T ss_pred             ceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH-----------
Confidence            3211 1112234667999999999999999999999999999998 89998654211      111111           


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11111122334567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.7e-44  Score=350.85  Aligned_cols=269  Identities=29%  Similarity=0.472  Sum_probs=225.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+....+.||+|.||.||+|....- ........||||.++..... ...+|.+|++++..|+|||||+++|+|.+++..
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l-~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGL-LPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCC-CCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            4556678899999999999976542 22345678999999877655 678899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhc--------C----CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcE
Q 040050          156 LLVYEYMPRGSLHNQLFRSY--------S----AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~--------~----~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                      |||+|||..|+|.++|....        +    .+++..+.+.|+.|||.|+.||-++.  +|||||...|+||.++..|
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEE
Confidence            99999999999999996431        1    23888999999999999999999666  9999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhh
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      ||+|||+++.....+......+-.-..+|||||.+..++|+.+|||||+||+|||+++ |.-||.+..            
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS------------  710 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS------------  710 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc------------
Confidence            9999999998777655443333344679999999999999999999999999999998 888887642            


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                          +.+.+..+....+ ...|.+++.++.+|+..||+.+|++||++.+|-..|...-.....
T Consensus       711 ----n~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~  768 (774)
T KOG1026|consen  711 ----NQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK  768 (774)
T ss_pred             ----hHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence                2233343444444 567888999999999999999999999999999999887655443

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7e-43  Score=320.60  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=211.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..+|++.+.||.|+||.||+|.+..       +..+++|.+..........+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            3568889999999999999998765       578999998766555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++.......+++..++.++.|++.||.|||+  .+|+|+||+|+||+++.++.+||+|||.+....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE--QNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999999999987656678999999999999999999995  559999999999999999999999999997654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....  .....++..|+|||++.+..++.++||||||+++|+|++ |..||......   .....   .          
T Consensus       156 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~---~----------  217 (261)
T cd05148         156 EDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQ---I----------  217 (261)
T ss_pred             Ccccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH---H----------
Confidence            32211  123346778999999998899999999999999999998 89999654211   01110   0          


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                       ........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       218 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         218 -TAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -HhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence             01111122344567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-42  Score=323.15  Aligned_cols=269  Identities=29%  Similarity=0.407  Sum_probs=211.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|.+.+.||+|+||.||++.+.... ....+..+|+|.+..........+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~-~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCC-CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            57889999999999999999764321 12245679999987555455667899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhc-----------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          157 LVYEYMPRGSLHNQLFRSY-----------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      +||||+++++|.+++....           ...+++..++.++.|++.||+|||+  .+++||||||+||+++.++.++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~--~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS--QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccCcceEEEccCCcEEe
Confidence            9999999999999986431           1358999999999999999999995  55999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ...   ..
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~---~i  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE---CI  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HH
Confidence            99999986543332222233446778999999999999999999999999999998 899986542110   111   01


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                      ...          . ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.....+
T Consensus       236 ~~~----------~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~  285 (288)
T cd05093         236 TQG----------R-VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPV  285 (288)
T ss_pred             HcC----------C-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhccc
Confidence            000          0 0011122356799999999999999999999999999998765443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-42  Score=321.87  Aligned_cols=262  Identities=28%  Similarity=0.417  Sum_probs=207.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|.+.+.||+|+||.||+|.+... .....+..||+|.+...... ....+.+|+++++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHL-EPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccc-cCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            5688889999999999999987542 11234678999998755443 456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcE
Q 040050          156 LLVYEYMPRGSLHNQLFRSY------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                      ++||||+++++|.+++....            ...+++..+..++.|++.|+.|||+  .+++||||||+||+++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS--QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh--CCeeccccccceEEEcCCCeE
Confidence            99999999999999996531            2457888999999999999999995  459999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhh
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      +|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......   .......
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~~  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECIT  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH
Confidence            9999999875433222111223346788999999999999999999999999999998 99998654221   1111110


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                                    .......+...+..+.+++.+||+.||.+||++.++++.|++
T Consensus       239 --------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         239 --------------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --------------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                          011111223346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-42  Score=330.76  Aligned_cols=266  Identities=27%  Similarity=0.408  Sum_probs=207.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE-  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~-  152 (401)
                      .++|++.+.||.|+||.||+|..... ....+++.||+|++..... .....+..|+.++.++ +|+||+++++++... 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~-~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGI-EKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHHhhhhcccccCcCceEEecccccc-ccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            46899999999999999999975431 2233568999999875432 2345678899999999 799999999988654 


Q ss_pred             CeEEEEEEecCCCChhHHHhhhc---------------------------------------------------------
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSY---------------------------------------------------------  175 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  175 (401)
                      ..++++|||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            56889999999999999886431                                                         


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccc
Q 040050          176 --SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA  253 (401)
Q Consensus       176 --~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~  253 (401)
                        ...+++..+..++.|++.||+|||+  .+|+||||||+|||++.++.++|+|||++................++..|+
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              1267899999999999999999995  459999999999999999999999999998654332222222345677899


Q ss_pred             cccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHH
Q 040050          254 APEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAA  332 (401)
Q Consensus       254 aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  332 (401)
                      |||++.+..++.++|||||||++|+|++ |..||.......  .+...              +........+...+..+.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~--------------~~~~~~~~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRR--------------LKEGTRMRAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHH--------------HhccCCCCCCccCCHHHH
Confidence            9999999999999999999999999998 999996532110  11110              001111112233456899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          333 ATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       333 ~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      +++.+||+.+|++||++.+++++|+.+-
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-42  Score=335.87  Aligned_cols=262  Identities=20%  Similarity=0.251  Sum_probs=200.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..+|.+.+.||+|+||.||+|.+..      +++.||+|....      ..+.+|+.++++++||||+++++++......
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNK------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECC------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            3689999999999999999999877      688999997532      3467899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++|||++ +++|..++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++....
T Consensus       159 ~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~--~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        159 CLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN--RIIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             EEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            9999999 57898888654  5789999999999999999999954  59999999999999999999999999997532


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc-----cccHHHHhhhhhcCcc-
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR-----EQSLAEWARPLLKEPR-  309 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~-  309 (401)
                      ... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.......     ...+..........+. 
T Consensus       234 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~  312 (391)
T PHA03212        234 DIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE  312 (391)
T ss_pred             ccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence            221 112234679999999999999999999999999999999999998765422110     0111111111000000 


Q ss_pred             -------chhhhc---------CCcCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 -------KLERLI---------DPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 -------~~~~~~---------~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             .+....         .+......  ....+.++.+|+.+||+.||.+|||+.++++.
T Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                   000000         00000000  11346689999999999999999999999863

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.4e-42  Score=324.44  Aligned_cols=265  Identities=23%  Similarity=0.350  Sum_probs=199.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||.|+||.||+|.+..      +++.||+|++..... .....+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            3689999999999999999998875      578999999875432 233467789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+ +++|.+++... ...++...+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          78 LTLVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR--YILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            99999999 56888887653 35688999999999999999999954  5999999999999999999999999998754


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc--c-
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR--K-  310 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~-  310 (401)
                      ....  .......|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..+..... ....+.  . 
T Consensus       154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~  229 (303)
T cd07869         154 SVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIFL-VLGTPNEDTW  229 (303)
T ss_pred             cCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHH-HhCCCChhhc
Confidence            3221  12234568999999999875 458899999999999999999999997642211 11111100 000000  0 


Q ss_pred             -----hhhhcCCcCCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          311 -----LERLIDPRLEGQFPI---------KGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       311 -----~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                           .............+.         ..+..+.+++.+||+.||++|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                 000000000000000         12356889999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.9e-43  Score=335.27  Aligned_cols=255  Identities=23%  Similarity=0.292  Sum_probs=198.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||+||+|.+..      +++.||+|++....   ......+.+|+.++..++||||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            478999999999999999998776      57899999986431   223356778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||++||+|.+++.+.  +.+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ--LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            999999999999999999765  689999999999999999999995  4599999999999999999999999999875


Q ss_pred             CCCCCcc---------------------------------eeeeccccccccccccccccCCCCccccHHhHHHHHHHHH
Q 040050          234 GPEGEET---------------------------------HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL  280 (401)
Q Consensus       234 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  280 (401)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            4321100                                 0012357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 040050          281 TGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLS--HHPRHRPTMSYVVRV  355 (401)
Q Consensus       281 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~~il~~  355 (401)
                      +|..||......      ............   +   ....  ....+..+.+++.+|+.  .++..||++.++++.
T Consensus       231 ~G~~Pf~~~~~~------~~~~~i~~~~~~---~---~~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         231 IGYPPFCSETPQ------ETYKKVMNWKET---L---IFPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hCCCCCCCCCHH------HHHHHHHcCcCc---c---cCCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999754211      111111100000   0   0000  01235678888888664  233356899999886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-42  Score=317.53  Aligned_cols=256  Identities=27%  Similarity=0.405  Sum_probs=206.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||.||+|....       +..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-------STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-------CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3678999999999999999998654       5679999876432 2356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|||+++++|.+++.......+++..++.++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  154 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER--KNYIHRDLRAANVLVSESLMCKIADFGLARVIE  154 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEecCCCcEEECCCccceecC
Confidence            999999999999999977656678999999999999999999995  459999999999999999999999999998654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......   ........           
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~-----------  219 (261)
T cd05072         155 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQR-----------  219 (261)
T ss_pred             CCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHc-----------
Confidence            32211 1223346678999999998889999999999999999998 99998653211   11111100           


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                         ..........+..+.+++.+||..+|++||+++++++.|+++
T Consensus       220 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         220 ---GYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence               000011123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.9e-43  Score=337.39  Aligned_cols=254  Identities=23%  Similarity=0.266  Sum_probs=198.8

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .|.+.+.||+|+||+||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++.+...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            68889999999999999998876      68899999986432   2334568889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~--~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHK--MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999999999999998764  678999999999999999999995  55999999999999999999999999997532


Q ss_pred             CCCCc---------------------------------------------ceeeeccccccccccccccccCCCCccccH
Q 040050          235 PEGEE---------------------------------------------THVITRVMGTQGYAAPEYVMTGHLTTMSDV  269 (401)
Q Consensus       235 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  269 (401)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                             001123579999999999999999999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhc--ccCCCCCC
Q 040050          270 YSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCL--SHHPRHRP  347 (401)
Q Consensus       270 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl--~~dP~~RP  347 (401)
                      |||||++|+|++|..||........      .........        ..........+.++.+++.+|+  ..+|..||
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~------~~~i~~~~~--------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTET------QLKVINWEN--------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHH------HHHHHcccc--------ccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            9999999999999999976421100      000000000        0000111134678889998854  55666699


Q ss_pred             CHHHHHHH
Q 040050          348 TMSYVVRV  355 (401)
Q Consensus       348 t~~~il~~  355 (401)
                      ++.+++++
T Consensus       298 ~~~~~l~h  305 (381)
T cd05626         298 GADDIKAH  305 (381)
T ss_pred             CHHHHhcC
Confidence            99999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.7e-42  Score=321.12  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=205.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..++|++.+.||+|+||.||+|.+..... ...+..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCC-CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45789999999999999999998754222 2245789999986432 223456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY--------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      ..++||||+++++|.+++....        ...+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999986532        1235778889999999999999995  45999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......   ....   ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~---~~  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLR---FV  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HH
Confidence            99999876544332222222345778999999999899999999999999999999 68888654211   1111   00


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                      ...          . ....+...+..+.+++.+||+.||++||++.++++.|++
T Consensus       235 ~~~----------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 MEG----------G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HcC----------C-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            000          0 001122345678999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-42  Score=331.70  Aligned_cols=264  Identities=24%  Similarity=0.362  Sum_probs=198.2

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC---
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE---  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~---  152 (401)
                      +|++.+.||+|+||.||+|++..      ++..||+|++...  .......+.+|+.+++.++||||+++++++...   
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            58899999999999999998876      5889999998643  223345688999999999999999999988643   


Q ss_pred             --CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          153 --EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       153 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                        ...|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          75 EFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA--NVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEccCcc
Confidence              2579999999 57898888654  5799999999999999999999955  599999999999999999999999999


Q ss_pred             CCCCCCCCc-ceeeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          231 AKDGPEGEE-THVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       231 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +........ ........||+.|+|||++.+  ..++.++|||||||++|+|++|++||........   ..........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~  226 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGT  226 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCC
Confidence            975433221 112234579999999999876  6789999999999999999999999976432110   0000000000


Q ss_pred             c--cchh--------hh---cCCcCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 P--RKLE--------RL---IDPRLEGQF---PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ~--~~~~--------~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +  ....        ..   +.......+   ....+..+.+++.+||+.||++||++.++++.
T Consensus       227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0  0000        00   000000000   01234678899999999999999999999865

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.7e-42  Score=329.64  Aligned_cols=264  Identities=24%  Similarity=0.349  Sum_probs=204.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||.||+|.+..      ++..+|+|.+..... .....+.+|+++++.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence            4789999999999999999998876      578899998875432 334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+. .+|+|+||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            99999999999999998664  5789999999999999999999952 24999999999999999999999999998754


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh-hhcC------
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP-LLKE------  307 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~------  307 (401)
                      ....    .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.......   +...... ....      
T Consensus       155 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  227 (333)
T cd06650         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE---LELMFGCPVEGDPAESET  227 (333)
T ss_pred             hhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH---HHHHhcCcccCCcccccc
Confidence            3221    233568999999999999899999999999999999999999996532110   0000000 0000      


Q ss_pred             ---------------c-----cchhhhcC---CcCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 ---------------P-----RKLERLID---PRLEGQFP-IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ---------------~-----~~~~~~~~---~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                     +     .....+.+   .......+ ...+.++.+|+.+||+.||++|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                           0     00000000   00000111 1235678999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.6e-42  Score=325.23  Aligned_cols=265  Identities=24%  Similarity=0.379  Sum_probs=207.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|++.+.||+|+||.||+|.+...  .......||+|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecC--CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            35799999999999999999987542  11223459999987443 23456788999999999999999999998765 4


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++++|+.+|+|.+++... ...+++..++.++.||+.||+|||+  .+|+||||||+|||++.++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~--~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEE--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHh--cCeeccccchhheEecCCCcEEEccccccccc
Confidence            67999999999999998764 2468899999999999999999995  45999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............++..|+|||++.+..++.++|||||||++|+|++ |..||......   .+..              
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~~~~--------------  222 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISS--------------  222 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH--------------
Confidence            54333222223345678999999999999999999999999999998 99998754211   1111              


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      ++........+..++..+.+++.+||..+|.+||++.+++..|..+..-.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            11111111122234567899999999999999999999999988885443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=336.53  Aligned_cols=254  Identities=28%  Similarity=0.317  Sum_probs=205.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||+||+|.+..      +++.||+|++...   .......+.+|+.++..++||||+++++++.+++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            478999999999999999998876      5889999998643   2234566888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+.+++|.+++.+.  ..+++..++.++.|++.||.|||+  .||+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~--~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK--LGFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999999999999765  689999999999999999999995  5599999999999999999999999999976


Q ss_pred             CCCCC---------------------------cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCC
Q 040050          234 GPEGE---------------------------ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAM  286 (401)
Q Consensus       234 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  286 (401)
                      .....                           .........||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            54332                           001123356999999999999999999999999999999999999999


Q ss_pred             CCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 040050          287 DNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-MSYVVRV  355 (401)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~~il~~  355 (401)
                      ......      ..........        ...........+..+.+++.+||. ||.+||+ +.++++.
T Consensus       231 ~~~~~~------~~~~~i~~~~--------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         231 YSDTLQ------ETYNKIINWK--------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCHH------HHHHHHhccC--------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            765311      1111111100        000000011146789999999997 9999999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-42  Score=315.60  Aligned_cols=261  Identities=26%  Similarity=0.417  Sum_probs=207.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||.||+|.+....   .....||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~---~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPG---KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCC---CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            367899999999999999999876421   1346799999875432 234568889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|||+++++|.+++... ...+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          80 VMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999999998664 3478999999999999999999995  45999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .+.....           
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~-----------  222 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVE-----------  222 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHH-----------
Confidence            52222222222345678999999998899999999999999999998 99998653211   1111110           


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                         .......+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       223 ---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 ---DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               0001111223467889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.2e-42  Score=319.49  Aligned_cols=261  Identities=28%  Similarity=0.407  Sum_probs=205.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|++.+.||+|+||+||+|.+...  ....+..|++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~--~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLP--GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecC--CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            4678889999999999999986421  11246789999987433 23345688899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSY---------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      |++|||+++++|.+++....               ...+++..++.++.|++.||.|||+  ++|+|+||||+||+++.+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~nili~~~  160 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS--HFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--cCeehhccccceEEEcCC
Confidence            99999999999999985321               1357888999999999999999995  559999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  299 (401)
                      +.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.....   ..+.+
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~  237 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIE  237 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH
Confidence            9999999999986544332222334456778999999998889999999999999999998 8889865421   11111


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                      ...              .......+..++..+.+++.+||+.||.+||++.++++.|..
T Consensus       238 ~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 MVR--------------KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHH--------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            111              111111223346788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-43  Score=337.55  Aligned_cols=254  Identities=23%  Similarity=0.297  Sum_probs=201.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||+||+|.+..      +++.||+|++....   ......+.+|+.++..++||||+++++++.++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            478999999999999999998876      57899999986431   233456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL--GYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            999999999999999998764  5799999999999999999999954  599999999999999999999999999865


Q ss_pred             CCCCCcce------------------------------------eeeccccccccccccccccCCCCccccHHhHHHHHH
Q 040050          234 GPEGEETH------------------------------------VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLL  277 (401)
Q Consensus       234 ~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  277 (401)
                      ........                                    .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            42211000                                    011246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 040050          278 ELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT---MSYVVR  354 (401)
Q Consensus       278 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~~il~  354 (401)
                      +|++|..||......      ............        +........+..+.+++.+|+. +|.+|++   +.++++
T Consensus       231 el~~G~~Pf~~~~~~------~~~~~i~~~~~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQ------ETYRKIINWKET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHH------HHHHHHHcCCCc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999999999764311      111111110000        0000011236688899999996 9999998   888877


Q ss_pred             H
Q 040050          355 V  355 (401)
Q Consensus       355 ~  355 (401)
                      +
T Consensus       296 h  296 (364)
T cd05599         296 H  296 (364)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-42  Score=316.15  Aligned_cols=256  Identities=29%  Similarity=0.436  Sum_probs=205.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|++|.||+|.+..       ++.||+|.+.... .....+.+|+.++++++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            4678999999999999999998654       4679999987543 3356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|||+.+++|.+++.......+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA--QNYIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            999999999999999976544578999999999999999999995  559999999999999999999999999998654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..... ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||......   .+...              
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~--------------  216 (261)
T cd05068         155 EDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EVLQQ--------------  216 (261)
T ss_pred             CCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH--------------
Confidence            32111 1111223457999999999899999999999999999999 99998654211   00100              


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      +........+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            000111112233467899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=327.73  Aligned_cols=254  Identities=26%  Similarity=0.305  Sum_probs=213.1

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccC-CCceeeEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLR-HPHLVKLIGYC  149 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpnI~~~~~~~  149 (401)
                      .+...|.+.+.||+|.||.||+++...      +++.+|+|.+.....   .....+.+|+.+|+++. ||||+.++++|
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~  105 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKS------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF  105 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecC------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            345789999999999999999998877      689999999975532   34568899999999998 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC----CCcEEE
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS----DYTAKL  225 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~----~~~vkL  225 (401)
                      .+...+++|||++.||.|++.+...   .+++..+..++.|++.|+.|||+  .||+||||||+|+|+..    ++.+|+
T Consensus       106 e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~--~gvvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  106 EDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS--LGVVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             EcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh--CCceeccCCHHHeeeccccCCCCcEEE
Confidence            9999999999999999999999876   39999999999999999999996  45999999999999953    358999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      +|||++.....   .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.......  ........  
T Consensus       181 ~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~~~~i~~~--  253 (382)
T KOG0032|consen  181 IDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--IFLAILRG--  253 (382)
T ss_pred             eeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--HHHHHHcC--
Confidence            99999998765   334577899999999999999999999999999999999999999997753211  11111000  


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                +.......-...+..+.+++..||..||.+|+|+.+++++
T Consensus       254 ----------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 ----------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                      0111222334558899999999999999999999999984

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-45  Score=309.63  Aligned_cols=254  Identities=22%  Similarity=0.336  Sum_probs=207.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..+.|++.+.||+|.|+.|++..+..      +++.+|+|++...  .....+.+.+|+.|-+.|+||||+++.+.+...
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~   82 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   82 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhcc------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence            45678888999999999999987766      7899999988643  334678899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEEecC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFG  229 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~DfG  229 (401)
                      ...|||+|++.|++|..-|...  ...++..+-..+.||++||.|+|.++  |||||+||+|+++..   ..-+||+|||
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccc
Confidence            9999999999999998877665  46778888899999999999999655  999999999999943   3569999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      +|.....+   .....+.|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+....  ..+..    +...  
T Consensus       159 vAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye~----I~~g--  227 (355)
T KOG0033|consen  159 LAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYEQ----IKAG--  227 (355)
T ss_pred             eEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHHH----Hhcc--
Confidence            99987733   2446678999999999999999999999999999999999999999874211  00111    1100  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            .-...+..-..++++.++|+.+||..||.+|.|+.|.+++
T Consensus       228 ------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  228 ------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                  0111122234567899999999999999999999887754

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.3e-43  Score=338.85  Aligned_cols=254  Identities=22%  Similarity=0.251  Sum_probs=199.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.+|+.++||||+++++.+.+++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVD------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD   74 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            468999999999999999998776      58899999986421   223456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||+++|+|.+++.+.  ..+++..+..++.||+.||+|||++  +|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          75 NLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999999999999764  6789999999999999999999954  599999999999999999999999999753


Q ss_pred             CCCCC-----------------------------------------cceeeeccccccccccccccccCCCCccccHHhH
Q 040050          234 GPEGE-----------------------------------------ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSF  272 (401)
Q Consensus       234 ~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  272 (401)
                      .....                                         .........||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            21000                                         0000123579999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC---CH
Q 040050          273 GVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP---TM  349 (401)
Q Consensus       273 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~  349 (401)
                      ||++|+|++|..||.......      .........        ...........+..+.+++.+|+ .+|.+|+   ++
T Consensus       231 Gvilyell~G~~Pf~~~~~~~------~~~~i~~~~--------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~  295 (376)
T cd05598         231 GVILYEMLVGQPPFLADTPAE------TQLKVINWE--------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA  295 (376)
T ss_pred             cceeeehhhCCCCCCCCCHHH------HHHHHhccC--------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH
Confidence            999999999999997643211      000000000        00000111234667888898876 5999999   89


Q ss_pred             HHHHHH
Q 040050          350 SYVVRV  355 (401)
Q Consensus       350 ~~il~~  355 (401)
                      .++++.
T Consensus       296 ~ell~h  301 (376)
T cd05598         296 DEIKAH  301 (376)
T ss_pred             HHHhCC
Confidence            999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-42  Score=344.97  Aligned_cols=257  Identities=26%  Similarity=0.319  Sum_probs=206.5

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ...++|.+.+.||+|+||+||+|.+..      +++.||+|++....  ......+.+|+.++..++|+||+++++.+..
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVS------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcC------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            345799999999999999999998776      58899999987543  2334567889999999999999999887754


Q ss_pred             CC--------eEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          152 EE--------YRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       152 ~~--------~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      ..        .+++||||+.+|+|.+++...  ....+++..+..++.|++.||.|||+  ++|+||||||+|||++.++
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~--~~IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS--KHMIHRDIKSANILLCSNG  180 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEeCCC
Confidence            32        368999999999999988643  23578999999999999999999995  4599999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ....
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~  254 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVM  254 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHH
Confidence            9999999999765433222223456799999999999999999999999999999999999999975421      1111


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ....          . ......+...+..+.+++.+||+.||.+||++.+++++
T Consensus       255 ~~~~----------~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 HKTL----------A-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHh----------c-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111          0 01112344457789999999999999999999999864

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-42  Score=327.79  Aligned_cols=246  Identities=27%  Similarity=0.356  Sum_probs=197.5

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC----CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD----GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||++.....   ..+++.||+|++...    .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~---~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTG---ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEccc---CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            6899999999999976432   125789999998642    122334577899999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+.+++|.+++.+.  +.+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          79 LEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999999998664  6788899999999999999999954  59999999999999999999999999987533222


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      .  ......|++.|+|||++.+..++.++|||||||++|+|++|..||......      ...          ..+....
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~----------~~~~~~~  216 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTI----------DKILKGK  216 (323)
T ss_pred             C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHH----------HHHHcCC
Confidence            1  123357999999999999988999999999999999999999999764211      111          1111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                        ..++...+..+.+++.+||+.||++||     ++.++++.
T Consensus       217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence              122334467889999999999999999     78888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-43  Score=337.09  Aligned_cols=254  Identities=22%  Similarity=0.264  Sum_probs=198.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||.|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            368899999999999999998876      6889999998643   1223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~--~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK--LGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            999999999999999998754  678999999999999999999995  4599999999999999999999999999863


Q ss_pred             CCCCCcc---------------------------------------------eeeeccccccccccccccccCCCCcccc
Q 040050          234 GPEGEET---------------------------------------------HVITRVMGTQGYAAPEYVMTGHLTTMSD  268 (401)
Q Consensus       234 ~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  268 (401)
                      .......                                             ......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            2110000                                             0001246999999999999999999999


Q ss_pred             HHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC--
Q 040050          269 VYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHR--  346 (401)
Q Consensus       269 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R--  346 (401)
                      ||||||++|+|++|..||......      ...........        .+........+..+.+++.+||. +|.+|  
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~------~~~~~i~~~~~--------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSH------ETYRKIINWRE--------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHH------HHHHHHHccCC--------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            999999999999999999754211      00011110000        00000011245688999999997 77765  


Q ss_pred             -CCHHHHHHH
Q 040050          347 -PTMSYVVRV  355 (401)
Q Consensus       347 -Pt~~~il~~  355 (401)
                       +++.+++.+
T Consensus       296 r~~~~~~l~h  305 (377)
T cd05629         296 RGGAHEIKSH  305 (377)
T ss_pred             CCCHHHHhcC
Confidence             599998876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.5e-42  Score=313.11  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=197.3

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.||+|+||.||+|.+..      +++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEec------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            469999999999998876      57889999876433 23346788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +++++|.+++... ...+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.+||+|||++..........
T Consensus        75 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLES--KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            9999999998653 3468999999999999999999995  459999999999999999999999999987543321111


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE  320 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (401)
                      ......++..|+|||.+.++.++.++||||||+++|+|++ |..||.......   ...              .+.....
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~--------------~~~~~~~  214 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TRE--------------AIEQGVR  214 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHH--------------HHHcCCC
Confidence            1111123457999999999899999999999999999998 888886432110   000              0111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       321 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                      ...+...+..+.+++.+||+.+|++||++.+++++|.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1223344678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=2.5e-42  Score=327.46  Aligned_cols=247  Identities=27%  Similarity=0.388  Sum_probs=199.0

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCC-ceeeEEEEEEeCC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHP-HLVKLIGYCWEEE  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp-nI~~~~~~~~~~~  153 (401)
                      +|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+..|..++..+.|+ +|+.+++++...+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            58889999999999999998776      5789999998643   223445678899999999764 6889999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            999999999999999988654  578999999999999999999995  4599999999999999999999999999875


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   ...   ...         
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~i---------  213 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELF---QSI---------  213 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHH---------
Confidence            322221  223457999999999999999999999999999999999999999754211   011   111         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM-----SYVVR  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~~il~  354 (401)
                       ..  ....++...+..+.+++.+||..||.+|++.     .++++
T Consensus       214 -~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         214 -ME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             -Hc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             10  0112333456788999999999999999986     55554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.2e-42  Score=321.39  Aligned_cols=265  Identities=25%  Similarity=0.344  Sum_probs=197.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhcc---CCCceeeEEEEEEe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQL---RHPHLVKLIGYCWE  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnI~~~~~~~~~  151 (401)
                      .+|++.+.||+|+||.||+|.+...     .+..||+|.+.....  .....+.+|+.+++.+   +||||+++++++..
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~   75 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   75 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCC-----CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEec
Confidence            3789999999999999999987541     367899999875432  2234566677776665   69999999998852


Q ss_pred             -----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          152 -----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       152 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                           ....++||||+. ++|.+++.......+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~--~~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          76 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             ccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEEcCCCCEEEc
Confidence                 446899999995 699999876655678999999999999999999995  459999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh-
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL-  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-  305 (401)
                      |||++.......   ......|++.|+|||++.+..++.++|||||||++|+|++|.+||.......  .+........ 
T Consensus       153 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~  227 (290)
T cd07862         153 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGL  227 (290)
T ss_pred             cccceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCC
Confidence            999997654321   2234568999999999998899999999999999999999999997643211  1111111000 


Q ss_pred             cCccchhh-------hcCCcCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          306 KEPRKLER-------LIDPRLEG---QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       306 ~~~~~~~~-------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ..+.....       .+......   ......+..+.+++.+||+.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000000       00000000   011234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=7.9e-43  Score=330.98  Aligned_cols=244  Identities=28%  Similarity=0.379  Sum_probs=198.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|+.++..++||||+++++++......|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            469999999999998766      6889999998643   2233456778999999999999999999999999999999


Q ss_pred             EecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCc
Q 040050          160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE  239 (401)
Q Consensus       160 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~  239 (401)
                      ||+.+++|..++...  ..+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||++........
T Consensus        75 E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~-~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          75 EYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            999999999888654  6789999999999999999999951 4599999999999999999999999999875332211


Q ss_pred             ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ....   ...          ..  
T Consensus       152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~---~i~----------~~--  211 (325)
T cd05594         152 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE---LIL----------ME--  211 (325)
T ss_pred             --ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHH---HHh----------cC--
Confidence              223457999999999999999999999999999999999999999654211   0000   000          00  


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                      ...++...+..+.+++.+||+.||++|+     ++.++++.
T Consensus       212 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            0112334467889999999999999997     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.3e-42  Score=327.69  Aligned_cols=246  Identities=26%  Similarity=0.395  Sum_probs=195.9

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHH---hccCCCceeeEEEEEEeC
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFL---GQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~hpnI~~~~~~~~~~  152 (401)
                      |++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.++   +.++||||+++++++...
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            6778999999999999998876      6889999998643   122334566666554   567899999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..|+||||+.+++|..++..   ..+++..++.++.||+.||.|||+.  +|+||||||+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~--~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN--KIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC--CeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            999999999999999887754   5799999999999999999999954  59999999999999999999999999987


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ......  .......|++.|+|||++.+..++.++|||||||++|+|++|..||......      ......        
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i--------  213 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSI--------  213 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHH--------
Confidence            532221  1224467999999999999999999999999999999999999999754211      111111        


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                        ...  ...++...+..+.+++.+||+.||.+||     ++.++++.
T Consensus       214 --~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         214 --VND--EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             --HhC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence              110  0112334567889999999999999999     56676653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-42  Score=319.06  Aligned_cols=255  Identities=36%  Similarity=0.548  Sum_probs=199.1

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEE
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      +.+.||.|.||.||+|.+..  .....+..|+||.+..... .....+.+|++.+++++||||+++++++......++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~--~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQ--KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEES--TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEc--ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence            45789999999999999883  2334678999999965433 34678999999999999999999999999888899999


Q ss_pred             EecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCc
Q 040050          160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE  239 (401)
Q Consensus       160 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~  239 (401)
                      ||+++|+|.+++.......+++..++.++.|++.||.|||+.+  |+|++|+++||+++.++.+||+|||++........
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence            9999999999998865678999999999999999999999654  99999999999999999999999999987633333


Q ss_pred             ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      ........+...|+|||.+.+..++.++||||||+++|||++ |+.||.....      .++....           ...
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~-----------~~~  221 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKL-----------KQG  221 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHH-----------HTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-----------ccc
Confidence            322333457789999999998889999999999999999999 6788865421      1111111           111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                      .....+..++..+.+++.+||..+|.+||++.++++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11123334567889999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.7e-42  Score=321.39  Aligned_cols=267  Identities=28%  Similarity=0.395  Sum_probs=210.1

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      ...++|++.+.||+|+||.||+|.+..... ......+|+|.+.... ......+.+|+.++.++ +||||+++++++..
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCC-CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344678999999999999999998764211 2245789999987542 23345688899999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRS--------------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL  217 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv  217 (401)
                      +...+++|||+++++|..++...              ....+++..++.++.|++.||.|||+  .+|+||||||+||++
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~--~~ivH~dlkp~Nil~  165 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS--KKCIHRDLAARNVLV  165 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCccccccceeeEEE
Confidence            99999999999999999998642              23568899999999999999999995  559999999999999


Q ss_pred             cCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCccccccc
Q 040050          218 DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQS  296 (401)
Q Consensus       218 ~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  296 (401)
                      +.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......   
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  242 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  242 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence            9999999999999986544322222222345678999999999999999999999999999997 889986542111   


Q ss_pred             HHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                         ...           .+........+...+..+.+++.+||..||.+|||+.++++.|+.+.
T Consensus       243 ---~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 ---LFK-----------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---HHH-----------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               000           01111111223344678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.5e-42  Score=327.04  Aligned_cols=250  Identities=23%  Similarity=0.372  Sum_probs=197.8

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            479999999999998876      5789999998743   223345677899999888 699999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|..++.+.  ..+++..++.++.|++.||.|||+  ++|+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          75 IEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE--RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            9999999999888654  679999999999999999999995  459999999999999999999999999987432211


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc--cccHHHHhhhhhcCccchhhhcC
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR--EQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                        .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......  ......+....         +..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~~  219 (329)
T cd05588         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV---------ILE  219 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH---------HHc
Confidence              12234679999999999999999999999999999999999999996432111  11111111111         111


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT------MSYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~~il~~  355 (401)
                      ..  ..+|...+..+.+++.+||+.||.+||+      +.++++.
T Consensus       220 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 KQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            11  1233345678899999999999999997      5677643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-42  Score=327.31  Aligned_cols=237  Identities=27%  Similarity=0.388  Sum_probs=192.6

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||+||+|.+..      +++.||+|++...   .......+..|..++..+ +||||+++++++...+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            469999999999998876      5789999998643   223345677888888776 699999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|.+++.+.  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~--~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          75 MEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            9999999999988764  679999999999999999999995  459999999999999999999999999987532221


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ........          ..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~----------~~  212 (320)
T cd05590         151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN----------DE  212 (320)
T ss_pred             --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhc----------CC
Confidence              1223457999999999999999999999999999999999999999754211      11111111          00


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  349 (401)
                        ..++...+..+.+++.+||+.||.+||++
T Consensus       213 --~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 --VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence              11233346788999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.8e-42  Score=328.17  Aligned_cols=256  Identities=26%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC----CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD----GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      +|++.+.||+|+||.||+|+....   ..+++.||+|++...    .......+..|+.+++.+ +||||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTG---HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEccc---CCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            488899999999999999976431   225789999998632    122345677899999999 499999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ..+++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++.
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK--LGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999999998764  678999999999999999999995  459999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......  ...........     
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~-----  225 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSEVSRRILK-----  225 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHHHHHHHhc-----
Confidence            65433222 12345799999999999865 47889999999999999999999996532211  11111111110     


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                             ....++...+..+.+++.+||+.||++||     +++++++.
T Consensus       226 -------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 -------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                   11122334567889999999999999999     67788754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.6e-42  Score=320.55  Aligned_cols=266  Identities=27%  Similarity=0.382  Sum_probs=209.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      ..++|.+.+.||+|+||.||+|.+... .....+..||+|++.... ......+.+|+.+++++ +||||+++++++...
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGL-SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecC-CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            346799999999999999999986431 122356689999987543 23345688999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++.
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999999765444589999999999999999999954  59999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .+..            
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~------------  255 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYK------------  255 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHH------------
Confidence            6544322211222346788999999999999999999999999999998 999986542210  0100            


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                        ..........+...+..+.+++.+||..+|++||++.++++.|+++
T Consensus       256 --~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 --LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              1111111112223456899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-42  Score=336.44  Aligned_cols=253  Identities=23%  Similarity=0.268  Sum_probs=197.8

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +|++.+.||+|+||+||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++.+.+...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            68899999999999999998876      57899999986432   2234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|+||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+.  +|+||||||+|||++.+|.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~--~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM--GFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999999999999998764  5789999999999999999999955  5999999999999999999999999997532


Q ss_pred             CCCC---------------------------------------------cceeeeccccccccccccccccCCCCccccH
Q 040050          235 PEGE---------------------------------------------ETHVITRVMGTQGYAAPEYVMTGHLTTMSDV  269 (401)
Q Consensus       235 ~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  269 (401)
                      ....                                             ........+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            1000                                             0000123469999999999999999999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-
Q 040050          270 YSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-  348 (401)
Q Consensus       270 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-  348 (401)
                      |||||++|+|++|..||.......      ........        ............+..+.+++.+|+ .+|.+|++ 
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~--------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLE------TQMKVINW--------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHH------HHHHHHcc--------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            999999999999999997642110      00000000        000100111234677888888876 59999997 


Q ss_pred             --HHHHHHH
Q 040050          349 --MSYVVRV  355 (401)
Q Consensus       349 --~~~il~~  355 (401)
                        +.+++++
T Consensus       297 ~~~~ei~~h  305 (382)
T cd05625         297 NGADEIKAH  305 (382)
T ss_pred             CCHHHHhcC
Confidence              8887753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-43  Score=317.46  Aligned_cols=266  Identities=28%  Similarity=0.382  Sum_probs=204.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC----
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE----  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~----  153 (401)
                      .|.-.+++|.|+||.||.|...+      +.+.||||++-.+..    .-.+|+++|+.+.||||+++.-+|....    
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            46677999999999999999887      578999999864432    2346999999999999999998886432    


Q ss_pred             -eEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEEecC
Q 040050          154 -YRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFG  229 (401)
Q Consensus       154 -~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~DfG  229 (401)
                       +..+||||++ .+|..++..  ..+..++...+.-+..||++||+|||+  .||+||||||.|+|||.+ |.+||||||
T Consensus        95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~--~~IcHRDIKPqNlLvD~~tg~LKicDFG  171 (364)
T KOG0658|consen   95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS--HGICHRDIKPQNLLVDPDTGVLKICDFG  171 (364)
T ss_pred             hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh--cCcccCCCChheEEEcCCCCeEEeccCC
Confidence             3468999995 599998874  234788888999999999999999996  459999999999999987 999999999


Q ss_pred             CCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .|+....+..+   ..+..|..|+|||.+.| ..|+.+.||||.||++.||+.|++.|.+....  ..+..++.-+-...
T Consensus       172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPT  246 (364)
T ss_pred             cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCC
Confidence            99987666544   44568999999999987 57999999999999999999999999875322  22222222111110


Q ss_pred             -------------cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 040050          309 -------------RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV--LDSLQD  361 (401)
Q Consensus       309 -------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~--L~~l~~  361 (401)
                                   ....++....+..-+....++++.+|+.++|..+|.+|.++.+++.+  ++.++.
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence                         01111111111112344557899999999999999999999999865  444443

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.1e-42  Score=324.76  Aligned_cols=242  Identities=30%  Similarity=0.407  Sum_probs=193.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhc-cCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQ-LRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++....   ......+..|..++.. .+||||+++++++......++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            469999999999998876      57899999987431   2233445667777664 4799999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||++||+|..++...  ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~--~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          75 MEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            9999999999988654  579999999999999999999995  459999999999999999999999999997543322


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||......      ........            
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~------------  210 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILN------------  210 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc------------
Confidence              1223457999999999999999999999999999999999999999764211      11111100            


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS-YVVR  354 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~il~  354 (401)
                      ....++...+..+.+++.+||+.||.+||++. ++++
T Consensus       211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            01123334567889999999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-42  Score=319.56  Aligned_cols=253  Identities=27%  Similarity=0.364  Sum_probs=204.0

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +|++.+.||+|+||+||++.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++..++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            47888999999999999998765      57899999986432   1223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++.......+++..+..++.|++.||.|||+.  +|+||||||+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE--RIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC--CcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            99999999999999888765456799999999999999999999954  5999999999999999999999999998765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....   .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......  ........           
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~~~~-----------  216 (285)
T cd05605         153 PEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEVERR-----------  216 (285)
T ss_pred             CCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHHHHH-----------
Confidence            43221   234578999999999999899999999999999999999999997642211  00010000           


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                      +. .....++...+..+.+++.+||+.||.+||     ++.++++.
T Consensus       217 ~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         217 VK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            00 011123334577889999999999999999     88888664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.3e-42  Score=327.29  Aligned_cols=243  Identities=27%  Similarity=0.384  Sum_probs=196.2

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|..++..+ +||||+++++++......|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            469999999999998776      5789999998643   223345577888888866 799999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|..++...  ..+++..+..++.|++.||.|||++  +|+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          75 MEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH--GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            9999999999888664  6789999999999999999999954  59999999999999999999999999987533222


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......      ........          ..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~----------~~  212 (321)
T cd05591         151 V--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILH----------DD  212 (321)
T ss_pred             c--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHc----------CC
Confidence            1  223457999999999999999999999999999999999999999764311      11111111          00


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRP-------TMSYVVRV  355 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~~il~~  355 (401)
                        ..++...+..+.+++.+||+.||++||       ++.++++.
T Consensus       213 --~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 --VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence              112333467889999999999999999       77888755

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.3e-42  Score=320.58  Aligned_cols=273  Identities=25%  Similarity=0.377  Sum_probs=213.7

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcC-CCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKL-KPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCW  150 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~  150 (401)
                      +...+|.+.+.||+|+||.||+|.+.... .....+..||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            34578899999999999999999764311 112245679999986432 33456788999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEE
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNIL  216 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIl  216 (401)
                      .....+++|||+.+++|.+++....              ...+++..++.++.|++.||.|||++  ||+||||||+||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--givH~dlkp~Nil  169 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ--KCIHRDLAARNVL  169 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC--CeeecccccceEE
Confidence            9999999999999999999997532              23578888999999999999999954  5999999999999


Q ss_pred             EcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccc
Q 040050          217 LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQ  295 (401)
Q Consensus       217 v~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  295 (401)
                      ++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.....    
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----  245 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----  245 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH----
Confidence            99999999999999986644332222233446778999999999899999999999999999998 7788865321    


Q ss_pred             cHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          296 SLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                        .+...... .          ......+..++..+.+++.+||+.+|.+||++.++++.|.++..+...
T Consensus       246 --~~~~~~~~-~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         246 --EELFKLLK-E----------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             --HHHHHHHH-c----------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence              11111111 0          111112334567899999999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.1e-41  Score=317.81  Aligned_cols=263  Identities=29%  Similarity=0.410  Sum_probs=206.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      +|++.+.||+|+||.||+|++..... ......+++|.+..... .....+.+|+.+++.++||||+++++.+......+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKG-RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCC-CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            47888999999999999998754211 12345788998864432 23457889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCc
Q 040050          157 LVYEYMPRGSLHNQLFRSY----------------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASN  214 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~N  214 (401)
                      ++|||+.+++|.+++....                      ...+++..++.++.|++.||.|||+  .+|+||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE--MKLVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH--CCeehhhhhhhe
Confidence            9999999999999886421                      1357889999999999999999995  459999999999


Q ss_pred             EEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccc
Q 040050          215 ILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGR  293 (401)
Q Consensus       215 Ilv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  293 (401)
                      |++++++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999976533322111222345778999999988889999999999999999998 99998654211 


Q ss_pred             cccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                        .+..              ..........+...+..+.+++.+||+.+|.+||++.++++.|+++-
T Consensus       237 --~~~~--------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         237 --RLFN--------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             --HHHH--------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence              1111              11111112223344678999999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=331.49  Aligned_cols=271  Identities=31%  Similarity=0.461  Sum_probs=218.1

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ...++..+.++||+|+||.||+|.......  .....||+|.....   ......++++|+++|+.++||||+++||+..
T Consensus       154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~--~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNG--FKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             EeccCccccceeecccccEEEEEEEEecCC--ceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            334566677999999999999998876321  11223999998853   2455678999999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      ....+++|||+|.||+|.++|.+.. +.++..+...++.+.+.||+|||+.+  +|||||...|+|++.++.+||+|||+
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCcccc
Confidence            9999999999999999999998763 36999999999999999999999555  99999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++....-..  ......-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....                .
T Consensus       309 s~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----------------~  370 (474)
T KOG0194|consen  309 SRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----------------E  370 (474)
T ss_pred             ccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----------------H
Confidence            886431110  0001124578999999999999999999999999999999 88899875321                1


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCCC
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV  367 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~~  367 (401)
                      ....+.....+...+...+..+..++.+|+..+|++||+|.++.+.|+.+.....+..
T Consensus       371 v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~  428 (474)
T KOG0194|consen  371 VKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD  428 (474)
T ss_pred             HHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence            1112222233334455668889999999999999999999999999999977776543

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-41  Score=315.40  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|++.+.||+|+||+||+|.+...  +......+++|.+..... .....+..|+.+++.+.||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPE--GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCC--CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            5788899999999999999987541  011123588888754322 234567778889999999999999998764 457


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++++||+++|+|.+++... ...+++..+..++.|++.||.|||+  ++++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEE--HRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            8899999999999998753 3578999999999999999999995  559999999999999999999999999998654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ............++..|+|||.+.+..++.++|||||||++|+|++ |..||......   ...+..             
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~~~-------------  224 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EVPDLL-------------  224 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH-------------
Confidence            4333222334557788999999998899999999999999999998 99998654211   111111             


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                       ........+..++..+..++.+||..||.+||++.++++.|..+..
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 -EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence             1111111111234567889999999999999999999999888764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-42  Score=332.77  Aligned_cols=253  Identities=23%  Similarity=0.280  Sum_probs=202.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ..++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~  114 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKS------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD  114 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            34689999999999999999998876      5889999998632   22334457789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      +...|+||||+++|+|.+++..   ..+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         115 DKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEcCCCCEEEEeccce
Confidence            9999999999999999998864   3688999999999999999999954  5999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccC----CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTG----HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ......... ......||+.|+|||++.+.    .++.++|||||||++|+|++|..||......      ....     
T Consensus       190 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~-----  257 (370)
T cd05596         190 MKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYS-----  257 (370)
T ss_pred             eeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHH-----
Confidence            765432211 12345799999999998753    4789999999999999999999999764211      1111     


Q ss_pred             ccchhhhcCCcCCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040050          308 PRKLERLIDPRLEGQFP--IKGAQKAAATAFKCLSHHPRH--RPTMSYVVRV  355 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPt~~~il~~  355 (401)
                           .+........++  ...+..+.+++.+||+.+|.+  ||++.++++.
T Consensus       258 -----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         258 -----KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -----HHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                 111110001111  134678999999999999988  9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-41  Score=311.57  Aligned_cols=253  Identities=28%  Similarity=0.398  Sum_probs=204.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-----ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-----QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ++|.+.+.||+|++|.||.|.+..      +++.||+|.+.....     .....+.+|+.++++++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            578999999999999999998765      578999999864321     123467889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      +...+++|||+++++|.+++...  ..++...+..++.|++.||.|||.  .+|+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            99999999999999999988764  578999999999999999999995  55999999999999999999999999998


Q ss_pred             CCCCCCCcce-eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          232 KDGPEGEETH-VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       232 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .......... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......     ...          
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~----------  216 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AAI----------  216 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HHH----------
Confidence            7543321111 112346888999999999988999999999999999999999998653211     100          


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       ...........++...+..+.+++.+||..+|.+|||+.++++.
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         217 -FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             00111111123344456788999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.3e-41  Score=311.57  Aligned_cols=251  Identities=26%  Similarity=0.411  Sum_probs=200.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|++.+.||+|+||.||+|.+..       +..+|+|.+... ......+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-------QIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-------CceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            568888999999999999998754       457999987633 233567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+++++|.+++.... ..+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||.+.....
T Consensus        76 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER--NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            9999999999999886532 468999999999999999999995  4599999999999999999999999999886543


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .... ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||......   .....   ....        
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~---i~~~--------  217 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEM---ISRG--------  217 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---HHCC--------
Confidence            2211 1122335668999999998899999999999999999999 89998654211   11111   1000        


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                         .....+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus       218 ---~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 ---FRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               00011222356789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.3e-42  Score=325.64  Aligned_cols=242  Identities=27%  Similarity=0.386  Sum_probs=196.1

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      +|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+..|..++..+ +|++|+.+++++...+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            57889999999999999998876      57899999987432   22334566788888777 5899999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+++|+|.+++...  ..+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHS--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            999999999999999988664  678999999999999999999995  4599999999999999999999999999875


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+.   ...         
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~---~~i---------  213 (323)
T cd05616         151 NMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---QSI---------  213 (323)
T ss_pred             cCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHH---HHH---------
Confidence            432211  123467999999999999999999999999999999999999999764211   111   111         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  349 (401)
                       ....  ..++...+..+.+++.+||+.||.+|++.
T Consensus       214 -~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         214 -MEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -HhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             1111  12333456788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.2e-41  Score=311.72  Aligned_cols=260  Identities=22%  Similarity=0.354  Sum_probs=208.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|++..      +++.||+|.+....   ......+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            579999999999999999998876      57899999876432   233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ..+++|||+++++|.+++...  ....++...++.++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh--CCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            999999999999999888542  23468899999999999999999995  45999999999999999999999999998


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......    ...+.....      
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~------  221 (267)
T cd08228         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIE------  221 (267)
T ss_pred             eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHh------
Confidence            76543221  112346889999999999888999999999999999999999998653211    111111100      


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                          ........+...+..+.+++.+||+.+|.+||++.++++.|++++
T Consensus       222 ----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         222 ----QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ----cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                000111112234678999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.5e-42  Score=336.45  Aligned_cols=262  Identities=24%  Similarity=0.370  Sum_probs=196.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC---
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE---  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~---  152 (401)
                      ..+|.+++.||+|+||.||+|.+..      +++.||||++....    ....+|+.+++.++||||+++++++...   
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            4689999999999999999998876      57899999885332    2345799999999999999999987542   


Q ss_pred             -----CeEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEE
Q 040050          153 -----EYRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAK  224 (401)
Q Consensus       153 -----~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vk  224 (401)
                           ..+++||||++ ++|.+++..  .....+++..++.++.||+.||+|||+  ++|+||||||+|||++.++ .+|
T Consensus       135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~--~~IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCcCHHHEEEcCCCCcee
Confidence                 24679999995 578777653  234678999999999999999999995  4599999999999998664 799


Q ss_pred             EEecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      |+|||++........   .....||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+....  ..+......
T Consensus       212 L~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~  286 (440)
T PTZ00036        212 LCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQV  286 (440)
T ss_pred             eeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHH
Confidence            999999986544322   234578999999999876 46899999999999999999999999764321  111111111


Q ss_pred             hhcCccc--------hhh-----hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          304 LLKEPRK--------LER-----LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       304 ~~~~~~~--------~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .......        ...     .....+...+|...+.++.+|+.+||+.||.+|||+.+++++
T Consensus       287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0000000        000     000111112233346789999999999999999999999855

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-41  Score=312.88  Aligned_cols=259  Identities=28%  Similarity=0.459  Sum_probs=202.7

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe--
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY--  154 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~--  154 (401)
                      |.+++.||+|+||.||+|.....   ...+..||+|.+....  ......+.+|+..++.++||||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD---DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC---CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            56789999999999999987542   1135789999987543  2334578899999999999999999998866554  


Q ss_pred             ----EEEEEEecCCCChhHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          155 ----RLLVYEYMPRGSLHNQLFRS----YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       155 ----~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                          .+++|||+++++|..++...    ....+++..+..++.|++.||.|||+  .+|+||||||+||++++++.+||+
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh--CCeeccccchheEEECCCCeEEEC
Confidence                79999999999999888543    22468999999999999999999995  459999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......   .+.....   
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~---  229 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLR---  229 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---
Confidence            9999986544332211222345678999999988899999999999999999999 88888653211   1111110   


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                                . ......+...+..+.+++.+||+.||.+||++.++++.|+++
T Consensus       230 ----------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         230 ----------H-GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----------c-CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      0 011122334567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-41  Score=320.48  Aligned_cols=269  Identities=26%  Similarity=0.377  Sum_probs=209.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCC-CCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKP-GLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+....+. ......+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            36799999999999999999986542111 1234579999987543 33345688899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYS--------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD  218 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~  218 (401)
                      ...++||||+.+++|.+++.....              ..+++..++.++.|++.||+|||+  .+++||||||+||+++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~  174 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVT  174 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCcccccccHHheEEc
Confidence            999999999999999999976421              358889999999999999999995  5599999999999999


Q ss_pred             CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccH
Q 040050          219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSL  297 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  297 (401)
                      .++.++|+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..||.....      
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------  248 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  248 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------
Confidence            999999999999876543222111122234578999999999899999999999999999998 8888865321      


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      .+.....           ........+...+..+.+++.+||..+|.+||++.++++.|+++....
T Consensus       249 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         249 EELFKLL-----------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHHHH-----------HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            1111110           011111223345678999999999999999999999999999986653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.2e-42  Score=324.48  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=196.3

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|+.++.++ +||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            479999999999998876      5789999998743   223345577888888776 799999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|..++...  ..+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            9999999998888654  6799999999999999999999954  59999999999999999999999999987532211


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc--cccHHHHhhhhhcCccchhhhcC
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR--EQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+....         +..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------i~~  219 (329)
T cd05618         151 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV---------ILE  219 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---------Hhc
Confidence            1  1234579999999999999999999999999999999999999996422111  11111111111         011


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM------SYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~~il~~  355 (401)
                      .  ...+|...+..+.+++.+||+.||++||++      .++++.
T Consensus       220 ~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            1  112344456788999999999999999984      566543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-41  Score=315.70  Aligned_cols=262  Identities=28%  Similarity=0.396  Sum_probs=206.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|.+.+.||+|+||.||+|..... ....++..+++|.+..........+.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC-CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            5678889999999999999975431 122346689999887655555678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcE
Q 040050          157 LVYEYMPRGSLHNQLFRSYS-------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                      ++|||+++++|.+++.....             ..+++..++.++.|++.|++|||+  .+|+|+||||+||++++++.+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS--LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH--CCeecccccHhhEEEcCCCCE
Confidence            99999999999999865321             357899999999999999999995  559999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhh
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      +|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |.+||.......   ...   
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIE---  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHH---
Confidence            9999999875543222111222345778999999999999999999999999999998 899986532111   000   


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                                .+.. ......+..++..+.+++.+||+.||.+||++.++++.|+.
T Consensus       236 ----------~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         236 ----------CITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ----------HHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                      0000 00111222345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.7e-42  Score=324.33  Aligned_cols=241  Identities=28%  Similarity=0.380  Sum_probs=193.5

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++....   .........|..++... +||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            479999999999998876      67899999986431   22344566788777654 899999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+.+++|..++...  ..+++..+..++.|++.||+|||++  +|+||||||+||+++.++.++|+|||++.......
T Consensus        75 ~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          75 MEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK--GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             ECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            9999999999988664  6789999999999999999999954  59999999999999999999999999987532222


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+.....   .          . 
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~---~----------~-  211 (316)
T cd05620         151 N--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIR---V----------D-  211 (316)
T ss_pred             C--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH---h----------C-
Confidence            1  234567999999999999999999999999999999999999999754211   1111000   0          0 


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS-YVV  353 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~il  353 (401)
                       ...++...+..+.+++.+||+.||.+||++. +++
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 -TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             1122333467889999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.1e-42  Score=331.34  Aligned_cols=254  Identities=23%  Similarity=0.300  Sum_probs=201.2

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ...++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKS------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            345789999999999999999998876      5789999998532   2223455778999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      ++...|+||||+++|+|.+++..   ..+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~--~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM--GLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHEEECCCCCEEEEeccc
Confidence            99999999999999999998864   3688999999999999999999954  599999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccC----CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTG----HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      +........ .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||.....      ....     
T Consensus       189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~-----  256 (370)
T cd05621         189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTY-----  256 (370)
T ss_pred             ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHH-----
Confidence            986543221 122346799999999998754    378899999999999999999999975421      1111     


Q ss_pred             CccchhhhcCCcCCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040050          307 EPRKLERLIDPRLEGQFP--IKGAQKAAATAFKCLSHHPRH--RPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPt~~~il~~  355 (401)
                           ..+........++  ...+..+.+++.+||..++.+  |+++.+++++
T Consensus       257 -----~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         257 -----SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -----HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                 1111111111111  234678899999999855543  8899999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-41  Score=313.12  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=198.8

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC----
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE----  152 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~----  152 (401)
                      |.+++.||+|+||.||+|.+....    ....||+|.+....  ......+.+|+.+++.++||||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~----~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD----SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC----CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            457789999999999999876521    12369999886542  33356788899999999999999999987432    


Q ss_pred             --CeEEEEEEecCCCChhHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 --EYRLLVYEYMPRGSLHNQLFRS----YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 --~~~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                        ...+++|||+.+++|.+++...    ....+++..+..++.|++.||+|||+  ++|+||||||+||+++.++.++|+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS--KSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhheEEcCCCCEEEC
Confidence              2468999999999999887432    23458899999999999999999995  559999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||......   .+.....   
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---  228 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYLR---  228 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH---
Confidence            9999987544332211222346778999999999999999999999999999999 78888653211   1111110   


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                       ...          ....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       229 -~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 -QGN----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -cCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             100          0112223456789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-41  Score=311.85  Aligned_cols=256  Identities=29%  Similarity=0.440  Sum_probs=205.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..++|.+.+.||+|+||.||+|....       ++.||+|.+.... .....+.+|+.++++++||||+++++++. ...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-------~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   74 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNG-------HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEP   74 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCC-------CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCC
Confidence            45789999999999999999998653       6789999987443 33567889999999999999999999874 456


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|||+.+++|.+++.......+++..+..++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER--KNYIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence            8999999999999999877656678999999999999999999995  45999999999999999999999999999765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......   .....   .         
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~---~---------  216 (260)
T cd05067         153 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQN---L---------  216 (260)
T ss_pred             CCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHH---H---------
Confidence            422211 1123345678999999998889999999999999999999 99999754211   01110   0         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                        ........+...+..+.+++.+||+.+|++||+++++++.|+.+
T Consensus       217 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         217 --ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             --HcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence              00111112233456899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.3e-41  Score=311.13  Aligned_cols=255  Identities=28%  Similarity=0.408  Sum_probs=202.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||.||+|.+..       ...||+|++.... .....+.+|+.+++.++||||+++++.+.. ...
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~   75 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI   75 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC-------CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCc
Confidence            3679999999999999999998754       3469999987432 234678899999999999999999998754 567


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+++|.+++.......+++..++.++.|++.||+|||+  .+|+|+||||+||+++.++.++|+|||.+....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~  153 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE  153 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH--CCccccccCcccEEEcCCCcEEeccCCceeecc
Confidence            999999999999999976544568999999999999999999995  559999999999999999999999999997654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..... ......++..|+|||+..+..++.++|||||||++|+|++ |..||......   ...   ....         
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~---~~~~---------  217 (262)
T cd05071         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVL---DQVE---------  217 (262)
T ss_pred             ccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHH---HHHh---------
Confidence            33221 1123346778999999998899999999999999999999 78888654211   000   0000         


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                        .......+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus       218 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         218 --RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              0001112334567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.8e-42  Score=322.12  Aligned_cols=242  Identities=29%  Similarity=0.407  Sum_probs=193.7

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhc-cCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQ-LRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++....   .........|..++.. ++||||+++++++.+.+.+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            469999999999998876      57899999987431   2234456677778775 4899999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.......
T Consensus        75 ~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~--~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          75 MEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK--GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            9999999999998654  5789999999999999999999954  59999999999999999999999999987533222


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+.....   .            
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~---~------------  210 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR---M------------  210 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---h------------
Confidence            1  123457999999999999999999999999999999999999999754211   1111100   0            


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS-YVVR  354 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~il~  354 (401)
                      ....++...+..+.+++.+||+.||.+||++. ++++
T Consensus       211 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         211 DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            00112333467789999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.6e-41  Score=310.61  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=205.1

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      +|++.+.||.|+||.||++.+..      +++.+|+|.+.... ......+.+|+.+++.++||||+++++.+..+..++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            57889999999999999998776      57899999986442 334567788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|||+++++|.+++.......++...++.++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||.+.....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE--KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            99999999999998876555678999999999999999999995  4599999999999999999999999999876543


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ...  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....      .........          
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~~----------  214 (255)
T cd08219         153 PGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVCQ----------  214 (255)
T ss_pred             ccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHhc----------
Confidence            221  12345689999999999988899999999999999999999999975321      111111100          


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       ......+...+..+.+++.+||+.||.+||++.+++..
T Consensus       215 -~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 -GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             01111233456678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-41  Score=309.28  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=206.4

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|.+.+.||+|++|.||+|.+..      +++.|++|.+...  .......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            47788999999999999998876      5789999998643  233456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++.......+++..++.++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~--~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            999999999999999977655789999999999999999999995  569999999999999999999999999987654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||......      ......          .
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~----------~  214 (256)
T cd08529         153 DNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------ALILKI----------I  214 (256)
T ss_pred             Cccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH----------H
Confidence            3321  123356889999999999999999999999999999999999999754311      000000          0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      . ......+...+..+.+++.+||+.+|++||++.++++.
T Consensus       215 ~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 R-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             c-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            0 11112233456789999999999999999999999764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.9e-41  Score=311.08  Aligned_cols=254  Identities=29%  Similarity=0.434  Sum_probs=202.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||.||+|.+..       +..||+|.+..... ....+.+|+.++++++||||+++++++. ....
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG-------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI   75 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC-------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence            4679999999999999999997654       56799999875432 3467889999999999999999999875 4567


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|||+.+++|.+++.......+++..++.++.|++.||.|||++  +|+|+||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~--~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM--NYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            8999999999999999765556789999999999999999999954  59999999999999999999999999997654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||......   .....   .          
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~---~----------  216 (260)
T cd05070         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQ---V----------  216 (260)
T ss_pred             Ccccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH---H----------
Confidence            32211 1122345668999999988889999999999999999999 88898653211   11111   1          


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                       ........+...+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus       217 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         217 -ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -HcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0011112233446789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.3e-42  Score=328.49  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=195.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|+..+.||+|+||.||+|.+..      +++.||+|++..... .....+.+|+++++.++|+||+++++++...+.+
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  147 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRP------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI  147 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECC------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence            456777899999999999998776      578999999865432 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+++|...      ....+..+..++.||+.||.|||++  +|+||||||+|||++.++.+||+|||++....
T Consensus       148 ~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        148 QVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRR--HIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             EEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            999999999998643      3456778889999999999999954  59999999999999999999999999997653


Q ss_pred             CCCcceeeecccccccccccccccc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....  ......||..|+|||++..     ...+.++|||||||++|+|++|+.||.......   .........     
T Consensus       220 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~-----  289 (353)
T PLN00034        220 QTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAIC-----  289 (353)
T ss_pred             cccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHh-----
Confidence            3211  1234579999999998743     334568999999999999999999997432211   111100000     


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            .......+...+..+.+|+.+||+.||++||++.++++.
T Consensus       290 ------~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 ------MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ------ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  001112233456789999999999999999999999875

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.7e-41  Score=320.23  Aligned_cols=268  Identities=24%  Similarity=0.370  Sum_probs=208.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCC-CCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+....+ .......+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3678899999999999999997643211 11245679999887442 23355688899999999 599999999999998


Q ss_pred             CeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD  218 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~  218 (401)
                      ...+++|||+++++|.+++....              ...+++..+..++.|++.||.|||+  .||+||||||+||+++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~--~gi~H~dlkp~Nill~  168 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES--RRCIHRDLAARNVLVT  168 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH--CCeeeccccceeEEEc
Confidence            99999999999999999996532              2458899999999999999999995  5599999999999999


Q ss_pred             CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccH
Q 040050          219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSL  297 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  297 (401)
                      .++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......   .+
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---EL  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH---HH
Confidence            999999999999986543221111122234567999999999999999999999999999999 88888654211   11


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ....    .          .......+..++..+.+++.+||..+|++||++.++++.|.++...
T Consensus       246 ~~~~----~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         246 FKLL----R----------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHH----H----------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence            1110    0          0111122334466888999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.9e-41  Score=314.38  Aligned_cols=265  Identities=24%  Similarity=0.355  Sum_probs=206.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|++.+.||+|+||+||+|.+....  ......||+|++..... .....+.+|+.++..++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDG--ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCC--CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            367889999999999999999876521  11123589999875432 3345788899999999999999999998754 4


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|+|+++|+|.+++... ...+++..++.++.|++.||+|||+  ++|+||||||+||+++.++.+||+|||++...
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~--~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEE--VRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence            68999999999999998653 3568999999999999999999995  45999999999999999999999999999866


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   ..+..+..           
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~-----------  225 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE-----------  225 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH-----------
Confidence            44322222222345678999999999899999999999999999998 8899865321   11111111           


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                         .......+...+..+.+++.+||+.||++||++.++++.|..+..-+
T Consensus       226 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         226 ---KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ---CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence               11111112234667899999999999999999999999998886554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-41  Score=314.90  Aligned_cols=250  Identities=25%  Similarity=0.344  Sum_probs=197.3

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ||+|+||.||++.+..      +++.||+|.+....   ......+..|+++++.++||||+++++++..+...++||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKN------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEcc------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            7999999999998876      58899999986321   12234456799999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      ++|++|.+++.......+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS--MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH--CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            999999988876555678999999999999999999995  559999999999999999999999999987654332   


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG  321 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (401)
                      ......|+..|+|||++.+..++.++|||||||++|+|++|..||.......  ...........          .... 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~----------~~~~-  216 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE----------DEVK-  216 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc----------cccc-
Confidence            1234568999999999998889999999999999999999999997542211  11111111110          0000 


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          322 QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       322 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                      ......+.++.+++.+||+.||.+||++.++++.+..
T Consensus       217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence            0111346678999999999999999999776644443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3e-41  Score=313.79  Aligned_cols=275  Identities=30%  Similarity=0.409  Sum_probs=206.5

Q ss_pred             cCC-CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeC--
Q 040050           77 SNF-SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--  152 (401)
Q Consensus        77 ~~y-~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--  152 (401)
                      ++| .+.+.||+|+||+||++....  .....+..||+|.+..... .....+.+|+.+++.++||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDP--ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEcc--ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345 888999999999999876432  1123567899999875432 3356788999999999999999999987653  


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...+++|||+.+++|.+++..   ..+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccChheEEEcCCCcEEEeeccccc
Confidence            468999999999999999865   369999999999999999999995  459999999999999999999999999998


Q ss_pred             CCCCCCccee-eeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHV-ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ......... .....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~~~  233 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVVRL  233 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchhhh
Confidence            6544322111 1123456679999999988899999999999999999999999864321100 000000000 000111


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      ............+...+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1111222222233445678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-41  Score=316.40  Aligned_cols=262  Identities=25%  Similarity=0.389  Sum_probs=205.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|.+.+.||+|+||.||+|.+.... ....+..||+|++...... ....+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTA-PGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCC-CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            34677789999999999999875421 1224578999998755432 235678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRS--------------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      ++++||+.+++|.+++...              ....+++..++.++.|++.||.|||+  .+|+||||||.||++++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~--~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS--HHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH--cCccccccchhheEecCCC
Confidence            9999999999999998532              12357888899999999999999995  4599999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHH
Q 040050          222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  300 (401)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......      ++
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~  235 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV  235 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence            999999999886544332222333456789999999998889999999999999999998 88888653211      11


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                      .....          . ......+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       236 ~~~i~----------~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIR----------N-RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHH----------c-CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            11111          1 11112234456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.1e-42  Score=328.74  Aligned_cols=254  Identities=21%  Similarity=0.208  Sum_probs=202.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||+||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            368899999999999999998776      58899999987432   223456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~--~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM--GYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            999999999999999998764 35789999999999999999999954  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccc------cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVM------TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ....... ......||+.|+|||++.      +..++.++|||||||++|+|++|..||......      .........
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~  224 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNF  224 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcC
Confidence            5443222 223457999999999986      456789999999999999999999999754211      111111111


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..        ...-......+..+.+++.+||+ +|.+||++.++++.
T Consensus       225 ~~--------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         225 QR--------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CC--------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            00        00000112346778999999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.2e-42  Score=323.04  Aligned_cols=243  Identities=28%  Similarity=0.411  Sum_probs=196.5

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||+||+|.+..      +++.||+|++...   .......+..|..++..+ +||||+++++++...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            469999999999998876      5789999998743   223345677888888877 699999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|..++.+.  ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          75 MEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE--RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            9999999999888664  579999999999999999999995  459999999999999999999999999987532221


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      .  .....+|++.|+|||++.+..++.++|||||||++|+|++|..||.....      .........          . 
T Consensus       151 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~----------~-  211 (318)
T cd05570         151 V--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILE----------D-  211 (318)
T ss_pred             C--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHc----------C-
Confidence            1  12335699999999999999999999999999999999999999975421      111111110          0 


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTM-----SYVVRV  355 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~~il~~  355 (401)
                       ...++...+..+.+++.+||+.||.+||++     .++++.
T Consensus       212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 -EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence             011233456789999999999999999999     777654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.3e-41  Score=311.67  Aligned_cols=256  Identities=24%  Similarity=0.334  Sum_probs=203.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++......
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLH------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECC------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            3679999999999999999998766      5789999999765545556788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++...  ..+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999999999988654  578999999999999999999995  459999999999999999999999999998653


Q ss_pred             CCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ....  ......|+..|+|||.+.   ...++.++|+|||||++|+|++|+.||.........  ...     .. .   
T Consensus       158 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~-----~~-~---  224 (267)
T cd06646         158 ATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLM-----SK-S---  224 (267)
T ss_pred             cccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eee-----ec-C---
Confidence            3211  112346889999999885   345788999999999999999999998543211000  000     00 0   


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                      ....+..  ......+..+.+++.+||+.+|++||+++++++.|
T Consensus       225 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 NFQPPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0000111  11123457899999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=315.07  Aligned_cols=263  Identities=27%  Similarity=0.398  Sum_probs=207.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|+||.||+|.+..... ...+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK-GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC-CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            4688999999999999999998765321 2345789999986443 2334568889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          155 RLLVYEYMPRGSLHNQLFRSY--------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      .++||||+++++|.+++....        ...+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.+||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA--KKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccChheEEEcCCCCEEEC
Confidence            999999999999999986532        1346888999999999999999995  559999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||......   .......   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~---  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI---  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh---
Confidence            9999876543322112223456789999999998889999999999999999998 89998653211   1111110   


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                                 .......+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus       236 -----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 -----------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                       011111233346789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-41  Score=322.37  Aligned_cols=244  Identities=25%  Similarity=0.353  Sum_probs=194.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++....   ......+..|+.++.++ +||||+.+++++...+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            479999999999998876      57899999997532   23345677899998888 599999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|..++...  ..+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~--~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          75 IEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE--RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            9999999999888654  679999999999999999999995  459999999999999999999999999987532211


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.............+.....         ....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------~~~~  219 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------LEKP  219 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------HhCC
Confidence              12244679999999999999999999999999999999999999996532221111111111110         0111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  349 (401)
                        ..+|...+..+.+++.+||..||.+|+++
T Consensus       220 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         220 --IRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence              12333456778999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.3e-41  Score=310.07  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|.+.+.||+|+||+||+|.+..       +..+|+|.+.... .....+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-------~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-------CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            568889999999999999997654       3469999887432 33467889999999999999999999999888899


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+  .+++|+||||.||+++.++.+||+|||++.....
T Consensus        76 lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLES--KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            9999999999999986542 378999999999999999999995  5599999999999999999999999999876543


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .... ......++..|+|||++.+..++.++|||||||++|+|++ |..||......   ....   .....        
T Consensus       153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~---~~~~~--------  217 (256)
T cd05113         153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETVE---KVSQG--------  217 (256)
T ss_pred             Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH---HHhcC--------
Confidence            2211 1122345678999999998889999999999999999998 99998654311   0111   11000        


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                         .....+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       218 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 ---LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               000111223578899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.3e-42  Score=324.07  Aligned_cols=238  Identities=29%  Similarity=0.386  Sum_probs=190.6

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHH-HHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEII-FLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||+||+|.+..      +++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            469999999999999876      68899999986431   222344555554 56789999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+.+++|..++.+.  ..+++..+..++.||+.||.|||+  .+|+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~--~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          75 LDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            9999999999988764  678999999999999999999995  459999999999999999999999999987532221


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .+........          .
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~----------~  212 (323)
T cd05575         151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNK----------P  212 (323)
T ss_pred             --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC----------C
Confidence              122345799999999999999999999999999999999999999975421      1111111111          1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS  350 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  350 (401)
                      .  ..+...+..+.+++.+||+.||.+||++.
T Consensus       213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 L--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            1  12223467889999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.8e-41  Score=327.74  Aligned_cols=266  Identities=26%  Similarity=0.391  Sum_probs=207.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~  153 (401)
                      .++|.+.+.||+|+||.||+|++... .....+..||+|++..... .....+.+|+.+|.++. ||||+++++++....
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGL-SHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCC-CCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            35688889999999999999987532 1223467899999975432 22346889999999997 999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcC---------------------------------------------------------
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYS---------------------------------------------------------  176 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  176 (401)
                      ..++||||+.+|+|.+++.+...                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999865311                                                         


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE
Q 040050          177 ---------------------------------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL  217 (401)
Q Consensus       177 ---------------------------------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv  217 (401)
                                                             ..+++..++.++.|++.||.|||+  .+|+||||||+|||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~--~~ivHrdlkp~NiLl  272 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS--KNCVHRDLAARNVLI  272 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--CCcCcccCCcceEEE
Confidence                                                   235677788999999999999995  559999999999999


Q ss_pred             cCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCccccccc
Q 040050          218 DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQS  296 (401)
Q Consensus       218 ~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  296 (401)
                      +.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.......  .
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--~  350 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--Q  350 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--H
Confidence            9999999999999976433221111223457889999999998889999999999999999998 888986542110  0


Q ss_pred             HHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      +..              .+........+...+..+.+++.+||..+|.+||++.+|++.|+.+-
T Consensus       351 ~~~--------------~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 FYN--------------AIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHH--------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            000              01111111233345678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.1e-41  Score=314.46  Aligned_cols=247  Identities=24%  Similarity=0.351  Sum_probs=196.6

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ||+|+||+||++.+..      +++.||+|.+....   ......+..|+.+++.++||||+++.+++......++||||
T Consensus         1 lg~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRA------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEcc------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            7999999999998876      57899999986432   22335667899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCc
Q 040050          162 MPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE  239 (401)
Q Consensus       162 ~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~  239 (401)
                      +++|+|..++...  ....+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ--RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999998887542  23578999999999999999999995  4599999999999999999999999999976544322


Q ss_pred             ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                      .  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........  ........          .... 
T Consensus       153 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~----------~~~~-  217 (280)
T cd05608         153 K--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRI----------LNDS-  217 (280)
T ss_pred             c--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhh----------cccC-
Confidence            1  2345789999999999999999999999999999999999999975421110  00101111          1110 


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                       ..++...+..+.+++.+||+.||++||     ++++++++
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         218 -VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             -CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence             123334567899999999999999999     66777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.9e-41  Score=308.54  Aligned_cols=250  Identities=27%  Similarity=0.370  Sum_probs=197.7

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      .||+|+||.||+|.+...    .++..+|+|++.....  .....+.+|+.+++.+.||||+++++++.. ...++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK----KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecC----CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEec
Confidence            589999999999976431    2467899999864432  234578899999999999999999998754 467899999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+  ++|+||||||.||+++.++.++|+|||++..........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~--~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE--TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            9999999998654  578999999999999999999995  559999999999999999999999999998654432211


Q ss_pred             e-eeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          242 V-ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       242 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                      . .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||......   .....              +....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~--------------i~~~~  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQM--------------IESGE  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH--------------HHCCC
Confidence            1 122234678999999988889999999999999999998 99999754211   11111              11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ....+...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1223344567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-41  Score=320.91  Aligned_cols=272  Identities=26%  Similarity=0.371  Sum_probs=211.0

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCC-CCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPG-LEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCW  150 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~  150 (401)
                      ....+|.+++.||+|+||.||+|.+....+.. .....||+|.+.... ......+.+|+.+++++ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            33467999999999999999999865422211 234579999887543 23356788999999999 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEE
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNIL  216 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIl  216 (401)
                      .....+++|||+++++|.+++.+..              ...+++..++.++.|++.||.|||+  .+|+||||||+||+
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~givH~dlkp~Nil  166 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS--QKCIHRDLAARNVL  166 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH--CCeeccccccceEE
Confidence            9999999999999999999987532              2357888999999999999999995  55999999999999


Q ss_pred             EcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccc
Q 040050          217 LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQ  295 (401)
Q Consensus       217 v~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  295 (401)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.....    
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  242 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  242 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH----
Confidence            99999999999999976543322211222334567999999999999999999999999999998 8888865421    


Q ss_pred             cHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          296 SLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                        ........           .......+...+..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus       243 --~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         243 --EELFKLLK-----------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             --HHHHHHHH-----------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence              11111110           011111233345688999999999999999999999999999986554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.7e-42  Score=330.26  Aligned_cols=254  Identities=22%  Similarity=0.296  Sum_probs=198.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.++..++||||+++++.+.+..
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            368899999999999999998876      5889999998642   2233456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||++||+|.+++.+.  ..+++..+..++.|++.||.|||+  +||+||||||+|||++.+|.++|+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~--~givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ--LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            999999999999999998764  678999999999999999999995  5599999999999999999999999999874


Q ss_pred             CCCCCcc---------------------------------eeeeccccccccccccccccCCCCccccHHhHHHHHHHHH
Q 040050          234 GPEGEET---------------------------------HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL  280 (401)
Q Consensus       234 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  280 (401)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            4221100                                 0012357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 040050          281 TGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT---MSYVVRV  355 (401)
Q Consensus       281 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~~il~~  355 (401)
                      +|..||......      ............   +   ....  ....+..+.+++.+|+ .||.+|++   +.+++++
T Consensus       231 tG~~Pf~~~~~~------~~~~~i~~~~~~---~---~~p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         231 IGYPPFCSETPQ------ETYRKVMNWKET---L---VFPP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             cCCCCCCCCCHH------HHHHHHHcCCCc---e---ecCC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            999999764321      111111100000   0   0000  1124568889998877 49999985   6666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.8e-41  Score=316.29  Aligned_cols=265  Identities=25%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||.||+|......    ....+++|.+... .......+.+|+.++.++ +||||+++++++.....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC----CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            57899999999999999999876521    1234788887642 233456788999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      .+++|||+++++|.+++....              ...+++..++.++.|++.||+|||+  .+|+||||||+||+++.+
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~--~~ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE--KQFIHRDLAARNVLVGEN  155 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCcCCcceEEECCC
Confidence            999999999999999996532              1358889999999999999999995  559999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  299 (401)
                      +.+||+|||++........   ......+..|+|||++.+..++.++|||||||++|+|++ |..||......      .
T Consensus       156 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------~  226 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------E  226 (297)
T ss_pred             CeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence            9999999999864321110   111123557999999998889999999999999999997 99999654211      1


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCCC
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV  367 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~~  367 (401)
                      .....           ........+..++..+.+++.+||+.+|.+||++.++++.|+.+......+.
T Consensus       227 ~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~  283 (297)
T cd05089         227 LYEKL-----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV  283 (297)
T ss_pred             HHHHH-----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence            11111           1111112233356788999999999999999999999999998876554443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.1e-41  Score=312.76  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=203.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|++|.||+|.+.... .......|++|.+..... .....+..|+.+++.++|+||+++++++.+...
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRD-GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCC-CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            367899999999999999999876421 112467899998865432 234568889999999999999999999999889


Q ss_pred             EEEEEEecCCCChhHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC---cEEEE
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYS-----AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY---TAKLS  226 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~---~vkL~  226 (401)
                      .++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.  +++|+||||+||+++.++   .+||+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN--HFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccchheEEEeccCCCcceEec
Confidence            9999999999999999865421     3588999999999999999999954  599999999999998654   69999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......   +...     
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~-----  233 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEF-----  233 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-----
Confidence            9999986533221111112234568999999999999999999999999999997 999987543211   1111     


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                               +........+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       234 ---------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 ---------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ---------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                     0011111223344678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-40  Score=306.98  Aligned_cols=260  Identities=23%  Similarity=0.386  Sum_probs=209.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|.++...   ......+.+|++++++++|+||+++++++...+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            579999999999999999998875      57899999886422   223567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ..++||||+++++|..++...  ....+++..++.++.+++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS--KRIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh--CCEecCCcChhhEEECCCCcEEEecccee
Confidence            999999999999999988642  23568999999999999999999995  45999999999999999999999999998


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....    .........       
T Consensus       154 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-------  220 (267)
T cd08224         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKI-------  220 (267)
T ss_pred             eeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhh-------
Confidence            75433221  12234688999999999998899999999999999999999999865321    111111110       


Q ss_pred             hhhcCCcCCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          312 ERLIDPRLEGQFPI-KGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       312 ~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                          ........+. ..+..+.+++.+||..+|++||++.+|++.|..+++
T Consensus       221 ----~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~  267 (267)
T cd08224         221 ----EKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA  267 (267)
T ss_pred             ----hcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence                0011111222 456789999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.3e-41  Score=314.37  Aligned_cols=265  Identities=26%  Similarity=0.403  Sum_probs=205.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..++|++.+.||+|+||.||+|.+..... ...+..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCC-CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45789999999999999999998664222 12356899998764432 22345778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY--------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      ..++||||+++|+|.+++....        ....+...+..++.|++.||.|||++  +|+||||||+||+++.++.++|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK--KFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999996532        13346778899999999999999954  5999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||......   .....   .
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~---~  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKF---V  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---H
Confidence            99999876543322222222345678999999998899999999999999999998 78888653211   11110   0


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                                .... ....+...+..+.+++.+||+.||++||++.++++.|.+.
T Consensus       235 ----------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 ----------MDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             ----------HcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                      0000 0111223357899999999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.9e-41  Score=307.02  Aligned_cols=251  Identities=30%  Similarity=0.475  Sum_probs=205.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..+|.+.+.||.|+||.||+|...        ++.||+|.+..... ....+.+|+.+++.++|+||+++++++......
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            357889999999999999999753        57899999875543 456788999999999999999999999988999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++.......+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||.+....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~  153 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS  153 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccchhcccceEEEeCCCCEEEcccccccccc
Confidence            999999999999999977644579999999999999999999995  459999999999999999999999999998653


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ...     ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......   .+..   ..          
T Consensus       154 ~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~----------  212 (256)
T cd05039         154 QGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---HV----------  212 (256)
T ss_pred             ccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HH----------
Confidence            321     12235667999999998889999999999999999997 99998654211   1111   00          


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                       ........+...+..+.+++.+||..+|.+||++.++++.|..+
T Consensus       213 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         213 -EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence             01111122333467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.6e-41  Score=310.28  Aligned_cols=260  Identities=22%  Similarity=0.354  Sum_probs=208.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      ++..+|+|.+....   ......+.+|+.+++.++||||+++++++..++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            468888999999999999998766      57899999876432   223457888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            999999999999999988642  23568999999999999999999995  45999999999999999999999999998


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......    ........       
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-------  220 (267)
T cd08229         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-------  220 (267)
T ss_pred             hccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhh-------
Confidence            76543221  123456899999999999888999999999999999999999998653211    11111100       


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                         .........+...+..+.+++.+||+.||.+|||+.+|++.+.++.
T Consensus       221 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         221 ---EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---hcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence               0001111112235678999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-42  Score=301.25  Aligned_cols=253  Identities=26%  Similarity=0.393  Sum_probs=206.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc----cc----HHHHHHHHHHHhccC-CCceeeEE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT----QG----HKEWMAEIIFLGQLR-HPHLVKLI  146 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l~-hpnI~~~~  146 (401)
                      -..|.-.+.||.|..++|-++.++.      ++..+|+|++.....    +.    .+.-+.|+.||+++. ||+|+++.
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKE------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcc------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            3567778899999999999888777      688999999864321    11    233456999999985 99999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          147 GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      ++|..+..+++|+|.|+.|.|++++...  -.+++.....|++|+++|+.|||..+  ||||||||+|||++++.++||+
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEEe
Confidence            9999999999999999999999999876  78999999999999999999999655  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccc------cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM------TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      |||.++....+..   ....||||+|+|||.+.      ...|+...|+|++|+++|.|+.|.+||.....    .+  .
T Consensus       166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----ml--M  236 (411)
T KOG0599|consen  166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----ML--M  236 (411)
T ss_pred             ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----HH--H
Confidence            9999998877654   45689999999999985      35688899999999999999999999965321    00  0


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+.+.....        .....--.+.+....+||.+||+.||.+|.|+.+++.+
T Consensus       237 LR~ImeGky--------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  237 LRMIMEGKY--------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHHhccc--------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            111111000        01111123567789999999999999999999999875

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=8.6e-42  Score=323.88  Aligned_cols=243  Identities=28%  Similarity=0.348  Sum_probs=191.8

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHH-HHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEI-IFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||+||+|.+..      +++.||+|++....   ......+..|. .+++.++||||+++++++...+..|+|
T Consensus         1 ~~lg~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECC------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            469999999999998876      57889999986431   12223444444 456788999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+.+++|.+++...  ..+++..+..++.||+.||.|||++  ||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~--giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          75 LDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            9999999999988764  6788899999999999999999954  59999999999999999999999999987533221


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||......      .........          .
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~----------~  212 (325)
T cd05602         151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILNK----------P  212 (325)
T ss_pred             --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHhC----------C
Confidence              1223467999999999999999999999999999999999999999754211      111111111          0


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .  .++...+..+.+++.+||+.||.+||++.+.+..
T Consensus       213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         213 L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             c--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            0  1223446788999999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=308.04  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=199.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|++.+.||+|+||.||+|.+..       +..+|+|.+... ......+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-------~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-------KIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIF   75 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-------CccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceE
Confidence            458888999999999999997653       457999987633 223456888999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+++++|.+++.... ..+++..++.++.|++.||+|||+.  +|+||||||+||+++.++.+||+|||++.....
T Consensus        76 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          76 IVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN--GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             EEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC--CcccccccHhhEEECCCCcEEECCcccceeccc
Confidence            9999999999999987542 4789999999999999999999954  599999999999999999999999999876543


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......   ....   ..           
T Consensus       153 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~-----------  214 (256)
T cd05059         153 DQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---EVVE---SV-----------  214 (256)
T ss_pred             cccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---HHHH---HH-----------
Confidence            2211 1111223457999999999999999999999999999999 78888653211   0111   00           


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                      ........+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         215 SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            00111112233467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-41  Score=327.74  Aligned_cols=268  Identities=23%  Similarity=0.269  Sum_probs=203.6

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ....+|.+.+.||.|+||.||+|....    ...+..||+|.+...     ....+|+.+|+.++||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~----~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHG----DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcC----CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            345689999999999999999997543    224678999987532     23467999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|++||++ +++|.+++...  ..+++..++.++.||+.||.|||+  .+|+||||||+|||++.++.++|+|||++..
T Consensus       160 ~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~--~givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        160 TVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            999999999 57898888443  689999999999999999999995  4599999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc-ccHHHHhhhhhcCccc--
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE-QSLAEWARPLLKEPRK--  310 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~--  310 (401)
                      ..............||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+...... ..+..........+..  
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            5544333333456799999999999999999999999999999999999999976543211 1111111111000000  


Q ss_pred             ------hhh---hcCCcCCCCC--C-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 ------LER---LIDPRLEGQF--P-----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ------~~~---~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            +..   .........+  +     ...+.++.++|.+||..||++||++.+++..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  000   0000011111  1     1224578899999999999999999999875

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-41  Score=306.91  Aligned_cols=253  Identities=34%  Similarity=0.485  Sum_probs=205.3

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc-HHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.||+|+||.||+|.+....   ..+..|++|.+....... ...+.+|+.++..++|+||+++++++......+++|||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            46999999999999887521   236789999987654333 57788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          162 MPRGSLHNQLFRSY-------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       162 ~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +++++|.+++....       ...+++..++.++.|++.||+|||+  .+|+|+||+|+||+++.++.++|+|||.+...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS--KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc--CCcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999987642       3678999999999999999999995  55999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||.....      ........        
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~--------  221 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLR--------  221 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHH--------
Confidence            55432222334567889999999998889999999999999999999 6899876421      11111110        


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                         .......+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       222 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 ---KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               01111233445778999999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.7e-41  Score=307.14  Aligned_cols=254  Identities=28%  Similarity=0.401  Sum_probs=202.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|.+...||.|++|.||+|.+..       +..+|+|.+.... .....+.+|+.+++.++|||++++++++. ....
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNG-------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPI   75 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcC-------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCc
Confidence            3678999999999999999998754       3469999876432 33467889999999999999999999875 4567


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|||+.+++|.+++.......+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER--MNYIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            899999999999999976555568999999999999999999995  559999999999999999999999999997653


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ........           
T Consensus       154 ~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~-----------  218 (260)
T cd05069         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVER-----------  218 (260)
T ss_pred             CCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc-----------
Confidence            32211 1122346678999999998889999999999999999999 88998653211   11111000           


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                         ......+...+..+.+++.+||..||.+||+++++++.|++
T Consensus       219 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 ---GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01111233456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=308.68  Aligned_cols=256  Identities=30%  Similarity=0.436  Sum_probs=206.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..++|.+.+.||.|+||.||+|.+..       +..||+|.+.... .....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-------~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-------TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP   75 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-------CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc
Confidence            35789999999999999999998654       4679999987433 345678899999999999999999999998889


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|||+++++|.+++.......+++..+..++.|++.|+.|||++  +++|+||||+||+++.++.++|+|||++...
T Consensus        76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~--~i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR--NYIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcchheEEEcCCCCEEECccccceec
Confidence            99999999999999999776556789999999999999999999954  5999999999999999999999999998765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......   .......           
T Consensus       154 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~-----------  218 (261)
T cd05034         154 EDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVE-----------  218 (261)
T ss_pred             cchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-----------
Confidence            432111 1112234568999999999899999999999999999998 99998653211   1111000           


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                         .......+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       219 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 ---RGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               001111122235688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.1e-41  Score=313.56  Aligned_cols=270  Identities=26%  Similarity=0.395  Sum_probs=207.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcC----------CCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceee
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKL----------KPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVK  144 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~----------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~  144 (401)
                      .++|++.+.||+|+||.||+|.+....          .....+..||+|.+..... .....+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            368999999999999999999876421          1112346799999875533 34567889999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcE
Q 040050          145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY---------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNI  215 (401)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NI  215 (401)
                      +++++..+...+++||++.+++|.+++....         ...+++..++.++.|++.||+|||+.  +|+|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~--~i~H~dlkp~Ni  161 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL--NFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc--Cccccccchhce
Confidence            9999999999999999999999999987642         12689999999999999999999954  599999999999


Q ss_pred             EEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh--CCCCCCCCcccc
Q 040050          216 LLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT--GKRAMDNTRLGR  293 (401)
Q Consensus       216 lv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~  293 (401)
                      +++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            999999999999999876544332222334456788999999998889999999999999999998  66777543211 


Q ss_pred             cccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                        .............       ........+...+.++.+++.+||+.||.+||++.++++.|.
T Consensus       241 --~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 --QVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              1111111110000       001111122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.5e-41  Score=313.85  Aligned_cols=253  Identities=27%  Similarity=0.378  Sum_probs=202.7

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .|++.+.||+|+||+||+|.+..      +++.||+|.+.....   .....+..|+.+++.++|++|+++++.+.+.+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcC------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            37788999999999999998877      688999999864321   223456789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++.......+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ--ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh--CCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            9999999999999998876545579999999999999999999995  55999999999999999999999999998764


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....   .....|+..|+|||++.+..++.++||||||+++|+|++|..||........   .........        
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~---~~~~~~~~~--------  218 (285)
T cd05630         153 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVK--------  218 (285)
T ss_pred             CCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch---HHHHHhhhh--------
Confidence            33221   2234689999999999999999999999999999999999999975421100   000000000        


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                         .....++...+..+.+++.+||+.||.+|||     +.+++++
T Consensus       219 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         219 ---EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ---hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence               0001122334567899999999999999999     8888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2e-41  Score=321.07  Aligned_cols=242  Identities=26%  Similarity=0.380  Sum_probs=195.6

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEE  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~  153 (401)
                      +|++.+.||+|+||+||+|.+..      +++.||+|++...   .......+..|..++..+. |++|+++++++...+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            47788999999999999998876      5889999998743   2233456778888888885 578889999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||+++|+|.+++...  ..+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~--~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR--RGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            999999999999999988664  679999999999999999999995  4599999999999999999999999999875


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ...   ..          
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~---~~----------  212 (323)
T cd05615         151 HMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELF---QS----------  212 (323)
T ss_pred             cCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HH----------
Confidence            432211  123456999999999999999999999999999999999999999764211   111   11          


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  349 (401)
                      +....  ..++...+..+.+++.+||+.+|.+|++.
T Consensus       213 i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         213 IMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            11111  12333456788999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7e-42  Score=323.52  Aligned_cols=242  Identities=27%  Similarity=0.335  Sum_probs=194.3

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e  160 (401)
                      +.||+|+||.||++.....   ..+++.||+|++....  ......+..|++++++++||||+++++++..+...|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG---PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc---CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            6799999999999876421   1257899999987432  1223456789999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc
Q 040050          161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~  240 (401)
                      |+.+++|.+++.+.  ..+++..+..++.||+.||.|||+.  +|+||||||+||+++.++.+||+|||++........ 
T Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          79 FLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            99999999998654  5789999999999999999999954  599999999999999999999999999876433211 


Q ss_pred             eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCC
Q 040050          241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE  320 (401)
Q Consensus       241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (401)
                       ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......      ......          ....  
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i----------~~~~--  214 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMI----------LKAK--  214 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHH----------HcCC--
Confidence             223467999999999999988999999999999999999999999754211      111111          1101  


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 040050          321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSY  351 (401)
Q Consensus       321 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~  351 (401)
                      ..++...+..+.+++.+||+.||.+||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1223345678899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-41  Score=327.59  Aligned_cols=261  Identities=23%  Similarity=0.266  Sum_probs=202.6

Q ss_pred             HHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEE
Q 040050           70 AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLI  146 (401)
Q Consensus        70 ~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~  146 (401)
                      .+.....++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||++++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~  109 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF  109 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECC------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3344556899999999999999999998876      6889999998632   122334577899999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          147 GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      +++.++...|+||||+++|+|.+++..   ..+++..+..++.||+.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~--~~ivHrDLkp~NIll~~~~~ikL~  184 (371)
T cd05622         110 YAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHS--MGFIHRDVKPDNMLLDKSGHLKLA  184 (371)
T ss_pred             EEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCEEeCCCCHHHEEECCCCCEEEE
Confidence            999999999999999999999998865   368899999999999999999995  459999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccC----CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG----HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      |||++........ .......||+.|+|||++.+.    .++.++|||||||++|+|++|..||.....      .....
T Consensus       185 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~  257 (371)
T cd05622         185 DFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYS  257 (371)
T ss_pred             eCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHH
Confidence            9999976543221 112346799999999998754    378999999999999999999999975421      11111


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH--RPTMSYVVRVL  356 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~il~~L  356 (401)
                      ........        +........+..+.+++.+||..++.+  |+++.+++++.
T Consensus       258 ~i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         258 KIMNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHcCCCc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11111000        000111235678899999999844433  78999988763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.9e-41  Score=311.24  Aligned_cols=266  Identities=25%  Similarity=0.361  Sum_probs=209.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEe-C
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE-E  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~-~  152 (401)
                      -.++|.+.+.||+|+||.||+|.+...  ....+..|++|.+.... ......+.+|+.+++.++||||+++++++.. +
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~--~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDE--KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecC--CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            347899999999999999999987651  12236789999886442 2335668889999999999999999998766 4


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcC------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYS------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      ...+++++|+.+++|.+++.....      ..+++..++.++.|++.||+|||+  .+++|+||||+||+++.++.+||+
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccCHhhEEEcCCCcEEEC
Confidence            678999999999999999865322      468999999999999999999995  459999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||+++...............++..|+|||++.+..++.++|||||||++|++++ |..||.....   ..+..+...  
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~--  234 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKD--  234 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHc--
Confidence            9999986544332222233456778999999998889999999999999999998 9999965421   111111111  


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                                  ......+..++..+.+++.+||..||++|||+.++++.|..+..
T Consensus       235 ------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         235 ------------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ------------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                        11111122345688999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.4e-41  Score=306.46  Aligned_cols=249  Identities=27%  Similarity=0.400  Sum_probs=200.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEE-eCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCW-EEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~-~~~~~  155 (401)
                      .+|.+.+.||+|+||.||+|...        +..||+|.+....  ....+.+|+.++++++|+|++++++++. .....
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--------~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--------CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            57889999999999999999653        5679999986432  3467889999999999999999999764 45678


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|||+++++|.+++.......+++..++.++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeccccchheEEEcCCCcEEecCCccceecc
Confidence            999999999999999977655568999999999999999999995  459999999999999999999999999987543


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ...     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.....      ........         
T Consensus       154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~---------  213 (256)
T cd05082         154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVE---------  213 (256)
T ss_pred             ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHh---------
Confidence            321     22345668999999998899999999999999999997 9999864321      11111110         


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                        .......+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       214 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         214 --KGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              0111122334467889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.9e-41  Score=320.46  Aligned_cols=267  Identities=28%  Similarity=0.405  Sum_probs=204.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE-  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~-  152 (401)
                      .++|++.+.||+|+||.||+|.+.. .....+++.||+|+++.... .....+.+|+.++.++ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             hhHhcccccccCCccceEEEEeecc-CCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            4689999999999999999998543 12233578999999975432 3345688899999999 689999999987654 


Q ss_pred             CeEEEEEEecCCCChhHHHhhhc---------------------------------------------------------
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSY---------------------------------------------------------  175 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  175 (401)
                      ...+++|||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            46789999999999999986421                                                         


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccc
Q 040050          176 --------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM  247 (401)
Q Consensus       176 --------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~  247 (401)
                              ...+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.+||+|||++................
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    1246788889999999999999995  459999999999999999999999999997653322211122234


Q ss_pred             cccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHH
Q 040050          248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIK  326 (401)
Q Consensus       248 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (401)
                      ++..|+|||++.+..++.++||||||+++|+|++ |..||.......  .+..   . ..          .......+..
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~---~-~~----------~~~~~~~~~~  306 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR---R-LK----------EGTRMRAPDY  306 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH---H-Hh----------ccCCCCCCCC
Confidence            5678999999999999999999999999999997 889986532110  0110   0 00          0011111222


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          327 GAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       327 ~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      .+..+.+++.+||+.+|.+||++.++++.|+.+.+
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            34678999999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=345.90  Aligned_cols=265  Identities=29%  Similarity=0.464  Sum_probs=216.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ...++.+.||+|.||.||.|....... ......||+|.+... ..+...+|++|..+|+.++||||++++|++.+....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~-~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPG-SVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCC-CccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            456678999999999999998876322 122556999998754 345677899999999999999999999999999899


Q ss_pred             EEEEEecCCCChhHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          156 LLVYEYMPRGSLHNQLFRS-----YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~-----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      +|++|||.||+|..+|++.     ....++....+.++.+||+|+.||++..  .|||||...|+|++....|||+|||+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999999764     1457899999999999999999999544  99999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      |+.............-.-...|||||.+..+.++.++|||||||++||+++ |..||......                .
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----------------~  912 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----------------E  912 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----------------H
Confidence            996554433322221123468999999999999999999999999999999 78898765211                1


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      .+...+... +...|..++..+.+++.+||+.+|++||++..|++.+..+..
T Consensus       913 v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  913 VLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             HHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            111122222 445677889999999999999999999999999998887743

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.1e-41  Score=316.13  Aligned_cols=262  Identities=26%  Similarity=0.428  Sum_probs=202.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||.||+|.+....    ....+++|.+.... ......+.+|+.++.++ +||||+++++++..++.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~----~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCC----ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            57888999999999999999876510    12346777765332 23345688899999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      .++||||+++++|.+++....              ...+++..++.++.|++.||+|||+  .||+||||||+|||++.+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGEN  160 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh--CCccccccchheEEecCC
Confidence            999999999999999986532              2357899999999999999999995  559999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  299 (401)
                      +.+||+|||++........   .....++..|+|||++.+..++.++|||||||++|+|++ |..||......      +
T Consensus       161 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~  231 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E  231 (303)
T ss_pred             CcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------H
Confidence            9999999999864321110   111234667999999988889999999999999999998 99998653211      1


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      .....           ........+...+..+.+++.+||+.+|++||++.++++.|..+..-..
T Consensus       232 ~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         232 LYEKL-----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             HHHHH-----------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            11100           0011111222345678999999999999999999999999988754444

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=327.59  Aligned_cols=246  Identities=31%  Similarity=0.420  Sum_probs=204.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc---HHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG---HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .|.-++.||.|+||.||.|++..      +.+.||||++...+.+.   ..+++.|+..|+++.|||++.+.|+|..+..
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccC------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            46667889999999999999887      68899999998776554   3567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .||||||| -|+-.+++.-. .+++-+..+..|+.+.+.||+|||+++  .||||||..|||+++.|.|||+|||.|...
T Consensus       101 aWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  101 AWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhhc
Confidence            99999999 56777776432 378999999999999999999999877  999999999999999999999999998764


Q ss_pred             CCCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ..      ...++|||+|||||++.   .+.|+.++||||||++..||.-.++|+.+.+..      .....+-.+..  
T Consensus       177 ~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM------SALYHIAQNes--  242 (948)
T KOG0577|consen  177 AP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES--  242 (948)
T ss_pred             Cc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH------HHHHHHHhcCC--
Confidence            33      35678999999999986   578999999999999999999999998765321      11111111111  


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           |.+   .....+..++.|+..||+.-|.+|||.+++++.
T Consensus       243 -----PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  243 -----PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -----CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                 111   134568899999999999999999998877654

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.1e-41  Score=312.82  Aligned_cols=262  Identities=26%  Similarity=0.361  Sum_probs=196.1

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhcc---CCCceeeEEEEEEe-
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQL---RHPHLVKLIGYCWE-  151 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~hpnI~~~~~~~~~-  151 (401)
                      +|++.+.||+|+||+||+|.+..      +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            58889999999999999998876      688999999875422  2234456677776665   69999999998864 


Q ss_pred             ----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          152 ----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       152 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                          ....+++|||+. ++|.+++.......+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.+||+|
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN--CIVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECc
Confidence                345799999996 5898888765556789999999999999999999954  599999999999999999999999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ||++.......   ......|+..|+|||++.+..++.++|||||||++|+|++|.+||.......  .+..... ....
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~-~~~~  225 (288)
T cd07863         152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFD-LIGL  225 (288)
T ss_pred             cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHH-HhCC
Confidence            99997654322   1233568999999999999999999999999999999999999996543211  1111110 0000


Q ss_pred             c--cchhh-------hcCCcCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          308 P--RKLER-------LIDPRLE---GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       308 ~--~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      +  ..+..       ...+...   .......+..+.+++.+||+.||++|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0  00000       0000000   0111234567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-40  Score=312.24  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=205.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..+|++.+.||+|+||.||+|++..      +++.|++|.+..........+.+|+.+++.+.||||+++++.+......
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECC------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            3689999999999999999998765      5789999998866555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      |+||||+++++|.+++..   ..+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~--~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999999998854   468899999999999999999995  559999999999999999999999999987543


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.......  .+...    ..         
T Consensus       168 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~~~----~~---------  230 (296)
T cd06654         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLI----AT---------  230 (296)
T ss_pred             cccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHHHH----hc---------
Confidence            3221  1233468999999999998889999999999999999999999996542110  00000    00         


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........+...+..+.+++.+||..+|++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0000111233456778999999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-41  Score=323.02  Aligned_cols=243  Identities=28%  Similarity=0.362  Sum_probs=191.9

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHH-HHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEII-FLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++...   .......+..|.. +++.++||||+++++++...+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            469999999999998776      5889999998643   1222344555554 57789999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+.+++|..++...  ..+++..+..++.||+.||.|||+  .||+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~--~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          75 LDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS--INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            9999999999888654  679999999999999999999995  459999999999999999999999999987532221


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      .  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      .........          ..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~----------~~  212 (325)
T cd05604         151 D--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILH----------KP  212 (325)
T ss_pred             C--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHc----------CC
Confidence            1  22345799999999999999999999999999999999999999975421      111111111          11


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .  ..+...+..+.+++.+||+.+|.+||++.+.++.
T Consensus       213 ~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         213 L--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            0  1122345678899999999999999988643333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.7e-41  Score=311.10  Aligned_cols=275  Identities=27%  Similarity=0.365  Sum_probs=205.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--EEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--~~~  154 (401)
                      .+|++.+.||+|+||.||+|....  ....++..||+|.+..........+.+|+.+++.++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP--LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC--CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            578899999999999999997532  1122577899999876655556678899999999999999999998754  346


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||+  .||+||||||+||+++.++.++|+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~--~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGS--KRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            89999999999999998653 2468999999999999999999995  55999999999999999999999999999876


Q ss_pred             CCCCcceeee-ccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc---cc
Q 040050          235 PEGEETHVIT-RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---RK  310 (401)
Q Consensus       235 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~  310 (401)
                      .......... ...++..|+|||++.+..++.++||||||+++|+|++|..++......    +...........   ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchHH
Confidence            4433221111 122345699999999889999999999999999999988765432110    000000000000   00


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      +...+........+...+..+.+++.+||..+|++|||+.++++.|+.++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            11111111111223344678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9.2e-41  Score=321.19  Aligned_cols=264  Identities=23%  Similarity=0.297  Sum_probs=198.5

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+.++|.+.+.||+|+||.||+|.+..      ++..||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTV------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcC------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            345899999999999999999998766      5889999998643  22334567889999999999999999999865


Q ss_pred             CC------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          152 EE------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       152 ~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      ..      ..|+||||+. ++|...+.    ..++...+..++.|++.||.|||++  +|+||||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~--~ivHrDlkp~NIl~~~~~~~kl  164 (359)
T cd07876          92 QKSLEEFQDVYLVMELMD-ANLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKI  164 (359)
T ss_pred             CCCccccceeEEEEeCCC-cCHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEECCCCCEEE
Confidence            43      4799999995 56766653    3588899999999999999999954  5999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh--
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP--  303 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--  303 (401)
                      +|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  .+......  
T Consensus       165 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~--~~~~~~~~~~  239 (359)
T cd07876         165 LDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID--QWNKVIEQLG  239 (359)
T ss_pred             ecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcC
Confidence            9999997543221   1234568999999999999999999999999999999999999997643211  00000000  


Q ss_pred             ----------------hhcCcc-----chhhhcCCcC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          304 ----------------LLKEPR-----KLERLIDPRL---EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       304 ----------------~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                      ......     ..........   ........+..+.+|+.+||+.||++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                            000000     0000000000   000111235678999999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.9e-41  Score=308.22  Aligned_cols=260  Identities=24%  Similarity=0.400  Sum_probs=204.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|.+.+.||+|+||.||+|.+....+   ....||+|.+.... ......+..|+.+++.++||||+++++++..+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCC---CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            468889999999999999998765211   23469999987542 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~--~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSE--MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999999988654 3568999999999999999999995  559999999999999999999999999987654


Q ss_pred             CCCcceeeeccc---cccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          236 EGEETHVITRVM---GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       236 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ............   ++..|+|||.+.+..++.++|||||||++|||++ |..||......   ........        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~--------  226 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQ--------  226 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHc--------
Confidence            332221111111   2457999999999999999999999999999886 99998654211   11111110        


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                            ......+..++..+.+++.+||..+|.+||++.+++..|+++
T Consensus       227 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 ------DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  001111223456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-40  Score=306.78  Aligned_cols=261  Identities=25%  Similarity=0.410  Sum_probs=205.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|.+.+.||+|+||.||+|.+....   .....+|+|.+.... ......+.+|+.+++.++||||+++++++..++.
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPG---KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCC---CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            367889999999999999999875421   124479999986543 2334578889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~--~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSD--MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999998754 3568999999999999999999995  45999999999999999999999999999866


Q ss_pred             CCCCccee-eeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          235 PEGEETHV-ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       235 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ........ .....++..|+|||.+.+..++.++|+||||+++|++++ |..||......   ........         
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~---------  224 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEE---------  224 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhC---------
Confidence            54322111 112233568999999998899999999999999999886 99998654211   01111100         


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                           ......+...+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus       225 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 -----GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                 001112223466889999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-40  Score=308.36  Aligned_cols=250  Identities=25%  Similarity=0.362  Sum_probs=198.4

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      +|++.++||+|+||.||+|.+..      +++.||+|.+.... ......+.+|+.++++++||||+++++++...+..+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLL------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcC------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence            67888999999999999998776      57899999986542 233456889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+++++|..+      ..+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++.....
T Consensus        76 lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          76 ICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWS--LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHH--CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            99999999988543      357888899999999999999995  4599999999999999999999999999976533


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc-HHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-LAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  315 (401)
                      ..    .....|+..|+|||++.+..++.++|+||||+++|+|++|..||.......... ........          .
T Consensus       148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------~  213 (279)
T cd06619         148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI----------V  213 (279)
T ss_pred             cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH----------h
Confidence            21    234578999999999999899999999999999999999999996532211110 00100000          0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ............+..+.+++.+||+.+|++||++.++++.
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         214 DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0000000112235678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-40  Score=313.10  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=204.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|++.+.||+|+||.||+|.+..      ++..+|+|.+..... .....+.+|++++++++||||+++++++..++..
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            368899999999999999998776      578899999875432 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhh-CCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999999999999765  6789999999999999999999952 359999999999999999999999999987543


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc---Ccc---
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK---EPR---  309 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~---  309 (401)
                      ...    .....|+..|+|||++.+..++.++|+||||+++|+|++|..||......   ....+......   .+.   
T Consensus       152 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~  224 (308)
T cd06615         152 DSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHR  224 (308)
T ss_pred             ccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcc
Confidence            321    23457899999999998888999999999999999999999998653211   11111100000   000   


Q ss_pred             -----------------chhhhcCCcCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 -----------------KLERLIDPRLEGQFP-IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 -----------------~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                       ....+.. ......+ ...+.++.+++.+||..+|++||++.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         225 PVSGHPPDSPRPMAIFELLDYIVN-EPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cccCCCCCccchhhHHHHHHHHhc-CCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             0000000 0000111 1245679999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-40  Score=305.07  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=203.0

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE-EEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~-~~~  154 (401)
                      +|++.+.||.|++|.||++.+..      +++.||+|.+....  ......+.+|++++++++|||++++++.+.. +..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            58899999999999999998766      57789999986542  2334568889999999999999999998764 446


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      ++++|||+++++|.+++.......+++..++.++.+++.|+.+||+  .+|+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~--~~i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE--KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence            8999999999999999977555678999999999999999999995  45999999999999999999999999998755


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ....  .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....      .........        
T Consensus       153 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~--------  216 (257)
T cd08223         153 ENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIE--------  216 (257)
T ss_pred             cccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh--------
Confidence            3321  122345689999999999999999999999999999999999999875321      111111100        


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ......+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       217 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         217 ---GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ---cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               01112234456789999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=304.31  Aligned_cols=253  Identities=31%  Similarity=0.434  Sum_probs=198.8

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.||+|+||.||+|.+....   .....+|+|.+..... .....+.+|+.+++.+.||||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~---~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS---GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccC---CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            46999999999999875521   1347899999875543 24457889999999999999999999876 4467999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +.+++|.+++...  ..+++..++.++.|++.||.|||.  .+++|+||||+||+++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~--~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhh--cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999999765  478999999999999999999995  559999999999999999999999999998654432211


Q ss_pred             e-eeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          242 V-ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       242 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..+......              ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~--------------~~  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES--------------GE  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc--------------CC
Confidence            1 111223567999999999999999999999999999998 9999865421   111111110              00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      ....+...+..+.+++.+||..+|.+||++.++++.|+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            11122334578899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.5e-40  Score=311.23  Aligned_cols=271  Identities=24%  Similarity=0.399  Sum_probs=204.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcC----------CCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceee
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKL----------KPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVK  144 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~----------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~  144 (401)
                      .++|++.+.||+|+||.||++.+....          ........||+|++..... .....+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            367999999999999999998654311          1112345799999875432 33467889999999999999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhHHHhhhcC---------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcE
Q 040050          145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS---------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNI  215 (401)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NI  215 (401)
                      +++++......+++|||+.+++|.+++.....         ..+++..+..++.|++.||+|||+  .+|+|+||||+||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dlkp~Ni  161 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS--LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH--CCeecccCChheE
Confidence            99999999999999999999999999875321         246788899999999999999995  4599999999999


Q ss_pred             EEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh--CCCCCCCCcccc
Q 040050          216 LLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT--GKRAMDNTRLGR  293 (401)
Q Consensus       216 lv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~  293 (401)
                      +++.++.++|+|||++................++..|+|||+..++.++.++|+|||||++|+|++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986544322222222345678999999888889999999999999999998  677886432211


Q ss_pred             cccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                         .............       .......+..++..+.+++.+||+.||.+||++.+|++.|.+
T Consensus       242 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 ---VIENTGEFFRDQG-------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ---HHHHHHHHHhhcc-------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               1110000000000       000001122345789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.5e-40  Score=306.38  Aligned_cols=261  Identities=25%  Similarity=0.426  Sum_probs=204.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|+..+.||+|+||.||+|......   .....+++|.+.... ......+..|+.+++.++||||+++.+++.....
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPG---RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCC---CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            457888899999999999999876421   123479999986542 3335678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++... ...+++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          81 AMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSD--MNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999999988653 3578999999999999999999995  45999999999999999999999999999765


Q ss_pred             CCCCcceee-eccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          235 PEGEETHVI-TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       235 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ......... .....+..|+|||++.+..++.++|||||||++|+|++ |..||......      ....... .     
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~-~-----  225 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAIN-D-----  225 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHh-c-----
Confidence            433221111 11223457999999998889999999999999999997 99998653211      1111110 0     


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                           ......+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       226 -----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 -----GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -----CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 011111223456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-41  Score=312.78  Aligned_cols=269  Identities=24%  Similarity=0.387  Sum_probs=202.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcC--------CCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKL--------KPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIG  147 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~--------~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~  147 (401)
                      .+|++.+.||+|+||.||++.+....        ........||+|.+..... .....+.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            68999999999999999998765310        0011234689999875432 23456889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhHHHhhhc----------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE
Q 040050          148 YCWEEEYRLLVYEYMPRGSLHNQLFRSY----------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL  217 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv  217 (401)
                      ++......++||||+.+++|.+++....          ...+++..++.++.|++.||+|||+  .+++|+||||+||++
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~--~~i~H~dlkp~Nill  162 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS--LNFVHRDLATRNCLV  162 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh--cCeeccccChhhEEE
Confidence            9999999999999999999999885431          1246888999999999999999995  459999999999999


Q ss_pred             cCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh--CCCCCCCCcccccc
Q 040050          218 DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT--GKRAMDNTRLGREQ  295 (401)
Q Consensus       218 ~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~~~  295 (401)
                      +.++.+||+|||++................++..|+|||++.++.++.++|+|||||++|+|++  |..||......  .
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~--~  240 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE--Q  240 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--H
Confidence            9999999999999976544332222223445778999999998899999999999999999998  55677543211  1


Q ss_pred             cHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          296 SLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                       ..............       ......+...+..+.+++.+||+.||.+||++.+|++.|.
T Consensus       241 -~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 -VIENTGEFFRNQGR-------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHhhhhccc-------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             11100000000000       0000112223568999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1e-40  Score=331.49  Aligned_cols=266  Identities=21%  Similarity=0.289  Sum_probs=194.1

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC------CCceeeE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR------HPHLVKL  145 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnI~~~  145 (401)
                      +....++|.+.+.||+|+||+||+|.+..      .++.||||+++... .....+..|+.+++.++      |++++.+
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i  196 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRK------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKI  196 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcC------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence            33456889999999999999999998876      57899999986432 22334555666666664      4568899


Q ss_pred             EEEEEeC-CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC---
Q 040050          146 IGYCWEE-EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY---  221 (401)
Q Consensus       146 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~---  221 (401)
                      ++++..+ .+.|+||+++ +++|.+++.+.  ..+++..+..++.||+.||.|||+. .|||||||||+|||++.++   
T Consensus       197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-~gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTE-LHLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEEEEcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEecCCccc
Confidence            9988765 4789999998 78999988764  6799999999999999999999952 3599999999999998765   


Q ss_pred             -------------cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          222 -------------TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       222 -------------~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                                   .+||+|||.+......     .....||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                         4999999988643221     2346799999999999999999999999999999999999999976


Q ss_pred             CcccccccHH-HHhhh----------------hhcCc---------cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccC
Q 040050          289 TRLGREQSLA-EWARP----------------LLKEP---------RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHH  342 (401)
Q Consensus       289 ~~~~~~~~~~-~~~~~----------------~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  342 (401)
                      .......... .....                .+...         ..+..+.....  .........+.+||.+||+.|
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARP--VREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccc--hhhhhchHHHHHHHHHhCCcC
Confidence            4321110000 00000                00000         00000000000  000112456789999999999


Q ss_pred             CCCCCCHHHHHHH
Q 040050          343 PRHRPTMSYVVRV  355 (401)
Q Consensus       343 P~~RPt~~~il~~  355 (401)
                      |++|||+.+++++
T Consensus       426 P~~R~ta~e~L~H  438 (467)
T PTZ00284        426 RQKRLNARQMTTH  438 (467)
T ss_pred             hhhCCCHHHHhcC
Confidence            9999999999863

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-40  Score=307.66  Aligned_cols=257  Identities=31%  Similarity=0.481  Sum_probs=201.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.||+|+||.||+|.+.........+..+|+|.+.... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46999999999999876533223345789999876443 23456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-----cEEEEecCCC
Q 040050          162 MPRGSLHNQLFRSY-----SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-----TAKLSDFGLA  231 (401)
Q Consensus       162 ~~~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-----~vkL~DfG~a  231 (401)
                      +++++|.+++....     ...+++..++.++.|++.||.|||+  .+++|+||||+||+++.++     .++|+|||++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ--MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh--CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            99999999996532     2347889999999999999999995  4599999999999999877     8999999998


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ................++..|+|||++.+..++.++|||||||++|+|++ |..||......   ......         
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~---------  226 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV---------  226 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH---------
Confidence            76543322222223345788999999999999999999999999999998 99998643211   111110         


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                           ........+...+..+.+++.+||..+|.+||++.++++.|.+
T Consensus       227 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         227 -----TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 0011112233456788999999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-40  Score=305.97  Aligned_cols=256  Identities=27%  Similarity=0.426  Sum_probs=204.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..++|.+.+.||+|+||.||+|.+..       +..+|+|.+... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~-------~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   74 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP   74 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC-------CccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence            45789999999999999999997654       456999987643 2234678899999999999999999999887 77


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|||+++++|.+++.......+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||.+...
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ--RNYIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCCcceeec
Confidence            8999999999999999977555678899999999999999999995  55999999999999999999999999998765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...... ......++..|+|||++.+..++.++|+|||||++|++++ |..||......   .+.....           
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~-----------  217 (260)
T cd05073         153 EDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE-----------  217 (260)
T ss_pred             cCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh-----------
Confidence            432211 1122345678999999998889999999999999999998 89998653211   1111100           


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                         .......+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       218 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         218 ---RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ---CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence               0001111223456799999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.4e-40  Score=313.41  Aligned_cols=264  Identities=21%  Similarity=0.332  Sum_probs=200.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|.+.+.||+|+||.||+|++..      +++.||+|.+..... .....+.+|+.++++++||||+++++++..++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            578999999999999999998765      578899999875432 2334677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+. ++|.+++... ...++...+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHR--RKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            99999996 5888887654 3468899999999999999999995  459999999999999999999999999987543


Q ss_pred             CCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc------
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP------  308 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  308 (401)
                      ....  ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||........  +...........      
T Consensus       156 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  231 (309)
T cd07872         156 VPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE--LHLIFRLLGTPTEETWPG  231 (309)
T ss_pred             CCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHhh
Confidence            3221  1233468899999998865 5689999999999999999999999976532211  111110000000      


Q ss_pred             ----cchhhhcCCcCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 ----RKLERLIDPRLEG----QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ----~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                          ......-.+....    ......+.++.+++.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         232 ISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                0000000000000    001234667899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.2e-40  Score=305.08  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc---------cHHHHHHHHHHHhccCCCceeeEEEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---------GHKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      +|.+.+.||.|++|.||+|.+..      .++.||+|.+......         ....+.+|+.++++++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            57888999999999999998765      5788999988654322         12457789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                      +......+++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~--~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR--GIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc--CcccccCCHHHEEEcCCCCEEeccc
Confidence            99999999999999999999999664  6788999999999999999999954  5999999999999999999999999


Q ss_pred             CCCCCCCCCCcc----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          229 GLAKDGPEGEET----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       229 G~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |.+.........    .......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......     ..     
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~-----  220 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----QA-----  220 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----HH-----
Confidence            998765422111    1112345889999999999888999999999999999999999999754211     00     


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                            +..... ......+...+..+.+++.+||+.||.+||++.++++
T Consensus       221 ------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         221 ------IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                  000000 1112233445678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.2e-41  Score=319.44  Aligned_cols=238  Identities=29%  Similarity=0.388  Sum_probs=189.7

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHH-HHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEII-FLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+..      +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECC------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            479999999999998876      57899999986431   222334555554 67889999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|...+...  ..+++..+..++.||+.||.|||+  .+|+||||||+||+++.+|.+||+|||++.......
T Consensus        75 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~--~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          75 LDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS--LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            9999999998888654  678899999999999999999995  459999999999999999999999999987532221


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ..........          .
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~----------~  212 (321)
T cd05603         151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILHK----------P  212 (321)
T ss_pred             --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhcC----------C
Confidence              122446799999999999999999999999999999999999999975421      1111111111          1


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS  350 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  350 (401)
                        ..++...+..+.+++.+||+.||.+||++.
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 --LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              122333466889999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.3e-40  Score=309.98  Aligned_cols=253  Identities=27%  Similarity=0.375  Sum_probs=201.9

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .|+..+.||.|+||+||+|.+..      +++.||+|.+....   ......+.+|+.+++.++|+||+++++++..++.
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRA------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECC------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence            36778899999999999998876      57899999986432   2223457789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|||+.+++|.+++.......+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR--ENTVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            9999999999999988876545679999999999999999999995  45999999999999999999999999998754


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....   .....|+..|+|||++.+..++.++|+|||||++|+|++|..||.......  ...........        
T Consensus       153 ~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~~~~--------  219 (285)
T cd05632         153 PEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRRVLE--------  219 (285)
T ss_pred             CCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhhc--------
Confidence            33221   234568999999999999999999999999999999999999997542110  00111110000        


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                        .  ...++...+..+.+|+.+||+.||++||+     +.+++..
T Consensus       220 --~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         220 --T--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             --c--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence              0  01122334567899999999999999999     6677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.3e-41  Score=307.99  Aligned_cols=254  Identities=23%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|.++.........+.+|+.+++.++||||+++++.+......+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVN------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcC------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            578888999999999999998776      57899999987665555566788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|||+.+++|.+++...  +.+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++.....
T Consensus        83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK--GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            999999999999988654  6799999999999999999999954  599999999999999999999999999875432


Q ss_pred             CCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          237 GEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..  .......|+..|+|||++.   +..++.++|+|||||++|+|++|..||........  .......         .
T Consensus       159 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~~~~~~~---------~  225 (267)
T cd06645         159 TI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LFLMTKS---------N  225 (267)
T ss_pred             cc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--HHhhhcc---------C
Confidence            21  1123457899999999874   45688999999999999999999999865321110  0000000         0


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...+...  .....+..+.+++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 FQPPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0000010  011234578899999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-41  Score=307.69  Aligned_cols=253  Identities=32%  Similarity=0.522  Sum_probs=201.6

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHH--HHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK--EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      |++.+.||+|+||+||+|.+..      +++.||+|.+.........  ...+|+.++++++||||+++++++......+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECC------CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            6788999999999999999887      6789999999876543322  3456999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++||++.+++|.+++...  ..+++..++.++.|++.||.+||+.  +|+|+||||+||+++.++.++|+|||.+.... 
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~--~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-  149 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK--GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-  149 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT--TEEESSBSGGGEEESTTSEEEESSGTTTEEST-
T ss_pred             cccccccccccccccccc--ccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccc-
Confidence            999999988999999843  6889999999999999999999965  49999999999999999999999999997531 


Q ss_pred             CCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                       ..........++..|+|||++. +..++.++|+||||+++|+|++|..||............   .........     
T Consensus       150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~-----  220 (260)
T PF00069_consen  150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILKRPLP-----  220 (260)
T ss_dssp             -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHHTHHH-----
T ss_pred             -ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhccccccc-----
Confidence             1122345567899999999998 888999999999999999999999999865211111111   000000000     


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       ....  ........+.+++.+||+.||++||++.++++
T Consensus       221 -~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  221 -SSSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             -HHTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             -cccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000  00001378999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.4e-41  Score=308.36  Aligned_cols=253  Identities=25%  Similarity=0.342  Sum_probs=200.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC-
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE-  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~-  152 (401)
                      ..+.|++.+.||+|+||.||+|.+..      +++.||+|.+.... .....+..|+.++.++ +||||+++++++... 
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcC------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            45788999999999999999998876      57899999987543 3345778899999998 699999999998753 


Q ss_pred             -----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          153 -----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       153 -----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                           ...|++|||+.+++|.+++.......+++..+..++.|++.||+|||+  ++|+|+||||+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~--~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--HKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH--CCCccCCCCHHHEEECCCCCEEEcc
Confidence                 468999999999999999876545678999999999999999999995  4599999999999999999999999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhh
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      ||++.......  .......|+..|+|||++.     +..++.++|+|||||++|+|++|..||......     .....
T Consensus       155 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~  227 (272)
T cd06637         155 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL  227 (272)
T ss_pred             CCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHH
Confidence            99987543221  1123456899999999986     346788999999999999999999999643211     00000


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       ....          ......+...+..+.+++.+||..+|.+|||+.++++
T Consensus       228 -~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         228 -IPRN----------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -HhcC----------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             0000          0000111234567899999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-40  Score=327.15  Aligned_cols=264  Identities=22%  Similarity=0.253  Sum_probs=198.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..+|.+.+.||+|+||.||+|.+..      .++.||+|...      ...+.+|+.+|++++|+||+++++++......
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~------~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD------YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC------CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            4579999999999999999998876      57899999643      23456899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||+++ .++|..++... ...+++..++.++.|++.||.|||+  .+|+||||||+|||++.++.++|+|||+++...
T Consensus       236 ~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~--~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        236 CLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            9999999 57898888653 2479999999999999999999995  459999999999999999999999999997654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccc-cc----ccHHHHhhhhhcC---
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLG-RE----QSLAEWARPLLKE---  307 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~----~~~~~~~~~~~~~---  307 (401)
                      ............||+.|+|||++.+..++.++|||||||++|||++|..++...... ..    ..+...+......   
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            332222223457999999999999999999999999999999999988665332211 11    1111111111000   


Q ss_pred             -cc----chh-hhc-------CCcCC-CCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 -PR----KLE-RLI-------DPRLE-GQFP--IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 -~~----~~~-~~~-------~~~~~-~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       +.    .+. .+.       .+... ..+.  ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence             00    000 000       00000 0000  1234578899999999999999999999865

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.3e-41  Score=318.25  Aligned_cols=256  Identities=20%  Similarity=0.247  Sum_probs=198.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||++.+..      +++.||+|++...   .......+.+|..++..++|+||+.+++++.+.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            478999999999999999998776      5788999998642   1223345778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+.||+|.+++.+. ...+++..+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQ--LHYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence            999999999999999999763 3578999999999999999999995  5599999999999999999999999999876


Q ss_pred             CCCCCcceeeecccccccccccccccc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT-----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ...... .......||+.|+|||++.+     +.++.++|||||||++|+|++|+.||.....      .+.........
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~  224 (331)
T cd05624         152 MNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHE  224 (331)
T ss_pred             ccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCC
Confidence            543221 11233569999999999875     5678999999999999999999999975421      11111111100


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH--RPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~il~~  355 (401)
                      ...      .. .......+..+.+++.+||...+++  |+++++++++
T Consensus       225 ~~~------~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         225 ERF------QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             Ccc------cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            000      00 0111224678999999999876554  4688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.8e-41  Score=325.33  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=199.1

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE--  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~--  153 (401)
                      +|++.+.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+.+++.++||||+++++++....  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            47889999999999999998765      5789999998643  2233457889999999999999999999998776  


Q ss_pred             ---eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          154 ---YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       154 ---~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                         ..|+||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA--GILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChHHEEECCCCCEEeccccc
Confidence               7899999995 6888887554  6799999999999999999999955  599999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      +........ .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||........  +.. +......+.
T Consensus       150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-i~~~~g~~~  225 (372)
T cd07853         150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDL-ITDLLGTPS  225 (372)
T ss_pred             eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHcCCCC
Confidence            976433221 122345689999999998874 579999999999999999999999976532111  000 000000000


Q ss_pred             --c-------h-hhhcCCcCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 --K-------L-ERLIDPRLE-------GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 --~-------~-~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        .       . ..+......       .......+..+.+|+.+||+.||++|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence              0       0 000000000       01112235678999999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=306.81  Aligned_cols=249  Identities=27%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|.+.+.||.|++|.||+|.+..      +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence            468889999999999999998876      57899999987553 33445678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++|+||+++++|.+++...   .+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999988653   78999999999999999999995  459999999999999999999999999997664


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ...  .......|++.|+|||.+.+..++.++||||||+++|+|++|..||......   ....              .+
T Consensus       150 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~---~~~~--------------~~  210 (274)
T cd06609         150 STM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM---RVLF--------------LI  210 (274)
T ss_pred             ccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH---HHHH--------------Hh
Confidence            432  1223456888999999999888999999999999999999999999654211   0000              00


Q ss_pred             CCcCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIK-GAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........+.. .+..+.+++.+||..+|++||+++++++.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         211 PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             hhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            00111111112 46678999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.5e-40  Score=302.83  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=205.7

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|++.+.||.|+||.||.+....      +++.+++|.+....  ......+.+|+.++++++|+||+++++++.+....
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            58899999999999999998776      57899999886542  33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|||+++++|.+++.+.....+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA--GILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            9999999999999999765456789999999999999999999954  49999999999999999999999999987653


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      +.....          .
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~----------~  214 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKI----------V  214 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH----------H
Confidence            3321  223456899999999999888999999999999999999999999653211      111111          1


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .... ...+...+..+.+++.+||..+|.+||++.++++.
T Consensus       215 ~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         215 QGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             cCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1111 11123346789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-40  Score=300.88  Aligned_cols=248  Identities=29%  Similarity=0.446  Sum_probs=197.9

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ++||.|+||.||+|.+..       ++.|++|.+...... ....+.+|++++++++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            469999999999998654       678999998755433 456788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +.+++|.+++... ...++...++.++.+++.||.|||++  +++||||+|+||+++.++.++|+|||++..........
T Consensus        74 ~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~--~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK--NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CEehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            9999999998654 34688999999999999999999954  49999999999999999999999999998654322111


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE  320 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (401)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......   ....              +.....
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~--------------~~~~~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRER--------------IESGYR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHH--------------HhcCCC
Confidence            1111234567999999998899999999999999999999 788886542211   1110              001111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       321 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                      ...+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1123344678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.2e-41  Score=320.69  Aligned_cols=264  Identities=22%  Similarity=0.274  Sum_probs=199.0

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+.++|.+.+.||+|+||.||+|.+..      .++.||+|.+....  ......+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecC------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            345799999999999999999998765      57899999987532  2334567889999999999999999998864


Q ss_pred             C------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          152 E------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       152 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      .      ...|+||||+. ++|.+.+..    .++...+..++.|++.||.|||+  .||+||||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~--~givHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          88 QKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             cccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCChHHEEECCCCCEEE
Confidence            3      35799999995 577776643    58889999999999999999995  45999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh--
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP--  303 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--  303 (401)
                      +|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........  +......  
T Consensus       161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  235 (355)
T cd07874         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNKVIEQLG  235 (355)
T ss_pred             eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhC
Confidence            9999998643321   22345789999999999999999999999999999999999999976432111  0000000  


Q ss_pred             ----------------hhcCccchhhh-----cCCcC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          304 ----------------LLKEPRKLERL-----IDPRL---EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       304 ----------------~~~~~~~~~~~-----~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                      ..........+     .....   ....+...+..+.+++.+||+.||++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                            00000000000     00000   001112235678999999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.4e-40  Score=302.51  Aligned_cols=251  Identities=26%  Similarity=0.372  Sum_probs=196.6

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEec
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYM  162 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~  162 (401)
                      .||+|+||.||+|.+....    .+..||+|++..... .....+.+|+.++++++||||+++++++.. ...++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCC----CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeC
Confidence            3899999999999775321    345799999875533 234568899999999999999999998754 5689999999


Q ss_pred             CCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCccee
Q 040050          163 PRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV  242 (401)
Q Consensus       163 ~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~  242 (401)
                      ++++|.+++... ...+++..++.++.|++.||.|||+  ++++|+||||+||+++.++.+||+|||++...........
T Consensus        77 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            999999988643 3578999999999999999999995  4599999999999999999999999999975543322111


Q ss_pred             -eeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCC
Q 040050          243 -ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE  320 (401)
Q Consensus       243 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (401)
                       .....++..|+|||++.+..++.++|||||||++|+|++ |..||......   ....              .+.....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~--------------~~~~~~~  216 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP---EVMS--------------FIEQGKR  216 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH---HHHH--------------HHHCCCC
Confidence             111234578999999988889999999999999999996 99999754211   0111              1111111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       321 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ...+..++.++.+++.+||..+|++||++.+|++.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            223344577899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-40  Score=315.71  Aligned_cols=262  Identities=20%  Similarity=0.296  Sum_probs=195.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ...+|.+.+.||+|+||.||+|.+..      +++.||+|+....      ....|+.++++++||||+++++++.....
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  131 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPG------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI  131 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECC------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCe
Confidence            34689999999999999999998776      5778999985422      23568999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++|||++ .++|.+++... ...+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++...
T Consensus       132 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        132 TCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             eEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            99999999 56888888653 35789999999999999999999954  5999999999999999999999999999753


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCC-CCCcccccc-------cHHHHhhhhhc
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAM-DNTRLGREQ-------SLAEWARPLLK  306 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~-------~~~~~~~~~~~  306 (401)
                      ....   ......||+.|+|||++.+..++.++|||||||++|+|+++..++ .........       .+.........
T Consensus       208 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~  284 (357)
T PHA03209        208 VVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV  284 (357)
T ss_pred             ccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence            3221   123456999999999999999999999999999999999865544 332211111       11111111100


Q ss_pred             Cccchh---------hhcCC--cCCCC---C----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPRKLE---------RLIDP--RLEGQ---F----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~~~---------~~~~~--~~~~~---~----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+..+.         ..+..  .....   +    ....+..+.++|.+||+.||.+|||+.+++++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            010000         00000  00000   0    01224566789999999999999999999864

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.3e-40  Score=303.21  Aligned_cols=253  Identities=31%  Similarity=0.449  Sum_probs=200.8

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.||+|++|.||+|.+...   ......||+|.+..... .....+.+|+.++++++||||+++++++.. ...+++|||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS---GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecC---CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            4689999999999987652   11234699999986655 456678899999999999999999999988 889999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +++++|.+++.......+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES--KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh--CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999999976533578999999999999999999995  559999999999999999999999999998764432211


Q ss_pred             ee-eccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          242 VI-TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       242 ~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                      .. ....++..|+|||.+.+..++.++|||||||++|+|++ |..||......      +........          ..
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~----------~~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKE----------GE  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhc----------CC
Confidence            11 22457788999999999899999999999999999998 99998653211      111111000          00


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                      ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11112234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.7e-40  Score=339.50  Aligned_cols=262  Identities=22%  Similarity=0.317  Sum_probs=204.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|++..      +++.||+|++.....   .....+.+|+.+++.++||||+++++++.+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            589999999999999999998876      578999999875422   23456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc---------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEE
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY---------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK  224 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vk  224 (401)
                      ..+++|||++|++|.+++....         ...++...++.++.||+.||+|||+  .||+||||||+||+++.++.++
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs--~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH--CCccccCCchheEEEcCCCCEE
Confidence            9999999999999999886421         1345667788999999999999995  4599999999999999999999


Q ss_pred             EEecCCCCCCCCCCc----------------ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          225 LSDFGLAKDGPEGEE----------------THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       225 L~DfG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                      |+|||++........                ........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999976521100                0011224699999999999999999999999999999999999999965


Q ss_pred             CcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 040050          289 TRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-TMSYVVRVLDSLQD  361 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~~il~~L~~l~~  361 (401)
                      .....   ..  .......+...          ......+..+.+++.+||+.||++|| +++++++.|+....
T Consensus       234 ~~~~k---i~--~~~~i~~P~~~----------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        234 KKGRK---IS--YRDVILSPIEV----------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             cchhh---hh--hhhhccChhhc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            32110   00  00000011000          00123456788999999999999995 67777777777643

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=316.83  Aligned_cols=256  Identities=20%  Similarity=0.216  Sum_probs=197.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||+||++.+..      +++.||+|++...   .......+.+|+.++..++|+||+++++++.++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            478999999999999999998876      5789999998632   2223455788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||+.+++|.+++.+. ...+++..+..++.||+.||+|||+  ++|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ--LGYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh--CCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence            999999999999999998653 3578999999999999999999995  4599999999999999999999999999876


Q ss_pred             CCCCCcceeeecccccccccccccccc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT-----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ....... ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.....      .+.........
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~  224 (331)
T cd05597         152 LLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHK  224 (331)
T ss_pred             cCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCC
Confidence            4432211 1123469999999999863     4578899999999999999999999975421      11111111110


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPR--HRPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~~il~~  355 (401)
                      ...      .+ .......+..+.+++.+||..++.  .||++.++++.
T Consensus       225 ~~~------~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         225 EHF------QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             Ccc------cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            000      00 011112467888999998865443  37899999877

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-40  Score=319.42  Aligned_cols=263  Identities=22%  Similarity=0.288  Sum_probs=198.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||.||+|++..      .++.||+|++....  ......+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAI------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECC------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            45789999999999999999998776      57889999986432  23345678899999999999999999987643


Q ss_pred             ------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 ------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 ------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                            ...|+||||+. ++|...+..    .++...+..++.|++.||.|||+  ++|+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~--~~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          96 KSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             ccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEECCCCcEEEE
Confidence                  35799999995 577777643    57888999999999999999995  459999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh-
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL-  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-  305 (401)
                      |||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .+........ 
T Consensus       169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~  243 (364)
T cd07875         169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGT  243 (364)
T ss_pred             eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence            999998653321   2234578999999999999999999999999999999999999997643211  1111100000 


Q ss_pred             -----------------cC-cc----chhhhcCCcC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 -----------------KE-PR----KLERLIDPRL---EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 -----------------~~-~~----~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                       .. +.    ....+.....   ...........+.+++.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                             00 00    0000000000   000111124578999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-41  Score=318.47  Aligned_cols=253  Identities=24%  Similarity=0.319  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccC-CCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~  152 (401)
                      ...|++++.||+||.+.||++...+       .+.||+|++...  ..+...-+.+|+..|.+|+ |.+|+.+++|-..+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~-------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSD-------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCC-------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            4579999999999999999997654       467888876543  3445667999999999996 99999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ..+|||||+- ..+|..+|.+... .++.-.++.+..|++.|+.++|.++  |||.||||.|+|+.. |.+||+|||+|.
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEEe-eeEEeeeechhc
Confidence            9999999985 6799999877533 3332378899999999999999655  999999999999964 699999999999


Q ss_pred             CCCCCCcceeeeccccccccccccccccC-----------CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTG-----------HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      ..............+||+.||+||.+...           +.+.++||||||||||+|+.|++||.....          
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------  577 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------  577 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------
Confidence            88777666666678999999999998532           246789999999999999999999975311          


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKG-AQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           ....+..+.++.-.-.||..- ..++.+++..||+.||++||++.++|+.
T Consensus       578 -----~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 -----QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -----HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                 112344455553332333222 2239999999999999999999999753

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-40  Score=305.40  Aligned_cols=263  Identities=25%  Similarity=0.388  Sum_probs=206.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|.+.+.||+|+||.||+|.+...  .......||+|....... .....+.+|+.+++.++||||+++++++.. ..
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPE--GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecC--CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            36788999999999999999987542  112234699998865533 334678889999999999999999999987 67


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||+|||+  .+|+|+||||+||+++.++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE--KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh--CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            89999999999999998754 3468999999999999999999995  55999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............++..|+|||.+.+..++.++|+||||+++|++++ |..||......   .+.....           
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~-----------  225 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLLE-----------  225 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHh-----------
Confidence            54332222222234568999999988889999999999999999998 99999764211   1111110           


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                         .......+...+..+.+++.+||..+|.+||++.++++.|..+..
T Consensus       226 ---~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         226 ---KGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ---CCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               111111222345678899999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.9e-40  Score=309.18  Aligned_cols=263  Identities=25%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||.||+|.+... ....++..||+|++..... .....+.+|+.+++.+.||||+++++++..+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc-CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            36789999999999999999986431 1123567899999875433 234568889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhc--------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCc
Q 040050          155 RLLVYEYMPRGSLHNQLFRSY--------------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASN  214 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~N  214 (401)
                      .+++|||+++++|.+++....                    ...+++..++.++.|++.||.|||+  .+++||||||.|
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~--~~i~H~dl~p~n  160 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE--RKFVHRDLATRN  160 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh--CCeecccccHhh
Confidence            999999999999999996431                    1247788899999999999999995  559999999999


Q ss_pred             EEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccc
Q 040050          215 ILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGR  293 (401)
Q Consensus       215 Ilv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  293 (401)
                      |+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.....  
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999875433222211222345677999999998999999999999999999998 7788854321  


Q ss_pred             cccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                          .+......          +... ...+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       239 ----~~~~~~~~----------~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 ----EEVIYYVR----------DGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ----HHHHHHHh----------cCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                11111110          0000 01222346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.5e-40  Score=310.93  Aligned_cols=200  Identities=25%  Similarity=0.373  Sum_probs=161.6

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--EEYRLLVY  159 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--~~~~~lv~  159 (401)
                      ++.||+|+||+||+|.+...    .+++.||+|.+....  ....+.+|+.++++++||||+++++++..  +...|++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~----~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG----KDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccC----CCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            46899999999999986531    246789999986432  23457789999999999999999999864  45789999


Q ss_pred             EecCCCChhHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE----cCCCcEEEEec
Q 040050          160 EYMPRGSLHNQLFRS-------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL----DSDYTAKLSDF  228 (401)
Q Consensus       160 e~~~~~~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv----~~~~~vkL~Df  228 (401)
                      ||+ +++|.+++...       ....+++..+..++.||+.||.|||+.  +|+||||||+|||+    +.++.+||+||
T Consensus        80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            998 56888877532       123588999999999999999999954  59999999999999    45689999999


Q ss_pred             CCCCCCCCCCc-ceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCc
Q 040050          229 GLAKDGPEGEE-THVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTR  290 (401)
Q Consensus       229 G~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~  290 (401)
                      |++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            99986543221 112234678999999999986 468999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.6e-40  Score=308.81  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=206.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..+|++.+.||.|+||.||+|.+..      +++.||+|.+..........+.+|+.+++.++||||+++++++..+...
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIA------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECC------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            4789999999999999999998765      5789999999766555566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++.+   ..+++..+..++.|++.||.|||+.  +|+|+||||+|||++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~--~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             EEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999999999998864   4688999999999999999999954  59999999999999999999999999987543


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....  ......|++.|+|||.+.+..++.++|+|||||++|+|++|..||......... ..            ..  .
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-~~------------~~--~  229 (297)
T cd06656         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YL------------IA--T  229 (297)
T ss_pred             CCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-ee------------ec--c
Confidence            3221  123346889999999999988999999999999999999999999654221100 00            00  0


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........+...+..+.+++.+||..+|.+||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000111233456778999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-40  Score=301.62  Aligned_cols=254  Identities=26%  Similarity=0.352  Sum_probs=206.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|.+.+.||.|+||.||+|.+..      +++.+++|.+..........+.+|+.+++.++||||+++++++.....+|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            578999999999999999998766      46789999998765556678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|||+.+++|.+++... ...+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        77 l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHE--TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh--CCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999999887653 3578999999999999999999995  4599999999999999999999999999876543


Q ss_pred             CCcceeeeccccccccccccccccC---CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTG---HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...  ......|+..|+|||.+.+.   .++.++|+||||+++|+|++|..||.......  .........         
T Consensus       154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~~~~~~~~---------  220 (262)
T cd06613         154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--ALFLISKSN---------  220 (262)
T ss_pred             hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcc---------
Confidence            211  12345688899999999876   88999999999999999999999997542111  011000000         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       . .......+...+..+.+++.+||..+|.+||++.+++.
T Consensus       221 -~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         221 -F-PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -C-CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             0 00011123445678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.1e-40  Score=306.39  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=202.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+.|++.+.||.|+||.||+|.+..      ++..|++|.+..........+.+|+.+++.++||||+++++.+..+...
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   84 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKL   84 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECC------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeE
Confidence            3679999999999999999998776      5789999998766555667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|..++.+. ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  161 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHS--MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV  161 (292)
T ss_pred             EEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhc--CCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999998877543 3578999999999999999999995  459999999999999999999999999987543


Q ss_pred             CCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ...  .......|++.|+|||++.     ...++.++|+|||||++|+|++|..||......  .....    ....   
T Consensus       162 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~~---  230 (292)
T cd06644         162 KTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAKS---  230 (292)
T ss_pred             ccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HHHHH----HhcC---
Confidence            221  1123456889999999985     345788999999999999999999998653210  00111    1000   


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          ..+  ....+...+..+.+++.+||..+|++||++.++++.
T Consensus       231 ----~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         231 ----EPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ----CCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                000  001123345678999999999999999999999753

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-40  Score=307.30  Aligned_cols=266  Identities=27%  Similarity=0.394  Sum_probs=204.4

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Ce
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--EY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--~~  154 (401)
                      .|.+.+.||+|+||.||+|.+..  ....++..||+|.+.... ......+.+|+.+++.++||||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEcc--CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            46888999999999999997643  123357889999987543 33346788999999999999999999998775  56


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||++|++|.+++.+. ...+++..++.++.|++.||+|||+  ++|+||||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~--~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            89999999999999998654 2468999999999999999999995  55999999999999999999999999999865


Q ss_pred             CCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccc---------ccccHHHHhhhh
Q 040050          235 PEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLG---------REQSLAEWARPL  304 (401)
Q Consensus       235 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~~~~~~~~  304 (401)
                      ...... .......|+..|+|||++.+..++.++|||||||++|+|++++.|+......         ..........  
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  237 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR--  237 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH--
Confidence            443221 1122345777899999999888999999999999999999987764321100         0000000000  


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                               ..........+...+..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus       238 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 ---------VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ---------HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                     0001111112233567899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.4e-40  Score=308.88  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=205.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|++.+.||.|++|.||+|.+..      +++.|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVA------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcC------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            579999999999999999998766      58899999987665555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+.+++|..++..   ..+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.++|+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~--~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          93 VVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN--QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            99999999999998864   4689999999999999999999955  599999999999999999999999999876543


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ...  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........  ...    ....         
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~----~~~~---------  230 (296)
T cd06655         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL----IATN---------  230 (296)
T ss_pred             ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHhc---------
Confidence            221  12334688999999999988899999999999999999999999976432111  000    0000         


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .......+...+..+.+++.+||..||.+||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         231 GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            000011223346688999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.6e-40  Score=300.26  Aligned_cols=256  Identities=33%  Similarity=0.505  Sum_probs=203.2

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      +++.+.||.|+||.||+|.+....  ...+..||+|.+...... ....+..|+.++..++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLS--GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCC--CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            457789999999999999887621  123488999999755433 46688899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      +|||+++++|.+++.......+++..+..++.|++.||+|||+.  +++|+||+|+||+++.++.++|+|||++......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~--~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC--CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999998765333389999999999999999999954  5999999999999999999999999999866544


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ..... ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.....   ..+..   ...           
T Consensus       157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~---~~~-----------  218 (258)
T smart00219      157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE---YLK-----------  218 (258)
T ss_pred             ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH---HHh-----------
Confidence            22111 12236789999999988889999999999999999998 7888765311   01111   100           


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                      .......+...+..+.+++.+||..+|.+|||+.++++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0011112223567899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-41  Score=320.50  Aligned_cols=241  Identities=24%  Similarity=0.301  Sum_probs=187.7

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhcc---CCCceeeEEEEEEeCCeEEEE
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQL---RHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      ||+|+||+||+|.+..      +++.||+|++....   .........|..++...   .||||+.+++++......|+|
T Consensus         1 lG~G~~g~Vy~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKD------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECC------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            7999999999998876      68899999986321   22233455666666655   699999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+.+++|..++.+.  ..+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.++|+|||++.......
T Consensus        75 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~--~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          75 TDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY--DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            9999999999988764  6799999999999999999999954  59999999999999999999999999987543322


Q ss_pred             cceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCC
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP  317 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (401)
                      .  .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.....      .+.........        .
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~--------~  214 (330)
T cd05586         151 K--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGK--------V  214 (330)
T ss_pred             C--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCC--------C
Confidence            1  12345799999999998764 589999999999999999999999965421      11111110000        0


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 040050          318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRP----TMSYVVR  354 (401)
Q Consensus       318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~~il~  354 (401)
                      .+   .....+..+.+++.+||+.||.+||    ++.++++
T Consensus       215 ~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         215 RF---PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CC---CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            00   0112366788999999999999998    5666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-41  Score=319.38  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=197.8

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ..+.++|.+.+.||.|+||+||+|.+..      +++.||+|++.....  .....+.+|+.+++.++||||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTR------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECC------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence            3456899999999999999999998776      578999999864322  23355778999999999999999999875


Q ss_pred             eC------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEE
Q 040050          151 EE------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK  224 (401)
Q Consensus       151 ~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vk  224 (401)
                      ..      ...|++|+++ +++|.+++..   ..+++..+..++.|++.||.|||++  +|+||||||+||+++.++.+|
T Consensus        85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrdikp~Nil~~~~~~~k  158 (343)
T cd07878          85 PATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDCELR  158 (343)
T ss_pred             ccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CeecccCChhhEEECCCCCEE
Confidence            43      3468999998 7899887743   5799999999999999999999954  599999999999999999999


Q ss_pred             EEecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      |+|||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......  ..+..+...
T Consensus       159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~  231 (343)
T cd07878         159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEV  231 (343)
T ss_pred             EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHH
Confidence            9999999865432     234568999999999876 57899999999999999999999999654311  111111000


Q ss_pred             hhcCc-cch--------hhhcCC--cCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          304 LLKEP-RKL--------ERLIDP--RLEG----QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       304 ~~~~~-~~~--------~~~~~~--~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..... ..+        ......  ....    .......+.+.+|+.+||..||.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000 000        000000  0000    0001123467899999999999999999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.9e-40  Score=342.00  Aligned_cols=255  Identities=20%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ....+|.+.+.||.|+||+||+|.+..      ++..||+|.+....  ......+..|+.+++.++||||++++++|..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d   83 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKR------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN   83 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECC------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence            344789999999999999999998876      57899999987542  2335678899999999999999999998865


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCC-----CCeeeccCCCCcEEEcC---
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGED-----KPVIYRDFKASNILLDS---  219 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~-----~~iiH~Dlkp~NIlv~~---  219 (401)
                        ...+||||||+.+++|.++|...  ....+++..++.|+.||+.||.|||+.+     .+||||||||+||||+.   
T Consensus        84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~  163 (1021)
T PTZ00266         84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR  163 (1021)
T ss_pred             cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence              35789999999999999998653  2357999999999999999999999643     56999999999999954   


Q ss_pred             --------------CCcEEEEecCCCCCCCCCCcceeeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCC
Q 040050          220 --------------DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGK  283 (401)
Q Consensus       220 --------------~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~  283 (401)
                                    .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||+|+|++|.
T Consensus       164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk  240 (1021)
T PTZ00266        164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK  240 (1021)
T ss_pred             ccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence                          3458999999998653322   1234579999999999864  45889999999999999999999


Q ss_pred             CCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          284 RAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       284 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .||.....     .......+...+         .+   .....+..+.+||..||+.+|.+||++.+++.
T Consensus       241 ~PF~~~~~-----~~qli~~lk~~p---------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        241 TPFHKANN-----FSQLISELKRGP---------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCcCCc-----HHHHHHHHhcCC---------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99965321     111111111100         00   01123567999999999999999999999984

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-42  Score=326.15  Aligned_cols=251  Identities=24%  Similarity=0.395  Sum_probs=207.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      -|.|+..||.|+||.||+|.+++      ++-..|.|++.........+++-|++||..+.||+|+++++.|..++.+||
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nke------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKE------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhccc------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            45666789999999999998876      567778898887777778899999999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      +.|||.||.....+... ...+++..+..+++|++.||.|||+++  |||||||..|||++.+|.|+|+|||.+......
T Consensus       107 liEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             EEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchhH
Confidence            99999999997777654 468999999999999999999999655  999999999999999999999999998754322


Q ss_pred             Ccceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          238 EETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                        ...-..++|||+|||||++.     ..+|+.++||||||++|.||..+.+|-...+..                ..+.
T Consensus       184 --~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----------------RVll  245 (1187)
T KOG0579|consen  184 --RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVLL  245 (1187)
T ss_pred             --HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----------------HHHH
Confidence              12235689999999999986     468999999999999999999999997653211                1111


Q ss_pred             hhcCC-cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDP-RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ++... ..-...|...+..+.+|+.+||..||..||++.+++++
T Consensus       246 KiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  246 KIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            11110 00112366778899999999999999999999999864

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=325.18  Aligned_cols=245  Identities=24%  Similarity=0.390  Sum_probs=208.7

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEecC
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMP  163 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~  163 (401)
                      +||+|+||+||-|++..      +....|||.+........+.+..|+.+.++|+|.|||+++|.+.++.++-|.||-++
T Consensus       582 VLGKGTYG~VYA~RD~~------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeecccc------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            69999999999999887      678999999987777777889999999999999999999999999999999999999


Q ss_pred             CCChhHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEEEEecCCCCCCCCCCcc
Q 040050          164 RGSLHNQLFRSYSAAL--PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       164 ~~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vkL~DfG~a~~~~~~~~~  240 (401)
                      ||+|.+++...- +++  ++.+.-.+..||++||.|||.+.  |||||||.+||||+. .|.+||+|||-++....  .+
T Consensus       656 GGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--in  730 (1226)
T KOG4279|consen  656 GGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--IN  730 (1226)
T ss_pred             CCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhcc--CC
Confidence            999999997653 455  78888999999999999999655  999999999999965 69999999999987543  33


Q ss_pred             eeeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          241 HVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       241 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      ....++.||..|||||++..  ..|+.++|||||||++.||.||++||-......               -.+.+..--.
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---------------AAMFkVGmyK  795 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---------------AAMFKVGMYK  795 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---------------Hhhhhhccee
Confidence            34566889999999999985  468999999999999999999999996532111               1122222233


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ..+.+|...+.+...+|.+|+.+||.+||++.+++.
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            455778899999999999999999999999999975

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.3e-40  Score=306.54  Aligned_cols=260  Identities=25%  Similarity=0.333  Sum_probs=202.9

Q ss_pred             cHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEE
Q 040050           68 TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLI  146 (401)
Q Consensus        68 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~  146 (401)
                      ++.+.....+.|++.+.||.|+||.||+|.+..      +++.||+|.+.... .....+..|+.+++++ +||||++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~   79 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYY   79 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcC------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence            344444556889999999999999999998876      57899999986543 2345677899999988 699999999


Q ss_pred             EEEEe------CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          147 GYCWE------EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       147 ~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      +++..      ....|++|||+.+++|.+++.......+++..++.++.|++.||.|||+.  +|+|+||+|+||+++.+
T Consensus        80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~ivH~dl~~~nili~~~  157 (282)
T cd06636          80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH--KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCC
Confidence            99853      45789999999999999998765556788999999999999999999954  59999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ  295 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  295 (401)
                      +.++|+|||++........  ......|++.|+|||++.     +..++.++|+|||||++|+|++|..||........ 
T Consensus       158 ~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-  234 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-  234 (282)
T ss_pred             CCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-
Confidence            9999999999875432111  123356899999999886     35678899999999999999999999965321100 


Q ss_pred             cHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          296 SLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       ...              +.............+..+.+++.+||+.||.+||++.++++
T Consensus       235 -~~~--------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 -LFL--------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -hhh--------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             000              00000001111234668999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=310.90  Aligned_cols=254  Identities=26%  Similarity=0.343  Sum_probs=203.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc---cHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .+|.+.+.||+|++|.||+|....      +++.||+|.+......   ....+..|+++++.++||||+++++.+....
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            368899999999999999998776      5789999998754322   3456888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+.+++|.+++.......+++..+..++.|++.||+|||+  .+++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~--~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH--CCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            99999999999999999876555789999999999999999999995  4599999999999999999999999999875


Q ss_pred             CCCCCcc---------------------------eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCC
Q 040050          234 GPEGEET---------------------------HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAM  286 (401)
Q Consensus       234 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  286 (401)
                      .......                           .......|+..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4322110                           0011246889999999999988999999999999999999999999


Q ss_pred             CCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 040050          287 DNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT----MSYVVR  354 (401)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~~il~  354 (401)
                      ......  ..+              ..+.............+..+.+++.+||+.||++||+    +.+++.
T Consensus       233 ~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         233 KGSNRD--ETF--------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCchH--HHH--------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            754321  001              1111111110111125778999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.2e-40  Score=315.17  Aligned_cols=256  Identities=20%  Similarity=0.218  Sum_probs=198.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||++.+..      +++.||+|++...   .......+..|+.++..++|+||+++++++.+..
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            368899999999999999998876      5788999998532   1222345778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+.+|+|.+++.+. ...+++..+..++.|++.||.|||+  .+|+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~--~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            999999999999999999753 3578999999999999999999995  4599999999999999999999999999875


Q ss_pred             CCCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ...... .......||+.|+|||++.     ...++.++|||||||++|+|++|+.||.....      .+.........
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~  224 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHK  224 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCC
Confidence            433221 1223357999999999986     34688999999999999999999999975421      11111111110


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH--RPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~il~~  355 (401)
                      ...      . .......++..+.+++.+||..++.+  |+++.+++++
T Consensus       225 ~~~------~-~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         225 ERF------Q-FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccc------c-CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            000      0 00111234678899999988665444  6899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-40  Score=303.20  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=195.2

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeEEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~~lv~e  160 (401)
                      +.||+|+||.||+|.+....    ....+++|.+.... ......+.+|++++.++ +||||+++++++......+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCC----CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            36899999999999876521    12357888876432 33445788999999999 79999999999999999999999


Q ss_pred             ecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          161 YMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      |+++++|.+++....              ...+++..++.++.|++.||+|||+  .+++|+||||+||+++.++.+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH--CCEeecccccceEEEcCCCeEEEC
Confidence            999999999986532              1357899999999999999999995  559999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||++.......   .......+..|+|||++.+..++.++|||||||++|+|++ |..||......      ...... 
T Consensus       155 dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~-  224 (270)
T cd05047         155 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL-  224 (270)
T ss_pred             CCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHH-
Confidence            999986322111   0111234567999999988889999999999999999997 99999653211      111111 


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                                ........+...+..+.+++.+||..+|.+||++.+++..|..+.
T Consensus       225 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 ----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ----------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                      001111122234567899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.2e-41  Score=306.66  Aligned_cols=247  Identities=25%  Similarity=0.376  Sum_probs=192.9

Q ss_pred             ceecccCCeeEEEEEecCcCCC-CCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKP-GLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.||.|+||.||+|.+...... ......|++|.+..........+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            4699999999999987542211 234556899988655444556788899999999999999999999998999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc--------EEEEecCCCCC
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT--------AKLSDFGLAKD  233 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~--------vkL~DfG~a~~  233 (401)
                      +.+|+|..++... ...+++..++.++.||+.||+|||+  ++|+||||||+||+++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~--~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLED--KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999998754 2468999999999999999999994  55999999999999977654        69999999875


Q ss_pred             CCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCC-CCCCCCcccccccHHHHhhhhhcCccch
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK-RAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ....      ....++..|+|||++.+ ..++.++||||||+++|+|++|. .||.......   ...    ..      
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~~----~~------  218 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KLQ----FY------  218 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HHH----HH------
Confidence            4322      23457889999999986 45799999999999999999995 5554321110   000    00      


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                          ..  ...++......+.+++.+||+.||++|||++++++.|+
T Consensus       219 ----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 ----ED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----Hc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                00  11223333467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-39  Score=302.14  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=205.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..|+..+.||.|+||.||+|.+..      ++..||+|.+.... ......+.+|+.+++.+.||||+++++++.++...
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNR------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEcc------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            467788999999999999998876      57899999987543 33456788899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++..   ..++...+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~--~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--CCccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999999999998864   468899999999999999999995  459999999999999999999999999997654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....  ......++..|+|||++.+..++.++|+|||||++|+|++|..||.......                 .....
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----------------~~~~~  213 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-----------------VLFLI  213 (277)
T ss_pred             CCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-----------------Hhhhh
Confidence            3221  1233468889999999998889999999999999999999999986542110                 00001


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........+...+..+.+++.+||+.+|.+||++.+++..
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            1111223444567889999999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.1e-40  Score=305.30  Aligned_cols=251  Identities=25%  Similarity=0.367  Sum_probs=200.4

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      |++.+.||.|+||.||+|.+..      ++..+++|.+..........+.+|+++++.++||||+++++++......++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            5677899999999999998776      5778999998765555567788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|..++.+. ...+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~--~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE--NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            9999999998877543 3578999999999999999999995  459999999999999999999999999987643321


Q ss_pred             cceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          239 ETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                        .......|++.|+|||++.     +..++.++|+|||||++|+|++|++||......  ........    .      
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~~~----~------  223 (282)
T cd06643         158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLKIAK----S------  223 (282)
T ss_pred             --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHHHhh----c------
Confidence              1223456899999999984     455788999999999999999999998653210  01111000    0      


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       ..+  ....+...+..+.+++.+||+.||.+||++.++++.
T Consensus       224 -~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         224 -EPP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -CCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000  001223346789999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.5e-40  Score=301.24  Aligned_cols=251  Identities=29%  Similarity=0.424  Sum_probs=198.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-----ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-----QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+|...+.||+|+||.||+|.+..      ++..|++|.+.....     .....+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            478999999999999999998776      578999998864321     223467789999999999999999998876


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                        ....+++|||+++++|.+++...  ..+++...+.++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~--~~i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCCHHHEEECCCCCEEEccCC
Confidence              35788999999999999998764  568899999999999999999995  459999999999999999999999999


Q ss_pred             CCCCCCCCCc-ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          230 LAKDGPEGEE-THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       230 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ++........ ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||......     .          
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~----------  216 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----A----------  216 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----H----------
Confidence            9875432111 11122345889999999999988999999999999999999999999653210     0          


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       .+...........++......+.+++ +||..+|++||++.++++
T Consensus       217 -~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         217 -AIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             -HHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence             01111111112234445567788888 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.5e-40  Score=303.73  Aligned_cols=265  Identities=24%  Similarity=0.291  Sum_probs=199.2

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|.+.+.||.|++|.||+|++..      ++..||+|.+....  ......+.+|+.+++.++||||+++++++..+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            47888999999999999998876      57899999987542  22345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      ++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh--CCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99999996 68888876533 3578999999999999999999995  45999999999999999999999999998754


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc-------
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK-------  306 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------  306 (401)
                      ....  .......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.......  ...........       
T Consensus       152 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  227 (285)
T cd07861         152 GIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWP  227 (285)
T ss_pred             CCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhh
Confidence            3221  12233467889999998875 457899999999999999999999997542211  01000000000       


Q ss_pred             Ccc---chhhhcCCcCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPR---KLERLIDPRLE---GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~---~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...   ...........   .......+.++.+++.+||+.||.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         228 GVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             cchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000   00000000000   00111246788899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.5e-40  Score=310.48  Aligned_cols=265  Identities=18%  Similarity=0.205  Sum_probs=196.7

Q ss_pred             CCceeccc--CCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           81 RSNLLGEG--GFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        81 ~~~~Lg~G--~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      +.++||+|  +|++||++.+..      +++.||+|.+....  ......+.+|+.+++.++||||+++++++..++..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecc------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            45789999  789999998876      68999999987543  223456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.++++||+.+.....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM--GYVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            999999999999999765456789999999999999999999954  599999999999999999999999987543321


Q ss_pred             CCcce-----eeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC--
Q 040050          237 GEETH-----VITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE--  307 (401)
Q Consensus       237 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  307 (401)
                      .....     ......++..|+|||++.+  ..++.++|||||||++|+|++|..||.......  ............  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  231 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLL  231 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccc
Confidence            11100     0112346778999999976  468999999999999999999999997532110  000000000000  


Q ss_pred             ------ccch-------------hh------h---cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 ------PRKL-------------ER------L---IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ------~~~~-------------~~------~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            +..+             ..      .   .............+..+.+++.+||+.||.+|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                  0000             00      0   00000011122346689999999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.3e-40  Score=309.19  Aligned_cols=263  Identities=26%  Similarity=0.404  Sum_probs=202.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|+..+.||+|+||.||+|.+....  ......||+|.+..... .....+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEG--ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCC--CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            357888899999999999999876521  11123679998865432 2234678899999999999999999998754 4


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++++|+++|+|.+++... ...+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~--~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE--RRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhh--cCeeccccccceeeecCCCceEEccccccccc
Confidence            67899999999999998654 3468899999999999999999995  55999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |+.||......   ....+..    .      
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~------  226 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLLE----K------  226 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----C------
Confidence            43322222223445778999999999999999999999999999997 88998654211   1111111    0      


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                          ......+...+..+.+++.+||..+|++||++.++++.|..+..
T Consensus       227 ----~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         227 ----GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                00011122235678899999999999999999999999888743

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4.8e-40  Score=308.52  Aligned_cols=263  Identities=22%  Similarity=0.362  Sum_probs=200.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|.+.+.||.|+||.||+|.+..      +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            579999999999999999998765      57899999987543 22345677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR--KVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            99999995 6898888654 35688999999999999999999954  59999999999999999999999999987543


Q ss_pred             CCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc--cchh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP--RKLE  312 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  312 (401)
                      ....  ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||........   .......+..+  ..+.
T Consensus       156 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~  230 (301)
T cd07873         156 IPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWP  230 (301)
T ss_pred             CCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhch
Confidence            3221  1233457899999998875 4578899999999999999999999976432111   11111110000  0000


Q ss_pred             hhcC---------CcCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          313 RLID---------PRLEG----QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       313 ~~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .+..         +....    ......+..+.+++.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         231 GILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             hhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000         00000    011234567899999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.2e-40  Score=298.29  Aligned_cols=247  Identities=30%  Similarity=0.471  Sum_probs=195.7

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ++||+|+||.||+|....       +..||+|.+...... ....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~~-------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKD-------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEecC-------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence            369999999999997543       678999998754332 234688899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +++++|.+++... ...+++..++.++.+++.||.|||+  .+++|+||||+||+++.++.++|+|||++......... 
T Consensus        74 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  149 (250)
T cd05085          74 VPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-  149 (250)
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeecccChheEEEcCCCeEEECCCccceeccccccc-
Confidence            9999999988654 3468899999999999999999995  45999999999999999999999999998754332111 


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE  320 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (401)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ...   ..           .....
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~---~~-----------~~~~~  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---ARE---QV-----------EKGYR  212 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH---HH-----------HcCCC
Confidence            1112234667999999998899999999999999999998 999986542110   000   00           00111


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       321 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                      ...+...+..+.+++.+||..+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1222334678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6e-40  Score=303.57  Aligned_cols=261  Identities=27%  Similarity=0.375  Sum_probs=204.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|.+.+.||.|+||.||+|+..... .....+.|++|.+...... ....+.+|+.++++++||||+++++++.+....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIE-EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCC-cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            67889999999999999999875421 2334578999988654333 346788999999999999999999999998899


Q ss_pred             EEEEEecCCCChhHHHhhhcC-------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          156 LLVYEYMPRGSLHNQLFRSYS-------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                      ++||||+++++|.+++.....       ..+++..+..++.|++.||+|||+.  +|+||||||+||+++.++.++|+||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~--~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA--RFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc--CcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999976431       2689999999999999999999954  4999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcC
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .+...   .   
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~---~---  231 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNR---L---  231 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHH---H---
Confidence            9987543221 112233456778999999988888999999999999999998 77888543211   11110   0   


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                             .........+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus       232 -------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 -------QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------HcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                   0001111112234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.9e-40  Score=302.36  Aligned_cols=256  Identities=27%  Similarity=0.376  Sum_probs=192.4

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.||+|+||.||+|.+..    ..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   76 (269)
T cd05087           1 KEIGNGWFGKVILGEVNS----GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEF   76 (269)
T ss_pred             CcccccCCceEEEEEEcC----CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEEC
Confidence            469999999999997653    22467799999875543 2335688899999999999999999999998899999999


Q ss_pred             cCCCChhHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          162 MPRGSLHNQLFRSY---SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       162 ~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      +++++|.+++....   ....++..+..++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            99999999986532   2345677888999999999999995  559999999999999999999999999987543322


Q ss_pred             cceeeeccccccccccccccccC-------CCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTG-------HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .........|+..|+|||++.+.       .++.++|+||||+++|+|++ |..||........  .. ..  ..   ..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~-~~--~~---~~  226 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LT-YT--VR---EQ  226 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HH-HH--hh---cc
Confidence            22222234578899999998642       35789999999999999996 9999965422111  00 00  00   00


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                      ......+.    .....+..+.+++.+|+ .+|.+|||+++|+..|+
T Consensus       227 ~~~~~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00111111    11223557888999998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=304.47  Aligned_cols=249  Identities=28%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      |.++..||+|+||.||+|.+++      +|+.||||.+..+  .+.+++..|+.++.+.+.|++|++||.+.....+|||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~E------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRE------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhc------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            5566889999999999999988      7999999998754  4568899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      ||||..|++.+.+..+ ++++.+.++..++...+.||+|||...  -||||||..|||++.+|+.||+|||.|.......
T Consensus       107 MEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            9999999999887654 589999999999999999999999554  8999999999999999999999999998654432


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      ..  -.+..|||.|||||++..-.|+.++||||||++..||..|++||..--+.         +.++..|..      +.
T Consensus       184 AK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------RAIFMIPT~------PP  246 (502)
T KOG0574|consen  184 AK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------RAIFMIPTK------PP  246 (502)
T ss_pred             Hh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------ceeEeccCC------CC
Confidence            21  24578999999999999999999999999999999999999999753111         111111111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..-.-|...+.++.+++++||-.+|++|-|+-.++++
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            1112245668899999999999999999999888775

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.1e-39  Score=300.28  Aligned_cols=252  Identities=25%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-----cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-----TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+|.+.+.||+|+||.||.|.+..      ++..||+|.+....     ......+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            578999999999999999998776      57899999886432     1224567889999999999999999998876


Q ss_pred             C--CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          152 E--EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       152 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      .  ..++++|||+++++|.+++.+.  ..+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEecCCCCEEECcCc
Confidence            3  4688999999999999998754  568899999999999999999995  459999999999999999999999999


Q ss_pred             CCCCCCCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          230 LAKDGPEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ++......... .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||......     ..         
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~---------  217 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA---------  217 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH---------
Confidence            98754321111 1123356889999999999888999999999999999999999999643111     11         


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        .............+...+..+.+++.+|+. +|++||+++++++.
T Consensus       218 --~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         218 --IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence              011111111223455667788999999994 99999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-40  Score=305.58  Aligned_cols=253  Identities=27%  Similarity=0.393  Sum_probs=203.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|++.+.||.|+||.||+|.+..      ++..||+|.+..........+.+|+.++++++||||+++++++..+...|
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            568899999999999999998765      57899999987665555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+++++|.+++... ...+++..++.++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~--~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          79 ILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHS--HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999888653 3579999999999999999999995  4599999999999999999999999999875433


Q ss_pred             CCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          237 GEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ...  ......|++.|+|||++.     +..++.++|+||||+++|+|++|..||......  .....    ....    
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~----  223 (280)
T cd06611         156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVLLK----ILKS----  223 (280)
T ss_pred             ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHHHH----HhcC----
Confidence            221  123356899999999875     345678999999999999999999999754211  00111    1000    


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ..+.  ...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       224 ---~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 ---EPPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ---CCCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence               0000  01123346688999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=9.3e-40  Score=300.03  Aligned_cols=255  Identities=29%  Similarity=0.429  Sum_probs=193.6

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEE-eCCeEEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCW-EEEYRLLVYE  160 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~-~~~~~~lv~e  160 (401)
                      +.||+|+||.||+|.+...   ......||+|.+... .......+.+|+.+++.++||||+++++++. .+...+++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS---DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecC---CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            4689999999999986542   123567999987533 2334567888999999999999999999775 4556789999


Q ss_pred             ecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc
Q 040050          161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~  240 (401)
                      |+.+++|.+++.+. ...+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||++.........
T Consensus        78 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~--~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLAS--KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999999998654 2456778888999999999999995  45999999999999999999999999998754332111


Q ss_pred             e--eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhC-CCCCCCCcccccccHHHHhhhhhcCccchhhhcCC
Q 040050          241 H--VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG-KRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP  317 (401)
Q Consensus       241 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (401)
                      .  ......++..|+|||.+.+..++.++|||||||++|+|++| .+||.....   ......   ...           
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~---~~~-----------  217 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVY---LLQ-----------  217 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---Hhc-----------
Confidence            1  11223467789999999888999999999999999999995 556654311   011111   100           


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      ......+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       218 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         218 GRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            0001112223567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.8e-40  Score=303.47  Aligned_cols=261  Identities=26%  Similarity=0.367  Sum_probs=204.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|.+.+.||+|+||.||+|.+....   .....|++|...... ......+.+|+.+++.++||||+++++++.+ ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPE---NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCC---CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            356888999999999999999875421   124579999887554 3345678899999999999999999998875 45


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||+  .+++|+||||+||+++.++.++|+|||++...
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLES--KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            68999999999999998654 2468999999999999999999995  55999999999999999999999999998765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......   ......    ..      
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~----~~------  223 (270)
T cd05056         158 EDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI----EN------  223 (270)
T ss_pred             ccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH----Hc------
Confidence            43321 11222334568999999988889999999999999999986 99999654321   011100    00      


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                          ......+..++..+.+++.+|+..+|.+|||+.++++.|+++..
T Consensus       224 ----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         224 ----GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                00111233446789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.4e-40  Score=299.07  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|++.+.||+|+||.||+|.+..      +++.+|+|.+....  ......+.+|+.+++.++||||+++++.+......
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            58889999999999999998776      57899999987542  23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEEecCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDG  234 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~DfG~a~~~  234 (401)
                      ++||||+++++|.+++.......+++..+..++.+++.||.|||+  .+|+|+||+|+||+++.+ +.++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            999999999999999977655678999999999999999999995  459999999999999865 56899999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....   .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......   ....   ..          
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~---~~----------  213 (256)
T cd08220         153 SSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVL---KI----------  213 (256)
T ss_pred             CCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHH---HH----------
Confidence            44321   12346889999999999888999999999999999999999999654321   0110   00          


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .. ......+...+..+.+++.+||+.+|.+|||+.+++..
T Consensus       214 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         214 MS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             Hh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            00 00111223356789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.9e-40  Score=300.31  Aligned_cols=251  Identities=22%  Similarity=0.353  Sum_probs=204.4

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|++.+.||+|+||.||++....      +++.||+|.+....  ......+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            58889999999999999998776      57899999986432  23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+++|.+++.......+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            999999999999998876544568999999999999999999995  459999999999999999999999999997654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .....  .....|++.|+|||++.+..++.++|+|||||++|+|++|..||.....      .........         
T Consensus       153 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~---------  215 (256)
T cd08218         153 STVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIR---------  215 (256)
T ss_pred             cchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhc---------
Confidence            32211  1234588899999999988899999999999999999999999865321      111111110         


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        ......+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       216 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         216 --GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --CCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              01111233446789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-40  Score=306.28  Aligned_cols=265  Identities=25%  Similarity=0.367  Sum_probs=209.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|++.+.||+|+||+||+|.+..      +++.||+|++.... ......+.+|+++++.++||||+++++++......
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIP------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcC------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            568888999999999999998876      57889999886543 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++.+.  +.+++..+..++.+++.||.|||+. .+++|+||+|+||+++.++.++|+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNV-HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHh-cCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            9999999999999888654  6789999999999999999999952 359999999999999999999999999986542


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc-----ccHHHHhhhhhcCccc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE-----QSLAEWARPLLKEPRK  310 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~  310 (401)
                      ...    .....|+..|+|||++.+..++.++|+|||||++|+|++|..||........     ..+..+.....     
T Consensus       156 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  226 (284)
T cd06620         156 NSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV-----  226 (284)
T ss_pred             hhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh-----
Confidence            221    1235689999999999888999999999999999999999999975432111     01111111111     


Q ss_pred             hhhhcCCcCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          311 LERLIDPRLEGQFP-IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       311 ~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                           .... ...+ ...+..+.+++.+||+.||.+||++.+++++..-++....+
T Consensus       227 -----~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         227 -----QEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             -----hccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence                 0000 1111 12456789999999999999999999999875555544433

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.9e-40  Score=301.11  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=200.0

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      +|.+.+.||.|+||.||+|...       +++.+|+|.+.....      .....+.+|+++++.++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            4788999999999999999754       377899998865421      123457889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ....+++|||+++++|.+++.+.  ..+++..+..++.|++.||+|||+.  +|+|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN--CVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCcCHHhEEECCCCeEEeccchhh
Confidence            99999999999999999999664  5788999999999999999999954  5999999999999999999999999998


Q ss_pred             CCCCCCC----cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          232 KDGPEGE----ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       232 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      .......    .........|+..|+|||++.+..++.++|+||||+++|+|++|..||......     .... ... .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~-~~~-~  222 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-----AAMF-YIG-A  222 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH-----HHHH-Hhh-h
Confidence            7542211    111123356899999999999988999999999999999999999999653211     0000 000 0


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                              ........+...+..+.+++.+||+.+|.+||++.++++
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 --------HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --------ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    000111223345678899999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.2e-40  Score=300.49  Aligned_cols=247  Identities=28%  Similarity=0.456  Sum_probs=198.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|++.+.||+|+||.||++..        +++.||+|.+....  ....+.+|+.+++.++||||+++++++..+ ..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            5689999999999999998853        36789999986542  345788999999999999999999998765 479


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|||+.+++|.+++.......+++..++.++.|++.||.|||+  .+++||||||+||+++.++.++|+|||++.....
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES--KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            99999999999999976655578999999999999999999995  5599999999999999999999999999875432


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ..     .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......   ...   ..           
T Consensus       153 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~-----------  210 (254)
T cd05083         153 GV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKE---CV-----------  210 (254)
T ss_pred             cC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---HH-----------
Confidence            21     22234668999999998899999999999999999997 999986542210   111   00           


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                      ........+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         211 EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            0111111223346788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.1e-40  Score=300.54  Aligned_cols=246  Identities=24%  Similarity=0.357  Sum_probs=190.2

Q ss_pred             ceecccCCeeEEEEEecCcCC------CCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLK------PGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      +.||+|+||.||+|+...+..      .......|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998643211      11234468999877655445567888999999999999999999999998999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc-------EEEEecC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT-------AKLSDFG  229 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~-------vkL~DfG  229 (401)
                      ++|||+++++|..++... ...+++..++.++.|++.||+|||+  ++|+||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhh--CCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999998877543 3568999999999999999999995  55999999999999986654       8999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHH-hCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELL-TGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ++......      ....|+..|+|||++. +..++.++|||||||++|+|+ .|..||.......   ...    ..  
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~----~~--  222 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---KER----FY--  222 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---HHH----HH--
Confidence            98754322      2345788999999887 567899999999999999998 5778776432110   000    00  


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                              .....  ........+.+++.+||+.||.+||++.+|++.|
T Consensus       223 --------~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         223 --------EGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --------hcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                    00000  1111246789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.5e-40  Score=298.91  Aligned_cols=248  Identities=29%  Similarity=0.452  Sum_probs=202.2

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-----cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-----TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +|+..+.||+|++|.||+|....      ++..|++|.+....     .+....+.+|+.+++.++||||+++++++...
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            57888999999999999998875      57899999986543     22446788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...+++|||+++++|.+++.+.  ..+++..+..++.|++.||+|||+.  +|+|+||+|+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR--NTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEEccCccce
Confidence            9999999999999999998764  5689999999999999999999955  49999999999999999999999999987


Q ss_pred             CCCCCCcceeeeccccccccccccccccCC-CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ......   ......|+..|+|||.+.+.. ++.++|+||||+++|+|++|+.||......  .....    .       
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~----~-------  214 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFK----I-------  214 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHH----H-------
Confidence            654332   223456899999999988766 899999999999999999999999754210  00000    0       


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                         .........+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       215 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         215 ---GRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---HhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               0000011223345678899999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.2e-40  Score=305.07  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=201.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ..|...+.||+|+||.||+|.+..      ++..||+|.+.... ......+.+|+.+++.++||||+++++++..+...
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNR------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcC------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            346667889999999999998765      57889999987543 23345688899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++..   ..+++..+..++.|++.|+.|||+  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~--~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc--CCeeccCCChheEEEeCCCCEEEcccccccccc
Confidence            999999999999988754   468999999999999999999995  559999999999999999999999999987654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....  ......|+..|+|||++.+..++.++|+|||||++|+|++|..||.......   ...              ..
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~--------------~~  213 (277)
T cd06642         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF--------------LI  213 (277)
T ss_pred             Ccch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh--------------hh
Confidence            3221  1123468889999999999889999999999999999999999986432110   000              00


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            0111112233446788999999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-39  Score=297.76  Aligned_cols=250  Identities=29%  Similarity=0.408  Sum_probs=204.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|++.+.||.|+||.||+|.+..      ++..+++|.+.....  ...+.+|+.+++.++||||+++++++......|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            678999999999999999998876      478899999875432  678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +++||+.+++|.+++... ...+++..++.++.|++.||.|||+  .+|+|+||+|.||+++.++.++|+|||++.....
T Consensus        75 l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~--~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          75 IVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999999988643 3678999999999999999999995  4599999999999999999999999999886544


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ...  ......|+..|+|||++.+..++.++||||||+++|+|++|..||.........  .    ...   .      .
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--~----~~~---~------~  214 (256)
T cd06612         152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--F----MIP---N------K  214 (256)
T ss_pred             Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--h----hhc---c------C
Confidence            321  123345889999999999989999999999999999999999999754221100  0    000   0      0


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .......+...+..+.+++.+||+.||.+||++.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            00011123345678999999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.8e-40  Score=303.23  Aligned_cols=274  Identities=28%  Similarity=0.371  Sum_probs=207.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEe--CC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWE--EE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--~~  153 (401)
                      ..|.+.+.||+|+||.||+|.+...  ...++..||+|.+...... ....+.+|+.+++.+.||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL--GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC--CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            5678889999999999999986531  1225788999998755443 45678999999999999999999999877  55


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..+++|||+++++|.+++... ...+++..+..++.|++.||+|||+  .+|+|+||||+||+++.++.++|+|||.+..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGS--QRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            789999999999999998764 2368999999999999999999995  4599999999999999999999999999987


Q ss_pred             CCCCCcceee-eccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh--cCccc
Q 040050          234 GPEGEETHVI-TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL--KEPRK  310 (401)
Q Consensus       234 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~  310 (401)
                      .......... ....++..|+|||.+.+..++.++||||||+++|+|++|..|+.........    +.....  .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~  234 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIVTR  234 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccHHH
Confidence            6533222111 1234556799999998888999999999999999999999988543211100    000000  00000


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      +...+........+..++..+.+++.+||+.+|.+||++.+++++|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         235 LLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111111111122334457899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-39  Score=300.77  Aligned_cols=259  Identities=26%  Similarity=0.417  Sum_probs=200.2

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC---
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE---  153 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~---  153 (401)
                      |.+.+.||+|+||.||+|.+...   ..++..||+|++....  ......+.+|+.+++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE---DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc---CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            66788999999999999986542   2257899999987542  334567889999999999999999999886532   


Q ss_pred             ---eEEEEEEecCCCChhHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          154 ---YRLLVYEYMPRGSLHNQLFRSY----SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       154 ---~~~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                         ..+++++|+.+++|.+++....    ...++...++.++.|++.||+|||+  .+|+||||||+||+++.++.+||+
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCEeecccchhhEEEcCCCCEEEC
Confidence               2478899999999988875321    2357889999999999999999995  459999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||++................+++.|++||.+.+..++.++|||||||++|+|++ |.+||.....   ..+..+..   
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~---  229 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI---  229 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH---
Confidence            9999986544332222223345678999999998889999999999999999999 8888865421   11111110   


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                       ...          ....+...+..+.+++.+||+.+|.+||++.++++.|+++
T Consensus       230 -~~~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         230 -KGN----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -cCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             000          0011223456899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-39  Score=299.88  Aligned_cols=254  Identities=23%  Similarity=0.394  Sum_probs=203.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      +|+..+.||+|++|.||+|.+..      +++.||+|.+.....      .....+.+|+.++++++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            47888999999999999998765      578999999864321      124568889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEecCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGL  230 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~DfG~  230 (401)
                      .+..++||||+.+++|.+++.+.  ..+++..++.++.|++.||.|||+  .+++|+||+|.||+++.++ .++|+|||.
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~--~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE--NQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            99999999999999999998654  578999999999999999999995  4599999999999998776 599999999


Q ss_pred             CCCCCCCCcc--eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          231 AKDGPEGEET--HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       231 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      +.........  .......|+..|+|||++.+..++.++|+||||+++|+|++|..||........   ...        
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~--------  219 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LAL--------  219 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHH--------
Confidence            8765432111  111234688899999999988899999999999999999999999965322110   000        


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                        +............+...+..+.+++.+||..+|.+||++.++++
T Consensus       220 --~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         220 --IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              00111111123345566788999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-39  Score=298.15  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=199.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|++.+.||.|+||.||+|.+..       +..+|+|.+... ......+.+|++++++++||||+++++++......+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-------~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-------KRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC   75 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-------CCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceE
Confidence            578888999999999999998753       467999988643 223467889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|||+.+++|.+++... ...+++..++.++.|++.|++|||+.  +++|+||||.||+++.++.++|+|||.+.....
T Consensus        76 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~--~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  152 (256)
T cd05112          76 LVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESS--NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC--CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence            999999999999988653 24688999999999999999999954  599999999999999999999999999875433


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .... ......++..|+|||++.++.++.++||||||+++|+|++ |..||......   ...+   ...          
T Consensus       153 ~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~---~~~----------  215 (256)
T cd05112         153 DQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVE---TIN----------  215 (256)
T ss_pred             Cccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH---HHh----------
Confidence            2211 1122335678999999998899999999999999999998 89998653211   1111   110          


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                       .......+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       216 -~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         216 -AGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             -CCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence             0001011122357899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.6e-40  Score=304.04  Aligned_cols=254  Identities=27%  Similarity=0.429  Sum_probs=202.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|++.+.||+|+||.||+|.+..      ++..||+|.+.... ......+.+|+.++++++||||+++++.+..++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV   74 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE
Confidence            368889999999999999998875      57899999887542 23346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      ++||||+++++|..++.... ...+++..+..++.|++.||.|||.. .+|+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  153 (286)
T cd06622          75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL  153 (286)
T ss_pred             EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999999999988876531 24789999999999999999999942 35999999999999999999999999998754


Q ss_pred             CCCCcceeeeccccccccccccccccC------CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTG------HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ....    .....|++.|+|||++.+.      .++.++|+|||||++|+|++|..||......   .....        
T Consensus       154 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~--------  218 (286)
T cd06622         154 VASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQ--------  218 (286)
T ss_pred             cCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHH--------
Confidence            3221    2234688899999998643      3578999999999999999999999653211   01100        


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        +..+.. ......+...+.++.+++.+||+.+|.+||++.+++..
T Consensus       219 --~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         219 --LSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             --HHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence              011111 11122344567889999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.4e-40  Score=302.77  Aligned_cols=245  Identities=24%  Similarity=0.355  Sum_probs=189.3

Q ss_pred             eecccCCeeEEEEEecCcC------------------CCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeE
Q 040050           84 LLGEGGFGPVYKGFVDEKL------------------KPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKL  145 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~------------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~  145 (401)
                      .||+|+||.||+|......                  ........|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999999753211                  1122345689999865544445678889999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC----
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----  221 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~----  221 (401)
                      ++++..+...++||||+++++|..++.+. ...+++..+..++.|++.||+|||+  ++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED--KNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc--CCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999998887643 3578999999999999999999995  5699999999999997643    


Q ss_pred             ---cEEEEecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHH-hCCCCCCCCccccccc
Q 040050          222 ---TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELL-TGKRAMDNTRLGREQS  296 (401)
Q Consensus       222 ---~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~  296 (401)
                         .++|+|||++......      ....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||.......   
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---  229 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---  229 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence               4899999988643221      12357888999998875 56899999999999999995 6889886542111   


Q ss_pred             HHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                      ...+..              ...  ..+......+.+++.+||+.+|.+||++.++++.|
T Consensus       230 ~~~~~~--------------~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         230 KERFYE--------------KKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHH--------------hcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            011100              000  11111235688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-39  Score=300.45  Aligned_cols=256  Identities=27%  Similarity=0.423  Sum_probs=200.0

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc----------ccHHHHHHHHHHHhccCCCceeeEEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT----------QGHKEWMAEIIFLGQLRHPHLVKLIG  147 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~hpnI~~~~~  147 (401)
                      +|.+.+.||.|+||.||+|....      +++.||+|.+.....          ...+.+.+|+.+++.++||||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeecC------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            57788999999999999998765      578999998764211          01235678999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          148 YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                      ++...+..++||||+++++|.+++.+.  ..++...+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK--GILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC--CeeecCCChhhEEEcCCCeEEEee
Confidence            999999999999999999999998765  6789999999999999999999954  599999999999999999999999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccCC--CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      ||++................|+..|+|||++.+..  ++.++|+||||+++|+|++|..||......     ... ....
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~  225 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----AAM-FKLG  225 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----HHH-HHhh
Confidence            99997654322222223356889999999987654  789999999999999999999998643211     100 0000


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .  ...    ............+..+.+++.+||..+|.+||++.++++.
T Consensus       226 ~--~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         226 N--KRS----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             c--ccc----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0  000    0011111122346789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.3e-39  Score=298.64  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=200.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      +.+.....||+|+||.||+|.+..      ++..|++|.+..........+.+|+.+++.++|+||+++++++..++..+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLS------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecC------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            444455689999999999998766      57889999987665556678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEEEEecCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAAL--PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD  233 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vkL~DfG~a~~  233 (401)
                      ++|||+++++|.+++.... ..+  +...+..++.|++.||+|||+  .+|+||||||.||+++. ++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~--~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD--NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH--CCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999987542 334  788889999999999999995  55999999999999976 67999999999875


Q ss_pred             CCCCCcceeeeccccccccccccccccC--CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ......  ......|++.|+|||++.+.  .++.++|+||||+++|+|++|..||........   ..+.          
T Consensus       159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~----------  223 (268)
T cd06624         159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFK----------  223 (268)
T ss_pred             cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhh----------
Confidence            433221  12234589999999998754  378899999999999999999999864321100   0000          


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        .........++...+..+.+++.+||+.+|.+||++.++++.
T Consensus       224 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         224 --VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              000011122344567789999999999999999999999753

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-39  Score=299.79  Aligned_cols=255  Identities=27%  Similarity=0.358  Sum_probs=189.3

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.||+|+||.||+|.....    .....+++|.+..... .....+.+|+.+++.++||||+++++.+......++||||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~   76 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRG----MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEF   76 (269)
T ss_pred             CcCCccCCceEEEEEEecC----CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEe
Confidence            3699999999999975432    2456789998764432 2345678899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          162 MPRGSLHNQLFRSYS---AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      +.+|+|.+++.....   ...++..++.++.|++.||+|||+.  +|+||||||+||+++.++.+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc--CEecccccHhheEecCCCcEEEeccccccccccch
Confidence            999999999876422   2346778899999999999999954  59999999999999999999999999987543322


Q ss_pred             cceeeeccccccccccccccc-------cCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          239 ETHVITRVMGTQGYAAPEYVM-------TGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .........++..|+|||++.       +..++.++|||||||++|+|++ |..||......  ..+......   ..  
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~---~~--  227 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVVRE---QD--  227 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhhc---cC--
Confidence            111112234577899999874       2456889999999999999999 77888653211  111111000   00  


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                       ....    ....+...+..+.+++..|+ .||.+||++.+|++.|
T Consensus       228 -~~~~----~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         228 -IKLP----KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             -ccCC----CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence             0011    11122334567778888888 5999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.8e-40  Score=304.65  Aligned_cols=263  Identities=24%  Similarity=0.314  Sum_probs=197.9

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|++.+.||+|+||.||+|++..      +++.||+|.+....  ......+.+|+.+++.++||||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            58889999999999999998876      57899999987542  22235677899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++++||+. ++|.+++... ...+++..++.++.||+.||.|||+  .+|+|+||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHS--HNVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            99999995 6888877643 3578999999999999999999995  459999999999999999999999999987653


Q ss_pred             CCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc-----
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR-----  309 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  309 (401)
                      ....  ......+++.|+|||++.+. .++.++|||||||++|+|++|..||....... ..+..... ....+.     
T Consensus       151 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~  226 (284)
T cd07839         151 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFR-LLGTPTEESWP  226 (284)
T ss_pred             CCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHHHHHHH-HhCCCChHHhH
Confidence            3221  12334678999999998764 47899999999999999999998864332111 11111000 000000     


Q ss_pred             chhhhcCC----cCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          310 KLERLIDP----RLE-----GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       310 ~~~~~~~~----~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .+....+.    ...     .......+..+.+++.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000    000     0111234678899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9.4e-40  Score=304.09  Aligned_cols=265  Identities=26%  Similarity=0.352  Sum_probs=202.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|.+....  ......+.+|+++++.++|+||+++++++...+.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKA------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCC------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            468899999999999999998876      57899999886432  3334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|||++++.+..+..+  ...+++..+..++.|++.||.|||..  +++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          75 LYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSH--NIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            9999999987666554433  25689999999999999999999954  5999999999999999999999999998875


Q ss_pred             CCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..... .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||.......  .+..........+.....
T Consensus       151 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  227 (288)
T cd07833         151 RARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQE  227 (288)
T ss_pred             CCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhh
Confidence            54332 122345688999999999887 88999999999999999999999997543211  111100000000000000


Q ss_pred             hc------------CC----cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          314 LI------------DP----RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       314 ~~------------~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ..            ..    .....++...+..+.+++.+||..+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00            00    0001122234678999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-39  Score=297.04  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=204.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--CC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--EE  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--~~  153 (401)
                      +|++.+.||.|+||.||+|.+..      ++..||+|.+....  ......+..|+.+++.++||||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            57888999999999999998776      57889999986442  2334567889999999999999999998764  45


Q ss_pred             eEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCC---CCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          154 YRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGE---DKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~---~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                      ..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||..   ..+|+|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~  154 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF  154 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence            689999999999999998653  246789999999999999999999933   345999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |++........  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....   ..+...        
T Consensus       155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~--------  221 (265)
T cd08217         155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASK--------  221 (265)
T ss_pred             cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHH--------
Confidence            99987654332  12345689999999999988899999999999999999999999976421   111111        


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            .........+...+..+.+++.+||+.+|.+||++.+|+++
T Consensus       222 ------~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         222 ------IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  11111123344557789999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.7e-39  Score=303.10  Aligned_cols=246  Identities=27%  Similarity=0.386  Sum_probs=202.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|++++++++||||+++++++....
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            468899999999999999998876      57899999986432   233466888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+++|.+++...  ..++...+..++.|++.||.|||+  .+|+|+||+|.||+++.++.+||+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~--~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS--LDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999998765  679999999999999999999995  5599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||......  . ..             ..
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-~~-------------~~  209 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--Q-IY-------------EK  209 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--H-HH-------------HH
Confidence            5443     23446899999999998888899999999999999999999999654310  0 00             00


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                      +...  ...++...+..+.+++.+||..||.+|+     ++.++++.
T Consensus       210 ~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         210 ILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            0100  0122333467889999999999999999     77777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4e-39  Score=296.29  Aligned_cols=258  Identities=28%  Similarity=0.391  Sum_probs=205.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|++.+.||.|+||+||+|.+..      ++..+++|++.... ......+.+|+.+++.++|+||+++++.+...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            478999999999999999998765      57789999987543 23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYS-AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +++||++++++|.+++..... ..+++..+..++.|++.||+|||+  .+|+|+||+|+||++++++.++|+|||++...
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~--~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS--NGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999976433 578999999999999999999995  45999999999999999999999999998765


Q ss_pred             CCCCcce--eeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          235 PEGEETH--VITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       235 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .......  ......|+..|+|||++... .++.++|+||||+++|+|++|..||......  ..+......   .+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~---~~---  224 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN---DP---  224 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcC---CC---
Confidence            4433221  12334689999999998876 7899999999999999999999999754221  111111110   00   


Q ss_pred             hhhcCCcCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQ-FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           +..... .....+..+.+++.+||..||++||++.++++.
T Consensus       225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         225 -----PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             -----CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                 011100 012456788999999999999999999999763

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=298.21  Aligned_cols=243  Identities=26%  Similarity=0.358  Sum_probs=206.9

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .-++|..+++||+|+||.|.+++-+.      +++.+|+|+++..   .......-+.|-.+|+..+||++..+-..|..
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKa------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt  239 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKA------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT  239 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecc------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence            34789999999999999999997666      7999999999754   33445667789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+.+|+||||..||.|+-.+.+.  ..+++.....+-..|+.||.|||+.+  ||+||||.+|.|+|.+|++||+|||++
T Consensus       240 ~drlCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLC  315 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLC  315 (516)
T ss_pred             CceEEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccc
Confidence            99999999999999999988765  78999999999999999999999655  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ..-...  ...+.++||||.|+|||++....|+.++|+|.+|+++|||++|+.||....-+                 .+
T Consensus       316 KE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----------------kL  376 (516)
T KOG0690|consen  316 KEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----------------KL  376 (516)
T ss_pred             hhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----------------HH
Confidence            864433  23457799999999999999999999999999999999999999999764221                 11


Q ss_pred             hhh-cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040050          312 ERL-IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT  348 (401)
Q Consensus       312 ~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  348 (401)
                      ..+ +-..  -.+|...+++...|+..+|..||.+|..
T Consensus       377 FeLIl~ed--~kFPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  377 FELILMED--LKFPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             HHHHHhhh--ccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence            111 1111  2467777889999999999999999963

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.1e-39  Score=303.56  Aligned_cols=199  Identities=25%  Similarity=0.375  Sum_probs=160.3

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--CCeEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--EEYRLLVY  159 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--~~~~~lv~  159 (401)
                      +..||+|+||+||+|.....    .++..||+|.+....  ....+.+|+.+++.++||||+++++++..  +...++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~----~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG----KDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC----CccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            36899999999999986542    246789999886432  23467889999999999999999998854  55789999


Q ss_pred             EecCCCChhHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE----cCCCcEEEEec
Q 040050          160 EYMPRGSLHNQLFRS-------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL----DSDYTAKLSDF  228 (401)
Q Consensus       160 e~~~~~~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv----~~~~~vkL~Df  228 (401)
                      ||+. ++|.+++...       ....+++..++.++.|++.||.|||+.  +|+||||||+||++    +.++.+||+||
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC--CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9985 5887877432       123588999999999999999999954  59999999999999    55689999999


Q ss_pred             CCCCCCCCCCcc-eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCC
Q 040050          229 GLAKDGPEGEET-HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNT  289 (401)
Q Consensus       229 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~  289 (401)
                      |+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            999865432211 11234568999999999876 45899999999999999999999999654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-39  Score=298.66  Aligned_cols=254  Identities=27%  Similarity=0.362  Sum_probs=200.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      ..++|++.+.||.|++|.||+|.+..      +++.+++|++..... ....+.+|+.+++++ .|+||+++++++....
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            35789999999999999999998865      578899999875433 346788999999999 6999999999997644


Q ss_pred             ------eEEEEEEecCCCChhHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          154 ------YRLLVYEYMPRGSLHNQLFRSY--SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       154 ------~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                            ..++||||+.+++|.+++....  ...+++..+..++.|++.||.|||+.  +++|+||+|+||+++.++.++|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN--KVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEEccCCeEEE
Confidence                  4899999999999999886543  46789999999999999999999954  4999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeecccccccccccccccc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      +|||++........  ......|+..|+|||++..     ..++.++||||||+++|+|++|..||......  ..+.. 
T Consensus       155 ~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-  229 (275)
T cd06608         155 VDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK-  229 (275)
T ss_pred             CCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH-
Confidence            99999875433221  1233568999999998753     35678999999999999999999999643211  01111 


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                         ....       ..+  ....+...+..+.+++.+||..||++|||+.++++
T Consensus       230 ---~~~~-------~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 ---IPRN-------PPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ---hhcc-------CCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               0000       000  11112235678999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-39  Score=300.70  Aligned_cols=266  Identities=26%  Similarity=0.309  Sum_probs=200.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            478899999999999999998876      57899999886432  2234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|..++...  ..+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK--HNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCChhhEEEcCCCcEEECccccceec
Confidence            99999999888777665443  568999999999999999999995  45999999999999999999999999999865


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc-HHHHhhhhhc------
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-LAEWARPLLK------  306 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~------  306 (401)
                      .....  ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||.......... ..........      
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            44321  1223457889999999876 567899999999999999999999997543211100 0000000000      


Q ss_pred             -CccchhhhcCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          307 -EPRKLERLIDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       307 -~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       ..........+......     ....+..+.+++.+||+.+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             00000000000000000     0123577899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-40  Score=314.41  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=214.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..+.|.+.+.||+|.|+.|.+|++..      ++..||||.+....  ....+.+.+|+++|+.++||||++++.+....
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHIL------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE  127 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecC------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence            34789999999999999999998877      68999999987542  23345588999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ..+|+||||+.+|.+++++.+.  +.+.+..+..++.|++.|++|||+  +.|||||||++|||++.+.++||+|||++.
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~--k~ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHS--KNIVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhh--cceeccccchhhcccccccceeeeccccce
Confidence            9999999999999999999876  677779999999999999999995  559999999999999999999999999999


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .+..+.   ...+++|++.|.|||++.|..| ++.+|+||+|+++|.|+.|..||++...                    
T Consensus       204 ~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------  260 (596)
T KOG0586|consen  204 FFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------  260 (596)
T ss_pred             eecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------
Confidence            876443   4567899999999999999887 5789999999999999999999987531                    


Q ss_pred             hhhcCCcCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          312 ERLIDPRLEG--QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       312 ~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ..+..+.+.+  .+|...+.+..++|+++|-.+|.+|++++++.+.-...
T Consensus       261 k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n  310 (596)
T KOG0586|consen  261 KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN  310 (596)
T ss_pred             ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence            1111222222  23455677899999999999999999999998764443

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=310.91  Aligned_cols=267  Identities=27%  Similarity=0.423  Sum_probs=219.8

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccH-HHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ...+...+.+.||+|.||.|.++....       +..||+|+++.+..... .+|..|+++|.+++||||+.++++|..+
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg-------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D  607 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD  607 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecC-------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence            445678889999999999999997654       68899999997765544 7899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +.+|+|+||++.|+|.+++.+.....+.......|+.||+.|++||.+.+  +|||||.+.|+|++.++++||+|||+++
T Consensus       608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCccccc
Confidence            99999999999999999998875555556667889999999999999666  9999999999999999999999999999


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh--CCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT--GKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....+.......+.+-..+|||+|.+..++++.++|+|+||+++||+++  ...||.....  ++ ..+-...++..   
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~-vven~~~~~~~---  759 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQ-VVENAGEFFRD---  759 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HH-HHHhhhhhcCC---
Confidence            8888877766666667789999999999999999999999999999876  5677764321  11 11111111111   


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                          -........|.-++..+.+++.+||..+-.+||+++++-..|.+.
T Consensus       760 ----~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  760 ----QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ----CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                112223345667788999999999999999999999998877653

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5e-39  Score=295.29  Aligned_cols=251  Identities=29%  Similarity=0.427  Sum_probs=202.1

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|.+.+.||+|+||.||+|....      +++.|++|.+......  ....+.+|+.+++.++|+||+++++.+...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            58889999999999999998765      5789999998765432  567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++|+||+++++|.+++...  ..+++..+..++.+++.||.|||+  .+|+|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS--HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            9999999999999998764  568899999999999999999995  459999999999999999999999999988654


Q ss_pred             CCCccee--eeccccccccccccccccCC---CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          236 EGEETHV--ITRVMGTQGYAAPEYVMTGH---LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       236 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .......  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||.......     ........    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~~~~----  221 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFHVGA----  221 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHHHhc----
Confidence            4322111  12356788999999998766   8899999999999999999999996542110     00000000    


Q ss_pred             hhhhcCCcCCCCCCH--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          311 LERLIDPRLEGQFPI--KGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                             ......+.  ..+..+.+++.+||+.+|.+||++.+++.
T Consensus       222 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 -------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -------CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                   00111122  23677889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=306.27  Aligned_cols=249  Identities=27%  Similarity=0.387  Sum_probs=209.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      +.|...++||+||||.||-+..+.      +|+.+|.|.+...   ......-.++|-.+|.+++.++||.+-..|.+.+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvra------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRA------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             cceeeeEEEecccccceeEEEEec------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            578899999999999999988777      7999999987532   2334556788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||..|.||+|.-.|.+..+..+++..++.++.+|+.||.+||+  .+||+|||||+|||+|+.|+|+|+|+|+|..
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~--~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR--RRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh--cceeeccCChhheeeccCCCeEeeccceEEe
Confidence            99999999999999999988767799999999999999999999995  5599999999999999999999999999998


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...+...   ...+||.+|||||++.++.|+...|+|||||++|+|+.|+.||.........  .+.-+.....      
T Consensus       337 i~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eEvdrr~~~~------  405 (591)
T KOG0986|consen  337 IPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EEVDRRTLED------  405 (591)
T ss_pred             cCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HHHHHHHhcc------
Confidence            8776532   4458999999999999999999999999999999999999999764321110  0111111111      


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS  350 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  350 (401)
                            ...++...++++.++....|+.||.+|....
T Consensus       406 ------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  406 ------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ------hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                  1245667789999999999999999997644

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-39  Score=299.99  Aligned_cols=264  Identities=25%  Similarity=0.325  Sum_probs=202.6

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|.+.+.||.|+||.||+|.+..      +++.||+|++....  ......+.+|+.++++++||||+++++++..+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            58889999999999999998876      57899999987553  23356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999999 999999886543 6799999999999999999999954  59999999999999999999999999988664


Q ss_pred             CCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc------
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP------  308 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  308 (401)
                      .... .......|+..|+|||++.+. .++.++||||||+++|+|++|.+||......  ..+. ........+      
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~  226 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLA-IVFRTLGTPNEETWP  226 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHH-HHHHHcCCCChHHHh
Confidence            4321 122345689999999998754 4689999999999999999998888654221  1111 111100000      


Q ss_pred             -----cchhhhcCCcCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 -----RKLERLIDPRLE----GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 -----~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           .....+..+...    .......+..+.+++.+||+.+|.+||++++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         227 GLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                 000000000000    00111235789999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.2e-39  Score=303.56  Aligned_cols=257  Identities=23%  Similarity=0.284  Sum_probs=200.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.|++|.+....   ......+.+|+.+++.++||||+++++.+..+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            368899999999999999998876      57899999986543   223456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||++|++|.+++...  ..+++..+..++.|++.||.|||+.  +++|+||||.||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY--GIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999999999998654  6789999999999999999999954  599999999999999999999999998863


Q ss_pred             CCCCCc-------------ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          234 GPEGEE-------------THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       234 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      ......             ........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+....      +.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~  224 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------EL  224 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH
Confidence            211100             00111245788999999999888999999999999999999999999653211      11


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                      ........     ...+    ......+..+.+++.+||+.+|++||+...+.+.|+.
T Consensus       225 ~~~~~~~~-----~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         225 FGQVISDD-----IEWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHhcc-----cCCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11100000     0000    0111346678999999999999999997666655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.8e-39  Score=297.20  Aligned_cols=255  Identities=27%  Similarity=0.375  Sum_probs=204.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|++.+.||.|++|.||+|.+..      +++.||+|.+.... ......+.+|+++++.++||||+++++.+......
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI   74 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence            367888999999999999998876      57899999987653 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|||+.+++|.+++.... ..+++..+..++.|++.||+|||+ ..+++|+||||+||+++.++.++|+|||.+....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~-~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          75 SICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC-CCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999999999999886542 678999999999999999999995 1459999999999999999999999999987543


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....    ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ...........         
T Consensus       153 ~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~---------  218 (265)
T cd06605         153 NSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN---------  218 (265)
T ss_pred             HHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc---------
Confidence            2211    115688999999999999999999999999999999999999975432111 11111111111         


Q ss_pred             CCcCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIK-GAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       . .....+.. .+..+.+++.+||..||++|||+.+++..
T Consensus       219 -~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         219 -E-PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             -C-CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence             0 01112222 56789999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.7e-39  Score=300.97  Aligned_cols=259  Identities=26%  Similarity=0.326  Sum_probs=199.7

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCW  150 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~  150 (401)
                      +....++|++.+.||+|+||.||+|.+..      +++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   85 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKK------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYY   85 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECC------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence            34456899999999999999999998876      57899999876432 2235677899999999 6999999999874


Q ss_pred             -----eCCeEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcE
Q 040050          151 -----EEEYRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       151 -----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                           .+...++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN--KTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC--CccccCCCHHhEEECCCCCE
Confidence                 345789999999999999887532  235688999999999999999999954  59999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                      +|+|||++........  ......|++.|+|||++.     +..++.++|||||||++|+|++|..||.......  .+.
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~  239 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALF  239 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHh
Confidence            9999999876533221  122346899999999885     3457889999999999999999999986542110  000


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                      .    ..       ....+.  ...+...+..+.+++.+||+.||++||++.++++.+
T Consensus       240 ~----~~-------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 K----IP-------RNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             h----cc-------ccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0    00       000000  011222356789999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.2e-39  Score=300.98  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=204.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|.+.+.||.|+||.||+|....      ++..|++|.+..........+.+|+.+++.++||||+++++++...+..|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            689999999999999999998765      46789999987554445567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +|+||+++++|.+++.+   ..+++..+..++.|++.||.|||++  +++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~--gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC--CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            99999999999998865   3678999999999999999999954  599999999999999999999999998875443


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ...  ......|++.|+|||.+.+..++.++|+||||+++|++++|..||..........  .    .       .  ..
T Consensus       168 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~----~-------~--~~  230 (293)
T cd06647         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----I-------A--TN  230 (293)
T ss_pred             ccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--e----h-------h--cC
Confidence            221  1233468899999999988889999999999999999999999997543211000  0    0       0  00


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .......+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         231 GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000111223346679999999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=299.90  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=196.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|++.+.||.|++|.||+|.+..      +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            678999999999999999998765      578999999875432 2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.++|+|||++....
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR--RVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC--CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            99999996 59988886542 4789999999999999999999954  59999999999999999999999999987543


Q ss_pred             CCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc--cchh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP--RKLE  312 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  312 (401)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|+|++|..||........ .+... ......+  ....
T Consensus       155 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~  230 (291)
T cd07844         155 VPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKI-FRVLGTPTEETWP  230 (291)
T ss_pred             CCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHH-HHhcCCCChhhhh
Confidence            2211  1123356889999999875 5688999999999999999999999965431111 01000 0000000  0000


Q ss_pred             hh------c--------CCcCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          313 RL------I--------DPRLEGQFP-IKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       313 ~~------~--------~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ..      .        ........+ ......+.+++.+||+.+|.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00      0        000000000 011267889999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.1e-39  Score=295.40  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=201.4

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----------cccHHHHHHHHHHHhc-cCCCceeeEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----------TQGHKEWMAEIIFLGQ-LRHPHLVKLI  146 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~hpnI~~~~  146 (401)
                      +|++.+.||+|+||.||+|.+...     .++.+|+|.+....          ......+..|+.++.+ ++||||++++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~-----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~   75 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN-----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYY   75 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC-----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEE
Confidence            478889999999999999987652     35789999875321          1223456778888765 7899999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEE
Q 040050          147 GYCWEEEYRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK  224 (401)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vk  224 (401)
                      +++..+...+++|||+++++|.+++..  .....+++..++.++.|++.||.|||. ..+++|+||+|+||+++.++.++
T Consensus        76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EKRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CCceeecCCCHHHEEECCCCcEE
Confidence            999999999999999999999998854  234578999999999999999999994 24599999999999999999999


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||++.......   ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......      ......
T Consensus       155 l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~~~  225 (269)
T cd08528         155 ITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLATKI  225 (269)
T ss_pred             Eecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHHHH
Confidence            99999998654432   234456899999999999888999999999999999999999998643211      000000


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                                .............+..+.+++.+||+.||.+||++.++.+++.
T Consensus       226 ----------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         226 ----------VEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ----------hhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                      0000000011123568899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.6e-39  Score=293.93  Aligned_cols=254  Identities=28%  Similarity=0.416  Sum_probs=207.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|++.+.||.|++|.||+|.+..      +++.|++|++..... .....+.+|+..+.+++|+||+++++++......
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKP------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI   74 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcC------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence            368889999999999999998876      588999999876544 3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++...  ..+++..++.++.|++.|+.|||+. .+++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~-~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          75 SIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK-RHIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhcc-CCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999999765  6799999999999999999999950 559999999999999999999999999988654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .....  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......   ...+......          
T Consensus       152 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~----------  216 (264)
T cd06623         152 NTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAIC----------  216 (264)
T ss_pred             cCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHh----------
Confidence            43322  12345889999999999989999999999999999999999999765321   1111111111          


Q ss_pred             CCcCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIK-GAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      . ......+.. .+..+.+++.+||..+|++||++.++++.
T Consensus       217 ~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         217 D-GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             c-CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0 111112223 56789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.6e-39  Score=294.11  Aligned_cols=245  Identities=26%  Similarity=0.414  Sum_probs=190.5

Q ss_pred             ceecccCCeeEEEEEecCcCCC----CCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKP----GLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||+|+||.||+|.+......    ......|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            4699999999999998763210    122246888877644333 5778899999999999999999999988 778999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-------cEEEEecCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-------TAKLSDFGLA  231 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-------~vkL~DfG~a  231 (401)
                      |||+++++|.+++.... ..+++..+..++.|++.||+|||+  .+|+||||||+||+++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~--~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLED--KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhh--CCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999987652 378999999999999999999995  5599999999999999887       7999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccC--CCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......      ....++..|+|||++.+.  .++.++||||||+++|+|++ |..||.......   ...+..    . 
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~~----~-  221 (259)
T cd05037         156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFYQ----D-  221 (259)
T ss_pred             cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHHh----c-
Confidence            865431      223467789999999876  78999999999999999999 467775432110   000000    0 


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                              ..   ..+......+.+++.+||..+|.+||++.++++.|+
T Consensus       222 --------~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 --------QH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             --------CC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    00   001111268899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1e-38  Score=295.88  Aligned_cols=249  Identities=25%  Similarity=0.377  Sum_probs=201.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .-|.+.+.||.|+||.||+|.+..      ++..||+|.+.... ......+.+|+.++++++||||+++++++..+...
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   77 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNR------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   77 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECC------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence            347788999999999999998765      57899999876443 23345688899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++..   ..+++..+..++.|++.|+.|||+  .+++|+||+|.||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~--~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          78 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHcc--CCeecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999999999988854   468999999999999999999995  559999999999999999999999999987554


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||......   ....   ..           
T Consensus       153 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~---~~-----------  213 (277)
T cd06641         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM---KVLF---LI-----------  213 (277)
T ss_pred             cchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH---HHHH---HH-----------
Confidence            3221  123356888999999998888899999999999999999999998653211   0000   00           


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0001112223346788999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-39  Score=304.08  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=200.0

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      .|.....||+|+||.||++.+..      ++..||||.+..........+.+|+.+++.++||||+++++.+...+..++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l   96 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKH------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV   96 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECC------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence            34445679999999999998765      578999999876555556678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      ||||+++++|.+++..   ..+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.++|+|||++......
T Consensus        97 v~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (292)
T cd06658          97 VMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ--GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE  171 (292)
T ss_pred             EEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence            9999999999988754   4689999999999999999999965  5999999999999999999999999998754322


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP  317 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (401)
                      ..  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......  ..+.. ..          .....
T Consensus       172 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~-~~----------~~~~~  236 (292)
T cd06658         172 VP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRR-IR----------DNLPP  236 (292)
T ss_pred             cc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HH----------hcCCC
Confidence            11  123356899999999999888999999999999999999999999753211  00000 00          00111


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...  .....+..+.+++.+||..||.+|||+.++++.
T Consensus       237 ~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         237 RVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111  111245678899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=286.33  Aligned_cols=252  Identities=26%  Similarity=0.393  Sum_probs=199.1

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~  155 (401)
                      +..++..||.|+.|.||+++...      ++...|||.+...+ .+..+++++.+.++..-+ +|+||+.+|+|..+...
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV  166 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRS------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV  166 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcc------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence            34455779999999999999887      68899999997654 455677888888776665 99999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++.||.| + .-.+.|.+.-.+++++..+-++...++.||.||.. .++|||||+||.|||+|..|++||||||++....
T Consensus       167 ~IcMelM-s-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  167 FICMELM-S-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             HHHHHHH-H-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccceee
Confidence            9999998 3 44444444445789999999999999999999974 4459999999999999999999999999998765


Q ss_pred             CCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ....   .+...|.+.|||||.+.   ...|+.++||||||++++||.||+.||.+...+.+ .+.....   ..     
T Consensus       244 dSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~ltkvln---~e-----  311 (391)
T KOG0983|consen  244 DSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-VLTKVLN---EE-----  311 (391)
T ss_pred             cccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-HHHHHHh---cC-----
Confidence            5432   34567999999999986   35789999999999999999999999988543211 1111111   01     


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         .+.+.+  ....++.+.+|+..||+.|+.+||...+++++
T Consensus       312 ---PP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  312 ---PPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ---CCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence               112211  11257899999999999999999999988753

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-40  Score=317.66  Aligned_cols=244  Identities=24%  Similarity=0.420  Sum_probs=198.4

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecC----CCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe--
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL----DGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY--  154 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~--  154 (401)
                      ...+||+|+|-+||+|.+..      +|..||=-.++.    ..+...+++..|+.+|+.|+||||+++|+++.+...  
T Consensus        44 ~~evLGrGafKtVYka~De~------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~  117 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEE------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT  117 (632)
T ss_pred             hhhhcccccceeeeeccccc------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence            44789999999999999876      576776443332    133445789999999999999999999999987654  


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEEecCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKD  233 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~DfG~a~~  233 (401)
                      +.+|+|++..|+|..|+.+.  +.++...+..|++||+.||.|||+++++|||||||.+||||+.+ |.|||+|+|+|..
T Consensus       118 in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  118 INFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            78999999999999999876  78999999999999999999999999999999999999999775 9999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc--Cccch
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK--EPRKL  311 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~  311 (401)
                      .....    ....+|||.|||||+.. ..|++.+||||||+.+.||+|+.+||.....     .+++.+.+..  .|..+
T Consensus       196 ~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SGiKP~sl  265 (632)
T KOG0584|consen  196 LRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSGIKPAAL  265 (632)
T ss_pred             hhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcCCCHHHh
Confidence            54332    34478999999999776 8899999999999999999999999976531     2222222211  11111


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .++            -.+++++||.+||.. ..+||++.|+|+.
T Consensus       266 ~kV------------~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  266 SKV------------KDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             hcc------------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            111            145789999999999 9999999999864

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.4e-39  Score=297.40  Aligned_cols=252  Identities=26%  Similarity=0.339  Sum_probs=195.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHH-HhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIF-LGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|.+.... ......+..|+.+ ++.++||||+++++++..+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            368899999999999999998876      68899999987543 2233456666665 666789999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      .|++|||++ ++|.+++...  ....+++..++.++.|++.||.|||++ .+++||||||+||+++.++.+||+|||++.
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999995 6888877542  235789999999999999999999953 259999999999999999999999999988


Q ss_pred             CCCCCCcceeeecccccccccccccccc----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ......   ......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||....... ..+..         
T Consensus       153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~---------  219 (283)
T cd06617         153 YLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQ---------  219 (283)
T ss_pred             cccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHH---------
Confidence            653321   1123468899999998865    456889999999999999999999996432110 00110         


Q ss_pred             cchhhhcCCcCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQF-PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           ..... ...+ ....+..+.+++.+||..+|.+||++.++++.
T Consensus       220 -----~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         220 -----VVEEP-SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             -----HHhcC-CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00000 0011 12246789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.8e-39  Score=300.54  Aligned_cols=264  Identities=25%  Similarity=0.326  Sum_probs=200.4

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-----cHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-----GHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +|.+.+.||.|+||.||+|.+..      +++.||+|.+......     ....+..|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            57888999999999999998776      5789999998754322     234567899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.  +|+|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN--WILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeecCCChhhEEEcCCCCEEEccceeee
Confidence            9999999999 899999987642 3799999999999999999999954  59999999999999999999999999998


Q ss_pred             CCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc---
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---  308 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  308 (401)
                      .......  ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.......  .+...........   
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~  226 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEEN  226 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhh
Confidence            6544321  1233456888999998865 567899999999999999999988876543211  1111111000000   


Q ss_pred             ----cchhhhcCCcCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 ----RKLERLIDPRLE-----GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ----~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          ..+.........     .......+..+.+++.+||..+|++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                000000000000     01112346789999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=308.30  Aligned_cols=266  Identities=29%  Similarity=0.429  Sum_probs=218.2

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      +..........+.||.|.||.||.|+...-.  ....-.||||..+.+. ....+.|+.|.-+|+.++||||++++|++.
T Consensus       384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~--kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~  461 (974)
T KOG4257|consen  384 YELRRELITLKRLIGEGQFGDVYKGVYTDPE--KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV  461 (974)
T ss_pred             ceeehhhccHHHhhcCCcccceeeeEecccc--cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence            3334445566789999999999999886532  2244569999988654 445678999999999999999999999998


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      +. ..|||||+++-|.|..+++.+ ...++......++.||+.||+|||+  ++.|||||...||||.....|||+|||+
T Consensus       462 e~-P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeS--krfVHRDIAaRNiLVsSp~CVKLaDFGL  537 (974)
T KOG4257|consen  462 EQ-PMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLES--KRFVHRDIAARNILVSSPQCVKLADFGL  537 (974)
T ss_pred             cc-ceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHh--hchhhhhhhhhheeecCcceeeecccch
Confidence            65 479999999999999999765 4678999999999999999999996  4499999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++......... .+...-...|||||.++-..++.++|||.||+.+||++. |..||.+...                .+
T Consensus       538 SR~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sD  600 (974)
T KOG4257|consen  538 SRYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SD  600 (974)
T ss_pred             hhhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cc
Confidence            99876544332 233334567999999999999999999999999999987 8899976521                12


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      .+. .+..+-+...|+++++.+..|+.+||+.+|.+||.+.++...|..+..
T Consensus       601 VI~-~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  601 VIG-HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             eEE-EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            222 233455567788999999999999999999999999999998887744

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=294.17  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=188.6

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEec
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYM  162 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~  162 (401)
                      .||+|+||.||+|.....    .....+++|.+.... ......+.+|+.+++.++||||+++++.+......|+||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD----TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcC----CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            599999999999975431    123456777766443 234567889999999999999999999999999999999999


Q ss_pred             CCCChhHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc
Q 040050          163 PRGSLHNQLFRSY--SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       163 ~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~  240 (401)
                      ++++|.+++.+..  ....+...++.++.|++.||+|||+  .+|+||||||+|||++.++.++|+|||++.........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~--~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--CCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999997542  2356777888999999999999995  45999999999999999999999999998643222211


Q ss_pred             eeeecccccccccccccccc-------CCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          241 HVITRVMGTQGYAAPEYVMT-------GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       241 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .......|+..|+|||++..       ..++.++||||||+++|+|++ |..||.....  ...+..    ....  ...
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~----~~~~--~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNH----VIKD--QQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--HHHHHH----HHhh--ccc
Confidence            12234568899999998753       245789999999999999997 4667754321  111111    1100  001


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                      ...++..    +...+..+.+++..|+ .+|++||++.+|++.|.
T Consensus       228 ~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1111222    2224567888999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.7e-39  Score=298.97  Aligned_cols=265  Identities=25%  Similarity=0.332  Sum_probs=200.6

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|++.+.||.|++|.||+|++..      +++.||+|.+....  ......+.+|++++++++||||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            47888999999999999998776      57899999987543  22345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+. ++|..++.......+++..++.++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~--~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999995 689888876655778999999999999999999995  459999999999999999999999999987553


Q ss_pred             CCCcceeeeccccccccccccccccCC-CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch---
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL---  311 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  311 (401)
                      ....  ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||......  ..+.............+   
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07860         152 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPG  227 (284)
T ss_pred             cCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhh
Confidence            3221  123345788999999887644 688999999999999999999999654211  11111111110000000   


Q ss_pred             -------hhhcCCcCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 -------ERLIDPRLE---GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 -------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             ...+.....   .......+..+.+++.+||+.||.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         228 VTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                   000000000   00112245678899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-38  Score=288.78  Aligned_cols=251  Identities=29%  Similarity=0.440  Sum_probs=204.6

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      +|.+.+.||+|++|.||+|.+..      +++.+++|++..........+.+|+.+++.++||||+++++++..+...++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   74 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI   74 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            47888999999999999998875      578899999976655456788899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      ++||+++++|.+++.... ..+++..+..++.|++.||.+||.  .+++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~--~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS--NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc--CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            999999999999886642 578999999999999999999995  55999999999999999999999999999876543


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP  317 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (401)
                      ..   .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......      ........  ...     +
T Consensus       152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~--~~~-----~  215 (253)
T cd05122         152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFKIAT--NGP-----P  215 (253)
T ss_pred             cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHHHHh--cCC-----C
Confidence            32   23456889999999999888999999999999999999999999754211      00000000  000     0


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..  ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus       216 ~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         216 GL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             Cc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  0111125789999999999999999999999753

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=295.06  Aligned_cols=249  Identities=26%  Similarity=0.389  Sum_probs=199.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccC---CCceeeEEEEEEeCC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLR---HPHLVKLIGYCWEEE  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpnI~~~~~~~~~~~  153 (401)
                      .|++.+.||.|+||.||+|.+..      +++.||+|.+.... ......+.+|+.+++.++   |||++++++++....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            47788999999999999998866      57899999987543 334567888999999986   999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+++++|.+++..   ..+++..++.++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~--~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHK--VGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            99999999999999998854   378999999999999999999995  5599999999999999999999999999876


Q ss_pred             CCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ......  ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||........      ..       ...
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~-------~~~  215 (277)
T cd06917         151 LNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM-------LIP  215 (277)
T ss_pred             cCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh-------ccc
Confidence            544321  1234568999999998875 4578999999999999999999999975421110      00       000


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ....+.+..   ...+..+.+++.+||+.||.+||++.++++.
T Consensus       216 ~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         216 KSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             cCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            000011111   1145688999999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.4e-39  Score=301.18  Aligned_cols=267  Identities=27%  Similarity=0.337  Sum_probs=199.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|.+.....  .....+.+|+++++.++||||+++++++..+..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            368899999999999999998876      578999998764322  234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|..+....  ..+++..++.++.|++.||+|||+.  +|+|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~--~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            99999999988887766443  4689999999999999999999954  5999999999999999999999999998765


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCccccc-ccHHHHhhhhhcCc----
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE-QSLAEWARPLLKEP----  308 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~----  308 (401)
                      ....  .......++..|+|||++.+ ..++.++||||||+++|+|++|.+||........ ..+..+...+....    
T Consensus       151 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            4332  12234568899999999875 4578899999999999999999999865421100 00011000000000    


Q ss_pred             ---cchhhhcCCcCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 ---RKLERLIDPRLEG-----QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ---~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ........+....     ......+..+.+++.+||+.+|.+||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence               0000000000000     0112346789999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-38  Score=296.51  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=200.9

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      +|...+.||.|++|.||+|.+..      +++.+++|.+..........+.+|+.+++.++||||+++++++...+..++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            45556899999999999998765      578899999876554455678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      ++||+.+++|.+++..   ..+++..+..++.|++.||+|||++  +|+||||+|+||+++.++.++|+|||.+......
T Consensus        94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ--GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            9999999999998865   4689999999999999999999955  4999999999999999999999999988754332


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP  317 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (401)
                      ..  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      .........       ..+
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-------~~~  233 (285)
T cd06648         169 VP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-------LPP  233 (285)
T ss_pred             Cc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-------CCC
Confidence            11  123356899999999999888999999999999999999999998653211      111111000       000


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..  ..+...+..+.+++.+||+.+|++||++.++++.
T Consensus       234 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         234 KL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CC--cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            00  0112245689999999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.6e-39  Score=296.45  Aligned_cols=248  Identities=25%  Similarity=0.316  Sum_probs=203.8

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +|++.+.||.|+||.||+|.+..      +++.||+|.+....   ......+.+|++++++++||||+++++++..+..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            58889999999999999998775      57899999987432   2345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||.+  +++|+||+|.||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~--~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK--GIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999999999999998764  6889999999999999999999954  5999999999999999999999999998865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ....   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......   ..... ..          
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~-~~----------  213 (258)
T cd05578         151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---RDQIR-AK----------  213 (258)
T ss_pred             CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---HHHHH-HH----------
Confidence            4432   1234568899999999998889999999999999999999999997653210   11110 00          


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM--SYVV  353 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~~il  353 (401)
                      ... .....+...+..+.+++.+||..||.+||++  .+++
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            000 1123344456889999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-38  Score=292.86  Aligned_cols=259  Identities=26%  Similarity=0.316  Sum_probs=201.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeC--C
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--E  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--~  153 (401)
                      ++|...+.||.|++|.||+|.+..      +++.+|+|.+..... .....+.+|+++++.++||||+++++++...  .
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            367888999999999999999876      578999999875433 3456788999999999999999999988653  4


Q ss_pred             eEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+++||||+++++|.+++..  .....++...+..++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--RKIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCHHHEEEecCCeEEEeecccc
Confidence            78999999999999888754  223568899999999999999999995  55999999999999999999999999998


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccc--ccccHHHHhhhhhcCcc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLG--REQSLAEWARPLLKEPR  309 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  309 (401)
                      .......    .....++..|+|||.+.+..++.++|||||||++|+|++|..||......  .......+....  ...
T Consensus       153 ~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~  226 (287)
T cd06621         153 GELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM--PNP  226 (287)
T ss_pred             ccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC--Cch
Confidence            7543322    12345788999999999999999999999999999999999999765321  111111211110  000


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+    ....  ......+..+.+++.+||..+|.+|||+.++++.
T Consensus       227 ~~----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         227 EL----KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hh----ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            00    0000  0001246788999999999999999999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.9e-39  Score=300.62  Aligned_cols=250  Identities=23%  Similarity=0.317  Sum_probs=200.5

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      .|.....||.|+||.||+|.+..      +++.||+|.+..........+.+|+.++..+.||||+++++++..++..++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~i   95 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKH------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWV   95 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcC------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEE
Confidence            34455689999999999998765      578999999876554555678899999999999999999999999999999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      +|||+++++|..++..   ..+++..++.++.|++.||.|||++  +|+|+||||+||+++.++.++|+|||++......
T Consensus        96 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~  170 (297)
T cd06659          96 LMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD  170 (297)
T ss_pred             EEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence            9999999999887644   4689999999999999999999955  4999999999999999999999999998754332


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP  317 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (401)
                      ..  ......|+..|+|||++.+..++.++|||||||++|+|++|..||......   .......   ..+       ..
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~---~~~-------~~  235 (297)
T cd06659         171 VP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLR---DSP-------PP  235 (297)
T ss_pred             cc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh---ccC-------CC
Confidence            21  123356899999999999888999999999999999999999999653211   0111000   000       00


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        ........+..+.+++.+||+.+|.+||++.++++.
T Consensus       236 --~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         236 --KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              001112235678999999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.5e-38  Score=290.43  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=206.9

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|.+.+.||.|+||.||+|.+..      ++..|++|.+.....  .....+.+|+++++.++|||++++++.+......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            57888999999999999999876      578999999876533  4456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSY--SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      +++||++++++|.+++....  ...+++..+..++.+++.||.|||+.  +++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--KILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC--CEecccCChHHeEEcCCCcEEECCccceee
Confidence            99999999999999987643  46799999999999999999999954  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .....  .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....      ........        
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~--------  216 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL--------  216 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh--------
Confidence            54432  122345689999999999988899999999999999999999999965421      11111110        


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         .......+...+..+.+++.+||..+|.+||++.++++.
T Consensus       217 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         217 ---KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ---cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               011112233456789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.6e-39  Score=293.77  Aligned_cols=251  Identities=23%  Similarity=0.404  Sum_probs=202.7

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|.+.+.||.|+||.||+|.+..      .+..||+|.+....  ......+.+|+.+++.++|+||+++++.+......
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            57888999999999999998876      57889999986542  23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEecCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDG  234 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~DfG~a~~~  234 (401)
                      ++|+||+++++|.+++.......+++..+..++.|++.||.|||+.  +++|+||||.||+++.++ .++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR--KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            9999999999999999765445689999999999999999999954  599999999999998885 4699999998765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.....      ..........       
T Consensus       153 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-------  217 (257)
T cd08225         153 NDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQG-------  217 (257)
T ss_pred             cCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhcc-------
Confidence            43221  12234689999999999888899999999999999999999999865321      1111111110       


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         . ....+...+..+.+++.+||..+|++|||+.++++.
T Consensus       218 ---~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         218 ---Y-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---c-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               0 111222345689999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-38  Score=292.84  Aligned_cols=243  Identities=28%  Similarity=0.382  Sum_probs=198.5

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ||.|++|.||+|++..      +++.||+|++....   ......+.+|+.+++.++||||+++++.+.++...+++|||
T Consensus         1 lg~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKS------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            6899999999999876      57899999986432   23346788899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +++++|.+++.+.  ..++...+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~--~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          75 CLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHN--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            9999999999764  568999999999999999999995  559999999999999999999999999998765432   


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG  321 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (401)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......    ...          ...+.......
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~----------~~~~~~~~~~~  213 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEI----------YNDILKGNGKL  213 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHH----------HHHHhccCCCC
Confidence            1223468999999999988889999999999999999999999997653211    111          11111111222


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 040050          322 QFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVR  354 (401)
Q Consensus       322 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~  354 (401)
                      .++...+..+.+++.+||+.+|.+||+     +.++++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            334444778999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.4e-38  Score=297.07  Aligned_cols=259  Identities=28%  Similarity=0.361  Sum_probs=200.4

Q ss_pred             HHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 040050           71 ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYC  149 (401)
Q Consensus        71 ~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~  149 (401)
                      .+....++|.+.+.||+|+||.||+|....      +++.+|+|.+.... .....+.+|+.++.++ +||||+++++++
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKK------DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEECC------CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            334456889999999999999999998876      57899999986432 2345677899999998 799999999998


Q ss_pred             EeC-----CeEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc
Q 040050          150 WEE-----EYRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT  222 (401)
Q Consensus       150 ~~~-----~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~  222 (401)
                      ...     ...++||||+++++|.+++..  .....+++..++.++.|++.||.|||+  .+|+|+||||+||+++.++.
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~--~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN--NRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCC
Confidence            754     358999999999999998854  224578999999999999999999995  45999999999999999999


Q ss_pred             EEEEecCCCCCCCCCCcceeeeccccccccccccccccC-----CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccH
Q 040050          223 AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-----HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL  297 (401)
Q Consensus       223 vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  297 (401)
                      ++|+|||++.........  .....|+..|+|||++...     .++.++|||||||++|+|++|+.||......  ..+
T Consensus       167 ~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~  242 (291)
T cd06639         167 VKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTL  242 (291)
T ss_pred             EEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHH
Confidence            999999998765432211  1234688999999988643     3688999999999999999999999654211  111


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..+..    .+       .+..  ..+......+.+++.+||+.+|++||++.++++.
T Consensus       243 ~~~~~----~~-------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         243 FKIPR----NP-------PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHHhc----CC-------CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11100    00       0000  1122345679999999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-38  Score=296.35  Aligned_cols=266  Identities=24%  Similarity=0.336  Sum_probs=197.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|.+.+.||+|+||.||+|.+..      ++..||+|.+..... .....+.+|+.+++.++|+||+++++++..+..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            3679999999999999999998776      578999999875432 223467789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .|+||||+. ++|.+++... ...+++..+..++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++...
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ--HILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999999994 7887777543 35678888999999999999999954  5999999999999999999999999998754


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh---------
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL---------  304 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------  304 (401)
                      .....  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......+ .+.......         
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~  230 (291)
T cd07870         154 SIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWP  230 (291)
T ss_pred             CCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhh
Confidence            32211  1223457889999999876 4578899999999999999999999975432111 111100000         


Q ss_pred             --hcCccchhhhcCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          305 --LKEPRKLERLIDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                        ...+...............     ....+..+.+++.+|+..||.+|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence              0000000000000000000     0011467889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.7e-38  Score=297.52  Aligned_cols=248  Identities=29%  Similarity=0.397  Sum_probs=197.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..+|.+.+.||+|+||.||+|.+..      +++.||+|.+.....   .....+.+|+.+++.++||||+++++++...
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~   87 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE   87 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcC------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence            3678899999999999999998765      578999999864332   2335688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.  +|+|+||+|.||+++.++.++|+|||++.
T Consensus        88 ~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~--~i~H~dl~p~nIl~~~~~~~kL~dfg~~~  163 (307)
T cd06607          88 HTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH--ERIHRDIKAGNILLTEPGTVKLADFGSAS  163 (307)
T ss_pred             CeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEECCCCCEEEeecCcce
Confidence            99999999995 6777776543 35789999999999999999999954  59999999999999999999999999987


Q ss_pred             CCCCCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      .....      ....|++.|+|||++.   ...++.++||||||+++|+|++|..||........  ..    .....  
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~----~~~~~--  229 (307)
T cd06607         164 LVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY----HIAQN--  229 (307)
T ss_pred             ecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HH----HHhcC--
Confidence            54322      2346888999999874   45688999999999999999999999865421100  00    00000  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                              ......+...+..+.+++.+||+.+|.+||++.+++..
T Consensus       230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         230 --------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                    00001122346789999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-40  Score=286.60  Aligned_cols=254  Identities=24%  Similarity=0.274  Sum_probs=202.7

Q ss_pred             HHhcCCCCC-ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           74 LITSNFSRS-NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~-~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      .++++|.+. ++||-|-.|.|..+.++.      +++.+|+|++..     ....++|+++.-.. .|||||.++++|..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~------T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKR------TQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEecc------chhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            345666664 689999999999998887      799999999862     24567888876555 59999999998864


Q ss_pred             ----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEE
Q 040050          152 ----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAK  224 (401)
Q Consensus       152 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vk  224 (401)
                          ...+.+|||.|+||.|+..++.+....+++.++..|+.||+.|+.|||+++  |.||||||+|+|...   +..+|
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceE
Confidence                346789999999999999999987788999999999999999999999766  999999999999964   45799


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||+|+....   .....+.+-||.|.|||++...+|+..+|+||+||++|-||+|.+||-..-. ..          
T Consensus       205 LtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~a----------  270 (400)
T KOG0604|consen  205 LTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LA----------  270 (400)
T ss_pred             ecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-cc----------
Confidence            999999987543   2235667899999999999999999999999999999999999999954211 00          


Q ss_pred             hcCccchhhhcCCcC--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKEPRKLERLIDPRL--EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       -.++--.++.....  ...--..+++...++|+.+|..+|.+|.|+.++++.
T Consensus       271 -ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  271 -ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence             01111111111111  011124668999999999999999999999999865

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=291.31  Aligned_cols=251  Identities=26%  Similarity=0.378  Sum_probs=201.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-----cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-----TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+|.+.+.||+|+||.||+|.+..      ++..||+|.+....     ......+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            578999999999999999998765      68899999875321     2234568889999999999999999999876


Q ss_pred             C--CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          152 E--EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       152 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      .  ..++++|||+++++|.+++...  ..+++..+..++.|++.||.|||+  .+|+|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~--~~i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEEcCCCCEEECccc
Confidence            4  4688999999999999998654  568899999999999999999995  459999999999999999999999999


Q ss_pred             CCCCCCCCCc-ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          230 LAKDGPEGEE-THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       230 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ++........ ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||......                
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------------  215 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----------------  215 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----------------
Confidence            9976432111 11123356899999999999888999999999999999999999999653111                


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ..+...........++...+..+.+++.+||. +|..||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            01111111122234556677889999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.9e-38  Score=304.43  Aligned_cols=264  Identities=23%  Similarity=0.282  Sum_probs=200.0

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+..+|++.+.||+|+||.||+|.+..      +++.||+|.+...  .......+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTV------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECC------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            456889999999999999999998876      5789999998643  22334567789999999999999999998864


Q ss_pred             C------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          152 E------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       152 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      .      ...|+||||+. ++|.+.+..    .++...+..++.|++.||+|||+.  ||+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~--gi~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          87 QKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             CCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEECCCCCEEE
Confidence            4      35799999994 688887753    388899999999999999999954  5999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      +|||++........   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......  ..........
T Consensus       160 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~  234 (353)
T cd07850         160 LDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID--QWNKIIEQLG  234 (353)
T ss_pred             ccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcC
Confidence            99999986543221   233468899999999999999999999999999999999999997543211  0000000000


Q ss_pred             cCc-----------------------cchhhhcCCcC----CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEP-----------------------RKLERLIDPRL----EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~-----------------------~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..+                       ..+..+.....    ....+...+..+.+++.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000                       00001110000    001122346678999999999999999999999865

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=312.34  Aligned_cols=259  Identities=30%  Similarity=0.417  Sum_probs=216.1

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ...+.++||+|.||.|++|.|...   ....-.||||.++.+... ...+|++|+.+|.+|+|||++++||+..+ ....
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~p---sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQP---SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCC---CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            344568899999999999999863   224567999999876443 56789999999999999999999999987 5678


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ||||+++.|+|.+.|.+.....+.......++.||+.|+.||.+  +++|||||...|+++.....|||+|||+.+.+..
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes--krlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES--KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999999999988666788899999999999999999995  5599999999999999999999999999998877


Q ss_pred             CCcceeeec-cccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          237 GEETHVITR-VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       237 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ....+.+.. ..-...|+|||.+....++.++|||++||++|||++ |..||-+...                 -.+.+.
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~  327 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKN  327 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHh
Confidence            666655543 234558999999999999999999999999999999 6789876531                 222333


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      +|.+-+..-|..+++++.+++..||..+|++|||+.+|.+.+-..
T Consensus       328 iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  328 IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            444444455777899999999999999999999999998554433

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.4e-38  Score=288.08  Aligned_cols=252  Identities=31%  Similarity=0.456  Sum_probs=207.5

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC--C
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--E  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--~  153 (401)
                      +|.+.+.||+|++|.||+|.+..      +++.|++|++.....  .....+.+|+.++++++||||+++++.+...  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            47788999999999999998876      578999999875542  3456788999999999999999999999988  8


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..+++|||+.+++|.+++...  ..+++..++.++.|++.||+|||+  .+++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~--~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHS--NGIVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            899999999999999998765  489999999999999999999995  5599999999999999999999999999887


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..............++..|+|||.+.+..++.++|+||||+++|+|++|..||.....     ....          +..
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~----------~~~  215 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAA----------LYK  215 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHH----------HHh
Confidence            6554321112345688999999999988899999999999999999999999976530     1110          111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      +........++...+..+.+++.+|+..+|.+||++.+++.
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11112222344455789999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.1e-38  Score=296.12  Aligned_cols=265  Identities=24%  Similarity=0.320  Sum_probs=200.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC--
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--  152 (401)
                      ++|++.+.||.|+||.||+|.+..      +++.+++|.+.....  .....+.+|+.++++++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            478889999999999999998876      578899999875432  2234567899999999999999999999877  


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...|+||||+. ++|.+++.... ..+++..++.++.|++.||+|||+.  +|+|+||||+||+++.++.++|+|||++.
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN--WILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCCHHHEEECCCCcEEEeecCcee
Confidence            88999999996 58988886542 4689999999999999999999954  59999999999999999999999999988


Q ss_pred             CCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC----
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE----  307 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  307 (401)
                      .......  ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.......  ............    
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~  230 (293)
T cd07843         155 EYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNKIFKLLGTPTEKI  230 (293)
T ss_pred             eccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchHH
Confidence            6544321  12334578899999998754 46889999999999999999999997543211  111110000000    


Q ss_pred             -------c----cchhhhcCCcCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 -------P----RKLERLIDPRLEGQFPIK-GAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 -------~----~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             +    ..........+...++.. .+..+.+++.+||+.+|++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                   0    000000011111222222 46778999999999999999999999753

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=332.04  Aligned_cols=259  Identities=25%  Similarity=0.282  Sum_probs=213.2

Q ss_pred             HHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecC---CCcccHHHHHHHHHHHhccCCCceeeE
Q 040050           69 LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL---DGTQGHKEWMAEIIFLGQLRHPHLVKL  145 (401)
Q Consensus        69 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnI~~~  145 (401)
                      +.+++.-.++|.++++||+|+||.|.+++.+.      +++.||+|++..   -......-|..|-.+|..-+.+-|+.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~L  140 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQL  140 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeec------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence            45566667899999999999999999999887      789999999874   234445678889999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      +..|.+++++|+||||++||+|..++.+.  ..+++..+..++..|+.||.-||+.+  +|||||||+|||+|..|++||
T Consensus       141 hyAFQD~~~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  141 HYAFQDERYLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             HHHhcCccceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEee
Confidence            99999999999999999999999999775  48999999999999999999999665  999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccc----c-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM----T-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      +|||.+..+...+.. .....+|||.|.+||++.    + +.|+..+|+||+||++|||+.|..||...      +++..
T Consensus       217 ADFGsClkm~~dG~V-~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveT  289 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTV-RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVET  289 (1317)
T ss_pred             ccchhHHhcCCCCcE-EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHH
Confidence            999999877654433 335578999999999986    3 67999999999999999999999999643      33333


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFP--IKGAQKAAATAFKCLSHHPRHRPT---MSYVVRV  355 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~~il~~  355 (401)
                      ...++          +-.-.-.+|  ..++..+.+||.+.+ -+|..|..   ++++-.+
T Consensus       290 Y~KIm----------~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  290 YGKIM----------NHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             HHHHh----------chhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence            33222          221112233  457889999997666 56888887   8887654

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.3e-38  Score=293.76  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=205.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ....|++.+.||.|++|.||+|.+..      .+..|++|++..... ....+.+|+++++.++|+||+++++.+.....
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   89 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDE   89 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence            34678888999999999999998875      578899999876544 45678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++++||+++++|.+++.... ..+++..+..++.|++.||.|||+  .||+|+||+|+||+++.++.++|+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~--~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh--CCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            999999999999999997652 379999999999999999999995  55999999999999999999999999988754


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....  ......++..|+|||++.+..++.++|+||||+++|+|++|..||.......  ....    ....  ..   
T Consensus       167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~----~~~~--~~---  233 (286)
T cd06614         167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFL----ITTK--GI---  233 (286)
T ss_pred             ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----HHhc--CC---
Confidence            33221  1133457889999999998889999999999999999999999986542210  0000    0000  00   


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        +.  ...+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       234 --~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 --PP--LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --CC--CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              00  01122246789999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=321.11  Aligned_cols=266  Identities=26%  Similarity=0.428  Sum_probs=223.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .....+.++||.|.||.|++|+.+...+   ....||||.++.... ....+|+.|+.||.+++||||+++.|+....+.
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgk---re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGK---REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCC---cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            4567788999999999999998876433   456899999986643 345689999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      ..||.|||++|+|..+|..+. +.++..++..+++.|+.|++||-.++  +|||||...||||+.+...|++|||+++..
T Consensus       705 vMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeec
Confidence            999999999999999998764 56999999999999999999999555  999999999999999999999999999976


Q ss_pred             CCCCcceeeecccc--ccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          235 PEGEETHVITRVMG--TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       235 ~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ..+. ....++..|  ..+|.|||.+...+++.++||||+|++|||.++ |..||......                + .
T Consensus       782 edd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ----------------d-V  843 (996)
T KOG0196|consen  782 EDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----------------D-V  843 (996)
T ss_pred             ccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH----------------H-H
Confidence            5544 222333334  468999999999999999999999999999887 89998765321                1 1


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                      -+-+....+...|.+++..+.+|+..||++|-.+||.+.+|+..|+++-.-+++
T Consensus       844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S  897 (996)
T KOG0196|consen  844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS  897 (996)
T ss_pred             HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence            122334555566778999999999999999999999999999999999766654

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-38  Score=317.75  Aligned_cols=278  Identities=20%  Similarity=0.253  Sum_probs=191.5

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCC---------CCCCc----eEEEEEecCCCcccHHHHHHHHHHHhccCC
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKP---------GLEAQ----PVAVKALDLDGTQGHKEWMAEIIFLGQLRH  139 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~---------~~~~~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  139 (401)
                      ....++|.+.+.||+|+||+||++........         ...+.    .++.|.+. ........+.+|+.+|++++|
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~H  222 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNH  222 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCC
Confidence            34457899999999999999999876432100         00001    11122221 112234567889999999999


Q ss_pred             CceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEE
Q 040050          140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY---SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNIL  216 (401)
Q Consensus       140 pnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIl  216 (401)
                      |||+++++++...+..|+|++++ +++|..++....   ........+..++.||+.||.|||+  ++||||||||+|||
T Consensus       223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~--~gIiHrDLKP~NIL  299 (501)
T PHA03210        223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD--KKLIHRDIKLENIF  299 (501)
T ss_pred             CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEE
Confidence            99999999999999999999998 568888775431   1233456778899999999999995  45999999999999


Q ss_pred             EcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCC-CCCCcccccc
Q 040050          217 LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA-MDNTRLGREQ  295 (401)
Q Consensus       217 v~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~~  295 (401)
                      ++.++.+||+|||++......... ......||..|+|||++.+..++.++|||||||++|+|++|..+ +.........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            999999999999999865433221 12345799999999999999999999999999999999998754 4332211111


Q ss_pred             cHHHHhhhhhcC----c---cchhhhcCCcC----CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          296 SLAEWARPLLKE----P---RKLERLIDPRL----EGQFP-----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       296 ~~~~~~~~~~~~----~---~~~~~~~~~~~----~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+..........    +   ..+...+....    ....+     ...+..+.+++.+||+.||.+|||+.+++.+
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            222211111000    0   00111110000    00000     0124467788999999999999999999874

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.8e-38  Score=295.74  Aligned_cols=255  Identities=28%  Similarity=0.394  Sum_probs=200.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..|...+.||+|+||.||+|.+..      ++..||+|.+.....   .....+.+|+.+++.++|||++++++++..+.
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVR------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH   98 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcC------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            347788999999999999998766      578999999864422   23456888999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+. |+|.+.+... ...+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++..
T Consensus        99 ~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~--~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635          99 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             eEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH--CCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence            9999999996 5787776543 3568999999999999999999995  4599999999999999999999999999875


Q ss_pred             CCCCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....      ....|+..|+|||++.   ++.++.++|||||||++|+|++|..||......  .....           
T Consensus       175 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~-----------  235 (317)
T cd06635         175 ASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYH-----------  235 (317)
T ss_pred             cCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHHHH-----------
Confidence            4322      2346889999999874   456889999999999999999999998653211  00001           


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                         +.............+..+.+++.+||+.+|.+||++.++++.+..+....
T Consensus       236 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         236 ---IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ---HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence               00000011112234567899999999999999999999998766554333

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.1e-38  Score=297.29  Aligned_cols=255  Identities=26%  Similarity=0.332  Sum_probs=196.8

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~  155 (401)
                      +|...+.||+|+||.||++.+..      +++.||+|.+.... ......+.+|+.++.++. ||||+++++++..+...
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKP------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECC------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            45666889999999999998876      57899999987543 233456788999999996 99999999999999999


Q ss_pred             EEEEEecCCCChhHHH---hhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          156 LLVYEYMPRGSLHNQL---FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l---~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +++|||+. +++.++.   .......+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.++|+|||++.
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            99999984 5665543   223346799999999999999999999952 359999999999999999999999999987


Q ss_pred             CCCCCCcceeeeccccccccccccccccC---CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTG---HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      .......   .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....     ............  
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~--  226 (288)
T cd06616         157 QLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG--  226 (288)
T ss_pred             HhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC--
Confidence            5433221   1234588999999998865   68999999999999999999999997542     111111111100  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           ..+.+....+...+..+.+|+.+||+.+|.+|||+.++++.
T Consensus       227 -----~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 -----DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -----CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00111112223356789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.4e-38  Score=292.36  Aligned_cols=245  Identities=27%  Similarity=0.379  Sum_probs=194.8

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ||+|+||+||+|.+..      +++.||+|.+....   ......+.+|+++++.++||||+++++++...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKA------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcC------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            6899999999998776      57899999986432   22344567899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +++++|.+++.+.....+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~--~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---  149 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ--RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---  149 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence            999999999977644579999999999999999999995  459999999999999999999999999987643321   


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG  321 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (401)
                      ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||........  .........            ....
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~------------~~~~  215 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEELKRRTL------------EMAV  215 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHHHHhccc------------cccc
Confidence            12334678899999999888899999999999999999999999965432100  001000000            0011


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 040050          322 QFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVR  354 (401)
Q Consensus       322 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~  354 (401)
                      ..+...+..+.+++.+||+.+|.+||     ++.+++.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            22333467889999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=286.17  Aligned_cols=248  Identities=32%  Similarity=0.488  Sum_probs=204.5

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|.+.+.||+|++|.||+|.+..      .++.|++|.+.....  .....+.+|++++.+++|||++++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            57889999999999999998776      578899999876543  3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+  .||+|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~--~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE--QGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh--CCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999999999998765  679999999999999999999995  459999999999999999999999999998665


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .....  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....     ...... ..          
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~----------  212 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR-IV----------  212 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-Hh----------
Confidence            43321  2335688999999999888889999999999999999999999865321     000000 00          


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       .......+...+..+.+++.+||..+|++||++.+++.
T Consensus       213 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         213 -QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             01111233344678999999999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7.1e-38  Score=292.69  Aligned_cols=266  Identities=24%  Similarity=0.295  Sum_probs=198.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||.|++|+||+|.+..      +++.||+|.+.....  .....+.+|+.+++.++||||+++++++.....
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            478999999999999999998766      578999999865422  234567889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEEEEecCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD  233 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vkL~DfG~a~~  233 (401)
                      .++||||+. ++|.+++.......+++..+..++.||+.||+|||+  ++|+|+||+|+||+++. ++.+||+|||++..
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~--~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS--HRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh--CCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            999999995 688888766544456888999999999999999995  55999999999999985 56799999999976


Q ss_pred             CCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch-
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL-  311 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  311 (401)
                      .....  .......|++.|+|||++.+ ..++.++||||||+++|+|++|.+||......  ..+.............. 
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~  228 (294)
T PLN00009        153 FGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFKIFRILGTPNEETW  228 (294)
T ss_pred             cCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChhhc
Confidence            43321  11233467889999998876 46789999999999999999999999754221  11111100000000000 


Q ss_pred             ------hhhc--CCcCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ------ERLI--DPRLEGQ----FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ------~~~~--~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            ....  .+.....    .....+..+.+++.+||+.+|++||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000  0000000    112235678999999999999999999999863

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.1e-38  Score=292.26  Aligned_cols=243  Identities=25%  Similarity=0.340  Sum_probs=189.0

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHH---HhccCCCceeeEEEEEEeCCeEEE
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIF---LGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~---l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      .||+|+||.||+|.+..      +++.||+|.+.....   .....+.+|..+   +....||||+.+++++...+..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECC------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            48999999999998766      578999998864321   112233444443   334479999999999999999999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      ||||+.+++|.+++...  +.+++..+..++.|++.||.|||+.  +|+|+||||+||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~--~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          75 ILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            99999999999888654  6799999999999999999999954  4999999999999999999999999998754332


Q ss_pred             Ccceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          238 EETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      .    .....|+..|+|||.+. +..++.++|+|||||++|+|++|..||..........+...   .            
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~------------  211 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---T------------  211 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---h------------
Confidence            1    12346899999999886 46689999999999999999999999965422111100000   0            


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                      .......+...+..+.+++.+||..||.+||     ++.+++++
T Consensus       212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0111223445577899999999999999999     59988775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.5e-38  Score=293.13  Aligned_cols=266  Identities=17%  Similarity=0.166  Sum_probs=189.6

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccH-----------HHHHHHHHHHhccCCCce
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-----------KEWMAEIIFLGQLRHPHL  142 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnI  142 (401)
                      ....+|.+.+.||+|+||.||+|.+...   ......+|+|+.........           .....++..+..+.|+||
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~---~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i   85 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASD---HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI   85 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCC---cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence            3457899999999999999999987652   11245677776544332211           112234455667789999


Q ss_pred             eeEEEEEEeCC----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc
Q 040050          143 VKLIGYCWEEE----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD  218 (401)
Q Consensus       143 ~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~  218 (401)
                      +++++++....    ..+++|+++ ..++.+.+...  ...++..+..++.|++.||.|||+  .+|+||||||+|||++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~--~~iiHrDiKp~Nill~  160 (294)
T PHA02882         86 PKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE--HGISHGDIKPENIMVD  160 (294)
T ss_pred             CcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEc
Confidence            99998766543    447888887 45776666543  346788899999999999999995  4599999999999999


Q ss_pred             CCCcEEEEecCCCCCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc
Q 040050          219 SDYTAKLSDFGLAKDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR  293 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  293 (401)
                      .++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999765322111     11122469999999999999999999999999999999999999997652211


Q ss_pred             cccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                      .  .......     ..+..+.....   .....+..+.+++..|+..+|.+||++.++++.|+
T Consensus       241 ~--~~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        241 N--LIHAAKC-----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             H--HHHHhHH-----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1  1100000     00011111111   01123578999999999999999999999998763

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=338.39  Aligned_cols=257  Identities=28%  Similarity=0.369  Sum_probs=209.8

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ..++-++..+..||.|.||.||.|.+.+      +|+..|+|-+....  ......+.+|..+|..++|||++++||+-.
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLD------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCC------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence            3445678888999999999999999888      79999999887542  334456788999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      ..+..+|.||||.+|+|.+.+...  ...++.....+..|++.|++|||+++  ||||||||+||+++.+|.+|++|||.
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccc
Confidence            999999999999999999998653  45667777788899999999999655  99999999999999999999999999


Q ss_pred             CCCCCCCC--cceeeeccccccccccccccccC---CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          231 AKDGPEGE--ETHVITRVMGTQGYAAPEYVMTG---HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       231 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |.......  .........||+.|||||++.+.   .-..++|||||||++.||+||+.||...+.+             
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------------- 1447 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------------- 1447 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------------
Confidence            98765432  11122346899999999999863   4567899999999999999999999764311             


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ..+-..+-..-.+++|...+.+-++|+.+||..||+.|-++.++++.
T Consensus      1448 ---~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1448 ---WAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ---hHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence               11111222233456777789999999999999999999888877654

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.4e-38  Score=288.31  Aligned_cols=249  Identities=24%  Similarity=0.359  Sum_probs=204.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|++.+.||.|+||.||++.+..      +++.+++|.+....  ......+.+|+.+++.++|+||+++++++......
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            57888999999999999998765      57899999987542  23345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ++||||+++++|.+++.+.  ....+++..++.++.|++.||.|||+.  +++|+||+|.||+++.++.++|+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~--~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ--KILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC--CcccCCCCcceEEEecCCcEEEeeccchhh
Confidence            9999999999999988652  235789999999999999999999954  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....    ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......   .+..              
T Consensus       153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~--------------  211 (256)
T cd08530         153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---DLRY--------------  211 (256)
T ss_pred             hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH--------------
Confidence            5443    122346889999999999999999999999999999999999999754211   0000              


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..........+...+.++.+++.+||..+|.+||++.++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         212 KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            001111122334567889999999999999999999999753

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.1e-38  Score=301.03  Aligned_cols=271  Identities=25%  Similarity=0.351  Sum_probs=202.4

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +..+|.+.+.||+|+||+||+|++..      ++..||+|.+...  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   76 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSE------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP   76 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecC------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence            34689999999999999999998776      6889999998643  233345677899999999999999999987654


Q ss_pred             -----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          153 -----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       153 -----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                           ...|++|||+ +++|.+++...  ..+++..+..++.|++.||.|||+.  +++|+||||+||+++.++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--~i~H~dlkp~Nil~~~~~~~kL~D  151 (337)
T cd07858          77 HREAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICD  151 (337)
T ss_pred             cccccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCCCCEEECc
Confidence                 3579999999 57898888654  6799999999999999999999954  599999999999999999999999


Q ss_pred             cCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc-HHHHhhh--
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-LAEWARP--  303 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~--  303 (401)
                      ||++.......  .......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.......... .......  
T Consensus       152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  229 (337)
T cd07858         152 FGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS  229 (337)
T ss_pred             CccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99998654322  12234568899999998875 568999999999999999999999996542111000 0000000  


Q ss_pred             -----hhcCccchhhhc---CCcCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 040050          304 -----LLKEPRKLERLI---DPRLE---GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV--LDSL  359 (401)
Q Consensus       304 -----~~~~~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~--L~~l  359 (401)
                           ...... .....   .....   .......+..+.+++.+||+.+|++|||+.++++.  +..+
T Consensus       230 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         230 EEDLGFIRNEK-ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hHHhhhcCchh-hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                 000000 00000   00000   00112346788999999999999999999999987  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-38  Score=292.63  Aligned_cols=264  Identities=23%  Similarity=0.287  Sum_probs=199.4

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      |++.+.||.|++|.||+|.+..      ++..||+|++....  ......+.+|+.+++.++||||+++++++.+....+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            6778999999999999998876      57899999987543  223456788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|||+ +++|.+++.......+++..++.++.|++.||.|||+.  +++|+||+|.||+++.++.++|+|||++.....
T Consensus        75 iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~--~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH--RVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            999999 56899988765445789999999999999999999954  599999999999999999999999999975433


Q ss_pred             CCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc-------
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP-------  308 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------  308 (401)
                      ...  ......++..|+|||++.+. .++.++|+||||+++|+|++|+.||......  ..+...........       
T Consensus       152 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07835         152 PVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGV  227 (283)
T ss_pred             Ccc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhh
Confidence            211  12334568899999988754 5789999999999999999999999654221  11111111100000       


Q ss_pred             ----cchhhhcCC--cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 ----RKLERLIDP--RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ----~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          .........  ..........+..+.+++.+||+.+|.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         228 TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                000000000  00001122335688999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=297.50  Aligned_cols=271  Identities=23%  Similarity=0.298  Sum_probs=198.6

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--  152 (401)
                      +|.+.+.||+|+||.||+|.+...    ..+..||+|.+....   ......+.+|+.+++.++||||+++++++...  
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~----~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   76 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG----KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD   76 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC----CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC
Confidence            588889999999999999987652    147899999987632   33446778899999999999999999999988  


Q ss_pred             CeEEEEEEecCCCChhHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC----CCcEEE
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSY---SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS----DYTAKL  225 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~----~~~vkL  225 (401)
                      ...++||||+. ++|.+++....   ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.    ++.+||
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          77 KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN--WVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC--CEeeCCCCHHHEEEcCCCCccceEEE
Confidence            78999999995 57777764321   23689999999999999999999954  5999999999999999    899999


Q ss_pred             EecCCCCCCCCCCc-ceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCccccc-------cc
Q 040050          226 SDFGLAKDGPEGEE-THVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE-------QS  296 (401)
Q Consensus       226 ~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~  296 (401)
                      +|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|.+||........       ..
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            99999886543222 111233567899999998876 4578999999999999999999999975433220       00


Q ss_pred             HHHHhhhhhcCcc----------chhhhcCCcCCCCCC-----H------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          297 LAEWARPLLKEPR----------KLERLIDPRLEGQFP-----I------KGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       297 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~-----~------~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +......+.....          ......+......++     .      ..+..+.+++.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111000000000          000000000000111     0      234578899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-39  Score=304.44  Aligned_cols=266  Identities=22%  Similarity=0.332  Sum_probs=198.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeC-
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE-  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-  152 (401)
                      +.++|.+.+.||+|+||.||+|++..      +++.||+|.+.... ......+.+|+.+++.++||||+++++++... 
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKP------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcC------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            34789999999999999999998876      57899999986432 33455678899999999999999999987654 


Q ss_pred             ----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          153 ----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       153 ----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                          ...+++|||+. ++|...+..   ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+||
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~df  150 (336)
T cd07849          77 FESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDF  150 (336)
T ss_pred             ccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcc
Confidence                35799999995 588777643   57999999999999999999999654  999999999999999999999999


Q ss_pred             CCCCCCCCCCcc-eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          229 GLAKDGPEGEET-HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       229 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      |++......... .......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......   ........+.
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~  227 (336)
T cd07849         151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLG  227 (336)
T ss_pred             cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcC
Confidence            998765332211 11233568999999998764 568999999999999999999999996542110   0111111111


Q ss_pred             Cc--cchhhhcCCc---------CCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EP--RKLERLIDPR---------LEGQ-----FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~--~~~~~~~~~~---------~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+  ..+..+....         ....     .....+..+.+++.+||+.+|.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00  1111000000         0000     011235678999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.3e-38  Score=290.52  Aligned_cols=264  Identities=26%  Similarity=0.359  Sum_probs=199.9

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      +|++.+.||.|++|.||+|++..      ++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            58889999999999999999876      578999999876533 23456778999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +||||+. ++|.+++.... ...+++..+..++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        75 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          75 LVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE--NRVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH--CCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            9999996 58888876532 2468999999999999999999995  459999999999999999999999999997543


Q ss_pred             CCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC-ccchhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE-PRKLER  313 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  313 (401)
                      ....  ......++..|+|||++.+ ..++.++|+||||+++|+|++|..||......  ............. ...+..
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE--DQLLKIFRIMGTPTESTWPG  227 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhHHH
Confidence            3211  1233457889999998875 45788999999999999999999999764321  1111111000000 000000


Q ss_pred             hcC-CcCC-----------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          314 LID-PRLE-----------GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       314 ~~~-~~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      +.. +.+.           ..+....+..+.+++.+||+.||.+||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         228 ISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000 0000           0111234678899999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.3e-38  Score=290.09  Aligned_cols=260  Identities=22%  Similarity=0.281  Sum_probs=194.7

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccC-CCceeeEEEEEEeC--Ce
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEE--EY  154 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~--~~  154 (401)
                      |.+.+.||+|+||.||+|.+..      ++..||+|.+.... ........+|+.++.++. ||||+++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcC------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            6778899999999999998776      57899999987532 222334567888998885 99999999999987  88


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+. ++|.+.+... ...+++..++.++.|++.||.|||+  .+|+|+||+|+||+++. +.+||+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHR--NGIFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH--CCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            999999995 5888887653 2578999999999999999999995  55999999999999999 99999999999865


Q ss_pred             CCCCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC-ccchh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE-PRKLE  312 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  312 (401)
                      .....   .....++..|+|||++. ++.++.++|||||||++|+|++|..||.......   ........... +..+.
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~  223 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVL  223 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence            43221   12346889999999765 4567889999999999999999999997643211   11111111100 00000


Q ss_pred             hhcC---------CcCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLID---------PRLE----GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~---------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ....         +...    .......+..+.+++.+||+.+|.+||++.++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000         0000    00112347899999999999999999999999763

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=305.90  Aligned_cols=258  Identities=26%  Similarity=0.426  Sum_probs=219.3

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ++.-..+..+..+||.|.||.||.|+|++      ..-.||||.++.+. -...+|+.|..+|+.++|||+|+++|+|..
T Consensus       262 WEmeRtdItMkhKLGGGQYGeVYeGvWKk------yslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  262 WEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             hhccchheeeeeccCCCcccceeeeeeec------cceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            33444566677899999999999999998      56789999987543 346789999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      +..+|||+|||..|+|.+||.+-+...++....+.++.||..|+.||.  .+++|||||...|+||.++..||++|||++
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--HhhhhhhhhhhhhccccccceEEeeccchh
Confidence            999999999999999999999887888999999999999999999999  556999999999999999999999999999


Q ss_pred             CCCCCCCcceeeecccc---ccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcC
Q 040050          232 KDGPEGEETHVITRVMG---TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +.+..+.    ++...|   ...|.|||-+....++.++|||+|||+|||+.| |..||.+...                
T Consensus       413 RlMtgDT----YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------------  472 (1157)
T KOG4278|consen  413 RLMTGDT----YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------  472 (1157)
T ss_pred             hhhcCCc----eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------------
Confidence            9875543    233334   457999999999999999999999999999988 7788876421                


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                       .....++....+-.-|..|++.+.+|++.||+.+|.+||++.++-+.++.|
T Consensus       473 -SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  473 -SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             -HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence             112223333444445667888999999999999999999999999998887

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.7e-38  Score=293.89  Aligned_cols=264  Identities=24%  Similarity=0.296  Sum_probs=195.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|.+....  ......+.+|+.+++.+. ||||+++++++....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            468899999999999999998876      57899999986542  223456788999999995 699999999988766


Q ss_pred             e-----EEEEEEecCCCChhHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEE
Q 040050          154 Y-----RLLVYEYMPRGSLHNQLFRSY---SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAK  224 (401)
Q Consensus       154 ~-----~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vk  224 (401)
                      .     .|+||||+.+ +|.+++....   ...+++..++.++.||+.||.|||+  .+|+||||+|+||+++. ++.++
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~--~~i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK--HGVMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCChHHEEEecCCCeEE
Confidence            5     8999999964 8988886532   2468999999999999999999995  45999999999999998 89999


Q ss_pred             EEecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      |+|||++........  ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||.......  .+......
T Consensus       152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~  227 (295)
T cd07837         152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKL  227 (295)
T ss_pred             EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHH
Confidence            999999875433211  1223357889999998865 567899999999999999999999997542111  11111110


Q ss_pred             hhcCccc--hhh---hcC----CcCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          304 LLKEPRK--LER---LID----PRLE----GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       304 ~~~~~~~--~~~---~~~----~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      . ..+..  ...   ...    +...    .......+..+.++|.+||..||.+||++.+++.
T Consensus       228 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         228 L-GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             h-CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0 00000  000   000    0000    0001234677899999999999999999999975

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=305.99  Aligned_cols=250  Identities=26%  Similarity=0.346  Sum_probs=210.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecC---CCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL---DGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .++.+...||-||||.|=++....      ....+|+|+++.   ......+....|-.+|...+.|+|+++|-.|.++.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~------~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNS------QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecc------cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            566777889999999999987665      233578887753   34455677889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ++|+.||-|-||.|+..+..+  +.++..++..++..+++|+.|||+  ++||+|||||+|++++.+|-+||.|||+|..
T Consensus       494 yvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~--k~iIYRDLKPENllLd~~Gy~KLVDFGFAKk  569 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHR--KGIIYRDLKPENLLLDNRGYLKLVDFGFAKK  569 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHh--cCceeccCChhheeeccCCceEEeehhhHHH
Confidence            999999999999999999776  889999999999999999999995  4599999999999999999999999999998


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...+..+   .++||||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++..-                ...
T Consensus       570 i~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt----------------Yn~  630 (732)
T KOG0614|consen  570 IGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT----------------YNL  630 (732)
T ss_pred             hccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH----------------HHH
Confidence            8776644   467999999999999999999999999999999999999999987643211                111


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                      ++...-.-.+|..+.....+++.+++..+|.+|..     +.+|-++
T Consensus       631 ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  631 ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            11112222456677888999999999999999976     6777665

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.4e-38  Score=294.88  Aligned_cols=266  Identities=25%  Similarity=0.334  Sum_probs=195.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~-  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|.+....  ......+.+|+.++++++||||+++++++.... 
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKK------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECC------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            679999999999999999998776      68899999886442  222345678999999999999999999987653 


Q ss_pred             -------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          154 -------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       154 -------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                             ..++||||+. ++|.+++... ...+++..++.++.|++.||.|||++  +++|+||||+||+++.++.+||+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN--KILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEECCCCcEEEC
Confidence                   4599999995 5888877543 34789999999999999999999955  59999999999999999999999


Q ss_pred             ecCCCCCCCCCCcc--eeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          227 DFGLAKDGPEGEET--HVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       227 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      |||++.........  .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.................
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG  241 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999755332211  112334678899999988764 478899999999999999999999965432111111111000


Q ss_pred             hh-----cC------------ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          304 LL-----KE------------PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       304 ~~-----~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..     ..            +..........+.   +......+.+++.+||..||.+|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLK---PYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CCChhhcccccchhhhhhccCCCccchhhHHhcc---cccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00     00            0000000000000   00123567899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.1e-38  Score=295.83  Aligned_cols=264  Identities=27%  Similarity=0.328  Sum_probs=197.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC--
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--  152 (401)
                      ++|++.+.||.|+||.||+|.+..      +++.||+|.+.....  .....+.+|+.++++++|+||+++++++...  
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTT------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL   80 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECC------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence            679999999999999999998876      688999999875432  2233566899999999999999999998765  


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+.  +++||||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          81 DSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN--FIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             CeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEECccceee
Confidence            46899999995 5888887653 36789999999999999999999954  49999999999999999999999999998


Q ss_pred             CCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc-cc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP-RK  310 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~  310 (401)
                      .......  ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.......  .+.... .....+ ..
T Consensus       157 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~~-~~~~~~~~~  231 (309)
T cd07845         157 TYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLII-QLLGTPNES  231 (309)
T ss_pred             ecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HhcCCCChh
Confidence            6543221  1223346788999999875 567899999999999999999999997543211  111100 000000 00


Q ss_pred             h-hhh------cCCcCCCC-C------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 L-ERL------IDPRLEGQ-F------PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~-~~~------~~~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      + ...      ........ +      ....+..+.++|.+||+.||++|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 000      00000000 0      01136678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=308.37  Aligned_cols=270  Identities=27%  Similarity=0.395  Sum_probs=203.2

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC---
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE---  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~---  153 (401)
                      .+...+.||+|+||.||+|+++.      +|+.||||.++... ....+.+.+|+++|++++|||||++.++-.+..   
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnke------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~   87 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKE------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGL   87 (732)
T ss_pred             ceeehhhhcCCccceeeeecccc------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCc
Confidence            45566889999999999998887      79999999987543 334567889999999999999999998765543   


Q ss_pred             ---eEEEEEEecCCCChhHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc--CCC--cEEE
Q 040050          154 ---YRLLVYEYMPRGSLHNQLFR-SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD--SDY--TAKL  225 (401)
Q Consensus       154 ---~~~lv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~--~~~--~vkL  225 (401)
                         ...+|||||.||+|...+.+ .+..++++.+.+.++..++.||.|||.  .|||||||||.||++-  .+|  ..||
T Consensus        88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE--n~IvHRDlKP~NIvl~~Gedgq~IyKL  165 (732)
T KOG4250|consen   88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE--NGIVHRDLKPGNIVLQIGEDGQSIYKL  165 (732)
T ss_pred             ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH--cCceeccCCCCcEEEeecCCCceEEee
Confidence               45799999999999999976 345689999999999999999999995  4599999999999983  333  4799


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||+|+....+.   .+....||+.|.+||+.. .+.|+..+|.|||||++|+..||..||..........-..|.. .
T Consensus       166 tDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~  241 (732)
T KOG4250|consen  166 TDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-I  241 (732)
T ss_pred             ecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-h
Confidence            9999999876654   567889999999999998 4899999999999999999999999997664432211111110 0


Q ss_pred             hcCccchhhhcCCcC------------CCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhh
Q 040050          305 LKEPRKLERLIDPRL------------EGQFPIKGAQKAAATAFKCLSHHPRHRP--TMSYVVRVLDSL  359 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~~il~~L~~l  359 (401)
                      ...+....-......            .-.........+...+..+|..+|++|-  ...+....+..+
T Consensus       242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            011111111111110            1112233445566777789999999998  655555555555

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.4e-37  Score=295.47  Aligned_cols=263  Identities=22%  Similarity=0.281  Sum_probs=194.2

Q ss_pred             ceeccc--CCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEG--GFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G--~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      ..||+|  +||+||+|.+..      +++.||+|++....  ....+.+.+|+.+++.++||||++++++|..+...++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            346666  899999998866      68899999987543  22346678899999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+.+++|.+++.+.....+++..+..++.|++.||+|||+  .+|+||||||+||+++.++.++++||+.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~--~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ--NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh--CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            999999999999887655678999999999999999999995  559999999999999999999999998654221111


Q ss_pred             cce--e---eeccccccccccccccccC--CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc---
Q 040050          239 ETH--V---ITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---  308 (401)
Q Consensus       239 ~~~--~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  308 (401)
                      ...  .   .....++..|+|||++.+.  .++.++|||||||++|+|++|..||......  .............+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccc
Confidence            000  0   0112356679999999763  5789999999999999999999999754211  00111000000000   


Q ss_pred             ----------------------------cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 ----------------------------RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ----------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                                  ..........+....+...+..+.+|+.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                                        00000001111122234467789999999999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.2e-38  Score=298.12  Aligned_cols=267  Identities=31%  Similarity=0.392  Sum_probs=198.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      +.++|++.+.||+|+||.||+|.+..      +++.+|+|.+...  .......+.+|+.+++++ +||||+++++++..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~   78 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRR------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA   78 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcC------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc
Confidence            45789999999999999999998765      5788999987532  223345677899999999 99999999999865


Q ss_pred             C--CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          152 E--EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       152 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      .  ...++||||+. ++|..++...   .+++..++.++.|++.||+|||+  .+|+|+||||+||+++.++.++|+|||
T Consensus        79 ~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~--~~i~H~dl~p~nill~~~~~~kl~d~g  152 (337)
T cd07852          79 ENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFG  152 (337)
T ss_pred             CCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEEeecc
Confidence            4  36899999996 6998887653   78888999999999999999995  559999999999999999999999999


Q ss_pred             CCCCCCCCCcc---eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          230 LAKDGPEGEET---HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       230 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      ++.........   .......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.||........  .........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~  230 (337)
T cd07852         153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIG  230 (337)
T ss_pred             chhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhC
Confidence            99865443221   22334568999999998765 5678899999999999999999999965432111  000000000


Q ss_pred             cC------------cc-chhhhcCCcC--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KE------------PR-KLERLIDPRL--EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~------------~~-~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..            .. .+..+.....  ........+..+.+++.+||+.||.+|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00            00 0000000000  000111246789999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.5e-38  Score=292.40  Aligned_cols=246  Identities=24%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ...||+|+||.||+|....      +++.||+|.+..........+.+|+.+++.++|+||+++++.+...+..+++|||
T Consensus        25 ~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcC------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            3679999999999998876      5889999998755545556788999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +++++|.+++..   ..+++..+..++.|++.||+|||+.  |++|+||+|+||+++.++.++|+|||++........  
T Consensus        99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~--givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--  171 (292)
T cd06657          99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ--GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--  171 (292)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCCEEEcccccceecccccc--
Confidence            999999887743   4688999999999999999999954  599999999999999999999999998875433221  


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG  321 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (401)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......   ........          .....+. 
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~----------~~~~~~~-  237 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD----------NLPPKLK-  237 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----------hCCcccC-
Confidence            123356889999999998888899999999999999999999998753211   00111100          0001110 


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          322 QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       322 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       .....+..+.+++.+||+.+|.+||++.++++.
T Consensus       238 -~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         238 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             -CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence             111235678899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=293.22  Aligned_cols=244  Identities=28%  Similarity=0.393  Sum_probs=204.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccC-CCceeeEEEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCW  150 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~  150 (401)
                      -..+|.++.+||+|+||.|.+|..+.      +.+.+|||+++.+-   ..+.+--+.|-.+|.... -|.++.++.+|.
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkg------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ  420 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKG------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ  420 (683)
T ss_pred             eecccceEEEeccCccceeeeecccC------cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence            34688999999999999999996554      68899999997552   233334456778887664 679999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      .-+.+|+||||+.||+|.-.|++.  +.+.+..+..++..|+-||-+||  .+|||+||||.+|||++.+|++||+|||+
T Consensus       421 TmDRLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh--~kgIiYRDLKLDNvmLd~eGHiKi~DFGm  496 (683)
T KOG0696|consen  421 TMDRLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLH--SKGIIYRDLKLDNVMLDSEGHIKIADFGM  496 (683)
T ss_pred             hhhheeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhh--cCCeeeeeccccceEeccCCceEeeeccc
Confidence            999999999999999999888775  78889999999999999999999  56699999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +.....+..+  ..+++|||.|+|||++...+|+.++|+||+|++||||+.|++||++....                .-
T Consensus       497 cKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------el  558 (683)
T KOG0696|consen  497 CKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------EL  558 (683)
T ss_pred             ccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HH
Confidence            9875554433  46789999999999999999999999999999999999999999886321                11


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT  348 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  348 (401)
                      ...+.+...  .+|...+.+..++....|..+|.+|..
T Consensus       559 F~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  559 FQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccC
Confidence            122222222  467778899999999999999999964

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.3e-38  Score=288.77  Aligned_cols=244  Identities=26%  Similarity=0.366  Sum_probs=194.9

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ||.|+||.||+|.+..      +++.+++|.+.....   .....+.+|++++++++||||+++++.+......|++|||
T Consensus         1 lg~g~~~~vy~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKS------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECC------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            6899999999998876      578999999865432   3456788899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCc--
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE--  239 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~--  239 (401)
                      +.+++|.+++.+.  ..+++..++.++.|++.||+|||.  .+++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~--~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHS--NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            9999999998765  478999999999999999999995  5599999999999999999999999999875443321  


Q ss_pred             ----ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          240 ----THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       240 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                          ........++..|+|||.+.+..++.++|+||||+++|+|++|..||......      ........         
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~---------  215 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN---------  215 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc---------
Confidence                11223356888999999998888999999999999999999999999654211      11111100         


Q ss_pred             CCcCCCCCCHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          316 DPRLEGQFPIK--GAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       316 ~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                       ...  ..+..  .+..+.+++.+||+.+|.+|||+..+.+.|
T Consensus       216 -~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         216 -GKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             -CCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence             000  11111  267889999999999999999995554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.6e-37  Score=331.12  Aligned_cols=269  Identities=32%  Similarity=0.509  Sum_probs=211.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +...|...++||+|+||.||+|.+..      .+..||+|.+.....    ....|++++++++||||+++++++.+...
T Consensus       688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        688 ILSSLKEENVISRGKKGASYKGKSIK------NGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             HHhhCCcccEEccCCCeeEEEEEECC------CCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence            34567788899999999999998765      578999999864322    12346889999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC-CCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE-DKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .++||||+++|+|.+++.     .+++..+..++.|++.||+|||.. .++|+||||||+||+++.++..++. ||....
T Consensus       758 ~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~  831 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL  831 (968)
T ss_pred             CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccc
Confidence            999999999999999984     378999999999999999999954 4569999999999999998888775 665543


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....      ....|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........|.+..... .....
T Consensus       832 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~-~~~~~  903 (968)
T PLN00113        832 LCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSD-CHLDM  903 (968)
T ss_pred             cccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCc-cchhh
Confidence            2111      22368899999999999999999999999999999999999995432 2234455555543322 22333


Q ss_pred             hcCCcCCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCCC
Q 040050          314 LIDPRLEGQ--FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV  367 (401)
Q Consensus       314 ~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~~  367 (401)
                      .+++.+...  .+.....++.+++.+||+.||++||++.++++.|+++.....+..
T Consensus       904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~~~  959 (968)
T PLN00113        904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSSCV  959 (968)
T ss_pred             eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccccc
Confidence            444444332  334556678899999999999999999999999999876555443

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.5e-37  Score=283.40  Aligned_cols=247  Identities=22%  Similarity=0.227  Sum_probs=192.1

Q ss_pred             HHHhcCCCCCcee--cccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 040050           73 RLITSNFSRSNLL--GEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYC  149 (401)
Q Consensus        73 ~~~~~~y~~~~~L--g~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~  149 (401)
                      ....++|.+.+.+  |.|+||.||++....      ++..+|+|.+........     |+.....+ +||||+++++.+
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKP------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcC------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE
Confidence            3344677777776  999999999998776      578899999864321111     22222222 699999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEec
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDF  228 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~Df  228 (401)
                      ...+..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.  +++||||||+||+++.++ .++|+||
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH--NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            9999999999999999999998765  4899999999999999999999954  499999999999999988 9999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |++......      ....|+..|+|||++.+..++.++|+||||+++|+|++|..||...... ......+....    
T Consensus       155 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~----  223 (267)
T PHA03390        155 GLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ----  223 (267)
T ss_pred             ccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh----
Confidence            998764322      2346899999999999989999999999999999999999999743221 11111111111    


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-MSYVVR  354 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~~il~  354 (401)
                             ..  ....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus       224 -------~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 -------QK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -------cc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                   00  01122245778999999999999999996 588874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.2e-38  Score=300.55  Aligned_cols=267  Identities=21%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      ..+|++.+.||.|+||.||+|.+..      ++..||+|++....  ......+.+|+.+++.++||||+++++++..  
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   77 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTR------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG   77 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcC------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence            4789999999999999999998876      58899999987542  2345667889999999999999999998763  


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                        ....++||||+ +++|.+++...  ..+++..+..++.|++.||.|||+  .+|+||||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~--~~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          78 ADFKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             CCCceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHEEEcCCCcEEecccc
Confidence              34689999999 46898888654  569999999999999999999995  459999999999999999999999999


Q ss_pred             CCCCCCCCCc--ceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          230 LAKDGPEGEE--THVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       230 ~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ++........  ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||........  +.........
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~--~~~~~~~~g~  230 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ--LKLILSVLGS  230 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH--HHHHHHHhCC
Confidence            9875433221  111234578999999998865 5689999999999999999999999965432111  0000000000


Q ss_pred             Ccc---------chhhhcCC-cCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPR---------KLERLIDP-RLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~---------~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+.         ........ ......     ....+..+.+++.+||+.+|.+||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            000         00000000 000001     12346789999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=290.93  Aligned_cols=267  Identities=22%  Similarity=0.286  Sum_probs=205.1

Q ss_pred             HHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-C-C----ceee
Q 040050           71 ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-H-P----HLVK  144 (401)
Q Consensus        71 ~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p----nI~~  144 (401)
                      ....+..+|.+...||+|+||.|..+.+..      ++..||||+++... ...+..+-|+++|.++. + |    -++.
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRE------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecC------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            344568999999999999999999998877      47899999997442 23456677999999994 2 2    3788


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc------
Q 040050          145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD------  218 (401)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~------  218 (401)
                      +.++|.-.++.|||+|.+ |.++++++..++-.+++...+..++.|+++++++||+++  ++|.||||+|||+.      
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEE
Confidence            889999999999999998 789999998887788999999999999999999999655  99999999999993      


Q ss_pred             --------------CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCC
Q 040050          219 --------------SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR  284 (401)
Q Consensus       219 --------------~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  284 (401)
                                    .+..|+|+|||.|+......     +..+.|..|+|||++.+..++..+||||+||||+|+.+|..
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                          13458999999998755443     34567899999999999999999999999999999999999


Q ss_pred             CCCCCcccccccHHHHhhhhhc-Cccch--------------------------hhhcCCcCCC----CCCHHHHHHHHH
Q 040050          285 AMDNTRLGREQSLAEWARPLLK-EPRKL--------------------------ERLIDPRLEG----QFPIKGAQKAAA  333 (401)
Q Consensus       285 pf~~~~~~~~~~~~~~~~~~~~-~~~~~--------------------------~~~~~~~~~~----~~~~~~~~~l~~  333 (401)
                      .|........  + ..+..++. .|..+                          ....++....    .........+.+
T Consensus       308 LFqtHen~EH--L-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD  384 (415)
T KOG0671|consen  308 LFQTHENLEH--L-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD  384 (415)
T ss_pred             ecccCCcHHH--H-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence            9876541110  0 11111111 01000                          0011100000    011234557999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHH
Q 040050          334 TAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       334 li~~cl~~dP~~RPt~~~il~~  355 (401)
                      |+.+||..||.+|+|+.|++..
T Consensus       385 Ll~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  385 LLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHHccCccccccHHHHhcC
Confidence            9999999999999999999753

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=285.26  Aligned_cols=243  Identities=25%  Similarity=0.307  Sum_probs=188.4

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHH-HhccCCCceeeEEEEEEeCCeEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIF-LGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +.||.|+||.||+|.+..      +++.||+|.+.....   .....+..|..+ ....+||||+++++++...+..++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecC------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            579999999999998766      578999999864321   122234445444 4455899999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|.+++...  ..+++..+..++.|++.||.|||+.  +++|+||+|.||+++.++.++|+|||++.....  
T Consensus        76 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          76 MEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR--GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            9999999999998654  5789999999999999999999965  599999999999999999999999999875432  


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                          .....|+..|+|||.+.+..++.++||||||+++|+|++|..||......      .........        ...
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~--------~~~  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSR--------RIN  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhc--------ccC
Confidence                12346889999999998888999999999999999999999999654211      111111000        000


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........++..+.+++.+||+.+|++||++..+.+.
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence            1111122346789999999999999999977655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.2e-39  Score=282.54  Aligned_cols=274  Identities=24%  Similarity=0.318  Sum_probs=200.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe-CC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE-EE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~-~~  153 (401)
                      ..|++...||+|++|.||+|...+..  ....+.+|||++.-.  .........+|+.+++.++||||+.+..+|.. +.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n--~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTN--DKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCC--cccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            57999999999999999999655421  112457999998754  23334678899999999999999999999887 77


Q ss_pred             eEEEEEEecCCCChhHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC----CcEEEE
Q 040050          154 YRLLVYEYMPRGSLHNQLFRS---YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD----YTAKLS  226 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~----~~vkL~  226 (401)
                      .+++++||.+. +|+..|...   ..+.++...+..|+.||+.|+.|||++-  |+||||||.||||..+    |+|||+
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEee
Confidence            89999999964 888888542   2357899999999999999999999877  9999999999999776    999999


Q ss_pred             ecCCCCCCCCCCcc-eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc----HH--
Q 040050          227 DFGLAKDGPEGEET-HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS----LA--  298 (401)
Q Consensus       227 DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~--  298 (401)
                      |||+++.+...-.. ......+-|.+|+|||.+.| ..|+.+.|||++|||+.||+|..+.|.+........    ..  
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999976553222 12344567999999999987 579999999999999999999999987643221110    00  


Q ss_pred             HHhhhhhcCcc-----chhhh------c-CCcCCCCCCH----------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          299 EWARPLLKEPR-----KLERL------I-DPRLEGQFPI----------KGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       299 ~~~~~~~~~~~-----~~~~~------~-~~~~~~~~~~----------~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +-+..++..|.     .+.++      + +.......+.          .-++...+|+.+||..||.+|.|+++.++.
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            11111111110     00000      0 0000000010          012347789999999999999999998765

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.7e-37  Score=286.54  Aligned_cols=242  Identities=24%  Similarity=0.341  Sum_probs=188.1

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHH---HHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEI---IFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      .||+|+||.||+|.+..      +++.||+|.+.....   .....+..|.   ..++...||+|+.+++++......++
T Consensus         1 ~ig~g~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEec------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            48999999999998766      578999999864321   1112233343   34555679999999999999999999


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      ||||+.|++|..++...  ..+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.++|+|||++......
T Consensus        75 v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~--~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            99999999999888654  6799999999999999999999954  5999999999999999999999999998755332


Q ss_pred             Ccceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      .    .....|+..|+|||++.+ ..++.++||||+|+++|+|++|..||.............              .. 
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~--------------~~-  211 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--------------MT-  211 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH--------------Hh-
Confidence            1    123468999999999875 468999999999999999999999997642211100000              00 


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVR  354 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~  354 (401)
                      .......+...+..+.+++.+||..+|.+||     ++.++++
T Consensus       212 ~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            0011122333467899999999999999999     9999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-38  Score=323.06  Aligned_cols=252  Identities=29%  Similarity=0.421  Sum_probs=190.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEe---
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE---  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~---  151 (401)
                      ..+|+.+++||+||||.||+++++-      .|+.||||++.... ......+.+|+..|.+|+|||||+++..+.+   
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKl------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~  551 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKL------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA  551 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecc------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence            3578888999999999999997765      79999999998764 3345678899999999999999998764320   


Q ss_pred             --------------------------------------------------------------------------------
Q 040050          152 --------------------------------------------------------------------------------  151 (401)
Q Consensus       152 --------------------------------------------------------------------------------  151 (401)
                                                                                                      
T Consensus       552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S  631 (1351)
T KOG1035|consen  552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS  631 (1351)
T ss_pred             ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence                                                                                            


Q ss_pred             ----------------------------C--------CeEEEEEEecCCCChhHHHhhhcCCCC-CHHHHHHHHHHHHHH
Q 040050          152 ----------------------------E--------EYRLLVYEYMPRGSLHNQLFRSYSAAL-PWSTRMKIALGAAKG  194 (401)
Q Consensus       152 ----------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~l-~~~~~~~i~~qi~~a  194 (401)
                                                  +        ..+||-||||+..+|.+++.++  ... ....+++++++|++|
T Consensus       632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILEG  709 (1351)
T ss_pred             cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHHH
Confidence                                        0        2358999999887776666554  222 467889999999999


Q ss_pred             HHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC----------------CCCcceeeecccccccccccccc
Q 040050          195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP----------------EGEETHVITRVMGTQGYAAPEYV  258 (401)
Q Consensus       195 l~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~  258 (401)
                      |+|+|+  .|||||||||.||+++.++.|||+|||+|....                .+......+..+||.-|+|||++
T Consensus       710 LaYIH~--~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  710 LAYIHD--QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHHHh--CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            999995  559999999999999999999999999998611                11112234567899999999999


Q ss_pred             ccC---CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCC--CCCCHHHHHHHHH
Q 040050          259 MTG---HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE--GQFPIKGAQKAAA  333 (401)
Q Consensus       259 ~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~  333 (401)
                      .+.   .|+.|+|+||||++++||+.   ||.....  ..             ..+..+.+..+.  ..+.......-+.
T Consensus       788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra-------------~iL~~LR~g~iP~~~~f~~~~~~~e~s  849 (1351)
T KOG1035|consen  788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RA-------------SILTNLRKGSIPEPADFFDPEHPEEAS  849 (1351)
T ss_pred             cccccccccchhhhHHHHHHHHHHhc---cCCchHH--HH-------------HHHHhcccCCCCCCcccccccchHHHH
Confidence            864   59999999999999999986   4654321  01             111111111111  1223333456678


Q ss_pred             HHHHhcccCCCCCCCHHHHHHH
Q 040050          334 TAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       334 li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +|.+|++.||.+||||.++|..
T Consensus       850 lI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  850 LIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHhcCCCccCCCHHHHhhc
Confidence            9999999999999999999753

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.1e-37  Score=289.63  Aligned_cols=245  Identities=29%  Similarity=0.416  Sum_probs=193.8

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      |...+.||+|+||+||+|++..      +++.|++|.+.....   .....+.+|+.+++.++|||++++++++.+....
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            6667889999999999998765      578999999865422   2335678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      |+||||+. ++|.+++... ...+++..++.++.|++.||.|||+  .+|+|+||+|+||+++.++.++|+|||++....
T Consensus        97 ~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~--~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            99999995 6787777543 3578999999999999999999995  459999999999999999999999999986432


Q ss_pred             CCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .      .....|+..|+|||++.   +..++.++|||||||++|+|++|..||.......   ..   ......     
T Consensus       173 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~---~~---~~~~~~-----  235 (313)
T cd06633         173 P------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---AL---YHIAQN-----  235 (313)
T ss_pred             C------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH---HH---HHHHhc-----
Confidence            2      12356889999999984   4568889999999999999999999986542110   00   000000     


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           ..........+..+.+++.+||+.+|.+||++.+++..
T Consensus       236 -----~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         236 -----DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00001112234578999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=287.60  Aligned_cols=261  Identities=26%  Similarity=0.347  Sum_probs=200.4

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      |.+.+.||.|++|.||+|.+..      +++.+++|.+.....  .....+.+|+.+++.++|+||+++++++..+...+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            6678899999999999998765      578999999875432  23567888999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+. ++|.+++.... ..+++..+..++.|++.||.|||..  +|+|+||+|+||+++.++.++|+|||.+.....
T Consensus        75 ~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH--GILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC--CeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            9999996 58888876642 5789999999999999999999954  599999999999999999999999999876544


Q ss_pred             CCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc--cchhh
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP--RKLER  313 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~  313 (401)
                      ..  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........  +... ......+  .....
T Consensus       151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~  225 (283)
T cd05118         151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKI-FRTLGTPDPEVWPK  225 (283)
T ss_pred             Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HHHcCCCchHhccc
Confidence            32  122335688899999998876 789999999999999999999999965432111  0000 0000000  00000


Q ss_pred             hcC---------Cc----CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          314 LID---------PR----LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       314 ~~~---------~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ...         +.    .........+..+.+++.+||+.||.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            000         00    001112345788999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=5.5e-38  Score=290.73  Aligned_cols=250  Identities=28%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccC-CCceeeEEEEEEeC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEE  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~  152 (401)
                      ++|.+.+.||.|+||.||+|....      +++.||+|++....   ......+.+|+.+++++. ||||+++++++...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            368899999999999999998876      58899999986432   223456788999999998 99999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..++|||++.+++|.+++.+.  ..+++..++.++.|++.||.|||+  .+++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~--~~~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH--CCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence            9999999999999999999765  579999999999999999999995  459999999999999999999999999987


Q ss_pred             CCCCCCcc------------------eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc
Q 040050          233 DGPEGEET------------------HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE  294 (401)
Q Consensus       233 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  294 (401)
                      ........                  .......|+..|+|||++.+..++.++|+||||++++++++|..||......  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--  228 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--  228 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--
Confidence            65432210                  1123356789999999998888999999999999999999999999754210  


Q ss_pred             ccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 040050          295 QSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM----SYVVR  354 (401)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~~il~  354 (401)
                      ..+              ....  .....++...+..+.+++.+||+.+|.+||++    .++++
T Consensus       229 ~~~--------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         229 LTF--------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH--------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            000              0011  01112333446789999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-37  Score=291.17  Aligned_cols=252  Identities=29%  Similarity=0.393  Sum_probs=197.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..|...+.||.|+||.||+|++..      ++..+|+|.+....   ......+.+|+.+++.++|+|++++++++....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcC------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            447777899999999999998876      57889999986432   223456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+. ++|.+.+... ...+++..+..++.|++.||.|||+  .+++|+||+|.||+++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHhEEECCCCcEEECCccccee
Confidence            9999999995 6887776543 3568999999999999999999995  4599999999999999999999999999875


Q ss_pred             CCCCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....      ....|+..|+|||++.   ...++.++|||||||++|+|++|..||......  .....+.         
T Consensus       165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~---------  227 (308)
T cd06634         165 MAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIA---------  227 (308)
T ss_pred             ecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHh---------
Confidence            4332      2346889999999975   356788999999999999999999998653211  0000000         


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                           ............+..+.+++.+||+.+|.+||++.++++.-.-+.
T Consensus       228 -----~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         228 -----QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             -----hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                 000001112234677899999999999999999999987744433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-38  Score=256.89  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=204.7

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      +|.-.+.||+|++|+||+|++.+      +++.||+|.++.+..  ......++|+-+|+.++|.||++++++...++.+
T Consensus         3 ~ydkmekigegtygtvfkarn~~------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkl   76 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL   76 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence            45667889999999999998877      789999999987643  3467889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      -+|+||| ..+|..+... -++.++...+..++.|+++||.++|+++  +.|||+||+|.+|+.+|.+||+|||+++.+.
T Consensus        77 tlvfe~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   77 TLVFEFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             EEeHHHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            9999999 5688777654 3578999999999999999999999776  9999999999999999999999999999764


Q ss_pred             CCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhc----Ccc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLK----EPR  309 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~----~~~  309 (401)
                      -.  ...++..+-|..|++|.++.| +-|+...|+||.||++.|+.. |.+.|.+....+  .+..+.+.+-.    .-.
T Consensus       153 ip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~lg~p~ed~wp  228 (292)
T KOG0662|consen  153 IP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEDQWP  228 (292)
T ss_pred             Cc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHhCCCccccCC
Confidence            32  334566678999999999987 458999999999999999987 556666543222  22222221111    111


Q ss_pred             chhhhcCCcCCCCCC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          310 KLERLIDPRLEGQFP---------IKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .+.++.+-...+.+|         +.....-++++.+.|.-+|..|.++++.++
T Consensus       229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            222222222222222         223345678899999999999999998864

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.1e-37  Score=290.28  Aligned_cols=263  Identities=21%  Similarity=0.232  Sum_probs=193.3

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +++.+|.|  |.||.+....      +++.||+|++...  .......+.+|+.+++.++||||+++++++...+..+++
T Consensus         6 i~~~~~~~--~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   77 (314)
T cd08216           6 IGKCFEDL--MIVHLAKHKP------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV   77 (314)
T ss_pred             hhHhhcCC--ceEEEEEecC------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEE
Confidence            33444444  4455554444      5789999998755  234456788999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|.+++.......+++..+..++.|++.||.|||++  +|+||||||+||+++.++.++|+|||.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~--~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK--GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            9999999999999876556789999999999999999999954  59999999999999999999999999886543221


Q ss_pred             c-----ceeeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh----c-
Q 040050          239 E-----THVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL----K-  306 (401)
Q Consensus       239 ~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----~-  306 (401)
                      .     ........++..|+|||++.+  ..++.++|+|||||++|+|++|..||.......  ...+......    . 
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~  233 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCcccccc
Confidence            1     111123457788999999875  458899999999999999999999997542111  1111100000    0 


Q ss_pred             -----Cccchhh----h----cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 -----EPRKLER----L----IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 -----~~~~~~~----~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           ....+..    .    .............+.++.+++.+||..||++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                 0000000    0    00011112234456789999999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-37  Score=284.37  Aligned_cols=261  Identities=26%  Similarity=0.344  Sum_probs=196.1

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--cHHHHHHHHHHHhcc---CCCceeeEEEEEEeCC
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEIIFLGQL---RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnI~~~~~~~~~~~  153 (401)
                      |++.+.||.|+||.||+|.+..      ++..||+|.+......  ....+.+|+.+++++   .||||+++++++....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            6778999999999999999875      5789999999754322  234566777776655   5999999999998877


Q ss_pred             e-----EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          154 Y-----RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       154 ~-----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                      .     .+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.  +++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~--~i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH--RIVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeccCChhhEEEccCCCEEEecc
Confidence            6     899999995 5898888765445689999999999999999999954  5999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |++........   .....++..|+|||++.+..++.++|+|||||++|+|++|.+||......  ..+..+..... .+
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~-~~  225 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIG-LP  225 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcC-CC
Confidence            99876543321   12335788999999999999999999999999999999999998754321  11111111000 00


Q ss_pred             cch---------hhhcCCcCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 RKL---------ERLIDPRLE---GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ~~~---------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ...         .........   .......+..+.+++.+||+.||.+||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000         000000000   1112244678899999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=294.02  Aligned_cols=265  Identities=24%  Similarity=0.318  Sum_probs=197.2

Q ss_pred             hcCCC-CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc--------------HHHHHHHHHHHhccCCC
Q 040050           76 TSNFS-RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--------------HKEWMAEIIFLGQLRHP  140 (401)
Q Consensus        76 ~~~y~-~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hp  140 (401)
                      .++|. +.+.||.|+||+||+|.+..      .++.||+|.+.......              ...+.+|+.+++.++||
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   80 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTL------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHE   80 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECC------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCc
Confidence            46676 45789999999999998765      57899999986432211              12467899999999999


Q ss_pred             ceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       141 nI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      ||+++++++......+++|||+. ++|.+++...  ..+++..+..++.|++.||.|||+  .+|+|+||+|+||+++.+
T Consensus        81 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~--~~i~H~dl~~~nill~~~  155 (335)
T PTZ00024         81 NIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK--WYFMHRDLSPANIFINSK  155 (335)
T ss_pred             ceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeecccccHHHeEECCC
Confidence            99999999999999999999995 6898888654  578999999999999999999995  559999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCC------------cceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCC
Q 040050          221 YTAKLSDFGLAKDGPEGE------------ETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMD  287 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~  287 (401)
                      +.++|+|||++.......            .........+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            999999999987654111            01112234568899999998764 46899999999999999999999997


Q ss_pred             CCcccccccHHHHhhhhhcCccc--hhhh------------cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040050          288 NTRLGREQSLAEWARPLLKEPRK--LERL------------IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV  353 (401)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il  353 (401)
                      ......  .+.. .......+..  +...            ...... ......+..+.+++.+||+.+|++||++.+++
T Consensus       236 ~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l  311 (335)
T PTZ00024        236 GENEID--QLGR-IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEAL  311 (335)
T ss_pred             CCCHHH--HHHH-HHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence            653211  1111 1001110000  0000            000000 01122356788999999999999999999998


Q ss_pred             HH
Q 040050          354 RV  355 (401)
Q Consensus       354 ~~  355 (401)
                      ..
T Consensus       312 ~~  313 (335)
T PTZ00024        312 KH  313 (335)
T ss_pred             cC
Confidence            63

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=284.91  Aligned_cols=263  Identities=26%  Similarity=0.351  Sum_probs=198.7

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--Ce
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--EY  154 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--~~  154 (401)
                      |.+.+.||.|++|.||+|.+..      +++.+|+|.+....  ......+.+|+.+++.++|||++++++++...  ..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            6778999999999999998876      57899999998653  33345688899999999999999999999988  78


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||++ ++|.+++... ...+++..++.++.|++.||+|||+  .+++|+||+|.||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~--~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             EEEEecccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHH--CCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            999999996 5888887653 2578999999999999999999995  45999999999999999999999999999865


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc--cch
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP--RKL  311 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~  311 (401)
                      ..... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......  .+... ......+  ...
T Consensus       151 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~-~~~~~~~~~~~~  226 (287)
T cd07840         151 TKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKI-FELCGSPTDENW  226 (287)
T ss_pred             cCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH-HHHhCCCchhhc
Confidence            44321 11233457889999998765 467899999999999999999999997643211  11110 0000000  000


Q ss_pred             hhh--------cC------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERL--------ID------PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~--------~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...        ..      ..+...+...++..+.+++.+||+.+|.+||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000        00      000000111126688999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-37  Score=294.17  Aligned_cols=270  Identities=26%  Similarity=0.347  Sum_probs=204.8

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE--  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~--  153 (401)
                      +|.+.+.||.|++|.||+|.+..      +++.||+|.+....  ......+.+|+.+++.++||||+++++++....  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            58899999999999999998765      57899999987543  334567889999999999999999999988775  


Q ss_pred             ---eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          154 ---YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       154 ---~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                         .+|++|+|+. ++|.+++...  ..+++..++.++.|++.||.|||+.  ||+|+||||.||+++.++.++|+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~--gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA--NVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence               7899999996 5888888654  4899999999999999999999954  599999999999999999999999999


Q ss_pred             CCCCCCCCc-ceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          231 AKDGPEGEE-THVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       231 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      +........ ........++..|+|||++.+. .++.++|+||||+++|+|++|.+||........  +... ......+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i-~~~~~~~  226 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLI-VEVLGTP  226 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHH-HHhcCCC
Confidence            986544321 0112345688999999999887 889999999999999999999999976532110  0000 0000000


Q ss_pred             ----------cchhhhcC-CcCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 040050          309 ----------RKLERLID-PRLE-----GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV--LDSLQD  361 (401)
Q Consensus       309 ----------~~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~--L~~l~~  361 (401)
                                ......+. ....     .......+..+.+++.+||+.+|.+||++.+++..  +..++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                      00000000 0000     00112246788999999999999999999999874  555443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.2e-37  Score=289.23  Aligned_cols=268  Identities=27%  Similarity=0.288  Sum_probs=198.6

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ...++|++.+.||.|+||.||+|.+..      +++.||+|.+....  ......+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~   77 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTD   77 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence            345789999999999999999999876      57899999987543  2233567789999999999999999999876


Q ss_pred             CC----------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          152 EE----------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       152 ~~----------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      ..          .+++||||+++ ++...+... ...+++..++.++.|++.||+|||+.  +|+|+||+|.||+++.++
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~i~H~dl~p~nili~~~~  153 (302)
T cd07864          78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK--NFLHRDIKCSNILLNNKG  153 (302)
T ss_pred             cchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCC
Confidence            54          78999999965 777777543 35789999999999999999999954  599999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      .+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|+|++|++||......  ..+...
T Consensus       154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~  230 (302)
T cd07864         154 QIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELI  230 (302)
T ss_pred             cEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHH
Confidence            999999999986543321 11222346788999998865 45788999999999999999999999753211  111111


Q ss_pred             hhhhhcC-ccchhhhc--------------CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 ARPLLKE-PRKLERLI--------------DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 ~~~~~~~-~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ....... +.....+.              ....... ....+..+.+++.+||+.+|.+||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000000 00000000              0000000 11235688999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.8e-37  Score=293.82  Aligned_cols=267  Identities=24%  Similarity=0.284  Sum_probs=193.7

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC--
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE--  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~--  152 (401)
                      +|.+.+.||+|+||.||+|.+...    ..+..||+|.+...  .......+.+|+.+++++ +||||+++++.+...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET----SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC----CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            578889999999999999987651    12678999998643  222345678899999999 599999999875432  


Q ss_pred             --CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          153 --EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       153 --~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                        ...+++|+++ +++|.+++...  ..+++..++.++.||+.||.|||+  .+|+||||||+|||++.++.++|+|||+
T Consensus        77 ~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS--ANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence              4578999998 57898888653  678999999999999999999995  4599999999999999999999999999


Q ss_pred             CCCCCCCCcc--eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          231 AKDGPEGEET--HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       231 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +.........  .......|++.|+|||++.+ ..++.++||||||+++|+|++|.+||.......  .+..........
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~  229 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQVLGTP  229 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCC
Confidence            9765432211  11233568999999998765 568999999999999999999999997643110  010000000000


Q ss_pred             c-cchhhh-----------cCCcCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 P-RKLERL-----------IDPRLEG---QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ~-~~~~~~-----------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      + ..+..+           .......   ......+..+.+++.+||+.||.+|||+.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0 000000           0000000   0011125678999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-38  Score=295.62  Aligned_cols=245  Identities=26%  Similarity=0.309  Sum_probs=201.3

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e  160 (401)
                      ++||.|.||+||-|++++      +|+.||||++..-  ......++++|+.||..++||+||.+.-.|+..+.+++|||
T Consensus       570 evLGSGQFG~VYgg~hRk------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRK------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             hhccCCcceeeecceecc------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            899999999999999887      7999999998643  23345788899999999999999999999999999999999


Q ss_pred             ecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEEecCCCCCCCCC
Q 040050          161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~DfG~a~~~~~~  237 (401)
                      .+ .|++.+.|-....+.+++.....++.||+.||.|||  .++|+|+||||+|||+..   -..+||||||.|+...+.
T Consensus       644 Kl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk  720 (888)
T KOG4236|consen  644 KL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK  720 (888)
T ss_pred             hh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hcceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence            99 567778887777789999999999999999999999  566999999999999954   368999999999987664


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP  317 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (401)
                      ..   -...+|||.|+|||++.++.|+..-|+||+|+|+|.-+.|..||.....    ...++     ++..-   +..+
T Consensus       721 sF---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----IndQI-----QNAaF---MyPp  785 (888)
T KOG4236|consen  721 SF---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----INDQI-----QNAAF---MYPP  785 (888)
T ss_pred             hh---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hhHHh-----hcccc---ccCC
Confidence            42   2457899999999999999999999999999999999999999965321    11111     11000   0000


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          ..-..++....+||..+|+..-++|-+....+..
T Consensus       786 ----~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  786 ----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             ----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence                1112457789999999999999999998876643

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-37  Score=295.09  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYC  149 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~  149 (401)
                      +..+.++|.+.+.||+|+||.||+|.+..      ++..||+|.+....  ......+.+|+.+++.++||||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECC------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence            34567899999999999999999998776      57899999985432  22345678899999999999999999998


Q ss_pred             EeCC------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcE
Q 040050          150 WEEE------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       150 ~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                      ..+.      ..++||+|+ +++|.+++..   ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~--gi~H~dlkp~Nill~~~~~~  157 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA--GIIHRDLKPGNLAVNEDCEL  157 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCE
Confidence            7654      358999998 7899887754   5789999999999999999999954  59999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhh
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      +|+|||++......     .....+++.|+|||++.+ ..++.++|+||||+++|+|++|..||......  ..+.....
T Consensus       158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~  230 (343)
T cd07880         158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMK  230 (343)
T ss_pred             EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHH
Confidence            99999999865332     123467899999999876 45889999999999999999999999754311  01111100


Q ss_pred             hhhcCccchh---------hhcC--CcCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          303 PLLKEPRKLE---------RLID--PRLE----GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       303 ~~~~~~~~~~---------~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .....+..+.         ....  +...    .......+..+.+++.+||+.||++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000         0000  0000    0011233557889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=6.1e-37  Score=290.92  Aligned_cols=265  Identities=24%  Similarity=0.286  Sum_probs=198.8

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ..+.++|++.+.||.|+||.||+|.+..      ++..||+|.+....  ......+..|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   79 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQL------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI   79 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECC------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe
Confidence            4467899999999999999999998776      68899999875432  233466788999999999999999999987


Q ss_pred             e-CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          151 E-EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       151 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      . ....+++|||+ +++|..++..   ..++...+..++.|++.||.|||+.  +|+|+||+|.||+++.++.++|+|||
T Consensus        80 ~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~--~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          80 SPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA--GVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             cCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEeECCCCCEEeCccc
Confidence            6 55789999998 6788887753   4688888999999999999999954  59999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc-cHHHHh------
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-SLAEWA------  301 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~------  301 (401)
                      ++......     .....++..|+|||++.+ ..++.++|+||||+++|+|++|..||......... .+.+..      
T Consensus       154 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         154 LARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             cccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            98754321     123457889999998765 67899999999999999999999999654321100 000100      


Q ss_pred             --hhhhcCccchhhhcCCcCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          302 --RPLLKEPRKLERLIDPRLEGQFP-----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       302 --~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        .... .................+     ...+..+.+++.+||+.+|++||++.+++..
T Consensus       229 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         229 VINTIC-SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHhcc-chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              0000 000000000000111111     1235789999999999999999999998654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-37  Score=286.22  Aligned_cols=265  Identities=25%  Similarity=0.338  Sum_probs=197.7

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~  156 (401)
                      |.+.+.||.|++|+||+|+...      +++.|++|.+..... .......+|+..+++++ ||||+++++++..+...+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            6778999999999999998876      478899999864422 22334567999999999 999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+ +++|.+++.......+++..++.++.|++.+|.|||++  +++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~--~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH--GFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            999999 88999988776445789999999999999999999954  599999999999999999999999999976543


Q ss_pred             CCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc-cHHHHhhhhhc----Cccc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-SLAEWARPLLK----EPRK  310 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~----~~~~  310 (401)
                      ...   .....|+..|+|||++. +..++.++|+||||+++|+|++|++||......... ....+......    ....
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            221   23346888999999885 456789999999999999999999999654321110 00000000000    0000


Q ss_pred             hhhhcCCcCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLE-------GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +.........       .......+..+.+++.+||+.+|++||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000       00011124679999999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.7e-37  Score=286.95  Aligned_cols=259  Identities=28%  Similarity=0.338  Sum_probs=200.5

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      +|.+.+.||+|++|.||+|.....   ...+..||+|.+....    ......+.+|+.++.++ +||||+++++.+..+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~---~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGG---HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecc---ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            478889999999999999976432   1246789999986431    22345677899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+  .+++|+||+|.||+++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~--~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ--LGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH--CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999999998654  578999999999999999999995  559999999999999999999999999987


Q ss_pred             CCCCCCcceeeeccccccccccccccccCC--CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ........ ......|+..|+|||.+.+..  .+.++|+||||+++|+|++|..||......  .....+.......   
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~---  227 (288)
T cd05583         154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKS---  227 (288)
T ss_pred             cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHcc---
Confidence            65433211 112346899999999987654  788999999999999999999999643211  1111111111100   


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS  358 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~  358 (401)
                               ....+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       228 ---------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ---------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ---------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                     112233345678999999999999999998888766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-37  Score=294.13  Aligned_cols=268  Identities=23%  Similarity=0.287  Sum_probs=200.4

Q ss_pred             HHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEE
Q 040050           69 LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLI  146 (401)
Q Consensus        69 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~  146 (401)
                      ...+..+.++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.++++++||||++++
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~   82 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL   82 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcC------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence            44566778999999999999999999998765      57899999986432  22245677899999999999999999


Q ss_pred             EEEEeC------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          147 GYCWEE------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       147 ~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      +++...      ...|++++++ +++|.+++..   ..+++..++.++.|++.||+|||+.  +|+||||||+||+++.+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIll~~~  156 (345)
T cd07877          83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNED  156 (345)
T ss_pred             eeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChHHEEEcCC
Confidence            988643      3468888887 7899887754   4689999999999999999999954  59999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      +.++|+|||++......     .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......  .+..
T Consensus       157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~  229 (345)
T cd07877         157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKL  229 (345)
T ss_pred             CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence            99999999998764322     233468899999998876 568899999999999999999999996532211  1111


Q ss_pred             HhhhhhcCccchh---------hh---cCCcCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          300 WARPLLKEPRKLE---------RL---IDPRLEG---QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       300 ~~~~~~~~~~~~~---------~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........+..+.         ..   +......   ......+..+.+++.+||+.||.+||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            1000000000000         00   0000000   0001235678999999999999999999999876

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.6e-37  Score=284.80  Aligned_cols=256  Identities=28%  Similarity=0.337  Sum_probs=198.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      +|++.+.||.|+||.||+|......   .++..||+|++....    ......+.+|+.++..+ +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~---~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH---DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC---CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            4788899999999999999865321   157889999986432    22345677899999999 599999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+++++|.+++...  ..+++..+..++.|++.||.|||+  .+++||||+|+||+++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~--~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK--LGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999999998764  578899999999999999999995  459999999999999999999999999987


Q ss_pred             CCCCCCcceeeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ........ ......|+..|+|||.+.+  ..++.++||||||+++|+|++|..||.....  ......+.......   
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~---  227 (290)
T cd05613         154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKS---  227 (290)
T ss_pred             eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhcc---
Confidence            65432211 1223568999999999875  3467899999999999999999999864321  11111111111110   


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                               ...++...+..+.+++.+||+.||.+||     ++.++++.
T Consensus       228 ---------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 ---------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                     1122334567889999999999999997     66776553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.5e-37  Score=287.04  Aligned_cols=253  Identities=27%  Similarity=0.392  Sum_probs=194.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||.|+||.||+|.+..      +++.||+|.+.... ......+..|+.++.+.. ||||+++++++.....
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKK------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECC------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            678899999999999999998876      57899999987543 223445667777666665 9999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .|++|||+ +++|.+++... ...+++..+..++.|++.||+|||+. .+|+||||+|+||+++.++.++|+|||++...
T Consensus        89 ~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          89 VFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99999998 55777766543 35789999999999999999999952 35999999999999999999999999998765


Q ss_pred             CCCCcceeeeccccccccccccccccCC----CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGH----LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .....   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||...... ...+..    ...... 
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~----~~~~~~-  236 (296)
T cd06618         166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTK----ILQEEP-  236 (296)
T ss_pred             cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHH----HhcCCC-
Confidence            33221   12335788999999987553    788999999999999999999999653211 001111    110000 


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            +..  ......+.++.+++.+||+.||.+||++.+++++
T Consensus       237 ------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 ------PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ------CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  000  0011235678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.9e-37  Score=296.14  Aligned_cols=266  Identities=22%  Similarity=0.289  Sum_probs=196.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC---
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE---  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~---  152 (401)
                      .++|.+.+.||.|+||.||+|.+..      ++..||+|.+..........+.+|+++++.++||||+++++++...   
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSD------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECC------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence            4789999999999999999998876      6889999998766555667788999999999999999999776543   


Q ss_pred             -----------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-C
Q 040050          153 -----------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-D  220 (401)
Q Consensus       153 -----------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~  220 (401)
                                 ...|+||||+. ++|.+++..   ..+++..++.++.|++.||.|||+  .+|+||||||+||+++. +
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~--~givH~dikp~Nili~~~~  151 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHh--CCcccCCCCHHHEEEcCCC
Confidence                       35789999995 688887753   468999999999999999999995  45999999999999974 5


Q ss_pred             CcEEEEecCCCCCCCCCCcc-eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          221 YTAKLSDFGLAKDGPEGEET-HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                      +.++|+|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........  ..
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~  229 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQ  229 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH
Confidence            67899999998754322111 11122357889999998754 5678899999999999999999999965432111  00


Q ss_pred             HHhhhhhc-Cccc-------hhhhcC-CcCCCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          299 EWARPLLK-EPRK-------LERLID-PRLEGQ-----FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       299 ~~~~~~~~-~~~~-------~~~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........ .+..       +..... ......     .....+..+.+++.+||+.||.+||++.+++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000000 0000       000000 000000     011245678899999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-38  Score=276.85  Aligned_cols=266  Identities=24%  Similarity=0.359  Sum_probs=205.7

Q ss_pred             cHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEE
Q 040050           68 TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLI  146 (401)
Q Consensus        68 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~  146 (401)
                      .+.++..+++     +.||+|+++.|-.+....      ++..||||++.........+..+|++++...+ |+||+.++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLi  142 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQ------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLI  142 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeec------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHH
Confidence            3555555544     689999999999888776      78999999998765556678999999999996 99999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC---CcE
Q 040050          147 GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD---YTA  223 (401)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~---~~v  223 (401)
                      ++|.++..+|||||.|.||+|...|.+.  +.+++.++..+...|+.||.+||  .+||.||||||+|||-...   .-|
T Consensus       143 efFEdd~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH--~kgIAHRDlKPENiLC~~pn~vsPv  218 (463)
T KOG0607|consen  143 EFFEDDTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH--TKGIAHRDLKPENILCESPNKVSPV  218 (463)
T ss_pred             HHhcccceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh--hcCcccccCCccceeecCCCCcCce
Confidence            9999999999999999999999999876  78999999999999999999999  6779999999999999654   358


Q ss_pred             EEEecCCCCCCCCC-----Ccceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc
Q 040050          224 KLSDFGLAKDGPEG-----EETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR  293 (401)
Q Consensus       224 kL~DfG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  293 (401)
                      |||||.+..-....     ..+....+.+|+..|||||++.     ...|+.++|.||||+|+|-||.|.+||.+.-..+
T Consensus       219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d  298 (463)
T KOG0607|consen  219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD  298 (463)
T ss_pred             eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence            99999886432111     1222345578999999999874     3578999999999999999999999997643211


Q ss_pred             cccHHHHhhhhhcCcc-chhhhcCCcCCCC--CC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          294 EQSLAEWARPLLKEPR-KLERLIDPRLEGQ--FP----IKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~----~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                          .-|.+.  .... --..++.....+.  +|    ..++.+..+++..+|..|+.+|.++..++.
T Consensus       299 ----CGWdrG--e~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  299 ----CGWDRG--EVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ----CCccCC--CccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                000000  0000 0011111122222  22    356788999999999999999999988876

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.3e-37  Score=288.75  Aligned_cols=269  Identities=26%  Similarity=0.312  Sum_probs=194.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .++|.+.+.||.|+||.||+|.+..      +++.||+|.+.....  .....+.+|+++++.++||||+++++++....
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            3789999999999999999998776      578899998864422  22345678999999999999999999875433


Q ss_pred             --------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          154 --------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       154 --------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                              .+++||+|+. ++|...+... ...+++..+..++.|++.||.|||+.  +|+|+||||+||+++.++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~--~i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN--HILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCCCCEEE
Confidence                    4699999995 5777766543 35799999999999999999999954  5999999999999999999999


Q ss_pred             EecCCCCCCCCCCcc---------eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc
Q 040050          226 SDFGLAKDGPEGEET---------HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ  295 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  295 (401)
                      +|||++.........         ...+...|++.|+|||++.+ ..++.++|||||||++|+|++|.+||.........
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999754332211         11123457889999998865 45889999999999999999999999754321110


Q ss_pred             c-HHHHhhhhhc----CccchhhhcCCcCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          296 S-LAEWARPLLK----EPRKLERLIDPRLEGQFP-------IKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       296 ~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      . +.........    ....+............+       ......+.+++.+||+.||.+|||+.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0 0000000000    000000000000000011       112367889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5e-37  Score=281.64  Aligned_cols=250  Identities=22%  Similarity=0.312  Sum_probs=195.5

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-----CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-----GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +|.+.+.||+|+||.||++.+..      .+..+++|+++..     .......+..|+.+++.++||||+++++++.+.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            58889999999999999998765      2444555554421     122334567799999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      ...++||||+++++|.+++..  .....+++..++.++.|++.||.|||+  .+++|+||+|+||+++. +.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ--RRILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH--cCccccCCChhheEeec-CCEeecccCc
Confidence            999999999999999988864  234578999999999999999999995  55999999999999975 5799999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ........     
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~-----  218 (260)
T cd08222         152 SRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV-----  218 (260)
T ss_pred             eeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-----
Confidence            876533221  12345688999999999888889999999999999999999999864321      11111110     


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           . ......+...+..+.+++.+||..+|++||++.++++.
T Consensus       219 -----~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         219 -----E-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -----c-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                 0 11112344556789999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=285.40  Aligned_cols=272  Identities=27%  Similarity=0.397  Sum_probs=206.0

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhc--cCCCceeeEEEEEEeCC---
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ--LRHPHLVKLIGYCWEEE---  153 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnI~~~~~~~~~~~---  153 (401)
                      ..+..+||+|.||.||+|...        ++.||||++..   +..+.|.+|.+|.+.  ++|+||++++++-....   
T Consensus       212 l~l~eli~~Grfg~V~KaqL~--------~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD--------NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc--------CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            445688999999999999765        47999999874   345678888877665  47999999998866544   


Q ss_pred             -eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC-------CCCeeeccCCCCcEEEcCCCcEEE
Q 040050          154 -YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE-------DKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       154 -~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                       .++||++|.+.|+|.++|..   ..++|....+++..+++||+|||..       .++|+|||||.+||||..+++..|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence             78999999999999999987   4899999999999999999999942       457999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCC-CC-----ccccHHhHHHHHHHHHhCCCCCCCCccccc-ccHH
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH-LT-----TMSDVYSFGVVLLELLTGKRAMDNTRLGRE-QSLA  298 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~  298 (401)
                      +|||+|..+..+......-..+||.+|||||++.|.- +.     .+.||||+|.++|||++....+........ ..+.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            9999999887666555555588999999999997642 22     368999999999999998765532111111 1111


Q ss_pred             HHhhhhhcCccchhh-hcCCcCCCCCCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          299 EWARPLLKEPRKLER-LIDPRLEGQFPIK-----GAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                      .-++.-... +.++. .+..+.++.++..     ...-+.+.+..||+.||+.|.|+.=+.+.+.++..+...
T Consensus       438 ~evG~hPt~-e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  438 AEVGNHPTL-EEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             HHhcCCCCH-HHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            111110000 11111 1223333333322     245788899999999999999999999999999877753

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7e-37  Score=292.28  Aligned_cols=267  Identities=24%  Similarity=0.360  Sum_probs=197.9

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+..+|.+.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~   85 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKR------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTS   85 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCC------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecc
Confidence            345789999999999999999998765      57899999986432  2234567899999999999999999999875


Q ss_pred             CC------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          152 EE------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       152 ~~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      ..      ..++||||+. .+|..++    ...+++..+..++.|++.||+|||++  +|+||||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~--~i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          86 AVSGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA--GIIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             cccCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCCEEE
Confidence            43      4689999984 4666554    24689999999999999999999955  4999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||++......     .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .+.... ..
T Consensus       159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~-~~  230 (342)
T cd07879         159 LDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQIL-KV  230 (342)
T ss_pred             eeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-Hh
Confidence            999998764322     123467889999999876 568899999999999999999999997643211  011100 00


Q ss_pred             hcCc--cchhhh--------cC--Cc-CCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhhh
Q 040050          305 LKEP--RKLERL--------ID--PR-LEGQF---PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV--LDSLQD  361 (401)
Q Consensus       305 ~~~~--~~~~~~--------~~--~~-~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~--L~~l~~  361 (401)
                      ...+  .....+        ..  +. ....+   .+..+..+.+++.+||+.||.+||++.+++..  ++.++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0000  000000        00  00 00000   01235678899999999999999999999854  666654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=280.01  Aligned_cols=250  Identities=25%  Similarity=0.303  Sum_probs=195.1

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHh-ccCCCceeeEEEEEEeCCeEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLG-QLRHPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      +..||.|+||+|++-.++.      +++..|||.++.... ....+++.|.+... .-++||||++||....+..+||.|
T Consensus        69 lg~iG~G~fG~V~KM~hk~------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKP------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             HHHhcCCcchhhhhhhcCc------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            3579999999999988777      799999999987654 45667888887654 447999999999999999999999


Q ss_pred             EecCCCChhHHHh---hhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          160 EYMPRGSLHNQLF---RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       160 e~~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      |+| ..+|..+..   ......+++..+-.|....+.||.||.. ...|||||+||.|||++..|.|||||||++.....
T Consensus       143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            999 567754432   2234689999999999999999999975 34499999999999999999999999999876543


Q ss_pred             CCcceeeeccccccccccccccc--cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh-cCccchhh
Q 040050          237 GEETHVITRVMGTQGYAAPEYVM--TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL-KEPRKLER  313 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  313 (401)
                      .   ...+...|...|||||.+.  +..|+.+||+||||++|||+.||..|+.....     +.+-+..+. .++     
T Consensus       221 S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdp-----  287 (361)
T KOG1006|consen  221 S---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDP-----  287 (361)
T ss_pred             H---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCC-----
Confidence            2   2234457899999999997  35699999999999999999999999987532     111111111 111     


Q ss_pred             hcCCcCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQ-FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         +.+... -....+..+..++..||.+|-..||...++.++
T Consensus       288 ---p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 ---PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ---CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence               111111 113457789999999999999999999998754

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=281.00  Aligned_cols=261  Identities=28%  Similarity=0.366  Sum_probs=199.1

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      |++.+.||+|++|.||+|....      +++.||+|.+....  ......+..|+.+++.++|+||+++++++......+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecC------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            5677889999999999998876      58899999987653  333467788999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+. ++|.+++.+.. ..+++..+..++.|++.||.|||+.  +|+|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~--~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH--RILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9999996 69999987642 4799999999999999999999954  599999999999999999999999999876543


Q ss_pred             CCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc------
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR------  309 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------  309 (401)
                      ...  ......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.......  .+............      
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07829         151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID--QLFKIFQILGTPTEESWPGV  226 (282)
T ss_pred             Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHHHhCCCcHHHHHhh
Confidence            321  12334567889999998766 88999999999999999999999996643211  01000000000000      


Q ss_pred             --------chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          310 --------KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       310 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                              .............+ ...+..+.+++.+||..||++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         227 TKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                    00000000000011 122668999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-37  Score=292.63  Aligned_cols=262  Identities=24%  Similarity=0.318  Sum_probs=199.1

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+.++|.+.+.||+|++|.||+|.+..      ++..||+|++....  ......+.+|+.+++.++||||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTK------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECC------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            356889999999999999999998876      57899999986432  2234567789999999999999999988876


Q ss_pred             CCe------EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          152 EEY------RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       152 ~~~------~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      ...      .++|+||+ +++|.+++..   ..+++..++.++.|++.||.|||+  .||+|+||+|+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~--~gi~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH--CCeecCCCCHHHeEECCCCCEEE
Confidence            554      89999998 7799888864   579999999999999999999995  45999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......  .+... ...
T Consensus       160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i-~~~  231 (343)
T cd07851         160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRI-MNL  231 (343)
T ss_pred             cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH-HHh
Confidence            999999865432     234468889999998865 467899999999999999999999997543211  01110 000


Q ss_pred             hcC-ccc---------hhhh---cCCcCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKE-PRK---------LERL---IDPRLEGQF---PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~-~~~---------~~~~---~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ... +..         ....   +.......+   ....+..+.+++.+||+.+|.+|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000 000         0000   000000000   11236789999999999999999999999754

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=275.94  Aligned_cols=237  Identities=30%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      ||.|+||.||++.+..      +++.+|+|.+.....   .....+..|+.+++.++||||+++++.+..+...+++|||
T Consensus         1 lg~G~~~~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKD------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECC------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            6899999999998765      578999999865432   2345788899999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH  241 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~  241 (401)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||.  .+++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        75 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~--~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~  148 (250)
T cd05123          75 APGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--S  148 (250)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--C
Confidence            9999999999765  578999999999999999999995  559999999999999999999999999987654432  1


Q ss_pred             eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCC
Q 040050          242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG  321 (401)
Q Consensus       242 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (401)
                      ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....      .......          ..  ...
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~----------~~--~~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKI----------LK--DPL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH----------hc--CCC
Confidence            12345688899999999988889999999999999999999999965421      1111111          11  111


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 040050          322 QFPIKGAQKAAATAFKCLSHHPRHRPTMSY  351 (401)
Q Consensus       322 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~  351 (401)
                      .++...+..+.+++.+||..||++||++.+
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            233334678899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.2e-36  Score=311.14  Aligned_cols=146  Identities=27%  Similarity=0.352  Sum_probs=130.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||+||+|.+..      +++.||+|++....   ......+..|+.+++.++||||+++++++....
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKN------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            679999999999999999999876      57899999986432   222456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ..||||||+.+++|.+++...  ..+++..++.++.||+.||.|||..  +||||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~--gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH--GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999998654  5788999999999999999999954  59999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=279.96  Aligned_cols=265  Identities=23%  Similarity=0.304  Sum_probs=208.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-----C---CceeeEEEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-----H---PHLVKLIGY  148 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pnI~~~~~~  148 (401)
                      ++|-+.++||.|.|++||+|++..      ..+.||+|+.+. .....+..+.||.+|+++.     |   ..||++++.
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq------~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQ------NKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ceEEEEEeccccccceeEEEeecc------CCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            799999999999999999999887      678999999873 3334567889999999983     3   369999999


Q ss_pred             EEe----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc------
Q 040050          149 CWE----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD------  218 (401)
Q Consensus       149 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~------  218 (401)
                      |..    +.++|||+|++ |.+|..+|.....+.++...+..|+.||+.||.|||. ..||||.||||+|||+.      
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-ECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hcCccccCCCcceeeeeccccch
Confidence            974    55899999999 8899999999888999999999999999999999997 57899999999999993      


Q ss_pred             --------------------------------------------------------------------------------
Q 040050          219 --------------------------------------------------------------------------------  218 (401)
Q Consensus       219 --------------------------------------------------------------------------------  218 (401)
                                                                                                      
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------------C---------------------------------------------------
Q 040050          219 ----------------------------S---------------------------------------------------  219 (401)
Q Consensus       219 ----------------------------~---------------------------------------------------  219 (401)
                                                  .                                                   
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                        0                                                   


Q ss_pred             -CCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc----c
Q 040050          220 -DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR----E  294 (401)
Q Consensus       220 -~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~  294 (401)
                       +-+|||+|||-|+....     .++.-+.|..|+|||++.|..|+..+||||++|++|||+||...|+......    +
T Consensus       389 ~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE  463 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE  463 (590)
T ss_pred             cceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence             01367888887776432     2345567889999999999999999999999999999999999997654322    2


Q ss_pred             ccHHHH-----------------hhhhhcCccchhhhcCCcCC---------CCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040050          295 QSLAEW-----------------ARPLLKEPRKLERLIDPRLE---------GQFPIKGAQKAAATAFKCLSHHPRHRPT  348 (401)
Q Consensus       295 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt  348 (401)
                      +-++.+                 -+.++...+.+..+..-+..         -.++.....++.+|+.-||+.+|++|||
T Consensus       464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t  543 (590)
T KOG1290|consen  464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT  543 (590)
T ss_pred             HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence            222222                 12233333333333221111         1245667889999999999999999999


Q ss_pred             HHHHHHH
Q 040050          349 MSYVVRV  355 (401)
Q Consensus       349 ~~~il~~  355 (401)
                      |.++++.
T Consensus       544 A~~cl~h  550 (590)
T KOG1290|consen  544 AAQCLKH  550 (590)
T ss_pred             HHHHhcC
Confidence            9999753

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-36  Score=298.47  Aligned_cols=255  Identities=26%  Similarity=0.370  Sum_probs=210.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe--
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE--  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~--  151 (401)
                      -++.|++..+||.|.+|.||++...+      +++.+|+|+...+... ..++..|.++|+.+ .|||++.++++|..  
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~------~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVK------TGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeee------cCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            34678999999999999999998877      6889999998765433 35667789999888 49999999999864  


Q ss_pred             ---CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          152 ---EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       152 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                         ++.+|||||||.||+..+++....+..+.+..+..|++.++.|+.+||++.  ++|||||-.|||++.+|.|||+||
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDF  167 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDF  167 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeee
Confidence               568999999999999999998776788999999999999999999999655  999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeecccccccccccccccc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      |++.........  -.+.+|||.|||||++..     ..|+..+|+||||++..||.-|.+|+...-.         ++.
T Consensus       168 GvSaQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------mra  236 (953)
T KOG0587|consen  168 GVSAQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------MRA  236 (953)
T ss_pred             eeeeeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------hhh
Confidence            999876553322  245789999999999963     4578899999999999999999999875421         111


Q ss_pred             hhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          304 LLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ++..+.      .|.....-|...+..+.++|..||..|-.+||++.+++++
T Consensus       237 LF~IpR------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  237 LFLIPR------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             hccCCC------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            111111      1222233466778999999999999999999999988754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.9e-36  Score=273.05  Aligned_cols=220  Identities=23%  Similarity=0.262  Sum_probs=178.4

Q ss_pred             cCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEecCCCCh
Q 040050           88 GGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL  167 (401)
Q Consensus        88 G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L  167 (401)
                      |.+|.||++.+..      +++.||+|.+....     ....|...+....||||+++++++......+++|||+++++|
T Consensus         4 g~~~~v~~~~~~~------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTR------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEcc------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            8899999999877      68899999987542     223445555556799999999999999999999999999999


Q ss_pred             hHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccc
Q 040050          168 HNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM  247 (401)
Q Consensus       168 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~  247 (401)
                      .+++.+.  ..+++..+..++.|++.||.|||+  ++|+||||||+||+++.++.++|+|||.+......     .....
T Consensus        73 ~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~--~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~  143 (237)
T cd05576          73 WSHISKF--LNIPEECVKRWAAEMVVALDALHR--EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEA  143 (237)
T ss_pred             HHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHh--CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCC
Confidence            9998765  568999999999999999999995  55999999999999999999999999987654332     12345


Q ss_pred             cccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHH
Q 040050          248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKG  327 (401)
Q Consensus       248 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (401)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|..|+......                  ...    ......+...
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~~~----~~~~~~~~~~  201 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------------INT----HTTLNIPEWV  201 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------ccc----ccccCCcccC
Confidence            677899999998888999999999999999999999887542110                  000    0001123345


Q ss_pred             HHHHHHHHHHhcccCCCCCCCH
Q 040050          328 AQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       328 ~~~l~~li~~cl~~dP~~RPt~  349 (401)
                      +..+.+++.+||+.||.+||++
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCC
Confidence            6788999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=276.95  Aligned_cols=270  Identities=26%  Similarity=0.391  Sum_probs=205.1

Q ss_pred             HHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhc--cCCCceeeEE
Q 040050           69 LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ--LRHPHLVKLI  146 (401)
Q Consensus        69 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnI~~~~  146 (401)
                      +.--+.+.....+.+.||+|.||.||+|.|+        |+.||||++...   +...+.+|.+|...  |+|+||+.++
T Consensus       203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFI  271 (513)
T KOG2052|consen  203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFI  271 (513)
T ss_pred             hHhHHhhhheeEEEEEecCccccceeecccc--------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhh
Confidence            3334566778889999999999999999886        678999998643   44677777777665  5899999999


Q ss_pred             EEEEeCC----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCCCcEE
Q 040050          147 GYCWEEE----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE------DKPVIYRDFKASNIL  216 (401)
Q Consensus       147 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~iiH~Dlkp~NIl  216 (401)
                      +.-..++    .+|||++|.+.|+|+|+|.+   .+++....++++..++.||++||..      .+.|.|||||..|||
T Consensus       272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL  348 (513)
T KOG2052|consen  272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL  348 (513)
T ss_pred             hccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence            8766543    57999999999999999987   5899999999999999999999932      345999999999999


Q ss_pred             EcCCCcEEEEecCCCCCCCCCCc--ceeeeccccccccccccccccCC----C--CccccHHhHHHHHHHHHhC------
Q 040050          217 LDSDYTAKLSDFGLAKDGPEGEE--THVITRVMGTQGYAAPEYVMTGH----L--TTMSDVYSFGVVLLELLTG------  282 (401)
Q Consensus       217 v~~~~~vkL~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~il~ell~g------  282 (401)
                      |..+|...|+|+|+|........  .......+||.+|||||++...-    +  -..+||||||.++||++..      
T Consensus       349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi  428 (513)
T KOG2052|consen  349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI  428 (513)
T ss_pred             EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence            99999999999999986655421  11223468999999999986421    2  1369999999999999763      


Q ss_pred             ----CCCCCCCcccccccHHHHhhhhhcCccchhhh-cCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 040050          283 ----KRAMDNTRLGREQSLAEWARPLLKEPRKLERL-IDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYV  352 (401)
Q Consensus       283 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~i  352 (401)
                          +.||...-.. ..++.+           +.+. ...++++..     ....-..+.++++.||..||..|.|+--+
T Consensus       429 ~eey~~Pyyd~Vp~-DPs~ee-----------MrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  429 VEEYQLPYYDVVPS-DPSFEE-----------MRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             ehhhcCCcccCCCC-CCCHHH-----------HhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence                2455332111 111111           1111 112222222     23456788999999999999999999999


Q ss_pred             HHHHHhhhhccc
Q 040050          353 VRVLDSLQDFQD  364 (401)
Q Consensus       353 l~~L~~l~~~~~  364 (401)
                      -+.|.++...++
T Consensus       497 KKtl~~l~~~~e  508 (513)
T KOG2052|consen  497 KKTLAKLSNSDE  508 (513)
T ss_pred             HHHHHHHhcChh
Confidence            999999887554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=294.81  Aligned_cols=242  Identities=24%  Similarity=0.253  Sum_probs=198.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      ....|.+...+|.|+|+.|-.+.+..      +++..++|++....    .+..+|+.++... +||||+++.+.+.+..
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~------t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSP------TDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccc------cccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCc
Confidence            34678888889999999999988776      68899999987542    1233467555554 6999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE-cCCCcEEEEecCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL-DSDYTAKLSDFGLAK  232 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv-~~~~~vkL~DfG~a~  232 (401)
                      ..|+|||++.|+-|.+.+...   ......+..|+.+|+.|+.|||.  +|||||||||+|||+ +..|+++|+|||.+.
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~--~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHE--QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHh--cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence            999999999999998888764   33337888899999999999995  559999999999999 688999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .....     ..+.+-|..|.|||++....|++++||||||++||+||+|+.||.....+                   .
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------------------~  520 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------------------I  520 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------------------H
Confidence            76544     33456788999999999999999999999999999999999999765322                   1


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+......+.+...++..+++|+.+||+.||.+||++.++...
T Consensus       521 ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  521 EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            1122222233346678999999999999999999999999765

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=282.68  Aligned_cols=259  Identities=25%  Similarity=0.343  Sum_probs=203.7

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-------ccHHHHHHHHHHHhccCCCceeeEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-------QGHKEWMAEIIFLGQLRHPHLVKLI  146 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpnI~~~~  146 (401)
                      .+.++|-++.+||+|||+.||+|.+..      ..+.||+|+-.....       .......+|..|.+.|.||.||++|
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLT------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccc------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            456789999999999999999998876      578999998765421       1245677899999999999999999


Q ss_pred             EEEEe-CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCc
Q 040050          147 GYCWE-EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYT  222 (401)
Q Consensus       147 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~  222 (401)
                      ++|.- .+.+|-|+|||+|.+|.-+|...  +.+++.++..|+.||+.||.||.....+|||-||||.|||+..   -|.
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence            99965 45789999999999998888665  7899999999999999999999988889999999999999943   488


Q ss_pred             EEEEecCCCCCCCCCCcc-----eeeecccccccccccccccc----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccc
Q 040050          223 AKLSDFGLAKDGPEGEET-----HVITRVMGTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR  293 (401)
Q Consensus       223 vkL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  293 (401)
                      +||+|||++..+......     ...+...||.+|++||.+.-    .+.+.++||||+|||+|..+.|+.||+..... 
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-  690 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-  690 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-
Confidence            999999999876543322     22344789999999998863    34678999999999999999999999764211 


Q ss_pred             cccHHHHhhhhhcCccchhhhcCC-cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040050          294 EQSLAEWARPLLKEPRKLERLIDP-RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV  353 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il  353 (401)
                       +.+.+.       ..    ++.. ...-...+.++.+..+||++||++-.++|....++.
T Consensus       691 -QdILqe-------NT----IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  691 -QDILQE-------NT----ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -HHHHhh-------hc----hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence             111111       00    0100 011111234577899999999999999998887774

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=273.13  Aligned_cols=273  Identities=26%  Similarity=0.382  Sum_probs=233.2

Q ss_pred             HHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEE
Q 040050           69 LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIG  147 (401)
Q Consensus        69 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~  147 (401)
                      ..++.+-..+++...++-+|+||.||.|++.+. +...+.+.|.+|.++....+ ....++.|.-.+..+.|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eE-dt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREE-DTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeeccc-CCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            456667778999999999999999999988753 23335577888888755443 2456788999999999999999999


Q ss_pred             EEEeC-CeEEEEEEecCCCChhHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          148 YCWEE-EYRLLVYEYMPRGSLHNQLFR------SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       148 ~~~~~-~~~~lv~e~~~~~~L~~~l~~------~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      ++.++ ...+.++.++.-|+|..++..      +....++..+...++.|++.|++|||+++  |||.||...|++|++.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh
Confidence            88664 467888999988999999972      23356778888999999999999999655  9999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  299 (401)
                      .+|||+|=.+++....++..+...+...+..||+||.+.+..|+.++|+||||+++|||+| |+.|+..-          
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI----------  502 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI----------  502 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc----------
Confidence            9999999999999888888777777778889999999999999999999999999999998 88888653          


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                             +|..+..++..+.+...|.++++++..++..||+.+|++||+++++..-|.+...
T Consensus       503 -------DPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  503 -------DPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             -------CHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                   4566777777777778899999999999999999999999999999999887653

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=295.92  Aligned_cols=261  Identities=26%  Similarity=0.381  Sum_probs=219.5

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      ....++||+|+||+||+|.+...  ...-.-+||+|++... ..+...++++|+-+|.++.|||++++++++.... +-|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pe--ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPE--GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecC--CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            34558999999999999999874  3445678999998754 3445678999999999999999999999998776 778


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG  237 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~  237 (401)
                      |++|+++|.|.++++.. ...+-....+.|..||++||.|||  ++++|||||...||||..-.+|||+|||+++.....
T Consensus       775 vtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe--~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLE--EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH--hcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999999764 567888899999999999999999  566999999999999999999999999999987766


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ..........-.+.|||-|.+....|+.++|||||||++||++| |..|+++...                 ..+..++.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------------~eI~dlle  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------------EEIPDLLE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------------HHhhHHHh
Confidence            55544444444678999999999999999999999999999999 8899887532                 23334444


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ...+...|+.++.++.-++.+||-.|+..||+++++...+.++-.-
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            4444566778899999999999999999999999999988877443

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-36  Score=265.44  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=204.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      -.+|.++++||+|++..|.++++.+      +.+.+|+|+++..   ..+++.....|-.+..+- +||+++-++.+|..
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKK------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcc------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            3689999999999999999998887      6889999998743   345556666777777666 69999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      +..+++|.||++||+|.-.++++  ..++++.+..+...|+.||.|||  .+|||+||||.+|||++..|++||+|+|++
T Consensus       323 esrlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh--~rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH--ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh--hcCeeeeeccccceEEccCCceeecccchh
Confidence            99999999999999998888776  78999999999999999999999  566999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcc-cccccHHHHhhhhhcCccc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL-GREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  310 (401)
                      +......  ...++++|||.|.|||++.|..|+..+|+|+||++++||+.|+.||+-..- ....+..++...++     
T Consensus       399 ke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi-----  471 (593)
T KOG0695|consen  399 KEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI-----  471 (593)
T ss_pred             hcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH-----
Confidence            8643322  234678999999999999999999999999999999999999999975431 12222233322221     


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT  348 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt  348 (401)
                          +...+  .+|...+-....++...|.+||.+|..
T Consensus       472 ----lekqi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  472 ----LEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ----hhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence                11111  245555667788899999999999964

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-35  Score=295.30  Aligned_cols=268  Identities=28%  Similarity=0.429  Sum_probs=214.3

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCC-CCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKP-GLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYC  149 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~  149 (401)
                      .....+..+.+.||.|.||.|++|........ ......||||.++... ......+..|+++|+.+ +||||+.++|++
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            33445567778999999999999986643322 1236789999987543 34567789999999999 599999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhc------------C--CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcE
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSY------------S--AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNI  215 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NI  215 (401)
                      ......++|+||+..|+|..++....            .  ..++....+.++.||+.|++||++  +++|||||...||
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~--~~~vHRDLAaRNV  449 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS--VPCVHRDLAARNV  449 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh--CCccchhhhhhhE
Confidence            99889999999999999999997653            0  138899999999999999999994  5599999999999


Q ss_pred             EEcCCCcEEEEecCCCCCCCCCCcceeeecccc--ccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCccc
Q 040050          216 LLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG--TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLG  292 (401)
Q Consensus       216 lv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  292 (401)
                      |+..+..+||+|||+|+......... ...-.|  ...|||||.+....|+.++||||+|++||||++ |..||.+... 
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-  527 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-  527 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence            99999999999999999755543322 122222  345999999999999999999999999999999 7788865210 


Q ss_pred             ccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          293 REQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                                     ...+...+....+...|..+..++.+++..||+.+|++||++.++.+.|+.+
T Consensus       528 ---------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 ---------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             ---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                           0111222333444455677788999999999999999999999999999994

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-37  Score=265.08  Aligned_cols=269  Identities=24%  Similarity=0.339  Sum_probs=198.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe---
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE---  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~---  151 (401)
                      +.|....+||+|.||.||+|+...      +++.||+|++-.++  .......++|+.+|..++|+|++.+++.|..   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKN------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcC------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            567777899999999999998776      68889999875443  2334568899999999999999998887643   


Q ss_pred             -----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          152 -----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       152 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                           ...+|+||.+|+ -+|...+... ...++...+.+++.+++.||.|+|++.  |+|||+|++|+||+.+|.+||+
T Consensus        91 p~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             CcccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEee
Confidence                 235899999995 4888877542 367899999999999999999999777  9999999999999999999999


Q ss_pred             ecCCCCCCCCCC--cceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccH-HHH--
Q 040050          227 DFGLAKDGPEGE--ETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW--  300 (401)
Q Consensus       227 DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~--  300 (401)
                      |||+++.+....  ....+++.+.|..|++||.+.| ..|+++.|||..||++.+|++|.+.+.+......-.+ ...  
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            999997554322  2223455677999999999986 5789999999999999999999998866432111111 000  


Q ss_pred             -----hhhhhcCccchhhhcCCcC-CCCC--------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 -----ARPLLKEPRKLERLIDPRL-EGQF--------PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 -----~~~~~~~~~~~~~~~~~~~-~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           .++...+-.-+..+-.+.+ .+.+        |..-.++..+|+.++|..||.+|+++.+++..
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                 1111111011111100001 0000        11113478899999999999999999998865

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-34  Score=275.36  Aligned_cols=203  Identities=26%  Similarity=0.348  Sum_probs=172.5

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      -|..++.||-|+||.|.++.-.+      +...||.|.++...   .........|-.||..-..+-||++|..|.+.+.
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvD------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn  703 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVD------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN  703 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecc------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence            46677899999999999997655      57789999886432   2334567789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|+||+|++||++..+|.+.  +.+++..+..++.++..|+.+.|.++  .|||||||+|||||.+|++||+|||++.-+
T Consensus       704 LYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccc
Confidence            99999999999999999886  78999999999999999999999555  999999999999999999999999998521


Q ss_pred             C---------CCCcc-------------------------------eeeeccccccccccccccccCCCCccccHHhHHH
Q 040050          235 P---------EGEET-------------------------------HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGV  274 (401)
Q Consensus       235 ~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  274 (401)
                      .         .+...                               ...-..+||+.|+|||++....|+..+|+||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            1         11000                               0001257999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCc
Q 040050          275 VLLELLTGKRAMDNTR  290 (401)
Q Consensus       275 il~ell~g~~pf~~~~  290 (401)
                      |||||+.|++||-...
T Consensus       860 il~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADT  875 (1034)
T ss_pred             HHHHHhhCCCCccCCC
Confidence            9999999999996543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.2e-34  Score=257.04  Aligned_cols=238  Identities=32%  Similarity=0.426  Sum_probs=192.8

Q ss_pred             CCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc-HHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEecCCCCh
Q 040050           89 GFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL  167 (401)
Q Consensus        89 ~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L  167 (401)
                      +||.||+|.+..      +++.+++|++....... ...+.+|+..+++++|+||+++++++......+++||++.+++|
T Consensus         1 ~~g~v~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKK------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECC------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            589999998876      57899999997665444 67889999999999999999999999999999999999998899


Q ss_pred             hHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccc
Q 040050          168 HNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM  247 (401)
Q Consensus       168 ~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~  247 (401)
                      .+++...  ..++...++.++.+++.++.+||+.  +++|+||+|.||+++.++.++|+|||.+.......   ......
T Consensus        75 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       75 FDLLKKR--GRLSEDEARFYARQILSALEYLHSN--GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             HHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHc--CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            9998764  3389999999999999999999965  59999999999999999999999999998765432   223456


Q ss_pred             cccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCH-H
Q 040050          248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPI-K  326 (401)
Q Consensus       248 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  326 (401)
                      |+..|+|||.+.+..++.++|+||||+++|+|++|..||.....  .....+...             .......... .
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~-------------~~~~~~~~~~~~  212 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG-------------KPKPPFPPPEWK  212 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh-------------ccCCCCcccccc
Confidence            88999999999988899999999999999999999999865311  111111100             0000000000 0


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          327 GAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       327 ~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .+..+.+++.+||..+|++||++.++++
T Consensus       213 ~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      213 ISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            4568899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=241.75  Aligned_cols=203  Identities=26%  Similarity=0.346  Sum_probs=169.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~  154 (401)
                      +....+..||+|++|.|-+-++..      +|...|+|.++.. +.+...+.++|+.+..+. .+|+++++||....+..
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQ------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeecc------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            334445679999999998887776      7999999999765 345567788899886655 69999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      .+|.||.| ..+|..+..+  ..++.+++..+-+|+..++.||.|||+. ..|||||+||.|||++.+|+||+||||++.
T Consensus       120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccce
Confidence            99999999 6788666543  3467899999999999999999999974 459999999999999999999999999998


Q ss_pred             CCCCCCcceeeecccccccccccccccc----CCCCccccHHhHHHHHHHHHhCCCCCCCCc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLTGKRAMDNTR  290 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~  290 (401)
                      .....-.   .+-..|...|||||.+..    ..|+.++||||||+++.||.+++.||+...
T Consensus       198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            6544321   122468899999999863    479999999999999999999999998764

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=8e-34  Score=285.64  Aligned_cols=265  Identities=21%  Similarity=0.251  Sum_probs=169.4

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEE------
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGY------  148 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~------  148 (401)
                      ..++|.+.+.||+|+||.||+|++....  ...+..||+|++......  ..+..+  .+....+.++..+...      
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~--~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~  203 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ--SKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVS  203 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc--cccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence            3468999999999999999999887611  112788999987633221  111111  1122222222222111      


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSA------------------ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDF  210 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dl  210 (401)
                      ...+...++||||+.+++|.+++......                  ......+..++.|++.||.|||+  ++|+||||
T Consensus       204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~--~gIiHRDL  281 (566)
T PLN03225        204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS--TGIVHRDV  281 (566)
T ss_pred             cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH--CCEEeCcC
Confidence            23456789999999999999988653210                  11233466899999999999995  45999999


Q ss_pred             CCCcEEEcC-CCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccC----------------------CCCccc
Q 040050          211 KASNILLDS-DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG----------------------HLTTMS  267 (401)
Q Consensus       211 kp~NIlv~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~  267 (401)
                      ||+|||++. ++.+||+|||++........ .......|++.|+|||++...                      .++.++
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            999999986 58999999999986543221 223456789999999976422                      234567


Q ss_pred             cHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc---chhhhcCCcCCCC------CCHHHHHHHHHHHHHh
Q 040050          268 DVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR---KLERLIDPRLEGQ------FPIKGAQKAAATAFKC  338 (401)
Q Consensus       268 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~l~~li~~c  338 (401)
                      |||||||++|||+++..+++..       +..+...+.....   .+.....+.....      ..........+|+.+|
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence            9999999999999977654321       1111111100000   0111111110000      0001123456899999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 040050          339 LSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       339 l~~dP~~RPt~~~il~~  355 (401)
                      |+.||++|||+.+++++
T Consensus       434 L~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        434 MRFKGRQRISAKAALAH  450 (566)
T ss_pred             ccCCcccCCCHHHHhCC
Confidence            99999999999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3e-35  Score=274.66  Aligned_cols=273  Identities=24%  Similarity=0.247  Sum_probs=207.6

Q ss_pred             HHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCC------Cce
Q 040050           69 LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH------PHL  142 (401)
Q Consensus        69 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnI  142 (401)
                      +.....+.++|.+....|+|-|++|..|.+..      .++.||||+++.. ...+..=+.|+++|++|+.      -++
T Consensus       424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~------r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQA------RGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             EehhhhhcceeEEEeccccceeeeeeeccccC------CCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHH
Confidence            44456788999999999999999999998776      4679999999743 3345666789999999963      378


Q ss_pred             eeEEEEEEeCCeEEEEEEecCCCChhHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-
Q 040050          143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS-YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-  220 (401)
Q Consensus       143 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-  220 (401)
                      ++++..|...+++|||+|.+ ..+|.+.|.+. .+-+|....+..++.|++.||..|.  ..||+|.||||+||||++. 
T Consensus       497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK--~c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK--KCGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH--hcCeeecccCccceEeccCc
Confidence            99999999999999999998 67999999764 3457888999999999999999999  6779999999999999876 


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc-cccHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR-EQSLAE  299 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~  299 (401)
                      ..+||||||.|.......    .+.+..+..|.|||++.|.+|+...|+||+||+||||.||+..|.+..... -..+.+
T Consensus       574 ~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             ceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence            568999999998765543    234456778999999999999999999999999999999999997743211 001111


Q ss_pred             Hhhhh----hcC-----------------------------------c-cchhhhcCCcC-CCCCCHHHHHHHHHHHHHh
Q 040050          300 WARPL----LKE-----------------------------------P-RKLERLIDPRL-EGQFPIKGAQKAAATAFKC  338 (401)
Q Consensus       300 ~~~~~----~~~-----------------------------------~-~~~~~~~~~~~-~~~~~~~~~~~l~~li~~c  338 (401)
                      .-..+    +..                                   | ..+...+.... .+.-.......+.+|+.+|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            10000    000                                   0 01111111100 0111234567899999999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 040050          339 LSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       339 l~~dP~~RPt~~~il~~  355 (401)
                      |..||++|.|..++|++
T Consensus       730 l~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  730 LILDPEKRITVNQALKH  746 (752)
T ss_pred             hccChhhcCCHHHHhcC
Confidence            99999999999988753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-32  Score=271.36  Aligned_cols=273  Identities=19%  Similarity=0.286  Sum_probs=181.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCc----------CCCCCCCceEEEEEecCCCcccHHH--------------HHHH
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEK----------LKPGLEAQPVAVKALDLDGTQGHKE--------------WMAE  130 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~----------~~~~~~~~~vavK~~~~~~~~~~~~--------------~~~E  130 (401)
                      ..++|.+.++||+|+||+||+|.....          ......++.||||.+..........              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999975321          1122345789999987554332222              3346


Q ss_pred             HHHHhccCCCce-----eeEEEEEEe--------CCeEEEEEEecCCCChhHHHhhhc----------------------
Q 040050          131 IIFLGQLRHPHL-----VKLIGYCWE--------EEYRLLVYEYMPRGSLHNQLFRSY----------------------  175 (401)
Q Consensus       131 ~~~l~~l~hpnI-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~----------------------  175 (401)
                      +.++.+++|.++     ++++++|..        ....++||||+.+++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            667777766544     566776643        346799999999999999886421                      


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccc
Q 040050          176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP  255 (401)
Q Consensus       176 ~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aP  255 (401)
                      ...+++..+..++.|++.+|.|||+.  +|+||||||+|||++.++.+||+|||++.......... .....+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~--~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI--GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeCh
Confidence            12345678889999999999999954  59999999999999999999999999997654322111 1122358899999


Q ss_pred             cccccCC--------------------C--CccccHHhHHHHHHHHHhCCC-CCCCCcccccccHHHHhhhhhcCccchh
Q 040050          256 EYVMTGH--------------------L--TTMSDVYSFGVVLLELLTGKR-AMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       256 E~~~~~~--------------------~--~~~~DiwslG~il~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      |++....                    |  ..+.|+||+||++|+|++|.. ||........ .+..+    ......+.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-~~~~~----~~~~~~~r  454 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-ELRQY----DNDLNRWR  454 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-HHhhc----cchHHHHH
Confidence            9875322                    1  124799999999999999875 6643211000 00000    00000000


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHP---RHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~~il~~  355 (401)
                      ........-......+....+|+.+||..+|   .+|+|+.+++++
T Consensus       455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0000111111122346789999999999766   789999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=268.75  Aligned_cols=197  Identities=24%  Similarity=0.363  Sum_probs=170.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--------cccHHHHHHHHHHHhccC---CCceeeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--------TQGHKEWMAEIIFLGQLR---HPHLVKL  145 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---hpnI~~~  145 (401)
                      .+|...+.||.|+||.|++|++++      +...|+||.+....        ....-..-.|+.||..++   |+||+++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~------n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKE------NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             ccceeeeeccccccceEEEeeecc------cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence            468999999999999999999988      57789999986432        111122446999999997   9999999


Q ss_pred             EEEEEeCCeEEEEEEec-CCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEE
Q 040050          146 IGYCWEEEYRLLVYEYM-PRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK  224 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vk  224 (401)
                      +++|++++++||+||.. +|-+|+++|..+  ..+++.++..|+.||+.|+++||+++  |||||||-+||.++.+|.+|
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~k  710 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVK  710 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEE
Confidence            99999999999999975 455899999765  78999999999999999999999555  99999999999999999999


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCC
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMD  287 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~  287 (401)
                      |+|||.+....++.    +..+.||..|.|||++.|.+| +..-|||+||++||.++....||-
T Consensus       711 lidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  711 LIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999998765543    456789999999999999888 456899999999999999888874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=276.98  Aligned_cols=246  Identities=28%  Similarity=0.396  Sum_probs=186.3

Q ss_pred             CCCCceecccCCee-EEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEE
Q 040050           79 FSRSNLLGEGGFGP-VYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        79 y~~~~~Lg~G~~g~-V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~  156 (401)
                      |.-.+++|.|+.|+ ||+|...        ++.||||.+-.   +....+.+|+..|+.-+ ||||+++++.-.+..+.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--------~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~Y  579 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--------GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLY  579 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--------CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEE
Confidence            33446789999876 7888764        57999998753   23346778999998884 999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---C--CcEEEEecC
Q 040050          157 LVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---D--YTAKLSDFG  229 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~--~~vkL~DfG  229 (401)
                      |+.|.| ..+|.+++...  ......-...+.++.|++.||++||+.+  ||||||||+||||+.   +  .+++|+|||
T Consensus       580 IalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  580 IALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccc
Confidence            999999 67999999763  1111111345788999999999999755  999999999999965   3  578999999


Q ss_pred             CCCCCCCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhC-CCCCCCCcccccccHHHHhhhhhcC
Q 040050          230 LAKDGPEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG-KRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      +++....+... ....+..||.+|+|||++....-+.++|||||||++|+.++| .+||+..-....        +++..
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~  728 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTG  728 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcC
Confidence            99987765432 223457799999999999988888899999999999999996 899976421110        11111


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...+..+.      ..+   ..+..+||.+|++++|..||++.+|+.+
T Consensus       729 ~~~L~~L~------~~~---d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  729 NYTLVHLE------PLP---DCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ccceeeec------cCc---hHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            11111110      011   1178999999999999999999999854

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.98  E-value=7.8e-33  Score=234.50  Aligned_cols=260  Identities=19%  Similarity=0.267  Sum_probs=196.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEE-  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~-  153 (401)
                      .++|++.+.+|+|.++.||.|....      +.+.++||+++...   ...+.+|+.||..|. ||||++++++..++. 
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~------~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINIT------NNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccC------CCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            3689999999999999999998766      57899999997543   357889999999997 999999999998754 


Q ss_pred             -eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEEecCCC
Q 040050          154 -YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLA  231 (401)
Q Consensus       154 -~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~DfG~a  231 (401)
                       ...+|+||+.+.+...+.     ..++...+..++.+++.||.|||+++  |+|||+||.|+||+.. ..++|+|+|+|
T Consensus       108 ktpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             cCchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchH
Confidence             567999999877665443     56888899999999999999999766  9999999999999875 57999999999


Q ss_pred             CCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH----------
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW----------  300 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----------  300 (401)
                      .+...+...   .-.+.+..|--||.+.. ..|+...|+|||||++..|+..+.||........ .++..          
T Consensus       181 EFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~  256 (338)
T KOG0668|consen  181 EFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELY  256 (338)
T ss_pred             hhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHH
Confidence            987766543   22356778999998874 6789999999999999999999999865432211 11111          


Q ss_pred             --hhh-hhcCccchhhhcCCcCCCC----CC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 --ARP-LLKEPRKLERLIDPRLEGQ----FP----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 --~~~-~~~~~~~~~~~~~~~~~~~----~~----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        ... .+..+.....++....+..    .+    --.+++..+|+.++|..|-++|||+.|++.+
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence              110 0111122222221111111    01    1125789999999999999999999998653

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4e-34  Score=248.16  Aligned_cols=264  Identities=24%  Similarity=0.333  Sum_probs=197.2

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE--  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~--  153 (401)
                      +.+-.+.||-|+||.||.+++.+      .++.|++|++...  +-...+.+.+|+.+|..++|.|++..+++..-..  
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPR------dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~d  127 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPR------SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPS  127 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCC------CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCch
Confidence            44556899999999999998776      6899999998633  2223467889999999999999999988776543  


Q ss_pred             ---eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          154 ---YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       154 ---~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                         .+|+++|++ ..+|+..|..-  ..++...+.-++.||++||+|||+.+  |.||||||.|.|++.+..+||||||+
T Consensus       128 fFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  128 FFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEeccccc
Confidence               357888888 46888877553  78888999999999999999999766  99999999999999999999999999


Q ss_pred             CCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc-
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP-  308 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  308 (401)
                      ++....... ..++..+-|.+|+|||+++| ..|+.+.||||+||++.||+..+..|........-   +.+..++..| 
T Consensus       203 ARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL---~lItdLLGTPs  278 (449)
T KOG0664|consen  203 ARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL---QMIIDLLGTPS  278 (449)
T ss_pred             ccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH---HHHHHHhCCCc
Confidence            997655433 33566678999999999997 57999999999999999999988888654322111   1111111111 


Q ss_pred             ---------cchhhhcCCcCCC-C--------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          309 ---------RKLERLIDPRLEG-Q--------FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       309 ---------~~~~~~~~~~~~~-~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                               +.-..++....+. .        -+.....+...++..++..||++|.+..+.+..+
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                     1111111111110 0        1123345667788899999999999999887664

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-33  Score=270.28  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=205.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|+....+|.|++|.||+|++..      +++..|+|+++.....+..-+..|+-+++..+||||+.+++.+.....+
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKR------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccc------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            3789999999999999999998887      6899999999988888888888999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++.||||.||+|.+..+-  .+++++.++...++..+++++|||+.+  -+|||||-.||++++.|.|||+|||.+....
T Consensus        88 wicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqit  163 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQIT  163 (829)
T ss_pred             EEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhh
Confidence            999999999999876543  478999999999999999999999544  8999999999999999999999999987654


Q ss_pred             CCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..-.  .-..+.||++|||||+..   .+.|...+|||++|++..|+---++|....-..  ..+.-.....        
T Consensus       164 ati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~LmTkS~--------  231 (829)
T KOG0576|consen  164 ATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALFLMTKSG--------  231 (829)
T ss_pred             hhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHHHhhccC--------
Confidence            3221  124578999999999874   578999999999999999998888875432110  0000000000        


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                        +++ .....+....+.+.+|++.||..+|++||+++-++.
T Consensus       232 --~qp-p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  232 --FQP-PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             --CCC-CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence              000 011123344778999999999999999999887665

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=9e-33  Score=244.78  Aligned_cols=264  Identities=23%  Similarity=0.310  Sum_probs=197.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +..+|.-++.+|.|.- .|..|.+.-      .+++||+|+....  .....++..+|+..+..++|+||++++.+|.-.
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQV------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhh------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            4578888899999988 666665443      6889999987543  334456788999999999999999999998644


Q ss_pred             C------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 E------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 ~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      .      ..|+|||+| ..+|...+..    .++-.++..++.|++.|++|||+.+  |+||||||+||++..+..+||.
T Consensus        88 ~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             ccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeec
Confidence            3      469999999 6799888863    4667788999999999999999666  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc-----------
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-----------  295 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------  295 (401)
                      |||+|+.....   -.++.++.|..|+|||++.+-.|.+.+||||+||++.||++|+..|.+....+.-           
T Consensus       161 dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd  237 (369)
T KOG0665|consen  161 DFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD  237 (369)
T ss_pred             cchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence            99999864432   3567788999999999999988999999999999999999999988764311100           


Q ss_pred             -----cHHHHhhhhhcC-cc----chhhhcCCc-CCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          296 -----SLAEWARPLLKE-PR----KLERLIDPR-LEG--QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       296 -----~~~~~~~~~~~~-~~----~~~~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           .+....+....+ +.    ...+.+... ...  ..+..-...+++++.+||-.||++|.+++++|++
T Consensus       238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                 000111111110 11    011111100 000  0112235568899999999999999999999754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.6e-30  Score=227.74  Aligned_cols=211  Identities=36%  Similarity=0.550  Sum_probs=182.3

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEecC
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMP  163 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~  163 (401)
                      ||+|++|.||++....      +++.+++|++...... ....+.+|+..++.+.|++|+++++++......+++||++.
T Consensus         1 l~~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKK------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecC------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            6899999999998765      5789999998755432 34678899999999999999999999999999999999998


Q ss_pred             CCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEEEEecCCCCCCCCCCccee
Q 040050          164 RGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGEETHV  242 (401)
Q Consensus       164 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vkL~DfG~a~~~~~~~~~~~  242 (401)
                      +++|.+++.... ..++...++.++.+++.++.+||+.  +++|+||+|.||+++. ++.++|+|||.+........  .
T Consensus        75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~--~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (215)
T cd00180          75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN--GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L  149 (215)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence            899999886532 4689999999999999999999954  5999999999999999 89999999999986544321  1


Q ss_pred             eeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCC
Q 040050          243 ITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG  321 (401)
Q Consensus       243 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (401)
                      .....+...|++||.+... .++.++|+|++|+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2335578899999999877 888999999999999999                                          


Q ss_pred             CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          322 QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       322 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             ..+.+++.+|++.+|.+||++.++++.
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                   467789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-31  Score=231.02  Aligned_cols=254  Identities=24%  Similarity=0.373  Sum_probs=189.4

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEE-EEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGY-CWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~-~~~~  152 (401)
                      +.+.|.+.+.||+|.||.+-++.++.      +...+++|.+... .....+|.+|...--.|. |.||+.-|++ |...
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~------s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQ------SKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccC------CceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            34789999999999999999998887      6889999998744 234678999988766664 8999988864 6677


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc--CCCcEEEEecCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD--SDYTAKLSDFGL  230 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~--~~~~vkL~DfG~  230 (401)
                      +.++++|||++.|+|..-+..   .++-+.....++.|+++||.|+|+  +++||||||.+||||-  +..+|||||||+
T Consensus        95 d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHs--knlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHS--KNLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             ceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhc--cchhhcccccceEEEecCCccEEEeeeccc
Confidence            788899999999999887644   578888899999999999999995  4499999999999993  346899999999


Q ss_pred             CCCCCCCCcceeeecccccccccccccccc---C--CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMT---G--HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      .+..+..     ......+..|.+||+...   +  ..++.+|+|.||+++|.++||+.||..... +...+.+|..-..
T Consensus       170 t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~  243 (378)
T KOG1345|consen  170 TRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLK  243 (378)
T ss_pred             ccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhc
Confidence            8864332     222345667999998753   2  246789999999999999999999974322 2333333322111


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...        +.+...+ ...++.+.++..+-|..+|++|--+.++.++
T Consensus       244 rk~--------~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  244 RKN--------PALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             ccC--------ccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            100        0111111 1235678888999999999999555555444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.6e-29  Score=225.86  Aligned_cols=199  Identities=34%  Similarity=0.472  Sum_probs=172.3

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~l  157 (401)
                      |.+.+.||.|++|.||+|.+..      +++.+++|.+...... ....+.+|++.++.++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            5677899999999999998876      5788999999866544 56788899999999999999999999999899999


Q ss_pred             EEEecCCCChhHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          158 VYEYMPRGSLHNQLFRSYSAA-LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ++|++.+++|.+++...  .. +++..+..++.+++.++.+||..  +++|+||+|.||+++.++.++|+|||.+.....
T Consensus        75 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~--~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       75 VMEYCEGGDLFDYLRKK--GGKLSEEEARFYLRQILEALEYLHSL--GIVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             EEeccCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            99999998999998764  33 88999999999999999999954  599999999999999999999999999887654


Q ss_pred             CCcceeeecccccccccccccc-ccCCCCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          237 GEETHVITRVMGTQGYAAPEYV-MTGHLTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                      .... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       151 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      151 DLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            3211 12334678899999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=1.5e-30  Score=238.75  Aligned_cols=271  Identities=27%  Similarity=0.338  Sum_probs=198.5

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCW  150 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~  150 (401)
                      ...+...|...++||.|+|++||+|++...   ....+.||+|.+....  ....+.+|++.|..+. +.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh---ccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhc
Confidence            344567899999999999999999987762   3467899999987543  3367889999999996 999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEEecC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFG  229 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~DfG  229 (401)
                      .++..++||||++.....++..     .++...+..+++.++.||+++|.++  ||||||||.|++.+.. +.-.|+|||
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEech
Confidence            9999999999999888877763     4678899999999999999999555  9999999999999764 788999999


Q ss_pred             CCCCCC-----------------C--CC---------------cc--------eeeecccccccccccccccc-CCCCcc
Q 040050          230 LAKDGP-----------------E--GE---------------ET--------HVITRVMGTQGYAAPEYVMT-GHLTTM  266 (401)
Q Consensus       230 ~a~~~~-----------------~--~~---------------~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~  266 (401)
                      +|....                 .  +.               ..        ..-....||++|+|||++.. ..-+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            986100                 0  00               00        00012579999999999875 556889


Q ss_pred             ccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh--------hhhhcCccc------------------hhhh-cCCcC
Q 040050          267 SDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA--------RPLLKEPRK------------------LERL-IDPRL  319 (401)
Q Consensus       267 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~------------------~~~~-~~~~~  319 (401)
                      +||||.|+|+..++++..||.....+. ..+.+..        +..-..++.                  ...+ .....
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             cceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            999999999999999999996543221 1111110        000000000                  0000 00000


Q ss_pred             C--------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          320 E--------GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       320 ~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .        .......+..+.+++.+||..||.+|.|+++.|++
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0        00111224478899999999999999999999764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3.5e-29  Score=263.65  Aligned_cols=197  Identities=18%  Similarity=0.232  Sum_probs=137.7

Q ss_pred             ccCC-CceeeEEEEE-------EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 040050          136 QLRH-PHLVKLIGYC-------WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIY  207 (401)
Q Consensus       136 ~l~h-pnI~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH  207 (401)
                      .++| +||+.++++|       .....++++||++ +++|.+++... ...+++..++.++.||+.||.|||+  +||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~--~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS--QGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh--CCeee
Confidence            3445 5788888877       2334567888987 67999999643 3569999999999999999999995  55999


Q ss_pred             ccCCCCcEEEcCCCcE-------------------EEEecCCCCCCCCCCc--------------ceeeecccccccccc
Q 040050          208 RDFKASNILLDSDYTA-------------------KLSDFGLAKDGPEGEE--------------THVITRVMGTQGYAA  254 (401)
Q Consensus       208 ~Dlkp~NIlv~~~~~v-------------------kL~DfG~a~~~~~~~~--------------~~~~~~~~gt~~y~a  254 (401)
                      |||||+||||+..|.+                   ||+|||+++.......              ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            9999999999655544                   5555555542110000              000112458899999


Q ss_pred             ccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHH
Q 040050          255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAAT  334 (401)
Q Consensus       255 PE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  334 (401)
                      ||++.+..|+.++|||||||++|||++|.+|+....    .........          .+.+..     .........+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~----------~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR----------VLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh----------hcChhh-----hhcCHHHHHH
Confidence            999999999999999999999999999988865321    011111000          000000     0112345678


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 040050          335 AFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       335 i~~cl~~dP~~RPt~~~il~~  355 (401)
                      +.+||+.+|.+||++.++++.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            889999999999999999864

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.8e-27  Score=204.08  Aligned_cols=168  Identities=23%  Similarity=0.196  Sum_probs=126.4

Q ss_pred             CChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeee
Q 040050          165 GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT  244 (401)
Q Consensus       165 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~  244 (401)
                      |+|.+++... ...+++..++.++.|++.||.|||+.+        ||+||+++.++.+++  ||++......       
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6898988753 357999999999999999999999533        999999999999999  9998764332       


Q ss_pred             ccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCC
Q 040050          245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP  324 (401)
Q Consensus       245 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (401)
                      ...|++.|||||++.+..++.++|||||||++|+|++|..||...... ...+..+.......        .+. ....+
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~--------~~~-~~~~~  132 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGMPAD--------DPR-DRSNL  132 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHhccC--------Ccc-ccccH
Confidence            125899999999999999999999999999999999999999653211 11111111111000        000 00112


Q ss_pred             HHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          325 IKGAQ--KAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       325 ~~~~~--~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      .....  .+.+++.+||..+|.+||++.++++.+..+.
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            22333  6999999999999999999999999987663

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-26  Score=216.02  Aligned_cols=263  Identities=24%  Similarity=0.250  Sum_probs=198.9

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC----CCceeeEEEEE-EeC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR----HPHLVKLIGYC-WEE  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----hpnI~~~~~~~-~~~  152 (401)
                      +|.+.+.||+|+||.||.|.+...     ....+|+|............+..|..++..+.    .+++..+++.. ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~-----~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSE-----KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCC-----CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            899999999999999999987652     14579999887543332236777888888886    26899999999 577


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-----CcEEEEe
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-----YTAKLSD  227 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-----~~vkL~D  227 (401)
                      ...++||+.+ |.+|.++......+.++..++..++.|++.+|.+||+  .|++||||||.|+++...     ..+.|.|
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~--~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS--KGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh--cCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            7899999998 8999998866656889999999999999999999994  559999999999999765     4699999


Q ss_pred             cCCCCCCC--CCCc----ce-e-eeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc-ccHH
Q 040050          228 FGLAKDGP--EGEE----TH-V-ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE-QSLA  298 (401)
Q Consensus       228 fG~a~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~  298 (401)
                      ||+++...  ....    .. . ...+.||..|+++.++.+...+.+.|+||++.++.+++.|..||........ ..+.
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99998322  1111    01 1 1235699999999999999999999999999999999999999965432111 1111


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ........         ..     .....+..+.++...+-..+...+|....+...|......
T Consensus       251 ~~~~~~~~---------~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  251 KDPRKLLT---------DR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHhhhhcc---------cc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            11111000         00     1122345677777777779999999999999998777443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-25  Score=196.94  Aligned_cols=277  Identities=18%  Similarity=0.262  Sum_probs=210.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~  153 (401)
                      +.-.|.++++||+|.||.++.|.+.-      ++++||||.-....  ...++..|....+.|. .++|..+|.+..++.
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~------nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~   97 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLY------NNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK   97 (449)
T ss_pred             ecccceeccccccCcceeeecccccc------cCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence            44689999999999999999997654      68999999875432  2356778888888885 899999999888888


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-----CcEEEEec
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-----YTAKLSDF  228 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-----~~vkL~Df  228 (401)
                      +-.||||++ |.+|.|+.. .-+..++..++..+|.|++.-++|+|.++  +|.|||||+|+||...     ..|.|+||
T Consensus        98 ~NiLVidLL-GPSLEDLFD-~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDF  173 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFD-LCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDF  173 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHH-HhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEec
Confidence            889999998 889987654 44578999999999999999999999655  9999999999999643     45899999


Q ss_pred             CCCCCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          229 GLAKDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       229 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      |+|.........     .......||.+||+-..+.|..-+.+.|+-|||-++++.|-|..||.+....   .       
T Consensus       174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~---t-------  243 (449)
T KOG1165|consen  174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD---T-------  243 (449)
T ss_pred             cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc---c-------
Confidence            999865443221     1123467999999999999999999999999999999999999999875321   1       


Q ss_pred             hhcCccchhhhcCCcCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh-hhcccCCCCceEEecCC
Q 040050          304 LLKEPRKLERLIDPRLEGQF---PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL-QDFQDSFVGPFVYVVPN  376 (401)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l-~~~~~~~~~~~~~~~~~  376 (401)
                         +....++|-+.......   -...+.++..-+...=..+-.+-|+.+-+...+..+ .......+.-++|....
T Consensus       244 ---nK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln  317 (449)
T KOG1165|consen  244 ---NKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN  317 (449)
T ss_pred             ---hHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence               11222233222221111   112356677777767777888889999888887776 44444555556655544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.2e-25  Score=212.71  Aligned_cols=169  Identities=20%  Similarity=0.166  Sum_probs=129.1

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-----CcccHHHHHHHHHHHhccCCCceee-E
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-----GTQGHKEWMAEIIFLGQLRHPHLVK-L  145 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnI~~-~  145 (401)
                      ...+.++|.+.+.||+|+||+||+|++...     +++.||||++...     .......+.+|+++|+.++|+||++ +
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~-----~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGD-----PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCC-----CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            345668999999999999999999987642     3566899986532     1122456889999999999999985 4


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCcEEEcCCCcEE
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDF-KASNILLDSDYTAK  224 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dl-kp~NIlv~~~~~vk  224 (401)
                      +++    ...|+||||++|++|.. +..     ..   ...++.+++.||.|||+  .||+|||| ||+|||++.++.+|
T Consensus        88 ~~~----~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~--~gIiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         88 LAT----GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHR--AGITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             EEc----CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHH--CCCeeCCCCCcceEEEcCCCCEE
Confidence            432    45799999999999962 211     11   14678899999999995  45999999 99999999999999


Q ss_pred             EEecCCCCCCCCCCccee------eecccccccccccccccc
Q 040050          225 LSDFGLAKDGPEGEETHV------ITRVMGTQGYAAPEYVMT  260 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  260 (401)
                      |+|||+|...........      ..+..+++.|+|||.+..
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999999986654332111      135678889999998863

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=9.1e-27  Score=202.42  Aligned_cols=247  Identities=21%  Similarity=0.345  Sum_probs=198.8

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      +..+|.+...|..|+|++..        ..++.|++....  ....+.|..|.-.|+-+.||||+++++.|..+..+.++
T Consensus       194 l~tkl~e~hsgelwrgrwqg--------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~i  265 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQG--------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII  265 (448)
T ss_pred             hhhhhccCCCcccccccccC--------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence            34568889999999998764        567888876542  22345788899999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE--ecCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS--DFGLAKDGPE  236 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~--DfG~a~~~~~  236 (401)
                      ..||+.|+|+..+....+-.++..++.+++..+++|++|||+.++-|.---|....++||++.+.+|.  |--++..   
T Consensus       266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq---  342 (448)
T KOG0195|consen  266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---  342 (448)
T ss_pred             eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---
Confidence            99999999999998876667788899999999999999999987756666899999999998776654  3222211   


Q ss_pred             CCcceeeeccccccccccccccccCCCC---ccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLT---TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                            .....-.|.||+||.+..++-+   .++|+|||++++|||.|...||......                +--.+
T Consensus       343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm----------------ecgmk  400 (448)
T KOG0195|consen  343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM----------------ECGMK  400 (448)
T ss_pred             ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch----------------hhhhh
Confidence                  1223457899999999876543   5799999999999999999999765321                11112


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      +....++..+|+..+..+.+++.-|+..||.+||.+..|+-.|++++
T Consensus       401 ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            33456667788889999999999999999999999999999999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.2e-26  Score=233.20  Aligned_cols=256  Identities=18%  Similarity=0.260  Sum_probs=187.9

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEec-----CCCcccH-HHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD-----LDGTQGH-KEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~-----~~~~~~~-~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ....++|.|++|.|+.+.....      ....+.|..+     ....... ..+..|+.+-..++|||++..+..+.+..
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~------~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~  394 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSD------LKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID  394 (601)
T ss_pred             CccceeeecccCceEEEEecCC------CccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence            4568899999997777655432      2223333322     1111111 12556888888899999988777766655


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..+-.||||++ +|+.++...  ..+....+-.++.|++.|+.|+|.++  |.|||||++|++++.+|.+||+|||.+..
T Consensus       395 ~~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  395 GILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             cchhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCccee
Confidence            55555999998 999998764  57888899999999999999999555  99999999999999999999999999987


Q ss_pred             CCCCCcc--eeeeccccccccccccccccCCCCc-cccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          234 GPEGEET--HVITRVMGTQGYAAPEYVMTGHLTT-MSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       234 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +......  ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||......+......       ....
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~  542 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSD  542 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------cccc
Confidence            6555544  5567789999999999999999987 5899999999999999999997654332211000       0000


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...+..  -...+...++...+.++.+||+.||.+|.|+.+|++.
T Consensus       543 ~~~~~~--~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  543 QRNIFE--GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cccccc--ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            000000  0001223457788999999999999999999999763

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.6e-25  Score=190.22  Aligned_cols=261  Identities=20%  Similarity=0.269  Sum_probs=196.5

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEE  152 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~  152 (401)
                      +..+.|.+.+.||.|+||.+|.|....      ++..||||+-....  ...++.-|..+.+.|+ ..+|..+..+..+.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~------~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~   83 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISIT------SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEK   83 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeecc------CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence            345889999999999999999998877      79999999976443  3356778999998887 56889999899899


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEEecC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFG  229 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~DfG  229 (401)
                      .+-.+||+++ |.+|.+++.-- ...++..+++-++-|++.-++|+|  .++.|||||||+|+|+.-   ...+.|+|||
T Consensus        84 ~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH--~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   84 DYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVH--LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             ccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHH--hhccccccCCccceeeccccccceEEEEecc
Confidence            9999999998 89998877542 467899999999999999999999  455999999999999954   3579999999


Q ss_pred             CCCCCCCCCc-----ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          230 LAKDGPEGEE-----THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       230 ~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|........     ........||..|.+-..+.+..-+.+.|+-|+|.++.++.-|..||.+.......         
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~---------  230 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK---------  230 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH---------
Confidence            9986544322     11223467999999988888888888999999999999999999999875422111         


Q ss_pred             hcCccchhhhcCCcCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          305 LKEPRKLERLIDPRLEGQ---FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                          ...+++......-.   +-...+.++.-.+..|-..--++-|+...+.+.+.-+
T Consensus       231 ----QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  231 ----QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             ----HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence                11111111111100   0011244566666677777777888877666665544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=1.5e-23  Score=196.84  Aligned_cols=261  Identities=32%  Similarity=0.437  Sum_probs=196.3

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc---cHHHHHHHHHHHhccCCC-ceeeEEEEEEeCCe
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAEIIFLGQLRHP-HLVKLIGYCWEEEY  154 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hp-nI~~~~~~~~~~~~  154 (401)
                      |.+.+.||.|+||.||.+.+.         ..+++|.+......   ....+.+|+.++..+.|+ +|+++++.+.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            677889999999999999765         47899988755332   356788999999999988 79999999987778


Q ss_pred             EEEEEEecCCCChhHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEecCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYS-AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAK  232 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~DfG~a~  232 (401)
                      .+++++++.++++.+++..... ..+.......++.|++.++.|+|+.+  ++|||+||+||+++..+ .++++|||.+.
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            8999999999999966644311 27899999999999999999999655  99999999999999988 79999999997


Q ss_pred             CCCCCCcce----eeecccccccccccccccc---CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          233 DGPEGEETH----VITRVMGTQGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       233 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      .........    ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||......  ...........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~  228 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIIL  228 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHH
Confidence            554433221    2356789999999999987   57889999999999999999999997654321  00111111111


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .....   .................+.+++..|+..+|..|.+.......
T Consensus       229 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         229 ELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             hcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11110   000000000002234678899999999999999998887765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=8.3e-24  Score=186.53  Aligned_cols=174  Identities=11%  Similarity=0.110  Sum_probs=133.2

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHH---------HHHHHHHHhccCCCce
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---------WMAEIIFLGQLRHPHL  142 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnI  142 (401)
                      ...+.++|.+.++||.|+||.||++.. .       +..+|+|+++.........         +.+|+..+.++.||+|
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~-------~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI   97 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-D-------YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL   97 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec-C-------CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC
Confidence            356789999999999999999998643 2       4579999997543322222         5789999999999999


Q ss_pred             eeEEEEEEeC--------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCc
Q 040050          143 VKLIGYCWEE--------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASN  214 (401)
Q Consensus       143 ~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~N  214 (401)
                      ..+.+++...        ...+|+|||++|.+|.++.      .++.    ....+++.+|..+|..  |++|||+||.|
T Consensus        98 ~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~--gi~H~Dikp~N  165 (232)
T PRK10359         98 ASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQH--GMVSGDPHKGN  165 (232)
T ss_pred             CcceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHc--CCccCCCChHH
Confidence            9999886643        3478999999999997763      1222    2456899999999954  59999999999


Q ss_pred             EEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHH
Q 040050          215 ILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL  280 (401)
Q Consensus       215 Ilv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  280 (401)
                      |+++.+| ++|+|||...........              ...+....|+.++|+|+||+++..+.
T Consensus       166 ili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        166 FIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999988 999999988754322111              11344556778999999999987654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=2.6e-24  Score=217.25  Aligned_cols=250  Identities=23%  Similarity=0.259  Sum_probs=183.6

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-cc---HHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QG---HKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~---~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      +|...+.||.+.|=.|.+|.+.+       |. |+||++-...+ -.   ..+.+.|++ ...++|||.+++.-+...+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence            67778999999999999998876       44 99999864432 22   334444555 55678999999988888888


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|||-+|.. -+|+|++..+  ..+...+.+.|+.|++.||..+|.  .||+|+|||.+||||+.-.-+.|+||..-+-
T Consensus        95 AAylvRqyvk-hnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~--~gVcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   95 AAYLVRQYVK-HNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHK--LGVCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHHh-hhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHH--cCccccccccceEEEeeechhhhhcccccCC
Confidence            8899999984 5999999654  667888889999999999999995  5599999999999999999999999986542


Q ss_pred             --CCCC---CcceeeeccccccccccccccccC----------C-CCccccHHhHHHHHHHHHh-CCCCCCCCccccccc
Q 040050          234 --GPEG---EETHVITRVMGTQGYAAPEYVMTG----------H-LTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQS  296 (401)
Q Consensus       234 --~~~~---~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  296 (401)
                        .+.+   +....+.+-..-.+|.|||.+...          . .+++.||||+||+++||++ |++||....      
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------  243 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------  243 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------
Confidence              2221   222233333344579999988531          1 5678999999999999998 688886431      


Q ss_pred             HHHHhhhhhcCcc-chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          297 LAEWARPLLKEPR-KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       297 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      +..|...--.++. .++++-            ...++.++..|++.||.+|.++++.++.-..+
T Consensus       244 L~aYr~~~~~~~e~~Le~Ie------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLLEKIE------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             HHhHhccCccCHHHHHHhCc------------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            2222221111111 111111            22578899999999999999999999884443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.5e-24  Score=205.65  Aligned_cols=229  Identities=26%  Similarity=0.361  Sum_probs=183.9

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEEEEEE
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~lv~e  160 (401)
                      ++|+|+||.|+++.-.   .....+..+|+|+.....  .........|..++...+ ||.++++...+..+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~---~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKA---GGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHh---ccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            4799999999976422   233356778888776432  111124556888888887 9999999999999999999999


Q ss_pred             ecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc
Q 040050          161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~  240 (401)
                      +..||.|...+...  ..+.+.....+...++-|+.++|..+  |+|||+|++||+++.+|++++.|||+++........
T Consensus        78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            99999998888654  66778888888999999999999655  999999999999999999999999999876544322


Q ss_pred             eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCC
Q 040050          241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE  320 (401)
Q Consensus       241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (401)
                            |||..|||||++.  ....++|.||||+++++|++|..||...                    .+..++  ...
T Consensus       154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il--~~~  203 (612)
T KOG0603|consen  154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRIL--KAE  203 (612)
T ss_pred             ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHh--hhc
Confidence                  8999999999998  5688999999999999999999999751                    111221  122


Q ss_pred             CCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040050          321 GQFPIKGAQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       321 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~  349 (401)
                      ...|...+..+++++..++..+|.+|.-.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            34677778899999999999999999765

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.6e-22  Score=175.98  Aligned_cols=139  Identities=15%  Similarity=0.118  Sum_probs=106.4

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--c-------H-----------------HHHHHHHHHHh
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--G-------H-----------------KEWMAEIIFLG  135 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~  135 (401)
                      ...||+|+||.||+|.+.       +++.||+|+++.....  .       .                 .....|+.++.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATTA-------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEECC-------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            468999999999999764       3789999999754211  0       0                 12234999999


Q ss_pred             ccCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-hCCCCCeeeccCCCCc
Q 040050          136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL-HGEDKPVIYRDFKASN  214 (401)
Q Consensus       136 ~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~iiH~Dlkp~N  214 (401)
                      ++.++++.....+...  ..+|||||++|+++...+..  ...++...+..++.|++.+|.++ |+.  ||+||||||+|
T Consensus        75 ~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~--giiHrDlkP~N  148 (190)
T cd05147          75 RLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDC--RLVHADLSEYN  148 (190)
T ss_pred             HHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHH
Confidence            9988776443333222  23899999988777654333  25788999999999999999999 754  59999999999


Q ss_pred             EEEcCCCcEEEEecCCCCCC
Q 040050          215 ILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       215 Ilv~~~~~vkL~DfG~a~~~  234 (401)
                      ||++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=6.8e-22  Score=179.53  Aligned_cols=233  Identities=18%  Similarity=0.239  Sum_probs=148.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCC----------Cceee
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRH----------PHLVK  144 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------pnI~~  144 (401)
                      .+..++.||.|+++.||.+++.+      +++.+|+|+.....   ....+.+.+|.-....+.+          -.++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEEccccccCCceEEEEEEEcc------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            34567899999999999999988      79999999986443   2234556666544444322          12222


Q ss_pred             EEEEEE---------eC---C-----eEEEEEEecCCCChhHHHhh---hcC--CCCCHHHHHHHHHHHHHHHHHHhCCC
Q 040050          145 LIGYCW---------EE---E-----YRLLVYEYMPRGSLHNQLFR---SYS--AALPWSTRMKIALGAAKGLAFLHGED  202 (401)
Q Consensus       145 ~~~~~~---------~~---~-----~~~lv~e~~~~~~L~~~l~~---~~~--~~l~~~~~~~i~~qi~~al~~LH~~~  202 (401)
                      .++...         ..   .     ..+++|+.+ .++|.+++..   ...  ..+.....+.+..|+++.+++||+.+
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence            222221         11   1     236788887 5788777532   211  12334455667789999999999655


Q ss_pred             CCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeecccccccccccccccc--------CCCCccccHHhHHH
Q 040050          203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT--------GHLTTMSDVYSFGV  274 (401)
Q Consensus       203 ~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~  274 (401)
                        |+|+||+|+|++++.+|.++|+||+........     ......+..|.|||....        -.++.+.|.|+||+
T Consensus       166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~-----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR-----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             --EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE-----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             --eEecccceeeEEEcCCCCEEEcChHHHeecCce-----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence              999999999999999999999999887754321     121345678999997643        24788999999999


Q ss_pred             HHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 040050          275 VLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHR  346 (401)
Q Consensus       275 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  346 (401)
                      ++|.|++|..||+.........            .         ...... +.++.++.||..+|+.||.+|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~------------~---------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPE------------W---------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSG------------G---------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCcccccc------------c---------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9999999999998653221100            0         111233 668899999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=4.4e-22  Score=204.46  Aligned_cols=199  Identities=22%  Similarity=0.242  Sum_probs=164.6

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC---CCceeeEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR---HPHLVKLIGY  148 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnI~~~~~~  148 (401)
                      ..+-...|.|.+.||+|+||.||+|...+       ++.||+|+-.....-   +|.--.+++.+|+   -+.|..+..+
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-------~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a  762 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-------GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSA  762 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-------CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHH
Confidence            34445678999999999999999998765       889999998765443   2222334444444   4556677777


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-------CC
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-------DY  221 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-------~~  221 (401)
                      +...+..++|++|.+.|+|.++++  ..+.+++..++.++.|++..+.+||..+  |||+||||+|+||..       ..
T Consensus       763 ~~~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  763 HVFQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             HccCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCccc
Confidence            777788899999999999999997  4589999999999999999999999655  999999999999942       34


Q ss_pred             cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCC
Q 040050          222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR  284 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  284 (401)
                      -++|+|||.+..+..-.....+...++|-.+-.+|+..|..++..+|.|.|+.+++.||.|++
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            589999999987665555556778889999999999999999999999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=2e-21  Score=169.65  Aligned_cols=142  Identities=15%  Similarity=0.105  Sum_probs=109.6

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc---------------------c-----HHHHHHHHHHH
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---------------------G-----HKEWMAEIIFL  134 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l  134 (401)
                      +.+.||+|++|.||+|.+.       +++.||||+++.....                     .     ...+..|+..+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   73 (190)
T cd05145           1 INGCISTGKEANVYHARTG-------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNL   73 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHH
Confidence            3578999999999999754       3789999998754211                     0     11235689999


Q ss_pred             hccCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCc
Q 040050          135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASN  214 (401)
Q Consensus       135 ~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~N  214 (401)
                      .++.|++|.....+....  .+|||||++|+++.......  ..++...+..++.|++.++.++|+ ..||+||||||+|
T Consensus        74 ~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~-~~givHrDlkP~N  148 (190)
T cd05145          74 KRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQ-EAGLVHGDLSEYN  148 (190)
T ss_pred             HHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCChhh
Confidence            999999885554443333  48999999887654432222  467888999999999999999995 1459999999999


Q ss_pred             EEEcCCCcEEEEecCCCCCCC
Q 040050          215 ILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       215 Ilv~~~~~vkL~DfG~a~~~~  235 (401)
                      |+++ ++.++|+|||++....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEEE-CCCEEEEEcccceecC
Confidence            9998 8899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=6.1e-21  Score=164.90  Aligned_cols=188  Identities=18%  Similarity=0.092  Sum_probs=137.2

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc----HHHHHHHHHHHhccC-CCceeeEEEEEEeCCe
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG----HKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEY  154 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~  154 (401)
                      .+...|++|+||+|+.+..        .+.+++.+.+.....-.    ...+.+|+++|+++. |++|++++++    +.
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~   72 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG   72 (218)
T ss_pred             ccceeecCCCcceEEEeec--------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC
Confidence            4567899999999997643        25677777665443211    124678999999995 5889999886    34


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccC-CCCcEEEcCCCcEEEEecCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDF-KASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dl-kp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+++|+|+.|.+|...+..         ....++.|++.+|.++|++  ||+|||| ||+|||++.+|.++|+|||++..
T Consensus        73 ~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~--GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~  141 (218)
T PRK12274         73 RHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC--GVAHNDLAKEANWLVQEDGSPAVIDFQLAVR  141 (218)
T ss_pred             EEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC--cCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence            6999999999888654321         1135778999999999954  5999999 79999999999999999999985


Q ss_pred             CCCCCcc----e--e-----eecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCc
Q 040050          234 GPEGEET----H--V-----ITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTR  290 (401)
Q Consensus       234 ~~~~~~~----~--~-----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~  290 (401)
                      .......    .  -     .....+++.|++|+...-  ..--.+.++++.|+-+|.++|+..+.....
T Consensus       142 ~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        142 GNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             cCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            4432210    0  0     001236778888876542  222367899999999999999998875543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=7.2e-21  Score=173.86  Aligned_cols=197  Identities=21%  Similarity=0.266  Sum_probs=143.4

Q ss_pred             CCCceeeEEEEEEe---------------------------CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHH
Q 040050          138 RHPHLVKLIGYCWE---------------------------EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG  190 (401)
Q Consensus       138 ~hpnI~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~q  190 (401)
                      +||||+++.++|.+                           +..+|+||..+ ..+|..++-.+   ..+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence            59999999987753                           34679999988 56999998663   5667778889999


Q ss_pred             HHHHHHHHhCCCCCeeeccCCCCcEEE--cCC--CcEEEEecCCCCCCCCCCcc----eeeeccccccccccccccccC-
Q 040050          191 AAKGLAFLHGEDKPVIYRDFKASNILL--DSD--YTAKLSDFGLAKDGPEGEET----HVITRVMGTQGYAAPEYVMTG-  261 (401)
Q Consensus       191 i~~al~~LH~~~~~iiH~Dlkp~NIlv--~~~--~~vkL~DfG~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~-  261 (401)
                      +++|+.|||+++  |.|||+|.+|||+  +++  ..+.|+|||++-........    .-.....|.-..||||+...- 
T Consensus       350 lLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999665  9999999999999  444  45789999998543321111    111234688899999988632 


Q ss_pred             -C----CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHH
Q 040050          262 -H----LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAF  336 (401)
Q Consensus       262 -~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  336 (401)
                       +    .-.++|.|+.|.+.||+++...||-.....   .+         +...    ......+.+|..+++.+++++.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L---------~~r~----Yqe~qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LL---------DTRT----YQESQLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchh---ee---------chhh----hhhhhCCCCcccCChHHHHHHH
Confidence             1    135899999999999999999999653110   00         0000    1112233456677889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHH
Q 040050          337 KCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       337 ~cl~~dP~~RPt~~~il~~L  356 (401)
                      ..|+.||.+|++..-....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999976555443

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=3.8e-20  Score=162.74  Aligned_cols=137  Identities=20%  Similarity=0.243  Sum_probs=105.8

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-----CCCceeeEEEEEEeCC-
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-----RHPHLVKLIGYCWEEE-  153 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnI~~~~~~~~~~~-  153 (401)
                      .-.++||+|+||.||.  +..      ++. .+||++..........+.+|+.+++.+     .||||+++++++.++. 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~------~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g   75 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE------DAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG   75 (210)
T ss_pred             CCcceecCCCceEEEE--CCC------CcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence            3457899999999995  333      233 479998765455567789999999999     5799999999999874 


Q ss_pred             --eEE-EEEEe--cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHhCCCCCeeeccCCCCcEEEcC----CCcE
Q 040050          154 --YRL-LVYEY--MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL-AFLHGEDKPVIYRDFKASNILLDS----DYTA  223 (401)
Q Consensus       154 --~~~-lv~e~--~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al-~~LH~~~~~iiH~Dlkp~NIlv~~----~~~v  223 (401)
                        ..+ +||||  +.+++|.+++.+.   .+++.  ..++.+++.++ .|||+++  |+||||||+|||++.    ++.+
T Consensus        76 ~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         76 TGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             CeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcE
Confidence              333 78999  5579999999652   35555  35677888777 8999655  999999999999974    3489


Q ss_pred             EEEecCCCC
Q 040050          224 KLSDFGLAK  232 (401)
Q Consensus       224 kL~DfG~a~  232 (401)
                      +|+||+.+.
T Consensus       149 ~LiDg~G~~  157 (210)
T PRK10345        149 VVCDNIGES  157 (210)
T ss_pred             EEEECCCCc
Confidence            999955443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=7.5e-21  Score=192.18  Aligned_cols=214  Identities=25%  Similarity=0.336  Sum_probs=147.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ...+|..++.|..|++|.||.++++.      +.+.+|+|+-+ .+     .+++-  ++.....|.++           
T Consensus        81 ~e~df~~IklisngAygavylvrh~~------trqrfa~kiNk-q~-----lilRn--ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKE------TRQRFAMKINK-QN-----LILRN--ILTFAGNPFVV-----------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccc------cccchhhcccc-cc-----hhhhc--cccccCCccee-----------
Confidence            45789999999999999999998876      67888885422 11     11111  33333344433           


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                                |+-...+..-  +.++...        +.+++|||+  .||+|||+||+|.+|+.-|++|++|||++...
T Consensus       136 ----------gDc~tllk~~--g~lPvdm--------vla~Eylh~--ygivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 ----------GDCATLLKNI--GPLPVDM--------VLAVEYLHS--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ----------chhhhhcccC--CCCcchh--------hHHhHhhcc--CCeecCCCCCCcceeeecccccccchhhhhhh
Confidence                      4444444332  4454433        678999995  55999999999999999999999999998643


Q ss_pred             CCCCccee-------------eeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          235 PEGEETHV-------------ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       235 ~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      .....+..             -...+|||.|+|||++..+.|+..+|+|++|+|+|+.+.|+.||.+...+  ..+...+
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--elfg~vi  271 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQVI  271 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--HHHhhhh
Confidence            22111111             12358999999999999999999999999999999999999999875321  1122222


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS  350 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  350 (401)
                      ...+..++.             ....+.++++++.++|+.+|..|.-..
T Consensus       272 sd~i~wpE~-------------dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  272 SDDIEWPEE-------------DEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             hhhcccccc-------------CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence            222211111             112356899999999999999995433

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=1.3e-19  Score=163.16  Aligned_cols=148  Identities=16%  Similarity=0.153  Sum_probs=112.1

Q ss_pred             HHHHhcC--CCCCceecccCCeeEEEEE-ecCcCCCCCCCceEEEEEecCCCcc------------------------cH
Q 040050           72 LRLITSN--FSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQ------------------------GH  124 (401)
Q Consensus        72 ~~~~~~~--y~~~~~Lg~G~~g~V~~a~-~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~  124 (401)
                      .......  |.+.+.||+|+||.||+|+ +..      +++.||+|+++.....                        ..
T Consensus        21 ~~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (237)
T smart00090       21 YSLLNRGILSAIGGCISTGKEANVYHALDFDG------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVR   94 (237)
T ss_pred             HHHHhcCchHHhCCeeccCcceeEEEEEecCC------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHH
Confidence            3344444  8899999999999999998 333      5889999998754210                        01


Q ss_pred             HHHHHHHHHHhccCCCc--eeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC
Q 040050          125 KEWMAEIIFLGQLRHPH--LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED  202 (401)
Q Consensus       125 ~~~~~E~~~l~~l~hpn--I~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~  202 (401)
                      ..+..|+.++.++.+.+  +.+++++   . ..++||||+.|.+|.......  ..+....+..++.|++.++.+||  .
T Consensus        95 ~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH--~  166 (237)
T smart00090       95 LWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY--K  166 (237)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH--h
Confidence            23457999999997533  3444442   2 348999999888886654332  45566677899999999999999  6


Q ss_pred             CC-eeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          203 KP-VIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       203 ~~-iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .| |+|+||||+||+++ ++.++|+|||.+...
T Consensus       167 ~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      167 EGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             cCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            67 99999999999999 889999999998753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.4e-19  Score=174.56  Aligned_cols=221  Identities=27%  Similarity=0.357  Sum_probs=162.8

Q ss_pred             HhccCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 040050          134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKAS  213 (401)
Q Consensus       134 l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~  213 (401)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++.-...+++.++.||.|||+...+ .|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIG-YHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcce-eeeeeccc
Confidence            46788999999999999999999999999999999999763 46788888899999999999999965422 89999999


Q ss_pred             cEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCC-------CCccccHHhHHHHHHHHHhCCCCC
Q 040050          214 NILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH-------LTTMSDVYSFGVVLLELLTGKRAM  286 (401)
Q Consensus       214 NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~g~~pf  286 (401)
                      |++++....+||+|||+.................-..-|.|||.+.+..       .+.+.|+||+|++++|+++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987653211111111112344699999987631       466799999999999999999999


Q ss_pred             CCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          287 DNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      .........  .+.+..+...   ....+.|.+....  ...+.+..++..||..+|.+||++..+-..++.+....
T Consensus       159 ~~~~~~~~~--~eii~~~~~~---~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  159 DLRNLVEDP--DEIILRVKKG---GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccCCh--HHHHHHHHhc---CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            764322211  1111111110   0001111111000  23447889999999999999999999999988886654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=2.3e-18  Score=152.94  Aligned_cols=134  Identities=19%  Similarity=0.228  Sum_probs=110.8

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--------cHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--------GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +.||+|++|.||+|.+.        +..|++|+.......        ....+.+|+.++..+.|++|.....++.....
T Consensus         2 ~~l~~G~~~~vy~~~~~--------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL--------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEeeC--------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            57999999999999763        567999986543211        12346789999999999998887777777778


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+++|||++|++|.+++...  .   . ....++.+++.+|.++|+  .+++|+|++|.||+++ ++.++|+|||++..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~--~---~-~~~~i~~~i~~~l~~lH~--~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSN--G---M-EELELSREIGRLVGKLHS--AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhc--c---H-HHHHHHHHHHHHHHHHHh--CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            89999999999999988543  1   1 778999999999999995  4599999999999999 78999999998874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=3.1e-18  Score=150.64  Aligned_cols=130  Identities=20%  Similarity=0.259  Sum_probs=104.2

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--------cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--------GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .||+|+||.||+|.+.        +..|++|........        ....+.+|++++..+.|+++.....++......
T Consensus         1 ~ig~G~~~~vy~~~~~--------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeecC--------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            4899999999999743        567999986533211        124566899999999988766655566667777


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ++||||++|++|.+++...  ..       .++.+++.+|.+||+  .+++|+|++|.||+++ ++.++++|||++..
T Consensus        73 ~lv~e~~~g~~l~~~~~~~--~~-------~~~~~i~~~l~~lH~--~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEG--ND-------ELLREIGRLVGKLHK--AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhc--HH-------HHHHHHHHHHHHHHH--CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999999998887542  11       789999999999995  5599999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=6.5e-20  Score=173.88  Aligned_cols=172  Identities=25%  Similarity=0.361  Sum_probs=128.0

Q ss_pred             eEEEEEEecCCCChhHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFR-SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ++||.|++|.-.+|.+||.+ ......++...+.++.|++.|+.|     ++.+|+|+||.||+...+..+||.|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence            57899999999999999974 334567788899999999999999     459999999999999999999999999987


Q ss_pred             CCCCCC----cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcC
Q 040050          233 DGPEGE----ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       233 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ......    .....+...||..||+||++.+..|+.++||||||++|+|+++ =...|+..                  
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------------------  466 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------------------  466 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------------------
Confidence            665543    1223455789999999999999999999999999999999997 12222111                  


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS  350 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  350 (401)
                       ..+..+.+..+.+.+. ..-+.-..|+.+++...|.+||++.
T Consensus       467 -~t~~d~r~g~ip~~~~-~d~p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  467 -ATLTDIRDGIIPPEFL-QDYPEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             -HhhhhhhcCCCChHHh-hcCcHHHHHHHHhcCCCcccCchHH
Confidence             1111111111110000 0012345789999999999999443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=1.3e-17  Score=146.57  Aligned_cols=138  Identities=21%  Similarity=0.152  Sum_probs=106.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc----------------------cHHHHHHHHHHHh
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ----------------------GHKEWMAEIIFLG  135 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  135 (401)
                      .|.+.+.||+|+||.||+|...       +++.||||+++.....                      .......|+.++.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            3888899999999999999764       4789999987643210                      0113567888898


Q ss_pred             ccCCCc--eeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 040050          136 QLRHPH--LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKAS  213 (401)
Q Consensus       136 ~l~hpn--I~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~  213 (401)
                      .+.|++  ++.+++    ....++||||++|++|......        .....++.+++.++.++|.  .+|+|+||+|.
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~--~gi~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK--HGIIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH--CCCCcCCCCcc
Confidence            888774  444443    2345899999999888654321        2456788999999999995  55999999999


Q ss_pred             cEEEcCCCcEEEEecCCCCCCCC
Q 040050          214 NILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       214 NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ||+++.++.++|+|||.+.....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.6e-17  Score=167.60  Aligned_cols=137  Identities=22%  Similarity=0.231  Sum_probs=109.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--Cc------ccHHHHHHHHHHHhccCCCceeeEEE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GT------QGHKEWMAEIIFLGQLRHPHLVKLIG  147 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~E~~~l~~l~hpnI~~~~~  147 (401)
                      ...|...+.||+|+||+||+|.+..        ..+++|+....  ..      .....+.+|+++++.++|++|+....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG--------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC--------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            3455678999999999999987654        23444433211  11      11345778999999999999998887


Q ss_pred             EEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          148 YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                      ++......++||||++|++|.+++.          ....++.+++.+|.+||+  .+|+||||||+||++ .++.++|+|
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~--~giiHrDlkp~NILl-~~~~~~liD  470 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK--AGIVHGDLTTSNFIV-RDDRLYLID  470 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh--CCCccCCCChHHEEE-ECCcEEEEe
Confidence            7777777899999999999998874          346789999999999995  459999999999999 678999999


Q ss_pred             cCCCCC
Q 040050          228 FGLAKD  233 (401)
Q Consensus       228 fG~a~~  233 (401)
                      ||+++.
T Consensus       471 FGla~~  476 (535)
T PRK09605        471 FGLGKY  476 (535)
T ss_pred             Cccccc
Confidence            999875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=5.1e-19  Score=178.27  Aligned_cols=258  Identities=24%  Similarity=0.291  Sum_probs=193.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~  153 (401)
                      ..|.+.+.||+|+|+.|-.+.....     ....+|.|.+....  .........|..+-+.+. |+|++.+++......
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~-----~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRD-----PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCC-----CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc
Confidence            4567778899999999987654331     34566777665443  222334445777877787 999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHh-CCCCCeeeccCCCCcEEEcCCC-cEEEEecCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH-GEDKPVIYRDFKASNILLDSDY-TAKLSDFGLA  231 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~iiH~Dlkp~NIlv~~~~-~vkL~DfG~a  231 (401)
                      ..++++++..|+++++.+........+...+..++.|+..++.|+| ..+  +.|+||||+|.+++..+ .+++.|||+|
T Consensus        95 ~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             ccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhh
Confidence            9999999999999999884332336677788899999999999999 544  99999999999999999 9999999999


Q ss_pred             CCCCC-CCcceeeecccc-ccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          232 KDGPE-GEETHVITRVMG-TQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       232 ~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ..... ..........+| ++.|+|||...+. ...+..|+||+|+++..+++|..|+........ ....|..    ..
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~----~~  247 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKS----NK  247 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecc----cc
Confidence            87776 555555566788 9999999999884 557789999999999999999999876432211 1111100    00


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .        ...............+++.+++..+|..|.+.+++-.
T Consensus       248 ~--------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 G--------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             c--------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            0        0001112233556778888999999999999988744

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.8e-16  Score=137.96  Aligned_cols=138  Identities=21%  Similarity=0.195  Sum_probs=96.0

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc--HHH----------------------HHHHHHHHhc
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--HKE----------------------WMAEIIFLGQ  136 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~  136 (401)
                      +.+.||+|+||+||+|.+.       +++.||+|++.......  ...                      ...|...+..
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~   73 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKR   73 (187)
T ss_pred             CCcccccccceeEEEEECC-------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHH
Confidence            3578999999999999754       37899999987532111  011                      1245666666


Q ss_pred             cCCCc--eeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCc
Q 040050          137 LRHPH--LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASN  214 (401)
Q Consensus       137 l~hpn--I~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~N  214 (401)
                      +.+.+  +.+++++    ...++||||++++.+........  ... ..+..++.+++.++.++|. ..+|+|+||||+|
T Consensus        74 l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~-~~~ivH~Dl~p~N  145 (187)
T cd05119          74 LYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYR-EAGLVHGDLSEYN  145 (187)
T ss_pred             HHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhh-ccCcCcCCCChhh
Confidence            54432  4444443    23589999998854432111110  011 5678899999999999995 1459999999999


Q ss_pred             EEEcCCCcEEEEecCCCCCC
Q 040050          215 ILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       215 Ilv~~~~~vkL~DfG~a~~~  234 (401)
                      |+++ ++.++|+|||.+...
T Consensus       146 ili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE-CCcEEEEECcccccc
Confidence            9999 899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=5.5e-16  Score=129.35  Aligned_cols=134  Identities=20%  Similarity=0.162  Sum_probs=111.5

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCC--CceeeEEEEEEeCCeEEEE
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH--PHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnI~~~~~~~~~~~~~~lv  158 (401)
                      +.+.||.|.++.||++....        ..+++|.......  ...+..|+.+++.++|  .++++++.++...+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEecC--------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            45789999999999997643        5799999865433  4578889999999976  5899999988887889999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED-KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      |||+.++.+..+         +......++.+++.+++++|... .+++|+|++|+||+++..+.++++|||.+..
T Consensus        72 ~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          72 MEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999988777543         45566788999999999999642 4699999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=7.7e-16  Score=138.90  Aligned_cols=134  Identities=22%  Similarity=0.168  Sum_probs=100.9

Q ss_pred             ceec-ccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-------------cccHHHHHHHHHHHhccCCCce--eeEE
Q 040050           83 NLLG-EGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-------------TQGHKEWMAEIIFLGQLRHPHL--VKLI  146 (401)
Q Consensus        83 ~~Lg-~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--~~~~  146 (401)
                      ..|| .||.|+||.+...        +..++||.+...+             ......+.+|+.++..+.|++|  +..+
T Consensus        37 ~~lg~~~g~gtv~~v~~~--------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl  108 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPI  108 (239)
T ss_pred             ceeecCCCCccEEEEEeC--------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeE
Confidence            5677 7888899988653        4678998774311             1123457789999999998875  6677


Q ss_pred             EEEEeCC-e---EEEEEEecCC-CChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          147 GYCWEEE-Y---RLLVYEYMPR-GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       147 ~~~~~~~-~---~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      ++..... .   .++|||+++| .+|.+++..   ..++..    .+.+++.+|.+||.  .||+|+||||.|||++.++
T Consensus       109 ~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~--~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        109 AARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHD--AGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHH--CCCCCCCCCchhEEEcCCC
Confidence            6644332 2   2599999987 688887754   345543    35689999999995  5599999999999999999


Q ss_pred             cEEEEecCCCCC
Q 040050          222 TAKLSDFGLAKD  233 (401)
Q Consensus       222 ~vkL~DfG~a~~  233 (401)
                      .++|+|||.+..
T Consensus       180 ~v~LIDfg~~~~  191 (239)
T PRK01723        180 KFWLIDFDRGEL  191 (239)
T ss_pred             CEEEEECCCccc
Confidence            999999998875

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=2.2e-15  Score=145.86  Aligned_cols=254  Identities=24%  Similarity=0.276  Sum_probs=185.8

Q ss_pred             HhcCCCCCceecc--cCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccC-CCceeeEEEEE
Q 040050           75 ITSNFSRSNLLGE--GGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLR-HPHLVKLIGYC  149 (401)
Q Consensus        75 ~~~~y~~~~~Lg~--G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~  149 (401)
                      ....|.+.+.+|.  |.+|.||.+....    .-.+..+|+|.-...  .......-++|+...+.++ |+|.++.+..+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~----~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTN----SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCc----ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc
Confidence            3456778899999  9999999997722    125788999985433  2333344556777777775 99999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHhCCCCCeeeccCCCCcEEEcCC-CcEE
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK----GLAFLHGEDKPVIYRDFKASNILLDSD-YTAK  224 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~----al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vk  224 (401)
                      ...+..++-+|++ +.+|..+.... ...++...++..+.+...    ||.++|+..  ++|-|+||.||++..+ ...+
T Consensus       188 e~~~~lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  188 EGSGILFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             ccCCcceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceee
Confidence            9999999999998 67887776543 345788888888888888    999999655  9999999999999999 8899


Q ss_pred             EEecCCCCCCCCCCcceee---eccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          225 LSDFGLAKDGPEGEETHVI---TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      ++|||+......+......   .+..|...|++||... +.++..+|+|+||.++.+..+|..+.......         
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---------  333 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS---------  333 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC---------
Confidence            9999999877665432222   2336788999999654 56788999999999999999987765432110         


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                              .+..+....+...+-...+.++...+..|++.+|..|++.+.+..
T Consensus       334 --------~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  334 --------SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             --------CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                    011110111111222223456666888999999999999887754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.50  E-value=1.3e-13  Score=135.04  Aligned_cols=140  Identities=20%  Similarity=0.171  Sum_probs=94.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccH--------------------------------------
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--------------------------------------  124 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------  124 (401)
                      +.||.|++|.||+|+..+       |+.||||+.+..-....                                      
T Consensus       123 ~plasaSigQVh~A~l~~-------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~  195 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVD-------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR  195 (437)
T ss_pred             cceeeeehhheEEEEecC-------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence            689999999999998764       78999999864321100                                      


Q ss_pred             --HHHHHHHHHHhcc----CCCceeeEEEEEE-eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHH-HHH
Q 040050          125 --KEWMAEIIFLGQL----RHPHLVKLIGYCW-EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-GLA  196 (401)
Q Consensus       125 --~~~~~E~~~l~~l----~hpnI~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~-al~  196 (401)
                        -++.+|...+.++    +|.+-+.+-.++. .....+|||||++|++|.+...... ....   ...++..++. .+.
T Consensus       196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLN  271 (437)
T ss_pred             HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHH
Confidence              0133455444444    2222223222322 2344689999999999988764321 1222   2345555555 467


Q ss_pred             HHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       197 ~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      .+|.  .|++|+|++|.||+++.+|.++|+|||++....
T Consensus       272 ql~~--~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       272 QVLR--DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHh--CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7884  459999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=3.2e-14  Score=127.82  Aligned_cols=203  Identities=25%  Similarity=0.330  Sum_probs=140.1

Q ss_pred             HHHHhccCCCceeeEEEEEEeCC-----eEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCC
Q 040050          131 IIFLGQLRHPHLVKLIGYCWEEE-----YRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDK  203 (401)
Q Consensus       131 ~~~l~~l~hpnI~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~  203 (401)
                      +.-|-.+-|.||++++.|+.+..     ...++.||+..|++..+|++  +..+.+......+++.||+.||.|||+-..
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            34455567999999999886543     46789999999999999975  345678888889999999999999999999


Q ss_pred             CeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC--cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh
Q 040050          204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT  281 (401)
Q Consensus       204 ~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  281 (401)
                      .|+|+++..+-|++..+|-+|+.--.-........  .........|.++|.|||.=...+.+.++|||+||+...+|..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999999988884211111000000  0111122347889999997666677889999999999999988


Q ss_pred             CCCCCCCCc--ccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          282 GKRAMDNTR--LGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       282 g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      |..--....  ...+.....          .+..+-+.            .-+.++.+|++..|..||++++++-+
T Consensus       278 lEiq~tnseS~~~~ee~ia~----------~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIAN----------VIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             heeccCCCcceeehhhhhhh----------heeeccCc------------cccCcCcccccCCCCCCcchhhhhcC
Confidence            764211110  000000000          00000011            11245668999999999999988654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.45  E-value=1.6e-12  Score=127.32  Aligned_cols=164  Identities=18%  Similarity=0.200  Sum_probs=124.4

Q ss_pred             CCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHH
Q 040050          107 EAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK  186 (401)
Q Consensus       107 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~  186 (401)
                      ++.+|.|...............+-+..|+.++||||+++++.+..+...|||+|.+  ..|..++.+.     ....+..
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHHHHHH
Confidence            56778888776554444456777889999999999999999999999999999998  4677777553     2566777


Q ss_pred             HHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCcc
Q 040050          187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTM  266 (401)
Q Consensus       187 i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  266 (401)
                      -+.||+.||.+||. +.+++|++|.-..|+|+..|..||++|.++.........  .....---.|..|+.+....  -.
T Consensus       109 Gl~qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  109 GLFQILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             HHHHHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc--cc
Confidence            88999999999985 567999999999999999999999999988654322210  01111122355665443222  34


Q ss_pred             ccHHhHHHHHHHHHhC
Q 040050          267 SDVYSFGVVLLELLTG  282 (401)
Q Consensus       267 ~DiwslG~il~ell~g  282 (401)
                      .|.|-|||++++++.|
T Consensus       184 ~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhhhHHHHHHHHhCc
Confidence            6999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=4.7e-12  Score=109.54  Aligned_cols=145  Identities=12%  Similarity=0.069  Sum_probs=99.0

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC------------c----------ccHHH----HHHHHHHHh
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG------------T----------QGHKE----WMAEIIFLG  135 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~------------~----------~~~~~----~~~E~~~l~  135 (401)
                      ...||.|..+.||.|...........+..+|||+.+...            .          .....    ..+|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            357999999999999754311111235789999885310            0          00112    237999999


Q ss_pred             ccCC--CceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-hCCCCCeeeccCCC
Q 040050          136 QLRH--PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL-HGEDKPVIYRDFKA  212 (401)
Q Consensus       136 ~l~h--pnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~L-H~~~~~iiH~Dlkp  212 (401)
                      ++..  -+++.++++    ...+|||||+.+..+.....+.  ..++......+..+++.+|..| |.  .||||+||++
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~--~glVHGDLs~  153 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKE--CNLVHADLSE  153 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHh--CCeecCCCCH
Confidence            9863  456666654    3458999999654442221111  3455566778889999999998 84  4599999999


Q ss_pred             CcEEEcCCCcEEEEecCCCCCCC
Q 040050          213 SNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       213 ~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      .||++. ++.+.|+|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999887643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=9.8e-13  Score=112.39  Aligned_cols=129  Identities=20%  Similarity=0.081  Sum_probs=93.9

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCcee-eEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV-KLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~-~~~~~~~~~~~~~lv~e~  161 (401)
                      +.|+.|.++.||++...        +..|++|....... ....+..|+.+++.+.+.+++ +++.+.  ....++||||
T Consensus         4 ~~l~~G~~~~vy~~~~~--------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA--------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eecCCcccCceEEEEEC--------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            57899999999998753        56799998754322 123456789999888655544 444443  3345799999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC---CCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED---KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ++|.++...  .     .   ....++.+++.+|+.||+..   .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        73 i~G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            999887543  0     0   11345678999999999654   1259999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.41  E-value=1.2e-12  Score=129.79  Aligned_cols=145  Identities=18%  Similarity=0.148  Sum_probs=95.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc--------------------------------
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--------------------------------  123 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------  123 (401)
                      ...|+. +.||.|++|.||+|+..+      +|+.||||+.+..-...                                
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKD------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECC------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            346776 899999999999998876      58899999997431100                                


Q ss_pred             --HH------HHHHHHHHHhccC----CCceeeEEEEEEe-CCeEEEEEEecCCCChhHHHhhhcCC----CCCHHHHHH
Q 040050          124 --HK------EWMAEIIFLGQLR----HPHLVKLIGYCWE-EEYRLLVYEYMPRGSLHNQLFRSYSA----ALPWSTRMK  186 (401)
Q Consensus       124 --~~------~~~~E~~~l~~l~----hpnI~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~----~l~~~~~~~  186 (401)
                        ..      ++.+|+..+.++.    +.+.+.+-.++.+ ....+|||||+.|+.+.+.-.-...+    .+....+..
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence              01      1233444444442    4444444444433 44568999999999997743211111    233333444


Q ss_pred             HHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC----cEEEEecCCCCCCCC
Q 040050          187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----TAKLSDFGLAKDGPE  236 (401)
Q Consensus       187 i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~----~vkL~DfG~a~~~~~  236 (401)
                      ++.|++         ..|++|+|+||.||+++.+|    .++++|||++.....
T Consensus       272 ~~~Qif---------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FFTQVF---------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHH---------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            444543         23499999999999999887    999999999876544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.9e-11  Score=102.35  Aligned_cols=132  Identities=22%  Similarity=0.255  Sum_probs=100.9

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--------cHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--------GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+++|+-+.++.+.+.        +.++++|.-......        ....-.+|+.++.++.--+|...+=++.+...
T Consensus         2 ~~i~~GAEa~i~~~~~~--------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~   73 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN   73 (204)
T ss_pred             chhhCCcceeEEeeecc--------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC
Confidence            46889999999998553        445777765433211        12345579999999987777776667777778


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      ..|+|||++|..|.+.+...         ...++..+-..+.-||..+  |||+||.+.||++..++ +.++|||++...
T Consensus        74 ~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            88999999998888888653         2456777777889999655  99999999999997764 999999999853

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.32  E-value=1.8e-10  Score=107.33  Aligned_cols=270  Identities=17%  Similarity=0.190  Sum_probs=168.4

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEE----EE---eC
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGY----CW---EE  152 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~----~~---~~  152 (401)
                      ..++.||+|+.+.+|-.-         +-...+.|+..........+...|  +.+.-.||-+..-+.+    ..   ..
T Consensus        14 ~~gr~LgqGgea~ly~l~---------e~~d~VAKIYh~Pppa~~aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~~~~   82 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG---------EVRDQVAKIYHAPPPAAQAQKVAE--LAATPDAPLLNYRVAWPQATLHGGRRG   82 (637)
T ss_pred             CCCccccCCccceeeecc---------hhhchhheeecCCCchHHHHHHHH--hccCCCCcchhhhhcccHHHhhCCCcc
Confidence            356889999999998642         123356677765443322222222  2222246643331111    11   12


Q ss_pred             CeEEEEEEecCCCCh-hHHH----hhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          153 EYRLLVYEYMPRGSL-HNQL----FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L-~~~l----~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                      ..+.++|+.+.|..- ..++    .++......|..+++.++.++.+.+.||.++  .+-+|++++|+||.+++.|.|.|
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEc
Confidence            236788998876532 2222    1233456789999999999999999999555  88899999999999999999998


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhC-CCCCCCCcccccc--cHH-
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTG-KRAMDNTRLGREQ--SLA-  298 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~--~~~-  298 (401)
                      =..-....+   .......+|.+.|.+||...     +-.-+...|.|.||+++++++.| ++||.+.......  .+. 
T Consensus       161 sDsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         161 SDSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ccceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            654433322   22345578999999999765     34456789999999999999887 8999875432111  111 


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCC-HHHHHHHHHHHHHhcc--cCCCCCCCHHHHHHHHHhhhhcccCC
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFP-IKGAQKAAATAFKCLS--HHPRHRPTMSYVVRVLDSLQDFQDSF  366 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~--~dP~~RPt~~~il~~L~~l~~~~~~~  366 (401)
                      .+....+.....-..-..+.- ...| .-.++.+..+.-+|+.  .++.-|||++.++..|..+.+.-..+
T Consensus       238 ~Ia~g~f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C  307 (637)
T COG4248         238 DIAHGRFAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC  307 (637)
T ss_pred             hhhcceeeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence            111111111000000000000 1112 2346678888889986  34779999999999999997666554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.31  E-value=3.8e-11  Score=100.17  Aligned_cols=144  Identities=20%  Similarity=0.183  Sum_probs=107.8

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--------ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--------QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ...+|.+|+.+.|+++.+.        |+.++||.......        -...+..+|+.+|.++.--+|.-..-++.+.
T Consensus        11 ~l~likQGAEArv~~~~~~--------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccC--------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            5678999999999998654        67788886543221        1234566799999998766766666667777


Q ss_pred             CeEEEEEEecCC-CChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC---cEEEEec
Q 040050          153 EYRLLVYEYMPR-GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY---TAKLSDF  228 (401)
Q Consensus       153 ~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~---~vkL~Df  228 (401)
                      ..-.|+|||++| .++.+++...............++..|-+.+.-||.++  |||+||..+||++..++   .+.|+||
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEee
Confidence            777899999966 37888887653333333444788899999999999666  99999999999996654   3589999


Q ss_pred             CCCCCC
Q 040050          229 GLAKDG  234 (401)
Q Consensus       229 G~a~~~  234 (401)
                      |++...
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.30  E-value=7.3e-13  Score=135.06  Aligned_cols=251  Identities=22%  Similarity=0.226  Sum_probs=173.9

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      .-.+.+.+.+.+..|.++.++.+.-..      ++...+.|+....   .....+..+.+-.++-.-.+|.++.....+.
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~------sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~  874 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAG------SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP  874 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccc------cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC
Confidence            344677788899999999998774332      3433444433221   1222333444444444445677776555555


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      .....+++++|+.+++|...++..  ...+...+...+..+..++.+||+..  ++|+|++|.|.++..+|+.+++|||.
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCcccc
Confidence            666789999999999999988765  46777777778888899999999544  89999999999999999999999984


Q ss_pred             CCCCCCC--------C---------------------cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh
Q 040050          231 AKDGPEG--------E---------------------ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT  281 (401)
Q Consensus       231 a~~~~~~--------~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  281 (401)
                      .......        .                     .........||+.|.+||...+......+|+|++|+++++.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            3211100        0                     0011123568999999999999999999999999999999999


Q ss_pred             CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040050          282 GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL-EGQFPIKGAQKAAATAFKCLSHHPRHRPTMS  350 (401)
Q Consensus       282 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  350 (401)
                      |.+||.......                ....++.... ...-+...+....+++...+..+|.+|..+.
T Consensus      1031 g~pp~na~tpq~----------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQ----------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhh----------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999997643211                0111111111 1122334567888999999999999998766

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.27  E-value=1e-10  Score=111.66  Aligned_cols=215  Identities=17%  Similarity=0.193  Sum_probs=151.1

Q ss_pred             CeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe----CCeEEEEEEecCC-
Q 040050           90 FGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE----EEYRLLVYEYMPR-  164 (401)
Q Consensus        90 ~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~----~~~~~lv~e~~~~-  164 (401)
                      -.+.|+++...      +|..|++|+++.+..........-+++++++.|+|||++.++|..    +..+++|++|+++ 
T Consensus       289 ~~Ttyk~~s~~------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  289 SITTYKATSNV------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             cceeEeeeecc------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            35788887765      688999999965544444444556889999999999999998873    4578999999875 


Q ss_pred             CChhHHHhhh-------------cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          165 GSLHNQLFRS-------------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       165 ~~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ++|.++....             .+...++..+|.++.|+..||.++|+.+  +.-+-|.|.+|+++.+.+++|...|..
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccce
Confidence            4677765432             1245678999999999999999999766  888999999999999999999988877


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........                +-+.+   -.+-|.=.||.+++.|.||..--....     .....         .+
T Consensus       441 Dvl~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d-----~~~~s---------~~  487 (655)
T KOG3741|consen  441 DVLQEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTD-----STQSS---------HL  487 (655)
T ss_pred             eeecCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccccccccc-----chHHH---------HH
Confidence            65444320                00111   235788999999999999975311100     00000         00


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                               ..+....+.++++++......++++ -++.+++.+
T Consensus       488 ---------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  488 ---------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ---------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                     0123345667777777777777776 466666554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=6.9e-11  Score=105.41  Aligned_cols=141  Identities=19%  Similarity=0.223  Sum_probs=105.9

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCC--CceeeEEEEEEeCC---eEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRH--PHLVKLIGYCWEEE---YRL  156 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnI~~~~~~~~~~~---~~~  156 (401)
                      +.|+.|..+.||++...+       +..+++|....... .....+..|..+++.+.+  .++.+++.+.....   ..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecC-------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            578999999999987542       46899999764332 134567889999999975  34677777766532   568


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE-----------------------------------  201 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-----------------------------------  201 (401)
                      +||||++|.++.+.+..   ..++......++.+++.+|..||+.                                   
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999888765431   3466667777777888888888742                                   


Q ss_pred             -------------------CCCeeeccCCCCcEEEcC--CCcEEEEecCCCCC
Q 040050          202 -------------------DKPVIYRDFKASNILLDS--DYTAKLSDFGLAKD  233 (401)
Q Consensus       202 -------------------~~~iiH~Dlkp~NIlv~~--~~~vkL~DfG~a~~  233 (401)
                                         ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               134799999999999988  67789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=6.2e-12  Score=122.09  Aligned_cols=252  Identities=17%  Similarity=0.144  Sum_probs=174.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHH--HHHHHHHHhccC-CCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE--WMAEIIFLGQLR-HPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-hpnI~~~~~~~~~~  152 (401)
                      ..+|..+..||.|.|+.|+....+     ...+..|++|...........+  -+.|+.+...+. |.+++..+..+...
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r-----~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKR-----PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             cCCcceeEEccCCccccceeeeec-----CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            357888899999999999986533     1256788888775443222222  345666666663 88888877777777


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEEecCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLA  231 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~DfG~a  231 (401)
                      ...|+-.|||.++++...+.-.  ..+.+...+.+..|++.++.++|+..  ++|+|++|.||++..+ +..++.|||+.
T Consensus       339 r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  339 RQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccc
Confidence            7778999999999887766332  56778888999999999999999544  9999999999999876 77899999998


Q ss_pred             CCCCCCCcceeeeccccccccc--cccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          232 KDGPEGEETHVITRVMGTQGYA--APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ..+....     ....+..++.  ++.......+..++|++|||..+.+.++|...-...                   .
T Consensus       415 t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-------------------~  470 (524)
T KOG0601|consen  415 TRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-------------------V  470 (524)
T ss_pred             cccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccc-------------------c
Confidence            6422111     1112333444  444444677889999999999999999987643221                   1


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ....+.. ......+ .....+..+...++..++..||.+.++..+.+..++.
T Consensus       471 ~~~~i~~-~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~  521 (524)
T KOG0601|consen  471 QSLTIRS-GDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS  521 (524)
T ss_pred             cceeeec-ccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence            1111111 1111112 2236677788899999999999999887776655543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=4.2e-09  Score=96.22  Aligned_cols=124  Identities=13%  Similarity=-0.003  Sum_probs=89.6

Q ss_pred             CceEEEEEecCCCcc-----------cHHHHHHHHHHHhccCCCcee--eEEEEEEe-----CCeEEEEEEecCCC-Chh
Q 040050          108 AQPVAVKALDLDGTQ-----------GHKEWMAEIIFLGQLRHPHLV--KLIGYCWE-----EEYRLLVYEYMPRG-SLH  168 (401)
Q Consensus       108 ~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnI~--~~~~~~~~-----~~~~~lv~e~~~~~-~L~  168 (401)
                      |+.|.||........           ....+.+|...+.++..-+|.  .++++...     ....+||||++++. +|.
T Consensus        45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~  124 (268)
T PRK15123         45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE  124 (268)
T ss_pred             CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence            568999976433211           011377899988888544443  34445543     23468999999875 788


Q ss_pred             HHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-------CCcEEEEecCCCCC
Q 040050          169 NQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-------DYTAKLSDFGLAKD  233 (401)
Q Consensus       169 ~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-------~~~vkL~DfG~a~~  233 (401)
                      +++........+......++.+++..+.-||.  .||+|+|+++.|||++.       ++.+.|+||+.+..
T Consensus       125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~--~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        125 DYCADWATNPPDPRLKRMLIKRVATMVRDMHA--AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH--CcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            88754323455667778999999999999995  55999999999999975       46899999998753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=5.4e-09  Score=92.98  Aligned_cols=135  Identities=21%  Similarity=0.147  Sum_probs=95.1

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------------------c----cHHHHHHHHHHHhc
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------------------Q----GHKEWMAEIIFLGQ  136 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------------------~----~~~~~~~E~~~l~~  136 (401)
                      +.++..||-|.-+.||.|.+.+       +.++|+|.-+....                  .    ......+|.++|.+
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~-------g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~  165 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPK-------GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR  165 (304)
T ss_pred             HhhccccccCccceEEEEECCC-------CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence            6788999999999999998764       78999997643110                  0    12335679999999


Q ss_pred             cCCC--ceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCc
Q 040050          137 LRHP--HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASN  214 (401)
Q Consensus       137 l~hp--nI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~N  214 (401)
                      |.-.  .+++.+++    +...+|||+++|-.|...-       ++......++..|+.-+..+-  ..||||+|+++-|
T Consensus       166 L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~--~~GiVHGDlSefN  232 (304)
T COG0478         166 LYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY--RRGIVHGDLSEFN  232 (304)
T ss_pred             hhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH--HcCccccCCchhe
Confidence            8744  67776653    4568999999886664432       122223334444444444444  2459999999999


Q ss_pred             EEEcCCCcEEEEecCCCCC
Q 040050          215 ILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       215 Ilv~~~~~vkL~DfG~a~~  233 (401)
                      |+++++|.+.++||--+..
T Consensus       233 IlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             EEEecCCCEEEEeCccccc
Confidence            9999999999999976654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=1.2e-08  Score=88.04  Aligned_cols=126  Identities=23%  Similarity=0.241  Sum_probs=78.1

Q ss_pred             eEEEEEecCcCCCCCCCceEEEEEecCCC--------------c--------cc----HHHHHHHHHHHhccCCC--cee
Q 040050           92 PVYKGFVDEKLKPGLEAQPVAVKALDLDG--------------T--------QG----HKEWMAEIIFLGQLRHP--HLV  143 (401)
Q Consensus        92 ~V~~a~~~~~~~~~~~~~~vavK~~~~~~--------------~--------~~----~~~~~~E~~~l~~l~hp--nI~  143 (401)
                      .||.|...+       +..+|+|+.+...              .        ..    .....+|.+.|.++..-  +++
T Consensus         1 ~Vy~~~~~~-------~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP   73 (188)
T PF01163_consen    1 DVYHAIDPD-------GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP   73 (188)
T ss_dssp             EEEEEEECT-------TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-
T ss_pred             CEEEEECCC-------CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            378887654       6789999885310              0        00    13356799999999866  456


Q ss_pred             eEEEEEEeCCeEEEEEEecC--CCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HhCCCCCeeeccCCCCcEEEcCC
Q 040050          144 KLIGYCWEEEYRLLVYEYMP--RGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF-LHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       144 ~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~-LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      +++++.  .  .+|||||+.  |..+.. +...   .++......++.+++..+.. +|.  .||+|+||.+.||+++++
T Consensus        74 ~p~~~~--~--~~ivME~I~~~G~~~~~-l~~~---~~~~~~~~~~~~~il~~~~~~~~~--~givHGDLs~~NIlv~~~  143 (188)
T PF01163_consen   74 KPYDYN--R--NVIVMEYIGEDGVPLPR-LKDV---DLSPEEPKELLEEILEEIIKMLHK--AGIVHGDLSEYNILVDDG  143 (188)
T ss_dssp             -EEEEE--T--TEEEEE--EETTEEGGC-HHHC---GGGGSTHHHHHHHHHHHHHHHHHC--TTEEESS-STTSEEEETT
T ss_pred             cEEEEe--C--CEEEEEecCCCccchhh-HHhc---cccchhHHHHHHHHHHHHHHHHHh--cCceecCCChhhEEeecc
Confidence            666442  2  379999997  544533 3332   11133455667777775555 574  459999999999999887


Q ss_pred             CcEEEEecCCCCCCC
Q 040050          221 YTAKLSDFGLAKDGP  235 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~  235 (401)
                       .+.|+|||.+....
T Consensus       144 -~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 -KVYIIDFGQAVDSS  157 (188)
T ss_dssp             -CEEE--GTTEEETT
T ss_pred             -eEEEEecCcceecC
Confidence             99999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.86  E-value=8.5e-10  Score=108.94  Aligned_cols=150  Identities=22%  Similarity=0.283  Sum_probs=102.5

Q ss_pred             HHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcce--eee-----ccccccccccccccccC
Q 040050          189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH--VIT-----RVMGTQGYAAPEYVMTG  261 (401)
Q Consensus       189 ~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~--~~~-----~~~gt~~y~aPE~~~~~  261 (401)
                      .+++.|+.|+|+. -++||+.|.|++|.++.+|..||+.|+.+..........  .++     -..-...|.|||.+.+.
T Consensus       106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3455999999974 459999999999999999999999999886543321100  000     01234579999999998


Q ss_pred             CCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcc
Q 040050          262 HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLS  340 (401)
Q Consensus       262 ~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  340 (401)
                      ..+.++|+||||+++|.+.. |+..+............              ...+......+...++.++++=+.+++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHHhc
Confidence            88999999999999999994 55544332111111000              0011111112335567888999999999


Q ss_pred             cCCCCCCCHHHHH
Q 040050          341 HHPRHRPTMSYVV  353 (401)
Q Consensus       341 ~dP~~RPt~~~il  353 (401)
                      .++.-||++..+.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999766654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=9.1e-08  Score=84.46  Aligned_cols=106  Identities=25%  Similarity=0.215  Sum_probs=81.8

Q ss_pred             HHHHHHHHHHHhccCCCc--eeeEEEEEEeCC----eEEEEEEecCCC-ChhHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 040050          124 HKEWMAEIIFLGQLRHPH--LVKLIGYCWEEE----YRLLVYEYMPRG-SLHNQLFRSYSAALPWSTRMKIALGAAKGLA  196 (401)
Q Consensus       124 ~~~~~~E~~~l~~l~hpn--I~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~  196 (401)
                      .....+|...+..+..-+  +++++++.....    ..++|+|++++. +|.+++....  ..+......++.+++..++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence            346778888888876443  445555555422    458999999874 7888886642  2666778899999999999


Q ss_pred             HHhCCCCCeeeccCCCCcEEEcCCC---cEEEEecCCCCC
Q 040050          197 FLHGEDKPVIYRDFKASNILLDSDY---TAKLSDFGLAKD  233 (401)
Q Consensus       197 ~LH~~~~~iiH~Dlkp~NIlv~~~~---~vkL~DfG~a~~  233 (401)
                      -||.  .||+|+|+++.|||++.++   .+.|+||+-+..
T Consensus       133 ~lH~--~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHD--AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHH--CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9995  4599999999999998887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.76  E-value=1.4e-07  Score=82.01  Aligned_cols=138  Identities=15%  Similarity=0.099  Sum_probs=99.7

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC------CcccHHHHHHHHHHHhccCCCc--eeeEEEEEE-e----
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD------GTQGHKEWMAEIIFLGQLRHPH--LVKLIGYCW-E----  151 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~hpn--I~~~~~~~~-~----  151 (401)
                      -|+||.+.|+.....        ++.+-+|.-...      -+-....|.+|+..|..+..-+  ++++. ++. .    
T Consensus        26 ~~rgG~SgV~r~~~~--------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~   96 (216)
T PRK09902         26 YRRNGMSGVQCVERN--------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG   96 (216)
T ss_pred             cCCCCcceEEEEEeC--------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence            456888889886543        346888876411      0224567999999999986333  44444 222 1    


Q ss_pred             CCeEEEEEEecCC-CChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc--EEEEec
Q 040050          152 EEYRLLVYEYMPR-GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT--AKLSDF  228 (401)
Q Consensus       152 ~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~--vkL~Df  228 (401)
                      .-..+||+|-+.| .+|.+++....-.+.+......++.+++.+++-||.  .|+.|+|+.+.||+++.+|.  +.++||
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~--~Gv~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS--VNRQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH--CCCcCCCCCHhheeecCCCCeeEEEEEh
Confidence            1235799998743 578888766433456777788999999999999995  55999999999999986667  999999


Q ss_pred             CCCCC
Q 040050          229 GLAKD  233 (401)
Q Consensus       229 G~a~~  233 (401)
                      ..++.
T Consensus       175 Ek~r~  179 (216)
T PRK09902        175 EKSRR  179 (216)
T ss_pred             hccch
Confidence            87764

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=1.3e-07  Score=93.73  Aligned_cols=141  Identities=18%  Similarity=0.205  Sum_probs=93.4

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc---------------------------------------
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG---------------------------------------  123 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------------  123 (401)
                      ..|+.++-|.||+|+...       |+.||||+.+..-.+.                                       
T Consensus       131 ~PiAsASIaQVH~A~L~s-------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEecC-------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            789999999999999885       8999999986421110                                       


Q ss_pred             -HHHHHHHHHHHhccC-----CCceeeEEEEEEe-CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 040050          124 -HKEWMAEIIFLGQLR-----HPHLVKLIGYCWE-EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA  196 (401)
Q Consensus       124 -~~~~~~E~~~l~~l~-----hpnI~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~  196 (401)
                       .-++.+|...+.++.     .|+ +.+-.++.+ .+...|+|||++|-.+.+...... .+.+...+.....++.--.-
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~  281 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL  281 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence             011334444444442     232 222233332 345689999999988888753332 45665554444444332222


Q ss_pred             HHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       197 ~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +-|  +  +.|.|.+|.||+++.+|++.+.|||+......
T Consensus       282 ~~d--g--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 LRD--G--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             Hhc--C--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            334  5  99999999999999999999999999876544

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.64  E-value=8.2e-07  Score=79.44  Aligned_cols=138  Identities=14%  Similarity=0.104  Sum_probs=85.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc--eeeEEEEEEeCCeEEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH--LVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--I~~~~~~~~~~~~~~lv~e  160 (401)
                      ..||+|..+.||+.          .+..+++|......  ......+|.++++.+..-+  +.+++++....+...+||+
T Consensus         7 ~~i~~G~t~~~y~~----------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTH----------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEe----------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            57899999999984          13468889876432  3355788999998886433  4677777777777889999


Q ss_pred             ecCCCC-hhHHH--------------hh----hcC---CCCCHHHHHH-HHH----------HHHHH-HHHH--hCCCCC
Q 040050          161 YMPRGS-LHNQL--------------FR----SYS---AALPWSTRMK-IAL----------GAAKG-LAFL--HGEDKP  204 (401)
Q Consensus       161 ~~~~~~-L~~~l--------------~~----~~~---~~l~~~~~~~-i~~----------qi~~a-l~~L--H~~~~~  204 (401)
                      ++.|.+ +...+              .+    -..   ...+...... +..          .+... ..+|  +.....
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~  154 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST  154 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence            998863 21111              00    000   1111111100 000          00111 1122  222345


Q ss_pred             eeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          205 VIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       205 iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ++|+|+.|.||++++++ +.|+||+.+..
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            78999999999999888 99999997763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.47  E-value=3.5e-06  Score=73.71  Aligned_cols=140  Identities=11%  Similarity=0.087  Sum_probs=90.8

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHH---------HHHHHHHhccC---CC
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---------MAEIIFLGQLR---HP  140 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---hp  140 (401)
                      ..+.++|.+.+++......-|.+-..        ++..+++|..+.......+.+         .+.+..+.++.   .-
T Consensus        27 ~i~~~~~~~~kv~k~~~r~~ValIei--------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~   98 (229)
T PF06176_consen   27 KILDNNYKIIKVFKNTKRNYVALIEI--------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT   98 (229)
T ss_pred             HHHhCCceEEEeecCCCccEEEEEEE--------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence            45678899999998887777766533        467899998875432222222         22333333332   22


Q ss_pred             ceeeEEEEEE-----eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcE
Q 040050          141 HLVKLIGYCW-----EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNI  215 (401)
Q Consensus       141 nI~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NI  215 (401)
                      ....++.+..     -....+++|||++|..|.+..      .++.    .++..+.+++.-||..+  +.|+|.+|.|+
T Consensus        99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNF  166 (229)
T PF06176_consen   99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNF  166 (229)
T ss_pred             ccccceeeeeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcE
Confidence            3333333322     223456899999998886643      1222    24456677899999655  99999999999


Q ss_pred             EEcCCCcEEEEecCCCCC
Q 040050          216 LLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       216 lv~~~~~vkL~DfG~a~~  233 (401)
                      +++.+ .++++||+..+.
T Consensus       167 lv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  167 LVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             EEECC-cEEEEECccccc
Confidence            99865 499999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.46  E-value=6.6e-06  Score=71.62  Aligned_cols=128  Identities=20%  Similarity=0.267  Sum_probs=90.1

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----------------cccHHHHHHHHHHHhccC------C
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----------------TQGHKEWMAEIIFLGQLR------H  139 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h  139 (401)
                      ...||+|+.-.||.-  .       .....+||+.....                .....+..+|+.....+.      +
T Consensus         6 ~~~i~~G~~R~cy~H--P-------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~   76 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW   76 (199)
T ss_pred             CcccccCCCceEEEC--C-------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence            467999999999963  2       24568999987655                122455666666555554      7


Q ss_pred             CceeeEEEEEEeCCeEEEEEEecCC------CChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 040050          140 PHLVKLIGYCWEEEYRLLVYEYMPR------GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKAS  213 (401)
Q Consensus       140 pnI~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~  213 (401)
                      ..|.+++|+..++....+|+|.+.+      .+|.+++..   +.++. .....+.++.   .||-.+.  |+.+|++|.
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~~f~---~~l~~~~--Iv~~dl~~~  147 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALDEFK---RYLLDHH--IVIRDLNPH  147 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHHHHH---HHHHHcC--CeecCCCcc
Confidence            8999999999999999999998743      367777744   45655 4455555554   4444334  999999999


Q ss_pred             cEEEcCC---C-cEEEEe
Q 040050          214 NILLDSD---Y-TAKLSD  227 (401)
Q Consensus       214 NIlv~~~---~-~vkL~D  227 (401)
                      ||++...   . .+.|+|
T Consensus       148 NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cEEEEecCCCceEEEEEe
Confidence            9999542   2 578887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.43  E-value=2.3e-06  Score=75.62  Aligned_cols=154  Identities=19%  Similarity=0.139  Sum_probs=98.8

Q ss_pred             cccHHHHHHHhcCCCCCcee---cccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-------------------c
Q 040050           66 VFTLAELRLITSNFSRSNLL---GEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-------------------G  123 (401)
Q Consensus        66 ~~~~~~~~~~~~~y~~~~~L---g~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-------------------~  123 (401)
                      ..+...+..+..+..+....   +.|..+.||+|...       .+..+|+|+.+.....                   .
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~  106 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSN  106 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCC
Confidence            34455566666666665554   56667789998653       3678999998642110                   1


Q ss_pred             H-----HHHHHHHHHHhccC--CCceeeEEEEEEeCCeEEEEEEecCCCCh-hHHHhhhcCCCCCHHHHHHHHHHHHHHH
Q 040050          124 H-----KEWMAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYEYMPRGSL-HNQLFRSYSAALPWSTRMKIALGAAKGL  195 (401)
Q Consensus       124 ~-----~~~~~E~~~l~~l~--hpnI~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~l~~~~~~~i~~qi~~al  195 (401)
                      .     .....|+.-|+++.  +=.+.+.+++..    -.|||||+..... .-.|.   .-++....+..+..++++.+
T Consensus       107 rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~  179 (268)
T COG1718         107 RRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYM  179 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHH
Confidence            1     12345777887774  334455555442    3699999943311 11111   12333335677777888888


Q ss_pred             HHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       196 ~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      .-|-. ..++||+||+.-|||+. ++.+.|+|||-|....
T Consensus       180 ~~l~~-~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         180 RRLYK-EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHH-hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            77764 24599999999999999 8899999999887643

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.38  E-value=5.9e-06  Score=74.91  Aligned_cols=138  Identities=19%  Similarity=0.087  Sum_probs=82.7

Q ss_pred             eecccCC-eeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEEEEEEe
Q 040050           84 LLGEGGF-GPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        84 ~Lg~G~~-g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      .|..|.. ..||+....        +..+++|......   ...+.+|+.+++.+. +--+.+++++.......++||++
T Consensus         5 ~~~~g~~~~~v~~~~~~--------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   73 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSA   73 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEe
Confidence            4555555 788987432        3478888875432   235667888888874 44466777777766678999999


Q ss_pred             cCCCChhHHHh----------------hhcC-----CCCCHH--HHHHH-----------------------HHHHHHHH
Q 040050          162 MPRGSLHNQLF----------------RSYS-----AALPWS--TRMKI-----------------------ALGAAKGL  195 (401)
Q Consensus       162 ~~~~~L~~~l~----------------~~~~-----~~l~~~--~~~~i-----------------------~~qi~~al  195 (401)
                      ++|.+|.....                +-..     ......  .....                       +..+...|
T Consensus        74 i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  153 (244)
T cd05150          74 VPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAEL  153 (244)
T ss_pred             eCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHH
Confidence            99877754310                0000     011100  00000                       11111111


Q ss_pred             HHHh--CCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          196 AFLH--GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       196 ~~LH--~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ....  .....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       154 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         154 EATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             HhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            1111  113448999999999999998788999998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=3.9e-06  Score=70.25  Aligned_cols=129  Identities=18%  Similarity=0.102  Sum_probs=88.2

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceee-EEEEEEeCCeEEEE
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK-LIGYCWEEEYRLLV  158 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~-~~~~~~~~~~~~lv  158 (401)
                      ...+.|++|++|.||++.+.        +..+|+|+-+.+.+  ...+..|+++|..+.-.++.+ +|.+..+    ++.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~   90 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGED----FIR   90 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEechh----hhh
Confidence            34578999999999999776        45899999876544  367888999999988766654 4443322    456


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC-CCcEEEcCCCcEEEEecCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFK-ASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlk-p~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      |||+.|-.|.+.-..     .+...+    ..++++---|-  ..||-|..|. |...++..++.+.|+||..|..
T Consensus        91 me~i~G~~L~~~~~~-----~~rk~l----~~vlE~a~~LD--~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          91 MEYIDGRPLGKLEIG-----GDRKHL----LRVLEKAYKLD--RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcCcchhhhhhc-----ccHHHH----HHHHHHHHHHH--HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            999988888765432     122222    23334433334  3348899886 6666666666999999998873

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.37  E-value=2.3e-06  Score=76.65  Aligned_cols=140  Identities=21%  Similarity=0.181  Sum_probs=80.6

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCC--ceeeEEEEEEe---CCeEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP--HLVKLIGYCWE---EEYRLL  157 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nI~~~~~~~~~---~~~~~l  157 (401)
                      +.|+.|..+.||++....        ..+++|.....  .....+..|..+++.+...  .+.+++.+...   ....++
T Consensus         3 ~~l~~G~~n~~~~v~~~~--------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD--------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEESSSSEEEEEEETT--------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             ccCCCCCeeeEEEEEECC--------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            678999999999987543        48999997543  3445677888888888533  35566664432   335789


Q ss_pred             EEEecCCCChhH----------------HHhh---h--cCCCCCHHH---------HHHH------------HHHHHH-H
Q 040050          158 VYEYMPRGSLHN----------------QLFR---S--YSAALPWST---------RMKI------------ALGAAK-G  194 (401)
Q Consensus       158 v~e~~~~~~L~~----------------~l~~---~--~~~~l~~~~---------~~~i------------~~qi~~-a  194 (401)
                      +|++++|..+..                .+..   .  .........         ....            ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999998887766                1111   0  001111000         0000            011111 2


Q ss_pred             HHHHh-----CCCCCeeeccCCCCcEEEc-CCCcEEEEecCCCC
Q 040050          195 LAFLH-----GEDKPVIYRDFKASNILLD-SDYTAKLSDFGLAK  232 (401)
Q Consensus       195 l~~LH-----~~~~~iiH~Dlkp~NIlv~-~~~~vkL~DfG~a~  232 (401)
                      +..++     .....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            22332     1345599999999999999 66777899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.22  E-value=1.1e-05  Score=79.78  Aligned_cols=142  Identities=16%  Similarity=0.140  Sum_probs=90.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc-------------------------------------HH
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-------------------------------------HK  125 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------~~  125 (401)
                      +.||..+.|.||+|+...       |+.||||+-+..-...                                     .-
T Consensus       167 ~piaaASlaQVhrA~L~~-------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             chhhhcchhheEEEEecC-------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            789999999999998875       8899999876421110                                     01


Q ss_pred             HHHHHHHHHhc----cCCCc---eeeEEEEEEe-CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHH
Q 040050          126 EWMAEIIFLGQ----LRHPH---LVKLIGYCWE-EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF  197 (401)
Q Consensus       126 ~~~~E~~~l~~----l~hpn---I~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~  197 (401)
                      +|..|++-..+    +.|-+   -+.+-.++.+ .....|+||||+|..+.+.-.-. ...++...+..-+.+...-+-+
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~~i~~~l~~~~~~qIf  318 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID-KRGISPHDILNKLVEAYLEQIF  318 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH-HcCCCHHHHHHHHHHHHHHHHH
Confidence            12334333222    23444   1222233332 23568999999998876654322 2355555555444444333333


Q ss_pred             HhCCCCCeeeccCCCCcEEEcC----CCcEEEEecCCCCCCCC
Q 040050          198 LHGEDKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       198 LH~~~~~iiH~Dlkp~NIlv~~----~~~vkL~DfG~a~~~~~  236 (401)
                      .|  +  .+|+|=+|.||+++.    ++.+.+.|||+......
T Consensus       319 ~~--G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 KT--G--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             hc--C--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            34  5  999999999999984    67899999999876543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.20  E-value=2.2e-07  Score=91.37  Aligned_cols=187  Identities=19%  Similarity=0.130  Sum_probs=129.9

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeEE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH-LVKLIGYCWEEEYRL  156 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-I~~~~~~~~~~~~~~  156 (401)
                      .+...+-+++|+.+.+++.+...       -+....+.+...     ....-++++|.+++||| .+..++-+..+...+
T Consensus       243 ws~~fh~fvK~altknpKkRpta-------eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~  310 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTA-------EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW  310 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCCh-------hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence            34455668889999999875433       122234444322     44556899999999999 666666666677889


Q ss_pred             EEEEecCCC-ChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          157 LVYEYMPRG-SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       157 lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +.|+++.++ +-...+... .-.+.......+.+.-+++++++|+..  =+|+|    ||+..+ +.+++.||+......
T Consensus       311 i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L~  382 (829)
T KOG0576|consen  311 IPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQLT  382 (829)
T ss_pred             hhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCcccC
Confidence            999999766 221111110 012333344566677778899999543  48888    776654 689999999987665


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCC
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD  287 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  287 (401)
                      ...   ......+++.++|||+.....+....|+|++|.-..++.-|-+|-.
T Consensus       383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            443   2345679999999999999999999999999987777777776653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.18  E-value=1.9e-05  Score=71.15  Aligned_cols=73  Identities=12%  Similarity=0.149  Sum_probs=45.2

Q ss_pred             ceecccCCe-eEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCC---ceeeEEEEEEeC---CeE
Q 040050           83 NLLGEGGFG-PVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP---HLVKLIGYCWEE---EYR  155 (401)
Q Consensus        83 ~~Lg~G~~g-~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nI~~~~~~~~~~---~~~  155 (401)
                      +.|+.|+.. .||+.           +..+++|.....  .....+.+|..++..+...   -+..+++.....   ...
T Consensus         3 ~~~~~gG~~n~vy~~-----------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~   69 (235)
T cd05155           3 EPVDSGGTDNATFRL-----------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP   69 (235)
T ss_pred             eeccCCCcccceEEc-----------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence            467777766 58875           234778875432  2234678899998877532   344444433322   234


Q ss_pred             EEEEEecCCCChh
Q 040050          156 LLVYEYMPRGSLH  168 (401)
Q Consensus       156 ~lv~e~~~~~~L~  168 (401)
                      +++|++++|.++.
T Consensus        70 ~~l~~~i~G~~l~   82 (235)
T cd05155          70 WSVYRWLEGETAT   82 (235)
T ss_pred             eEEEEeecCCCCC
Confidence            8899999887764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.14  E-value=5e-05  Score=80.91  Aligned_cols=82  Identities=16%  Similarity=0.189  Sum_probs=56.4

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccC-CCce--eeEEEEEEeC---Ce
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLR-HPHL--VKLIGYCWEE---EY  154 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpnI--~~~~~~~~~~---~~  154 (401)
                      .+.|+.|.+..+|+......    .....+++|+..... ......+.+|+.+|+.+. |+++  .+++.++.+.   ..
T Consensus        43 v~~l~gG~sn~ty~l~~~~~----~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNG----GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCC----CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            47789999999998765431    012467888765332 123356789999999995 6665  7777777654   35


Q ss_pred             EEEEEEecCCCCh
Q 040050          155 RLLVYEYMPRGSL  167 (401)
Q Consensus       155 ~~lv~e~~~~~~L  167 (401)
                      .|+||||++|..+
T Consensus       119 ~flVME~v~G~~~  131 (822)
T PLN02876        119 AFYIMEYLEGRIF  131 (822)
T ss_pred             ceEEEEecCCccc
Confidence            7899999987643

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.94  E-value=0.00015  Score=65.18  Aligned_cols=75  Identities=19%  Similarity=0.134  Sum_probs=46.1

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH-LVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-I~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.|..|-...+|+......     .+..|++|+...... ......+|+.+++.+...+ .++++..+.  .  .++|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~-----~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED-----NQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCC-----CCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEe
Confidence            5677788889998854310     135788997653322 1123346888888885433 344444332  2  489999


Q ss_pred             cCCCCh
Q 040050          162 MPRGSL  167 (401)
Q Consensus       162 ~~~~~L  167 (401)
                      ++|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            988766

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.94  E-value=7.6e-05  Score=68.19  Aligned_cols=137  Identities=16%  Similarity=0.050  Sum_probs=76.2

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeEEEEEEec
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL-VKLIGYCWEEEYRLLVYEYM  162 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-~~~~~~~~~~~~~~lv~e~~  162 (401)
                      .+..|-.+.+|+...        .+..+++|..........-...+|..+++.+...++ .+++...  .  -++||+|+
T Consensus         3 ~~~~G~tn~~y~~~~--------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i   70 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWL   70 (256)
T ss_pred             cCCCcCcCCeEEEEe--------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEec
Confidence            355677788998752        256788887653322211234678888888864333 3344332  2  36899999


Q ss_pred             CCCChhHH----------H----hhhc-----CCCCCHH-HHHHHHHHH---------HHHHHHHhC------CCCCeee
Q 040050          163 PRGSLHNQ----------L----FRSY-----SAALPWS-TRMKIALGA---------AKGLAFLHG------EDKPVIY  207 (401)
Q Consensus       163 ~~~~L~~~----------l----~~~~-----~~~l~~~-~~~~i~~qi---------~~al~~LH~------~~~~iiH  207 (401)
                      +|..+...          +    .+-.     ..+++.. .+..+..++         ...+..+-.      ....++|
T Consensus        71 ~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H  150 (256)
T TIGR02721        71 EGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLH  150 (256)
T ss_pred             cCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeec
Confidence            88665321          1    1100     1112211 111111111         111221211      1234899


Q ss_pred             ccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          208 RDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       208 ~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      +|+.|.||++++++ +.|+||+.+..
T Consensus       151 ~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       151 MDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCCcCcEEEeCCC-CEEEeccccCc
Confidence            99999999999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.91  E-value=5.1e-05  Score=79.91  Aligned_cols=195  Identities=21%  Similarity=0.249  Sum_probs=132.8

Q ss_pred             HHHHHHHHhccCCCceeeEEEEEEeCCeEE----EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC
Q 040050          127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRL----LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED  202 (401)
Q Consensus       127 ~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~  202 (401)
                      ..-|+..+.++.|+|++.++.|-.......    +..+++...++...+...  ..++....+.+..+++.|+.|+|++.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            334677788889999999998876654333    345677777887777654  67889999999999999999999764


Q ss_pred             CCeeeccCCCC---cEEEcCCCcEEEE--ecCCCCCCCCCCcceeeeccccccccccccccccCCCCc--cccHHhHHHH
Q 040050          203 KPVIYRDFKAS---NILLDSDYTAKLS--DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTT--MSDVYSFGVV  275 (401)
Q Consensus       203 ~~iiH~Dlkp~---NIlv~~~~~vkL~--DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG~i  275 (401)
                        ..|.-+...   +.-++..+.+.++  ||+.+........   .....-+..+.++|......++.  ..|+|.+|..
T Consensus       307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             --cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence              444444333   3444556677777  8888876544322   12233455678888776655544  4799999999


Q ss_pred             HHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          276 LLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       276 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +..+..|..+-....                   ....+++.        .......+...+|+.-++++|+++.+++..
T Consensus       382 ~~~~~~~~~i~~~~~-------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSA-------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCccccccc-------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            999998876543221                   11111110        001145677789999999999999999865

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.91  E-value=5.4e-05  Score=65.56  Aligned_cols=99  Identities=30%  Similarity=0.325  Sum_probs=78.1

Q ss_pred             HHHHHHhccCC-CceeeEEEEEEeCCeEEEEEEecCCCChhHH---HhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC-C
Q 040050          129 AEIIFLGQLRH-PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQ---LFRSYSAALPWSTRMKIALGAAKGLAFLHGED-K  203 (401)
Q Consensus       129 ~E~~~l~~l~h-pnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-~  203 (401)
                      .|.-++..+++ +++++++|+|-    .++|.||...+++...   +...  -..+|..+.+|+.++++.+.+|+... .
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            47888888876 69999999983    3688999976666431   1111  35689999999999999999998532 2


Q ss_pred             CeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          204 PVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       204 ~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+.-.|++++|+-++++|++|++|...+..
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            377889999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.83  E-value=0.00049  Score=64.29  Aligned_cols=78  Identities=14%  Similarity=0.054  Sum_probs=55.2

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCC---CceeeEEEEEEeC---C
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH---PHLVKLIGYCWEE---E  153 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnI~~~~~~~~~~---~  153 (401)
                      .-.+.||.|..+.||.....+        ..+++|..+..  .....+..|...|+.+.-   -.+.++++++...   +
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~--------~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g   86 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ--------GNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG   86 (297)
T ss_pred             heeeecCCccceeEEEEEcCC--------CCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC
Confidence            334679999999999975432        35777875421  122577889999988853   3678888877543   5


Q ss_pred             eEEEEEEecCCCCh
Q 040050          154 YRLLVYEYMPRGSL  167 (401)
Q Consensus       154 ~~~lv~e~~~~~~L  167 (401)
                      ..+||||+++|.++
T Consensus        87 ~~~LVmE~i~G~~~  100 (297)
T PRK10593         87 PDVLLLERLRGVSV  100 (297)
T ss_pred             CeEEEEeccCCEec
Confidence            67999999988765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.82  E-value=0.00045  Score=59.84  Aligned_cols=125  Identities=26%  Similarity=0.376  Sum_probs=86.4

Q ss_pred             cCCCCCceecccCC-eeEEEEEecCcCCCCCCCceEEEEEec---CCCc------------------ccHHHHHHHHHHH
Q 040050           77 SNFSRSNLLGEGGF-GPVYKGFVDEKLKPGLEAQPVAVKALD---LDGT------------------QGHKEWMAEIIFL  134 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~-g~V~~a~~~~~~~~~~~~~~vavK~~~---~~~~------------------~~~~~~~~E~~~l  134 (401)
                      .+++..+.||.|.. |.||++...        ++.+|+|++.   ....                  .....|..|.+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--------g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf  108 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--------GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF  108 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--------CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence            78889999999999 999999764        5799999932   1110                  1123467788777


Q ss_pred             hccC---CCce--eeEEEEEEeC------------------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHH
Q 040050          135 GQLR---HPHL--VKLIGYCWEE------------------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA  191 (401)
Q Consensus       135 ~~l~---hpnI--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi  191 (401)
                      .+|+   +.++  ++++||..-.                  ....||.||++...           .+    ...-+.+|
T Consensus       109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~  173 (207)
T PF13095_consen  109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQM  173 (207)
T ss_pred             HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHH
Confidence            7775   4566  8999987422                  12346777765432           12    23345667


Q ss_pred             HHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       192 ~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+-+..+|..+  |+-+|+++.|..     .-+|+|||.+
T Consensus       174 ~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence            77788999555  999999999985     3479999864

>PRK05231 homoserine kinase; Provisional

Probab=97.79  E-value=0.0013  Score=62.14  Aligned_cols=32  Identities=28%  Similarity=0.393  Sum_probs=27.1

Q ss_pred             CCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       202 ~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||+|+.|.||+++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45799999999999998766568999998764

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.76  E-value=0.00027  Score=66.16  Aligned_cols=81  Identities=19%  Similarity=0.201  Sum_probs=48.6

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL-VKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.|..|-...+|+............++.+++|+..... .......+|..++..+...++ .++++++. +   .+|++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            45666777789988644311112235789999976432 222345678888888753333 34555543 2   368999


Q ss_pred             cCCCChh
Q 040050          162 MPRGSLH  168 (401)
Q Consensus       162 ~~~~~L~  168 (401)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.73  E-value=3.6e-05  Score=70.66  Aligned_cols=136  Identities=21%  Similarity=0.145  Sum_probs=91.7

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------------------cc----HHHHHHHHHHHh
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------------------QG----HKEWMAEIIFLG  135 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------------------~~----~~~~~~E~~~l~  135 (401)
                      =+.+++.||-|.-+.||.+-+.+       |++.++|.-+....                  .+    .-...+|+..|+
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~-------G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk  165 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE-------GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK  165 (465)
T ss_pred             hhhhccccccccccceEEEecCC-------CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence            37789999999999999997664       78888886542110                  01    112446888888


Q ss_pred             ccC-CC-ceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 040050          136 QLR-HP-HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKAS  213 (401)
Q Consensus       136 ~l~-hp-nI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~  213 (401)
                      .|. |- -+++.++    .+..++|||++.|..|...-.     ..+...+..-   +..-+.-|-  +.|+||+|..-=
T Consensus       166 aL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~---lm~~Iv~la--~~GlIHgDFNEF  231 (465)
T KOG2268|consen  166 ALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDD---LMGLIVRLA--NHGLIHGDFNEF  231 (465)
T ss_pred             HHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHH---HHHHHHHHH--HcCceecccchh
Confidence            885 33 2444444    345689999999888865432     2233333332   333344455  345999999999


Q ss_pred             cEEEcCCCcEEEEecCCCCCC
Q 040050          214 NILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       214 NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      ||+|++++.++++||--....
T Consensus       232 Nimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  232 NIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             eeEEecCCCEEEeechHhhcc
Confidence            999999999999999765543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.69  E-value=0.0014  Score=63.28  Aligned_cols=76  Identities=21%  Similarity=0.172  Sum_probs=52.3

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC----C---cccHHHHHHHHHHHhccC---CCceeeEEEEEEeC
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD----G---TQGHKEWMAEIIFLGQLR---HPHLVKLIGYCWEE  152 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~---hpnI~~~~~~~~~~  152 (401)
                      +.||.|.+..||++...+      .++.|+||.-...    +   .-...+...|.+.|..+.   ...+++++.+  +.
T Consensus        32 ~elggGn~N~VyrV~~~~------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~  103 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE  103 (401)
T ss_pred             eEcCCCceEEEEEEEeCC------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence            679999999999997654      1257999985311    1   123456677888888763   2356777766  34


Q ss_pred             CeEEEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGS  166 (401)
Q Consensus       153 ~~~~lv~e~~~~~~  166 (401)
                      ...++|||++++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            55789999997643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.60  E-value=0.0018  Score=60.36  Aligned_cols=141  Identities=17%  Similarity=0.141  Sum_probs=81.4

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc--eeeEEEE------EEeCC
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH--LVKLIGY------CWEEE  153 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--I~~~~~~------~~~~~  153 (401)
                      .+.|..|....+|+....        +..+++|+...   .....+..|+.++..+.+.+  +.+++..      ....+
T Consensus        19 i~~i~~G~~n~~y~v~~~--------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             eecccCccccceEEEEeC--------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            456777877899987533        34689998764   22345666777777774332  4444331      22345


Q ss_pred             eEEEEEEecCCCChhH----HH----------hhh---cCCC------CCHHHHH----------HHHHHHHHHHHHHhC
Q 040050          154 YRLLVYEYMPRGSLHN----QL----------FRS---YSAA------LPWSTRM----------KIALGAAKGLAFLHG  200 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~----~l----------~~~---~~~~------l~~~~~~----------~i~~qi~~al~~LH~  200 (401)
                      ..++++++++|..+..    ..          +..   ....      ..+....          .....+..++.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6689999998876532    00          000   0000      0111000          011112233334332


Q ss_pred             -----CCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          201 -----EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       201 -----~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                           ...+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                 234699999999999999887788999987763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.57  E-value=0.00097  Score=62.65  Aligned_cols=142  Identities=18%  Similarity=0.151  Sum_probs=79.3

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc--eeeEEEE------EEeCC
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH--LVKLIGY------CWEEE  153 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--I~~~~~~------~~~~~  153 (401)
                      .+.++.|....+|+....        +..+++|+......  ......|++++..|...+  +++++..      ....+
T Consensus        27 i~~~~~G~~n~~y~v~t~--------~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g   96 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--------VGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG   96 (307)
T ss_pred             ccccCCccccceEEEEeC--------CCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence            456777777889987532        23588898754221  234455667766664222  3344331      11245


Q ss_pred             eEEEEEEecCCCChhH-----------HH---hhh---cCCC----CC---HHHHH------------HHHHHHHHHHHH
Q 040050          154 YRLLVYEYMPRGSLHN-----------QL---FRS---YSAA----LP---WSTRM------------KIALGAAKGLAF  197 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~-----------~l---~~~---~~~~----l~---~~~~~------------~i~~qi~~al~~  197 (401)
                      ..+++|+|++|..+..           .+   +..   ....    ..   |....            .....+...+.+
T Consensus        97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~  176 (307)
T TIGR00938        97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY  176 (307)
T ss_pred             eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence            6789999998854321           01   100   0000    00   10000            001112334444


Q ss_pred             Hh-----CCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          198 LH-----GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       198 LH-----~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      +.     ....++||+|+++.||+++.++.+.|+||+.+..
T Consensus       177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            43     1246799999999999999888778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=97.32  E-value=0.0034  Score=59.94  Aligned_cols=144  Identities=17%  Similarity=0.119  Sum_probs=80.0

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL-VKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.|..|-...+|++......  ...++.|++|+......... ...+|..+++.+..-++ .++++.+...    .|.+|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~--~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef  114 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKE--GNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF  114 (344)
T ss_pred             EEcCCcccceeEEEEeCCCC--CCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence            45555777889987643210  11346799998765433222 23678888888864444 3555555332    57899


Q ss_pred             cCCCChhHH----------H----hhhcC-----C--CCCHHHHHHHHHHH-----------------HHHHHH----Hh
Q 040050          162 MPRGSLHNQ----------L----FRSYS-----A--ALPWSTRMKIALGA-----------------AKGLAF----LH  199 (401)
Q Consensus       162 ~~~~~L~~~----------l----~~~~~-----~--~l~~~~~~~i~~qi-----------------~~al~~----LH  199 (401)
                      +++.+|...          +    .+-..     .  ...+..+..+..++                 ...+..    +.
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            877666321          0    11000     0  11122222222111                 111111    22


Q ss_pred             --CCCCCeeeccCCCCcEEEcC-CCcEEEEecCCCCC
Q 040050          200 --GEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD  233 (401)
Q Consensus       200 --~~~~~iiH~Dlkp~NIlv~~-~~~vkL~DfG~a~~  233 (401)
                        .....++|+|+++.||++++ ++.+.|+||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence              11335899999999999976 47899999987763

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.22  E-value=0.0028  Score=59.55  Aligned_cols=141  Identities=14%  Similarity=0.083  Sum_probs=91.3

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC------------------------Ccc-cH-HHHHHHHHHH
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD------------------------GTQ-GH-KEWMAEIIFL  134 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~------------------------~~~-~~-~~~~~E~~~l  134 (401)
                      +...|..|.-+.||.|...+       |..+|||+.+-.                        ++. .. -....|+.-|
T Consensus       148 inGCiSTGKEANVYHat~~d-------G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL  220 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEED-------GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL  220 (520)
T ss_pred             cccccccCccceeEeeecCC-------CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence            44678888899999987654       778999987421                        000 01 1233578888


Q ss_pred             hccCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCc
Q 040050          135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASN  214 (401)
Q Consensus       135 ~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~N  214 (401)
                      ++++..+|.-.--+...  ...|||+++. .+=+-. -+.....++...+..+-.+++..+.-|.+ ..++||.||.--|
T Consensus       221 kRl~~aGIP~PePIlLk--~hVLVM~FlG-rdgw~a-PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LVHADLSEfN  295 (520)
T KOG2270|consen  221 KRLNNAGIPCPEPILLK--NHVLVMEFLG-RDGWAA-PKLKDASLSTSKARELYQQCVRIMRRLYQ-KCRLVHADLSEFN  295 (520)
T ss_pred             HHHHhcCCCCCCceeee--cceEeeeecc-CCCCcC-cccccccCChHHHHHHHHHHHHHHHHHHH-Hhceeccchhhhh
Confidence            88876554422222211  2369999994 322111 11122456666777777777777777754 4569999999999


Q ss_pred             EEEcCCCcEEEEecCCCCCC
Q 040050          215 ILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       215 Ilv~~~~~vkL~DfG~a~~~  234 (401)
                      +|+ .+|.+.|+|-+-+...
T Consensus       296 ~Ly-hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  296 LLY-HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             heE-ECCEEEEEEccccccC
Confidence            998 4579999999887654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.15  E-value=5.4e-05  Score=81.65  Aligned_cols=157  Identities=13%  Similarity=0.017  Sum_probs=112.8

Q ss_pred             HHHHHHHhccCCCceeeEEEEEEe--CCeEEEEEEecCCCChhHHHhhhcC--CCCCHHHHHHHHHHHHHHHHHHhCC--
Q 040050          128 MAEIIFLGQLRHPHLVKLIGYCWE--EEYRLLVYEYMPRGSLHNQLFRSYS--AALPWSTRMKIALGAAKGLAFLHGE--  201 (401)
Q Consensus       128 ~~E~~~l~~l~hpnI~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~--  201 (401)
                      +.|..-++...|+++...+.-...  ....+..++++.+|.+++.|.+.-.  ..+...-+...-.+.+.+..-+|+.  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            345555566689888776654433  3356889999999999999976422  2333333333333335555555543  


Q ss_pred             -CCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHH
Q 040050          202 -DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL  280 (401)
Q Consensus       202 -~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  280 (401)
                       +.-.+|+++|+-|.+|..+..||+.++|+.+.....  ........+++.|++|++.+.-.++.++|+|..|+-+|...
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             CCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             334789999999999999999999999999832221  12234456888999999988888999999999999999999


Q ss_pred             hCCCCC
Q 040050          281 TGKRAM  286 (401)
Q Consensus       281 ~g~~pf  286 (401)
                      .|..+|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            988876

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.03  E-value=0.0083  Score=56.07  Aligned_cols=139  Identities=17%  Similarity=0.150  Sum_probs=79.8

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEec-CCCcccHHHHHHHHHHHhccCC--CceeeEEEEEEeCC--e
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD-LDGTQGHKEWMAEIIFLGQLRH--PHLVKLIGYCWEEE--Y  154 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--pnI~~~~~~~~~~~--~  154 (401)
                      .+.+.+..|..-.+|....        +++.+++..-. ...........+|+.+++.+.-  --+...++++.++.  .
T Consensus        28 ~~v~~~~~G~sn~t~~~~~--------~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~   99 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGD--------TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGT   99 (321)
T ss_pred             ceeeeccCCcccceEEEec--------CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCC
Confidence            3444454444444554432        14567777221 1222334556678888877642  23445566666655  6


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHH-HHHHHHHHHHhCC--------------------------------
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA-LGAAKGLAFLHGE--------------------------------  201 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~-~qi~~al~~LH~~--------------------------------  201 (401)
                      .+.||+|++|..+.+.+...     +..  ..++ ..++..|+-||+.                                
T Consensus       100 pf~v~~~veGe~~~~~~~~~-----~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~  172 (321)
T COG3173         100 PFYVMEWVEGEVVWSALPPE-----SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKE  172 (321)
T ss_pred             ceEEEEEecceeccCcCCcc-----cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHh
Confidence            69999999885333222110     000  1111 1334444444421                                


Q ss_pred             ------------------------CCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          202 ------------------------DKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       202 ------------------------~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                                              ...++|+|+.+.||+++..+.+=++||+.+..
T Consensus       173 ~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         173 LGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                                    12589999999999999988899999999875

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.89  E-value=0.0029  Score=55.89  Aligned_cols=29  Identities=34%  Similarity=0.446  Sum_probs=20.7

Q ss_pred             CeeeccCCCCcEEE-cCCCcEEEEecCCCC
Q 040050          204 PVIYRDFKASNILL-DSDYTAKLSDFGLAK  232 (401)
Q Consensus       204 ~iiH~Dlkp~NIlv-~~~~~vkL~DfG~a~  232 (401)
                      .++|+|+.|.||++ +.++.++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            47899999999999 888999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.88  E-value=0.0089  Score=55.20  Aligned_cols=30  Identities=30%  Similarity=0.400  Sum_probs=25.3

Q ss_pred             CeeeccCCCCcEEEcCCCc-EEEEecCCCCC
Q 040050          204 PVIYRDFKASNILLDSDYT-AKLSDFGLAKD  233 (401)
Q Consensus       204 ~iiH~Dlkp~NIlv~~~~~-vkL~DfG~a~~  233 (401)
                      .++|+|++|.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.88  E-value=0.0067  Score=56.96  Aligned_cols=75  Identities=20%  Similarity=0.213  Sum_probs=57.7

Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ..+.|++|++- |++|.- +     +...+.++..++.+.+..+.-+.. +-..=|||+.-.||+|+ +|+|-|+||-++
T Consensus       298 ~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfkls  368 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLS  368 (488)
T ss_pred             ceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeee
Confidence            34668888885 666632 2     345677888899888777776654 44578999999999999 999999999999


Q ss_pred             CCCC
Q 040050          232 KDGP  235 (401)
Q Consensus       232 ~~~~  235 (401)
                      +...
T Consensus       369 Rl~~  372 (488)
T COG5072         369 RLSY  372 (488)
T ss_pred             eccc
Confidence            8543

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.77  E-value=0.016  Score=54.95  Aligned_cols=143  Identities=15%  Similarity=0.134  Sum_probs=77.2

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL-VKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.|..|=-..+|+.......   .....|++++...... ..-...+|..+++.+..-++ +++++++.  +.  +|.+|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~---~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~f   91 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEEN---GNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSF   91 (330)
T ss_pred             EEeCCcccceEEEEEecCCC---CCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeehh
Confidence            44555666778887543310   1234788998764332 22233568888888865555 35555552  22  58888


Q ss_pred             cCCCChhH----------HH----hhhcCCC------C-CHHHHHHHHHHH-------------------------HHHH
Q 040050          162 MPRGSLHN----------QL----FRSYSAA------L-PWSTRMKIALGA-------------------------AKGL  195 (401)
Q Consensus       162 ~~~~~L~~----------~l----~~~~~~~------l-~~~~~~~i~~qi-------------------------~~al  195 (401)
                      ++|.+|..          .+    .+-....      . .+..+..+..++                         +..+
T Consensus        92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l  171 (330)
T PLN02421         92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL  171 (330)
T ss_pred             hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence            87765521          01    1111101      1 122222222111                         1111


Q ss_pred             H-HHhCC--CCCeeeccCCCCcEEEcC-CCcEEEEecCCCCC
Q 040050          196 A-FLHGE--DKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD  233 (401)
Q Consensus       196 ~-~LH~~--~~~iiH~Dlkp~NIlv~~-~~~vkL~DfG~a~~  233 (401)
                      . .+...  ..-.+|+|+.+.||++++ ++.++++||..|..
T Consensus       172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 12111  123689999999999975 57899999998764

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.76  E-value=0.024  Score=53.83  Aligned_cols=73  Identities=18%  Similarity=0.217  Sum_probs=45.8

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEec----CCC---cccHHHHHHHHHHHhccC--CC-ceeeEEEEEEeCC
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD----LDG---TQGHKEWMAEIIFLGQLR--HP-HLVKLIGYCWEEE  153 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~----~~~---~~~~~~~~~E~~~l~~l~--hp-nI~~~~~~~~~~~  153 (401)
                      .||.|-..-||++....      .++.|+||.-.    ..+   +-...+..-|.+.|+...  .| .++++|.  .++.
T Consensus         2 EigdGnlN~VfrV~~~~------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCC------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc
Confidence            47889999999997532      23579999753    111   223445566777777653  45 3444543  3445


Q ss_pred             eEEEEEEecCC
Q 040050          154 YRLLVYEYMPR  164 (401)
Q Consensus       154 ~~~lv~e~~~~  164 (401)
                      ...+|||+++.
T Consensus        74 ~~~~vMEdL~~   84 (370)
T TIGR01767        74 MAVTVMEDLSH   84 (370)
T ss_pred             cceehHhhCcc
Confidence            56799999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.75  E-value=0.0034  Score=61.36  Aligned_cols=163  Identities=21%  Similarity=0.276  Sum_probs=91.8

Q ss_pred             HHHHHHHHHHHhccCCCceeeEEEEEEeC-CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC
Q 040050          124 HKEWMAEIIFLGQLRHPHLVKLIGYCWEE-EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED  202 (401)
Q Consensus       124 ~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~  202 (401)
                      ..+++....+++.+.|+|....+++.... ....+|||++ +.+|.+.+...+   +......            -|  +
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s~~------------~~--~   87 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDESLL------------AH--G   87 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchhhhc------------cc--c
Confidence            35677889999999999999998887653 3577899998 789999886642   2111100            12  2


Q ss_pred             CCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhC
Q 040050          203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG  282 (401)
Q Consensus       203 ~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  282 (401)
                        +.|-     |       .++.+| .++..                  |  |-     ...+++||||+|.++.++..|
T Consensus        88 --~~~~-----~-------~~~~td-~~~t~------------------~--~~-----~~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   88 --VLHL-----N-------IIYITD-HFLTK------------------Y--PS-----PIGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             --ccee-----h-------hhhccc-ccccc------------------C--CC-----CCCcchhhhhHHHHHHHHHHh
Confidence              3331     1       233333 11100                  0  10     011499999999999999998


Q ss_pred             CCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040050          283 KRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS  350 (401)
Q Consensus       283 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  350 (401)
                      ...+.....   .............+.....+....   .+...+...+.++...|+-..|..||...
T Consensus       128 ~~l~~~~~~---s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~  189 (725)
T KOG1093|consen  128 ISLEAELTE---SEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPM  189 (725)
T ss_pred             hHHHHHHHH---HHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchh
Confidence            865533211   111111222222222111111000   12233456677888899999999888643

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.69  E-value=0.012  Score=51.57  Aligned_cols=104  Identities=14%  Similarity=0.083  Sum_probs=67.9

Q ss_pred             eEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHH
Q 040050          110 PVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA  188 (401)
Q Consensus       110 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~  188 (401)
                      +..+|+++.-... ...-+..+..++.+++  +|+++..=  ..-.+.++.|+|.....           .+.    .++
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~~----N~i  147 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NFS----NFI  147 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------chh----HHH
Confidence            4566666533222 3345677888888764  46666521  22245688999843211           111    111


Q ss_pred             HHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       189 ~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ..=+.+|.-.|+...+.+|+|..|+|||-|..|-+||.|=+...
T Consensus       148 ~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll  191 (308)
T PF07387_consen  148 TAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL  191 (308)
T ss_pred             HHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh
Confidence            11146678889888889999999999999999999999977653

The function of this family is unknown.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.62  E-value=0.012  Score=54.63  Aligned_cols=74  Identities=18%  Similarity=0.201  Sum_probs=46.7

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCeEEE
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR---HPHLVKLIGYCWEEEYRLL  157 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnI~~~~~~~~~~~~~~l  157 (401)
                      -.+.|+.|....+|+.. .       .++.+.+|+-..   .....+..|.+-|+.|.   .-.+++++++....+..+|
T Consensus        21 ~~~~v~GG~i~~a~~~~-~-------~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fL   89 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-T-------DGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFL   89 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-T-------TS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEE
T ss_pred             eeEecCCCChhheEEEE-C-------CCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceE
Confidence            34678989999999875 2       467899998762   22345677888777773   4468889998887777799


Q ss_pred             EEEecCCC
Q 040050          158 VYEYMPRG  165 (401)
Q Consensus       158 v~e~~~~~  165 (401)
                      +|||++.+
T Consensus        90 lle~l~~~   97 (288)
T PF03881_consen   90 LLEFLEMG   97 (288)
T ss_dssp             EEE-----
T ss_pred             EEEeecCC
Confidence            99998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.43  E-value=0.057  Score=52.26  Aligned_cols=73  Identities=15%  Similarity=0.159  Sum_probs=48.2

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC----Cc---ccHHHHHHHHHHHhccC---CCceeeEEEEEEe
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD----GT---QGHKEWMAEIIFLGQLR---HPHLVKLIGYCWE  151 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---hpnI~~~~~~~~~  151 (401)
                      .+.||.|....||+....        +..++||.-...    +.   -...+...|...|+.+.   ...+++++.++. 
T Consensus        37 ~~eiggGn~N~VyrV~~~--------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            467899999999997642        345999976511    11   12344455667666653   247788887776 


Q ss_pred             CCeEEEEEEecCC
Q 040050          152 EEYRLLVYEYMPR  164 (401)
Q Consensus       152 ~~~~~lv~e~~~~  164 (401)
                       +..+++||++++
T Consensus       108 -d~~vlvME~L~~  119 (418)
T PLN02756        108 -TMALIGMRYLEP  119 (418)
T ss_pred             -CCCEEEEeecCC
Confidence             345788999966

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.39  E-value=0.06  Score=50.57  Aligned_cols=32  Identities=16%  Similarity=0.152  Sum_probs=28.5

Q ss_pred             CCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       202 ~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||+|+.+.||+++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34699999999999999999999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.30  E-value=0.055  Score=47.80  Aligned_cols=75  Identities=23%  Similarity=0.256  Sum_probs=52.0

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCeEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR---HPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      +.+..|..-..|...+.        ..++.+|+-.   .+....|..|+.-|..|.   .-.+.+++.+.....+.|+||
T Consensus        22 ~~v~gG~inea~~v~dg--------~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVl   90 (286)
T COG3001          22 EEVSGGDINEAWRLRDG--------TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVL   90 (286)
T ss_pred             cccCCccccceeEeecC--------CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEE
Confidence            44555666666665433        3678898743   333456777877666664   456888888888899999999


Q ss_pred             EecCCCChh
Q 040050          160 EYMPRGSLH  168 (401)
Q Consensus       160 e~~~~~~L~  168 (401)
                      +|++-+.+.
T Consensus        91 e~L~~~~~d   99 (286)
T COG3001          91 EYLPTGPLD   99 (286)
T ss_pred             eeccCCCCC
Confidence            999876654

>PTZ00384 choline kinase; Provisional

Probab=96.27  E-value=0.067  Score=51.75  Aligned_cols=81  Identities=14%  Similarity=0.121  Sum_probs=45.8

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeEEEEEEe
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL-VKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-~~~~~~~~~~~~~~lv~e~  161 (401)
                      +.|..|-...+|++............+.|++.... ......-.-.+|+.+++.+...++ .++++.+..    +++.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            45656777889988654321111111234444432 222222234568999999875544 455666542    599999


Q ss_pred             cCCCChh
Q 040050          162 MPRGSLH  168 (401)
Q Consensus       162 ~~~~~L~  168 (401)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9887663

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.91  E-value=0.054  Score=52.18  Aligned_cols=75  Identities=16%  Similarity=0.166  Sum_probs=48.2

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecC---CC---cccHHHHHHHHHHHhccC--CC-ceeeEEEEEEeC
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL---DG---TQGHKEWMAEIIFLGQLR--HP-HLVKLIGYCWEE  152 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~---~~---~~~~~~~~~E~~~l~~l~--hp-nI~~~~~~~~~~  152 (401)
                      .+.||.|--.-||++.+..      .++.|+||.-..   .+   +-...+..-|.+.|+...  .| .++++|.+  ++
T Consensus        34 ~~eigdGnlN~VfrV~~~~------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc
Confidence            4678999999999997632      235699996431   11   223456667888887764  45 34555533  44


Q ss_pred             CeEEEEEEecCC
Q 040050          153 EYRLLVYEYMPR  164 (401)
Q Consensus       153 ~~~~lv~e~~~~  164 (401)
                      ....+|||+++.
T Consensus       106 e~~~~vMEdL~~  117 (409)
T PRK12396        106 VMNCCVMEDLSD  117 (409)
T ss_pred             HHhhHHHHhCcc
Confidence            456788998854

>PRK06148 hypothetical protein; Provisional

Probab=95.83  E-value=0.16  Score=55.67  Aligned_cols=34  Identities=38%  Similarity=0.402  Sum_probs=27.9

Q ss_pred             CCCCCeeeccCCCCcEEEcCCC--cEE-EEecCCCCC
Q 040050          200 GEDKPVIYRDFKASNILLDSDY--TAK-LSDFGLAKD  233 (401)
Q Consensus       200 ~~~~~iiH~Dlkp~NIlv~~~~--~vk-L~DfG~a~~  233 (401)
                      ....++||+|+.+.||+++.++  .+. |+|||-+..
T Consensus       200 ~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        200 ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3345699999999999998775  565 999998874

>PTZ00296 choline kinase; Provisional

Probab=95.65  E-value=0.19  Score=49.67  Aligned_cols=81  Identities=11%  Similarity=0.031  Sum_probs=47.5

Q ss_pred             CceecccCCeeEEEEEecCcCC--CCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCcee-eEEEEEEeCCeEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLK--PGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV-KLIGYCWEEEYRLLV  158 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~-~~~~~~~~~~~~~lv  158 (401)
                      .+.|..|---.+|++.......  ....++.|++++......... ....|..+++.+..-+|. ++++.+.    -+.|
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            4566667677888886543211  112356788888764433222 345678877777644443 4555542    2467


Q ss_pred             EEecCCCCh
Q 040050          159 YEYMPRGSL  167 (401)
Q Consensus       159 ~e~~~~~~L  167 (401)
                      .+|++|-+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            899987644

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.50  E-value=0.45  Score=45.02  Aligned_cols=30  Identities=23%  Similarity=0.216  Sum_probs=25.0

Q ss_pred             CCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       202 ~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||+|+.+.||+++ + .+.|+||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            45689999999999995 4 578999998764

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=95.35  E-value=0.095  Score=48.73  Aligned_cols=77  Identities=19%  Similarity=0.149  Sum_probs=45.0

Q ss_pred             cccCCeeEEEEEecC--cCCCCCCCceEEEEEecCCCc-----ccHHHHHHHHHHHhccC-------------CCceeeE
Q 040050           86 GEGGFGPVYKGFVDE--KLKPGLEAQPVAVKALDLDGT-----QGHKEWMAEIIFLGQLR-------------HPHLVKL  145 (401)
Q Consensus        86 g~G~~g~V~~a~~~~--~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~-------------hpnI~~~  145 (401)
                      |.|-.|.+|++...-  ..........++||.......     .....+.+|+.....+-             .....++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            567778888887643  223344567899998762211     11234666776555441             1234566


Q ss_pred             EEEEEeCCeEEEEEEec
Q 040050          146 IGYCWEEEYRLLVYEYM  162 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~  162 (401)
                      +....+....+||||-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            65555555678898876

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.32  E-value=0.3  Score=46.17  Aligned_cols=139  Identities=19%  Similarity=0.229  Sum_probs=77.2

Q ss_pred             eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCC---Cc---eeeEEE----EEEeCC
Q 040050           84 LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH---PH---LVKLIG----YCWEEE  153 (401)
Q Consensus        84 ~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pn---I~~~~~----~~~~~~  153 (401)
                      .|.+ .-..+|+....+        ..+++|+.+..  ....++..|+..|..+.-   +=   +...=|    ......
T Consensus        33 ~l~s-~eN~~f~~~~~~--------g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~  101 (331)
T COG2334          33 GLNS-EENSNFRVQTED--------GRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGP  101 (331)
T ss_pred             cccc-ccCceEEEEecC--------CCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCc
Confidence            3444 456788876554        34599998755  334556667777777631   11   121111    111223


Q ss_pred             eEEEEEEecCCCChhH-HH--------------hh---hcC-------CCCCHH-------------HHHHHHHHHHHHH
Q 040050          154 YRLLVYEYMPRGSLHN-QL--------------FR---SYS-------AALPWS-------------TRMKIALGAAKGL  195 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~-~l--------------~~---~~~-------~~l~~~-------------~~~~i~~qi~~al  195 (401)
                      ..+-+++|++|..+.. .-              ..   ...       ....|.             .-.....++...+
T Consensus       102 r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~  181 (331)
T COG2334         102 RPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAAL  181 (331)
T ss_pred             eeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHH
Confidence            6778899998877762 10              00   000       011121             0011223333444


Q ss_pred             HHHhCC------CCC--eeeccCCCCcEEEcCCCc-EEEEecCCCCC
Q 040050          196 AFLHGE------DKP--VIYRDFKASNILLDSDYT-AKLSDFGLAKD  233 (401)
Q Consensus       196 ~~LH~~------~~~--iiH~Dlkp~NIlv~~~~~-vkL~DfG~a~~  233 (401)
                      ..+...      ..+  +||+|+.|.||+++.+.. +-++|||-+..
T Consensus       182 ~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         182 DRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             HHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            444321      223  999999999999998874 89999997763

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	401
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-53
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-51
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-50
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-42
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-41
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-40
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-25
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-24
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-21
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-20
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-20
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-20
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-20
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-20
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-20
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-20
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-20
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-20
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-20
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-20
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-20
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-20
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		9e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-19
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-19
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-19
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-19
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		9e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-19
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-18
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-18
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-18
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-18
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-18
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-18
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		8e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-17
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-17
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-17
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-17
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-17
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-17
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-17
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-17
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-17
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-17
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-17
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-17
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-17
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-17
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-17
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-17
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-17
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-17
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-17
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-16
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		8e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		9e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-15
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-15
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-15
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-15
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-15
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-15
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-15
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		8e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-14
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-14
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		6e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-12
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-12
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		7e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-12
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		8e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		9e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		9e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-09
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-09
3soa_A	444	Full-Length Human Camkii Length = 444		5e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-09
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		7e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		5e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		6e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		9e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-05
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-05
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-05
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-05
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 126/301 (41%), Positives = 180/301 (59%), Gaps = 15/301 (4%)
Query: 63  KLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           +L  F+L EL++ + NFS  N+LG GGFG VYKG    +L  G     VAVK L  +  Q
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKG----RLADG---TLVAVKRLKEERXQ 76
Query: 123 GHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP- 180
           G + ++  E+  +    H +L++L G+C     RLLVY YM  GS+ + L     +  P 
Sbjct: 77  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 136
Query: 181 -WSTRMKIALGAAKGLAFLHGEDKP-VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
            W  R +IALG+A+GLA+LH    P +I+RD KA+NILLD ++ A + DFGLAK   + +
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYK 195
Query: 239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-- 296
           + HV   V GT G+ APEY+ TG  +  +DV+ +GV+LLEL+TG+RA D  RL  +    
Sbjct: 196 DXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 255
Query: 297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
           L +W + LLKE +KLE L+D  L+G +  +  ++    A  C    P  RP MS VVR+L
Sbjct: 256 LLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314
Query: 357 D 357
           +
Sbjct: 315 E 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  204 bits (520), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 125/301 (41%), Positives = 179/301 (59%), Gaps = 15/301 (4%)
Query: 63  KLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           +L  F+L EL++ + NF   N+LG GGFG VYKG    +L  G     VAVK L  + TQ
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKG----RLADG---XLVAVKRLKEERTQ 68
Query: 123 GHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP- 180
           G + ++  E+  +    H +L++L G+C     RLLVY YM  GS+ + L     +  P 
Sbjct: 69  GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 181 -WSTRMKIALGAAKGLAFLHGEDKP-VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
            W  R +IALG+A+GLA+LH    P +I+RD KA+NILLD ++ A + DFGLAK   + +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYK 187
Query: 239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-- 296
           + HV   V G  G+ APEY+ TG  +  +DV+ +GV+LLEL+TG+RA D  RL  +    
Sbjct: 188 DXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247
Query: 297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
           L +W + LLKE +KLE L+D  L+G +  +  ++    A  C    P  RP MS VVR+L
Sbjct: 248 LLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
Query: 357 D 357
           +
Sbjct: 307 E 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 121/302 (40%), Positives = 177/302 (58%), Gaps = 14/302 (4%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           L +L   T+NF    L+G G FG VYKG + +  K       VA+K    + +QG +E+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-------VALKRRTPESSQGIEEFE 83
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY--SAALPWSTRMK 186
            EI  L   RHPHLV LIG+C E    +L+Y+YM  G+L   L+ S   + ++ W  R++
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           I +GAA+GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E ++TH+   V
Sbjct: 144 ICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-SLAEWARPLL 305
            GT GY  PEY + G LT  SDVYSFGVVL E+L  + A+  + L RE  +LAEWA    
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS-LPREMVNLAEWAVE-S 259
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
               +LE+++DP L  +   +  +K   TA KCL+     RP+M  V+  L+     Q+S
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
Query: 366 FV 367
            +
Sbjct: 320 VI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 121/302 (40%), Positives = 176/302 (58%), Gaps = 14/302 (4%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           L +L   T+NF    L+G G FG VYKG + +  K       VA+K    + +QG +E+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK-------VALKRRTPESSQGIEEFE 83
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY--SAALPWSTRMK 186
            EI  L   RHPHLV LIG+C E    +L+Y+YM  G+L   L+ S   + ++ W  R++
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           I +GAA+GL +LH   + +I+RD K+ NILLD ++  K++DFG++K G E  +TH+   V
Sbjct: 144 ICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-SLAEWARPLL 305
            GT GY  PEY + G LT  SDVYSFGVVL E+L  + A+  + L RE  +LAEWA    
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS-LPREMVNLAEWAVE-S 259
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
               +LE+++DP L  +   +  +K   TA KCL+     RP+M  V+  L+     Q+S
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
Query: 366 FV 367
            +
Sbjct: 320 VI 321

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 113/312 (36%), Positives = 172/312 (55%), Gaps = 25/312 (8%)
Query: 59  VIGSKLHVFTLAELRLITSNFSR------SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVA 112
           V  ++ H F+  EL+ +T+NF         N +GEGGFG VYKG+V+           VA
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--------TVA 58
Query: 113 VKAL----DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH 168
           VK L    D+   +  +++  EI  + + +H +LV+L+G+  + +   LVY YMP GSL 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 169 NQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
           ++L     +  L W  R KIA GAA G+ FLH  +   I+RD K++NILLD  +TAK+SD
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISD 176
Query: 228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           FGLA+   +  +T + +R++GT  Y APE  + G +T  SD+YSFGVVLLE++TG  A+D
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 288 NTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP 347
             R    Q L +    +  E + +E  ID ++         +   + A +CL      RP
Sbjct: 236 EHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRP 292
Query: 348 TMSYVVRVLDSL 359
            +  V ++L  +
Sbjct: 293 DIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 113/312 (36%), Positives = 171/312 (54%), Gaps = 25/312 (8%)
Query: 59  VIGSKLHVFTLAELRLITSNFSR------SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVA 112
           V  ++ H F+  EL+ +T+NF         N +GEGGFG VYKG+V+           VA
Sbjct: 7   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--------TVA 58
Query: 113 VKAL----DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH 168
           VK L    D+   +  +++  EI  + + +H +LV+L+G+  + +   LVY YMP GSL 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118
Query: 169 NQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
           ++L     +  L W  R KIA GAA G+ FLH  +   I+RD K++NILLD  +TAK+SD
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISD 176
Query: 228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           FGLA+   +  +T +  R++GT  Y APE  + G +T  SD+YSFGVVLLE++TG  A+D
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 288 NTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP 347
             R    Q L +    +  E + +E  ID ++         +   + A +CL      RP
Sbjct: 236 EHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRP 292
Query: 348 TMSYVVRVLDSL 359
            +  V ++L  +
Sbjct: 293 DIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 112/312 (35%), Positives = 170/312 (54%), Gaps = 25/312 (8%)
Query: 59  VIGSKLHVFTLAELRLITSNFSR------SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVA 112
           V  ++ H F+  EL+ +T+NF         N +GEGGFG VYKG+V+           VA
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--------TVA 52
Query: 113 VKAL----DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH 168
           VK L    D+   +  +++  EI  + + +H +LV+L+G+  + +   LVY YMP GSL 
Sbjct: 53  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 112
Query: 169 NQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
           ++L     +  L W  R KIA GAA G+ FLH  +   I+RD K++NILLD  +TAK+SD
Sbjct: 113 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISD 170
Query: 228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           FGLA+   +  +  +  R++GT  Y APE  + G +T  SD+YSFGVVLLE++TG  A+D
Sbjct: 171 FGLARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD 229
Query: 288 NTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP 347
             R    Q L +    +  E + +E  ID ++         +   + A +CL      RP
Sbjct: 230 EHR--EPQLLLDIKEEIEDEEKTIEDYIDKKMNDA-DSTSVEAMYSVASQCLHEKKNKRP 286
Query: 348 TMSYVVRVLDSL 359
            +  V ++L  +
Sbjct: 287 DIKKVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  161 bits (407), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 97/240 (40%), Positives = 140/240 (58%), Gaps = 22/240 (9%)
Query: 62  SKLHVFTLAELRLITSNFSR------SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA 115
           ++ H F+  EL+ +T+NF         N  GEGGFG VYKG+V+           VAVK 
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNT--------TVAVKK 52
Query: 116 L----DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL 171
           L    D+   +  +++  EI    + +H +LV+L+G+  + +   LVY Y P GSL ++L
Sbjct: 53  LAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL 112
Query: 172 -FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
                +  L W  R KIA GAA G+ FLH  +   I+RD K++NILLD  +TAK+SDFGL
Sbjct: 113 SCLDGTPPLSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGL 170
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTR 290
           A+   +  +    +R++GT  Y APE  + G +T  SD+YSFGVVLLE++TG  A+D  R
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 144/296 (48%), Gaps = 56/296 (18%)
Query: 85  LGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALDLDGTQGH-------KEWMAEIIFLGQ 136
           +G+GGFG V+KG  V +K         VA+K+L L  ++G        +E+  E+  +  
Sbjct: 27  IGKGGFGLVHKGRLVKDK-------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP++VKL G         +V E++P G L+++L    +  + WS ++++ L  A G+ 
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIE 136
Query: 197 FLHGEDKPVIYRDFKASNILLDS-----DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           ++  ++ P+++RD ++ NI L S        AK++DFGL++     +  H ++ ++G   
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQ 191
Query: 252 YAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL----AEWARPLL 305
           + APE +       T  +D YSF ++L  +LTG+   D    G+ + +     E  RP +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 306 KE--PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
            E  P +L  +I+                     C S  P+ RP  SY+V+ L  L
Sbjct: 252 PEDCPPRLRNVIE--------------------LCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 143/296 (48%), Gaps = 56/296 (18%)
Query: 85  LGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALDLDGTQGH-------KEWMAEIIFLGQ 136
           +G+GGFG V+KG  V +K         VA+K+L L  ++G        +E+  E+  +  
Sbjct: 27  IGKGGFGLVHKGRLVKDK-------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP++VKL G         +V E++P G L+++L    +  + WS ++++ L  A G+ 
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIE 136
Query: 197 FLHGEDKPVIYRDFKASNILLDS-----DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           ++  ++ P+++RD ++ NI L S        AK++DFG ++     +  H ++ ++G   
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQ 191
Query: 252 YAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL----AEWARPLL 305
           + APE +       T  +D YSF ++L  +LTG+   D    G+ + +     E  RP +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 306 KE--PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
            E  P +L  +I+                     C S  P+ RP  SY+V+ L  L
Sbjct: 252 PEDCPPRLRNVIE--------------------LCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 29/278 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK--EWMAEIIFLGQLRHPHL 142
           +G G FG V++               VAVK L        +  E++ E+  + +LRHP++
Sbjct: 45  IGAGSFGTVHRA--------EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS-AALPWSTRMKIALGAAKGLAFLHGE 201
           V  +G   +     +V EY+ RGSL+  L +S +   L    R+ +A   AKG+ +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG 261
           + P+++RD K+ N+L+D  YT K+ DFGL++   +           GT  + APE +   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 262 HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG 321
                SDVYSFGV+L EL T ++   N    +  +   +    L+ PR L   +   +EG
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG 274
Query: 322 QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                           C ++ P  RP+ + ++ +L  L
Sbjct: 275 ----------------CWTNEPWKRPSFATIMDLLRPL 296

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 81/296 (27%), Positives = 143/296 (48%), Gaps = 56/296 (18%)
Query: 85  LGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALDLDGTQGH-------KEWMAEIIFLGQ 136
           +G+GGFG V+KG  V +K         VA+K+L L  ++G        +E+  E+  +  
Sbjct: 27  IGKGGFGLVHKGRLVKDK-------SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP++VKL G         +V E++P G L+++L    +  + WS ++++ L  A G+ 
Sbjct: 80  LNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIE 136
Query: 197 FLHGEDKPVIYRDFKASNILLDS-----DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           ++  ++ P+++RD ++ NI L S        AK++DF L++     +  H ++ ++G   
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQ 191
Query: 252 YAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL----AEWARPLL 305
           + APE +       T  +D YSF ++L  +LTG+   D    G+ + +     E  RP +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251
Query: 306 KE--PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
            E  P +L  +I+                     C S  P+ RP  SY+V+ L  L
Sbjct: 252 PEDCPPRLRNVIE--------------------LCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 31/279 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK--EWMAEIIFLGQLRHPHL 142
           +G G FG V++               VAVK L        +  E++ E+  + +LRHP++
Sbjct: 45  IGAGSFGTVHRA--------EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS-AALPWSTRMKIALGAAKGLAFLHGE 201
           V  +G   +     +V EY+ RGSL+  L +S +   L    R+ +A   AKG+ +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR-VMGTQGYAAPEYVMT 260
           + P+++R+ K+ N+L+D  YT K+ DFGL++       T + ++   GT  + APE +  
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
                 SDVYSFGV+L EL T ++   N    +  +   +    L+ PR L   +   +E
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           G                C ++ P  RP+ + ++ +L  L
Sbjct: 274 G----------------CWTNEPWKRPSFATIMDLLRPL 296

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/202 (39%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG V   +  +    G   + VAVKAL  D G Q    W  EI  L  L H H++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 144 KLIGYCWE--EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           K  G C +  E+   LV EY+P GSL + L R    ++  +  +  A    +G+A+LH +
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPEYVM 259
               I+R+  A N+LLD+D   K+ DFGLAK  PEG E + + R  G     + APE + 
Sbjct: 137 H--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV-REDGDSPVFWYAPECLK 193
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
                  SDV+SFGV L ELLT
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/202 (39%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG V   +  +    G   + VAVKAL  D G Q    W  EI  L  L H H++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 144 KLIGYCWE--EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           K  G C +  E+   LV EY+P GSL + L R    ++  +  +  A    +G+A+LH +
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPEYVM 259
               I+R+  A N+LLD+D   K+ DFGLAK  PEG E + + R  G     + APE + 
Sbjct: 137 H--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV-REDGDSPVFWYAPECLK 193
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
                  SDV+SFGV L ELLT
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 79/202 (39%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG V   +  +    G   + VAVKAL  D G Q    W  EI  L  L H H++
Sbjct: 39  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 144 KLIGYCWEE--EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           K  G C +       LV EY+P GSL + L R    ++  +  +  A    +G+A+LH +
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPEYVM 259
               I+RD  A N+LLD+D   K+ DFGLAK  PEG E + + R  G     + APE + 
Sbjct: 154 H--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRV-REDGDSPVFWYAPECLK 210
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
                  SDV+SFGV L ELLT
Sbjct: 211 EYKFYYASDVWSFGVTLYELLT 232

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 138/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGLA+   D PE   T        
Sbjct: 157 ASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRA---MDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 139/291 (47%), Gaps = 53/291 (18%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           ++G G FG V K            A+ VA+K ++ +  +  K ++ E+  L ++ HP++V
Sbjct: 16  VVGRGAFGVVCKA--------KWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 65
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR---MKIALGAAKGLAFLHG 200
           KL G C       LV EY   GSL+N L  +    LP+ T    M   L  ++G+A+LH 
Sbjct: 66  KLYGACLNP--VCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 201 -EDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
            + K +I+RD K  N+LL +  T  K+ DFG A D     +TH +T   G+  + APE  
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTH-MTNNKGSAAWMAPEVF 176
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA------RPLLKE-PRKL 311
              + +   DV+S+G++L E++T ++  D   +G       WA       PL+K  P+ +
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWAVHNGTRPPLIKNLPKPI 234
Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF 362
           E L+                     +C S  P  RP+M  +V+++  L  +
Sbjct: 235 ESLMT--------------------RCWSKDPSQRPSMEEIVKIMTHLMRY 265

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 143/314 (45%), Gaps = 51/314 (16%)
Query: 61  GSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLD 119
           GS   V   A+  L  +N S   ++G G FG V  G    +LK P  +   VA+K L + 
Sbjct: 1   GSTQTVHEFAK-ELDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVG 55
Query: 120 GTQGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
            T+  + +++ E   +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A 
Sbjct: 56  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ 114
Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGP 235
                 + +  G A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D P
Sbjct: 115 FTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 172
Query: 236 EGEETHVITRVMGTQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---A 285
           E   T        T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    
Sbjct: 173 EAAYT--------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 286 MDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH 345
           M N  + +         P +  P  L +L+                      C      +
Sbjct: 225 MSNQDVIKAVDEGYRLPPPMDCPAALYQLM--------------------LDCWQKDRNN 264
Query: 346 RPTMSYVVRVLDSL 359
           RP    +V +LD L
Sbjct: 265 RPKFEQIVSILDKL 278

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 139/291 (47%), Gaps = 53/291 (18%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           ++G G FG V K            A+ VA+K ++ +  +  K ++ E+  L ++ HP++V
Sbjct: 15  VVGRGAFGVVCKA--------KWRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR---MKIALGAAKGLAFLHG 200
           KL G C       LV EY   GSL+N L  +    LP+ T    M   L  ++G+A+LH 
Sbjct: 65  KLYGACLNP--VCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 201 -EDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
            + K +I+RD K  N+LL +  T  K+ DFG A D     +TH +T   G+  + APE  
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTH-MTNNKGSAAWMAPEVF 175
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA------RPLLKE-PRKL 311
              + +   DV+S+G++L E++T ++  D   +G       WA       PL+K  P+ +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF 362
           E L+                     +C S  P  RP+M  +V+++  L  +
Sbjct: 234 ESLMT--------------------RCWSKDPSQRPSMEEIVKIMTHLMRY 264

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        
Sbjct: 157 ASGMKYL--SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/314 (27%), Positives = 143/314 (45%), Gaps = 51/314 (16%)
Query: 61  GSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLD 119
           GS   V   A+  L  +N S   ++G G FG V  G    +LK P  +   VA+K L + 
Sbjct: 18  GSTQTVHEFAK-ELDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVG 72
Query: 120 GTQGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
            T+  + +++ E   +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A 
Sbjct: 73  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQ 131
Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGP 235
                 + +  G A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D P
Sbjct: 132 FTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 189
Query: 236 EGEETHVITRVMGTQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---A 285
           E   T        T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    
Sbjct: 190 EAAYT--------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 241
Query: 286 MDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH 345
           M N  + +         P +  P  L +L+                      C      +
Sbjct: 242 MSNQDVIKAVDEGYRLPPPMDCPAALYQLM--------------------LDCWQKDRNN 281
Query: 346 RPTMSYVVRVLDSL 359
           RP    +V +LD L
Sbjct: 282 RPKFEQIVSILDKL 295

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 12/213 (5%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLG 135
           S  +R  ++G G FG VYKG +  K   G +  PVA+K L    T+  + +++ E   +G
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 101
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           Q  H ++++L G   + +  +++ EYM  G+L ++  R           + +  G A G+
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQGY 252
            +L   +   ++RD  A NIL++S+   K+SDFGL++   D PE   T    ++     +
Sbjct: 161 KYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRW 216
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR 284
            APE +     T+ SDV+SFG+V+ E++T G+R
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        
Sbjct: 157 ASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        
Sbjct: 157 ASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        
Sbjct: 157 ASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        
Sbjct: 157 ASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 40  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 95
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A       + +  G 
Sbjct: 96  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 154
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        
Sbjct: 155 ASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-------- 204
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 205 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 264
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 265 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 304
Query: 359 L 359
           L
Sbjct: 305 L 305

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/246 (31%), Positives = 119/246 (48%), Gaps = 35/246 (14%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL----DLDGTQGHKEWMAEII 132
           +  +   ++G GGFG VY+ F             VAVKA     D D +Q  +    E  
Sbjct: 7   AELTLEEIIGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
               L+HP+++ L G C +E    LV E+   G L+  L       +P    +  A+  A
Sbjct: 59  LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIA 115
Query: 193 KGLAFLHGED-KPVIYRDFKASNILLD--------SDYTAKLSDFGLAKDGPEGEETHVI 243
           +G+ +LH E   P+I+RD K+SNIL+         S+   K++DFGLA+      E H  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------EWHRT 169
Query: 244 TRVMGTQGYA--APEYVMTGHLTTMSDVYSFGVVLLELLTGK---RAMDNTRLGREQSLA 298
           T++     YA  APE +     +  SDV+S+GV+L ELLTG+   R +D   +    ++ 
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
Query: 299 EWARPL 304
           + A P+
Sbjct: 230 KLALPI 235

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 137/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V EYM  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL +   D PE   T        
Sbjct: 157 ASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/202 (39%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG V   +  +    G   + VAVKAL +  G Q    W  EI  L  L H H+V
Sbjct: 17  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 144 KLIGYCWE--EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           K  G C +  E+   LV EY+P GSL + L R     +  +  +  A    +G+A+LH +
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH---CVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPEYVM 259
               I+R   A N+LLD+D   K+ DFGLAK  PEG E + + R  G     + APE + 
Sbjct: 132 H--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV-REDGDSPVFWYAPECLK 188
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
                  SDV+SFGV L ELLT
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/202 (39%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           LGEG FG V   +  +    G   + VAVKAL +  G Q    W  EI  L  L H H+V
Sbjct: 16  LGEGHFGKV-SLYCYDPTNDG-TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 144 KLIGYCWE--EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           K  G C +  E+   LV EY+P GSL + L R     +  +  +  A    +G+A+LH +
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH---CVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPEYVM 259
               I+R   A N+LLD+D   K+ DFGLAK  PEG E + + R  G     + APE + 
Sbjct: 131 H--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV-REDGDSPVFWYAPECLK 187
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
                  SDV+SFGV L ELLT
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT 209

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 142/314 (45%), Gaps = 51/314 (16%)
Query: 61  GSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLD 119
           GS   V   A+  L  +N S   ++G G FG V  G    +LK P  +   VA+K L + 
Sbjct: 1   GSTQTVHEFAK-ELDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVG 55
Query: 120 GTQGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
            T+  + +++ E   +GQ  HP++++L G   + +  ++V E M  GSL +   R + A 
Sbjct: 56  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQ 114
Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGP 235
                 + +  G A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D P
Sbjct: 115 FTVIQLVGMLRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 172
Query: 236 EGEETHVITRVMGTQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---A 285
           E   T        T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    
Sbjct: 173 EAAYT--------TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 286 MDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH 345
           M N  + +         P +  P  L +L+                      C      +
Sbjct: 225 MSNQDVIKAVDEGYRLPPPMDCPAALYQLM--------------------LDCWQKDRNN 264
Query: 346 RPTMSYVVRVLDSL 359
           RP    +V +LD L
Sbjct: 265 RPKFEQIVSILDKL 278

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE 126
             + EL+L+ +       +G+G FG V  G              VAVK +  D T   + 
Sbjct: 3   LNMKELKLLQT-------IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QA 45
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           ++AE   + QLRH +LV+L+G   EE+  L +V EYM +GSL + L     + L     +
Sbjct: 46  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K +L   + + +L G +   ++RD  A N+L+  D  AK+SDFGL K+    ++T  +  
Sbjct: 106 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-- 161
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA 285
                 + APE +     +T SDV+SFG++L E+ +  R 
Sbjct: 162 ---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 137/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V E M  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        
Sbjct: 157 ASGMKYL--SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE 126
             + EL+L+ +       +G+G FG V  G              VAVK +  D T   + 
Sbjct: 9   LNMKELKLLQT-------IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QA 51
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           ++AE   + QLRH +LV+L+G   EE+  L +V EYM +GSL + L     + L     +
Sbjct: 52  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 111
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K +L   + + +L G +   ++RD  A N+L+  D  AK+SDFGL K+    ++T  +  
Sbjct: 112 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-- 167
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA 285
                 + APE +     +T SDV+SFG++L E+ +  R 
Sbjct: 168 ---PVKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRV 204

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 129/280 (46%), Gaps = 36/280 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+    ++  K       VAVK +   G+   + ++AE   +  L+H  LVK
Sbjct: 23  LGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 74
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E    ++ E+M +GSL + L     +  P    +  +   A+G+AF+  E + 
Sbjct: 75  LHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 131
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+ +    K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFT 190
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---RKLERLID-PRLE 320
             SDV+SFG++L+E++T  R                  P +  P   R LER    PR  
Sbjct: 191 IKSDVWSFGILLMEIVTYGRI---------------PYPGMSNPEVIRALERGYRMPR-- 233
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
              P    ++      +C  + P  RPT  Y+  VLD  +
Sbjct: 234 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFE 270

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE 126
             + EL+L+ +       +G+G FG V  G              VAVK +  D T   + 
Sbjct: 18  LNMKELKLLQT-------IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QA 60
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           ++AE   + QLRH +LV+L+G   EE+  L +V EYM +GSL + L     + L     +
Sbjct: 61  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 120
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K +L   + + +L G +   ++RD  A N+L+  D  AK+SDFGL K+    ++T  +  
Sbjct: 121 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-- 176
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA 285
                 + APE +     +T SDV+SFG++L E+ +  R 
Sbjct: 177 ---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 111/220 (50%), Gaps = 25/220 (11%)
Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE 126
             + EL+L+ +       +G+G FG V  G              VAVK +  D T   + 
Sbjct: 190 LNMKELKLLQT-------IGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QA 232
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           ++AE   + QLRH +LV+L+G   EE+  L +V EYM +GSL + L     + L     +
Sbjct: 233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K +L   + + +L G +   ++RD  A N+L+  D  AK+SDFGL K+    ++T  +  
Sbjct: 293 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-- 348
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA 285
                 + APE +     +T SDV+SFG++L E+ +  R 
Sbjct: 349 ---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 137/301 (45%), Gaps = 50/301 (16%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E 
Sbjct: 42  LDATNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++++L G   + +  ++V E M  GSL +   R + A       + +  G 
Sbjct: 98  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGI 156
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T        
Sbjct: 157 ASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT-------- 206
Query: 249 TQG------YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
           T+G      + +PE +     T+ SDV+S+G+VL E+++ G+R    M N  + +     
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +  P  L +L+                      C      +RP    +V +LD 
Sbjct: 267 YRLPPPMDCPAALYQLM--------------------LDCWQKDRNNRPKFEQIVSILDK 306
Query: 359 L 359
           L
Sbjct: 307 L 307

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+    ++  K       VAVK +   G+   + ++AE   +  L+H  LVK
Sbjct: 196 LGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E    ++ E+M +GSL + L     +  P    +  +   A+G+AF+  E + 
Sbjct: 248 LHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 304
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+ +    K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFT 363
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---RKLERLID-PRLE 320
             SDV+SFG++L+E++T  R                  P +  P   R LER    PR  
Sbjct: 364 IKSDVWSFGILLMEIVTYGRI---------------PYPGMSNPEVIRALERGYRMPR-- 406
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
              P    ++      +C  + P  RPT  Y+  VLD  
Sbjct: 407 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 89/292 (30%), Positives = 138/292 (47%), Gaps = 43/292 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 30  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 81
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E    ++ EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 82  LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 138
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFT 197
Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKE--PRKLERLIDPR 318
             SDV+SFG++L E++T  R     M N  +   Q+L    R +  +  P +L +L+  R
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNLERGYRMVRPDNCPEELYQLM--R 253
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPF 370
           L                  C    P  RPT  Y+  V   L+DF  +  G F
Sbjct: 254 L------------------CWKERPEDRPTFDYLRSV---LEDFFTATEGQF 284

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 32/282 (11%)
Query: 84  LLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPH 141
           ++G G  G V  G    +L+ PG    PVA+KAL    T+  + ++++E   +GQ  HP+
Sbjct: 56  IIGSGDSGEVCYG----RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           +++L G        ++V EYM  GSL +   R++         + +  G   G+ +L   
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL--S 168
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQGYAAPEYV 258
           D   ++RD  A N+L+DS+   K+SDFGL++   D P+   T    ++     + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRWTAPEAI 226
Query: 259 MTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP 317
                ++ SDV+SFGVV+ E+L  G+R   N             R ++    +  RL   
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----------NRDVISSVEEGYRL--- 273
Query: 318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                 P+            C       RP  S +V VLD+L
Sbjct: 274 ----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E    ++ EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 79  LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 135
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFT 194
Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKE--PRKLERLIDPR 318
             SDV+SFG++L E++T  R     M N  +   Q+L    R +  +  P +L +L+  R
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNLERGYRMVRPDNCPEELYQLM--R 250
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L                  C    P  RPT  Y+  VL+  
Sbjct: 251 L------------------CWKERPEDRPTFDYLRSVLEDF 273

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 29  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 80
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 81  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 137
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFT 196
Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKE--PRKLERLIDPR 318
             SDV+SFG++L E++T  R     M N  +   Q+L    R +  +  P +L +L+  R
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNLERGYRMVRPDNCPEELYQLM--R 252
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L                  C    P  RPT  Y+  VL+  
Sbjct: 253 L------------------CWKERPEDRPTFDYLRSVLEDF 275

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E    ++ EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 73  LYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFT 188
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP 324
             SDV+SFG++L E++T  R                  P +  P  ++ L +       P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNL-ERGYRMVRP 232
Query: 325 IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
               ++       C    P  RPT  Y+  VL+  
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 22  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 74  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 130
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFT 189
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP 324
             SDV+SFG++L E++T  R                  P +  P  ++ L +       P
Sbjct: 190 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNL-ERGYRMVRP 233
Query: 325 IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
               ++       C    P  RPT  Y+  VL+  
Sbjct: 234 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 268

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 23  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 74
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 75  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 131
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFT 190
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP 324
             SDV+SFG++L E++T  R                  P +  P  ++ L +       P
Sbjct: 191 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNL-ERGYRMVRP 234
Query: 325 IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
               ++       C    P  RPT  Y+  VL+  
Sbjct: 235 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 269

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFT 188
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP 324
             SDV+SFG++L E++T  R                  P +  P  ++ L +       P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNL-ERGYRMVRP 232
Query: 325 IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
               ++       C    P  RPT  Y+  VL+  
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 46/279 (16%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+    ++  K       VAVK +   G+   + ++AE   +  L+H  LVK
Sbjct: 190 LGAGQFGEVWMATYNKHTK-------VAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVK 241
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  E+M +GSL + L     +  P    +  +   A+G+AF+  E + 
Sbjct: 242 LHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRN 298
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+ +    K++DFGLA+ G +               + APE +  G  T
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFGSFT 347
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---RKLERLID-PRLE 320
             SDV+SFG++L+E++T  R                  P +  P   R LER    PR  
Sbjct: 348 IKSDVWSFGILLMEIVTYGRI---------------PYPGMSNPEVIRALERGYRMPR-- 390
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
              P    ++      +C  + P  RPT  Y+  VLD  
Sbjct: 391 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 105/234 (44%), Gaps = 28/234 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LGEG FG V+       L P  +   VAVKAL        +++  E   L  L+H H+V+
Sbjct: 26  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS--------------AALPWSTRMKIALG 190
             G C E    L+V+EYM  G L N+  RS+                 L     + +A  
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 143
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            A G+ +L G     ++RD    N L+      K+ DFG+++D    +   V  R M   
Sbjct: 144 VAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---------AMDNTRLGRE 294
            +  PE ++    TT SDV+SFGVVL E+ T GK+         A+D    GRE
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 255

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 16  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 67
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 68  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 124
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFT 183
Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKE--PRKLERLIDPR 318
             SDV+SFG++L E++T  R     M N  +   Q+L    R +  +  P +L +L+  R
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNLERGYRMVRPDNCPEELYQLM--R 239
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L                  C    P  RPT  Y+  VL+  
Sbjct: 240 L------------------CWKERPEDRPTFDYLRSVLEDF 262

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 129/282 (45%), Gaps = 32/282 (11%)
Query: 84  LLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPH 141
           ++G G  G V  G    +L+ PG    PVA+KAL    T+  + ++++E   +GQ  HP+
Sbjct: 56  IIGSGDSGEVCYG----RLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           +++L G        ++V EYM  GSL +   R++         + +  G   G+ +L   
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYL--S 168
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQGYAAPEYV 258
           D   ++RD  A N+L+DS+   K+SDFGL++   D P+   T    ++     + APE +
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRWTAPEAI 226
Query: 259 MTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP 317
                ++ SDV+SFGVV+ E+L  G+R   N             R ++    +  RL   
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----------NRDVISSVEEGYRL--- 273
Query: 318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                 P+            C       RP  S +V VLD+L
Sbjct: 274 ----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 130/296 (43%), Gaps = 47/296 (15%)
Query: 85  LGEGGFGPVYKGFVDE--KLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           LGEG FG V   F+ E   L P  +   VAVKAL        K++  E   L  L+H H+
Sbjct: 23  LGEGAFGKV---FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS---------------AALPWSTRMKI 187
           VK  G C + +  ++V+EYM  G L N+  R++                  L  S  + I
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   A G+ +L  +    ++RD    N L+ ++   K+ DFG+++D    +   V    M
Sbjct: 139 ASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLAEWARP 303
               +  PE +M    TT SDV+SFGV+L E+ T GK+    + NT +            
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE---------- 246
Query: 304 LLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
            + + R LER   PR+         ++       C    P+ R  +  + ++L +L
Sbjct: 247 CITQGRVLER---PRV-------CPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALD-LDGTQGHKE 126
           A+LR++  +   R  +LG G FG VYKG +V E     +   PVA+K L+   G + + E
Sbjct: 7   AQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKI---PVAIKILNETTGPKANVE 63
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
           +M E + +  + HPHLV+L+G C     + LV + MP G L  +    +   +     + 
Sbjct: 64  FMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLL-EYVHEHKDNIGSQLLLN 121
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             +  AKG+ +L  E++ +++RD  A N+L+ S    K++DFGLA+     E+ +     
Sbjct: 122 WCVQIAKGMMYL--EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 179
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + A E +     T  SDV+S+GV + EL+T
Sbjct: 180 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 27  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 79  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 135
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFT 194
Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKE--PRKLERLIDPR 318
             SDV+SFG++L E++T  R     M N  +   Q+L    R +  +  P +L +L+  R
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNLERGYRMVRPDNCPEELYQLM--R 250
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L                  C    P  RPT  Y+  VL+  
Sbjct: 251 L------------------CWKERPEDRPTFDYLRSVLEDF 273

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALD-LDGTQGHKE 126
           A+LR++  +   R  +LG G FG VYKG +V E     +   PVA+K L+   G + + E
Sbjct: 30  AQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKI---PVAIKILNETTGPKANVE 86
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
           +M E + +  + HPHLV+L+G C     + LV + MP G L  +    +   +     + 
Sbjct: 87  FMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLL-EYVHEHKDNIGSQLLLN 144
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             +  AKG+ +L  E++ +++RD  A N+L+ S    K++DFGLA+     E+ +     
Sbjct: 145 WCVQIAKGMMYL--EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 202
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + A E +     T  SDV+S+GV + EL+T
Sbjct: 203 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 105/234 (44%), Gaps = 28/234 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LGEG FG V+       L P  +   VAVKAL        +++  E   L  L+H H+V+
Sbjct: 20  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS--------------AALPWSTRMKIALG 190
             G C E    L+V+EYM  G L N+  RS+                 L     + +A  
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 137
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            A G+ +L G     ++RD    N L+      K+ DFG+++D    +   V  R M   
Sbjct: 138 VAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---------AMDNTRLGRE 294
            +  PE ++    TT SDV+SFGVVL E+ T GK+         A+D    GRE
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 249

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 31  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 82
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 83  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 139
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFT 198
Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKE--PRKLERLIDPR 318
             SDV+SFG++L E++T  R     M N  +   Q+L    R +  +  P +L +L+  R
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNLERGYRMVRPDNCPEELYQLM--R 254
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L                  C    P  RPT  Y+  VL+  
Sbjct: 255 L------------------CWKERPEDRPTFDYLRSVLEDF 277

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 105/234 (44%), Gaps = 28/234 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LGEG FG V+       L P  +   VAVKAL        +++  E   L  L+H H+V+
Sbjct: 49  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS--------------AALPWSTRMKIALG 190
             G C E    L+V+EYM  G L N+  RS+                 L     + +A  
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            A G+ +L G     ++RD    N L+      K+ DFG+++D    +   V  R M   
Sbjct: 167 VAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---------AMDNTRLGRE 294
            +  PE ++    TT SDV+SFGVVL E+ T GK+         A+D    GRE
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFT 188
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP 324
             SDV+SFG++L E++T  R                  P +  P  ++ L +       P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNL-ERGYRMVRP 232
Query: 325 IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
               ++       C    P  RPT  Y+  VL+  
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 26  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 78  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFT 193
Query: 265 TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP 324
             SDV+SFG++L E++T  R                  P +  P  ++ L +       P
Sbjct: 194 IKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNL-ERGYRMVRP 237
Query: 325 IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
               ++       C    P  RPT  Y+  VL+  
Sbjct: 238 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 272

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 130/279 (46%), Gaps = 36/279 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V+ G+        L    VA+K +  +G    ++++ E   + +L HP LV+
Sbjct: 15  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G C E+    LV+E+M  G L + L R+        T + + L   +G+A+L  E+  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAS 123
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMTG 261
           VI+RD  A N L+  +   K+SDFG+ +   + +     T   GT+    +A+PE     
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFS 179
Query: 262 HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
             ++ SDV+SFGV++ E+ + GK   +N    R  S       ++++     RL  PRL 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNS------EVVEDISTGFRLYKPRL- 228
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                  +         C    P  RP  S ++R L ++
Sbjct: 229 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V+ G+        L    VA+K +  +G    ++++ E   + +L HP LV+
Sbjct: 13  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G C E+    LV+E+M  G L + L R+        T + + L   +G+A+L  E+  
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 121
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMTG 261
           VI+RD  A N L+  +   K+SDFG+ +   + +     T   GT+    +A+PE     
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFS 177
Query: 262 HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
             ++ SDV+SFGV++ E+ + GK   +N    R  S       ++++     RL  PRL 
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNS------EVVEDISTGFRLYKPRL- 226
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
                  +         C    P  RP  S ++R L  + +
Sbjct: 227 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V+ G+        L    VA+K +  +G    ++++ E   + +L HP LV+
Sbjct: 15  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G C E+    LV+E+M  G L + L R+        T + + L   +G+A+L  E+  
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 123
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMTG 261
           VI+RD  A N L+  +   K+SDFG+ +   + +     T   GT+    +A+PE     
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFS 179
Query: 262 HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
             ++ SDV+SFGV++ E+ + GK   +N    R  S       ++++     RL  PRL 
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNS------EVVEDISTGFRLYKPRL- 228
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
                  +         C    P  RP  S ++R L  + +
Sbjct: 229 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V+ G+        L    VA+K +  +G+    +++ E   + +L HP LV+
Sbjct: 35  IGSGQFGLVHLGY-------WLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQ 86
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G C E+    LV+E+M  G L + L R+        T + + L   +G+A+L  E+  
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 143
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMTG 261
           VI+RD  A N L+  +   K+SDFG+ +   + +     T   GT+    +A+PE     
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFS 199
Query: 262 HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
             ++ SDV+SFGV++ E+ + GK   +N    R  S       ++++     RL  PRL 
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNS------EVVEDISTGFRLYKPRL- 248
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
                  +         C    P  RP  S ++R L  + +
Sbjct: 249 ------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V+ G+        L    VA+K +  +G    ++++ E   + +L HP LV+
Sbjct: 18  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G C E+    LV+E+M  G L + L R+        T + + L   +G+A+L  E+  
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 126
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMTG 261
           VI+RD  A N L+  +   K+SDFG+ +   + +     T   GT+    +A+PE     
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFS 182
Query: 262 HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
             ++ SDV+SFGV++ E+ + GK   +N    R  S       ++++     RL  PRL 
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNS------EVVEDISTGFRLYKPRL- 231
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
                  +         C    P  RP  S ++R L  + +
Sbjct: 232 ------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ FL 
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL- 150
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D    E +  H  T       + A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 92
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ FL 
Sbjct: 93  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL- 150
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D    E +  H  T       + A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ FL 
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL- 149
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D    E +  H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ FL 
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL- 147
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D    E +  H  T       + A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 96
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ FL 
Sbjct: 97  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL- 154
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D    E +  H  T       + A E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 150
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ FL 
Sbjct: 151 NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL- 208
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D    E +  H  T       + A E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ FL 
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFL- 149
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D    E +  H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 133/281 (47%), Gaps = 40/281 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 17  LGAGQFGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 68
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 69  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 125
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+R+ +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFT 184
Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKE--PRKLERLIDPR 318
             SDV+SFG++L E++T  R     M N  +   Q+L    R +  +  P +L +L+  R
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNLERGYRMVRPDNCPEELYQLM--R 240
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L                  C    P  RPT  Y+  VL+  
Sbjct: 241 L------------------CWKERPEDRPTFDYLRSVLEDF 263

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 85  LGEGGFGPVYKGFVDE--KLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           LGEG FG V   F+ E   L P  +   VAVK L        K++  E   L  L+H H+
Sbjct: 21  LGEGAFGKV---FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS------------AALPWSTRMKIALG 190
           VK  G C E +  ++V+EYM  G L N+  R++               L  S  + IA  
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            A G+ +L  +    ++RD    N L+  +   K+ DFG+++D    +   V    M   
Sbjct: 137 IAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            +  PE +M    TT SDV+S GVVL E+ T
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 82  SNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRH 139
           + +LGEG FG VY+G + + K     E   VAVK    D T  +KE +M+E + +  L H
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKG----EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 68
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           PH+VKLIG   EEE   ++ E  P G L + L R+   +L   T +  +L   K +A+L 
Sbjct: 69  PHIVKLIGII-EEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYL- 125
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            E    ++RD    NIL+ S    KL DFGL++   E E+ +  +       + +PE + 
Sbjct: 126 -ESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESIN 183
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
               TT SDV+ F V + E+L+
Sbjct: 184 FRRFTTASDVWMFAVCMWEILS 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 82  SNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRH 139
           + +LGEG FG VY+G + + K     E   VAVK    D T  +KE +M+E + +  L H
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKG----EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 84
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           PH+VKLIG   EEE   ++ E  P G L + L R+   +L   T +  +L   K +A+L 
Sbjct: 85  PHIVKLIGII-EEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYL- 141
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            E    ++RD    NIL+ S    KL DFGL++   E E+ +  +       + +PE + 
Sbjct: 142 -ESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESIN 199
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
               TT SDV+ F V + E+L+
Sbjct: 200 FRRFTTASDVWMFAVCMWEILS 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 130/276 (47%), Gaps = 34/276 (12%)
Query: 49  PLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFV---DEKLKPG 105
           PL   + +N V+     +F   ELR       +  +LG G FG V+KG      E +K  
Sbjct: 13  PLDPSEKANKVLA---RIFKETELR-------KLKVLGSGVFGTVHKGVWIPEGESIK-- 60
Query: 106 LEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPR 164
               PV +K + D  G Q  +     ++ +G L H H+V+L+G C     +L V +Y+P 
Sbjct: 61  ---IPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPL 116
Query: 165 GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK 224
           GSL + + R +  AL     +   +  AKG+ +L  E+  +++R+  A N+LL S    +
Sbjct: 117 GSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL--EEHGMVHRNLAARNVLLKSPSQVQ 173
Query: 225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GK 283
           ++DFG+A   P  ++  + +       + A E +  G  T  SDV+S+GV + EL+T G 
Sbjct: 174 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGA 233
Query: 284 RAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
                 RL     L E          K ERL  P++
Sbjct: 234 EPYAGLRLAEVPDLLE----------KGERLAQPQI 259

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 15/215 (6%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEIIF 133
            S  +   ++G G FG V  G    +LK PG    PVA+K L +  T+  + +++ E   
Sbjct: 21  ASCITIERVIGAGEFGEVCSG----RLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASI 76
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           +GQ  HP+++ L G   + +  ++V EYM  GSL +   +           + +  G + 
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISA 135
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQ 250
           G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T    ++    
Sbjct: 136 GMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PI 191
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR 284
            + APE +     T+ SDV+S+G+V+ E+++ G+R
Sbjct: 192 RWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGER 226

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 82  SNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRH 139
           + +LGEG FG VY+G + + K     E   VAVK    D T  +KE +M+E + +  L H
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKG----EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           PH+VKLIG   EEE   ++ E  P G L + L R+   +L   T +  +L   K +A+L 
Sbjct: 73  PHIVKLIGII-EEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYL- 129
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            E    ++RD    NIL+ S    KL DFGL++   E E+ +  +       + +PE + 
Sbjct: 130 -ESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
               TT SDV+ F V + E+L+
Sbjct: 188 FRRFTTASDVWMFAVCMWEILS 209

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 101/204 (49%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 148
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D    E    H  T       + A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 132/281 (46%), Gaps = 40/281 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G  G V+ G+ +   K       VAVK+L   G+     ++AE   + QL+H  LV+
Sbjct: 21  LGAGQAGEVWMGYYNGHTK-------VAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +E   ++  EYM  GSL + L       L  +  + +A   A+G+AF+  E++ 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERN 129
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+NIL+    + K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK-WTAPEAINYGTFT 188
Query: 265 TMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKE--PRKLERLIDPR 318
             SDV+SFG++L E++T  R     M N  +   Q+L    R +  +  P +L +L+  R
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--QNLERGYRMVRPDNCPEELYQLM--R 244
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L                  C    P  RPT  Y+  VL+  
Sbjct: 245 L------------------CWKERPEDRPTFDYLRSVLEDF 267

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 127/244 (52%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 11  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 67
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 68  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 125
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 126 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 183
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 184 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 242
Query: 305 LKEP 308
            + P
Sbjct: 243 PQPP 246

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 128/283 (45%), Gaps = 48/283 (16%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G  +   K       VA+K L   GT   + ++ E   + +L+H  LV+
Sbjct: 17  LGNGQFGEVWMGTWNGNTK-------VAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      EE   +V EYM +GSL + L      AL     + +A   A G+A++  E   
Sbjct: 69  LYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI--ERMN 125
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            I+RD +++NIL+ +    K++DFGLA+   + E T         QG      + APE  
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXT-------ARQGAKFPIKWTAPEAA 178
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKR----AMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           + G  T  SDV+SFG++L EL+T  R     M+N             R +L++  +  R+
Sbjct: 179 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------------REVLEQVERGYRM 225
Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
             P+     PI   +        C    P  RPT  Y+   L+
Sbjct: 226 PCPQ---DCPISLHE----LMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 36/281 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V+ G+        L    VA+K +  +G    ++++ E   + +L HP LV+
Sbjct: 16  IGSGQFGLVHLGY-------WLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G C E+    LV E+M  G L + L R+        T + + L   +G+A+L  E+  
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEAC 124
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMTG 261
           VI+RD  A N L+  +   K+SDFG+ +   + +     T   GT+    +A+PE     
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ----YTSSTGTKFPVKWASPEVFSFS 180
Query: 262 HLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLE 320
             ++ SDV+SFGV++ E+ + GK   +N    R  S       ++++     RL  PRL 
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNS------EVVEDISTGFRLYKPRL- 229
Query: 321 GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
                  +         C    P  RP  S ++R L  + +
Sbjct: 230 ------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 127/244 (52%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 8   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 64
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 65  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 122
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 123 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 181 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 239
Query: 305 LKEP 308
            + P
Sbjct: 240 PQPP 243

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 127/244 (52%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 63
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 305 LKEP 308
            + P
Sbjct: 239 PQPP 242

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 13  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 69
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 70  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 127
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 128 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 185
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 186 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 244
Query: 305 LKEP 308
            + P
Sbjct: 245 PQPP 248

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 17  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 73
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 74  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 131
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 132 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 189
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 190 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 248
Query: 305 LKEP 308
            + P
Sbjct: 249 PQPP 252

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 121/245 (49%), Gaps = 28/245 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +   +V ++    SL++ L  S          + IA   A+G+ +LH   
Sbjct: 83  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM--- 259
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 260 TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR----PLLKE-----PRK 310
           +   +  SDVY+FG+VL EL+TG+    N    R+Q +    R    P L +     P++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 311 LERLI 315
           ++RL+
Sbjct: 258 MKRLM 262

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 127/244 (52%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 65
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 124 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 305 LKEP 308
            + P
Sbjct: 241 PQPP 244

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 127/244 (52%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 10  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 66
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 124
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 125 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 183 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 305 LKEP 308
            + P
Sbjct: 242 PQPP 245

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 65
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 124 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 181
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 305 LKEP 308
            + P
Sbjct: 241 PQPP 244

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 149
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 10  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 66
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 124
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 125 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 183 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 305 LKEP 308
            + P
Sbjct: 242 PQPP 245

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 110
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 111 NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 168
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 127/244 (52%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 8   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 64
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 65  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYV-REHKDNIGSQYLLN 122
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 123 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 180
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 181 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 239
Query: 305 LKEP 308
            + P
Sbjct: 240 PQPP 243

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 14  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 70
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 128
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 129 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 187 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 305 LKEP 308
            + P
Sbjct: 246 PQPP 249

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LGEG +G VYK    E        Q VA+K + ++     +E + EI  + Q   PH+VK
Sbjct: 37  LGEGSYGSVYKAIHKET------GQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
             G  ++     +V EY   GS+ + + R  +  L       I     KGL +LH   K 
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAAPEYVMTG 261
            I+RD KA NILL+++  AKL+DFG+A     G+ T  + +   V+GT  + APE +   
Sbjct: 147 -IHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDXMAKRNXVIGTPFWMAPEVIQEI 200
Query: 262 HLTTMSDVYSFGVVLLELLTGK 283
               ++D++S G+  +E+  GK
Sbjct: 201 GYNCVADIWSLGITAIEMAEGK 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 32  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 88
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 89  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 146
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 147 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 204
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 205 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 263
Query: 305 LKEP 308
            + P
Sbjct: 264 PQPP 267

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 10  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 66
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 124
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 125 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 183 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 305 LKEP 308
            + P
Sbjct: 242 PQPP 245

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 63
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 305 LKEP 308
            + P
Sbjct: 239 PQPP 242

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 10  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 66
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 67  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 124
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 125 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 182
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 183 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 241
Query: 305 LKEP 308
            + P
Sbjct: 242 PQPP 245

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 63
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 305 LKEP 308
            + P
Sbjct: 239 PQPP 242

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 91
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 92  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 149
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 90
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 91  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 148
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 109
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 110 NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 167
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 1   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 57
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 58  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 115
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 116 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 174 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232
Query: 305 LKEP 308
            + P
Sbjct: 233 PQPP 236

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 89
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 90  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 147
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 89  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 146
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 83
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 84  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 141
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQLRHP 140
           + ++G G FG VY G + +     +     AVK+L+     G   +++ E I +    HP
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHC---AVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 141 HLVKLIGYCWEEEYR-LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +++ L+G C   E   L+V  YM  G L N   R+ +        +   L  AKG+ +L 
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKYL- 144
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEY 257
              K  ++RD  A N +LD  +T K++DFGLA+D  + E    H  T       + A E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           + T   TT SDV+SFGV+L EL+T
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 14/230 (6%)
Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S   V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +
Sbjct: 4   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 62
Query: 122 QGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL- 179
              + E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS    + 
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEME 121
Query: 180 --------PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                     S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ 
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 180 RDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/244 (30%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 63
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYV-REHKDNIGSQYLLN 121
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 305 LKEP 308
            + P
Sbjct: 239 PQPP 242

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 120/245 (48%), Gaps = 28/245 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 32  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY    +   +V ++    SL++ L  S          + IA   A+G+ +LH   
Sbjct: 83  LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA-- 138
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM--- 259
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 260 TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR----PLLKE-----PRK 310
           +   +  SDVY+FG+VL EL+TG+    N    R+Q +    R    P L +     P++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 311 LERLI 315
           ++RL+
Sbjct: 258 MKRLM 262

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 114/230 (49%), Gaps = 14/230 (6%)
Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S   V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 68
Query: 122 QGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP 180
              + E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS   A+ 
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMA 127
Query: 181 ---------WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                     S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ 
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 30/291 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALP------WSTRMKIALGAAKGL 195
           +L+G   + +  L+V E M  G L + L   R  +   P          +++A   A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E +      + +    + AP
Sbjct: 141 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 243
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P+ RPT   +V +L    D   SF
Sbjct: 244 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD--DLHPSF 291

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 30/291 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALP------WSTRMKIALGAAKGL 195
           +L+G   + +  L+V E M  G L + L   R  +   P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E +      + +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P+ RPT   +V +L    D   SF
Sbjct: 247 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD--DLHPSF 294

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 15/217 (6%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEI 131
           L  S      ++G G FG V  G    +LK PG     VA+K L +  T+  + +++ E 
Sbjct: 40  LDASCIKIERVIGAGEFGEVCSG----RLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +GQ  HP++V L G     +  ++V E+M  G+L +   R +         + +  G 
Sbjct: 96  SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGI 154
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMG 248
           A G+ +L   D   ++RD  A NIL++S+   K+SDFGL++   D PE   T    ++  
Sbjct: 155 AAGMRYL--ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKI-- 210
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR 284
              + APE +     T+ SDV+S+G+V+ E+++ G+R
Sbjct: 211 PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 247

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 127/246 (51%), Gaps = 13/246 (5%)
Query: 68  TLAELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGH 124
            +A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +
Sbjct: 2   AMALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKAN 58
Query: 125 KEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR 184
           KE + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     
Sbjct: 59  KEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYL 116
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVI 243
           +   +  A+G+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H  
Sbjct: 117 LNWCVQIAEGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 174
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWAR 302
              +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E   
Sbjct: 175 GGKVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 233
Query: 303 PLLKEP 308
            L + P
Sbjct: 234 RLPQPP 239

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 113/226 (50%), Gaps = 14/226 (6%)
Query: 66  VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK 125
           V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +   +
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRER 62
Query: 126 -EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP---- 180
            E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS   A+     
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPAMANNPV 121
Query: 181 -----WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
                 S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ +D  
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 179
Query: 236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 180 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 113/230 (49%), Gaps = 14/230 (6%)
Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S   VF   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +
Sbjct: 1   SAADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 59
Query: 122 QGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL- 179
              + E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS    + 
Sbjct: 60  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEME 118
Query: 180 --------PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                     S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ 
Sbjct: 119 NNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMT 176
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 177 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 30/291 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALP------WSTRMKIALGAAKGL 195
           +L+G   + +  L+V E M  G L + L   R  +   P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E +      + +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P  RPT   +V +L    D   SF
Sbjct: 247 DGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD--DLHPSF 294

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/245 (29%), Positives = 120/245 (48%), Gaps = 28/245 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 20  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +   +V ++    SL++ L  S          + IA   A+G+ +LH   
Sbjct: 71  LLFMGYSTKPQL-AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA-- 126
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM--- 259
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 127 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 260 TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR----PLLKE-----PRK 310
           +   +  SDVY+FG+VL EL+TG+    N    R+Q +    R    P L +     P++
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIEMVGRGSLSPDLSKVRSNCPKR 245
Query: 311 LERLI 315
           ++RL+
Sbjct: 246 MKRLM 250

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 123/259 (47%), Gaps = 31/259 (11%)
Query: 66  VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFV---DEKLKPGLEAQPVAVKAL-DLDGT 121
           +F   ELR       +  +LG G FG V+KG      E +K      PV +K + D  G 
Sbjct: 9   IFKETELR-------KLKVLGSGVFGTVHKGVWIPEGESIK-----IPVCIKVIEDKSGR 56
Query: 122 QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
           Q  +     ++ +G L H H+V+L+G C     +L V +Y+P GSL + + R +  AL  
Sbjct: 57  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHV-RQHRGALGP 114
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
              +   +  AKG+ +L  E+  +++R+  A N+LL S    +++DFG+A   P  ++  
Sbjct: 115 QLLLNWGVQIAKGMYYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEW 300
           + +       + A E +  G  T  SDV+S+GV + EL+T G       RL     L E 
Sbjct: 173 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE- 231
Query: 301 ARPLLKEPRKLERLIDPRL 319
                    K ERL  P++
Sbjct: 232 ---------KGERLAQPQI 241

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 11  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 67
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 68  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 125
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFG AK  G E +E H    
Sbjct: 126 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 183
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 184 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 242
Query: 305 LKEP 308
            + P
Sbjct: 243 PQPP 246

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 34/284 (11%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHL 142
           ++G G FG V  G +  KL PG     VA+K L    T+  + ++++E   +GQ  HP++
Sbjct: 40  VIGAGEFGEVCSGHL--KL-PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           + L G   +    +++ E+M  GSL +   R           + +  G A G+ +L   D
Sbjct: 97  IHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--AD 153
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVM 259
              ++RD  A NIL++S+   K+SDFGL++   +       T  +G +    + APE + 
Sbjct: 154 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 260 TGHLTTMSDVYSFGVVLLELLT-GKRAM-DNTRLGREQSLAEWAR--PLLKEPRKLERLI 315
               T+ SDV+S+G+V+ E+++ G+R   D T      ++ +  R  P +  P  L +L+
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 273
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                                 C      HRP    +V  LD +
Sbjct: 274 --------------------LDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 11/197 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK L   GT   + ++ E   +  L+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 72
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      EE   ++ EYM +GSL + L       +     +  +   A+G+A++  E K 
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKN 130
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+N+L+      K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFT 189
Query: 265 TMSDVYSFGVVLLELLT 281
             SDV+SFG++L E++T
Sbjct: 190 IKSDVWSFGILLYEIVT 206

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 14/221 (6%)
Query: 71  ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMA 129
           E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +   + E++ 
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLN 62
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL---------P 180
           E   + +    H+V+L+G   + +  L++ E M RG L + L RS    +          
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 121
Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
            S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ +D  E +  
Sbjct: 122 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 65
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFG AK  G E +E H    
Sbjct: 124 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 305 LKEP 308
            + P
Sbjct: 241 PQPP 244

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +L  G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 14  ALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 70
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 128
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 129 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 187 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 305 LKEP 308
            + P
Sbjct: 246 PQPP 249

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 125/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +L  G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 7   ALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 63
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 305 LKEP 308
            + P
Sbjct: 239 PQPP 242

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 126/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 65
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L++ + MP G L + + R +   +     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFG AK  G E +E H    
Sbjct: 124 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 305 LKEP 308
            + P
Sbjct: 241 PQPP 244

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPH 141
           +++GEG FG V K  +    K GL       +  +      H+++  E+  L +L  HP+
Sbjct: 31  DVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS--------------YSAALPWSTRMKI 187
           ++ L+G C    Y  L  EY P G+L + L +S               ++ L     +  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   A+G+ +L    K  I+RD  A NIL+  +Y AK++DFGL++    G+E +V  + M
Sbjct: 148 AADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTM 200
Query: 248 GT--QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
           G     + A E +     TT SDV+S+GV+L E+++         LG           L 
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LGGTPYCGMTCAELY 251
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
           ++  +  RL       + P+    +      +C    P  RP+ + ++  L+ + + + +
Sbjct: 252 EKLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304
Query: 366 FVGPFVY 372
           +V   +Y
Sbjct: 305 YVNTTLY 311

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 244 LYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 353
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 400
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 401 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 67
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE   + V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 68  LYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 124
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT-------ARQGAKFPIKWTAPEAA 177
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 178 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 224
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 225 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE   +++ EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 78  LYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT-------ARQGAKFPIKWTAPEAA 187
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 234
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 235 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 244 LYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 353
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 400
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 401 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 125/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +L  G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 14  ALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 70
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 128
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 129 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 186
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 187 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 305 LKEP 308
            + P
Sbjct: 246 PQPP 249

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 125/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 9   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 65
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 66  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 123
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFG AK  G E +E H    
Sbjct: 124 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 181
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 182 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 240
Query: 305 LKEP 308
            + P
Sbjct: 241 PQPP 244

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 125/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 63
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 121
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFG AK  G E +E H    
Sbjct: 122 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 179
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 180 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 305 LKEP 308
            + P
Sbjct: 239 PQPP 242

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPH 141
           +++GEG FG V K  +    K GL       +  +      H+++  E+  L +L  HP+
Sbjct: 21  DVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 77
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS--------------YSAALPWSTRMKI 187
           ++ L+G C    Y  L  EY P G+L + L +S               ++ L     +  
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   A+G+ +L    K  I+RD  A NIL+  +Y AK++DFGL++    G+E +V  + M
Sbjct: 138 AADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTM 190
Query: 248 GT--QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
           G     + A E +     TT SDV+S+GV+L E+++         LG           L 
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LGGTPYCGMTCAELY 241
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
           ++  +  RL       + P+    +      +C    P  RP+ + ++  L+ + + + +
Sbjct: 242 EKLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 294
Query: 366 FVGPFVY 372
           +V   +Y
Sbjct: 295 YVNTTLY 301

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 14/230 (6%)
Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S   V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 61
Query: 122 QGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL- 179
              + E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS    + 
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEME 120
Query: 180 --------PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                     S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ 
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMT 178
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 179 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 327 LYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 383
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 436
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 437 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 483
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 484 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 14/230 (6%)
Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S   V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +
Sbjct: 10  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 68
Query: 122 QGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL- 179
              + E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS    + 
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEME 127
Query: 180 --------PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                     S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ 
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMT 185
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 125/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+K L +    + +KE
Sbjct: 14  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIKELREATSPKANKE 70
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 71  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 128
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFG AK  G E +E H    
Sbjct: 129 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGG 186
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 187 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 245
Query: 305 LKEP 308
            + P
Sbjct: 246 PQPP 249

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/244 (29%), Positives = 125/244 (51%), Gaps = 13/244 (5%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKAL-DLDGTQGHKE 126
           A LR++  + F +  +LG G FG VYKG ++ E  K  +   PVA+  L +    + +KE
Sbjct: 41  ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI---PVAIMELREATSPKANKE 97
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  + +PH+ +L+G C     +L+  + MP G L + + R +   +     + 
Sbjct: 98  ILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLN 155
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-DGPEGEETHVITR 245
             +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK  G E +E H    
Sbjct: 156 WCVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 213
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
            +  + + A E ++    T  SDV+S+GV + EL+T G +  D        S+ E    L
Sbjct: 214 KVPIK-WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 272
Query: 305 LKEP 308
            + P
Sbjct: 273 PQPP 276

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 14/230 (6%)
Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S   V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +
Sbjct: 3   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 61
Query: 122 QGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL- 179
              + E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS    + 
Sbjct: 62  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEME 120
Query: 180 --------PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                     S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ 
Sbjct: 121 NNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMT 178
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 179 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 30/291 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALP------WSTRMKIALGAAKGL 195
           +L+G   + +  L+V E M  G L + L   R  +   P          +++A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E +      + +    + AP
Sbjct: 143 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 245
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P+ RPT   +V +L    D   SF
Sbjct: 246 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD--DLHPSF 293

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 14/230 (6%)
Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S   V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +
Sbjct: 4   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 62
Query: 122 QGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL- 179
              + E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS    + 
Sbjct: 63  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEME 121
Query: 180 --------PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                     S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ 
Sbjct: 122 NNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMT 179
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 180 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 133/291 (45%), Gaps = 30/291 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALP------WSTRMKIALGAAKGL 195
           +L+G   + +  L+V E M  G L + L   R  +   P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E +      + +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P+ RPT   +V +L    D   SF
Sbjct: 247 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD--DLHPSF 294

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 244 LYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 300
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 353
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 400
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 401 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE   +++ EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 78  LYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 187
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 234
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 235 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 78  LYAVVSEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 187
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 234
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 235 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 70
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 71  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMN 127
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 128 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 180
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 181 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 227
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 228 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 84  LLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPH 141
           ++G G FG V  G    +LK PG     VA+K L    T +  +++++E   +GQ  HP+
Sbjct: 36  VIGVGEFGEVCSG----RLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 91
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L G   + +  +++ EYM  GSL +   R           + +  G   G+ +L   
Sbjct: 92  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL--S 148
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQGYAAPEYV 258
           D   ++RD  A NIL++S+   K+SDFG+++   D PE   T    ++     + APE +
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAI 206
Query: 259 MTGHLTTMSDVYSFGVVLLELLT 281
                T+ SDV+S+G+V+ E+++
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 128/297 (43%), Gaps = 38/297 (12%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           S+     +LG+G FG   K    E        + + +K L     +  + ++ E+  +  
Sbjct: 10  SDLIHGEVLGKGCFGQAIKVTHRET------GEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP+++K IG  ++++    + EY+  G+L   + +S  +  PWS R+  A   A G+A
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMA 122
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA------KDGPEG------EETHVIT 244
           +LH  +  +I+RD  + N L+  +    ++DFGLA      K  PEG       +     
Sbjct: 123 YLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL 304
            V+G   + APE +         DV+SFG+VL E++ G+   D   L R        R  
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGF 239
Query: 305 LKEPRKLERLIDPRLEGQ-FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
                 L+R   P      FPI           +C    P  RP+   +   L++L+
Sbjct: 240 ------LDRYCPPNCPPSFFPI---------TVRCCDLDPEKRPSFVKLEHWLETLR 281

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 66
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 67  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 123
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 176
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 177 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 223
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 224 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 14/230 (6%)
Query: 62  SKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
           S   V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +
Sbjct: 32  SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS 90
Query: 122 QGHK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL- 179
              + E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS    + 
Sbjct: 91  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEME 149
Query: 180 --------PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                     S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ 
Sbjct: 150 NNPVLAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMT 207
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 208 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 68
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 69  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 125
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 178
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 179 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 225
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 226 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 78  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 187
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 234
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 235 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 36  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 86
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +   +V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 87  LLFMGYSTKPQL-AIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 142
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-- 260
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 143 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 202
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDN 288
               +  SDVY+FG+VL EL+TG+    N
Sbjct: 203 KNPYSFQSDVYAFGIVLYELMTGQLPYSN 231

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 30/291 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALP------WSTRMKIALGAAKGL 195
           +L+G   + +  L+V E M  G L + L   R  +   P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++RD  A N ++  D+T K+ DFG+ +D  E        + +    + AP
Sbjct: 144 AYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P+ RPT   +V +L    D   SF
Sbjct: 247 DGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD--DLHPSF 294

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 30/278 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V       KL        VAVK +  +G+    E+  E   + +L HP LVK
Sbjct: 16  LGSGQFGVV-------KLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
             G C +E    +V EY+  G L N L RS+   L  S  +++     +G+AFL  E   
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQ 124
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD  A N L+D D   K+SDFG+ +   + +    +      + ++APE       +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK-WSAPEVFHYFKYS 183
Query: 265 TMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQF 323
           + SDV++FG+++ E+ + GK   D         L   +  +LK  +   RL  P L    
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYD---------LYTNSEVVLKVSQG-HRLYRPHL---- 229
Query: 324 PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
               +       + C    P  RPT   ++  ++ L++
Sbjct: 230 ---ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 84  LLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPH 141
           ++G G FG V  G    +LK PG     VA+K L    T +  +++++E   +GQ  HP+
Sbjct: 21  VIGVGEFGEVCSG----RLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L G   + +  +++ EYM  GSL +   R           + +  G   G+ +L   
Sbjct: 77  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL--S 133
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQGYAAPEYV 258
           D   ++RD  A NIL++S+   K+SDFG+++   D PE   T    ++     + APE +
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAI 191
Query: 259 MTGHLTTMSDVYSFGVVLLELLT 281
                T+ SDV+S+G+V+ E+++
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMS 214

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +   +V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 95  LLFMGYSTKPQL-AIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 150
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 263 ---LTTMSDVYSFGVVLLELLTGKRAMDN 288
               +  SDVY+FG+VL EL+TG+    N
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSN 239

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 105/203 (51%), Gaps = 14/203 (6%)
Query: 84  LLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPH 141
           ++G G FG V  G    +LK PG     VA+K L    T +  +++++E   +GQ  HP+
Sbjct: 15  VIGVGEFGEVCSG----RLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPN 70
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L G   + +  +++ EYM  GSL +   R           + +  G   G+ +L   
Sbjct: 71  IIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL--S 127
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQGYAAPEYV 258
           D   ++RD  A NIL++S+   K+SDFG+++   D PE   T    ++     + APE +
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKI--PIRWTAPEAI 185
Query: 259 MTGHLTTMSDVYSFGVVLLELLT 281
                T+ SDV+S+G+V+ E+++
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + ++RH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQ 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 78  LYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 187
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 234
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 235 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 138/307 (44%), Gaps = 43/307 (14%)
Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPH 141
           +++GEG FG V K  +    K GL       +  +      H+++  E+  L +L  HP+
Sbjct: 28  DVIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 84
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS--------------YSAALPWSTRMKI 187
           ++ L+G C    Y  L  EY P G+L + L +S               ++ L     +  
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   A+G+ +L    K  I+R+  A NIL+  +Y AK++DFGL++    G+E +V  + M
Sbjct: 145 AADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYV-KKTM 197
Query: 248 GT--QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
           G     + A E +     TT SDV+S+GV+L E+++         LG           L 
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LGGTPYCGMTCAELY 248
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
           ++  +  RL       + P+    +      +C    P  RP+ + ++  L+ + + + +
Sbjct: 249 EKLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 301
Query: 366 FVGPFVY 372
           +V   +Y
Sbjct: 302 YVNTTLY 308

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 14/221 (6%)
Query: 71  ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMA 129
           E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +   + E++ 
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERIEFLN 64
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL---------P 180
           E   + +    H+V+L+G   + +  L++ E M RG L + L RS    +          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVLAPPS 123
Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
            S  +++A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ +D  E +  
Sbjct: 124 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 84  LLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPH 141
           ++G G FG V +G    +LK PG +   VA+K L    T+  + E+++E   +GQ  HP+
Sbjct: 21  VIGAGEFGEVCRG----RLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           +++L G        +++ E+M  G+L +   R           + +  G A G+ +L   
Sbjct: 77  IIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGMRYLA-- 133
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYV 258
           +   ++RD  A NIL++S+   K+SDFGL++   E       T  +G +    + APE +
Sbjct: 134 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 259 MTGHLTTMSDVYSFGVVLLELLT-GKR 284
                T+ SD +S+G+V+ E+++ G+R
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGER 220

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 18/209 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +  + V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-- 260
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDN 288
               +  SDVY+FG+VL EL+TG+    N
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + ++   A G+A++  E   
Sbjct: 75  LYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV--ERMN 131
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 184
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 231
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 232 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 74
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      EE   +V EYM +GSL + L       L     + ++   A G+A++  E   
Sbjct: 75  LYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV--ERMN 131
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWT-------ARQGAKFPIKWTAPEAA 184
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 185 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 231
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 232 ---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V+ G+ +   K       VAVK L   GT   + ++ E   +  L+H  LV+
Sbjct: 20  LGAGQFGEVWMGYYNNSTK-------VAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     +EE   ++ E+M +GSL + L       +     +  +   A+G+A++  E K 
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI--ERKN 129
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
            I+RD +A+N+L+      K++DFGLA+   + E T         + + APE +  G  T
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFT 188
Query: 265 TMSDVYSFGVVLLELLT 281
             S+V+SFG++L E++T
Sbjct: 189 IKSNVWSFGILLYEIVT 205

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      EE   +V EYM +G L + L       L     + +A   A G+A++  E   
Sbjct: 78  LYAVV-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 187
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 234
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 235 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 84  LLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPH 141
           ++G G FG V +G    +LK PG +   VA+K L    T+  + E+++E   +GQ  HP+
Sbjct: 23  VIGAGEFGEVCRG----RLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPN 78
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           +++L G        +++ E+M  G+L +   R           + +  G A G+ +L   
Sbjct: 79  IIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIASGMRYLA-- 135
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYV 258
           +   ++RD  A NIL++S+   K+SDFGL++   E       T  +G +    + APE +
Sbjct: 136 EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 259 MTGHLTTMSDVYSFGVVLLELLT-GKR 284
                T+ SD +S+G+V+ E+++ G+R
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGER 222

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/279 (28%), Positives = 123/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      EE   +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 78  LYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD  A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 187
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 234
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 235 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 111/226 (49%), Gaps = 14/226 (6%)
Query: 66  VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK 125
           V+   E  +     + S  LG+G FG VY+G     +K   E + VA+K ++   +   +
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRER 59
Query: 126 -EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL----- 179
            E++ E   + +    H+V+L+G   + +  L++ E M RG L + L RS    +     
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPV 118
Query: 180 ----PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
                 S  +++A   A G+A+L+      ++RD  A N  +  D+T K+ DFG+ +D  
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           E +      + +    + +PE +  G  TT SDV+SFGVVL E+ T
Sbjct: 177 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   GT   + ++ E   + +LRH  LV+
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQ 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +G L + L       L     + +A   A G+A++  E   
Sbjct: 78  LYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 134
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGLA+   + E T         QG      + APE  
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAA 187
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 188 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 234
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 235 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 133/293 (45%), Gaps = 36/293 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+G FG V +G  D    P  +   VAVK L    L   +   +++ E+  +  L H +
Sbjct: 20  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           L++L G       ++ V E  P GSL ++L R +       T  + A+  A+G+ +L  E
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 132
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ-GYAAPEYVMT 260
            K  I+RD  A N+LL +    K+ DFGL +  P+ ++ +V+         + APE + T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWARPLLKEPRKLERLIDPRL 319
              +  SD + FGV L E+ T          G+E  +    ++ L K  ++ ERL  PR 
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT---------YGQEPWIGLNGSQILHKIDKEGERL--PR- 240
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL--------DSLQDFQD 364
               P    Q       +C +H P  RPT   +   L         +LQDF++
Sbjct: 241 ----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRALQDFEE 289

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 128/284 (45%), Gaps = 34/284 (11%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHL 142
           ++G G FG V  G +  KL PG     VA+K L    T+  + ++++E   +GQ  HP++
Sbjct: 14  VIGAGEFGEVCSGHL--KL-PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           + L G   +    +++ E+M  GSL +   R           + +  G A G+ +L   D
Sbjct: 71  IHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL--AD 127
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVM 259
              ++R   A NIL++S+   K+SDFGL++   +       T  +G +    + APE + 
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 260 TGHLTTMSDVYSFGVVLLELLT-GKRA-MDNTRLGREQSLAEWAR--PLLKEPRKLERLI 315
               T+ SDV+S+G+V+ E+++ G+R   D T      ++ +  R  P +  P  L +L+
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLM 247
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                                 C      HRP    +V  LD +
Sbjct: 248 --------------------LDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 132/291 (45%), Gaps = 30/291 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALP------WSTRMKIALGAAKGL 195
           +L+G   + +  L+V E M  G L + L   R  +   P          +++A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++R+  A N ++  D+T K+ DFG+ +D  E +      + +    + AP
Sbjct: 144 AYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P  RPT   +V +L    D   SF
Sbjct: 247 DGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD--DLHPSF 294

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 132/291 (45%), Gaps = 30/291 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG+G FG VY+G   + +K   E + VAVK ++   +   + E++ E   +      H+V
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALP------WSTRMKIALGAAKGL 195
           +L+G   + +  L+V E M  G L + L   R  +   P          +++A   A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L+   K  ++R+  A N ++  D+T K+ DFG+ +D  E +      + +    + AP
Sbjct: 145 AYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +  G  TT SD++SFGVVL E+                SLAE     L   + L+ ++
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 247
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           D     Q P    ++       C   +P  RPT   +V +L    D   SF
Sbjct: 248 DGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD--DLHPSF 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 167
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 167
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 123/299 (41%), Gaps = 45/299 (15%)
Query: 79  FSRSNL-----LGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKE- 126
           F R+NL     LG G FG V +      G  D  LK       VAVK L        KE 
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEA 87
Query: 127 WMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL------ 179
            M+E+  +  L +H ++V L+G C      L++ EY   G L N L R   A L      
Sbjct: 88  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR 147
Query: 180 PWSTR--MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 237
           P   R  +  +   A+G+AFL    K  I+RD  A N+LL + + AK+ DFGLA+D    
Sbjct: 148 PLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 205
Query: 238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
               V         + APE +     T  SDV+S+G++L E+                SL
Sbjct: 206 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF---------------SL 250
Query: 298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
                P +    K  +L+    +   P    +   +    C +  P HRPT   +   L
Sbjct: 251 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 8   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 117 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 172
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 114 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 169
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 123/299 (41%), Gaps = 45/299 (15%)
Query: 79  FSRSNL-----LGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKE- 126
           F R+NL     LG G FG V +      G  D  LK       VAVK L        KE 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEA 95
Query: 127 WMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL------ 179
            M+E+  +  L +H ++V L+G C      L++ EY   G L N L R   A L      
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGR 155
Query: 180 PWSTR--MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 237
           P   R  +  +   A+G+AFL    K  I+RD  A N+LL + + AK+ DFGLA+D    
Sbjct: 156 PLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 213
Query: 238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
               V         + APE +     T  SDV+S+G++L E+                SL
Sbjct: 214 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF---------------SL 258
Query: 298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
                P +    K  +L+    +   P    +   +    C +  P HRPT   +   L
Sbjct: 259 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 317

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 119
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 120 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 175
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 176 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 18  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 68
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +  + V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 69  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 124
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-- 260
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 125 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 184
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDN 288
               +  SDVY+FG+VL EL+TG+    N
Sbjct: 185 KNPYSFQSDVYAFGIVLYELMTGQLPYSN 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 43  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 93
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +   +V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 94  LLFMGYSTKPQL-AIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 149
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 150 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 209
Query: 263 ---LTTMSDVYSFGVVLLELLTGKRAMDN 288
               +  SDVY+FG+VL EL+TG+    N
Sbjct: 210 KNPYSFQSDVYAFGIVLYELMTGQLPYSN 238

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 18/209 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 44  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 94
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +   +V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 95  LLFMGYSTKPQL-AIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 150
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 151 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 210
Query: 263 ---LTTMSDVYSFGVVLLELLTGKRAMDN 288
               +  SDVY+FG+VL EL+TG+    N
Sbjct: 211 KNPYSFQSDVYAFGIVLYELMTGQLPYSN 239

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 115/245 (46%), Gaps = 28/245 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 21  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +  + V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 72  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 127
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-- 260
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE---------PRK 310
               +  SDVY+FG+VL EL+TG+    N    R+Q +    R  L           P+ 
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPKA 246
Query: 311 LERLI 315
           ++RL+
Sbjct: 247 MKRLM 251

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 122/279 (43%), Gaps = 40/279 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG V+ G  +   +       VA+K L   G    + ++ E   + +LRH  LV+
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-------VAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQ 244
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     EE    +V EYM +GSL + L       L     + +A   A G+A++  E   
Sbjct: 245 LYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV--ERMN 301
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEYV 258
            ++RD +A+NIL+  +   K++DFGL +   + E T         QG      + APE  
Sbjct: 302 YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYT-------ARQGAKFPIKWTAPEAA 354
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
           + G  T  SDV+SFG++L EL T  R      + RE         +L +  +  R+    
Sbjct: 355 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRM---- 401
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                P +  +       +C    P  RPT  Y+   L+
Sbjct: 402 ---PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +  + V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-- 260
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
               +  SDVY+FG+VL EL+TG+    N    R+Q +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQII 219

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 115/245 (46%), Gaps = 28/245 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 21  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 71
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY  + +  + V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 72  LLFMGYSTKPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 127
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-- 260
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 128 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 187
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE---------PRK 310
               +  SDVY+FG+VL EL+TG+    N    R+Q +    R  L           P+ 
Sbjct: 188 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRGYLSPDLSKVRSNCPKA 246
Query: 311 LERLI 315
           ++RL+
Sbjct: 247 MKRLM 251

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 11  NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 64
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 65  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 119
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 120 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 175
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 176 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GL+F H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 113 LQGLSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 19/218 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++     Q  + +  E+  L + RH ++
Sbjct: 16  IGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY    +  + V ++    SL++ L             + IA   A+G+ +LH   
Sbjct: 67  LLFMGYSTAPQLAI-VTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-- 260
           K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + APE +    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
               +  SDVY+FG+VL EL+TG+    N    R+Q +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQII 219

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +L HP++VKL+     E    LV+E++    L   +  S    +P            +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGL 115
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           AF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  Y AP
Sbjct: 116 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAP 171
Query: 256 EYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           E ++   + +T  D++S G +  E++T +RA+
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 28/269 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+G FG V +G  D    P  +   VAVK L    L   +   +++ E+  +  L H +
Sbjct: 20  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           L++L G       ++ V E  P GSL ++L R +       T  + A+  A+G+ +L  E
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 132
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ-GYAAPEYVMT 260
            K  I+RD  A N+LL +    K+ DFGL +  P+ ++ +V+         + APE + T
Sbjct: 133 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWARPLLKEPRKLERLIDPRL 319
              +  SD + FGV L E+ T          G+E  +    ++ L K  ++ ERL  PR 
Sbjct: 193 RTFSHASDTWMFGVTLWEMFT---------YGQEPWIGLNGSQILHKIDKEGERL--PR- 240
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
               P    Q       +C +H P  RPT
Sbjct: 241 ----PEDCPQDIYNVMVQCWAHKPEDRPT 265

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 28/269 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+G FG V +G  D    P  +   VAVK L    L   +   +++ E+  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           L++L G       ++ V E  P GSL ++L R +       T  + A+  A+G+ +L  E
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 128
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ-GYAAPEYVMT 260
            K  I+RD  A N+LL +    K+ DFGL +  P+ ++ +V+         + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWARPLLKEPRKLERLIDPRL 319
              +  SD + FGV L E+ T          G+E  +    ++ L K  ++ ERL  PR 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT---------YGQEPWIGLNGSQILHKIDKEGERL--PR- 236
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
               P    Q       +C +H P  RPT
Sbjct: 237 ----PEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 28/269 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+G FG V +G  D    P  +   VAVK L    L   +   +++ E+  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           L++L G       ++ V E  P GSL ++L R +       T  + A+  A+G+ +L  E
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 138
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ-GYAAPEYVMT 260
            K  I+RD  A N+LL +    K+ DFGL +  P+ ++ +V+         + APE + T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWARPLLKEPRKLERLIDPRL 319
              +  SD + FGV L E+ T          G+E  +    ++ L K  ++ ERL  PR 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT---------YGQEPWIGLNGSQILHKIDKEGERL--PR- 246
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
               P    Q       +C +H P  RPT
Sbjct: 247 ----PEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 28/269 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+G FG V +G  D    P  +   VAVK L    L   +   +++ E+  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           L++L G       ++ V E  P GSL ++L R +       T  + A+  A+G+ +L  E
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 128
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ-GYAAPEYVMT 260
            K  I+RD  A N+LL +    K+ DFGL +  P+ ++ +V+         + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWARPLLKEPRKLERLIDPRL 319
              +  SD + FGV L E+ T          G+E  +    ++ L K  ++ ERL  PR 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT---------YGQEPWIGLNGSQILHKIDKEGERL--PR- 236
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
               P    Q       +C +H P  RPT
Sbjct: 237 ----PEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +L HP++VKL+     E    LV+E++    L + +  S    +P            +GL
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           AF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y AP
Sbjct: 117 AFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 172
Query: 256 EYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           E ++   + +T  D++S G +  E++T +RA+
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA--ALPWSTRMKIALGAAK 193
           +L HP++VKL+     E    LV+E++   S+  + F   SA   +P            +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y 
Sbjct: 118 GLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYR 173
Query: 254 APEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA--ALPWSTRMKIALGAAK 193
           +L HP++VKL+     E    LV+E++   S+  + F   SA   +P            +
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQ 115
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y 
Sbjct: 116 GLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYR 171
Query: 254 APEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+  + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+  + LD  T+G     + EI  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLK 56
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G      T  + T  
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 167
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 167
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA--ALPWSTRMKIALGAAK 193
           +L HP++VKL+     E    LV+E++   S+  + F   SA   +P            +
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 117
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y 
Sbjct: 118 GLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYR 173
Query: 254 APEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L ++++  +     ++      KG+ +L
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 134 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 114/243 (46%), Gaps = 27/243 (11%)
Query: 55  LSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVK 114
           L N    +KL   +L+ +R +         LGE  FG VYKG +     PG + Q VA+K
Sbjct: 11  LINQHKQAKLKEISLSAVRFMEE-------LGEDRFGKVYKGHLFGP-APGEQTQAVAIK 62
Query: 115 ALDLDGTQG--HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF 172
            L  D  +G   +E+  E +   +L+HP++V L+G   +++   +++ Y   G LH  L 
Sbjct: 63  TLK-DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLV 121
Query: 173 --------------RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                         R+  +AL     + +    A G+ +L      V+++D    N+L+ 
Sbjct: 122 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY 179
Query: 219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLE 278
                K+SD GL ++    +   ++   +    + APE +M G  +  SD++S+GVVL E
Sbjct: 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 239
Query: 279 LLT 281
           + +
Sbjct: 240 VFS 242

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 115 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 170
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA--ALPWSTRMKIALGAAK 193
           +L HP++VKL+     E    LV+E++   S+  + F   SA   +P            +
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQ 116
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y 
Sbjct: 117 GLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYR 172
Query: 254 APEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 116 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 171
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 115 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 170
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 114 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 169
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 56
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 167
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 4   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 57
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 58  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 168
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 6   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 59
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 60  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 114
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 115 LQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 170
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSA--ALPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L  F   SA   +P           
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKTFMDASALTGIPLPLIKSYLFQL 115
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 116 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 171
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 8   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 61
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 62  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 117 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 172
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 114 LQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 169
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 122/305 (40%), Gaps = 51/305 (16%)
Query: 79  FSRSNL-----LGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKE- 126
           F R+NL     LG G FG V +      G  D  LK       VAVK L        KE 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEA 95
Query: 127 WMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR- 184
            M+E+  +  L +H ++V L+G C      L++ EY   G L N L R     L +S   
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNP 155
Query: 185 -------------MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
                        +  +   A+G+AFL    K  I+RD  A N+LL + + AK+ DFGLA
Sbjct: 156 SHNPEEQLSSRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 213
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           +D        V         + APE +     T  SDV+S+G++L E+            
Sbjct: 214 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----------- 262
Query: 292 GREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSY 351
               SL     P +    K  +L+    +   P    +   +    C +  P HRPT   
Sbjct: 263 ----SLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ 318
Query: 352 VVRVL 356
           +   L
Sbjct: 319 ICSFL 323

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 125/282 (44%), Gaps = 41/282 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-MAEIIFLGQL 137
           F++ + +G+G FG VYKG +D   K     + VA+K +DL+  +   E    EI  L Q 
Sbjct: 21  FTKLDRIGKGSFGEVYKG-IDNHTK-----EVVAIKIIDLEEAEDEIEDIQQEITVLSQC 74
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
             P++ +  G   +     ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 75  DSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDY 131
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH E K  I+RD KA+N+LL      KL+DFG+A     G+ T    +    +GT  + A
Sbjct: 132 LHSERK--IHRDIKAANVLLSEQGDVKLADFGVA-----GQLTDTQIKRNXFVGTPFWMA 184
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +        +D++S G+  +EL  G+    +    R   L     P           
Sbjct: 185 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP----------- 233
Query: 315 IDPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
             P LEGQ   P K   +A      CL+  PR RPT   +++
Sbjct: 234 --PTLEGQHSKPFKEFVEA------CLNKDPRFRPTAKELLK 267

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 115
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 116 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 171
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 5   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 58
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGA 191
           +L HP++VKL+     E    LV+E+     LH  L +   A+    +P           
Sbjct: 59  ELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASALTGIPLPLIKSYLFQL 113
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLAF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  
Sbjct: 114 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 169
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           Y APE ++   + +T  D++S G +  E++T +RA+
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+G FG V +G  D    P  +   VAVK L    L   +   +++ E+  +  L H +
Sbjct: 26  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           L++L G       ++ V E  P GSL ++L R +       T  + A+  A+G+ +L  E
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 138
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ-GYAAPEYVMT 260
            K  I+RD  A N+LL +    K+ DFGL +  P+ ++  V+         + APE + T
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWARPLLKEPRKLERLIDPRL 319
              +  SD + FGV L E+ T          G+E  +    ++ L K  ++ ERL  PR 
Sbjct: 199 RTFSHASDTWMFGVTLWEMFT---------YGQEPWIGLNGSQILHKIDKEGERL--PR- 246
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
               P    Q       +C +H P  RPT
Sbjct: 247 ----PEDCPQDIYNVMVQCWAHKPEDRPT 271

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/269 (29%), Positives = 123/269 (45%), Gaps = 28/269 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           LG+G FG V +G  D    P  +   VAVK L    L   +   +++ E+  +  L H +
Sbjct: 16  LGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           L++L G       ++ V E  P GSL ++L R +       T  + A+  A+G+ +L  E
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL--E 128
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ-GYAAPEYVMT 260
            K  I+RD  A N+LL +    K+ DFGL +  P+ ++  V+         + APE + T
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWARPLLKEPRKLERLIDPRL 319
              +  SD + FGV L E+ T          G+E  +    ++ L K  ++ ERL  PR 
Sbjct: 189 RTFSHASDTWMFGVTLWEMFT---------YGQEPWIGLNGSQILHKIDKEGERL--PR- 236
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
               P    Q       +C +H P  RPT
Sbjct: 237 ----PEDCPQDIYNVMVQCWAHKPEDRPT 261

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 70
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 130 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEII 132
           F R NL     LGEG FG V K      LK       VAVK L  + +    ++ ++E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFH-LKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA--------------- 177
            L Q+ HPH++KL G C ++   LL+ EY   GSL   L  S                  
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 178 -------ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
                  AL     +  A   ++G+ +L   +  +++RD  A NIL+      K+SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 231 AKDGPEGEETHVITRVMGT--QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           ++D    EE   + R  G     + A E +     TT SDV+SFGV+L E++T
Sbjct: 197 SRD--VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 22/229 (9%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--HKE 126
           L E+ L    F     LGE  FG VYKG +     PG + Q VA+K L  D  +G   +E
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLK-DKAEGPLREE 58
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-------------- 172
           +  E +   +L+HP++V L+G   +++   +++ Y   G LH  L               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 173 RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK 232
           R+  +AL     + +    A G+ +L      V+++D    N+L+      K+SD GL +
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +    +   ++   +    + APE +M G  +  SD++S+GVVL E+ +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEII 132
           F R NL     LGEG FG V K      LK       VAVK L  + +    ++ ++E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFH-LKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA--------------- 177
            L Q+ HPH++KL G C ++   LL+ EY   GSL   L  S                  
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 178 -------ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
                  AL     +  A   ++G+ +L   +  +++RD  A NIL+      K+SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 231 AKDGPEGEETHVITRVMGT--QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           ++D    EE   + R  G     + A E +     TT SDV+SFGV+L E++T
Sbjct: 197 SRD--VYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 76
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 136 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 134 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 78
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 138 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT 219

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 77
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 137 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT 218

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 131 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 106/233 (45%), Gaps = 35/233 (15%)
Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEII 132
           F R NL     LGEG FG V K      LK       VAVK L  + +    ++ ++E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFH-LKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA--------------- 177
            L Q+ HPH++KL G C ++   LL+ EY   GSL   L  S                  
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 178 -------ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
                  AL     +  A   ++G+ +L   +  +++RD  A NIL+      K+SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 231 AKDGPEGEETHVITRVMGT--QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           ++D    EE   + R  G     + A E +     TT SDV+SFGV+L E++T
Sbjct: 197 SRD--VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 75
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 135 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 131 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 69
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 129 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 102
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 162 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 89
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 149 G--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQG-HKEWMAEIIFLG 135
           NF +   +GEG +G VYK       +  L  + VA+K + LD  T+G     + EI  L 
Sbjct: 7   NFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLK 60
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +L HP++VKL+     E    LV+E++ +  L   +  S    +P            +GL
Sbjct: 61  ELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           AF H     V++RD K  N+L++++   KL+DFGLA+    G         + T  Y AP
Sbjct: 120 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAP 175
Query: 256 EYVM-TGHLTTMSDVYSFGVVLLELLTGKRAM 286
           E ++   + +T  D++S G +  E++T +RA+
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
             R   LGEG FG V     D +       + VAVK+L  +    H  +   EI  L  L
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 138 RHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
            H ++VK  G C E+      L+ E++P GSL   L ++ +  +    ++K A+   KG+
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGM 139
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AA 254
            +L    +  ++RD  A N+L++S++  K+ DFGL K     +E   +     +  +  A
Sbjct: 140 DYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 197
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLT 281
           PE +M       SDV+SFGV L ELLT
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 135/299 (45%), Gaps = 44/299 (14%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 66
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-------DGPEGEETHVITRVMGT 249
           +L  E K  I+RD  A N L+  ++  K++DFGL++         P G +  +       
Sbjct: 127 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI------- 177
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEP 308
             + APE +     +  SDV++FGV+L E+ T G        L +          LL++ 
Sbjct: 178 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKD 229
Query: 309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
            ++ER          P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 230 YRMER----------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 276

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 123/303 (40%), Gaps = 49/303 (16%)
Query: 79  FSRSNL-----LGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKE- 126
           F R+NL     LG G FG V +      G  D  LK       VAVK L        KE 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEA 95
Query: 127 WMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS--------- 176
            M+E+  +  L +H ++V L+G C      L++ EY   G L N L R            
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 177 -AALPWSTR--MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 233
            A    STR  +  +   A+G+AFL    K  I+RD  A N+LL + + AK+ DFGLA+D
Sbjct: 156 IANSTLSTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR 293
                   V         + APE +     T  SDV+S+G++L E+              
Sbjct: 214 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------- 260
Query: 294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
             SL     P +    K  +L+    +   P    +   +    C +  P HRPT   + 
Sbjct: 261 --SLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318
Query: 354 RVL 356
             L
Sbjct: 319 SFL 321

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 9/207 (4%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
             R   LGEG FG V     D +       + VAVK+L  +    H  +   EI  L  L
Sbjct: 11  LKRIRDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNL 68
Query: 138 RHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
            H ++VK  G C E+      L+ E++P GSL   L ++ +  +    ++K A+   KG+
Sbjct: 69  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGM 127
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AA 254
            +L    +  ++RD  A N+L++S++  K+ DFGL K     +E   +     +  +  A
Sbjct: 128 DYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 185
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLT 281
           PE +M       SDV+SFGV L ELLT
Sbjct: 186 PECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 135/299 (45%), Gaps = 44/299 (14%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 67
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-------DGPEGEETHVITRVMGT 249
           +L  E K  I+RD  A N L+  ++  K++DFGL++         P G +  +       
Sbjct: 128 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI------- 178
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEP 308
             + APE +     +  SDV++FGV+L E+ T G        L +          LL++ 
Sbjct: 179 -KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKD 230
Query: 309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
            ++ER          P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 231 YRMER----------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 277

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 89
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 149 G--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 137/301 (45%), Gaps = 28/301 (9%)
Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE 126
            +L +  +  ++ +  + LG G FG VY+G   +       +  VAVK L  D T   +E
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKY------SLTVAVKTLKED-TMEVEE 53
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
           ++ E   + +++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + 
Sbjct: 54  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 113
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           +A   +  + +L  E K  I+RD  A N L+  ++  K++DFGL++    G+        
Sbjct: 114 MATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGA 170
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
                + APE +     +  SDV++FGV+L E+ T   +                 P + 
Sbjct: 171 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI- 214
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           +P ++  L++     + P    +K       C   +P  RP+ + + +  +++  FQ+S 
Sbjct: 215 DPSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESS 272
Query: 367 V 367
           +
Sbjct: 273 I 273

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 123/303 (40%), Gaps = 49/303 (16%)
Query: 79  FSRSNL-----LGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKE- 126
           F R+NL     LG G FG V +      G  D  LK       VAVK L        KE 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEA 95
Query: 127 WMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS--------- 176
            M+E+  +  L +H ++V L+G C      L++ EY   G L N L R            
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 177 -AALPWSTR--MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 233
            A    STR  +  +   A+G+AFL    K  I+RD  A N+LL + + AK+ DFGLA+D
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR 293
                   V         + APE +     T  SDV+S+G++L E+              
Sbjct: 214 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF------------- 260
Query: 294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
             SL     P +    K  +L+    +   P    +   +    C +  P HRPT   + 
Sbjct: 261 --SLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318
Query: 354 RVL 356
             L
Sbjct: 319 SFL 321

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 131 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 14  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 70
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY PRG ++ +L +  S      T   I    A  L++
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYIT-ELANALSY 128
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 129 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 182
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 224
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLG 135
           FS    +G G FG VY        +    ++ VA+K +   G Q +++W   + E+ FL 
Sbjct: 17  FSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +LRHP+ ++  G    E    LV EY    +  + L   +   L       +  GA +GL
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+LH  +  +I+RD KA NILL      KL DFG A               +GT  + AP
Sbjct: 129 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAP 180
Query: 256 EYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDN 288
           E ++    G      DV+S G+  +EL   K  + N
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLG 135
           FS    +G G FG VY        +    ++ VA+K +   G Q +++W   + E+ FL 
Sbjct: 56  FSDLREIGHGSFGAVYFA------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +LRHP+ ++  G    E    LV EY   GS  + L   +   L       +  GA +GL
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+LH  +  +I+RD KA NILL      KL DFG A               +GT  + AP
Sbjct: 168 AYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAP 219
Query: 256 EYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDN 288
           E ++    G      DV+S G+  +EL   K  + N
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 72
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++      KG+ +L
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+R+    NIL++++   K+ DFGL K  P+ +E + +     +  +  APE 
Sbjct: 132 GT--KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 14  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 66
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 127 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 183
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 234
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 235 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 276

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 65
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 126 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 233
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 234 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 275

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 114/248 (45%), Gaps = 31/248 (12%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-LEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           F    +LG+GG+G V++         G + A  V  KA+ +   +      AE   L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 138 RHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----YSAALPWSTRMKIALGAA 192
           +HP +V LI Y ++   +L L+ EY+  G L  QL R        A  +   + +ALG  
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG-- 135
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
                 H   K +IYRD K  NI+L+     KL+DFGL K+   +G  TH      GT  
Sbjct: 136 ------HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIE 186
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG---------KRAMD---NTRLGREQSLAE 299
           Y APE +M        D +S G ++ ++LTG         K+ +D     +L     L +
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246
Query: 300 WARPLLKE 307
            AR LLK+
Sbjct: 247 EARDLLKK 254

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEIIFLGQLRHPHL 142
           LG G FG V +G    + K       VA+K L   GT+    +E M E   + QL +P++
Sbjct: 18  LGCGNFGSVRQGVYRMRKK----QIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V+LIG C + E  +LV E    G LH  L       +P S   ++    + G+ +L  E+
Sbjct: 73  VRLIGVC-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL--EE 128
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMT 260
           K  ++RD  A N+LL + + AK+SDFGL+K     ++++   R  G     + APE +  
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 261 GHLTTMSDVYSFGVVLLELLT 281
              ++ SDV+S+GV + E L+
Sbjct: 188 RKFSSRSDVWSYGVTMWEALS 208

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL---DGTQGHKEWMA 129
           ++I   +   + LG GG   VY        +  +    VA+KA+ +   +  +  K +  
Sbjct: 7   KIINERYKIVDKLGGGGMSTVYLA------EDTILNIKVAIKAIFIPPREKEETLKRFER 60
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+    QL H ++V +I    E++   LV EY+  G   ++   S+    P S    I  
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI-EGPTLSEYIESHG---PLSVDTAINF 116
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                    H  D  +++RD K  NIL+DS+ T K+ DFG+AK   E   T     V+GT
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGT 175
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             Y +PE          +D+YS G+VL E+L G+
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 71  ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---------DLDGT 121
           +++L   +F    +LG+G FG V   F+ E  K     Q  A+KAL         D++ T
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKV---FLAEFKKTN---QFFAIKALKKDVVLMDDDVECT 65
Query: 122 QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
              K  ++         HP L  +      +E    V EY+  G L   +   +   L  
Sbjct: 66  MVEKRVLS-----LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR 120
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
           +T    A     GL FLH   K ++YRD K  NILLD D   K++DFG+ K+   G+   
Sbjct: 121 ATF--YAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 175
Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
                 GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 176 -TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 18/215 (8%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EII 132
           +F   NLLG+G F  VY+    E +  GLE   VA+K +D      +K  M      E+ 
Sbjct: 12  DFKVGNLLGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAM--YKAGMVQRVQNEVK 63
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
              QL+HP +++L  Y  +  Y  LV E    G + N+  ++       +          
Sbjct: 64  IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEM-NRYLKNRVKPFSENEARHFMHQII 122
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            G+ +LH     +++RD   SN+LL  +   K++DFGLA       E H    + GT  Y
Sbjct: 123 TGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
            +PE          SDV+S G +   LL G+   D
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 65
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 126 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 233
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 234 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 275

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 114/248 (45%), Gaps = 31/248 (12%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-LEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           F    +LG+GG+G V++         G + A  V  KA+ +   +      AE   L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 138 RHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----YSAALPWSTRMKIALGAA 192
           +HP +V LI Y ++   +L L+ EY+  G L  QL R        A  +   + +ALG  
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG-- 135
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
                 H   K +IYRD K  NI+L+     KL+DFGL K+   +G  TH      GT  
Sbjct: 136 ------HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC---GTIE 186
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG---------KRAMD---NTRLGREQSLAE 299
           Y APE +M        D +S G ++ ++LTG         K+ +D     +L     L +
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQ 246
Query: 300 WARPLLKE 307
            AR LLK+
Sbjct: 247 EARDLLKK 254

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 65
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 126 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 233
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 234 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 275

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 70
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 130
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 131 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 238
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 239 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 280

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK--EWMAEIIFLGQLRHPH 141
           +LGEG FG V +G + ++    L+   VAVK + LD +   +  E+++E   +    HP+
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLK---VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 142 LVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAA----LPWSTRMKIALGAA 192
           +++L+G C E   +     +++  +M  G LH  L  S        +P  T +K  +  A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            G+ +L   ++  ++RD  A N +L  D T  ++DFGL+K    G+             +
Sbjct: 158 LGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            A E +     T+ SDV++FGV + E+ T
Sbjct: 216 IAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 123/312 (39%), Gaps = 58/312 (18%)
Query: 79  FSRSNL-----LGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKE- 126
           F R+NL     LG G FG V +      G  D  LK       VAVK L        KE 
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLK-------VAVKMLKSTAHADEKEA 80
Query: 127 WMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAAL------ 179
            M+E+  +  L +H ++V L+G C      L++ EY   G L N L R   A L      
Sbjct: 81  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAP 140
Query: 180 -------------PWSTR--MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK 224
                        P   R  +  +   A+G+AFL    K  I+RD  A N+LL + + AK
Sbjct: 141 GQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAK 198
Query: 225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
           + DFGLA+D        V         + APE +     T  SDV+S+G++L E+     
Sbjct: 199 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF---- 254
Query: 285 AMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPR 344
                      SL     P +    K  +L+    +   P    +   +    C +  P 
Sbjct: 255 -----------SLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPT 303
Query: 345 HRPTMSYVVRVL 356
           HRPT   +   L
Sbjct: 304 HRPTFQQICSFL 315

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 65
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 125
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 126 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 233
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 234 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 275

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D         + VAVK L     +  +++  EI  L  L+H 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNT------GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++VK  G C+    R   L+ E++P GSL   L + +   +     ++      KG+ +L
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY-AAPEY 257
               K  I+RD    NIL++++   K+ DFGL K  P+ +E   +     +  +  APE 
Sbjct: 134 GT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 258 VMTGHLTTMSDVYSFGVVLLELLT 281
           +     +  SDV+SFGVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 118/234 (50%), Gaps = 18/234 (7%)
Query: 54  DLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAV 113
           DL ++++     V    E R++T +     ++G+G FG VY G   ++ +  ++    A+
Sbjct: 2   DLDSALLAEVKDVLIPHE-RVVTHS---DRVIGKGHFGVVYHGEYIDQAQNRIQC---AI 54
Query: 114 KALD-LDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-YRLLVYEYMPRGSLHNQL 171
           K+L  +   Q  + ++ E + +  L HP+++ LIG     E    ++  YM  G L  Q 
Sbjct: 55  KSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL-LQF 113
Query: 172 FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
            RS          +   L  A+G+ +L   ++  ++RD  A N +LD  +T K++DFGLA
Sbjct: 114 IRSPQRNPTVKDLISFGLQVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 232 KDGPEGE----ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +D  + E    + H   R+     + A E + T   TT SDV+SFGV+L ELLT
Sbjct: 172 RDILDREYYSVQQHRHARL--PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 132/290 (45%), Gaps = 30/290 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 70
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 131 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAKFPIKWTAPE 187
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 238
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
                   P    +K       C   +P  RP+ + + +  +++  FQ+S
Sbjct: 239 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQES 278

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG G FG V    ++G  D           VA+K +  +G+    E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            LV+L G C ++    ++ EYM  G L N L R           +++     + + +L  
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-- 136
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
           E K  ++RD  A N L++     K+SDFGL++   + EET  +      + ++ PE +M 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVR-WSPPEVLMY 195
Query: 261 GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
              ++ SD+++FGV++ E+ + GK  M   R    ++    A+ L        RL  P L
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGK--MPYERFTNSETAEHIAQGL--------RLYRPHL 245
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT----MSYVVRVLD 357
                   ++K     + C       RPT    +S ++ V+D
Sbjct: 246 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 10/215 (4%)
Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQ-PVAVKALDLDGT-QGHKE 126
           A LR++  +   +  +LG G FG VYKG     +  G   + PVA+K L  + + + +KE
Sbjct: 9   ALLRILKETELRKVKVLGSGAFGTVYKGI---WIPDGENVKIPVAIKVLRENTSPKANKE 65
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            + E   +  +  P++ +L+G C     +L V + MP G L + + R     L     + 
Sbjct: 66  ILDEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHV-RENRGRLGSQDLLN 123
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             +  AKG+++L  ED  +++RD  A N+L+ S    K++DFGLA+     E  +     
Sbjct: 124 WCMQIAKGMSYL--EDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 181
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + A E ++    T  SDV+S+GV + EL+T
Sbjct: 182 KVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 26  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 78
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 79  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 138
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 139 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 195
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 246
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 247 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 288

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 70
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 131 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 238
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 239 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 280

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 10/218 (4%)
Query: 64  LHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG 123
           L+  ++ +  +  ++ +  + LG G +G VY G   +       +  VAVK L  D T  
Sbjct: 19  LYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKY------SLTVAVKTLKED-TME 71
Query: 124 HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWST 183
            +E++ E   + +++HP+LV+L+G C  E    +V EYMP G+L + L       +    
Sbjct: 72  VEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVV 131
Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
            + +A   +  + +L  E K  I+RD  A N L+  ++  K++DFGL++    G+     
Sbjct: 132 LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAH 188
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                   + APE +     +  SDV++FGV+L E+ T
Sbjct: 189 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 137/300 (45%), Gaps = 28/300 (9%)
Query: 68  TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW 127
           +L +  +  ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E+
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEF 54
Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           + E   + +++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   +  + +L  E K  I+RD  A N L+  ++  K++DFGL++    G+         
Sbjct: 115 ATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE 307
               + APE +     +  SDV++FGV+L E+ T   +                 P + +
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-D 215
Query: 308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
           P ++  L++     + P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 216 PSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 273

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 67
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 128 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 184
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 235
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 236 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 277

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 15  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 67
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 128 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 184
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 235
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 236 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 277

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           +GEG FG V++G     + P   A  VA+K   +       ++++ E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           KLIG   E     ++ E    G L + L  R YS  L  ++ +  A   +  LA+L  E 
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYL--ES 129
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
           K  ++RD  A N+L+ S+   KL DFGL++   E    +  ++      + APE +    
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 263 LTTMSDVYSFGVVLLELL 280
            T+ SDV+ FGV + E+L
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 132/290 (45%), Gaps = 30/290 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 65
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 126 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 233
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
                   P    +K       C   +P  RP+ + + +  +++  FQ+S
Sbjct: 234 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQES 273

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 126/282 (44%), Gaps = 41/282 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-MAEIIFLGQL 137
           F++   +G+G FG V+KG +D + +     + VA+K +DL+  +   E    EI  L Q 
Sbjct: 29  FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
             P++ K  G   ++    ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDY 139
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH E K  I+RD KA+N+LL      KL+DFG+A     G+ T    +    +GT  + A
Sbjct: 140 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMA 192
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +      + +D++S G+  +EL  G+         +   L     P           
Sbjct: 193 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP----------- 241
Query: 315 IDPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
             P LEG +  P+K   +A      CL+  P  RPT   +++
Sbjct: 242 --PTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELLK 275

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 26/222 (11%)
Query: 71  ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---------DLDGT 121
           +++L   +F    +LG+G FG V   F+ E  K     Q  A+KAL         D++ T
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKV---FLAEFKKTN---QFFAIKALKKDVVLMDDDVECT 64
Query: 122 QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
              K  ++         HP L  +      +E    V EY+  G L   +   +   L  
Sbjct: 65  MVEKRVLS-----LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR 119
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
           +T    A     GL FLH   K ++YRD K  NILLD D   K++DFG+ K+   G+   
Sbjct: 120 ATFY--AAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 174
Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
                 GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 175 -TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG FG V++G       P L       K    D  +  ++++ E + + Q  HPH+VK
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 75
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           LIG   E     ++ E    G L + L  R YS  L  ++ +  A   +  LA+L  E K
Sbjct: 76  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYL--ESK 130
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             ++RD  A N+L+ S+   KL DFGL++   E    +  ++      + APE +     
Sbjct: 131 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 264 TTMSDVYSFGVVLLELL 280
           T+ SDV+ FGV + E+L
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 132/290 (45%), Gaps = 30/290 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 69
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 129
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 130 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 186
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 237
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
                   P    +K       C   +P  RP+ + + +  +++  FQ+S
Sbjct: 238 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQES 277

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG FG V++G       P L       K    D  +  ++++ E + + Q  HPH+VK
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 77
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           LIG   E     ++ E    G L + L  R YS  L  ++ +  A   +  LA+L  E K
Sbjct: 78  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYL--ESK 132
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             ++RD  A N+L+ S+   KL DFGL++   E    +  ++      + APE +     
Sbjct: 133 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 264 TTMSDVYSFGVVLLELL 280
           T+ SDV+ FGV + E+L
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG FG V++G       P L       K    D  +  ++++ E + + Q  HPH+VK
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 72
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           LIG   E     ++ E    G L + L  R YS  L  ++ +  A   +  LA+L  E K
Sbjct: 73  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYL--ESK 127
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             ++RD  A N+L+ S+   KL DFGL++   E    +  ++      + APE +     
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 264 TTMSDVYSFGVVLLELL 280
           T+ SDV+ FGV + E+L
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG FG V++G       P L       K    D  +  ++++ E + + Q  HPH+VK
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 80
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           LIG   E     ++ E    G L + L  R YS  L  ++ +  A   +  LA+L  E K
Sbjct: 81  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYL--ESK 135
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             ++RD  A N+L+ S+   KL DFGL++   E    +  ++      + APE +     
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 264 TTMSDVYSFGVVLLELL 280
           T+ SDV+ FGV + E+L
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG FG V++G       P L       K    D  +  ++++ E + + Q  HPH+VK
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 103
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           LIG   E     ++ E    G L + L  R YS  L  ++ +  A   +  LA+L  E K
Sbjct: 104 LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYL--ESK 158
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             ++RD  A N+L+ S+   KL DFGL++   E    +  ++      + APE +     
Sbjct: 159 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 264 TTMSDVYSFGVVLLELL 280
           T+ SDV+ FGV + E+L
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 9/197 (4%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG FG V++G       P L       K    D  +  ++++ E + + Q  HPH+VK
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDHPHIVK 78
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           LIG   E     ++ E    G L + L  R YS  L  ++ +  A   +  LA+L  E K
Sbjct: 79  LIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYL--ESK 133
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
             ++RD  A N+L+ S+   KL DFGL++   E    +  ++      + APE +     
Sbjct: 134 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 264 TTMSDVYSFGVVLLELL 280
           T+ SDV+ FGV + E+L
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 49/286 (17%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-MAEIIFLGQL 137
           F++   +G+G FG V+KG +D + +     + VA+K +DL+  +   E    EI  L Q 
Sbjct: 24  FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
             P++ K  G   ++    ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 78  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDY 134
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH E K  I+RD KA+N+LL      KL+DFG+A     G+ T    +    +GT  + A
Sbjct: 135 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNXFVGTPFWMA 187
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +      + +D++S G+  +EL  G+                        P K+  L
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----------------PMKVLFL 230
Query: 315 I----DPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
           I     P LEG +  P+K   +A      CL+  P  RPT   +++
Sbjct: 231 IPKNNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELLK 270

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 137/300 (45%), Gaps = 28/300 (9%)
Query: 68  TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW 127
           +L +  +  ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E+
Sbjct: 2   SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEF 54
Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           + E   + +++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   +  + +L  E K  I+RD  A N L+  ++  K++DFGL++    G+         
Sbjct: 115 ATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAK 171
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE 307
               + APE +     +  SDV++FGV+L E+ T   +                 P + +
Sbjct: 172 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGI-D 215
Query: 308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
           P ++  L++     + P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 216 PSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 273

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 14  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 70
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY PRG ++ +L +  S      T   I    A  L++
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL-QKLSKFDEQRTATYIT-ELANALSY 128
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE 
Sbjct: 129 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEM 182
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 224
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           +GEG FG V++G     + P   A  VA+K   +       ++++ E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           KLIG   E     ++ E    G L + L  R +S  L  ++ +  A   +  LA+L  E 
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYL--ES 129
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG-----YAAPEY 257
           K  ++RD  A N+L+ S+   KL DFGL++   +       T    ++G     + APE 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TXXKASKGKLPIKWMAPES 183
Query: 258 VMTGHLTTMSDVYSFGVVLLELL 280
           +     T+ SDV+ FGV + E+L
Sbjct: 184 INFRRFTSASDVWMFGVCMWEIL 206

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 49/286 (17%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-MAEIIFLGQL 137
           F++   +G+G FG V+KG +D + +     + VA+K +DL+  +   E    EI  L Q 
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
             P++ K  G   ++    ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDY 119
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH E K  I+RD KA+N+LL      KL+DFG+A     G+ T    +    +GT  + A
Sbjct: 120 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMA 172
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +      + +D++S G+  +EL  G+                        P K+  L
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----------------PMKVLFL 215
Query: 315 I----DPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
           I     P LEG +  P+K   +A      CL+  P  RPT   +++
Sbjct: 216 IPKNNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELLK 255

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK +  + A  V  KA  L+      +   E+     L
Sbjct: 6   DFEIGRPLGKGKFGNVY--LAREKQRKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 62
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 120
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 121 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 174
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 216
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 217 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 252

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 9   DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 65
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 123
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE 
Sbjct: 124 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDYLPPEM 177
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 219
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG VYK    E       +   A K +D    +  +++M EI  L    HP++VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L+   + E    ++ E+   G++ + +       L  S    +       L +LH  D  
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAAPEYVMTG 261
           +I+RD KA NIL   D   KL+DFG++      + T  I R    +GT  + APE VM  
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCE 210
Query: 262 H-----LTTMSDVYSFGVVLLEL 279
                     +DV+S G+ L+E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 49/286 (17%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-MAEIIFLGQL 137
           F++   +G+G FG V+KG +D + +     + VA+K +DL+  +   E    EI  L Q 
Sbjct: 9   FTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
             P++ K  G   ++    ++ EY+  GS  + L       L  +    I     KGL +
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDY 119
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH E K  I+RD KA+N+LL      KL+DFG+A     G+ T    +    +GT  + A
Sbjct: 120 LHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNXFVGTPFWMA 172
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +      + +D++S G+  +EL  G+                        P K+  L
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-----------------PMKVLFL 215
Query: 315 I----DPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
           I     P LEG +  P+K   +A      CL+  P  RPT   +++
Sbjct: 216 IPKNNPPTLEGNYSKPLKEFVEA------CLNKEPSFRPTAKELLK 255

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 26  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 82
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 140
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 141 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 194
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 236
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 237 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 272

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 10  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 66
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 124
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE 
Sbjct: 125 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEM 178
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 220
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 221 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL-DGT-QGHKEWMAEIIFLGQLRH 139
           S  +G G FG VYKG              VAVK L + D T +  + +  E+  L + RH
Sbjct: 41  STRIGSGSFGTVYKGKWHGD---------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRH 91
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
            +++  +GY  ++    +V ++    SL+  L             + IA   A+G+ +LH
Sbjct: 92  VNILLFMGYMTKDNL-AIVTQWCEGSSLYKHL-HVQETKFQMFQLIDIARQTAQGMDYLH 149
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
              K +I+RD K++NI L    T K+ DFGLA        +  + +  G+  + APE + 
Sbjct: 150 A--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 260 ---TGHLTTMSDVYSFGVVLLELLTGK 283
                  +  SDVYS+G+VL EL+TG+
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 35  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 91
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 149
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 150 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 203
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 245
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 246 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 9   DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 65
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 123
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE 
Sbjct: 124 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEM 177
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 219
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 118/251 (47%), Gaps = 37/251 (14%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--------DLDGTQGHKEWM 128
           S F    +LG+G FG V   F+ +K+      Q  A+K L        D   T+  ++ +
Sbjct: 24  SQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            E+       HP +VKL  Y ++ E +L L+ +++  G L  +L +     +     +K 
Sbjct: 81  VEV------NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKF 130
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            L A   LA  H     +IYRD K  NILLD +   KL+DFGL+K+  + E+        
Sbjct: 131 YL-AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFC 187
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG---------KRAMD---NTRLGREQ 295
           GT  Y APE V     T  +D +SFGV++ E+LTG         K  M      +LG  Q
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ 247
Query: 296 SLAEWARPLLK 306
            L+  A+ LL+
Sbjct: 248 FLSPEAQSLLR 258

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 123/280 (43%), Gaps = 37/280 (13%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-MAEIIFLGQL 137
           F++   +G+G FG V+KG +D + +     Q VA+K +DL+  +   E    EI  L Q 
Sbjct: 25  FTKLERIGKGSFGEVFKG-IDNRTQ-----QVVAIKIIDLEEAEDEIEDIQQEITVLSQC 78
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
              ++ K  G   +     ++ EY+  GS  + L          +T +K  L   KGL +
Sbjct: 79  DSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDY 135
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH E K  I+RD KA+N+LL      KL+DFG+A     G+ T    +    +GT  + A
Sbjct: 136 LHSEKK--IHRDIKAANVLLSEQGDVKLADFGVA-----GQLTDTQIKRNTFVGTPFWMA 188
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +      + +D++S G+  +EL  G+    +    R   L     P           
Sbjct: 189 PEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP----------- 237
Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
             P L G F     +   A    CL+  P  RPT   +++
Sbjct: 238 --PTLVGDFTKSFKEFIDA----CLNKDPSFRPTAKELLK 271

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 14  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 70
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 128
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 129 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEX 182
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 224
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVL 260

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 118/251 (47%), Gaps = 37/251 (14%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--------DLDGTQGHKEWM 128
           S F    +LG+G FG V   F+ +K+      Q  A+K L        D   T+  ++ +
Sbjct: 24  SQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            E+       HP +VKL  Y ++ E +L L+ +++  G L  +L +     +     +K 
Sbjct: 81  VEV------NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKF 130
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            L A   LA  H     +IYRD K  NILLD +   KL+DFGL+K+  + E+        
Sbjct: 131 YL-AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFC 187
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG---------KRAMD---NTRLGREQ 295
           GT  Y APE V     T  +D +SFGV++ E+LTG         K  M      +LG  Q
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ 247
Query: 296 SLAEWARPLLK 306
            L+  A+ LL+
Sbjct: 248 FLSPEAQSLLR 258

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 85  LGEGGFGPVYKGFV--DEKL---KPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH 139
           +G G FG V+ G +  D  L   K   E  P  +KA          +++ E   L Q  H
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA----------KFLQEARILKQYSH 171
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           P++V+LIG C +++   +V E +  G       R+  A L   T +++   AA G+ +L 
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYL- 229
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            E K  I+RD  A N L+      K+SDFG++++  +G              + APE + 
Sbjct: 230 -ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALN 288
Query: 260 TGHLTTMSDVYSFGVVLLELLT 281
            G  ++ SDV+SFG++L E  +
Sbjct: 289 YGRYSSESDVWSFGILLWETFS 310

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 118/251 (47%), Gaps = 37/251 (14%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--------DLDGTQGHKEWM 128
           S F    +LG+G FG V   F+ +K+      Q  A+K L        D   T+  ++ +
Sbjct: 25  SQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 81
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            E+       HP +VKL  Y ++ E +L L+ +++  G L  +L +     +     +K 
Sbjct: 82  VEV------NHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKF 131
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            L A   LA  H     +IYRD K  NILLD +   KL+DFGL+K+  + E+        
Sbjct: 132 YL-AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFC 188
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG---------KRAMD---NTRLGREQ 295
           GT  Y APE V     T  +D +SFGV++ E+LTG         K  M      +LG  Q
Sbjct: 189 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ 248
Query: 296 SLAEWARPLLK 306
            L+  A+ LL+
Sbjct: 249 FLSPEAQSLLR 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 14  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 70
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 128
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE 
Sbjct: 129 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEM 182
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 224
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 12  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 68
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 126
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 127 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 180
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 222
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 272
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+R+  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 333 YL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 389
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 440
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 441 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 482

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG VYK    E       +   A K +D    +  +++M EI  L    HP++VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L+   + E    ++ E+   G++ + +       L  S    +       L +LH  D  
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAAPEYVMTG 261
           +I+RD KA NIL   D   KL+DFG++      + T  I R    +GT  + APE VM  
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRXIQRRDXFIGTPYWMAPEVVMCE 210
Query: 262 H-----LTTMSDVYSFGVVLLEL 279
                     +DV+S G+ L+E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG VYK    E       +   A K +D    +  +++M EI  L    HP++VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L+   + E    ++ E+   G++ + +       L  S    +       L +LH  D  
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDALNYLH--DNK 155
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAAPEYVMTG 261
           +I+RD KA NIL   D   KL+DFG++      + T  I R    +GT  + APE VM  
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRXIQRRDSFIGTPYWMAPEVVMCE 210
Query: 262 H-----LTTMSDVYSFGVVLLEL 279
                     +DV+S G+ L+E+
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM 233

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 70
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 131 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 238
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD 364
                   P    +K       C   +P  RP+ + + +  +++  FQ+
Sbjct: 239 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQE 277

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 9   DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 65
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 123
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE 
Sbjct: 124 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEM 177
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 219
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           +GEG FG V++G     + P   A  VA+K   +       ++++ E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           KLIG   E     ++ E    G L + L  R +S  L  ++ +  A   +  LA+L  E 
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYL--ES 509
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG-----YAAPEY 257
           K  ++RD  A N+L+ S+   KL DFGL++   +       T    ++G     + APE 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPES 563
Query: 258 VMTGHLTTMSDVYSFGVVLLELL 280
           +     T+ SDV+ FGV + E+L
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 9   DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 65
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 123
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 124 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 177
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 219
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D           VAVK L   G    +++  EI  L  L   
Sbjct: 18  LGKGNFGSVELCRYDPLGDNT------GALVAVKQLQHSGPDQQRDFQREIQILKALHSD 71
Query: 141 HLVKLIG--YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
            +VK  G  Y    +   LV EY+P G L + L R + A L  S  +  +    KG+ +L
Sbjct: 72  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL 130
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPE 256
               +  ++RD  A NIL++S+   K++DFGLAK  P  ++ +V+ R  G     + APE
Sbjct: 131 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPE 187
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT 281
            +     +  SDV+SFGVVL EL T
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 36/282 (12%)
Query: 85  LGEGGFGPVYKGFV--DEKL---KPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH 139
           +G G FG V+ G +  D  L   K   E  P  +KA          +++ E   L Q  H
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA----------KFLQEARILKQYSH 171
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           P++V+LIG C +++   +V E +  G       R+  A L   T +++   AA G+ +L 
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEYL- 229
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            E K  I+RD  A N L+      K+SDFG++++  +G              + APE + 
Sbjct: 230 -ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288
Query: 260 TGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
            G  ++ SDV+SFG++L E  + G     N    + +   E          K  RL  P 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGGRLPCPE 338
Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
           L      +  +       +C ++ P  RP+ S + + L S++
Sbjct: 339 LCPDAVFRLME-------QCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D           VAVK L   G    +++  EI  L  L   
Sbjct: 15  LGKGNFGSVELCRYDPLGDNT------GALVAVKQLQHSGPDQQRDFQREIQILKALHSD 68
Query: 141 HLVKLIGYCW---EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
            +VK  G  +     E RL V EY+P G L + L R + A L  S  +  +    KG+ +
Sbjct: 69  FIVKYRGVSYGPGRPELRL-VMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEY 126
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAP 255
           L    +  ++RD  A NIL++S+   K++DFGLAK  P  ++  V+ R  G     + AP
Sbjct: 127 LGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVV-REPGQSPIFWYAP 183
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLT 281
           E +     +  SDV+SFGVVL EL T
Sbjct: 184 ESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 18  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 70
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 131 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 187
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 238
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD 364
                   P    +K       C   +P  RP+ + + +  +++  FQ+
Sbjct: 239 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQE 277

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 14  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 70
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 128
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 129 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 182
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 224
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 225 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 260

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D           VAVK L   G    +++  EI  L  L   
Sbjct: 19  LGKGNFGSVELCRYDPLGDNT------GALVAVKQLQHSGPDQQRDFQREIQILKALHSD 72
Query: 141 HLVKLIG--YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
            +VK  G  Y    +   LV EY+P G L + L R + A L  S  +  +    KG+ +L
Sbjct: 73  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL 131
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPE 256
               +  ++RD  A NIL++S+   K++DFGLAK  P  ++ +V+ R  G     + APE
Sbjct: 132 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPE 188
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT 281
            +     +  SDV+SFGVVL EL T
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 8   DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 64
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 122
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 123 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 176
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 218
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 219 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 254

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 12  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 68
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 126
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 127 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 180
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 222
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/205 (34%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG+G FG V    Y    D           VAVK L   G    +++  EI  L  L   
Sbjct: 31  LGKGNFGSVELCRYDPLGDNT------GALVAVKQLQHSGPDQQRDFQREIQILKALHSD 84
Query: 141 HLVKLIG--YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
            +VK  G  Y    +   LV EY+P G L + L R + A L  S  +  +    KG+ +L
Sbjct: 85  FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEYL 143
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--YAAPE 256
               +  ++RD  A NIL++S+   K++DFGLAK  P  ++ +V+ R  G     + APE
Sbjct: 144 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV-REPGQSPIFWYAPE 200
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT 281
            +     +  SDV+SFGVVL EL T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 104/201 (51%), Gaps = 14/201 (6%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEIIFLGQLRHPHL 142
           LG G FG V +G    + K       VA+K L   GT+    +E M E   + QL +P++
Sbjct: 344 LGCGNFGSVRQGVYRMRKK----QIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V+LIG C + E  +LV E    G LH  L       +P S   ++    + G+ +L  E+
Sbjct: 399 VRLIGVC-QAEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYL--EE 454
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMT 260
           K  ++R+  A N+LL + + AK+SDFGL+K     ++++   R  G     + APE +  
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 261 GHLTTMSDVYSFGVVLLELLT 281
              ++ SDV+S+GV + E L+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS 534

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 9   DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 65
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 123
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 124 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGTLDYLPPEM 177
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 219
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 10  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 66
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 124
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 125 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR----TTLSGTLDYLPPEM 178
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 220
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 221 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/292 (24%), Positives = 133/292 (45%), Gaps = 30/292 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 259 TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 311
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 312 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 371
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+R+  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 372 YL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPE 428
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 479
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                   P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 480 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 521

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG G FG V    ++G  D           VA+K +  +G+    E++ E   +  L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 59
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            LV+L G C ++    ++ EYM  G L N L R           +++     + + +L  
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-- 116
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
           E K  ++RD  A N L++     K+SDFGL++   + E T  +      + ++ PE +M 
Sbjct: 117 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 175
Query: 261 GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
              ++ SD+++FGV++ E+ + GK  M   R    ++    A+ L        RL  P L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGK--MPYERFTNSETAEHIAQGL--------RLYRPHL 225
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT----MSYVVRVLD 357
                   ++K     + C       RPT    +S ++ V+D
Sbjct: 226 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 260

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +S                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 155 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 13  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 69
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 127
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE 
Sbjct: 128 CH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 181
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 223
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 224 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 259

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 128/284 (45%), Gaps = 28/284 (9%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D T   +E++ E   + +
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKED-TMEVEEFLKEAAVMKE 65
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L  E K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 126 YL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 182
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +     +  SDV++FGV+L E+ T G        L +          LL++  ++ER  
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMER-- 233
Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                   P    +K       C   +P  RP+ + + +  +++
Sbjct: 234 --------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG G FG V    ++G  D           VA+K +  +G+    E++ E   +  L H 
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 63
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            LV+L G C ++    ++ EYM  G L N L R           +++     + + +L  
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-- 120
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
           E K  ++RD  A N L++     K+SDFGL++   + E T  +      + ++ PE +M 
Sbjct: 121 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 179
Query: 261 GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
              ++ SD+++FGV++ E+ + GK  M   R    ++    A+ L        RL  P L
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGK--MPYERFTNSETAEHIAQGL--------RLYRPHL 229
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT----MSYVVRVLD 357
                   ++K     + C       RPT    +S ++ V+D
Sbjct: 230 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 264

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG G FG V    ++G  D           VA+K +  +G+    E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            LV+L G C ++    ++ EYM  G L N L R           +++     + + +L  
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-- 136
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
           E K  ++RD  A N L++     K+SDFGL++   + E T  +      + ++ PE +M 
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 195
Query: 261 GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
              ++ SD+++FGV++ E+ + GK  M   R    ++    A+ L        RL  P L
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGK--MPYERFTNSETAEHIAQGL--------RLYRPHL 245
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT----MSYVVRVLD 357
                   ++K     + C       RPT    +S ++ V+D
Sbjct: 246 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG G FG V    ++G  D           VA+K +  +G+    E++ E   +  L H 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 64
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            LV+L G C ++    ++ EYM  G L N L R           +++     + + +L  
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-- 121
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
           E K  ++RD  A N L++     K+SDFGL++   + E T  +      + ++ PE +M 
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 180
Query: 261 GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
              ++ SD+++FGV++ E+ + GK  M   R    ++    A+ L        RL  P L
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGK--MPYERFTNSETAEHIAQGL--------RLYRPHL 230
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT----MSYVVRVLD 357
                   ++K     + C       RPT    +S ++ V+D
Sbjct: 231 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 83
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +S                + 
Sbjct: 84  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 144 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 11  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 67
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 125
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE 
Sbjct: 126 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEM 179
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 221
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 222 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 42/282 (14%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG G FG V    ++G  D           VA+K +  +G+    E++ E   +  L H 
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 70
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            LV+L G C ++    ++ EYM  G L N L R           +++     + + +L  
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-- 127
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
           E K  ++RD  A N L++     K+SDFGL++   + E T  +      + ++ PE +M 
Sbjct: 128 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMY 186
Query: 261 GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
              ++ SD+++FGV++ E+ + GK  M   R    ++    A+ L        RL  P L
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGK--MPYERFTNSETAEHIAQGL--------RLYRPHL 236
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT----MSYVVRVLD 357
                   ++K     + C       RPT    +S ++ V+D
Sbjct: 237 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 35  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 91
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 149
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE 
Sbjct: 150 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEM 203
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 245
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 246 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 281

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E + L  + HP ++++ G   + +   ++ +Y+  G L + L +S     P       A 
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAA 113
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                L +LH +D  +IYRD K  NILLD +   K++DFG AK  P+     V   + GT
Sbjct: 114 EVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGT 166
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             Y APE V T       D +SFG+++ E+L G
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 11  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 67
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 125
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K+++FG +   P        T + GT  Y  PE 
Sbjct: 126 CHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEM 179
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 221
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 222 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 257

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 87
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +S                + 
Sbjct: 88  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 148 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 9   DFEIGRPLGKGKFGNVY--LAREKNSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 65
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 123
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE 
Sbjct: 124 CHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGTLDYLPPEM 177
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRIS------------------ 219
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 86
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +S                + 
Sbjct: 87  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 147 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK---EWMA 129
           R+   ++   + LG G FG V  G      K  L    VAVK L+    +      +   
Sbjct: 12  RVKIGHYILGDTLGVGTFGKVKVG------KHELTGHKVAVKILNRQKIRSLDVVGKIRR 65
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           EI  L   RHPH++KL           +V EY+  G L + + ++    L      ++  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQ 123
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
               G+ + H     V++RD K  N+LLD+   AK++DFGL+    +GE    +    G+
Sbjct: 124 QILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGS 178
Query: 250 QGYAAPEYVMTGHLTT--MSDVYSFGVVLLELLTGKRAMDNTRL 291
             YAAPE V++G L      D++S GV+L  LL G    D+  +
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +S                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 155 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 10  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 66
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 124
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE 
Sbjct: 125 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEM 178
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 220
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 221 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 12  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 68
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 126
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K+++FG +   P        T + GT  Y  PE 
Sbjct: 127 CHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEM 180
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 222
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +L H
Sbjct: 39  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNH 93
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 154 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           +GEG FG V++G     + P   A  VA+K   +       ++++ E + + Q  HPH+V
Sbjct: 398 IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           KLIG   E     ++ E    G L + L  R +S  L  ++ +  A   +  LA+L  E 
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYL--ES 509
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG-----YAAPEY 257
           K  ++RD  A N+L+ +    KL DFGL++   +       T    ++G     + APE 
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS------TYYKASKGKLPIKWMAPES 563
Query: 258 VMTGHLTTMSDVYSFGVVLLELL 280
           +     T+ SDV+ FGV + E+L
Sbjct: 564 INFRRFTSASDVWMFGVCMWEIL 586

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +S                + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 155 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           +GEG FG V++G     + P   A  VA+K   +       ++++ E + + Q  HPH+V
Sbjct: 18  IGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           KLIG   E     ++ E    G L + L  R +S  L  ++ +  A   +  LA+L  E 
Sbjct: 75  KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYL--ES 129
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
           K  ++RD  A N+L+ +    KL DFGL++   E    +  ++      + APE +    
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 263 LTTMSDVYSFGVVLLELL 280
            T+ SDV+ FGV + E+L
Sbjct: 189 FTSASDVWMFGVCMWEIL 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 12  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 68
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 126
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE 
Sbjct: 127 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEM 180
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 222
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 12  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 68
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 126
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE 
Sbjct: 127 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEM 180
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 222
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 98/232 (42%), Gaps = 33/232 (14%)
Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEII 132
           F R NL     LG G FG V         K G+  Q VAVK L        +E  M+E+ 
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQ-VAVKMLKEKADSSEREALMSELK 100
Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA-------------- 177
            + QL  H ++V L+G C       L++EY   G L N L RS                 
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL-RSKREKFSEDEIEYENQKR 159
Query: 178 --------ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG 229
                    L +   +  A   AKG+ FL  E K  ++RD  A N+L+      K+ DFG
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           LA+D        V         + APE +  G  T  SDV+S+G++L E+ +
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +S                + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 196 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +L H
Sbjct: 53  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNH 107
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 108 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 168 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 9   DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 65
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 123
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE 
Sbjct: 124 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGTLDYLPPEM 177
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 219
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 9   DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 65
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 123
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE 
Sbjct: 124 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEM 177
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 219
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 220 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 115/277 (41%), Gaps = 31/277 (11%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     EK    + A  V  KA  L+      +   E+     L
Sbjct: 12  DFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKA-QLEKAGVEHQLRREVEIQSHL 68
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT-ELANALSY 126
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE 
Sbjct: 127 CHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEM 180
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLKEPRKLERLID 316
           +         D++S GV+  E L GK   + NT     + ++                  
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------------------ 222
Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
            R+E  FP    + A     + L H+P  RP +  V+
Sbjct: 223 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +                 + 
Sbjct: 80  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 140 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EII 132
           +   + +   +GEG +G VYK           + + VA+K + LD         A  EI 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKA-------KDSQGRIVALKRIRLDAEDEGIPSTAIREIS 71
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GA 191
            L +L HP++V LI     E    LV+E+M +     ++       L   +++KI L   
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQ-DSQIKIYLYQL 128
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +G+A  H     +++RD K  N+L++SD   KL+DFGLA+    G      T  + T  
Sbjct: 129 LRGVA--HCHQHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLW 184
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           Y AP+ +M +   +T  D++S G +  E++TGK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EII 132
           +   + +   +GEG +G VYK           + + VA+K + LD         A  EI 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKA-------KDSQGRIVALKRIRLDAEDEGIPSTAIREIS 71
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GA 191
            L +L HP++V LI     E    LV+E+M +     ++       L   +++KI L   
Sbjct: 72  LLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDL--KKVLDENKTGLQ-DSQIKIYLYQL 128
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +G+A  H     +++RD K  N+L++SD   KL+DFGLA+    G      T  + T  
Sbjct: 129 LRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHEVVTLW 184
Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           Y AP+ +M +   +T  D++S G +  E++TGK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/240 (30%), Positives = 106/240 (44%), Gaps = 45/240 (18%)
Query: 70  AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA 129
           +E  L   N     L+G G +G VYKG +DE+        PVAVK       Q       
Sbjct: 6   SEPSLDLDNLKLLELIGRGRYGAVYKGSLDER--------PVAVKVFSFANRQNFIN-EK 56
Query: 130 EIIFLGQLRHPHLVKLIGYCWEE--------EYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
            I  +  + H ++ + I    +E        EY LLV EY P GSL   L    S    W
Sbjct: 57  NIYRVPLMEHDNIARFI--VGDERVTADGRMEY-LLVMEYYPNGSLXKYLSLHTS---DW 110
Query: 182 STRMKIALGAAKGLAFLHGE------DKPVI-YRDFKASNILLDSDYTAKLSDFGLA--- 231
            +  ++A    +GLA+LH E       KP I +RD  + N+L+ +D T  +SDFGL+   
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 232 ---KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT--------TMSDVYSFGVVLLELL 280
              +    GEE +     +GT  Y APE V+ G +            D+Y+ G++  E+ 
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 65  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 119
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 120 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 180 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 237
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP      VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPN-RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 94
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------------MK 186
           +++ L+G C ++    ++ EY  +G+L   L       L +                 + 
Sbjct: 95  NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    +     T  
Sbjct: 155 CAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV+L E+ T
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 39  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 93
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 154 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 45  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 99
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 100 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 160 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 217
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 55  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 109
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 110 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 170 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 227
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 38  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 153 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 38  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 153 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 39  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 93
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 94  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 154 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK 211
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 53  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 107
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 108 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 168 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPG---LEAQPVAVKAL----DLDGTQGHKEWMA 129
           S+F    +LG+G FG V+   V +  +P    L A  V  KA     D   T+  ++ +A
Sbjct: 28  SHFELLKVLGQGSFGKVF--LVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILA 85
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
           ++       HP +VKL  Y ++ E +L L+ +++  G L  +L +     +     +K  
Sbjct: 86  DV------NHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTEEDVKFY 135
Query: 189 LGA-AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           L   A GL  LH     +IYRD K  NILLD +   KL+DFGL+K+  + E+        
Sbjct: 136 LAELALGLDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKK--AYSFC 191
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG---------KRAMD---NTRLGREQ 295
           GT  Y APE V     +  +D +S+GV++ E+LTG         K  M      +LG  Q
Sbjct: 192 GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQ 251
Query: 296 SLAEWARPLLK 306
            L+  A+ LL+
Sbjct: 252 FLSTEAQSLLR 262

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 29/284 (10%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---DLDGTQGHKEWMAEIIF 133
           +NF     +G G F  VY+          L+  PVA+K +   DL   +   + + EI  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAAC------LLDGVPVALKKVQIFDLMDAKARADCIKEIDL 85
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALPWSTRMKIALGA 191
           L QL HP+++K      E+    +V E    G L   +  F+     +P  T  K  +  
Sbjct: 86  LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
              L  +H   + V++RD K +N+ + +    KL D GL +      +T     ++GT  
Sbjct: 146 CSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPY 201
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL 311
           Y +PE +        SD++S G +L E+     A+ +   G + +L           +K+
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLC-------KKI 250
Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV 355
           E+   P L        +++       C++  P  RP ++YV  V
Sbjct: 251 EQCDYPPLPSD---HYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 42/282 (14%)
Query: 85  LGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP 140
           LG G FG V    ++G  D           VA+K +  +G+    E++ E   +  L H 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHE 64
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            LV+L G C ++    ++ EYM  G L N L R           +++     + + +L  
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL-- 121
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
           E K  ++RD  A N L++     K+SDFGL++   + E T         + ++ PE +M 
Sbjct: 122 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR-WSPPEVLMY 180
Query: 261 GHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL 319
              ++ SD+++FGV++ E+ + GK  M   R    ++    A+ L        RL  P L
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGK--MPYERFTNSETAEHIAQGL--------RLYRPHL 230
Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPT----MSYVVRVLD 357
                   ++K     + C       RPT    +S ++ V+D
Sbjct: 231 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 41/236 (17%)
Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGL-EAQP---VAVKALDLDGTQGHK-EWM 128
           + R+N+     +GEG FG V++        PGL   +P   VAVK L  + +   + ++ 
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQA-----RAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 98
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS------------ 176
            E   + +  +P++VKL+G C   +   L++EYM  G L N+  RS S            
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDL 157
Query: 177 -----------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL 225
                        L  + ++ IA   A G+A+L   ++  ++RD    N L+  +   K+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKI 215
Query: 226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +DFGL+++    +             +  PE +     TT SDV+++GVVL E+ +
Sbjct: 216 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 30  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 84
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 85  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 145 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 202
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 111/291 (38%), Gaps = 36/291 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQL-RHPHL 142
           LG G FG V +      +K    A  VAVK L        +E  M+E+  L  L  H ++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI--------------- 187
           V L+G C      L++ EY   G L N L R   + +   T   I               
Sbjct: 90  VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 188 -ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            +   AKG+AFL    K  I+RD  A NILL      K+ DFGLA+D        V    
Sbjct: 150 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
                + APE +     T  SDV+S+G+ L EL                SL     P + 
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPYPGMP 252
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
              K  ++I        P     +       C    P  RPT   +V++++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 111/291 (38%), Gaps = 36/291 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQL-RHPHL 142
           LG G FG V +      +K    A  VAVK L        +E  M+E+  L  L  H ++
Sbjct: 47  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 105
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI--------------- 187
           V L+G C      L++ EY   G L N L R   + +   T   I               
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 188 -ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            +   AKG+AFL    K  I+RD  A NILL      K+ DFGLA+D        V    
Sbjct: 166 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
                + APE +     T  SDV+S+G+ L EL                SL     P + 
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPYPGMP 268
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
              K  ++I        P     +       C    P  RPT   +V++++
Sbjct: 269 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 79  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 194 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQL 137
           + R   LG+GGF   Y+   D   K     + V  K++ L   Q  KE M+ EI     L
Sbjct: 44  YMRGRFLGKGGFAKCYE-ITDMDTKEVFAGK-VVPKSMLLKPHQ--KEKMSTEIAIHKSL 99
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP---WSTRMKIALGAAKG 194
            +PH+V   G+  ++++  +V E   R SL     R  +   P   +  R  I     +G
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYA 253
           + +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +GE    +    GT  Y 
Sbjct: 155 VQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC---GTPNYI 209
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           APE +     +   D++S G +L  LL GK   + + L
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 247

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 111/291 (38%), Gaps = 36/291 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQL-RHPHL 142
           LG G FG V +      +K    A  VAVK L        +E  M+E+  L  L  H ++
Sbjct: 49  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 107
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI--------------- 187
           V L+G C      L++ EY   G L N L R   + +   T   I               
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 188 -ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            +   AKG+AFL    K  I+RD  A NILL      K+ DFGLA+D        V    
Sbjct: 168 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
                + APE +     T  SDV+S+G+ L EL                SL     P + 
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPYPGMP 270
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
              K  ++I        P     +       C    P  RPT   +V++++
Sbjct: 271 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 56  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 110
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 111 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 171 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 228
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 11/232 (4%)
Query: 54  DLSNSVIGSKLHVFTLAELRLITSN-FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVA 112
           D  +S+  ++   +   E + +T N F +  +LG+GGFG V    V      G       
Sbjct: 160 DYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKK 216
Query: 113 VKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQL 171
           ++   +   +G    + E   L ++    +V L  Y +E +  L LV   M  G L   +
Sbjct: 217 LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 172 FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
           +    A  P +  +  A     GL  LH E   ++YRD K  NILLD     ++SD GLA
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLA 333
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
              PEG+    I   +GT GY APE V     T   D ++ G +L E++ G+
Sbjct: 334 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDG 120
             L EL+    +F + + LG G  G V+K      G V  +    LE +P A++      
Sbjct: 1   MALGELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIR------ 51
Query: 121 TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP 180
                + + E+  L +   P++V   G  + +    +  E+M  GSL   L ++    +P
Sbjct: 52  ----NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIP 105
Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
                K+++   KGL +L  E   +++RD K SNIL++S    KL DFG++  G   +E 
Sbjct: 106 EQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE- 161
Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            +    +GT+ Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 162 -MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFL 134
           +S F +   LG G +  VYKG              VA+K + LD  +G     + EI  +
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTT------GVYVALKEVKLDSEEGTPSTAIREISLM 57
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK- 193
            +L+H ++V+L      E    LV+E+M      N L +   +    +T   + L   K 
Sbjct: 58  KELKHENIVRLYDVIHTENKLTLVFEFM-----DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 194 -------GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                  GLAF H E+K +++RD K  N+L++     KL DFGLA+    G   +  +  
Sbjct: 113 FQWQLLQGLAFCH-ENK-ILHRDLKPQNLLINKRGQLKLGDFGLAR--AFGIPVNTFSSE 168
Query: 247 MGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           + T  Y AP+ +M     + S D++S G +L E++TGK
Sbjct: 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 78  NFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI 131
           +F R + LG G  G V K      G +  +    LE +P A++           + + E+
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKP-AIR----------NQIIREL 65
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             L +   P++V   G  + +    +  E+M  GSL +Q+ +  +  +P     K+++  
Sbjct: 66  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKE-AKRIPEEILGKVSIAV 123
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GLA+L  E   +++RD K SNIL++S    KL DFG++    +     +    +GT+ 
Sbjct: 124 LRGLAYLR-EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 178
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE +   H +  SD++S G+ L+EL  G+
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQL 137
           + R   LG+GGF   Y+   D   K     + V  K++ L   Q  KE M+ EI     L
Sbjct: 44  YMRGRFLGKGGFAKCYE-ITDMDTKEVFAGK-VVPKSMLLKPHQ--KEKMSTEIAIHKSL 99
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP---WSTRMKIALGAAKG 194
            +PH+V   G+  ++++  +V E   R SL     R  +   P   +  R  I     +G
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYA 253
           + +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +GE    +    GT  Y 
Sbjct: 155 VQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC---GTPNYI 209
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           APE +     +   D++S G +L  LL GK   + + L
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 247

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG VYK    E           A K ++    +  ++++ EI  L    HP++VK
Sbjct: 27  LGDGAFGKVYKAKNKET------GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L+G  + +    ++ E+ P G++ + +       L       +     + L FLH   K 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS--KR 137
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
           +I+RD KA N+L+  +   +L+DFG++    +  +       +GT  + APE VM   + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVMCETMK 195
Query: 265 TM-----SDVYSFGVVLLEL 279
                  +D++S G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 11/232 (4%)
Query: 54  DLSNSVIGSKLHVFTLAELRLITSN-FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVA 112
           D  +S+  ++   +   E + +T N F +  +LG+GGFG V    V      G       
Sbjct: 160 DYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKK 216
Query: 113 VKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQL 171
           ++   +   +G    + E   L ++    +V L  Y +E +  L LV   M  G L   +
Sbjct: 217 LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHI 275
Query: 172 FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
           +    A  P +  +  A     GL  LH E   ++YRD K  NILLD     ++SD GLA
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLA 333
Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
              PEG+    I   +GT GY APE V     T   D ++ G +L E++ G+
Sbjct: 334 VHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQP----VAVKAL-DLDGTQGHKEWMAEIIFLGQLRH 139
           LG G FG VY+G V      G+   P    VAVK L ++   Q   +++ E + + +  H
Sbjct: 53  LGHGAFGEVYEGQVS-----GMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNH 107
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKG 194
            ++V+ IG   +   R ++ E M  G L + L       S  ++L     + +A   A G
Sbjct: 108 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             +L  E+   I+RD  A N LL        AK+ DFG+A+D             M    
Sbjct: 168 CQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +  PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 22/251 (8%)
Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR I S       ++R   +G+G  G VY       +  G   Q VA++ ++L    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 59
Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
             +  + EI+ + + ++P++V  +      +   +V EY+  GSL + +  +    +   
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEG 116
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETH 241
               +     + L FLH     VI+RD K+ NILL  D + KL+DFG  A+  PE  +  
Sbjct: 117 QIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173
Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW 300
             + ++GT  + APE V         D++S G++ +E++ G+    N    R   L A  
Sbjct: 174 --SEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 301 ARPLLKEPRKL 311
             P L+ P KL
Sbjct: 232 GTPELQNPEKL 242

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 111/291 (38%), Gaps = 36/291 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQL-RHPHL 142
           LG G FG V +      +K    A  VAVK L        +E  M+E+  L  L  H ++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 112
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI--------------- 187
           V L+G C      L++ EY   G L N L R   + +   T   I               
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 188 -ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            +   AKG+AFL    K  I+RD  A NILL      K+ DFGLA+D        V    
Sbjct: 173 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
                + APE +     T  SDV+S+G+ L EL                SL     P + 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPYPGMP 275
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
              K  ++I        P     +       C    P  RPT   +V++++
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG VYK    E           A K ++    +  ++++ EI  L    HP++VK
Sbjct: 19  LGDGAFGKVYKAKNKET------GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L+G  + +    ++ E+ P G++ + +       L       +     + L FLH   K 
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEALNFLHS--KR 129
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
           +I+RD KA N+L+  +   +L+DFG++    +  +       +GT  + APE VM   + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVMCETMK 187
Query: 265 TM-----SDVYSFGVVLLEL 279
                  +D++S G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF--------------RSYSAALPWSTRMK 186
           +++ L+G C ++    ++ EY  +G+L   L               R     + +   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/218 (33%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMA 129
           RL   NF    +LG+G FG V    V E           AVK L  D      +    M 
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKET------GDLYAVKVLKKDVILQDDDVECTMT 72
Query: 130 EIIFLGQLR-HPHLVKLIGYCWEEEYRLL-VYEYMPRGSL--HNQLFRSYSAALPWSTRM 185
           E   L   R HP L +L   C++   RL  V E++  G L  H Q  R +  A     R 
Sbjct: 73  EKRILSLARNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RA 126
Query: 186 KI-ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT 244
           +  A      L FLH  DK +IYRD K  N+LLD +   KL+DFG+ K+G     T    
Sbjct: 127 RFYAAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TA 182
Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
              GT  Y APE +         D ++ GV+L E+L G
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 22/251 (8%)
Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR I S       ++R   +G+G  G VY       +  G   Q VA++ ++L    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 59
Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
             +  + EI+ + + ++P++V  +      +   +V EY+  GSL + +  +    +   
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEG 116
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETH 241
               +     + L FLH     VI+RD K+ NILL  D + KL+DFG  A+  PE  +  
Sbjct: 117 QIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173
Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW 300
             + ++GT  + APE V         D++S G++ +E++ G+    N    R   L A  
Sbjct: 174 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 301 ARPLLKEPRKL 311
             P L+ P KL
Sbjct: 232 GTPELQNPEKL 242

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 22/251 (8%)
Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR I S       ++R   +G+G  G VY       +  G   Q VA++ ++L    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 59
Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
             +  + EI+ + + ++P++V  +      +   +V EY+  GSL + +  +    +   
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEG 116
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETH 241
               +     + L FLH     VI+RD K+ NILL  D + KL+DFG  A+  PE  +  
Sbjct: 117 QIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173
Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW 300
             + ++GT  + APE V         D++S G++ +E++ G+    N    R   L A  
Sbjct: 174 --SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 301 ARPLLKEPRKL 311
             P L+ P KL
Sbjct: 232 GTPELQNPEKL 242

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHK 125
           + L   +F + + LG G  G V+K      G V  +    LE +P               
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----------RN 49
Query: 126 EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           + + E+  L +   P++V   G  + +    +  E+M  GSL   L ++    +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG 107
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K+++   KGL +L  + K +++RD K SNIL++S    KL DFG++    +     +   
Sbjct: 108 KVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            +GT+ Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHK 125
           + L   +F + + LG G  G V+K      G V  +    LE +P A++           
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIR----------N 49
Query: 126 EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           + + E+  L +   P++V   G  + +    +  E+M  GSL   L ++    +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG 107
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K+++   KGL +L  E   +++RD K SNIL++S    KL DFG++    +     +   
Sbjct: 108 KVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            +GT+ Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           HPH++ LI       +  LV++ M +G L + L  +   AL       I     + ++FL
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLEAVSFL 216
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
           H  +  +++RD K  NILLD +   +LSDFG +     GE+   +  + GT GY APE +
Sbjct: 217 HANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEIL 271
Query: 259 MTGHLTTMS------DVYSFGVVLLELLTG 282
                 T        D+++ GV+L  LL G
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 74  LITSNFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW 127
           L   +F + + LG G  G V+K      G V  +    LE +P               + 
Sbjct: 65  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----------RNQI 113
Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           + E+  L +   P++V   G  + +    +  E+M  GSL   L ++    +P     K+
Sbjct: 114 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKV 171
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           ++   KGL +L  + K +++RD K SNIL++S    KL DFG++    +     +    +
Sbjct: 172 SIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 226
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           GT+ Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 117/251 (46%), Gaps = 22/251 (8%)
Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR+I S       ++R   +G+G  G VY       +  G   Q VA++ ++L    
Sbjct: 7   LEKLRIIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 60
Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
             +  + EI+ + + ++P++V  +      +   +V EY+  GSL + +  +    +   
Sbjct: 61  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEG 117
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETH 241
               +     + L FLH     VI+R+ K+ NILL  D + KL+DFG  A+  PE  +  
Sbjct: 118 QIAAVCRECLQALEFLHSNQ--VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 174
Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW 300
             + ++GT  + APE V         D++S G++ +E++ G+    N    R   L A  
Sbjct: 175 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 232
Query: 301 ARPLLKEPRKL 311
             P L+ P KL
Sbjct: 233 GTPELQNPEKL 243

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHK 125
           + L   +F + + LG G  G V+K      G V  +    LE +P               
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----------RN 49
Query: 126 EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           + + E+  L +   P++V   G  + +    +  E+M  GSL   L ++    +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG 107
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K+++   KGL +L  E   +++RD K SNIL++S    KL DFG++    +     +   
Sbjct: 108 KVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            +GT+ Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHK 125
           + L   +F + + LG G  G V+K      G V  +    LE +P               
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----------RN 49
Query: 126 EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           + + E+  L +   P++V   G  + +    +  E+M  GSL   L ++    +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG 107
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K+++   KGL +L  E   +++RD K SNIL++S    KL DFG++    +     +   
Sbjct: 108 KVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            +GT+ Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHK 125
           + L   +F + + LG G  G V+K      G V  +    LE +P               
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----------RN 49
Query: 126 EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
           + + E+  L +   P++V   G  + +    +  E+M  GSL   L ++    +P     
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILG 107
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           K+++   KGL +L  E   +++RD K SNIL++S    KL DFG++    +     +   
Sbjct: 108 KVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANS 162
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            +GT+ Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKE 126
           L ++ +    F+   +LG+G FG V +  + ++    ++   VAVK L  D+  +   +E
Sbjct: 15  LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVK---VAVKMLKADIIASSDIEE 71
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYR------LLVYEYMPRGSLHNQLFRSYSAA-- 178
           ++ E   + +  HPH+ KL+G       +      +++  +M  G LH  L  S      
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 179 --LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 236
             LP  T ++  +  A G+ +L   +   I+RD  A N +L  D T  ++DFGL++    
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
Query: 237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           G+             + A E +     T  SDV++FGV + E++T
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 78  NFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI 131
           +F + + LG G  G V+K      G V  +    LE +P               + + E+
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----------RNQIIREL 74
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             L +   P++V   G  + +    +  E+M  GSL   L ++    +P     K+++  
Sbjct: 75  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAV 132
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            KGL +L  E   +++RD K SNIL++S    KL DFG++    +     +    +GT+ 
Sbjct: 133 IKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 187
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 116/251 (46%), Gaps = 22/251 (8%)
Query: 69  LAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR I S       ++R   +G+G  G VY       +  G   Q VA++ ++L    
Sbjct: 7   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAM---DVATG---QEVAIRQMNLQQQP 60
Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
             +  + EI+ + + ++P++V  +      +   +V EY+  GSL + +  +    +   
Sbjct: 61  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEG 117
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL-AKDGPEGEETH 241
               +     + L FLH     VI+RD K+ NILL  D + KL+DFG  A+  PE  +  
Sbjct: 118 QIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 174
Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL-AEW 300
             + ++GT  + APE V         D++S G++ +E++ G+    N    R   L A  
Sbjct: 175 --SXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 232
Query: 301 ARPLLKEPRKL 311
             P L+ P KL
Sbjct: 233 GTPELQNPEKL 243

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 74  LITSNFSRSNLLGEGGFGPVYK------GFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW 127
           L   +F + + LG G  G V+K      G V  +    LE +P               + 
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI-----------RNQI 78
Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           + E+  L +   P++V   G  + +    +  E+M  GSL   L ++    +P     K+
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKV 136
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           ++   KGL +L  E   +++RD K SNIL++S    KL DFG++    +     +    +
Sbjct: 137 SIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 191
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           GT+ Y +PE +   H +  SD++S G+ L+E+  G+
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQL 137
           + R   LG+GGF   Y+   D   K     + V  K++ L   Q  KE M+ EI     L
Sbjct: 28  YMRGRFLGKGGFAKCYE-ITDMDTKEVFAGK-VVPKSMLLKPHQ--KEKMSTEIAIHKSL 83
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP---WSTRMKIALGAAKG 194
            +PH+V   G+  ++++  +V E   R SL     R  +   P   +  R  I     +G
Sbjct: 84  DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QG 138
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYA 253
           + +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +GE       + GT  Y 
Sbjct: 139 VQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYI 193
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           APE +     +   D++S G +L  LL GK   + + L
Sbjct: 194 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 231

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQL 137
           + R   LG+GGF   Y+   D   K     + V  K++ L   Q  KE M+ EI     L
Sbjct: 44  YMRGRFLGKGGFAKCYE-ITDMDTKEVFAGK-VVPKSMLLKPHQ--KEKMSTEIAIHKSL 99
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP---WSTRMKIALGAAKG 194
            +PH+V   G+  ++++  +V E   R SL     R  +   P   +  R  I     +G
Sbjct: 100 DNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QG 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYA 253
           + +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +GE       + GT  Y 
Sbjct: 155 VQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KDLCGTPNYI 209
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           APE +     +   D++S G +L  LL GK   + + L
Sbjct: 210 APEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCL 247

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 13  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 123
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 15  LGEGAYGEVQLAVNR------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 118/293 (40%), Gaps = 38/293 (12%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 36  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTRMKI------------ 187
           ++V L+G C +    L+V  E+   G+L   L    +  +P+ T   +            
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 188 -ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +       
Sbjct: 153 YSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
                + APE +     T  SDV+SFGV+L E+                SL     P +K
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVK 255
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
              +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 11/205 (5%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     E+    + A  V  K   L+      +   E+     L
Sbjct: 13  DFDIGRPLGKGKFGNVY--LARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQSHL 69
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYIT-ELANALSY 127
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S+   K++DFG +   P        T + GT  Y  PE 
Sbjct: 128 CHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEM 181
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           +         D++S GV+  E L G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 208 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 95/218 (43%), Gaps = 13/218 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW 300
                DV+S G+VL  +L G+   D       Q  ++W
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPS-DSXQEYSDW 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ-LRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD------LDGTQGHKE 126
           R+   ++   + LG G FG V  G      +  L    VAVK L+      LD     K 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
              EI  L   RHPH++KL           +V EY+  G L + + +        + R+ 
Sbjct: 61  ---EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF 117
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             + +A      H     V++RD K  N+LLD+   AK++DFGL+    +GE    +   
Sbjct: 118 QQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTS 170
Query: 247 MGTQGYAAPEYVMTGHLTT--MSDVYSFGVVLLELLTGKRAMDN 288
            G+  YAAPE V++G L      D++S GV+L  LL G    D+
Sbjct: 171 CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           R+  + F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTEN 202
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    +S       G
Sbjct: 203 RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGG----ELFFHLSRERVFSEDRARFYG 257
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH E K V+YRD K  N++LD D   K++DFGL K+G +   T  +    G
Sbjct: 258 AEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCG 314
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 315 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 35  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 147
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 35  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 93  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 147
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 101/224 (45%), Gaps = 25/224 (11%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD------LDGTQGHKE 126
           R+   ++   + LG G FG V  G      +  L    VAVK L+      LD     K 
Sbjct: 7   RVKIGHYVLGDTLGVGTFGKVKIG------EHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
              EI  L   RHPH++KL           +V EY+  G L + + +        + R+ 
Sbjct: 61  ---EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF 117
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
             + +A      H     V++RD K  N+LLD+   AK++DFGL+    +GE    +   
Sbjct: 118 QQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRDS 170
Query: 247 MGTQGYAAPEYVMTGHLTT--MSDVYSFGVVLLELLTGKRAMDN 288
            G+  YAAPE V++G L      D++S GV+L  LL G    D+
Sbjct: 171 CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 33  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 91  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 145
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 205 FSSKSDVWSFGVLMWEAFS 223

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           R+  + F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTEN 199
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    +S       G
Sbjct: 200 RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGG----ELFFHLSRERVFSEDRARFYG 254
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH E K V+YRD K  N++LD D   K++DFGL K+G +   T  +    G
Sbjct: 255 AEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCG 311
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 13  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 71  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 125
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 185 FSSKSDVWSFGVLMWEAFS 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 15  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 73  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 127
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 187 FSSKSDVWSFGVLMWEAFS 205

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ-LRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E + + I + + L H ++V
Sbjct: 14  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 88
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 89  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 148
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 149 CTYQLARGMEYLASQK--CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 19  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 131
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 377 LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 435 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 489
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 549 FSSKSDVWSFGVLMWEAFS 567

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 90
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 91  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 150
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 151 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 25  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 83  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 137
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 102 NIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 102 NIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 102/199 (51%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 378 LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 436 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 490
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E +   +  G     + APE +    
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 550 FSSKSDVWSFGVLMWEAFS 568

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-----DLDGTQGHKEWMAEII 132
           +F    ++G G +  V    V  K    + A  V  K L     D+D  Q  K      +
Sbjct: 21  DFDLLRVIGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH-----V 73
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLL-VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           F     HP LV L   C++ E RL  V EY+  G L   + R     LP       +   
Sbjct: 74  FEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEI 130
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           +  L +LH  ++ +IYRD K  N+LLDS+   KL+D+G+ K+G    +T   +   GT  
Sbjct: 131 SLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPN 186
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           Y APE +         D ++ GV++ E++ G+   D
Sbjct: 187 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 93
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 94  NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 153
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 154 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           R+  + F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTEN 59
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    +S       G
Sbjct: 60  RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGG----ELFFHLSRERVFSEDRARFYG 114
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH E K V+YRD K  N++LD D   K++DFGL K+G +   T  +    G
Sbjct: 115 AEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCG 171
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 97/218 (44%), Gaps = 16/218 (7%)
Query: 70  AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWM 128
           A  R+  + F    LLG+G FG V    V EK      A  +  K + +   +  H   +
Sbjct: 2   AMARVTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT--L 57
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            E   L   RHP L  L  Y ++   RL  V EY   G    +LF   S    +S     
Sbjct: 58  TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGG----ELFFHLSRERVFSEDRAR 112
Query: 188 ALGA--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             GA     L +LH E K V+YRD K  N++LD D   K++DFGL K+G +   T  +  
Sbjct: 113 FYGAEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 169
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             GT  Y APE +         D +  GVV+ E++ G+
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ-LRHPHLV 143
           LGEG +G V            +  + VAVK +D+       E + + I + + L H ++V
Sbjct: 15  LGEGAYGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 96/215 (44%), Gaps = 16/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           R+  + F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHT--LTEN 61
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    +S       G
Sbjct: 62  RVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGG----ELFFHLSRERVFSEDRARFYG 116
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH E K V+YRD K  N++LD D   K++DFGL K+G +   T  +    G
Sbjct: 117 AEIVSALDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCG 173
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++ EY  +G+L   L       + +S  +               
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   +++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-----DLDGTQGHKEWMAEII 132
           +F    ++G G +  V    V  K    + A  V  K L     D+D  Q  K      +
Sbjct: 6   DFDLLRVIGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH-----V 58
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLL-VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           F     HP LV L   C++ E RL  V EY+  G L   + R     LP       +   
Sbjct: 59  FEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEI 115
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           +  L +LH  ++ +IYRD K  N+LLDS+   KL+D+G+ K+G    +T   +   GT  
Sbjct: 116 SLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPN 171
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           Y APE +         D ++ GV++ E++ G+   D
Sbjct: 172 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 61  GSKLH----VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL 116
           G  LH    +F      + +  +    +LG+G FG V         K  +  Q  AVK +
Sbjct: 29  GDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVI 82
Query: 117 ---DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-- 171
               +      +  + E+  L QL HP+++KL  +  ++ Y  LV E    G L +++  
Sbjct: 83  SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 142
Query: 172 ---FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKL 225
              F    AA       +I      G+ ++H     +++RD K  N+LL+S   D   ++
Sbjct: 143 RKRFSEVDAA-------RIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRI 193
Query: 226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            DFGL+      E +  +   +GT  Y APE V+ G      DV+S GV+L  LL+G
Sbjct: 194 IDFGLS---THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 20/216 (9%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-----DLDGTQGHKEWMAEII 132
           +F    ++G G +  V    V  K    + A  V  K L     D+D  Q  K      +
Sbjct: 53  DFDLLRVIGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH-----V 105
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLL-VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           F     HP LV L   C++ E RL  V EY+  G L   + R     LP       +   
Sbjct: 106 FEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEI 162
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           +  L +LH  ++ +IYRD K  N+LLDS+   KL+D+G+ K+G    +T   +   GT  
Sbjct: 163 SLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 218
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           Y APE +         D ++ GV++ E++ G+   D
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-----DLDGTQGHKEWMAEI 131
            +F    ++G G +  V    V  K    + A  V  K L     D+D  Q  K      
Sbjct: 9   QDFDLLRVIGRGSYAKVL--LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH----- 61
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLL-VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
           +F     HP LV L   C++ E RL  V EY+  G L   + R     LP       +  
Sbjct: 62  VFEQASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAE 118
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            +  L +LH  ++ +IYRD K  N+LLDS+   KL+D+G+ K+G    +T   +   GT 
Sbjct: 119 ISLALNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTP 174
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
            Y APE +         D ++ GV++ E++ G+   D
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 10/199 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V KG+   ++K  ++   V +   + +      E +AE   + QL +P++V+
Sbjct: 19  LGSGNFGTVKKGYY--QMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           +IG C E E  +LV E    G L+  L ++          +++    + G+ +L  E+  
Sbjct: 77  MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD--KNIIELVHQVSMGMKYL--EESN 131
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMTGH 262
            ++RD  A N+LL + + AK+SDFGL+K     +E     +  G     + APE +    
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 263 LTTMSDVYSFGVVLLELLT 281
            ++ SDV+SFGV++ E  +
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 61  GSKLH----VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL 116
           G  LH    +F      + +  +    +LG+G FG V         K  +  Q  AVK +
Sbjct: 30  GDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVI 83
Query: 117 ---DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-- 171
               +      +  + E+  L QL HP+++KL  +  ++ Y  LV E    G L +++  
Sbjct: 84  SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS 143
Query: 172 ---FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKL 225
              F    AA       +I      G+ ++H     +++RD K  N+LL+S   D   ++
Sbjct: 144 RKRFSEVDAA-------RIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRI 194
Query: 226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            DFGL+      E +  +   +GT  Y APE V+ G      DV+S GV+L  LL+G
Sbjct: 195 IDFGLS---THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 90/205 (43%), Gaps = 12/205 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHLV 143
           LGEG  G V            +  + VAVK +D+       E +  EI     L H ++V
Sbjct: 14  LGEGAAGEVQLAV------NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           K  G+  E   + L  EY   G L +++        P + R    L A  G+ +LHG   
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL 263
            + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 264 TTMS-DVYSFGVVLLELLTGKRAMD 287
                DV+S G+VL  +L G+   D
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 22/210 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQ-PVAVKALD---LDGTQGHKEWMAEIIFLGQLRHP 140
           LGEG FG V       KL    + Q  VA+K +    L  +  H     EI +L  LRHP
Sbjct: 17  LGEGSFGKV-------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           H++KL          ++V EY   G L + +            R    +  A      H 
Sbjct: 70  HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
               +++RD K  N+LLD +   K++DFGL+    +G   + +    G+  YAAPE V+ 
Sbjct: 129 ----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPE-VIN 180
Query: 261 GHLTT--MSDVYSFGVVLLELLTGKRAMDN 288
           G L      DV+S G+VL  +L G+   D+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 117/290 (40%), Gaps = 35/290 (12%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA---TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTRMK----------IAL 189
           ++V L+G C +    L+V  E+   G+L   L    +  +P+    K           + 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
             AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +          
Sbjct: 152 QVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR 309
             + APE +     T  SDV+SFGV+L E+                SL     P +K   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKIDE 254
Query: 310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 255 EFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 110/291 (37%), Gaps = 36/291 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQL-RHPHL 142
           LG G FG V +      +K    A  VAVK L        +E  M+E+  L  L  H ++
Sbjct: 54  LGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 112
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI--------------- 187
           V L+G C      L++ EY   G L N L R   + +   T   I               
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 188 -ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
            +   AKG+AFL    K  I+RD  A NILL      K+ DFGLA+         V    
Sbjct: 173 FSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
                + APE +     T  SDV+S+G+ L EL                SL     P + 
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPYPGMP 275
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
              K  ++I        P     +       C    P  RPT   +V++++
Sbjct: 276 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 32/228 (14%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLG 135
           ++F     LG GGFG V++       K  ++    A+K + L   +  +E  M E+  L 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEA------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALP-W------------S 182
           +L HP +V+      E+     +    P+  L+ Q+       L  W            S
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
             + I L  A+ + FLH   K +++RD K SNI    D   K+ DFGL     + EE   
Sbjct: 119 VCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 243 ITRVM----------GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL 280
           +   M          GT+ Y +PE +     +   D++S G++L ELL
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 143 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 245
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 66  VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---DLDGTQ 122
           +F      + +  +    +LG+G FG V         K  +  Q  AVK +    +    
Sbjct: 15  MFVQHSTAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKT 68
Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSA 177
             +  + E+  L QL HP+++KL  +  ++ Y  LV E    G L +++     F    A
Sbjct: 69  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 128
Query: 178 ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDG 234
           A       +I      G+ ++H     +++RD K  N+LL+S   D   ++ DFGL+   
Sbjct: 129 A-------RIIRQVLSGITYMHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLS--- 176
Query: 235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
              E +  +   +GT  Y APE V+ G      DV+S GV+L  LL+G
Sbjct: 177 THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 143 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 245
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 117/292 (40%), Gaps = 37/292 (12%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTA---TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR------------MKI 187
           ++V L+G C +    L+V  E+   G+L   L    +  +P+               +  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +        
Sbjct: 154 SFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE 307
               + APE +     T  SDV+SFGV+L E+                SL     P +K 
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKI 256
Query: 308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
             +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 91/205 (44%), Gaps = 11/205 (5%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F     LG+G FG VY     E+    + A  V  K   L+      +   E+     L
Sbjct: 13  DFDIGRPLGKGKFGNVY--LARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQSHL 69
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           RHP++++L GY  +     L+ EY P G+++ +L +  S      T   I    A  L++
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSRFDEQRTATYIT-ELANALSY 127
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            H   K VI+RD K  N+LL S+   K++DFG +   P          + GT  Y  PE 
Sbjct: 128 CHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEM 181
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           +         D++S GV+  E L G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 13/206 (6%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA-LDLDGTQGHKEWMAEIIFLGQ 136
           +F     LG+G FG VY     EK    + A  V  K+ ++ +G +   +   EI     
Sbjct: 24  DFEIGRPLGKGKFGNVY--LAREKKSHFIVALKVLFKSQIEKEGVE--HQLRREIEIQAH 79
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP++++L  Y ++     L+ EY PRG L+ +L +  S          I    A  L 
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK--SCTFDEQRTATIMEELADALM 137
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           + HG  K VI+RD K  N+LL      K++DFG +   P          + GT  Y  PE
Sbjct: 138 YCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTMCGTLDYLPPE 191
Query: 257 YVMTGHLTTMSDVYSFGVVLLELLTG 282
            +         D++  GV+  ELL G
Sbjct: 192 MIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 96/218 (44%), Gaps = 17/218 (7%)
Query: 70  AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWM 128
           A  ++  ++F    LLG+G FG V    V EK      A  +  K + +   +  H   +
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT--V 56
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            E   L   RHP L  L  Y ++   RL  V EY   G    +LF   S    ++     
Sbjct: 57  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERAR 111
Query: 188 ALGA--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             GA     L +LH  D  V+YRD K  N++LD D   K++DFGL K+G     T  +  
Sbjct: 112 FYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKT 167
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             GT  Y APE +         D +  GVV+ E++ G+
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/290 (27%), Positives = 117/290 (40%), Gaps = 35/290 (12%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA---TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTRMK----------IAL 189
           ++V L+G C +    L+V  E+   G+L   L    +  +P+    K           + 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
             AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +          
Sbjct: 152 QVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR 309
             + APE +     T  SDV+SFGV+L E+                SL     P +K   
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKIDE 254
Query: 310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 255 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 254
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 112/240 (46%), Gaps = 20/240 (8%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKP----GLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           NF    +LG G +G V   F+  K+       L A  V  KA  +   +  +    E   
Sbjct: 55  NFELLKVLGTGAYGKV---FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           L  +R    +  + Y ++ E +L L+ +Y+  G L   L +           ++I +G  
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHEVQIYVGEI 168
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
             LA  H     +IYRD K  NILLDS+    L+DFGL+K+    +ET       GT  Y
Sbjct: 169 V-LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEY 226
Query: 253 AAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK-EP 308
            AP+ V    +GH   + D +S GV++ ELLTG  A   T  G + S AE +R +LK EP
Sbjct: 227 MAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKSEP 283

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 123/289 (42%), Gaps = 48/289 (16%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHL 142
           L E   G ++KG          +   + VK L +    T+  +++  E   L    HP++
Sbjct: 18  LNENHSGELWKG--------RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 143 VKLIGYCWE--EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           + ++G C      +  L+  +MP GSL+N L    +  +  S  +K AL  A+G+AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLS--DFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
            +  +      + ++++D D TA++S  D   +   P           M    + APE +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---------MYAPAWVAPEAL 180
Query: 259 MTGHLTT---MSDVYSFGVVLLELLTGKRA---MDNTRLGREQSLAEWARPLLKEPRKLE 312
                 T    +D++SF V+L EL+T +     + N  +G + +L E  RP +       
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-EGLRPTIPPG---- 235
Query: 313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
             I P +     I            C++  P  RP    +V +L+ +QD
Sbjct: 236 --ISPHVSKLMKI------------CMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 31/282 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPG-LEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           LG+G F  ++KG   E    G L    V +K LD       + +      + +L H HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA-LPWSTRMKIALGAAKGLAFLHGED 202
              G C+  +  +LV E++  GSL   L ++ +   + W  ++++A   A  + FL  E+
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFL--EE 131
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMT 260
             +I+ +  A NILL  +   K  +    K    G    V+ + +  +   +  PE +  
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL--LKEPRKLERLIDP 317
             +L   +D +SFG  L E+ +G                   +PL  L   RKL+   D 
Sbjct: 192 PKNLNLATDKWSFGTTLWEICSGG-----------------DKPLSALDSQRKLQFYED- 233
Query: 318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
               Q P   A + A     C+ + P HRP+   ++R L+SL
Sbjct: 234 --RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 66  VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---DLDGTQ 122
           +F      + +  +    +LG+G FG V         K  +  Q  AVK +    +    
Sbjct: 21  MFVQHSTAIFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKT 74
Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSA 177
             +  + E+  L QL HP+++KL  +  ++ Y  LV E    G L +++     F    A
Sbjct: 75  DKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA 134
Query: 178 ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDG 234
           A       +I      G+ ++H     +++RD K  N+LL+S   D   ++ DFGL+   
Sbjct: 135 A-------RIIRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--- 182
Query: 235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
              E +  +   +GT  Y APE V+ G      DV+S GV+L  LL+G
Sbjct: 183 THFEASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++  Y  +G+L   L       + +S  +               
Sbjct: 102 NIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 73  RLITSNFSRSNLLGEGGFGPVY----KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           R+  ++F+   +LG+G FG V     KG  +E     +  + V ++  D++ T      M
Sbjct: 15  RVKLTDFNFLMVLGKGSFGKVMLADRKG-TEELYAIKILKKDVVIQDDDVECT------M 67
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSL--HNQLFRSYS--AALPWST 183
            E   L  L  P  +  +  C++   RL  V EY+  G L  H Q    +    A+ ++ 
Sbjct: 68  VEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA 127
Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
            + I      GL FLH   + +IYRD K  N++LDS+   K++DFG+ K   E     V 
Sbjct: 128 EISI------GLFFLH--KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVT 176
Query: 244 TR-VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           TR   GT  Y APE +         D +++GV+L E+L G+   D
Sbjct: 177 TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD-LDGTQGHKEWMAEIIF 133
           I+S+F   +LLGEG +G V         KP  E   VA+K ++  D        + EI  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSA----THKPTGEI--VAIKKIEPFDKPLFALRTLREIKI 62
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAA 192
           L   +H +++ +      + +      Y+ +  +   L R  S  +     ++  +    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---------DGPEGEETHVI 243
           + +  LHG +  VI+RD K SN+L++S+   K+ DFGLA+           P G+++  +
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG-M 179
Query: 244 TRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
           T  + T+ Y APE ++T    +   DV+S G +L EL   +R +   R  R Q L
Sbjct: 180 TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLL 233

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEIIFLGQLRHPH 141
           L+GEG +G V K       +     + VA+K      D     K  M EI  L QLRH +
Sbjct: 32  LVGEGSYGMVMK------CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           LV L+  C +++   LV+E++    L +     +   L +    K       G+ F H  
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDD--LELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGYAAPEYVMT 260
           +  +I+RD K  NIL+      KL DFG A+     GE   V    + T+ Y APE ++ 
Sbjct: 144 N--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYDDEVATRWYRAPE-LLV 197
Query: 261 GHLT--TMSDVYSFGVVLLELLTGK 283
           G +      DV++ G ++ E+  G+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQ 136
           + R   +GEG FG   K  +   +K   + +   +K +++    ++  +E   E+  L  
Sbjct: 26  YVRLQKIGEGSFG---KAIL---VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQ-------LFRSYSAALPWSTRMKIAL 189
           ++HP++V+      E     +V +Y   G L  +       LF+     L W  ++ +AL
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-DQILDWFVQICLAL 138
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                    H  D+ +++RD K+ NI L  D T +L DFG+A+         +    +GT
Sbjct: 139 K--------HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELARACIGT 188
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
             Y +PE          SD+++ G VL EL T K A +
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/223 (31%), Positives = 105/223 (47%), Gaps = 40/223 (17%)
Query: 88  GGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAE--IIFLGQLRHPHLVKL 145
           G FG V+K          L    VAVK   L   Q  + W +E  I     ++H +L++ 
Sbjct: 26  GRFGCVWKA--------QLMNDFVAVKIFPL---QDKQSWQSEREIFSTPGMKHENLLQF 74
Query: 146 I-----GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           I     G   E E   L+  +  +GSL + L       + W+    +A   ++GL++LH 
Sbjct: 75  IAAEKRGSNLEVEL-WLITAFHDKGSLTDYL---KGNIITWNELCHVAETMSRGLSYLH- 129
Query: 201 EDKP----------VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
           ED P          + +RDFK+ N+LL SD TA L+DFGLA     G+        +GT+
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 251 GYAAPEYVMTGHLTTMS------DVYSFGVVLLELLTGKRAMD 287
            Y APE V+ G +          D+Y+ G+VL EL++  +A D
Sbjct: 190 RYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD-LDGTQGHKEWMAEIIF 133
           I+S+F   +LLGEG +G V         KP  E   VA+K ++  D        + EI  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSA----THKPTGEI--VAIKKIEPFDKPLFALRTLREIKI 62
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAA 192
           L   +H +++ +      + +      Y+ +  +   L R  S  +     ++  +    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---------DGPEGEETHVI 243
           + +  LHG +  VI+RD K SN+L++S+   K+ DFGLA+           P G+++  +
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG-M 179
Query: 244 TRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
           T  + T+ Y APE ++T    +   DV+S G +L EL   +R +   R  R Q L
Sbjct: 180 TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLL 233

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 254
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 111/248 (44%), Gaps = 41/248 (16%)
Query: 54  DLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAV 113
           D++ S  GS L +      R I         +G+G FG V++G            + VAV
Sbjct: 22  DMTTSGSGSGLPLLVQ---RTIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAV 70
Query: 114 KALDLDGTQGHKEWM--AEIIFLGQLRHPHLVKLIGY------CWEEEYRLLVYEYMPRG 165
           K      ++  + W   AEI     LRH +++  I         W + +  LV +Y   G
Sbjct: 71  KIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW--LVSDYHEHG 125
Query: 166 SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE-----DKPVI-YRDFKASNILLDS 219
           SL + L R Y+  +     +K+AL  A GLA LH E      KP I +RD K+ NIL+  
Sbjct: 126 SLFDYLNR-YTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182
Query: 220 DYTAKLSDFGLAKDGPEGEETHVI--TRVMGTQGYAAPEY----VMTGHLTTM--SDVYS 271
           + T  ++D GLA       +T  I     +GT+ Y APE     +   H  +   +D+Y+
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242
Query: 272 FGVVLLEL 279
            G+V  E+
Sbjct: 243 MGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 111/248 (44%), Gaps = 41/248 (16%)
Query: 54  DLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAV 113
           D++ S  GS L +      R I         +G+G FG V++G            + VAV
Sbjct: 9   DMTTSGSGSGLPLLVQ---RTIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAV 57
Query: 114 KALDLDGTQGHKEWM--AEIIFLGQLRHPHLVKLIGY------CWEEEYRLLVYEYMPRG 165
           K      ++  + W   AEI     LRH +++  I         W + +  LV +Y   G
Sbjct: 58  KIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW--LVSDYHEHG 112
Query: 166 SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE-----DKPVI-YRDFKASNILLDS 219
           SL + L R Y+  +     +K+AL  A GLA LH E      KP I +RD K+ NIL+  
Sbjct: 113 SLFDYLNR-YTVTV--EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 169
Query: 220 DYTAKLSDFGLAKDGPEGEETHVI--TRVMGTQGYAAPEY----VMTGHLTTM--SDVYS 271
           + T  ++D GLA       +T  I     +GT+ Y APE     +   H  +   +D+Y+
Sbjct: 170 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 229
Query: 272 FGVVLLEL 279
            G+V  E+
Sbjct: 230 MGLVFWEI 237

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 143 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 245
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD-LDGTQGHKEWMAEIIF 133
           I+S+F   +LLGEG +G V         KP  E   VA+K ++  D        + EI  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSA----THKPTGEI--VAIKKIEPFDKPLFALRTLREIKI 62
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAA 192
           L   +H +++ +      + +      Y+ +  +   L R  S  +     ++  +    
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---------DGPEGEETHVI 243
           + +  LHG +  VI+RD K SN+L++S+   K+ DFGLA+           P G+++ ++
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 244 TRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL 297
             V  T+ Y APE ++T    +   DV+S G +L EL   +R +   R  R Q L
Sbjct: 181 EFV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGRDYRHQLL 233

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           ++  ++F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT--VTES 56
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    ++       G
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG 111
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH  D  V+YRD K  N++LD D   K++DFGL K+G     T  +    G
Sbjct: 112 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCG 167
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 189 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 291
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 85  LGEGGFGPVY--KGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL-RHP 140
           LGEG FG V   +    +K KP  EA  VAVK L  D T+    + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK-EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK-------------- 186
           +++ L+G C ++    ++  Y  +G+L   L       + +S  +               
Sbjct: 102 NIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
                A+G+ +L  +    I+RD  A N+L+  +   K++DFGLA+D    +     T  
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                + APE +     T  SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 143 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 245
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 246 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 78  NFSRSNLLGEGGFGPV---YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           N+     LGEG FG V   Y     +K+   +  + V  K+      QG  E   EI +L
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS----DMQGRIE--REISYL 68
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEY---------MPRGSLHNQ----LFRSYSAALPW 181
             LRHPH++KL      ++  ++V EY         + R  +  Q     F+   +A+ +
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEY 128
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
             R KI                  ++RD K  N+LLD     K++DFGL+    +G   +
Sbjct: 129 CHRHKI------------------VHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---N 167
Query: 242 VITRVMGTQGYAAPEYVMTGHLTT--MSDVYSFGVVLLELLTGKRAMDN 288
            +    G+  YAAPE V++G L      DV+S GV+L  +L  +   D+
Sbjct: 168 FLKTSCGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPG-LEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           LG+G F  ++KG   E    G L    V +K LD       + +      + +L H HLV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA-LPWSTRMKIALGAAKGLAFLHGED 202
              G C   +  +LV E++  GSL   L ++ +   + W  ++++A   A  + FL  E+
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFL--EE 131
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--GYAAPEYVMT 260
             +I+ +  A NILL  +   K  +    K    G    V+ + +  +   +  PE +  
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 261 -GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL--LKEPRKLERLIDP 317
             +L   +D +SFG  L E+ +G                   +PL  L   RKL+   D 
Sbjct: 192 PKNLNLATDKWSFGTTLWEICSGG-----------------DKPLSALDSQRKLQFYED- 233
Query: 318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
               Q P   A + A     C+ + P HRP+   ++R L+SL
Sbjct: 234 --RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           ++  ++F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT--VTES 56
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    ++       G
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG 111
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH  D  V+YRD K  N++LD D   K++DFGL K+G     T  +    G
Sbjct: 112 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCG 167
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           ++  ++F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT--VTES 56
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    ++       G
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG 111
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH  D  V+YRD K  N++LD D   K++DFGL K+G     T  +    G
Sbjct: 112 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 167
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           ++  ++F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT--VTES 56
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    ++       G
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG 111
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH  D  V+YRD K  N++LD D   K++DFGL K+G     T  +    G
Sbjct: 112 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCG 167
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 78  NFSRSNLLGEGGFGPV---YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           N+     LGEG FG V   Y     +K+   +  + V  K+      QG  E   EI +L
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS----DMQGRIE--REISYL 58
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEY---------MPRGSLHNQ----LFRSYSAALPW 181
             LRHPH++KL      ++  ++V EY         + R  +  Q     F+   +A+ +
Sbjct: 59  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEY 118
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
             R KI                  ++RD K  N+LLD     K++DFGL+    +G   +
Sbjct: 119 CHRHKI------------------VHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---N 157
Query: 242 VITRVMGTQGYAAPEYVMTGHLTT--MSDVYSFGVVLLELLTGKRAMDN 288
            +    G+  YAAPE V++G L      DV+S GV+L  +L  +   D+
Sbjct: 158 FLKTSCGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 78  NFSRSNLLGEGGFGPV---YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           N+     LGEG FG V   Y     +K+   +  + V  K+      QG  E   EI +L
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS----DMQGRIE--REISYL 67
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEY---------MPRGSLHNQ----LFRSYSAALPW 181
             LRHPH++KL      ++  ++V EY         + R  +  Q     F+   +A+ +
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEY 127
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
             R KI                  ++RD K  N+LLD     K++DFGL+    +G   +
Sbjct: 128 CHRHKI------------------VHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---N 166
Query: 242 VITRVMGTQGYAAPEYVMTGHLTT--MSDVYSFGVVLLELLTGKRAMDN 288
            +    G+  YAAPE V++G L      DV+S GV+L  +L  +   D+
Sbjct: 167 FLKTSCGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           ++  ++F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT--VTES 56
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    ++       G
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG 111
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH  D  V+YRD K  N++LD D   K++DFGL K+G     T  +    G
Sbjct: 112 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCG 167
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEI 131
           ++  ++F    LLG+G FG V    V EK      A  +  K + +   +  H   + E 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHT--VTES 61
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L   RHP L  L  Y ++   RL  V EY   G    +LF   S    ++       G
Sbjct: 62  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFYG 116
Query: 191 A--AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           A     L +LH  D  V+YRD K  N++LD D   K++DFGL K+G     T  +    G
Sbjct: 117 AEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCG 172
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T  Y APE +         D +  GVV+ E++ G+
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 254
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           ++  + R   LG G +G V      +KL  G E     +K   +  T      + E+  L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVL--LCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVL 58
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAK 193
            QL HP+++KL  +  ++    LV E    G L +++  R   + +  +  MK  L    
Sbjct: 59  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS--- 115
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
           G  +LH  +  +++RD K  N+LL+S   D   K+ DFGL+     G +   +   +GT 
Sbjct: 116 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTA 170
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            Y APE V+        DV+S GV+L  LL G
Sbjct: 171 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 16/212 (7%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           ++  + R   LG G +G V      +KL  G E     +K   +  T      + E+  L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVL--LCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVL 75
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSYSAALPWSTRMKIALGAAK 193
            QL HP+++KL  +  ++    LV E    G L +++  R   + +  +  MK  L    
Sbjct: 76  KQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS--- 132
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
           G  +LH  +  +++RD K  N+LL+S   D   K+ DFGL+     G +   +   +GT 
Sbjct: 133 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK---MKERLGTA 187
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            Y APE V+        DV+S GV+L  LL G
Sbjct: 188 YYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLGQLRHPH 141
           +LG+G FG V K       K  +  Q  AVK ++    +       + E+  L +L HP+
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIALGAAKGLA 196
           ++KL     +     +V E    G L +++     F  + AA       +I      G+ 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGIT 135
Query: 197 FLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           ++H  +  +++RD K  NILL+S   D   K+ DFGL+    +   T +  R+ GT  Y 
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYI 190
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE V+ G      DV+S GV+L  LL+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 46/229 (20%)
Query: 78  NFSRSNLLGEGGFGPV---YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           N+     LGEG FG V   Y     +K+   +  + V  K+      QG  E   EI +L
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKS----DMQGRIE--REISYL 62
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEY---------MPRGSLHNQ----LFRSYSAALPW 181
             LRHPH++KL      ++  ++V EY         + R  +  Q     F+   +A+ +
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEY 122
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
             R KI                  ++RD K  N+LLD     K++DFGL+    +G   +
Sbjct: 123 CHRHKI------------------VHRDLKPENLLLDEHLNVKIADFGLSNIMTDG---N 161
Query: 242 VITRVMGTQGYAAPEYVMTGHLTT--MSDVYSFGVVLLELLTGKRAMDN 288
            +    G+  YAAPE V++G L      DV+S GV+L  +L  +   D+
Sbjct: 162 FLKTSCGSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 117/294 (39%), Gaps = 39/294 (13%)
Query: 85  LGEGGFGPVYKG--FVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQL-RHP 140
           LG G FG V +   F  +K       + VAVK L    T   H+  M+E+  L  +  H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTA---TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 141 HLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTR--------------M 185
           ++V L+G C +    L+V  E+   G+L   L    +  +P+                 +
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
             +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +      
Sbjct: 154 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
                 + APE +     T  SDV+SFGV+L E+                SL     P +
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 256
Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           K   +  R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 257 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL-------DGTQGHKEWMAEI 131
           + + + LGEG F  VYK       +     Q VA+K + L       DG   ++  + EI
Sbjct: 12  YEKLDFLGEGQFATVYKA------RDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREI 63
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             L +L HP+++ L+     +    LV+++M        + +  S  L  S      L  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDL--EVIIKDNSLVLTPSHIKAYMLMT 121
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            +GL +LH     +++RD K +N+LLD +   KL+DFGLAK    G         + T+ 
Sbjct: 122 LQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXHQVVTRW 177
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELL 280
           Y APE +    +  +  D+++ G +L ELL
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHK-EWMAEIIFLGQLR---H 139
           +GEG +G V+K      LK G   + VA+K + +  G +G     + E+  L  L    H
Sbjct: 19  IGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 140 PHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           P++V+L   C     + E +L LV+E++ +  L   L +     +P  T   +     +G
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L FLH     V++RD K  NIL+ S    KL+DFGLA+          +T V+ T  Y A
Sbjct: 133 LDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRA 187
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE ++     T  D++S G +  E+   K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 99/224 (44%), Gaps = 30/224 (13%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFL 134
           N+     +G+G F  V      +  +  L  + VAVK +D   L+ T   K    E+  +
Sbjct: 16  NYRLQKTIGKGNFAKV------KLARHVLTGREVAVKIIDKTQLNPTSLQK-LFREVRIM 68
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK- 193
             L HP++VKL      E+   LV EY   G + + L            RMK     AK 
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKF 120
Query: 194 -----GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
                 + + H   K +++RD KA N+LLD D   K++DFG + +   G +   +    G
Sbjct: 121 RQIVSAVQYCH--QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK---LDTFCG 175
Query: 249 TQGYAAPE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           +  YAAPE +    +     DV+S GV+L  L++G    D   L
Sbjct: 176 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LG+GGF   ++  + +     + A  +  K+L L   Q  K  M EI     L H H+V
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVV 102
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAAKGLAFLHGE 201
              G+  + ++  +V E   R SL     R  +   P +     +I LG      +LH  
Sbjct: 103 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN 158
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYAAPEYVMT 260
              VI+RD K  N+ L+ D   K+ DFGLA K   +GE   V+    GT  Y APE +  
Sbjct: 159 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSK 213
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
              +   DV+S G ++  LL GK   + + L
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 244

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 24/219 (10%)
Query: 73  RLITSNFSRSNLLGEGGFGPVY----KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           R+  ++F+   +LG+G FG V     KG  DE     +  + V ++  D++ T      M
Sbjct: 337 RMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECT------M 389
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSL--HNQLFRSYSAALPWSTRM 185
            E   L     P  +  +  C++   RL  V EY+  G L  H Q    +          
Sbjct: 390 VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA 449
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR 245
           +IA+G    L FL  + K +IYRD K  N++LDS+   K++DFG+ K   E     V T+
Sbjct: 450 EIAIG----LFFL--QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTK 500
Query: 246 VM-GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
              GT  Y APE +         D ++FGV+L E+L G+
Sbjct: 501 XFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LG+GGF   ++  + +     + A  +  K+L L   Q  K  M EI     L H H+V
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVV 104
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAAKGLAFLHGE 201
              G+  + ++  +V E   R SL     R  +   P +     +I LG      +LH  
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN 160
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYAAPEYVMT 260
              VI+RD K  N+ L+ D   K+ DFGLA K   +GE   V+    GT  Y APE +  
Sbjct: 161 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSK 215
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
              +   DV+S G ++  LL GK   + + L
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AEIIFLGQLRHPHL 142
           +G+G FG V++G            + VAVK      ++  + W   AEI     LRH ++
Sbjct: 11  IGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI 59
Query: 143 VKLIGY------CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           +  I         W + +  LV +Y   GSL + L R Y+  +     +K+AL  A GLA
Sbjct: 60  LGFIAADNKDNGTWTQLW--LVSDYHEHGSLFDYLNR-YTVTV--EGMIKLALSTASGLA 114
Query: 197 FLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI--TRVMG 248
            LH E      KP I +RD K+ NIL+  + T  ++D GLA       +T  I     +G
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 249 TQGYAAPEY----VMTGHLTTM--SDVYSFGVVLLEL 279
           T+ Y APE     +   H  +   +D+Y+ G+V  E+
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AEIIFLGQLRHPHL 142
           +G+G FG V++G            + VAVK      ++  + W   AEI     LRH ++
Sbjct: 12  IGKGRFGEVWRG--------KWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENI 60
Query: 143 VKLIGY------CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           +  I         W + +  LV +Y   GSL + L R Y+  +     +K+AL  A GLA
Sbjct: 61  LGFIAADNKDNGTWTQLW--LVSDYHEHGSLFDYLNR-YTVTV--EGMIKLALSTASGLA 115
Query: 197 FLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI--TRVMG 248
            LH E      KP I +RD K+ NIL+  + T  ++D GLA       +T  I     +G
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 175
Query: 249 TQGYAAPEY----VMTGHLTTM--SDVYSFGVVLLEL 279
           T+ Y APE     +   H  +   +D+Y+ G+V  E+
Sbjct: 176 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LG+GGF   ++  + +     + A  +  K+L L   Q  K  M EI     L H H+V
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVV 78
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAAKGLAFLHGE 201
              G+  + ++  +V E   R SL     R  +   P +     +I LG      +LH  
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN 134
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYAAPEYVMT 260
              VI+RD K  N+ L+ D   K+ DFGLA K   +GE   V+    GT  Y APE +  
Sbjct: 135 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSK 189
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
              +   DV+S G ++  LL GK   + + L
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 18/225 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM-AEIIFLGQLRHPHLV 143
           LG G FG V+   V+E+   GLE     +K ++ D +Q   E + AEI  L  L HP+++
Sbjct: 30  LGSGAFGDVH--LVEER-SSGLER---VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYS--AALPWSTRMKIALGAAKGLAFLHGE 201
           K+     +     +V E    G L  ++  + +   AL      ++       LA+ H +
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 202 DKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
              V+++D K  NIL          K+ DFGLA+     E +   T   GT  Y APE V
Sbjct: 144 H--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAPE-V 197
Query: 259 MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP 303
               +T   D++S GVV+  LLTG      T L   Q  A +  P
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AEIIFLGQLRHPHL 142
           +G+G FG V++G            + VAVK      ++  + W   AEI     LRH ++
Sbjct: 17  IGKGRFGEVWRG--------KWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENI 65
Query: 143 VKLIGY------CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           +  I         W + +  LV +Y   GSL + L R Y+  +     +K+AL  A GLA
Sbjct: 66  LGFIAADNKDNGTWTQLW--LVSDYHEHGSLFDYLNR-YTVTV--EGMIKLALSTASGLA 120
Query: 197 FLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI--TRVMG 248
            LH E      KP I +RD K+ NIL+  + T  ++D GLA       +T  I     +G
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 180
Query: 249 TQGYAAPEY----VMTGHLTTM--SDVYSFGVVLLEL 279
           T+ Y APE     +   H  +   +D+Y+ G+V  E+
Sbjct: 181 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHK-EWMAEIIFLGQLR---H 139
           +GEG +G V+K      LK G   + VA+K + +  G +G     + E+  L  L    H
Sbjct: 19  IGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 140 PHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           P++V+L   C     + E +L LV+E++ +  L   L +     +P  T   +     +G
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L FLH     V++RD K  NIL+ S    KL+DFGLA+          +T V+ T  Y A
Sbjct: 133 LDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRA 187
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE ++     T  D++S G +  E+   K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 38/217 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AEIIFLGQLRHPHL 142
           +G+G FG V++G            + VAVK      ++  + W   AEI     LRH ++
Sbjct: 14  IGKGRFGEVWRG--------KWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENI 62
Query: 143 VKLIGY------CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           +  I         W + +  LV +Y   GSL + L R Y+  +     +K+AL  A GLA
Sbjct: 63  LGFIAADNKDNGTWTQLW--LVSDYHEHGSLFDYLNR-YTVTV--EGMIKLALSTASGLA 117
Query: 197 FLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI--TRVMG 248
            LH E      KP I +RD K+ NIL+  + T  ++D GLA       +T  I     +G
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 177
Query: 249 TQGYAAPEY----VMTGHLTTM--SDVYSFGVVLLEL 279
           T+ Y APE     +   H  +   +D+Y+ G+V  E+
Sbjct: 178 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHK-EWMAEIIFLGQLR---H 139
           +GEG +G V+K      LK G   + VA+K + +  G +G     + E+  L  L    H
Sbjct: 19  IGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 140 PHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           P++V+L   C     + E +L LV+E++ +  L   L +     +P  T   +     +G
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L FLH     V++RD K  NIL+ S    KL+DFGLA+          +T V+ T  Y A
Sbjct: 133 LDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWYRA 187
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE ++     T  D++S G +  E+   K
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 22/228 (9%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKE 126
           +A+L +   N+     +G+G F  V      +  +  L  + VAVK +D     +   ++
Sbjct: 1   MADLHI--GNYRLLKTIGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQK 52
Query: 127 WMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
              E+  +  L HP++VKL      E+   LV EY   G + +     Y  A  W  + K
Sbjct: 53  LFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFD-----YLVAHGW-MKEK 106
Query: 187 IALGAAKGL--AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT 244
            A    + +  A  +   K +++RD KA N+LLD+D   K++DFG + +   G +     
Sbjct: 107 EARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC 166
Query: 245 RVMGTQGYAAPE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
              G+  YAAPE +    +     DV+S GV+L  L++G    D   L
Sbjct: 167 ---GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 211

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 30/220 (13%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---DLDGTQGHKEWMAE 130
           + +  +    +LG+G FG V         K  +  Q  AVK +    +      +  + E
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 131 IIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRM 185
           +  L QL HP++ KL  +  ++ Y  LV E    G L +++     F    AA       
Sbjct: 77  VQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------- 129
Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHV 242
           +I      G+ + H     +++RD K  N+LL+S   D   ++ DFGL+      E +  
Sbjct: 130 RIIRQVLSGITYXHK--NKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKK 184
Query: 243 ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
               +GT  Y APE V+ G      DV+S GV+L  LL+G
Sbjct: 185 XKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWM 128
           + L  ++FS   ++G GGFG VY        +     +  A+K LD   +   QG    +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 129 AEIIFLGQLRH---PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS--YSAALPWS 182
            E I L  +     P +V  + Y +    +L  + + M  G LH  L +   +S A    
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              +I LG        H  ++ V+YRD K +NILLD     ++SD GLA D  + ++ H 
Sbjct: 297 YAAEIILGLE------HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 349
Query: 243 ITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTG 282
               +GT GY APE +  G    + +D +S G +L +LL G
Sbjct: 350 ---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWM 128
           + L  ++FS   ++G GGFG VY        +     +  A+K LD   +   QG    +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 129 AEIIFLGQLRH---PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS--YSAALPWS 182
            E I L  +     P +V  + Y +    +L  + + M  G LH  L +   +S A    
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              +I LG        H  ++ V+YRD K +NILLD     ++SD GLA D  + ++ H 
Sbjct: 297 YAAEIILGLE------HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 349
Query: 243 ITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTG 282
               +GT GY APE +  G    + +D +S G +L +LL G
Sbjct: 350 ---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 73  RLITSNFSRSNLLGEGGFGPVY----KGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           R+  ++F+   +LG+G FG V     KG  DE     +  + V ++  D++ T      M
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECT------M 68
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            E   L     P  +  +  C++   RL  V EY+  G L   + +      P +     
Sbjct: 69  VEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY-- 126
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   A GL FL  + K +IYRD K  N++LDS+   K++DFG+ K   E     V T+  
Sbjct: 127 AAEIAIGLFFL--QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXF 181
Query: 248 -GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            GT  Y APE +         D ++FGV+L E+L G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F    L+G GGFG V+K       K  ++ +   +K +  +  +  +E  A    L +L
Sbjct: 12  DFKEIELIGSGGFGQVFKA------KHRIDGKTYVIKRVKYNNEKAEREVKA----LAKL 61
Query: 138 RHPHLVKLIGYCWE-----------------EEYRLLVYEYMPRGSLHNQLFRSYSAALP 180
            H ++V   G CW+                  +   +  E+  +G+L   + +     L 
Sbjct: 62  DHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120
Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA----KDGPE 236
               +++     KG+ ++H   K +I RD K SNI L      K+ DFGL      DG  
Sbjct: 121 KVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL 280
                   R  GT  Y +PE + +       D+Y+ G++L ELL
Sbjct: 179 -------XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWM 128
           + L  ++FS   ++G GGFG VY        +     +  A+K LD   +   QG    +
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 129 AEIIFLGQLRH---PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS--YSAALPWS 182
            E I L  +     P +V  + Y +    +L  + + M  G LH  L +   +S A    
Sbjct: 238 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              +I LG        H  ++ V+YRD K +NILLD     ++SD GLA D  + ++ H 
Sbjct: 297 YAAEIILGLE------HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 349
Query: 243 ITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTG 282
               +GT GY APE +  G    + +D +S G +L +LL G
Sbjct: 350 ---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWM 128
           + L  ++FS   ++G GGFG VY        +     +  A+K LD   +   QG    +
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLAL 236
Query: 129 AEIIFLGQLRH---PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS--YSAALPWS 182
            E I L  +     P +V  + Y +    +L  + + M  G LH  L +   +S A    
Sbjct: 237 NERIMLSLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 295
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              +I LG        H  ++ V+YRD K +NILLD     ++SD GLA D  + ++ H 
Sbjct: 296 YAAEIILGLE------HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHA 348
Query: 243 ITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTG 282
               +GT GY APE +  G    + +D +S G +L +LL G
Sbjct: 349 ---SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLGQLRHPH 141
           +LG+G FG V K       K  +  Q  AVK ++    +       + E+  L +L HP+
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIALGAAKGLA 196
           ++KL     +     +V E    G L +++     F  + AA       +I      G+ 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGIT 135
Query: 197 FLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           ++H  +  +++RD K  NILL+S   D   K+ DFGL+    +   T +  R+ GT  Y 
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYI 190
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE V+ G      DV+S GV+L  LL+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLGQLRHPH 141
           +LG+G FG V K       K  +  Q  AVK ++    +       + E+  L +L HP+
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIALGAAKGLA 196
           ++KL     +     +V E    G L +++     F  + AA       +I      G+ 
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGIT 135
Query: 197 FLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           ++H  +  +++RD K  NILL+S   D   K+ DFGL+    +   T +  R+ GT  Y 
Sbjct: 136 YMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYI 190
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE V+ G      DV+S GV+L  LL+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
           N+     +G+G F  V      +  +  L  + VAVK +D     +   ++   E+  + 
Sbjct: 15  NYRLLKTIGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-- 193
            L HP++VKL      E+   LV EY   G + + L            RMK     AK  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 194 ----GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                + + H   K +++RD KA N+LLD+D   K++DFG + +   G +        G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GS 175
Query: 250 QGYAAPE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
             YAAPE +    +     DV+S GV+L  L++G    D   L
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
           N+     +G+G F  V      +  +  L  + VAVK +D     +   ++   E+  + 
Sbjct: 15  NYRLLKTIGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-- 193
            L HP++VKL      E+   LV EY   G + + L            RMK     AK  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 194 ----GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                + + H   K +++RD KA N+LLD+D   K++DFG + +   G +        G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GS 175
Query: 250 QGYAAPE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
             YAAPE +    +     DV+S GV+L  L++G    D   L
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEII 132
           +   + +   +GEG +G V+K       +     Q VA+K      D     K  + EI 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFK------CRNRDTGQIVAIKKFLESEDDPVIKKIALREIR 54
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            L QL+HP+LV L+     +    LV+EY     LH      Y   +P      I     
Sbjct: 55  MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHE--LDRYQRGVPEHLVKSITWQTL 112
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHVITRVMGTQ 250
           + + F H  +   I+RD K  NIL+      KL DFG A+   GP    +      + T+
Sbjct: 113 QAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGP----SDYYDDEVATR 166
Query: 251 GYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTG 282
            Y +PE ++         DV++ G V  ELL+G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL-DGTQGHK-EWMAEI 131
           + TS +     +G G +G VYK       +       VA+K++ + +G +G     + E+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVREV 54
Query: 132 IFLGQLR---HPHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWST 183
             L +L    HP++V+L+  C     + E ++ LV+E++ +  L   L ++    LP  T
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 113
Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
              +     +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+          +
Sbjct: 114 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMAL 168
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+ T  Y APE ++     T  D++S G +  E+   K
Sbjct: 169 APVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 18/226 (7%)
Query: 68  TLAEL---RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA-LDLDGTQG 123
            LAE+   +    +F     LG+G FG VY     EK    + A  V  K+ L+ +G + 
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVE- 59
Query: 124 HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWST 183
             +   EI     LRHP+++++  Y  + +   L+ E+ PRG L+ +L +        S 
Sbjct: 60  -HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 118
Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
                L  A  L + H  ++ VI+RD K  N+L+      K++DFG +   P      + 
Sbjct: 119 TFMEEL--ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LR 169
Query: 244 TRVM-GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDN 288
            R M GT  Y  PE +         D++  GV+  E L G    D+
Sbjct: 170 RRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 215

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LG+GGF   ++  + +     + A  +  K+L L   Q  K  M EI     L H H+V
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVV 80
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAAKGLAFLHGE 201
              G+  + ++  +V E   R SL     R  +   P +     +I LG      +LH  
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN 136
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYAAPEYVMT 260
              VI+RD K  N+ L+ D   K+ DFGLA K   +GE    +    GT  Y APE +  
Sbjct: 137 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---GTPNYIAPEVLSK 191
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
              +   DV+S G ++  LL GK   + + L
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 222

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 16/210 (7%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAE-II 132
           S+F    ++G+G FG V         +   E    AVK L        KE    M+E  +
Sbjct: 38  SDFHFLKVIGKGSFGKVLLA------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV 91
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            L  ++HP LV L       +    V +Y+  G L   L R      P +      + +A
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASA 151
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
             L +LH  +  ++YRD K  NILLDS     L+DFGL K+  E   T   +   GT  Y
Sbjct: 152 --LGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEY 205
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            APE +         D +  G VL E+L G
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
           N+     +G+G F  V      +  +  L  + VAV+ +D     +   ++   E+  + 
Sbjct: 15  NYRLLKTIGKGNFAKV------KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMK 68
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-- 193
            L HP++VKL      E+   LV EY   G + + L            RMK     AK  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 194 ----GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                + + H   K +++RD KA N+LLD+D   K++DFG + +   G +   +    G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK---LDEFCGS 175
Query: 250 QGYAAPE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
             YAAPE +    +     DV+S GV+L  L++G    D   L
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LG+GGF   ++  + +     + A  +  K+L L   Q  K  M EI     L H H+V
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVV 84
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAAKGLAFLHGE 201
              G+  + ++  +V E   R SL     R  +   P +     +I LG      +LH  
Sbjct: 85  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN 140
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYAAPEYVMT 260
              VI+RD K  N+ L+ D   K+ DFGLA K   +GE    +    GT  Y APE +  
Sbjct: 141 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---GTPNYIAPEVLSK 195
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
              +   DV+S G ++  LL GK   + + L
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 226

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 28/223 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
           N+     +G+G F  V      +  +  L  + VAVK +D     +   ++   E+  + 
Sbjct: 15  NYRLLKTIGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMK 68
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-- 193
            L HP++VKL      E+   LV EY   G + + L            RMK     AK  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 194 ----GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                + + H   K +++RD KA N+LLD+D   K++DFG + +   G +        G 
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC---GA 175
Query: 250 QGYAAPE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
             YAAPE +    +     DV+S GV+L  L++G    D   L
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL-DGTQGHK-EWMAEI 131
           + TS +     +G G +G VYK       +       VA+K++ + +G +G     + E+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVREV 54
Query: 132 IFLGQLR---HPHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWST 183
             L +L    HP++V+L+  C     + E ++ LV+E++ +  L   L ++    LP  T
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 113
Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
              +     +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+          +
Sbjct: 114 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMAL 168
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+ T  Y APE ++     T  D++S G +  E+   K
Sbjct: 169 DPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 26/216 (12%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEII 132
           RL+  ++ +   +GEG  G V         +     + VAVK +DL   Q  +    E++
Sbjct: 44  RLLLDSYVK---IGEGSTGIVCLA------REKHSGRQVAVKMMDLRKQQRRELLFNEVV 94
Query: 133 FLGQLRHPHLVKLI-GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            +   +H ++V++   Y   EE  +L+ E++  G+L + + +        +T  +  L A
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQVRLNEEQIATVCEAVLQA 153
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEETHVITRVM 247
              LA+LH +   VI+RD K+ +ILL  D   KLSDFG    ++KD P+ +       ++
Sbjct: 154 ---LAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX------LV 202
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           GT  + APE +      T  D++S G++++E++ G+
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LG+GGF   ++  + +     + A  +  K+L L   Q  K  M EI     L H H+V
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVV 80
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAAKGLAFLHGE 201
              G+  + ++  +V E   R SL     R  +   P +     +I LG      +LH  
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN 136
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYAAPEYVMT 260
              VI+RD K  N+ L+ D   K+ DFGLA K   +GE    +    GT  Y APE +  
Sbjct: 137 R--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---GTPNYIAPEVLSK 191
Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
              +   DV+S G ++  LL GK   + + L
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 222

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 86/173 (49%), Gaps = 7/173 (4%)
Query: 111 VAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQ 170
           VAVK +DL   Q  +    E++ +    H ++V +       +   +V E++  G+L + 
Sbjct: 73  VAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDI 132
Query: 171 LFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
           +  +       +T   + L   + L++LH +   VI+RD K+ +ILL SD   KLSDFG 
Sbjct: 133 VTHTRMNEEQIAT---VCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGF 187
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
                  +E      ++GT  + APE +      T  D++S G++++E++ G+
Sbjct: 188 CAQ--VSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA---- 129
           + TS +     +G G +G VYK       +       VA+K++ +    G    +     
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGGGGGGGLPISTV 59
Query: 130 -EIIFLGQLR---HPHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALP 180
            E+  L +L    HP++V+L+  C     + E ++ LV+E++ +  L   L ++    LP
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
             T   +     +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+        
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQ 173
Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             +T V+ T  Y APE ++     T  D++S G +  E+   K
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
           N+     +G+G F  V      +  +  L  + VAV+ +D     +   ++   E+  + 
Sbjct: 15  NYRLLKTIGKGNFAKV------KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMK 68
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-- 193
            L HP++VKL      E+   LV EY   G + + L            RMK     AK  
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKFR 120
Query: 194 ----GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                + + H   K +++RD KA N+LLD+D   K++DFG + +   G +        G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC---GS 175
Query: 250 QGYAAPE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
             YAAPE +    +     DV+S GV+L  L++G    D   L
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 16/225 (7%)
Query: 68  TLAEL---RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA-LDLDGTQG 123
            LAE+   +    +F     LG+G FG VY     EK    + A  V  K+ L+ +G + 
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVE- 58
Query: 124 HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWST 183
             +   EI     LRHP+++++  Y  + +   L+ E+ PRG L+ +L +        S 
Sbjct: 59  -HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA 117
Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
                L  A  L + H  ++ VI+RD K  N+L+      K++DFG +   P      + 
Sbjct: 118 TFMEEL--ADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC 173
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDN 288
               GT  Y  PE +         D++  GV+  E L G    D+
Sbjct: 174 ----GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 85  LGEGGFGPVYKG-------FVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +GEG +G VYK        F  +K++  LE +   + +  +           EI  L +L
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTI----------REISILKEL 57
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           +H ++VKL      ++  +LV+E++ +     +L       L   T     L    G+A+
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG--PEGEETHVITRVMGTQGYAAP 255
            H  D+ V++RD K  N+L++ +   K++DFGLA+    P  + TH I     T  Y AP
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAP 169
Query: 256 EYVM-TGHLTTMSDVYSFGVVLLELLTG 282
           + +M +   +T  D++S G +  E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 22/220 (10%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL-DGTQGHK-EWMAEI 131
           + TS +     +G G +G VYK       +       VA+K++ + +G +G     + E+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKA------RDPHSGHFVALKSVRVPNGEEGLPISTVREV 54
Query: 132 IFLGQLR---HPHLVKLIGYCW----EEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWST 183
             L +L    HP++V+L+  C     + E ++ LV+E++ +  L   L ++    LP  T
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 113
Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
              +     +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+          +
Sbjct: 114 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMAL 168
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+ T  Y APE ++     T  D++S G +  E+   K
Sbjct: 169 FPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 21/219 (9%)
Query: 72  LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI 131
           L++   ++    ++G G FG V    V  K    + A  +  K   +  +     W    
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQ--LVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERD 127
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW----STRMKI 187
           I +     P +V+L     +++Y  +V EYMP G L N L  +Y     W    +  + +
Sbjct: 128 I-MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVL 185
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           AL A   +  +H        RD K  N+LLD     KL+DFG      E    H  T V 
Sbjct: 186 ALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV- 236
Query: 248 GTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLTG 282
           GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 237 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 105/225 (46%), Gaps = 45/225 (20%)
Query: 88  GGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAE--IIFLGQLRHPHLVKL 145
           G FG V+K          L  + VAVK   +   Q  + W  E  +  L  ++H ++++ 
Sbjct: 35  GRFGCVWKA--------QLLNEYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQF 83
Query: 146 IGYCWEEEYR--------LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           IG     E R         L+  +  +GSL + L    +  + W+    IA   A+GLA+
Sbjct: 84  IG----AEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAY 136
Query: 198 LHGED--------KPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
           LH ED        KP I +RD K+ N+LL ++ TA ++DFGLA     G+        +G
Sbjct: 137 LH-EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 249 TQGYAAPEYVMTGHLTTMS------DVYSFGVVLLELLTGKRAMD 287
           T+ Y APE V+ G +          D+Y+ G+VL EL +   A D
Sbjct: 196 TRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 54/237 (22%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F    L+G GGFG V+K       K  ++ +   ++ +  +  +  +E  A    L +L
Sbjct: 13  DFKEIELIGSGGFGQVFKA------KHRIDGKTYVIRRVKYNNEKAEREVKA----LAKL 62
Query: 138 RHPHLVKLIGYCWE---------------EEYR---------------LLVYEYMPRGSL 167
            H ++V   G CW+                +Y                 +  E+  +G+L
Sbjct: 63  DHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 168 HNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
              + +     L     +++     KG+ ++H   K +I+RD K SNI L      K+ D
Sbjct: 122 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 228 FGLA----KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL 280
           FGL      DG         TR  GT  Y +PE + +       D+Y+ G++L ELL
Sbjct: 180 FGLVTSLKNDGKR-------TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 13/163 (7%)
Query: 124 HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWS 182
           H+E   EI  L  L HP+++KL     +++Y  LV E+   G L  Q+  R        +
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT---AKLSDFGLAKDGPEGEE 239
             MK  L    G+ +LH  +  +++RD K  NILL++  +    K+ DFGL+       +
Sbjct: 150 NIMKQILS---GICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSK 201
Query: 240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            + +   +GT  Y APE V+        DV+S GV++  LL G
Sbjct: 202 DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 18/218 (8%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFL 134
           N+     +G+G F  V      +  +  L  + VA+K +D   L+ T   K    E+  +
Sbjct: 13  NYRLLKTIGKGNFAKV------KLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIM 65
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
             L HP++VKL      E+   L+ EY   G + + L  ++        R K        
Sbjct: 66  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEARSKFR-QIVSA 123
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           + + H   K +++RD KA N+LLD+D   K++DFG + +   G +        G+  YAA
Sbjct: 124 VQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC---GSPPYAA 178
Query: 255 PE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           PE +    +     DV+S GV+L  L++G    D   L
Sbjct: 179 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPHLV 143
           LG GGFG V +    +        + VA+K    + +  ++E W  EI  + +L HP++V
Sbjct: 22  LGTGGFGYVLRWIHQDT------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 144 KL------IGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALPWSTRMKIALGAAKGL 195
                   +      +  LL  EY   G L   L  F +         R  ++   +  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 134
Query: 196 AFLHGEDKPVIYRDFKASNILLD---SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            +LH  +  +I+RD K  NI+L         K+ D G AK+  +GE   + T  +GT  Y
Sbjct: 135 RYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 189
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
            APE +     T   D +SFG +  E +TG R
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 85  LGEGGFGPVYKG-------FVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +GEG +G VYK        F  +K++  LE +   + +  +           EI  L +L
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTI----------REISILKEL 57
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           +H ++VKL      ++  +LV+E++ +     +L       L   T     L    G+A+
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG--PEGEETHVITRVMGTQGYAAP 255
            H  D+ V++RD K  N+L++ +   K++DFGLA+    P  + TH +     T  Y AP
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAP 169
Query: 256 EYVM-TGHLTTMSDVYSFGVVLLELLTG 282
           + +M +   +T  D++S G +  E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPHLV 143
           LG GGFG V +    +        + VA+K    + +  ++E W  EI  + +L HP++V
Sbjct: 23  LGTGGFGYVLRWIHQDT------GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 144 KL------IGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYSAALPWSTRMKIALGAAKGL 195
                   +      +  LL  EY   G L   L  F +         R  ++   +  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 135
Query: 196 AFLHGEDKPVIYRDFKASNILLD---SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            +LH  +  +I+RD K  NI+L         K+ D G AK+  +GE   + T  +GT  Y
Sbjct: 136 RYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 190
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
            APE +     T   D +SFG +  E +TG R
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 16/217 (7%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
           N+     +G+G F  V      +  +  L  + VAVK +D     +   ++   E+    
Sbjct: 15  NYRLLKTIGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXK 68
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
            L HP++VKL      E+   LV EY   G + + L  ++        R K        +
Sbjct: 69  VLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLV-AHGRXKEKEARAKFR-QIVSAV 126
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
            + H   K +++RD KA N+LLD+D   K++DFG + +   G +   +    G   YAAP
Sbjct: 127 QYCH--QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK---LDAFCGAPPYAAP 181
Query: 256 E-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           E +    +     DV+S GV+L  L++G    D   L
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 218

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 85  LGEGGFGPVYKG-------FVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +GEG +G VYK        F  +K++  LE +   + +  +           EI  L +L
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTI----------REISILKEL 57
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           +H ++VKL      ++  +LV+E++ +     +L       L   T     L    G+A+
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG--PEGEETHVITRVMGTQGYAAP 255
            H  D+ V++RD K  N+L++ +   K++DFGLA+    P  + TH +     T  Y AP
Sbjct: 116 CH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYRAP 169
Query: 256 EYVM-TGHLTTMSDVYSFGVVLLELLTG 282
           + +M +   +T  D++S G +  E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           I   +   ++LG G F  V     D++ +  +  + +A KAL+  G +G  E   EI  L
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKKALE--GKEGSME--NEIAVL 70
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAK 193
            +++HP++V L        +  L+ + +  G L +++  + +      S  +   L A K
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 194 GLAFLHGEDKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
              +LH  D  +++RD K  N+L   LD D    +SDFGL+K    G    V++   GT 
Sbjct: 131 ---YLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 182
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           GY APE +     +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 17/178 (9%)
Query: 111 VAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL--- 167
           VAVK +DL   Q  +    E++ +   +H ++V++       +   +V E++  G+L   
Sbjct: 179 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 238
Query: 168 --HNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL 225
             H ++     AA        + L   + L+ LH +   VI+RD K+ +ILL  D   KL
Sbjct: 239 VTHTRMNEEQIAA--------VCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKL 288
Query: 226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           SDFG        +E      ++GT  + APE +         D++S G++++E++ G+
Sbjct: 289 SDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 49/299 (16%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQ 136
           ++    ++G G    V   +   K       + VA+K ++L+  Q    E + EI  + Q
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPK------KEKVAIKRINLEKCQTSMDELLKEIQAMSQ 69
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY------SAALPWSTRMKIALG 190
             HP++V        ++   LV + +  GS+ + +          S  L  ST   I   
Sbjct: 70  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA---KDGPEGEETHVITRVM 247
             +GL +LH   +  I+RD KA NILL  D + +++DFG++     G +     V    +
Sbjct: 130 VLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 248 GTQGYAAPEYV--MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
           GT  + APE +  + G+    +D++SFG+  +EL TG                  A P  
Sbjct: 188 GTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATG------------------AAPYH 228
Query: 306 KEPRKLERLID-----PRLEGQFPIKGAQKAAATAFK-----CLSHHPRHRPTMSYVVR 354
           K P     ++      P LE     K   K    +F+     CL   P  RPT + ++R
Sbjct: 229 KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFL 134
           N+     +G+G F  V      +  +  L  + VA+K +D   L+ T   K    E+  +
Sbjct: 16  NYRLLKTIGKGNFAKV------KLARHILTGREVAIKIIDKTQLNPTSLQK-LFREVRIM 68
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
             L HP++VKL      E+   L+ EY   G + + L  ++        R K        
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLV-AHGRMKEKEARSKFR-QIVSA 126
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           + + H   K +++RD KA N+LLD+D   K++DFG + +   G +        G   YAA
Sbjct: 127 VQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAA 181
Query: 255 PE-YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL 291
           PE +    +     DV+S GV+L  L++G    D   L
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 71/310 (22%), Positives = 127/310 (40%), Gaps = 57/310 (18%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
            S+F    +LG+G FG V K       +  L+++  A+K +     +     ++E++ L 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIR-HTEEKLSTILSEVMLLA 57
Query: 136 QLRHPHLVKLIGYCWEEEYRL--------------LVYEYMPRGSLHNQLFRSYSAALPW 181
            L H ++V+     W E                  +  EY   G+L++ L  S +     
Sbjct: 58  SLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQR 115
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE-- 239
               ++     + L+++H +   +I+RD K  NI +D     K+ DFGLAK+     +  
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 240 ----------THVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELL----TGKR 284
                     +  +T  +GT  Y A E +  TGH     D+YS G++  E++    TG  
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 285 AMDNTRLGREQSLA---EWARPLLKEPRKLERLI---DPRLE---------GQFPIKGAQ 329
            ++  +  R  S+    ++    +K  +K+ RL+   DP            G  P+K   
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293
Query: 330 KAAATAFKCL 339
           +    A K L
Sbjct: 294 EVIKEALKSL 303

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AE 130
           R +    +    +G+G +G V++G            + VAVK      ++  + W    E
Sbjct: 4   RTVARQVALVECVGKGRYGEVWRGL--------WHGESVAVKIF---SSRDEQSWFRETE 52
Query: 131 IIFLGQLRHPHLVKLIGYCWEEEYR----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
           I     LRH +++  I              L+  Y   GSL++ L R     L     ++
Sbjct: 53  IYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ---TLEPHLALR 109
Query: 187 IALGAAKGLAFLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
           +A+ AA GLA LH E      KP I +RDFK+ N+L+ S+    ++D GLA    +G + 
Sbjct: 110 LAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDY 169
Query: 241 HVITR--VMGTQGYAAPEYVMTGHLTT-------MSDVYSFGVVLLELLTGKRAMDN 288
             I     +GT+ Y APE V+   + T        +D+++FG+VL E+   +R + N
Sbjct: 170 LDIGNNPRVGTKRYMAPE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIVN 223

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 29/241 (12%)
Query: 54  DLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAV 113
           ++ N +   K  +  + +LR+   ++    ++G G FG V    V  K    + A  +  
Sbjct: 46  NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLS 103
Query: 114 KALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR 173
           K   +  +     W    I +     P +V+L     ++ Y  +V EYMP G L N L  
Sbjct: 104 KFEMIKRSDSAFFWEERDI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMS 161
Query: 174 SYSAALPW----STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG 229
           +Y     W    +  + +AL A   + F+H        RD K  N+LLD     KL+DFG
Sbjct: 162 NYDVPEKWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFG 213
Query: 230 ----LAKDGPEGEETHVITRVMGTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLT 281
               + K+G    +T V     GT  Y +PE + +    G+     D +S GV L E+L 
Sbjct: 214 TCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
Query: 282 G 282
           G
Sbjct: 269 G 269

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 49/299 (16%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQ 136
           ++    ++G G    V   +   K       + VA+K ++L+  Q    E + EI  + Q
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPK------KEKVAIKRINLEKCQTSMDELLKEIQAMSQ 64
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY------SAALPWSTRMKIALG 190
             HP++V        ++   LV + +  GS+ + +          S  L  ST   I   
Sbjct: 65  CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA---KDGPEGEETHVITRVM 247
             +GL +LH   +  I+RD KA NILL  D + +++DFG++     G +     V    +
Sbjct: 125 VLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 248 GTQGYAAPEYV--MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
           GT  + APE +  + G+    +D++SFG+  +EL TG                  A P  
Sbjct: 183 GTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATG------------------AAPYH 223
Query: 306 KEPRKLERLID-----PRLEGQFPIKGAQKAAATAFK-----CLSHHPRHRPTMSYVVR 354
           K P     ++      P LE     K   K    +F+     CL   P  RPT + ++R
Sbjct: 224 KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 282

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 139/324 (42%), Gaps = 54/324 (16%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AE 130
           R I         +G+G +G V+ G            + VAVK      T     W    E
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMG--------KWRGEKVAVKVF---FTTEEASWFRETE 81
Query: 131 IIFLGQLRHPHLVKLIGY------CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR 184
           I     +RH +++  I         W + Y  L+ +Y   GSL++ L    S  L   + 
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLY--LITDYHENGSLYDYL---KSTTLDAKSM 136
Query: 185 MKIALGAAKGLAFLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLA-KDGPEG 237
           +K+A  +  GL  LH E      KP I +RD K+ NIL+  + T  ++D GLA K   + 
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 238 EETHVI--TRVMGTQGYAAPEY----VMTGHLTT--MSDVYSFGVVLLELLTGKRAMDNT 289
            E  +   TRV GT+ Y  PE     +   H  +  M+D+YSFG++L E+   +R +   
Sbjct: 197 NEVDIPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGG 253
Query: 290 RLGREQ----SLAEWARPLLKEPRKLERLIDPRLEGQFPIKGA-----QKAAATAFKCLS 340
            +   Q     L   + P  ++ R++  +   +L   FP + +     ++      +C +
Sbjct: 254 IVEEYQLPYHDLVP-SDPSYEDMREI--VCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310
Query: 341 HHPRHRPTMSYVVRVLDSLQDFQD 364
           H+P  R T   V + L  + + QD
Sbjct: 311 HNPASRLTALRVKKTLAKMSESQD 334

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLV-YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           + +L HP  VKL  +C++++ +L     Y   G L   + R   +     TR   A    
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 147
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQG 251
             L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQ 204
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y +PE +        SD+++ G ++ +L+ G
Sbjct: 205 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 29/226 (12%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           + +LR+   ++    ++G G FG V    V  K    + A  +  K   +  +     W 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW----STR 184
              I +     P +V+L     ++ Y  +V EYMP G L N L  +Y     W    +  
Sbjct: 124 ERDI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 181
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEET 240
           + +AL A   + F+H        RD K  N+LLD     KL+DFG    + K+G    +T
Sbjct: 182 VVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 241 HVITRVMGTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLTG 282
            V     GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 234 AV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 29/226 (12%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           + +LR+   ++    ++G G FG V    V  K    + A  +  K   +  +     W 
Sbjct: 66  IRDLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW----STR 184
              I +     P +V+L     ++ Y  +V EYMP G L N L  +Y     W    +  
Sbjct: 124 ERDI-MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAE 181
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEET 240
           + +AL A   + F+H        RD K  N+LLD     KL+DFG    + K+G    +T
Sbjct: 182 VVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 241 HVITRVMGTQGYAAPEYVMT----GHLTTMSDVYSFGVVLLELLTG 282
            V     GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 234 AV-----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG  G V    V          + VAVK +DL   Q  +    E++ +   +H ++V+
Sbjct: 37  IGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 145 LIGYCWEEEYRLLVYEYMPRGSL-----HNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +       +   +V E++  G+L     H ++     AA        + L   + L+ LH
Sbjct: 91  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALSVLH 142
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            +   VI+RD K+ +ILL  D   KLSDFG        +E      ++GT  + APE + 
Sbjct: 143 AQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELIS 198
Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D++S G++++E++ G+
Sbjct: 199 RLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG  G V    V          + VAVK +DL   Q  +    E++ +   +H ++V+
Sbjct: 39  IGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 145 LIGYCWEEEYRLLVYEYMPRGSL-----HNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +       +   +V E++  G+L     H ++     AA        + L   + L+ LH
Sbjct: 93  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALSVLH 144
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            +   VI+RD K+ +ILL  D   KLSDFG        +E      ++GT  + APE + 
Sbjct: 145 AQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELIS 200
Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D++S G++++E++ G+
Sbjct: 201 RLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 85/178 (47%), Gaps = 17/178 (9%)
Query: 111 VAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL--- 167
           VAVK +DL   Q  +    E++ +   +H ++V++       +   +V E++  G+L   
Sbjct: 102 VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDI 161
Query: 168 --HNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL 225
             H ++     AA        + L   + L+ LH +   VI+RD K+ +ILL  D   KL
Sbjct: 162 VTHTRMNEEQIAA--------VCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKL 211
Query: 226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           SDFG        +E      ++GT  + APE +         D++S G++++E++ G+
Sbjct: 212 SDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           I   +   ++LG G F  V     D++ +  +  + +A +AL+  G +G  E   EI  L
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALE--GKEGSME--NEIAVL 70
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAK 193
            +++HP++V L        +  L+ + +  G L +++  + +      S  +   L A K
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 194 GLAFLHGEDKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
              +LH  D  +++RD K  N+L   LD D    +SDFGL+K    G    V++   GT 
Sbjct: 131 ---YLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 182
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           GY APE +     +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG  G V    V          + VAVK +DL   Q  +    E++ +   +H ++V+
Sbjct: 28  IGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 145 LIGYCWEEEYRLLVYEYMPRGSL-----HNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +       +   +V E++  G+L     H ++     AA        + L   + L+ LH
Sbjct: 82  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALSVLH 133
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            +   VI+RD K+ +ILL  D   KLSDFG        +E      ++GT  + APE + 
Sbjct: 134 AQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELIS 189
Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D++S G++++E++ G+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           I   +   ++LG G F  V     D++ +  +  + +A +AL+  G +G  E   EI  L
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALE--GKEGSME--NEIAVL 70
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAK 193
            +++HP++V L        +  L+ + +  G L +++  + +      S  +   L A K
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 194 GLAFLHGEDKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
              +LH  D  +++RD K  N+L   LD D    +SDFGL+K    G    V++   GT 
Sbjct: 131 ---YLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 182
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           GY APE +     +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG  G V    V          + VAVK +DL   Q  +    E++ +   +H ++V+
Sbjct: 32  IGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 145 LIGYCWEEEYRLLVYEYMPRGSL-----HNQLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           +       +   +V E++  G+L     H ++     AA        + L   + L+ LH
Sbjct: 86  MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALSVLH 137
Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM 259
            +   VI+RD K+ +ILL  D   KLSDFG        +E      ++GT  + APE + 
Sbjct: 138 AQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGTPYWMAPELIS 193
Query: 260 TGHLTTMSDVYSFGVVLLELLTGK 283
                   D++S G++++E++ G+
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 17/212 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           I   +   ++LG G F  V     D++ +  +  + +A +AL+  G +G  E   EI  L
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILA-EDKRTQKLVAIKCIAKEALE--GKEGSME--NEIAVL 70
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAK 193
            +++HP++V L        +  L+ + +  G L +++  + +      S  +   L A K
Sbjct: 71  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 130
Query: 194 GLAFLHGEDKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
              +LH  D  +++RD K  N+L   LD D    +SDFGL+K    G    V++   GT 
Sbjct: 131 ---YLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 182
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           GY APE +     +   D +S GV+   LL G
Sbjct: 183 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +     QG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 128
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 183
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 29  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLK 142
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +     QG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 128
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 183
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +     QG      E+  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKV----LQGKAFKNRELQIMRKL 70
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P  +   ++ R YS A   LP        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 183
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +G G +G V K       KP    Q +AVK +   +D  +  +  M   + +     P++
Sbjct: 30  IGRGAYGSVNKMV----HKPS--GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 143 VKLIGYCWEEEYRLLVYEYMPRG--SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           V+  G  + E    +  E M       +  ++      +P     KI L   K L  L  
Sbjct: 84  VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK- 142
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI--TRVMGTQGYAAPEYV 258
           E+  +I+RD K SNILLD     KL DFG++     G+    I  TR  G + Y APE +
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPERI 197
Query: 259 MTGH----LTTMSDVYSFGVVLLELLTGK 283
                       SDV+S G+ L EL TG+
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           F    + G+G FG V  G      K       VA+K +  D    ++E +  +  L  L 
Sbjct: 25  FQVERMAGQGTFGTVQLG------KEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 139 HPHLVKLIGYCW-------EEEYRLLVYEYMPRGSLHNQLFRSYSAAL-PWSTRMKIAL- 189
           HP++V+L  Y +        + Y  +V EY+P  +LH      Y   + P    +K+ L 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLD-SDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
              + +  LH     V +RD K  N+L++ +D T KL DFG AK     E        + 
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYIC 193
Query: 249 TQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           ++ Y APE +    H TT  D++S G +  E++ G+
Sbjct: 194 SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 11/203 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG +G V+K     K +   E   +    LD D        + EI  L +L+H ++V+
Sbjct: 10  IGEGTYGTVFKA----KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      ++   LV+E+  +     + F S +  L             KGL F H  +  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
           V++RD K  N+L++ +   KL+DFGLA+    G      +  + T  Y  P+ +    L 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 265 TMS-DVYSFGVVLLELLTGKRAM 286
           + S D++S G +  EL    R +
Sbjct: 180 STSIDMWSAGCIFAELANAARPL 202

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 23  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 76
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 77  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 137 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 29  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 70
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 128
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 183
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 78
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 136
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 137 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 191
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 192 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 30  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 83
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 84  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 144 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 201
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 23  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 76
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 77  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 136
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 137 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 194
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 195 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 31  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 84
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 85  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 144
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 145 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 202
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 203 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 22  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 75
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 76  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 135
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 136 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 193
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 194 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 29  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 29  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRF 82
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           +++   +GEG +G V   +        +    VA+K +     Q + +  + EI  L + 
Sbjct: 45  YTQLQYIGEGAYGMVSSAY------DHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRF 98
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIALGAAKGLA 196
           RH +++ +           +   Y+ +  +   L++   S  L             +GL 
Sbjct: 99  RHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLK 158
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+L+++    K+ DFGLA+   PE + T  +T  + T+ Y AP
Sbjct: 159 YIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAP 216
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 70
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 128
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 183
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 89
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 147
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 148 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 202
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 203 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 71
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 129
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 130 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 184
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 70
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 128
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 183
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 82
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 140
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 141 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 195
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 82
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 140
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 141 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 195
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 196 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 83
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 141
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 142 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 196
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 197 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/310 (22%), Positives = 126/310 (40%), Gaps = 57/310 (18%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
            S+F    +LG+G FG V K       +  L+++  A+K +     +     ++E++ L 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIR-HTEEKLSTILSEVMLLA 57
Query: 136 QLRHPHLVKLIGYCWEEEYRL--------------LVYEYMPRGSLHNQLFRSYSAALPW 181
            L H ++V+     W E                  +  EY    +L++ L  S +     
Sbjct: 58  SLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQR 115
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE-- 239
               ++     + L+++H +   +I+RD K  NI +D     K+ DFGLAK+     +  
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 240 ----------THVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELL----TGKR 284
                     +  +T  +GT  Y A E +  TGH     D+YS G++  E++    TG  
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 285 AMDNTRLGREQSLA---EWARPLLKEPRKLERLI---DPRLE---------GQFPIKGAQ 329
            ++  +  R  S+    ++    +K  +K+ RL+   DP            G  P+K   
Sbjct: 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293
Query: 330 KAAATAFKCL 339
           +    A K L
Sbjct: 294 EVIKEALKSL 303

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 63  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 120
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 121 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 177
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++    + V GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 200
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +     +  SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 74
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 132
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 133 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 187
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 98
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 156
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 157 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 211
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 212 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 64  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 121
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 122 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 178
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 75
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 133
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 134 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 188
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 62  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 119
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 120 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 176
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 104
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 162
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 163 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 217
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 61  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 118
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 119 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 175
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LGEG +  VYKG      K  L    VA+K + L+  +G     + E+  L  L+H ++V
Sbjct: 10  LGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
            L      E+   LV+EY+ +     Q        +             +GLA+ H +  
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDKDL--KQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK- 120
Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-TGH 262
            V++RD K  N+L++     KL+DFGLA+   +   T      + T  Y  P+ ++ +  
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 263 LTTMSDVYSFGVVLLELLTGK 283
            +T  D++  G +  E+ TG+
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 104
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 162
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 163 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 217
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 68  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 125
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 126 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 182
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 200
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 143 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 108
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 166
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 167 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 221
Query: 248 GTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 222 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 198
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 149
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 207
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 208 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 262
Query: 248 GTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 263 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 106
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +E Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 164
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 165 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 219
Query: 248 GTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 220 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 198
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 144
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++    + V GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 201
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 140
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++    + V GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQY 197
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 198
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQG 251
           +GL ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +T  + T+ 
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           Y APE ++     T S D++S G +L E+L+ +
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 200
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 84  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 141
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 142 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NAFVGTAQY 198
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 200
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 83  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 140
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 141 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 197
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 87  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 144
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 145 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 201
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 86/351 (24%), Positives = 142/351 (40%), Gaps = 57/351 (16%)
Query: 64  LHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG 123
           L    L+ LR     F    L+G G +G VYKG     +K G   Q  A+K +D+ G + 
Sbjct: 11  LDEIDLSALRDPAGIFELVELVGNGTYGQVYKG---RHVKTG---QLAAIKVMDVTGDE- 63
Query: 124 HKEWMAEIIFLGQL-RHPHLVKLIGYCWE------EEYRLLVYEYMPRGSLHNQLFRSYS 176
            +E   EI  L +   H ++    G   +      ++   LV E+   GS+ + +  +  
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 177 AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DG 234
             L       I     +GL+ LH     VI+RD K  N+LL  +   KL DFG++   D 
Sbjct: 124 NTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
Query: 235 PEGEETHVITRVMGTQGYAAPEYVMTGH-----LTTMSDVYSFGVVLLELLTGKRAMDNT 289
             G     I    GT  + APE +             SD++S G+  +E+  G   + + 
Sbjct: 182 TVGRRNTFI----GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
Query: 290 RLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
                       R L   PR       PRL+ +   K ++K  +    CL  +   RP  
Sbjct: 238 HP---------MRALFLIPRNPA----PRLKSK---KWSKKFQSFIESCLVKNHSQRPAT 281
Query: 350 SYVVRVLDSLQDFQDSFVGPFVYVVPNETESSVYLRNGKETNSEEESGEKN 400
             +++              PF+   PNE +  + L++  +  ++++ GEK+
Sbjct: 282 EQLMK-------------HPFIRDQPNERQVRIQLKDHID-RTKKKRGEKD 318

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 200
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 89  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 146
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 147 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 203
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVI 243
           +++   A + L F H     +I+RD K +NIL+ +    K+ DFG+A+     G      
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+GT  Y +PE      +   SDVYS G VL E+LTG+
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 25/216 (11%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           ++  + R   LG G +G V      +K+     A  +  K      T  + + + E+  L
Sbjct: 35  LSEMYQRVKKLGSGAYGEVL--LCRDKVTHVERAIKIIRKTSV--STSSNSKLLEEVAVL 90
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIAL 189
             L HP+++KL  +  ++    LV E    G L +++     F    AA+       I  
Sbjct: 91  KLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-------IIK 143
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRV 246
               G+ +LH  +  +++RD K  N+LL+S   D   K+ DFGL+      E    +   
Sbjct: 144 QVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKER 198
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           +GT  Y APE V+        DV+S GV+L  LL G
Sbjct: 199 LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
           + N+     LG+G F  V +  V +       A+ +  K L     +  ++   E     
Sbjct: 28  SDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICR 83
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAKG 194
           +L+HP++V+L     EE +  LV++ +  G L   +  R + +    S  ++  L   + 
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ES 140
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           +A+ H     +++R+ K  N+LL S       KL+DFGLA +  + E  H      GT G
Sbjct: 141 IAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPG 195
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y +PE +     +   D+++ GV+L  LL G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 80  SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH 139
           S++ +LG G FG V+K    E+   GL+   +A K +   G +  +E   EI  + QL H
Sbjct: 92  SKTEILGGGRFGQVHKC---EETATGLK---LAAKIIKTRGMKDKEEVKNEISVMNQLDH 145
Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYS-AALPWSTRMKIALGAAKGLAF 197
            +L++L      +   +LV EY+  G L +++   SY+   L     MK      +G+  
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRH 202
Query: 198 LHGEDKPVIYRDFKASNIL-LDSDYTA-KLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           +H     +++ D K  NIL ++ D    K+ DFGLA+     E+  V     GT  + AP
Sbjct: 203 MH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAP 257
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTG 282
           E V    ++  +D++S GV+   LL+G
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +L HP  VKL     ++E       Y   G L   + R   +     TR   A     
Sbjct: 86  MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIVS 143
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVMGTQGY 252
            L +LHG  K +I+RD K  NILL+ D   +++DFG AK   PE ++       +GT  Y
Sbjct: 144 ALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQY 200
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 31/217 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           ++   ++G G FG V++     KL   +E+  VA+K +  D    ++E     I    ++
Sbjct: 42  YTNCKVIGNGSFGVVFQA----KL---VESDEVAIKKVLQDKRFKNRELQIMRI----VK 90
Query: 139 HPHLVKLIGYCW------EEEYRLLVYEYMP----RGSLHNQLFRSYSAALPWSTRMKIA 188
           HP++V L  + +      +E +  LV EY+P    R S H    +     L     M   
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGEETHVITRVM 247
           L   + LA++H     + +RD K  N+LLD      KL DFG AK    GE        +
Sbjct: 151 L---RSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSXI 202
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +    + TT  D++S G V+ EL+ G+
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 29  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 83  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +   + T+ Y AP
Sbjct: 143 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 200
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 98/209 (46%), Gaps = 12/209 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIFLGQL 137
           ++  + +GEG +G V   +        L    VA+K +     Q + +  + EI  L + 
Sbjct: 30  YTNLSYIGEGAYGMVCSAY------DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 83
Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL-GAAKGLA 196
           RH +++ +           +   Y+ +  +   L++        +  +   L    +GL 
Sbjct: 84  RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLK 143
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG-PEGEETHVITRVMGTQGYAAP 255
           ++H  +  V++RD K SN+LL++    K+ DFGLA+   P+ + T  +   + T+ Y AP
Sbjct: 144 YIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAP 201
Query: 256 EYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
           E ++     T S D++S G +L E+L+ +
Sbjct: 202 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
           + N+     LG+G F  V +  V +       A+ +  K L     +  ++   E     
Sbjct: 5   SDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICR 60
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAKG 194
           +L+HP++V+L     EE +  LV++ +  G L   +  R + +    S  ++  L   + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ES 117
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           +A+ H     +++R+ K  N+LL S       KL+DFGLA +  + E  H      GT G
Sbjct: 118 IAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPG 172
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y +PE +     +   D+++ GV+L  LL G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
           + N+     LG+G F  V +  V +       A+ +  K L     +  ++   E     
Sbjct: 4   SDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICR 59
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAKG 194
           +L+HP++V+L     EE +  LV++ +  G L   +  R + +    S  ++  L   + 
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---ES 116
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           +A+ H     +++R+ K  N+LL S       KL+DFGLA +  + E  H      GT G
Sbjct: 117 IAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTPG 171
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y +PE +     +   D+++ GV+L  LL G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEIIFLGQLRHPHL 142
           +G G +G V    +D++       + VA+K L          K    E++ L  ++H ++
Sbjct: 32  VGSGAYGSVCSA-IDKR-----SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW-STRMKIALGAA--------- 192
           + L+              + P  SL N  F  +   +P+  T ++  +G           
Sbjct: 86  IGLLDV------------FTPASSLRN--FYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL 131
Query: 193 -----KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
                KGL ++H     V++RD K  N+ ++ D   K+ DFGLA+        +V+TR  
Sbjct: 132 VYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-- 187
Query: 248 GTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
               Y APE +++  H     D++S G ++ E+LTGK
Sbjct: 188 ---WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 11/203 (5%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +GEG +G V+K     K +   E   +    LD D        + EI  L +L+H ++V+
Sbjct: 10  IGEGTYGTVFKA----KNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L      ++   LV+E+  +     + F S +  L             KGL F H  +  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDL--KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT 264
           V++RD K  N+L++ +   KL++FGLA+    G      +  + T  Y  P+ +    L 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 265 TMS-DVYSFGVVLLELLTGKRAM 286
           + S D++S G +  EL    R +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPL 202

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 16/212 (7%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
            + N+     LG+G F  V +  V +       A+ +  K L     +  ++   E    
Sbjct: 4   FSDNYDVKEELGKGAFS-VVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARIC 59
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAK 193
            +L+HP++V+L     EE +  LV++ +  G L   +  R + +    S  ++  L   +
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL---E 116
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            +A+ H     +++R+ K  N+LL S       KL+DFGLA +  + E  H      GT 
Sbjct: 117 SIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---GTP 171
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           GY +PE +     +   D+++ GV+L  LL G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQP-VAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +LG+G +G VY G         L  Q  +A+K +    ++  +    EI     L+H ++
Sbjct: 29  VLGKGTYGIVYAG-------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK---GLAFLH 199
           V+ +G   E  +  +  E +P GSL + L RS    L       I     +   GL +LH
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLK-DNEQTIGFYTKQILEGLKYLH 139
Query: 200 GEDKPVIYRDFKASNILLDSDYTA--KLSDFG----LAKDGPEGEETHVITRVMGTQGYA 253
             D  +++RD K  N+L+++ Y+   K+SDFG    LA   P  E         GT  Y 
Sbjct: 140 --DNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTE------TFTGTLQYM 190
Query: 254 APEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
           APE +  G       +D++S G  ++E+ TGK
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVI 243
           +++   A + L F H     +I+RD K +NI++ +    K+ DFG+A+     G      
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+GT  Y +PE      +   SDVYS G VL E+LTG+
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVI 243
           +++   A + L F H     +I+RD K +NI++ +    K+ DFG+A+     G      
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+GT  Y +PE      +   SDVYS G VL E+LTG+
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVI 243
           +++   A + L F H     +I+RD K +NI++ +    K+ DFG+A+     G      
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+GT  Y +PE      +   SDVYS G VL E+LTG+
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVI 243
           +++   A + L F H     +I+RD K +NI++ +    K+ DFG+A+     G      
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+GT  Y +PE      +   SDVYS G VL E+LTG+
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEIIFLGQLRHPHL 142
           +G G +G V    +D++       + VA+K L          K    E++ L  ++H ++
Sbjct: 50  VGSGAYGSVCSA-IDKR-----SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 103
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW-STRMKIALGAA--------- 192
           + L+              + P  SL N  F  +   +P+  T ++  +G           
Sbjct: 104 IGLLDV------------FTPASSLRN--FYDFYLVMPFMQTDLQKIMGMEFSEEKIQYL 149
Query: 193 -----KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
                KGL ++H     V++RD K  N+ ++ D   K+ DFGLA+        +V+TR  
Sbjct: 150 VYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-- 205
Query: 248 GTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
               Y APE +++  H     D++S G ++ E+LTGK
Sbjct: 206 ---WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 89/209 (42%), Gaps = 26/209 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G F  VYKG   E     +E     ++   L  ++  + +  E   L  L+HP++V+
Sbjct: 34  IGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQR-FKEEAEXLKGLQHPNIVR 89
Query: 145 LIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALP----WSTRMKIALGAAKGL 195
                WE   +     +LV E    G+L   L R     +     W  ++       KGL
Sbjct: 90  FYD-SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGL 142
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
            FLH    P+I+RD K  NI +     + K+ D GLA      +       V+GT  + A
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFXA 198
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           PE     +  ++ DVY+FG   LE  T +
Sbjct: 199 PEXYEEKYDESV-DVYAFGXCXLEXATSE 226

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 28/217 (12%)
Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +++ + ++G G FG VY+  + +        + VA+K +  D    ++E       + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKRFKNRELQ----IMRKL 70
Query: 138 RHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAA---LPWSTRMKIA 188
            H ++V+L  + +      +  Y  LV +Y+P      ++ R YS A   LP        
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLYM 128
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEETHVITRVM 247
               + LA++H     + +RD K  N+LLD D    KL DFG AK    GE        +
Sbjct: 129 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXI 183
Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            ++ Y APE +      T+  DV+S G VL ELL G+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           HP++++L        +  LV++ M +G L + L  +    L      KI     + +  L
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICAL 127
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
           H  +  +++RD K  NILLD D   KL+DFG +     GE+   +  V GT  Y APE +
Sbjct: 128 HKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEII 182
Query: 259 MTGHLTTMS------DVYSFGVVLLELLTG 282
                          D++S GV++  LL G
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 3/100 (3%)
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVI 243
           +++   A + L F H     +I+RD K +NI++ +    K+ DFG+A+     G      
Sbjct: 136 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             V+GT  Y +PE      +   SDVYS G VL E+LTG+
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           HP++++L        +  LV++ M +G L + L  +    L      KI     + +  L
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICAL 140
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
           H  +  +++RD K  NILLD D   KL+DFG +     GE+   +  V GT  Y APE +
Sbjct: 141 HKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEII 195
Query: 259 MTGHLTTMS------DVYSFGVVLLELLTG 282
                          D++S GV++  LL G
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +      +T  + T+ Y
Sbjct: 165 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 217
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WY 195
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V++      +K        AVK + L+  +     + E++    L  P +V 
Sbjct: 80  LGRGSFGEVHR------MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 128
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G   E  +  +  E +  GSL  QL +     LP    +     A +GL +LH   + 
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSL-GQLIKQM-GCLPEDRALYYLGQALEGLEYLH--TRR 184
Query: 205 VIYRDFKASNILLDSDYT-AKLSDFGLAKD-GPEGEETHVIT--RVMGTQGYAAPEYVMT 260
           +++ D KA N+LL SD + A L DFG A    P+G    ++T   + GT+ + APE VM 
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 261 GHLTTMSDVYSFGVVLLELLTG 282
                  D++S   ++L +L G
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 90/217 (41%), Gaps = 16/217 (7%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-----KEWM 128
           L    +    ++G+G F  V +    E        Q  AVK +D+           ++  
Sbjct: 21  LFEDVYELCEVIGKGAFSVVRRCINRET------GQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
            E      L+HPH+V+L+     +    +V+E+M    L  ++ +   A   +S  +   
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA---KLSDFGLAKDGPEGEETHVITR 245
                  A  +  D  +I+RD K  N+LL S   +   KL DFG+A     GE   V   
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGG 192
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +GT  + APE V         DV+  GV+L  LL+G
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +      +T  + T+ Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 194
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           HP++++L        +  LV++ M +G L + L  +    L      KI     + +  L
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICAL 140
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
           H  +  +++RD K  NILLD D   KL+DFG +     GE+   +  V GT  Y APE +
Sbjct: 141 HKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LRSVCGTPSYLAPEII 195
Query: 259 MTGHLTTMS------DVYSFGVVLLELLTG 282
                          D++S GV++  LL G
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 143 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 195
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 135 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 187
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 107/270 (39%), Gaps = 33/270 (12%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G  G V+K      ++       +AVK +   G   +  +  M   + L     P++
Sbjct: 33  MGSGTCGQVWK------MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V+  G         +  E M  G+   +L +     +P     K+ +   K L +L  E 
Sbjct: 87  VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK-EK 143
Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
             VI+RD K SNILLD     KL DFG++    + +      R  G   Y APE +    
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD---RSAGCAAYMAPERIDPPD 200
Query: 263 LT-----TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP 317
            T       +DV+S G+ L+EL TG+    N +   E       + L +EP        P
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV----LTKVLQEEP--------P 248
Query: 318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRP 347
            L G     G  ++      CL+   R RP
Sbjct: 249 LLPGHMGFSGDFQSFVK--DCLTKDHRKRP 276

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHL 142
           LG+G F  V       +    L  Q  A K ++      + H++   E      L+HP++
Sbjct: 30  LGKGAFSVV------RRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           V+L     EE +  L+++ +  G L   +  R Y +    S  ++  L A      LH  
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LHCH 138
Query: 202 DKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
              V++RD K  N+LL S       KL+DFGLA +  EGE+        GT GY +PE +
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFG-FAGTPGYLSPEVL 196
Query: 259 MTGHLTTMSDVYSFGVVLLELLTG 282
                    D+++ GV+L  LL G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +      +T  + T+ Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 194
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 146 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 141 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 147 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 53/92 (57%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +      +T  + T+ Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 148 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WY 211
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 155 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQP-VAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +LG+G +G VY G         L  Q  +A+K +    ++  +    EI     L+H ++
Sbjct: 15  VLGKGTYGIVYAG-------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK---GLAFLH 199
           V+ +G   E  +  +  E +P GSL + L RS    L       I     +   GL +LH
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLK-DNEQTIGFYTKQILEGLKYLH 125
Query: 200 GEDKPVIYRDFKASNILLDSDYTA--KLSDFG----LAKDGPEGEETHVITRVMGTQGYA 253
             D  +++RD K  N+L+++ Y+   K+SDFG    LA   P  E         GT  Y 
Sbjct: 126 --DNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTE------TFTGTLQYM 176
Query: 254 APEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
           APE +  G       +D++S G  ++E+ TGK
Sbjct: 177 APEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 159 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 211
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 138 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 117/289 (40%), Gaps = 48/289 (16%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHL 142
           L E   G ++KG          +   + VK L +    T+  +++  E   L    HP++
Sbjct: 18  LNENHSGELWKG--------RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 143 VKLIGYCWEEE--YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           + ++G C      +  L+  + P GSL+N L    +  +  S  +K AL  A+G AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT 129
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLS--DFGLAKDGPEGEETHVITRVMGTQGYAAPEYV 258
            +  +      + ++ +D D TA++S  D   +   P G              + APE +
Sbjct: 130 LEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSP-GRXY--------APAWVAPEAL 180
Query: 259 MTGHLTT---MSDVYSFGVVLLELLTGKRA---MDNTRLGREQSLAEWARPLLKEPRKLE 312
                 T    +D +SF V+L EL+T +     + N  +G + +L E  RP +       
Sbjct: 181 QKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVAL-EGLRPTIPP----- 234
Query: 313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
             I P +     I            C +  P  RP    +V +L+  QD
Sbjct: 235 -GISPHVSKLXKI------------CXNEDPAKRPKFDXIVPILEKXQD 270

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 134 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 186
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 142 RGLKYIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR      Y
Sbjct: 133 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G F  V +     K+  G E   + +    L   + H++   E      L+HP++V+
Sbjct: 19  LGKGAFSVVRRCV---KVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVR 74
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           L     EE +  L+++ +  G L   +  R Y +    S  ++  L A      LH    
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----LHCHQM 129
Query: 204 PVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
            V++R+ K  N+LL S       KL+DFGLA +  EGE+        GT GY +PE +  
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFG-FAGTPGYLSPEVLRK 187
Query: 261 GHLTTMSDVYSFGVVLLELLTG 282
                  D+++ GV+L  LL G
Sbjct: 188 DPYGKPVDLWACGVILYILLVG 209

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V++    E  + G +    AVK + L+  +       E++    L  P +V 
Sbjct: 101 LGRGSFGEVHR---MEDKQTGFQC---AVKKVRLEVFRAE-----ELMACAGLTSPRIVP 149
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G   E  +  +  E +  GSL  QL +     LP    +     A +GL +LH   + 
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSL-GQLVKE-QGCLPEDRALYYLGQALEGLEYLH--SRR 205
Query: 205 VIYRDFKASNILLDSDYT-AKLSDFGLAKD-GPEGEETHVIT--RVMGTQGYAAPEYVMT 260
           +++ D KA N+LL SD + A L DFG A    P+G    ++T   + GT+ + APE V+ 
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 261 GHLTTMSDVYSFGVVLLELLTG 282
                  DV+S   ++L +L G
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   +G G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTIGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EYMP G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     K++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   +G G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTIGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EYMP G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     K++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V++    E  + G +    AVK + L+  +       E++    L  P +V 
Sbjct: 82  LGRGSFGEVHR---MEDKQTGFQC---AVKKVRLEVFRAE-----ELMACAGLTSPRIVP 130
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G   E  +  +  E +  GSL  QL +     LP    +     A +GL +LH   + 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSL-GQLVKE-QGCLPEDRALYYLGQALEGLEYLH--SRR 186
Query: 205 VIYRDFKASNILLDSDYT-AKLSDFGLAKD-GPEGEETHVIT--RVMGTQGYAAPEYVMT 260
           +++ D KA N+LL SD + A L DFG A    P+G    ++T   + GT+ + APE V+ 
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 261 GHLTTMSDVYSFGVVLLELLTG 282
                  DV+S   ++L +L G
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V++      +K        AVK + L+  +     + E++    L  P +V 
Sbjct: 66  VGRGSFGEVHR------MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G   E  +  +  E +  GSL  QL +     LP    +     A +GL +LH   + 
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSL-GQLIKQM-GCLPEDRALYYLGQALEGLEYLH--TRR 170
Query: 205 VIYRDFKASNILLDSDYT-AKLSDFGLAKD-GPEGEETHVIT--RVMGTQGYAAPEYVMT 260
           +++ D KA N+LL SD + A L DFG A    P+G    ++T   + GT+ + APE VM 
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 261 GHLTTMSDVYSFGVVLLELLTG 282
                  D++S   ++L +L G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEIIFLGQLRHPHL 142
           +G G +G V   F     K GL    VAVK L          K    E+  L  ++H ++
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 143 VKLI-----GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           + L+         EE   + +  ++    L+N +    S  L       +     +GL +
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KSQKLTDDHVQFLIYQILRGLKY 140
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
           +H  D  +I+RD K SN+ ++ D   K+ DFGL +   +    +V TR      Y APE 
Sbjct: 141 IHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPEI 193
Query: 258 VMTG-HLTTMSDVYSFGVVLLELLTGK 283
           ++   H     D++S G ++ ELLTG+
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 24/210 (11%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLG 135
           F R   LG G FG V    + + ++ G      A+K LD       KE    + E   L 
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKEIEHTLNEKRILQ 96
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
            +  P LVKL     +     +V EY P G + + L R    + P +     A       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGY 252
            +LH  D  +IYRD K  N+++D     K++DFGLAK         V  R   + GT  Y
Sbjct: 155 EYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTWXLCGTPEY 204
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            APE +++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V++      +K        AVK + L+  +     + E++    L  P +V 
Sbjct: 82  VGRGSFGEVHR------MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 130
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L G   E  +  +  E +  GSL  QL +     LP    +     A +GL +LH   + 
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSL-GQLIKQM-GCLPEDRALYYLGQALEGLEYLH--TRR 186
Query: 205 VIYRDFKASNILLDSDYT-AKLSDFGLAKD-GPEGEETHVIT--RVMGTQGYAAPEYVMT 260
           +++ D KA N+LL SD + A L DFG A    P+G    ++T   + GT+ + APE VM 
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 261 GHLTTMSDVYSFGVVLLELLTG 282
                  D++S   ++L +L G
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR      Y
Sbjct: 132 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 184
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DFGLA+   +     V TR      Y
Sbjct: 156 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WY 208
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 39/225 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH---KEWMAEIIFLGQLR-HP 140
           LG+G +G V+K  +D +       + VAVK +  D  Q     +    EI+ L +L  H 
Sbjct: 17  LGKGAYGIVWKS-IDRR-----TGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 141 HLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           ++V L+     +  R   LV++YM    LH  +    +  L    +  +     K + +L
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVI---RANILEPVHKQYVVYQLIKVIKYL 125
Query: 199 HGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK-----------------DGPEG--EE 239
           H     +++RD K SNILL+++   K++DFGL++                 +  E   ++
Sbjct: 126 HS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 240 THVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
             ++T  + T+ Y APE ++ +   T   D++S G +L E+L GK
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEIIFLGQLRHPHL 142
           +G G +G V   + D +L+     Q VAVK L          +    E+  L  L+H ++
Sbjct: 36  VGSGAYGSVCSAY-DARLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 89
Query: 143 VKLIGYC--------WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           + L+           + E Y  LV   M  G+  N + +S   AL       +     +G
Sbjct: 90  IGLLDVFTPATSIEDFSEVY--LVTTLM--GADLNNIVKS--QALSDEHVQFLVYQLLRG 143
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L ++H     +I+RD K SN+ ++ D   ++ DFGLA+   E    +V TR      Y A
Sbjct: 144 LKYIHSAG--IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRA 196
Query: 255 PEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
           PE ++   H     D++S G ++ ELL GK
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ D+GLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
                P LVKL  Y +++   L +V EY+P G + + L R    + P +     A     
Sbjct: 101 -----PFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQIVL 152
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQ 250
              +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 19/225 (8%)
Query: 64  LHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLE--AQPVAVKALDLDGT 121
           L+   +A     T ++     LG+G F  V +     K  P  E  A+ +  K L     
Sbjct: 18  LYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCV---KKTPTQEYAAKIINTKKL---SA 71
Query: 122 QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALP 180
           + H++   E      L+HP++V+L     EE +  LV++ +  G L   +  R Y +   
Sbjct: 72  RDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD 131
Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEG 237
            S  +   L   + +  +H  D  +++RD K  N+LL S       KL+DFGLA +  +G
Sbjct: 132 ASHCIHQIL---ESVNHIHQHD--IVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQG 185
Query: 238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           E+        GT GY +PE +         D+++ GV+L  LL G
Sbjct: 186 EQQAWFG-FAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 95/232 (40%), Gaps = 38/232 (16%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
            S+F    +LG+G FG V K       +  L+++  A+K +     +     ++E+  L 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIR-HTEEKLSTILSEVXLLA 57
Query: 136 QLRHPHLVKLIGYCWEEEYRL--------------LVYEYMPRGSLHNQLFRSYSAALPW 181
            L H ++V+     W E                  +  EY    +L++ L  S +     
Sbjct: 58  SLNHQYVVRYYA-AWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQR 115
Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE-- 239
               ++     + L+++H +   +I+R+ K  NI +D     K+ DFGLAK+     +  
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 240 ----------THVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELL 280
                     +  +T  +GT  Y A E +  TGH     D YS G++  E +
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
                P LVKL  Y +++   L +V EY+P G + + L R    + P +     A     
Sbjct: 101 -----PFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQIVL 152
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQ 250
              +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 68/169 (40%), Gaps = 17/169 (10%)
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +           
Sbjct: 207 VAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
            + APE +     T  SDV+SFGV+L E+                SL     P +K   +
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKIDEE 309
Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
             R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 310 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 28/212 (13%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
                P LVKL  Y +++   L +V EY+P G + + L R    + P +     A     
Sbjct: 101 -----PFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQIVL 152
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQ 250
              +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT 
Sbjct: 153 TFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTP 202
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            Y APE +++       D ++ GV++ E+  G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 68/169 (40%), Gaps = 17/169 (10%)
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +           
Sbjct: 209 VAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
            + APE +     T  SDV+SFGV+L E+                SL     P +K   +
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKIDEE 311
Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
             R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 312 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 68/169 (40%), Gaps = 17/169 (10%)
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +           
Sbjct: 202 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
            + APE +     T  SDV+SFGV+L E+                SL     P +K   +
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKIDEE 304
Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
             R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 305 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H     +I+RD K SN+ ++ D   ++ DFGLA+   E    +V TR      Y
Sbjct: 134 RGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WY 186
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELL GK
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 68/169 (40%), Gaps = 17/169 (10%)
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +           
Sbjct: 200 VAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
            + APE +     T  SDV+SFGV+L E+                SL     P +K   +
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKIDEE 302
Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
             R +      + P     +   T   C    P  RPT S +V  L +L
Sbjct: 303 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 52/106 (49%), Gaps = 12/106 (11%)
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT 244
           + I +  A+ + FLH   K +++RD K SNI    D   K+ DFGL     + EE   + 
Sbjct: 167 LHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 245 RVM----------GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELL 280
             M          GT+ Y +PE +   + +   D++S G++L ELL
Sbjct: 225 TPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 101/238 (42%), Gaps = 43/238 (18%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH---- 124
           +AEL  + S ++    +  G +G V  G VD       E  PVA+K +    + G     
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAG-VDS------EGIPVAIKRVFNTVSDGRTVNI 66
Query: 125 -------KEWMAEIIFLGQLRHPHLVKL--IGYCWEEEYRLLVYEYMPRGSLHNQLFRSY 175
                  K  + EI  L    HP+++ L  I   +EE         M +  L  +L R+ 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA-------MHKLYLVTELMRTD 119
Query: 176 SAALPWSTRMKIALGAAK--------GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
            A +    R+ I+    +        GL  LH  +  V++RD    NILL  +    + D
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICD 177
Query: 228 FGLAK-DGPEGEETHVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLTGK 283
           F LA+ D  +  +TH +T     + Y APE VM     T + D++S G V+ E+   K
Sbjct: 178 FNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 99
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R    + P +     A   
Sbjct: 100 NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQI 151
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
                +LH  D  +IYRD K  N+L+D     +++DFG AK       T     + GT  
Sbjct: 152 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPE 204
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 26/213 (12%)
Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMA 129
             F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  + 
Sbjct: 27  DQFERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQ 82
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
            + F      P LVKL     +     +V EY+P G + + L R    + P +     A 
Sbjct: 83  AVNF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AA 134
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                  +LH  D  +IYRD K  N+L+D     +++DFG AK       T     + GT
Sbjct: 135 QIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGT 187
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             Y APE +++       D ++ GV++ E+  G
Sbjct: 188 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 101/238 (42%), Gaps = 43/238 (18%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH---- 124
           +AEL  + S ++    +  G +G V  G VD       E  PVA+K +    + G     
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAG-VDS------EGIPVAIKRVFNTVSDGRTVNI 66
Query: 125 -------KEWMAEIIFLGQLRHPHLVKL--IGYCWEEEYRLLVYEYMPRGSLHNQLFRSY 175
                  K  + EI  L    HP+++ L  I   +EE         M +  L  +L R+ 
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA-------MHKLYLVTELMRTD 119
Query: 176 SAALPWSTRMKIALGAAK--------GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
            A +    R+ I+    +        GL  LH  +  V++RD    NILL  +    + D
Sbjct: 120 LAQVIHDQRIVISPQHIQYFMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICD 177
Query: 228 FGLAK-DGPEGEETHVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLTGK 283
           F LA+ D  +  +TH +T     + Y APE VM     T + D++S G V+ E+   K
Sbjct: 178 FNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 11/208 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           F    +LG GGFG V+   +    K     +    +     G QG    M E   L ++ 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV- 242
Query: 139 HPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--AKGL 195
           H   +  + Y +E +  L LV   M  G +   ++        +     I   A    GL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
             LH   + +IYRD K  N+LLD D   ++SD GLA +   G+         GT G+ AP
Sbjct: 303 EHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           E ++        D ++ GV L E++  +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H     +I+RD K SN+ ++ D   ++ DFGLA+   E    +V TR      Y
Sbjct: 142 RGLKYIHSAG--IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WY 194
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELL GK
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 11/208 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           F    +LG GGFG V+   +    K     +    +     G QG    M E   L ++ 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV- 242
Query: 139 HPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--AKGL 195
           H   +  + Y +E +  L LV   M  G +   ++        +     I   A    GL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
             LH   + +IYRD K  N+LLD D   ++SD GLA +   G+         GT G+ AP
Sbjct: 303 EHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           E ++        D ++ GV L E++  +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 11/208 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           F    +LG GGFG V+   +    K     +    +     G QG    M E   L ++ 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV- 242
Query: 139 HPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--AKGL 195
           H   +  + Y +E +  L LV   M  G +   ++        +     I   A    GL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
             LH   + +IYRD K  N+LLD D   ++SD GLA +   G+         GT G+ AP
Sbjct: 303 EHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           E ++        D ++ GV L E++  +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 11/208 (5%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           F    +LG GGFG V+   +    K     +    +     G QG    M E   L ++ 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKV- 242
Query: 139 HPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA--AKGL 195
           H   +  + Y +E +  L LV   M  G +   ++        +     I   A    GL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
             LH   + +IYRD K  N+LLD D   ++SD GLA +   G+         GT G+ AP
Sbjct: 303 EHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAP 358
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           E ++        D ++ GV L E++  +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 101
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+P G + + L R    + P +     A      
Sbjct: 102 -----PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 204
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 93
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+P G + + L R    + P +     A      
Sbjct: 94  -----PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 146
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 147 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 196
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 101
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+P G + + L R    + P +     A      
Sbjct: 102 -----PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 204
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 44/240 (18%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEII 132
           I   +   +L+G G +G V + +        LE + VA+K +    +     K  + EI 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAY------DKLEKRVVAIKKILRVFEDLIDCKRILREIA 104
Query: 133 FLGQLRHPHLVKLIGYCWE---EEYRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKI 187
            L +L H H+VK++        E++  L        S   +LFR+  Y   L   T +  
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETHV--- 242
            L    G+ ++H     +++RD K +N L++ D + K+ DFGLA+  D PE   + +   
Sbjct: 165 LLV---GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 243 --------------------ITRVMGTQGYAAPEYV-MTGHLTTMSDVYSFGVVLLELLT 281
                               +T  + T+ Y APE + +  + T   DV+S G +  ELL 
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 101
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+P G + + L R    + P +     A      
Sbjct: 102 -----PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 204
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 24/210 (11%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLG 135
           F R   LG G FG V    + + ++ G      A+K LD       KE    + E   L 
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETG---NHYAMKILDKQKVVKLKEIEHTLNEKRILQ 96
Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
            +  P LVKL     +     +V EY P G + + L R    + P +     A       
Sbjct: 97  AVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--AAQIVLTF 154
Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGY 252
            +LH  D  +IYRD K  N+++D     +++DFGLAK         V  R   + GT  Y
Sbjct: 155 EYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCGTPEY 204
Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            APE +++       D ++ GV++ E+  G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   +G G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTIGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     K++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 101
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY P G + + L R    + P +     A      
Sbjct: 102 -----PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+++D     K++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPE 204
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 121
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+P G + + L R    + P +     A      
Sbjct: 122 -----PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 174
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 175 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 224
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 101/245 (41%), Gaps = 32/245 (13%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           +  N+   +L+G G +G VY  + D+     +  + V     DL      K  + EI  L
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAY-DKNANKNVAIKKVNRMFEDLIDC---KRILREITIL 81
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--MKIALGAA 192
            +L+  ++++L      E+       Y+      + L + +   +  + +    I     
Sbjct: 82  NRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLL 141
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI--------- 243
            G  F+H  +  +I+RD K +N LL+ D + K+ DFGLA+     ++ H++         
Sbjct: 142 LGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEEN 199
Query: 244 --------------TRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGKRAMDN 288
                         T  + T+ Y APE ++     T S D++S G +  ELL   ++  N
Sbjct: 200 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHIN 259
Query: 289 TRLGR 293
               R
Sbjct: 260 NPTNR 264

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIF 133
           I   F     LG G F  V     +EK    L     AVK +     +G +  +  EI  
Sbjct: 20  IKKIFEFKETLGTGAFSEVV--LAEEKATGKL----FAVKCIPKKALKGKESSIENEIAV 73
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAA 192
           L +++H ++V L        +  LV + +  G L +++  + +      ST ++  L A 
Sbjct: 74  LRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA- 132
Query: 193 KGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
             + +LH     +++RD K  N+L    D +    +SDFGL+K   +G+   V++   GT
Sbjct: 133 --VYYLH--RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTACGT 185
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            GY APE +     +   D +S GV+   LL G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 99
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R    + P +     A   
Sbjct: 100 NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQI 151
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + G
Sbjct: 152 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 201
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 93
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+P G + + L R      P +     A      
Sbjct: 94  -----PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY--AAQIVLT 146
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 147 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 196
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 197 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K     + F 
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKV-VKLKQIEHTLNEKRIQQAVNF- 101
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY P G + + L R    + P +     A      
Sbjct: 102 -----PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     K++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPE 204
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY P G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+++D     K++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLE--AQPVAVKALDLDGTQGHKEWMAEII 132
           +T  +     +G+G F  V +     KL  G E  A+ +  K L     + H++   E  
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCV---KLCTGHEYAAKIINTKKL---SARDHQKLEREAR 55
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGA 191
               L+H ++V+L     EE +  LV++ +  G L   +  R Y +    S  ++  L A
Sbjct: 56  ICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 115
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMG 248
                 LH     V++RD K  N+LL S       KL+DFGLA +  +G++        G
Sbjct: 116 V-----LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGDQQAWFG-FAG 168
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T GY +PE +         D+++ GV+L  LL G
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+  FGLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH-----NQLFRSYSAALPWSTR 184
           EI  L +L HP ++K+  +   E+Y  +V E M  G L      N+  +  +  L +  +
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 121
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETH 241
           M +A+       +LH  +  +I+RD K  N+LL S   D   K++DFG +K      ET 
Sbjct: 122 MLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETS 170
Query: 242 VITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTG 282
           ++  + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 171 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 36/236 (15%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEII 132
           R +  + +    +G+G +G V++G          + + VAVK      ++  K W  E  
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETE 52
Query: 133 FLG--QLRHPHLVKLIGYCWEEEYR----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
                 LRH +++  I       +      L+  Y   GSL++ L       L   + ++
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLR 109
Query: 187 IALGAAKGLAFLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
           I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA    +    
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 241 HVITR--VMGTQGYAAPEYV-MTGHLTTMS-----DVYSFGVVLLELLTGKRAMDN 288
             +     +GT+ Y APE +  T  +         D+++FG+VL E+   +R + N
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSN 223

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH-----NQLFRSYSAALPWSTR 184
           EI  L +L HP ++K+  +   E+Y  +V E M  G L      N+  +  +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETH 241
           M +A+       +LH  +  +I+RD K  N+LL S   D   K++DFG +K      ET 
Sbjct: 123 MLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETS 171
Query: 242 VITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTG 282
           ++  + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ DF LA+   +      +T  + T+ Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH-----NQLFRSYSAALPWSTR 184
           EI  L +L HP ++K+  +   E+Y  +V E M  G L      N+  +  +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETH 241
           M +A+       +LH  +  +I+RD K  N+LL S   D   K++DFG +K      ET 
Sbjct: 123 MLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETS 171
Query: 242 VITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTG 282
           ++  + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH-----NQLFRSYSAALPWSTR 184
           EI  L +L HP ++K+  +   E+Y  +V E M  G L      N+  +  +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETH 241
           M +A+       +LH  +  +I+RD K  N+LL S   D   K++DFG +K      ET 
Sbjct: 123 MLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETS 171
Query: 242 VITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTG 282
           ++  + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 172 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ D GLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 80/164 (48%), Gaps = 24/164 (14%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH-----NQLFRSYSAALPWSTR 184
           EI  L +L HP ++K+  +   E+Y  +V E M  G L      N+  +  +  L +  +
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 128
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETH 241
           M +A+       +LH  +  +I+RD K  N+LL S   D   K++DFG +K      ET 
Sbjct: 129 MLLAV------QYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETS 177
Query: 242 VITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTG 282
           ++  + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 178 LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLE--AQPVAVKALDLDGTQGHKEWMAEII 132
           +T  +     LG+G F  V +     K+  G E  A+ +  K L     + H++   E  
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCM---KIPTGQEYAAKIINTKKL---SARDHQKLEREAR 55
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGA 191
               L+HP++V+L     EE +  LV++ +  G L   +  R Y +    S  ++  L +
Sbjct: 56  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILES 115
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMG 248
                  H     +++RD K  N+LL S       KL+DFGLA +  +G++        G
Sbjct: 116 VN-----HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQQAWFG-FAG 168
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T GY +PE +         D+++ GV+L  LL G
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R      P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R      P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 99
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+P G + + L R      P +     A   
Sbjct: 100 NF------PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFY--AAQI 151
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + G
Sbjct: 152 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 201
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ D GLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 90/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY P G + + L R      P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+++D     K++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
            EI  L +L HP ++K+  +   E+Y  +V E M  G L +++  +    L  +T     
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN--KRLKEATCKLYF 245
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITR 245
                 + +LH  +  +I+RD K  N+LL S   D   K++DFG +K      ET ++  
Sbjct: 246 YQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRT 300
Query: 246 VMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTG 282
           + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQ 250
           +GL ++H     VI+RD K SN+L++ +   K+ DFG+A+       E  + +T  + T+
Sbjct: 170 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 251 GYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGKR 284
            Y APE +++ H  T + D++S G +  E+L  ++
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLE--AQPVAVKALDLDGTQGHKEWMAEII 132
           +T  +     LG+G F  V +     K+  G E  A+ +  K L     + H++   E  
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCM---KIPTGQEYAAKIINTKKL---SARDHQKLEREAR 55
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGA 191
               L+HP++V+L     EE +  LV++ +  G L   +  R Y +    S  ++  L +
Sbjct: 56  ICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILES 115
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDFGLAKDGPEGEETHVITRVMG 248
                  H     +++RD K  N+LL S       KL+DFGLA +  +G++        G
Sbjct: 116 VN-----HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQQAWFG-FAG 168
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T GY +PE +         D+++ GV+L  LL G
Sbjct: 169 TPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
            EI  L +L HP ++K+  +   E+Y  +V E M  G L +++  +    L  +T     
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN--KRLKEATCKLYF 259
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITR 245
                 + +LH  +  +I+RD K  N+LL S   D   K++DFG +K      ET ++  
Sbjct: 260 YQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRT 314
Query: 246 VMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTG 282
           + GT  Y APE ++   T       D +S GV+L   L+G
Sbjct: 315 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GL ++H  D  +I+RD K SN+ ++ D   K+ D GLA+   +    +V TR      Y
Sbjct: 136 RGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WY 188
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++   H     D++S G ++ ELLTG+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 20/208 (9%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 121
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 122 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 174
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
             +LH  D  +IYRD K  N+L+D     +++DFG AK       T     + GT  Y A
Sbjct: 175 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLA 227
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           PE +++       D ++ GV++ E+  G
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 45/287 (15%)
Query: 77  SNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
           + +    LLG+GGFG V+ G  + ++L+  ++  P   + L             E+  L 
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRN-RVLGWSPLSDSVTCPLEVALLW 89
Query: 136 QLR----HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           ++     HP +++L+ +   +E  +LV E   R      LF   +   P           
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLD-SDYTAKLSDFG---LAKDGPEGEETHVITRVM 247
               A  H   + V++RD K  NIL+D     AKL DFG   L  D P        T   
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-------YTDFD 199
Query: 248 GTQGYAAPEYVMTGHLTTM-SDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           GT+ Y+ PE++       + + V+S G++L +++ G    +     R+Q + E       
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE-----RDQEILE------- 247
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
                        E  FP   +    A   +CL+  P  RP++  ++
Sbjct: 248 ------------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 36/236 (15%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEII 132
           R +    +    +G+G +G V++G          + + VAVK      ++  K W  E  
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETE 52
Query: 133 FLG--QLRHPHLVKLIGYCWEEEYR----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
                 LRH +++  I       +      L+  Y   GSL++ L       L   + ++
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLR 109
Query: 187 IALGAAKGLAFLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
           I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA    +    
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 241 HVITR--VMGTQGYAAPEYV-MTGHLTTMS-----DVYSFGVVLLELLTGKRAMDN 288
             +     +GT+ Y APE +  T  +         D+++FG+VL E+   +R + N
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSN 223

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 36/236 (15%)
Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEII 132
           R +    +    +G+G +G V++G          + + VAVK      ++  K W  E  
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRG--------SWQGENVAVKIF---SSRDEKSWFRETE 81
Query: 133 FLG--QLRHPHLVKLIGYCWEEEYR----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
                 LRH +++  I       +      L+  Y   GSL++ L       L   + ++
Sbjct: 82  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLR 138
Query: 187 IALGAAKGLAFLHGE-----DKPVI-YRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
           I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA    +    
Sbjct: 139 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 198
Query: 241 HVITR--VMGTQGYAAPEYV-MTGHLTTMS-----DVYSFGVVLLELLTGKRAMDN 288
             +     +GT+ Y APE +  T  +         D+++FG+VL E+   +R + N
Sbjct: 199 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSN 252

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           F   + LG G    VY+       K     +P A+K L    T   K    EI  L +L 
Sbjct: 55  FEVESELGRGATSIVYR------CKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLS 106
Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAKGLAF 197
           HP+++KL           LV E +  G L +++  + Y +    +  +K  L A   +A+
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA---VAY 163
Query: 198 LHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           LH  +  +++RD K  N+L  +   D   K++DFGL+K     E   ++  V GT GY A
Sbjct: 164 LH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGTPGYCA 218
Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           PE +         D++S G++   LL G
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 55/95 (57%), Gaps = 5/95 (5%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQ 250
           +GL ++H     VI+RD K SN+L++ +   K+ DFG+A+       E  + +T  + T+
Sbjct: 169 RGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 251 GYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGKR 284
            Y APE +++ H  T + D++S G +  E+L  ++
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY P G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+++D     +++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    A P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 19/212 (8%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           I   F    +LG G F  V+       +K  L  +  A+K +             EI  L
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFL------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAK 193
            +++H ++V L        +  LV + +  G L +++  R        S  ++  L A K
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVK 120
Query: 194 GLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
              +LH  +  +++RD K  N+L    + +    ++DFGL+K     E+  +++   GT 
Sbjct: 121 ---YLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK----MEQNGIMSTACGTP 171
Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           GY APE +     +   D +S GV+   LL G
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+         V+TR      Y
Sbjct: 139 KGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WY 191
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELLTGK 283
            APE ++     T   D++S G ++ E++TGK
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V++  V E+      A    +   + D     KE    I  +  LRHP LV 
Sbjct: 59  LGTGAFGVVHR--VTERATGNNFAAKFVMTPHESDKETVRKE----IQTMSVLRHPTLVN 112
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     ++   +++YE+M  G L  ++   ++  +     ++      KGL  +H  +  
Sbjct: 113 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN-- 169
Query: 205 VIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
            ++ D K  NI+  +  +   KL DFGL       +   V T   GT  +AAPE      
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 226
Query: 263 LTTMSDVYSFGVVLLELLTG 282
           +   +D++S GV+   LL+G
Sbjct: 227 VGYYTDMWSVGVLSYILLSG 246

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 102/247 (41%), Gaps = 39/247 (15%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           +  N+   +L+G G +G VY  + D+  +  +  + V     DL      K  + EI  L
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLAY-DKNTEKNVAIKKVNRMFEDLIDC---KRILREITIL 79
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--MKIALGAA 192
            +L+  ++++L      ++       Y+      + L + +   +  +      I     
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL 139
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK------------DGPEGEE- 239
            G  F+H  +  +I+RD K +N LL+ D + K+ DFGLA+            D  E EE 
Sbjct: 140 LGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 240 ------------THVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGKRAM 286
                       +HV+TR      Y APE ++     T S D++S G +  ELL   ++ 
Sbjct: 198 GPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252
Query: 287 DNTRLGR 293
            N    R
Sbjct: 253 INDPTNR 259

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 99
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P L KL     +     +V EY P G + + L R    + P +     A   
Sbjct: 100 NF------PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--AAQI 151
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+++D     K++DFG AK         V  R   + G
Sbjct: 152 VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 201
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 99
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P L KL     +     +V EY P G + + L R    + P +     A   
Sbjct: 100 NF------PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFY--AAQI 151
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+++D     K++DFG AK         V  R   + G
Sbjct: 152 VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 201
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 2/94 (2%)
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           +   A+G+ FL    +  I+RD  A NILL  +   K+ DFGLA+D  +  +        
Sbjct: 205 SFQVARGMEFLSS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTR 262
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               + APE +     +T SDV+S+GV+L E+ +
Sbjct: 263 LPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+         ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ EL+ G
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG G FG V++  V E+      A    +   + D     KE    I  +  LRHP LV 
Sbjct: 165 LGTGAFGVVHR--VTERATGNNFAAKFVMTPHESDKETVRKE----IQTMSVLRHPTLVN 218
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
           L     ++   +++YE+M  G L  ++   ++  +     ++      KGL  +H  +  
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENN-- 275
Query: 205 VIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
            ++ D K  NI+  +  +   KL DFGL       +   V T   GT  +AAPE      
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKP 332
Query: 263 LTTMSDVYSFGVVLLELLTG 282
           +   +D++S GV+   LL+G
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+  +  L HP LV L     +EE   +V + +  G L   L    +      T      
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC 122
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                L +L  +++ +I+RD K  NILLD      ++DF +A   P   ET  IT + GT
Sbjct: 123 ELVMALDYL--QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQ-ITTMAGT 177
Query: 250 QGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKR 284
           + Y APE   +      +   D +S GV   ELL G+R
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEI-IFLGQLRHPHL 142
           LG G +G V      EK++     Q +AVK +     +Q  K  + ++ I +  +  P  
Sbjct: 59  LGRGAYGVV------EKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 112
Query: 143 VKLIGYCWEEEYRLLVYEYMPRG--SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           V   G  + E    +  E M       + Q+       +P     KIA+   K L  LH 
Sbjct: 113 VTFYGALFREGDVWICMELMDTSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS 171
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM--GTQGYAAPEYV 258
           +   VI+RD K SN+L+++    K+ DFG++     G     + + +  G + Y APE +
Sbjct: 172 K-LSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDSVAKTIDAGCKPYMAPERI 225
Query: 259 -----MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER 313
                  G+ +  SD++S G+ ++EL   +   D+           W  P     ++L++
Sbjct: 226 NPELNQKGY-SVKSDIWSLGITMIELAILRFPYDS-----------WGTPF----QQLKQ 269
Query: 314 LID---PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
           +++   P+L      K + +      +CL  + + RPT
Sbjct: 270 VVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPT 304

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 104/261 (39%), Gaps = 35/261 (13%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI-I 132
           ++   +     +  GG G +Y       L   +  +PV +K L   G    +        
Sbjct: 77  IVAGQYEVKGCIAHGGLGWIYLA-----LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQ 131
Query: 133 FLGQLRHPHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           FL ++ HP +V++  +    +        +V EY+   SL     RS    LP +  +  
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIAY 187
Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            L     L++LH     ++Y D K  NI+L ++   KL D G           +    + 
Sbjct: 188 LLEILPALSYLHSIG--LVYNDLKPENIML-TEEQLKLIDLGAVS------RINSFGYLY 238
Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD-NTRLGREQSLAEWARPLLK 306
           GT G+ APE V TG  T  +D+Y+ G  L  L      +D  TR GR         P+LK
Sbjct: 239 GTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL-----TLDLPTRNGRYVDGLPEDDPVLK 292
Query: 307 E----PRKLERLIDPRLEGQF 323
                 R L R IDP    +F
Sbjct: 293 TYDSYGRLLRRAIDPDPRQRF 313

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 89/214 (41%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 44  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 99
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P L KL     +     +V EY P G + + L R      P +     A   
Sbjct: 100 NF------PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFY--AAQI 151
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+++D     K++DFG AK         V  R   + G
Sbjct: 152 VLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCG 201
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 80/172 (46%), Gaps = 20/172 (11%)
Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM 128
           L ELRL         +L EGGF  VY+    + +  G E    A+K L  +  + ++  +
Sbjct: 25  LGELRLRVRR-----VLAEGGFAFVYEA---QDVGSGRE---YALKRLLSNEEEKNRAII 73
Query: 129 AEIIFLGQLR-HPHLVKLIGYCW---EE----EYRLLVYEYMPRGSLHNQLFRSYS-AAL 179
            E+ F+ +L  HP++V+         EE    +   L+   + +G L   L +  S   L
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133
Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA 231
              T +KI     + +  +H +  P+I+RD K  N+LL +  T KL DFG A
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLXGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 101
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 102 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 154
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 155 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 204
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 205 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 65/129 (50%), Gaps = 8/129 (6%)
Query: 156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNI 215
           +L+ EY   G + +      +  +  +  +++     +G+ +LH  +  +++ D K  NI
Sbjct: 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNI 162
Query: 216 LLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSF 272
           LL S Y     K+ DFG+++      E   +  +MGT  Y APE +    +TT +D+++ 
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 273 GVVLLELLT 281
           G++   LLT
Sbjct: 220 GIIAYMLLT 228

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLAGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 87
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 88  -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 140
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 141 FEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 190
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 191 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+         ++T  + T+ Y 
Sbjct: 136 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYR 190
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNT 289
           APE ++        D++S G ++ EL+ G      T
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 226

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 49/283 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRH--P 140
           +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L +L+    
Sbjct: 64  IGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLH-NQLFRSYSAALPWSTR--MKIALGAAKGLAF 197
            +++L  Y   ++Y   +Y  M  G++  N   +   +  PW  +   K  L A   +  
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-H 172
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            HG    +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE 
Sbjct: 173 QHG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 258 V-----------MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +               ++  SDV+S G +L  +  GK                  + ++ 
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIIN 272
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           +  KL  +IDP  E +FP    +        CL   P+ R ++
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGL-EAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
           LGEGGF      +VD  L  GL +    A+K +     Q  +E   E        HP+++
Sbjct: 37  LGEGGFS-----YVD--LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 144 KLIGYCWEE----EYRLLVYEYMPRGSLHNQLFRSYSAA--LPWSTRMKIALGAAKGLAF 197
           +L+ YC  E        L+  +  RG+L N++ R       L     + + LG  +GL  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP---EGEETHVITRVMGTQ---- 250
           +H   K   +RD K +NILL  +    L D G         EG    +  +    Q    
Sbjct: 150 IHA--KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 251 GYAAPE-YVMTGH--LTTMSDVYSFGVVLLELLTGKRAMD 287
            Y APE + +  H  +   +DV+S G VL  ++ G+   D
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 49/283 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRH--P 140
           +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L +L+    
Sbjct: 36  IGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLH-NQLFRSYSAALPWSTR--MKIALGAAKGLAF 197
            +++L  Y   ++Y   +Y  M  G++  N   +   +  PW  +   K  L A   +  
Sbjct: 89  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-H 144
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            HG    +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE 
Sbjct: 145 QHG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 258 V-----------MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +               ++  SDV+S G +L  +  GK                  + ++ 
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIIN 244
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           +  KL  +IDP  E +FP    +        CL   P+ R ++
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 26/213 (12%)
Query: 77  SNFSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEII 132
             F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVN 94
Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           F      P LVKL     +     +V EY+  G + + L R      P +     A    
Sbjct: 95  F------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--AAQIV 146
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGT 249
               +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT
Sbjct: 147 LTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGT 196
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             Y APE +++       D ++ GV++ E+  G
Sbjct: 197 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 49/283 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRH--P 140
           +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L +L+    
Sbjct: 20  IGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLH-NQLFRSYSAALPWSTR--MKIALGAAKGLAF 197
            +++L  Y   ++Y   +Y  M  G++  N   +   +  PW  +   K  L A   +  
Sbjct: 73  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-H 128
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            HG    +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE 
Sbjct: 129 QHG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 183
Query: 258 V-----------MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +               ++  SDV+S G +L  +  GK                  + ++ 
Sbjct: 184 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIIN 228
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           +  KL  +IDP  E +FP    +        CL   P+ R ++
Sbjct: 229 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 271

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R      P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 108/247 (43%), Gaps = 29/247 (11%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG GG G V+   VD         + VA+K + L   Q  K  + EI  + +L H ++VK
Sbjct: 19  LGCGGNGLVFSA-VDNDCD-----KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 145 L--------------IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
           +              +G   E     +V EYM    L N L       L    R+     
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLLEEHARL-FMYQ 128
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKD-GPEGEETHVITRVMG 248
             +GL ++H  +  V++RD K +N+ +++ D   K+ DFGLA+   P       ++  + 
Sbjct: 129 LLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 249 TQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE 307
           T+ Y +P  +++  + T   D+++ G +  E+LTGK          +  L   + P++ E
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 308 PRKLERL 314
             + E L
Sbjct: 247 EDRQELL 253

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R      P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 49/283 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRH--P 140
           +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L +L+    
Sbjct: 17  IGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLH-NQLFRSYSAALPWSTR--MKIALGAAKGLAF 197
            +++L  Y   ++Y   +Y  M  G++  N   +   +  PW  +   K  L A   +  
Sbjct: 70  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-H 125
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            HG    +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE 
Sbjct: 126 QHG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 258 V-----------MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +               ++  SDV+S G +L  +  GK                  + ++ 
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIIN 225
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           +  KL  +IDP  E +FP    +        CL   P+ R ++
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 91/214 (42%), Gaps = 32/214 (14%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPG-------LEAQPVAVKALDLDGTQGHKEWMAEI 131
           F R   LG G FG V    + + ++ G       L+ Q V VK   ++ T   K  +  +
Sbjct: 43  FERIKTLGTGSFGRV---MLVKHMETGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAV 98
Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
            F      P LVKL     +     +V EY+  G + + L R    + P +     A   
Sbjct: 99  NF------PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQI 150
Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMG 248
                +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + G
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG 200
Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           T  Y APE +++       D ++ GV++ E+  G
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R      P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 121
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R      P +     A      
Sbjct: 122 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFY--AAQIVLT 174
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 175 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 224
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 225 YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+++D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ E+  G
Sbjct: 204 YLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWM-AEIIFLGQLRHPHL 142
           +G G +G        +K++   + + +  K LD    T+  K+ + +E+  L +L+HP++
Sbjct: 14  IGTGSYGRC------QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 143 VKLIGYCWEEEYRLL--VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           V+      +     L  V EY   G L + + +             + +     LA    
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 201 EDKP-----VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
             +      V++RD K +N+ LD     KL DFGLA+      +T      +GT  Y +P
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKTFVGTPYYMSP 185
Query: 256 EYVMTGHLTTMSDVYSFGVVLLEL 279
           E +        SD++S G +L EL
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 49/283 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRH--P 140
           +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L +L+    
Sbjct: 64  IGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLH-NQLFRSYSAALPWSTR--MKIALGAAKGLAF 197
            +++L  Y   ++Y   +Y  M  G++  N   +   +  PW  +   K  L A   +  
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-H 172
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            HG    +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE 
Sbjct: 173 QHG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 258 V-----------MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +               ++  SDV+S G +L  +  GK                  + ++ 
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIIN 272
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           +  KL  +IDP  E +FP    +        CL   P+ R ++
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +++       D ++ GV++ ++  G
Sbjct: 204 YLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 49/283 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRH--P 140
           +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L +L+    
Sbjct: 36  IGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLH-NQLFRSYSAALPWSTR--MKIALGAAKGLAF 197
            +++L  Y   ++Y   +Y  M  G++  N   +   +  PW  +   K  L A   +  
Sbjct: 89  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-H 144
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            HG    +++ D K +N L+  D   KL DFG+A          V    +GT  Y  PE 
Sbjct: 145 QHG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEA 199
Query: 258 V-----------MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +               ++  SDV+S G +L  +  GK                  + ++ 
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIIN 244
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           +  KL  +IDP  E +FP    +        CL   P+ R ++
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 77/164 (46%), Gaps = 19/164 (11%)
Query: 124 HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL--HNQLF----RSYSA 177
           + ++  E+  +  +++ + +   G     +   ++YEYM   S+   ++ F    ++Y+ 
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 178 ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 237
            +P      I        +++H E K + +RD K SNIL+D +   KLSDFG +      
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHNE-KNICHRDVKPSNILMDKNGRVKLSDFGES------ 199
Query: 238 EETHVITRVMGTQG---YAAPEYVM--TGHLTTMSDVYSFGVVL 276
            E  V  ++ G++G   +  PE+    + +     D++S G+ L
Sbjct: 200 -EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 49/283 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRH--P 140
           +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L +L+    
Sbjct: 16  IGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLH-NQLFRSYSAALPWSTR--MKIALGAAKGLAF 197
            +++L  Y   ++Y   +Y  M  G++  N   +   +  PW  +   K  L A   +  
Sbjct: 69  KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-H 124
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            HG    +++ D K +N L+  D   KL DFG+A        + V    +GT  Y  PE 
Sbjct: 125 QHG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 179
Query: 258 V-----------MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +               ++  SDV+S G +L  +  GK                  + ++ 
Sbjct: 180 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIIN 224
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           +  KL  +IDP  E +FP    +        CL   P+ R ++
Sbjct: 225 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 267

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWM-AEIIFLGQLRHPHL 142
           +G G +G        +K++   + + +  K LD    T+  K+ + +E+  L +L+HP++
Sbjct: 14  IGTGSYGRC------QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 143 VKLIGYCWEEEYRLL--VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           V+      +     L  V EY   G L + + +             + +     LA    
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 201 EDKP-----VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
             +      V++RD K +N+ LD     KL DFGLA+      +T      +GT  Y +P
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNHDTSFAKAFVGTPYYMSP 185
Query: 256 EYVMTGHLTTMSDVYSFGVVLLEL 279
           E +        SD++S G +L EL
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 17/205 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAEIIFLGQLRHPH 141
           LG G F  V K    EK   GLE     +K      ++     +E   E+  L Q+ HP+
Sbjct: 20  LGSGQFAIVKK--CREK-STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L          +L+ E +  G L +  F +   +L              G+ +LH  
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 202 DKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            K + + D K  NI LLD +      KL DFGLA +  +G E      + GT  + APE 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEI 189
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           V    L   +D++S GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+    G    ++  V+ T+ Y 
Sbjct: 140 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVV-TRYYR 194
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE ++        D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 67/149 (44%), Gaps = 5/149 (3%)
Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L+HPH+V+L+     +    +V+E+M    L  ++ +   A   +S  +          A
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTA---KLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
             +  D  +I+RD K   +LL S   +   KL  FG+A     GE   V    +GT  + 
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFM 202
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE V         DV+  GV+L  LL+G
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 16/217 (7%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-----KEWM 128
           L    +    ++G+G F  V +    E        Q  AVK +D+           ++  
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRET------GQQFAVKIVDVAKFTSSPGLSTEDLK 74
Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
            E      L+HPH+V+L+     +    +V+E+M    L  ++ +   A   +S  +   
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA---KLSDFGLAKDGPEGEETHVITR 245
                  A  +  D  +I+RD K   +LL S   +   KL  FG+A     GE   V   
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGG 192
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            +GT  + APE V         DV+  GV+L  LL+G
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 17/216 (7%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAE 130
           ++  ++     LG G F  V K     +   G E     +K   L  ++     +E   E
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKC---RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 58
Query: 131 IIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
           +  L ++RHP+++ L      +   +L+ E +  G L +  F +   +L      +    
Sbjct: 59  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD--FLAEKESLTEDEATQFLKQ 116
Query: 191 AAKGLAFLHGEDKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEETHVITRV 246
              G+ +LH   K + + D K  NI LLD +      KL DFG+A     G E      +
Sbjct: 117 ILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNI 171
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 7/149 (4%)
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRG-SLHNQLFRSYSAALPWSTRMKIALGAAK 193
           G+L+ PH+V +  +  E + +L V   +  G  L   L R    A P +  +   +G+A 
Sbjct: 89  GRLQEPHVVPIHDF-GEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSAL 147
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
             A   G      +RD K  NIL+ +D  A L DFG+A      E+   +   +GT  Y 
Sbjct: 148 DAAHAAGA----THRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYX 202
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           APE     H T  +D+Y+   VL E LTG
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTG 231

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 46/278 (16%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEI-IFLGQLRHPHL 142
           LG G +G V      EK++     Q +AVK +     +Q  K  + ++ I +  +  P  
Sbjct: 15  LGRGAYGVV------EKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 143 VKLIGYCWEEEYRLLVYEYMPRG--SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           V   G  + E    +  E M       + Q+       +P     KIA+   K L  LH 
Sbjct: 69  VTFYGALFREGDVWICMELMDTSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS 127
Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM--GTQGYAAPEYV 258
           +   VI+RD K SN+L+++    K+ DFG++     G     + + +  G + Y APE +
Sbjct: 128 K-LSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDIDAGCKPYMAPERI 181
Query: 259 -----MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER 313
                  G+ +  SD++S G+ ++EL   +   D+           W  P     ++L++
Sbjct: 182 NPELNQKGY-SVKSDIWSLGITMIELAILRFPYDS-----------WGTPF----QQLKQ 225
Query: 314 LID---PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
           +++   P+L      K + +      +CL  + + RPT
Sbjct: 226 VVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPT 260

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
           EI  + QL HP L+ L    +E++Y + L+ E++  G L +++  +    +  +  +   
Sbjct: 98  EISIMNQLHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYM 155
Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY--TAKLSDFGLAKDGPEGEETHVITRV 246
             A +GL  +H  +  +++ D K  NI+ ++    + K+ DFGLA      E   V T  
Sbjct: 156 RQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-- 211
Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             T  +AAPE V    +   +D+++ GV+   LL+G
Sbjct: 212 -ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWM-AEIIFLGQLRHPHL 142
           +G G +G        +K++   + + +  K LD    T+  K+ + +E+  L +L+HP++
Sbjct: 14  IGTGSYGRC------QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 143 VKLIGYCWEEEYRLL--VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           V+      +     L  V EY   G L + + +             + +     LA    
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 201 EDKP-----VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
             +      V++RD K +N+ LD     KL DFGLA+     E+       +GT  Y +P
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSP 185
Query: 256 EYVMTGHLTTMSDVYSFGVVLLEL 279
           E +        SD++S G +L EL
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 27/206 (13%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG      V   ++  L  + VAVK ++  G    +    EII    LRHP++V+
Sbjct: 28  IGSGNFG------VARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVR 80
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIALGAAKGLAFLH 199
                    +  ++ EY   G L+ ++     F    A   +   +        G+++ H
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL-------SGVSYCH 133
Query: 200 GEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
                + +RD K  N LLD       K+ DFG +K      +       +GT  Y APE 
Sbjct: 134 SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEV 188
Query: 258 VMTGHLT-TMSDVYSFGVVLLELLTG 282
           ++       ++DV+S GV L  +L G
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 125 KEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR 184
           +E   E+  L ++RHP+++ L      +   +L+ E +  G L +  F +   +L     
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD--FLAEKESLTEDEA 117
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEET 240
            +       G+ +LH   K + + D K  NI LLD +      KL DFG+A     G E 
Sbjct: 118 TQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE- 174
Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
                + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 175 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y AP  +++       D ++ GV++ E+  G
Sbjct: 204 YLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 137 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 191
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 125 KEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR 184
           +E   E+  L ++RHP+++ L      +   +L+ E +  G L +  F +   +L     
Sbjct: 74  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD--FLAEKESLTEDEA 131
Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEET 240
            +       G+ +LH   K + + D K  NI LLD +      KL DFG+A     G E 
Sbjct: 132 TQFLKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE- 188
Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
                + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 189 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 139 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 230
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 176 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 230
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 131 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG--EETHVITRVMGTQG 251
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+        E  V+TR      
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY----- 190
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE ++        D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 143 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 197
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 58
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYEYM-----------PRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E M            RG+L  +L RS
Sbjct: 59  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARS 118
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 119 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 164
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 165 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y 
Sbjct: 132 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           APE ++        D++S G ++ E++  K
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 49/283 (17%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRH--P 140
           +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L +L+    
Sbjct: 64  IGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLH-NQLFRSYSAALPWSTR--MKIALGAAKGLAF 197
            +++L  Y   ++Y   +Y  M  G++  N   +   +  PW  +   K  L A   +  
Sbjct: 117 KIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI-H 172
Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            HG    +++ D K +N L+  D   KL DFG+A        + V    +G   Y  PE 
Sbjct: 173 QHG----IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 258 V-----------MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +               ++  SDV+S G +L  +  GK                  + ++ 
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF---------------QQIIN 272
Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           +  KL  +IDP  E +FP    +        CL   P+ R ++
Sbjct: 273 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 315

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL--DGTQGHKEWMAEIIFLGQLRHPH 141
           L+G+G FG VY G    +         VA++ +D+  D     K +  E++   Q RH +
Sbjct: 40  LIGKGRFGQVYHGRWHGE---------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           +V  +G C    + L +   + +G     + R     L  +   +IA    KG+ +LH  
Sbjct: 91  VVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA- 148
Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGL 230
            K ++++D K+ N+  D+     ++DFGL
Sbjct: 149 -KGILHKDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 79  FSRSNLLGEGGFGPV----YKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           F R   LG G FG V    +K   +      L+ Q V VK   ++ T   K  +  + F 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNF- 100
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
                P LVKL     +     +V EY+  G + + L R    + P +     A      
Sbjct: 101 -----PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFY--AAQIVLT 153
Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQG 251
             +LH  D  +IYRD K  N+L+D     +++DFG AK         V  R   + GT  
Sbjct: 154 FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPE 203
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             APE +++       D ++ GV++ E+  G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           HP++VKL     ++ +  LV E +  G L  ++ +    +   ++ +   L +A      
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS---- 120
Query: 199 HGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           H  D  V++RD K  N+L    + +   K+ DFG A+  P   +   +     T  YAAP
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP--LKTPCFTLHYAAP 178
Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           E +         D++S GV+L  +L+G+
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 9/92 (9%)
Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG--EETHVITRVMGTQG 251
           G+  LH     +I+RD K SNI++ SD T K+ DFGLA+        E  V+TR      
Sbjct: 138 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY----- 190
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE ++        D++S G ++ E++  K
Sbjct: 191 YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 44/221 (19%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWE--EEYRLLVYEYMPRGS---------LHNQLFRSYSAA 178
           EI  L +L HP++VKL+    +  E++  +V+E + +G          L     R Y   
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQD 145
Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
           L             KG+ +LH +   +I+RD K SN+L+  D   K++DFG++ +  +G 
Sbjct: 146 L------------IKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGS 190
Query: 239 ETHVITRVMGTQGYAAPE------YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLG 292
           +  +++  +GT  + APE       + +G      DV++ GV L   + G+    + R+ 
Sbjct: 191 DA-LLSNTVGTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQCPFMDERIM 246
Query: 293 ------REQSLAEWARPLLKEPRK--LERLIDPRLEGQFPI 325
                 + Q+L    +P + E  K  + R++D   E +  +
Sbjct: 247 CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV 287

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 19/184 (10%)
Query: 112 AVKALDLDGTQGHKEWMAEI-IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQ 170
           AVK +D    +  ++   EI I L   +HP+++ L     + +Y  +V E M  G L ++
Sbjct: 51  AVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDK 106
Query: 171 LFRSYSAALPWSTR--MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----TAK 224
           + R       +S R    +     K + +LH +   V++RD K SNIL   +     + +
Sbjct: 107 ILRQKF----FSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIR 160
Query: 225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
           + DFG AK      E  ++     T  + APE +         D++S GV+L  +LTG  
Sbjct: 161 ICDFGFAKQ--LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYT 218
Query: 285 AMDN 288
              N
Sbjct: 219 PFAN 222

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 13/214 (6%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           +   +   +LLGEG +G V +    E L     A  +  K        G      EI  L
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETL--CRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 135 GQLRHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            +LRH ++++L+   + EE +   +V EY   G +   L        P            
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            GL +LH +   ++++D K  N+LL +  T K+S  G+A+               G+  +
Sbjct: 120 DGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 253 AAPEYVMTGHLTTMS----DVYSFGVVLLELLTG 282
             PE  +   L T S    D++S GV L  + TG
Sbjct: 178 QPPE--IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL----DGTQGHKEWMAEIIFL 134
           + R   LGEG +G VYK  +D      +  + VA+K + L    +G  G    + E+  L
Sbjct: 36  YRRITKLGEGTYGEVYKA-IDT-----VTNETVAIKRIRLEHEEEGVPGTA--IREVSLL 87
Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAA 192
            +L+H ++++L           L++EY       N L +        S R+         
Sbjct: 88  KELQHRNIIELKSVIHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 193 KGLAFLHGEDKPVIYRDFKASNILL---DSDYTA--KLSDFGLAKDG--PEGEETHVITR 245
            G+ F H   +  ++RD K  N+LL   D+  T   K+ DFGLA+    P  + TH I  
Sbjct: 143 NGVNFCHS--RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII- 199
Query: 246 VMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELL 280
              T  Y  PE ++ + H +T  D++S   +  E+L
Sbjct: 200 ---TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 18  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 70
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 176
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 177 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 229
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 230 ILLYDMVCG 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 19  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 71
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 177
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 178 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 230
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 231 ILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 18  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 70
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 176
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 177 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 229
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 230 ILLYDMVCG 238

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 5   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 57
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 58  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 117
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 118 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 163
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 164 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 216
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 217 ILLYDMVCG 225

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 19  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 71
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 177
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 178 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 230
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 231 ILLYDMVCG 239

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 33  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 85
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 86  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 145
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 191
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 192 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 244
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 245 ILLYDMVCG 253

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 58
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 59  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 164
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 165 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 217
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 218 ILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 58
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 59  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 164
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 165 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 217
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 218 ILLYDMVCG 226

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 19  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 71
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 177
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 178 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 230
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 231 ILLYDMVCG 239

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 33  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 85
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 86  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 145
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 191
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 192 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 244
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 245 ILLYDMVCG 253

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 6   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 58
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 59  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 164
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 165 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 217
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 218 ILLYDMVCG 226

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 5   NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 57
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 58  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 117
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 118 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 163
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 164 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 216
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 217 ILLYDMVCG 225

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 18  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 70
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 176
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 177 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 229
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 230 ILLYDMVCG 238

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 25  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 77
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 78  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 137
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 138 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 183
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 184 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 236
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 237 ILLYDMVCG 245

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 19  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 71
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 72  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 177
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 178 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 230
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 231 ILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 18  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 70
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 71  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 176
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 177 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 229
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 230 ILLYDMVCG 238

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 56/249 (22%)
Query: 62  SKLHVFTLA---ELRLITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALD 117
           + LH   LA   E   + S +    LLG GGFG VY G  V + L       PVA+K ++
Sbjct: 38  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVE 90
Query: 118 LDGTQGHKEW------MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE--------- 160
            D      E         E++ L ++      +++L+ +    +  +L+ E         
Sbjct: 91  KDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 150
Query: 161 --YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
                RG+L  +L RS+   +  + R              H  +  V++RD K  NIL+D
Sbjct: 151 DFITERGALQEELARSFFWQVLEAVR--------------HCHNCGVLHRDIKDENILID 196
Query: 219 SDY-TAKLSDFG---LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFG 273
            +    KL DFG   L KD        V T   GT+ Y+ PE++        S  V+S G
Sbjct: 197 LNRGELKLIDFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG 249
Query: 274 VVLLELLTG 282
           ++L +++ G
Sbjct: 250 ILLYDMVCG 258

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 59
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 120 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 166 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 59
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 120 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 166 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 58
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 59  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 118
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 119 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 164
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 165 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 54
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 55  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 115 FFWQVLEAVR--------------HCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 161 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 59
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 60  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 119
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 120 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 165
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 166 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG      V   ++     + VAVK ++  G +  +    EII    LRHP++V+
Sbjct: 26  IGSGNFG------VARLMRDKQSNELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 78
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIALGAAKGLAFLH 199
                    +  +V EY   G L  ++     F    A   +   +        G+++ H
Sbjct: 79  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCH 131
Query: 200 GEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
                V +RD K  N LLD       K+ DFG +K      +       +GT  Y APE 
Sbjct: 132 AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEV 186
Query: 258 VMTGHLT-TMSDVYSFGVVLLELLTG 282
           ++       ++DV+S GV L  +L G
Sbjct: 187 LLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 81
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 82  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 141
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 142 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 187
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 188 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 57
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 58  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 117
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 118 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 163
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 164 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 54
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 55  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 115 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 161 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 53/233 (22%)
Query: 75  ITSNFSRSNLLGEGGFGPVYKGF-VDEKLKPGLEAQPVAVKALDLDGTQGHKEW------ 127
           + S +    LLG GGFG VY G  V + L       PVA+K ++ D      E       
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNL-------PVAIKHVEKDRISDWGELPNGTRV 54
Query: 128 MAEIIFLGQLR--HPHLVKLIGYCWEEEYRLLVYE-----------YMPRGSLHNQLFRS 174
             E++ L ++      +++L+ +    +  +L+ E              RG+L  +L RS
Sbjct: 55  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 114
Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFG---L 230
           +   +  + R              H  +  V++RD K  NIL+D +    KL DFG   L
Sbjct: 115 FFWQVLEAVR--------------HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160
Query: 231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
            KD        V T   GT+ Y+ PE++        S  V+S G++L +++ G
Sbjct: 161 LKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIF 133
            S + +   +G+G FG V+K       K G   Q VA+K + ++  +      A  EI  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKA---RHRKTG---QKVALKKVLMENEKEGFPITALREIKI 70
Query: 134 LGQLRHPHLVKLIGYCWEEE--YR------LLVYEYMPR---GSLHNQLFRSYSAALPWS 182
           L  L+H ++V LI  C  +   Y        LV+++      G L N L +   + +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 130
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPEGEE 239
            +M +      GL ++H     +++RD KA+N+L+  D   KL+DFGLA+        + 
Sbjct: 131 MQMLL-----NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 240 THVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLT 281
                RV+ T  Y  PE ++         D++  G ++ E+ T
Sbjct: 184 NRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 84/206 (40%), Gaps = 27/206 (13%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG      V   ++     + VAVK ++  G +       EII    LRHP++V+
Sbjct: 27  IGSGNFG------VARLMRDKQSNELVAVKYIE-RGEKIAANVKREIINHRSLRHPNIVR 79
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIALGAAKGLAFLH 199
                    +  +V EY   G L  ++     F    A   +   +        G+++ H
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCH 132
Query: 200 GEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
                V +RD K  N LLD       K+ DFG +K      +       +GT  Y APE 
Sbjct: 133 AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEV 187
Query: 258 VMTGHLT-TMSDVYSFGVVLLELLTG 282
           ++       ++DV+S GV L  +L G
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIF 133
            S + +   +G+G FG V+K       K G   Q VA+K + ++  +      A  EI  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKA---RHRKTG---QKVALKKVLMENEKEGFPITALREIKI 70
Query: 134 LGQLRHPHLVKLIGYCWEEE--YR------LLVYEYMPR---GSLHNQLFRSYSAALPWS 182
           L  L+H ++V LI  C  +   Y        LV+++      G L N L +   + +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 130
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPEGEE 239
            +M +      GL ++H     +++RD KA+N+L+  D   KL+DFGLA+        + 
Sbjct: 131 MQMLL-----NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 240 THVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLT 281
                RV+ T  Y  PE ++         D++  G ++ E+ T
Sbjct: 184 NRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAEIIFLGQLRHPH 141
           LG G F  V K    EK   GLE     +K      ++     +E   E+  L Q+ H +
Sbjct: 20  LGSGQFAIVKK--CREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L          +L+ E +  G L +  F +   +L              G+ +LH  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 202 DKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            K + + D K  NI LLD +      KL DFGLA +  +G E      + GT  + APE 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEI 189
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           V    L   +D++S GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAEIIFLGQLRHPH 141
           LG G F  V K    EK   GLE     +K      ++     +E   E+  L Q+ H +
Sbjct: 20  LGSGQFAIVKK--CREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L          +L+ E +  G L +  F +   +L              G+ +LH  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 202 DKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            K + + D K  NI LLD +      KL DFGLA +  +G E      + GT  + APE 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEI 189
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           V    L   +D++S GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIF 133
            S + +   +G+G FG V+K       K G   Q VA+K + ++  +      A  EI  
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKA---RHRKTG---QKVALKKVLMENEKEGFPITALREIKI 70
Query: 134 LGQLRHPHLVKLIGYCWEEE--YR------LLVYEYMPR---GSLHNQLFRSYSAALPWS 182
           L  L+H ++V LI  C  +   Y        LV+++      G L N L +   + +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 130
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPEGEE 239
            +M +      GL ++H     +++RD KA+N+L+  D   KL+DFGLA+        + 
Sbjct: 131 MQMLL-----NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 240 THVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLT 281
                RV+ T  Y  PE ++         D++  G ++ E+ T
Sbjct: 184 NRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 11/209 (5%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK--EWMAEIIF 133
           +  +S  + LG G FG V+     EK K  +       K L+    +  K  +   EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRG-SLHNQLFRSYSAALPWSTRMKIALGAA 192
           L ++ H +++K++     + +  LV E    G  L   + R      P ++ +   L +A
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            G   L    K +I+RD K  NI++  D+T KL DFG A     G+  +      GT  Y
Sbjct: 143 VGYLRL----KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEY 195
Query: 253 AAPEYVMTG-HLTTMSDVYSFGVVLLELL 280
            APE +M   +     +++S GV L  L+
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAEIIFLGQLRHPH 141
           LG G F  V K    EK   GLE     +K      ++     +E   E+  L Q+ H +
Sbjct: 20  LGSGQFAIVKK--CREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L          +L+ E +  G L +  F +   +L              G+ +LH  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 202 DKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            K + + D K  NI LLD +      KL DFGLA +  +G E      + GT  + APE 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEI 189
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           V    L   +D++S GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 57/130 (43%), Gaps = 9/130 (6%)
Query: 156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNI 215
           L++ E M  G L +++      A       +I       + FLH  +  + +RD K  N+
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 159
Query: 216 LLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSF 272
           L  S   D   KL+DFG AK+  +    + +     T  Y APE +         D++S 
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 273 GVVLLELLTG 282
           GV++  LL G
Sbjct: 216 GVIMYILLCG 225

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 57/130 (43%), Gaps = 9/130 (6%)
Query: 156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNI 215
           L++ E M  G L +++      A       +I       + FLH  +  + +RD K  N+
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENL 140
Query: 216 LLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSF 272
           L  S   D   KL+DFG AK+  +    + +     T  Y APE +         D++S 
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 196
Query: 273 GVVLLELLTG 282
           GV++  LL G
Sbjct: 197 GVIMYILLCG 206

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAEIIFLGQLRHPH 141
           LG G F  V K    EK   GLE     +K      ++     +E   E+  L Q+ H +
Sbjct: 20  LGSGQFAIVKK--CREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L          +L+ E +  G L +  F +   +L              G+ +LH  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 202 DKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            K + + D K  NI LLD +      KL DFGLA +  +G E      + GT  + APE 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEI 189
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           V    L   +D++S GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)
Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIF 133
            S + +   +G+G FG V+K       K G   Q VA+K + ++  +      A  EI  
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKA---RHRKTG---QKVALKKVLMENEKEGFPITALREIKI 69
Query: 134 LGQLRHPHLVKLIGYCWEEE--YR------LLVYEYMPR---GSLHNQLFRSYSAALPWS 182
           L  L+H ++V LI  C  +   Y        LV+++      G L N L +   + +   
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV 129
Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD---GPEGEE 239
            +M +      GL ++H     +++RD KA+N+L+  D   KL+DFGLA+        + 
Sbjct: 130 MQMLL-----NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 240 THVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLT 281
                RV+ T  Y  PE ++         D++  G ++ E+ T
Sbjct: 183 NRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 27/206 (13%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG      V   ++     + VAVK ++  G +  +    EII    LRHP++V+
Sbjct: 27  IGAGNFG------VARLMRDKQANELVAVKYIE-RGEKIDENVKREIINHRSLRHPNIVR 79
Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQL-----FRSYSAALPWSTRMKIALGAAKGLAFLH 199
                    +  +V EY   G L  ++     F    A   +   +        G+++ H
Sbjct: 80  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYAH 132
Query: 200 GEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
                V +RD K  N LLD       K++DFG +K      +       +GT  Y APE 
Sbjct: 133 AMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP---KSAVGTPAYIAPEV 187
Query: 258 VMTGHLT-TMSDVYSFGVVLLELLTG 282
           ++       ++DV+S GV L  +L G
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
               +F R + LG G +G V+K    E      + +  AVK   +   +G K+   ++  
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKE------DGRLYAVKR-SMSPFRGPKDRARKLAE 106
Query: 134 LGQL----RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           +G      +HP  V+L    WEE   L +   +   SL  Q   ++ A+LP +       
Sbjct: 107 VGSHEKVGQHPCCVRLE-QAWEEGGILYLQTELCGPSL-QQHCEAWGASLPEAQVWGYLR 164
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
                LA LH +   +++ D K +NI L      KL DFGL  +        V     G 
Sbjct: 165 DTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GD 219
Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLEL 279
             Y APE ++ G   T +DV+S G+ +LE+
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEV 248

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+  L +++HP+++ L      +   +L+ E +  G L +  F +   +L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLK 121
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEETHVITR 245
               G+ +LH     + + D K  NI LLD +      K+ DFGLA     G E      
Sbjct: 122 QILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKN 176
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 177 IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---GHKEWMAEIIFLGQLRHPH 141
           LG G F  V K    EK   GLE     +K      ++     +E   E+  L Q+ H +
Sbjct: 20  LGSGQFAIVKK--CREK-STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           ++ L          +L+ E +  G L +  F +   +L              G+ +LH  
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFD--FLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 202 DKPVIYRDFKASNI-LLDSDYTA---KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
            K + + D K  NI LLD +      KL DFGLA +  +G E      + GT  + APE 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEI 189
Query: 258 VMTGHLTTMSDVYSFGVVLLELLTG 282
           V    L   +D++S GV+   LL+G
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 69  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 128 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPY 182
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 183 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 82  SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HP 140
           S LLGEG +  V +G V   L+ G E    AVK ++            E+  L Q + + 
Sbjct: 18  SELLGEGAYAKV-QGAV--SLQNGKE---YAVKIIEKQAGHSRSRVFREVETLYQCQGNK 71
Query: 141 HLVKLIGYCWEEEYRL-LVYEYMPRGSL--HNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           ++++LI + +E++ R  LV+E +  GS+  H Q  + ++         ++    A  L F
Sbjct: 72  NILELIEF-FEDDTRFYLVFEKLQGGSILAHIQKQKHFNE----REASRVVRDVAAALDF 126
Query: 198 LHGEDKPVIYRDFKASNILLDSDYT---AKLSDFGLA-----KDGPEGEETHVITRVMGT 249
           LH   K + +RD K  NIL +S       K+ DF L       +      T  +T   G+
Sbjct: 127 LH--TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 250 QGYAAPEY--VMTGHLT---TMSDVYSFGVVLLELLTG 282
             Y APE   V T   T      D++S GVVL  +L+G
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 115 PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 174 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 228
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 19/184 (10%)
Query: 112 AVKALDLDGTQGHKEWMAEI-IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQ 170
           AVK +D    +  ++   EI I L   +HP+++ L     + +Y  +V E    G L ++
Sbjct: 51  AVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDK 106
Query: 171 LFRSYSAALPWSTRMKIAL--GAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----TAK 224
           + R       +S R   A+     K + +LH +   V++RD K SNIL   +     + +
Sbjct: 107 ILRQKF----FSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIR 160
Query: 225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
           + DFG AK      E  ++     T  + APE +         D++S GV+L   LTG  
Sbjct: 161 ICDFGFAKQ--LRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYT 218
Query: 285 AMDN 288
              N
Sbjct: 219 PFAN 222

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 121 PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 179
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 180 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 234
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 235 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 117/300 (39%), Gaps = 59/300 (19%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHL 142
           +LG G  G V         +   + +PVAVK + +D        + EI  L +   HP++
Sbjct: 40  ILGYGSSGTVV-------FQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNV 89
Query: 143 VKLIGYCWEEEYRLL----------VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           ++   YC E   R L          + + +   ++ ++  +      P S   +IA G A
Sbjct: 90  IRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 193 KGLAFLHGEDKPVIYRDFKASNILL--DSDYTAK-----------LSDFGLAKDGPEGEE 239
                 H     +I+RD K  NIL+   S +TA            +SDFGL K    G+ 
Sbjct: 148 ------HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 201
Query: 240 THV--ITRVMGTQGYAAPEYV---MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE 294
                +    GT G+ APE +       LT   D++S G V   +L+  +     +  RE
Sbjct: 202 XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 261
Query: 295 QSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
            ++      L     +++ L D  L  +        A     + + H P  RPT   V+R
Sbjct: 262 SNIIRGIFSL----DEMKCLHDRSLIAE--------ATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 75  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 134 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 188
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 189 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 71  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 130 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 184
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 185 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 77  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 136 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 190
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 191 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 76  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 135 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 189
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 190 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 63/304 (20%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHL 142
           +LG G  G V         +   + +PVAVK + +D        + EI  L +   HP++
Sbjct: 22  ILGYGSSGTVV-------FQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNV 71
Query: 143 VKLIGYCWEEEYRLL----------VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           ++   YC E   R L          + + +   ++ ++  +      P S   +IA G A
Sbjct: 72  IRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 193 KGLAFLHGEDKPVIYRDFKASNILL--DSDYTAK-----------LSDFGLAKDGPEGEE 239
                 H     +I+RD K  NIL+   S +TA            +SDFGL K    G+ 
Sbjct: 130 ------HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 240 THV--ITRVMGTQGYAAPEYVMTGH-------LTTMSDVYSFGVVLLELLTGKRAMDNTR 290
           +    +    GT G+ APE +   +       LT   D++S G V   +L+  +     +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 291 LGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
             RE ++      L     +++ L D  L  +        A     + + H P  RPT  
Sbjct: 244 YSRESNIIRGIFSL----DEMKCLHDRSLIAE--------ATDLISQMIDHDPLKRPTAM 291
Query: 351 YVVR 354
            V+R
Sbjct: 292 KVLR 295

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 70  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 128
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 129 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 183
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 184 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 85  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 143
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 144 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 198
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 199 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 71  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 130 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 184
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 185 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/300 (24%), Positives = 117/300 (39%), Gaps = 59/300 (19%)
Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHL 142
           +LG G  G V         +   + +PVAVK + +D        + EI  L +   HP++
Sbjct: 40  ILGYGSSGTVV-------FQGSFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDDHPNV 89
Query: 143 VKLIGYCWEEEYRLL----------VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           ++   YC E   R L          + + +   ++ ++  +      P S   +IA G A
Sbjct: 90  IRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 193 KGLAFLHGEDKPVIYRDFKASNILL--DSDYTAK-----------LSDFGLAKDGPEGEE 239
                 H     +I+RD K  NIL+   S +TA            +SDFGL K    G+ 
Sbjct: 148 ------HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQX 201
Query: 240 THV--ITRVMGTQGYAAPEYV---MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE 294
                +    GT G+ APE +       LT   D++S G V   +L+  +     +  RE
Sbjct: 202 XFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 261
Query: 295 QSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
            ++      L     +++ L D  L  +        A     + + H P  RPT   V+R
Sbjct: 262 SNIIRGIFSL----DEMKCLHDRSLIAE--------ATDLISQMIDHDPLKRPTAMKVLR 309

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+  L +++HP+++ L      +   +L+ E +  G L +  F +   +L      +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLK 120
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEETHVITR 245
               G+ +LH     + + D K  NI LLD +      K+ DFGLA     G E      
Sbjct: 121 QILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKN 175
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 14/151 (9%)
Query: 140 PHLVKLIGYCWEEEYR-----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           PH+V+++   +E  Y      L+V E +  G L +++      A       +I     + 
Sbjct: 69  PHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 195 LAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           + +LH  +  + +RD K  N+L  S   +   KL+DFG AK   E    + +T    T  
Sbjct: 128 IQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPY 182
Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           Y APE +         D++S GV++  LL G
Sbjct: 183 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+  L +++HP+++ L      +   +L+ E +  G L +  F +   +L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLK 121
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEETHVITR 245
               G+ +LH     + + D K  NI LLD +      K+ DFGLA     G E      
Sbjct: 122 QILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKN 176
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+  L +++HP+++ L      +   +L+ E +  G L +  F +   +L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLK 121
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEETHVITR 245
               G+ +LH     + + D K  NI LLD +      K+ DFGLA     G E      
Sbjct: 122 QILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKN 176
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E+  L +++HP+++ L      +   +L+ E +  G L +  F +   +L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD--FLAEKESLTEEEATEFLK 121
Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNI-LLDSDY---TAKLSDFGLAKDGPEGEETHVITR 245
               G+ +LH     + + D K  NI LLD +      K+ DFGLA     G E      
Sbjct: 122 QILNGVYYLHS--LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKN 176
Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	401
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-179
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-151
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-86
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-62
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-61
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-58
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-56
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-54
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-54
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-53
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-52
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-47
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-46
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-43
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-43
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-42
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-41
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-40
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-40
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-40
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-39
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-39
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-39
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-39
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-39
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-38
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-37
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-36
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-35
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-34
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-32
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-32
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-31
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-28
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-27
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-27
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	6e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-25
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-23
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-23
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-22
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-19
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-17
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-10
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-16
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  514 bits (1327), Expect = 0.0
 Identities = 114/320 (35%), Positives = 175/320 (54%), Gaps = 25/320 (7%)

Query: 53  DDLSNSVIGSKLHVFTLAELRLITSNFSR------SNLLGEGGFGPVYKGFVDEKLKPGL 106
           ++ S  V  ++ H F+  EL+ +T+NF         N +GEGGFG VYKG+V+       
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN------ 54

Query: 107 EAQPVAVKAL----DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYM 162
               VAVK L    D+   +  +++  EI  + + +H +LV+L+G+  + +   LVY YM
Sbjct: 55  --TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 163 PRGSLHNQLF-RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY 221
           P GSL ++L     +  L W  R KIA GAA G+ FLH  +   I+RD K++NILLD  +
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAF 170

Query: 222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           TAK+SDFGLA+   +  +T + +R++GT  Y APE  + G +T  SD+YSFGVVLLE++T
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIIT 229

Query: 282 GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSH 341
           G  A+D  R    Q L +    +  E + +E  ID ++         +   + A +CL  
Sbjct: 230 GLPAVDEHR--EPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHE 286

Query: 342 HPRHRPTMSYVVRVLDSLQD 361
               RP +  V ++L  +  
Sbjct: 287 KKNKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  501 bits (1292), Expect = e-179
 Identities = 121/329 (36%), Positives = 185/329 (56%), Gaps = 12/329 (3%)

Query: 41  SDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDE 100
           S  S  ++ ++    S+ ++  + +   L +L   T+NF    L+G G FG VYKG + +
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 101 KLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYE 160
                     VA+K    + +QG +E+  EI  L   RHPHLV LIG+C E    +L+Y+
Sbjct: 63  G-------AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115

Query: 161 YMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD 218
           YM  G+L   L+ S   + ++ W  R++I +GAA+GL +LH     +I+RD K+ NILLD
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AIIHRDVKSINILLD 173

Query: 219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLE 278
            ++  K++DFG++K G E ++TH+ T V GT GY  PEY + G LT  SDVYSFGVVL E
Sbjct: 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233

Query: 279 LLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKC 338
           +L  + A+  +      +LAEWA        +LE+++DP L  +   +  +K   TA KC
Sbjct: 234 VLCARSAIVQSLPREMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPESLRKFGDTAVKC 292

Query: 339 LSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
           L+     RP+M  V+  L+     Q+S +
Sbjct: 293 LALSSEDRPSMGDVLWKLEYALRLQESVI 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  428 bits (1103), Expect = e-151
 Identities = 129/301 (42%), Positives = 179/301 (59%), Gaps = 15/301 (4%)

Query: 64  LHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG 123
           L  F+L EL++ + NFS  N+LG GGFG VYKG    +L  G     VAVK L  + TQG
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKG----RLADG---TLVAVKRLKEERTQG 69

Query: 124 HK-EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF--RSYSAALP 180
            + ++  E+  +    H +L++L G+C     RLLVY YM  GS+ + L         L 
Sbjct: 70  GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129

Query: 181 WSTRMKIALGAAKGLAFLHGEDKP-VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
           W  R +IALG+A+GLA+LH    P +I+RD KA+NILLD ++ A + DFGLAK     + 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD- 188

Query: 240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS--L 297
           THV T V GT G+ APEY+ TG  +  +DV+ +GV+LLEL+TG+RA D  RL  +    L
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248

Query: 298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
            +W + LLKE +KLE L+D  L+G +  +  ++    A  C    P  RP MS VVR+L+
Sbjct: 249 LDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

Query: 358 S 358
            
Sbjct: 308 G 308

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  264 bits (677), Expect = 2e-86
 Identities = 74/322 (22%), Positives = 125/322 (38%), Gaps = 38/322 (11%)

Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE 126
                L   +       +   G FG V+K  +          + VAVK       Q  + 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--------EYVAVKIFP---IQDKQS 62

Query: 127 WMAE--IIFLGQLRHPHLVKLIGYCWE----EEYRLLVYEYMPRGSLHNQLFRSYSAALP 180
           W  E  +  L  ++H ++++ IG        +    L+  +  +GSL + L  +    + 
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVS 119

Query: 181 WSTRMKIALGAAKGLAFLH-------GEDKP-VIYRDFKASNILLDSDYTAKLSDFGLAK 232
           W+    IA   A+GLA+LH          KP + +RD K+ N+LL ++ TA ++DFGLA 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTT-----MSDVYSFGVVLLELLTGKRAMD 287
               G+        +GT+ Y APE +              D+Y+ G+VL EL +   A D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 288 NTRLGREQSLAE--WARPLLKEPRKL--ERLIDPRLEGQF-PIKGAQKAAATAFKCLSHH 342
                      E     P L++ +++   +   P L   +    G      T  +C  H 
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299

Query: 343 PRHRPTMSYVVRVLDSLQDFQD 364
              R +   V   +  +Q   +
Sbjct: 300 AEARLSAGCVGERITQMQRLTN 321

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  212 bits (542), Expect = 4e-66
 Identities = 77/336 (22%), Positives = 122/336 (36%), Gaps = 53/336 (15%)

Query: 67  FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE 126
              +E  L   N     L+G G +G VYKG +DE        +PVAVK          + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--------RPVAVKVFS---FANRQN 51

Query: 127 WMAE--IIFLGQLRHPHLVKLIGYC------WEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
           ++ E  I  +  + H ++ + I            EY LLV EY P GSL   L       
Sbjct: 52  FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYLSLH---T 107

Query: 179 LPWSTRMKIALGAAKGLAFLHGEDK-------PVIYRDFKASNILLDSDYTAKLSDFGLA 231
             W +  ++A    +GLA+LH E          + +RD  + N+L+ +D T  +SDFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 232 K------DGPEGEETHVITRVMGTQGYAAPEYVM-------TGHLTTMSDVYSFGVVLLE 278
                      GEE +     +GT  Y APE +                D+Y+ G++  E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

Query: 279 LLTGKRAMDNTRLGREQSLA----EWARPLLKEPRKL-----ERLIDPRLEGQFPIKGAQ 329
           +      +       E  +A        P  ++ + L     +R   P    +  +   +
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVR 286

Query: 330 KAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS 365
               T   C       R T       +  L    + 
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  200 bits (511), Expect = 8e-62
 Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 47/288 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLGQLRHPHL 142
           +G G FG V++               VAVK L           E++ E+  + +LRHP++
Sbjct: 45  IGAGSFGTVHRAEWHG--------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA-ALPWSTRMKIALGAAKGLAFLHGE 201
           V  +G   +     +V EY+ RGSL+  L +S +   L    R+ +A   AKG+ +LH  
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG 261
           + P+++R+ K+ N+L+D  YT K+ DFGL++       +       GT  + APE +   
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDE 214

Query: 262 HLTTMSDVYSFGVVLLELLTGK---RAMDNTRL----GREQSLAEWARPLLKE--PRKLE 312
                SDVYSFGV+L EL T +     ++  ++    G +       R  +      ++ 
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-----KRLEIPRNLNPQVA 269

Query: 313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
            +I+                     C ++ P  RP+ + ++ +L  L 
Sbjct: 270 AIIE--------------------GCWTNEPWKRPSFATIMDLLRPLI 297

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  198 bits (505), Expect = 4e-61
 Identities = 79/296 (26%), Positives = 142/296 (47%), Gaps = 56/296 (18%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-------KEWMAEIIFLGQL 137
           +G+GGFG V+KG    +L    +   VA+K+L L  ++G        +E+  E+  +  L
Sbjct: 27  IGKGGFGLVHKG----RLVK--DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
            HP++VKL G         +V E++P G L+++L    +  + WS ++++ L  A G+ +
Sbjct: 81  NHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGIEY 137

Query: 198 LHGEDKPVIYRDFKASNILLDS-----DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +  ++ P+++RD ++ NI L S        AK++DFGL++     +  H ++ ++G   +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQW 192

Query: 253 AAPEYVMTG---HLTTMSDVYSFGVVLLELLTGK---RAMDNTRLGREQSLA-EWARPLL 305
            APE  +       T  +D YSF ++L  +LTG+         ++     +  E  RP +
Sbjct: 193 MAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251

Query: 306 KE--PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
            E  P +L  +I+                     C S  P+ RP  SY+V+ L  L
Sbjct: 252 PEDCPPRLRNVIE--------------------LCWSGDPKKRPHFSYIVKELSEL 287

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  199 bits (507), Expect = 4e-61
 Identities = 80/320 (25%), Positives = 135/320 (42%), Gaps = 51/320 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G FG V K            A+ VA+K ++ +  +  K ++ E+  L ++ HP++VK
Sbjct: 16  VGRGAFGVVCKAK--------WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVK 65

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA-LPWSTRMKIALGAAKGLAFLHGED- 202
           L G C       LV EY   GSL+N L  +        +  M   L  ++G+A+LH    
Sbjct: 66  LYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 203 KPVIYRDFKASNILLDSDYT-AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG 261
           K +I+RD K  N+LL +  T  K+ DFG A      +    +T   G+  + APE     
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGS 178

Query: 262 HLTTMSDVYSFGVVLLELLTGK---RAMDNTRLGREQSLAEWARPLLKE--PRKLERLID 316
           + +   DV+S+G++L E++T +     +         ++    RP L +  P+ +E L+ 
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 238

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPN 376
                               +C S  P  RP+M  +V+++  L  +      P  Y    
Sbjct: 239 --------------------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY---- 274

Query: 377 ETESSVYLRNGKETNSEEES 396
                  L  G++   E   
Sbjct: 275 --PCQHSLPPGEDGRVEPYV 292

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  197 bits (503), Expect = 4e-61
 Identities = 63/290 (21%), Positives = 117/290 (40%), Gaps = 50/290 (17%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHL 142
           L E   G ++KG          +   + VK L +    T+  +++  E   L    HP++
Sbjct: 18  LNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 143 VKLIGYCWEEEYRLL--VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           + ++G C          +  +MP GSL+N L    +  +  S  +K AL  A+G+AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
            +  +      + ++++D D TA++S   +         +      M    + APE  + 
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE-ALQ 181

Query: 261 G----HLTTMSDVYSFGVVLLELLTGK---RAMDNTRLGREQSLAEWARPLLKE--PRKL 311
                     +D++SF V+L EL+T +     + N  +G  +   E  RP +       +
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-MKVALEGLRPTIPPGISPHV 240

Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
            +L+                      C++  P  RP    +V +L+ +QD
Sbjct: 241 SKLMK--------------------ICMNEDPAKRPKFDMIVPILEKMQD 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  190 bits (485), Expect = 6e-58
 Identities = 61/293 (20%), Positives = 116/293 (39%), Gaps = 46/293 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           LG+G FG   K       +     + + +K L     +  + ++ E+  +  L HP+++K
Sbjct: 18  LGKGCFGQAIKV----THRE--TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
            IG  ++++    + EY+  G+L   + +S  +  PWS R+  A   A G+A+LH     
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLR-GIIKSMDSQYPWSQRVSFAKDIASGMAYLH--SMN 128

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAK------------DGPEGEETHVITRVMGTQGY 252
           +I+RD  + N L+  +    ++DFGLA+               +  +      V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA---MDNTRLGREQSLAEWARPLLKE-- 307
            APE +         DV+SFG+VL E++    A        +    ++  +         
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNC 248

Query: 308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
           P     +                      +C    P  RP+   +   L++L+
Sbjct: 249 PPSFFPIT--------------------VRCCDLDPEKRPSFVKLEHWLETLR 281

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  186 bits (475), Expect = 1e-56
 Identities = 74/289 (25%), Positives = 127/289 (43%), Gaps = 46/289 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLGQLRHPHL 142
           +G G FG VYKG              VAVK L++        + +  E+  L + RH ++
Sbjct: 32  IGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           +  +GY    +   +V ++    SL++ L  +          + IA   A+G+ +LH   
Sbjct: 83  LLFMGYSTAPQL-AIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHA-- 138

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE---YVM 259
           K +I+RD K++NI L  D T K+ DFGLA +      +H   ++ G+  + APE      
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 260 TGHLTTMSDVYSFGVVLLELLTGK---RAMDNTRLGREQSLAEWARPLLKE-----PRKL 311
           +   +  SDVY+FG+VL EL+TG+     ++N     E        P L +     P+++
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
           +RL+                     +CL      RP+   ++  ++ L 
Sbjct: 259 KRLMA--------------------ECLKKKRDERPSFPRILAEIEELA 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  185 bits (473), Expect = 2e-56
 Identities = 78/293 (26%), Positives = 124/293 (42%), Gaps = 54/293 (18%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL----DLDGTQGHKEWMAEIIFLGQLRHP 140
           +G GGFG VY+ F             VAVKA     D D +Q  +    E      L+HP
Sbjct: 15  IGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           +++ L G C +E    LV E+   G L+  L       +P    +  A+  A+G+ +LH 
Sbjct: 67  NIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHD 123

Query: 201 ED-KPVIYRDFKASNILLD--------SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           E   P+I+RD K+SNIL+         S+   K++DFGLA++              G   
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYA 179

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK---RAMDNTRLGREQSLAEWARPLLKE- 307
           + APE +     +  SDV+S+GV+L ELLTG+   R +D   +             +   
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYGVAMNKLALPIPST 238

Query: 308 -PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
            P    +L++                     C +  P  RP+ + ++  L ++
Sbjct: 239 CPEPFAKLME--------------------DCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  183 bits (466), Expect = 6e-55
 Identities = 58/312 (18%), Positives = 113/312 (36%), Gaps = 65/312 (20%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLGQLRHP 140
            L+G+G FG VY G              VA++ +D++       K +  E++   Q RH 
Sbjct: 39  ELIGKGRFGQVYHGRWH---------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           ++V  +G C    +  ++       +L++ + R     L  +   +IA    KG+ +LH 
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHA 148

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAK---DGPEGEETHVITRVMGTQGYAAPEY 257
             K ++++D K+ N+  D +    ++DFGL         G     +    G   + APE 
Sbjct: 149 --KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 258 VMTG---------HLTTMSDVYSFGVVLLELLTGK---RAMDNTRLGREQSLAEWA---- 301
           +              +  SDV++ G +  EL   +   +               W     
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTG 258

Query: 302 -RPLLKE---PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
            +P L +    +++  ++                      C +     RPT + ++ +L+
Sbjct: 259 MKPNLSQIGMGKEISDILL--------------------FCWAFEQEERPTFTKLMDMLE 298

Query: 358 SLQDFQDSFVGP 369
            L         P
Sbjct: 299 KLPKRNRRLSHP 310

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  180 bits (459), Expect = 3e-54
 Identities = 66/332 (19%), Positives = 118/332 (35%), Gaps = 80/332 (24%)

Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAE-- 130
           R +  + +    +G+G +G V++G            + VAVK      ++  K W  E  
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQG--------ENVAVKIFS---SRDEKSWFRETE 52

Query: 131 IIFLGQLRHPHLVKLIGYCWEEEYR----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
           +     LRH +++  I       +      L+  Y   GSL++ L  +    L   + ++
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLR 109

Query: 187 IALGAAKGLAFLHGEDK------PVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGE 238
           I L  A GLA LH E         + +RD K+ NIL+  +    ++D GLA        +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169

Query: 239 ETHVITRVMGTQGYAAPEYVMTGHL-------TTMSDVYSFGVVLLELLTGKRAMDNTR- 290
                   +GT+ Y APE V+   +           D+++FG+VL E+     +      
Sbjct: 170 LDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

Query: 291 --------LGREQSLAEW--------ARPLLKE-------PRKLERLIDPRLEGQFPIKG 327
                   +  + S  +          RP +            L +L+            
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK----------- 277

Query: 328 AQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                    +C   +P  R T   + + L  +
Sbjct: 278 ---------ECWYQNPSARLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  180 bits (459), Expect = 8e-54
 Identities = 72/317 (22%), Positives = 123/317 (38%), Gaps = 40/317 (12%)

Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AE 130
           R I         +G+G +G V+ G            + VAVK      T     W    E
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWRG--------EKVAVKVFF---TTEEASWFRETE 81

Query: 131 IIFLGQLRHPHLVKLIGYCWEEEYR----LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
           I     +RH +++  I    +         L+ +Y   GSL++ L    S  L   + +K
Sbjct: 82  IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLK 138

Query: 187 IALGAAKGLAFLHGEDK------PVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGE 238
           +A  +  GL  LH E         + +RD K+ NIL+  + T  ++D GLA        E
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198

Query: 239 ETHVITRVMGTQGYAAPEYVMTGHL-------TTMSDVYSFGVVLLELLTGKRAMDNTRL 291
                   +GT+ Y  PE V+   L         M+D+YSFG++L E+     +      
Sbjct: 199 VDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257

Query: 292 GRE-QSLAEWARPLLKEPRKL--ERLIDPRLEGQFPIKGAQKA-AATAFKCLSHHPRHRP 347
            +        + P  ++ R++   + + P    ++      +       +C +H+P  R 
Sbjct: 258 YQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317

Query: 348 TMSYVVRVLDSLQDFQD 364
           T   V + L  + + QD
Sbjct: 318 TALRVKKTLAKMSESQD 334

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  177 bits (450), Expect = 2e-52
 Identities = 80/339 (23%), Positives = 130/339 (38%), Gaps = 53/339 (15%)

Query: 53  DDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVA 112
            D++ S  GS L    L   R I         +G+G FG V++G            + VA
Sbjct: 21  YDMTTSGSGSGL---PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--------EEVA 69

Query: 113 VKALDLDGTQGHKEWMAE--IIFLGQLRHPHLVKLIGYCWEEEYR----LLVYEYMPRGS 166
           VK      ++  + W  E  I     LRH +++  I    ++        LV +Y   GS
Sbjct: 70  VKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS 126

Query: 167 LHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE-----DKPVI-YRDFKASNILLDSD 220
           L + L R     +     +K+AL  A GLA LH E      KP I +RD K+ NIL+  +
Sbjct: 127 LFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN 183

Query: 221 YTAKLSDFGLA--KDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-------TTMSDVYS 271
            T  ++D GLA   D             +GT+ Y APE V+   +          +D+Y+
Sbjct: 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYA 242

Query: 272 FGVVLLELLTGKRAMDNTR---------LGREQSLAEWARPLLKEPRKLERLIDPRLEGQ 322
            G+V  E+                    +  + S+ E  + + ++  +    I  R +  
Sbjct: 243 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPN--IPNRWQ-- 298

Query: 323 FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
              +  +  A    +C   +   R T   + + L  L  
Sbjct: 299 -SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (415), Expect = 7e-47
 Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 42/285 (14%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLV 143
           +G G FG V+ G    +L+       VAVK+           +++ E   L Q  HP++V
Sbjct: 122 IGRGNFGEVFSG----RLRAD--NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +LIG C +++   +V E +  G     L R+  A L   T +++   AA G+ +L  E K
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYL--ESK 232

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY----AAPEYVM 259
             I+RD  A N L+      K+SDFG++++  +G          G +       APE + 
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVPVKWTAPEALN 288

Query: 260 TGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            G  ++ SDV+SFG++L E  + G      + N     +Q+              +E+  
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTR-----------EFVEK-- 330

Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
             RL    P            +C ++ P  RP+ S + + L S++
Sbjct: 331 GGRLP--CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  159 bits (404), Expect = 5e-46
 Identities = 77/296 (26%), Positives = 120/296 (40%), Gaps = 28/296 (9%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEII 132
           F +  L     LGEG FG V     D   +     + VAVK+L    G     +   EI 
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75

Query: 133 FLGQLRHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
            L  L H ++VK  G C E+      L+ E++P GSL   L       +    ++K A+ 
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQ 134

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
             KG+ +L    +  ++RD  A N+L++S++  K+ DFGL K     +E + +       
Sbjct: 135 ICKGMDYL--GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DD 188

Query: 251 G-----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
                 + APE +M       SDV+SFGV L ELLT          L  +       +  
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248

Query: 305 LKE-PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           +      L+     RL    P     +      KC    P +R +   ++   ++L
Sbjct: 249 VTRLVNTLKE--GKRLPC--PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  159 bits (404), Expect = 1e-45
 Identities = 85/301 (28%), Positives = 124/301 (41%), Gaps = 39/301 (12%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           F   +L     LG+G FG V     D           VAVK L   G    +++  EI  
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYD--PLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77

Query: 134 LGQLRHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           L  L    +VK  G  +    +   LV EY+P G L + L + + A L  S  +  +   
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQI 136

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            KG+ +L    +  ++RD  A NIL++S+   K++DFGLAK  P  ++ +    V+   G
Sbjct: 137 CKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPG 190

Query: 252 -----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL 305
                + APE +     +  SDV+SFGVVL EL T   ++   +         E   P L
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250

Query: 306 KE-PRKLERLIDPRLEGQFPIKGAQKAAATA------FKCLSHHPRHRPTMSYVVRVLDS 358
                 LE     RL            A  A        C +  P+ RP+ S +   LD 
Sbjct: 251 SRLLELLEE--GQRLP--------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300

Query: 359 L 359
           L
Sbjct: 301 L 301

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  157 bits (399), Expect = 2e-45
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 32/300 (10%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           F   +L     LG+G FG V     D         + VAVK L     +  +++  EI  
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYD--PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 64

Query: 134 LGQLRHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           L  L+H ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++     
Sbjct: 65  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQI 123

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            KG+ +L    K  I+RD    NIL++++   K+ DFGL K  P+ +E   +      + 
Sbjct: 124 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--PGES 179

Query: 252 ---YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP 308
              + APE +     +  SDV+SFGVVL EL T      +      + +    +  +   
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239

Query: 309 RKLERLID-PRLEGQFPIKGAQKAAATA------FKCLSHHPRHRPTMSYVVRVLDSLQD 361
             +E L +  RL         +             +C +++   RP+   +   +D ++D
Sbjct: 240 HLIELLKNNGRLP--------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  157 bits (400), Expect = 3e-45
 Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 36/302 (11%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           F   +L     LG+G FG V     D         + VAVK L     +  +++  EI  
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYD--PLQDNTGEVVAVKKLQHSTEEHLRDFEREIEI 95

Query: 134 LGQLRHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
           L  L+H ++VK  G C+    R   L+ EY+P GSL + L + +   +     ++     
Sbjct: 96  LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQI 154

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
            KG+ +L    K  I+RD    NIL++++   K+ DFGL K  P+ +E + +       G
Sbjct: 155 CKGMEYL--GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPG 208

Query: 252 -----YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
                + APE +     +  SDV+SFGVVL EL T      +      + +    +  + 
Sbjct: 209 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268

Query: 307 EPRKLERLID-PRLEGQFPIKGAQKAAATA------FKCLSHHPRHRPTMSYVVRVLDSL 359
               +E L +  RL         +             +C +++   RP+   +   +D +
Sbjct: 269 VFHLIELLKNNGRLP--------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

Query: 360 QD 361
           +D
Sbjct: 321 RD 322

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  157 bits (398), Expect = 6e-45
 Identities = 93/301 (30%), Positives = 128/301 (42%), Gaps = 36/301 (11%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEII 132
           F +  L     LGEG FG V     D         + VAVKAL  D G Q    W  EI 
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYD--PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85

Query: 133 FLGQLRHPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
            L  L H H++K  G C +       LV EY+P GSL + L   +S  +  +  +  A  
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHS--IGLAQLLLFAQQ 142

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
             +G+A+L    +  I+RD  A N+LLD+D   K+ DFGLAK  PEG E +     +   
Sbjct: 143 ICEGMAYL--HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVRED 196

Query: 251 G-----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL 304
           G     + APE +        SDV+SFGV L ELLT    +        E       +  
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

Query: 305 LKEPRKL----ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
           +    +L    ERL  PR     P K   +       C       RPT   ++ +L ++ 
Sbjct: 257 VLRLTELLERGERL--PR-----PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

Query: 361 D 361
           +
Sbjct: 310 E 310

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  153 bits (390), Expect = 1e-43
 Identities = 75/313 (23%), Positives = 127/313 (40%), Gaps = 56/313 (17%)

Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EW 127
           A LR++  + F +  +LG G FG VYKG      +      PVA+K L    +     E 
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLW--IPEGEKVKIPVAIKELREATSPKANKEI 64

Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           + E   +  + +PH+ +L+G C       L+ + MP G L + + R +   +     +  
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNW 122

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK     E+ +      
Sbjct: 123 CVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----H 175

Query: 248 GTQG-----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLA 298
              G     + A E ++    T  SDV+S+GV + EL+T G +    +  + +       
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------- 228

Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATA------FKCLSHHPRHRPTMSYV 352
                       LE+    RL         Q    T        KC       RP    +
Sbjct: 229 ---------SSILEK--GERLP--------QPPICTIDVYMIMRKCWMIDADSRPKFREL 269

Query: 353 VRVLDSLQDFQDS 365
           +     +   +D 
Sbjct: 270 IIEFSKM--ARDP 280

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  152 bits (386), Expect = 4e-43
 Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 15/212 (7%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLV 143
           +G G FG VYKG +  K   G +  PVA+K L    T +   +++ E   +GQ  H +++
Sbjct: 52  IGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +L G   + +  +++ EYM  G+L   L R           + +  G A G+ +L   + 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL--ANM 166

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYAAPEYVMT 260
             ++RD  A NIL++S+   K+SDFGL++   +  E    T   G +    + APE +  
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIPIRWTAPEAISY 224

Query: 261 GHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
              T+ SDV+SFG+V+ E++T G+R    + N
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  149 bits (379), Expect = 1e-42
 Identities = 65/215 (30%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG G FG V +G      +   +   VA+K L     +    E M E   + QL +P++V
Sbjct: 18  LGCGNFGSVRQG----VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +LIG C + E  +LV E    G LH  L       +P S   ++    + G+ +L  E+K
Sbjct: 74  RLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL--EEK 129

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG------TQGYAAPEY 257
             ++RD  A N+LL + + AK+SDFGL+K     +  +   R  G           APE 
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWY----APEC 184

Query: 258 VMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
           +     ++ SDV+S+GV + E L+ G++    M  
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  149 bits (378), Expect = 2e-42
 Identities = 66/299 (22%), Positives = 115/299 (38%), Gaps = 45/299 (15%)

Query: 77  SNFSRSNLLGEGGFGPVYKG-FVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
            +   +  LG+G F  ++KG   +      L    V +K LD       + +      + 
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +L H HLV   G C   +  +LV E++  GSL   L +     +    ++++A   A  +
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAM 126

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYT--------AKLSDFGLAKDGPEGEETHVITRVM 247
            FL  E+  +I+ +  A NILL  +           KLSD G++      +        +
Sbjct: 127 HFL--EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV 184

Query: 248 GTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLAEWAR 302
                  PE +    +L   +D +SFG  L E+ + G +   A+D+ R            
Sbjct: 185 ------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----------KL 228

Query: 303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
              ++  +L       L            A     C+ + P HRP+   ++R L+SL  
Sbjct: 229 QFYEDRHQLPAPKAAEL------------ANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  150 bits (380), Expect = 3e-42
 Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 22/215 (10%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           +G G  G V  G +     PG    PVA+KAL    T+  + ++++E   +GQ  HP+++
Sbjct: 57  IGSGDSGEVCYGRL---RVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +L G        ++V EYM  GSL   L R++         + +  G   G+ +L   D 
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL--SDL 170

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG------YAAPEY 257
             ++RD  A N+L+DS+   K+SDFGL++   +  +         T G      + APE 
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAPEA 225

Query: 258 VMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
           +     ++ SDV+SFGVV+ E+L  G+R    M N
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  148 bits (375), Expect = 4e-42
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 22/219 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
              +    LG G FG V  G    +         VAVK +  +G+    E+  E   + +
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQY-------DVAVKMIK-EGSMSEDEFFQEAQTMMK 59

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP LVK  G C +E    +V EY+  G L N L RS+   L  S  +++     +G+A
Sbjct: 60  LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYA 253
           FL  E    I+RD  A N L+D D   K+SDFG+ +   + +        +GT+    ++
Sbjct: 119 FL--ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----VSSVGTKFPVKWS 172

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
           APE       ++ SDV++FG+++ E+ + GK       N
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  148 bits (375), Expect = 4e-42
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 22/219 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           S  +    +G G FG V+ G+   K         VA+K +  +G    ++++ E   + +
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNK-------DKVAIKTIR-EGAMSEEDFIEEAEVMMK 59

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP LV+L G C E+    LV E+M  G L + L R+        T + + L   +G+A
Sbjct: 60  LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMA 118

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYA 253
           +L  E+  VI+RD  A N L+  +   K+SDFG+ +   + +     T   GT+    +A
Sbjct: 119 YL--EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY----TSSTGTKFPVKWA 172

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
           +PE       ++ SDV+SFGV++ E+ + GK       N
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  150 bits (382), Expect = 4e-42
 Identities = 70/221 (31%), Positives = 117/221 (52%), Gaps = 18/221 (8%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEIIFL 134
           +N S   ++G G FG V  G    +LK P  +   VA+K L +  T+  + +++ E   +
Sbjct: 45  TNISIDKVVGAGEFGEVCSG----RLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           GQ  HP++++L G   + +  ++V EYM  GSL + L R + A       + +  G A G
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASG 159

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---G 251
           + +L   D   ++RD  A NIL++S+   K+SDFGL +   +  E    TR  G +    
Sbjct: 160 MKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIR 215

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
           + +PE +     T+ SDV+S+G+VL E+++ G+R    M N
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  147 bits (373), Expect = 1e-41
 Identities = 57/219 (26%), Positives = 101/219 (46%), Gaps = 22/219 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
            + +    LG G FG V  G    +         VA+K +  +G+    E++ E   +  
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQY-------DVAIKMIK-EGSMSEDEFIEEAKVMMN 75

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L H  LV+L G C ++    ++ EYM  G L N L R           +++     + + 
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAME 134

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ---GYA 253
           +L  E K  ++RD  A N L++     K+SDFGL++   + E     T  +G++    ++
Sbjct: 135 YL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWS 188

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
            PE +M    ++ SD+++FGV++ E+ + GK       N
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  147 bits (372), Expect = 2e-41
 Identities = 60/276 (21%), Positives = 99/276 (35%), Gaps = 43/276 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPH 141
            +G G F  VYKG   E          VA   L          + +  E   L  L+HP+
Sbjct: 33  EIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 142 LVKLIGYC---WEEEYRLLVY-EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           +V+         + +  +++  E M  G+L     + +   +             KGL F
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLK-TYLKRFKV-MKIKVLRSWCRQILKGLQF 144

Query: 198 LHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           LH    P+I+RD K  NI +     + K+ D GLA      +       V+GT  + APE
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPE 200

Query: 257 YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE--PRKLERL 314
                +     DVY+FG+ +LE+ T +           Q+ A+  R +     P   +++
Sbjct: 201 MYEEKY-DESVDVYAFGMCMLEMATSEYPYSE-----CQNAAQIYRRVTSGVKPASFDKV 254

Query: 315 IDPRLEGQFPIKGAQKAAATAF--KCLSHHPRHRPT 348
             P                      C+  +   R +
Sbjct: 255 AIP--------------EVKEIIEGCIRQNKDERYS 276

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  146 bits (371), Expect = 2e-41
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKAL---DLDGTQGHKEWMAEII 132
            +      LG+G FG V +G    +   P  +   VAVK L    L   +   +++ E+ 
Sbjct: 18  KDLRLLEKLGDGSFGVVRRG----EWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            +  L H +L++L G         +V E  P GSL ++L R +       T  + A+  A
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVA 131

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG- 251
           +G+ +L  E K  I+RD  A N+LL +    K+ DFGL +  P+ ++ +    VM     
Sbjct: 132 EGMGYL--ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY----VMQEHRK 185

Query: 252 ----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               + APE + T   +  SD + FGV L E+ T
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  146 bits (371), Expect = 3e-41
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 42/289 (14%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPH 141
            ++G G FG VY G +   L    +    AVK+L+     G   +++ E I +    HP+
Sbjct: 31  EVIGRGHFGCVYHGTL---LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 142 LVKLIGYCWEEE-YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           ++ L+G C   E   L+V  YM  G L N + R+ +        +   L  AKG+ +L  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL-- 144

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA------A 254
             K  ++RD  A N +LD  +T K++DFGLA+D  + E       V    G        A
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 200

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLAEWARPLLKEPRK 310
            E + T   TT SDV+SFGV+L EL+T G      ++   +             L + R+
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV----------YLLQGRR 250

Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L +          P            KC       RP+ S +V  + ++
Sbjct: 251 LLQ----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  147 bits (373), Expect = 3e-41
 Identities = 77/340 (22%), Positives = 136/340 (40%), Gaps = 74/340 (21%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEII 132
            +R  +     LG+G FG VY+G   + +        VA+K ++   +     E++ E  
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVA-KGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--------FRSYSAALPWSTR 184
            + +    H+V+L+G   + +  L++ E M RG L + L             A    S  
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT 244
           +++A   A G+A+L       ++RD  A N ++  D+T K+ DFG+ +D  E +      
Sbjct: 141 IQMAGEIADGMAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY---- 194

Query: 245 RVMGTQGY-----AAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQ 295
              G +G       +PE +  G  TT SDV+SFGVVL E+ T  ++    + N ++ R  
Sbjct: 195 -RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR-- 251

Query: 296 SLAEWARPLLKE----------PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH 345
                    + E          P  L  L+                      C  ++P+ 
Sbjct: 252 --------FVMEGGLLDKPDNCPDMLFELM--------------------RMCWQYNPKM 283

Query: 346 RPTMSYVVRVLDSLQDFQDSFV-GPFVYVVPNETESSVYL 384
           RP+   ++  +   ++ +  F    F Y   N+      L
Sbjct: 284 RPSFLEIISSIK--EEMEPGFREVSFYYSEENKLPEPEEL 321

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  146 bits (371), Expect = 4e-41
 Identities = 73/313 (23%), Positives = 127/313 (40%), Gaps = 58/313 (18%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEI 131
             R+ L     LGEG FG V +G + +       +  VAVK + LD +  +  +E+++E 
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQ---EDGTSLKVAVKTMKLDNSSQREIEEFLSEA 87

Query: 132 IFLGQLRHPHLVKLIGYCWEEE-----YRLLVYEYMPRGSLHNQL----FRSYSAALPWS 182
             +    HP++++L+G C E         +++  +M  G LH  L      +    +P  
Sbjct: 88  ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
           T +K  +  A G+ +L   ++  ++RD  A N +L  D T  ++DFGL+K    G+    
Sbjct: 148 TLLKFMVDIALGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205

Query: 243 ITRV------MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLG 292
                     +      A E +     T+ SDV++FGV + E+ T G      + N  + 
Sbjct: 206 GRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259

Query: 293 REQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYV 352
                       L    +L++          P     +     + C    P  RPT S +
Sbjct: 260 D----------YLLHGHRLKQ----------PEDCLDELYEIMYSCWRTDPLDRPTFSVL 299

Query: 353 VRVLDS-LQDFQD 364
              L+  L+   D
Sbjct: 300 RLQLEKLLESLPD 312

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  145 bits (368), Expect = 6e-41
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 27/224 (12%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHK-EWMAEIIFL 134
            +   + +LGEG FG VY+G           E   VAVK    D T  +K ++M+E + +
Sbjct: 12  EDVVLNRILGEGFFGEVYEG----VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
             L HPH+VKLIG   EEE   ++ E  P G L + L      +L   T +  +L   K 
Sbjct: 68  KNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKA 125

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG--- 251
           +A+L  E    ++RD    NIL+ S    KL DFGL++   + +                
Sbjct: 126 MAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-------ASVTRL 176

Query: 252 ---YAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
              + +PE +     TT SDV+ F V + E+L+ GK+    ++N
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  145 bits (367), Expect = 1e-40
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
             R+++     LG G +G VY+G      K    +  VAVK L  + T   +E++ E   
Sbjct: 10  MERTDITMKHKLGGGQYGEVYEG----VWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAV 62

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + +++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   + 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE-ETHVITRV----MG 248
            + +L  E K  I+RD  A N L+  ++  K++DFGL++         H   +       
Sbjct: 123 AMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT- 179

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                APE +     +  SDV++FGV+L E+ T
Sbjct: 180 -----APESLAYNKFSIKSDVWAFGVLLWEIAT 207

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  145 bits (369), Expect = 1e-40
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 18/219 (8%)

Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EW 127
           A LR++  + F +  +LG G FG VYKG      +      PVA+K L    +     E 
Sbjct: 7   ALLRILKETEFKKIKVLGSGAFGTVYKGLW--IPEGEKVKIPVAIKELREATSPKANKEI 64

Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           + E   +  + +PH+ +L+G C       L+ + MP G L + + R +   +     +  
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV-REHKDNIGSQYLLNW 122

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            +  AKG+ +L  ED+ +++RD  A N+L+ +    K++DFGLAK     E+ +      
Sbjct: 123 CVQIAKGMNYL--EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----H 175

Query: 248 GTQG-----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
              G     + A E ++    T  SDV+S+GV + EL+T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  145 bits (369), Expect = 1e-40
 Identities = 75/327 (22%), Positives = 122/327 (37%), Gaps = 77/327 (23%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
             R ++     LGEG FG V+       L P  +   VAVKAL        +++  E   
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR--------- 184
           L  L+H H+V+  G C E    L+V+EYM  G L+  L      A   +           
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 185 ----MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
               + +A   A G+ +L       ++RD    N L+      K+ DFG+++D    +  
Sbjct: 157 LGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214

Query: 241 HVITRV------MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTR 290
            V  R       M       PE ++    TT SDV+SFGVVL E+ T GK+    + N  
Sbjct: 215 RVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-- 266

Query: 291 LGREQSLAEWARPLLKE----------PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLS 340
               +++       + +          P ++  ++                      C  
Sbjct: 267 ---TEAID-----CITQGRELERPRACPPEVYAIM--------------------RGCWQ 298

Query: 341 HHPRHRPTMSYVVRVLDSLQDFQDSFV 367
             P+ R ++  V   L +L      ++
Sbjct: 299 REPQQRHSIKDVHARLQALAQAPPVYL 325

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  145 bits (369), Expect = 1e-40
 Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 17/211 (8%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLG 135
           +   +  +LG G FG V+KG      +      PV +K + D  G Q  +     ++ +G
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVW--IPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
            L H H+V+L+G C       LV +Y+P GSL + + R +  AL     +   +  AKG+
Sbjct: 71  SLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGM 128

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG---- 251
            +L  E+  +++R+  A N+LL S    +++DFG+A   P  ++      ++ ++     
Sbjct: 129 YYL--EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----LLYSEAKTPI 181

Query: 252 -YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            + A E +  G  T  SDV+S+GV + EL+T
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  144 bits (366), Expect = 1e-40
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 24/215 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEIIFLGQLRHPHL 142
           LG G FG V KG      +     + VAVK L  + +      E +AE   + QL +P++
Sbjct: 25  LGSGNFGTVKKG----YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V++IG C E E  +LV E    G L+  L    +  +     +++    + G+ +L  E+
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EE 135

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG-----YAAPEY 257
              ++RD  A N+LL + + AK+SDFGL+K     E  +       T G     + APE 
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPEC 191

Query: 258 VMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
           +     ++ SDV+SFGV++ E  + G++    M  
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  144 bits (366), Expect = 2e-40
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPH 141
            ++G+G FG VY G     +         A+K+L           ++ E + +  L HP+
Sbjct: 27  RVIGKGHFGVVYHGEY---IDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 142 LVKLIGYCWEEE-YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           ++ LIG     E    ++  YM  G L   + RS          +   L  A+G+ +L  
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL-- 140

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG------TQGYAA 254
            ++  ++RD  A N +LD  +T K++DFGLA+D  + E   V            T    A
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLT 281
            E + T   TT SDV+SFGV+L ELLT
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (364), Expect = 2e-40
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 21/212 (9%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLG 135
                   +GEG FG V++G     + P   A  VA+K      +   + +++ E + + 
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIY---MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 71

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           Q  HPH+VKLIG    E    ++ E    G L + L +    +L  ++ +  A   +  L
Sbjct: 72  QFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTAL 129

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG---- 251
           A+L  E K  ++RD  A N+L+ S+   KL DFGL++   +                   
Sbjct: 130 AYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-------ASKGKLP 180

Query: 252 --YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
             + APE +     T+ SDV+ FGV + E+L 
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEILM 212

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  143 bits (364), Expect = 3e-40
 Identities = 82/314 (26%), Positives = 129/314 (41%), Gaps = 62/314 (19%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
             R ++     LGEG FG V+       L P  +   VAVKAL        K++  E   
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAEC-YNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--------------FRSYSAAL 179
           L  L+H H+VK  G C + +  ++V+EYM  G L+  L               R     L
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
             S  + IA   A G+ +L    +  ++RD    N L+ ++   K+ DFG+++D    + 
Sbjct: 131 GLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 240 THVITRV------MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNT 289
             V          M       PE +M    TT SDV+SFGV+L E+ T GK+    + NT
Sbjct: 189 YRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 242

Query: 290 RLGREQSLAEWARPLLKEPRKLERLIDPRL--EGQFPIKGAQKAAATAFKCLSHHPRHRP 347
            +             + + R LER   PR+  +  + +            C    P+ R 
Sbjct: 243 EVIE----------CITQGRVLER---PRVCPKEVYDVM---------LGCWQREPQQRL 280

Query: 348 TMSYVVRVLDSLQD 361
            +  + ++L +L  
Sbjct: 281 NIKEIYKILHALGK 294

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  143 bits (362), Expect = 3e-40
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 31/213 (14%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
            +   L     +G+G FG V  G              VAVK +  D T   + ++AE   
Sbjct: 18  LNMKELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASV 67

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           + QLRH +LV+L+G   EE+  L +V EYM +GSL + L     + L     +K +L   
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 127

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV----MG 248
           + + +L  E    ++RD  A N+L+  D  AK+SDFGL K+      T    ++      
Sbjct: 128 EAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE---ASSTQDTGKLPVKWT- 181

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                APE +     +T SDV+SFG++L E+ +
Sbjct: 182 -----APEALREKKFSTKSDVWSFGILLWEIYS 209

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  145 bits (368), Expect = 4e-40
 Identities = 67/207 (32%), Positives = 100/207 (48%), Gaps = 18/207 (8%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEIIFLGQLRHPH 141
            ++G G FG VY G +   L    +    AVK+L  +       +++ E I +    HP+
Sbjct: 95  EVIGRGHFGCVYHGTL---LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 142 LVKLIGYCWEEEY-RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           ++ L+G C   E   L+V  YM  G L N + R+ +        +   L  AKG+ FL  
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL-- 208

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG------TQGYAA 254
             K  ++RD  A N +LD  +T K++DFGLA+D  + E   V  +              A
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----A 264

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLT 281
            E + T   TT SDV+SFGV+L EL+T
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (371), Expect = 6e-40
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 25/210 (11%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
            +   L     +G+G FG V  G              VAVK +  D T   + ++AE   
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASV 239

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           + QLRH +LV+L+G   EE+  L +V EYM +GSL + L     + L     +K +L   
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 299

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI-TRVMGTQG 251
           + + +L  E    ++RD  A N+L+  D  AK+SDFGL K+    ++T  +  +      
Sbjct: 300 EAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---- 353

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
             APE +     +T SDV+SFG++L E+ +
Sbjct: 354 --APEALREKKFSTKSDVWSFGILLWEIYS 381

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  143 bits (363), Expect = 7e-40
 Identities = 81/347 (23%), Positives = 141/347 (40%), Gaps = 70/347 (20%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEII 132
              +++     +GEG FG V K     ++K        A+K +    ++  H+++  E+ 
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 77

Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--------------FRSYSA 177
            L +L  HP+++ L+G C    Y  L  EY P G+L + L                S ++
Sbjct: 78  VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137

Query: 178 ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 237
            L     +  A   A+G+ +L    K  I+RD  A NIL+  +Y AK++DFGL++     
Sbjct: 138 TLSSQQLLHFAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195

Query: 238 EETHVITRV----MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNT 289
            +   + R+    M      A E +     TT SDV+S+GV+L E+++ G      M   
Sbjct: 196 VKKT-MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248

Query: 290 RLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
            L             L +  +LE+          P+    +      +C    P  RP+ 
Sbjct: 249 EL----------YEKLPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSF 288

Query: 350 SYVVRVLDSLQDFQDSFVGPFVYVVPNETESSVYLRNGKETNSEEES 396
           + ++  L+ +            YV     E   Y   G + ++EE +
Sbjct: 289 AQILVSLNRM------LEERKTYVNTTLYEKFTYA--GIDCSAEEAA 327

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  147 bits (372), Expect = 7e-40
 Identities = 68/281 (24%), Positives = 127/281 (45%), Gaps = 34/281 (12%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           + LG G +G VY+G      K    +  VAVK L  + T   +E++ E   + +++HP+L
Sbjct: 226 HKLGGGQYGEVYEG----VWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           V+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + +L  E 
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EK 336

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH 262
           K  I+R+  A N L+  ++  K++DFGL++    G+             + APE +    
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 263 LTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
            +  SDV++FGV+L E+ T G      +D ++             LL++  ++ER     
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMER----- 440

Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                P    +K       C   +P  RP+ + + +  +++
Sbjct: 441 -----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  145 bits (367), Expect = 2e-39
 Identities = 75/288 (26%), Positives = 119/288 (41%), Gaps = 38/288 (13%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
            +      LG+G FG V+ G              VA+K L   GT   + ++ E   + +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMG----TWNG---TTRVAIKTLK-PGTMSPEAFLQEAQVMKK 235

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           LRH  LV+L      EE   +V EYM +GSL + L       L     + +A   A G+A
Sbjct: 236 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE-ETHVITRVMGTQGYAAP 255
           ++  E    ++RD +A+NIL+  +   K++DFGLA+   + E       +      + AP
Sbjct: 295 YV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAP 350

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDNTRLGREQSLAEWARPLLKEPRKL 311
           E  + G  T  SDV+SFG++L EL T G+     M N                ++   ++
Sbjct: 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------VLDQVERGYRM 400

Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                       P +  +       +C    P  RPT  Y+   L+  
Sbjct: 401 PC----------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  142 bits (360), Expect = 3e-39
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 27/222 (12%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEII 132
             R N+     LG G FG VY+G V   +        VAVK L ++   Q   +++ E +
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS-----YSAALPWSTRMKI 187
            + +  H ++V+ IG   +   R ++ E M  G L + L  +       ++L     + +
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLD---SDYTAKLSDFGLAKDGPEGEETHVIT 244
           A   A G  +L  E+   I+RD  A N LL        AK+ DFG+A+D           
Sbjct: 146 ARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY---- 199

Query: 245 RVMGTQGY-----AAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
              G           PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 200 -RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  147 bits (373), Expect = 3e-39
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEII 132
             R  +     +GEG FG V++G     + P   A  VA+K      +   + +++ E +
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIY---MSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            + Q  HPH+VKLIG    E    ++ E    G L + L +    +L  ++ +  A   +
Sbjct: 444 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLS 501

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG- 251
             LA+L  E K  ++RD  A N+L+ S+   KL DFGL++   +            ++G 
Sbjct: 502 TALAYL--ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY------KASKGK 553

Query: 252 ----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               + APE +     T+ SDV+ FGV + E+L 
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  147 bits (371), Expect = 4e-39
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLGQLRHPHLV 143
           LG G FG V +G      +   +   VA+K L     +    E M E   + QL +P++V
Sbjct: 344 LGCGNFGSVRQG----VYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
           +LIG C + E  +LV E    G LH  L       +P S   ++    + G+ +L  E+K
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL--EEK 455

Query: 204 PVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG-----YAAPEYV 258
             ++R+  A N+LL + + AK+SDFGL+K     +  +       + G     + APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECI 511

Query: 259 MTGHLTTMSDVYSFGVVLLELLT 281
                ++ SDV+S+GV + E L+
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALS 534

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  142 bits (360), Expect = 5e-39
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 27/222 (12%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL-DLDGTQGHKEWMAEII 132
             R N+     LG G FG VY+G V   +        VAVK L ++   Q   +++ E +
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS-----YSAALPWSTRMKI 187
            + +  H ++V+ IG   +   R ++ E M  G L + L  +       ++L     + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLD---SDYTAKLSDFGLAKDGPEGEETHVIT 244
           A   A G  +L  E+   I+RD  A N LL        AK+ DFG+A+D           
Sbjct: 187 ARDIACGCQYL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY---- 240

Query: 245 RVMGTQGY-----AAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
              G           PE  M G  T+ +D +SFGV+L E+ +
Sbjct: 241 -RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  140 bits (354), Expect = 6e-39
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 35/229 (15%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEII 132
            S S +     LGE  FG VYKG +     PG + Q VA+K L         +E+  E +
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHL-FGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--------------FRSYSAA 178
              +L+HP++V L+G   +++   +++ Y   G LH  L               R+  +A
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
           L     + +    A G+ +L      V+++D    N+L+      K+SD GL ++    +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

Query: 239 ETHVIT------RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
              ++       R M      APE +M G  +  SD++S+GVVL E+ +
Sbjct: 183 YYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  140 bits (355), Expect = 9e-39
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 34/226 (15%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEI 131
                      LG+G FG V +  +    +       VAVK L  D+  +   +E++ E 
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQL---KQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYR------LLVYEYMPRGSLHNQL----FRSYSAALPW 181
             + +  HPH+ KL+G       +      +++  +M  G LH  L           LP 
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--E 239
            T ++  +  A G+ +L    +  I+RD  A N +L  D T  ++DFGL++    G+   
Sbjct: 137 QTLVRFMVDIACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194

Query: 240 THVITRV----MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
               +++    +      A E +     T  SDV++FGV + E++T
Sbjct: 195 QGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (366), Expect = 1e-38
 Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 14/206 (6%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
            +      LG+G FG V+ G              VA+K L   GT   + ++ E   + +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMG----TWNG---TTRVAIKTLK-PGTMSPEAFLQEAQVMKK 318

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           LRH  LV+L      EE   +V EYM +GSL + L       L     + +A   A G+A
Sbjct: 319 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE-ETHVITRVMGTQGYAAP 255
           ++  E    ++RD +A+NIL+  +   K++DFGLA+   + E       +      + AP
Sbjct: 378 YV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAP 433

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLT 281
           E  + G  T  SDV+SFG++L EL T
Sbjct: 434 EAALYGRFTIKSDVWSFGILLTELTT 459

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  139 bits (352), Expect = 1e-38
 Identities = 71/222 (31%), Positives = 109/222 (49%), Gaps = 27/222 (12%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
             R  L     LG G FG V+ G              VAVK+L   G+     ++AE   
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMG----YYNG---HTKVAVKSLK-QGSMSPDAFLAEANL 61

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           + QL+H  LV+L      +E   ++ EYM  GSL + L       L  +  + +A   A+
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ--- 250
           G+AF+  E++  I+RD +A+NIL+    + K++DFGLA+   + E     T   G +   
Sbjct: 121 GMAFI--EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE----YTAREGAKFPI 174

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
            + APE +  G  T  SDV+SFG++L E++T G+     M N
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (360), Expect = 3e-38
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 22/219 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
            +      LG G FG V+                VAVK +   G+   + ++AE   +  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMA----TYNK---HTKVAVKTMK-PGSMSVEAFLAEANVMKT 239

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L+H  LVKL     +E    ++ E+M +GSL + L     +  P    +  +   A+G+A
Sbjct: 240 LQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG---YA 253
           F+  E +  I+RD +A+NIL+ +    K++DFGLA+   + E     T   G +    + 
Sbjct: 299 FI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWT 352

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMDN 288
           APE +  G  T  SDV+SFG++L+E++T G+     M N
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  135 bits (342), Expect = 7e-37
 Identities = 72/237 (30%), Positives = 105/237 (44%), Gaps = 43/237 (18%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEII 132
           F R NL     LGEG FG V K      LK       VAVK L  + +    ++ ++E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATA-FHLKGRAGYTTVAVKMLKENASPSELRDLLSEFN 78

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS------------------ 174
            L Q+ HPH++KL G C ++   LL+ EY   GSL   L  S                  
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 175 ----YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
                  AL     +  A   ++G+ +L   +  +++RD  A NIL+      K+SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGL 196

Query: 231 AKDGPEGEETHVIT------RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           ++D  E +     +      + M      A E +     TT SDV+SFGV+L E++T
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  135 bits (343), Expect = 7e-37
 Identities = 56/236 (23%), Positives = 99/236 (41%), Gaps = 41/236 (17%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEII 132
           + R+N+     +GEG FG V++      L P      VAVK L  + +     ++  E  
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR-------- 184
            + +  +P++VKL+G C   +   L++EYM  G L+  L       +   +         
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 185 --------------MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
                         + IA   A G+A+L   ++  ++RD    N L+  +   K++DFGL
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGL 220

Query: 231 AKDGPEGEETHVITRVMGTQGY-----AAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           +++    +                     PE +     TT SDV+++GVVL E+ +
Sbjct: 221 SRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  135 bits (342), Expect = 8e-37
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 61/318 (19%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEII 132
           F R+NL     LG G FG V +      L        VAVK L         +  M+E+ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATA-FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101

Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL------------FRSYSAAL 179
            +  L +H ++V L+G C      L++ EY   G L N L            F   ++  
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
                +  +   A+G+AFL    K  I+RD  A N+LL + + AK+ DFGLA+D      
Sbjct: 162 STRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

Query: 240 THVIT------RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR----AMDN 288
             V        + M      APE +     T  SDV+S+G++L E+ + G       + N
Sbjct: 220 YIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273

Query: 289 TRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
           ++  +          L+K+  ++ +          P    +   +    C +  P HRPT
Sbjct: 274 SKFYK----------LVKDGYQMAQ----------PAFAPKNIYSIMQACWALEPTHRPT 313

Query: 349 MSYVVRVLDSLQDFQDSF 366
              +   L      Q+  
Sbjct: 314 FQQICSFLQEQ--AQEDR 329

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  135 bits (342), Expect = 1e-36
 Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 36/231 (15%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQG-HKEWMAEI 131
           F R  L     LGEG FG V         K    EA  VAVK L  D T+    + ++E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91

Query: 132 IFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--------------FRSYS 176
             +  + +H +++ L+G C ++    ++ EY  +G+L   L               R   
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 177 AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 236
             + +   +      A+G+ +L    +  I+RD  A N+L+  +   K++DFGLA+D   
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 237 GEETHVIT------RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            +     T      + M      APE +     T  SDV+SFGV++ E+ T
Sbjct: 210 IDYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (339), Expect = 1e-36
 Identities = 76/337 (22%), Positives = 116/337 (34%), Gaps = 49/337 (14%)

Query: 16  KSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLI 75
            SS  +  T N         Q   +S     S  L +     S   S             
Sbjct: 7   HSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQ---------- 56

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIF 133
             +F R + LG G +G V+K       + G   +  AVK       G +     +AE+  
Sbjct: 57  -QSFQRLSRLGHGSYGEVFKVR---SKEDG---RLYAVKRSMSPFRGPKDRARKLAEVGS 109

Query: 134 LGQL-RHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             ++ +HP  V+L    WEE   L L  E     SL      ++ A+LP +         
Sbjct: 110 HEKVGQHPCCVRLEQ-AWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDT 166

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
              LA LH   + +++ D K +NI L      KL DFGL  +        V     G   
Sbjct: 167 LLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPR 221

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL 311
           Y APE +   +  T +DV+S G+ +LE+                        L       
Sbjct: 222 YMAPELLQGSY-GTAADVFSLGLTILEVACNM-------------------ELPHGGEGW 261

Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
           ++L    L  +F    + +  +     L   P+ R T
Sbjct: 262 QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRAT 298

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  135 bits (342), Expect = 2e-36
 Identities = 86/372 (23%), Positives = 142/372 (38%), Gaps = 68/372 (18%)

Query: 28  QVDKQTSFQRLCLSDVSNPSS-----PLSADDLSNSVIGSKLHVFTLAELRLITSN---F 79
           ++ K+   +R       + SS     PL       S       +  ++E  L       F
Sbjct: 19  KLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEF 78

Query: 80  SRSNL-----LGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQG-HKEWMAEII 132
            R  L     LGEG FG V         K    EA  VAVK L  D T+    + ++E+ 
Sbjct: 79  PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138

Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--------------FRSYSA 177
            +  + +H +++ L+G C ++    ++ EY  +G+L   L               R    
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 178 ALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEG 237
            + +   +      A+G+ +L    +  I+RD  A N+L+  +   K++DFGLA+D    
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 238 EETHVIT------RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKR---AMD 287
           +     T      + M      APE +     T  SDV+SFGV++ E+ T G      + 
Sbjct: 257 DYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310

Query: 288 NTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP 347
              L +          LLKE  ++++          P     +       C    P  RP
Sbjct: 311 VEELFK----------LLKEGHRMDK----------PANCTNELYMMMRDCWHAVPSQRP 350

Query: 348 TMSYVVRVLDSL 359
           T   +V  LD +
Sbjct: 351 TFKQLVEDLDRI 362

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (338), Expect = 3e-36
 Identities = 70/232 (30%), Positives = 92/232 (39%), Gaps = 38/232 (16%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEII 132
           F R+ L     LG G FG V +      L     A  VAVK L        +   M+E+ 
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATA-YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78

Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL----------------FRSY 175
            L  L  H ++V L+G C      L++ EY   G L N L                    
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
             AL     +  +   AKG+AFL    K  I+RD  A NILL      K+ DFGLA+D  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 236 EGEETHVIT------RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
                 V        + M      APE +     T  SDV+S+G+ L EL +
Sbjct: 197 NDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  132 bits (334), Expect = 3e-35
 Identities = 64/230 (27%), Positives = 99/230 (43%), Gaps = 34/230 (14%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQG-HKEWMAEI 131
             R  L     LGEG FG V         K        VAVK L  D T+    + ++E+
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125

Query: 132 IFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR------ 184
             +  + +H +++ L+G C ++    ++ EY  +G+L   L       L +S        
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 185 --------MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 236
                   +  A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D   
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243

Query: 237 GEETHVITRVMGTQG-----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
            +          T G     + APE +     T  SDV+SFGV+L E+ T
Sbjct: 244 IDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  130 bits (330), Expect = 3e-35
 Identities = 64/230 (27%), Positives = 95/230 (41%), Gaps = 35/230 (15%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEII 132
           F R  L     LG G FG V +      +      + VAVK L    T   H+  M+E+ 
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82

Query: 133 FLGQL-RHPHLVKLIGYCWEEEY-RLLVYEYMPRGSLHNQL--------------FRSYS 176
            L  +  H ++V L+G C +     +++ E+   G+L   L                 Y 
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 177 AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 236
             L     +  +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 237 GEETHVITRVMGTQG-----YAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
             +      V          + APE +     T  SDV+SFGV+L E+ +
Sbjct: 201 DPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (328), Expect = 6e-35
 Identities = 63/305 (20%), Positives = 108/305 (35%), Gaps = 51/305 (16%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           ++     LGEGGF  V         +   +    A+K +     Q  +E   E       
Sbjct: 30  HYLFIQKLGEGGFSYVDLV------EGLHDGHFYALKRILCHEQQDREEAQREADMHRLF 83

Query: 138 RHPHLVKLIGYCWEEEYR----LLVYEYMPRGSLHNQLFRSYSAALPWSTR--MKIALGA 191
            HP++++L+ YC  E        L+  +  RG+L N++ R        +    + + LG 
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET--------HVI 243
            +GL  +H   K   +RD K +NILL  +    L D G         E            
Sbjct: 144 CRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201

Query: 244 TRVMGTQGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL--- 297
            +   T  Y APE         +   +DV+S G VL  ++ G+   D      +      
Sbjct: 202 AQR-CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260

Query: 298 -AEWARPLLKE-PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV 355
             + + P        L +L++                      ++  P  RP +  ++  
Sbjct: 261 QNQLSIPQSPRHSSALWQLLN--------------------SMMTVDPHQRPHIPLLLSQ 300

Query: 356 LDSLQ 360
           L++LQ
Sbjct: 301 LEALQ 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (322), Expect = 7e-34
 Identities = 59/220 (26%), Positives = 91/220 (41%), Gaps = 21/220 (9%)

Query: 70  AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA 129
            E R      +    +G G FG V++       + G      AVK + L+  +     + 
Sbjct: 51  YEYREEVHWMTHQPRVGRGSFGEVHRMK---DKQTG---FQCAVKKVRLEVFR-----VE 99

Query: 130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
           E++    L  P +V L G   E  +  +  E +  GSL  QL +     LP    +    
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG-QLIKQM-GCLPEDRALYYLG 157

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAK---DGPEGEETHVITR 245
            A +GL +LH     +++ D KA N+LL SD   A L DFG A        G+       
Sbjct: 158 QALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

Query: 246 VMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKR 284
           + GT+ + APE VM         D++S   ++L +L G  
Sbjct: 216 IPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCH 254

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  126 bits (319), Expect = 7e-34
 Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 24/218 (11%)

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG 135
                   +LG+G +G VY G     L        +A+K +    ++  +    EI    
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGR---DLSNQ---VRIAIKEIPERDSRYSQPLHEEIALHK 74

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW--STRMKIALGAAK 193
            L+H ++V+ +G   E  +  +  E +P GSL   L RS    L     T         +
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIGFYTKQILE 133

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAK---DGPEGEETHVITRVMGT 249
           GL +LH     +++RD K  N+L+++     K+SDFG +K         ET       GT
Sbjct: 134 GLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-----FTGT 186

Query: 250 QGYAAPEYV---MTGHLTTMSDVYSFGVVLLELLTGKR 284
             Y APE +     G+    +D++S G  ++E+ TGK 
Sbjct: 187 LQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKP 223

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  127 bits (322), Expect = 8e-34
 Identities = 66/237 (27%), Positives = 94/237 (39%), Gaps = 43/237 (18%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEII 132
           F R NL     LG G FG V        +     +  VAVK L         +  M+E+ 
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATA-YGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100

Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-------------------- 171
            + QL  H ++V L+G C       L++EY   G L N L                    
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 172 -FRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
                   L +   +  A   AKG+ FL  E K  ++RD  A N+L+      K+ DFGL
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGL 218

Query: 231 AKDGPEGEETHVIT------RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT 281
           A+D        V        + M      APE +  G  T  SDV+S+G++L E+ +
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (315), Expect = 3e-33
 Identities = 65/292 (22%), Positives = 109/292 (37%), Gaps = 57/292 (19%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
            +F    L+G GGFG V+K     ++    + +   +K +  +  +  +E    +  L +
Sbjct: 11  MDFKEIELIGSGGFGQVFK--AKHRI----DGKTYVIKRVKYNNEKAERE----VKALAK 60

Query: 137 LRHPHLVKLIGYCWEEEYRL-----------------LVYEYMPRGSLHNQLFRSYSAAL 179
           L H ++V   G CW+                      +  E+  +G+L   + +     L
Sbjct: 61  LDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119

Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
                +++     KG+ ++H   K +I RD K SNI L      K+ DFGL       + 
Sbjct: 120 DKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKN 174

Query: 240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLA 298
               TR  GT  Y +PE + +       D+Y+ G++L ELL     A + ++        
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------- 227

Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
                          L D  +   F     +K      K LS  P  RP  S
Sbjct: 228 ------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTS 263

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  124 bits (314), Expect = 6e-33
 Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 39/289 (13%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEIIF 133
           +NF     +G G F  VY+      L  G    PVA+K + +      K     + EI  
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAA---CLLDG---VPVALKKVQIFDLMDAKARADCIKEIDL 85

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQL--FRSYSAALPWSTRMKIALG 190
           L QL HP+++K     + E+  L +  E    G L   +  F+     +P  T  K  + 
Sbjct: 86  LKQLNHPNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
               L  +H   + V++RD K +N+ + +    KL D GL +     + T   + V GT 
Sbjct: 145 LCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTP 200

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
            Y +PE +        SD++S G +L E+   +                   P   +   
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMN 242

Query: 311 LERLIDPRLEGQFP--IKGAQKAAATAF--KCLSHHPRHRPTMSYVVRV 355
           L  L     +  +P                 C++  P  RP ++YV  V
Sbjct: 243 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (309), Expect = 2e-32
 Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 55/304 (18%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLG 135
           ++F     LG GGFG V++       K  ++    A+K + L   +  +E  M E+  L 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEA------KNKVDDCNYAIKRIRLPNRELAREKVMREVKALA 58

Query: 136 QLRHPHLVKLIGYCWEEE----------YRLLVY---EYMPRGSLHNQL-FRSYSAALPW 181
           +L HP +V+     W E+           ++ +Y   +   + +L + +  R        
Sbjct: 59  KLEHPGIVRYFN-AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--------- 232
           S  + I L  A+ + FLH   K +++RD K SNI    D   K+ DFGL           
Sbjct: 118 SVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 233 -DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG-KRAMDNTR 290
                       T  +GT+ Y +PE +     +   D++S G++L ELL      M+  R
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVR 235

Query: 291 LGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
              +    ++     ++      ++                       LS  P  RP   
Sbjct: 236 TLTDVRNLKFPPLFTQKYPCEYVMVQ--------------------DMLSPSPMERPEAI 275

Query: 351 YVVR 354
            ++ 
Sbjct: 276 NIIE 279

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  128 bits (322), Expect = 2e-32
 Identities = 60/273 (21%), Positives = 97/273 (35%), Gaps = 55/273 (20%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQLRHPHL 142
            +  GG G +Y   +D  +      +PV +K L   G    +   MAE  FL ++ HP +
Sbjct: 87  CIAHGGLGWIYLA-LDRNV----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141

Query: 143 VKLIGYCWEEEYRL-----LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           V++  +    +        +V EY+   SL           LP +  +   L     L++
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSY 197

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH     ++Y D K  NI+L  +   KL D G             I     + GT G+ A
Sbjct: 198 LH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS---------RINSFGYLYGTPGFQA 245

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE ++    T  +D+Y+ G  L  L       +   +           P+LK      RL
Sbjct: 246 PE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPE----DDPVLKTYDSYGRL 300

Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP 347
           +                     + +   PR R 
Sbjct: 301 LR--------------------RAIDPDPRQRF 313

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  124 bits (313), Expect = 3e-32
 Identities = 64/349 (18%), Positives = 124/349 (35%), Gaps = 56/349 (16%)

Query: 17  SSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLIT 76
             +P  +   E    +   Q +   D+       ++   +  +              +  
Sbjct: 9   GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECI-------------SVKG 55

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFL 134
             +S    +G GG   V++   ++K       Q  A+K ++L+    Q    +  EI +L
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 135 GQLRHP--HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
            +L+     +++L  Y   ++Y  +V E      L++ L +  S  +    R        
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNML 165

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           + +  +H     +++ D K +N L+      KL DFG+A        + V    +G   Y
Sbjct: 166 EAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222

Query: 253 AAPEYVM-----------TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA 301
             PE +               ++  SDV+S G +L  +  GK                  
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ------------- 269

Query: 302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
             ++ +  KL  +IDP  E +FP    +        CL   P+ R ++ 
Sbjct: 270 --IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 316

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (309), Expect = 3e-32
 Identities = 59/288 (20%), Positives = 108/288 (37%), Gaps = 43/288 (14%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLG 135
            +S    +G GG   V++   ++K       Q  A+K ++L+         +  EI +L 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLN 81

Query: 136 QLRHP--HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           +L+     +++L  Y   ++Y  +V E      L++ L +   + +    R        +
Sbjct: 82  KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKS-IDPWERKSYWKNMLE 138

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
            +  +H     +++ D K +N L+      KL DFG+A        + V    +GT  Y 
Sbjct: 139 AVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195

Query: 254 APEYVM-----------TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR 302
            PE +               ++  SDV+S G +L  +  GK                   
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------------ 243

Query: 303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
               +  KL  +IDP  E +FP    +        CL   P+ R ++ 
Sbjct: 244 ---NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  123 bits (311), Expect = 3e-32
 Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 43/288 (14%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--KEWMAEIIFLG 135
            +S    +G GG   V++   ++K       Q  A+K ++L+         +  EI +L 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKK-------QIYAIKYVNLEEADNQTLDSYRNEIAYLN 62

Query: 136 QLRHP--HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           +L+     +++L  Y   ++Y  +V E      L++ L +  S  +    R        +
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS--IDPWERKSYWKNMLE 119

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
            +  +H     +++ D K +N L+      KL DFG+A        + V    +GT  Y 
Sbjct: 120 AVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176

Query: 254 APEYVM-----------TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR 302
            PE +               ++  SDV+S G +L  +  GK                   
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII------------ 224

Query: 303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
               +  KL  +IDP  E +FP    +        CL   P+ R ++ 
Sbjct: 225 ---NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  121 bits (306), Expect = 8e-32
 Identities = 63/311 (20%), Positives = 110/311 (35%), Gaps = 70/311 (22%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
             S+F    +LG+G FG V K       +  L+++  A+K +     +     ++E++ L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKIRHTEEK-LSTILSEVMLL 56

Query: 135 GQLRHPHLVKLIGYCWEEEYRL--------------LVYEYMPRGSLHN-----QLFRSY 175
             L H ++V+     W E                  +  EY   G+L++      L +  
Sbjct: 57  ASLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115

Query: 176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--- 232
                   ++       + L+++H   + +I+RD K  NI +D     K+ DFGLAK   
Sbjct: 116 DEYWRLFRQI------LEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

Query: 233 ---------DGPEGEETHVITRVMGTQGYAAPEYVM--TGHLTTMSDVYSFGVVLLELLT 281
                           +  +T  +GT  Y A E V+  TGH     D+YS G++  E++ 
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY 226

Query: 282 GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAF--KCL 339
                                 +LK+ R +     P  +                    +
Sbjct: 227 PFSTGMERVN------------ILKKLRSVSIEFPPDFDDNKM------KVEKKIIRLLI 268

Query: 340 SHHPRHRPTMS 350
            H P  RP   
Sbjct: 269 DHDPNKRPGAR 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (304), Expect = 3e-31
 Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 16/212 (7%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFL 134
            + R   +GEG FG        +  + G   +   +K +++      KE      E+  L
Sbjct: 25  KYVRLQKIGEGSFGKAILV---KSTEDG---RQYVIKEINISR-MSSKEREESRREVAVL 77

Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
             ++HP++V+     +EE   L +V +Y   G L  ++             +   +    
Sbjct: 78  ANMKHPNIVQYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICL 136

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
            L  +H  D+ +++RD K+ NI L  D T +L DFG+A+         +    +GT  Y 
Sbjct: 137 ALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYL 192

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRA 285
           +PE          SD+++ G VL EL T K A
Sbjct: 193 SPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  118 bits (298), Expect = 8e-31
 Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 28/211 (13%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL--------- 134
            LG GG   VY    D  L        VA+KA+             +   L         
Sbjct: 18  KLGGGGMSTVYLA-EDTILN-----IKVAIKAI-------FIPPREKEETLKRFEREVHN 64

Query: 135 -GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
             QL H ++V +I    E++   LV EY+   +L   +       L   T +        
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILD 122

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           G+   H  D  +++RD K  NIL+DS+ T K+ DFG+AK   E   T     V+GT  Y 
Sbjct: 123 GIKHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYF 179

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
           +PE          +D+YS G+VL E+L G+ 
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  119 bits (300), Expect = 1e-30
 Identities = 42/232 (18%), Positives = 71/232 (30%), Gaps = 27/232 (11%)

Query: 71  ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAE 130
           E +L +      +LLGEG F  VY+      L      Q   +K            W   
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEA-TQGDLNDAKNKQKFVLKVQKPA-----NPWEFY 112

Query: 131 IIF-----LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH---NQLFRSYSAALPWS 182
           I       L        +K       +   +LV E    G+L    N    +    +P  
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-----------KLSDFGLA 231
             +  A+     +  +H  +  +I+ D K  N +L + +              L D G +
Sbjct: 173 LVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230

Query: 232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            D     +  + T    T G+   E +         D +     +  +L G 
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  118 bits (297), Expect = 3e-30
 Identities = 67/361 (18%), Positives = 129/361 (35%), Gaps = 61/361 (16%)

Query: 46  PSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPG 105
            S   ++    +  +G  + +  L              +L EGGF  VY+       +  
Sbjct: 5   GSLGGASGRDQSDFVGQTVELGEL--------RLRVRRVLAEGGFAFVYEA------QDV 50

Query: 106 LEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCW-------EEEYRLL 157
              +  A+K L  +  + ++  + E+ F+ +L  HP++V+               +   L
Sbjct: 51  GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110

Query: 158 VYEYMPRGSLHNQLFRSYSAA-LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNIL 216
           +   + +G L   L +  S   L   T +KI     + +  +H +  P+I+RD K  N+L
Sbjct: 111 LLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170

Query: 217 LDSDYTAKLSDFGLA---KDGPEGEET--------HVITRVMGTQGYAAPEYV-MTGHL- 263
           L +  T KL DFG A      P+   +          ITR   T  Y  PE + +  +  
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN-TTPMYRTPEIIDLYSNFP 229

Query: 264 -TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP-LLKEPRKLERLIDPRLEG 321
                D+++ G +L  L   +   ++    R  +  +++ P    +      LI      
Sbjct: 230 IGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN-GKYSIPPHDTQYTVFHSLIR----- 283

Query: 322 QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV-GPFVYVVPNETES 380
                            L  +P  R +++ VV  L  +   ++     P   ++      
Sbjct: 284 ---------------AMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGY 328

Query: 381 S 381
            
Sbjct: 329 G 329

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (295), Expect = 3e-30
 Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 49/294 (16%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLG 135
            ++    ++G G    V         K     + VA+K ++L+  Q   + +  EI  + 
Sbjct: 15  DDYELQEVIGSGATAVVQAA-YCAPKK-----EKVAIKRINLEKCQTSMDELLKEIQAMS 68

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMK---IAL-- 189
           Q  HP++V      +  +  L LV + +  GS+ + +    +     S  +    IA   
Sbjct: 69  QCHHPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127

Query: 190 -GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA---KDGPEGEETHVITR 245
               +GL +LH   +  I+RD KA NILL  D + +++DFG++     G +     V   
Sbjct: 128 REVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

Query: 246 VMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL 304
            +GT  + APE +         +D++SFG+  +EL TG                    P 
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA------------------APY 227

Query: 305 LKE-PRKLERLI----DPRLEGQFPIKGAQKAAATAFK-----CLSHHPRHRPT 348
            K  P K+  L      P LE     K   K    +F+     CL   P  RPT
Sbjct: 228 HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  115 bits (290), Expect = 2e-29
 Identities = 42/226 (18%), Positives = 86/226 (38%), Gaps = 42/226 (18%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--------------- 129
           L +G F  +     ++        +  A+K  +    +  +++                 
Sbjct: 39  LNQGKFNKII--LCEKD------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 130 --EIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSL------HNQLFRSYSAALP 180
             E+  +  +++ + +   G        + ++YEYM   S+         L ++Y+  +P
Sbjct: 91  KNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
                 I        +++H E K + +RD K SNIL+D +   KLSDFG ++   + +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNE-KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-- 206

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTT---MSDVYSFGVVLLELLTGK 283
             I    GT  +  PE   +   +      D++S G+ L  +    
Sbjct: 207 --IKGSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  114 bits (288), Expect = 3e-29
 Identities = 80/293 (27%), Positives = 126/293 (43%), Gaps = 69/293 (23%)

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFL 134
              F++   +G+G FG V+KG +D + +     + VA+K +DL+  +   E    EI  L
Sbjct: 21  EELFTKLEKIGKGSFGEVFKG-IDNRTQ-----KVVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSL-----HNQLFRSYSAALPWSTRMKIA 188
            Q   P++ K  G  + ++ +L ++ EY+  GS         L  +  A         I 
Sbjct: 75  SQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT--------IL 125

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR--- 245
               KGL +LH E K  I+RD KA+N+LL      KL+DFG+A     G+ T    +   
Sbjct: 126 REILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKRNT 178

Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
            +GT  + APE +      + +D++S G+  +EL  G+                   P  
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP------------------PHS 220

Query: 306 KE-PRKLERLID----PRLEGQFPIKGAQKAAATAFK-----CLSHHPRHRPT 348
           +  P K+  LI     P LEG +         +   K     CL+  P  RPT
Sbjct: 221 ELHPMKVLFLIPKNNPPTLEGNY---------SKPLKEFVEACLNKEPSFRPT 264

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (288), Expect = 3e-29
 Identities = 54/211 (25%), Positives = 84/211 (39%), Gaps = 28/211 (13%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL--------- 134
           L+G GG G VY+   D   +     + VA+K +        +   ++ +F          
Sbjct: 41  LVGRGGMGDVYEA-EDTVRE-----RIVALKLM-------SETLSSDPVFRTRMQREART 87

Query: 135 -GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
            G+L+ PH+V +  +   +    +    +    L   L R     L     + I      
Sbjct: 88  AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGS 145

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
            L   H       +RD K  NIL+ +D  A L DFG+A    + + T +    +GT  Y 
Sbjct: 146 ALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYM 202

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
           APE     H T  +D+Y+   VL E LTG  
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSP 233

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  118 bits (296), Expect = 4e-29
 Identities = 60/218 (27%), Positives = 87/218 (39%), Gaps = 22/218 (10%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQ 136
            +     LG GGFG V +         G   + VA+K    + +  ++E W  EI  + +
Sbjct: 15  PWEMKERLGTGGFGYVLRW---IHQDTG---EQVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 137 LRHPHLVKLI------GYCWEEEYRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIAL 189
           L HP++V               +  LL  EY   G L   L        L       +  
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRV 246
             +  L +LH  +  +I+RD K  NI+L         K+ D G AK+  +GE       V
Sbjct: 129 DISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV 184

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
            GT  Y APE +     T   D +SFG +  E +TG R
Sbjct: 185 -GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (284), Expect = 1e-28
 Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 32/216 (14%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL--------- 134
           +LG GG   V+    D +       + VAVK L         +   +  F          
Sbjct: 19  ILGFGGMSEVHLA-RDLRDH-----RDVAVKVL-------RADLARDPSFYLRFRREAQN 65

Query: 135 -GQLRHPHLVKLIGYCWEEEYRL----LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
              L HP +V +      E        +V EY+   +L + +       +     +++  
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIA 123

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT-RVMG 248
            A + L F H     +I+RD K +NI++ +    K+ DFG+A+   +   +   T  V+G
Sbjct: 124 DACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
           T  Y +PE      +   SDVYS G VL E+LTG+ 
Sbjct: 182 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  112 bits (282), Expect = 1e-28
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 23/213 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EI 131
            +F     LG+G FG VY      + +       +A+K L     Q  K  +      E+
Sbjct: 9   EDFEIGRPLGKGKFGNVYLA---REKQSK---FILALKVLFKA--QLEKAGVEHQLRREV 60

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
                LRHP++++L GY  +     L+ EY P G+++ +L +   +              
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITEL 118

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM-GTQ 250
           A  L++ H   K VI+RD K  N+LL S    K++DFG +   P           + GT 
Sbjct: 119 ANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDLCGTL 171

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            Y  PE +         D++S GV+  E L GK
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  112 bits (281), Expect = 2e-28
 Identities = 71/307 (23%), Positives = 119/307 (38%), Gaps = 76/307 (24%)

Query: 69  LAELRLITSN------FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +LR I S       ++R   +G+G  G VY              Q VA++ ++L    
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVAT------GQEVAIRQMNLQQQP 59

Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSL-----HNQLFRSYS 176
             +  + EI+ + + ++P++V  +   +     L +V EY+  GSL        +     
Sbjct: 60  KKELIINEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI 118

Query: 177 AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE 236
           AA        +     + L FLH      I+RD K+ NILL  D + KL+DFG       
Sbjct: 119 AA--------VCRECLQALEFLHSNQV--IHRDIKSDNILLGMDGSVKLTDFGFC----- 163

Query: 237 GEETHVITR---VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK---------R 284
            + T   ++   ++GT  + APE V         D++S G++ +E++ G+         R
Sbjct: 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

Query: 285 AMDNTRLGREQSLAEWARPLLKEPRKL-ERLIDPRLEGQFPIKGAQKAAATAF--KCLSH 341
           A+          +A    P L+ P KL     D                   F  +CL  
Sbjct: 224 AL--------YLIATNGTPELQNPEKLSAIFRD-------------------FLNRCLEM 256

Query: 342 HPRHRPT 348
               R +
Sbjct: 257 DVEKRGS 263

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  112 bits (281), Expect = 3e-28
 Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 27/222 (12%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQ 136
            +  S++LG+G    V++G      K G      A+K  +        +  M E   L +
Sbjct: 10  LWLLSDILGQGATANVFRG---RHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 137 LRHPHLVKLIGYCWEEEYRL--LVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAAK 193
           L H ++VKL     E   R   L+ E+ P GSL+  L   S +  LP S  + +      
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123

Query: 194 GLAFLHGEDKPVIYRDFKASNILL----DSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
           G+  L   +  +++R+ K  NI+     D     KL+DFG A++  + E+    +   GT
Sbjct: 124 GMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GT 178

Query: 250 QGYAAPEYVMTGHLTTMS--------DVYSFGVVLLELLTGK 283
           + Y  P+      L            D++S GV      TG 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  111 bits (279), Expect = 3e-28
 Identities = 53/303 (17%), Positives = 97/303 (32%), Gaps = 67/303 (22%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEII 132
            T+ F     +G G FG V+K     K   G      A+K       G+   +  + E+ 
Sbjct: 9   YTTEFHELEKIGSGEFGSVFKCV---KRLDG---CIYAIKRSKKPLAGSVDEQNALREVY 62

Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLVY-EYMPRGSLHNQL--FRSYSAALPWSTRMKIA 188
               L +H H+V+     W E+  +L+  EY   GSL + +       +    +    + 
Sbjct: 63  AHAVLGQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-------------------YTAKLSDFG 229
           L   +GL ++H     +++ D K SNI +                         K+ D G
Sbjct: 122 LQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 230 LAKDGPEGEETHVITRVMGTQGYAAPEYVM--TGHLTTMSDVYSFGVVLLELLTGKRAMD 287
                       V     G   + A E +     HL   +D+++  + ++     +    
Sbjct: 180 HVT---RISSPQVEE---GDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPLPR 232

Query: 288 NTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAF--KCLSHHPRH 345
           N          +W         ++ +   PR+              T      +   P  
Sbjct: 233 N--------GDQW--------HEIRQGRLPRIPQVLS------QEFTELLKVMIHPDPER 270

Query: 346 RPT 348
           RP+
Sbjct: 271 RPS 273

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  113 bits (284), Expect = 4e-28
 Identities = 36/322 (11%), Positives = 80/322 (24%), Gaps = 84/322 (26%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT----------------- 121
             R  +LG+       +   D++       +   V                         
Sbjct: 80  LVRGTVLGQEDPYAYLEA-TDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133

Query: 122 -----------QGHKEWMAEIIFLGQLRHPHLVKLIG----YCWEEEYRLLVYEYMPRGS 166
                      + H  ++     +   +   ++++            + L         +
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193

Query: 167 LHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK 224
               L    S   +L    R+++ L   + LA LH     +++   +  +I+LD      
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVF 251

Query: 225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM----------TGHLTTMSDVYSFGV 274
           L+ F       +G            +G+A PE                +T   D ++ G+
Sbjct: 252 LTGFEHLV--RDGAS----AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305

Query: 275 VLLELLTGKR--AMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAA 332
            +  +         D    G E             P+ +  L++                
Sbjct: 306 AIYWIWCADLPNTDDAALGGSEWIFRSCKNI----PQPVRALLE---------------- 345

Query: 333 ATAFKCLSHHPRHRPTMSYVVR 354
                 L +    R      + 
Sbjct: 346 ----GFLRYPKEDRLLPLQAME 363

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (282), Expect = 4e-28
 Identities = 70/316 (22%), Positives = 119/316 (37%), Gaps = 47/316 (14%)

Query: 60  IGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD 119
              K+      +   I       + LG G  G V+K       KP      +A K + L+
Sbjct: 23  QKQKVGELKDDDFEKI-------SELGAGNGGVVFKV----SHKPSG--LVMARKLIHLE 69

Query: 120 GTQG-HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA 178
                  + + E+  L +   P++V   G  + +    +  E+M  GSL   L    +  
Sbjct: 70  IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGR 127

Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
           +P     K+++   KGL +L  + K +++RD K SNIL++S    KL DFG++    +  
Sbjct: 128 IPEQILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLI 183

Query: 239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK------------RAM 286
           ++   + V GT+ Y +PE +   H +  SD++S G+ L+E+  G+               
Sbjct: 184 DSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242

Query: 287 DNTRLGREQSLAEWARPLLKEPRKLERLIDPR-----LEGQFPIKGAQKAAATAF----- 336
                G         R   +   K      P      L      +   K  +  F     
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302

Query: 337 ----KCLSHHPRHRPT 348
               KCL  +P  R  
Sbjct: 303 DFVNKCLIKNPAERAD 318

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  110 bits (276), Expect = 7e-28
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 17/217 (7%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLG 135
           ++     +G G +G   K  +  K     + + +  K LD         +  ++E+  L 
Sbjct: 7   DYEVLYTIGTGSYGRCQK--IRRKS----DGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60

Query: 136 QLRHPHLVKLIGYCWEEEYRLL--VYEYMPRGSLHNQL--FRSYSAALPWSTRMKIALGA 191
           +L+HP++V+      +     L  V EY   G L + +         L     +++    
Sbjct: 61  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 192 AKGLAFLH---GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
              L   H        V++RD K +N+ LD     KL DFGLA+      +T      +G
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVG 178

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA 285
           T  Y +PE +        SD++S G +L EL      
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  110 bits (277), Expect = 2e-27
 Identities = 36/340 (10%), Positives = 68/340 (20%), Gaps = 63/340 (18%)

Query: 47  SSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGL 106
                 + ++ +V          + L            L  G    V+    D +     
Sbjct: 32  EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLV-RDVERL--- 87

Query: 107 EAQPVAVKALDLDGTQGHKEWMA---EIIFLGQLRHPHLVKLIGYC-------------- 149
             +  A+K   +       E            +L      +                   
Sbjct: 88  --EDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ 145

Query: 150 ------------WEEEYRLLVYEYMPRGSLHN-----QLFRSYSAALPWSTRMKIALGAA 192
                       +     LL+        L            +           +     
Sbjct: 146 PPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLI 204

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +  A L    K +++  F   N+ +  D    L D                        Y
Sbjct: 205 RLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSVPVTY 257

Query: 253 AAPEYVMTGHL--TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
           A  E++       T   + +  G+ +  +           L        W RP L+ P  
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG---LVTPGIKGSWKRPSLRVP-- 312

Query: 311 LERLIDPRLEGQFPIKGAQKAAATAF--KCLSHHPRHRPT 348
                       F               + L+   R R  
Sbjct: 313 ------GTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (275), Expect = 2e-27
 Identities = 70/308 (22%), Positives = 120/308 (38%), Gaps = 78/308 (25%)

Query: 69  LAELRLITSN------FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
            A LR++               +GEG  G V               + VAVK +DL   Q
Sbjct: 31  KAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS------GRQVAVKMMDLRKQQ 84

Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIG-YCWEEEYRL-LVYEYMPRGSL-----HNQLFRSY 175
             +    E++ +   +H ++V++   Y   EE  L ++ E++  G+L       +L    
Sbjct: 85  RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQVRLNEEQ 142

Query: 176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
            A         +     + LA+LH +    I+RD K+ +ILL  D   KLSDFG      
Sbjct: 143 IAT--------VCEAVLQALAYLHAQGV--IHRDIKSDSILLTLDGRVKLSDFGFC---- 188

Query: 236 EGEETHVITR---VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK--------- 283
             + +  + +   ++GT  + APE +      T  D++S G++++E++ G+         
Sbjct: 189 -AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247

Query: 284 RAMDNTRLGREQSLAEWARPLLKEPRKL-ERLIDPRLEGQFPIKGAQKAAATAF--KCLS 340
           +AM        + L +   P LK   K+   L D                   F  + L 
Sbjct: 248 QAM--------KRLRDSPPPKLKNSHKVSPVLRD-------------------FLERMLV 280

Query: 341 HHPRHRPT 348
             P+ R T
Sbjct: 281 RDPQERAT 288

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (278), Expect = 2e-27
 Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 29/223 (13%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLGQ 136
            +  S++LG+G    V++G      K G      A+K  +        +  M E   L +
Sbjct: 10  LWLLSDILGQGATANVFRG---RHKKTG---DLFAIKVFNNISFLRPVDVQMREFEVLKK 63

Query: 137 LRHPHLVKLIGYCWEEE---YRLLVYEYMPRGSLHNQLF-RSYSAALPWSTRMKIALGAA 192
           L H ++VKL     EE    +++L+ E+ P GSL+  L   S +  LP S  + +     
Sbjct: 64  LNHKNIVKLFA-IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 193 KGLAFLHGEDKPVIYRDFKASNILL----DSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
            G+  L   +  +++R+ K  NI+     D     KL+DFG A++  + E+    +   G
Sbjct: 123 GGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-G 177

Query: 249 TQGYAAPEYVMTGHLTTMS--------DVYSFGVVLLELLTGK 283
           T+ Y  P+      L            D++S GV      TG 
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  108 bits (272), Expect = 3e-27
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 18/211 (8%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFL 134
           +F   NLLG+G F  VY+    E +  G     VA+K +D   +      +    E+   
Sbjct: 12  DFKVGNLLGKGSFAGVYRA---ESIHTG---LEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
            QL+HP +++L  Y  +  Y  LV E    G ++  L            R  +      G
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITG 124

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQGYA 253
           + +LH     +++RD   SN+LL  +   K++DFGLA +     E+ + +    GT  Y 
Sbjct: 125 MLYLH--SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYI 179

Query: 254 APEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           +PE    + H    SDV+S G +   LL G+
Sbjct: 180 SPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  112 bits (282), Expect = 3e-27
 Identities = 77/277 (27%), Positives = 109/277 (39%), Gaps = 26/277 (9%)

Query: 16  KSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLI 75
           +  +       EQ   +  FQ L        S    AD L +      L    L    + 
Sbjct: 123 RQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVT 182

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEII 132
            + F +  +LG+GGFG V       +    +     A K L+    +  K     + E  
Sbjct: 183 KNTFRQYRVLGKGGFGEVC--ACQVRATGKM----YACKKLEKKRIKKRKGEAMALNEKQ 236

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMK----- 186
            L ++    +V L  Y +E +  L LV   M  G L   ++    A  P   R       
Sbjct: 237 ILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAE 294

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           I  G    L  LH E   ++YRD K  NILLD     ++SD GLA   PEG+      RV
Sbjct: 295 ICCG----LEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV 346

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            GT GY APE V     T   D ++ G +L E++ G+
Sbjct: 347 -GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (271), Expect = 4e-27
 Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 21/212 (9%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EI 131
            +F     LG+G FG VY     EK +       +A+K L     Q  KE +      EI
Sbjct: 14  DDFDIGRPLGKGKFGNVY--LAREK-QNK---FIMALKVLFKS--QLEKEGVEHQLRREI 65

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
                LRHP+++++  Y  + +   L+ E+ PRG L+ +L +                  
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEEL 123

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
           A  L + H   + VI+RD K  N+L+      K++DFG +   P       +    GT  
Sbjct: 124 ADALHYCHE--RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLD 177

Query: 252 YAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           Y  PE +         D++  GV+  E L G 
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (275), Expect = 5e-27
 Identities = 52/314 (16%), Positives = 94/314 (29%), Gaps = 51/314 (16%)

Query: 76  TSNFSRSNLLGEG--GFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEI 131
              +    ++G+G      V      +        + V V+ ++L+            E+
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLA-RYKPTG-----EYVTVRRINLEACSNEMVTFLQGEL 77

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
                  HP++V      +  +  L +V  +M  GS  + +   +   +       I  G
Sbjct: 78  HVSKLFNHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQG 136

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG----LAKDGPEGEETHVITRV 246
             K L ++H      ++R  KAS+IL+  D    LS       +   G      H   + 
Sbjct: 137 VLKALDYIHHMGY--VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 247 M-GTQGYAAPEYVMTGHL---TTMSDVYSFGVVLLELLTGK---------RAM------- 286
                 + +PE V+  +L      SD+YS G+   EL  G          + +       
Sbjct: 195 SVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253

Query: 287 -------DNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFK-- 337
                                +         L         G  P     +  +  F   
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313

Query: 338 ---CLSHHPRHRPT 348
              CL  +P  RP+
Sbjct: 314 VEQCLQRNPDARPS 327

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (278), Expect = 8e-27
 Identities = 66/275 (24%), Positives = 103/275 (37%), Gaps = 27/275 (9%)

Query: 20  PESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLIT-SN 78
            E+            FQ   L  V          +  +S+   +   +   E + +    
Sbjct: 128 AETVARARAGAGDGLFQP-LLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDW 186

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLG 135
           F    +LG GGFG V+      K    L     A K L+    +  K +   M E   L 
Sbjct: 187 FLDFRVLGRGGFGEVFA--CQMKATGKL----YACKKLNKKRLKKRKGYQGAMVEKKILA 240

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWS-TRMK-----IA 188
           ++    +V L  Y +E +  L LV   M  G +   ++        +   R       I 
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
            G    L  LH  +  +IYRD K  N+LLD D   ++SD GLA +   G+         G
Sbjct: 300 SG----LEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-G 351

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           T G+ APE ++        D ++ GV L E++  +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  107 bits (269), Expect = 8e-27
 Identities = 65/278 (23%), Positives = 111/278 (39%), Gaps = 46/278 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEI-IFLGQLRHPHL 142
           LG G +G V K     +  P    Q +AVK +     +Q  K  + ++ I +  +  P  
Sbjct: 15  LGRGAYGVVEKM----RHVPS--GQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM--KIALGAAKGLAFLHG 200
           V   G  + E    +  E M   SL     +           +  KIA+   K L  LH 
Sbjct: 69  VTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
           +   VI+RD K SN+L+++    K+ DFG++       +        G + Y APE +  
Sbjct: 128 KLS-VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINP 183

Query: 261 GHL----TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID 316
                  +  SD++S G+ ++EL   +                W  P     ++L+++++
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILR-----------FPYDSWGTPF----QQLKQVVE 228

Query: 317 ---PRL-EGQFPIKGAQKAAATAF--KCLSHHPRHRPT 348
              P+L   +F       A    F  +CL  + + RPT
Sbjct: 229 EPSPQLPADKFS------AEFVDFTSQCLKKNSKERPT 260

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  107 bits (269), Expect = 1e-26
 Identities = 70/225 (31%), Positives = 108/225 (48%), Gaps = 27/225 (12%)

Query: 69  LAELRLITSN------FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ 122
           L +L   +        F     LGEG +G VYK    E        Q VA+K + ++   
Sbjct: 15  LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKE------TGQIVAIKQVPVE--S 66

Query: 123 GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPW 181
             +E + EI  + Q   PH+VK  G  + +   L +V EY   GS+ + + R  +  L  
Sbjct: 67  DLQEIIKEISIMQQCDSPHVVKYYG-SYFKNTDLWIVMEYCGAGSV-SDIIRLRNKTLTE 124

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
                I     KGL +LH   K  I+RD KA NILL+++  AKL+DFG+A     G+ T 
Sbjct: 125 DEIATILQSTLKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVA-----GQLTD 177

Query: 242 VITR---VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            + +   V+GT  + APE +       ++D++S G+  +E+  GK
Sbjct: 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (266), Expect = 3e-26
 Identities = 51/214 (23%), Positives = 98/214 (45%), Gaps = 24/214 (11%)

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR 138
           +     LG+G FG VYK   +++          A K ++    +  ++++ EI  L    
Sbjct: 21  WEIVGELGDGAFGKVYKA-KNKETG-----ALAAAKVIETKSEEELEDYIVEIEILATCD 74

Query: 139 HPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
           HP++VKL+G  +  + +L ++ E+ P G++   +       L       +     + L F
Sbjct: 75  HPYIVKLLG-AYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNF 132

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITR---VMGTQGYAA 254
           LH +    I+RD KA N+L+  +   +L+DFG++      +    + +    +GT  + A
Sbjct: 133 LHSKRI--IHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKRDSFIGTPYWMA 185

Query: 255 PEYVMTGHLTTMS-----DVYSFGVVLLELLTGK 283
           PE VM   +         D++S G+ L+E+   +
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (265), Expect = 5e-26
 Identities = 59/244 (24%), Positives = 98/244 (40%), Gaps = 26/244 (10%)

Query: 47  SSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGL 106
           SS  S        IG + +   + +L  +         +G G  G V+K     + +   
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLENL-------GEMGSGTCGQVWKM----RFRKT- 49

Query: 107 EAQPVAVKALDLDGT-QGHKEWMAEI-IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPR 164
               +AVK +   G  + +K  + ++ + L     P++V+  G         +  E M  
Sbjct: 50  -GHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGT 108

Query: 165 GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK 224
            +   +L +     +P     K+ +   K L +L  +   VI+RD K SNILLD     K
Sbjct: 109 CAE--KLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG-VIHRDVKPSNILLDERGQIK 165

Query: 225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-----TTMSDVYSFGVVLLEL 279
           L DFG++       +     R  G   Y APE +             +DV+S G+ L+EL
Sbjct: 166 LCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

Query: 280 LTGK 283
            TG+
Sbjct: 223 ATGQ 226

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  107 bits (267), Expect = 5e-26
 Identities = 45/360 (12%), Positives = 95/360 (26%), Gaps = 86/360 (23%)

Query: 43  VSNPSSPLSADDL-SNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEK 101
            ++     +AD L S S+  +       +EL        R  +LG+       +      
Sbjct: 38  TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEA---TD 94

Query: 102 LKPGLEAQPVAVKALDLDG----------------------------TQGHKEWMAEIIF 133
            + G   +   V                                    + H  ++     
Sbjct: 95  QETG---ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151

Query: 134 LGQLRHPHLVKLIGYC--WEEEYRLLVYEYM--PRGSLHNQLFRSYSA--ALPWSTRMKI 187
           +   +   ++++           R  +Y  M     +    L    S   +L    R+++
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            L   + LA LH     +++   +  +I+LD      L+ F       +G          
Sbjct: 212 TLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGAR----VVSS 263

Query: 248 GTQGYAAPEYVMT-----------GHLTTMSDVYSFGVVLLELLTGKR--AMDNTRLGRE 294
            ++G+  PE                 +T   D ++ G+V+  +         D    G E
Sbjct: 264 VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE 323

Query: 295 QSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
                        P+ +  L++                      L +    R      + 
Sbjct: 324 WIFRSCKNI----PQPVRALLE--------------------GFLRYPKEDRLLPLQAME 359

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  104 bits (263), Expect = 6e-26
 Identities = 61/213 (28%), Positives = 86/213 (40%), Gaps = 23/213 (10%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EII 132
            + R   LG+GGF   ++             +  A K +    +   K         EI 
Sbjct: 16  RYVRGRFLGKGGFAKCFEI---SDADTK---EVFAGKIVP--KSLLLKPHQREKMSMEIS 67

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
               L H H+V   G+  + ++  +V E   R SL     R    AL             
Sbjct: 68  IHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIV 125

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRVMGTQG 251
            G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +GE   V+    GT  
Sbjct: 126 LGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPN 180

Query: 252 YAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           Y APE +   GH +   DV+S G ++  LL GK
Sbjct: 181 YIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 212

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (264), Expect = 8e-26
 Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 24/210 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEI-IFLGQLRHPHL 142
           +G G +G V K       KP    Q +AVK +      +  K+ + ++ + +     P++
Sbjct: 30  IGRGAYGSVNKM----VHKPS--GQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHN---QLFRSYSAALPWSTRMKIALGAAKGLAFLH 199
           V+  G  + E    +  E M   S       ++      +P     KI L   K L  L 
Sbjct: 84  VQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 200 GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI--TRVMGTQGYAAPEY 257
              K +I+RD K SNILLD     KL DFG++     G+    I  TR  G + Y APE 
Sbjct: 143 ENLK-IIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRDAGCRPYMAPER 196

Query: 258 VMTGHL----TTMSDVYSFGVVLLELLTGK 283
           +            SDV+S G+ L EL TG+
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  105 bits (263), Expect = 1e-25
 Identities = 61/218 (27%), Positives = 86/218 (39%), Gaps = 33/218 (15%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD----LDGTQGHKEWMAEIIF 133
            + R   LG+GGF   ++             +  A K +     L   Q  K    EI  
Sbjct: 42  RYVRGRFLGKGGFAKCFEI---SDADTK---EVFAGKIVPKSLLLKPHQREK-MSMEISI 94

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM------KI 187
              L H H+V   G+  + ++  +V E   R SL     R           +        
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--------KALTEPEARYY 146

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA-KDGPEGEETHVITRV 246
                 G  +LH     VI+RD K  N+ L+ D   K+ DFGLA K   +GE   V+   
Sbjct: 147 LRQIVLGCQYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-- 202

Query: 247 MGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
            GT  Y APE +   GH +   DV+S G ++  LL GK
Sbjct: 203 -GTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 238

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  104 bits (262), Expect = 6e-25
 Identities = 62/324 (19%), Positives = 110/324 (33%), Gaps = 79/324 (24%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           +F   ++LG G  G +        +      + VAVK +  +          E+  L + 
Sbjct: 25  SFCPKDVLGHGAEGTIVY----RGMFDN---RDVAVKRILPECFSFADR---EVQLLRES 74

Query: 138 -RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
             HP++++      + +++ +  E     +L  +       A      + +      GLA
Sbjct: 75  DEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ-EYVEQKDFAHLGLEPITLLQQTTSGLA 132

Query: 197 FLHGEDKPVIYRDFKASNILL-----DSDYTAKLSDFGLAKDGPEGEET-HVITRVMGTQ 250
            LH     +++RD K  NIL+          A +SDFGL K    G  +    + V GT+
Sbjct: 133 HLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 251 GYAAPEYV---MTGHLTTMSDVYSFGVVLLELLTG----------------KRAMDNTRL 291
           G+ APE +      + T   D++S G V   +++                   A     L
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL 250

Query: 292 GREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSY 351
             E+     AR L++                              K ++  P+ RP+  +
Sbjct: 251 HPEKHEDVIARELIE------------------------------KMIAMDPQKRPSAKH 280

Query: 352 V---------VRVLDSLQDFQDSF 366
           V          + L   QD  D  
Sbjct: 281 VLKHPFFWSLEKQLQFFQDVSDRI 304

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (256), Expect = 1e-24
 Identities = 74/254 (29%), Positives = 109/254 (42%), Gaps = 27/254 (10%)

Query: 40  LSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLI---TSNFSRSNLLGEGGFGPVYKG 96
           +    N     + D +        L    +AEL         FS    +G G FG VY  
Sbjct: 14  IPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFA 73

Query: 97  FVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFLGQLRHPHLVKLIGYCWEEE 153
             D +       + VA+K +   G Q +++W   + E+ FL +LRHP+ ++  G C+  E
Sbjct: 74  -RDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG-CYLRE 126

Query: 154 YRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKA 212
           +   LV EY   GS  + L   +   L       +  GA +GLA+LH  +   I+RD KA
Sbjct: 127 HTAWLVMEYCL-GSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM--IHRDVKA 182

Query: 213 SNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT---GHLTTMSDV 269
            NILL      KL DFG A            +  +GT  + APE ++    G      DV
Sbjct: 183 GNILLSEPGLVKLGDFGSA-----SIMAPANS-FVGTPYWMAPEVILAMDEGQYDGKVDV 236

Query: 270 YSFGVVLLELLTGK 283
           +S G+  +EL   K
Sbjct: 237 WSLGITCIELAERK 250

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 2e-24
 Identities = 60/244 (24%), Positives = 98/244 (40%), Gaps = 29/244 (11%)

Query: 55  LSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVK 114
           +++      L    L+ LR     F    L+G G +G VYKG    K       Q  A+K
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-RHVKTG-----QLAAIK 55

Query: 115 ALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIG-----YCWEEEYRL-LVYEYMPRGSL 167
            +D+ G    +E   EI  L +   H ++    G          + +L LV E+   GS+
Sbjct: 56  VMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV 114

Query: 168 HNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
            + +  +    L       I     +GL+ LH      I+RD K  N+LL  +   KL D
Sbjct: 115 TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV--IHRDIKGQNVLLTENAEVKLVD 172

Query: 228 FGLAKDGPEGEETHVITR---VMGTQGYAAPEYVMTGHLTTMS-----DVYSFGVVLLEL 279
           FG++      +    + R    +GT  + APE +        +     D++S G+  +E+
Sbjct: 173 FGVS-----AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

Query: 280 LTGK 283
             G 
Sbjct: 228 AEGA 231

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  103 bits (259), Expect = 3e-24
 Identities = 68/225 (30%), Positives = 98/225 (43%), Gaps = 43/225 (19%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIF 133
           ++FS   ++G GGFG VY      K   G   +  A+K LD    +  +     + E I 
Sbjct: 189 NDFSVHRIIGRGGFGEVYGC---RKADTG---KMYAMKCLDKKRIKMKQGETLALNERIM 242

Query: 134 LGQL---RHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAAL 179
           L  +     P +V +  Y +    +L  + + M  G LH  L +           Y+A  
Sbjct: 243 LSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-- 299

Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
                 +I LG    L  +H     V+YRD K +NILLD     ++SD GLA D  +  +
Sbjct: 300 ------EIILG----LEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-K 346

Query: 240 THVITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
            H    V GT GY APE +  G     S D +S G +L +LL G 
Sbjct: 347 PH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 37/222 (16%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIF 133
            +F    +LGEG F  V      E       ++  A+K L+        +      E   
Sbjct: 30  EDFKFGKILGEGSFSTVV--LARELA----TSREYAIKILEKRHIIKENKVPYVTRERDV 83

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWS 182
           + +L HP  VKL  + ++++ +L     Y   G L   + +           Y+A     
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA----- 137

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              +I       L +LHG+   +I+RD K  NILL+ D   +++DFG AK      +   
Sbjct: 138 ---EIVSA----LEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

Query: 243 ITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK 283
               +GT  Y +PE +         SD+++ G ++ +L+ G 
Sbjct: 189 ANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  101 bits (253), Expect = 1e-23
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 30/219 (13%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEI 131
            +  +    +LG+G FG V      +    G   Q  AVK +    +      +  + E+
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILC---KDKITG---QECAVKVISKRQVKQKTDKESLLREV 77

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS---AALPWSTRMK 186
             L QL HP+++KL  +  ++ Y  LV E    G L +++     +S   AA      ++
Sbjct: 78  QLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----RIIR 133

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVI 243
             L     + ++H     +++RD K  N+LL+S   D   ++ DFGL+      E +  +
Sbjct: 134 QVLSG---ITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKM 185

Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
              +GT  Y APE V+ G      DV+S GV+L  LL+G
Sbjct: 186 KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (253), Expect = 2e-23
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 29/220 (13%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEII 132
           ++  + R   LG G +G V                  A+K +      T  + + + E+ 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLC---RDKVTH---VERAIKIIRKTSVSTSSNSKLLEEVA 88

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS---AALPWSTRMKI 187
            L  L HP+++KL  +  ++    LV E    G L +++     ++   AA      +K 
Sbjct: 89  VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA----VIIKQ 144

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVIT 244
            L     + +LH     +++RD K  N+LL+S   D   K+ DFGL+      +    + 
Sbjct: 145 VLSG---VTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMK 196

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
             +GT  Y APE V+        DV+S GV+L  LL G  
Sbjct: 197 ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 98.4 bits (246), Expect = 3e-23
 Identities = 72/222 (32%), Positives = 105/222 (47%), Gaps = 37/222 (16%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW--MAEIIFL 134
           S F    +LG+G FG V   F+ +K+      Q  A+K L     +         E   L
Sbjct: 24  SQFELLKVLGQGSFGKV---FLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80

Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWST 183
            ++ HP +VKL  Y ++ E +L L+ +++  G L  +L +           Y A      
Sbjct: 81  VEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA------ 133

Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
             ++AL     L  LH     +IYRD K  NILLD +   KL+DFGL+K+  + E+    
Sbjct: 134 --ELALA----LDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--- 182

Query: 244 TRVM-GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
                GT  Y APE V   GH T  +D +SFGV++ E+LTG 
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 97.2 bits (243), Expect = 6e-23
 Identities = 69/240 (28%), Positives = 103/240 (42%), Gaps = 39/240 (16%)

Query: 61  GSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---D 117
           GS          ++    F    +LG+GG+G V   F   K+      +  A+K L    
Sbjct: 1   GSSETSVNRGPEKIRPECFELLRVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAM 57

Query: 118 LDGTQGHKEW-MAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS- 174
           +           AE   L +++HP +V LI Y ++   +L L+ EY+  G L  QL R  
Sbjct: 58  IVRNAKDTAHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREG 116

Query: 175 ---------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL 225
                    Y A        +I++     L  LH +   +IYRD K  NI+L+     KL
Sbjct: 117 IFMEDTACFYLA--------EISMA----LGHLHQKG--IIYRDLKPENIMLNHQGHVKL 162

Query: 226 SDFGLAKDGPEGEETHVITRVM-GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           +DFGL K+          T    GT  Y APE +M +GH     D +S G ++ ++LTG 
Sbjct: 163 TDFGLCKESIHDGTV---THTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 97.8 bits (244), Expect = 9e-23
 Identities = 55/227 (24%), Positives = 94/227 (41%), Gaps = 45/227 (19%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPV-AVKALDLDGTQGHKEW---MAEII 132
            +F     +G+G FG V    V +      + + + A+K ++        E      E+ 
Sbjct: 15  DHFEILRAIGKGSFGKVCI--VQKN-----DTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPW 181
            +  L HP LV L  Y +++E  + +V + +  G L   L ++          +      
Sbjct: 68  IMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC---- 122

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
               ++ +     L +L  +   +I+RD K  NILLD      ++DF +A   P   +  
Sbjct: 123 ----ELVMA----LDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI- 171

Query: 242 VITRVMGTQGYAAPEYVM----TGHLTTMSDVYSFGVVLLELLTGKR 284
             T + GT+ Y APE        G+ +   D +S GV   ELL G+R
Sbjct: 172 --TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 58/231 (25%), Positives = 93/231 (40%), Gaps = 40/231 (17%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD------------LDGTQ 122
           I  ++ +   LG G +G V      ++          A+K +                 +
Sbjct: 34  IGESYFKVRKLGSGAYGEVLLC---KEKNGH---SEKAIKVIKKSQFDKGRYSDDNKNIE 87

Query: 123 GHKEWMA-EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL--FRSYS--- 176
              E +  EI  L  L HP+++KL     +++Y  LV E+   G L  Q+     +    
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147

Query: 177 AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKD 233
           AA      MK  L     + +LH     +++RD K  NILL++       K+ DFGL+  
Sbjct: 148 AA----NIMKQILSG---ICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198

Query: 234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR 284
             +      +   +GT  Y APE V+        DV+S GV++  LL G  
Sbjct: 199 FSKDY---KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 64/221 (28%), Positives = 92/221 (41%), Gaps = 32/221 (14%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIF 133
           I   F     LG G FG V+   V+E+           +K ++ D +Q   E +  EI  
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHL--VEERSS----GLERVIKTINKDRSQVPMEQIEAEIEV 73

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL------HNQLFRSYS---AALPWSTR 184
           L  L HP+++K+     +     +V E    G L           ++ S    A      
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA----EL 129

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETH 241
           MK  + A   LA+ H   + V+++D K  NIL          K+ DFGLA+     E   
Sbjct: 130 MKQMMNA---LAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--- 181

Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             T   GT  Y APE V    +T   D++S GVV+  LLTG
Sbjct: 182 HSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 50/236 (21%), Positives = 84/236 (35%), Gaps = 41/236 (17%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           + +      +LG G  G V         +   + +PVAVK + +D          EI  L
Sbjct: 13  LKNLVVSEKILGYGSSGTVV-------FQGSFQGRPVAVKRMLIDFCDIALM---EIKLL 62

Query: 135 GQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLH-----NQLFRSYSAALPWSTRMKIA 188
            +   HP++++       + +  +  E     +L        +             + + 
Sbjct: 63  TESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDS-------------DYTAKLSDFGLAK--D 233
              A G+A LH     +I+RD K  NIL+ +             +    +SDFGL K  D
Sbjct: 122 RQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 234 GPEGEETHVITRVMGTQGYAAPE-------YVMTGHLTTMSDVYSFGVVLLELLTG 282
             +      +    GT G+ APE             LT   D++S G V   +L+ 
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.5 bits (240), Expect = 2e-22
 Identities = 44/246 (17%), Positives = 84/246 (34%), Gaps = 34/246 (13%)

Query: 117 DLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL-FRSY 175
            L           +I  +      + V  +     + Y  +  +   + +L + +  R  
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157

Query: 176 SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-- 233
                    + I +  A+ + FLH   K +++RD K SNI    D   K+ DFGL     
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 215

Query: 234 --------GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR- 284
                             T  +GT+ Y +PE +   + +   D++S G++L ELL     
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275

Query: 285 AMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPR 344
            M+  R+  +    ++     ++  +   ++                       LS  P 
Sbjct: 276 QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ--------------------DMLSPSPT 315

Query: 345 HRPTMS 350
            RP  +
Sbjct: 316 ERPEAT 321

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 97.1 bits (242), Expect = 3e-22
 Identities = 81/282 (28%), Positives = 111/282 (39%), Gaps = 48/282 (17%)

Query: 19  MPESNTNNEQVDKQTSFQRLCLSDV--SNPSSPLSADDLSNSVIGSKLHVFTLAELRLIT 76
             E  T  + V      Q     D    +PS    A+++  S+   K  V T+ E   + 
Sbjct: 96  REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRV-TMNEFEYLK 154

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIF 133
                  LLG+G FG V    V EK          A+K L  +      E    + E   
Sbjct: 155 -------LLGKGTFGKVI--LVKEKATGRY----YAMKILKKEVIVAKDEVAHTLTENRV 201

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWS 182
           L   RHP L  L  Y ++   RL  V EY   G L   L R           Y A     
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA----- 255

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              +I       L +LH E K V+YRD K  N++LD D   K++DFGL K+G +   T  
Sbjct: 256 ---EIVSA----LDYLHSE-KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-- 305

Query: 243 ITRVM-GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
             +   GT  Y APE +         D +  GVV+ E++ G+
Sbjct: 306 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 96.7 bits (241), Expect = 5e-22
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 37/222 (16%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEII 132
               ++   +LG+G FG V K    +        Q  AVK ++      +     + E+ 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLKC---KDRITQ---QEYAVKVINKASAKNKDTSTILREVE 73

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF------RSYS---AALPWST 183
            L +L HP+++KL     +     +V E    G    +LF      + +S   AA     
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAA----R 125

Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEET 240
            +K        + ++H     +++RD K  NILL+S   D   K+ DFGL+    +    
Sbjct: 126 IIKQVFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             +   +GT  Y APE V+ G      DV+S GV+L  LL+G
Sbjct: 179 -KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 72/260 (27%), Positives = 108/260 (41%), Gaps = 44/260 (16%)

Query: 43  VSNPSSP--LSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDE 100
           +S P  P  ++A+         ++++   +      S+F    ++G+G FG V       
Sbjct: 2   ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVL--LARH 59

Query: 101 KLKPGLEAQPVAVKALDLDGTQGHKEW---MAE-IIFLGQLRHPHLVKLIGYCWEEEYRL 156
           K +        AVK L        KE    M+E  + L  ++HP LV L  + ++   +L
Sbjct: 60  KAEEVF----YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL 114

Query: 157 -LVYEYMPRGSLHNQLFRS----------YSAALPWSTRMKIALGAAKGLAFLHGEDKPV 205
             V +Y+  G L   L R           Y+A        +IA      L +LH  +  +
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAA--------EIASA----LGYLHSLN--I 160

Query: 206 IYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM-GTQGYAAPEYVM-TGHL 263
           +YRD K  NILLDS     L+DFGL K+  E   T   T    GT  Y APE +    + 
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPY- 216

Query: 264 TTMSDVYSFGVVLLELLTGK 283
               D +  G VL E+L G 
Sbjct: 217 DRTVDWWCLGAVLYEMLYGL 236

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 94.6 bits (236), Expect = 6e-22
 Identities = 67/223 (30%), Positives = 92/223 (41%), Gaps = 41/223 (18%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIF 133
           ++F    LLG+G FG V    V EK          A+K L  +      E    + E   
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRY----YAMKILRKEVIIAKDEVAHTVTESRV 58

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWS 182
           L   RHP L  L  Y ++   RL  V EY   G L   L R           Y A     
Sbjct: 59  LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----- 112

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              +I       L +LH   + V+YRD K  N++LD D   K++DFGL K+G     T  
Sbjct: 113 ---EIVSA----LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161

Query: 243 ITRVM-GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
             +   GT  Y APE +    +     D +  GVV+ E++ G+
Sbjct: 162 -MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 92.6 bits (231), Expect = 1e-21
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 30/210 (14%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHL 142
            LGEG +G V               + VAVK +D+       E +  EI     L H ++
Sbjct: 14  TLGEGAYGEVQLA---VNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-------G 194
           VK  G    E     L  EY   G L +++             M     A +       G
Sbjct: 68  VKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPD-AQRFFHQLMAG 117

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           + +LHG    + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y A
Sbjct: 118 VVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 255 PEYVMTGHL--TTMSDVYSFGVVLLELLTG 282
           PE ++          DV+S G+VL  +L G
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEII 132
               ++   +LG+G FG V K    +++      Q  AVK ++      +     + E+ 
Sbjct: 20  FAERYNIVCMLGKGSFGEVLK--CKDRIT----QQEYAVKVINKASAKNKDTSTILREVE 73

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS---AALPWSTRMKI 187
            L +L HP+++KL     +     +V E    G L +++ +   +S   AA      +K 
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----RIIKQ 129

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVIT 244
                  + ++H     +++RD K  NILL+S   D   K+ DFGL+      ++   + 
Sbjct: 130 VFSG---ITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMK 181

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             +GT  Y APE V+ G      DV+S GV+L  LL+G
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 27/216 (12%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           I   ++  N +G G +G V       +          A K +     +    +  EI  +
Sbjct: 7   INQYYTLENTIGRGSWGEVKIA---VQKGTR---IRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS---AALPWSTRMKIAL 189
             L HP++++L     +     LV E    G L  ++     +    AA      MK  L
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----RIMKDVL 116

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRV 246
            A   +A+ H     V +RD K  N L  +   D   KL DFGLA     G+   ++   
Sbjct: 117 SA---VAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTK 168

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           +GT  Y +P+ V+ G      D +S GV++  LL G
Sbjct: 169 VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 36/227 (15%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
               F    + G+G FG V  G              VA+K +  D    ++E +  +  L
Sbjct: 21  EMDRFQVERMAGQGTFGTVQLGKEKS------TGMSVAIKKVIQDPRFRNRE-LQIMQDL 73

Query: 135 GQLRHPHLVKLIGY-------CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
             L HP++V+L  Y          + Y  +V EY+P  +LH +  R+Y            
Sbjct: 74  AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLH-RCCRNYYRR---QVAPPP 128

Query: 188 ALG------AAKGLAFLHGEDKPVIYRDFKASNILLD-SDYTAKLSDFGLAKDGPEGEE- 239
            L         + +  LH     V +RD K  N+L++ +D T KL DFG AK     E  
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188

Query: 240 TH-VITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
              + +R      Y APE ++ G  H TT  D++S G +  E++ G+
Sbjct: 189 VAYICSRY-----YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 70/280 (25%), Positives = 107/280 (38%), Gaps = 42/280 (15%)

Query: 24  TNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSN 83
            ++    ++        +  S          L+        ++   AE ++   NF    
Sbjct: 2   AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAE-KVGIENFELLK 60

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW----MAE-IIFLGQLR 138
           +LG G +G V   F+  K+      +  A+K L         +       E  +     +
Sbjct: 61  VLGTGAYGKV---FLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117

Query: 139 HPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWSTRMKI 187
            P LV L  Y ++ E +L L+ +Y+  G L   L +           Y          +I
Sbjct: 118 SPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG--------EI 168

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            L     L  LH     +IYRD K  NILLDS+    L+DFGL+K+    E         
Sbjct: 169 VLA----LEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE--RAYDF 220

Query: 248 -GTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGK 283
            GT  Y AP+ V    +GH     D +S GV++ ELLTG 
Sbjct: 221 CGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTGA 259

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 25/215 (11%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           I   F    +LG G F  V+     ++   G   +  A+K +             EI  L
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLV---KQRLTG---KLFALKCIKKSPAFRDSSLENEIAVL 60

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALPWSTRMKIALG 190
            +++H ++V L        +  LV + +  G L +++     Y+   A   S  ++  L 
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA---SLVIQQVLS 117

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   + +LH  +  +++RD K  N+L  +   +    ++DFGL+K    G    +++   
Sbjct: 118 A---VKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTAC 168

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           GT GY APE +     +   D +S GV+   LL G
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 50/276 (18%)

Query: 31  KQTSFQRLCLSDVSNPS--SPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEG 88
           + TSF   C       +  S   + D   S + + +        R    +++ + ++G G
Sbjct: 6   RTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNG 65

Query: 89  GFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGY 148
            FG VY+  + +        + VA+K +  D     +    E+  + +L H ++V+L  +
Sbjct: 66  SFGVVYQAKLCDS------GELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 149 ------CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA---------- 192
                   +E Y  LV +Y+P  +++ ++ R YS       R K  L             
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVY-RVARHYS-------RAKQTLPVIYVKLYMYQLF 166

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGEE-TH-VITRVMGT 249
           + LA++H     + +RD K  N+LLD D    KL DFG AK    GE     + +R    
Sbjct: 167 RSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221

Query: 250 QGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
             Y APE ++ G    T+  DV+S G VL ELL G+
Sbjct: 222 --YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 42/224 (18%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAE-II 132
           ++F+   +LG+G FG V     + K    L     AVK L  D      +    M E  +
Sbjct: 20  TDFNFLMVLGKGSFGKVM--LSERKGTDEL----YAVKILKKDVVIQDDDVECTMVEKRV 73

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPW 181
                + P L +L   C++   RL  V EY+  G L   + +           Y+A    
Sbjct: 74  LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA---- 128

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
               +IA+G    L FL  +   +IYRD K  N++LDS+   K++DFG+ K+      T 
Sbjct: 129 ----EIAIG----LFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT- 177

Query: 242 VITRVM-GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
             T+   GT  Y APE +    +     D ++FGV+L E+L G+
Sbjct: 178 --TKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 65/222 (29%), Positives = 93/222 (41%), Gaps = 40/222 (18%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAE-II 132
            +F    +LG+G FG V+    + K          A+KAL  D      +    M E  +
Sbjct: 17  EDFILHKMLGKGSFGKVF--LAEFKKTNQF----FAIKALKKDVVLMDDDVECTMVEKRV 70

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPW 181
                 HP L  +    ++ +  L  V EY+  G L   +             Y+A    
Sbjct: 71  LSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE--- 126

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
                I LG    L FLH +   ++YRD K  NILLD D   K++DFG+ K+   G+   
Sbjct: 127 -----IILG----LQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 174

Query: 242 VITRVM-GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             T    GT  Y APE ++        D +SFGV+L E+L G
Sbjct: 175 --TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 92.2 bits (230), Expect = 4e-21
 Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 44/222 (19%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIF 133
            +F     LG G FG V+   +  +       +  A+K L  +     K+      E + 
Sbjct: 6   QDFQILRTLGTGSFGRVH--LIRSRH----NGRYYAMKVLKKEIVVRLKQVEHTNDERLM 59

Query: 134 LGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWS 182
           L  + HP ++++    +++  ++ ++ +Y+  G L + L +S          Y+A     
Sbjct: 60  LSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----- 113

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHV 242
              ++ L     L +LH +D  +IYRD K  NILLD +   K++DFG AK  P+      
Sbjct: 114 ---EVCLA----LEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------ 158

Query: 243 ITRVM-GTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTG 282
           +T  + GT  Y APE V T  +     D +SFG+++ E+L G
Sbjct: 159 VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAG 199

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 94.7 bits (235), Expect = 4e-21
 Identities = 70/290 (24%), Positives = 113/290 (38%), Gaps = 57/290 (19%)

Query: 15  YKSSMPESNTNNEQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRL 74
           Y +       +    + +  F+R  +   +      +A+ +S            L +   
Sbjct: 286 YFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNF 345

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---------DLDGTQGHK 125
           +        +LG+G FG V     + K    L     AVK L         D++ T   K
Sbjct: 346 LM-------VLGKGSFGKVM--LSERKGTDEL----YAVKILKKDVVIQDDDVECTMVEK 392

Query: 126 EWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS---------- 174
                 +     + P L +L   C++   RL  V EY+  G L   + +           
Sbjct: 393 R-----VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 446

Query: 175 YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG 234
           Y+A         IA+G    L FL  +   +IYRD K  N++LDS+   K++DFG+ K+ 
Sbjct: 447 YAAE--------IAIG----LFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492

Query: 235 PEGEETHVITRVM-GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
                T   T+   GT  Y APE +         D ++FGV+L E+L G+
Sbjct: 493 IWDGVT---TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 63/285 (22%), Positives = 104/285 (36%), Gaps = 45/285 (15%)

Query: 20  PESNTNNEQVDKQTSFQRL-CLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSN 78
             + TN +    +T    L CL D  N S      ++   +  +K     + ++RL   +
Sbjct: 16  GPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHRED 75

Query: 79  FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEIIFLG 135
           F    ++G G FG V    V  K       +  A+K L+        E   +  E   L 
Sbjct: 76  FEILKVIGRGAFGEVA--VVKLKNA----DKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 136 QLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS-----------YSAALPWST 183
                 +  L  Y ++++  L LV +Y   G L   L +            Y A      
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA------ 182

Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
             ++ +     +  +H      ++RD K  NIL+D +   +L+DFG      E       
Sbjct: 183 --EMVIA----IDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234

Query: 244 TRVMGTQGYAAPEYVMT------GHLTTMSDVYSFGVVLLELLTG 282
             V GT  Y +PE +         +     D +S GV + E+L G
Sbjct: 235 VAV-GTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYG 277

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.6 bits (228), Expect = 5e-21
 Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 31/215 (14%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA----EIIFLGQLRH 139
           LLGEG +G V +  +D +          AVK L     +      A    EI  L +LRH
Sbjct: 12  LLGEGSYGKVKEV-LDSETL-----CRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 140 PHLVKLIG-YCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK---- 193
            ++++L+     EE+ ++ +V EY   G    ++            R  +          
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGM--QEML-DSVP----EKRFPVCQAHGYFCQL 118

Query: 194 --GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             GL +LH   + ++++D K  N+LL +  T K+S  G+A+               G+  
Sbjct: 119 IDGLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176

Query: 252 YAAPEYVMTGHLT---TMSDVYSFGVVLLELLTGK 283
           +  PE +  G  T      D++S GV L  + TG 
Sbjct: 177 FQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.1 bits (229), Expect = 6e-21
 Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 38/259 (14%)

Query: 44  SNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLK 103
            N + P   ++L    +G +  +   A  +     +   +++G G    V +     +  
Sbjct: 61  LNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV--HRAT 118

Query: 104 PGLEAQPVAVKALDLDGTQGHKEWMA--------EIIFLGQLR-HPHLVKLIGYCWEEEY 154
                   AVK +++   +   E +         E   L Q+  HPH++ LI       +
Sbjct: 119 ----GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174

Query: 155 RLLVYEYMPRGSLHNQLFR--SYS--AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDF 210
             LV++ M +G L + L    + S        + M+  L A   ++FLH     +++RD 
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKET---RSIMRSLLEA---VSFLH--ANNIVHRDL 226

Query: 211 KASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMS--- 267
           K  NILLD +   +LSDFG +     GE+        GT GY APE ++   +       
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLEPGEKLR--ELC-GTPGYLAPE-ILKCSMDETHPGY 282

Query: 268 ----DVYSFGVVLLELLTG 282
               D+++ GV+L  LL G
Sbjct: 283 GKEVDLWACGVILFTLLAG 301

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 60/218 (27%), Positives = 85/218 (38%), Gaps = 33/218 (15%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EII 132
            + +   +GEG +G V+K   +         Q VA+K             +      EI 
Sbjct: 4   KYEKIGKIGEGSYGVVFKC-RNRDTG-----QIVAIKKFLESED---DPVIKKIALREIR 54

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHN--QLFRSYSAALPWSTRMKIALG 190
            L QL+HP+LV L+     +    LV+EY      H        Y   +P      I   
Sbjct: 55  MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQ 110

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETH-VITRVM 247
             + + F H      I+RD K  NIL+      KL DFG A+   GP       V TR  
Sbjct: 111 TLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-- 166

Query: 248 GTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
               Y +PE ++ G        DV++ G V  ELL+G 
Sbjct: 167 ---WYRSPE-LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 91.6 bits (228), Expect = 7e-21
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 30/210 (14%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHL 142
            LGEG +G V               + VAVK +D+       E +  EI     L H ++
Sbjct: 14  TLGEGAYGEVQLA---VNRVTE---EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67

Query: 143 VKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK-------G 194
           VK  G    E     L  EY   G L +++             M     A +       G
Sbjct: 68  VKFYG-HRREGNIQYLFLEYCSGGELFDRIEPD--------IGMPEPD-AQRFFHQLMAG 117

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           + +LHG    + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y A
Sbjct: 118 VVYLHG--IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 255 PEYVMTGHL--TTMSDVYSFGVVLLELLTG 282
           PE ++          DV+S G+VL  +L G
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 92.0 bits (229), Expect = 9e-21
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 49/230 (21%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
               ++   ++G G FG V++     KL    E   VA+K +  D    ++E    +  +
Sbjct: 38  REIAYTNCKVIGNGSFGVVFQA----KLVESDE---VAIKKVLQDKRFKNRE----LQIM 86

Query: 135 GQLRHPHLVKLI------GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
             ++HP++V L       G   +E +  LV EY+P  +++ +  R Y+       ++K  
Sbjct: 87  RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVY-RASRHYA-------KLKQT 137

Query: 189 LGAA----------KGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEG 237
           +             + LA++H     + +RD K  N+LLD      KL DFG AK    G
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195

Query: 238 EE-TH-VITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
           E     + +R      Y APE ++ G  + TT  D++S G V+ EL+ G+
Sbjct: 196 EPNVSYICSRY-----YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 31/220 (14%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-----WMAEI 131
           S F +   LG G +  VYKG              VA+K + LD     +E      + EI
Sbjct: 5   SQFKQLEKLGNGTYATVYKG------LNKTTGVYVALKEVKLD----SEEGTPSTAIREI 54

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMP---RGSLHNQLFRSYSAALPWSTRMKIA 188
             + +L+H ++V+L      E    LV+E+M    +  + ++   +    L  +      
Sbjct: 55  SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGEETH-VITR 245
               +GLAF H  +  +++RD K  N+L++     KL DFGLA     P    +  V+T 
Sbjct: 115 WQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172

Query: 246 VMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
                 Y AP+ V+ G    +T  D++S G +L E++TGK
Sbjct: 173 -----WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 53/277 (19%), Positives = 92/277 (33%), Gaps = 59/277 (21%)

Query: 57  NSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL 116
           +   G +   F    L  +   +     +G+G +G V      E  +        A+K +
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAI--EN-QTR---AIRAIKIM 59

Query: 117 D---LDGTQGHKEWMA--EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL---- 167
           +   +             E+  + +L HP++ +L     +E+Y  LV E    G L    
Sbjct: 60  NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKL 119

Query: 168 ----HNQLFRSYSAALPWSTRMKIALG-----------------------AAK------- 193
                +   +     +                                   +        
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAK--DGPEGEETHVITRVMGT 249
            L +LH  ++ + +RD K  N L  ++ +   KL DFGL+K        E + +T   GT
Sbjct: 180 ALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

Query: 250 QGYAAPEYVMTGHL---TTMSDVYSFGVVLLELLTGK 283
             + APE V+           D +S GV+L  LL G 
Sbjct: 238 PYFVAPE-VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 56/217 (25%), Positives = 88/217 (40%), Gaps = 31/217 (14%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EII 132
            +    L+GEG +G V K   ++        + VA+K           + +      EI 
Sbjct: 26  KYENLGLVGEGSYGMVMKC-RNKDTG-----RIVAIKKFLESDD---DKMVKKIAMREIK 76

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHN--QLFRSYSAALPWSTRMKIALG 190
            L QLRH +LV L+  C +++   LV+E++     H        +   L +    K    
Sbjct: 77  LLKQLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQ 132

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETH-VITRVM 247
              G+ F H     +I+RD K  NIL+      KL DFG A+    P       V TR  
Sbjct: 133 IINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-- 188

Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
               Y APE ++         DV++ G ++ E+  G+
Sbjct: 189 ---WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 40/220 (18%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIF 133
             F R   LG G FG V    V  K          A+K LD       K+    + E   
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKE----SGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS----------YSAALPWST 183
           L  +  P LVKL     +     +V EY+  G + + L R           Y+A      
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA------ 148

Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
             +I L       +LH  D  +IYRD K  N+L+D     +++DFG AK       T   
Sbjct: 149 --QIVLT----FEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT--- 197

Query: 244 TRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTG 282
             + GT    APE +++ G+     D ++ GV++ E+  G
Sbjct: 198 --LCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAG 234

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 34/219 (15%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-----WMAEI 131
             + +   +GEG +G VYK     K   G   + VA+K + LD      E      + EI
Sbjct: 21  EKYQKLEKVGEGTYGVVYKA----KDSQG---RIVALKRIRLDAE---DEGIPSTAIREI 70

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHN--QLFRSYSAALPWSTRMKIAL 189
             L +L HP++V LI     E    LV+E+M      +  ++       L  S       
Sbjct: 71  SLLKELHHPNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLY 126

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETH-VITRV 246
              +G+A  H     +++RD K  N+L++SD   KL+DFGLA+    P    TH V+T  
Sbjct: 127 QLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTL- 183

Query: 247 MGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
                Y AP+ V+ G    +T  D++S G +  E++TGK
Sbjct: 184 ----WYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 42/217 (19%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAE-IIFLGQLRH 139
           ++G G +  V    V  K    +     A+K +  +     ++      E  +F     H
Sbjct: 16  VIGRGSYAKVL--LVRLKKTDRI----YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 140 PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWSTRMKIA 188
           P LV L   C++ E RL  V EY+  G L   + R           YSA        +I+
Sbjct: 70  PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------EIS 120

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM- 247
           L     L +LH     +IYRD K  N+LLDS+   KL+D+G+ K+G    +T   T    
Sbjct: 121 LA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFC 171

Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           GT  Y APE +    +     D ++ GV++ E++ G+
Sbjct: 172 GTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 207

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 39/229 (17%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---------LDGTQGHK 125
              N+    +LG G    V +     K     E    AVK +D          +  +  +
Sbjct: 15  FYENYEPKEILGRGVSSVVRRCI--HK-PTCKE---YAVKIIDVTGGGSFSAEEVQELRE 68

Query: 126 EWMAEIIFLGQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALP 180
             + E+  L ++  HP++++L        +  LV++ M +G L + L    + S      
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET-- 126

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
               M+  L     +  LH     +++RD K  NILLD D   KL+DFG +     GE  
Sbjct: 127 -RKIMRALLEV---ICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-- 178

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMS-------DVYSFGVVLLELLTG 282
             +  V GT  Y APE ++   +           D++S GV++  LL G
Sbjct: 179 -KLREVCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 26/213 (12%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
             S++ +LG G FG V+K   +E    GL+   +A K +   G +  +E   EI  + QL
Sbjct: 90  TVSKTEILGGGRFGQVHK--CEET-ATGLK---LAAKIIKTRGMKDKEEVKNEISVMNQL 143

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR---SYS---AALPWSTRMKIALGA 191
            H +L++L      +   +LV EY+  G L +++     + +           MK     
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI----LFMKQICE- 198

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGT 249
             G+  +H     +++ D K  NIL  +      K+ DFGLA+     E+  V     GT
Sbjct: 199 --GIRHMH--QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGT 251

Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             + APE V    ++  +D++S GV+   LL+G
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 60/229 (26%), Positives = 94/229 (41%), Gaps = 42/229 (18%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMA-- 129
           +   +  S  LG G  G V   F  E+ K     + VA++ +           +   A  
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAF--ER-KTC---KKVAIRIISKRKFAIGSAREADPALN 186

Query: 130 ---EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL------HNQLFRSYSAALP 180
              EI  L +L HP ++K+  +  + E   +V E M  G L      + +L  +      
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY- 244

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEG 237
                   L A   + +LH  +  +I+RD K  N+LL S   D   K++DFG +K     
Sbjct: 245 ----FYQMLLA---VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK---IL 292

Query: 238 EETHVITRVMGTQGYAAPEYVMTGHL----TTMSDVYSFGVVLLELLTG 282
            ET ++  + GT  Y APE V+            D +S GV+L   L+G
Sbjct: 293 GETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMA--EI 131
             + + + LGEG F  VYK             Q VA+K + L      K+     A  EI
Sbjct: 10  KRYEKLDFLGEGQFATVYKA---RDKNTN---QIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHN--QLFRSYSAALPWSTRMKIAL 189
             L +L HP+++ L+     +    LV+++M      +   + +  S  L  S      L
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYML 119

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK--DGPEGEETH-VITRV 246
              +GL +LH     +++RD K +N+LLD +   KL+DFGLAK    P    TH V+TR 
Sbjct: 120 MTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR- 176

Query: 247 MGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
                Y APE ++ G        D+++ G +L ELL   
Sbjct: 177 ----WYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 52/222 (23%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL---------DLDGTQGHKEWMAEIIFL 134
           ++G G +  V    V  K    +     A++ +         D+D  Q  K      +F 
Sbjct: 59  VIGRGSYAKVL--LVRLKKTDRI----YAMRVVKKELVNDDEDIDWVQTEKH-----VFE 107

Query: 135 GQLRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWST 183
               HP LV L   C++ E RL  V EY+  G L   + R           YSA      
Sbjct: 108 QASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA------ 160

Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI 243
             +I+L     L +LH     +IYRD K  N+LLDS+   KL+D+G+ K+G    +T   
Sbjct: 161 --EISLA----LNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--- 209

Query: 244 TRVM-GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           T    GT  Y APE +    +     D ++ GV++ E++ G+
Sbjct: 210 TSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGR 250

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 26/216 (12%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           +   +     LG G FG V++    EK   G        K ++            EI  +
Sbjct: 49  VYDYYDILEELGSGAFGVVHR--CVEK-ATGRV---FVAKFINTPYPLDKYTVKNEISIM 102

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR---SYS---AALPWSTRMKIA 188
            QL HP L+ L     ++   +L+ E++  G L +++       S           M+ A
Sbjct: 103 NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI----NYMRQA 158

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDS--DYTAKLSDFGLAKDGPEGEETHVITRV 246
                GL  +H  +  +++ D K  NI+ ++    + K+ DFGLA      E   ++   
Sbjct: 159 CE---GLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVT 210

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             T  +AAPE V    +   +D+++ GV+   LL+G
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 58/258 (22%), Positives = 96/258 (37%), Gaps = 26/258 (10%)

Query: 38  LCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGF 97
           L +      S       +++ +  ++  V  L E+RL   +F    ++G G F  V    
Sbjct: 22  LGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVA--V 79

Query: 98  VDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEIIFLGQLRHPHLVKLIGYCWEEEY 154
           V  K       Q  A+K ++        E   +  E   L       + +L  + +++E 
Sbjct: 80  VKMKQT----GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDEN 134

Query: 155 RL-LVYEYMPRGSLHNQLFRSYSAALPWS-TRMKIA-LGAAKGLAFLHGEDKPVIYRDFK 211
            L LV EY   G L   L + +   +P    R  +A +  A  +  +H      ++RD K
Sbjct: 135 YLYLVMEYYVGGDLLTLLSK-FGERIPAEMARFYLAEIVMA--IDSVHRLG--YVHRDIK 189

Query: 212 ASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVY- 270
             NILLD     +L+DFG             +  V GT  Y +PE +        +  Y 
Sbjct: 190 PDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYG 248

Query: 271 ------SFGVVLLELLTG 282
                 + GV   E+  G
Sbjct: 249 PECDWWALGVFAYEMFYG 266

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 90.0 bits (224), Expect = 3e-20
 Identities = 66/217 (30%), Positives = 91/217 (41%), Gaps = 42/217 (19%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAE-IIFLGQLRH 139
           +LG+G FG V       K    L     AVK L  D      +    M E  I      H
Sbjct: 30  VLGKGSFGKVM--LARVKETGDL----YAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83

Query: 140 PHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRS----------YSAALPWSTRMKIA 188
           P L +L   C++   RL  V E++  G L   + +S          Y+A        +I 
Sbjct: 84  PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------EII 134

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM- 247
                 L FLH +   +IYRD K  N+LLD +   KL+DFG+ K+G     T   T    
Sbjct: 135 SA----LMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFC 185

Query: 248 GTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
           GT  Y APE +    +     D ++ GV+L E+L G 
Sbjct: 186 GTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGH 221

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.7 bits (221), Expect = 4e-20
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 34/218 (15%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-----WMAEII 132
            +     +GEG +G VYK     +   G   +  A+K + L+      E      + EI 
Sbjct: 3   KYHGLEKIGEGTYGVVYKA----QNNYG---ETFALKKIRLEKE---DEGIPSTTIREIS 52

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHN--QLFRSYSAALPWSTRMKIALG 190
            L +L+H ++VKL      ++  +LV+E++      +  +L       L   T     L 
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETH-VITRVM 247
              G+A+ H  D+ V++RD K  N+L++ +   K++DFGLA+    P  + TH ++T   
Sbjct: 109 LLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-- 164

Query: 248 GTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
               Y AP+ V+ G    +T  D++S G +  E++ G 
Sbjct: 165 ---WYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 90.7 bits (225), Expect = 7e-20
 Identities = 56/247 (22%), Positives = 93/247 (37%), Gaps = 26/247 (10%)

Query: 44  SNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLK 103
              +   + D+    +           +   +  ++     LG G FG V++  V E+  
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHR--VTERAT 181

Query: 104 PGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMP 163
                   A K +        +    EI  +  LRHP LV L     ++   +++YE+M 
Sbjct: 182 ----GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237

Query: 164 RGSLHNQLFR---SYS---AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL 217
            G L  ++       S   A       M+      KGL  +H  +   ++ D K  NI+ 
Sbjct: 238 GGELFEKVADEHNKMSEDEAV----EYMRQVC---KGLCHMH--ENNYVHLDLKPENIMF 288

Query: 218 DS--DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVV 275
            +      KL DFGL       +   V     GT  +AAPE      +   +D++S GV+
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345

Query: 276 LLELLTG 282
              LL+G
Sbjct: 346 SYILLSG 352

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 34/218 (15%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-----WMAEII 132
            + + + LGEG +  VYKG      K  L    VA+K + L+    H+E      + E+ 
Sbjct: 3   TYIKLDKLGEGTYATVYKG------KSKLTDNLVALKEIRLE----HEEGAPCTAIREVS 52

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHN--QLFRSYSAALPWSTRMKIALG 190
            L  L+H ++V L      E+   LV+EY+      +  Q        +           
Sbjct: 53  LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA--KDGPEGEETH-VITRVM 247
             +GLA+ H   + V++RD K  N+L++     KL+DFGLA  K  P     + V+T   
Sbjct: 109 LLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTL-- 164

Query: 248 GTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
               Y  P+ ++ G    +T  D++  G +  E+ TG+
Sbjct: 165 ---WYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.1 bits (216), Expect = 1e-19
 Identities = 36/280 (12%), Positives = 77/280 (27%), Gaps = 58/280 (20%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHP 140
             G       ++  +D  L      + VA+  +D  G       +E ++  + L ++  P
Sbjct: 38  FHGGVPPLQFWQA-LDTAL-----DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            + +++         L+V E++  GSL          +      ++     A      H 
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT 260
               V       S + +  D    L+                                  
Sbjct: 148 AG--VALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA---- 179

Query: 261 GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW-ARPLLKEPRKLERLIDPRL 319
                  D+   G  L  LL  +  +    +    + AE        EP  ++R I  ++
Sbjct: 180 ---NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI 236

Query: 320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                        A A + +      R   + ++ ++   
Sbjct: 237 S------------AVAARSVQGDGGIRSAST-LLNLMQQA 263

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 87.2 bits (217), Expect = 1e-19
 Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 33/221 (14%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-----WMAEII 132
            + +   +GEG +G V+K       K     + VA+K + LD      E      + EI 
Sbjct: 3   KYEKLEKIGEGTYGTVFKA------KNRETHEIVALKRVRLDDD---DEGVPSSALREIC 53

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHN--QLFRSYSAALPWSTRMKIALG 190
            L +L+H ++V+L      ++   LV+E+       +  + F S +  L           
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETH-VITRVM 247
             KGL F H   + V++RD K  N+L++ +   KL++FGLA+    P    +  V+T   
Sbjct: 110 LLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL-- 165

Query: 248 GTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGKRAM 286
               Y  P+ V+ G    +T  D++S G +  EL    R +
Sbjct: 166 ---WYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 26/222 (11%)

Query: 74  LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF 133
           L    +    ++G+G F  V +     +       Q  AVK +D+           E + 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCI--NRET----GQQFAVKIVDVAKFTSSPGLSTEDLK 74

Query: 134 -----LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR---- 184
                   L+HPH+V+L+     +    +V+E+M    L  ++ +   A   +S      
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134

Query: 185 -MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEET 240
            M+  L A   L + H  D  +I+RD K   +LL S       KL  FG+A    E    
Sbjct: 135 YMRQILEA---LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL- 188

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            V    +GT  + APE V         DV+  GV+L  LL+G
Sbjct: 189 -VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 26/217 (11%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEII 132
            + N+     LG+G F  V +         G      A K ++      +  ++   E  
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRC---VHKTTG---LEFAAKIINTKKLSARDFQKLEREAR 57

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALPWSTRMKIA 188
              +L+HP++V+L     EE +  LV++ +  G L   +     YS   A   S  ++  
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA---SHCIQQI 114

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITR 245
           L +   +A+ H     +++R+ K  N+LL S       KL+DFGLA +  + E       
Sbjct: 115 LES---IAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHG 166

Query: 246 VMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             GT GY +PE +     +   D+++ GV+L  LL G
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 34/218 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHL 142
           +LGEG    V        L      Q  AVK ++            E+  L Q + H ++
Sbjct: 20  VLGEGAHARVQTC---INLITS---QEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSL--HNQLFRSYS--AALPWSTRMKIALGAAKGLAFL 198
           ++LI +  EE+   LV+E M  GS+  H    R ++   A   S  ++    A   L FL
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA---SVVVQDVASA---LDFL 127

Query: 199 HGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVM-----GTQ 250
           H  +K + +RD K  NIL    +     K+ DF L        +   I+        G+ 
Sbjct: 128 H--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 251 GYAAPEYVMTGHLTTMS------DVYSFGVVLLELLTG 282
            Y APE V+       S      D++S GV+L  LL+G
Sbjct: 186 EYMAPE-VVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 31/222 (13%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD------LDGTQGHKEWM 128
           +  ++     LG G F  V K    +K   G E    A K +              +E  
Sbjct: 3   VEDHYEMGEELGSGQFAIVRK--CRQK-GTGKE---YAAKFIKKRRLSSSRRGVSREEIE 56

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALPWSTR 184
            E+  L ++RHP+++ L      +   +L+ E +  G L + L    S +   A   +  
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA---TQF 113

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPEGEET 240
           +K  L    G+ +LH   K + + D K  NI+L      +   KL DFG+A     G E 
Sbjct: 114 LKQILD---GVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             I    GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 169 KNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 60/229 (26%), Positives = 91/229 (39%), Gaps = 42/229 (18%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMA-- 129
           +   +  S  LG G  G V   F  E+       + VA+K +           +   A  
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAF--ERKT----CKKVAIKIISKRKFAIGSAREADPALN 61

Query: 130 ---EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSL------HNQLFRSYSAALP 180
              EI  L +L HP ++K+  + ++ E   +V E M  G L      + +L  +      
Sbjct: 62  VETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY- 119

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEG 237
                   L A   + +LH  +  +I+RD K  N+LL S   D   K++DFG +K   E 
Sbjct: 120 ----FYQMLLA---VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170

Query: 238 EETHVITRVMGTQGYAAPEYVMTGHL----TTMSDVYSFGVVLLELLTG 282
                 T   GT  Y APE V+            D +S GV+L   L+G
Sbjct: 171 SLMR--TLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 65/215 (30%), Positives = 93/215 (43%), Gaps = 39/215 (18%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EIIFLGQLR 138
            LG G FG V  G   E    G     VAVK L+    +     +      EI  L   R
Sbjct: 18  TLGVGTFGKVKIG---EHQLTG---HKVAVKILN--RQKIRSLDVVGKIKREIQNLKLFR 69

Query: 139 HPHLVKLIGY-CWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK--- 193
           HPH++KL  Y          +V EY+  G L + + +          R++          
Sbjct: 70  HPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKH--------GRVEEMEARRLFQQ 119

Query: 194 ---GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
               + + H     V++RD K  N+LLD+   AK++DFGL+    +GE     T   G+ 
Sbjct: 120 ILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--TSC-GSP 174

Query: 251 GYAAPEYVMTGHL--TTMSDVYSFGVVLLELLTGK 283
            YAAPE V++G L      D++S GV+L  LL G 
Sbjct: 175 NYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 62/214 (28%), Positives = 95/214 (44%), Gaps = 40/214 (18%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIFLGQLRHPH 141
           +G+G F  V        +  G   + VA+K +D   L+ T   K    E+  +  L HP+
Sbjct: 23  IGKGNFAKVKLA---RHILTG---REVAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPN 75

Query: 142 LVKLIGY-CWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK------ 193
           +VKL  +   E E  L L+ EY   G + + L            RMK     +K      
Sbjct: 76  IVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAH--------GRMKEKEARSKFRQIVS 125

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE--ETHVITRVMGTQG 251
            + + H   K +++RD KA N+LLD+D   K++DFG + +   G   +        G   
Sbjct: 126 AVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPP 178

Query: 252 YAAPEYVMTGHLTT--MSDVYSFGVVLLELLTGK 283
           YAAPE +  G        DV+S GV+L  L++G 
Sbjct: 179 YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 59/238 (24%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMA--EI 131
           S + +   +G+G FG V+K     K       Q VA+K + ++     KE     A  EI
Sbjct: 17  SKYEKLAKIGQGTFGEVFKA-RHRKTG-----QKVALKKVLMEN---EKEGFPITALREI 67

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRL--------LVYEYM----------PRGSLHNQLFR 173
             L  L+H ++V LI  C  +            LV+++                     +
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 127

Query: 174 SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA-- 231
                      M++ L    GL ++H     +++RD KA+N+L+  D   KL+DFGLA  
Sbjct: 128 RV---------MQMLL---NGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARA 173

Query: 232 ----KDGPEGEETH-VITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGK 283
               K+      T+ V+T       Y  PE ++         D++  G ++ E+ T  
Sbjct: 174 FSLAKNSQPNRYTNRVVTL-----WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 34/219 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G G +G VYK     K K G + +  A+K ++  G         EI  L +L+HP+++ 
Sbjct: 29  VGRGTYGHVYKA----KRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVIS 82

Query: 145 LIGYCWE-EEYRL-LVYEYMPRGSLH--NQLFRSYSAALPWSTRMKIALGAAK------- 193
           L        + ++ L+++Y      H    + + + A+      +++  G  K       
Sbjct: 83  LQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 194 -GLAFLHGEDKPVIYRDFKASNILLDSDYTA----KLSDFGLAK--DGPEGEETHVITRV 246
            G+ +LH     V++RD K +NIL+  +       K++D G A+  + P      +   V
Sbjct: 139 DGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 247 MGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
           + T  Y APE ++ G  H T   D+++ G +  ELLT +
Sbjct: 197 V-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 40/215 (18%), Positives = 85/215 (39%), Gaps = 25/215 (11%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           +   +  +  LG G FG V++    E        +    K + + G         EI  L
Sbjct: 3   LYEKYMIAEDLGRGEFGIVHR--CVETSS----KKTYMAKFVKVKG-TDQVLVKKEISIL 55

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR---SYS--AALPWSTRMKIAL 189
              RH +++ L       E  ++++E++    +  ++       +        + +    
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI---VSYVHQVC 112

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVM 247
              + L FLH     + + D +  NI+  +  ++  K+ +FG A+    G+   ++    
Sbjct: 113 ---EALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---F 164

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
               Y APE      ++T +D++S G ++  LL+G
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 59/243 (24%), Positives = 99/243 (40%), Gaps = 27/243 (11%)

Query: 49  PLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEA 108
           P  A       +G        A  +  + N+     LG+G F  V +         G   
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTK-FSDNYDVKEELGKGAFSVVRRC---VHKTTG--- 54

Query: 109 QPVAVKALDLDGTQG--HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGS 166
              A K ++         ++   E     +L+HP++V+L     EE +  LV++ +  G 
Sbjct: 55  LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 114

Query: 167 LHNQLFR--SYS--AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS--- 219
           L   +     YS   A   S  ++  L +   +A+ H     +++R+ K  N+LL S   
Sbjct: 115 LFEDIVAREFYSEADA---SHCIQQILES---IAYCH--SNGIVHRNLKPENLLLASKAK 166

Query: 220 DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLEL 279
               KL+DFGLA    E  ++       GT GY +PE +     +   D+++ GV+L  L
Sbjct: 167 GAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 223

Query: 280 LTG 282
           L G
Sbjct: 224 LVG 226

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 62/222 (27%), Positives = 91/222 (40%), Gaps = 31/222 (13%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD------LDGTQGHKEWM 128
           +   +     LG G F  V K    EK   GLE    A K +              +E  
Sbjct: 10  VEDFYDIGEELGSGQFAIVKK--CREK-STGLE---YAAKFIKKRQSRASRRGVCREEIE 63

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL----FRSYSAALPWSTR 184
            E+  L Q+ HP+++ L          +L+ E +  G L + L      S   A   ++ 
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA---TSF 120

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPEGEET 240
           +K  L    G+ +LH   K + + D K  NI+L          KL DFGLA +  +G E 
Sbjct: 121 IKQILD---GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             I    GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 176 KNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 62/222 (27%), Positives = 92/222 (41%), Gaps = 31/222 (13%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD------LDGTQGHKEWM 128
           +   +     LG G F  V K    EK   GLE    A K +              +E  
Sbjct: 10  VEDFYDIGEELGSGQFAIVKK--CREK-STGLE---YAAKFIKKRQSRASRRGVSREEIE 63

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALPWSTR 184
            E+  L Q+ H +++ L          +L+ E +  G L + L +  S S   A   ++ 
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA---TSF 120

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPEGEET 240
           +K  L    G+ +LH   K + + D K  NI+L          KL DFGLA +  +G E 
Sbjct: 121 IKQILD---GVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF 175

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             I    GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 176 KNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 63/262 (24%), Positives = 103/262 (39%), Gaps = 39/262 (14%)

Query: 38  LCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGF 97
             L    +  +     ++ N +   K  +  + +LR+   ++    ++G G FG V    
Sbjct: 30  DALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ--L 87

Query: 98  VDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEIIFLGQLRHPHLVKLIGYCWEEEY 154
           V  K    +     A+K L         +   +  E   +     P +V+L  Y ++++ 
Sbjct: 88  VRHKSTRKV----YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDR 142

Query: 155 RL-LVYEYMPRGSLHNQLFRS---------YSAALPWSTRMKIALGAAKGLAFLHGEDKP 204
            L +V EYMP G L N +            Y+A        ++ L     L  +H     
Sbjct: 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA--------EVVLA----LDAIHSMG-- 188

Query: 205 VIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT---- 260
            I+RD K  N+LLD     KL+DFG      +       T V GT  Y +PE + +    
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 247

Query: 261 GHLTTMSDVYSFGVVLLELLTG 282
           G+     D +S GV L E+L G
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVG 269

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 53/233 (22%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EI 131
             +     +GEG +G V+K   D K       + VA+K + +      +E M      E+
Sbjct: 11  QQYECVAEIGEGAYGKVFKA-RDLKNG----GRFVALKRVRVQTG---EEGMPLSTIREV 62

Query: 132 IFLGQLR---HPHLVKLI----GYCWEEEYRL-LVYEYM-----------PRGSLHNQLF 172
             L  L    HP++V+L         + E +L LV+E++           P   +  +  
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 173 RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK 232
           +           M   L   +GL FLH     V++RD K  NIL+ S    KL+DFGLA+
Sbjct: 123 KDM---------MFQLL---RGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 233 D-GPEGEETH-VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
               +   T  V+T       Y APE ++     T  D++S G +  E+   K
Sbjct: 169 IYSFQMALTSVVVTL-----WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 35/224 (15%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD------LDGTQGHKEWM 128
           +   +     LG G F  V K    EK   GL+    A K +              ++  
Sbjct: 9   VDDYYDTGEELGSGQFAVVKK--CREK-STGLQ---YAAKFIKKRRTKSSRRGVSREDIE 62

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS----AALPWS 182
            E+  L +++HP+++ L      +   +L+ E +  G L + L    S +          
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--- 119

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS----DYTAKLSDFGLAKDGPEGE 238
             +K  L     + +LH     + + D K  NI+L          K+ DFGLA     G 
Sbjct: 120 --LKQILNG---VYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
                  + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 173 ---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 51/233 (21%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EI 131
           S +     +G G +G VYK   D           VA+K++ +    G    +      E+
Sbjct: 9   SRYEPVAEIGVGAYGTVYKA-RDPHSG-----HFVALKSVRVPNGGGGGGGLPISTVREV 62

Query: 132 IFLGQLR---HPHLVKLI----GYCWEEEYRL-LVYEYM-----------PRGSLHNQLF 172
             L +L    HP++V+L+        + E ++ LV+E++           P   L  +  
Sbjct: 63  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122

Query: 173 RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK 232
           +           M+  L   +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+
Sbjct: 123 KDL---------MRQFL---RGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168

Query: 233 D-GPEGEETH-VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
               +   T  V+T       Y APE ++     T  D++S G +  E+   K
Sbjct: 169 IYSYQMALTPVVVTL-----WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 68/273 (24%), Positives = 111/273 (40%), Gaps = 36/273 (13%)

Query: 19  MPESNTNNEQVDKQTSFQRL--CLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRLIT 76
           M   + ++  VD  T         S  ++ +   ++      + GS            ++
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDA--------LS 52

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
             F   + LG G    VY+    +K       +P A+K L    T   K    EI  L +
Sbjct: 53  DFFEVESELGRGATSIVYR--CKQK-GTQ---KPYALKVLK--KTVDKKIVRTEIGVLLR 104

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALPWSTRMKIALGAA 192
           L HP+++KL           LV E +  G L +++     YS   A   +  +K  L A 
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA---ADAVKQILEA- 160

Query: 193 KGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
             +A+LH  +  +++RD K  N+L      D   K++DFGL+K         ++  V GT
Sbjct: 161 --VAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGT 213

Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            GY APE +         D++S G++   LL G
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 55/212 (25%), Positives = 82/212 (38%), Gaps = 33/212 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEIIFLGQLRH-PH 141
           LG G F  V +     K   G E    A K L     G     E + EI  L   +  P 
Sbjct: 37  LGRGKFAVVRQ--CISK-STGQE---YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQL----FRSYS----AALPWSTRMKIALGAAK 193
           ++ L          +L+ EY   G + +          S      L     +K  L    
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE--- 142

Query: 194 GLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
           G+ +LH     +++ D K  NILL         K+ DFG+++      E   I   MGT 
Sbjct: 143 GVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI---MGTP 197

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            Y APE +    +TT +D+++ G++   LLT 
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 53/240 (22%), Positives = 90/240 (37%), Gaps = 62/240 (25%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---------------------LDGTQ 122
            +G+G +G V     +E           A+K L                        G  
Sbjct: 20  EIGKGSYGVVKLA-YNENDN-----TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 123 GHKEWMA-----EIIFLGQLRHPHLVKLIGYC-WE--EEYRL-LVYEYMPRGSLHNQLFR 173
                       EI  L +L HP++VKL      +   E  L +V+E + +G     +  
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQG----PVM- 126

Query: 174 SYSAALPWSTRMKIALGAAK-------GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS 226
                +P    +     A         G+ +LH   + +I+RD K SN+L+  D   K++
Sbjct: 127 ----EVPTLKPLSEDQ-ARFYFQDLIKGIEYLH--YQKIIHRDIKPSNLLVGEDGHIKIA 179

Query: 227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT---TMSDVYSFGVVLLELLTGK 283
           DFG++ +  +G +  +   V GT  + APE +            DV++ GV L   + G+
Sbjct: 180 DFGVSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 35/213 (16%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA---EIIFLGQLRHP 140
            LG G FG V  G   +    G     VAVK L+    +          EI  L   RHP
Sbjct: 23  TLGVGTFGKVKVG---KHELTG---HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 141 HLVKLIGY-CWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK----- 193
           H++KL  Y        + +V EY+  G L + + ++         R+             
Sbjct: 77  HIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKN--------GRLDEKESRRLFQQIL 126

Query: 194 -GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
            G+ + H     V++RD K  N+LLD+   AK++DFGL+    +GE     T   G+  Y
Sbjct: 127 SGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR--TSC-GSPNY 181

Query: 253 AAPEYVMTGHL--TTMSDVYSFGVVLLELLTGK 283
           AAPE V++G L      D++S GV+L  LL G 
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AEII 132
            T  +     LG+G F  V +     K+  G   Q  A   ++              E  
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRC---VKVLAG---QEYAAMIINTKKLSARDHQKLEREAR 62

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALPWSTRMKIA 188
               L+HP++V+L     EE +  L+++ +  G L   +     YS   A   S  ++  
Sbjct: 63  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA---SHCIQQI 119

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITR 245
           L A   +   H     V++R+ K  N+LL S       KL+DFGLA +    ++      
Sbjct: 120 LEA---VLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFG 172

Query: 246 VMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTG 282
             GT GY +PE V+         D+++ GV+L  LL G
Sbjct: 173 FAGTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.8 bits (205), Expect = 7e-18
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 35/214 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD----LDGTQGHKEWMA----EIIFLGQ 136
           LG G FG V+        +     + V VK +     L+        +     EI  L +
Sbjct: 32  LGSGAFGFVWTA---VDKEKN---KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK--- 193
           + H +++K++     + +  LV E    G     LF ++    P   R+   L +     
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGL---DLF-AFIDRHP---RLDEPLASYIFRQ 138

Query: 194 ---GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
               + +L    K +I+RD K  NI++  D+T KL DFG A     G+  +      GT 
Sbjct: 139 LVSAVGYLR--LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT---FCGTI 193

Query: 251 GYAAPEYVMTGHLTT--MSDVYSFGVVLLELLTG 282
            Y APE V+ G+       +++S GV L  L+  
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.7 bits (205), Expect = 9e-18
 Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 37/221 (16%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEI 131
            T  +     +G G +    +  + +           AVK +D    D T+       EI
Sbjct: 20  FTDGYEVKEDIGVGSYSVCKRC-IHKATN-----MEFAVKIIDKSKRDPTE-------EI 66

Query: 132 -IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALPWSTRMK 186
            I L   +HP+++ L     + +Y  +V E M  G L +++ R   +S   A   S  + 
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA---SAVLF 123

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD----YTAKLSDFGLAKDGPEGEETHV 242
                   + +LH   + V++RD K SNIL   +     + ++ DFG AK         +
Sbjct: 124 TITKT---VEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--L 176

Query: 243 ITRVMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTG 282
           +     T  + APE V+       + D++S GV+L  +LTG
Sbjct: 177 LMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 58/210 (27%), Positives = 89/210 (42%), Gaps = 35/210 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA----EIIFLGQLR-H 139
           LGEG F    K       K     Q  AVK +        K   A    EI  L     H
Sbjct: 19  LGEGSFSICRKC---VHKKSN---QAFAVKIIS-------KRMEANTQKEITALKLCEGH 65

Query: 140 PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--SYS--AALPWSTRMKIALGAAKGL 195
           P++VKL     ++ +  LV E +  G L  ++ +   +S   A   S  M+  + A   +
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA---SYIMRKLVSA---V 119

Query: 196 AFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           + +H  D  V++RD K  N+L    + +   K+ DFG A+  P   +   +     T  Y
Sbjct: 120 SHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCFTLHY 175

Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
           AAPE +         D++S GV+L  +L+G
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 55/231 (23%), Positives = 95/231 (41%), Gaps = 53/231 (22%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-----EI 131
             + R   LGEG +G VYK  +D         + VA+K + L+     +E +      E+
Sbjct: 34  DRYRRITKLGEGTYGEVYKA-IDTVTN-----ETVAIKRIRLEHE---EEGVPGTAIREV 84

Query: 132 IFLGQLRHPHLVKLIGYCWEEEYRLLVYEYM---------PRGSLHNQLFRSYSAALPWS 182
             L +L+H ++++L           L++EY              +  ++ +S+   L   
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL--- 141

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-----KLSDFGLAKD--GP 235
                      G+ F H   +  ++RD K  N+LL     +     K+ DFGLA+    P
Sbjct: 142 ---------INGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190

Query: 236 EGEETH-VITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGK 283
             + TH +IT       Y  PE ++ G  H +T  D++S   +  E+L   
Sbjct: 191 IRQFTHEIITL-----WYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 52/210 (24%), Positives = 81/210 (38%), Gaps = 33/210 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA-EIIFLGQLRHPHL 142
            +G G FG                 + VAVK ++        E +  EII    LRHP++
Sbjct: 27  DIGSGNFGVARLM---RDKLTK---ELVAVKYIER--GAAIDENVQREIINHRSLRHPNI 78

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK------GLA 196
           V+         +  ++ EY   G L+ ++  +         R               G++
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNA--------GRFSEDEARFFFQQLLSGVS 130

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           + H     + +RD K  N LLD       K+ DFG +K      +    + V GT  Y A
Sbjct: 131 YCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIA 185

Query: 255 PEYVMTGHL--TTMSDVYSFGVVLLELLTG 282
           PE V+        ++DV+S GV L  +L G
Sbjct: 186 PE-VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 80.1 bits (198), Expect = 6e-17
 Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 37/213 (17%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI-IFLGQLRHPHL 142
           +LG G  G V + F     + G   Q  A+K L         +   E+         PH+
Sbjct: 36  VLGLGVNGKVLECF---HRRTG---QKCALKLLY-----DSPKARQEVDHHWQASGGPHI 84

Query: 143 VKLIGYC----WEEEYRLLVYEYMPRGSL----HNQLFRSYS--AALPWSTRMKIALGAA 192
           V ++         +   L++ E M  G L      +  ++++   A   +  M+    A 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREA---AEIMRDIGTA- 140

Query: 193 KGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVMGT 249
             + FLH     + +RD K  N+L    + D   KL+DFG AK+  +     + T    T
Sbjct: 141 --IQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YT 192

Query: 250 QGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
             Y APE +         D++S GV++  LL G
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 65/213 (30%), Positives = 91/213 (42%), Gaps = 36/213 (16%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA---EIIFLGQLRHP 140
            LGEG FG V         K     Q VA+K +     +     M    EI +L  LRHP
Sbjct: 16  TLGEGSFGKVKLA---THYKTQ---QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 141 HLVKLIGY-CWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK----- 193
           H++KL  Y        + +V EY        +LF  Y        RM    G        
Sbjct: 70  HIIKL--YDVITTPTDIVMVIEYA-----GGELF-DYIVE---KKRMTEDEGRRFFQQII 118

Query: 194 -GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
             + + H     +++RD K  N+LLD +   K++DFGL+    +G      T   G+  Y
Sbjct: 119 CAIEYCHR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK--TSC-GSPNY 173

Query: 253 AAPEYVMTGHL--TTMSDVYSFGVVLLELLTGK 283
           AAPE V+ G L      DV+S G+VL  +L G+
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 54/204 (26%), Positives = 77/204 (37%), Gaps = 29/204 (14%)

Query: 168 HNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD 227
                  Y   L     +  +   AKG+ FL    +  I+RD  A NILL      K+ D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICD 236

Query: 228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD 287
           FGLA+D  +  +            + APE +     T  SDV+SFGV+L E+ +      
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS------ 290

Query: 288 NTRLGRE-----QSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHH 342
              LG       +   E+ R  LKE  ++            P     +   T   C    
Sbjct: 291 ---LGASPYPGVKIDEEFCR-RLKEGTRMRA----------PDYTTPEMYQTMLDCWHGE 336

Query: 343 PRHRPTMSYVVRVLDSLQDFQDSF 366
           P  RPT S +V  L +L   Q + 
Sbjct: 337 PSQRPTFSELVEHLGNL--LQANA 358

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 45/164 (27%), Positives = 63/164 (38%), Gaps = 19/164 (11%)

Query: 79  FSRSNL-----LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEII 132
           F R  L     LG G FG V +       K     + VAVK L    T   H+  M+E+ 
Sbjct: 19  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTA-TCRTVAVKMLKEGATHSEHRALMSELK 77

Query: 133 FLGQL-RHPHLVKLIGYCWEEEYRLLV-YEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
            L  +  H ++V L+G C +    L+V  E+   G+L   L          S R +    
Sbjct: 78  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPY 128

Query: 191 AAKGLAFLHGEDKP-VIYRDFKASNILLDSDYTAKLSDFGLAKD 233
             KG  F  G+D    I  D K     + S  ++  S F   K 
Sbjct: 129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 43/220 (19%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD------LDGTQGHKEWMAEIIFLGQL 137
           LLG+GGFG V+ G    +L        VA+K +                   E+  L ++
Sbjct: 38  LLGKGGFGTVFAG---HRLTDR---LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 138 R----HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
                HP +++L+ +   +E  +LV E          LF  Y         +        
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLF-DYITE---KGPLGEGPSRCF 144

Query: 194 ------GLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLA---KDGPEGEETHVI 243
                  +   H   + V++RD K  NIL+D     AKL DFG      D P        
Sbjct: 145 FGQVVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFD- 199

Query: 244 TRVMGTQGYAAPEYVMTGHLT-TMSDVYSFGVVLLELLTG 282
               GT+ Y+ PE++         + V+S G++L +++ G
Sbjct: 200 ----GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 59/266 (22%), Positives = 111/266 (41%), Gaps = 26/266 (9%)

Query: 27  EQVDKQTSFQRLCLSDVSNPSSPLSADDLSNSVIGSKLHVFTLAELRL-ITSNFSRSNLL 85
             +D + +F +       + S      ++S S + ++ +   + +    +   +     +
Sbjct: 12  PTLDVKIAFCQ-GFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPI 70

Query: 86  GEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEIIFLGQLRHPHLV 143
           G G  G V     D  L      + VA+K L          K    E++ +  + H +++
Sbjct: 71  GSGAQGIVCAA-YDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124

Query: 144 KLI----GYCWEEEYR--LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
            L+         EE++   LV E M   +L  Q+ +        S  +   L    G+  
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMELDHERMSYLLYQML---CGIKH 179

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
           LH     +I+RD K SNI++ SD T K+ DFGLA+       + ++T  + T+ Y APE 
Sbjct: 180 LHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEV 234

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGK 283
           ++        D++S G ++ E++  K
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 60/235 (25%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEII 132
           +   +     +G G  G V     D  L+     + VA+K L          K    E++
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAA-YDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELV 76

Query: 133 FLGQLRHPHLVKLI--------GYCWEEEYRLLVYEYMPRGSLHN--------------- 169
            +  + H +++ L+           +++ Y  +V E M   +L                 
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVY--IVMELMD-ANLCQVIQMELDHERMSYLL 133

Query: 170 -QLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF 228
            Q+                      G+  LH     +I+RD K SNI++ SD T K+ DF
Sbjct: 134 YQMLC--------------------GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDF 171

Query: 229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
           GLA        + ++T  + T+ Y APE ++        D++S G ++ E++ G 
Sbjct: 172 GLA---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 58/236 (24%), Positives = 86/236 (36%), Gaps = 51/236 (21%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA----- 129
           + S ++    +  G +G V  G VD       E  PVA+K +    + G    +      
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAG-VDS------EGIPVAIKRVFNTVSDGRTVNILSDSFL 72

Query: 130 ------EIIFLGQLRHPHLVKLI-------GYCWEEEYRLLVYEYMPRGSLHNQLFRSYS 176
                 EI  L    HP+++ L             + Y  LV E M    L  Q+     
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY--LVTELMRT-DLA-QVIHDQR 128

Query: 177 AALPWSTRMKI------ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
             +   +   I       L    GL  LH     V++RD    NILL  +    + DF L
Sbjct: 129 IVI---SPQHIQYFMYHIL---LGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNL 180

Query: 231 AKDGPEGEET--HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK 283
           A++         +V  R      Y APE VM     T + D++S G V+ E+   K
Sbjct: 181 AREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 49/223 (21%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA------EIIFLGQL 137
           LLG GGFG VY G    ++       PVA+K ++ D      E         E++ L ++
Sbjct: 50  LLGSGGFGSVYSG---IRVSDN---LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 138 RH--PHLVKLIGYCWEE--EYRLLVYEY-MPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
                 +++L    W E  +  +L+ E   P   L + +             ++  L  +
Sbjct: 104 SSGFSGVIRL--LDWFERPDSFVLILERPEPVQDLFDFITER--------GALQEELARS 153

Query: 193 K------GLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLA---KDGPEGEETHV 242
                   +   H  +  V++RD K  NIL+D +    KL DFG     KD         
Sbjct: 154 FFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFD 209

Query: 243 ITRVMGTQGYAAPEYVMTGHL--TTMSDVYSFGVVLLELLTGK 283
                GT+ Y+ PE++   H      + V+S G++L +++ G 
Sbjct: 210 -----GTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD 246

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 36/212 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI-IFLGQLRHPHLV 143
           LG G  G V + F     +     +  A+K L         +   E+ +     + PH+V
Sbjct: 70  LGLGINGKVLQIF---NKRTQ---EKFALKMLQ-----DCPKARREVELHWRASQCPHIV 118

Query: 144 KLIGYC----WEEEYRLLVYEYMPRGSL----HNQLFRSYS--AALPWSTRMKIALGAAK 193
           +++          +  L+V E +  G L     ++  ++++   A   S  MK    A  
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA---SEIMKSIGEA-- 173

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            + +LH     + +RD K  N+L  S   +   KL+DFG AK+         +T    T 
Sbjct: 174 -IQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTP 227

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            Y APE +         D++S GV++  LL G
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 60/258 (23%), Positives = 101/258 (39%), Gaps = 72/258 (27%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
            +  +S    LG G FG V + F  E        +  A+K +  D    ++E    +  +
Sbjct: 5   SSKKYSLGKTLGTGSFGIVCEVFDIE------SGKRFALKKVLQDPRYKNRE----LDIM 54

Query: 135 GQLRHPHLVKLIGY--------------------------------------CWEEEYRL 156
             L H +++KL+ Y                                        + +Y  
Sbjct: 55  KVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLN 114

Query: 157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG------AAKGLAFLHGEDKPVIYRDF 210
           ++ EY+P  +LH ++ +S+  +      + + L         + + F+H     + +RD 
Sbjct: 115 VIMEYVP-DTLH-KVLKSFIRS---GRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDI 167

Query: 211 KASNILLDS-DYTAKLSDFGLAKDGPEGEE-TH-VITRVMGTQGYAAPEYVMTG--HLTT 265
           K  N+L++S D T KL DFG AK     E     + +R      Y APE +M G    T 
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE-LMLGATEYTP 221

Query: 266 MSDVYSFGVVLLELLTGK 283
             D++S G V  EL+ GK
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 58/236 (24%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIF 133
           +   ++  + +GEG +G V     D   K       VA+K +     Q + +  + EI  
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSA-YDNLNK-----VRVAIKKISPFEHQTYCQRTLREIKI 78

Query: 134 LGQLRHPHLVKLI-------GYCWEEEYRLLVYEYMPRGSLHN----------------- 169
           L + RH +++ +            ++ Y  +V + M    L+                  
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVY--IVQDLME-TDLYKLLKTQHLSNDHICYFLY 135

Query: 170 QLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG 229
           Q+ R                    GL ++H  +  V++RD K SN+LL++    K+ DFG
Sbjct: 136 QILR--------------------GLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG 173

Query: 230 LAK-DGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK 283
           LA+   P+ + T  +T  + T+ Y APE ++     T   D++S G +L E+L+ +
Sbjct: 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 58/243 (23%), Positives = 97/243 (39%), Gaps = 63/243 (25%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           + S +     LG GG G V+   VD         + VA+K + L   Q  K  + EI  +
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSA-VDNDCD-----KRVAIKKIVLTDPQSVKHALREIKII 62

Query: 135 GQLRHPHLVKLI------------GYCWEEEYR--LLVYEYMPRGSLHN----------- 169
            +L H ++VK+                   E     +V EYM    L N           
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEH 121

Query: 170 ------QLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYT 222
                 QL R                    GL ++H  +  V++RD K +N+ +++ D  
Sbjct: 122 ARLFMYQLLR--------------------GLKYIHSAN--VLHRDLKPANLFINTEDLV 159

Query: 223 AKLSDFGLAK-DGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELL 280
            K+ DFGLA+   P       ++  + T+ Y +P  +++  + T   D+++ G +  E+L
Sbjct: 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219

Query: 281 TGK 283
           TGK
Sbjct: 220 TGK 222

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 63/236 (26%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEII 132
           +   +     +G G +G V    +D++       + VA+K L          K    E++
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSA-IDKRSG-----EKVAIKKLSRPFQSEIFAKRAYRELL 75

Query: 133 FLGQLRHPHLVKLI--------GYCWEEEYRLLVYEYMPRGSLHN--------------- 169
            L  ++H +++ L+           + + Y  LV  +M    L                 
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFY--LVMPFMQT-DLQKIMGLKFSEEKIQYLV 132

Query: 170 -QLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF 228
            Q+ +                    GL ++H     V++RD K  N+ ++ D   K+ DF
Sbjct: 133 YQMLK--------------------GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDF 170

Query: 229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK 283
           GLA+        +V+TR      Y APE +++  H     D++S G ++ E+LTGK
Sbjct: 171 GLARHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 58/243 (23%), Positives = 93/243 (38%), Gaps = 65/243 (26%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIF 133
           I+S+F   +LLGEG +G V      +        + VA+K ++           + EI  
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSA-THKPTG-----EIVAIKKIEPFDKPLFALRTLREIKI 62

Query: 134 LGQLRHPHLVKLI-------GYCWEEEYRLLVYEYMPRGSLHN----------------- 169
           L   +H +++ +           + E Y  ++ E M    LH                  
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVY--IIQELMQT-DLHRVISTQMLSDDHIQYFIY 119

Query: 170 QLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG 229
           Q  R                     +  LHG +  VI+RD K SN+L++S+   K+ DFG
Sbjct: 120 QTLR--------------------AVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFG 157

Query: 230 LA----KDGPEGEETHVITRVM----GTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELL 280
           LA    +   +  E       M     T+ Y APE ++T    +   DV+S G +L EL 
Sbjct: 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

Query: 281 TGK 283
             +
Sbjct: 218 LRR 220

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 48/227 (21%), Positives = 87/227 (38%), Gaps = 44/227 (19%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
              ++     LG G +  V++  ++         + V VK L        K+   EI  L
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEA-INITNN-----EKVVVKILKPVK---KKKIKREIKIL 84

Query: 135 GQLR-HPHLVKLIGYCWEEEYR--LLVYEYMPRGSLH-------NQLFRSYSAALPWSTR 184
             LR  P+++ L     +   R   LV+E++             +   R Y         
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY--------- 135

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA-KLSDFGLAKDGPEGEE-TH- 241
           M   L   K L + H     +++RD K  N+++D ++   +L D+GLA+    G+E    
Sbjct: 136 MYEIL---KALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190

Query: 242 VITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGKRAM 286
           V +R      +  PE ++          D++S G +L  ++  K   
Sbjct: 191 VASRY-----FKGPE-LLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 30/220 (13%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEII 132
           + + +     +G G +G V    VD +         VA+K L          K    E+ 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSA-VDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELR 76

Query: 133 FLGQLRHPHLVKLI--------GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR 184
            L  +RH +++ L+           + + Y  LV  +M    L   +       L     
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFY--LVMPFMGT-DLGKLM---KHEKLGEDRI 130

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT 244
             +     KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+        +V+T
Sbjct: 131 QFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 188

Query: 245 RVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK 283
           R      Y APE ++     T   D++S G ++ E++TGK
Sbjct: 189 RW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 55/260 (21%), Positives = 103/260 (39%), Gaps = 63/260 (24%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDGTQGHKEWMAEII 132
           +  N+   +L+G G +G VY    D+  +     + VA+K ++   +     K  + EI 
Sbjct: 24  VPDNYIIKHLIGRGSYGYVYLA-YDKNTE-----KNVAIKKVNRMFEDLIDCKRILREIT 77

Query: 133 FLGQLRHPHLVKLI-------GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRM 185
            L +L+  ++++L           ++E Y  +V E      L  +LF++           
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELY--IVLEIADS-DLK-KLFKT----------- 122

Query: 186 KIALGAA----------KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP 235
            I L              G  F+H     +I+RD K +N LL+ D + K+ DFGLA+   
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

Query: 236 EGEETHVITRVMGTQGYAAP---------EYVMT------------GHLTTMSDVYSFGV 274
             ++T+++  +   +               +V+T             + T   D++S G 
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240

Query: 275 VLLELLTGKRAMDNTRLGRE 294
           +  ELL   ++  N    R 
Sbjct: 241 IFAELLNMLQSHINDPTNRF 260

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 53/267 (19%), Positives = 93/267 (34%), Gaps = 74/267 (27%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA----- 129
           I   +   +L+G G +G V +   D+  K     + VA+K +                  
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEA-YDKLEK-----RVVAIKKILRVF---EDLIDCKRILR 101

Query: 130 EIIFLGQLRHPHLVKLI-------GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWS 182
           EI  L +L H H+VK++          ++E Y  +V E         +LFR+        
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELY--VVLEIADS-DFK-KLFRT-------- 149

Query: 183 TRMKIALGAA----------KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK 232
               + L              G+ ++H     +++RD K +N L++ D + K+ DFGLA+
Sbjct: 150 ---PVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLAR 204

Query: 233 DGPEGEETHVITRVMGTQGYAAP--------------EYVMT------------GHLTTM 266
                E  +    +   +                    +V+T             + T  
Sbjct: 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264

Query: 267 SDVYSFGVVLLELLTGKRAMDNTRLGR 293
            DV+S G +  ELL   +        R
Sbjct: 265 IDVWSIGCIFAELLNMIKENVAYHADR 291

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 56/180 (31%)

Query: 130 EIIFLGQLRHPHLVKLI--------GYCWEEEYRLLVYEYMPRGSLHN------------ 169
           E+  L  ++H +++ L+           + + Y  LV   M    L+N            
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLMG-ADLNNIVKCQKLTDDHV 134

Query: 170 -----QLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK 224
                Q+ R                    GL ++H  D  +I+RD K SN+ ++ D   K
Sbjct: 135 QFLIYQILR--------------------GLKYIHSAD--IIHRDLKPSNLAVNEDCELK 172

Query: 225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGK 283
           + DFGLA+   +    +V TR      Y APE ++   H     D++S G ++ ELLTG+
Sbjct: 173 ILDFGLARHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 59/258 (22%), Positives = 99/258 (38%), Gaps = 85/258 (32%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVK----ALDLDGTQGHKEWMA- 129
           +   +     LG+G +G V+K  +D +       + VAVK    A             A 
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKS-IDRRTG-----EVVAVKKIFDAFQ-------NSTDAQ 53

Query: 130 ----EIIFLGQLR-HPHLVKLIGYCWEEEYR--LLVYEYMPRGSLHN------------- 169
               EI+ L +L  H ++V L+     +  R   LV++YM    LH              
Sbjct: 54  RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQ 112

Query: 170 ----QLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL 225
               QL +                     + +LH     +++RD K SNILL+++   K+
Sbjct: 113 YVVYQLIK--------------------VIKYLHSGG--LLHRDMKPSNILLNAECHVKV 150

Query: 226 SDFGLA-------------------KDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TT 265
           +DFGL+                         ++  ++T  + T+ Y APE ++     T 
Sbjct: 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTK 210

Query: 266 MSDVYSFGVVLLELLTGK 283
             D++S G +L E+L GK
Sbjct: 211 GIDMWSLGCILGEILCGK 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 44/221 (19%), Positives = 85/221 (38%), Gaps = 35/221 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR----- 138
            LG G F  V+    D           VA+K +        +    EI  L ++      
Sbjct: 26  KLGWGHFSTVWLAK-DMVNN-----THVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 139 ------HPHLVKLIGY----CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
                   H++KL+ +         + ++V+E +   +L   + +     +P     +I+
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS 137

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLD------SDYTAKLSDFGLAKDGPEGEETHV 242
                GL ++H     +I+ D K  N+L++      +    K++D G A    E     +
Sbjct: 138 KQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196

Query: 243 ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK 283
            TR      Y +PE ++       +D++S   ++ EL+TG 
Sbjct: 197 QTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 49/217 (22%), Positives = 80/217 (36%), Gaps = 37/217 (17%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA--LDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +GEG FG +++G     L      Q VA+K      D  Q   E+    +  G      +
Sbjct: 18  IGEGSFGVIFEG---TNLLNN---QQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGI 68

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
             +  +  E  + +LV + +   SL   L           T    A      +  +H  +
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGP-SL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--E 124

Query: 203 KPVIYRDFKASNILLDSDYTAK-----LSDFGLAK---DGPEGEETHVITR----VMGTQ 250
           K ++YRD K  N L+    +       + DFG+ K   D    +  H+  R    + GT 
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ--HIPYREKKNLSGTA 182

Query: 251 GYAAPEYVMTGHL-TTMS---DVYSFGVVLLELLTGK 283
            Y +    +  HL    S   D+ + G V +  L G 
Sbjct: 183 RYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP-- 140
           +L+G+G FG V K + D   +     + VA+K +  +      +   E+  L  +     
Sbjct: 60  SLIGKGSFGQVVKAY-DRVEQ-----EWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDT 112

Query: 141 ----HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQL----FRSYSAALPWSTRMKIALGAA 192
               ++V L  +     +  LV+E +   +L++ L    FR  S  L   TR K A    
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNL---TR-KFAQQMC 167

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITRVMGTQ 250
             L FL   +  +I+ D K  NILL +   +  K+ DFG +    +    ++ +R     
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF---- 223

Query: 251 GYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
            Y +PE V+ G    ++ D++S G +L+E+ TG+
Sbjct: 224 -YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 32/164 (19%), Positives = 62/164 (37%), Gaps = 20/164 (12%)

Query: 85  LGEGGFGPVYKGF--VDEKLKPGLEAQPVAVKALDLDGTQGHKEW-----------MAEI 131
                 G +Y+           G + Q  ++K LD    +   E            + + 
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108

Query: 132 IFLGQLRHPHLVKLIGY-CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
             L       +   +G+   +++YR LV   + R SL + L  S    L   + +++A  
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK--LSDFGLAK 232
               L FLH  +   ++ +  A NI +D +  ++  L+ +G A 
Sbjct: 168 LLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.2 bits (141), Expect = 9e-10
 Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 33/214 (15%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH-PHLV 143
           +G G FG +Y G     +  G   + VA+K   +     H +   E      ++    + 
Sbjct: 17  IGSGSFGDIYLG---TDIAAG---EEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 68

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
            +     E +Y ++V E +   SL   LF   S      T + +A      + ++H   K
Sbjct: 69  TIRWCGAEGDYNVMVMELLGP-SL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIH--SK 124

Query: 204 PVIYRDFKASNILLDSDYTAK---LSDFGLAK---DGPEGEETHVITR----VMGTQGYA 253
             I+RD K  N L+          + DFGLAK   D    +  H+  R    + GT  YA
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ--HIPYRENKNLTGTARYA 182

Query: 254 APEYVMTGHL-TTMS---DVYSFGVVLLELLTGK 283
           +    +  HL    S   D+ S G VL+    G 
Sbjct: 183 S----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 46/212 (21%), Positives = 79/212 (37%), Gaps = 57/212 (26%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI-IFLGQLRHPHLV 143
           LG G  G V +       +     +  A+K L         +   E+ +     + PH+V
Sbjct: 26  LGLGINGKVLQI---FNKRTQ---EKFALKMLQ-----DCPKARREVELHWRASQCPHIV 74

Query: 144 KLIGYC----WEEEYRLLVYEYMPRGSL----HNQLFRSYS--AALPWSTRMKIALGAAK 193
           +++          +  L+V E +  G L     ++  ++++   A   S  MK    A  
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA---SEIMKSIGEA-- 129

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            + +LH     + +RD K  N+L  S   +   KL+DFG A    E           G +
Sbjct: 130 -IQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE---------TTG-E 173

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG 282
            Y               D++S GV++  LL G
Sbjct: 174 KYDKS-----------CDMWSLGVIMYILLCG 194

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 45/219 (20%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH---- 139
           ++G+G FG V K + D K+      Q VA+K +  +  + H++   EI  L  LR     
Sbjct: 104 VIGKGSFGQVVKAY-DHKVH-----QHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKD 156

Query: 140 --PHLVKLIGY-------CWEEEYRLL---VYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
              +++ ++         C   E  LL   +YE + +       F+ +S  L    R K 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNK-----FQGFSLPL---VR-KF 205

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA--KLSDFGLAKDGPEGEETHVITR 245
           A    + L  LH     +I+ D K  NILL     +  K+ DFG +       E   +  
Sbjct: 206 AHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY-----EHQRVYT 258

Query: 246 VMGTQGYAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGK 283
            + ++ Y APE V+ G    M  D++S G +L ELLTG 
Sbjct: 259 YIQSRFYRAPE-VILGARYGMPIDMWSLGCILAELLTGY 296

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 55/215 (25%), Positives = 85/215 (39%), Gaps = 35/215 (16%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKA--LDLDGTQGHKEWMAEIIFLGQLR-HPH 141
           +G G FG +Y G     ++     + VA+K   +     Q   E          L+    
Sbjct: 15  IGSGSFGEIYLG---TNIQTN---EEVAIKLENVKTKHPQLLYES----KIYRILQGGTG 64

Query: 142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE 201
           +  +  +  E +Y +LV + +   SL   LF   S  L   T + +A      + F+H  
Sbjct: 65  IPNVRWFGVEGDYNVLVMDLLGP-SL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVH-- 120

Query: 202 DKPVIYRDFKASNILLDSDYTAK---LSDFGLAKD--GPEGEETHVITR----VMGTQGY 252
            K  ++RD K  N L+     A    + DFGLAK        + H+  R    + GT  Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ-HIPYRENKNLTGTARY 179

Query: 253 AAPEYVMTGHL-TTMS---DVYSFGVVLLELLTGK 283
           A+    +  HL    S   D+ S G VL+  L G 
Sbjct: 180 AS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 48/217 (22%), Positives = 81/217 (37%), Gaps = 37/217 (17%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVK--ALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
           +G G FG +  G   + L      + VA+K   +     Q H E+              +
Sbjct: 17  IGCGNFGELRLG---KNLYTN---EYVAIKLEPMKSRAPQLHLEYRFYKQLGSG---DGI 67

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
            ++  +    +Y  +V E +   SL   LF          T + IA+     + ++H ++
Sbjct: 68  PQVYYFGPCGKYNAMVLELLGP-SL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125

Query: 203 KPVIYRDFKASNILLDSDYTAK-----LSDFGLAK---DGPEGEETHVITR----VMGTQ 250
             +IYRD K  N L+            + DF LAK   D    +  H+  R    + GT 
Sbjct: 126 --LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK--HIPYREHKSLTGTA 181

Query: 251 GYAAPEYVMTGHL-TTMS---DVYSFGVVLLELLTGK 283
            Y +    +  HL    S   D+ + G + +  L G 
Sbjct: 182 RYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 46/226 (20%), Positives = 86/226 (38%), Gaps = 35/226 (15%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-----------GHKEWMAEII 132
            +G+GGFG +Y   ++   +      P  VK    D                 E + + I
Sbjct: 42  PIGQGGFGCIYLADMNSS-ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 133 FLGQLRHPHLVKLIGY----CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
              +L++  + K  G        + YR ++ +      L   ++ + +      T ++++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQK-IYEANAKRFSRKTVLQLS 158

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK--LSDFGLAKD-GPEGEETHVITR 245
           L     L ++H  +   ++ D KASN+LL+     +  L D+GLA    PEG        
Sbjct: 159 LRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216

Query: 246 ----VMGTQGYAAPEYVMTGHL-TTMS---DVYSFGVVLLELLTGK 283
                 GT  + +    +  H     S   D+   G  +++ LTG 
Sbjct: 217 PKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 48/271 (17%), Positives = 79/271 (29%), Gaps = 86/271 (31%)

Query: 157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNIL 216
           +V+E +    L   + +S    LP     KI     +GL +LH + + +I+ D K  NIL
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR-IIHTDIKPENIL 179

Query: 217 L-------------------------------------------------DSDYTAKLSD 227
           L                                                       K++D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR--- 284
            G A    +   T  I     T+ Y + E ++     T +D++S   +  EL TG     
Sbjct: 240 LGNACWVHK-HFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294

Query: 285 AMDNTRLGREQS-LAEWA-------RPLLK-------------EPRKLERLIDPRLEGQF 323
                   R++  +A          R L+              + + + +L    L    
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354

Query: 324 P----IKGAQKAAATAF--KCLSHHPRHRPT 348
                    + A  T F    L   P  R T
Sbjct: 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.5 bits (130), Expect = 2e-08
 Identities = 40/201 (19%), Positives = 62/201 (30%), Gaps = 53/201 (26%)

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH--------KEW 127
           T    R   +GEG FG V++   D          PVA+K + ++G            +E 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADHT--------PVAIKIIAIEGPDLVNGSHQKTFEEI 70

Query: 128 MAEIIFLGQL---------RHPHLVKLIG-YCWEEEYR---LLVYEYM----------PR 164
           + EII   +L         R    + L   +C +  Y    L  +++           P 
Sbjct: 71  LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130

Query: 165 GSLHNQLF-------------RSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFK 211
               +QLF             +  +     +T   I       LA          +RD  
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFEHRDLH 189

Query: 212 ASNILLDSDYTAKLSDFGLAK 232
             N+LL      KL      K
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 44/230 (19%), Positives = 82/230 (35%), Gaps = 46/230 (20%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            +G GGFG +Y         P  + +  A   + ++  Q +    +E+ F  ++     +
Sbjct: 44  KIGSGGFGLIYLA------FPTNKPEKDARHVVKVE-YQENGPLFSELKFYQRVAKKDCI 96

Query: 144 ---------------KLIGY----CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR 184
                             G          YR +V E +    L  ++    +     ST 
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQ-KISG-QNGTFKKSTV 153

Query: 185 MKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK--LSDFGLAKD-GPEGEETH 241
           +++ +     L ++H  +   ++ D KA+N+LL      +  L+D+GL+    P G    
Sbjct: 154 LQLGIRMLDVLEYIH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211

Query: 242 VITRV----MGTQGYAAPEYVMTGHL-TTMS---DVYSFGVVLLELLTGK 283
                     GT  + +    +  H    +S   DV   G  +L  L GK
Sbjct: 212 YQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 78/322 (24%), Positives = 110/322 (34%), Gaps = 91/322 (28%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW----MAEIIFLGQLRH 139
            LGEG FG V +   D K       + VAVK +     +    +     +EI  L  L  
Sbjct: 21  TLGEGAFGKVVECI-DHKAG----GRHVAVKIV-----KNVDRYCEAARSEIQVLEHLNT 70

Query: 140 P------HLVKLIGYCWEEEYR--------LL---VYEYMPRGSLHNQLFRSYSAALPWS 182
                    V+++ +    E+         LL    Y+++      N  F  +       
Sbjct: 71  TDPNSTFRCVQMLEWF---EHHGHICIVFELLGLSTYDFIKE----NG-FLPFRLDH--- 119

Query: 183 TRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL-DSDYTA------------------ 223
            R K+A    K + FLH     + + D K  NIL   SDYT                   
Sbjct: 120 IR-KMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176

Query: 224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTG 282
           K+ DFG A    E   T V TR      Y APE V+     +   DV+S G +L+E   G
Sbjct: 177 KVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALGWSQPCDVWSIGCILIEYYLG 230

Query: 283 KRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATA--FKCLS 340
              +  T   +E  LA            +ER++     G  P    QK            
Sbjct: 231 F-TVFPTHDSKEH-LA-----------MMERIL-----GPLPKHMIQKTRKRKYFHHDRL 272

Query: 341 HHPRHRPTMSYVVRVLDSLQDF 362
               H     YV R    L++F
Sbjct: 273 DWDEHSSAGRYVSRACKPLKEF 294

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 52/237 (21%), Positives = 83/237 (35%), Gaps = 63/237 (26%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP--- 140
            LGEG FG V +     + K       VA+K +  +  +  +    EI  L +++     
Sbjct: 26  NLGEGTFGKVVECLDHARGK-----SQVALKIIR-NVGKYREAARLEINVLKKIKEKDKE 79

Query: 141 ---HLVKLIGYCWEEEYR--------LL---VYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
                V +  +     +         LL    +E++   +     F+ Y        R  
Sbjct: 80  NKFLCVLMSDWF---NFHGHMCIAFELLGKNTFEFLKENN-----FQPYPLPH---VR-H 127

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILL-DSDYTA------------------KLSD 227
           +A      L FLH  +  + + D K  NIL  +S++                    +++D
Sbjct: 128 MAYQLCHALRFLH--ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185

Query: 228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGK 283
           FG A    E   T V TR      Y  PE V+         DV+S G +L E   G 
Sbjct: 186 FGSATFDHEHHTTIVATRH-----YRPPE-VILELGWAQPCDVWSIGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 54/246 (21%), Positives = 85/246 (34%), Gaps = 77/246 (31%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW----MAEIIFLGQLRH 139
            +G+G FG V         K     +  AVK +     +  K++      E   L ++++
Sbjct: 42  KMGDGTFGRVLLCQ-HIDNK-----KYYAVKVV-----RNIKKYTRSAKIEADILKKIQN 90

Query: 140 -----PHLVKLIGYCWEEEYR--------LL---VYEYMPRGSLHNQLFRSYSAALPWST 183
                 ++VK  G      Y          L   +YE + R    N  +  +        
Sbjct: 91  DDINNNNIVKYHGKF---MYYDHMCLIFEPLGPSLYEIITR----NN-YNGFHIED---I 139

Query: 184 RMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL-DSDYTA------------------- 223
           +    +   K L +L      + + D K  NILL D  +                     
Sbjct: 140 K-LYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 224 -----KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLL 277
                KL DFG A       ++     ++ T+ Y APE V+        SD++SFG VL 
Sbjct: 197 KSTGIKLIDFGCATF-----KSDYHGSIINTRQYRAPE-VILNLGWDVSSDMWSFGCVLA 250

Query: 278 ELLTGK 283
           EL TG 
Sbjct: 251 ELYTGS 256

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	401
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.83
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.72
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.14
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.63
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.63
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.63
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.46
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.36
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.09
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.86
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.76
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.59
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.55
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.48
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.46
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.45
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.44
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.22
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.19
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.11
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.73
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.72
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.24
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.44
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.05
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.21
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	82.12

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9e-59  Score=437.15  Aligned_cols=268  Identities=28%  Similarity=0.391  Sum_probs=212.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|.+.+.||+|+||+||+|.+... ....++..||||+++.......+.|.+|+.+|++++|||||++++++.+...+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS-CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc-ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5677889999999999999987532 122357899999998666666678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcE
Q 040050          157 LVYEYMPRGSLHNQLFRSY-------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                      ||||||++|+|.+++....             ...+++..++.++.||+.||+|||+.  +||||||||+|||++.++.+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTTEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecccccHhhEEECCCCcE
Confidence            9999999999999997532             24689999999999999999999964  59999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhh
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      ||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......      +...
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAID  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence            9999999987655444444455789999999999999999999999999999999999 89999764311      1111


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      .+.           .......|..+++++.+|+.+||+.||++|||+.+|++.|+.+...+.
T Consensus       272 ~i~-----------~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          272 CIT-----------QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             HHH-----------HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             HHH-----------cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence            111           111223445567889999999999999999999999999999876543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-59  Score=435.58  Aligned_cols=266  Identities=29%  Similarity=0.397  Sum_probs=216.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|.+.+.||+|+||+||+|.+... ....++..||||+++.......+.|.+|+.+|++++||||+++++++.+++.+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNL-CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSC-C----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCc-ccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            5788899999999999999987542 122357889999998666666678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          157 LVYEYMPRGSLHNQLFRS-----------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~-----------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      ||||||++|+|.++|...           ....+++..++.++.||+.||.|||++  +||||||||+|||++.++.+||
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ--HFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccCHhhEEECCCCcEEE
Confidence            999999999999999753           235799999999999999999999965  4999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......      +.....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~i  243 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECI  243 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHH
Confidence            99999986544333333334569999999999999999999999999999999998 89999764311      111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      .           .......|..++.++.+|+.+||+.||++|||+.+|.+.|+++...
T Consensus       244 ~-----------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          244 T-----------QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             H-----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-----------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1           1111233455678899999999999999999999999999988653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-59  Score=441.47  Aligned_cols=252  Identities=21%  Similarity=0.348  Sum_probs=206.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++++.||+|+||+||+|++..      +++.||||++....  ......+.+|+.+|++++||||+++++++.+++.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTE------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETT------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            689999999999999999999877      68999999997543  3345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|||||||+||+|.++|.......+++..++.++.||+.||.|||+++  ||||||||+|||++.+|.+||+|||+|+..
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999999999999998765667899999999999999999999654  999999999999999999999999999875


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ....  ......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.....      .+........       
T Consensus       176 ~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~-------  240 (350)
T 4b9d_A          176 NSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISG-------  240 (350)
T ss_dssp             CHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT-------
T ss_pred             cCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcC-------
Confidence            4321  123456899999999999999999999999999999999999999976421      1111111111       


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         . ....+..++.++.+||.+||+.||++|||+.++++.
T Consensus       241 ---~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 ---S-FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ---C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---C-CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               0 012233457789999999999999999999999873

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.4e-59  Score=434.75  Aligned_cols=249  Identities=23%  Similarity=0.296  Sum_probs=212.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++++.||+|+||+||+|++..      +++.||+|++...   .......+.+|+++|++++||||++++++|.+++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELA------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEecccCeEEEEEEECC------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            579999999999999999999887      6899999998642   2334577899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|||||||+||+|.+++.+.  +.+++..+..++.||+.||.|||+++  ||||||||+|||++.+|.+||+|||+|+.
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            999999999999999999775  68999999999999999999999655  99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............+||+.|||||++.+..|+.++|||||||++|+|++|..||.....      ..........      
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~------  249 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKL------  249 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT------
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC------
Confidence            6554444445668999999999999999999999999999999999999999976421      1111111111      


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV  353 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il  353 (401)
                          .  ..+|...+.++.+||.+||+.||++|||+.+++
T Consensus       250 ----~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          250 ----E--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ----C--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ----C--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                1  123344567899999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.3e-58  Score=432.04  Aligned_cols=264  Identities=25%  Similarity=0.294  Sum_probs=212.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ..|.+.+.||+|+||+||+|++..      +++.||||+++....     ..+|+.+|+.++|||||++++++.+++.+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~------~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~  126 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQ------TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVN  126 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECC------CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            468888999999999999999877      689999999975432     246999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEecCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAKDGP  235 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~DfG~a~~~~  235 (401)
                      ||||||+||+|.+++.+.  +.+++..+..++.||+.||.|||++  +||||||||+||||+.+| ++||+|||+|+...
T Consensus       127 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~--~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR--RILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            999999999999999775  6899999999999999999999954  599999999999999987 69999999998764


Q ss_pred             CCCcc---eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          236 EGEET---HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       236 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .....   ......+||+.|||||++.+..|+.++|||||||++|||++|++||.......  .+....    ..+... 
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~----~~~~~~-  275 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--LCLKIA----SEPPPI-  275 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--CHHHHH----HSCCGG-
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHH----cCCCCc-
Confidence            43221   11234679999999999999999999999999999999999999997643221  111111    111110 


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCCCCce
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPF  370 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~~~~~  370 (401)
                              ..++..++..+.+||.+||+.||.+|||+.|+++.|.....-...-..||
T Consensus       276 --------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw  325 (336)
T 4g3f_A          276 --------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW  325 (336)
T ss_dssp             --------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred             --------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence                    12344557889999999999999999999999998877644333333333

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-58  Score=434.05  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=211.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ..|++.+.||+|+||+||+|++..      +++.||||++........+.+.+|+.+|+.++||||++++++|.+++.+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            569999999999999999999887      68999999997655555567889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ||||||+||+|.+++.+   ..+++..+..++.||+.||.|||+++  ||||||||+|||++.+|.+||+|||+|+....
T Consensus       148 ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            99999999999998865   47999999999999999999999655  99999999999999999999999999987644


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ...  .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+....      +....+...       ..
T Consensus       223 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~-------~~  287 (346)
T 4fih_A          223 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRDN-------LP  287 (346)
T ss_dssp             SSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-------SC
T ss_pred             CCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcC-------CC
Confidence            322  235678999999999999999999999999999999999999999764211      111111100       00


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +  ....+..++.++.+||.+||+.||++|||+.+++++
T Consensus       288 ~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          288 P--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             C--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             C--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1  111233457889999999999999999999999763

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-57  Score=423.83  Aligned_cols=261  Identities=26%  Similarity=0.406  Sum_probs=204.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .+++.+.+.||+|+||+||+|++..         .||||+++...  ....+.|.+|+.+|++++||||+++++++.+ +
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D  104 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence            3678889999999999999997543         59999987542  3345679999999999999999999998865 5


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|||||||+||+|.+++... ...+++..++.++.||+.||+|||++  +||||||||+|||++.++.+||+|||+|+.
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~--~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK--NIIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            689999999999999999754 35799999999999999999999965  499999999999999999999999999987


Q ss_pred             CCCCCcceeeecccccccccccccccc---CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .............+||+.|||||++.+   ..|+.++|||||||++|||+||+.||......  ..+........     
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~-----  254 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGY-----  254 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTC-----
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCC-----
Confidence            654443444456789999999999964   46899999999999999999999999764321  11111111100     


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                          ..+. ....+..++..+.+|+.+||+.||++|||+.+|++.|+.++.
T Consensus       255 ----~~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          255 ----ASPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ----CCCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ----CCCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                0111 112344567889999999999999999999999999988753

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.4e-58  Score=429.33  Aligned_cols=265  Identities=25%  Similarity=0.396  Sum_probs=213.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++++.+.||+|+||+||+|.+... ....+++.||||+++... ....+.|.+|+.++++++||||++++|++.++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~-~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGP-APGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCC-ccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            4566778999999999999987431 112356889999997543 33457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      +||||||++|+|.++|....              ...+++..++.++.||+.||+|||+++  ||||||||+||||+.++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCC
Confidence            99999999999999996532              246899999999999999999999655  99999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHH
Q 040050          222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  300 (401)
                      .+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |..||.+....   .+...
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHH
Confidence            999999999986544433333455689999999999999999999999999999999998 89999765321   11111


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      +              ........|..++..+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus       260 i--------------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          260 I--------------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             H--------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             H--------------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            1              1111223455567889999999999999999999999999987643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-57  Score=420.24  Aligned_cols=250  Identities=25%  Similarity=0.365  Sum_probs=201.7

Q ss_pred             cCC-CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           77 SNF-SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        77 ~~y-~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      ++| .+.+.||+|+||+||+|.+..      ++..||+|++...  .......+.+|+.+|++++||||++++++|.+  
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECC------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            344 567789999999999999877      6889999998643  23335678999999999999999999999875  


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEEEEec
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDF  228 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vkL~Df  228 (401)
                        +..+|||||||+||+|.+++.+.  ..+++..+..++.||+.||+|||+++.+||||||||+|||++. +|.+||+||
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeC
Confidence              34689999999999999999775  6899999999999999999999976666999999999999974 799999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |+|+.....    .....+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.....     ............
T Consensus       177 Gla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~~  246 (290)
T 3fpq_A          177 GLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGV  246 (290)
T ss_dssp             TGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTC
T ss_pred             cCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcCC
Confidence            999864332    2345789999999998865 699999999999999999999999965321     111111111110


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                                ....++...++++.+|+.+||+.||++|||+.++++
T Consensus       247 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 ----------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      000112223567899999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.6e-57  Score=414.48  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=194.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||+||+|++..      +++.||+|++....   ......+.+|+.+|+.++||||+++++++.+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            689999999999999999998876      68999999997542   334567899999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+||||||+ +|+|.+++.+.  +.+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCee
Confidence            999999999 78999999765  68999999999999999999999655  99999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .....   .....+||+.|||||++.+..| +.++|||||||++|+|++|+.||.....      ..........     
T Consensus       162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~-----  227 (275)
T 3hyh_A          162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNG-----  227 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT-----
T ss_pred             cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcC-----
Confidence            54332   2345789999999999998876 5799999999999999999999976421      1111111111     


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           .  ..+|...+.++.+|+.+||+.||++|||+.++++.
T Consensus       228 -----~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          228 -----V--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -----C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -----C--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                 0  12333456789999999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.5e-57  Score=436.53  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=211.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ..|++.+.||+|+||.||+|++..      +++.||||++........+.+.+|+.+|+.++||||++++++|.+++.+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRS------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECC------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            569999999999999999999887      68999999998766666677899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      ||||||+||+|.+++..   ..+++..+..++.||+.||.|||+++  ||||||||+||||+.+|.+||+|||+|.....
T Consensus       225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            99999999999998865   47999999999999999999999655  99999999999999999999999999987544


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ...  .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+....      +....+...       ..
T Consensus       300 ~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~-------~~  364 (423)
T 4fie_A          300 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRDN-------LP  364 (423)
T ss_dssp             SCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-------CC
T ss_pred             CCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcC-------CC
Confidence            322  235678999999999999999999999999999999999999999764211      111111110       00


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +.+  ..+..++.++.+||.+||+.||++|||+.+++++
T Consensus       365 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          365 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111  1223356789999999999999999999999763

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.7e-57  Score=419.91  Aligned_cols=251  Identities=28%  Similarity=0.341  Sum_probs=200.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||+||+|++...   ..+++.||+|++....  ......+.+|+.+|++++||||+++++++.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISG---SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSS---TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccC---CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            6799999999999999999986431   2257899999986432  2223467889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|||||||+||+|.+++.+.  +.+++..+..++.||+.||.|||+++  ||||||||+|||++.+|.+||+|||+|+..
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999999775  68999999999999999999999655  999999999999999999999999999864


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ....  ......+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+...      .+.......        
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~--------  240 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILK--------  240 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH--------
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHc--------
Confidence            3322  123457899999999999999999999999999999999999999976421      111111111        


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM-----SYVVR  354 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~~il~  354 (401)
                        ..  ..+|..+++++.+|+.+||+.||++|||+     +++++
T Consensus       241 --~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          241 --AK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --CC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              11  12344457889999999999999999984     66664

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-56  Score=425.81  Aligned_cols=275  Identities=26%  Similarity=0.371  Sum_probs=223.0

Q ss_pred             HHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCC-CceeeEE
Q 040050           69 LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRH-PHLVKLI  146 (401)
Q Consensus        69 ~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-pnI~~~~  146 (401)
                      ...+++-.++|++++.||+|+||+||+|.+... .....++.||||++..... .....+.+|+.+|.++.| ||||+++
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~-~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCC-CcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            344555568999999999999999999987642 2234567899999975543 335678999999999965 9999999


Q ss_pred             EEEEeC-CeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 040050          147 GYCWEE-EYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFK  211 (401)
Q Consensus       147 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlk  211 (401)
                      ++|.+. ..+|||||||++|+|.++|....              ...+++..++.++.||+.||.|||+++  |||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK  212 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLA  212 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccC
Confidence            999764 56899999999999999997532              245899999999999999999999655  9999999


Q ss_pred             CCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCc
Q 040050          212 ASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTR  290 (401)
Q Consensus       212 p~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  290 (401)
                      |+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.+..
T Consensus       213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987665544444456789999999999999999999999999999999998 899997653


Q ss_pred             ccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          291 LGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ...  .+.              ..+........|..+++++.+++.+||+.||++|||+.+|+++|+.+.+.
T Consensus       293 ~~~--~~~--------------~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          293 IDE--EFC--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CSH--HHH--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH--HHH--------------HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            211  111              11111222234455677899999999999999999999999999988543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.9e-55  Score=407.83  Aligned_cols=264  Identities=26%  Similarity=0.364  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHH--HHHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWM--AEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..+|.+.+.||+|+||+||+|++.        ++.||||++....   ...+.  .|+..+.+++||||+++++++.+++
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~--------g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            356888899999999999999763        6789999986432   23333  4566667889999999999998754


Q ss_pred             ----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCCCcEEEcCCCcE
Q 040050          154 ----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE------DKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       154 ----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                          .+|||||||++|+|.+++..   ..+++..+..++.|++.||+|||++      .++||||||||+|||++.++.+
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence                57999999999999999976   4799999999999999999999975      3479999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcce--eeeccccccccccccccccC------CCCccccHHhHHHHHHHHHhCCCCCCCCccccc-
Q 040050          224 KLSDFGLAKDGPEGEETH--VITRVMGTQGYAAPEYVMTG------HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE-  294 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-  294 (401)
                      ||+|||+|+.........  .....+||+.|||||++.+.      .|+.++|||||||++|||+||.+||........ 
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            999999997654433221  22346799999999999764      467899999999999999999988754322110 


Q ss_pred             --------ccHHHHhhhhhcCccchhhhcCCcCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          295 --------QSLAEWARPLLKEPRKLERLIDPRLEGQFP-----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       295 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                              .......          ..+....+++.+|     ...+..+.+|+.+||+.||++|||+.+|++.|+++..
T Consensus       228 ~~~~~~~~~~~~~~~----------~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          228 YYDLVPSDPSVEEMR----------KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             TTTTSCSSCCHHHHH----------HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhcccccchHHHHH----------HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                    0011111          1111222222222     3456789999999999999999999999999999865


Q ss_pred             cc
Q 040050          362 FQ  363 (401)
Q Consensus       362 ~~  363 (401)
                      -+
T Consensus       298 ~~  299 (303)
T 3hmm_A          298 QE  299 (303)
T ss_dssp             C-
T ss_pred             Hc
Confidence            43

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-54  Score=402.79  Aligned_cols=251  Identities=24%  Similarity=0.371  Sum_probs=189.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE--  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~--  153 (401)
                      ++|++.+.||+|+||+||+|++..      +++.||||++...... ....+.+|+.+|++++||||+++++++.+.+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            458999999999999999999876      6889999999755433 3467889999999999999999999987644  


Q ss_pred             ----------eEEEEEEecCCCChhHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc
Q 040050          154 ----------YRLLVYEYMPRGSLHNQLFRSYS-AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT  222 (401)
Q Consensus       154 ----------~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~  222 (401)
                                .+|||||||.||+|.+++..... ...++..++.++.||+.||+|||+++  ||||||||+|||++.+|.
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~  156 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDV  156 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCc
Confidence                      37999999999999999976421 23456778999999999999999654  999999999999999999


Q ss_pred             EEEEecCCCCCCCCCCcc----------eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccc
Q 040050          223 AKLSDFGLAKDGPEGEET----------HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLG  292 (401)
Q Consensus       223 vkL~DfG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  292 (401)
                      +||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||..... 
T Consensus       157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-  232 (299)
T 4g31_A          157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-  232 (299)
T ss_dssp             EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-
Confidence            999999999865443221          12234689999999999999999999999999999999996   6653210 


Q ss_pred             ccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          293 REQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                          ......          .+..... +......++.+.+|+.+||+.||++|||+.++++
T Consensus       233 ----~~~~~~----------~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 ----RVRTLT----------DVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             ----HHHHHH----------HHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHHHH----------HHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                001000          0000000 0111233456788999999999999999999976

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-52  Score=404.42  Aligned_cols=267  Identities=20%  Similarity=0.282  Sum_probs=204.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      .++|++++.||+|+||+||+|++..      +++.||||++....  ......+++|+.+|+.++||||+++++++..  
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRL------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCeEEEEEEecccCeEEEEEEECC------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            4689999999999999999999877      68999999997543  2334578899999999999999999999764  


Q ss_pred             ----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          152 ----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       152 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                          ...+|||||||. |+|.+++.+.  +.+++..+..++.||+.||.|||+++  ||||||||+|||++.+|.+||+|
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEee
Confidence                357899999995 7899998664  78999999999999999999999655  99999999999999999999999


Q ss_pred             cCCCCCCCCCC--cceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          228 FGLAKDGPEGE--ETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       228 fG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      ||+|+......  ........+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.....  .+.......
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~~~  279 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMMVL  279 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHH
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhc
Confidence            99998654322  12234567899999999998875 56999999999999999999999997653211  111111111


Q ss_pred             hcCccch---------hhhcCC-cCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKEPRKL---------ERLIDP-RLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~~~~---------~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...+...         ...+.. ......     ....+.++.+||.+||..||.+|||+.+++++
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000         000000 000000     11235788999999999999999999999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.3e-52  Score=397.01  Aligned_cols=204  Identities=24%  Similarity=0.335  Sum_probs=171.9

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      .+.++|++.+.||+|+||+||+|++...   ..+++.||+|.+....  ....+.+|+++|+.+ +||||++++++|.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~---~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ---VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBT---TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEccc---CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            3568899999999999999999987531   1257899999986443  346788999999988 699999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEEecCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLA  231 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~DfG~a  231 (401)
                      +++||||||++||+|.+++     +.+++..+..++.||+.||+|||+++  ||||||||+|||++.+ +.+||+|||+|
T Consensus        93 ~~~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CEEEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            9999999999999999988     35899999999999999999999655  9999999999999876 89999999999


Q ss_pred             CCCCCCCc--------------------------ceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCC
Q 040050          232 KDGPEGEE--------------------------THVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKR  284 (401)
Q Consensus       232 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~  284 (401)
                      +.......                          .......+||+.|||||++.+. .|+.++||||+||++|+|++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            75432211                          1123446899999999999875 58999999999999999999999


Q ss_pred             CCCCC
Q 040050          285 AMDNT  289 (401)
Q Consensus       285 pf~~~  289 (401)
                      ||...
T Consensus       246 Pf~~~  250 (361)
T 4f9c_A          246 PFYKA  250 (361)
T ss_dssp             SSSCC
T ss_pred             CCCCC
Confidence            99654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.6e-51  Score=412.99  Aligned_cols=250  Identities=25%  Similarity=0.334  Sum_probs=204.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHH---HHHHHHhccCCCceeeEEEEEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWM---AEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~---~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ++|+++++||+|+||.||+|++..      +++.||+|++...   .........   .++.+++.++||||++++++|.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECC------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            579999999999999999999887      7899999998632   112222333   4467778889999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      +.+.+|||||||.||+|.++|.+.  +.+++..+..++.||+.||.|||++  |||||||||+|||++.+|++||+|||+
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~--gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCchHHeEEeCCCCEEecccce
Confidence            999999999999999999999875  7899999999999999999999954  599999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      |+......    ..+.+||+.|||||++. +..|+.++|||||||++|+|++|.+||........   ..........  
T Consensus       339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~--  409 (689)
T 3v5w_A          339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTM--  409 (689)
T ss_dssp             CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHC--
T ss_pred             eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCC--
Confidence            98764432    24568999999999997 46899999999999999999999999975432211   1111111111  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                                ...+|..++.++.+||.+||+.||.+|++     +.+|+++
T Consensus       410 ----------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          410 ----------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                      11234456788999999999999999998     6787664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.2e-51  Score=410.94  Aligned_cols=254  Identities=22%  Similarity=0.289  Sum_probs=212.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||+||+|.+..      +++.||+|++..........+.+|+.+|+.++||||++++++|.++..+
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~  229 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERA------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM  229 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECC------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            3689999999999999999999877      6899999999876655567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC--CcEEEEecCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD--YTAKLSDFGLAKD  233 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~--~~vkL~DfG~a~~  233 (401)
                      |||||||.||+|.+++... ...+++..+..++.||+.||.|||+++  |+||||||+|||++.+  +.+||+|||+|+.
T Consensus       230 ~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            9999999999999998653 357999999999999999999999655  9999999999999754  8999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .....   .....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+....      +....+.....    
T Consensus       307 ~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~~~~----  373 (573)
T 3uto_A          307 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDW----  373 (573)
T ss_dssp             CCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTTCC----
T ss_pred             ccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHhCCC----
Confidence            65443   234568999999999999999999999999999999999999999764321      11111111100    


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          .........++..+.+||.+||+.||.+|||+.+++++
T Consensus       374 ----~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          374 ----NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ----CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                01111122346789999999999999999999999873

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.7e-50  Score=381.34  Aligned_cols=284  Identities=41%  Similarity=0.700  Sum_probs=238.4

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      +....++|.+.+.||+|+||.||+|.+.       +++.||+|++..........+.+|+.+++.++||||+++++++..
T Consensus        34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             CCCCCCCCSCCCCSCBCSSSEEEEEECT-------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             HHHHHhccCccceeecCCCeeEEEEEEC-------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            3345689999999999999999999854       378999999887666667789999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSY--SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      .+..++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR--AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC--CeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999986542  23589999999999999999999964  59999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++................||+.|+|||++.+..++.++|||||||++|+|++|+.||.............|...... ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~  263 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NG  263 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TT
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cc
Confidence            99765433333333445689999999999999999999999999999999999999987655444445554433322 23


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                      .+...+++......+...+..+.+++.+||+.||++|||+.++++.|+.+...+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~  319 (321)
T 2qkw_B          264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES  319 (321)
T ss_dssp             CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred             cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence            34455566666677888999999999999999999999999999999999887765

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.7e-48  Score=365.28  Aligned_cols=288  Identities=43%  Similarity=0.716  Sum_probs=238.0

Q ss_pred             CcccccHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCc
Q 040050           63 KLHVFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPH  141 (401)
Q Consensus        63 ~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpn  141 (401)
                      ....++..++....++|.+.+.||+|+||.||+|.+.       +++.||+|++..... .....+.+|+.+++.++|||
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~   88 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN   88 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTT
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCC
Confidence            3456788899999999999999999999999999643       378899999875432 22336889999999999999


Q ss_pred             eeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhCC-CCCeeeccCCCCcEEEc
Q 040050          142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY--SAALPWSTRMKIALGAAKGLAFLHGE-DKPVIYRDFKASNILLD  218 (401)
Q Consensus       142 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~-~~~iiH~Dlkp~NIlv~  218 (401)
                      |+++++++......++||||+.+++|.+++....  ...+++..++.++.|++.||.|||+. ..+|+||||||+|||++
T Consensus        89 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           89 LLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD  168 (326)
T ss_dssp             BCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred             ccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence            9999999999999999999999999999997642  24599999999999999999999965 11599999999999999


Q ss_pred             CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcc--ccccc
Q 040050          219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL--GREQS  296 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~  296 (401)
                      .++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....  .....
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  247 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM  247 (326)
T ss_dssp             TTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred             CCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence            999999999999986544322 233446699999999999999999999999999999999999999964321  12334


Q ss_pred             HHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ...+...... ...+..+.+......++...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus       248 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          248 LLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             HHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            4555554433 2345556666677778888999999999999999999999999999999874

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.6e-48  Score=359.86  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=210.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||+||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++...+..
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            4689999999999999999998766      6889999999766555667889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+++|.+++..   ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999999999999876   3699999999999999999999965  59999999999999999999999999987654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........  .......            
T Consensus       168 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~------------  231 (297)
T 3fxz_A          168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATN------------  231 (297)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHH------------
T ss_pred             Cccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhC------------
Confidence            4322  23456799999999999999999999999999999999999999976432110  0000000            


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       .......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       232 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          232 -GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             001112234456789999999999999999999999863

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.2e-48  Score=363.90  Aligned_cols=263  Identities=24%  Similarity=0.404  Sum_probs=214.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|.+.+.||+|+||+||+|.+..      +++.||+|.+..........+.+|+.+++.++||||+++++++.++...
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRE------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECC------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            4789999999999999999999876      5889999998766666677899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+||+++.++.+||+|||++....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  159 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMV  159 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence            9999999999999999763 467999999999999999999999654  9999999999999999999999999997654


Q ss_pred             CCCcce------------eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          236 EGEETH------------VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       236 ~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      ......            ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------  232 (310)
T 3s95_A          160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------  232 (310)
T ss_dssp             --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------
T ss_pred             cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------
Confidence            332211            1114579999999999999999999999999999999999999986543211100       


Q ss_pred             hhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          304 LLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                          ..........    ..+..++..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus       233 ----~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          233 ----GLNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ----SBCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----hhhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                0000011111    11223355788999999999999999999999999999654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.8e-48  Score=371.23  Aligned_cols=270  Identities=26%  Similarity=0.381  Sum_probs=218.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCC-CCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+....+ ....+..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            4789999999999999999998753211 223567899999975533 3356788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD  218 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~  218 (401)
                      ..+|+||||+.+|+|.+++....              ...+++..++.++.||+.||.|||+.  +|+||||||+|||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEC
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CeeccccchhhEEEC
Confidence            99999999999999999997642              23588999999999999999999965  599999999999999


Q ss_pred             CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccH
Q 040050          219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSL  297 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  297 (401)
                      .++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......   .+
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~~  314 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---EL  314 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GH
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence            999999999999986544332222334567889999999999999999999999999999999 99999764321   11


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      ..              .+........+..++..+.+++.+||+.||.+||++.++++.|+.+..+..
T Consensus       315 ~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          315 FK--------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HH--------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HH--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            11              111111223344557789999999999999999999999999999876543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.4e-48  Score=361.97  Aligned_cols=265  Identities=28%  Similarity=0.428  Sum_probs=205.4

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ...++|.+.+.||+|+||+||+|.+.        ++.||+|++....  ......+.+|+.++++++||||+++++++..
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH--------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC--------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            34578999999999999999999753        5789999987553  2334578899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      ....++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+.+|+||||||+||+++.++.+||+|||+
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            999999999999999999997542 1248999999999999999999995444499999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ...   .       
T Consensus       186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~---~-------  250 (309)
T 3p86_A          186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVA---A-------  250 (309)
T ss_dssp             ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHH---H-------
T ss_pred             Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---H-------
Confidence            97543321  12234679999999999999999999999999999999999999997643211   000   0       


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                         +.........+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       251 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          251 ---VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ---HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ---HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence               000111123344556789999999999999999999999999998876544

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.7e-48  Score=364.64  Aligned_cols=250  Identities=24%  Similarity=0.375  Sum_probs=209.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..++|.+.+.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   86 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHIL------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE   86 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            34789999999999999999998876      6889999998643  233456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..|+||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~  162 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSN  162 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCG
T ss_pred             CEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCce
Confidence            9999999999999999999775  67999999999999999999999654  9999999999999999999999999997


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCC-ccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLT-TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ......   .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||......      ........     
T Consensus       163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-----  228 (328)
T 3fe3_A          163 EFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLR-----  228 (328)
T ss_dssp             GGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-----
T ss_pred             ecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-----
Confidence            654432   23456899999999999988775 7999999999999999999999765321      11111111     


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           ..  ...|...+..+.+++.+||..||.+|||+.++++.
T Consensus       229 -----~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          229 -----GK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -----CC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -----CC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                 11  12233456789999999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8e-48  Score=363.41  Aligned_cols=275  Identities=24%  Similarity=0.317  Sum_probs=210.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE--  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~--  153 (401)
                      .++|++.+.||+|+||+||+|.+.        ++.||||++.... ........|+.++++++||||+++++++....  
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             hhhchhhheecccCceEEEEEEEC--------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            378999999999999999999764        5789999986432 22344566899999999999999999998754  


Q ss_pred             --eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC--------CCCeeeccCCCCcEEEcCCCcE
Q 040050          154 --YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE--------DKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       154 --~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~--------~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                        .+++||||+++|+|.+++..   ..+++..++.++.|++.||.|||+.        ..+|+||||||+|||++.++.+
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             CceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence              47999999999999999966   4699999999999999999999965        1169999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcceeeecccccccccccccccc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                      ||+|||++................||+.|+|||++.+     ..++.++|||||||++|+|++|+.||..........+.
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            9999999976544433333344679999999999986     35667899999999999999999999765432222111


Q ss_pred             HHhhhhhcCccchh-hhcCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          299 EWARPLLKEPRKLE-RLIDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       299 ~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      ....... ....+. ...........     ....+..+.+|+.+||+.||++|||+.++++.|+.++...
T Consensus       251 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          251 EEIGQHP-SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHHCSSC-CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhccCC-chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1110000 000000 01111111111     2245677999999999999999999999999999997653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=361.25  Aligned_cols=267  Identities=27%  Similarity=0.416  Sum_probs=213.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|+||.||+|.+....   ..+..||||++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPG---QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTT---SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCC---CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            478999999999999999999886421   134569999997553 3345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++...
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL--GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999998653 35799999999999999999999965  4999999999999999999999999999865


Q ss_pred             CCCCc-ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          235 PEGEE-THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       235 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||......   .+..   .         
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~---~---------  266 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DVIS---S---------  266 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHH---H---------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HHHH---H---------
Confidence            44322 122233456788999999999999999999999999999999 99999764221   1111   0         


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                        +........+..++..+.+++.+||+.||.+||++.++++.|+.+.....+
T Consensus       267 --~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          267 --VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             --HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             --HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence              111111223344567899999999999999999999999999999765543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.5e-47  Score=360.88  Aligned_cols=249  Identities=26%  Similarity=0.356  Sum_probs=208.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~   78 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence            689999999999999999998876      6889999998643   2334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||++||+|..++.+.  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.+|.+||+|||++..
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            999999999999999999765  6799999999999999999999965  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......      ........       
T Consensus       155 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-------  219 (337)
T 1o6l_A          155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM-------  219 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-------
T ss_pred             cccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHc-------
Confidence            433221  234567999999999999999999999999999999999999999754211      11111111       


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                         ..  ..+|...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       220 ---~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          220 ---EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               11  123344577899999999999999999     89999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=367.58  Aligned_cols=276  Identities=26%  Similarity=0.361  Sum_probs=222.2

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCC-CCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCW  150 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~  150 (401)
                      ...++|.+.+.||+|+||.||+|.+....+ ....+..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            345789999999999999999998754221 123456899999976533 3346788999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEE
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNIL  216 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIl  216 (401)
                      ..+..++||||+.+++|.+++....              ...+++..++.++.||+.||.|||+.  +|+||||||+|||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVL  223 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC--CEecCCCCcceEE
Confidence            9999999999999999999997653              24589999999999999999999965  5999999999999


Q ss_pred             EcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccc
Q 040050          217 LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQ  295 (401)
Q Consensus       217 v~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  295 (401)
                      ++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......   
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~---  300 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---  300 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999987654433333344567899999999999999999999999999999999 99999764211   


Q ss_pred             cHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCCCC
Q 040050          296 SLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVG  368 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~~~  368 (401)
                      .+..              .+........+..++..+.+++.+||+.||.+|||+.++++.|+.+.........
T Consensus       301 ~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  359 (382)
T 3tt0_A          301 ELFK--------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM  359 (382)
T ss_dssp             HHHH--------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred             HHHH--------------HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence            1111              1111111222334567899999999999999999999999999999877654443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.1e-46  Score=347.75  Aligned_cols=285  Identities=38%  Similarity=0.629  Sum_probs=229.4

Q ss_pred             CcccccHHHHHHHhcCCCCC------ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----cccHHHHHHHHH
Q 040050           63 KLHVFTLAELRLITSNFSRS------NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----TQGHKEWMAEII  132 (401)
Q Consensus        63 ~~~~~~~~~~~~~~~~y~~~------~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~  132 (401)
                      ..+.++..++..++.+|...      +.||+|+||.||+|.+.        ++.||+|++....    ......+.+|+.
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~E~~   82 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--------NTTVAVKKLAAMVDITTEELKQQFDQEIK   82 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--------SCEEEEEEECCCTTSCTTTHHHHHHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--------CceEEEEEEecccCcchHHHHHHHHHHHH
Confidence            35667788888888777766      99999999999999753        5789999986432    233567889999


Q ss_pred             HHhccCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 040050          133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRS-YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFK  211 (401)
Q Consensus       133 ~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlk  211 (401)
                      +++.++||||+++++++.+.+..++||||+++++|.+++... ....+++..++.++.|++.||.|||+.  +|+|||||
T Consensus        83 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlk  160 (307)
T 2nru_A           83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--HHIHRDIK  160 (307)
T ss_dssp             HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCC
T ss_pred             HHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC--CeecCCCC
Confidence            999999999999999999999999999999999999998653 235799999999999999999999965  59999999


Q ss_pred             CCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcc
Q 040050          212 ASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRL  291 (401)
Q Consensus       212 p~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  291 (401)
                      |+||+++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999986554433333345679999999998865 478999999999999999999999976543


Q ss_pred             cccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          292 GREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ..  .+..+..........+...++... ...+...+..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       240 ~~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          240 PQ--LLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SS--BTTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hH--HHHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            21  222222222222333444444433 34567788999999999999999999999999999998864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.5e-46  Score=358.24  Aligned_cols=253  Identities=24%  Similarity=0.300  Sum_probs=207.6

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------ccHHHHHHHHHHHhccCCCceeeEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------QGHKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++.....      .....+.+|+.+++.++||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKS------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECC------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            45789999999999999999998876      688999999875432      135678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC----cEE
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----TAK  224 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~----~vk  224 (401)
                      +.+....++||||+.||+|.+++...  ..+++..+..++.||+.||.|||+.  ||+||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEeCCCCCccCEE
Confidence            99999999999999999999999654  6799999999999999999999965  499999999999998876    799


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||++.......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......      ......
T Consensus       160 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i  230 (361)
T 2yab_A          160 LIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANI  230 (361)
T ss_dssp             ECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHH
T ss_pred             EEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence            99999998765432   234567999999999999999999999999999999999999999764211      111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ......        ....+....+..+.+||.+||..||.+|||+.++++
T Consensus       231 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          231 TAVSYD--------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HTTCCC--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhcCCC--------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            110000        000001123568899999999999999999999985

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.5e-48  Score=370.73  Aligned_cols=260  Identities=25%  Similarity=0.389  Sum_probs=211.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRA------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEec------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            4688999999999999999999875      578999999875432 223467889999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            99999999999999999754 346899999999999999999999654  999999999999999999999999999864


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............+++.|+|||++.+..++.++|||||||++|||++ |..||......   .....             
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~---~~~~~-------------  327 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ---QTREF-------------  327 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH---HHHHH-------------
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH-------------
Confidence            43221111112235778999999999999999999999999999998 99999764321   11111             


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                       +........+..++..+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       328 -~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          328 -VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             -HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence             11111122334456789999999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.5e-46  Score=347.67  Aligned_cols=265  Identities=24%  Similarity=0.313  Sum_probs=209.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      +.++|++.+.||+|+||.||+|.+..      ++..||+|.+.....   .....+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTI------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETT------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECC------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            45789999999999999999998776      588999999865432   334678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+..|+||||++|++|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            99999999999999999999765  67999999999999999999999654  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||.......     .............
T Consensus       159 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~~~~~~~~~  232 (294)
T 4eqm_A          159 KALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKHIQDSVPNV  232 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHHHSSCCCCH
T ss_pred             cccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHhhccCCCc
Confidence            86543321 12234579999999999999999999999999999999999999997643110     0000000000000


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhcc
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-TMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~~il~~L~~l~~~~  363 (401)
                      .        ...+...+..+.+++.+||+.||.+|| +++++.+.|..+..-.
T Consensus       233 ~--------~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          233 T--------TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             H--------HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             c--------hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            0        011223457899999999999999998 8999999998875443

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-47  Score=366.70  Aligned_cols=275  Identities=26%  Similarity=0.371  Sum_probs=219.4

Q ss_pred             cHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeE
Q 040050           68 TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKL  145 (401)
Q Consensus        68 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~  145 (401)
                      ....+....++|.+.+.||+|+||.||+|.+... ....+++.||||++..... .....+.+|+.++.++ +||||+++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccc-cccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3445556678999999999999999999986531 2234678999999975433 3346788999999999 79999999


Q ss_pred             EEEEEeCC-eEEEEEEecCCCChhHHHhhhcC------------------------------------------------
Q 040050          146 IGYCWEEE-YRLLVYEYMPRGSLHNQLFRSYS------------------------------------------------  176 (401)
Q Consensus       146 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------  176 (401)
                      ++++.+.. ..++||||+.+|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998765 48999999999999999976422                                                


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc
Q 040050          177 ----------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       177 ----------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~  240 (401)
                                      ..+++..++.++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||++.........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC--CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                            1288999999999999999999965  4999999999999999999999999999876554444


Q ss_pred             eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       241 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                      .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.......  .+...              +....
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~--------------~~~~~  313 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR--------------LKEGT  313 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHH--------------HHHTC
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHH--------------HHcCC
Confidence            44455678999999999999999999999999999999998 999997653221  11111              11111


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ....+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            112233346789999999999999999999999999998864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.8e-47  Score=355.10  Aligned_cols=267  Identities=28%  Similarity=0.389  Sum_probs=216.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..++|.+.+.||+|+||.||+|.+... +....+..||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHL-KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETG-GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEecc-CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            357899999999999999999987532 112356899999997543 334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYS----------------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFK  211 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlk  211 (401)
                      ..++||||+.+++|.+++.....                      ..+++..++.++.||+.||.|||+++  |+|||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dik  177 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLA  177 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCS
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccccc
Confidence            99999999999999999976422                      34889999999999999999999654  9999999


Q ss_pred             CCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCc
Q 040050          212 ASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTR  290 (401)
Q Consensus       212 p~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  290 (401)
                      |+||+++.++.+||+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986654433333334567889999999999999999999999999999999 999997643


Q ss_pred             ccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          291 LGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ..   .+..              .+........+...+..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       258 ~~---~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          258 PE---RLFN--------------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GG---GHHH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH---HHHH--------------HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            21   1111              111111122334456789999999999999999999999999998743

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.6e-47  Score=358.33  Aligned_cols=255  Identities=26%  Similarity=0.370  Sum_probs=206.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||+||+|.+..      +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECC------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            4789999999999999999998876      588999999875432 223567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .|+||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  ||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~--givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccccchHHEEEeCCCCEEEEEeecccee
Confidence            99999999999999998654  6799999999999999999999954  5999999999999999999999999999765


Q ss_pred             CCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... .....+...          
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~----------  224 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK----------  224 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHHHTT----------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHHhcc----------
Confidence            43333333445789999999999987765 778999999999999999999997643211 111111110          


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          ..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          225 ----KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ----CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                00001112346778899999999999999999999865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=368.83  Aligned_cols=269  Identities=25%  Similarity=0.366  Sum_probs=212.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|+||.||+|.+... ....++..||||++.... ......+.+|+.+++.++||||+++++++.....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccC-CCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            47899999999999999999986531 122367899999986542 3345578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC---cEEEE
Q 040050          155 RLLVYEYMPRGSLHNQLFRSY-----SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY---TAKLS  226 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~---~vkL~  226 (401)
                      .++||||+.+|+|.+++....     ...+++..++.++.||+.||.|||+.  +|+||||||+|||++.+|   .+||+
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999997643     24589999999999999999999965  499999999999998554   59999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......   .+...   . 
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~~~~---i-  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEF---V-  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHH---H-
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---H-
Confidence            9999864322111112234568999999999999999999999999999999998 99999764211   11111   1 


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                                ........+..++..+.+|+.+||+.||.+||++.+|++.|+.+....+
T Consensus       300 ----------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          300 ----------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             ----------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             ----------HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence                      1111112233446789999999999999999999999999999976554

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=364.46  Aligned_cols=251  Identities=27%  Similarity=0.370  Sum_probs=203.6

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCW  150 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~  150 (401)
                      ..++|++.+.||+|+||.||+|++..      +++.||+|++...   .......+.+|..++..+ +||||+++++++.
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKE------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcC------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            34789999999999999999999876      6889999998643   223456678899999988 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      +...+|+||||+.||+|..++.+.  ..+++..++.++.||+.||.|||++  +|+||||||+|||++.+|.+||+|||+
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NILl~~~g~ikL~DFG~  170 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK--GIIYRDLKLDNVLLDHEGHCKLADFGM  170 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCHHHEEECCCCCEEEccccc
Confidence            999999999999999999999775  6799999999999999999999965  499999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +.......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......      +.......    
T Consensus       171 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~----  238 (353)
T 3txo_A          171 CKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN----  238 (353)
T ss_dssp             CBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH----
T ss_pred             eeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHc----
Confidence            98543322  2234568999999999999999999999999999999999999999764321      11111111    


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM------SYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~~il~~  355 (401)
                            ..  ..++...+..+.+++.+||+.||.+||++      .+++++
T Consensus       239 ------~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          239 ------DE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ------CC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                  11  12333456789999999999999999998      777653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.9e-47  Score=346.84  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=211.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||.||+|.+..       ++.||+|++.... .....+.+|+.++++++||||+++++++.+....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             hhhceeeheecCCCccEEEEEEecC-------CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            4689999999999999999998764       5679999997543 3456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  157 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  157 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEecccccccccc
Confidence            9999999999999998654 356899999999999999999999554  9999999999999999999999999998654


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .... .......|++.|+|||++.+..++.++||||||+++|+|++ |..||......      .......         
T Consensus       158 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~---------  221 (269)
T 4hcu_A          158 DDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIS---------  221 (269)
T ss_dssp             CHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH---------
T ss_pred             cccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHh---------
Confidence            3221 11233457788999999999999999999999999999999 99999764211      1111110         


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                        .......+...+..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       222 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          222 --TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             --TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence              011112233346789999999999999999999999999998864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-46  Score=355.60  Aligned_cols=269  Identities=25%  Similarity=0.414  Sum_probs=198.0

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ...++|.+.+.||+|+||.||+|.+....   .....||+|++...  .......+.+|+.+++.++||||+++++++..
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQED---GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccC---CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            34578999999999999999999876521   01237999998754  33446778999999999999999999999987


Q ss_pred             CCeE------EEEEEecCCCChhHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          152 EEYR------LLVYEYMPRGSLHNQLFRSY----SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       152 ~~~~------~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      ....      ++||||+.+++|.+++....    ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR--NFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTS
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC--CcccCCCCcceEEEcCCC
Confidence            7655      99999999999999986542    12689999999999999999999965  499999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHH
Q 040050          222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  300 (401)
                      .+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||......   .....
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~  251 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNY  251 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHH
Confidence            999999999987654443333344567889999999999999999999999999999999 89999764321   11110


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                                   +. .......+...+..+.+++.+||+.||.+|||+.++++.|+++..-..
T Consensus       252 -------------~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          252 -------------LI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             -------------HH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             -------------Hh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                         00 011112233456789999999999999999999999999999965443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-46  Score=350.64  Aligned_cols=278  Identities=25%  Similarity=0.345  Sum_probs=212.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC--
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--  152 (401)
                      ..++|++.+.||+|+||+||+|.+..  ....+++.||+|++..........+.+|+.+++.++||||+++++++...  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECT--TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEec--ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            35789999999999999999998532  11236889999999866666667889999999999999999999998653  


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            5689999999999999999764 24599999999999999999999965  49999999999999999999999999998


Q ss_pred             CCCCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc---
Q 040050          233 DGPEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP---  308 (401)
Q Consensus       233 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  308 (401)
                      ........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||......    ............   
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~  238 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIV  238 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTTCCTHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCccccchhH
Confidence            65443221 1223345788899999999999999999999999999999999998653211    000000000000   


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ..+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          239 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            00111111222223345567889999999999999999999999999998854

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=356.58  Aligned_cols=265  Identities=24%  Similarity=0.377  Sum_probs=205.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||.||+|.+...  .......||+|.+... .......+.+|+.+++.++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCT--TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCC--CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            47899999999999999999987652  1112334688877543 3345678999999999999999999999998765 


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||+++.+++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            78899999999999998764 357999999999999999999999654  999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   +.              .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~--------------~  230 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS--------------S  230 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH--------------H
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH--------------H
Confidence            54443333344567889999999999999999999999999999999 999997653211   11              1


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      .+........+...+..+.+++.+||+.||.+||++.++++.|+.+..-.
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            11111122233445678999999999999999999999999999987544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-46  Score=344.37  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=211.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||.||+|.+..       +..||+|++.... .....+.+|+.+++.++||||+++++++......
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-------QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-------ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            4789999999999999999997664       5679999997543 3346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH--QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCcCcceEEECCCCCEEEccCccceecc
Confidence            9999999999999999764 34699999999999999999999965  59999999999999999999999999998655


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......      .......         
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~---------  219 (268)
T 3sxs_A          156 DDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVS---------  219 (268)
T ss_dssp             TTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHH---------
T ss_pred             hhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHH---------
Confidence            43322 2234456788999999999899999999999999999999 99999754321      1000000         


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                        .......+...+..+.+++.+||+.||.+|||+.++++.|+.++.-
T Consensus       220 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          220 --QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             --TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             --cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence              0111112223456899999999999999999999999999998653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-46  Score=356.48  Aligned_cols=248  Identities=25%  Similarity=0.360  Sum_probs=206.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++...
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   81 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYK------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP   81 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            3789999999999999999999876      6889999998632   122345788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+ +|+|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        82 ~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           82 TDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             SEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             CEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEeccce
Confidence            9999999999 78999998765  67999999999999999999999654  9999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .......   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......                ...
T Consensus       157 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----------------~~~  217 (336)
T 3h4j_B          157 IMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP----------------NLF  217 (336)
T ss_dssp             TTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST----------------TCB
T ss_pred             eccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH----------------HHH
Confidence            6654332   244679999999999998776 68999999999999999999999764211                001


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..+..  .....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       218 ~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          218 KKVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             HHHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            11111  1112344457789999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.6e-46  Score=345.21  Aligned_cols=256  Identities=29%  Similarity=0.574  Sum_probs=207.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc-------HHHHHHHHHHHhccCCCceeeEEEE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-------HKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      .++|++.+.||+|+||+||+|.+..      +++.||+|++.......       ...+.+|+.+++.++||||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVK------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETT------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hccceehhccccCCceeEEEEEEcC------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            4789999999999999999999876      58899999986543221       1678899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc-----E
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT-----A  223 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~-----v  223 (401)
                      +.+..  ++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+.+|+||||||+||+++.++.     +
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence            87665  6999999999999988654 35799999999999999999999965444999999999999988776     9


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccc--cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM--TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      ||+|||++.....     ......||+.|+|||++.  +..++.++|||||||++|+|++|..||............   
T Consensus       169 kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---  240 (287)
T 4f0f_A          169 KVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN---  240 (287)
T ss_dssp             EECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH---
T ss_pred             EeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH---
Confidence            9999999985433     234567999999999984  556789999999999999999999999765322111011   


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                                 ...........+..++..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       241 -----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 -----------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -----------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -----------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                       11111222233445577899999999999999999999999999864

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=347.05  Aligned_cols=278  Identities=19%  Similarity=0.241  Sum_probs=215.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~-  153 (401)
                      .++|.+.+.||+|+||+||+|.+..      +++.||+|++.... ......+.+|+.++++++||||+++++++.... 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKK------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            4789999999999999999999876      58899999987433 234567889999999999999999999998765 


Q ss_pred             -eEEEEEEecCCCChhHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE----cCCCcEEEEe
Q 040050          154 -YRLLVYEYMPRGSLHNQLFRSYS-AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL----DSDYTAKLSD  227 (401)
Q Consensus       154 -~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv----~~~~~vkL~D  227 (401)
                       ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.  +|+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence             78999999999999999976432 3499999999999999999999965  49999999999999    7788899999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccc--------cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc--cH
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVM--------TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ--SL  297 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~  297 (401)
                      ||++........   .....||+.|+|||++.        +..++.++|||||||++|+|++|..||.........  .+
T Consensus       160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            999987644332   23457999999999986        578899999999999999999999999754322111  11


Q ss_pred             HHHhhhhhc-Cccchhhhc--------CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          298 AEWARPLLK-EPRKLERLI--------DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       298 ~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      ......... ....+....        .......++...+..+.+++.+||+.||++|||+.++++...+..-..+
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~~  312 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGN  312 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC---
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcCC
Confidence            111111100 000000000        0111224567888999999999999999999999999999876654433

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-46  Score=362.18  Aligned_cols=257  Identities=23%  Similarity=0.361  Sum_probs=205.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      .++|++.++||+|+||.||+|++..      +++.||+|++...   .......+.+|..++.++ +||||+++++++.+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKK------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            3689999999999999999999876      6889999998743   222334577899999887 79999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ...+|+||||+.||+|..++.+.  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+|.+||+|||++
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla  200 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMC  200 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeeccee
Confidence            99999999999999999999775  67999999999999999999999654  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc--ccHHHHhhhhhcCcc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE--QSLAEWARPLLKEPR  309 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~  309 (401)
                      .......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||........  ........       
T Consensus       201 ~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~-------  271 (396)
T 4dc2_A          201 KEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF-------  271 (396)
T ss_dssp             BCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH-------
T ss_pred             eecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH-------
Confidence            8633222  123557899999999999999999999999999999999999999965321110  00001000       


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM------SYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~~il~~  355 (401)
                        ..+...  ...+|...+..+.+||.+||+.||.+||++      .+++++
T Consensus       272 --~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          272 --QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             --HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             --HHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence              011111  112344557789999999999999999995      566553

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-46  Score=352.87  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=206.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+..
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   79 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRH------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   79 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence            679999999999999999998876      6889999998643   1234567788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||+.||+|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.+|.+||+|||++..
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChheEEEcCCCCEEEeecCccee
Confidence            999999999999999999765  6799999999999999999999954  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......      ......         
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i---------  215 (318)
T 1fot_A          156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKI---------  215 (318)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH---------
T ss_pred             cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHH---------
Confidence            5432     23467999999999999999999999999999999999999999754211      111111         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                       ....  ..++...+..+.+++.+||+.||.+||     ++++++++
T Consensus       216 -~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          216 -LNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -HHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -HhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence             1111  123344567899999999999999999     88998854

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-46  Score=356.38  Aligned_cols=264  Identities=24%  Similarity=0.380  Sum_probs=206.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|+||+||+|.+...  .......||+|.+.... ......+.+|+.++++++||||+++++++.... 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCC--CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence            36799999999999999999987652  11123456888876432 345678899999999999999999999998765 


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++|++|+.+|+|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            68899999999999998764 36799999999999999999999965  4999999999999999999999999999765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   +.              .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~--------------~  230 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS--------------S  230 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH--------------H
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH--------------H
Confidence            44433333344567889999999999999999999999999999999 999997643211   11              1


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      .+........+...+..+.+++.+||+.||.+||++.++++.|+.+..-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            1111112223344567899999999999999999999999999988643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1e-46  Score=358.33  Aligned_cols=271  Identities=25%  Similarity=0.355  Sum_probs=215.8

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      +....++|.+.+.||+|+||.||+|.+... ....+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCc-CCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            344568999999999999999999988641 1112568999999975533 33567889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSY----------------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYR  208 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~  208 (401)
                      +....++||||+.+++|.+++....                      ...+++..++.++.||+.||.|||+.  +|+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--~ivH~  198 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHR  198 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCS
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecC
Confidence            9999999999999999999997632                      15789999999999999999999965  49999


Q ss_pred             cCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCC
Q 040050          209 DFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMD  287 (401)
Q Consensus       209 Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~  287 (401)
                      ||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999875433222222344568999999999999999999999999999999999 999997


Q ss_pred             CCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          288 NTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      .....      +......          . ......+..++..+.+++.+||+.||.+||++.++++.|+++..-
T Consensus       279 ~~~~~------~~~~~~~----------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          279 GMAHE------EVIYYVR----------D-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TSCHH------HHHHHHH----------T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCChH------HHHHHHh----------C-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            64211      1111110          0 011122334567899999999999999999999999999988643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-46  Score=350.03  Aligned_cols=254  Identities=19%  Similarity=0.233  Sum_probs=208.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +.++|.+.+.||+|+||+||+|.+..      +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+...
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETS------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECC------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence            35789999999999999999998876      68899999987543 344568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC--CCcEEEEecCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS--DYTAKLSDFGLAK  232 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~--~~~vkL~DfG~a~  232 (401)
                      .++||||+.|++|.+++... ...+++..++.++.|++.||.|||+.  ||+||||||+|||++.  ++.+||+|||++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~--givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            99999999999999998653 34799999999999999999999965  5999999999999987  7899999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......  ..+..........+.   
T Consensus       153 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~i~~~~~~~~~---  224 (321)
T 1tki_A          153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIENIMNAEYTFDE---  224 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCCCCH---
T ss_pred             ECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHcCCCCCCh---
Confidence            765433   234467999999999999988999999999999999999999999764211  111111110000000   


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                               ......+..+.+++.+||..||.+|||+.++++.
T Consensus       225 ---------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          225 ---------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                     0001235689999999999999999999999985

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=366.04  Aligned_cols=256  Identities=21%  Similarity=0.255  Sum_probs=207.5

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+.++|.+.+.||+|+||+||+|.+..      +++.||+|++.....  .....+.+|+.+++.++||||+++++++.+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   81 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVL------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE   81 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETT------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECC------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE
Confidence            356789999999999999999998876      689999999875532  234568899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc---CCCcEEEEec
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD---SDYTAKLSDF  228 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~---~~~~vkL~Df  228 (401)
                      +...|+||||+.||+|.+++...  ..+++..+..++.||+.||.|||+.  ||+||||||+|||++   .++.+||+||
T Consensus        82 ~~~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~--givHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           82 EGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             SSEEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             CCEEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEeccCCCCcEEEccC
Confidence            99999999999999999999765  6799999999999999999999965  499999999999998   4688999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |++........  ......||+.|+|||++.+..|+.++|||||||++|+|++|.+||......  ..+.........  
T Consensus       158 G~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~~~~--  231 (444)
T 3soa_A          158 GLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQQIKAGAYD--  231 (444)
T ss_dssp             SSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHTCCC--
T ss_pred             ceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH--HHHHHHHhCCCC--
Confidence            99986554322  234567999999999999999999999999999999999999999764211  011111110000  


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                .........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       232 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          232 ----------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                      0001112346789999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=357.66  Aligned_cols=269  Identities=26%  Similarity=0.374  Sum_probs=213.9

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      ..++|.+.+.||+|+||.||+|.+... ....++..||+|++.... ......+.+|+.+++++ +||||+++++++...
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  121 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGI-SKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  121 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESC-SSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeecc-ccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence            457899999999999999999987431 112256789999997542 33456788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYS---------------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFK  211 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlk  211 (401)
                      +..++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+.  ||+|||||
T Consensus       122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dik  199 (344)
T 1rjb_A          122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLA  199 (344)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETTCS
T ss_pred             CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCC
Confidence            999999999999999999976422                     2479999999999999999999965  59999999


Q ss_pred             CCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCc
Q 040050          212 ASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTR  290 (401)
Q Consensus       212 p~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  290 (401)
                      |+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999986544433333344567889999999999999999999999999999998 999997653


Q ss_pred             ccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          291 LGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ...  .+..              .+........+...+..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       280 ~~~--~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          280 VDA--NFYK--------------LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CSH--HHHH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cHH--HHHH--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            211  1111              1111112223334567899999999999999999999999999988543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=349.30  Aligned_cols=254  Identities=23%  Similarity=0.309  Sum_probs=207.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------ccHHHHHHHHHHHhccCCCceeeEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------QGHKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++.....      .....+.+|+.+++.++||||++++++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKS------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   82 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECC------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            34679999999999999999998876      688999999875432      135778899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC----cEE
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----TAK  224 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~----~vk  224 (401)
                      +.+....++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+||+++.++    .+|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           83 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEE
Confidence            99999999999999999999999654  67999999999999999999999654  99999999999998877    899


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......  ..+.......
T Consensus       159 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~  233 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--ETLANVSAVN  233 (326)
T ss_dssp             ECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHHHHHTC
T ss_pred             EEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHHhcC
Confidence            999999987643322   24457999999999999999999999999999999999999999754211  0111100000


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          .        ..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       234 ----~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          234 ----Y--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----C--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----C--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                0        00000011235678999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.1e-46  Score=360.68  Aligned_cols=265  Identities=26%  Similarity=0.416  Sum_probs=202.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|.+.+.||+|+||.||+|.+...   ...+..||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLP---SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCT---TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecC---CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            46899999999999999999987521   1246789999997553 3345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++... ...+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM--GYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            99999999999999999754 35799999999999999999999965  5999999999999999999999999999865


Q ss_pred             CCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          235 PEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       235 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||......   .+....           
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i-----------  263 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAV-----------  263 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHH-----------
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH-----------
Confidence            443211 11122345778999999999999999999999999999998 99999754211   111111           


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                         ........+..++..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus       264 ---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          264 ---DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             ---HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             ---HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence               111111223345678999999999999999999999999999986543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=358.70  Aligned_cols=250  Identities=25%  Similarity=0.333  Sum_probs=206.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+..
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKND------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            689999999999999999998876      6889999998632   2334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+.||+|..++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+|.+||+|||++..
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeee
Confidence            999999999999999999764  67999999999999999999999654  99999999999999999999999999986


Q ss_pred             CCCCCcceeeecccccccccccccccc---CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .....   .....+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||..........+...   ...    
T Consensus       165 ~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---~~~----  234 (384)
T 4fr4_A          165 LPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---FET----  234 (384)
T ss_dssp             CCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH---HHH----
T ss_pred             ccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhh----
Confidence            54332   2345689999999999974   4689999999999999999999999975432211111111   100    


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-MSYVVR  354 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~~il~  354 (401)
                              ....++...+..+.+|+.+||+.||.+||+ ++++++
T Consensus       235 --------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 --------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                    011234445678999999999999999998 666654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.1e-46  Score=351.59  Aligned_cols=268  Identities=28%  Similarity=0.367  Sum_probs=217.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      ..++|.+.+.||+|+||.||+|.+... ....+++.||+|++..... .....+.+|+.+++++ +||||+++++++...
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGL-IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeec-cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            347899999999999999999986431 1123678999999975543 3356788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEE
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYS----------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNIL  216 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIl  216 (401)
                      +..++||||+++++|.+++.....                ..+++..++.++.|++.||.|||+.  +|+||||||+||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil  177 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK--NCIHRDLAARNIL  177 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCccceEE
Confidence            999999999999999999976532                2589999999999999999999965  5999999999999


Q ss_pred             EcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccc
Q 040050          217 LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQ  295 (401)
Q Consensus       217 v~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~  295 (401)
                      ++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.......  
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  255 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--  255 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence            99999999999999987665444333344567889999999999999999999999999999999 999997653211  


Q ss_pred             cHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          296 SLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ......              ........+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       256 ~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          256 KFYKMI--------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             HHHHHH--------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHh--------------ccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            111111              1111112233446789999999999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.1e-46  Score=342.88  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=209.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE-  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-  152 (401)
                      .++|.+.+.||+|+||.||+|.+.        ++.||+|++....  ......+.+|+.+++.++||||+++++++.+. 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            368999999999999999999864        5789999997653  23345788999999999999999999999887 


Q ss_pred             -CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          153 -EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       153 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                       ...++||||+++++|.+++.......+++..++.++.|++.||.|||+.+.+|+||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             7889999999999999999876555799999999999999999999965555999999999999999999999999887


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCc---cccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTT---MSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      .....       ....||+.|+|||++.+..++.   ++|||||||++|+|++|..||......      ..        
T Consensus       161 ~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~--------  219 (271)
T 3kmu_A          161 FSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EI--------  219 (271)
T ss_dssp             CTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HH--------
T ss_pred             eeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HH--------
Confidence            65322       2346899999999998765544   799999999999999999999764211      00        


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                        .............+...+..+.+++.+||+.||.+|||+.++++.|+.++.
T Consensus       220 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          220 --GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             --HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             --HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence              011111122223344557789999999999999999999999999998753

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-46  Score=347.37  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=217.9

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ....+|++.+.||+|+||.||+|.+..      ++..||+|++... ......+.+|+.+++.++||||+++++++.+..
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   82 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   82 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGG------GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ccccceeEEeecCCCCceeEEEeEecC------CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345789999999999999999999876      5789999998754 334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+++|.+++.......+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++..
T Consensus        83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            9999999999999999998766677999999999999999999999654  99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...... .......|++.|+|||++.+..++.++||||||+++|+|++ |..||......   ....             
T Consensus       161 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~-------------  223 (288)
T 3kfa_A          161 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE-------------  223 (288)
T ss_dssp             SCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH-------------
T ss_pred             ccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH-------------
Confidence            654332 22334557889999999999999999999999999999999 99999764321   1111             


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                       .+........+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       224 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          224 -LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence             111111222334456789999999999999999999999999988743

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.9e-47  Score=357.87  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=207.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||+||+|.+...  .......||+|.+.... ......+.+|+.+++.++||||+++++++. +..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPE--GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCT--TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCC--CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence            36899999999999999999988652  11123348888875432 233456778999999999999999999886 456


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             cEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCccccc
Confidence            89999999999999998653 357889999999999999999999654  999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............|+..|+|||++.+..++.++|||||||++|+|++ |..||.......   +....            
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~------------  230 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPDLL------------  230 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHHHH------------
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHHHH------------
Confidence            55544444455678889999999999999999999999999999999 999997653211   11111            


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                        ........+..++..+.+++.+||+.||.+||++.++++.|+.+..-
T Consensus       231 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          231 --EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             --HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             --HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              11111122223355678999999999999999999999999998543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-45  Score=347.64  Aligned_cols=249  Identities=23%  Similarity=0.321  Sum_probs=206.9

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEE
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv  158 (401)
                      |...+.||+|+||.||+|.+..      +++.||||++..........+.+|+.+++.++||||+++++++...+..++|
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  120 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKH------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL  120 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhccEEeccCCCeEEEEEEECC------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEE
Confidence            6777899999999999998875      5889999999877666677899999999999999999999999999999999


Q ss_pred             EEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCC
Q 040050          159 YEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE  238 (401)
Q Consensus       159 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~  238 (401)
                      |||+++++|.+++..   ..+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.......
T Consensus       121 ~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          121 MEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  195 (321)
T ss_dssp             ECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             EecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc
Confidence            999999999998864   4799999999999999999999965  59999999999999999999999999987654332


Q ss_pred             cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       239 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|..||......      .........       ..+.
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~~~~~~~~-------~~~~  260 (321)
T 2c30_A          196 P--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMKRLRDS-------PPPK  260 (321)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-------SCCC
T ss_pred             c--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhcC-------CCCC
Confidence            1  124467999999999999999999999999999999999999999754211      111111000       0001


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .  ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus       261 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          261 L--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             C--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             c--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1  1122346789999999999999999999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.7e-46  Score=357.56  Aligned_cols=255  Identities=22%  Similarity=0.326  Sum_probs=207.5

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++.+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   99 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE   99 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECC------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            345789999999999999999998876      68899999997543  2345678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC---CcEEEEec
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSDF  228 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~---~~vkL~Df  228 (401)
                      ....|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.+   +.+||+||
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~Df  175 (362)
T 2bdw_A          100 ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADF  175 (362)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCchHHEEEecCCCCCCEEEeec
Confidence            99999999999999999998764  6799999999999999999999965  49999999999999765   45999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |++.......   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||......   .+..   ......
T Consensus       176 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~---~i~~~~  246 (362)
T 2bdw_A          176 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA---QIKAGA  246 (362)
T ss_dssp             TTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHHTC
T ss_pred             CcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHhCC
Confidence            9998765432   224467999999999999999999999999999999999999999764211   1111   110000


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .        .........++..+.+|+.+||+.||.+||++.++++.
T Consensus       247 ~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          247 Y--------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             C--------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             C--------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0        00000112346789999999999999999999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-46  Score=358.22  Aligned_cols=251  Identities=28%  Similarity=0.410  Sum_probs=206.6

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQL-RHPHLVKLIGYC  149 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~  149 (401)
                      ...++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+..|..++..+ +||||+++++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~   87 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKK------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   87 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence            445789999999999999999999876      68899999986431   23456678899999877 899999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      .+...+|+||||++||+|.+++...  ..+++..+..++.||+.||.|||+++  |+||||||+|||++.+|.+||+|||
T Consensus        88 ~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           88 QTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeECh
Confidence            9999999999999999999999765  67999999999999999999999654  9999999999999999999999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++........  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......      .........  
T Consensus       164 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~--  233 (345)
T 1xjd_A          164 MCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMD--  233 (345)
T ss_dssp             TCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC--
T ss_pred             hhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHhC--
Confidence            9986433221  234568999999999999999999999999999999999999999764211      111111100  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS-YVVR  354 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~il~  354 (401)
                                ...++...+..+.+++.+||+.||.+||++. ++++
T Consensus       234 ----------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          234 ----------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ----------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence                      1123334567899999999999999999997 6653

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.8e-46  Score=355.88  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=207.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCW  150 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~  150 (401)
                      ..++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+..|..++..+ +||||+++++++.
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~   91 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKG------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   91 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETT------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence            34789999999999999999998876      5889999998643   223456788899999988 7999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      +.+.+|+||||++||+|.+++...  ..+++..++.++.||+.||.|||+.  ||+||||||+|||++.+|.+||+|||+
T Consensus        92 ~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--givHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           92 TMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            999999999999999999999765  6799999999999999999999965  499999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +........  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ......+.     
T Consensus       168 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~-----  234 (353)
T 2i0e_A          168 CKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIM-----  234 (353)
T ss_dssp             CBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-----
T ss_pred             ccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHH-----
Confidence            986433221  23456899999999999999999999999999999999999999976421      11111111     


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                           ...  ..+|...+..+.+++.+||+.||.+||+     +.+++++
T Consensus       235 -----~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          235 -----EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -----HCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -----hCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 111  1234445778999999999999999995     5777654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.7e-46  Score=355.79  Aligned_cols=246  Identities=23%  Similarity=0.297  Sum_probs=207.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+..
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKE------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             HHCEEEEEeecCcCcEEEEEEECC------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            689999999999999999998876      6889999998643   1234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.+|.+||+|||++..
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEccccccee
Confidence            999999999999999999775  67999999999999999999999654  99999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.....      ........        
T Consensus       191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~--------  251 (350)
T 1rdq_E          191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV--------  251 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH--------
T ss_pred             ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHH--------
Confidence            5432     2345799999999999999999999999999999999999999975421      11111111        


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                        ...  ..++...+..+.+++.+||+.||.+||+     +.+++++
T Consensus       252 --~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          252 --SGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --HCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --cCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence              111  1233445678999999999999999998     8888764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.1e-45  Score=343.75  Aligned_cols=265  Identities=23%  Similarity=0.293  Sum_probs=203.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||+||+|.+..      +++.||+|++.....  .....+.+|+.++++++||||+++++++.++..
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            579999999999999999999876      688999999975532  234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+. ++|.+.+... ...+++..++.++.|++.||.|||+.  ||+||||||+||+++.++.+||+|||++...
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~--~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           76 LTLVFEFCD-QDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCC-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999996 4666666543 36799999999999999999999965  4999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCC-CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc-cc--
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP-RK--  310 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~--  310 (401)
                      ....  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ...+........... ..  
T Consensus       152 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~  228 (292)
T 3o0g_A          152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWP  228 (292)
T ss_dssp             CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCT
T ss_pred             CCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhhh
Confidence            4322  1234467899999999998765 899999999999999999988886433211 111111111111000 00  


Q ss_pred             -hhhhcC---------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          311 -LERLID---------PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       311 -~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       +....+         ...........+..+.+|+.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence             000000         00011122345678899999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9e-46  Score=364.98  Aligned_cols=253  Identities=28%  Similarity=0.415  Sum_probs=209.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-e
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-Y  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~-~  154 (401)
                      .++|.+.+.||+|+||.||+|.+.        ++.||||+++...  ....+.+|+.+|++++||||+++++++.... .
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            467899999999999999999764        4689999997543  4578999999999999999999999987765 7


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+|+|.+++.......+++..++.++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||+++..
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            89999999999999999876555689999999999999999999965  4999999999999999999999999999854


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...     .....+++.|+|||++.+..++.++|||||||++|+|++ |..||.......   +..              
T Consensus       340 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~--------------  397 (450)
T 1k9a_A          340 SST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVP--------------  397 (450)
T ss_dssp             C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HHH--------------
T ss_pred             ccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH--------------
Confidence            322     122357889999999999999999999999999999998 999997653211   111              


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      .+........+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       398 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          398 RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            0111112233445678899999999999999999999999999988653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-46  Score=372.79  Aligned_cols=259  Identities=24%  Similarity=0.396  Sum_probs=216.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ...+|.+.+.||+|+||.||+|.+..      ++..||||++.... .....+.+|+.+|++++||||+++++++.....
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  290 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP  290 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGG------GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcC------CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            34678899999999999999999876      57899999987543 346789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+|+|.+++.......+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++..
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999999876556799999999999999999999965  4999999999999999999999999999875


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .... ........++..|+|||++.+..++.++|||||||++|+|++ |..||......   .+..              
T Consensus       369 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~~--------------  430 (495)
T 1opk_A          369 TGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE--------------  430 (495)
T ss_dssp             TTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH--------------
T ss_pred             cCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHHH--------------
Confidence            4322 112233456789999999999999999999999999999999 99999765321   1111              


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      .+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus       431 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          431 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            11112222334455778999999999999999999999999998874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.3e-45  Score=343.70  Aligned_cols=265  Identities=16%  Similarity=0.181  Sum_probs=211.6

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||+|++.....  ...+.+|+.+++.+ +|+||+.+++++...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLL------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECC------CCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            345789999999999999999998765      688999999864432  24577899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc-----EEEEe
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT-----AKLSD  227 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~-----vkL~D  227 (401)
                      ...++||||+ +++|.+++... ...+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.     +||+|
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D  154 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHE--KSLVYRDIKPDNFLIGRPNSKNANMIYVVD  154 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred             ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence            9999999999 99999999764 3569999999999999999999995  45999999999999987765     99999


Q ss_pred             cCCCCCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH-HHh
Q 040050          228 FGLAKDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWA  301 (401)
Q Consensus       228 fG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~  301 (401)
                      ||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ...
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (298)
T 1csn_A          155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG  234 (298)
T ss_dssp             CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred             CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence            9999865443221     1224467999999999999999999999999999999999999999875322211111 111


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ......  ....         ....++..+.+++.+||+.||.+||++.+|++.|+++..
T Consensus       235 ~~~~~~--~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          235 EKKQST--PLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHS--CHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhccCc--cHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            110000  0000         011235689999999999999999999999999999854

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=347.31  Aligned_cols=250  Identities=22%  Similarity=0.329  Sum_probs=197.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--------------------------ccHHHHHH
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--------------------------QGHKEWMA  129 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~  129 (401)
                      .++|.+.+.||+|+||.||+|++..      +++.||+|++.....                          .....+.+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNEN------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQ   85 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETT------TTEEEEEEEEECC-------------------------------CHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECC------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHH
Confidence            4789999999999999999998876      688999999865421                          11346789


Q ss_pred             HHHHHhccCCCceeeEEEEEEe--CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 040050          130 EIIFLGQLRHPHLVKLIGYCWE--EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIY  207 (401)
Q Consensus       130 E~~~l~~l~hpnI~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH  207 (401)
                      |+.+++.++||||+++++++.+  ....++||||+++++|.+++..   ..+++..++.++.|++.||.|||+.+  |+|
T Consensus        86 E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH  160 (298)
T 2zv2_A           86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK--IIH  160 (298)
T ss_dssp             HHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             HHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eec
Confidence            9999999999999999999987  5689999999999999876532   57999999999999999999999654  999


Q ss_pred             ccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCC---CCccccHHhHHHHHHHHHhCCC
Q 040050          208 RDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH---LTTMSDVYSFGVVLLELLTGKR  284 (401)
Q Consensus       208 ~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~  284 (401)
                      |||||+|||++.++.+||+|||++........  ......||+.|+|||++.+..   ++.++|||||||++|+|++|..
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  238 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC  238 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence            99999999999999999999999986544322  234567999999999998755   4788999999999999999999


Q ss_pred             CCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          285 AMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       285 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ||.....      ..........          ..........+..+.+++.+||+.||.+||++.++++
T Consensus       239 pf~~~~~------~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          239 PFMDERI------MCLHSKIKSQ----------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSCCSSH------HHHHHHHHHC----------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCccH------HHHHHHHhcc----------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            9975421      1111111000          0000111234568999999999999999999999975

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.6e-46  Score=343.78  Aligned_cols=262  Identities=24%  Similarity=0.337  Sum_probs=200.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..++|++.+.||+|+||.||+|.+...   ...+..||+|.+.... ......+.+|+.+++.++||||+++++++. ++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   88 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSP---ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecC---CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cC
Confidence            457899999999999999999987642   1135679999987543 233567889999999999999999999984 55


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           89 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             ccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CeecccccHHHEEECCCCCEEECccccccc
Confidence            689999999999999999754 34799999999999999999999965  599999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......   ......           
T Consensus       166 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i-----------  230 (281)
T 1mp8_A          166 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI-----------  230 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH-----------
T ss_pred             cCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHH-----------
Confidence            544321 12233457889999999999999999999999999999997 99999764321   111110           


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                        . .......+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       231 --~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          231 --E-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             --H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --H-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence              0 011112334456789999999999999999999999999998854

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.7e-46  Score=354.43  Aligned_cols=256  Identities=23%  Similarity=0.300  Sum_probs=205.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-----CcccHHHHHHHHHHHhccCCCceeeEEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-----GTQGHKEWMAEIIFLGQLRHPHLVKLIGYC  149 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~  149 (401)
                      +.++|++.+.||+|+||+||+|.+..      +++.||+|++...     .......+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRE------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECC------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45789999999999999999998876      6889999998532     122457789999999999999999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc---EE
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT---AK  224 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~---vk  224 (401)
                      .++...|+||||+++++|.+++...  ....+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.   +|
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECSSSTTCCEE
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChHHeEEecCCCCCcEE
Confidence            9999999999999999998888653  234689999999999999999999965  4999999999999976554   99


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ..........
T Consensus       174 l~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~i~~~~  248 (351)
T 3c0i_A          174 LGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLFEGIIKGK  248 (351)
T ss_dssp             ECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHHHHHHHTC
T ss_pred             EecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHHHHHHcCC
Confidence            999999987654322  22446799999999999999999999999999999999999999976421   1111111100


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...        .+..    ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       249 ~~~--------~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          249 YKM--------NPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CCC--------CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCC--------Cccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000        0000    01235689999999999999999999999863

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-45  Score=349.43  Aligned_cols=262  Identities=19%  Similarity=0.230  Sum_probs=209.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++.....  ...+.+|+.+++.+ +||||+++++++....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   78 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLY------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK   78 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETT------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECC------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC
Confidence            45789999999999999999998766      688999999875432  24578899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc-----EEEEec
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT-----AKLSDF  228 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~-----vkL~Df  228 (401)
                      ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.     +||+||
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           79 YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK--NLIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            999999999 99999998754 46899999999999999999999965  4999999999999998887     999999


Q ss_pred             CCCCCCCCCCcce-----eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH-HHhh
Q 040050          229 GLAKDGPEGEETH-----VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWAR  302 (401)
Q Consensus       229 G~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~  302 (401)
                      |++..........     ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ .+..
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            9998654322211     123567999999999999999999999999999999999999999875322111111 1111


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      .....+.  .     ....    ..+ .+.+++.+||+.||.+||++.+|.+.|+++.
T Consensus       235 ~~~~~~~--~-----~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~  280 (330)
T 2izr_A          235 TKRATPI--E-----VLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF  280 (330)
T ss_dssp             HHHHSCH--H-----HHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             hhccCCH--H-----HHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence            1000000  0     0000    123 8999999999999999999999999999884

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5e-46  Score=344.25  Aligned_cols=258  Identities=23%  Similarity=0.363  Sum_probs=208.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..++|++.+.||+|+||.||+|.+..       +..||+|++.... .....+.+|+.+++.++||||+++++++.+...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcC-------CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            34789999999999999999997764       6689999997543 335678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  170 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK--QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV  170 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred             eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCccceEEEcCCCCEEEccccccccc
Confidence            99999999999999999763 35799999999999999999999965  5999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||......      ......         
T Consensus       171 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~---------  234 (283)
T 3gen_A          171 LDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHI---------  234 (283)
T ss_dssp             CCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH---------
T ss_pred             ccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHH---------
Confidence            43221 11223456788999999999999999999999999999998 99999764321      100101         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                        ........+...+..+.+++.+||+.||.+|||+.++++.|.++..
T Consensus       235 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          235 --AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             --HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --hcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence              0111112233345789999999999999999999999999998854

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.8e-45  Score=350.43  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=205.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      ++|.+.+.||+|+||.||+|++..      +++.||+|++....   ......+.+|..++.++ +||||+++++++.+.
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKK------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hheEEEEEEEecCCeEEEEEEECC------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            679999999999999999999876      68899999997432   23345678899999887 899999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ..+|+||||+.||+|.+++.+.  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.+|.+||+|||++.
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEECCCCCEEEEeccccc
Confidence            9999999999999999999765  6799999999999999999999965  49999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc---ccHHHHhhhhhcCcc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE---QSLAEWARPLLKEPR  309 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~  309 (401)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........   .........      
T Consensus       159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------  230 (345)
T 3a8x_A          159 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV------  230 (345)
T ss_dssp             CSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH------
T ss_pred             cccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH------
Confidence            643222  123456899999999999999999999999999999999999999965321110   000000011      


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM------SYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~~il~~  355 (401)
                          +...  ...+|...+..+.+++.+||+.||.+||++      .+++++
T Consensus       231 ----i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          231 ----ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ----HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ----HHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                1111  112344557789999999999999999996      566543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-46  Score=353.59  Aligned_cols=269  Identities=25%  Similarity=0.361  Sum_probs=213.7

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      .....++|.+.+.||+|+||.||+|.+... ....+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGV-VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEE-ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCc-cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            345568899999999999999999987631 1112467899999875432 33456889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSY--------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT  222 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~  222 (401)
                      +....++||||+.+++|.+++....        ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECTTCC
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC--CCccCCCccceEEEcCCCe
Confidence            9999999999999999999986532        14678999999999999999999965  5999999999999999999


Q ss_pred             EEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHh
Q 040050          223 AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       223 vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  301 (401)
                      +||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......      ...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~  250 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVL  250 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHH
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------HHH
Confidence            99999999986543322222233457889999999999999999999999999999999 88998764211      111


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      .....          . .....+..++..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       251 ~~~~~----------~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          251 RFVME----------G-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHHHT----------T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHHHc----------C-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            11100          0 011223345678999999999999999999999999998873

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.9e-46  Score=354.83  Aligned_cols=254  Identities=20%  Similarity=0.277  Sum_probs=196.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|.+.+.||+|+||+||+|.+..      +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKL------TKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETT------TCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECC------CCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            3789999999999999999999876      688999999975432 335688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc--EEEEecCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT--AKLSDFGLAKD  233 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~--vkL~DfG~a~~  233 (401)
                      ++||||+.+|+|.+++...  ..+++..++.++.|++.||+|||+.  ||+||||||+||+++.++.  +||+|||++..
T Consensus        92 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~--~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999999999999999765  6799999999999999999999955  4999999999999987665  99999999974


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTM-SDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .....   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......  ............      
T Consensus       168 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~------  236 (361)
T 3uc3_A          168 SVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILS------  236 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHT------
T ss_pred             ccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhc------
Confidence            33222   2234579999999999998887665 89999999999999999999764321  111111111111      


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          ...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       237 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          237 ----VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ----TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ----CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                111111111235788999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.8e-46  Score=351.47  Aligned_cols=271  Identities=25%  Similarity=0.371  Sum_probs=216.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCC-CCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      ..++|.+.+.||+|+||.||+|.+....+ ...++..||+|++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            34789999999999999999998753211 123577899999975532 3456788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL  217 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv  217 (401)
                      .+..++||||+.+++|.+++....              ...+++..++.++.||+.||.|||+.  +|+||||||+||++
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ--KCIHRDLAARNVLV  190 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCccceEEE
Confidence            999999999999999999997642              13489999999999999999999965  49999999999999


Q ss_pred             cCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCccccccc
Q 040050          218 DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQS  296 (401)
Q Consensus       218 ~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  296 (401)
                      +.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......   .
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---H
Confidence            9999999999999986655433333344567889999999999899999999999999999999 99999764211   1


Q ss_pred             HHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      +..   ...           .......+..++..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus       268 ~~~---~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          268 LFK---LLK-----------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHH---HHH-----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHH---HHh-----------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            111   110           011112233456789999999999999999999999999999976544

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.4e-46  Score=358.25  Aligned_cols=270  Identities=17%  Similarity=0.216  Sum_probs=206.7

Q ss_pred             hcCCCCCceeccc--CCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           76 TSNFSRSNLLGEG--GFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G--~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .++|++.+.||+|  +||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKP------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcC------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            4789999999999  999999999876      68899999997543  3334667889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ++..|+||||+.+++|.+++.......+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||.+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999999999999998766678999999999999999999999654  999999999999999999999999988


Q ss_pred             CCCCCCCcc-----eeeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          232 KDGPEGEET-----HVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       232 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      .........     .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||.......  .+.......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~  253 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGT  253 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC----
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCC
Confidence            643222111     11122478999999999987  679999999999999999999999997643211  111100000


Q ss_pred             hc----C----cc-------------chhhhc---------CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          305 LK----E----PR-------------KLERLI---------DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       305 ~~----~----~~-------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ..    .    ..             .+....         .......++...+..+.+|+.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00    0    00             000000         000011123345678999999999999999999999986


Q ss_pred             H
Q 040050          355 V  355 (401)
Q Consensus       355 ~  355 (401)
                      .
T Consensus       334 h  334 (389)
T 3gni_B          334 H  334 (389)
T ss_dssp             S
T ss_pred             C
Confidence            5

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.8e-46  Score=353.46  Aligned_cols=294  Identities=27%  Similarity=0.306  Sum_probs=216.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEE--eCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCW--EEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~--~~~  153 (401)
                      ..+|++.+.||+|+||.||+|.+..  ....+++.||+|++..........+.+|+.++++++||||+++++++.  ...
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDP--LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECT--TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhhccCCCCeEEEEEEecc--CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            3689999999999999999998532  112268899999998776666677899999999999999999999987  456


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++..
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLGSR--RCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             eEEEEEeecCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChhhEEECCCCCEEEccccccee
Confidence            789999999999999999764 24699999999999999999999965  599999999999999999999999999987


Q ss_pred             CCCCCcce-eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhh-hhhcCccch
Q 040050          234 GPEGEETH-VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR-PLLKEPRKL  311 (401)
Q Consensus       234 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~  311 (401)
                      ........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......   ...... ........+
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALSRL  253 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC----CCHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhcccccccccHHHH
Confidence            65433221 2233568889999999999999999999999999999999999986532110   000000 000000111


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCCCCceEEecCCC
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPFVYVVPNE  377 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~~~~~~~~~~~~  377 (401)
                      ...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+.........+.....|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~p~~  319 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEG  319 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------------------
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccccccCcCc
Confidence            111222223334555678899999999999999999999999999999766655554444444443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=355.99  Aligned_cols=254  Identities=21%  Similarity=0.268  Sum_probs=208.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++.+....
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKA------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECC------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            4789999999999999999998876      6889999999866555556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC--CCcEEEEecCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS--DYTAKLSDFGLAKD  233 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~--~~~vkL~DfG~a~~  233 (401)
                      ++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.  +|+||||||+|||++.  .+.+||+|||++..
T Consensus       124 ~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC--CeeecccchHHeEEecCCCCceEEEeccccee
Confidence            9999999999999988653 34789999999999999999999965  4999999999999974  57899999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ..........     
T Consensus       201 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~~-----  266 (387)
T 1kob_A          201 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCD-----  266 (387)
T ss_dssp             CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCC-----
T ss_pred             cCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC-----
Confidence            654332   23457999999999999999999999999999999999999999764211      1111111000     


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ...........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       267 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          267 ---WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ---CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence               001111122346789999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.4e-46  Score=368.49  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=213.0

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .+..++|.+.+.||+|+||.||+|.+..       +..||||++.... .....+.+|+.+|+.++||||+++++++. .
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNK-------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETT-------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECC-------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            3445789999999999999999998764       5789999997543 45678999999999999999999999986 5


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+.+|+|.+++.......+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            67899999999999999997654457899999999999999999999654  9999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......   .+.....         
T Consensus       333 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~~~i~---------  399 (454)
T 1qcf_A          333 VIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE---------  399 (454)
T ss_dssp             GBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH---------
T ss_pred             EcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---------
Confidence            6543211 11123446788999999999999999999999999999999 99999764211   1111100         


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                           .......+..++..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus       400 -----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          400 -----RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -----cCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                 11111223445678999999999999999999999999999886443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7e-46  Score=341.01  Aligned_cols=253  Identities=30%  Similarity=0.464  Sum_probs=196.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc----ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT----QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .++|.+.+.||+|+||.||+|.+.        ++.||+|++.....    .....+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK   77 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            368999999999999999999864        57899999875432    235678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCC-CeeeccCCCCcEEEcC--------CCc
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK-PVIYRDFKASNILLDS--------DYT  222 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~-~iiH~Dlkp~NIlv~~--------~~~  222 (401)
                      +...++||||+.+++|.+++..   ..+++..++.++.|++.||.|||+.+. +|+||||||+||+++.        ++.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           78 EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             C--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             CCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            9999999999999999988853   579999999999999999999996442 2899999999999986        778


Q ss_pred             EEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhh
Q 040050          223 AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       223 vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      +||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......      .  
T Consensus       155 ~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~--  222 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------V--  222 (271)
T ss_dssp             EEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------H--
T ss_pred             eEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H--
Confidence            9999999998654322    124569999999999999999999999999999999999999997642110      0  


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                              .............+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          223 --------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                    0011111122233444567899999999999999999999999999864

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-45  Score=347.09  Aligned_cols=265  Identities=26%  Similarity=0.346  Sum_probs=201.6

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|++.+.||+|+||+||+|.+..       ++.||+|++.....  .....+.+|+.+++.++||||+++++++.++
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   91 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE   91 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC
Confidence            44789999999999999999998743       78999999875432  2346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+. ++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           92 RCLTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH--RILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             SCEEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCchHhEEECCCCCEEEccCcCce
Confidence            99999999996 5888887653 35699999999999999999999965  59999999999999999999999999998


Q ss_pred             CCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc-Cccc
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK-EPRK  310 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~  310 (401)
                      ......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  .+......... .+..
T Consensus       168 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~  243 (311)
T 3niz_A          168 AFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD--QLPKIFSILGTPNPRE  243 (311)
T ss_dssp             ETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT--HHHHHHHHHCCCCTTT
T ss_pred             ecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHHCCCChHH
Confidence            654322  12344578999999999876 568999999999999999999999997653321  11111111000 0000


Q ss_pred             hhhh------cCCcC--CCC-----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          311 LERL------IDPRL--EGQ-----FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       311 ~~~~------~~~~~--~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      +...      .....  ...     .....+.++.+|+.+||+.||.+|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          244 WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0000      00000  000     11123568899999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.2e-46  Score=367.14  Aligned_cols=252  Identities=27%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ..++|++.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++..
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~  219 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT  219 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcC------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence            34689999999999999999998876      6889999998642   23344567889999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+.+|+||||+++++|.+++...  ..+++..+..++.||+.||.|||+ .+||+||||||+|||++.++.+||+|||++
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~giiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh-cCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence            99999999999999999999765  689999999999999999999995 145999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......      .........    
T Consensus       297 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~----  364 (446)
T 4ejn_A          297 KEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME----  364 (446)
T ss_dssp             CTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC----
T ss_pred             eeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhC----
Confidence            8643322  2234578999999999999999999999999999999999999999764211      111111110    


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                              ...++...+..+.+||.+||+.||.+||     ++.+++++
T Consensus       365 --------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          365 --------EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --------CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                    0123334567899999999999999999     99999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=4.6e-46  Score=349.77  Aligned_cols=276  Identities=26%  Similarity=0.364  Sum_probs=218.9

Q ss_pred             cHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeE
Q 040050           68 TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKL  145 (401)
Q Consensus        68 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~  145 (401)
                      .........++|.+.+.||+|+||.||+|.+... ....+++.||+|++..... .....+.+|+.++.++ +||||+++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESS-SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecC-CccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            3444555678999999999999999999986431 1233678999999975533 3345788999999999 69999999


Q ss_pred             EEEEEeCC-eEEEEEEecCCCChhHHHhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccC
Q 040050          146 IGYCWEEE-YRLLVYEYMPRGSLHNQLFRSYS--------------AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDF  210 (401)
Q Consensus       146 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dl  210 (401)
                      ++++...+ ..++||||+.+++|.+++.....              ..+++..++.++.|++.||.|||+.  +|+||||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~i~H~di  174 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDL  174 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT--TCCCSCC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC--CcccccC
Confidence            99988755 58999999999999999976422              1288999999999999999999965  4999999


Q ss_pred             CCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCC
Q 040050          211 KASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNT  289 (401)
Q Consensus       211 kp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~  289 (401)
                      ||+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987655444333445668999999999999999999999999999999998 99999764


Q ss_pred             cccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          290 RLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ....  .+.....              .......+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       255 ~~~~--~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          255 KIDE--EFCRRLK--------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCSH--HHHHHHH--------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhH--HHHHHhc--------------cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            3211  1111100              0111122333467899999999999999999999999999988643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.4e-46  Score=353.57  Aligned_cols=268  Identities=26%  Similarity=0.366  Sum_probs=214.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      ..++|.+.+.||+|+||.||+|.+... ........||+|.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGL-GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTC-SSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCC-CcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            347899999999999999999987652 1122345899999975533 3456788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSY------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      ...++||||+++|+|.+++....            ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.+
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK--NCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGCEEEGG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC--CcccCCcccceEEECCC
Confidence            99999999999999999997542            34689999999999999999999965  59999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  299 (401)
                      +.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......  .+..
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~  278 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFYK  278 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHHH
Confidence            9999999999986544333333334567889999999999999999999999999999998 899997643211  1111


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ...              .......+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       279 ~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          279 LVK--------------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             HHH--------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHh--------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            111              111112233346789999999999999999999999999998754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3e-45  Score=344.96  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=191.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.+++.++||||+++++++..++.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEECSS------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence            3689999999999999999998766      68899999997553 2334678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSY----SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      .++||||+. ++|.+++....    ...+++..+..++.||+.||.|||+.  ||+||||||+|||++.++.+||+|||+
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--KILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            999999996 69999886542    24689999999999999999999955  599999999999999999999999999


Q ss_pred             CCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  .+..........+.
T Consensus       155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~  230 (317)
T 2pmi_A          155 ARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNE  230 (317)
T ss_dssp             CEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCT
T ss_pred             ceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCh
Confidence            986543221  2244578999999999986 468999999999999999999999997653211  11111110000000


Q ss_pred             ----------------------chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 ----------------------KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                            .+...+.+.    .+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH----TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGG----CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hHhhhhhhhhhcccccccccchhHHHhhccc----ccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                                  000000111    111235689999999999999999999999753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-46  Score=352.30  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=198.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCC--CceeeEEEEEEe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRH--PHLVKLIGYCWE  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--pnI~~~~~~~~~  151 (401)
                      ..+|++.+.||+|+||.||+|.+.       +++.||+|++....  ......+.+|+.+++.++|  |||+++++++..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            467999999999999999999764       37789999987543  2334678899999999976  999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      +...++|||+ .+++|.+++...  ..+++..+..++.|++.||.|||+.  +|+||||||+|||++ ++.+||+|||++
T Consensus        81 ~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~--~iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           81 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             CCEEEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCcceEEEE-CCcEEEeecccc
Confidence            9999999995 588999999764  6899999999999999999999965  499999999999997 678999999999


Q ss_pred             CCCCCCCcceeeecccccccccccccccc-----------CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMT-----------GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      ................||+.|+|||++.+           ..++.++|||||||++|+|++|..||......    .   
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~---  227 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I---  227 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H---
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----H---
Confidence            87655433333445679999999999865           67899999999999999999999999653211    0   


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                              ..+..++++.....++...+..+.+++.+||+.||.+|||+.++++.
T Consensus       228 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 --------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             --------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                    11112222222223343445688999999999999999999999876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-46  Score=364.83  Aligned_cols=258  Identities=22%  Similarity=0.257  Sum_probs=207.0

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      +....++|.+.+.||+|+||+||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||++++++
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~  137 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA  137 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECC------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            33445789999999999999999999876      6889999998632   11223457789999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                      +.+...+|+||||++||+|.+++..   ..+++..+..++.||+.||.|||+.  +|+||||||+|||++.+|.+||+||
T Consensus       138 ~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~--givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          138 FQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeccCCHHHeeECCCCCEEEecc
Confidence            9999999999999999999998865   4689999999999999999999965  4999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCC----CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH----LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |++........ ......+||+.|+|||++.+..    |+.++|||||||++|+|++|..||......      .....+
T Consensus       213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i  285 (410)
T 3v8s_A          213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKI  285 (410)
T ss_dssp             TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH
T ss_pred             ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHH
Confidence            99986544322 2234578999999999998665    889999999999999999999999764211      111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH--RPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~il~~  355 (401)
                      .....        .+........+..+.+||.+||+.+|.+  ||++.+|+++
T Consensus       286 ~~~~~--------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          286 MNHKN--------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HTHHH--------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             Hhccc--------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            10000        0000011124678999999999999988  9999999876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.3e-45  Score=352.41  Aligned_cols=289  Identities=17%  Similarity=0.177  Sum_probs=212.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc-----------HHHHHHHHHHHhccCCCceee
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-----------HKEWMAEIIFLGQLRHPHLVK  144 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnI~~  144 (401)
                      .++|.+.+.||+|+||.||+|.+... .....++.||+|++.......           ...+..|+..+..++||||++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSS-ESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCS-SCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCc-cccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            46899999999999999999987652 112246889999987553211           122345666778889999999


Q ss_pred             EEEEEEeC----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc--
Q 040050          145 LIGYCWEE----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD--  218 (401)
Q Consensus       145 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~--  218 (401)
                      +++++...    ...+|||||+ |++|.+++... ...+++..++.++.||+.||.|||+.  +|+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~--~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH--EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeEEecCCHHHEEEecC
Confidence            99998764    4689999999 99999998763 46799999999999999999999965  599999999999998  


Q ss_pred             CCCcEEEEecCCCCCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc
Q 040050          219 SDYTAKLSDFGLAKDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR  293 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  293 (401)
                      .++.+||+|||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999754332111     11133559999999999999999999999999999999999999998532211


Q ss_pred             cccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh-hcccCCCCceEE
Q 040050          294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ-DFQDSFVGPFVY  372 (401)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~-~~~~~~~~~~~~  372 (401)
                        ..........  ...+..+++..+.   ....+..+.+++.+||+.||.+||++.+|++.|+.+. ........++++
T Consensus       269 --~~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          269 --KYVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             --HHHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             --HHHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence              1111111000  0112222222221   1123568999999999999999999999999999884 444445566666


Q ss_pred             ecCC
Q 040050          373 VVPN  376 (401)
Q Consensus       373 ~~~~  376 (401)
                      ...+
T Consensus       342 ~~~~  345 (364)
T 3op5_A          342 SVVE  345 (364)
T ss_dssp             ----
T ss_pred             Eecc
Confidence            5444

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.3e-45  Score=344.92  Aligned_cols=265  Identities=26%  Similarity=0.406  Sum_probs=201.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..++|.+.+.||+|+||.||+|.+...   ..++..||+|.+....  ......+.+|+.++++++||||+++++++...
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQE---DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECT---TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             CHHHeeeccceeecCCeEEEEEEEecc---CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            457899999999999999999987642   2246789999987553  23346788999999999999999999999875


Q ss_pred             C-----eEEEEEEecCCCChhHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcE
Q 040050          153 E-----YRLLVYEYMPRGSLHNQLFRS----YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       153 ~-----~~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                      .     ..++||||+.+++|.+++...    ....+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR--NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCSGGGEEECTTSCE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCcE
Confidence            5     359999999999999998532    236799999999999999999999954  59999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhh
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWAR  302 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  302 (401)
                      ||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......   .......
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~  263 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYDYLL  263 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHHHHH
Confidence            9999999986654433233344567889999999999999999999999999999999 88998764321   1111100


Q ss_pred             hhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                                    .......+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       264 --------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~  308 (313)
T 3brb_A          264 --------------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE  308 (313)
T ss_dssp             --------------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                          111112333456789999999999999999999999999998854

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-45  Score=349.08  Aligned_cols=253  Identities=27%  Similarity=0.335  Sum_probs=198.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .++|++.+.||+|+||.||+|++...   ..+++.||+|++....    ......+.+|+.+++.++||||+++++++..
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTG---ANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSS---TTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEecc---CCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            47899999999999999999987521   1267899999987542    2234567789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+..|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.  ||+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~--~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC--CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            99999999999999999999765  6789999999999999999999965  5999999999999999999999999998


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||......      ........     
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-----  235 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK-----  235 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-----
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-----
Confidence            7543222  1234567999999999999999999999999999999999999999764211      11111111     


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                           ..  ..++...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       236 -----~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          236 -----CK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -----TC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -----CC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                 11  123334567899999999999999999     77888764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.6e-45  Score=345.81  Aligned_cols=263  Identities=24%  Similarity=0.308  Sum_probs=199.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      +.++|++.+.||+|+||.||+|.+..      +++.||+|++.....   .....+.+|+.+++.++||||+++++++..
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLR------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECC------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            35789999999999999999998876      588999999976532   234568899999999999999999999876


Q ss_pred             CC----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          152 EE----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       152 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                      ..    ..|+||||+++++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN--GIIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEETTSCEEECC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCCcCCCCHHHEEEcCCCCEEEee
Confidence            54    349999999999999999765  6799999999999999999999965  499999999999999999999999


Q ss_pred             cCCCCCCCCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          228 FGLAKDGPEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       228 fG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......      ........
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~  233 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVR  233 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhc
Confidence            9999865433221 1223457999999999999999999999999999999999999999764311      11111110


Q ss_pred             CccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH-HHHHHhhhh
Q 040050          307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYV-VRVLDSLQD  361 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~i-l~~L~~l~~  361 (401)
                      .......        ......+..+.+++.+||+.||.+||++.++ ...|..+..
T Consensus       234 ~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          234 EDPIPPS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CCCCCHH--------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CCCCCcc--------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            0000000        0011235689999999999999999965554 455555543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=342.15  Aligned_cols=268  Identities=26%  Similarity=0.346  Sum_probs=201.8

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-----cccHHHHHHHHHHHhccC---CCceeeE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-----TQGHKEWMAEIIFLGQLR---HPHLVKL  145 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---hpnI~~~  145 (401)
                      .+.++|++.+.||+|+||+||+|.+..      +++.||+|++....     ......+.+|+.+++.++   ||||+++
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            456899999999999999999998766      68899999986432     122346667777777664   9999999


Q ss_pred             EEEEEeCC-----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          146 IGYCWEEE-----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       146 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      ++++....     ..++||||+. ++|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+||+++.+
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG  156 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT
T ss_pred             eeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC
Confidence            99998765     5799999995 69999998765556999999999999999999999655  9999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      +.+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.......  .+...
T Consensus       157 ~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i  231 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKI  231 (308)
T ss_dssp             SCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHH
T ss_pred             CCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence            999999999998654332   2245679999999999999999999999999999999999999997643211  11111


Q ss_pred             hhhhhcCc-cchhh-------hcCCcCC---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 ARPLLKEP-RKLER-------LIDPRLE---GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 ~~~~~~~~-~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .......+ ..+..       .+.....   .......+..+.+|+.+||+.||.+|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            11110000 00000       0000000   00011235788999999999999999999999753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.5e-45  Score=348.25  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~-  153 (401)
                      .++|++.+.||+|+||.||+|.+..      +++.||||++..... .....+.+|+.++++++||||+++++++.+.. 
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   78 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKV------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP   78 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETT------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcC------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence            3679999999999999999999876      588999999975543 34567899999999999999999999986543 


Q ss_pred             --------------------------------------------------------eEEEEEEecCCCChhHHHhhhcC-
Q 040050          154 --------------------------------------------------------YRLLVYEYMPRGSLHNQLFRSYS-  176 (401)
Q Consensus       154 --------------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~-  176 (401)
                                                                              ..++||||+++++|.+++..... 
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~  158 (332)
T 3qd2_B           79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL  158 (332)
T ss_dssp             CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred             chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence                                                                    37999999999999999976422 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc----------eeeecc
Q 040050          177 AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET----------HVITRV  246 (401)
Q Consensus       177 ~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~----------~~~~~~  246 (401)
                      ...++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.........          ......
T Consensus       159 ~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T 3qd2_B          159 EDREHGVCLHIFIQIAEAVEFLHSK--GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ  236 (332)
T ss_dssp             GGSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred             cchhhHHHHHHHHHHHHHHHHHHhC--CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence            3456677899999999999999955  4999999999999999999999999999866543211          112345


Q ss_pred             ccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHH
Q 040050          247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIK  326 (401)
Q Consensus       247 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (401)
                      .||+.|+|||++.+..++.++|||||||++|+|++|..|+...        .......          .. .........
T Consensus       237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~~~~~~~----------~~-~~~~~~~~~  297 (332)
T 3qd2_B          237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------VRIITDV----------RN-LKFPLLFTQ  297 (332)
T ss_dssp             C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------HHHHHHH----------HT-TCCCHHHHH
T ss_pred             CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------HHHHHHh----------hc-cCCCccccc
Confidence            7999999999999999999999999999999999987765321        0000000          00 000111233


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          327 GAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       327 ~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+..+.+++.+||+.||.+|||+.++++.
T Consensus       298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          298 KYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            45678999999999999999999999863

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-45  Score=364.06  Aligned_cols=260  Identities=27%  Similarity=0.390  Sum_probs=207.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..++|.+.+.||+|+||.||+|.+..       +..||||++.... .....+.+|+.+|++++||||+++++++.+ ..
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            45678999999999999999998764       4679999997543 345678999999999999999999999876 66


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+|+|.+++.......+++..++.++.|++.||+|||+.  +|+||||||+|||++.++.+||+|||++...
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            89999999999999999765456799999999999999999999965  4999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......      +.....         
T Consensus       331 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i---------  394 (452)
T 1fmk_A          331 EDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQV---------  394 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHH---------
T ss_pred             CCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHH---------
Confidence            43221 11233457889999999999999999999999999999999 99999764211      111111         


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                        ........+..++..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       395 --~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          395 --ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             --HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence              111112234455778999999999999999999999999999886443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=345.17  Aligned_cols=247  Identities=24%  Similarity=0.266  Sum_probs=195.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      ..++|++.+.||+|+||+||+|.+..      +++.||||++.....  ........|+..+..+ +||||+++++++.+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKE------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECC------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            44789999999999999999999876      588999999865422  2334455566655555 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ....++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceee
Confidence            99999999999 77999988765 357999999999999999999999654  999999999999999999999999998


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+....     ....            
T Consensus       205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~------------  263 (311)
T 3p1a_A          205 VELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQ------------  263 (311)
T ss_dssp             EECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHH------------
T ss_pred             eecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHH------------
Confidence            7654332   2234569999999998876 78999999999999999999977664421     0111            


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                        +........++...+..+.+++.+||+.||++|||+.++++
T Consensus       264 --~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          264 --LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --HTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --HhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              00001111111223678999999999999999999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-45  Score=346.90  Aligned_cols=268  Identities=27%  Similarity=0.439  Sum_probs=207.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..+|.+.+.||+|+||.||+|.+...  ....+..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTS--SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecC--CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            46788899999999999999987642  112345699999975533 334568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             cEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999998653 35799999999999999999999965  4999999999999999999999999999865


Q ss_pred             CCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          235 PEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       235 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......   .+..   ...       
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~---~~~-------  264 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMK---AIN-------  264 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHH---HHH-------
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHH---HHH-------
Confidence            433211 11223456889999999999999999999999999999999 99999654211   1111   110       


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                          .......+..++..+.+++.+||+.||.+||++.++++.|+.+......
T Consensus       265 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          265 ----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             ----TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             ----CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence                0111122334567899999999999999999999999999998765544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-45  Score=362.62  Aligned_cols=249  Identities=27%  Similarity=0.378  Sum_probs=207.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++...
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~   88 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHEL------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP   88 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETT------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            3789999999999999999998876      68899999986431   22346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           89 SDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             SEEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCCcccccHHHEEEecCCCeEEEeccchh
Confidence            9999999999999999999654  6799999999999999999999954  59999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......      .....        
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~~~--------  227 (476)
T 2y94_A          165 MMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLFKK--------  227 (476)
T ss_dssp             ECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHHHH--------
T ss_pred             hccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHHHH--------
Confidence            764432   2345679999999999998766 68999999999999999999999764211      11111        


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        +.....  ..+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       228 --i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          228 --ICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --HHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --HhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence              111111  1223346689999999999999999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.7e-46  Score=355.87  Aligned_cols=250  Identities=28%  Similarity=0.326  Sum_probs=196.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHH-HhccCCCceeeEEEEEEe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIF-LGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~hpnI~~~~~~~~~  151 (401)
                      .++|.+.+.||+|+||.||+|++..      +++.||+|++....   ......+..|..+ ++.++||||+++++++.+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~  110 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKA------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT  110 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETT------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcC------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe
Confidence            3689999999999999999998876      68899999986432   2234456677776 577899999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+.+|+||||+.||+|.+++.+.  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.+|.+||+|||++
T Consensus       111 ~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a  186 (373)
T 2r5t_A          111 ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLC  186 (373)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCccc
Confidence            99999999999999999999765  67899999999999999999999654  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .......  ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.....      .........     
T Consensus       187 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-----  253 (373)
T 2r5t_A          187 KENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILN-----  253 (373)
T ss_dssp             GGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHH-----
T ss_pred             cccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHh-----
Confidence            7532221  123456899999999999999999999999999999999999999976421      111111111     


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                           ..  ..++...+..+.+++.+||+.||.+||++.+.++.
T Consensus       254 -----~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~  290 (373)
T 2r5t_A          254 -----KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  290 (373)
T ss_dssp             -----SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred             -----cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence                 11  11233456789999999999999999998543333

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.9e-45  Score=336.55  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=207.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +.++|.+.+.||+|+||.||+|.+..      ++..||+|++..........+.+|+.+++.++||||+++++++.+...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKG------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD   80 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCC------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence            45789999999999999999998876      578999999876555567789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE---cCCCcEEEEecCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLA  231 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv---~~~~~vkL~DfG~a  231 (401)
                      .++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||++   +.++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            99999999999999998765  6799999999999999999999965  49999999999999   78899999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .......   ......||+.|+|||++.+. ++.++||||||+++|+|++|..||......  ...........      
T Consensus       157 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~------  224 (277)
T 3f3z_A          157 ARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS--EVMLKIREGTF------  224 (277)
T ss_dssp             EECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC------
T ss_pred             eeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhCCC------
Confidence            8654432   22445799999999988764 899999999999999999999999764211  01111100000      


Q ss_pred             hhhcCCcCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 ERLIDPRLEGQFPI----KGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 ~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                .++.    ..+..+.+++.+||+.||.+|||+.++++.
T Consensus       225 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 ----------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ----------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      1111    235789999999999999999999999864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.2e-45  Score=355.72  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=198.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccC--CCceeeEEEEEEe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLR--HPHLVKLIGYCWE  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hpnI~~~~~~~~~  151 (401)
                      ..+|.+.+.||+|+||.||+|.+..       ++.||||++....  ......+.+|+.+|+.++  ||||+++++++..
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~  127 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT  127 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence            3569999999999999999997643       6789999987543  334567889999999996  5999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      +..+|+|||+ .+++|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++ ++.+||+|||++
T Consensus       128 ~~~~~lv~E~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~--~ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          128 DQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             SSEEEEEEEC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT--TCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             CCEEEEEEec-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            9999999994 588999999765  5789999999999999999999954  599999999999995 589999999999


Q ss_pred             CCCCCCCcceeeecccccccccccccccc-----------CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMT-----------GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      ...............+||+.|+|||++.+           ..++.++|||||||++|+|++|..||......     .. 
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~-  275 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS-  275 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HH-
T ss_pred             ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HH-
Confidence            87654433333345679999999999875           46899999999999999999999999653211     00 


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                               .+..++.+.....++...+..+.+|+.+||+.||.+||++.++++.
T Consensus       276 ---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          276 ---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                     1111222222222333335688999999999999999999999875

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=355.22  Aligned_cols=252  Identities=25%  Similarity=0.302  Sum_probs=200.0

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEEe
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      .+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETA------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEECC-----CEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEecCcCEEEEEEEEcC------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            5789999999999998876      5889999999876555667889999999999999999999999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE--cCCCcEEEEecCCCCCCCCCCc
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL--DSDYTAKLSDFGLAKDGPEGEE  239 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv--~~~~~vkL~DfG~a~~~~~~~~  239 (401)
                      +++++|.+++... ...+++..++.++.||+.||.|||+.+  |+||||||+|||+  +.++.+||+|||++........
T Consensus       168 ~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          168 VDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             CTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            9999999988653 346899999999999999999999654  9999999999999  5678999999999987644322


Q ss_pred             ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC
Q 040050          240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL  319 (401)
Q Consensus       240 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (401)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|..||......  ..+.........            .
T Consensus       245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~~~~~~------------~  307 (373)
T 2x4f_A          245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNILACRWD------------L  307 (373)
T ss_dssp             ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHHTCCC------------S
T ss_pred             ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCC------------C
Confidence               23456999999999999999999999999999999999999999764321  111111111000            0


Q ss_pred             CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhh
Q 040050          320 EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR--VLDSL  359 (401)
Q Consensus       320 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~--~L~~l  359 (401)
                      ........+..+.+|+.+||+.||.+|||+.++++  .+...
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            00011223678999999999999999999999997  44443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.8e-45  Score=343.54  Aligned_cols=275  Identities=27%  Similarity=0.366  Sum_probs=212.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeC--C
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--E  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--~  153 (401)
                      .+|++.+.||+|+||.||+|.+..  .+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDP--EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECT--TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEcc--ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            568999999999999999998532  122368999999997543 34457789999999999999999999999876  6


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+++|.+++... ...+++..++.++.|++.||+|||+.  +|+||||||+||+++.++.+||+|||++..
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR--QYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC--CcccCCCchheEEEcCCCCEEECccccccc
Confidence            789999999999999998654 35799999999999999999999965  499999999999999999999999999987


Q ss_pred             CCCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC--ccc
Q 040050          234 GPEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE--PRK  310 (401)
Q Consensus       234 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~  310 (401)
                      ....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+.....    .......+....  ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCSCCGGGHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCCcccccCHHH
Confidence            6544322 223345688899999999999999999999999999999999998753210    000000000000  001


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      +...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111122222344456788999999999999999999999999998874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.6e-45  Score=339.50  Aligned_cols=265  Identities=24%  Similarity=0.359  Sum_probs=201.2

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhc--cCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ--LRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnI~~~~~~~~~  151 (401)
                      .+.++|++.+.||+|+||+||+|.+.        ++.||+|++...   ....+..|.+++..  ++||||+++++++..
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~   73 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSWQ--------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMT   73 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEET--------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEEC--------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecc
Confidence            34678999999999999999999763        678999998643   34556666666665  789999999998764


Q ss_pred             C----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCCCcEEEcCCC
Q 040050          152 E----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE------DKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       152 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      .    ...++||||+.+|+|.+++..   ..+++..++.++.|++.||.|||..      ..+|+||||||+|||++.++
T Consensus        74 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           74 SRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             ccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence            3    468999999999999999954   5799999999999999999999922      34499999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCcce--eeeccccccccccccccccC------CCCccccHHhHHHHHHHHHhC----------C
Q 040050          222 TAKLSDFGLAKDGPEGEETH--VITRVMGTQGYAAPEYVMTG------HLTTMSDVYSFGVVLLELLTG----------K  283 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~  283 (401)
                      .+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|+|++|          .
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            99999999997543322211  12234799999999999876      456799999999999999999          7


Q ss_pred             CCCCCCcccccccHHHHhhhhhcCccchhhhcCCcC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          284 RAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRL-EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       284 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      .||........ ............ .     ..+.. ....+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       231 ~pf~~~~~~~~-~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          231 PPFYDVVPNDP-SFEDMRKVVCVD-Q-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CTTTTTSCSSC-CHHHHHHHHTTS-C-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccCCCCc-chhhhhHHHhcc-C-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            77754322211 111111111000 0     00000 0112345678999999999999999999999999999876

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.4e-46  Score=365.34  Aligned_cols=263  Identities=20%  Similarity=0.230  Sum_probs=208.9

Q ss_pred             HHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEE
Q 040050           70 AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLI  146 (401)
Q Consensus        70 ~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~  146 (401)
                      .++....++|++.++||+|+||+||+|.+..      +++.||+|++....   ......+.+|..++..++||||++++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  140 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKN------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH  140 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcC------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            3444556899999999999999999999876      68899999986321   11223478899999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          147 GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      +++.+...+|+||||+.||+|.+++.+. ...+++..++.++.||+.||.|||+.+  ||||||||+|||++.+|.+||+
T Consensus       141 ~~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          141 YAFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEc
Confidence            9999999999999999999999999763 367999999999999999999999654  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      |||++........ ......+||+.|+|||++.     +..|+.++|||||||++|||++|..||......      +..
T Consensus       218 DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~  290 (437)
T 4aw2_A          218 DFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETY  290 (437)
T ss_dssp             CCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH
T ss_pred             chhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHH
Confidence            9999976544322 2234468999999999997     567899999999999999999999999764321      111


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH--RPTMSYVVRV  355 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~~il~~  355 (401)
                      ..+.....   ....+    ......+..+.+||.+||..+|++  ||++++++++
T Consensus       291 ~~i~~~~~---~~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          291 GKIMNHKE---RFQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHHTHHH---HCCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             Hhhhhccc---cccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            11110000   00001    111224678999999999988888  9999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.4e-45  Score=341.02  Aligned_cols=262  Identities=27%  Similarity=0.462  Sum_probs=196.5

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      +..++|++.+.||+|+||+||+|.+..         .||+|++....  ......+.+|+.+++.++||||++++++. .
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~   90 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T   90 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence            345789999999999999999997543         59999987553  23356788999999999999999999965 4


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ....++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceec
Confidence            55689999999999999988653 367999999999999999999999654  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      ................||+.|+|||++.   +..++.++||||||+++|+|++|..||......  ..+........   
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~---  242 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--DQIIEMVGRGS---  242 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--HHHHHHHHHTS---
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--HHHHHHhcccc---
Confidence            8654433333344567999999999987   667889999999999999999999999764321  11111111100   


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                            ..+. .......++..+.+++.+||+.||.+||++.++++.|+++.
T Consensus       243 ------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          243 ------LSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ------CCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ------cCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                  0000 11122344678999999999999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.5e-45  Score=339.41  Aligned_cols=260  Identities=26%  Similarity=0.367  Sum_probs=207.4

Q ss_pred             hcCCCCCc-eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSN-LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~-~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..+|.+.+ .||+|+||.||+|.+...    ..++.||+|++.....  .....+.+|+.+++.++||||+++++++ ..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             chhhhhccCccccccCeeeEeeeecCC----CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            46788888 999999999999965431    1578999999975432  2356788999999999999999999999 56


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC--CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            6789999999999999999764  6799999999999999999999965  49999999999999999999999999998


Q ss_pred             CCCCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          233 DGPEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       233 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ........ .......|++.|+|||++.+..++.++||||||+++|+|++ |..||......   .+...          
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~----------  232 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAM----------  232 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHH----------
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHH----------
Confidence            66443322 11223456789999999998889999999999999999999 99999764321   11111          


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                          +........+..++..+.+++.+||+.||.+||++.++++.|+.+-.
T Consensus       233 ----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          233 ----LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             ----HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                11111122334456789999999999999999999999999998843

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.9e-45  Score=338.93  Aligned_cols=263  Identities=27%  Similarity=0.360  Sum_probs=208.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|+||+||+|.+...   ..++..||+|.+.... ......+.+|+.+++.++||||+++++++.++ .
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECT---TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCC---CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence            47899999999999999999987642   1145679999987653 33456788999999999999999999998654 5


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            68999999999999999764 35689999999999999999999965  4999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..... .......|++.|+|||++.+..++.++||||||+++|+|++ |..||......   ........          
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~~~----------  229 (281)
T 3cc6_A          164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVLEK----------  229 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHHHH----------
T ss_pred             ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHHhc----------
Confidence            44321 12233457889999999999999999999999999999998 99999754321   11111110          


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                          ......+...+..+.+++.+||+.||.+||++.++++.|+.+....
T Consensus       230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          230 ----GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                0111122334678999999999999999999999999999986543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-45  Score=336.90  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=210.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|.+.+.||+|+||.||+|.+..       ++.||+|++..... ....+.+|+.+++.++||||+++++++.+....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   78 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   78 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeEecCCCceeEEEEEecC-------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence            4689999999999999999998764       57899999975433 346789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           79 CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL  155 (267)
T ss_dssp             EEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred             EEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEECCCCCEEEcccccccccc
Confidence            9999999999999998754 35689999999999999999999955  49999999999999999999999999997653


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ... ........|++.|+|||++.+..++.++||||||+++|+|++ |..||......      ........        
T Consensus       156 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~--------  220 (267)
T 3t9t_A          156 DDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDIST--------  220 (267)
T ss_dssp             CHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHT--------
T ss_pred             ccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhc--------
Confidence            321 111223457889999999998999999999999999999999 89999764211      11111100        


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                         ......+...+..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       221 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          221 ---GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               11112233346789999999999999999999999999998864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.1e-45  Score=340.68  Aligned_cols=266  Identities=22%  Similarity=0.340  Sum_probs=203.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++...+
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLL------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN  105 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETT------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cceEEEEeecCCCCceEEEEEEcC------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            679999999999999999998776      57899999987532   334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ..++||||+.+++|.+++...  ....+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.+||+|||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--RVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC--CeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            999999999999999998642  346789999999999999999999965  4999999999999999999999999998


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........  ......|++.|+|||++.+..++.++||||||+++|+|++|..||......    ..........     
T Consensus       184 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-----  252 (310)
T 2wqm_A          184 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ-----  252 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHT-----
T ss_pred             eeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhc-----
Confidence            76543221  223457899999999999999999999999999999999999999754221    1111111100     


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCC
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF  366 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~  366 (401)
                           ...........+..+.+++.+||+.||.+||++.++++.|+++++...+.
T Consensus       253 -----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          253 -----CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             -----TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -----ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                 00011111234678999999999999999999999999999998776643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.2e-45  Score=349.88  Aligned_cols=271  Identities=23%  Similarity=0.282  Sum_probs=208.7

Q ss_pred             ccHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-----CCc
Q 040050           67 FTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-----HPH  141 (401)
Q Consensus        67 ~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpn  141 (401)
                      +++.....+.++|.+.+.||+|+||+||+|.+..      +++.||+|++... ......+..|+.+++.+.     |||
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID------NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECC------CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            3444455667899999999999999999999876      5789999998642 233456778999999886     999


Q ss_pred             eeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC--
Q 040050          142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS--  219 (401)
Q Consensus       142 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~--  219 (401)
                      |+++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||+.  +|+||||||+|||++.  
T Consensus        98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A           98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM--SLTHTDLKPENILLDDPY  174 (360)
T ss_dssp             BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCTT
T ss_pred             eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CeeeCCCCcccEEEcccc
Confidence            999999999999999999999 99999999877656799999999999999999999965  4999999999999975  


Q ss_pred             -----------------------CCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHH
Q 040050          220 -----------------------DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVL  276 (401)
Q Consensus       220 -----------------------~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  276 (401)
                                             ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                   789999999999864332     2345799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCcccccccHHHHhhhhhcCccch---------hhhcC-CcCCCCC--------------------CHH
Q 040050          277 LELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL---------ERLID-PRLEGQF--------------------PIK  326 (401)
Q Consensus       277 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-~~~~~~~--------------------~~~  326 (401)
                      |+|++|+.||........  +..........+..+         ..... ......+                    +..
T Consensus       250 ~ell~g~~pf~~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  327 (360)
T 3llt_A          250 AELYTGSLLFRTHEHMEH--LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII  327 (360)
T ss_dssp             HHHHHSSCSCCCSSHHHH--HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred             HHHHHCCCCCCCCcHHHH--HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence            999999999976432111  111100000000000         00000 0000000                    001


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          327 GAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       327 ~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ....+.+|+.+||+.||.+|||+.++++
T Consensus       328 ~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          328 KHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            1267889999999999999999999975

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=342.86  Aligned_cols=262  Identities=27%  Similarity=0.433  Sum_probs=203.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|++.+.||+|+||.||+|.+.        ++.||+|.+...  .....+.+|+.++++++||||+++++++.+  ..+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   75 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC   75 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence            67899999999999999999764        468999998643  345678899999999999999999998864  478


Q ss_pred             EEEEecCCCChhHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHhCCC-CCeeeccCCCCcEEEcCCCc-EEEEecCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYS-AALPWSTRMKIALGAAKGLAFLHGED-KPVIYRDFKASNILLDSDYT-AKLSDFGLAKD  233 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~~-~~iiH~Dlkp~NIlv~~~~~-vkL~DfG~a~~  233 (401)
                      +||||+++++|.+++..... ..++...++.++.|++.||.|||+.+ ++|+||||||+||+++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            99999999999999975422 24788999999999999999999633 56999999999999998886 79999999975


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     .....||+.|+|||++.+..++.++||||||+++|+|++|..||........    .......        
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~--------  218 (307)
T 2eva_A          156 IQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVH--------  218 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHH--------
T ss_pred             cccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHh--------
Confidence            4332     2334699999999999999999999999999999999999999975422111    1000000        


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCCCCce
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFVGPF  370 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~~~~~  370 (401)
                         .......+...+..+.+++.+||+.||.+|||+.++++.|+.+...-.....|.
T Consensus       219 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~  272 (307)
T 2eva_A          219 ---NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL  272 (307)
T ss_dssp             ---TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred             ---cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence               011112223346688999999999999999999999999999976554444333

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.8e-45  Score=346.59  Aligned_cols=279  Identities=32%  Similarity=0.413  Sum_probs=214.5

Q ss_pred             hcCC-CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeC-
Q 040050           76 TSNF-SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE-  152 (401)
Q Consensus        76 ~~~y-~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-  152 (401)
                      .++| ++.+.||+|+||+||++.+..  ....+++.||+|++..... .....+.+|+.+++.++||||+++++++.+. 
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDP--TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECS--CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEcc--CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            3555 999999999999999986543  2233688999999986533 3356788999999999999999999999884 


Q ss_pred             -CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          153 -EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       153 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                       ...++||||+++++|.+++...   .+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~--~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEEcCCCCEEECCcccc
Confidence             6789999999999999998653   599999999999999999999965  4999999999999999999999999999


Q ss_pred             CCCCCCCcc-eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          232 KDGPEGEET-HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       232 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ....+..... ....
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~-~~~~  259 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQM-TVLR  259 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHH-HHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccch-hHHH
Confidence            876554322 222345688899999999999999999999999999999999999865321100 0000000000 0001


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      +...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+...-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            11222222233344556788999999999999999999999999999986543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.5e-46  Score=344.03  Aligned_cols=261  Identities=25%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCC-CCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|+||+||+|.+..... ....+..||+|++..........+.+|+.+++.++||||+++++++..++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4689999999999999999998775210 011125799999976655667789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc--------EEEE
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT--------AKLS  226 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~--------vkL~  226 (401)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999764 234999999999999999999999654  999999999999988876        9999


Q ss_pred             ecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCC-CCCCCcccccccHHHHhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKR-AMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~-pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |||++......      ....||+.|+|||++.+ ..++.++|||||||++|+|++|.. ||......   .......  
T Consensus       164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~~~~--  232 (289)
T 4fvq_A          164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ---RKLQFYE--  232 (289)
T ss_dssp             CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH--
T ss_pred             cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH---HHHHHhh--
Confidence            99998754332      23458999999999987 778999999999999999999654 44332111   0011000  


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                        .            ....+...+..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus       233 --~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          233 --D------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             --T------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             --c------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence              0            001111224568899999999999999999999999998865443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.9e-45  Score=338.47  Aligned_cols=259  Identities=29%  Similarity=0.413  Sum_probs=210.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..++|.+.+.||+|+||.||+|.+..       +..||+|.+.... .....+.+|+.+++.++||||+++++++.. +.
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   81 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcC-------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence            45789999999999999999998653       5689999987543 345778999999999999999999999864 45


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+|||++...
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            899999999999999997653347999999999999999999999654  999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||......      +......        
T Consensus       160 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~--------  224 (279)
T 1qpc_A          160 EDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLE--------  224 (279)
T ss_dssp             SSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHH--------
T ss_pred             cCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHHh--------
Confidence            44321 11233457889999999998899999999999999999999 89999754211      1111110        


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                         .......+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       225 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          225 ---RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence               0111122334467899999999999999999999999999998544

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=349.91  Aligned_cols=254  Identities=24%  Similarity=0.297  Sum_probs=192.2

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ....+.+|+.++++++||||+++++++....
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKG------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECC------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            356789999999999999999998876      57899999987543  3356778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEEecCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGL  230 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~DfG~  230 (401)
                      ..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.   ++.+||+|||+
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             eEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            999999999999999998664  6799999999999999999999965  5999999999999975   88999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..   ......... 
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~---~~~i~~~~~-  268 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FM---FRRILNCEY-  268 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HH---HHHHHTTCC-
T ss_pred             ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HH---HHHHHhCCC-
Confidence            98654322   2244679999999999999999999999999999999999999996543211  01   111111000 


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             ..........+..+.+|+.+||+.||++|||+.++++.
T Consensus       269 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          269 -------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   00111122346789999999999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.2e-45  Score=335.92  Aligned_cols=255  Identities=26%  Similarity=0.374  Sum_probs=207.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..++|++.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             eecceEEEEEeecCCCcEEEEEEECC------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence            34789999999999999999998876      57899999986443 234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC--CeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            999999999999999988653  6799999999999999999999965  499999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ..............|++.|+|||++.+..+ +.++||||||+++|+|++|..||....... ..+..+...         
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~---------  224 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEK---------  224 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHHHTT---------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHhhhc---------
Confidence            543332223345679999999999987665 779999999999999999999997643211 111111110         


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                           ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       225 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          225 -----KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 0000111234668899999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.4e-45  Score=339.07  Aligned_cols=264  Identities=25%  Similarity=0.331  Sum_probs=199.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|.+.+.||+|+||+||+|.+.       +++.||+|++.....  .....+.+|+.+++.++||||+++++++...+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            57999999999999999999873       478999999875432  234678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           75 LVLVFEHLD-QDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR--RVLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEEECCS-EEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEEecC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            999999996 5898888653 36789999999999999999999965  5999999999999999999999999998754


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc-cchh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP-RKLE  312 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  312 (401)
                      ....  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......  ..+........... ....
T Consensus       151 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  226 (288)
T 1ob3_A          151 GIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQLMRIFRILGTPNSKNWP  226 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTST
T ss_pred             Cccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHHCCCChhhch
Confidence            3221  12234578999999999976 46899999999999999999999999764321  11111111100000 0000


Q ss_pred             ---hh--cCCcC-------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 ---RL--IDPRL-------EGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ---~~--~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ..  .++..       ...+....+..+.+++.+||+.||++|||+.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               00  00000       001112346788999999999999999999999753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-44  Score=339.53  Aligned_cols=267  Identities=24%  Similarity=0.278  Sum_probs=200.6

Q ss_pred             hcCCCCC-ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           76 TSNFSRS-NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~-~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      .++|.+. +.||+|+||+||+|.+..      +++.||||++..........+.+|+.++.++ +||||+++++++.+.+
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~   84 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLI------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED   84 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSS------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             ceeEEecCceecCCceEEEEEEEEcC------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            3678884 789999999999998765      6889999999866556677899999999885 7999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc---EEEEecCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT---AKLSDFGL  230 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~---vkL~DfG~  230 (401)
                      ..++||||+.+++|.+++...  ..+++..++.++.|++.||+|||+.  +|+||||||+||+++.++.   +||+|||+
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            999999999999999999775  6799999999999999999999965  4999999999999988765   99999999


Q ss_pred             CCCCCCCCc-----ceeeecccccccccccccccc-----CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          231 AKDGPEGEE-----THVITRVMGTQGYAAPEYVMT-----GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       231 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      +........     ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||..............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~  240 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE  240 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred             ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence            875432211     111234569999999999875     5688999999999999999999999976532210000000


Q ss_pred             hhhhhcCccchhhhcCCcCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 ARPLLKEPRKLERLIDPRLEGQFPI----KGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..... .......+.....  .++.    ..+..+.+|+.+||+.||.+|||+.++++.
T Consensus       241 ~~~~~-~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          241 ACPAC-QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CCHHH-HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cchhH-HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00000 0000000000000  1121    235689999999999999999999999874

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.7e-45  Score=356.41  Aligned_cols=267  Identities=24%  Similarity=0.372  Sum_probs=194.9

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccC-CCceeeEEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCW  150 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~  150 (401)
                      .+.++|++.+.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+.+++.+. ||||+++++++.
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~   79 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRR------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR   79 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETT------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECC------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence            456899999999999999999998876      6889999998643  2344567889999999997 999999999998


Q ss_pred             eCC--eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          151 EEE--YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       151 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                      .++  .+|+||||+. ++|..++..   ..++...+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DF  153 (388)
T 3oz6_A           80 ADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADF  153 (388)
T ss_dssp             CTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCC
T ss_pred             cCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecCC
Confidence            654  7899999996 689888865   47999999999999999999999655  999999999999999999999999


Q ss_pred             CCCCCCCCC-------------------Ccceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          229 GLAKDGPEG-------------------EETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       229 G~a~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                      |+++.....                   ......+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+
T Consensus       154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            999754321                   11122345689999999999986 6789999999999999999999999976


Q ss_pred             CcccccccHHHHhhhhhcCccc--hhhhc------------------CCcCCCCC------------CHHHHHHHHHHHH
Q 040050          289 TRLGREQSLAEWARPLLKEPRK--LERLI------------------DPRLEGQF------------PIKGAQKAAATAF  336 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~------------------~~~~~~~~------------~~~~~~~l~~li~  336 (401)
                      .....  .+.... ..+..+..  +..+.                  .......+            +...+..+.+|+.
T Consensus       234 ~~~~~--~~~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          234 SSTMN--QLERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             SSHHH--HHHHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCHHH--HHHHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            53211  111111 11111100  00000                  00000000            0123567899999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 040050          337 KCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       337 ~cl~~dP~~RPt~~~il~~  355 (401)
                      +||+.||.+|||+.+++++
T Consensus       311 ~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTS
T ss_pred             HhhccCcccCCCHHHHhCC
Confidence            9999999999999999865

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.1e-45  Score=345.43  Aligned_cols=262  Identities=26%  Similarity=0.442  Sum_probs=208.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCce--EEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQP--VAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      ++|.+.+.||+|+||.||+|.+..      ++..  ||+|.+.... ......+.+|+.+++++ +||||+++++++.+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKK------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             HHccceeeeecCCCceEEEEEEcc------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            689999999999999999998876      3554  4999887432 33455788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD  218 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~  218 (401)
                      +..++||||+++++|.+++....              ...+++..++.++.||+.||.|||+.  +|+||||||+||+++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVG  176 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCccceEEEc
Confidence            99999999999999999997542              34799999999999999999999965  499999999999999


Q ss_pred             CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccH
Q 040050          219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSL  297 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  297 (401)
                      .++.+||+|||++.......   ......+++.|+|||++.+..++.++|||||||++|+|++ |..||......     
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----  248 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----  248 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----
T ss_pred             CCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----
Confidence            99999999999987432211   1123457889999999999899999999999999999998 99999764211     


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccCC
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF  366 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~~  366 (401)
                       ......           ........+...+..+.+++.+||+.||.+||++.++++.|+.+..-...+
T Consensus       249 -~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  305 (327)
T 1fvr_A          249 -ELYEKL-----------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  305 (327)
T ss_dssp             -HHHHHG-----------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred             -HHHHHh-----------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence             111111           111112233345678999999999999999999999999999987655443

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.7e-45  Score=339.16  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=208.6

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      .+..+|.+.+.||+|+||.||+|.+..      +++.||+|++....    ..+.+|+.+++.++||||+++++++..  
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   77 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRI------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFD   77 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETT------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred             hhccccceeeeeccCCceEEEEEEEcC------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence            345789999999999999999998875      57899999997543    346789999999999999999998864  


Q ss_pred             --------------CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE
Q 040050          152 --------------EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL  217 (401)
Q Consensus       152 --------------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv  217 (401)
                                    ....++||||+++++|.+++.......+++..++.++.|++.||.|||+.  +|+|+||||+||++
T Consensus        78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~Nil~  155 (284)
T 2a19_B           78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK--KLINRDLKPSNIFL  155 (284)
T ss_dssp             EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEE
T ss_pred             cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCHHHEEE
Confidence                          44579999999999999999876567899999999999999999999965  59999999999999


Q ss_pred             cCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccH
Q 040050          218 DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL  297 (401)
Q Consensus       218 ~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  297 (401)
                      +.++.+||+|||++........   .....|++.|+|||++.+..++.++||||||+++|+|++|..|+....       
T Consensus       156 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------  225 (284)
T 2a19_B          156 VDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------  225 (284)
T ss_dssp             EETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------
T ss_pred             cCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------
Confidence            9999999999999986544322   234569999999999999999999999999999999999998874310       


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                       ....          .+....    .+...+..+.+++.+||+.||.+||++.++++.|+.++....
T Consensus       226 -~~~~----------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          226 -KFFT----------DLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             -HHHH----------HHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             -HHHH----------Hhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence             0000          011111    122235678899999999999999999999999999876544

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2e-44  Score=339.92  Aligned_cols=254  Identities=24%  Similarity=0.294  Sum_probs=207.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------ccHHHHHHHHHHHhccCCCceeeEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------QGHKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++.....      .....+.+|+.+++.++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKS------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECC------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            45779999999999999999998876      688999999875432      135678999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC----cEE
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----TAK  224 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~----~vk  224 (401)
                      +.+....++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++    .+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~--~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           84 YENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EecCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCChHHEEEecCCCCcCCEE
Confidence            99999999999999999999999764  6789999999999999999999965  499999999999999887    799


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ......
T Consensus       160 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i  230 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANI  230 (321)
T ss_dssp             ECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHH
T ss_pred             EccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHH
Confidence            999999986544321   23457999999999999999999999999999999999999999754211      111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ......        .........+..+.+++.+||+.||.+|||+.++++.
T Consensus       231 ~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 TSVSYD--------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HTTCCC--------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             Hhcccc--------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            100000        0000011235678999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=345.65  Aligned_cols=266  Identities=23%  Similarity=0.299  Sum_probs=208.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe----
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE----  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~----  151 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++..    
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLH------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETT------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecC------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            4789999999999999999998866      588999999876655566788999999999999999999999873    


Q ss_pred             CCeEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      ....++||||+.+++|.+++...  ....+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK--GYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCHHHEEEcCCCCEEEEecC
Confidence            34789999999999999998753  346799999999999999999999965  59999999999999999999999999


Q ss_pred             CCCCCCCCCcc-------eeeeccccccccccccccccCC---CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          230 LAKDGPEGEET-------HVITRVMGTQGYAAPEYVMTGH---LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       230 ~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      ++.........       .......||+.|+|||++.+..   ++.++||||||+++|+|++|..||........ ....
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~  258 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL  258 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH
Confidence            98754321100       0012245799999999987654   68899999999999999999999964211100 1111


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      ...              .......+...+..+.+++.+||+.||.+||++.++++.|+.++....
T Consensus       259 ~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          259 AVQ--------------NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             HHH--------------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             Hhh--------------ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            000              011111122346789999999999999999999999999998865443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-44  Score=340.75  Aligned_cols=272  Identities=25%  Similarity=0.365  Sum_probs=207.6

Q ss_pred             cHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc--CCCceeeE
Q 040050           68 TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL--RHPHLVKL  145 (401)
Q Consensus        68 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnI~~~  145 (401)
                      .......+.++|.+.+.||+|+||.||+|.+.        ++.||+|++...   ....+..|.+++..+  +||||+++
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~   96 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGF   96 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC--------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeE
Confidence            34445566789999999999999999999764        578999998632   234555666666555  89999999


Q ss_pred             EEEEEeC----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCCCcE
Q 040050          146 IGYCWEE----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE------DKPVIYRDFKASNI  215 (401)
Q Consensus       146 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~iiH~Dlkp~NI  215 (401)
                      ++++...    ...++||||+.+++|.+++..   ..+++..++.++.|++.||.|||+.      ..+|+||||||+||
T Consensus        97 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni  173 (337)
T 3mdy_A           97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI  173 (337)
T ss_dssp             EEEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred             EEEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence            9999887    789999999999999999965   4799999999999999999999965      22699999999999


Q ss_pred             EEcCCCcEEEEecCCCCCCCCCCccee--eeccccccccccccccccCCCCcc------ccHHhHHHHHHHHHhC-----
Q 040050          216 LLDSDYTAKLSDFGLAKDGPEGEETHV--ITRVMGTQGYAAPEYVMTGHLTTM------SDVYSFGVVLLELLTG-----  282 (401)
Q Consensus       216 lv~~~~~vkL~DfG~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~g-----  282 (401)
                      |++.++.+||+|||++...........  .....||+.|+|||++.+..++..      +|||||||++|+|++|     
T Consensus       174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~  253 (337)
T 3mdy_A          174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG  253 (337)
T ss_dssp             EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence            999999999999999976543322111  124579999999999987766654      9999999999999999     


Q ss_pred             -----CCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 040050          283 -----KRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFP-----IKGAQKAAATAFKCLSHHPRHRPTMSYV  352 (401)
Q Consensus       283 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~i  352 (401)
                           ..||........ ....... .         .........++     ..++..+.+++.+||+.||.+|||+.++
T Consensus       254 ~~~~~~~p~~~~~~~~~-~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  322 (337)
T 3mdy_A          254 IVEEYQLPYHDLVPSDP-SYEDMRE-I---------VCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV  322 (337)
T ss_dssp             BCCCCCCTTTTTSCSSC-CHHHHHH-H---------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             ccccccccHhhhcCCCC-chhhhHH-H---------HhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence                 555543221111 1111100 0         01111122222     3678899999999999999999999999


Q ss_pred             HHHHHhhhhccc
Q 040050          353 VRVLDSLQDFQD  364 (401)
Q Consensus       353 l~~L~~l~~~~~  364 (401)
                      ++.|+.+....+
T Consensus       323 l~~L~~l~~~~~  334 (337)
T 3mdy_A          323 KKTLAKMSESQD  334 (337)
T ss_dssp             HHHHHHHHHTTT
T ss_pred             HHHHHHHHhhcc
Confidence            999999976554

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=346.41  Aligned_cols=262  Identities=21%  Similarity=0.287  Sum_probs=193.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEE----
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCW----  150 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~----  150 (401)
                      ..+|++.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.++.++. ||||+++++++.    
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVG------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETT------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECC------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            4689999999999999999999876      58899999987665555677889999999996 999999999994    


Q ss_pred             ----eCCeEEEEEEecCCCChhHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          151 ----EEEYRLLVYEYMPRGSLHNQLFRS-YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       151 ----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                          ....+++||||+ +|+|.+++... ....+++..++.++.||+.||.|||+.+.+|+||||||+|||++.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence                334589999999 57999988652 345799999999999999999999965445999999999999999999999


Q ss_pred             EecCCCCCCCCCCcce----------eeecccccccccccccc---ccCCCCccccHHhHHHHHHHHHhCCCCCCCCccc
Q 040050          226 SDFGLAKDGPEGEETH----------VITRVMGTQGYAAPEYV---MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLG  292 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  292 (401)
                      +|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998654432111          11235689999999998   5677899999999999999999999999653211


Q ss_pred             ccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          293 REQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                            .              +.........+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus       260 ------~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          260 ------R--------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ------H--------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                  0              000001011111223457899999999999999999999999999976544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.8e-45  Score=347.73  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=203.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++......    ..+|++++.++ +||||+++++++.+..
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~   89 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKA------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGK   89 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCC
Confidence            45789999999999999999998876      6889999999754332    34688888887 7999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC----CcEEEEecC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD----YTAKLSDFG  229 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~----~~vkL~DfG  229 (401)
                      ..|+||||+.||+|.+++...  ..+++..+..++.||+.||.|||+.  ||+||||||+|||+...    +.+||+|||
T Consensus        90 ~~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~--givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           90 YVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            999999999999999999764  6799999999999999999999965  49999999999998443    359999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++........  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||........   .+......... 
T Consensus       166 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~-  239 (342)
T 2qr7_A          166 FAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EEILARIGSGK-  239 (342)
T ss_dssp             TCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HHHHHHHHHCC-
T ss_pred             CcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HHHHHHHccCC-
Confidence            9986543321  23456799999999999988899999999999999999999999976422111   11111111100 


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             ...........+..+.+|+.+||..||++||++.++++.
T Consensus       240 -------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          240 -------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             -------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   011111223456789999999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.4e-46  Score=350.17  Aligned_cols=270  Identities=25%  Similarity=0.363  Sum_probs=207.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..++|.+.+.||+|+||.||+|.+... ....++..||+|.+.... ......+.+|+.++++++||||+++++++....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGM-PNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCC-CCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            347899999999999999999985421 112357899999987443 334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEE
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYS-----AALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKL  225 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL  225 (401)
                      ..++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.   +..+||
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~--~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN--HFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC--CeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999976432     4589999999999999999999965  4999999999999984   456999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||......   .......  
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~--  259 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFVT--  259 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHHH--
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHHh--
Confidence            99999874333222222334568999999999999999999999999999999998 99999754211   1111110  


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                                  .......+..++..+.+++.+||+.||.+||++.++++.|+.+..-..
T Consensus       260 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          260 ------------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             ------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             ------------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence                        011112233446789999999999999999999999999999866544

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-45  Score=337.51  Aligned_cols=264  Identities=26%  Similarity=0.354  Sum_probs=211.0

Q ss_pred             cCCCCCc-eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSN-LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~-~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|.+.. .||+|+||.||+|.+...    ..+..||+|++.... ......+.+|+.+++.++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccC----CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            5666666 999999999999986531    146789999997653 33456788999999999999999999999 5566


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC--CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            89999999999999998643 45799999999999999999999965  4999999999999999999999999999866


Q ss_pred             CCCCcce-eeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          235 PEGEETH-VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       235 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||......   .+....           
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i-----------  226 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFI-----------  226 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHH-----------
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH-----------
Confidence            4432211 1223457899999999998899999999999999999998 99999764321   111111           


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                         ........+..++..+.+++.+||+.||.+||++.++++.|+.+......
T Consensus       227 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          227 ---EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             ---HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ---hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence               01111223445577899999999999999999999999999999655543

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.2e-45  Score=338.08  Aligned_cols=253  Identities=27%  Similarity=0.416  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC-Ce
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE-EY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-~~  154 (401)
                      .++|++.+.||+|+||.||+|.+.        ++.||+|++....  ..+.+.+|+.+++.++||||+++++++... ..
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            478999999999999999999753        5789999987443  456788999999999999999999997654 47


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++.......+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            89999999999999999765444589999999999999999999965  4999999999999999999999999998754


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     ....+++.|+|||++.+..++.++||||||+++|+|++ |..||......   ....              
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~--------------  225 (278)
T 1byg_A          168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP--------------  225 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHH--------------
T ss_pred             cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--------------
Confidence            3321     23357889999999999999999999999999999998 99999764321   1111              


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      .+........+...+..+.+++.+||+.||.+||++.++++.|+.++.-
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            0111111223344567899999999999999999999999999998653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.2e-45  Score=335.82  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=206.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.++++++||||+++++++...
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKT------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcC------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            45789999999999999999998876      58899999986542  23346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc---EEEEecC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT---AKLSDFG  229 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~---vkL~DfG  229 (401)
                      ...++||||+.+++|.+.+...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.   +||+|||
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999999999999988765  6799999999999999999999965  4999999999999976654   9999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||......  ............   
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~---  225 (284)
T 3kk8_A          154 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQIKAGAYD---  225 (284)
T ss_dssp             TCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTCCC---
T ss_pred             eeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--HHHHHHHhcccc---
Confidence            9976544322   23467999999999999999999999999999999999999999764321  111111110000   


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                               .........+..+.+++.+||+.||.+|||+.++++.
T Consensus       226 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 ---------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ---------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ---------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                     0001112345689999999999999999999999874

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-45  Score=345.99  Aligned_cols=251  Identities=25%  Similarity=0.310  Sum_probs=181.1

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~lv~e  160 (401)
                      .+.||+|+||+||+|.+..      +++.||+|++..   .....+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKK------SNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEETT------TCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCccccCCCeEEEEEEECC------CCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            3889999999999999876      688999999863   23467788999999997 9999999999999999999999


Q ss_pred             ecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC---cEEEEecCCCCCCCCC
Q 040050          161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY---TAKLSDFGLAKDGPEG  237 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~---~vkL~DfG~a~~~~~~  237 (401)
                      |+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++   .+||+|||++......
T Consensus        87 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           87 LLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV--GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             ccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999999765  6899999999999999999999965  499999999999997765   8999999999865433


Q ss_pred             CcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc-ccHHHHhhhhhcCccchhhhcC
Q 040050          238 EETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE-QSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       238 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....+..........       
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-------  233 (325)
T 3kn6_A          163 NQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-------  233 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-------
T ss_pred             CC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-------
Confidence            22  23456789999999999999999999999999999999999999976432111 111111111111000       


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       ..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       234 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          234 -SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             -CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             -CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence             00000012346789999999999999999999998743

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-45  Score=337.99  Aligned_cols=263  Identities=25%  Similarity=0.340  Sum_probs=206.7

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE-
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR-  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~-  155 (401)
                      .|.+.+.||+|+||+||+|.+....   ..+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQA---QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSS---SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCC---CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            4666799999999999999876521   1345799999875433 3456788999999999999999999999876655 


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++....
T Consensus        99 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ--KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999998653 46789999999999999999999965  49999999999999999999999999998654


Q ss_pred             CCCc--ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          236 EGEE--THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       236 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....  ........|++.|+|||++.+..++.++||||||+++|+|++|..|+......  ..+...             
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~~-------------  240 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHF-------------  240 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHHH-------------
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHHH-------------
Confidence            3221  11223456889999999999999999999999999999999965554332111  111111             


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                       +........+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       241 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          241 -LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             -HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence             111111122334467899999999999999999999999999998543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.8e-45  Score=366.07  Aligned_cols=255  Identities=27%  Similarity=0.379  Sum_probs=211.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+|+.++||||+++++++.+.
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRA------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECC------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            4679999999999999999998876      6889999998642   223456688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ..+|+||||++||+|.+++.......+++..++.++.||+.||.|||+++  |+||||||+|||++.+|.+||+|||++.
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccce
Confidence            99999999999999999997765556999999999999999999999654  9999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......  ............     
T Consensus       335 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~i~~~-----  404 (576)
T 2acx_A          335 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEV-----  404 (576)
T ss_dssp             ECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHHHHHC-----
T ss_pred             ecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHHhhcc-----
Confidence            765433   2344689999999999999999999999999999999999999997643211  111111111111     


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                             ...++...+..+.+|+.+||+.||.+||     ++.+++++
T Consensus       405 -------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 -------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                   1123344567899999999999999999     78888764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-46  Score=360.57  Aligned_cols=262  Identities=21%  Similarity=0.211  Sum_probs=206.8

Q ss_pred             HHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEE
Q 040050           70 AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLI  146 (401)
Q Consensus        70 ~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~  146 (401)
                      .+.....++|++.+.||+|+||.||+|++..      +++.||+|++....   ......+.+|..++..++||||++++
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  127 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH  127 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            3444556899999999999999999998876      68899999986321   12234577899999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          147 GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      +++.+.+.+|+||||++||+|.+++.+. ...+++..++.++.||+.||.|||+.  +|+||||||+|||++.+|++||+
T Consensus       128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~--giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          128 FAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccCHHHeeecCCCCEEEe
Confidence            9999999999999999999999999764 34799999999999999999999965  49999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccc-------cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-------TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      |||++........ ......+||+.|+|||++.       +..|+.++|||||||++|||++|..||......      +
T Consensus       205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~  277 (412)
T 2vd5_A          205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------E  277 (412)
T ss_dssp             CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H
T ss_pred             echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------H
Confidence            9999986544322 1223468999999999997       357899999999999999999999999764321      1


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHR---PTMSYVVRV  355 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~~il~~  355 (401)
                      ....+.....   ....+    ..+...+..+.+||.+||. +|.+|   |++++++++
T Consensus       278 ~~~~i~~~~~---~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          278 TYGKIVHYKE---HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHHHTHHH---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHHHhccc---CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1111110000   00001    1122346789999999999 99998   589998765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1e-44  Score=352.13  Aligned_cols=254  Identities=21%  Similarity=0.256  Sum_probs=193.8

Q ss_pred             hcCCCCC-ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHh-ccCCCceeeEEEEEEe--
Q 040050           76 TSNFSRS-NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLG-QLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        76 ~~~y~~~-~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnI~~~~~~~~~--  151 (401)
                      .++|.+. +.||+|+||+||+|.+..      +++.||||++..     ...+.+|+.++. ..+||||+++++++..  
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~------~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECC------CCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3567666 789999999999999876      688999999862     245678888874 4589999999999876  


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEE
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLS  226 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~  226 (401)
                        ...+|+||||+.||+|.+++.......+++..++.++.||+.||.|||+.  +|+||||||+|||++.   ++.+||+
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCcCcceEEEecCCCCccEEEE
Confidence              56789999999999999999875456799999999999999999999965  4999999999999987   7899999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc-ccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE-QSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~  305 (401)
                      |||++.......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||........ .........  
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~--  281 (400)
T 1nxk_A          207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--  281 (400)
T ss_dssp             CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH--
T ss_pred             ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc--
Confidence            999998654322   23456799999999999999999999999999999999999999976432111 001111000  


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                       .        ...........++..+.+||.+||+.||.+|||+.++++.-
T Consensus       282 -~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          282 -G--------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             -T--------CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             -C--------cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence             0        00000001123467899999999999999999999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=346.64  Aligned_cols=244  Identities=24%  Similarity=0.322  Sum_probs=204.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--------ccHHHHHHHHHHHhccCCCceeeEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--------QGHKEWMAEIIFLGQLRHPHLVKLI  146 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnI~~~~  146 (401)
                      ..++|.+.+.||+|+||.||+|.+..      +++.||+|++.....        .....+.+|+.+++.++||||++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~   95 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKE------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL   95 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETT------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECC------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            45789999999999999999998876      688999999875431        1233567899999999999999999


Q ss_pred             EEEEeCCeEEEEEEecCCC-ChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          147 GYCWEEEYRLLVYEYMPRG-SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      +++.+....++||||+.+| +|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A           96 DIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             EEEECSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEE
T ss_pred             EEEeeCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeEEeccCHHHEEEcCCCcEEE
Confidence            9999999999999998666 999988664  6799999999999999999999965  4999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||++........   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......            
T Consensus       172 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------  236 (335)
T 3dls_A          172 IDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------  236 (335)
T ss_dssp             CCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred             eecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence            99999987654332   234579999999999998776 88999999999999999999999653110            


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            ..    ...  ..+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       237 ------~~----~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ------VE----AAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------TT----TCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------Hh----hcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  00    000  1122246789999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-44  Score=357.75  Aligned_cols=270  Identities=22%  Similarity=0.313  Sum_probs=188.4

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||+||+|++..      +++.||||++...  .......+.+|+.+|+.++||||+++++++...
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKL------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECC------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            34789999999999999999998876      6889999998643  223456788999999999999999999998543


Q ss_pred             -----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          153 -----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       153 -----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                           ..+|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          125 DVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             CTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             CcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecc
Confidence                 5689999998 67999988654  67999999999999999999999654  99999999999999999999999


Q ss_pred             cCCCCCCCCCCc-------------------------ceeeecccccccccccccc-ccCCCCccccHHhHHHHHHHHHh
Q 040050          228 FGLAKDGPEGEE-------------------------THVITRVMGTQGYAAPEYV-MTGHLTTMSDVYSFGVVLLELLT  281 (401)
Q Consensus       228 fG~a~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~  281 (401)
                      ||+++.......                         ....+..+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            999986542211                         1123456899999999986 46779999999999999999999


Q ss_pred             -----------CCCCCCCCccccc-----------------ccHHHHhhhhhcCccc--h--------hhh---cCCcCC
Q 040050          282 -----------GKRAMDNTRLGRE-----------------QSLAEWARPLLKEPRK--L--------ERL---IDPRLE  320 (401)
Q Consensus       282 -----------g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~~~--~--------~~~---~~~~~~  320 (401)
                                 |.++|.+......                 ......+...+..+..  +        ...   +.....
T Consensus       280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  359 (458)
T 3rp9_A          280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG  359 (458)
T ss_dssp             TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred             hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence                       5666644321000                 0000000111111000  0        000   000000


Q ss_pred             ---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          321 ---GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       321 ---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         .......+..+.+|+.+||..||.+|||+.+++++
T Consensus       360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence               00112336789999999999999999999999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.4e-45  Score=336.25  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=203.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|++.+.||+|+||+||+|.+..      ++..||+|++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQ------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEcc------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            4789999999999999999998876      57899999985321   22346688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+++++|.+++...  ..+++..++.++.|++.||.|||+  .+|+||||||+||+++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~--~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT--TTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            9999999999999999999765  679999999999999999999995  459999999999999999999999999986


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ......    .....|++.|+|||++.+..++.++||||||+++|+|++|..||......      ........      
T Consensus       158 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~------  221 (279)
T 3fdn_A          158 HAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISR------  221 (279)
T ss_dssp             CC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH------
T ss_pred             cCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHh------
Confidence            543322    23457999999999999999999999999999999999999999754211      11000000      


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            ....++...+..+.+++.+||+.||.+|||+.++++.
T Consensus       222 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          222 ------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  0112233346788999999999999999999999976

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.4e-44  Score=354.76  Aligned_cols=202  Identities=26%  Similarity=0.394  Sum_probs=168.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++...  .......+.+|+.+|+.++||||+++++++...
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKN------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECC------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            35789999999999999999999876      6889999999753  223456788999999999999999999999876


Q ss_pred             -----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          153 -----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       153 -----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                           ...|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A           98 DLLKFDELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             CTTTCCCEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcCCeEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEcc
Confidence                 5789999998 46999998654  67999999999999999999999655  99999999999999999999999


Q ss_pred             cCCCCCCCCCCcc--------------------eeeecccccccccccccc-ccCCCCccccHHhHHHHHHHHHhCCCCC
Q 040050          228 FGLAKDGPEGEET--------------------HVITRVMGTQGYAAPEYV-MTGHLTTMSDVYSFGVVLLELLTGKRAM  286 (401)
Q Consensus       228 fG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf  286 (401)
                      ||+++........                    ...+..+||+.|+|||++ .+..|+.++|||||||++|+|++|..||
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9999865433211                    123567899999999986 4667999999999999999999865555


Q ss_pred             C
Q 040050          287 D  287 (401)
Q Consensus       287 ~  287 (401)
                      .
T Consensus       253 ~  253 (432)
T 3n9x_A          253 I  253 (432)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-45  Score=348.30  Aligned_cols=261  Identities=21%  Similarity=0.245  Sum_probs=201.1

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-----CcccHHHHHHHHHHHhccCCCceeeEEE
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-----GTQGHKEWMAEIIFLGQLRHPHLVKLIG  147 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnI~~~~~  147 (401)
                      ..+.++|.+.+.||+|+||.||+|.+..      +++.||+|++...     .......+.+|+.+++.++||||+++++
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQ------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECC------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            4567899999999999999999998876      6889999998632     2344567889999999999999999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhHHHhhhc--------------------------------------CCCCCHHHHHHHHH
Q 040050          148 YCWEEEYRLLVYEYMPRGSLHNQLFRSY--------------------------------------SAALPWSTRMKIAL  189 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~  189 (401)
                      ++.+....++||||+++++|.+++....                                      ...+++..++.++.
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            9999999999999999999999885210                                      11235777889999


Q ss_pred             HHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC--cEEEEecCCCCCCCCCC--cceeeecccccccccccccccc--CCC
Q 040050          190 GAAKGLAFLHGEDKPVIYRDFKASNILLDSDY--TAKLSDFGLAKDGPEGE--ETHVITRVMGTQGYAAPEYVMT--GHL  263 (401)
Q Consensus       190 qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~--~vkL~DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~  263 (401)
                      |++.||.|||+.  +|+||||||+||+++.++  .+||+|||++.......  .........||+.|+|||++.+  ..+
T Consensus       176 qi~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  253 (345)
T 3hko_A          176 QIFSALHYLHNQ--GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY  253 (345)
T ss_dssp             HHHHHHHHHHHT--TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred             HHHHHHHHHHHC--CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence            999999999965  499999999999998776  89999999997542211  1112345679999999999975  678


Q ss_pred             CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCC
Q 040050          264 TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHP  343 (401)
Q Consensus       264 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  343 (401)
                      +.++|||||||++|+|++|..||......      +...........        .........+..+.+++.+||+.||
T Consensus       254 ~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          254 GPKCDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLC--------FENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--------TTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccc--------cCCcccccCCHHHHHHHHHHcCCCh
Confidence            99999999999999999999999764321      111111111000        0000111246789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 040050          344 RHRPTMSYVVRV  355 (401)
Q Consensus       344 ~~RPt~~~il~~  355 (401)
                      .+||++.++++.
T Consensus       320 ~~Rps~~~~l~h  331 (345)
T 3hko_A          320 DERFDAMRALQH  331 (345)
T ss_dssp             TTSCCHHHHHHS
T ss_pred             hHCCCHHHHhcC
Confidence            999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.5e-45  Score=339.30  Aligned_cols=262  Identities=27%  Similarity=0.393  Sum_probs=204.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEE-eCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCW-EEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~-~~~~  154 (401)
                      .+|.+.+.||+|+||+||+|.+....   .....||+|.+..... .....+.+|+.++++++||||+++++++. .+..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCC---CceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            57889999999999999999875421   1345689999875433 34567889999999999999999999865 4557


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~--~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCchheEEECCCCCEEECcccccccc
Confidence            89999999999999999653 46789999999999999999999965  4999999999999999999999999999865


Q ss_pred             CCCCc--ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          235 PEGEE--THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       235 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .....  ........||+.|+|||++.+..++.++||||||+++|+|++ |.+||......   .......         
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~~~~---------  246 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYLL---------  246 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---THHHHHH---------
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHh---------
Confidence            44321  112234567889999999999999999999999999999999 55666543211   1111000         


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                           .......+...+..+.+++.+||+.||.+||++.++++.|+++..
T Consensus       247 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          247 -----QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                 011111223345689999999999999999999999999999854

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=337.31  Aligned_cols=268  Identities=25%  Similarity=0.305  Sum_probs=200.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--cHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .++|++.+.||+|+||+||+|.+..      +++.||+|++......  ....+.+|+.++++++||||+++++++....
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRD------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEeeEEeecCCeEEEEEEeCC------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            3689999999999999999999876      5889999998654322  2456788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.  ||+||||||+||+++.++.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH--NCIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            999999999998888877554  6799999999999999999999965  499999999999999999999999999986


Q ss_pred             CCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH-HHhhh-------h
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA-EWARP-------L  304 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~-------~  304 (401)
                      ......  ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||............ .....       .
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            543221  2244579999999999986 67899999999999999999999999765322111110 00000       0


Q ss_pred             hcCccchhhhcCCcCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFP-----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ............+......+     ...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000000000000000000     1345678999999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=351.56  Aligned_cols=276  Identities=20%  Similarity=0.238  Sum_probs=215.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE-  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~-  153 (401)
                      .++|.+.+.||+|+||+||+|.+..      +++.||+|++.... ......+.+|+.++++++||||+++++++.... 
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKK------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECC------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            4789999999999999999999876      68899999987433 234567889999999999999999999998765 


Q ss_pred             -eEEEEEEecCCCChhHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE----cCCCcEEEEe
Q 040050          154 -YRLLVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL----DSDYTAKLSD  227 (401)
Q Consensus       154 -~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv----~~~~~vkL~D  227 (401)
                       ..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+.  +|+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC--CEEECCcCHHHEEEeecCCCceeEEEec
Confidence             7899999999999999997643 23499999999999999999999965  49999999999999    7778899999


Q ss_pred             cCCCCCCCCCCcceeeecccccccccccccccc--------CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc--cH
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT--------GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ--SL  297 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~  297 (401)
                      ||++.......   ......||+.|+|||++.+        ..++.++|||||||++|+|++|..||.........  .+
T Consensus       160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             CCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            99998654432   2234679999999999875        56788999999999999999999999754322111  11


Q ss_pred             HHHhhhhhc-Cccchhhhc--------CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          298 AEWARPLLK-EPRKLERLI--------DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       298 ~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ......... .........        .......+....+..+.+++.+||+.||++||++.++++.++.+...
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111111000 000000000        01112234577889999999999999999999999999999988543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=345.10  Aligned_cols=270  Identities=19%  Similarity=0.217  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-----------cHHHHHHHHHHHhccCCCceee
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-----------GHKEWMAEIIFLGQLRHPHLVK  144 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnI~~  144 (401)
                      .++|.+.+.||+|+||.||+|.+...   ..++..||+|++......           ....+.+|+.+++.++||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNK---PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSS---CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCC---CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            46899999999999999999988642   124678999998755322           1123567888999999999999


Q ss_pred             EEEEEEe----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          145 LIGYCWE----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       145 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      +++++..    ....|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHEN--EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEESS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCcCHHHEEEccC
Confidence            9999988    67899999999 99999998765  4899999999999999999999965  59999999999999887


Q ss_pred             C--cEEEEecCCCCCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccc
Q 040050          221 Y--TAKLSDFGLAKDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR  293 (401)
Q Consensus       221 ~--~vkL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  293 (401)
                      +  .+||+|||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999755322111     11134579999999999999999999999999999999999999996432111


Q ss_pred             cccHHHHhhhhh-cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          294 EQSLAEWARPLL-KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       294 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      . .......... ..+..+.....       ....+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus       268 ~-~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 V-AVQTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             H-HHHHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             H-HHHHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1 1111111111 11111111110       01235689999999999999999999999999988653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.8e-45  Score=346.93  Aligned_cols=248  Identities=29%  Similarity=0.405  Sum_probs=201.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .+|.+.+.||+|+||+||+|.+..      +++.||||++.....   .....+.+|+.+++.++||||+++++++..+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  127 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH  127 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             hheeeeeEEccCCCEEEEEEEEcc------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            568999999999999999998766      688999999975432   22356889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+. |+|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       128 ~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          128 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             eEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            9999999996 6888887543 367999999999999999999999654  99999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....      ....||+.|+|||++.   +..++.++|||||||++|+|++|..||......      ..........  
T Consensus       204 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~--  269 (348)
T 1u5q_A          204 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE--  269 (348)
T ss_dssp             SSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSC--
T ss_pred             cCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcC--
Confidence            5332      3457999999999985   567899999999999999999999999764211      1111111100  


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL  356 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L  356 (401)
                           .+.   ..+...+..+.+++.+||+.||.+|||+.++++..
T Consensus       270 -----~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          270 -----SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             -----CCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             -----CCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                 000   11223356789999999999999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-44  Score=333.44  Aligned_cols=252  Identities=26%  Similarity=0.312  Sum_probs=199.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|.+.+.||+|+||.||+|.+..      ++..||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERS------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             hhheeecceeccCCCeEEEEEEEcc------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            4789999999999999999998876      58899999987543 3345788899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE---cCCCcEEEEecC
Q 040050          155 RLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFG  229 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv---~~~~~vkL~DfG  229 (401)
                      .++||||+.+++|.+++...  ....+++..++.++.|++.||.|||+.  +|+||||||+||++   +.++.+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~--~ivH~dikp~NIl~~~~~~~~~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEESSSSTTCCEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC--CEEECCCCHHHEEEecCCCCCCEEEEeee
Confidence            99999999999999988643  346799999999999999999999954  59999999999999   456889999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++.......   ......||+.|+|||++. ..++.++||||||+++|+|++|..||.......      ........  
T Consensus       173 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~--  240 (285)
T 3is5_A          173 LAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYK--  240 (285)
T ss_dssp             CCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHC--
T ss_pred             cceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccC--
Confidence            998654332   224457999999999875 568999999999999999999999997643211      11000000  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                            ..... ......+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ------~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 ------EPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ------CCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ------Ccccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  00000 000113567889999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.3e-44  Score=338.41  Aligned_cols=254  Identities=21%  Similarity=0.299  Sum_probs=205.9

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++.+..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRL------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT   79 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             chhccceeeeeccCCCCceEEEEEECC------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence            355789999999999999999998876      58899999998654444567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE---cCCCcEEEEecCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGL  230 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv---~~~~~vkL~DfG~  230 (401)
                      ..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||++   +.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            999999999999999998765  6799999999999999999999965  59999999999999   7789999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +.......    .....||+.|+|||++.+..++.++||||||+++|+|++|..||......   .+.   ........ 
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~---~~i~~~~~-  224 (304)
T 2jam_A          156 SKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF---EKIKEGYY-  224 (304)
T ss_dssp             TCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH---HHHHHCCC-
T ss_pred             ceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHcCCC-
Confidence            97643321    23356999999999999999999999999999999999999999764211   111   11110000 


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             ..........+..+.+++.+||+.||.+||++.++++.
T Consensus       225 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          225 -------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             -------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                   01111223346789999999999999999999999874

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-44  Score=338.23  Aligned_cols=262  Identities=22%  Similarity=0.249  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++.....   .....+.+|+.+++.++||||+++++++..+
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTV------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID  106 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETT------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcC------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence            4789999999999999999998876      578999999875422   2246788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA--GATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             CeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--cCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            9999999999999999999765  6799999999999999999999965  49999999999999999999999999997


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||......   .+......   ....  
T Consensus       183 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~---~~~~--  253 (309)
T 2h34_A          183 ATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQ---AIPR--  253 (309)
T ss_dssp             ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHS---CCCC--
T ss_pred             ccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhcc---CCCC--
Confidence            6544321 1233457999999999999999999999999999999999999999764211   11111110   0000  


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhhcc
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-TMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~~il~~L~~l~~~~  363 (401)
                             ....+...+..+.+++.+||+.||.+|| +++++++.|+.+....
T Consensus       254 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 -------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             -------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             -------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence                   0012233456789999999999999999 9999999998875443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.2e-44  Score=335.06  Aligned_cols=265  Identities=20%  Similarity=0.259  Sum_probs=204.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEE-EEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGY-CWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~-~~~~~  153 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++......  ..+.+|+.+++.++|++++..+.. +....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcC------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence            45889999999999999999998766      5889999987644322  357789999999998776655554 46778


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE---cCCCcEEEEecCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGL  230 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv---~~~~~vkL~DfG~  230 (401)
                      ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||+   +.++.+||+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            889999999 99999998743 357999999999999999999999655  9999999999999   7889999999999


Q ss_pred             CCCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc-HHHHhhhh
Q 040050          231 AKDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-LAEWARPL  304 (401)
Q Consensus       231 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~  304 (401)
                      +.........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +.......
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence            9865443221     11234679999999999999999999999999999999999999997654322211 11111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ...+.  .     ..    ....+..+.+++.+||+.||.+|||+.++++.|+++..-
T Consensus       235 ~~~~~--~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          235 MSTPI--E-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHSCH--H-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccchh--h-----hh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            11110  0     00    011256899999999999999999999999999998543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=341.35  Aligned_cols=277  Identities=25%  Similarity=0.339  Sum_probs=214.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE--  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~--  153 (401)
                      ..+|++.+.||+|+||.||+|.+..  ....+++.||+|++..........+.+|+.+++.++||||+++++++....  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECT--TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHHceeeeeeccCCCeEEEEEEecc--ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            4679999999999999999998532  112268899999998766666678999999999999999999999987654  


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++..
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK--RYIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC--CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            689999999999999999764 35699999999999999999999964  599999999999999999999999999987


Q ss_pred             CCCCCccee-eeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC---cc
Q 040050          234 GPEGEETHV-ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE---PR  309 (401)
Q Consensus       234 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~  309 (401)
                      ......... .....++..|+|||++.+..++.++||||||+++|+|++|..||.....    .+..........   ..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~  270 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQMIVF  270 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchhhhHH
Confidence            654332211 2234577889999999998999999999999999999999998864310    000000000000   00


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      .+...+........+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            0111111111222344557789999999999999999999999999998864

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.3e-44  Score=334.32  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=200.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe---
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE---  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~---  151 (401)
                      ..|.+.+.||+|+||.||+|.+..      ++..||+|.+...  .......+.+|+.+++.++||||+++++++..   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecC------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            457888999999999999998876      5789999998643  23345678899999999999999999999875   


Q ss_pred             -CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc-CCCcEEEEecC
Q 040050          152 -EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD-SDYTAKLSDFG  229 (401)
Q Consensus       152 -~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~-~~~~vkL~DfG  229 (401)
                       ....++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+.+|+|+||||+||+++ .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence             35689999999999999999765  679999999999999999999996554599999999999997 78999999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++.......    .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......     ..........  
T Consensus       178 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~--  245 (290)
T 1t4h_A          178 LATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSG--  245 (290)
T ss_dssp             GGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTT--
T ss_pred             Ccccccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhcc--
Confidence            997544332    234579999999998764 5899999999999999999999999754211     1111111100  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                              .....++...+..+.+++.+||+.||.+|||+.++++.
T Consensus       246 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          246 --------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    00001112224679999999999999999999999853

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=333.19  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=184.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIH------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN   84 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred             ccceeeeeecCCCceEEEEEEEcc------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence            679999999999999999998865      57899999986331   223467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.+||+|||++..
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           85 YVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            999999999999999988653 35789999999999999999999965  499999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......                .+..
T Consensus       162 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------------~~~~  223 (278)
T 3cok_A          162 LKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN----------------TLNK  223 (278)
T ss_dssp             CC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------------
T ss_pred             ccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH----------------HHHH
Confidence            543221  1234568999999999999999999999999999999999999997643210                0011


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      +....  ...+...+..+.+++.+||+.||.+||++.++++
T Consensus       224 ~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          224 VVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Hhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            11111  1123344678999999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.8e-45  Score=343.96  Aligned_cols=265  Identities=20%  Similarity=0.272  Sum_probs=195.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..++|.+.+.||+|+||+||+|.+..      +++.||+|++.....  .....+.+|+.+++.++||||+++++++.++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTV------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETT------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECC------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            34789999999999999999998876      688999999975532  2245677899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE-----cCCCcEEEEe
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL-----DSDYTAKLSD  227 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv-----~~~~~vkL~D  227 (401)
                      ...++||||+. ++|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||+     +..+.+||+|
T Consensus       106 ~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~--~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSR--RCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CEECCCCCHHHEEEecCCCCccceEEECc
Confidence            99999999996 5999998765  5799999999999999999999965  49999999999999     4456699999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ||++.......  .......||+.|+|||++.+. .++.++|||||||++|+|++|..||......  ..+.........
T Consensus       181 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~  256 (329)
T 3gbz_A          181 FGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVLGL  256 (329)
T ss_dssp             TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCC
T ss_pred             CCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHhCC
Confidence            99997543221  123445789999999999874 5899999999999999999999999764321  111111111000


Q ss_pred             Cc-cchhhhc-CCcCCCC------------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          307 EP-RKLERLI-DPRLEGQ------------FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       307 ~~-~~~~~~~-~~~~~~~------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .+ ....... .+.+...            .+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00 0000000 0000000            01123578899999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-44  Score=359.00  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=204.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||+||+|.+..      +++.||+|++...  .......+.+|+.++++++||||+++++++.+.
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   93 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRI------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS   93 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETT------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECC------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence            45789999999999999999998876      6889999998532  233457789999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc---CCCcEEEEecC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD---SDYTAKLSDFG  229 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~---~~~~vkL~DfG  229 (401)
                      ...|+||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++   .++.+||+|||
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  169 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFG  169 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECC
Confidence            9999999999999999998765  67999999999999999999999654  99999999999995   45689999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++.......   ......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||......      +..........
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~  239 (486)
T 3mwu_A          170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKY  239 (486)
T ss_dssp             CTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC
T ss_pred             cCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC
Confidence            998654332   2345679999999999876 5899999999999999999999999764211      11111110000


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                              ..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       240 --------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          240 --------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             --------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             --------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00001112346789999999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.2e-45  Score=343.89  Aligned_cols=260  Identities=21%  Similarity=0.296  Sum_probs=207.4

Q ss_pred             HHHHHhcCCCCC-ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccC-CCceeeEE
Q 040050           71 ELRLITSNFSRS-NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLR-HPHLVKLI  146 (401)
Q Consensus        71 ~~~~~~~~y~~~-~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpnI~~~~  146 (401)
                      ....+.++|.+. +.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+.++..+. ||||++++
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKS------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            345667888887 899999999999998876      6889999998753  2334678889999999995 69999999


Q ss_pred             EEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcE
Q 040050          147 GYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTA  223 (401)
Q Consensus       147 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~v  223 (401)
                      +++......++||||+.+++|.+++.......+++..++.++.|++.||.|||+.  ||+||||||+||+++.   ++.+
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~--givH~Dikp~NIl~~~~~~~~~~  173 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDI  173 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEESCBTTBCCE
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC--CeecCcCChHHEEEecCCCCCcE
Confidence            9999999999999999999999998765567899999999999999999999965  5999999999999987   7899


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      ||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ........
T Consensus       174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~  248 (327)
T 3lm5_A          174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--TYLNISQV  248 (327)
T ss_dssp             EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT
T ss_pred             EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--HHHHHHhc
Confidence            999999998654332   2234579999999999999999999999999999999999999997643211  11110000


Q ss_pred             hhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          304 LLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                  ............+..+.+++.+||+.||.+|||+.++++.
T Consensus       249 ------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 ------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                        0011111222346789999999999999999999999754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.1e-44  Score=333.33  Aligned_cols=266  Identities=20%  Similarity=0.255  Sum_probs=208.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEE-EEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGY-CWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~-~~~~~  153 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++......  ..+.+|+.+++.++|++++..+.. .....
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcC------CCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            35789999999999999999998766      6889999998754332  468899999999998876555554 46677


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE---cCCCcEEEEecCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGL  230 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv---~~~~~vkL~DfG~  230 (401)
                      ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||++  +|+||||||+||++   +.++.+||+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  154 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK--NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC--CeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence            889999999 99999998643 35799999999999999999999965  49999999999999   4789999999999


Q ss_pred             CCCCCCCCcce-----eeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc-cHHHHhhhh
Q 040050          231 AKDGPEGEETH-----VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-SLAEWARPL  304 (401)
Q Consensus       231 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~  304 (401)
                      +..........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .+.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  234 (296)
T 3uzp_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK  234 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence            98654432211     123457999999999999999999999999999999999999999865432221 111111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                      ...+.  .     .    .....+..+.+++.+||+.||.+||++.++++.|+.+..-.
T Consensus       235 ~~~~~--~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          235 MSTPI--E-----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHSCH--H-----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCCch--H-----H----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            11110  0     0    01123567999999999999999999999999999985443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=343.75  Aligned_cols=259  Identities=18%  Similarity=0.189  Sum_probs=206.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC---CCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR---HPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnI~~~~~~~~~  151 (401)
                      ..++|.+.+.||+|+||+||+|++... ....+++.||+|++....   ...+..|+.+++.++   |+||+.+++++..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDL-NDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCC-cccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            457899999999999999999964321 122368899999997543   356677777777776   9999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---------
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRS---YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---------  219 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---------  219 (401)
                      .+..|+||||+++|+|.+++...   ....+++..++.++.||+.||+|||+  .+|+||||||+|||++.         
T Consensus       139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~--~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD--CEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT--TTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh--CCeecCCCCHHHEEecccccCccccc
Confidence            99999999999999999999753   24679999999999999999999995  45999999999999988         


Q ss_pred             --CCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccH
Q 040050          220 --DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL  297 (401)
Q Consensus       220 --~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  297 (401)
                        ++.+||+|||++...............+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence              89999999999975433333344566789999999999999999999999999999999999999986432110    


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhhh
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHR-PTMSYVVRVLDSLQD  361 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~~il~~L~~l~~  361 (401)
                                 ..+..    ... .++  ....+.+++..||+.+|.+| |++.++.+.|+.+..
T Consensus       293 -----------~~~~~----~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 -----------CKPEG----LFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             -----------EEECS----CCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -----------eeech----hcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                       00111    111 111  26678899999999999999 678888888887643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.3e-44  Score=355.81  Aligned_cols=263  Identities=22%  Similarity=0.276  Sum_probs=197.6

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|++.+.||+|+||+||+|++..      +++.||||++...  .......+.+|+.+++.++||||+++++++...
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECC------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            35789999999999999999998876      6889999999743  233456788999999999999999999999654


Q ss_pred             ------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 ------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 ------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                            ...|+||||+.+ +|.+.+.    ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus       134 ~~~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             CSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEEC
T ss_pred             CccccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEE
Confidence                  357999999954 6766663    35899999999999999999999654  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      |||+++......   .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.....  .+.........
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~  281 (464)
T 3ttj_A          207 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGT  281 (464)
T ss_dssp             CCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCS
T ss_pred             EEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence            999998654322   2345689999999999999999999999999999999999999997653211  11111110000


Q ss_pred             C-c----------------------cchhhhcCCcCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 E-P----------------------RKLERLIDPRLEGQ---FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~-~----------------------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      . +                      ..+...+.......   .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0 0                      00000010000000   011236789999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.6e-45  Score=346.51  Aligned_cols=272  Identities=18%  Similarity=0.224  Sum_probs=207.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCC--CCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceee---------
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLK--PGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK---------  144 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~---------  144 (401)
                      .++|.+.+.||+|+||.||+|.+.....  ....++.||+|++...     ..+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999998765210  0013689999998744     35788999999999999887         


Q ss_pred             ------EEEEEEe-CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE
Q 040050          145 ------LIGYCWE-EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL  217 (401)
Q Consensus       145 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv  217 (401)
                            +++++.. +...++||||+ +++|.+++.......+++..++.++.||+.||.|||+.  +|+||||||+||++
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN--EYVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCCHHHEEE
Confidence                  6777776 67899999999 99999999875457899999999999999999999965  59999999999999


Q ss_pred             cCCC--cEEEEecCCCCCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCc
Q 040050          218 DSDY--TAKLSDFGLAKDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTR  290 (401)
Q Consensus       218 ~~~~--~vkL~DfG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  290 (401)
                      +.++  .+||+|||++.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  9999999999765432211     11133579999999999999999999999999999999999999997653


Q ss_pred             ccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          291 LGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ... ..+..........+..+   .....   .....+..+.+++.+||+.||.+||++.++++.|+++..-
T Consensus       273 ~~~-~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          273 PNT-EDIMKQKQKFVDKPGPF---VGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TCH-HHHHHHHHHHHHSCCCE---ECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCH-HHHHHHHHhccCChhhh---hhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            221 11122111111111111   10000   0112357899999999999999999999999999998543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.3e-44  Score=360.08  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=208.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|.+.+.||+|+||.||+|++..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+..
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKA------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            679999999999999999998876      6889999998643   1234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY--SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      .+|+||||++||+|.+++....  ...+++..++.++.||+.||.|||+++  |+||||||+|||++.+|.+||+|||++
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeeccee
Confidence            9999999999999999987643  457999999999999999999999654  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ........  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......  ............    
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~----  408 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQ----  408 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHC----
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhc----
Confidence            87544322  1234589999999999999999999999999999999999999997643211  111111111111    


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM-----SYVVR  354 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~~il~  354 (401)
                              ...++...+..+.+++.+||+.||.+||++     .++++
T Consensus       409 --------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 --------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                    112344457789999999999999999975     66654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-44  Score=335.96  Aligned_cols=252  Identities=26%  Similarity=0.375  Sum_probs=208.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ...|.+.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNR------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECC------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            3679999999999999999998776      58899999997553 3446788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++..   ..+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.+||+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCChheEEECCCCCEEEeecccceec
Confidence            9999999999999998864   5799999999999999999999965  4999999999999999999999999999765


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....  ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......   ....   ...        
T Consensus       170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~---~~~--------  233 (303)
T 3a7i_A          170 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFL---IPK--------  233 (303)
T ss_dssp             BTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH---HHH--------
T ss_pred             Ccccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHH---hhc--------
Confidence            43321  1234579999999999999999999999999999999999999997542110   1100   000        


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                         ......+...+..+.+++.+||+.||.+|||+.++++...
T Consensus       234 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          234 ---NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             ---SCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             ---CCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence               0011122234567999999999999999999999987643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2e-44  Score=333.56  Aligned_cols=247  Identities=19%  Similarity=0.265  Sum_probs=201.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      ..++|.+.+.||+|+||+||+|.+..      +++.||+|++....  ......+.+|+..+..+ +||||+++++++.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRL------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcC------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            34789999999999999999998876      58899999987542  33456788899999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC---------
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSY--SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD---------  220 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~---------  220 (401)
                      .+..++||||+++++|.+++....  ...+++..++.++.||+.||.|||+.  +|+||||||+||+++.+         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM--SLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC-----------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC--CEeecCCCHHHEEEcCCCCCcccccc
Confidence            999999999999999999997642  26789999999999999999999965  49999999999999844         


Q ss_pred             ----------CcEEEEecCCCCCCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCC
Q 040050          221 ----------YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNT  289 (401)
Q Consensus       221 ----------~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~  289 (401)
                                ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++...
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                      479999999998654422      23599999999999865 6678999999999999999999876543


Q ss_pred             cccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          290 RLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .     .....              .. ......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       235 ~-----~~~~~--------------~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          235 D-----QWHEI--------------RQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             H-----HHHHH--------------HT-TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             h-----HHHHH--------------Hc-CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1     11110              00 11112333446789999999999999999999999753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-45  Score=349.59  Aligned_cols=261  Identities=28%  Similarity=0.402  Sum_probs=197.3

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE-EEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~-~~~~  155 (401)
                      .|.+.+.||+|+||.||+|.+...   ......||+|.+.... ......+.+|+.++++++||||+++++++.. ++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEET---TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECC---CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            477789999999999999987542   1124578999986433 3445778999999999999999999998754 4578


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++....
T Consensus       167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC--CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999999653 35688999999999999999999965  49999999999999999999999999998654


Q ss_pred             CCCcc--eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          236 EGEET--HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       236 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.......   ......          
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~~----------  310 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL----------  310 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHHH----------
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHHH----------
Confidence            32211  11233567889999999999999999999999999999999 677776543211   111110          


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                          .......+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       311 ----~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          311 ----QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             ----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                001111233446789999999999999999999999999999854

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.5e-45  Score=366.12  Aligned_cols=261  Identities=27%  Similarity=0.397  Sum_probs=211.8

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      +..++|.+.+.||+|+||.||+|.+..       +..||||++.... .....+.+|+.+|++++||||+++++++.+ .
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            345678899999999999999998765       4679999997543 345679999999999999999999999876 6


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..+|||||+.+|+|.+++.......+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++..
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            789999999999999999765456799999999999999999999965  499999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......   .+..   .+        
T Consensus       413 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~~~---~i--------  477 (535)
T 2h8h_A          413 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---QV--------  477 (535)
T ss_dssp             CCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HHHH---HH--------
T ss_pred             cCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HH--------
Confidence            543211 11123456789999999999999999999999999999999 89999764211   1111   11        


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                         ........+..++..+.+||.+||+.||++|||+.+|++.|+.+....
T Consensus       478 ---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          478 ---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ---HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ---HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence               111111233445678999999999999999999999999999875433

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.5e-44  Score=333.09  Aligned_cols=248  Identities=25%  Similarity=0.367  Sum_probs=206.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+..      ++..||+|++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   86 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQ------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR   86 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhceeeheecCCCCeEEEEEEEcC------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC
Confidence            3689999999999999999998876      57899999986431   22346788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.+||+|||++.
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCHHHEEEcCCCCEEEecccccc
Confidence            9999999999999999999765  5799999999999999999999954  59999999999999999999999999987


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ......    .....|++.|+|||++.+..++.++||||||+++|+|++|..||......      .......       
T Consensus       163 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~-------  225 (284)
T 2vgo_A          163 HAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIV-------  225 (284)
T ss_dssp             ECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH-------
T ss_pred             cCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHh-------
Confidence            544322    23457999999999999999999999999999999999999999754211      1111111       


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ..  ...++...+..+.+++.+||+.||.+||++.++++.
T Consensus       226 ---~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          226 ---NV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ---TT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ---cc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence               10  112333456789999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.7e-45  Score=361.08  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=206.9

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.++++++||||+++++++.+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKI------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECC------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            45789999999999999999998876      68899999986442   3456788999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE---cCCCcEEEEec
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDF  228 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv---~~~~~vkL~Df  228 (401)
                      ....++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            99999999999999999998764  67999999999999999999999654  9999999999999   56789999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |++.......   ......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||......      +.........
T Consensus       174 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~  243 (484)
T 3nyv_A          174 GLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEKGK  243 (484)
T ss_dssp             THHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC
T ss_pred             eeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCC
Confidence            9997654332   1234579999999999876 6899999999999999999999999764321      1111111000


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .        ..........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       244 ~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          244 Y--------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             C--------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C--------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            0        00001112346789999999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.1e-44  Score=358.29  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=201.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||+||+|.+..      ++..||+|++....  ......+.+|+.+++.++||||+++++++.+.
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  108 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKV------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK  108 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETT------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECC------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence            45679999999999999999999876      68899999987542  33356788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEEecC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFG  229 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~DfG  229 (401)
                      ...|+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.   ++.+||+|||
T Consensus       109 ~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          109 RNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH--NIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            9999999999999999998765  6799999999999999999999965  4999999999999976   4559999999


Q ss_pred             CCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ++.......   ......||+.|+|||++. ..|+.++|||||||++|+|++|.+||......      +..........
T Consensus       185 ~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~  254 (494)
T 3lij_A          185 LSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKY  254 (494)
T ss_dssp             TCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC
T ss_pred             CCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC
Confidence            998654432   234567999999999876 56899999999999999999999999764321      11111110000


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .    ....    .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       255 ~----~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 T----FDSP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             C----CCSG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             C----CCch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            0    0000    011246789999999999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-44  Score=347.05  Aligned_cols=267  Identities=22%  Similarity=0.322  Sum_probs=206.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.+++.++||||+++++++..+..
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKP------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccceeeeeecCCCCeEEEEEEECC------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            4689999999999999999999876      68899999997653 3335678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++...
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  182 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  182 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHh-CCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999999765  6799999999999999999999952 14999999999999999999999999998643


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH--hh----------
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW--AR----------  302 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~----------  302 (401)
                      ..    .......||+.|+|||++.+..++.++|||||||++|+|++|..||..............  ..          
T Consensus       183 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          183 ID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             cc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            21    112345799999999999999999999999999999999999999976432110000000  00          


Q ss_pred             ----------hhhcCcc----chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          303 ----------PLLKEPR----KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       303 ----------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                .....+.    .+..+.............+..+.+|+.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                      0000000    0000111111111112246689999999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-43  Score=328.25  Aligned_cols=259  Identities=22%  Similarity=0.312  Sum_probs=206.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------ccHHHHHHHHHHHhccCCCceeeEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------QGHKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      +.++|++.+.||+|+||.||+|.+..      +++.||+|++.....      .....+.+|+.+++.++||||++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKG------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcC------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            45689999999999999999999876      588999999865421      235778999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC----cEE
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----TAK  224 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~----~vk  224 (401)
                      +......++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++    .+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSSSSCCEE
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CccCCCCChHHEEEecCCCCCCceE
Confidence            99999999999999999999999765  6799999999999999999999965  599999999999998877    899


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||++.......   ......|++.|+|||++.+..++.++||||||+++|+|++|..||......      ......
T Consensus       153 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~  223 (283)
T 3bhy_A          153 LIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNI  223 (283)
T ss_dssp             ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH
T ss_pred             EEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHh
Confidence            99999998654332   223456999999999999999999999999999999999999999764211      111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhhh
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR--VLDSLQ  360 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~--~L~~l~  360 (401)
                      ......        .........+..+.+++.+||+.||.+||++.++++  .+..+.
T Consensus       224 ~~~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          224 SAVNYD--------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HTTCCC--------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             HhcccC--------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            000000        000001123567899999999999999999999997  355543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-44  Score=370.54  Aligned_cols=250  Identities=26%  Similarity=0.359  Sum_probs=208.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhcc-CCCceeeEEEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCW  150 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~  150 (401)
                      ..++|.+.+.||+|+||.||+|.+..      +++.||||++...   .......+..|..++..+ +||+|+.+++++.
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~  412 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKG------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ  412 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESS------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred             cccceEEEEEEccCCCEEEEEEEECC------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence            34689999999999999999999876      6889999998642   223456778899999988 6999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      +.+.+||||||+.||+|..++...  ..+++..++.++.||+.||.|||+.  +||||||||+||||+.+|.+||+|||+
T Consensus       413 ~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--gIiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          413 TMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--SEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             eCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeEeccCChhhEEEcCCCcEEEeecce
Confidence            999999999999999999999875  6799999999999999999999965  499999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      +........  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.....      .+....       
T Consensus       489 a~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~-------  553 (674)
T 3pfq_A          489 CKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQS-------  553 (674)
T ss_dssp             CEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-------
T ss_pred             eeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHH-------
Confidence            985433222  23457899999999999999999999999999999999999999976421      111111       


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM-----SYVVR  354 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~~il~  354 (401)
                         +....  ..+|...+.++.+||.+||+.||.+||++     ++|++
T Consensus       554 ---i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          554 ---IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---HHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---HHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence               11111  12444567889999999999999999997     66664

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.2e-44  Score=336.17  Aligned_cols=263  Identities=26%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|++.+.||+|+||+||+|.+....   .....||+|++...   .......+.+|+.+++.++||||+++++++...
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPS---GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTT---SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCC---CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            368999999999999999999865421   12346999998754   233456788999999999999999999999876


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      . .++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC--CcccCCCchheEEEcCCCCEEEccccccc
Confidence            5 78999999999999999764 35689999999999999999999965  59999999999999999999999999998


Q ss_pred             CCCCCCcce-eeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          233 DGPEGEETH-VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       233 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||......      .......     
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~-----  238 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKID-----  238 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHH-----
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHH-----
Confidence            765433221 2233567889999999999889999999999999999999 99999764211      1111111     


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                           ........+...+..+.+++.+||+.||.+||++.++++.|.+++.
T Consensus       239 -----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          239 -----KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -----TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -----ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                 1111112233456789999999999999999999999999998864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5e-44  Score=357.58  Aligned_cols=251  Identities=24%  Similarity=0.326  Sum_probs=203.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-------------ccHHHHHHHHHHHhccCCCc
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-------------QGHKEWMAEIIFLGQLRHPH  141 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpn  141 (401)
                      +.++|.+.+.||+|+||+||+|.+..      +++.||+|++.....             .....+.+|+.+++.++|||
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn  107 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKN------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPN  107 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETT------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTT
T ss_pred             cccceEEEeEecccCCeEEEEEEECC------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCC
Confidence            56889999999999999999999876      688999999875321             23567889999999999999


Q ss_pred             eeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          142 LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       142 I~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                      |+++++++.+....|+||||+.+|+|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.++
T Consensus       108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH--NIVHRDIKPENILLENKN  183 (504)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESSTT
T ss_pred             CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeEeCCCcHHHEEEecCC
Confidence            999999999999999999999999999999765  6799999999999999999999965  499999999999998775


Q ss_pred             ---cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          222 ---TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       222 ---~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                         .+||+|||++.......   ......||+.|+|||++. +.|+.++|||||||++|+|++|..||......      
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------  253 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------  253 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred             CCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence               69999999998664432   234467999999999886 46899999999999999999999999764321      


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQF--PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .........          ......  ...++..+.+|+.+||+.||.+|||+.++++.
T Consensus       254 ~~~~~i~~~----------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          254 DIIKKVEKG----------KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHHHHC----------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHcC----------CCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            111111100          000000  01235789999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.4e-44  Score=350.53  Aligned_cols=252  Identities=26%  Similarity=0.350  Sum_probs=193.7

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--------cccHHHHHHHHHHHhccCCCceeeE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--------TQGHKEWMAEIIFLGQLRHPHLVKL  145 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnI~~~  145 (401)
                      .+.++|.+.+.||+|+||+||+|.+..      +++.||+|++....        ......+.+|+.+|++++||||+++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  205 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERK------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI  205 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCC
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECC------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeE
Confidence            456899999999999999999999877      68899999986421        1112347789999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC---Cc
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD---YT  222 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~---~~  222 (401)
                      ++++. ....++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.+   +.
T Consensus       206 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~--~ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          206 KNFFD-AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             CEEEE-SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSSSCC
T ss_pred             EEEEe-cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEecCCCcce
Confidence            99975 45579999999999999988654  6899999999999999999999965  49999999999999654   45


Q ss_pred             EEEEecCCCCCCCCCCcceeeecccccccccccccccc---CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          223 AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       223 vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      +||+|||++.......   ......||+.|+|||++.+   ..|+.++|||||||++|+|++|..||......  ..+..
T Consensus       281 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~  355 (419)
T 3i6u_A          281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKD  355 (419)
T ss_dssp             EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHH
T ss_pred             EEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHH
Confidence            9999999998764322   2345679999999999863   67889999999999999999999999754221  11111


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCC---HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFP---IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ....              ......+   ...+..+.+|+.+||+.||.+||++.++++.
T Consensus       356 ~i~~--------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          356 QITS--------------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHHT--------------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhc--------------CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1110              0000001   1235789999999999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.5e-44  Score=333.80  Aligned_cols=250  Identities=27%  Similarity=0.355  Sum_probs=207.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            3789999999999999999998876      57899999986432   23356688899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChHhEEEcCCCCEEEEeccCce
Confidence            9999999999999999988765  6799999999999999999999965  59999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||......      +.......      
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~------  229 (294)
T 2rku_A          164 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKK------  229 (294)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT------
T ss_pred             ecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhh------
Confidence            6543222  123457999999999999999999999999999999999999999764321      11111100      


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          .  ....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       230 ----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          230 ----N--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----c--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                0  011233345688999999999999999999999874

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.3e-45  Score=336.54  Aligned_cols=259  Identities=21%  Similarity=0.301  Sum_probs=205.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|.+....  ......+.+|+.+++.++||||+++++++..  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKS------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECC------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            3689999999999999999998876      58899999997543  2345678899999999999999999998854  


Q ss_pred             CCeEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCC---CCeeeccCCCCcEEEcCCCcEEEE
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGED---KPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~---~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      ....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+   .+|+||||||+||+++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            56899999999999999999753  2345999999999999999999999543   239999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      |||++........  ......|++.|+|||++.+..++.++||||||+++|+|++|..||......   .+..   ....
T Consensus       159 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~i~~  230 (279)
T 2w5a_A          159 DFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG---KIRE  230 (279)
T ss_dssp             CCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH
T ss_pred             cCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHH---HHhh
Confidence            9999876543221  123356899999999999999999999999999999999999999764211   1111   1100


Q ss_pred             CccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                                 ......+...+..+.+++.+||+.||.+||++.++++.+...
T Consensus       231 -----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          231 -----------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             -----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             -----------cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence                       001122334567899999999999999999999998765443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.7e-44  Score=351.25  Aligned_cols=202  Identities=23%  Similarity=0.318  Sum_probs=175.6

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc------CCCceeeEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL------RHPHLVKLIG  147 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnI~~~~~  147 (401)
                      .+..+|++.+.||+|+||+||+|.+..      +++.||||++... ......+.+|+.+++.+      .|+||+++++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~------~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHK------VHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECC------CCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            345789999999999999999998876      6889999999743 23345667788887776      5789999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc--EEE
Q 040050          148 YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT--AKL  225 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~--vkL  225 (401)
                      ++......++||||+ +++|.+++.......+++..++.++.||+.||+|||+.  +|+||||||+|||++.++.  +||
T Consensus       167 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--~ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          167 NFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN--RIIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH--TEECSCCSGGGEEESSTTSCCEEE
T ss_pred             ecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEccCCCcceEE
Confidence            999999999999999 57999999876666799999999999999999999965  5999999999999999887  999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCc
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTR  290 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  290 (401)
                      +|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus       244 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          244 IDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999764332     234579999999999999999999999999999999999999997653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-44  Score=342.24  Aligned_cols=255  Identities=26%  Similarity=0.374  Sum_probs=199.2

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe-
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE-  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~-  151 (401)
                      ...++|++.+.||+|+||.||+|.+..      +++.||+|++.... .....+.+|+.+++++ +||||+++++++.. 
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVK------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECC------CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            346889999999999999999999876      57899999987543 3346788999999999 79999999999987 


Q ss_pred             -----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          152 -----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       152 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                           ....++||||+.+++|.+++.......+++..++.++.||+.||.|||+.  +|+|+||||+||+++.++.+||+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH--KVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCcHHHEEEcCCCCEEEe
Confidence                 46889999999999999999876556899999999999999999999965  49999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      |||++.......  .......|++.|+|||++.     +..++.++|||||||++|+|++|..||.......  ....  
T Consensus       172 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~--  245 (326)
T 2x7f_A          172 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--ALFL--  245 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH--
T ss_pred             eCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHH--
Confidence            999998654321  1123457999999999987     5678999999999999999999999996542110  0000  


Q ss_pred             hhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        ....+       .+.   ..+...+..+.+++.+||..||.+||++.++++.
T Consensus       246 --~~~~~-------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 --IPRNP-------APR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             --HHHSC-------CCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --hhcCc-------ccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              10000       000   1112235689999999999999999999999873

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=333.20  Aligned_cols=254  Identities=22%  Similarity=0.299  Sum_probs=202.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----cccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----TQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++....    ......+.+|+.+++.++||||+++++++.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSE------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTT------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEECC------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            35789999999999999999998766      67899999986431    233567889999999999999999999985


Q ss_pred             --eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          151 --EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       151 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                        +....++||||+.++ |.+++.......+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~--~i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           77 NEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             CC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC--CeeecCCCcccEEEcCCCcEEeecc
Confidence              445789999999765 77887765567899999999999999999999965  4999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCC--CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      |++................||+.|+|||++.+..  ++.++||||||+++|+|++|..||.....      .........
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~  227 (305)
T 2wtk_C          154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGK  227 (305)
T ss_dssp             TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHH
T ss_pred             ccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhc
Confidence            9998665433333345567999999999998644  37899999999999999999999976421      111111110


Q ss_pred             CccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .          .  ..++...+..+.+++.+||+.||.+|||+.++++.
T Consensus       228 ~----------~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          228 G----------S--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             C----------C--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C----------C--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0          0  11223346788999999999999999999999975

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-43  Score=336.92  Aligned_cols=272  Identities=25%  Similarity=0.367  Sum_probs=211.9

Q ss_pred             cccHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhc--cCCCcee
Q 040050           66 VFTLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ--LRHPHLV  143 (401)
Q Consensus        66 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnI~  143 (401)
                      ...+.....+.++|.+.+.||+|+||.||+|.+.        ++.||+|++..   .....+.+|.+++..  ++||||+
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~   99 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENIL   99 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--------TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBC
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc--------CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEE
Confidence            3445555677889999999999999999999763        67899999863   234567788888877  7899999


Q ss_pred             eEEEEEEeCC----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCCC
Q 040050          144 KLIGYCWEEE----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE------DKPVIYRDFKAS  213 (401)
Q Consensus       144 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~iiH~Dlkp~  213 (401)
                      ++++++....    ..++||||+.+++|.+++.+   ..+++..++.++.|++.||.|||..      ..+|+||||||+
T Consensus       100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~  176 (342)
T 1b6c_B          100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK  176 (342)
T ss_dssp             CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGG
T ss_pred             EEEeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHH
Confidence            9999998876    78999999999999999965   4789999999999999999999932      344999999999


Q ss_pred             cEEEcCCCcEEEEecCCCCCCCCCCcce--eeeccccccccccccccccC------CCCccccHHhHHHHHHHHHhC---
Q 040050          214 NILLDSDYTAKLSDFGLAKDGPEGEETH--VITRVMGTQGYAAPEYVMTG------HLTTMSDVYSFGVVLLELLTG---  282 (401)
Q Consensus       214 NIlv~~~~~vkL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g---  282 (401)
                      ||+++.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|+|++|   
T Consensus       177 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~  256 (342)
T 1b6c_B          177 NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI  256 (342)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             HEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCc
Confidence            9999999999999999997654332211  12345799999999999865      334789999999999999999   


Q ss_pred             -------CCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHH
Q 040050          283 -------KRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMS  350 (401)
Q Consensus       283 -------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~  350 (401)
                             ..||....... .....+....          .........     ....+..+.+++.+||+.||.+|||+.
T Consensus       257 ~~~~~~~~~p~~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  325 (342)
T 1b6c_B          257 GGIHEDYQLPYYDLVPSD-PSVEEMRKVV----------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  325 (342)
T ss_dssp             TTBCCCCCCTTTTTSCSS-CCHHHHHHHH----------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCcccccccCccccCcCc-ccHHHHHHHH----------HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence                   66775432211 1111111111          111111122     235678899999999999999999999


Q ss_pred             HHHHHHHhhhhc
Q 040050          351 YVVRVLDSLQDF  362 (401)
Q Consensus       351 ~il~~L~~l~~~  362 (401)
                      ++++.|+.+..-
T Consensus       326 ~i~~~L~~i~~~  337 (342)
T 1b6c_B          326 RIKKTLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHH
Confidence            999999998653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=363.89  Aligned_cols=259  Identities=26%  Similarity=0.361  Sum_probs=204.5

Q ss_pred             CCCCCc-eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           78 NFSRSN-LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~-~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++.+.+ .||+|+||.||+|.+...    ..+..||||+++... ......+.+|+.+|+.++||||+++++++.. +..
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECS----SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecC----CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            344444 799999999999987642    135789999997643 3456789999999999999999999999976 568


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...
T Consensus       411 ~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK--NFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            9999999999999998653 45799999999999999999999965  59999999999999999999999999998764


Q ss_pred             CCCcce-eeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          236 EGEETH-VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       236 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ...... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......   .+...             
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~-------------  551 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF-------------  551 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHH-------------
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH-------------
Confidence            332211 1122346789999999999999999999999999999998 99999764321   11111             


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                       +........+..++..+.+++.+||+.||.+||++.+|++.|+.+-.
T Consensus       552 -i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  598 (613)
T 2ozo_A          552 -IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  598 (613)
T ss_dssp             -HHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             11111223344567889999999999999999999999999998743

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-44  Score=341.90  Aligned_cols=265  Identities=26%  Similarity=0.353  Sum_probs=200.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--cHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++......  ....+.+|+.+++.++||||+++++++.+...
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKD------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETT------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhheeeeEEeecCCEEEEEEEECC------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            689999999999999999999876      6889999998654322  24557789999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSH--NIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC--CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            99999999988887776543  6799999999999999999999965  4999999999999999999999999999765


Q ss_pred             CCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc-------
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK-------  306 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------  306 (401)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......  .+.........       
T Consensus       175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHH
T ss_pred             cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhh
Confidence            43221  23445799999999999875 78999999999999999999999997653211  11111100000       


Q ss_pred             ---CccchhhhcCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 ---EPRKLERLIDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ---~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         ..........+......     ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence               00000000111111111     12346789999999999999999999999864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=344.32  Aligned_cols=262  Identities=22%  Similarity=0.296  Sum_probs=198.4

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++....  ......+.+|+.+++.++||||+++++++...
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETT------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECC------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            35789999999999999999998876      68899999986432  23346788999999999999999999999865


Q ss_pred             C------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 E------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 ~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      .      .+|+||||+ +++|.+++..   ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEE
Confidence            3      469999999 8899998865   57999999999999999999999655  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....  .+........
T Consensus       171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g  243 (367)
T 1cm8_A          171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTG  243 (367)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHC
T ss_pred             eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcC
Confidence            99999865432     244679999999999987 789999999999999999999999997653211  1111111100


Q ss_pred             cCccchh---------hh---cCC---cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLE---------RL---IDP---RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~---------~~---~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..+....         ..   +..   ..........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000000         00   000   00011122346789999999999999999999999874

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=342.24  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=196.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCccc-HHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|.+.+.||+|+||+||+|.+..      +++.||+|++....... ...+.+|+.+++.++||||+++++++......
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            579999999999999999998876      57899999987543221 12345799999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+. ++|.+++... ...+++..++.++.|++.||.|||+.  ||+||||||+||+++.++.+||+|||++....
T Consensus        76 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ--KVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT--TEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            99999996 6998888754 35799999999999999999999965  49999999999999999999999999997544


Q ss_pred             CCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc--cchh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP--RKLE  312 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~  312 (401)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......   ...........+  ..+.
T Consensus       152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~  226 (324)
T 3mtl_A          152 IPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWP  226 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTST
T ss_pred             CCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhch
Confidence            322  22344578999999999886 678999999999999999999999997653221   111111111110  0000


Q ss_pred             hhc---------CCcCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLI---------DPRLEGQ----FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~---------~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...         .+.....    .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            000         0000000    011235678999999999999999999999873

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.5e-44  Score=347.49  Aligned_cols=266  Identities=22%  Similarity=0.269  Sum_probs=206.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC--------CCceeeEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR--------HPHLVKLI  146 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnI~~~~  146 (401)
                      +.++|.+.+.||+|+||+||+|++..      +++.||+|++... ......+.+|+.+++.++        |+||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQ------GKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecC------CCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            45889999999999999999998876      6889999999743 334567888999999985        78899999


Q ss_pred             EEEE----eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-
Q 040050          147 GYCW----EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-  221 (401)
Q Consensus       147 ~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-  221 (401)
                      +++.    .....|+||||+ +++|.+++.......+++..++.++.||+.||.|||++ .||+||||||+|||++.++ 
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECCCCSGGGEEECCCHH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHeeEeccch
Confidence            9987    456889999999 77888888776557899999999999999999999964 1599999999999998775 


Q ss_pred             ------------------------------------------------cEEEEecCCCCCCCCCCcceeeeccccccccc
Q 040050          222 ------------------------------------------------TAKLSDFGLAKDGPEGEETHVITRVMGTQGYA  253 (401)
Q Consensus       222 ------------------------------------------------~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~  253 (401)
                                                                      .+||+|||++......     .....||+.|+
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~  260 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYR  260 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGC
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCccc
Confidence                                                            7999999999865432     23457999999


Q ss_pred             cccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc---HHHHhhhhhcC-cc-----------------chh
Q 040050          254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS---LAEWARPLLKE-PR-----------------KLE  312 (401)
Q Consensus       254 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~~~~~~~-~~-----------------~~~  312 (401)
                      |||++.+..++.++|||||||++|+|++|..||..........   ........... +.                 .+.
T Consensus       261 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  340 (397)
T 1wak_A          261 SLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLK  340 (397)
T ss_dssp             CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBS
T ss_pred             CChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccc
Confidence            9999999999999999999999999999999997654322110   01111111000 00                 000


Q ss_pred             hhcCCc---------CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          313 RLIDPR---------LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       313 ~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .+....         .....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000         011345677889999999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.3e-44  Score=340.53  Aligned_cols=250  Identities=27%  Similarity=0.362  Sum_probs=207.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            3789999999999999999998876      5789999998643   223456788899999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +..++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            9999999999999999988765  6799999999999999999999965  59999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||......      +........     
T Consensus       190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~-----  256 (335)
T 2owb_A          190 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKN-----  256 (335)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT-----
T ss_pred             ecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcC-----
Confidence            6543222  123457999999999999999999999999999999999999999764211      111111000     


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             ...++...+..+.+++.+||+.||.+||++.++++.
T Consensus       257 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 -------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   011223345678999999999999999999999874

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=330.44  Aligned_cols=254  Identities=23%  Similarity=0.348  Sum_probs=201.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      .+|.....||+|+||.||+|.+..      +++.||+|.+..........+.+|+.+++.++||||+++++++......+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLS------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETT------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECC------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            345555699999999999998876      57899999998766556678899999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEEEEecCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDG  234 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vkL~DfG~a~~~  234 (401)
                      +||||+++++|.+++.... ...+++..++.++.|++.||.|||+.  +|+|+||||+||+++. ++.+||+|||++...
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~  173 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL  173 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC--CEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence            9999999999999997642 23567889999999999999999965  5999999999999987 899999999999765


Q ss_pred             CCCCcceeeeccccccccccccccccCC--CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .....  ......|++.|+|||++.+..  ++.++||||||+++|+|++|..||......... ...  ...        
T Consensus       174 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~--~~~--------  240 (295)
T 2clq_A          174 AGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK--VGM--------  240 (295)
T ss_dssp             CC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH--HHH--------
T ss_pred             CCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh--hcc--------
Confidence            43221  123457999999999997643  889999999999999999999999653211100 000  000        


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          .......+...+..+.+++.+||+.||++||++.++++.
T Consensus       241 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 ----FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ----HCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ----ccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                011122334456789999999999999999999999753

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=335.74  Aligned_cols=274  Identities=24%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHH--HhccCCCceeeEEEEEEe--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIF--LGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnI~~~~~~~~~--  151 (401)
                      .++|.+.+.||+|+||.||+|.+.        ++.||+|++...   ....+..|.++  +..++||||+++++.+..  
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD--------ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET--------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             hHHhheeeecccCCCeEEEEEEEC--------CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            378999999999999999999653        678999998643   23344445554  455899999999986543  


Q ss_pred             ---CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC-------CCCeeeccCCCCcEEEcCCC
Q 040050          152 ---EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE-------DKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       152 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-------~~~iiH~Dlkp~NIlv~~~~  221 (401)
                         ...+++||||+++|+|.+++...   ..++..++.++.||+.||.|||+.       ..+|+||||||+|||++.++
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence               23678999999999999999653   558999999999999999999965       11699999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCc------ceeeecccccccccccccccc-------CCCCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          222 TAKLSDFGLAKDGPEGEE------THVITRVMGTQGYAAPEYVMT-------GHLTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                      .+||+|||++........      ........||+.|+|||++.+       ..++.++|||||||++|+|++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999999999976543211      122234579999999999987       4567889999999999999999777644


Q ss_pred             Cccccc-c-cHHHHhhhhhcCccchhhh-cCCcCCCC------CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          289 TRLGRE-Q-SLAEWARPLLKEPRKLERL-IDPRLEGQ------FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       289 ~~~~~~-~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ...... . .+...... ......+... ........      .....+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          238 GESVPEYQMAFQTEVGN-HPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             TSCCCCCCCTTHHHHCS-SCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchhHHHHhhhcccCC-CchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            322111 0 00000000 0000000000 01111111      1234677899999999999999999999999999999


Q ss_pred             hhccc
Q 040050          360 QDFQD  364 (401)
Q Consensus       360 ~~~~~  364 (401)
                      ...-.
T Consensus       317 l~~~~  321 (336)
T 3g2f_A          317 MMIWE  321 (336)
T ss_dssp             HHCCC
T ss_pred             HHHHH
Confidence            65544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-43  Score=342.56  Aligned_cols=271  Identities=24%  Similarity=0.322  Sum_probs=201.7

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe-
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE-  151 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~-  151 (401)
                      ....++|.+.+.||+|+||+||+|.+..      +++.||+|++..+...    ..+|+.+++.++||||+++++++.. 
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~------~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE------SGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETT------TCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECC------CCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeec
Confidence            3456789999999999999999998876      6889999998654322    2369999999999999999999844 


Q ss_pred             -------------------------------------CCeEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHH
Q 040050          152 -------------------------------------EEYRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAA  192 (401)
Q Consensus       152 -------------------------------------~~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~  192 (401)
                                                           ....++||||++ ++|.+.+..  .....+++..++.++.||+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                 335889999996 588877754  3357899999999999999


Q ss_pred             HHHHHHhCCCCCeeeccCCCCcEEEc-CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccC-CCCccccHH
Q 040050          193 KGLAFLHGEDKPVIYRDFKASNILLD-SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVY  270 (401)
Q Consensus       193 ~al~~LH~~~~~iiH~Dlkp~NIlv~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw  270 (401)
                      .||.|||+  .||+||||||+||+++ .++.+||+|||++........   .....||+.|+|||++.+. .++.++|||
T Consensus       152 ~aL~~LH~--~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          152 RAVGFIHS--LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHHT--TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHHH--CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            99999995  4599999999999997 689999999999986544332   2345789999999998875 589999999


Q ss_pred             hHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc-chh------------hhcCCcCCCCCCHHHHHHHHHHHHH
Q 040050          271 SFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR-KLE------------RLIDPRLEGQFPIKGAQKAAATAFK  337 (401)
Q Consensus       271 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~~~~~~~~~l~~li~~  337 (401)
                      ||||++|+|++|+.||......  ..+............ .+.            ......+...++...+..+.+|+.+
T Consensus       227 slG~il~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  304 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ  304 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence            9999999999999999764321  111111111100000 000            0000011111233456789999999


Q ss_pred             hcccCCCCCCCHHHHHHH--HHhhhh
Q 040050          338 CLSHHPRHRPTMSYVVRV--LDSLQD  361 (401)
Q Consensus       338 cl~~dP~~RPt~~~il~~--L~~l~~  361 (401)
                      ||+.||.+|||+.+++++  +..+..
T Consensus       305 ~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          305 ILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             HccCChhhCCCHHHHhcCHHHHHHHh
Confidence            999999999999999864  444433

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.7e-44  Score=341.54  Aligned_cols=257  Identities=24%  Similarity=0.376  Sum_probs=206.6

Q ss_pred             HHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--------cHHHHHHHHHHHhcc-CCC
Q 040050           70 AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--------GHKEWMAEIIFLGQL-RHP  140 (401)
Q Consensus        70 ~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~hp  140 (401)
                      .....+.++|.+.+.||+|+||.||+|.+..      +++.||||++......        ....+.+|+.+++.+ +||
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp  160 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP  160 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECC------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            3345566889999999999999999998875      5889999998754321        134577899999999 799


Q ss_pred             ceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       141 nI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      ||+++++++......++||||+.|++|.+++...  ..+++..+..++.||+.||.|||+.  ||+|+||||+||+++.+
T Consensus       161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~--gi~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDN  236 (365)
T ss_dssp             TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTT
T ss_pred             CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999999765  6799999999999999999999965  59999999999999999


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeecccccccccccccccc------CCCCccccHHhHHHHHHHHHhCCCCCCCCccccc
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT------GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE  294 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  294 (401)
                      |.+||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||......  
T Consensus       237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--  311 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--  311 (365)
T ss_dssp             CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--
Confidence            9999999999986654322   245679999999999863      35889999999999999999999999754211  


Q ss_pred             ccHHHHhhhhhcCccchhhhcCCcCCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          295 QSLAEWARPLLKEPRKLERLIDPRLEGQFP--IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       ....   .....          ......+  ...+..+.+++.+||+.||.+|||+.++++.
T Consensus       312 -~~~~---~i~~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          312 -LMLR---MIMEG----------QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             -HHHH---HHHHT----------CCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HHHH---HHHhC----------CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             1111   00000          0000000  1124678999999999999999999999863

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.8e-43  Score=340.14  Aligned_cols=206  Identities=23%  Similarity=0.295  Sum_probs=177.0

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CC-----ceeeE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HP-----HLVKL  145 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nI~~~  145 (401)
                      ...+.++|.+.+.||+|+||+||+|.+..      +++.||||++... ......+..|+.+++.+. |+     +|+++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~  121 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRV------EQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL  121 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcC------CCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence            34456899999999999999999998876      5889999999743 233456677888888775 44     59999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc--CCCcE
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD--SDYTA  223 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~--~~~~v  223 (401)
                      ++++......|+||||+. ++|.+++.......+++..+..++.|++.||.|||+++.+|+||||||+|||++  .++.+
T Consensus       122 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          122 KRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcE
Confidence            999999999999999995 699999987655679999999999999999999997667799999999999994  47889


Q ss_pred             EEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCc
Q 040050          224 KLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTR  290 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  290 (401)
                      ||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999865432     234679999999999999999999999999999999999999998653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.7e-44  Score=366.05  Aligned_cols=252  Identities=27%  Similarity=0.380  Sum_probs=200.8

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e  160 (401)
                      +.||+|+||.||+|.+...    ..++.||||+++...  ......+.+|+.+|++++||||+++++++.. +..++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS----SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCC----CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence            4799999999999976542    146889999997542  2345789999999999999999999999865 45789999


Q ss_pred             ecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc
Q 040050          161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~  240 (401)
                      |+.+|+|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++........
T Consensus       450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            99999999999654  67999999999999999999999654  999999999999999999999999999765443221


Q ss_pred             -eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          241 -HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       241 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                       .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......   .+.              ..+...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~--------------~~i~~~  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVT--------------AMLEKG  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH--------------HHHHTT
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHH--------------HHHHcC
Confidence             12233457889999999999999999999999999999998 99999764321   111              111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      .....+..++..+.+|+.+||+.||++||++.+|++.|+.+-
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            222334456788999999999999999999999999998763

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.5e-44  Score=327.62  Aligned_cols=250  Identities=26%  Similarity=0.357  Sum_probs=198.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ..++|.+.+.||+|+||.||+|.+..      +++.||+|++...   .......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   82 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQL------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST   82 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECC------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            44789999999999999999998875      5789999998643   12335678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ....++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeecccc
Confidence            99999999999999999999765  67999999999999999999999654  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      .......   ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||......      .........   
T Consensus       159 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~---  226 (276)
T 2h6d_A          159 NMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIRGG---  226 (276)
T ss_dssp             GCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC---
T ss_pred             cccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcC---
Confidence            8754432   1234568999999999988765 68999999999999999999999754211      111111000   


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                               ....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       227 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 ---------VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---------cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     001223345678999999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.8e-45  Score=351.30  Aligned_cols=248  Identities=16%  Similarity=0.169  Sum_probs=192.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHH---HHHhccCCCceeeEE---
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEI---IFLGQLRHPHLVKLI---  146 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnI~~~~---  146 (401)
                      .++|.+.+.||+|+||+||+|.+..      +++.||||++...   .......+.+|+   .+++.++||||++++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECC------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            4679999999999999999998765      5889999998743   333456788999   555566899999998   


Q ss_pred             ----EEEEeCC-----------------eEEEEEEecCCCChhHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHhC
Q 040050          147 ----GYCWEEE-----------------YRLLVYEYMPRGSLHNQLFRSYS-----AALPWSTRMKIALGAAKGLAFLHG  200 (401)
Q Consensus       147 ----~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~  200 (401)
                          +++...+                 ..|+||||+ +|+|.+++.....     ..+++..++.++.||+.||+|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                6666553                 278999999 6899999976411     123347888999999999999996


Q ss_pred             CCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccC-----------CCCccccH
Q 040050          201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-----------HLTTMSDV  269 (401)
Q Consensus       201 ~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di  269 (401)
                      .+  |+||||||+|||++.++.+||+|||++.....     ......| +.|+|||++.+.           .++.++||
T Consensus       225 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          225 YG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             TT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            54  99999999999999999999999999985322     2345678 999999999887           89999999


Q ss_pred             HhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 040050          270 YSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       270 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  349 (401)
                      |||||++|+|++|..||......                .....+...      ...++..+.+|+.+||+.||.+||++
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~----------------~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAAL----------------GGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC----------------------CCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccc----------------cchhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            99999999999999999654211                011111110      01235689999999999999999999


Q ss_pred             HHHHH--HHHhhh
Q 040050          350 SYVVR--VLDSLQ  360 (401)
Q Consensus       350 ~~il~--~L~~l~  360 (401)
                      .++++  .+..+.
T Consensus       355 ~e~l~hp~f~~~~  367 (377)
T 3byv_A          355 LQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHTSHHHHHHH
T ss_pred             HHHhhChHHHHHH
Confidence            99986  444443

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=331.00  Aligned_cols=254  Identities=28%  Similarity=0.383  Sum_probs=202.2

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ...++|.+.+.||+|+||.||+|.+..      +++.||+|.+....  ....+.+|+.+++.++||||+++++++....
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKE------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETT------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECC------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            345789999999999999999998876      58899999987543  3467889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            999999999999999998643 467999999999999999999999654  99999999999999999999999999976


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......  ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......      .........     
T Consensus       175 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-----  241 (314)
T 3com_A          175 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTNP-----  241 (314)
T ss_dssp             CBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHSC-----
T ss_pred             hhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCC-----
Confidence            543221  1234579999999999999999999999999999999999999997542110      000000000     


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          ......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       242 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          242 ----PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ----CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                00011233346789999999999999999999999863

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-43  Score=338.21  Aligned_cols=269  Identities=22%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe---
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE---  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~---  151 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++..   
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRK------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETT------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cceeEEEEEecCCCcEEEEEEECC------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            689999999999999999999876      68899999986543  2234578899999999999999999999987   


Q ss_pred             -----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          152 -----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       152 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                           .+..++||||+. ++|.+.+... ...+++..++.++.|++.||.|||+.  ||+||||||+|||++.++.+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~--~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC--CeeCCCCCHHHEEEcCCCCEEEc
Confidence                 446899999996 5787777553 35799999999999999999999965  49999999999999999999999


Q ss_pred             ecCCCCCCCCCC--cceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc-HHHHhh
Q 040050          227 DFGLAKDGPEGE--ETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-LAEWAR  302 (401)
Q Consensus       227 DfG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~  302 (401)
                      |||++.......  .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......... +.....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999997654222  1222345678999999999876 568999999999999999999999997653221110 111100


Q ss_pred             hhhcC----ccchh--hhcCC--cCCCCCCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          303 PLLKE----PRKLE--RLIDP--RLEGQFPIK-----GAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       303 ~~~~~----~~~~~--~~~~~--~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .....    .....  .....  .........     .+..+.+|+.+||+.||.+|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00000    00000  00000  000000001     14568899999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-43  Score=339.46  Aligned_cols=262  Identities=22%  Similarity=0.252  Sum_probs=194.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++....  ......+.+|+.+++.++||||+++++++....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            4789999999999999999998876      68899999987532  233456889999999999999999999997665


Q ss_pred             ------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          154 ------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       154 ------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                            ..|+||||+. ++|.+.+.    ..+++..+..++.||+.||.|||+.  +|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~--~ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC--CeecccCCHHHEEEcCCCCEEEEE
Confidence                  7899999995 57888774    3589999999999999999999965  599999999999999999999999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  .+..........
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~  245 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTP  245 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCCC
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence            99998654321   2344679999999999999999999999999999999999999997653211  111110000000


Q ss_pred             -----------------------ccchhhhcCCcCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 -----------------------PRKLERLIDPRLEGQ---FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 -----------------------~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                             ...+...........   .+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                                   000000111000000   112346789999999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-44  Score=338.89  Aligned_cols=268  Identities=24%  Similarity=0.308  Sum_probs=198.9

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-----cHHHHHHHHHHHhccCCCceeeEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-----GHKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      ...++|.+.+.||+|+||.||+|.+..      +++.||+|++......     ....+.+|+.+++.++||||++++++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKN------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA   80 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSS------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECC------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            345789999999999999999998776      5889999998753221     12467899999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                      +......++||||+.+ +|..++... ...+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           81 FGHKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             ECCTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             EeeCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEec
Confidence            9999999999999965 888887653 356889999999999999999999655  999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      |++.......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......  ..+..........
T Consensus       157 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~  232 (346)
T 1ua2_A          157 GLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTP  232 (346)
T ss_dssp             GGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCC
T ss_pred             ccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCC
Confidence            9998654322  12345679999999999976 45899999999999999999999999765321  1111111111000


Q ss_pred             c-cchh------hhcCCcCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 P-RKLE------RLIDPRLEGQFP-----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ~-~~~~------~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      . ..+.      ...........+     ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0 0000      000000001111     2335789999999999999999999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-43  Score=328.35  Aligned_cols=253  Identities=24%  Similarity=0.342  Sum_probs=205.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---------ccHHHHHHHHHHHhccC-CCceee
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---------QGHKEWMAEIIFLGQLR-HPHLVK  144 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-hpnI~~  144 (401)
                      ..++|.+.+.||+|+||.||+|.+..      +++.||+|++.....         .....+.+|+.+++++. ||||++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~   88 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKP------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ   88 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             hhhccceeeeecCCCceEEEEEEEcC------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence            45789999999999999999998876      688999999975431         12346778999999996 999999


Q ss_pred             EEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEE
Q 040050          145 LIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK  224 (401)
Q Consensus       145 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vk  224 (401)
                      +++++......++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+|+||||+||+++.++.+|
T Consensus        89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           89 LKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEE
T ss_pred             eeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCcceEEEcCCCcEE
Confidence            999999999999999999999999999765  6799999999999999999999965  499999999999999999999


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccc------cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM------TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                      |+|||++........   .....|++.|+|||++.      ...++.++||||||+++|+|++|..||......      
T Consensus       165 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------  235 (298)
T 1phk_A          165 LTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------  235 (298)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred             EecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------
Confidence            999999986544322   23457999999999985      456889999999999999999999999754211      


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ...........        ..........+..+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          236 LMLRMIMSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhcCCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11111110000        0000111234678999999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.4e-44  Score=334.23  Aligned_cols=254  Identities=23%  Similarity=0.365  Sum_probs=200.6

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ..++|++.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++..+..
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKE------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETT------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CccceeecceeccCCCeEEEEEEEcC------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            34789999999999999999999876      578999999987666667889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC--CcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            99999999999999888653 35799999999999999999999965  5999999999999999999999999987532


Q ss_pred             CCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ...  ........||+.|+|||++.     +..++.++||||||+++|+|++|..||......  .....    ....  
T Consensus       168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~----~~~~--  237 (302)
T 2j7t_A          168 LKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAKS--  237 (302)
T ss_dssp             HHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHS--
T ss_pred             ccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH--HHHHH----Hhcc--
Confidence            110  11123356899999999983     677899999999999999999999999764311  01111    1000  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                             .......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       238 -------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          238 -------DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -------CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -------CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                   00001123344678999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.8e-44  Score=341.09  Aligned_cols=265  Identities=22%  Similarity=0.319  Sum_probs=202.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeC--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE--  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~--  152 (401)
                      .++|++.+.||+|+||.||+|.+..      +++.||+|++..... .....+.+|+.++++++||||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNL------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEECC------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            4789999999999999999998876      688999999975432 3346788999999999999999999999765  


Q ss_pred             ---CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          153 ---EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       153 ---~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                         ...|+||||+. ++|.+++..   ..+++..++.++.|++.||.|||+.  ||+||||||+||+++.++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCChHhEEECCCCCEEEEeCc
Confidence               36899999995 699998865   4799999999999999999999965  49999999999999999999999999


Q ss_pred             CCCCCCCCCcc-eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          230 LAKDGPEGEET-HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       230 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  .+..... ....
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~-~~~~  250 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILG-ILGS  250 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHH-HHCS
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHH-HhCC
Confidence            99865432211 11234579999999998764 558999999999999999999999997653221  1111111 0000


Q ss_pred             cc--chhh--------h-cCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 PR--KLER--------L-IDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ~~--~~~~--------~-~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +.  .+..        . .........     ....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00  0000        0 000000001     12235678999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.1e-43  Score=332.95  Aligned_cols=254  Identities=26%  Similarity=0.347  Sum_probs=198.4

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--------ccHHHHHHHHHHHhccCCCceeeE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--------QGHKEWMAEIIFLGQLRHPHLVKL  145 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnI~~~  145 (401)
                      .+.++|.+.+.||+|+||.||+|.+..      +++.||||++.....        .....+.+|+.+++.++||||+++
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   80 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERK------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI   80 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcC------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceE
Confidence            355789999999999999999998876      688999999864321        122357889999999999999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc---
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT---  222 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~---  222 (401)
                      ++++..+. .++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+||+++.++.   
T Consensus        81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~dlkp~NIl~~~~~~~~~  155 (322)
T 2ycf_A           81 KNFFDAED-YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN--GIIHRDLKPENVLLSSQEEDCL  155 (322)
T ss_dssp             EEEEESSS-EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEESSSSSSCC
T ss_pred             eeEEcCCc-eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCCHHHEEEecCCCCCe
Confidence            99987665 89999999999999988654  6899999999999999999999965  4999999999999987654   


Q ss_pred             EEEEecCCCCCCCCCCcceeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          223 AKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       223 vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      +||+|||++.......   ......||+.|+|||++.   +..++.++|||||||++|+|++|..||.......  .+..
T Consensus       156 ~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~  230 (322)
T 2ycf_A          156 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD  230 (322)
T ss_dssp             EEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHH
T ss_pred             EEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHH
Confidence            9999999998654322   123456999999999974   5678999999999999999999999997643211  1111


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .......  ...     +    ......+..+.+++.+||+.||.+||++.++++
T Consensus       231 ~~~~~~~--~~~-----~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          231 QITSGKY--NFI-----P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHTCC--CCC-----H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhCcc--ccC-----c----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1110000  000     0    001123568899999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-43  Score=329.27  Aligned_cols=254  Identities=23%  Similarity=0.274  Sum_probs=188.8

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cH-HHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GH-KEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..++|++.+.||+|+||+||+|.+..      +++.||+|++...... .. ..+.++...++.++||||+++++++.+.
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~   78 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVP------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE   78 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecC------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc
Confidence            35789999999999999999999876      6889999999754322 22 2344455568888999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      ...++||||+. ++|.+++..  .....+++..++.++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+
T Consensus        79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK-LSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-SCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeecCC
Confidence            99999999996 588887754  2346899999999999999999999964 1599999999999999999999999999


Q ss_pred             CCCCCCCCcceeeecccccccccccccc----ccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYV----MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      +........   .....||+.|+|||++    .+..++.++|||||||++|+|++|..||........ .+..       
T Consensus       157 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~-------  225 (290)
T 3fme_A          157 SGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQ-------  225 (290)
T ss_dssp             ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHH-------
T ss_pred             ccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHH-------
Confidence            986544321   2334699999999996    566789999999999999999999999975321110 1111       


Q ss_pred             CccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                             ..........+...+..+.+++.+||+.||.+|||+.++++
T Consensus       226 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          226 -------VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -------HHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------HhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                   00011111112234678999999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.8e-43  Score=332.98  Aligned_cols=259  Identities=19%  Similarity=0.248  Sum_probs=201.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEe--CC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWE--EE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~--~~  153 (401)
                      ++|++.+.||+|+||+||+|.+..      +++.||+|++...   ....+.+|+.+++.++ ||||+++++++.+  ..
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINIT------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CceEEEEEecccCCeEEEEEEECC------CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            789999999999999999998876      5889999998743   3467889999999997 9999999999988  66


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEecCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAK  232 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~DfG~a~  232 (401)
                      ..++||||+.+++|.+++.     .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++ .+||+|||++.
T Consensus       107 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            7899999999999988873     4889999999999999999999654  99999999999999776 89999999998


Q ss_pred             CCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhh---------
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWAR---------  302 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------  302 (401)
                      .......   .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||........ .+.....         
T Consensus       180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYD  255 (330)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHH
T ss_pred             EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhh
Confidence            6544322   234579999999999987 6789999999999999999999999954322111 1111000         


Q ss_pred             ---hh-hcCccchhhhcC--------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          303 ---PL-LKEPRKLERLID--------PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       303 ---~~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         .. ...+........        .......+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               00 000000000000        001111222357789999999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=7.7e-43  Score=330.54  Aligned_cols=266  Identities=22%  Similarity=0.263  Sum_probs=206.1

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCC------ceeeEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP------HLVKLIG  147 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------nI~~~~~  147 (401)
                      .+.++|++.+.||+|+||.||+|.+...     +++.||+|++... ......+.+|+.+++.++|+      +|+++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKA-----GGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCC-----CCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            3457999999999999999999987431     5789999998643 23346678899999888765      4999999


Q ss_pred             EEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC--------
Q 040050          148 YCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS--------  219 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~--------  219 (401)
                      ++......++||||+ +++|.+++.......+++..++.++.|++.||+|||+.  +|+||||||+|||++.        
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN--KLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEEEeccccccccC
Confidence            999999999999999 89999999876556789999999999999999999965  4999999999999987        


Q ss_pred             -----------CCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          220 -----------DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       220 -----------~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                                 ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                       668999999999864332     2345799999999999999999999999999999999999999976


Q ss_pred             CcccccccHHHHhhhhhcCccchhh---------------------------hcCC-cCCCCCCHHHHHHHHHHHHHhcc
Q 040050          289 TRLGREQSLAEWARPLLKEPRKLER---------------------------LIDP-RLEGQFPIKGAQKAAATAFKCLS  340 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~-~~~~~~~~~~~~~l~~li~~cl~  340 (401)
                      ......  ...........+..+..                           ...+ ......+...+..+.+|+.+||+
T Consensus       237 ~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          237 HDSKEH--LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             SCHHHH--HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CChHHH--HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            532211  11110000000100000                           0000 00011234567889999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 040050          341 HHPRHRPTMSYVVRV  355 (401)
Q Consensus       341 ~dP~~RPt~~~il~~  355 (401)
                      .||.+|||+.++++.
T Consensus       315 ~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          315 YDPAKRITLREALKH  329 (339)
T ss_dssp             SSTTTSCCHHHHTTS
T ss_pred             cCcccccCHHHHhcC
Confidence            999999999999754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.7e-43  Score=333.60  Aligned_cols=271  Identities=26%  Similarity=0.314  Sum_probs=193.4

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      .....++|.+.+.||+|+||+||+|.+..      +++.||||++.... .......+++..+..++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKS------TGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETT------TCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            34556899999999999999999998876      58899999886442 223456778888899999999999999976


Q ss_pred             CCe-------EEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CC
Q 040050          152 EEY-------RLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DY  221 (401)
Q Consensus       152 ~~~-------~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~  221 (401)
                      ...       .++||||+.+ +|...+..  .....+++..+..++.|++.||.|||.+..+|+||||||+|||++. ++
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence            433       7899999965 66555543  2346789999999999999999999955566999999999999997 89


Q ss_pred             cEEEEecCCCCCCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHH
Q 040050          222 TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW  300 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  300 (401)
                      .+||+|||++........   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||......  ..+...
T Consensus       170 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~  244 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEI  244 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH
T ss_pred             cEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHH
Confidence            999999999987654332   2345789999999998764 4899999999999999999999999765321  111222


Q ss_pred             hhhhhcCccchhhhcCC----------------cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          301 ARPLLKEPRKLERLIDP----------------RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       301 ~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .......+........+                ..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11111111111000000                00011122346789999999999999999999999864

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.3e-43  Score=342.86  Aligned_cols=261  Identities=26%  Similarity=0.349  Sum_probs=196.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC----
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE----  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~----  152 (401)
                      .+|.+.+.||+|+||.||+|.+..      +++.||||++.....    ...+|+++|+.++||||+++++++...    
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECC------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            579999999999999999999876      588999999864422    234699999999999999999998542    


Q ss_pred             --CeEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC-CcEEEEe
Q 040050          153 --EYRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSD  227 (401)
Q Consensus       153 --~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~-~~vkL~D  227 (401)
                        ..+++||||+. ++|.+.+..  .....+++..++.++.||+.||.|||+.  +|+||||||+|||++.+ +.+||+|
T Consensus       124 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECSCCSGGGEEEETTTTEEEECC
T ss_pred             cceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCChhhEEEeCCCCeEEecc
Confidence              24679999996 477666643  2346899999999999999999999954  59999999999999965 6789999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+....  ..+.........
T Consensus       201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~  275 (420)
T 1j1b_A          201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGT  275 (420)
T ss_dssp             CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCS
T ss_pred             chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCC
Confidence            999986544322   2345799999999999764 7999999999999999999999999765321  112222111110


Q ss_pred             Cc-cchhhh-------cCCcCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EP-RKLERL-------IDPRLE-----GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~-~~~~~~-------~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .. ..+...       ..+...     ..++...+..+.+|+.+||+.||.+||++.+++++
T Consensus       276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            00 000000       000000     01223346789999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7e-44  Score=332.70  Aligned_cols=266  Identities=26%  Similarity=0.372  Sum_probs=187.7

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ....++|.+.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   84 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAP------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV   84 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----------CEEEEECCC----------------CCCCCCCTTBCCEEEEEES
T ss_pred             ccchhhhhhhheeccccceEEEEEEECC------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence            3445899999999999999999998765      57899999986543 2335678899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRS------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      .+..++||||+.+++|.+++...      ....+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~i~H~dl~p~Nil~~~~~~~kl  162 (303)
T 2vwi_A           85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQI  162 (303)
T ss_dssp             SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEECTTCCEEE
T ss_pred             cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CCCCCCCChhhEEEcCCCCEEE
Confidence            99999999999999999998641      235689999999999999999999965  5999999999999999999999


Q ss_pred             EecCCCCCCCCCCc---ceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHh
Q 040050          226 SDFGLAKDGPEGEE---THVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA  301 (401)
Q Consensus       226 ~DfG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  301 (401)
                      +|||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||........  .... 
T Consensus       163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~-  239 (303)
T 2vwi_A          163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV--LMLT-  239 (303)
T ss_dssp             CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHH-
T ss_pred             EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--HHHH-
Confidence            99999875443221   111234579999999999876 5789999999999999999999999976532211  1110 


Q ss_pred             hhhhcCccchhh-hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          302 RPLLKEPRKLER-LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       302 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        ....+..... ....    ......+..+.+++.+||+.||.+||++.++++.
T Consensus       240 --~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          240 --LQNDPPSLETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             --HTSSCCCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --hccCCCccccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              0011111110 0111    1112235678999999999999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-44  Score=339.92  Aligned_cols=258  Identities=28%  Similarity=0.322  Sum_probs=204.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----cccHHHHHHHHHHHhcc-CCCceeeEEEEEEe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~  151 (401)
                      ++|.+.+.||+|+||.||+|.+...   ..+++.||+|++....    ......+.+|+.+++.+ +||||+++++++..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISG---HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSS---TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEccc---CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            6899999999999999999987431   2257899999986432    12334567799999999 69999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ....++||||+.+++|.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||++
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~--~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999999765  6799999999999999999999965  4999999999999999999999999999


Q ss_pred             CCCCCCCcceeeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ........ .......||+.|+|||++.+  ..++.++|||||||++|+|++|..||......  .............  
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~--  281 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKS--  281 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHC--
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc--chHHHHHHHHhcc--
Confidence            76543221 22334679999999999986  45789999999999999999999999754321  1112211111111  


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRVL  356 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~L  356 (401)
                                ...++...+..+.+|+.+||..||.+||     ++.++++..
T Consensus       282 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                      1123334567889999999999999999     999998763

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.3e-43  Score=346.74  Aligned_cols=263  Identities=22%  Similarity=0.306  Sum_probs=208.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCC-CceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH-PHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnI~~~~~~~~~~~  153 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++......  ..+..|+.+++.++| ++|..+..++....
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~   76 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGD   76 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETT------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETT
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECC------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC
Confidence            35789999999999999999998776      5889999998754332  357889999999986 56777777778888


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE---cCCCcEEEEecCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGL  230 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv---~~~~~vkL~DfG~  230 (401)
                      ..+|||||+ +++|.+++... ...+++..++.++.||+.||.|||+.  +||||||||+||||   +.++.+||+|||+
T Consensus        77 ~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~--gIvHrDIKP~NILl~~~~~~~~vkL~DFGl  152 (483)
T 3sv0_A           77 YNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGL  152 (483)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             EEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC--CEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence            999999999 99999998743 36799999999999999999999965  59999999999999   5789999999999


Q ss_pred             CCCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccccc-HHHHhhhh
Q 040050          231 AKDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS-LAEWARPL  304 (401)
Q Consensus       231 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~  304 (401)
                      +.........     .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... +.......
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~  232 (483)
T 3sv0_A          153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK  232 (483)
T ss_dssp             CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred             ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence            9865443221     11225679999999999999999999999999999999999999998754322111 11111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      ..  ..+..+         ...++.++.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus       233 ~~--~~~~~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          233 VA--TSIEAL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HH--SCHHHH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cc--ccHHHH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            10  000000         0122568999999999999999999999999999883

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.7e-43  Score=339.68  Aligned_cols=261  Identities=25%  Similarity=0.339  Sum_probs=186.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++....  ......+.+|+.+++.++||||+++++++...
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETT------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECC------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            34789999999999999999998876      68899999986532  23356788999999999999999999998754


Q ss_pred             ------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 ------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 ------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                            ...|+|||++ +++|.+++..   ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEe
Confidence                  5679999999 7899888864   57999999999999999999999654  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.....  .+..... ..
T Consensus       175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~-~~  246 (367)
T 2fst_X          175 DFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILR-LV  246 (367)
T ss_dssp             C--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHH-HH
T ss_pred             ecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-Hh
Confidence            99999864332     344679999999999987 788999999999999999999999997653211  1111111 11


Q ss_pred             cCcc-c---------hhhhcCCc-CCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPR-K---------LERLIDPR-LEGQFP-----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~-~---------~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..+. .         ....+... .....+     ...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            1000 0         00000000 000000     1235678999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-43  Score=330.96  Aligned_cols=254  Identities=23%  Similarity=0.361  Sum_probs=197.1

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccC--CCceeeEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLR--HPHLVKLIGYC  149 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--hpnI~~~~~~~  149 (401)
                      ....+|.+.+.||+|+||.||+|.+..       ++.||+|++....  ......+.+|+.++++++  ||||+++++++
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~   97 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEK-------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE   97 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCC-------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence            345789999999999999999998643       7789999987543  334567889999999997  59999999999


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecC
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFG  229 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG  229 (401)
                      ......++|||+ .+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||++++ +.+||+|||
T Consensus        98 ~~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~dlkp~NIl~~~-~~~kL~Dfg  171 (313)
T 3cek_A           98 ITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH--GIVHSDLKPANFLIVD-GMLKLIDFG  171 (313)
T ss_dssp             ECSSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEEET-TEEEECCCS
T ss_pred             ecCCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCcccEEEEC-CeEEEeecc
Confidence            999999999995 588999999765  6789999999999999999999965  5999999999999964 899999999


Q ss_pred             CCCCCCCCCcceeeecccccccccccccccc-----------CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          230 LAKDGPEGEETHVITRVMGTQGYAAPEYVMT-----------GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       230 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                      ++................|++.|+|||++.+           ..++.++||||||+++|+|++|..||......    ..
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----~~  247 (313)
T 3cek_A          172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----IS  247 (313)
T ss_dssp             SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----HH
T ss_pred             ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----HH
Confidence            9987654333223344579999999999875           47888999999999999999999999654211    00


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                 .+...........++...+..+.+++.+||+.||.+||++.++++.
T Consensus       248 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          248 -----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                       1111122222222333335789999999999999999999999865

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.1e-43  Score=336.40  Aligned_cols=266  Identities=18%  Similarity=0.230  Sum_probs=205.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc---c--------------HHHHHHHHHHHhccC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---G--------------HKEWMAEIIFLGQLR  138 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~---~--------------~~~~~~E~~~l~~l~  138 (401)
                      .++|.+.+.||+|+||.||+|.+ .       ++.||+|++......   .              ...+.+|+.+++.++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-D-------NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-T-------TEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-C-------CceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            47899999999999999999987 3       789999998643111   1              178899999999999


Q ss_pred             CCceeeEEEEEEeCCeEEEEEEecCCCChhHH------HhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 040050          139 HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQ------LFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKA  212 (401)
Q Consensus       139 hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp  212 (401)
                      ||||+++++++.+.+..++||||+++++|.++      +.......+++..++.++.|++.||.|||+ ..||+|+||||
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dl~p  180 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKP  180 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TSCEECCCCCG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc-cCCEeecCCCh
Confidence            99999999999999999999999999999998      655445789999999999999999999995 14599999999


Q ss_pred             CcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccC-CCCc-cccHHhHHHHHHHHHhCCCCCCCCc
Q 040050          213 SNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTT-MSDVYSFGVVLLELLTGKRAMDNTR  290 (401)
Q Consensus       213 ~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~ell~g~~pf~~~~  290 (401)
                      +||+++.++.+||+|||++......    ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999865432    23456799999999999877 6766 9999999999999999999997643


Q ss_pred             ccccccHHHHhhhhhcCccchhhhcCCc---CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          291 LGREQSLAEWARPLLKEPRKLERLIDPR---LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .. ..............+........+.   .........+..+.+++.+||+.||.+||++.++++.
T Consensus       257 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          257 SL-VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             CS-HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cH-HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            21 0111111111011110000000000   0000113346789999999999999999999999863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.4e-43  Score=359.49  Aligned_cols=264  Identities=24%  Similarity=0.343  Sum_probs=208.4

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ....++|.+.+.||+|+||.||+|.+....   ..+..||+|.+..... .....+.+|+.+++.++||||+++++++. 
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  461 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPE---NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-  461 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSS---SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCC---CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence            344578999999999999999999876421   1456799999875433 33467889999999999999999999985 


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ++..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||++
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~--givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK--RFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC--CccccccchHhEEEeCCCCEEEEecCCC
Confidence            45689999999999999999754 34689999999999999999999965  5999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||......   .......        
T Consensus       539 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~~~i~--------  606 (656)
T 2j0j_A          539 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIE--------  606 (656)
T ss_dssp             CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH--------
T ss_pred             eecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHH--------
Confidence            87644322 12233457889999999999999999999999999999997 99999764321   1111100        


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                            .......+..++..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       607 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          607 ------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             ------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                  011112334456789999999999999999999999999998853

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=338.17  Aligned_cols=262  Identities=21%  Similarity=0.338  Sum_probs=199.7

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      ...++|.+.+.||+|+||.||+|.+..         .||+|++....  ......+.+|+.+++.++||||+++++++..
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            345789999999999999999997653         49999987542  2233457789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ....++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++ ++.+||+|||++
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~--~i~H~dlkp~NIl~~-~~~~~l~Dfg~~  176 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLF  176 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred             CCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCChhhEEEe-CCCEEEeecCCc
Confidence            99999999999999999998653 34789999999999999999999965  499999999999998 679999999998


Q ss_pred             CCCCCCC---cceeeecccccccccccccccc---------CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          232 KDGPEGE---ETHVITRVMGTQGYAAPEYVMT---------GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       232 ~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      .......   .........|++.|+|||++.+         ..++.++||||||+++|+|++|..||......      .
T Consensus       177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~  250 (319)
T 2y4i_B          177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------A  250 (319)
T ss_dssp             C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------H
T ss_pred             cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence            7543211   1112233568999999999874         45788999999999999999999999764211      1


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      ........       ..+..   .+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus       251 ~~~~~~~~-------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          251 IIWQMGTG-------MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             HHHHHHTT-------CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             HHHHhccC-------CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence            11111000       00110   111234578899999999999999999999999999876543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.3e-43  Score=324.31  Aligned_cols=255  Identities=24%  Similarity=0.322  Sum_probs=204.4

Q ss_pred             HHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           73 RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        73 ~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ..+.++|.+.+.||+|+||.||+|.+..      +++.||+|++...  .......+.+|+.++++++||||+++++++.
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRI------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcC------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            3456899999999999999999998875      5789999998643  2345678899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC---CcEEEEe
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD---YTAKLSD  227 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~---~~vkL~D  227 (401)
                      .....++||||+.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+|+||||+||+++.+   +.+||+|
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~--~i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeccCCChhhEEEecCCCcccEEEec
Confidence            999999999999999999988765  5799999999999999999999965  59999999999999654   4799999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ||++........   .....|++.|+|||++.+. ++.++||||||+++|+|++|..||......      .........
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~  237 (287)
T 2wei_A          168 FGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETG  237 (287)
T ss_dssp             TTGGGTBCCCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC
T ss_pred             cCcceeecCCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC
Confidence            999876543321   2334589999999988764 899999999999999999999999764311      111111100


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ...        .........+..+.+++.+||+.||.+|||+.++++.
T Consensus       238 ~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          238 KYA--------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCC--------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCC--------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            000        0000011235689999999999999999999999873

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.2e-43  Score=337.07  Aligned_cols=271  Identities=23%  Similarity=0.323  Sum_probs=198.9

Q ss_pred             cHHHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-----------cHHHHHHHHHHHhc
Q 040050           68 TLAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-----------GHKEWMAEIIFLGQ  136 (401)
Q Consensus        68 ~~~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~  136 (401)
                      .+.++..+.++|.+.+.||+|+||.||+|.+..       +..||+|++......           ....+.+|+.+++.
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   85 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH   85 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh
Confidence            456778889999999999999999999998653       789999998543211           13678899999999


Q ss_pred             cCCCceeeEEEEEEe-----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCC
Q 040050          137 LRHPHLVKLIGYCWE-----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFK  211 (401)
Q Consensus       137 l~hpnI~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlk  211 (401)
                      ++||||+++++++..     ....|+||||+. ++|.+++... ...+++..++.++.||+.||.|||+.  +|+|||||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~--~ivH~Dlk  161 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA--GVVHRDLH  161 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCC
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC--cCEecCCC
Confidence            999999999999854     336899999996 6888888653 35799999999999999999999965  49999999


Q ss_pred             CCcEEEcCCCcEEEEecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCc
Q 040050          212 ASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTR  290 (401)
Q Consensus       212 p~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~  290 (401)
                      |+||+++.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997543322   2244578999999999887 778999999999999999999999997643


Q ss_pred             ccccccHHHHhhhhhcCcc----------chhhhcCCcCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040050          291 LGREQSLAEWARPLLKEPR----------KLERLIDPRLE-------GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV  353 (401)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il  353 (401)
                      ...  .+... ......+.          ...........       .......+..+.+|+.+||+.||.+|||+.+++
T Consensus       239 ~~~--~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  315 (362)
T 3pg1_A          239 FYN--QLNKI-VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL  315 (362)
T ss_dssp             HHH--HHHHH-HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHH--HHHHH-HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence            211  11111 00000000          00000000000       001122356789999999999999999999998


Q ss_pred             HH
Q 040050          354 RV  355 (401)
Q Consensus       354 ~~  355 (401)
                      +.
T Consensus       316 ~h  317 (362)
T 3pg1_A          316 RH  317 (362)
T ss_dssp             TS
T ss_pred             cC
Confidence            64

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-43  Score=341.01  Aligned_cols=253  Identities=12%  Similarity=0.012  Sum_probs=182.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHH---HHHhccCCCceeeEE----
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEI---IFLGQLRHPHLVKLI----  146 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~hpnI~~~~----  146 (401)
                      ..|.+.+.||+|+||+||+|.+..      +++.||+|++.....   .....+.+|+   .+|+. +||||++++    
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~  134 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEE
Confidence            458899999999999999999876      588999999986542   2344566774   55555 799988865    


Q ss_pred             ---EEEEeC-----------------CeEEEEEEecCCCChhHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHhC
Q 040050          147 ---GYCWEE-----------------EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTR------MKIALGAAKGLAFLHG  200 (401)
Q Consensus       147 ---~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~------~~i~~qi~~al~~LH~  200 (401)
                         +++...                 ..+|+||||+. ++|.+++.... ..++...+      +.++.||+.||+|||+
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence               454433                 33799999997 89999997642 23455555      6788999999999996


Q ss_pred             CCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeecccccccccccccccc--CCCCccccHHhHHHHHHH
Q 040050          201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLE  278 (401)
Q Consensus       201 ~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e  278 (401)
                      ++  |+||||||+|||++.++.+||+|||++......     .....||+.|+|||++.+  ..++.++|||||||++|+
T Consensus       213 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          213 KG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             TT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             CC--CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence            54  999999999999999999999999999865321     224567799999999987  789999999999999999


Q ss_pred             HHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          279 LLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       279 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      |++|..||...........        .. ..................++..+.+|+.+||+.||++|||+.++++
T Consensus       286 lltg~~Pf~~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGSW--------KR-PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTCC--------CB-CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHhCCCCCCCcCcccccch--------hh-hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999999976532211000        00 0000000111111112345778999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-42  Score=331.63  Aligned_cols=266  Identities=23%  Similarity=0.323  Sum_probs=201.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeC-
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE-  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-  152 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||||++..... .....+.+|+.+++.++||||+++++++... 
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKP------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECC------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            35789999999999999999998876      688999999964432 3345678999999999999999999988764 


Q ss_pred             ----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          153 ----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       153 ----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                          ...++||||+. ++|.+++..   ..+++..++.++.|++.||.|||+.  ||+||||||+||+++.++.+||+||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~--~ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS--NVIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEECTTCCEEECCC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC--CeecCCCCHHHeEEcCCCcEEEEec
Confidence                67899999995 689888865   5799999999999999999999965  4999999999999999999999999


Q ss_pred             CCCCCCCCCCcc--------eeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          229 GLAKDGPEGEET--------HVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       229 G~a~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      |++.........        .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........  +..
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~  234 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLL  234 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH
Confidence            999865432211        11233578999999998764 7789999999999999999999999976532111  111


Q ss_pred             HhhhhhcCcc---c--------hhhhcCC--cC-C---CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          300 WARPLLKEPR---K--------LERLIDP--RL-E---GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       300 ~~~~~~~~~~---~--------~~~~~~~--~~-~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      . ......+.   .        .......  .. .   .......+..+.+++.+||+.||.+|||+.++++.
T Consensus       235 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          235 I-FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             H-HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             H-HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0 00000000   0        0000000  00 0   00012346788999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.4e-43  Score=337.91  Aligned_cols=266  Identities=21%  Similarity=0.238  Sum_probs=203.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-----------CCceee
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-----------HPHLVK  144 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnI~~  144 (401)
                      .++|.+.+.||+|+||+||+|.+..      +++.||+|++... ......+.+|+.+++++.           ||||++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMV------NNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecC------CCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            3689999999999999999998876      6889999998743 233456778999988886           899999


Q ss_pred             EEEEEEeCC----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc--
Q 040050          145 LIGYCWEEE----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD--  218 (401)
Q Consensus       145 ~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~--  218 (401)
                      +++++....    ..++|||++ +++|.+++.......+++..++.++.||+.||.|||++ .+|+||||||+|||++  
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~-~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR-CGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT-TCEECSCCSGGGEEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChHHeEEecc
Confidence            999998654    789999999 89999999876567799999999999999999999964 1599999999999994  


Q ss_pred             ----CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCccccc
Q 040050          219 ----SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGRE  294 (401)
Q Consensus       219 ----~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  294 (401)
                          ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                4458999999999765432     2345799999999999999999999999999999999999999976432111


Q ss_pred             ----ccHHHHhhhhhcCcc-----------------chhhhcCC---------cCCCCCCHHHHHHHHHHHHHhcccCCC
Q 040050          295 ----QSLAEWARPLLKEPR-----------------KLERLIDP---------RLEGQFPIKGAQKAAATAFKCLSHHPR  344 (401)
Q Consensus       295 ----~~~~~~~~~~~~~~~-----------------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~  344 (401)
                          ..+..........+.                 .+..+...         .....++...+..+.+||.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence                111111111100000                 00000000         001235677889999999999999999


Q ss_pred             CCCCHHHHHHH
Q 040050          345 HRPTMSYVVRV  355 (401)
Q Consensus       345 ~RPt~~~il~~  355 (401)
                      +|||+.++++.
T Consensus       324 ~Rpt~~ell~h  334 (373)
T 1q8y_A          324 KRADAGGLVNH  334 (373)
T ss_dssp             TCBCHHHHHTC
T ss_pred             ccCCHHHHhhC
Confidence            99999999874

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=340.44  Aligned_cols=272  Identities=22%  Similarity=0.288  Sum_probs=186.2

Q ss_pred             HhcCCCC-CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           75 ITSNFSR-SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        75 ~~~~y~~-~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      +.+.|.+ +++||+|+||+||+|.+...    .+++.||+|++....  ....+.+|+.+|+.++||||+++++++..  
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~----~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDG----KDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSS----SCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccC----CCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            3456776 56899999999999986531    257889999987443  23578899999999999999999999965  


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhc-------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE----cCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSY-------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL----DSD  220 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv----~~~  220 (401)
                      ...+|+||||+. ++|.+++....       ...+++..++.++.||+.||.|||+.+  |+||||||+|||+    +.+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCC
Confidence            678999999995 68888875321       235999999999999999999999655  9999999999999    677


Q ss_pred             CcEEEEecCCCCCCCCCCc-ceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccc-----
Q 040050          221 YTAKLSDFGLAKDGPEGEE-THVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR-----  293 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----  293 (401)
                      +.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......     
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            9999999999986543211 122344679999999999987 458999999999999999999999997543211     


Q ss_pred             --cccHHHHhhhhhcCcc-chhhh------------cCCcCCCCC---------CHHHHHHHHHHHHHhcccCCCCCCCH
Q 040050          294 --EQSLAEWARPLLKEPR-KLERL------------IDPRLEGQF---------PIKGAQKAAATAFKCLSHHPRHRPTM  349 (401)
Q Consensus       294 --~~~~~~~~~~~~~~~~-~~~~~------------~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~  349 (401)
                        ...+......+...+. .+..+            +........         ....+..+.+||.+||+.||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence              0111111111000000 00000            000000000         00114578899999999999999999


Q ss_pred             HHHHHH
Q 040050          350 SYVVRV  355 (401)
Q Consensus       350 ~~il~~  355 (401)
                      .+++++
T Consensus       329 ~e~L~h  334 (405)
T 3rgf_A          329 EQAMQD  334 (405)
T ss_dssp             HHHHTS
T ss_pred             HHHhcC
Confidence            999875

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.4e-43  Score=329.71  Aligned_cols=267  Identities=23%  Similarity=0.311  Sum_probs=196.9

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEE----
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCW----  150 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~----  150 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++..........+.+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDND------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETT------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECC------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            45789999999999999999999876      68899999998766666678899999999999999999999873    


Q ss_pred             ----------eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc-C
Q 040050          151 ----------EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD-S  219 (401)
Q Consensus       151 ----------~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~-~  219 (401)
                                .....++||||+. ++|.+++..   ..+++..++.++.|++.||+|||+.  +|+||||||+||+++ .
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~  156 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA--NVLHRDLKPANLFINTE  156 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT--TCBCCCCSGGGEEEETT
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHEEEcCC
Confidence                      3467899999996 699998854   5789999999999999999999965  499999999999997 5


Q ss_pred             CCcEEEEecCCCCCCCCCCc-ceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccH
Q 040050          220 DYTAKLSDFGLAKDGPEGEE-THVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL  297 (401)
Q Consensus       220 ~~~vkL~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  297 (401)
                      ++.+||+|||++........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......  .+
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~  234 (320)
T 2i6l_A          157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE--QM  234 (320)
T ss_dssp             TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH
T ss_pred             CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH--HH
Confidence            67999999999986543211 112234567999999998875 778999999999999999999999997653211  11


Q ss_pred             HHHhhhhhcCc-cchhhhc-------CCcC-CC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          298 AEWARPLLKEP-RKLERLI-------DPRL-EG-----QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       298 ~~~~~~~~~~~-~~~~~~~-------~~~~-~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ........... .....+.       .... ..     ......+..+.+++.+||+.||.+|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            11111000000 0000000       0000 00     0112346789999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.1e-42  Score=328.36  Aligned_cols=267  Identities=25%  Similarity=0.338  Sum_probs=201.9

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhcc---CCCceeeEEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQL---RHPHLVKLIGYC  149 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnI~~~~~~~  149 (401)
                      ..++|++.+.||+|+||.||+|.+...     +++.||+|++....  ......+.+|+.+++.+   .||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   83 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   83 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC-----CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeee
Confidence            347899999999999999999987521     47899999986432  12223456677776666   899999999998


Q ss_pred             E-----eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEE
Q 040050          150 W-----EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAK  224 (401)
Q Consensus       150 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vk  224 (401)
                      .     .....++||||+. ++|.+++.......+++..++.++.|++.||.|||+.  ||+||||||+||+++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEE
T ss_pred             eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCHHHeEEcCCCCEE
Confidence            7     4567899999996 6999999876556799999999999999999999965  599999999999999999999


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  .+.......
T Consensus       161 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~  235 (326)
T 1blx_A          161 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVI  235 (326)
T ss_dssp             ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHH
T ss_pred             EecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHc
Confidence            99999998654322   2244678999999999999999999999999999999999999997653211  111111100


Q ss_pred             hcC-ccchhh-------hcC---CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          305 LKE-PRKLER-------LID---PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       305 ~~~-~~~~~~-------~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ... ...+..       ...   ......+....+..+.+|+.+||+.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000 000000       000   00001122334678899999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.9e-42  Score=327.22  Aligned_cols=265  Identities=20%  Similarity=0.232  Sum_probs=204.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc------eeeEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH------LVKLIGY  148 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------I~~~~~~  148 (401)
                      +.++|.+.+.||+|+||+||+|.+...     .+..||+|++... ......+.+|+.+++.++|++      ++.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR-----GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC-----CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            458999999999999999999987652     2368999998743 233456788999999987665      9999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE-----------
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL-----------  217 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv-----------  217 (401)
                      +......++||||+ +++|.+++.......+++..++.++.||+.||.|||+.  +|+||||||+|||+           
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~--~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN--QLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC--CcccCCCCHHHEEEecccccccccc
Confidence            99999999999999 77888888776556799999999999999999999954  59999999999999           


Q ss_pred             --------cCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCC
Q 040050          218 --------DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNT  289 (401)
Q Consensus       218 --------~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  289 (401)
                              +.++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    56789999999999864332     23457999999999999999999999999999999999999999765


Q ss_pred             cccccccHHHHhhhhhcCccchhh---------------------------hcCC-cCCCCCCHHHHHHHHHHHHHhccc
Q 040050          290 RLGREQSLAEWARPLLKEPRKLER---------------------------LIDP-RLEGQFPIKGAQKAAATAFKCLSH  341 (401)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~-~~~~~~~~~~~~~l~~li~~cl~~  341 (401)
                      .....  +..........+..+..                           ...+ ..........+..+.+|+.+||+.
T Consensus       243 ~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          243 ENREH--LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             SHHHH--HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             CHHHH--HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence            32111  11110100001100000                           0000 000112234567899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 040050          342 HPRHRPTMSYVVRV  355 (401)
Q Consensus       342 dP~~RPt~~~il~~  355 (401)
                      ||.+|||+.++++.
T Consensus       321 dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          321 DPAQRITLAEALLH  334 (355)
T ss_dssp             STTTSCCHHHHTTS
T ss_pred             ChhhCcCHHHHhcC
Confidence            99999999999853

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.2e-42  Score=332.57  Aligned_cols=261  Identities=21%  Similarity=0.308  Sum_probs=198.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|.+.+.||+|+||.||+|.+..      +++.||+|++.....  .....+.+|+.+++.++||||+++++++...
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKR------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECC------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            45789999999999999999998876      688999999975432  2346788999999999999999999999877


Q ss_pred             CeE------EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 EYR------LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 ~~~------~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      ...      ++||||+. ++|.+++.    ..+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~--~ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCcCHHHeEECCCCCEEEE
Confidence            654      99999995 68877663    4599999999999999999999965  49999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......  ..+........
T Consensus       187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~  259 (371)
T 4exu_A          187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTG  259 (371)
T ss_dssp             STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHC
T ss_pred             ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhC
Confidence            99999864332     345678999999999987 78899999999999999999999999764321  11111111000


Q ss_pred             cCccchh---------hh---cCCcCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKLE---------RL---IDPRLEGQ---FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~~---------~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..+....         ..   +.......   .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0000000         00   00000000   112336789999999999999999999999864

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.7e-42  Score=335.84  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=194.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE--  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~--  153 (401)
                      ..+|.+.+.||+|+||+||+|.+..       +..||+|++......    ..+|+.+++.++||||+++++++....  
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~-------~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVE-------SDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECC-------CCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            4679999999999999999998765       345888887643221    236999999999999999999996543  


Q ss_pred             ----eEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc-CCCcEEEE
Q 040050          154 ----YRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD-SDYTAKLS  226 (401)
Q Consensus       154 ----~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~-~~~~vkL~  226 (401)
                          .+++||||+.+ ++...+..  .....+++..++.++.||+.||+|||+.  +|+||||||+|||++ .++.+||+
T Consensus       108 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CccCCCCCHHHEEEcCCCCcEEEe
Confidence                37899999965 55444432  2346899999999999999999999965  499999999999998 78999999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||++........   .....||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+....  ..+........
T Consensus       185 DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~~i~~~~g  259 (394)
T 4e7w_A          185 DFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLVEIIKVLG  259 (394)
T ss_dssp             CCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHC
T ss_pred             eCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhC
Confidence            9999986544332   2345789999999998764 5899999999999999999999999765321  11111111110


Q ss_pred             cC---------ccchhhhcC----CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KE---------PRKLERLID----PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~---------~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..         +......+.    ..+...++...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00         000000000    000001122346789999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.3e-42  Score=323.82  Aligned_cols=255  Identities=22%  Similarity=0.370  Sum_probs=194.2

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe---
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE---  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~---  151 (401)
                      +.++|++.+.||+|+||.||+|.+..      +++.||+|++... ......+.+|+.+++.++||||+++++++.+   
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNAL------DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcC------CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            34789999999999999999998876      5889999998632 2345678899999999999999999998865   


Q ss_pred             ----------CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC
Q 040050          152 ----------EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY  221 (401)
Q Consensus       152 ----------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~  221 (401)
                                ....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTS
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCC
Confidence                      35689999999999999999753 356788999999999999999999654  99999999999999999


Q ss_pred             cEEEEecCCCCCCCCCCc------------ceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          222 TAKLSDFGLAKDGPEGEE------------THVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       222 ~vkL~DfG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                      .+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            999999999986543210            1122345799999999999864 78999999999999999998   4432


Q ss_pred             CcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          289 TRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..     ...........        ........++...+..+.+++.+||+.||.+|||+.++++.
T Consensus       231 ~~-----~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          231 GM-----ERVNILKKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HH-----HHHHHHHHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ch-----hHHHHHHhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            11     00111111100        01111222344456778999999999999999999999863

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-42  Score=329.45  Aligned_cols=255  Identities=23%  Similarity=0.266  Sum_probs=176.3

Q ss_pred             HhcCCCCCc-eecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           75 ITSNFSRSN-LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        75 ~~~~y~~~~-~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      +.++|.+.+ +||+|+||+||+|.+..      +++.||+|++...    .....+....++.+.||||+++++++..  
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~------~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRR------TGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECC------CCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            457899854 69999999999999876      6889999998642    1222223334566789999999999876  


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEE
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLS  226 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~  226 (401)
                        ....++||||+.+|+|.+++.......+++..++.++.|++.||.|||+.  +|+||||||+||+++.   ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH--NIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CeecCCCCHHHEEEEecCCCceEEEe
Confidence              45689999999999999999876556899999999999999999999965  5999999999999976   4569999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      |||++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ........ 
T Consensus       174 Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~-  246 (336)
T 3fhr_A          174 DFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIR-  246 (336)
T ss_dssp             CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             ccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhh-
Confidence            99999765432    223457899999999999999999999999999999999999999654321100  00000000 


Q ss_pred             CccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             ..............+..+.+|+.+||+.||.+|||+.++++.
T Consensus       247 -------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          247 -------LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -------ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   000000111112346789999999999999999999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.2e-42  Score=326.60  Aligned_cols=257  Identities=24%  Similarity=0.306  Sum_probs=181.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHH-HHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEII-FLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++..... .....+..|+. +++.++||||+++++++...+
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~   94 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKP------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG   94 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETT------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred             HHHhhehheeccCCCEEEEEEEEcC------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence            3789999999999999999998876      588999999975532 23345556665 778889999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFR---SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      ..++||||+. ++|.+++..   .....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           95 DCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN-LKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH-HSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             ceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc-CCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            9999999996 588777753   2246899999999999999999999964 1599999999999999999999999999


Q ss_pred             CCCCCCCCcceeeecccccccccccccc----ccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYV----MTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      +.......   ......||+.|+|||++    .+..++.++|||||||++|+|++|..||.......     ....... 
T Consensus       173 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~-  243 (327)
T 3aln_A          173 SGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVV-  243 (327)
T ss_dssp             SCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-
T ss_pred             ceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHh-
Confidence            98654322   12334699999999998    46678999999999999999999999997542110     0000000 


Q ss_pred             CccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            ....+.+........+..+.+++.+||+.||.+||++.++++.
T Consensus       244 ------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          244 ------KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ------CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ------cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                  0000111111122346789999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=329.64  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=198.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||||++.....  .....+.+|+.+++.++||||+++++++....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKR------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECC------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            4789999999999999999998876      688999999875432  23457889999999999999999999998765


Q ss_pred             e------EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          154 Y------RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       154 ~------~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                      .      .|+||||+. ++|.+++.    ..+++..++.++.||+.||.|||+++  |+||||||+||+++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEee
Confidence            4      499999995 68877763    35999999999999999999999654  99999999999999999999999


Q ss_pred             cCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ||++......     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  .+.........
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~  242 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGV  242 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCB
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCC
Confidence            9999864332     234578999999999887 778999999999999999999999997653211  11111110000


Q ss_pred             Cccchh---------hh---cCC---cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPRKLE---------RL---IDP---RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~~~---------~~---~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+....         ..   +..   ..........+..+.+++.+||+.||.+|||+.++++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            000000         00   000   00111223457789999999999999999999999864

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=325.72  Aligned_cols=246  Identities=24%  Similarity=0.383  Sum_probs=193.2

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc------cHHHHHHHHHHHhcc----CCCc
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ------GHKEWMAEIIFLGQL----RHPH  141 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpn  141 (401)
                      ...+.++|.+.+.||+|+||.||+|.+..      +++.||+|++......      ....+.+|+.++.++    +|||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~   99 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLT------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG   99 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTT------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSS
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEcc------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCC
Confidence            45567899999999999999999998766      5789999998654321      123355688888888    8999


Q ss_pred             eeeEEEEEEeCCeEEEEEEe-cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc-C
Q 040050          142 LVKLIGYCWEEEYRLLVYEY-MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD-S  219 (401)
Q Consensus       142 I~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~-~  219 (401)
                      |+++++++...+..++|||+ +.+++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+||+++ .
T Consensus       100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~--~i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR--GVVHRDIKDENILIDLR  175 (312)
T ss_dssp             BCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH--TEECCCCSGGGEEEETT
T ss_pred             eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeecCCChhhEEEeCC
Confidence            99999999999999999999 7899999999775  5799999999999999999999965  499999999999999 7


Q ss_pred             CCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCC-ccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          220 DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLT-TMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       220 ~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                      ++.+||+|||++.......    .....|++.|+|||++.+..+. .++||||||+++|+|++|+.||.....       
T Consensus       176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------  244 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------  244 (312)
T ss_dssp             TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred             CCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------
Confidence            8999999999998654432    2345699999999999876664 589999999999999999999965310       


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       ...              .  ...++...+..+.+++.+||+.||++||++.++++.
T Consensus       245 -~~~--------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 -ILE--------------A--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -HHH--------------T--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -Hhh--------------h--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000              0  011233346788999999999999999999999864

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.3e-43  Score=329.58  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=201.4

Q ss_pred             HHHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc------cHHHHHHHHHHHhccC--CCc
Q 040050           70 AELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ------GHKEWMAEIIFLGQLR--HPH  141 (401)
Q Consensus        70 ~~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpn  141 (401)
                      .....+.++|.+.+.||+|+||.||+|.+..      +++.||+|++......      ....+.+|+.+++++.  |||
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVS------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETT------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            3445667899999999999999999998776      5889999998643211      1234667999999996  599


Q ss_pred             eeeEEEEEEeCCeEEEEEEecCC-CChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc-C
Q 040050          142 LVKLIGYCWEEEYRLLVYEYMPR-GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD-S  219 (401)
Q Consensus       142 I~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~-~  219 (401)
                      |+++++++...+..++|||++.+ ++|.+++...  ..+++..++.++.|++.||.|||+.  +|+||||||+|||++ .
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~--~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLN  185 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEETT
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CcEeCCCCHHHEEEeCC
Confidence            99999999999999999999976 8999999765  6799999999999999999999955  599999999999999 7


Q ss_pred             CCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHH
Q 040050          220 DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA  298 (401)
Q Consensus       220 ~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  298 (401)
                      ++.+||+|||++.......    .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....       
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------  254 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------  254 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred             CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence            8999999999998654322    234579999999999987665 6889999999999999999999965310       


Q ss_pred             HHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                       ...    ..            ..++...+..+.+++.+||+.||.+|||+.++++.
T Consensus       255 -~~~----~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          255 -IIR----GQ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -HHH----CC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -hhc----cc------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000    00            01122235688999999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.7e-41  Score=318.90  Aligned_cols=253  Identities=25%  Similarity=0.346  Sum_probs=181.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cH-HHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GH-KEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||.||+|.+..      +++.||+|++...... .. ..+.++..+++.++||||+++++++.....
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRK------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETT------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccccccceeeecCCeeEEEEEEec------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            679999999999999999999876      5789999999755332 22 234445567888899999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+ ++.+..+. ......+++..++.++.|++.||.|||+. .+|+|+||||+||+++.++.+||+|||++...
T Consensus        99 ~~lv~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEEEECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHH-HCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEEEecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhh-CCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            99999999 55554444 33356899999999999999999999952 15999999999999999999999999999765


Q ss_pred             CCCCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ....   ......|++.|+|||++.     +..++.++|||||||++|+|++|..||......     ............
T Consensus       176 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~  247 (318)
T 2dyl_A          176 VDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEP  247 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCC
T ss_pred             cCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCC
Confidence            4322   123456999999999984     567889999999999999999999999753211     111111111100


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                             +..  ......+..+.+++.+||+.||.+||++.++++.
T Consensus       248 -------~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 -------PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -------CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -------CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                   000  0011235689999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.4e-41  Score=331.92  Aligned_cols=253  Identities=24%  Similarity=0.327  Sum_probs=186.9

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~  154 (401)
                      .+.|.+.+.||+|+||+||.+...       +++.||||++...   ....+.+|+.+++.+ +||||+++++++.+...
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~-------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSF-------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEES-------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hheeeccCeEeeCCCeEEEEEEEE-------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            355667789999999999865332       4789999998643   345678899999876 89999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCC-----CCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC---------
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAA-----LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD---------  220 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~---------  220 (401)
                      .|+||||+. |+|.+++.......     .++..++.++.||+.||.|||+.+  |+||||||+|||++.+         
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccccc
Confidence            999999995 69999997642111     123345789999999999999654  9999999999999654         


Q ss_pred             ----CcEEEEecCCCCCCCCCCcc--eeeecccccccccccccccc-------CCCCccccHHhHHHHHHHHHh-CCCCC
Q 040050          221 ----YTAKLSDFGLAKDGPEGEET--HVITRVMGTQGYAAPEYVMT-------GHLTTMSDVYSFGVVLLELLT-GKRAM  286 (401)
Q Consensus       221 ----~~vkL~DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf  286 (401)
                          +.+||+|||++.........  .......||+.|+|||++.+       ..++.++|||||||++|+|++ |..||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                48999999999876543221  11234679999999999975       678999999999999999999 99999


Q ss_pred             CCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          287 DNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .......    .........         .+......+...+..+.+++.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~----~~i~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          241 GDKYSRE----SNIIRGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             CSTTTHH----HHHHHTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCchhhH----HHHhcCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            6542111    111111100         011111234567889999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.1e-41  Score=341.97  Aligned_cols=272  Identities=26%  Similarity=0.343  Sum_probs=205.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEe---
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE---  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~---  151 (401)
                      .++|.+.+.||+|+||.||+|.+..      +++.||+|++.... ......+.+|+.++++++||||+++++++..   
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQD------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTT------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECC------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            3789999999999999999997765      68899999987542 3345678899999999999999999998765   


Q ss_pred             ---CCeEEEEEEecCCCChhHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCc---EE
Q 040050          152 ---EEYRLLVYEYMPRGSLHNQLFRSY-SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYT---AK  224 (401)
Q Consensus       152 ---~~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~---vk  224 (401)
                         ....++||||+.|++|.+++.... ...+++..++.++.|++.||.|||+.  ||+||||||+||+++.++.   +|
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~--gIVHrDLKP~NILl~~~g~~~~vK  164 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN--RIIHRDLKPENIVLQPGPQRLIHK  164 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT--TBCCCCCCSTTEEEECCSSSCEEE
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC--CCccCCCCHHHeEeecCCCceeEE
Confidence               667899999999999999997642 23689999999999999999999965  4999999999999987664   99


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...|....
T Consensus       165 L~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i  236 (676)
T 3qa8_A          165 IIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKV  236 (676)
T ss_dssp             ECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTC
T ss_pred             Ecccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhh
Confidence            999999987654332   2446799999999999999999999999999999999999999975321     11111110


Q ss_pred             hcCc-------cchhhh--c--CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHhhhhcc
Q 040050          305 LKEP-------RKLERL--I--DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSY-----VVRVLDSLQDFQ  363 (401)
Q Consensus       305 ~~~~-------~~~~~~--~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~-----il~~L~~l~~~~  363 (401)
                      ....       ......  .  .......+....+..+.+++.+||..||++|||+.+     +++.++.+....
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            0000       000000  0  001112344567889999999999999999999988     556666665443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=327.67  Aligned_cols=249  Identities=23%  Similarity=0.300  Sum_probs=184.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|.+.+.||+|+||+|+.....       +++.||||++......   .+.+|+.+|+.+ +||||+++++++.+....
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~-------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMF-------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEES-------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEe-------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            56889999999999997643222       4789999998654332   356799999999 799999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-----CCcEEEEecCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-----DYTAKLSDFGL  230 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-----~~~vkL~DfG~  230 (401)
                      |+||||+. |+|.+++.... .......++.++.||+.||.|||+.+  |+||||||+|||++.     ...+||+|||+
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99999995 69999987642 34455567889999999999999655  999999999999953     23688999999


Q ss_pred             CCCCCCCCcc-eeeeccccccccccccccc---cCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhh
Q 040050          231 AKDGPEGEET-HVITRVMGTQGYAAPEYVM---TGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       231 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      +......... .......||+.|+|||++.   +..++.++|||||||++|+|++ |..||.......    ...   ..
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~---~~  242 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANI---LL  242 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHH---HT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHH---Hh
Confidence            9866543211 2234467999999999998   4667889999999999999999 899986532110    000   00


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .. ..       ......+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       243 ~~-~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          243 GA-CS-------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TC-CC-------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc-CC-------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00 00       0001112345677899999999999999999999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.8e-40  Score=305.61  Aligned_cols=236  Identities=14%  Similarity=0.116  Sum_probs=186.6

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      .+.++|++.+.||+|+||.||+|++..      +++.||+|++.....   .....+.+|+.++..++||||+++++++.
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~  101 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTA------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH  101 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETT------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecC------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence            345789999999999999999999876      688999999976533   22467889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      ..+..|+||||++|++|.+++..    ......+..++.|++.||.|||++  ||+||||||+|||++.+|.+||+++| 
T Consensus       102 ~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~--givH~Dikp~NIll~~~g~~kl~~~~-  174 (286)
T 3uqc_A          102 TRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA--GVALSIDHPSRVRVSIDGDVVLAYPA-  174 (286)
T ss_dssp             ETTEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCSGGGEEEETTSCEEECSCC-
T ss_pred             ECCcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHC--CCccCCCCcccEEEcCCCCEEEEecc-
Confidence            99999999999999999999843    245567889999999999999965  49999999999999999999997443 


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                                           |++|       ++.++|||||||++|+|++|+.||.........             ..
T Consensus       175 ---------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------------~~  213 (286)
T 3uqc_A          175 ---------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------------AP  213 (286)
T ss_dssp             ---------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-------------EE
T ss_pred             ---------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-------------HH
Confidence                                 3333       689999999999999999999999765321100             00


Q ss_pred             hhhhcCCcCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          311 LERLIDPRLE--GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       311 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      ..........  ......++..+.+++.+||+.||.+| |+.++++.|+.+.....
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          214 AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            0000000000  00112346789999999999999999 99999999999876554

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.1e-40  Score=305.29  Aligned_cols=229  Identities=22%  Similarity=0.310  Sum_probs=181.6

Q ss_pred             hcCCCCC-ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHH-hccCCCceeeEEEEEEe--
Q 040050           76 TSNFSRS-NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL-GQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        76 ~~~y~~~-~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnI~~~~~~~~~--  151 (401)
                      .++|.+. +.||+|+||.||+|.+..      +++.||+|++..     ...+.+|+.++ +.++||||+++++++..  
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcC------CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            3667776 789999999999998876      588999999863     24667888887 55689999999999987  


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEE
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLS  226 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~  226 (401)
                        ....++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+||+++.   ++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEe
Confidence              678899999999999999998765568999999999999999999999654  999999999999988   7899999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      |||++....                        +..++.++|||||||++|+|++|..||........            
T Consensus       163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------------  206 (299)
T 3m2w_A          163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------  206 (299)
T ss_dssp             CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------
T ss_pred             ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------------
Confidence            999886422                        24568899999999999999999999965421100            


Q ss_pred             CccchhhhcCCcCCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPRKLERLIDPRLEGQFP----IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .......+...  ...++    ...+..+.+++.+||+.||.+|||+.++++.
T Consensus       207 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          207 SPGMKTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             -CCSCCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hHHHHHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            00000000000  01112    2246789999999999999999999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-40  Score=342.10  Aligned_cols=243  Identities=25%  Similarity=0.395  Sum_probs=194.8

Q ss_pred             HHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           74 LITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        74 ~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      .+.++|.+.+.||+|+||+||+|.+...     +++.||||++..... .....+.+|+.++++++||||+++++++...
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  151 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNV-----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT  151 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGG-----TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCC-----CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence            4558999999999999999999988642     468899999865432 3345688999999999999999999999876


Q ss_pred             Ce-----EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          153 EY-----RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       153 ~~-----~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                      ..     .||||||++|++|.+++..    .+++..++.++.||+.||.|||+++  ||||||||+|||++.+ .+||+|
T Consensus       152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~D  224 (681)
T 2pzi_A          152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLID  224 (681)
T ss_dssp             CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEECC
T ss_pred             CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEEe
Confidence            65     7999999999999887643    7999999999999999999999654  9999999999999875 999999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ||++......      ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||......               
T Consensus       225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------  282 (681)
T 2pzi_A          225 LGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD---------------  282 (681)
T ss_dssp             CTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS---------------
T ss_pred             cccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc---------------
Confidence            9999865432      3456999999999987654 89999999999999999999887642110               


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHhh
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-MSYVVRVLDSL  359 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~~il~~L~~l  359 (401)
                        .+       .........+..+.+++.+||+.||.+||+ ++++.+.|..+
T Consensus       283 --~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          283 --GL-------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             --SC-------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             --cc-------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence              00       000111233567899999999999999995 66666666655

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3e-40  Score=322.01  Aligned_cols=242  Identities=17%  Similarity=0.165  Sum_probs=181.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCC-Cce----------
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRH-PHL----------  142 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnI----------  142 (401)
                      ..|...+.||+|+||+||+|.+..      +++.||||++.....   .....+.+|+.+++.+.| +|+          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQE------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             eeEEEecccccCCCEEEEEEEecC------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            457788999999999999999876      688999999874332   235678899999999977 211          


Q ss_pred             -----------eeEEEEEEe-----CCeEEEEEEecCCCChhHHHhh-----hcCCCCCHHHHHHHHHHHHHHHHHHhCC
Q 040050          143 -----------VKLIGYCWE-----EEYRLLVYEYMPRGSLHNQLFR-----SYSAALPWSTRMKIALGAAKGLAFLHGE  201 (401)
Q Consensus       143 -----------~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-----~~~~~l~~~~~~~i~~qi~~al~~LH~~  201 (401)
                                 ..+..++..     ....+++|+++ +++|.+++..     .....+++..++.++.|++.||.|||+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                       111111111     12457788876 7899988852     2234577889999999999999999965


Q ss_pred             CCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeecccccccccccccc----------ccCCCCccccHHh
Q 040050          202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYV----------MTGHLTTMSDVYS  271 (401)
Q Consensus       202 ~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diws  271 (401)
                      +  |+||||||+|||++.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++||||
T Consensus       231 ~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          231 G--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             T--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             C--cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            4  999999999999999999999999998764322     345678 999999999          5566889999999


Q ss_pred             HHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 040050          272 FGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSY  351 (401)
Q Consensus       272 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~  351 (401)
                      |||++|+|++|+.||.......                ....++...  .    ..+..+.+|+.+||+.||.+||++.+
T Consensus       303 lGvil~elltg~~Pf~~~~~~~----------------~~~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALG----------------GSEWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGS----------------CSGGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHCCCCCCCcchhh----------------hHHHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999999999997643210                111111111  1    12468999999999999999999887


Q ss_pred             HHHH
Q 040050          352 VVRV  355 (401)
Q Consensus       352 il~~  355 (401)
                      +++.
T Consensus       361 ~l~~  364 (413)
T 3dzo_A          361 AMET  364 (413)
T ss_dssp             HTTS
T ss_pred             HHhC
Confidence            7653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-39  Score=309.13  Aligned_cols=242  Identities=19%  Similarity=0.209  Sum_probs=185.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--------cccHHHHHHHHHHHhccC---------
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--------TQGHKEWMAEIIFLGQLR---------  138 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------  138 (401)
                      .++|.+.+.||+|+||+||+|++.        ++.||||++....        ......+.+|+.+++.++         
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~--------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~   90 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD--------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR   90 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET--------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred             cccchheeeecccCceEEEEEEeC--------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence            467999999999999999999862        5899999997542        223477888999988885         


Q ss_pred             CCceeeEEEEEE------------------------------eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHH
Q 040050          139 HPHLVKLIGYCW------------------------------EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA  188 (401)
Q Consensus       139 hpnI~~~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~  188 (401)
                      ||||+++.+++.                              .....|+||||+.+|++.+.+.+   ..+++..++.++
T Consensus        91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~  167 (336)
T 2vuw_A           91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSIL  167 (336)
T ss_dssp             CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHH
T ss_pred             CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHH
Confidence            888888777653                              26789999999999987777744   578999999999


Q ss_pred             HHHHHHHHHHh-CCCCCeeeccCCCCcEEEcCCC--------------------cEEEEecCCCCCCCCCCcceeeeccc
Q 040050          189 LGAAKGLAFLH-GEDKPVIYRDFKASNILLDSDY--------------------TAKLSDFGLAKDGPEGEETHVITRVM  247 (401)
Q Consensus       189 ~qi~~al~~LH-~~~~~iiH~Dlkp~NIlv~~~~--------------------~vkL~DfG~a~~~~~~~~~~~~~~~~  247 (401)
                      .||+.||.||| +.+  |+||||||+|||++.++                    .+||+|||+|+.....       ...
T Consensus       168 ~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~  238 (336)
T 2vuw_A          168 HQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV  238 (336)
T ss_dssp             HHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred             HHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence            99999999999 766  99999999999999887                    8999999999865332       236


Q ss_pred             cccccccccccccCCCCccccHHhHHHH-HHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHH
Q 040050          248 GTQGYAAPEYVMTGHLTTMSDVYSFGVV-LLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIK  326 (401)
Q Consensus       248 gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (401)
                      ||+.|+|||++.+.. +.++||||||++ .++++.|..||......  ....   ......     ...........+..
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~---~~~~~~-----~~~~~~~~~~~~~~  307 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLT---DKMLKQ-----MTFKTKCNTPAMKQ  307 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHH---HHHHHT-----CCCSSCCCSHHHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHH---Hhhhhh-----hccCcccchhhhhh
Confidence            999999999998776 899999998777 77788899988531000  0000   000000     00001111112346


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHH
Q 040050          327 GAQKAAATAFKCLSHHPRHRPTMSYVV  353 (401)
Q Consensus       327 ~~~~l~~li~~cl~~dP~~RPt~~~il  353 (401)
                      .+.++.+|+.+||+.|     |+.+++
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHH
Confidence            7899999999999976     899887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3e-33  Score=282.26  Aligned_cols=185  Identities=18%  Similarity=0.069  Sum_probs=129.0

Q ss_pred             ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----------cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           85 LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----------TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        85 Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      ++.|++|.+..++..      ..++.|++|++....          ....+++.+|+++|+++ .|+||+++++++.++.
T Consensus       242 ~~~~~~~~h~~~rr~------~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          242 PYAGAGLAHKRSRRY------FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             -C--------CCEEE------EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             cccCCcccccccccc------cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            444555544443322      267899999997542          12235688999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..||||||++|++|.++|.+.  +.++..   .|+.||+.||+|||+++  ||||||||+|||++.+|.+||+|||+|+.
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCee
Confidence            999999999999999999765  667654   58899999999999655  99999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCC
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA  285 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  285 (401)
                      ......  .....+||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus       389 ~~~~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence            544322  23457899999999998764 57789999999998888665544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.2e-28  Score=247.34  Aligned_cols=184  Identities=17%  Similarity=0.189  Sum_probs=142.4

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc--------cHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ--------GHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      ..+.||+|+||.||+|..        .+..+++|........        ..+.+.+|+.++++++||||+++..++...
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  411 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL  411 (540)
T ss_dssp             --------CCEEEEEEEC--------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred             CCCEEeeCCCEEEEEEEE--------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence            357899999999999943        3578999986543211        124478999999999999999655555577


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...||||||++|++|.+++..          +..++.|++.||.|||+++  |+||||||+|||++.  .+||+|||+++
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~  477 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGK  477 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred             CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCE
Confidence            778999999999999998854          5689999999999999654  999999999999998  99999999998


Q ss_pred             CCCCCCcce-----eeecccccccccccccccc--CCCCccccHHhHHHHHHHHHhCCCCC
Q 040050          233 DGPEGEETH-----VITRVMGTQGYAAPEYVMT--GHLTTMSDVYSFGVVLLELLTGKRAM  286 (401)
Q Consensus       233 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf  286 (401)
                      .........     ......||+.|||||++.+  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            765432211     1235679999999999987  67888999999999888888776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=3.3e-25  Score=204.45  Aligned_cols=158  Identities=16%  Similarity=0.100  Sum_probs=121.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------------------ccHHHHHHHHHHHhcc
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------------------QGHKEWMAEIIFLGQL  137 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l  137 (401)
                      ...|.+++.||+|+||.||+|.+ .      +++.||+|+++....                  .....+.+|+.+++++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~-~------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYS-E------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEE-T------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             CeEEEecCEeccCCCceEEEEEe-C------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            45677889999999999999988 4      588999999964321                  1235688999999999


Q ss_pred             CCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE
Q 040050          138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL  217 (401)
Q Consensus       138 ~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv  217 (401)
                      +|   +++.+++.. +..|+||||++|++|.+ +..        .....++.|++.||.|||+.+  |+||||||+|||+
T Consensus       162 ~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl  226 (282)
T 1zar_A          162 QG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV  226 (282)
T ss_dssp             TT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE
T ss_pred             cC---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEE
Confidence            84   455554433 45699999999999988 421        234579999999999999554  9999999999999


Q ss_pred             cCCCcEEEEecCCCCCCCCCCcceeeecccccccccccccccc----------CCCCccccHHh
Q 040050          218 DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT----------GHLTTMSDVYS  271 (401)
Q Consensus       218 ~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diws  271 (401)
                      + ++.+||+|||++..               +..++|||.+..          ..|+..+|+|.
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9 99999999999863               345789998753          34555566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.83  E-value=4.3e-21  Score=174.67  Aligned_cols=137  Identities=15%  Similarity=0.107  Sum_probs=104.7

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCce--EEEEEecCCCcc------------------------cHHHHHHHHH
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQP--VAVKALDLDGTQ------------------------GHKEWMAEII  132 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~  132 (401)
                      |.+.+.||+|+||.||+|.+..      +++.  ||||+++.....                        ....+.+|+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  122 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVF------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFR  122 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEE------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcC------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHH
Confidence            6788999999999999998743      4778  999987543211                        0135778999


Q ss_pred             HHhccCCCce--eeEEEEEEeCCeEEEEEEecCC-C----ChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHh-CCCCC
Q 040050          133 FLGQLRHPHL--VKLIGYCWEEEYRLLVYEYMPR-G----SLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLH-GEDKP  204 (401)
Q Consensus       133 ~l~~l~hpnI--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~~~  204 (401)
                      +|..+.|++|  +.++++    ...+|||||+.+ |    +|.+....     .++..+..++.|++.||.||| +.+  
T Consensus       123 ~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g--  191 (258)
T 1zth_A          123 NLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE--  191 (258)
T ss_dssp             HHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC--
T ss_pred             HHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC--
Confidence            9999988764  444432    246899999932 3    56555422     224467889999999999999 766  


Q ss_pred             eeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          205 VIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       205 iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      |+||||||.|||++.  .++|+|||+|...
T Consensus       192 ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          192 LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999999988  9999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.72  E-value=4.7e-18  Score=161.25  Aligned_cols=137  Identities=13%  Similarity=0.090  Sum_probs=98.0

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc--------------ccHHH--------HHHHHHHHhc
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--------------QGHKE--------WMAEIIFLGQ  136 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~  136 (401)
                      |.+++.||.|+||.||+|.+.       +|+.||||+++....              .....        ...|...|.+
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEECC-------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999999999865       378999998753210              00111        2346777777


Q ss_pred             cCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEE
Q 040050          137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNIL  216 (401)
Q Consensus       137 l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIl  216 (401)
                      +.+.++....-+....  .+|||||++|++|..+..      .  .....++.|++.+|.+||+.  |||||||||.|||
T Consensus       170 L~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~------~--~~~~~l~~qll~~l~~lH~~--gIVHrDLKp~NIL  237 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS------V--PDPASLYADLIALILRLAKH--GLIHGDFNEFNIL  237 (397)
T ss_dssp             HHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC------C--SCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEE
T ss_pred             HHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc------c--HHHHHHHHHHHHHHHHHHHC--CCcCCCCCHHHEE
Confidence            7655443221111222  379999999888865431      1  23457889999999999965  4999999999999


Q ss_pred             EcCCC----------cEEEEecCCCCCC
Q 040050          217 LDSDY----------TAKLSDFGLAKDG  234 (401)
Q Consensus       217 v~~~~----------~vkL~DfG~a~~~  234 (401)
                      ++++|          .+.|+||+-+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98776          4899999987653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=1e-12  Score=119.22  Aligned_cols=143  Identities=14%  Similarity=0.055  Sum_probs=110.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~  153 (401)
                      .-..|++...++.|+.+.||++...        +..+++|+...........+.+|+.+++.+. +..+.++++++....
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            3357888889999999999998532        4689999986421122345788999998885 677889999999888


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC-------------------------------
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED-------------------------------  202 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~-------------------------------  202 (401)
                      ..|+|||+++|.+|.+.+.       +......++.+++.+|+.||+..                               
T Consensus        84 ~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred             ceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence            9999999999999876531       11123467888999999999610                               


Q ss_pred             --------------------------CCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          203 --------------------------KPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       203 --------------------------~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                                                ..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                      348999999999999876566799998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.26  E-value=1.1e-11  Score=111.79  Aligned_cols=135  Identities=16%  Similarity=0.051  Sum_probs=96.7

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc--eeeEEEEEEeCCeE
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH--LVKLIGYCWEEEYR  155 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--I~~~~~~~~~~~~~  155 (401)
                      .|.+..+.+.|..+.||++...       ++..+++|+....   ....+..|+.+++.+.+.+  +.+++++...++..
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~-------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ-------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT-------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             CCceEecccCCCCceEEEEecC-------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            3444333345666999998543       3567999997643   2245678899888886444  56688888887788


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC---------------------------------
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED---------------------------------  202 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------  202 (401)
                      ++||||++|.+|.  ..     ...   ...++.+++..|..||+..                                 
T Consensus        91 ~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE  160 (264)
T ss_dssp             EEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred             EEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence            9999999998883  21     112   2356777778888888532                                 


Q ss_pred             -----------------------CCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          203 -----------------------KPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       203 -----------------------~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                                             ..++|+|++|.||+++.++.+.|+|||.+.
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   129999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.14  E-value=1.6e-10  Score=109.71  Aligned_cols=142  Identities=15%  Similarity=0.195  Sum_probs=105.1

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEec--CCC-cccHHHHHHHHHHHhccC--CCceeeEEEEEEeC--
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD--LDG-TQGHKEWMAEIIFLGQLR--HPHLVKLIGYCWEE--  152 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpnI~~~~~~~~~~--  152 (401)
                      ...+.|+.|.++.||++...        +..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.  
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~  112 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV  112 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred             ceEEEcCCcccceEEEEEEC--------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence            34578999999999998643        3578898875  322 122346778999999887  45688888888766  


Q ss_pred             -CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 040050          153 -EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE------------------------------  201 (401)
Q Consensus       153 -~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------------------------------  201 (401)
                       ...|+||||++|..+.+..    ...++......++.+++.+|+.||+.                              
T Consensus       113 ~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (359)
T 3dxp_A          113 IGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL  188 (359)
T ss_dssp             TSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence             3478999999988775421    13567888889999999999999962                              


Q ss_pred             --------------------------CCCeeeccCCCCcEEEcCCCc--EEEEecCCCCC
Q 040050          202 --------------------------DKPVIYRDFKASNILLDSDYT--AKLSDFGLAKD  233 (401)
Q Consensus       202 --------------------------~~~iiH~Dlkp~NIlv~~~~~--vkL~DfG~a~~  233 (401)
                                                ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                      246999999999999987653  68999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=6.6e-11  Score=109.76  Aligned_cols=182  Identities=19%  Similarity=0.191  Sum_probs=119.9

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCc--eeeEEEEEEeCC---eE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPH--LVKLIGYCWEEE---YR  155 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--I~~~~~~~~~~~---~~  155 (401)
                      .+.++.|....||++           +..+++|+....  .....+.+|..+|+.+. +..  +..++.......   ..
T Consensus        25 i~~~~~G~~n~v~~v-----------~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEI-----------NRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS   91 (304)
T ss_dssp             CCEEEECSSEEEEES-----------TTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred             eEecCCCCcceEEEE-----------CCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence            467899999999986           246999986422  23456888999998873 333  445555443333   34


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE----------------------------------  201 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----------------------------------  201 (401)
                      |+||++++|.+|.....    ..++......++.+++..++.||+.                                  
T Consensus        92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            88999999988865432    2466777778888888888888841                                  


Q ss_pred             ----------------------CCCeeeccCCCCcEEEcC--CCcEEEEecCCCCCCCCCCcceeeecccccccc---cc
Q 040050          202 ----------------------DKPVIYRDFKASNILLDS--DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY---AA  254 (401)
Q Consensus       202 ----------------------~~~iiH~Dlkp~NIlv~~--~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y---~a  254 (401)
                                            ...++|+|++|.||+++.  .+.+.|+||+.+..........      ....+   ..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~  241 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYG  241 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCC
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccC
Confidence                                  124799999999999988  5567899999886422111000      00001   12


Q ss_pred             ccccc----c-CCC---------CccccHHhHHHHHHHHHhCCCCC
Q 040050          255 PEYVM----T-GHL---------TTMSDVYSFGVVLLELLTGKRAM  286 (401)
Q Consensus       255 PE~~~----~-~~~---------~~~~DiwslG~il~ell~g~~pf  286 (401)
                      |+...    . +..         ....+.|++|.++|.+.+|..+|
T Consensus       242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            22111    0 001         12268999999999999999876

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.63  E-value=3.4e-07  Score=82.89  Aligned_cols=134  Identities=18%  Similarity=0.117  Sum_probs=94.6

Q ss_pred             eecccCCe-eEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEEEEEEe
Q 040050           84 LLGEGGFG-PVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRLLVYEY  161 (401)
Q Consensus        84 ~Lg~G~~g-~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~lv~e~  161 (401)
                      .+..|..| .||+.....      .+..+++|+-..   .....+.+|...|+.+. +--+.+++.++.+.+..++||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~------~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~  101 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKP------NAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA  101 (272)
T ss_dssp             EEECSSSSCEEEEEECCT------TCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             EccCCCcCCeEEEEEecC------CCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence            45556555 689876543      356799998653   23456778999888875 33477889999999999999999


Q ss_pred             cCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC---------------------------------------
Q 040050          162 MPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED---------------------------------------  202 (401)
Q Consensus       162 ~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------------------  202 (401)
                      ++|.++.+.....      ......++.+++..|+.||...                                       
T Consensus       102 l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          102 IPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             CCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             eCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            9998876654321      1122345556666666666421                                       


Q ss_pred             -----------------CCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          203 -----------------KPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       203 -----------------~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                                       ..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                             127899999999999987777899998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.63  E-value=2.1e-07  Score=86.06  Aligned_cols=135  Identities=20%  Similarity=0.141  Sum_probs=90.7

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCC---ceeeEEEEEE-eCCeEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHP---HLVKLIGYCW-EEEYRLL  157 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nI~~~~~~~~-~~~~~~l  157 (401)
                      .+.++.|....||+.           +..+++|+..  .......+.+|..+|+.+.+.   .+..++.+.. .....++
T Consensus        24 v~~l~~G~~n~v~~v-----------g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----------NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-----------TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred             eeecCCCcceeEEEE-----------CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence            466888888899987           3468999853  223345678899999998742   3566776664 3456789


Q ss_pred             EEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 040050          158 VYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE------------------------------------  201 (401)
Q Consensus       158 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------------------------------------  201 (401)
                      ||++++|.++.....    ..++......++.++...|+.||+.                                    
T Consensus        91 v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           91 GYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            999999988765321    1233334444444444444444422                                    


Q ss_pred             ----------------------CCCeeeccCCCCcEEEcC---CCc-EEEEecCCCCC
Q 040050          202 ----------------------DKPVIYRDFKASNILLDS---DYT-AKLSDFGLAKD  233 (401)
Q Consensus       202 ----------------------~~~iiH~Dlkp~NIlv~~---~~~-vkL~DfG~a~~  233 (401)
                                            ...++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                  234799999999999987   455 48999997763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.36  E-value=6.5e-07  Score=84.51  Aligned_cols=87  Identities=3%  Similarity=-0.146  Sum_probs=53.8

Q ss_pred             Ccee-cccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHHHHHHHHhccC-C--CceeeEEEEEEeC--
Q 040050           82 SNLL-GEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWMAEIIFLGQLR-H--PHLVKLIGYCWEE--  152 (401)
Q Consensus        82 ~~~L-g~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnI~~~~~~~~~~--  152 (401)
                      .+.| +.|....+|+............+..+++|+.....   ......+.+|+.+++.+. +  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88888999987543000000014578999865322   001235667888888774 3  3567788777655  


Q ss_pred             -CeEEEEEEecCCCChh
Q 040050          153 -EYRLLVYEYMPRGSLH  168 (401)
Q Consensus       153 -~~~~lv~e~~~~~~L~  168 (401)
                       ...++|||+++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             2468999999887654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.27  E-value=3.2e-06  Score=81.03  Aligned_cols=76  Identities=14%  Similarity=0.130  Sum_probs=49.1

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-------ccHHHHHHHHHHHhccCC--C-ceeeEEEEEEe
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-------QGHKEWMAEIIFLGQLRH--P-HLVKLIGYCWE  151 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-nI~~~~~~~~~  151 (401)
                      .+.||.|.++.||++....      .++.+++|.......       .....+..|.++++.+..  | .+.+++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECC------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            4689999999999996543      356799998653211       123456778888887742  3 34456543  3


Q ss_pred             CCeEEEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRG  165 (401)
Q Consensus       152 ~~~~~lv~e~~~~~  165 (401)
                      ....++|||++.+.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            44568999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.09  E-value=2.4e-05  Score=72.95  Aligned_cols=31  Identities=16%  Similarity=0.229  Sum_probs=27.6

Q ss_pred             CCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       202 ~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            4569999999999999888899999999765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.86  E-value=5.5e-05  Score=68.96  Aligned_cols=80  Identities=20%  Similarity=0.236  Sum_probs=56.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCC---CceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH---PHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnI~~~~~~~~~~~  153 (401)
                      ....-.+.+|.|..+.||+....+       |+.|++|+...........+..|...|+.+.-   --+++++++  .. 
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~D-------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~-   84 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELAD-------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD-   84 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETT-------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET-
T ss_pred             CCeEEEEecCCCCCeEEEEEEECC-------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC-
Confidence            455566889999999999997664       78899998765444444567789998888742   134555544  22 


Q ss_pred             eEEEEEEecCCCCh
Q 040050          154 YRLLVYEYMPRGSL  167 (401)
Q Consensus       154 ~~~lv~e~~~~~~L  167 (401)
                       -++|||++.++..
T Consensus        85 -~~lv~e~l~~~~~   97 (288)
T 3f7w_A           85 -RTLAMEWVDERPP   97 (288)
T ss_dssp             -TEEEEECCCCCCC
T ss_pred             -ceEEEEeecccCC
Confidence             3789999977654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.76  E-value=0.00018  Score=66.43  Aligned_cols=75  Identities=17%  Similarity=0.095  Sum_probs=58.5

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC---CCceeeEEEEEEeCCeEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR---HPHLVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnI~~~~~~~~~~~~~~lv  158 (401)
                      .+.|+.|....+|+....        +..+++|+....   ....+..|...|+.+.   ...+++++.+.......++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~--------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE--------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEECCSSSSEEEEEESS--------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eEEeCCccceeeeEEEEC--------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            467899999999998632        467899987532   3456788998888884   35688888888878889999


Q ss_pred             EEecCCCCh
Q 040050          159 YEYMPRGSL  167 (401)
Q Consensus       159 ~e~~~~~~L  167 (401)
                      ||+++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999988765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.71  E-value=0.00024  Score=61.05  Aligned_cols=102  Identities=14%  Similarity=0.029  Sum_probs=65.9

Q ss_pred             CChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeee
Q 040050          165 GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVIT  244 (401)
Q Consensus       165 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~  244 (401)
                      -+|.+.|... +.+++++++|.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|-+.+ +.+.            
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRR-QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT-CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcc-cCCceecCCcceEEecCCceeccc-cccc------------
Confidence            3688877654 589999999999999999988762100 011233457999999999998764 1111            


Q ss_pred             ccccccccccccccccCCCCccccHHhHHHHHHHHHhCCC
Q 040050          245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR  284 (401)
Q Consensus       245 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  284 (401)
                        .....+.|||... ...+.+.=|||||+++|..+--..
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence              1223466888653 344678889999999999986443

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.59  E-value=0.00037  Score=67.16  Aligned_cols=77  Identities=14%  Similarity=0.153  Sum_probs=46.2

Q ss_pred             CCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeecccc--ccccccccccccC---CCCccccHHhHHHHH
Q 040050          202 DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG--TQGYAAPEYVMTG---HLTTMSDVYSFGVVL  276 (401)
Q Consensus       202 ~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DiwslG~il  276 (401)
                      ...++|+|++|.|||++.++ +.|+||+.+......-..   ....+  ...|++|+.....   .-....++..+...+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            45599999999999998876 999999988742211000   00011  1245666544311   111234555777777


Q ss_pred             HHHHhC
Q 040050          277 LELLTG  282 (401)
Q Consensus       277 ~ell~g  282 (401)
                      |..+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.55  E-value=0.00023  Score=65.24  Aligned_cols=71  Identities=7%  Similarity=0.063  Sum_probs=44.1

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeEEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL-VKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-~~~~~~~~~~~~~~lv~e  160 (401)
                      .+.|+.|....+|+.            ..+++|+....... .....+|+.+++.+...++ .+++.+  +...-+++++
T Consensus        23 i~~l~gG~tN~~~~~------------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE------------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             eeEcCCcccccccee------------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            678988999999987            24899987643211 1123457777776642222 455544  3334578999


Q ss_pred             ec-CCCCh
Q 040050          161 YM-PRGSL  167 (401)
Q Consensus       161 ~~-~~~~L  167 (401)
                      |+ +|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66555

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.48  E-value=0.00079  Score=62.49  Aligned_cols=32  Identities=34%  Similarity=0.376  Sum_probs=27.5

Q ss_pred             CCCeeeccCCCCcEEEcCC----CcEEEEecCCCCC
Q 040050          202 DKPVIYRDFKASNILLDSD----YTAKLSDFGLAKD  233 (401)
Q Consensus       202 ~~~iiH~Dlkp~NIlv~~~----~~vkL~DfG~a~~  233 (401)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3469999999999999874    6899999998864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.46  E-value=0.00084  Score=65.29  Aligned_cols=75  Identities=11%  Similarity=-0.000  Sum_probs=46.5

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeEEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL-VKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-~~~~~~~~~~~~~~lv~e  160 (401)
                      .+.|+.|-...+|++....      .+..+++|+....... .-...+|..+++.+...++ .++++++  .+  .+||+
T Consensus       113 i~~lsgG~tN~~y~v~~~~------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e  181 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEE  181 (458)
T ss_dssp             EEEECC--CEEEEEEEETT------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEE
T ss_pred             EEEcCCCeEeEEEEEEECC------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEE
Confidence            3578888889999986543      2467899987532211 1112478888888864444 5677766  23  35999


Q ss_pred             ecCCCCh
Q 040050          161 YMPRGSL  167 (401)
Q Consensus       161 ~~~~~~L  167 (401)
                      |++|.+|
T Consensus       182 ~I~G~~l  188 (458)
T 2qg7_A          182 FMDGYAL  188 (458)
T ss_dssp             CCCSEEC
T ss_pred             eeCCccC
Confidence            9987544

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.45  E-value=0.00038  Score=67.27  Aligned_cols=80  Identities=20%  Similarity=0.164  Sum_probs=49.9

Q ss_pred             CceecccCCeeEEEEEecCcCC-CCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCce-eeEEEEEEeCCeEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL-VKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-~~~~~~~~~~~~~~lv~  159 (401)
                      .+.|+.|....||++....... ....+..+++|+.....  ....+..|..+++.+...++ +++++.+.  +  .+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            4678888889999987542100 01124679999874321  22456679988888853333 56666553  2  3899


Q ss_pred             EecCCCCh
Q 040050          160 EYMPRGSL  167 (401)
Q Consensus       160 e~~~~~~L  167 (401)
                      +|++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99976444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.44  E-value=0.00047  Score=65.32  Aligned_cols=146  Identities=18%  Similarity=0.182  Sum_probs=81.6

Q ss_pred             CceecccCCeeEEEEEecCcCC-CCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      .+.|..|-...+|++....... ....++.+++++.... ........+|..+++.+. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            3567778888999987542110 1113468999986322 223456678999988885 3333566666543    2999


Q ss_pred             EecCCCChhHH--------------Hhhhc------CCCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 040050          160 EYMPRGSLHNQ--------------LFRSY------SAALP--WSTRMKIALGAAK-------------------GLAF-  197 (401)
Q Consensus       160 e~~~~~~L~~~--------------l~~~~------~~~l~--~~~~~~i~~qi~~-------------------al~~-  197 (401)
                      ||++|.+|...              +.+-.      .+...  +..+..+..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99987655311              11100      11111  3344444433321                   1222 


Q ss_pred             ---HhC--CCCCeeeccCCCCcEEEcCC----CcEEEEecCCCC
Q 040050          198 ---LHG--EDKPVIYRDFKASNILLDSD----YTAKLSDFGLAK  232 (401)
Q Consensus       198 ---LH~--~~~~iiH~Dlkp~NIlv~~~----~~vkL~DfG~a~  232 (401)
                         |..  ....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               222  13358999999999999876    789999998775

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.22  E-value=0.0076  Score=55.36  Aligned_cols=154  Identities=13%  Similarity=0.119  Sum_probs=79.9

Q ss_pred             HHHHHHHhcCCCCC-----ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc--
Q 040050           69 LAELRLITSNFSRS-----NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH--  141 (401)
Q Consensus        69 ~~~~~~~~~~y~~~-----~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--  141 (401)
                      ..++..+-..|.++     +.|+.|....+|+.....        ..+++|+.....  ....+..|..++..+...+  
T Consensus         9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~--------g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~   78 (322)
T 2ppq_A            9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--------DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLS   78 (322)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--------CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC--------ccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCC
Confidence            33444444456552     456678888999886432        368999886421  1123455666666653212  


Q ss_pred             eeeEEE------EEEeCCeEEEEEEecCCCChhH--------------HHhhh---cCCC----CC---HHHHHH-----
Q 040050          142 LVKLIG------YCWEEEYRLLVYEYMPRGSLHN--------------QLFRS---YSAA----LP---WSTRMK-----  186 (401)
Q Consensus       142 I~~~~~------~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~---~~~~----l~---~~~~~~-----  186 (401)
                      +.+++.      +....+..+++|++++|..+..              .++..   ....    ..   +.....     
T Consensus        79 vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~  158 (322)
T 2ppq_A           79 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER  158 (322)
T ss_dssp             CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred             CCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHH
Confidence            222221      1123456789999998765421              01110   0000    11   111000     


Q ss_pred             -------HHHHHHHHHHHHhC-----CCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          187 -------IALGAAKGLAFLHG-----EDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       187 -------i~~qi~~al~~LH~-----~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                             +...+...+..++.     ...+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       159 ~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          159 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                   00112333444431     13459999999999999887666899998765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.19  E-value=0.0046  Score=57.01  Aligned_cols=140  Identities=14%  Similarity=0.114  Sum_probs=78.3

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc--eeeEEEE-----EEeCCeE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH--LVKLIGY-----CWEEEYR  155 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--I~~~~~~-----~~~~~~~  155 (401)
                      ..|+ |....||+....       .++.+++|...... .....+..|..++..+...+  +++++..     ....+..
T Consensus        32 ~~l~-g~~n~~y~v~~~-------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~  102 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY  102 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred             Eeec-CcccceEEEEcC-------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence            4577 778899987533       25579999986331 13355667887777764212  3333332     2234566


Q ss_pred             EEEEEecCCCChh----H-------H---Hhhh-c------CCCCCHHHH----------------------HHHHHHHH
Q 040050          156 LLVYEYMPRGSLH----N-------Q---LFRS-Y------SAALPWSTR----------------------MKIALGAA  192 (401)
Q Consensus       156 ~lv~e~~~~~~L~----~-------~---l~~~-~------~~~l~~~~~----------------------~~i~~qi~  192 (401)
                      +++|++++|..+.    +       .   ++.. .      ....+....                      ...+..++
T Consensus       103 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  182 (328)
T 1zyl_A          103 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI  182 (328)
T ss_dssp             EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred             EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence            8899999775432    0       0   1110 0      011121110                      11222222


Q ss_pred             HHHHHHhC--CCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          193 KGLAFLHG--EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       193 ~al~~LH~--~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..+.-+..  ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            22332211  244589999999999998 4 899999987753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.11  E-value=0.00071  Score=63.84  Aligned_cols=81  Identities=9%  Similarity=-0.002  Sum_probs=43.8

Q ss_pred             CceecccCCeeEEEEEecCcC--CCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCeEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKL--KPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH-LVKLIGYCWEEEYRLLV  158 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-I~~~~~~~~~~~~~~lv  158 (401)
                      .+.|+.|....+|+.......  .....+..+++|+...... .......|..+++.+...+ +.++++.+  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            356777888899998654200  0001135788898654321 1112356777777775333 44666544  2  2689


Q ss_pred             EEecCCCCh
Q 040050          159 YEYMPRGSL  167 (401)
Q Consensus       159 ~e~~~~~~L  167 (401)
                      |+|++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.73  E-value=0.0098  Score=55.31  Aligned_cols=31  Identities=16%  Similarity=0.188  Sum_probs=27.2

Q ss_pred             CCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       203 ~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.24  E-value=0.0077  Score=57.80  Aligned_cols=81  Identities=10%  Similarity=0.017  Sum_probs=47.7

Q ss_pred             CceecccCCeeEEEEEecCcCC-CCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLK-PGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      .+.|..|-...+|+........ ....+..+++++.... ....-...+|..+++.+. +.-..++++.+  .+  ++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEE
Confidence            4667778888899987642100 0011567999986532 222223356888887774 33345566533  22  6899


Q ss_pred             EecCCCCh
Q 040050          160 EYMPRGSL  167 (401)
Q Consensus       160 e~~~~~~L  167 (401)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99988654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.44  E-value=0.21  Score=47.31  Aligned_cols=28  Identities=29%  Similarity=0.358  Sum_probs=24.2

Q ss_pred             eeeccCCCCcEEE------cCCCcEEEEecCCCC
Q 040050          205 VIYRDFKASNILL------DSDYTAKLSDFGLAK  232 (401)
Q Consensus       205 iiH~Dlkp~NIlv------~~~~~vkL~DfG~a~  232 (401)
                      ++|+|+.+.||++      ++++.+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            5799999999999      345789999998875

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.05  E-value=0.4  Score=40.95  Aligned_cols=124  Identities=8%  Similarity=0.097  Sum_probs=82.2

Q ss_pred             HHHHHhccCCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeecc
Q 040050          130 EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRD  209 (401)
Q Consensus       130 E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~D  209 (401)
                      |+.+|. ..||+.+.. .+-.+++.+.+.++.-..+.=+..+     ..++....++++.+|+....+++  .  =+|--
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~--~--r~tf~  104 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNR--T--RYTFV  104 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGG--S--SEECC
T ss_pred             HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhc--C--ceEEE
Confidence            344443 358888877 5666667666666654322222223     45778899999999988886665  3  56778


Q ss_pred             CCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCC
Q 040050          210 FKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDN  288 (401)
Q Consensus       210 lkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  288 (401)
                      |.|+|++++.++.+++.-.|+-..                   ++|.     .++...=+-.+=|++..+++++..|+.
T Consensus       105 L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          105 LAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             CSGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999999999986665332                   2222     112222344567889999999888753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.21  E-value=0.49  Score=40.61  Aligned_cols=115  Identities=10%  Similarity=0.076  Sum_probs=77.6

Q ss_pred             CCCceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHH-HHhCCCCCeeeccCCCCcEE
Q 040050          138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA-FLHGEDKPVIYRDFKASNIL  216 (401)
Q Consensus       138 ~hpnI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~-~LH~~~~~iiH~Dlkp~NIl  216 (401)
                      .||++  -..+-.+++.+.+.++.-+++.-+..+     ..++....++++.+|+.... +++  .  -+|-=|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-----~~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-----RKTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-----HTSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-----HhcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            57887  444456777777777765444334444     35788899999999887766 555  3  577789999999


Q ss_pred             EcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCC
Q 040050          217 LDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD  287 (401)
Q Consensus       217 v~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  287 (401)
                      ++.++.+++.-.|+-.                   -++|.-+     +..-=+-.+=|++..++.++..|+
T Consensus       117 f~~~~~p~i~hRGi~~-------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKE-------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETT-------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcc-------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998666433                   2333311     222223456678888888887764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=82.12  E-value=0.19  Score=48.76  Aligned_cols=62  Identities=11%  Similarity=0.146  Sum_probs=18.1

Q ss_pred             CCCceecccCCeeEEEEEecCcCCCCCCCceEEE------EEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           80 SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAV------KALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        80 ~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      .+.+.||   ||.||+|.+..      ...+||+      |......  .+....+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYK------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccc------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456676   99999998764      2347888      6654321  223346788999999999999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	401
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-72
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-67
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-63
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-62
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-62
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-62
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-61
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-58
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-58
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-45
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	9e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-42
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 2e-72
 Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 30/289 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFL 134
              +    +G G FG VYKG    K         VAVK L++     Q  + +  E+  L
Sbjct: 8   GQITVGQRIGSGSFGTVYKG----KWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVL 58

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
            + RH +++  +GY        +V ++    SL++ L             + IA   A+G
Sbjct: 59  RKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQG 116

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           + +LH   K +I+RD K++NI L  D T K+ DFGLA        +H   ++ G+  + A
Sbjct: 117 MDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 255 PEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL 311
           PE +        +  SDVY+FG+VL EL+TG+    N     +         L  +  K+
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
                  +                 +CL      RP    ++  ++ L 
Sbjct: 235 RSNCPKAM------------KRLMAECLKKKRDERPLFPQILASIELLA 271

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (539), Expect = 8e-67
 Identities = 72/292 (24%), Positives = 129/292 (44%), Gaps = 23/292 (7%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLG 135
           S  +R  ++G G FG VYKG +  K   G +  PVA+K L    T+  + +++ E   +G
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGML--KTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           Q  H ++++L G   + +  +++ EYM  G+  ++  R           + +  G A G+
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGM 123

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE-THVITRVMGTQGYAA 254
            +L   +   ++RD  A NIL++S+   K+SDFGL++   +  E T+  +       + A
Sbjct: 124 KYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +     T+ SDV+SFG+V+ E++T                            ++ + 
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------------SNHEVMKA 225

Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSF 366
           I+       P+           +C       RP  + +V +LD L    DS 
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  209 bits (533), Expect = 9e-66
 Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 39/313 (12%)

Query: 63  KLHV--FTLAELRLITSNFSRS---------NLLGEGGFGPVYKGFVDEKLKPGLEAQPV 111
           K+ +  FT  +       F++           ++G G FG V  G       PG     V
Sbjct: 1   KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSG---HLKLPGKREIFV 57

Query: 112 AVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQ 170
           A+K L    T +  +++++E   +GQ  HP+++ L G   +    +++ E+M  GSL   
Sbjct: 58  AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-S 116

Query: 171 LFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL 230
             R           + +  G A G+ +L   D   ++RD  A NIL++S+   K+SDFGL
Sbjct: 117 FLRQNDGQFTVIQLVGMLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGL 174

Query: 231 AKDGPEGEETHVITRV---MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAM 286
           ++   +       T          + APE +     T+ SDV+S+G+V+ E+++ G+R  
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234

Query: 287 DNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHR 346
            +                    + +   I+       P+            C      HR
Sbjct: 235 WD-----------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277

Query: 347 PTMSYVVRVLDSL 359
           P    +V  LD +
Sbjct: 278 PKFGQIVNTLDKM 290

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 4e-65
 Identities = 71/285 (24%), Positives = 121/285 (42%), Gaps = 28/285 (9%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           S  +    +G G FG V+ G              VA+K +  +G    ++++ E   + +
Sbjct: 5   SELTFVQEIGSGQFGLVHLG----YWLNK---DKVAIKTIR-EGAMSEEDFIEEAEVMMK 56

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L HP LV+L G C E+    LV+E+M  G L     R+        T + + L   +G+A
Sbjct: 57  LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS-DYLRTQRGLFAAETLLGMCLDVCEGMA 115

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L   +  VI+RD  A N L+  +   K+SDFG+ +   + + T           +A+PE
Sbjct: 116 YLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPE 172

Query: 257 YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID 316
                  ++ SDV+SFGV++ E+ +  +     R   E         ++++     RL  
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYK 223

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
           PRL        +         C    P  RP  S ++R L  + +
Sbjct: 224 PRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 5e-64
 Identities = 72/281 (25%), Positives = 119/281 (42%), Gaps = 28/281 (9%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
                   LG G FG V+ G+ +           VAVK+L    +     ++AE   + Q
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGH-------TKVAVKSLKQG-SMSPDAFLAEANLMKQ 64

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L+H  LV+L      +E   ++ EYM  GSL + L       L  +  + +A   A+G+A
Sbjct: 65  LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           F+   ++  I+RD +A+NIL+    + K++DFGLA+   + E             + APE
Sbjct: 124 FIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPE 180

Query: 257 YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID 316
            +  G  T  SDV+SFG++L E++T  R                         ++ + ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----------------MTNPEVIQNLE 224

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD 357
                  P    ++       C    P  RPT  Y+  VL+
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-63
 Identities = 59/280 (21%), Positives = 108/280 (38%), Gaps = 28/280 (10%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
            + +    LG G FG V  G    K +       VA+K +  +G+    E++ E   +  
Sbjct: 4   KDLTFLKELGTGQFGVVKYG----KWRGQ---YDVAIKMIK-EGSMSEDEFIEEAKVMMN 55

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L H  LV+L G C ++    ++ EYM  G L N L             +++     + + 
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAME 114

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L    K  ++RD  A N L++     K+SDFGL++   +  E            ++ PE
Sbjct: 115 YLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPE 171

Query: 257 YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID 316
            +M    ++ SD+++FGV++ E+ +  +                         +    I 
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----------------TNSETAEHIA 215

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVL 356
             L    P   ++K     + C       RPT   ++  +
Sbjct: 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  203 bits (516), Expect = 2e-63
 Identities = 65/291 (22%), Positives = 129/291 (44%), Gaps = 28/291 (9%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
           ++ +  + LG G +G VY+G   +       +  VAVK L  D  +  +E++ E   + +
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKE 69

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           ++HP+LV+L+G C  E    ++ E+M  G+L + L       +     + +A   +  + 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +L    K  I+RD  A N L+  ++  K++DFGL++    G+             + APE
Sbjct: 130 YLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPE 186

Query: 257 YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID 316
            +     +  SDV++FGV+L E+ T   +                     +  ++  L++
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELLE 230

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDSFV 367
                + P    +K       C   +P  RP+ + + +  +++  FQ+S +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM--FQESSI 279

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 3e-63
 Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 40/306 (13%)

Query: 72  LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAE 130
           + L   +F + + LG G  G V+K    +          +A K + L+       + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKV-SHKPSG-----LVMARKLIHLEIKPAIRNQIIRE 54

Query: 131 IIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALG 190
           +  L +   P++V   G  + +    +  E+M  GSL   L ++    +P     K+++ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIA 112

Query: 191 AAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
             KGL +L  E   +++RD K SNIL++S    KL DFG++    +     +    +GT+
Sbjct: 113 VIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 167

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR----------------------AMDN 288
            Y +PE +   H +  SD++S G+ L+E+  G+                       A   
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 289 TRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAF----KCLSHHPR 344
            R               + P  +  L+D  +    P   +   +        KCL  +P 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 345 HRPTMS 350
            R  + 
Sbjct: 288 ERADLK 293

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-63
 Identities = 71/305 (23%), Positives = 108/305 (35%), Gaps = 41/305 (13%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLG 135
            N     +LG G FG V        +     +  VAVK L        +E  M+E+  + 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNA-TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95

Query: 136 QL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR--------------------- 173
           QL  H ++V L+G C       L++EY   G L N L                       
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 174 SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 233
                L +   +  A   AKG+ FL    K  ++RD  A N+L+      K+ DFGLA+D
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR 293
                   V         + APE +  G  T  SDV+S+G++L E+ +            
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY------ 267

Query: 294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVV 353
                    P +       +LI    +   P    ++       C +   R RP+   + 
Sbjct: 268 ---------PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318

Query: 354 RVLDS 358
             L  
Sbjct: 319 SFLGC 323

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 9e-63
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 34/285 (11%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
                   +G+G FG V  G              VAVK +  D T   + ++AE   + Q
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASVMTQ 56

Query: 137 LRHPHLVKLIGYCWEEEYRL-LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           LRH +LV+L+G   EE+  L +V EYM +GSL + L     + L     +K +L   + +
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
            +L       ++RD  A N+L+  D  AK+SDFGL K+    ++T           + AP
Sbjct: 117 EYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAP 169

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +     +T SDV+SFG++L E+ +  R          +   +   P +++  K++   
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPY------PRIPLKDVVPRVEKGYKMD--- 220

Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
                   P             C       RP+   +   L+ ++
Sbjct: 221 -------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 3e-62
 Identities = 68/316 (21%), Positives = 119/316 (37%), Gaps = 42/316 (13%)

Query: 69  LAELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEW 127
           L  L    +N      +GEG FG V++      L P      VAVK L  + +     ++
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQA-RAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-------------- 173
             E   + +  +P++VKL+G C   +   L++EYM  G L+  L                
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 174 --------SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL 225
                        L  + ++ IA   A G+A+L   ++  ++RD    N L+  +   K+
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKI 181

Query: 226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRA 285
           +DFGL+++    +             +  PE +     TT SDV+++GVVL E+ +    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 286 MDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRH 345
                   E                +  + D  +    P     +       C S  P  
Sbjct: 242 PYYGMAHEEV---------------IYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPAD 285

Query: 346 RPTMSYVVRVLDSLQD 361
           RP+   + R+L  + +
Sbjct: 286 RPSFCSIHRILQRMCE 301

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 3e-62
 Identities = 79/301 (26%), Positives = 112/301 (37%), Gaps = 36/301 (11%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLG 135
           +  S    LG G FG V +      L     A  VAVK L        +E  M+E+  L 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEA-TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81

Query: 136 QL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSA----------------A 178
            L  H ++V L+G C      L++ EY   G L N L R   +                A
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 179 LPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGE 238
           L     +  +   AKG+AFL    K  I+RD  A NILL      K+ DFGLA+D     
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 239 ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLA 298
              V         + APE +     T  SDV+S+G+ L EL +   +             
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----------- 248

Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
               P +    K  ++I        P     +       C    P  RPT   +V++++ 
Sbjct: 249 ----PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304

Query: 359 L 359
            
Sbjct: 305 Q 305

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 4e-62
 Identities = 80/289 (27%), Positives = 123/289 (42%), Gaps = 28/289 (9%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIF 133
           +  +F+   ++G G FG VY G     L    +    AVK+L+     G   +++ E I 
Sbjct: 27  LIVHFNE--VIGRGHFGCVYHG---TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 81

Query: 134 LGQLRHPHLVKLIGYCWEEE-YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           +    HP+++ L+G C   E   L+V  YM  G L     R+ +        +   L  A
Sbjct: 82  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVA 140

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD--GPEGEETHVITRVMGTQ 250
           KG+ FL    K  ++RD  A N +LD  +T K++DFGLA+D    E +  H  T      
Sbjct: 141 KGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
            + A E + T   TT SDV+SFGV+L EL+T            + +  +    LL+  R 
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQGRRL 253

Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           L            P            KC       RP+ S +V  + ++
Sbjct: 254 L-----------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 5e-61
 Identities = 72/283 (25%), Positives = 114/283 (40%), Gaps = 28/283 (9%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQ 136
            +      LG+G FG V+ G              VA+K L    T   + ++ E   + +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMG----TWNGT---TRVAIKTLKPG-TMSPEAFLQEAQVMKK 68

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           LRH  LV+L     EE    +V EYM +GSL + L       L     + +A   A G+A
Sbjct: 69  LRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           ++       ++RD +A+NIL+  +   K++DFGLA+   + E             + APE
Sbjct: 128 YVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPE 184

Query: 257 YVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID 316
             + G  T  SDV+SFG++L EL T  R                        R++   ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPG----------------MVNREVLDQVE 228

Query: 317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                  P +  +       +C    P  RPT  Y+   L+  
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 8e-61
 Identities = 74/319 (23%), Positives = 132/319 (41%), Gaps = 27/319 (8%)

Query: 70  AELRLIT-SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEW 127
           A LR++  + F +  +LG G FG VYKG      +      PVA+K L    + + +KE 
Sbjct: 1   ALLRILKETEFKKIKVLGSGAFGTVYKGL--WIPEGEKVKIPVAIKELREATSPKANKEI 58

Query: 128 MAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
           + E   +  + +PH+ +L+G C     +L + + MP G L + +             +  
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI-GSQYLLNW 116

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
            +  AKG+ +L   D+ +++RD  A N+L+ +    K++DFGLAK     E+ +      
Sbjct: 117 CVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE 307
               + A E ++    T  SDV+S+GV + EL+T      +                   
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG----------------IP 218

Query: 308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL-QDFQDSF 366
             ++  +++       P            KC       RP    ++     + +D Q   
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 278

Query: 367 V--GPFVYVVPNETESSVY 383
           V  G     +P+ T+S+ Y
Sbjct: 279 VIQGDERMHLPSPTDSNFY 297

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 9e-61
 Identities = 76/333 (22%), Positives = 140/333 (42%), Gaps = 49/333 (14%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLG 135
           ++    +++GEG FG V K     ++K        A+K +    +   H+++  E+  L 
Sbjct: 10  NDIKFQDVIGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 136 QL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSY--------------SAALP 180
           +L  HP+++ L+G C    Y  L  EY P G+L + L +S               ++ L 
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 181 WSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET 240
               +  A   A+G+ +L    K  I+RD  A NIL+  +Y AK++DFGL++      + 
Sbjct: 126 SQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 241 HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEW 300
              T       + A E +     TT SDV+S+GV+L E+++              + AE 
Sbjct: 184 ---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAEL 235

Query: 301 ARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
              L +  R            + P+    +      +C    P  RP+ + ++  L+ + 
Sbjct: 236 YEKLPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

Query: 361 DFQDSFVGPFVYVVPNETESSVYLRNGKETNSE 393
           + + ++V        N T    +   G + ++E
Sbjct: 285 EERKTYV--------NTTLYEKFTYAGIDCSAE 309

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-60
 Identities = 66/302 (21%), Positives = 115/302 (38%), Gaps = 34/302 (11%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVK 144
           +G+G FG V++G            + VAVK       +      AEI     LRH +++ 
Sbjct: 11  IGKGRFGEVWRGK--------WRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILG 61

Query: 145 LIGYCWEEE----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
            I    ++        LV +Y   GSL + L R     +     +K+AL  A GLA LH 
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHM 118

Query: 201 E------DKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI--TRVMGTQGY 252
           E         + +RD K+ NIL+  + T  ++D GLA       +T  I     +GT+ Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 253 AAPEYVMT------GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGR----EQSLAEWAR 302
            APE +              +D+Y+ G+V  E+             +    +   ++ + 
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 303 PLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF 362
             +++    ++L           +  +  A    +C   +   R T   + + L  L   
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

Query: 363 QD 364
           + 
Sbjct: 299 EG 300

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-60
 Identities = 72/293 (24%), Positives = 126/293 (43%), Gaps = 29/293 (9%)

Query: 71  ELRLITSNFSRSNL-LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWM 128
           +L L   N   +++ LG G FG V +G      +   +   VA+K L     +   +E M
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQG----VYRMRKKQIDVAIKVLKQGTEKADTEEMM 57

Query: 129 AEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
            E   + QL +P++V+LIG C + E  +LV E    G LH  L       +P S   ++ 
Sbjct: 58  REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELL 115

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRVM 247
              + G+ +L   +K  ++RD  A N+LL + + AK+SDFGL+K  G +       +   
Sbjct: 116 HQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLK 306
               + APE +     ++ SDV+S+GV + E L+ G++                      
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-----------------M 216

Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           +  ++   I+     + P +   +  A    C  +    RP    V + + + 
Sbjct: 217 KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-58
 Identities = 66/280 (23%), Positives = 120/280 (42%), Gaps = 30/280 (10%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--HKEWMAEIIFLGQLRHP 140
             LG G FG V KG      +     + VAVK L  +        E +AE   + QL +P
Sbjct: 13  KELGSGNFGTVKKG----YYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 68

Query: 141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHG 200
           ++V++IG C  E + +LV E    G L+  L ++    +     +++    + G+ +L  
Sbjct: 69  YIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE- 124

Query: 201 EDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI-TRVMGTQGYAAPEYVM 259
            +   ++RD  A N+LL + + AK+SDFGL+K     E  +   T       + APE + 
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 260 TGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR 318
               ++ SDV+SFGV++ E  + G++                      +  ++  +++  
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----------------MKGSEVTAMLEKG 226

Query: 319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDS 358
                P    ++       C ++   +RP  + V   L +
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 4e-58
 Identities = 74/287 (25%), Positives = 119/287 (41%), Gaps = 26/287 (9%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFL 134
           +      LG+G FG V +G  D    P  +   VAVK L  D     +   +++ E+  +
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWD---APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
             L H +L++L G       + +V E  P GSL     R +       T  + A+  A+G
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLL-DRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVI-TRVMGTQGYA 253
           + +L    K  I+RD  A N+LL +    K+ DFGL +  P+ ++ +V+         + 
Sbjct: 124 MGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER 313
           APE + T   +  SD + FGV L E+ T  +           + ++    + KE  +L R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDKEGERLPR 236

Query: 314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
                     P    Q       +C +H P  RPT   +   L   Q
Sbjct: 237 ----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-57
 Identities = 65/279 (23%), Positives = 106/279 (37%), Gaps = 27/279 (9%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQ 136
           ++     LGEG +G V    V+   +     + VAVK +D+       +    EI     
Sbjct: 6   DWDLVQTLGEGAYGEVQLA-VNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKM 59

Query: 137 LRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLA 196
           L H ++VK  G+  E   + L  EY   G L +++       +P     +       G+ 
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVV 117

Query: 197 FLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE 256
           +LH     + +RD K  N+LLD     K+SDFGLA          ++ ++ GT  Y APE
Sbjct: 118 YLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 257 YVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
            +          DV+S G+VL  +L G+   D      ++                    
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWK 220

Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
           + +       K      A   K L  +P  R T+  + +
Sbjct: 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-57
 Identities = 67/273 (24%), Positives = 107/273 (39%), Gaps = 31/273 (11%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHL 142
             LG+G FG VYK   +++          A K +D    +  +++M EI  L    HP++
Sbjct: 18  GELGDGAFGKVYKA-QNKETS-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 71

Query: 143 VKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED 202
           VKL+   + E    ++ E+   G++   +       L  S    +       L +LH  D
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLH--D 128

Query: 203 KPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-- 260
             +I+RD KA NIL   D   KL+DFG++       +       +GT  + APE VM   
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCET 186

Query: 261 ---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP 317
                    +DV+S G+ L+E+   +          E +       + K          P
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKIAKSEP-------P 233

Query: 318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
            L    P + +        KCL  +   R T S
Sbjct: 234 TLA--QPSRWSSNFKDFLKKCLEKNVDARWTTS 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-56
 Identities = 71/281 (25%), Positives = 115/281 (40%), Gaps = 35/281 (12%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEIIF 133
            +F     LG+G FG VY    +++ K       +A+K L    L+      +   E+  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLA-REKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEI 59

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
              LRHP++++L GY  +     L+ EY P G+++ +L +   +              A 
Sbjct: 60  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELAN 117

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
            L++ H   K VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y 
Sbjct: 118 ALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYL 171

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER 313
            PE +         D++S GV+  E L GK   +                     ++  +
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYK 214

Query: 314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
            I  R+E  FP    + A     + L H+P  RP +  V+ 
Sbjct: 215 RI-SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (470), Expect = 3e-56
 Identities = 76/286 (26%), Positives = 114/286 (39%), Gaps = 40/286 (13%)

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEII 132
              FS    +G G FG VY    D +       + VA+K +   G Q +++W   + E+ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFA-RDVRNS-----EVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 133 FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAA 192
           FL +LRHP+ ++  G    E    LV EY    +    L   +   L       +  GA 
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGAL 125

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           +GLA+LH     +I+RD KA NILL      KL DFG A               +GT  +
Sbjct: 126 QGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYW 177

Query: 253 AAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDN-TRLGREQSLAEWARPLLKEP 308
            APE ++    G      DV+S G+  +EL   K  + N   +     +A+   P L+  
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237

Query: 309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
              E   +                     CL   P+ RPT   +++
Sbjct: 238 HWSEYFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-55
 Identities = 61/277 (22%), Positives = 99/277 (35%), Gaps = 35/277 (12%)

Query: 85  LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLGQLRHPHL 142
           +G G F  VYKG +D +         VA   L          + +  E   L  L+HP++
Sbjct: 17  IGRGSFKTVYKG-LDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 143 VKLIGYCWE----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           V+           ++  +LV E M  G+L   L R     +             KGL FL
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFL 128

Query: 199 HGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
           H    P+I+RD K  NI +     + K+ D GLA      +       V+GT  + APE 
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPE- 183

Query: 258 VMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP 317
           +         DVY+FG+ +LE+ T +      +   +                  R+   
Sbjct: 184 MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSG 228

Query: 318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
                F      +       C+  +   R ++  ++ 
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 5e-55
 Identities = 69/294 (23%), Positives = 125/294 (42%), Gaps = 28/294 (9%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHK-EWMAEIIFLG 135
              + S  LG+G FG VY+G V + +        VA+K ++   +   + E++ E   + 
Sbjct: 20  EKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 78

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLF--------RSYSAALPWSTRMKI 187
           +    H+V+L+G   + +  L++ E M RG L + L             A    S  +++
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
           A   A G+A+L+      ++RD  A N ++  D+T K+ DFG+ +D  E +      + +
Sbjct: 139 AGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE 307
               + +PE +  G  TT SDV+SFGVVL E+ T                       L  
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSN 241

Query: 308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
            + L  +++  L    P             C  ++P+ RP+   ++  +    +
Sbjct: 242 EQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 1e-54
 Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 36/290 (12%)

Query: 68  TLAELRLITS------NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT 121
            L +LR I S       ++R   +G+G  G VY   +D         Q VA++ ++L   
Sbjct: 5   ILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTA-MDVATG-----QEVAIRQMNLQQQ 58

Query: 122 QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPW 181
              +  + EI+ + + ++P++V  +      +   +V EY+  GSL + +  +       
Sbjct: 59  PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DE 115

Query: 182 STRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH 241
                +     + L FLH     VI+RD K+ NILL  D + KL+DFG        +   
Sbjct: 116 GQIAAVCRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173

Query: 242 VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA 301
             + ++GT  + APE V         D++S G++ +E++ G+    N             
Sbjct: 174 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----------- 220

Query: 302 RPLLKEPRKLERLI-DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
                  R L  +  +   E Q P K +        +CL      R +  
Sbjct: 221 -----PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAK 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 2e-54
 Identities = 57/286 (19%), Positives = 105/286 (36%), Gaps = 34/286 (11%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
           ++     +G G +G   K     +   G   + +  K LD         +  ++E+  L 
Sbjct: 5   DYEVLYTIGTGSYGRCQKI---RRKSDG---KILVWKELDYGSMTEAEKQMLVSEVNLLR 58

Query: 136 QLRHPHLVKLIGYCWEEE--YRLLVYEYMPRGSLHNQLFRSYSA--ALPWSTRMKIALGA 191
           +L+HP++V+      +       +V EY   G L + + +       L     +++    
Sbjct: 59  ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 192 AKGLAFLH---GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMG 248
              L   H        V++RD K +N+ LD     KL DFGLA+      +T      +G
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVG 176

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP 308
           T  Y +PE +        SD++S G +L EL                S  E A  + +  
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGK 230

Query: 309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR 354
                    R+  ++      +      + L+    HRP++  ++ 
Sbjct: 231 F-------RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-54
 Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 25/286 (8%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIFLG 135
                   +GEG FG V++G     + P   A  VA+K      +   +E ++ E + + 
Sbjct: 7   ERIELGRCIGEGQFGDVHQG---IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           Q  HPH+VKLIG    E    ++ E    G L     +    +L  ++ +  A   +  L
Sbjct: 64  QFDHPHIVKLIGVI-TENPVWIIMELCTLGELR-SFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+L    K  ++RD  A N+L+ S+   KL DFGL++   +       ++      + AP
Sbjct: 122 AYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAP 178

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +     T+ SDV+ FGV + E+L           G +         ++      ERL 
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMH---------GVKPFQGVKNNDVIGRIENGERL- 228

Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD 361
                   P        +   KC ++ P  RP  + +   L ++ +
Sbjct: 229 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 9e-54
 Identities = 75/300 (25%), Positives = 112/300 (37%), Gaps = 35/300 (11%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG-HKEWMAEIIFLG 135
                   LG G FG V +      +      + VAVK L    T   H+  M+E+  L 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEA-DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILI 71

Query: 136 Q-LRHPHLVKLIGYCWEE-EYRLLVYEYMPRGSLHNQLFR--------------SYSAAL 179
               H ++V L+G C +     +++ E+   G+L   L                 Y   L
Sbjct: 72  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131

Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
                +  +   AKG+ FL    +  I+RD  A NILL      K+ DFGLA+D  +  +
Sbjct: 132 TLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE 299
                       + APE +     T  SDV+SFGV+L E+ +   +           + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDE 244

Query: 300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                LKE  ++            P     +   T   C    P  RPT S +V  L +L
Sbjct: 245 EFCRRLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 4e-52
 Identities = 71/300 (23%), Positives = 112/300 (37%), Gaps = 35/300 (11%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEA-QPVAVKALDLDGTQGH-KEWMAEIIFL 134
                   LGEG FG V         K        VAVK L  D T+    + ++E+  +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 135 GQL-RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAA--------------L 179
             + +H +++ L+G C ++    ++ EY  +G+L   L                     L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 180 PWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE 239
                +  A   A+G+ +L    K  I+RD  A N+L+  D   K++DFGLA+D    + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 240 THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE 299
               T       + APE +     T  SDV+SFGV+L E+ T   +              
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--------- 241

Query: 300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
                     +L +L+        P     +       C    P  RPT   +V  LD +
Sbjct: 242 -------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 9e-51
 Identities = 62/286 (21%), Positives = 99/286 (34%), Gaps = 31/286 (10%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFL 134
           +F    +LGEG F  V       +L      +  A+K L+               E   +
Sbjct: 9   DFKFGKILGEGSFSTVVLA---RELATS---REYAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
            +L HP  VKL     ++E       Y   G L   + +    +   +            
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSA 120

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L +LH   K +I+RD K  NILL+ D   +++DFG AK      +       +GT  Y +
Sbjct: 121 LEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +        SD+++ G ++ +L+ G                        E    +++
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG----------------NEYLIFQKI 222

Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ 360
           I  +LE  FP K   KA     K L      R     +        
Sbjct: 223 I--KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  166 bits (422), Expect = 9e-49
 Identities = 58/278 (20%), Positives = 100/278 (35%), Gaps = 28/278 (10%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           +  ++     LG G FG V++   +            A K +        +    EI  +
Sbjct: 24  VLDHYDIHEELGTGAFGVVHRV-TERATG-----NNFAAKFVMTPHESDKETVRKEIQTM 77

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
             LRHP LV L     ++   +++YE+M  G L  ++   ++  +     ++      KG
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKG 136

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDY--TAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           L  +H  +   ++ D K  NI+  +      KL DFGL       +   V     GT  +
Sbjct: 137 LCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEF 191

Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE 312
           AAPE      +   +D++S GV+   LL+G                E     L+  +  +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG----------GENDDETLRNVKSCD 241

Query: 313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
             +D            +       K L   P  R T+ 
Sbjct: 242 WNMDDSAFSGIS----EDGKDFIRKLLLADPNTRMTIH 275

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (422), Expect = 1e-48
 Identities = 56/278 (20%), Positives = 105/278 (37%), Gaps = 28/278 (10%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           +   +     LG G FG V++  V++        +    K ++            EI  +
Sbjct: 27  VYDYYDILEELGSGAFGVVHRC-VEKATG-----RVFVAKFINTPYPLDKYTVKNEISIM 80

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
            QL HP L+ L     ++   +L+ E++  G L +++  +    +  +  +     A +G
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEG 139

Query: 195 LAFLHGEDKPVIYRDFKASNILLDS--DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGY 252
           L  +H  +  +++ D K  NI+ ++    + K+ DFGLA      E          T  +
Sbjct: 140 LKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEF 194

Query: 253 AAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE 312
           AAPE V    +   +D+++ GV+   LL+G                E     L+  ++ +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA----------GEDDLETLQNVKRCD 244

Query: 313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
              D             +A       L   PR R T+ 
Sbjct: 245 WEFDEDAFSSVS----PEAKDFIKNLLQKEPRKRLTVH 278

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  157 bits (397), Expect = 6e-46
 Identities = 66/282 (23%), Positives = 108/282 (38%), Gaps = 32/282 (11%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG---HKEWMAEI 131
           ++  +    +LG GG   V+    D +L      + VAVK L  D  +    +  +  E 
Sbjct: 5   LSDRYELGEILGFGGMSEVHLA-RDLRLH-----RDVAVKVLRADLARDPSFYLRFRREA 58

Query: 132 IFLGQLRHPHLVKLIGYCWEEE----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
                L HP +V +      E        +V EY+   +L + +       +     +++
Sbjct: 59  QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEV 116

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD-GPEGEETHVITRV 246
              A + L F H     +I+RD K +NI++ +    K+ DFG+A+     G        V
Sbjct: 117 IADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK 306
           +GT  Y +PE      +   SDVYS G VL E+LTG+            S    A   ++
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG------DSPVSVAYQHVR 228

Query: 307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
           E           L        +    A   K L+ +P +R  
Sbjct: 229 EDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQ 262

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  159 bits (402), Expect = 1e-45
 Identities = 66/279 (23%), Positives = 102/279 (36%), Gaps = 36/279 (12%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD---LDGTQGHKEWMAEII-- 132
           +FS   ++G GGFG VY              +  A+K LD   +   QG    + E I  
Sbjct: 5   DFSVHRIIGRGGFGEVYGC-RKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIML 58

Query: 133 -FLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGA 191
             +     P +V +       +    + + M  G LH  L +        +     A   
Sbjct: 59  SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEI 116

Query: 192 AKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQG 251
             GL  +H  ++ V+YRD K +NILLD     ++SD GLA D  + +        +GT G
Sbjct: 117 ILGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHG 170

Query: 252 YAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
           Y APE +  G    + +D +S G +L +LL G          + +   E  R  L    +
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ---HKTKDKHEIDRMTLTMAVE 227

Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           L     P            +  +     L      R   
Sbjct: 228 LPDSFSP------------ELRSLLEGLLQRDVNRRLGC 254

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (392), Expect = 4e-45
 Identities = 61/289 (21%), Positives = 105/289 (36%), Gaps = 43/289 (14%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---------QGHKEWM 128
           N+    +LG G    V +  + +        +  AVK +D+ G          +  +  +
Sbjct: 4   NYEPKEILGRGVSSVVRRC-IHKPTC-----KEYAVKIIDVTGGGSFSAEEVQELREATL 57

Query: 129 AEIIFLGQLR-HPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            E+  L ++  HP++++L        +  LV++ M +G L + L    +  L      KI
Sbjct: 58  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKI 115

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
                + +  LH     +++RD K  NILLD D   KL+DFG +     GE+      V 
Sbjct: 116 MRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVC 170

Query: 248 GTQGYAAPEYVMTGHL------TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA 301
           GT  Y APE +               D++S GV++  LL G            +      
Sbjct: 171 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLML 224

Query: 302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
           R ++    +                 +        + L   P+ R T  
Sbjct: 225 RMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAE 265

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 53/269 (19%), Positives = 102/269 (37%), Gaps = 29/269 (10%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LG G FG V++  V+   K     +    K + + GT        EI  L   RH +++
Sbjct: 12  DLGRGEFGIVHRC-VETSSK-----KTYMAKFVKVKGTD-QVLVKKEISILNIARHRNIL 64

Query: 144 KLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDK 203
            L       E  ++++E++    +  ++  + +  L     +       + L FLH    
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEALQFLH--SH 121

Query: 204 PVIYRDFKASNILLDSD--YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG 261
            + + D +  NI+  +    T K+ +FG A+    G+   +   +     Y APE     
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHD 178

Query: 262 HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPRLEG 321
            ++T +D++S G ++  LL+G               AE  + +++     E   D     
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFL----------AETNQQIIENIMNAEYTFDEEAFK 228

Query: 322 QFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
           +       +A     + L    + R T S
Sbjct: 229 EIS----IEAMDFVDRLLVKERKSRMTAS 253

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 5e-45
 Identities = 69/276 (25%), Positives = 102/276 (36%), Gaps = 34/276 (12%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE----WMAEIIF 133
           +F    +LG+G FG V+     +K       Q  A+KAL  D      +     + + + 
Sbjct: 3   DFILHKMLGKGSFGKVFLA-EFKKTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVL 56

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
                HP L  +      +E    V EY+  G L   +   +      S     A     
Sbjct: 57  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIIL 114

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           GL FLH   K ++YRD K  NILLD D   K++DFG+ K+   G+         GT  Y 
Sbjct: 115 GLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYI 170

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER 313
           APE ++        D +SFGV+L E+L G+           Q   E    +  +     R
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG------QDEEELFHSIRMDNPFYPR 224

Query: 314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
            ++              A     K     P  R  +
Sbjct: 225 WLEKE------------AKDLLVKLFVREPEKRLGV 248

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 6e-45
 Identities = 59/280 (21%), Positives = 109/280 (38%), Gaps = 31/280 (11%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-WMAEIIF 133
           I   +   ++LG G F  V     D++ +     + VA+K +     +G +     EI  
Sbjct: 7   IRDIYDFRDVLGTGAFSEVILA-EDKRTQ-----KLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           L +++HP++V L        +  L+ + +  G L +++              ++      
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLD 118

Query: 194 GLAFLHGEDKPVIYRDFKASNILL---DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQ 250
            + +LH  D  +++RD K  N+L    D D    +SDFGL+K     +   V++   GT 
Sbjct: 119 AVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTP 173

Query: 251 GYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK 310
           GY APE +     +   D +S GV+   LL G     +      ++ A+    +LK   +
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD------ENDAKLFEQILKAEYE 227

Query: 311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
            +      +        +  A       +   P  R T  
Sbjct: 228 FDSPYWDDI--------SDSAKDFIRHLMEKDPEKRFTCE 259

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 61/293 (20%), Positives = 112/293 (38%), Gaps = 25/293 (8%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGH-KEWMAEIIF 133
           +   ++  + +GEG +G V     D   K       VA+K +     Q + +  + EI  
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSA-YDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKI 59

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFR-SYSAALPWSTRMKIALGAA 192
           L + RH +++ +           +   Y+    +   L++   +  L             
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 119

Query: 193 KGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH-VITRVMGTQG 251
           +GL ++H     V++RD K SN+LL++    K+ DFGLA+      +    +T  + T+ 
Sbjct: 120 RGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 252 YAAPEYVMTGHLTTMS-DVYSFGVVLLELLTGKR--AMDNTRLGREQSLAEWARPLLKEP 308
           Y APE ++     T S D++S G +L E+L+ +      +        L     P  ++ 
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 309 RKLERLIDPRLEGQFPIKGA-----------QKAAATAFKCLSHHPRHRPTMS 350
             +  L         P K              KA     K L+ +P  R  + 
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-43
 Identities = 71/284 (25%), Positives = 114/284 (40%), Gaps = 28/284 (9%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE-----WMAEIIFLGQL 137
           + LGEG F  VYK   D+        Q VA+K + L      K+      + EI  L +L
Sbjct: 4   DFLGEGQFATVYKA-RDKNTN-----QIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 138 RHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAF 197
            HP+++ L+     +    LV+++M        + +  S  L  S      L   +GL +
Sbjct: 58  SHPNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 198 LHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEY 257
           LH     +++RD K +N+LLD +   KL+DFGLAK    G      T  + T+ Y APE 
Sbjct: 116 LH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPEL 171

Query: 258 VMTGHL-TTMSDVYSFGVVLLELLTGKRAM--DNTRLGREQSLAEWARPLLKEPRKLERL 314
           +    +     D+++ G +L ELL     +  D+      +       P  ++   +  L
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 315 IDPRLEGQFPIKGAQKAAATAF--------KCLSHHPRHRPTMS 350
            D      FP        + A              +P  R T +
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT 275

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 7e-43
 Identities = 58/286 (20%), Positives = 102/286 (35%), Gaps = 37/286 (12%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA----- 129
           +   +     LG G F  V K   ++           A K +    T+  +  ++     
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKC-REKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIE 61

Query: 130 -EIIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
            E+  L +++HP+++ L      +   +L+ E +  G L + L    S  L      +  
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 119

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSD----YTAKLSDFGLAKDGPEGEETHVIT 244
                G+ +LH     + + D K  NI+L          K+ DFGLA     G E     
Sbjct: 120 KQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---K 174

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL 304
            + GT  + APE V    L   +D++S GV+   LL+G                      
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-------------- 220

Query: 305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
            +E       ++   E ++    +  A     + L   P+ R T+ 
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (377), Expect = 9e-43
 Identities = 62/298 (20%), Positives = 103/298 (34%), Gaps = 32/298 (10%)

Query: 71  ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAE 130
           ELR + + +     +G G FG +Y G  D         + VA+K   +     H +   E
Sbjct: 2   ELR-VGNRYRLGRKIGSGSFGDIYLG-TDIAAG-----EEVAIKLECVK--TKHPQLHIE 52

Query: 131 IIFLGQLRHPHLVKLIGYCWEE-EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIAL 189
                 ++    +  I +C  E +Y ++V E +        LF   S      T + +A 
Sbjct: 53  SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLAD 110

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNIL---LDSDYTAKLSDFGLAKDGPEGEETHVI--- 243
                + ++H   K  I+RD K  N L           + DFGLAK   +      I   
Sbjct: 111 QMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYR 168

Query: 244 --TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWA 301
               + GT  YA+    +    +   D+ S G VL+    G       +       A   
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK------AATKR 222

Query: 302 RPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
           +   +   K        L   +P     + A     C S     +P  SY+ ++  +L
Sbjct: 223 QKYERISEKKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-42
 Identities = 64/286 (22%), Positives = 109/286 (38%), Gaps = 23/286 (8%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
           NF +   +GEG +G VYK   ++        + VA+K + LD          + EI  L 
Sbjct: 3   NFQKVEKIGEGTYGVVYKA-RNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLK 56

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +L HP++VKL+     E    LV+E++ +  L   +  S    +P            +GL
Sbjct: 57  ELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGL 115

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           AF H     V++RD K  N+L++++   KL+DFGLA+             V+     A  
Sbjct: 116 AFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWYRAPE 172

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
             +   + +T  D++S G +  E++T +          +            E        
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232

Query: 316 DPRLEGQFPIKGAQK---------AAATAF--KCLSHHPRHRPTMS 350
            P  +  FP    Q              +   + L + P  R +  
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (373), Expect = 6e-42
 Identities = 62/275 (22%), Positives = 102/275 (37%), Gaps = 36/275 (13%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE---WMAEIIF 133
            +F     LG G FG V+              +  A+K L  +     K+      E + 
Sbjct: 4   QDFQILRTLGTGSFGRVHLI-RSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLM 57

Query: 134 LGQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
           L  + HP ++++ G   + +   ++ +Y+  G L + L +S     P       A     
Sbjct: 58  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCL 115

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
            L +LH   K +IYRD K  NILLD +   K++DFG AK  P+   T       GT  Y 
Sbjct: 116 ALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYI 168

Query: 254 APEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER 313
           APE V T       D +SFG+++ E+L G           + +  +    +L    +   
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELRFPP 222

Query: 314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT 348
             +                    + ++     R  
Sbjct: 223 FFNE------------DVKDLLSRLITRDLSQRLG 245

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-41
 Identities = 66/294 (22%), Positives = 109/294 (37%), Gaps = 30/294 (10%)

Query: 76  TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW-----MAE 130
              +     +GEG +G V+K      LK G   + VA+K + +   +          +A 
Sbjct: 6   DQQYECVAEIGEGAYGKVFKA---RDLKNG--GRFVALKRVRVQTGEEGMPLSTIREVAV 60

Query: 131 IIFLGQLRHPHLVKLIGYCWEEEYRLLVYEYMP----RGSLHNQLFRSYSAALPWSTRMK 186
           +  L    HP++V+L   C            +        L   L +     +P  T   
Sbjct: 61  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           +     +GL FLH     V++RD K  NIL+ S    KL+DFGLA+          +T V
Sbjct: 121 MMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSV 175

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNT----------RLGREQS 296
           + T  Y APE ++     T  D++S G +  E+   K     +           +     
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
             +W R  +  PR+       +   +F     +       KCL+ +P  R +  
Sbjct: 236 EEDWPRD-VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 2e-41
 Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 25/286 (8%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLG 135
            +     +GEG +G VYK     +   G   +  A+K + L+          + EI  L 
Sbjct: 3   KYHGLEKIGEGTYGVVYKA----QNNYG---ETFALKKIRLEKEDEGIPSTTIREISILK 55

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +L+H ++VKL      ++  +LV+E++ +      L       L   T     L    G+
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKK--LLDVCEGGLESVTAKSFLLQLLNGI 113

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           A+ H  D+ V++RD K  N+L++ +   K++DFGLA+        +    ++     A  
Sbjct: 114 AYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPD 170

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTR-----------LGREQSLAEWARPL 304
             + +   +T  D++S G +  E++ G                   LG   S        
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230

Query: 305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
           L +      + +P     F     +       K L   P  R T  
Sbjct: 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  145 bits (366), Expect = 3e-41
 Identities = 47/296 (15%), Positives = 90/296 (30%), Gaps = 33/296 (11%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFL 134
           +  ++     +GEG FG +++G  +         Q VA+K           +   E    
Sbjct: 3   VGVHYKVGRRIGEGSFGVIFEG-TNLLNN-----QQVAIKFEPRR--SDAPQLRDEYRTY 54

Query: 135 GQLRH-PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAK 193
             L     +  +  +  E  + +LV + +  G     L           T    A     
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLA 112

Query: 194 GLAFLHGEDKPVIYRDFKASNILLDSDYT-----AKLSDFGLAKDGPEGEETHVI----- 243
            +  +H  +K ++YRD K  N L+    +       + DFG+ K   +      I     
Sbjct: 113 RVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 244 TRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP 303
             + GT  Y +    +    +   D+ + G V +  L G               A   + 
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG------LKAATNKQK 224

Query: 304 LLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL 359
             +   K +      L   FP    ++         +      P   Y+  +   +
Sbjct: 225 YERIGEKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-40
 Identities = 67/297 (22%), Positives = 106/297 (35%), Gaps = 33/297 (11%)

Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEII 132
           R    +++ + ++G G FG VY+             + VA+K +  D     +    E+ 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQA-KLCDSG-----ELVAIKKVLQD----KRFKNRELQ 65

Query: 133 FLGQLRHPHLVKLIGYCWE------EEYRLLVYEYMPRGSLHNQLFRSYSA-ALPWSTRM 185
            + +L H ++V+L  + +       E Y  LV +Y+P          S +   LP     
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125

Query: 186 KIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGEETHVIT 244
                  + LA++H     + +RD K  N+LLD D    KL DFG AK    GE     +
Sbjct: 126 LYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--S 181

Query: 245 RVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNT-----------RLGR 293
            +      A          T+  DV+S G VL ELL G+                  LG 
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 294 EQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
                           K  ++        F  +   +A A   + L + P  R T  
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (355), Expect = 8e-40
 Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 47/286 (16%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKE------WM 128
           + S +    LLG GGFG VY G +           PVA+K ++ D      E        
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSG-IRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVP 55

Query: 129 AEIIFLGQLRHPH--LVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            E++ L ++      +++L+ +    +  +L+ E                 AL       
Sbjct: 56  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARS 114

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGEETHVITR 245
                 + +   H  +  V++RD K  NIL+D +    KL DFG      +   T     
Sbjct: 115 FFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-- 170

Query: 246 VMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL 304
             GT+ Y+ PE++    +    + V+S G++L +++ G    ++                
Sbjct: 171 --GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------------- 213

Query: 305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
            +E  + +     R+        + +       CL+  P  RPT  
Sbjct: 214 -EEIIRGQVFFRQRV--------SSECQHLIRWCLALRPSDRPTFE 250

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 3e-39
 Identities = 52/275 (18%), Positives = 99/275 (36%), Gaps = 34/275 (12%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEI-IFLGQLRHPHL 142
           +LG G  G V +   +++ +     +  A+K L     Q   +   E+ +     + PH+
Sbjct: 19  VLGLGINGKVLQI-FNKRTQ-----EKFALKML-----QDCPKARREVELHWRASQCPHI 67

Query: 143 VKLIGYC----WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFL 198
           V+++          +  L+V E +  G L +++      A       +I     + + +L
Sbjct: 68  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127

Query: 199 HGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
           H     + +RD K  N+L  S   +   KL+DFG AK+               T  Y AP
Sbjct: 128 H--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAP 182

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI 315
           E +         D++S GV++  LL G               +     +    +   R+ 
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY----------SNHGLAISPGMKTRIRMG 232

Query: 316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
                     + +++        L   P  R T++
Sbjct: 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 267

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 1e-38
 Identities = 67/275 (24%), Positives = 96/275 (34%), Gaps = 33/275 (12%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFL 134
           +F    LLG+G FG V     ++        +  A+K L  +      E    + E   L
Sbjct: 6   DFDYLKLLGKGTFGKVILV-REKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVL 59

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
              RHP L  L       +    V EY   G L   L R                     
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSA 117

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
           L +LH   + V+YRD K  N++LD D   K++DFGL K+G     T       GT  Y A
Sbjct: 118 LEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLA 173

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL 314
           PE +         D +  GVV+ E++ G+    N      Q        +L E  +  R 
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN------QDHERLFELILMEEIRFPRT 227

Query: 315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTM 349
           + P  +    +             L   P+ R   
Sbjct: 228 LSPEAK-SL-LA----------GLLKKDPKQRLGG 250

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-37
 Identities = 56/287 (19%), Positives = 107/287 (37%), Gaps = 25/287 (8%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT--QGHKEWMAEIIFLG 135
            + +   +GEG +G V+K   + +       + VA+K + LD          + EI  L 
Sbjct: 3   KYEKLEKIGEGTYGTVFKA-KNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLK 56

Query: 136 QLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGL 195
           +L+H ++V+L      ++   LV+E+  +       F S +  L             KGL
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKK--YFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 196 AFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAP 255
            F H   + V++RD K  N+L++ +   KL++FGLA+        +    V+        
Sbjct: 115 GFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPD 171

Query: 256 EYVMTGHLTTMSDVYSFGVVLLELLTGKR---AMDNTRLGREQSLAEWARPLLKEPRKLE 312
                   +T  D++S G +  EL    R     ++     ++       P  ++   + 
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 313 RLIDPRLEGQFPIKGAQKAAATAF---------KCLSHHPRHRPTMS 350
           +L D +    +P   +                   L  +P  R +  
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 4e-37
 Identities = 62/303 (20%), Positives = 112/303 (36%), Gaps = 41/303 (13%)

Query: 77  SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQG--HKEWMAEIIFL 134
           S + +   +G+G FG V+K     K       Q VA+K + ++  +       + EI  L
Sbjct: 10  SKYEKLAKIGQGTFGEVFKA-RHRKTG-----QKVALKKVLMENEKEGFPITALREIKIL 63

Query: 135 GQLRHPHLVKLIGYCWEEEYR--------LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
             L+H ++V LI  C  +            LV+++         L  +       S   +
Sbjct: 64  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLVKFTLSEIKR 121

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETH--VIT 244
           +      GL ++H     +++RD KA+N+L+  D   KL+DFGLA+     + +     T
Sbjct: 122 VMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179

Query: 245 RVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP 303
             + T  Y  PE ++         D++  G ++ E+ T    M       +  LA  ++ 
Sbjct: 180 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLALISQL 237

Query: 304 LLKEPRKLERLID--PRLEGQFPIKGAQKAAATAF--------------KCLSHHPRHRP 347
                 ++   +D     E    +KG ++                    K L   P  R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 348 TMS 350
              
Sbjct: 298 DSD 300

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 66/313 (21%), Positives = 114/313 (36%), Gaps = 39/313 (12%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKAL--DLDGTQGHKEWMAEII 132
           + + +     +G G +G V    VD +         VA+K L          K    E+ 
Sbjct: 16  VRAVYRDLQPVGSGAYGAVCSA-VDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELR 69

Query: 133 FLGQLRHPHLVKLIGYCWEEEYR------LLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            L  +RH +++ L+     +E         LV  +M  G+   +L +     L       
Sbjct: 70  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDRIQF 125

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           +     KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+      ++ +   V
Sbjct: 126 LVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYV 179

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKR---------AMDNTRLGREQSL 297
           +     A    +     T   D++S G ++ E++TGK           +           
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239

Query: 298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAF----KCLSHHPRHRPTMSYVV 353
           AE+ + L  +  K      P LE +        A+  A     K L      R T    +
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 354 R--VLDSLQDFQD 364
                +SL D +D
Sbjct: 300 AHPYFESLHDTED 312

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 9e-34
 Identities = 72/285 (25%), Positives = 104/285 (36%), Gaps = 29/285 (10%)

Query: 73  RLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALD----LDGTQGHKEWM 128
           ++   NF    +LG G +G V+      K+      +  A+K L     +   +  +   
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLV---RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTR 76

Query: 129 AEIIFLGQLRH-PHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            E   L  +R  P LV L      E    L+ +Y+  G L   L +              
Sbjct: 77  TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIY 134

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
                  L  LH     +IYRD K  NILLDS+    L+DFGL+K+    E         
Sbjct: 135 VGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-C 191

Query: 248 GTQGYAAPEYVMTGH--LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL 305
           GT  Y AP+ V  G        D +S GV++ ELLTG         G + S AE +R +L
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD--GEKNSQAEISRRIL 249

Query: 306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS 350
           K      + +               A     + L   P+ R    
Sbjct: 250 KSEPPYPQEMSA------------LAKDLIQRLLMKDPKKRLGCG 282

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  124 bits (313), Expect = 4e-33
 Identities = 58/269 (21%), Positives = 92/269 (34%), Gaps = 21/269 (7%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEW---MAEIIFL 134
            F R   LG G FG V      ++          A+K LD       K+    + E   L
Sbjct: 42  QFDRIKTLGTGSFGRVMLV-KHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRIL 95

Query: 135 GQLRHPHLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
             +  P LVKL     +     +V EY+  G + + L R              A      
Sbjct: 96  QAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLT 153

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAA 254
             +LH     +IYRD K  N+L+D     +++DFG AK       T     + GT    A
Sbjct: 154 FEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALA 206

Query: 255 PEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE--PRKLE 312
           PE +++       D ++ GV++ E+  G       +  +        +          L+
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 313 RLIDPRLEGQFPIKGAQKAAATAFKCLSH 341
            L+   L+     K             +H
Sbjct: 267 DLLRNLLQ-VDLTKRFGNLKNGVNDIKNH 294

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (304), Expect = 4e-32
 Identities = 53/298 (17%), Positives = 102/298 (34%), Gaps = 44/298 (14%)

Query: 78  NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL 137
           ++     LG G +  V++  ++         + V VK L        K+   EI  L  L
Sbjct: 36  DYQLVRKLGRGKYSEVFEA-INITNN-----EKVVVKILK---PVKKKKIKREIKILENL 86

Query: 138 R-HPHLVKLIGYCWEEEYRL--LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKG 194
           R  P+++ L     +   R   LV+E++                L             K 
Sbjct: 87  RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKA 141

Query: 195 LAFLHGEDKPVIYRDFKASNILLDSD-YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYA 253
           L + H     +++RD K  N+++D +    +L D+GLA+    G+E       + ++ + 
Sbjct: 142 LDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFK 196

Query: 254 APEYVMT-GHLTTMSDVYSFGVVLLELLTGKR------------AMDNTRLGREQSLAEW 300
            PE ++         D++S G +L  ++  K                   LG E      
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256

Query: 301 ARPLLKEPRKLERLID----PRLEGQFPIKGAQKAAATAF----KCLSHHPRHRPTMS 350
            +  ++   +   ++      R E     +     +  A     K L +  + R T  
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-28
 Identities = 59/308 (19%), Positives = 99/308 (32%), Gaps = 48/308 (15%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEII 132
           +   +     +G G  G V     D  L      + VA+K L          K    E++
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAA-YDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELV 68

Query: 133 FLGQLRHPHLVKLIGYCW------EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMK 186
            +  + H +++ L+          E +   LV E M                        
Sbjct: 69  LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSY 123

Query: 187 IALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRV 246
           +      G+  LH     +I+RD K SNI++ SD T K+ DFGLA+           T  
Sbjct: 124 LLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPY 178

Query: 247 MGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK----------------RAMDNTR 290
           + T+ Y APE ++        D++S G ++ E++  K                  +    
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238

Query: 291 LGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAF--------KCLSHH 342
               + L    R  ++   K   L  P+L          +              K L   
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298

Query: 343 PRHRPTMS 350
           P  R ++ 
Sbjct: 299 PAKRISVD 306

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 7e-28
 Identities = 59/296 (19%), Positives = 104/296 (35%), Gaps = 35/296 (11%)

Query: 75  ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEII 132
           +   +   + +G G +G V     D K         VAVK L          K    E+ 
Sbjct: 16  VPERYQNLSPVGSGAYGSVCAA-FDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELR 69

Query: 133 FLGQLRHPHLVKLIGYC-----WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKI 187
            L  ++H +++ L+         EE   + +  ++  G+  N + +     L       +
Sbjct: 70  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFL 126

Query: 188 ALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVM 247
                +GL ++H     +I+RD K SN+ ++ D   K+ DFGLA+   +    +V TR  
Sbjct: 127 IYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWY 184

Query: 248 GTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK---------RAMDNTRLGREQSLA 298
                A    +   H     D++S G ++ ELLTG+           +           A
Sbjct: 185 ----RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240

Query: 299 EWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAF----KCLSHHPRHRPTMS 350
           E  + +  E  +       ++           A   A     K L      R T +
Sbjct: 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (252), Expect = 1e-24
 Identities = 55/312 (17%), Positives = 100/312 (32%), Gaps = 53/312 (16%)

Query: 84  LLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV 143
            LG G F  V+    D           VA+K +  D     +    EI  L ++      
Sbjct: 20  KLGWGHFSTVWLA-KDMVNN-----THVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNT 72

Query: 144 KLIGYCWEEEYRLL-VYEYMPRGSLHNQLF-------------RSYSAALPWSTRMKIAL 189
           K          +LL  + +     +H  +              +     +P     +I+ 
Sbjct: 73  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132

Query: 190 GAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKLSDFGLAKDGPEGEETHVITRVMG 248
               GL ++H     +I+ D K  N+L++  D    L    +A  G         T  + 
Sbjct: 133 QLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 249 TQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMD--------------------- 287
           T+ Y +PE ++       +D++S   ++ EL+TG    +                     
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251

Query: 288 ------NTRLGREQSLAEWARPLLKEPRKLERL-IDPRLEGQFPIKGAQKAAATAF--KC 338
                   R G+       +R LL+   KL+   ++  L  ++     +    + F    
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311

Query: 339 LSHHPRHRPTMS 350
           L   PR R    
Sbjct: 312 LQLDPRKRADAG 323

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.7 bits (180), Expect = 4e-16
 Identities = 25/165 (15%), Positives = 50/165 (30%), Gaps = 33/165 (20%)

Query: 83  NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT----------QGHKEWMAEII 132
            L+GEG    V+     EK           VK   +  T           G   +    I
Sbjct: 6   KLMGEGKESAVFNC-YSEK------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAI 58

Query: 133 FLGQLRHPHLVKLIGYCWEEEY----RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIA 188
              +     L KL G    + Y      ++ E +    L+                 ++ 
Sbjct: 59  RSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------RVENPDEVL 109

Query: 189 LGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD 233
               + +A  +   + +++ D    N+L+  +    + DF  + +
Sbjct: 110 DMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	401
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.68
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.22
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.06
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.27
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.17
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.68

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=415.30  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=207.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      ++|++.+.||+|+||+||+|++..      +++.||||++..... ...+.+.+|+.+|++++||||+++++++.+++..
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~   78 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRV------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ   78 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCcee
Confidence            679999999999999999999876      688999999975532 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ||||||++||+|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||+|+...
T Consensus        79 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheeec
Confidence            9999999999999998654  68999999999999999999999654  9999999999999999999999999998765


Q ss_pred             CCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ...........+||+.|||||++.+..+ +.++|||||||++|+|++|+.||........ ......             
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~~-------------  220 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-------------  220 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHHH-------------
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHHHHh-------------
Confidence            4444444456789999999999988776 5789999999999999999999976432111 111110             


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       ............+..+.+|+.+||+.||++|||++++++
T Consensus       221 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         221 -EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             011111112334678899999999999999999999964

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=412.06  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=210.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|++.+.||+|+||+||+|.+..      +++.||||++........+.+.+|+.+|+.++||||+++++++.+++.+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVA------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTT------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECC------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            579999999999999999998876      68899999997665556678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||++||+|.+++.+   ..+++..++.++.||+.||.|||+.  ||+||||||+|||++.+|.+||+|||+|.....
T Consensus        94 ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~--~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            99999999999988765   4799999999999999999999965  599999999999999999999999999987644


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ...  .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||......  ..+......             
T Consensus       169 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~-------------  231 (293)
T d1yhwa1         169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATN-------------  231 (293)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHH-------------
T ss_pred             ccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHHHHhC-------------
Confidence            322  234568999999999999999999999999999999999999999764311  111111000             


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .......+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01111234455788999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=407.27  Aligned_cols=246  Identities=27%  Similarity=0.417  Sum_probs=209.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++++.||+|+||+||+|++..      +++.||+|++...   .......+.+|+.+++.++||||+++++++.+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQ------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECC------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            579999999999999999999876      6889999998632   2334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..|+||||+++|+|.+++.+.  ..+++..+..++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+|..
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~--~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--CeeeeeeccccceecCCCCEeecccceeee
Confidence            999999999999999999765  6799999999999999999999965  499999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .....    .....||+.|||||++.+..|+.++|||||||++|+|++|+.||.....      .+.......       
T Consensus       156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~-------  218 (263)
T d2j4za1         156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISR-------  218 (263)
T ss_dssp             CCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHT-------
T ss_pred             cCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHc-------
Confidence            54432    2456799999999999999999999999999999999999999975421      111111111       


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                         .  ...+|...++++.+|+.+||+.||.+|||+.++++
T Consensus       219 ---~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         219 ---V--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---C--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               1  11233445778999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.6e-57  Score=414.83  Aligned_cols=259  Identities=23%  Similarity=0.359  Sum_probs=217.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||+||+|++..      +++.||||+++.+. ...+.+.+|+.+|++++||||+++++++.+++..
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGG------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECC------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            4678999999999999999999876      58899999987543 3467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++|+|.+++.......+++..++.++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+|+...
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC--CcccCccccCeEEECCCCcEEEccccceeecC
Confidence            9999999999999999877677899999999999999999999965  59999999999999999999999999998765


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .... .......|++.|+|||++.+..|+.++|||||||++|||++|..||......     .           .+...+
T Consensus       167 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-----~-----------~~~~~i  229 (287)
T d1opja_         167 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----S-----------QVYELL  229 (287)
T ss_dssp             SSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----H-----------HHHHHH
T ss_pred             CCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-----H-----------HHHHHH
Confidence            4332 2334456899999999999999999999999999999999977665432111     1           111112


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      ........+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            222233445556788999999999999999999999999998774

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-56  Score=405.81  Aligned_cols=261  Identities=26%  Similarity=0.412  Sum_probs=204.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      .++|.+.+.||+|+||+||+|++.         ..||||+++..  .....+.+.+|+.+|++++||||+++++++.+ .
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~   76 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P   76 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c
Confidence            478999999999999999999743         25999998754  33445788999999999999999999998754 4


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+++||||+++|+|.+++... ...+++..+..++.||+.||+|||+.  +||||||||+|||++.++.+||+|||+|+.
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~--~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~  153 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK--SIIHRDLKSNNIFLHEDLTVKIGDFGLATV  153 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEETTSSEEECCCCCSCC
T ss_pred             EEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC--CEeccccCHHHEEEcCCCCEEEccccceee
Confidence            679999999999999999754 35799999999999999999999965  599999999999999999999999999987


Q ss_pred             CCCCCcceeeecccccccccccccccc---CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ..............||+.|||||++.+   ..|+.++|||||||++|||+||+.||.......  .+..........   
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~---  228 (276)
T d1uwha_         154 KSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYLS---  228 (276)
T ss_dssp             ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSCC---
T ss_pred             ccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH--HHHHHHhcCCCC---
Confidence            655444444566789999999999874   358999999999999999999999997643211  111111111000   


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                            +. ....+..+++.+.+|+.+||+.||.+|||+.+|++.|+.++.
T Consensus       229 ------p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         229 ------PD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ------CC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------Cc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  00 112233456789999999999999999999999999998864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=408.21  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=196.8

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--C
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--E  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--~  152 (401)
                      ++|++.+.||+|+||+||+|++..      +++.||+|++....  ....+.+.+|+++|++++||||+++++++.+  +
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            679999999999999999999876      68899999987553  2334568899999999999999999999865  4


Q ss_pred             CeEEEEEEecCCCChhHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHhCCC---CCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRS--YSAALPWSTRMKIALGAAKGLAFLHGED---KPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~al~~LH~~~---~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                      ..+|+||||+++|+|.+++.+.  ....+++..++.++.||+.||.|||+.+   .+||||||||+|||++.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            5689999999999999998652  3568999999999999999999999643   3499999999999999999999999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      ||+|.......  .......||+.|||||++.+..|+.++|||||||++|+|++|+.||......      +......  
T Consensus       158 FG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~--  227 (269)
T d2java1         158 FGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIR--  227 (269)
T ss_dssp             HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH--
T ss_pred             ccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHH--
Confidence            99998754432  2234568999999999999999999999999999999999999999764211      1111111  


Q ss_pred             ccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          308 PRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                              ... ....+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       228 --------~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         228 --------EGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             --------HTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------cCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                    011 11233445678999999999999999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-56  Score=411.29  Aligned_cols=251  Identities=23%  Similarity=0.288  Sum_probs=207.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++++.||+|+||+||+|.+..      +++.||||++...   .......+.+|+++|++++||||+++++++.+++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELA------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            679999999999999999999876      6889999998632   2234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||++||+|.+++...  +.+++..++.++.|++.||+|||+.+  ||||||||+|||++.+|.+||+|||+|+.
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEeccccccee
Confidence            999999999999999998765  78999999999999999999999654  99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      .............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.....      ........        
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~--------  223 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKII--------  223 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH--------
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHH--------
Confidence            6554444444567899999999999999999999999999999999999999976421      11111111        


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        ...  ..+|...++.+.+||.+||+.||.+|||++++++.
T Consensus       224 --~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         224 --KLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             --TTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             --cCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence              111  12334456789999999999999999999987543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-55  Score=408.04  Aligned_cols=265  Identities=24%  Similarity=0.388  Sum_probs=204.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||+||+|++....+   ....||||.+.... ....+.+.+|+.+|++++||||+++++++..++.
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGK---REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            3678889999999999999998765211   23468999886543 3345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +++||||+++|+|.+++... ...+++..++.++.||+.||.|||++  +|+||||||+||||+.++.+||+|||+++..
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC--CCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999999988653 35799999999999999999999964  5999999999999999999999999999865


Q ss_pred             CCCCccee---eeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          235 PEGEETHV---ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       235 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ........   .....||+.|||||++.++.|+.++|||||||++|||+| |..||......   .+...          
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~----------  245 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINA----------  245 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH----------
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHH----------
Confidence            44322211   223468999999999999999999999999999999998 89999764211   11111          


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcc
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQ  363 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~  363 (401)
                          +........+..++..+.+|+.+||+.||.+|||+.+|++.|+++..-+
T Consensus       246 ----i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         246 ----IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             ----HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ----HHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                1111222334456788999999999999999999999999999886543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=401.35  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=201.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|++.+.||+|+||+||+|++..       ++.||||+++.. ....+.+.+|+.++++++||||+++++++..++..+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-------KDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-------TEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-------CCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            678999999999999999998764       568999998754 334578999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+++|+|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++....
T Consensus        77 lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA--CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             EEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc--ceeecccchhheeecCCCCeEecccchheeccC
Confidence            999999999999988654 35789999999999999999999965  499999999999999999999999999986644


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhC-CCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTG-KRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      .... ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.....      .+......          
T Consensus       154 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~~i~----------  216 (263)
T d1sm2a_         154 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDIS----------  216 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHHHHH----------
T ss_pred             CCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHHHHH----------
Confidence            3322 22345799999999999999999999999999999999995 555543211      11111110          


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                       .......|..++..+.+|+.+||+.||++|||+++|++.|++++.
T Consensus       217 -~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         217 -TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -hcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence             111122334456789999999999999999999999999998864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-55  Score=399.36  Aligned_cols=250  Identities=25%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             cCC-CCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC--CcccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           77 SNF-SRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD--GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        77 ~~y-~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      ++| ++.+.||+|+||+||+|++..      +++.||+|++...  .....+.+.+|+++|++++||||+++++++.+  
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTE------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECC------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            445 567789999999999999876      6789999998644  23335678899999999999999999999875  


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc-CCCcEEEEec
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD-SDYTAKLSDF  228 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~-~~~~vkL~Df  228 (401)
                        ...+|+||||+++|+|.+++.+.  ..+++..++.++.||+.||+|||+++.+|+||||||+|||++ .++.+||+||
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence              34689999999999999999775  689999999999999999999997666699999999999996 5789999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP  308 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  308 (401)
                      |+|+......    ....+||+.|||||++.+ .|+.++|||||||++|+|++|+.||......     ...........
T Consensus       160 Gla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~~~~  229 (270)
T d1t4ha_         160 GLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGV  229 (270)
T ss_dssp             TGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTC
T ss_pred             CcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHHcCC
Confidence            9998643322    245689999999998875 5999999999999999999999999754211     11111111110


Q ss_pred             cchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 RKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                                ....++...++++.+|+.+||+.||++|||+.++++
T Consensus       230 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 ----------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ----------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                      001112223567899999999999999999999976

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=405.72  Aligned_cols=252  Identities=26%  Similarity=0.363  Sum_probs=209.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      +.|++.+.||+|+||+||+|++..      +++.||+|++........+.+.+|+++|++++||||+++++++.+++.+|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            568999999999999999999876      68899999998766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+++|+|.+++.+. ...+++..+..++.||+.||.|||+++  |+||||||+|||++.+|.+||+|||+|.....
T Consensus        86 lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999999999987654 357999999999999999999999654  99999999999999999999999999975432


Q ss_pred             CCcceeeeccccccccccccccc-----cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          237 GEETHVITRVMGTQGYAAPEYVM-----TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      .  ........||+.|+|||++.     +..|+.++|||||||++|+|++|+.||......  ..+......        
T Consensus       163 ~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~i~~~--------  230 (288)
T d2jfla1         163 T--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAKS--------  230 (288)
T ss_dssp             H--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHHS--------
T ss_pred             C--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHcC--------
Confidence            1  11223467999999999984     466899999999999999999999999765321  111111110        


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                           .......+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       231 -----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 -----EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 00111223455788999999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=413.12  Aligned_cols=268  Identities=22%  Similarity=0.333  Sum_probs=208.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..++|++.+.||+|+||+||+|++..      +++.||+|+++.... .....+.+|+.+|+.++||||++++++|.++.
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   77 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKP------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG   77 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETT------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            35789999999999999999999876      689999999976533 33567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||++||+|.+++.+.  ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.+|.+||+|||+|..
T Consensus        78 ~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          78 EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHH-HCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHh-CCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            999999999999999999765  6799999999999999999999952 2499999999999999999999999999985


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccH--HHHhhhhh------
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSL--AEWARPLL------  305 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~------  305 (401)
                      ....    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........  ........      
T Consensus       155 ~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         155 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             HHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             cCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence            4321    22456899999999999999999999999999999999999999976432111000  00000000      


Q ss_pred             --------------cCccc----hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 --------------KEPRK----LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 --------------~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                    .....    ...+.............+.++.+|+.+||+.||.+|||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                          00000    000000000000111235689999999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-55  Score=410.59  Aligned_cols=263  Identities=26%  Similarity=0.391  Sum_probs=213.1

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      .++|++++.||+|+||+||+|++.... .......||+|.+.... ......+.+|+.+|.++ +||||+++++++.+.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGIS-KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCS-SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCC-cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            368999999999999999999886521 12234579999986542 33456788999999998 8999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc---------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY---------------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKA  212 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~---------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp  212 (401)
                      .+|+||||+++|+|.+++....                     ...+++..++.++.||+.||+|||+.  +||||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~--~IiHRDlKp  192 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--SCVHRDLAA  192 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--TEEETTCSG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCch
Confidence            9999999999999999997542                     13589999999999999999999965  499999999


Q ss_pred             CcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcc
Q 040050          213 SNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRL  291 (401)
Q Consensus       213 ~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  291 (401)
                      +|||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||++ |..||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655544444455678999999999999999999999999999999998 8999976432


Q ss_pred             cccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 040050          292 GREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLD  357 (401)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~  357 (401)
                      .  ..              +..++........|..++..+.+|+.+||+.||++|||+++|+++|.
T Consensus       273 ~--~~--------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 D--AN--------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             S--HH--------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H--HH--------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1  11              11122222233445556789999999999999999999999999985

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-55  Score=399.94  Aligned_cols=256  Identities=29%  Similarity=0.420  Sum_probs=208.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||+||+|.+..       +..||||++... ....+.+.+|+.++++++||||+++++++.+ +..
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~   82 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNG-------HTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-------TEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECC-------CCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCe
Confidence            4678999999999999999998753       678999999754 3345679999999999999999999998754 567


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+++|+|.+++.......+++..++.++.||+.||.|||++  +|+||||||+||||+.++.+||+|||+|+...
T Consensus        83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~--~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER--NYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCccchhheeeecccceeeccccceEEcc
Confidence            9999999999999988766556799999999999999999999964  49999999999999999999999999998765


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhc
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLI  315 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (401)
                      ... ........||+.|+|||++.++.|+.++|||||||++|||+||..|+......     .+.....           
T Consensus       161 ~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~~~~i-----------  223 (272)
T d1qpca_         161 DNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNL-----------  223 (272)
T ss_dssp             SSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHH-----------
T ss_pred             CCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-----------
Confidence            432 22234467899999999999999999999999999999999966554332111     1111111           


Q ss_pred             CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          316 DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       316 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ........|..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            11122233445567899999999999999999999999998875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.6e-55  Score=405.63  Aligned_cols=254  Identities=22%  Similarity=0.321  Sum_probs=194.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      +.+.|++.+.||+|+||+||+|++..      +++.||||++..... .....+.+|+.+|+.++||||+++++++.+++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~   80 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKR------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG   80 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETT------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CccceEEEEEEeeccCeEEEEEEECC------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            45789999999999999999999876      688999999875432 23356778999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc---CCCcEEEEecCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD---SDYTAKLSDFGL  230 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~---~~~~vkL~DfG~  230 (401)
                      .+|||||||+||+|.+++...  ..+++..+..++.||+.||+|||++  +|+||||||+|||+.   .++.+||+|||+
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~--~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             EEEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc--eeeeEEecccceeecccCCCceEEEeccce
Confidence            999999999999999999764  6899999999999999999999955  599999999999994   578999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      |.......   .....+||+.|||||++.+..|+.++|||||||++|+|++|..||......      ..........  
T Consensus       157 a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~--  225 (307)
T d1a06a_         157 SKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAE--  225 (307)
T ss_dssp             -------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTC--
T ss_pred             eEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccC--
Confidence            98654332   234567999999999999999999999999999999999999999764211      1111111110  


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                            .......+..+++.+.+|+.+||+.||.+|||+.++++.
T Consensus       226 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         226 ------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                  011112233456789999999999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=397.68  Aligned_cols=269  Identities=27%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +++|++.++||+|+||+||+|.+....  ......||||++..... .....+++|+.++++++||||+++++++.+...
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~--~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~   83 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSS--GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP   83 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCC--CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence            357889999999999999999876521  11235799999875433 334578899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .++||||+.++++.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||||+.++.+||+|||+++..
T Consensus        84 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~--~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          84 MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc--ccccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999998877653 46799999999999999999999965  4999999999999999999999999999865


Q ss_pred             CCCCc-ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEE-THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..... ........||+.|+|||++.++.++.++|||||||++|||++|..|+......  ..+.              .
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~--------------~  224 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVM--------------K  224 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHH--------------H
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHH--------------H
Confidence            44322 22233456899999999999999999999999999999999976655432111  1111              1


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhcccC
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQDS  365 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~~  365 (401)
                      .+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+...+++
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~  276 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  276 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence            1112222334445677899999999999999999999999999998766543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-54  Score=395.46  Aligned_cols=251  Identities=27%  Similarity=0.381  Sum_probs=202.2

Q ss_pred             ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEEEEEE
Q 040050           83 NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        83 ~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~lv~e  160 (401)
                      +.||+|+||+||+|.+...    .+++.||||+++...  ......+.+|+.+|++++||||+++++++..+ ..+||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~----~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK----KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS----SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccC----CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEE
Confidence            5799999999999987542    246789999986542  23356799999999999999999999998654 5789999


Q ss_pred             ecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCcc
Q 040050          161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEET  240 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~  240 (401)
                      |+++|+|.+++.+.  ..+++..++.++.||+.||+|||++  +|+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~--~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES--NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC--CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            99999999998764  6799999999999999999999965  4999999999999999999999999999876543322


Q ss_pred             -eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhhcCCc
Q 040050          241 -HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDPR  318 (401)
Q Consensus       241 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (401)
                       .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....   .+..              .+...
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~--------------~i~~~  226 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTA--------------MLEKG  226 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHH--------------HHHTT
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHH--------------HHHcC
Confidence             22234679999999999999999999999999999999998 89999764211   1111              11111


Q ss_pred             CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          319 LEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       319 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      .....|..++.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            22234455678899999999999999999999999888764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=390.34  Aligned_cols=255  Identities=24%  Similarity=0.372  Sum_probs=212.7

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||+||+|++..       ++.||||+++... .....+.+|+.++++++||||+++++++.+++.+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~-------~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~   74 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRG-------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   74 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETT-------TEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECC-------CCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence            3689999999999999999999753       6789999998543 3456899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      ++||||+.+|+|..++... ...+++..++.++.|+++||.|||+  +||+||||||+|||++.++.+||+|||+++...
T Consensus        75 ~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~--~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          75 FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             EEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHH--TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             EEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhh--cCcccccccceeEEEcCCCcEEECcchhheecc
Confidence            9999999999999887654 3578999999999999999999995  459999999999999999999999999998655


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||......      +....+.         
T Consensus       152 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~i~---------  215 (258)
T d1k2pa_         152 DDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIA---------  215 (258)
T ss_dssp             SSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHH---------
T ss_pred             CCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHHHH---------
Confidence            43322 2344679999999999999999999999999999999998 89999765321      1111111         


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                        .......|...+..+.+|+.+||+.||++|||++++++.|.++
T Consensus       216 --~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         216 --QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             --hCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence              1112233445567899999999999999999999999998654

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-54  Score=402.85  Aligned_cols=246  Identities=28%  Similarity=0.382  Sum_probs=202.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..|+..+.||+|+||+||+|++..      +++.||||++.....   ...+.+.+|+.+|++++||||+++++++.+++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVR------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeEEEecCCCeEEEEEEECC------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            359999999999999999999876      688999999875532   23456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+|||||.+|+|..++...  ..+++..++.++.||+.||.|||+++  ||||||||+|||++.++.+||+|||+|..
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccc
Confidence            999999999999887666544  68999999999999999999999654  99999999999999999999999999986


Q ss_pred             CCCCCcceeeecccccccccccccccc---CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccc
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMT---GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRK  310 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  310 (401)
                      ....      ....||+.|||||++.+   +.|+.++|||||||++|+|++|..||......      +.......    
T Consensus       165 ~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~----  228 (309)
T d1u5ra_         165 MAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ----  228 (309)
T ss_dssp             SSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHH----
T ss_pred             cCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh----
Confidence            5432      34579999999999864   46899999999999999999999999754211      11111111    


Q ss_pred             hhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          311 LERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                            .......+...++.+.+|+.+||+.||.+|||++++++
T Consensus       229 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         229 ------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             ------SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ------CCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                  11111112234678999999999999999999999976

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-53  Score=404.33  Aligned_cols=253  Identities=22%  Similarity=0.293  Sum_probs=210.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|++.+.||+|+||+||+|++..      +++.||||++........+.+.+|+.+|++++||||+++++++.+++.+|
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERA------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            689999999999999999999876      68999999998666555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC--CCcEEEEecCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS--DYTAKLSDFGLAKDG  234 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~--~~~vkL~DfG~a~~~  234 (401)
                      ||||||+||+|.+++.+. ...+++..++.++.||+.||.|||+++  ||||||||+|||++.  ++.+||+|||++...
T Consensus       100 ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999999999999998653 357999999999999999999999655  999999999999954  588999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      .....   .....||+.|||||++.+..|+.++|||||||++|+|++|+.||.+....      +..........     
T Consensus       177 ~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~-----  242 (350)
T d1koaa2         177 DPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDW-----  242 (350)
T ss_dssp             CTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC-----
T ss_pred             ccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-----
Confidence            54332   34567999999999999999999999999999999999999999754211      11111111100     


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                         .........++..+.+||.+||+.||++|||+.+++++
T Consensus       243 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         243 ---NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ---CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ---CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               01111123346789999999999999999999999874

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=396.25  Aligned_cols=259  Identities=26%  Similarity=0.376  Sum_probs=208.7

Q ss_pred             cCCCCCce-ecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNL-LGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~-Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|.+.+. ||+|+||+||+|.+...    .++..||||++.... ......+.+|+.+|++++||||+++++++.. +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~----~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMR----KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecC----CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            45666674 99999999999987542    135679999997543 3345678999999999999999999999865 45


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +||||||+++|+|.+++... ...+++..++.++.||+.||+|||+.  +|+||||||+|||++.++.+||+|||+++..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~--~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK--NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC--CeecCcCchhheeeccCCceeeccchhhhcc
Confidence            79999999999999987543 36799999999999999999999964  5999999999999999999999999999876


Q ss_pred             CCCCcce-eeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          235 PEGEETH-VITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       235 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ....... ......||+.|+|||++.++.++.++|||||||++|||+| |..||......   .+...            
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~------------  224 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAF------------  224 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHH------------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHH------------
Confidence            5543222 2234568999999999999999999999999999999998 89999764311   11111            


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                        +........|..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       225 --i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         225 --IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             --HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              1111222345556788999999999999999999999999988763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=401.54  Aligned_cols=249  Identities=27%  Similarity=0.364  Sum_probs=210.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++++.||+|+||.||+|++..      +++.||+|++...   .......+.+|+.+|++++||||+++++++.+++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HhcEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            579999999999999999999876      6899999998643   2334577889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||+++  ||||||||+|||++.+|.+||+|||+|+.
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccc
Confidence            999999999999999999776  68999999999999999999999655  99999999999999999999999999986


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......  .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||......      .......        
T Consensus       155 ~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~--------  218 (337)
T d1o6la_         155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELIL--------  218 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH--------
T ss_pred             cccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHh--------
Confidence            543322  234578999999999999999999999999999999999999999765321      1111111        


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                        ..  ...+|...+.++.+||.+||+.||.+||+     +++++++
T Consensus       219 --~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         219 --ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --cC--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence              11  11234456778999999999999999995     8888764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.2e-53  Score=402.33  Aligned_cols=254  Identities=21%  Similarity=0.273  Sum_probs=211.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .++|++.+.||+|+||+||+|++..      +++.||||++..........+.+|+.+|++++||||++++++|.++..+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKA------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3679999999999999999999876      6889999999866555566788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc--CCCcEEEEecCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD--SDYTAKLSDFGLAKD  233 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~--~~~~vkL~DfG~a~~  233 (401)
                      |||||||+||+|.+++... ...+++..++.++.||+.||.|||+.  |||||||||+|||++  .++.+||+|||+|..
T Consensus       102 ~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~--~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC--CeeecccccccccccccCCCeEEEeeccccee
Confidence            9999999999999887543 35799999999999999999999954  599999999999997  578999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ......   .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....      .........      
T Consensus       179 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~------  243 (352)
T d1koba_         179 LNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRC------  243 (352)
T ss_dssp             CCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHC------
T ss_pred             cCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC------
Confidence            655432   34567999999999999999999999999999999999999999764211      111111110      


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        ...........++.++.+||.+||+.||.+|||+.+++++
T Consensus       244 --~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         244 --DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             --CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             --CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0111112233457789999999999999999999999874

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-53  Score=391.44  Aligned_cols=253  Identities=22%  Similarity=0.296  Sum_probs=208.1

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC------cccHHHHHHHHHHHhccCCCceeeEEEE
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG------TQGHKEWMAEIIFLGQLRHPHLVKLIGY  148 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpnI~~~~~~  148 (401)
                      +.++|++++.||+|+||+||+|++..      +++.||||++....      ....+.+.+|+.+|++++||||++++++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKS------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETT------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECC------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            45789999999999999999999876      68899999986431      2235778999999999999999999999


Q ss_pred             EEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC----cEE
Q 040050          149 CWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY----TAK  224 (401)
Q Consensus       149 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~----~vk  224 (401)
                      +.+++.+|||||||+||+|.+++...  +.+++..++.++.|++.||+|||+.+  |+||||||+|||++.++    .+|
T Consensus        82 ~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          82 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceE
Confidence            99999999999999999999999765  68999999999999999999999655  99999999999998776    599


Q ss_pred             EEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          225 LSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       225 L~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      |+|||+|........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....      +.....
T Consensus       158 l~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i  228 (293)
T d1jksa_         158 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANV  228 (293)
T ss_dssp             ECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred             ecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHH
Confidence            999999987654332   24567999999999999999999999999999999999999999764211      111111


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ......        .....+...+..+.+||.+||+.||.+|||++++++
T Consensus       229 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         229 SAVNYE--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HTTCCC--------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HhcCCC--------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111000        000111234668899999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=399.48  Aligned_cols=262  Identities=24%  Similarity=0.391  Sum_probs=207.7

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+|++.++||+|+||+||+|.+...  +......||+|.+... .....+.+.+|+.++++++||||+++++++.++. .
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCC--CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence            4699999999999999999987652  1112346999988643 3345678999999999999999999999998754 5


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      +++|+++.+++|.+++... ...+++..++.++.||+.||+|||++  +||||||||+|||++.++.+||+|||+|+...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~--~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR--RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc--CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence            7788999999999987654 46899999999999999999999965  49999999999999999999999999998765


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ............||+.|+|||++.++.|+.++|||||||++|||+| |.+||.......   +.              ..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~--------------~~  225 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS--------------SI  225 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH--------------HH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH--------------HH
Confidence            5444444445679999999999999999999999999999999998 788887643211   11              11


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      +........|..++..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            11122223445567789999999999999999999999999988753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-53  Score=390.62  Aligned_cols=258  Identities=28%  Similarity=0.398  Sum_probs=205.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCeEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYRL  156 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~~  156 (401)
                      ++|++++.||+|+||+||+|++..       ++.||||++... ....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-------~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-------TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-------TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-------CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            679999999999999999998865       457999999744 3345789999999999999999999999854 5578


Q ss_pred             EEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCC
Q 040050          157 LVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPE  236 (401)
Q Consensus       157 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~  236 (401)
                      +||||+++|+|..++.......+++..++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+++....
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccC
Confidence            9999999999999987765578999999999999999999999654  99999999999999999999999999986544


Q ss_pred             CCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcC
Q 040050          237 GEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLID  316 (401)
Q Consensus       237 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (401)
                      ... .......||+.|+|||++.++.++.++|||||||++|||++|..|+......     .+.....           .
T Consensus       166 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~~~~~i-----------~  228 (285)
T d1fmka3         166 NEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQV-----------E  228 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHH-----------H
T ss_pred             CCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHH-----------H
Confidence            332 2234467999999999999999999999999999999999976665443211     1111111           1


Q ss_pred             CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          317 PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       317 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      .......+..++..+.+++.+||+.||++||++++|+++|+..-..
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            1112233445677899999999999999999999999998886543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-53  Score=395.95  Aligned_cols=246  Identities=25%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++++.||+|+||+||+|++..      +++.||||++...   .....+.+.+|+.+|+.++||||+++++++.+++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRH------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECC------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            579999999999999999999876      6889999998632   2334577889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      .+|+||||+.||+|..++...  ..+++..+..++.||+.||.|||++  ||+||||||+|||++.+|.+||+|||+|..
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccC--cEEccccCchheeEcCCCCEEEecCccceE
Confidence            999999999999999988765  6789999999999999999999954  599999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.....      .+......        
T Consensus       154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~--------  214 (316)
T d1fota_         154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKIL--------  214 (316)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH--------
T ss_pred             eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHH--------
Confidence            6443     2346899999999999999999999999999999999999999976421      11111111        


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVRV  355 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~~  355 (401)
                        ...  ..+|...+.++.+++.+||..||.+|+     |+++++++
T Consensus       215 --~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         215 --NAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --HCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --cCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              111  123344567899999999999999996     89999874

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-52  Score=385.87  Aligned_cols=263  Identities=24%  Similarity=0.308  Sum_probs=205.3

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc---ccHHHHHHHHHHHhccCCCceeeEEEEEEe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT---QGHKEWMAEIIFLGQLRHPHLVKLIGYCWE  151 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~  151 (401)
                      +.++|++.+.||+|+||+||+|++..      +++.||||++.....   .....+.+|+.+++.++||||+++++++..
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLR------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECC------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence            35789999999999999999999876      689999999975432   334568899999999999999999999986


Q ss_pred             CC----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          152 EE----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       152 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                      .+    ..||||||++|++|.+++...  +.+++..++.++.||+.||.|||+++  |+||||||+|||++.++.++|+|
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeeh
Confidence            54    479999999999999988765  68999999999999999999999654  99999999999999999999999


Q ss_pred             cCCCCCCCCCC-cceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          228 FGLAKDGPEGE-ETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       228 fG~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      ||.+....... ........+||+.|+|||++.+..|+.++|||||||++|+|++|++||......      +.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~  228 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVR  228 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHh
Confidence            99987543322 222334567999999999999999999999999999999999999999764211      11111111


Q ss_pred             CccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhhh
Q 040050          307 EPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-TMSYVVRVLDSLQD  361 (401)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~~il~~L~~l~~  361 (401)
                      .....        .......++..+.+++.+||+.||.+|| |++++++.|.++++
T Consensus       229 ~~~~~--------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         229 EDPIP--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             CCCCC--------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             cCCCC--------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            11000        0011223467899999999999999999 89999998887753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=387.97  Aligned_cols=261  Identities=24%  Similarity=0.344  Sum_probs=201.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      .++|++++.||+|+||.||+|++...   ...+..||||.+..... .....+.+|+.++++++||||+++++++. ++.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~---~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSP---ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecC---CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            46899999999999999999987652   11346789998865433 33567899999999999999999999985 467


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|+||||+.+|+|.+++... ...+++..++.++.||+.||.|||+++  |+||||||+||+++.++.+||+|||+|+..
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheec
Confidence            89999999999999887654 467999999999999999999999655  999999999999999999999999999865


Q ss_pred             CCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ..... .......||+.|+|||++.+..|+.++|||||||++|||++ |.+||......   .+...+            
T Consensus       159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i------------  222 (273)
T d1mp8a_         159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRI------------  222 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHH------------
T ss_pred             cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHHHHH------------
Confidence            43322 22344678999999999999999999999999999999998 88999765321   111111            


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                       . .......+..++..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       223 -~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         223 -E-NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             -H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -H-cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             1 111123445567889999999999999999999999999998753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.8e-53  Score=399.35  Aligned_cols=245  Identities=23%  Similarity=0.300  Sum_probs=207.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++++.||+|+||.||+|++..      +++.||||++...   .......+.+|+.+|+.++||||+++++++.+..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKE------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECC------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            579999999999999999999876      6889999998632   2334567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+.+|+|..++.+.  +.+++..++.++.||+.||.|||+++  ||||||||+|||++.+|.+||+|||+|+.
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            999999999999999999776  68999999999999999999999655  99999999999999999999999999987


Q ss_pred             CCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhh
Q 040050          234 GPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLER  313 (401)
Q Consensus       234 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (401)
                      ....     .....||+.|||||++.+..|+.++|||||||++|+|++|..||.+...      .........       
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~-------  252 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVS-------  252 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-------
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHhc-------
Confidence            6432     2346799999999999999999999999999999999999999976421      111111111       


Q ss_pred             hcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 040050          314 LIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVR  354 (401)
Q Consensus       314 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~  354 (401)
                         ..  ..++..++.++.+++.+||+.||.+|+     |++++++
T Consensus       253 ---~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         253 ---GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence               11  122334567899999999999999994     8999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-53  Score=384.53  Aligned_cols=251  Identities=27%  Similarity=0.412  Sum_probs=201.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE-EEYR  155 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~-~~~~  155 (401)
                      ++|++.+.||+|+||.||+|.+.        +..||||+++.+  ...+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            56888999999999999999864        467999998643  345779999999999999999999999865 4568


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      |+||||+++|+|.+++.......+++..++.++.||+.||.|||+.  +|+||||||+|||++.++.+||+|||+++...
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~--~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC--ceeccccchHhheecCCCCEeecccccceecC
Confidence            9999999999999999776455799999999999999999999954  59999999999999999999999999998643


Q ss_pred             CCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccchhhh
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKLERL  314 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (401)
                      ..     .....++..|+|||++.++.++.++|||||||++|||+| |.+||......   .+...              
T Consensus       155 ~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~--------------  212 (262)
T d1byga_         155 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR--------------  212 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH--------------
T ss_pred             CC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH--------------
Confidence            32     233468999999999999999999999999999999998 67777654211   11111              


Q ss_pred             cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          315 IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       315 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      +.......++...++++.+|+.+||+.||.+|||+.+++++|+.++.
T Consensus       213 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            11222334455567889999999999999999999999999998865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=392.73  Aligned_cols=271  Identities=26%  Similarity=0.360  Sum_probs=206.4

Q ss_pred             HHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEE
Q 040050           71 ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGY  148 (401)
Q Consensus        71 ~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~  148 (401)
                      .+.+-.++|++.+.||+|+||.||+|.+... ....+++.||||++..... .....+.+|..++.++ +|+||+.++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGI-DKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEEST-TSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCC-CcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            3334457899999999999999999987642 2344668899999875432 3355677888887777 68999999998


Q ss_pred             EEeCC-eEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCC
Q 040050          149 CWEEE-YRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKAS  213 (401)
Q Consensus       149 ~~~~~-~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~  213 (401)
                      +...+ .+++|||||++|+|.+++....              ...+++..++.++.||+.||.|||+++  ||||||||+
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~  163 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR  163 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCcc
Confidence            87654 6899999999999999996532              235889999999999999999999654  999999999


Q ss_pred             cEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCC-CCCCCCccc
Q 040050          214 NILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK-RAMDNTRLG  292 (401)
Q Consensus       214 NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~  292 (401)
                      |||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998665544433344567999999999999999999999999999999999975 577654221


Q ss_pred             ccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          293 REQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      .  .+..              .+........+...++++.+++.+||+.||.+|||+.+++++|+.+.
T Consensus       244 ~--~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         244 E--EFCR--------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             H--HHHH--------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--HHHH--------------HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1  1111              11111222334445678999999999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.1e-53  Score=390.96  Aligned_cols=269  Identities=24%  Similarity=0.345  Sum_probs=215.2

Q ss_pred             HHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-cHHHHHHHHHHHhccCCCceeeEEEEEE
Q 040050           72 LRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-GHKEWMAEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        72 ~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ++...++|++.+.||+|+||+||+|++... ....+++.||||++...... ....+.+|+.+|++++||||+++++++.
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~-~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGL-LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETS-STTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCC-ccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            334457899999999999999999987531 22335678999998765433 3567899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeec
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSY----------------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYR  208 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~  208 (401)
                      .....+++|||+.+|+|.+++....                      ...+++..++.++.|++.||+|||+.  +||||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--~ivHr  164 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHR  164 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCS
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--CeEee
Confidence            9999999999999999999986421                      23588999999999999999999954  49999


Q ss_pred             cCCCCcEEEcCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCC-CCCC
Q 040050          209 DFKASNILLDSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK-RAMD  287 (401)
Q Consensus       209 Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~  287 (401)
                      ||||+|||++.++.+||+|||+|+...............|++.|+|||++.+..|+.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999997654444344445577999999999999999999999999999999999986 5676


Q ss_pred             CCcccccccHHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          288 NTRLGREQSLAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                      .....   .+..   .+          .. ......+..++.++.+|+.+||+.||++|||+.+|+++|++|.
T Consensus       245 ~~~~~---e~~~---~v----------~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHE---EVIY---YV----------RD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHH---HHHH---HH----------HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHH---HHHH---HH----------Hc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            54211   1111   11          11 1112234455678999999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=384.16  Aligned_cols=261  Identities=26%  Similarity=0.382  Sum_probs=201.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ++|++.+.||+|+||.||+|.+....   .....||||++...   .....+.+.+|+.+|++++||||+++++++.++ 
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~---~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPS---GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT---SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCC---CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence            67999999999999999999876421   13457999998654   233456789999999999999999999999764 


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                      ..++||||+++|++.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~--~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK--RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC--CEeeeeecHHHhccccccceeeccchhhhh
Confidence            678999999999999888764 35699999999999999999999965  499999999999999999999999999997


Q ss_pred             CCCCCccee-eeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccHHHHhhhhhcCccch
Q 040050          234 GPEGEETHV-ITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSLAEWARPLLKEPRKL  311 (401)
Q Consensus       234 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  311 (401)
                      ......... .....|+..|+|||++.+..++.++|||||||++|||+| |..||......      +...         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~---------  225 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILH---------  225 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHH---------
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHH---------
Confidence            655433322 233567889999999999999999999999999999998 89999754211      1111         


Q ss_pred             hhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhh
Q 040050          312 ERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQ  360 (401)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~  360 (401)
                       .+.........+..++..+.+|+.+||+.||++|||+.+|++.|.+.+
T Consensus       226 -~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         226 -KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             -HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence             111122222334455678999999999999999999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.8e-52  Score=393.65  Aligned_cols=250  Identities=25%  Similarity=0.343  Sum_probs=203.0

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC---cccHHHHH---HHHHHHhccCCCceeeEEEEEE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG---TQGHKEWM---AEIIFLGQLRHPHLVKLIGYCW  150 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~hpnI~~~~~~~~  150 (401)
                      ++|++.+.||+|+||.||+|++..      +++.||||++....   ......+.   .++.+++.++||||+++++++.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECC------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            579999999999999999999876      68899999985321   11222333   4577888889999999999999


Q ss_pred             eCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCC
Q 040050          151 EEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGL  230 (401)
Q Consensus       151 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~  230 (401)
                      +++.+|+||||++||+|.+++.+.  ..+++..++.++.||+.||.|||+.  +||||||||+|||++.+|.+||+|||+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~--~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR--FVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC--CccceeeccceeEEcCCCcEEEeeece
Confidence            999999999999999999999775  6789999999999999999999954  499999999999999999999999999


Q ss_pred             CCCCCCCCcceeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          231 AKDGPEGEETHVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       231 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      |+......    ....+||+.|+|||++. +..|+.++|||||||++|+|++|+.||........   ........    
T Consensus       154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~----  222 (364)
T d1omwa3         154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTL----  222 (364)
T ss_dssp             CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSS----
T ss_pred             eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcc----
Confidence            98665432    23457999999999997 45789999999999999999999999976532211   11111111    


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPT-----MSYVVRV  355 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~~il~~  355 (401)
                              .....++..+++.+.+||.+||+.||.+|||     +++++++
T Consensus       223 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         223 --------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --------SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --------cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                    1111233345778999999999999999999     6888764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=387.97  Aligned_cols=268  Identities=26%  Similarity=0.379  Sum_probs=213.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCC-CCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKP-GLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      .++|++++.||+|+||.||+|++....+. ...+..||||++..+.. .....+.+|...+.++ +||||+++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            46899999999999999999987653221 12346899999976543 3356788899999888 799999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSY--------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD  218 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~  218 (401)
                      ...++||||+.+|+|.+++....              ...+++..++.++.||+.||+|||+.+  ||||||||+|||++
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~  169 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT  169 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeec
Confidence            99999999999999999997542              246899999999999999999999655  99999999999999


Q ss_pred             CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCcccccccH
Q 040050          219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQSL  297 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  297 (401)
                      .++.+||+|||++................|++.|+|||++.++.|+.++|||||||++|||++ |.+||......   .+
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HH
Confidence            999999999999987655544444455779999999999999999999999999999999998 68888654221   11


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                      ..              .+........+..++..+.+|+.+||+.||.+|||+.+|++.|+++.++
T Consensus       247 ~~--------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         247 FK--------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             HH--------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH--------------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            11              1111222233445577899999999999999999999999999998654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=385.33  Aligned_cols=254  Identities=19%  Similarity=0.251  Sum_probs=207.6

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      +.++|++++.||+|+||+||+|++..      +++.||+|+++.... ....+.+|+.+|+.++||||+++++++.+++.
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETS------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECC------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            35789999999999999999999887      688999999976543 34567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC--CcEEEEecCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD--YTAKLSDFGLAK  232 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~--~~vkL~DfG~a~  232 (401)
                      +|||||||.||+|.+++... ...+++..++.++.||+.||.|||++  ||+||||||+|||++.+  +.+||+|||++.
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~--~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc--CCCcccccccceeecCCCceEEEEcccchhh
Confidence            99999999999999999654 34799999999999999999999965  49999999999999754  589999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      ......   ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||......      +.............
T Consensus       153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~~~  223 (321)
T d1tkia_         153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYTFD  223 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCCCC
T ss_pred             ccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCC
Confidence            764433   234457999999999999999999999999999999999999999764311      11111111100000


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .        .....++.++.+|+.+||..||.+|||+.+++++
T Consensus       224 ~--------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         224 E--------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             H--------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             h--------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0        0001236678999999999999999999999873

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=388.48  Aligned_cols=252  Identities=21%  Similarity=0.268  Sum_probs=201.4

Q ss_pred             hcCCCCC-ceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhcc-CCCceeeEEEEEEe--
Q 040050           76 TSNFSRS-NLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWE--  151 (401)
Q Consensus        76 ~~~y~~~-~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~--  151 (401)
                      .++|.+. +.||+|+||+||+|++..      +++.||||+++.     ...+.+|+.++.++ +||||++++++|.+  
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~------~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKR------TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETT------TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECC------CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            4688876 469999999999999876      688999999863     25677899886554 89999999999876  


Q ss_pred             --CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEE
Q 040050          152 --EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLS  226 (401)
Q Consensus       152 --~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~  226 (401)
                        +..+|||||||+||+|.+++.+.....+++..++.++.||+.||+|||+.+  |+||||||+|||++.   .+.+||+
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccc
Confidence              457899999999999999998765568999999999999999999999654  999999999999975   5679999


Q ss_pred             ecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      |||+|+.......   .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+......  ....      
T Consensus       157 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~------  225 (335)
T d2ozaa1         157 DFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGM------  225 (335)
T ss_dssp             CCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------
T ss_pred             ccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHH------
Confidence            9999986654332   3456799999999999999999999999999999999999999965421110  0000      


Q ss_pred             CccchhhhcCCcCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPRKLERLIDPRLE--GQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                          ...+......  ......+++++.+|+.+||+.||++|||+.+++++
T Consensus       226 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         226 ----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----HHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                0001111111  11123457889999999999999999999999874

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.8e-52  Score=378.61  Aligned_cols=252  Identities=24%  Similarity=0.337  Sum_probs=206.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc---------cHHHHHHHHHHHhccC-CCceeeE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ---------GHKEWMAEIIFLGQLR-HPHLVKL  145 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpnI~~~  145 (401)
                      .++|++.+.||+|+||+||+|++..      +++.||||++......         ....+.+|+.++++++ ||||+++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~   75 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKP------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   75 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cccCEEceEEecCcCeEEEEEEECC------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            3689999999999999999998876      6899999998754321         1235788999999997 9999999


Q ss_pred             EEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          146 IGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       146 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      ++++.+++..||||||+++|+|.+++...  ..+++..++.++.||+.||+|||+.  +|+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~--~ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          76 KDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL--NIVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEECTTCCEEE
T ss_pred             EeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc--CCcccccccceEEEcCCCCeEE
Confidence            99999999999999999999999999765  6899999999999999999999954  5999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeecccccccccccccccc------CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHH
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT------GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAE  299 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  299 (401)
                      +|||++........   .....||+.|+|||++.+      ..++.++||||+||++|+|++|+.||......      .
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~  222 (277)
T d1phka_         152 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------L  222 (277)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred             ccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------H
Confidence            99999987654332   245679999999999863      45788999999999999999999999765311      1


Q ss_pred             HhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          300 WARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      .........        ..........+++++.+|+.+||+.||++|||+.++++
T Consensus       223 ~~~~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         223 MLRMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            111111110        01111223356788999999999999999999999965

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=389.33  Aligned_cols=248  Identities=28%  Similarity=0.415  Sum_probs=205.5

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC---CcccHHHHHHHHHHHh-ccCCCceeeEEEEEEeC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD---GTQGHKEWMAEIIFLG-QLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~hpnI~~~~~~~~~~  152 (401)
                      ++|++++.||+|+||+||+|++..      +++.||||++...   .......+..|..++. .++||||+++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            579999999999999999999876      6899999998642   2234456677777665 68999999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                      +.+||||||+++|+|.+++...  ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhh
Confidence            9999999999999999999765  67999999999999999999999655  9999999999999999999999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchh
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLE  312 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  312 (401)
                      .......  ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+....      +........     
T Consensus       152 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~-----  218 (320)
T d1xjda_         152 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMD-----  218 (320)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-----
T ss_pred             hcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHcC-----
Confidence            6544322  234568999999999999999999999999999999999999999764211      111111100     


Q ss_pred             hhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 040050          313 RLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMS-YVVR  354 (401)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~il~  354 (401)
                             ...+|..++..+.+|+.+||+.||.+||++. ++++
T Consensus       219 -------~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         219 -------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -------CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                   1123444577899999999999999999996 6754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-52  Score=385.72  Aligned_cols=265  Identities=29%  Similarity=0.406  Sum_probs=217.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc-ccHHHHHHHHHHHhcc-CCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT-QGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~~  153 (401)
                      .++|+++++||+|+||.||+|++....+ ..+++.||||+++.... .....+.+|+.+++++ +||||+++++++.+..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEecccc-CCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            4789999999999999999998754222 24678999999976543 3445788999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEE
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY----------------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILL  217 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv  217 (401)
                      ..++||||+++|+|.+++....                ...+++..++.++.||+.||+|||+++  ||||||||+||++
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~  178 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL  178 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccccccc
Confidence            9999999999999999997542                236899999999999999999999655  9999999999999


Q ss_pred             cCCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHh-CCCCCCCCccccccc
Q 040050          218 DSDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLT-GKRAMDNTRLGREQS  296 (401)
Q Consensus       218 ~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  296 (401)
                      +.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||......    
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~----  254 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD----  254 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999999998766555444556789999999999999999999999999999999999 55555443221    


Q ss_pred             HHHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          297 LAEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                                  ..+..++........+...+..+.+|+.+||+.||.+|||+.+|+++|+++
T Consensus       255 ------------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         255 ------------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             ------------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                        111112222222333444577899999999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=383.26  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=208.2

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCc--eEEEEEecCC-CcccHHHHHHHHHHHhcc-CCCceeeEEEEEEeC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQ--PVAVKALDLD-GTQGHKEWMAEIIFLGQL-RHPHLVKLIGYCWEE  152 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnI~~~~~~~~~~  152 (401)
                      ++|++.+.||+|+||+||+|++..      ++.  .||||.+... .....+.+.+|+++|.++ +||||+++++++.++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKK------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECC------CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            678899999999999999999876      343  5788887543 333456789999999999 699999999999999


Q ss_pred             CeEEEEEEecCCCChhHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEc
Q 040050          153 EYRLLVYEYMPRGSLHNQLFRS--------------YSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLD  218 (401)
Q Consensus       153 ~~~~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~  218 (401)
                      +.+++||||+++|+|.+++...              ....+++..++.++.||+.||.|||+.  +|+||||||+|||++
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~--~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK--QFIHRDLAARNILVG  161 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEC
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC--CccccccccceEEEc
Confidence            9999999999999999999653              246799999999999999999999965  599999999999999


Q ss_pred             CCCcEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCC-CCCCCCcccccccH
Q 040050          219 SDYTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK-RAMDNTRLGREQSL  297 (401)
Q Consensus       219 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~  297 (401)
                      .++.+||+|||+++.......   .....||..|+|||.+.++.|+.++|||||||++|||++|. +||....      .
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~  232 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------C  232 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------H
T ss_pred             CCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------H
Confidence            999999999999976433221   22346899999999999999999999999999999999976 4665432      1


Q ss_pred             HHHhhhhhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhccc
Q 040050          298 AEWARPLLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDFQD  364 (401)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~~~  364 (401)
                      .+....           +........+..+++.+.+|+.+||+.||++|||+.+|++.|+++..-..
T Consensus       233 ~~~~~~-----------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         233 AELYEK-----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             HHHHHH-----------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHHH-----------HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            111111           11122233455567899999999999999999999999999999865443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-51  Score=378.15  Aligned_cols=266  Identities=25%  Similarity=0.336  Sum_probs=203.3

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||+||+|.+..      +++.||||++....  ......+.+|+++|++++||||+++++++.++..
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            579999999999999999999876      68899999996543  2335678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      +|+||||+. +++..++.......+++..+..++.||+.||.|||+.  +||||||||+|||++.++.+||+|||+|...
T Consensus        76 ~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~--~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          76 LYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH--RVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT--TCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC--CEEccccCchheeecccCcceeccCCcceec
Confidence            999999995 5666777666667899999999999999999999954  4999999999999999999999999999765


Q ss_pred             CCCCcceeeeccccccccccccccccCC-CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccch--
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKL--  311 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  311 (401)
                      .....  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||......  ..+..............  
T Consensus       153 ~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~~~~~i~~~~~~~~~~~~~  228 (298)
T d1gz8a_         153 GVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWP  228 (298)
T ss_dssp             CCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCTTTST
T ss_pred             cCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--HHHHHHHHhcCCCchhhcc
Confidence            43222  223457999999999987655 578999999999999999999999764321  11111111110000000  


Q ss_pred             --hhh------cCCcCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          312 --ERL------IDPRLEGQ---FPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       312 --~~~------~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                        ...      ........   .....+..+.+|+.+||..||++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence              000      00000000   011335788999999999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-51  Score=378.02  Aligned_cols=259  Identities=25%  Similarity=0.306  Sum_probs=195.3

Q ss_pred             CCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc-----cHHHHHHHHHHHhccCCCceeeEEEEEEeCCeE
Q 040050           81 RSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ-----GHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEYR  155 (401)
Q Consensus        81 ~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~~  155 (401)
                      .+++||+|+||+||+|++..      +++.||||++......     ....+.+|+.+|++++||||+++++++..++.+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~   75 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKN------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   75 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSS------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             cceEeccCcCeEEEEEEECC------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCce
Confidence            35789999999999998876      6889999998654321     134688999999999999999999999999999


Q ss_pred             EEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCC
Q 040050          156 LLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGP  235 (401)
Q Consensus       156 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~  235 (401)
                      |+||||+.++++..++..  ...+++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++....
T Consensus        76 ~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             eehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccC
Confidence            999999987766555433  367999999999999999999999654  9999999999999999999999999998655


Q ss_pred             CCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc-----
Q 040050          236 EGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR-----  309 (401)
Q Consensus       236 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  309 (401)
                      ....  .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||......  ..+..... ....+.     
T Consensus       152 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~l~~i~~-~~~~~~~~~~~  226 (299)
T d1ua2a_         152 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFE-TLGTPTEEQWP  226 (299)
T ss_dssp             SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-HHCCCCTTTSS
T ss_pred             CCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--HHHHHHHH-hcCCCChhhcc
Confidence            4322  2244679999999999875 56899999999999999999999999764321  11111111 111000     


Q ss_pred             ---chhhhcCCcCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          310 ---KLERLIDPRLEGQFP-----IKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       310 ---~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                         ..............+     ...+..+.+|+.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence               000000000000111     123578999999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=376.62  Aligned_cols=241  Identities=24%  Similarity=0.378  Sum_probs=198.3

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCc------ccHHHHHHHHHHHhccC--CCceeeEEE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGT------QGHKEWMAEIIFLGQLR--HPHLVKLIG  147 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpnI~~~~~  147 (401)
                      .++|++++.||+|+||+||+|++..      +++.||||++.....      .....+.+|+.+|++++  ||||+++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVS------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECC------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            5789999999999999999999876      688999999864311      11234668999999986  899999999


Q ss_pred             EEEeCCeEEEEEEecCC-CChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-CCcEEE
Q 040050          148 YCWEEEYRLLVYEYMPR-GSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-DYTAKL  225 (401)
Q Consensus       148 ~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-~~~vkL  225 (401)
                      ++.+++..++||||+.+ +++.+++...  ..+++..++.++.||+.||.|||+.  +|+||||||+|||++. ++.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~--~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT--TEECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC--CCccccCcccceEEecCCCeEEE
Confidence            99999999999999976 5777777665  6899999999999999999999965  4999999999999985 479999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCC-CccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHL-TTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||+|......    ..+...||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....        ....  
T Consensus       153 ~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i~~--  218 (273)
T d1xwsa_         153 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIR--  218 (273)
T ss_dssp             CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHH--
T ss_pred             Cccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HHhh--
Confidence            999999865432    2345689999999999987665 677999999999999999999997531        0000  


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                        .            ...++...+.++.+|+.+||+.||++|||++++++
T Consensus       219 --~------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         219 --G------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --C------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --c------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              0            00122234678999999999999999999999976

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=374.73  Aligned_cols=258  Identities=29%  Similarity=0.402  Sum_probs=203.9

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCC-CcccHHHHHHHHHHHhccCCCceeeEEEEEEe-CCeEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLD-GTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE-EEYRLLVY  159 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~-~~~~~lv~  159 (401)
                      .++||+|+||+||+|++....   .+...||||.+... .......+.+|+++|++++||||+++++++.. +...++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCC---CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            578999999999999876521   12346899998743 34455789999999999999999999999876 45889999


Q ss_pred             EecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCCCCCCc
Q 040050          160 EYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGEE  239 (401)
Q Consensus       160 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~~~~~~  239 (401)
                      ||+++|+|.+++... ...+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~--~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK--KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT--TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc--CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999999987653 45678889999999999999999954  599999999999999999999999999987654322


Q ss_pred             c--eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCccchhhhcCC
Q 040050          240 T--HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPRKLERLIDP  317 (401)
Q Consensus       240 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (401)
                      .  .......||+.|+|||.+.+..++.++||||||+++|||++|..||.......  .+...   ..           .
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~---i~-----------~  249 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY---LL-----------Q  249 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HH-----------T
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH---HH-----------c
Confidence            1  12233568999999999999999999999999999999999888875432110  11111   10           1


Q ss_pred             cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhh
Q 040050          318 RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQD  361 (401)
Q Consensus       318 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~  361 (401)
                      ......|..++..+.+|+.+||+.||++||++.+|++.|+++..
T Consensus       250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11222344456789999999999999999999999999998854

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-51  Score=380.88  Aligned_cols=265  Identities=25%  Similarity=0.363  Sum_probs=213.0

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..++|.+++.||+|+||+||+|.+.... ....+..||||+++... ......+.+|+.++++++||||+++++++..+.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~-~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~   96 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVV-KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   96 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEE-TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcc-cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence            3478999999999999999999875311 11235789999997543 233456889999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSY--------SAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      ..++||||+.+|+|.+++....        ...+++..+..++.|++.||.|||+.  +|+||||||+|||++.++++||
T Consensus        97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~--~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT--TCBCSCCSGGGEEECTTCCEEE
T ss_pred             ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC--CeeeceEcCCceeecCCceEEE
Confidence            9999999999999999886431        24578999999999999999999954  5999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCC-CCCCCCcccccccHHHHhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGK-RAMDNTRLGREQSLAEWARPL  304 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~  304 (401)
                      +|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||.....      .+.... 
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~~~-  247 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRF-  247 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHH-
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHHHH-
Confidence            9999998665444433344457899999999999999999999999999999999985 66754321      111111 


Q ss_pred             hcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          305 LKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                               +.+ ......+..++..+.+++.+||+.||.+|||+.+|++.|++.
T Consensus       248 ---------i~~-~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         248 ---------VME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ---------HHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---------HHh-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                     111 111223444567899999999999999999999999998776

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=374.10  Aligned_cols=265  Identities=25%  Similarity=0.344  Sum_probs=201.8

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHH--HHHHHhccCCCceeeEEEEEEeCC
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMA--EIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      ..+|.+.+.||+|+||+||+|++.        ++.||||++....   ...+..  |+..+..++||||+++++++.+..
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--------g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--------CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            356788899999999999999753        6799999986432   234444  455556789999999999998654


Q ss_pred             ----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC------CCCeeeccCCCCcEEEcCCCcE
Q 040050          154 ----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE------DKPVIYRDFKASNILLDSDYTA  223 (401)
Q Consensus       154 ----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~------~~~iiH~Dlkp~NIlv~~~~~v  223 (401)
                          .+|+||||+++|+|.+++.+   ..+++..++.++.|++.||.|||+.      .++||||||||+||||+.++.+
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence                57999999999999999976   4799999999999999999999964      3579999999999999999999


Q ss_pred             EEEecCCCCCCCCCCcce--eeeccccccccccccccccCC------CCccccHHhHHHHHHHHHhCCCCCCCCcccccc
Q 040050          224 KLSDFGLAKDGPEGEETH--VITRVMGTQGYAAPEYVMTGH------LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ  295 (401)
Q Consensus       224 kL~DfG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  295 (401)
                      ||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|||+||..||.........
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            999999998654433221  234568999999999987643      677899999999999999999887543321110


Q ss_pred             --------cHHHHhhhhhcCccchhhhcCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhhhc
Q 040050          296 --------SLAEWARPLLKEPRKLERLIDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSLQDF  362 (401)
Q Consensus       296 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l~~~  362 (401)
                              .........         .......+.+     +......+.+|+.+||+.||++|||+.+|++.|+++.+-
T Consensus       228 ~~~~~~~~~~~~~~~~~---------~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         228 YYDLVPSDPSVEEMRKV---------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTSCSSCCHHHHHHH---------HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhcccccchHHHHHHH---------HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence                    000111111         1111222222     234567799999999999999999999999999998754


Q ss_pred             c
Q 040050          363 Q  363 (401)
Q Consensus       363 ~  363 (401)
                      +
T Consensus       299 ~  299 (303)
T d1vjya_         299 E  299 (303)
T ss_dssp             H
T ss_pred             c
Confidence            3

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=371.21  Aligned_cols=267  Identities=24%  Similarity=0.330  Sum_probs=199.2

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhcc---CCCceeeEEEEEE
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQL---RHPHLVKLIGYCW  150 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnI~~~~~~~~  150 (401)
                      .++|++++.||+|+||+||+|++...     .++.||||++....  ......+.+|+.+|+.+   +||||++++++|.
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~   80 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   80 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT-----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC-----CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeec
Confidence            47899999999999999999988652     35679999986432  22233466777776665   7999999999986


Q ss_pred             e-----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEE
Q 040050          151 E-----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKL  225 (401)
Q Consensus       151 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL  225 (401)
                      .     ....+++|||+.++.+. +........+++..++.++.|++.||+|||+++  ||||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~~~~e~~~~~~~~-~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~kl  157 (305)
T d1blxa_          81 VSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKL  157 (305)
T ss_dssp             EEECSSEEEEEEEEECCSCBHHH-HHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEE
T ss_pred             ccccccCceEEEEEEeccCCchh-hhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCeee
Confidence            3     34689999999776554 444444578999999999999999999999655  999999999999999999999


Q ss_pred             EecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          226 SDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       226 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      +|||++.......   ......||+.|+|||++.+..|+.++|||||||++|+|++|++||......  ..+........
T Consensus       158 ~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~~~~i~~~~~  232 (305)
T d1blxa_         158 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--DQLGKILDVIG  232 (305)
T ss_dssp             CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHC
T ss_pred             cchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH--HHHHHHHHhhC
Confidence            9999988654332   234568999999999999999999999999999999999999999765321  11111111100


Q ss_pred             cCcc-c------h-hhhc---CCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPR-K------L-ERLI---DPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~-~------~-~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .... .      . ....   .......+....++.+.+|+.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000 0      0 0000   0001111233456788999999999999999999999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-49  Score=365.45  Aligned_cols=263  Identities=24%  Similarity=0.305  Sum_probs=199.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||+||+|++.       +++.||||++....  ......+.+|+.+|++++||||+++++++..++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeC-------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            58999999999999999999875       37899999997553  2235788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|+++.++.+..+...  .+.+++..+..++.||+.||+|||+++  ||||||||+|||++.++.+||+|||++...
T Consensus        75 ~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceec
Confidence            9999999976666555443  378999999999999999999999654  999999999999999999999999999765


Q ss_pred             CCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC------
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE------  307 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------  307 (401)
                      .....  ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......  .+..........      
T Consensus       151 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~  226 (286)
T d1ob3a_         151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWP  226 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTST
T ss_pred             ccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhcc
Confidence            43221  2234568999999999875 456899999999999999999999997643211  111111110000      


Q ss_pred             -ccchhhh------cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          308 -PRKLERL------IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       308 -~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       .......      ..+..........+..+.+|+.+||+.||++|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000000      0000011122334678999999999999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.9e-48  Score=359.00  Aligned_cols=274  Identities=16%  Similarity=0.175  Sum_probs=211.5

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCC-CceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH-PHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnI~~~~~~~~~~~  153 (401)
                      +.++|++.+.||+|+||+||+|++..      +++.||||++.....  ...+.+|++.++.+.| +||+.+++++....
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   74 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLL------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   74 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETT------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC
Confidence            45789999999999999999999876      688999999864432  2356778888888875 89999999999999


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC-----CCcEEEEec
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS-----DYTAKLSDF  228 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~-----~~~vkL~Df  228 (401)
                      ..++||||+ +++|.+++... ...++...+..++.|++.||.|||+.  ||+||||||+|||++.     .+.+||+||
T Consensus        75 ~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~--giiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK--SLVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             ccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC--CceeccCCccceeecCcccccCCceEEccc
Confidence            999999999 78998887653 45799999999999999999999954  4999999999999964     578999999


Q ss_pred             CCCCCCCCCCc-----ceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          229 GLAKDGPEGEE-----THVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       229 G~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      |+|+.......     ........||+.|||||++.+..++.++|||||||++|+|++|..||.+...............
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~  230 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  230 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence            99986543221     1123346799999999999999999999999999999999999999976543222111111110


Q ss_pred             hhcCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh-hhcccCCCCce
Q 040050          304 LLKEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL-QDFQDSFVGPF  370 (401)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l-~~~~~~~~~~~  370 (401)
                      ... ......     +    ...+++++.+++..|+..+|.+||+++.+.+.|+++ ++.......++
T Consensus       231 ~~~-~~~~~~-----l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~  288 (293)
T d1csna_         231 KKQ-STPLRE-----L----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF  288 (293)
T ss_dssp             HHH-HSCHHH-----H----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCC
T ss_pred             ccC-CCChHH-----h----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCC
Confidence            000 000111     1    112346789999999999999999999999988886 34443333343

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.6e-48  Score=358.44  Aligned_cols=261  Identities=20%  Similarity=0.251  Sum_probs=201.5

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCc-eeeEEEEEEeCCe
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPH-LVKLIGYCWEEEY  154 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-I~~~~~~~~~~~~  154 (401)
                      .++|++.+.||+|+||.||+|++..      +++.||||++......  ..+..|+++++.++|+| |+.+.+++.+...
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIA------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETT------TTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECC------CCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            4689999999999999999999876      6889999998754332  35778999999998665 5666677788889


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcC---CCcEEEEecCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDS---DYTAKLSDFGLA  231 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~---~~~vkL~DfG~a  231 (401)
                      .++||||+ +++|...+... ...+++..+..++.|++.||+|||+++  ||||||||+|||++.   +..+||+|||+|
T Consensus        78 ~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          78 NVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             EEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcc
Confidence            99999999 66776666443 468999999999999999999999655  999999999999854   457999999999


Q ss_pred             CCCCCCCcc-----eeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc-cHHHHhhhhh
Q 040050          232 KDGPEGEET-----HVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-SLAEWARPLL  305 (401)
Q Consensus       232 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~  305 (401)
                      +........     .......||+.|||||++.+..++.++|||||||++|||++|..||......... ..........
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  233 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence            865443221     1224467999999999999999999999999999999999999999765332211 1111111111


Q ss_pred             cCccchhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 040050          306 KEPRKLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRVLDSL  359 (401)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~L~~l  359 (401)
                      ..+.  .     .    ....++.++.+++.+||+.||.+||++.++.+.|+.+
T Consensus       234 ~~~~--~-----~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         234 STPI--E-----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HSCH--H-----H----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             CCCh--h-----H----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1100  0     0    0112356789999999999999999999999988876

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=365.88  Aligned_cols=262  Identities=22%  Similarity=0.293  Sum_probs=196.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE  152 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~  152 (401)
                      +.++|++.+.||+|+||+||+|++..      +++.||||++....  ......+.+|+.+|+.++||||++++++|...
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGR------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETT------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECC------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            35789999999999999999999876      68999999997542  23356788999999999999999999999865


Q ss_pred             C------eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          153 E------YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       153 ~------~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                      +      .+|+||||+ +.+|..++..   ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             ccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccc
Confidence            4      469999999 6677766543   57999999999999999999999655  9999999999999999999999


Q ss_pred             ecCCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh
Q 040050          227 DFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL  305 (401)
Q Consensus       227 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  305 (401)
                      |||+|......     .+...||+.|+|||++.+ ..++.++|||||||++|+|++|++||.......  .+........
T Consensus       164 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~  236 (346)
T d1cm8a_         164 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTG  236 (346)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHC
T ss_pred             cccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HHHHHHhccC
Confidence            99999875443     245679999999999886 456899999999999999999999997653211  1111111000


Q ss_pred             cCccch------------hhhcCC---cCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 KEPRKL------------ERLIDP---RLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ~~~~~~------------~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ..+...            ......   ..........+..+.+||.+||..||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000            000000   00011122346788999999999999999999999874

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-48  Score=360.47  Aligned_cols=267  Identities=21%  Similarity=0.261  Sum_probs=195.4

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe---
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE---  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~---  151 (401)
                      ++|++.+.||+|+||+||+|++..      +++.||||++....  ......+.+|+.+|++++||||+++++++..   
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~   83 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRK------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   83 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             CCEEEEEEEecCcCeEEEEEEECC------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence            789999999999999999999876      68899999986542  3345678899999999999999999998865   


Q ss_pred             -----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEE
Q 040050          152 -----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLS  226 (401)
Q Consensus       152 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~  226 (401)
                           ....|+||||+.++.+....  .....+++..++.++.|++.||.|||+.  +|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~--~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          84 PYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             -------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTSCEEEC
T ss_pred             cccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccC--CEEecCcCchheeecCCCcEEee
Confidence                 34689999999766554333  3346899999999999999999999965  49999999999999999999999


Q ss_pred             ecCCCCCCCCCCcc--eeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhh
Q 040050          227 DFGLAKDGPEGEET--HVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARP  303 (401)
Q Consensus       227 DfG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  303 (401)
                      |||++.........  ......+||+.|+|||++.+. .|+.++|||||||++|+|++|+.||.+.....  .+......
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~i~~~  237 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQL  237 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHH
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH--HHHHHHHh
Confidence            99999765432211  112335799999999998865 68999999999999999999999997643211  11111111


Q ss_pred             hhcCccch-hh--------hcCCcCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          304 LLKEPRKL-ER--------LIDPRLEGQFP-------IKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       304 ~~~~~~~~-~~--------~~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      ....+... ..        ..........+       ...+..+.+|+.+||+.||++|||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            11000000 00        00000000001       1114567889999999999999999999854

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-48  Score=365.37  Aligned_cols=264  Identities=27%  Similarity=0.342  Sum_probs=197.0

Q ss_pred             CCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCceeeEEEEEEeC-----
Q 040050           78 NFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE-----  152 (401)
Q Consensus        78 ~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-----  152 (401)
                      +|...++||+|+||+||+|++..      +++.||||++.....    ...+|+.+|++++||||++++++|...     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT------TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC------CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            68888999999999999999887      688999999975432    234699999999999999999998642     


Q ss_pred             -CeEEEEEEecCCCChhHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEec
Q 040050          153 -EYRLLVYEYMPRGSLHNQLFR--SYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDF  228 (401)
Q Consensus       153 -~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~Df  228 (401)
                       .++||||||++++ +...+..  .....+++..++.++.||+.||+|||++  ||+||||||+|||++.++ .+||+||
T Consensus        91 ~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~--~IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          91 EVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             CCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--TEECCCCCGGGEEECTTTCCEEECCC
T ss_pred             ceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--CCcccCCCcceEEEecCCCceeEecc
Confidence             3579999999655 4444422  3346899999999999999999999954  599999999999999775 8999999


Q ss_pred             CCCCCCCCCCcceeeecccccccccccccccc-CCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMT-GHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      |++........   .....||+.|+|||++.+ ..|+.++|||||||++|||++|++||.......  .+..........
T Consensus       168 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~  242 (350)
T d1q5ka_         168 GSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTP  242 (350)
T ss_dssp             TTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCC
T ss_pred             cchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence            99987644332   244679999999998875 578999999999999999999999997653211  111111100000


Q ss_pred             c---------c----chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhh
Q 040050          308 P---------R----KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV--LDSL  359 (401)
Q Consensus       308 ~---------~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~--L~~l  359 (401)
                      .         .    .........+........++.+.+|+.+||+.||++|||+.+++++  ++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            0         0    0000000001111123346789999999999999999999999864  4444

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=364.55  Aligned_cols=266  Identities=21%  Similarity=0.313  Sum_probs=197.7

Q ss_pred             HhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC-cccHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Q 040050           75 ITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG-TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEE  153 (401)
Q Consensus        75 ~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~  153 (401)
                      +..+|++++.||+|+||+||+|++..      +++.||||++.... ......+++|+.+|+.++||||+++++++....
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETT------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECC------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            34689999999999999999999876      68899999997543 334567889999999999999999999997653


Q ss_pred             -----eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          154 -----YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       154 -----~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                           ..|++ +++.+|+|.+++..   ..+++..++.++.|++.||+|||++  |||||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~~~l~-~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~--~iiHRDIKp~NILl~~~~~~kl~Df  153 (345)
T d1pmea_          80 IEQMKDVYLV-THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNTTCDLKICDF  153 (345)
T ss_dssp             TTTCCCEEEE-EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccceEEEE-EeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC--CCcCCCCCcceEEECCCCCEEEccc
Confidence                 34555 55669999999865   4799999999999999999999965  4999999999999999999999999


Q ss_pred             CCCCCCCCCCcc-eeeeccccccccccccccc-cCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhc
Q 040050          229 GLAKDGPEGEET-HVITRVMGTQGYAAPEYVM-TGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLK  306 (401)
Q Consensus       229 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  306 (401)
                      |++......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||.........   ........
T Consensus       154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~  230 (345)
T d1pmea_         154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILG  230 (345)
T ss_dssp             TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHC
T ss_pred             CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhcc
Confidence            999765433221 1224467999999999985 556789999999999999999999999765321111   00000000


Q ss_pred             Cccc----------hhh-hcCCcCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          307 EPRK----------LER-LIDPRLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       307 ~~~~----------~~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      .+..          ... ..........     ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000          000 0000000001     11234678999999999999999999999864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=353.25  Aligned_cols=264  Identities=22%  Similarity=0.277  Sum_probs=205.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeCCe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEEEY  154 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~~~  154 (401)
                      ++|++.+.||+|+||+||+|++..      +++.||||+++...  ......+.+|+.+|+.++||||+++++++.+...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            579999999999999999999876      68899999987553  2345788999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCCC
Q 040050          155 RLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKDG  234 (401)
Q Consensus       155 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~~  234 (401)
                      .+++|+++.+++|..++...  +.+++..+..++.|++.||+|||++  +|+||||||+|||++.++.+||+|||.+...
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~--~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR--NVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT--TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC--CEeeecccCcccccccCCceeeeecchhhcc
Confidence            99999999988887776544  7889999999999999999999954  5999999999999999999999999999876


Q ss_pred             CCCCcceeeeccccccccccccccccCC-CCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCc-----
Q 040050          235 PEGEETHVITRVMGTQGYAAPEYVMTGH-LTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEP-----  308 (401)
Q Consensus       235 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  308 (401)
                      ......  .....+++.|+|||++.+.. ++.++|||||||++|+|++|+.||........ .+.. .......+     
T Consensus       152 ~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~-~~~~~~~~~~~~~  227 (292)
T d1unla_         152 GIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKR-IFRLLGTPTEEQW  227 (292)
T ss_dssp             CSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHH-HHHHHCCCCTTTC
T ss_pred             cCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHH-HHhhcCCCChhhh
Confidence            543322  23346788999999988654 68999999999999999999999754322111 1111 11100000     


Q ss_pred             cchhhh---------cCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          309 RKLERL---------IDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       309 ~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                      ......         .............+..+.+|+.+||+.||.+|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000         0001111223345678999999999999999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3e-47  Score=358.13  Aligned_cols=259  Identities=19%  Similarity=0.240  Sum_probs=199.1

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEe--CC
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWE--EE  153 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~--~~  153 (401)
                      ++|++++.||+|+||+||+|++..      +++.||||+++..   ....+.+|+.+|+.++ ||||++++++|..  ..
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~------~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINIT------NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC------CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            579999999999999999999876      6899999998643   3467889999999995 9999999999975  35


Q ss_pred             eEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-cEEEEecCCCC
Q 040050          154 YRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-TAKLSDFGLAK  232 (401)
Q Consensus       154 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-~vkL~DfG~a~  232 (401)
                      .+++||||+.+++|....     +.+++..+..++.||+.||.|||+++  |+||||||+|||++.++ .+||+|||+|.
T Consensus       106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccce
Confidence            689999999999987653     57999999999999999999999655  99999999999998654 69999999998


Q ss_pred             CCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCccccccc--HHHHh--------
Q 040050          233 DGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQS--LAEWA--------  301 (401)
Q Consensus       233 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~--------  301 (401)
                      .......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..........  .....        
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            6654332   3456799999999998864 57999999999999999999999997653221110  00000        


Q ss_pred             -hh-hhcCccchhhhcC--------CcCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 040050          302 -RP-LLKEPRKLERLID--------PRLEGQFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVR  354 (401)
Q Consensus       302 -~~-~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~  354 (401)
                       .. .............        ...........+.++.+||.+||+.||++|||++++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             00 0000000011110        01111122334678999999999999999999999976

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-48  Score=359.82  Aligned_cols=256  Identities=28%  Similarity=0.334  Sum_probs=204.6

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC----cccHHHHHHHHHHHhccCC-CceeeEEEEEEe
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG----TQGHKEWMAEIIFLGQLRH-PHLVKLIGYCWE  151 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pnI~~~~~~~~~  151 (401)
                      ++|++++.||+|+||+||+|++...   ..+++.||||++....    ......+.+|+.++++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~---~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISG---HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSS---TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECcc---CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            6799999999999999999987432   2268899999986431    2234567889999999976 899999999999


Q ss_pred             CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEecCCC
Q 040050          152 EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDFGLA  231 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a  231 (401)
                      ....+++|||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+|.+||+|||++
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999999776  67889999999999999999999655  999999999999999999999999999


Q ss_pred             CCCCCCCcceeeeccccccccccccccccC--CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcCcc
Q 040050          232 KDGPEGEETHVITRVMGTQGYAAPEYVMTG--HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKEPR  309 (401)
Q Consensus       232 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  309 (401)
                      ......... ......|++.|+|||.+.+.  .++.++|||||||++|+|++|+.||......  ............   
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~--~~~~~i~~~~~~---  250 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILK---  250 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHH---
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhccc---
Confidence            865443322 23456799999999999754  5688999999999999999999999765322  111111111110   


Q ss_pred             chhhhcCCcCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 040050          310 KLERLIDPRLEGQFPIKGAQKAAATAFKCLSHHPRHRP-----TMSYVVR  354 (401)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~~il~  354 (401)
                               ....++...+..+.+|+.+||+.||.+||     |++++++
T Consensus       251 ---------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 ---------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                     01123445678999999999999999999     4788876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-47  Score=358.74  Aligned_cols=262  Identities=22%  Similarity=0.253  Sum_probs=192.4

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEe--
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWE--  151 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~--  151 (401)
                      .++|++.+.||+|+||+||+|++..      +++.||||++....  ......+.+|+.+|++++||||++++++|..  
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAV------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETT------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECC------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            3689999999999999999999876      68999999997543  3334568899999999999999999999964  


Q ss_pred             ----CCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEe
Q 040050          152 ----EEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSD  227 (401)
Q Consensus       152 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~D  227 (401)
                          ...+|+||||+.+ ++.+.+.    ..+++..++.++.||+.||.|||+++  |+||||||+|||++.++.++++|
T Consensus        90 ~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             STTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeec
Confidence                3688999999965 5555543    46899999999999999999999655  99999999999999999999999


Q ss_pred             cCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhh--
Q 040050          228 FGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLL--  305 (401)
Q Consensus       228 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--  305 (401)
                      ||++.......   ......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.....  ..........  
T Consensus       163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~--~~~~i~~~~~~~  237 (355)
T d2b1pa1         163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTP  237 (355)
T ss_dssp             CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCC
T ss_pred             hhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH--HHHHHHHhccCC
Confidence            99988654432   2345679999999999999999999999999999999999999997543111  0011000000  


Q ss_pred             ----------------cC-----ccchhhhcCCcCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          306 ----------------KE-----PRKLERLIDPRLEG---QFPIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       306 ----------------~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                                      ..     ..............   ......+..+.+|+.+||..||++|||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                            00     00011111111111   1123457889999999999999999999999754

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-46  Score=355.44  Aligned_cols=262  Identities=23%  Similarity=0.290  Sum_probs=196.0

Q ss_pred             hcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCC--cccHHHHHHHHHHHhccCCCceeeEEEEEEeC-
Q 040050           76 TSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDG--TQGHKEWMAEIIFLGQLRHPHLVKLIGYCWEE-  152 (401)
Q Consensus        76 ~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnI~~~~~~~~~~-  152 (401)
                      +++|++.+.||+|+||+||+|++..      +++.||||++....  ......+.+|+.+|+.++||||+++++++... 
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~   90 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   90 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence            5789999999999999999998876      68999999997543  23345788999999999999999999998643 


Q ss_pred             ----CeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCCcEEEEec
Q 040050          153 ----EYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDYTAKLSDF  228 (401)
Q Consensus       153 ----~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~~vkL~Df  228 (401)
                          ...+++|+++.||+|.+++..   ..+++..++.++.||+.||+|||++  ||+||||||+|||++.+|.+|++||
T Consensus        91 ~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~--giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          91 SLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA--DIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             STTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             ccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC--CCcccccCCcccccccccccccccc
Confidence                234566777789999998854   5799999999999999999999965  4999999999999999999999999


Q ss_pred             CCCCCCCCCCcceeeeccccccccccccccccC-CCCccccHHhHHHHHHHHHhCCCCCCCCcccccccHHHHhhhhhcC
Q 040050          229 GLAKDGPEGEETHVITRVMGTQGYAAPEYVMTG-HLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQSLAEWARPLLKE  307 (401)
Q Consensus       229 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  307 (401)
                      |++......     .....|++.|+|||++.+. .++.++|||||||++|+|++|++||.+......  ...........
T Consensus       166 g~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~  238 (348)
T d2gfsa1         166 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTP  238 (348)
T ss_dssp             ----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCC
T ss_pred             chhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCC
Confidence            999764332     2446799999999987765 568899999999999999999999976432110  11111111000


Q ss_pred             ccchh---------hhcCC-cCCCCC-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 040050          308 PRKLE---------RLIDP-RLEGQF-----PIKGAQKAAATAFKCLSHHPRHRPTMSYVVRV  355 (401)
Q Consensus       308 ~~~~~---------~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~il~~  355 (401)
                      +..+.         ..... ......     ....+..+.+||.+||+.||.+|||+.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            00000         00000 000000     11235678999999999999999999999873

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.9e-42  Score=324.57  Aligned_cols=265  Identities=21%  Similarity=0.218  Sum_probs=192.9

Q ss_pred             cCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-----------CCceeeE
Q 040050           77 SNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-----------HPHLVKL  145 (401)
Q Consensus        77 ~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnI~~~  145 (401)
                      ++|++++.||+|+||+||+|++..      +++.||||+++.+. .....+.+|+.+++.++           |+||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~------~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMV------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECC------CCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            579999999999999999999876      68999999997542 22356778888888775           5789999


Q ss_pred             EEEEEe--CCeEEEEEEecCCCC-hhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCCC-
Q 040050          146 IGYCWE--EEYRLLVYEYMPRGS-LHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSDY-  221 (401)
Q Consensus       146 ~~~~~~--~~~~~lv~e~~~~~~-L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~~-  221 (401)
                      ++++..  ....+++|.++..+. ............+++..+..++.||+.||.|||+ ..||+||||||+|||++.++ 
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~-~~~IvHrDlKp~NIll~~~~~  164 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDS  164 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEET
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh-hcCcccccCChhHeeeeccCc
Confidence            988764  456667777664443 3333444455788999999999999999999995 24599999999999997654 


Q ss_pred             -----cEEEEecCCCCCCCCCCcceeeeccccccccccccccccCCCCccccHHhHHHHHHHHHhCCCCCCCCcccccc-
Q 040050          222 -----TAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPEYVMTGHLTTMSDVYSFGVVLLELLTGKRAMDNTRLGREQ-  295 (401)
Q Consensus       222 -----~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-  295 (401)
                           .++|+|||.+......     .....||+.|+|||++.+..|+.++||||+||++++|++|+.||......... 
T Consensus       165 ~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         165 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             ccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence                 4999999999764332     24457999999999999999999999999999999999999999754322111 


Q ss_pred             ---cHHHHhhhhhcCccchh-------hhc---------CC----------cCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 040050          296 ---SLAEWARPLLKEPRKLE-------RLI---------DP----------RLEGQFPIKGAQKAAATAFKCLSHHPRHR  346 (401)
Q Consensus       296 ---~~~~~~~~~~~~~~~~~-------~~~---------~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~R  346 (401)
                         .+......+...+..+.       ...         ..          ..........+..+.+|+.+||..||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence               11111111100000000       000         00          01123456778899999999999999999


Q ss_pred             CCHHHHHH
Q 040050          347 PTMSYVVR  354 (401)
Q Consensus       347 Pt~~~il~  354 (401)
                      ||+.++++
T Consensus       320 pta~e~L~  327 (362)
T d1q8ya_         320 ADAGGLVN  327 (362)
T ss_dssp             BCHHHHHT
T ss_pred             cCHHHHhc
Confidence            99999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.3e-25  Score=193.19  Aligned_cols=165  Identities=15%  Similarity=0.106  Sum_probs=118.5

Q ss_pred             CCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcc------------------cHHHHHHHHHHHhccCCC
Q 040050           79 FSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQ------------------GHKEWMAEIIFLGQLRHP  140 (401)
Q Consensus        79 y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~hp  140 (401)
                      +.+++.||+|+||+||+|.+..       ++.||||+++.....                  .......|...+.++.|+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~-------g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~   74 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK-------FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGL   74 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT-------TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTS
T ss_pred             chhCCEeeeCcceEEEEEECCC-------CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCC
Confidence            4578999999999999998653       789999987632110                  012344688899999999


Q ss_pred             ceeeEEEEEEeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCCCCeeeccCCCCcEEEcCC
Q 040050          141 HLVKLIGYCWEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGEDKPVIYRDFKASNILLDSD  220 (401)
Q Consensus       141 nI~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~~~iiH~Dlkp~NIlv~~~  220 (401)
                      +++..+++..    .+++|||+++..+..         ++...+..++.|++.+|.|||+.  ||+||||||+|||++++
T Consensus        75 ~v~~~~~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~--giiHrDiKP~NILv~~~  139 (191)
T d1zara2          75 AVPKVYAWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR--GIVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             SSCCEEEEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT--TEECSCCSTTSEEEETT
T ss_pred             CcceEEEecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC--CEEEccCChhheeeeCC
Confidence            9999886532    379999997755432         33445678999999999999965  49999999999999865


Q ss_pred             CcEEEEecCCCCCCCCCCcceeeecccccccccccc-----ccccCCCCccccHHhHHHHH
Q 040050          221 YTAKLSDFGLAKDGPEGEETHVITRVMGTQGYAAPE-----YVMTGHLTTMSDVYSFGVVL  276 (401)
Q Consensus       221 ~~vkL~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwslG~il  276 (401)
                       .++|+|||+|.........          .|....     .+..+.|+.++|+||+.-.+
T Consensus       140 -~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence             5899999999765432211          111110     01246788999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.68  E-value=4.5e-08  Score=86.07  Aligned_cols=147  Identities=16%  Similarity=0.080  Sum_probs=98.6

Q ss_pred             HHHHHhcCCCCCceecccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEE
Q 040050           71 ELRLITSNFSRSNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYC  149 (401)
Q Consensus        71 ~~~~~~~~y~~~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~  149 (401)
                      ++......|+..+..+.++.+.||+...        .++.+++|+...........+.+|...+..+. +--+.+++.+.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~   79 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC--------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe--------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence            4455556777766655555678998753        25678889876443333345667888877664 43467788888


Q ss_pred             EeCCeEEEEEEecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCCC---------------------------
Q 040050          150 WEEEYRLLVYEYMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGED---------------------------  202 (401)
Q Consensus       150 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---------------------------  202 (401)
                      ..++..++||++++|.++.+....    ..   ....++.+++..++.||+..                           
T Consensus        80 ~~~~~~~lv~~~l~G~~~~~~~~~----~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          80 RHDGWSNLLMSEADGVLCSEEYED----EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHTTT----CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             ecCCceEEEEEecccccccccccc----cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            888899999999988877554321    11   12234445555555565321                           


Q ss_pred             ------------------------------CCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          203 ------------------------------KPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       203 ------------------------------~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                                                    ..++|+|+.|.||++++++.+-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                          127899999999999987667799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.22  E-value=4.5e-06  Score=72.40  Aligned_cols=129  Identities=18%  Similarity=0.064  Sum_probs=81.6

Q ss_pred             eecccCC-eeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCC--CceeeEEEEEEeCCeEEEEEE
Q 040050           84 LLGEGGF-GPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRH--PHLVKLIGYCWEEEYRLLVYE  160 (401)
Q Consensus        84 ~Lg~G~~-g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnI~~~~~~~~~~~~~~lv~e  160 (401)
                      .+..|.. +.||+.....       +..+++|........   .+..|...++.+..  -.+.+++.+..+++..++||+
T Consensus        17 ~~~~G~s~~~v~r~~~~~-------~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~   86 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-------RPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   86 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-------SCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             EcCCcccCCeEEEEEeCC-------CCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEE
Confidence            4455543 6789886543       566899987644332   35567777766642  336778888888888999999


Q ss_pred             ecCCCChhHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 040050          161 YMPRGSLHNQLFRSYSAALPWSTRMKIALGAAKGLAFLHGE---------------------------------------  201 (401)
Q Consensus       161 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---------------------------------------  201 (401)
                      +++|.++.+..       ....   .++.++...|+-||+.                                       
T Consensus        87 ~i~G~~~~~~~-------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (255)
T d1nd4a_          87 EVPGQDLLSSH-------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  156 (255)
T ss_dssp             CCSSEETTTSC-------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             eeecccccccc-------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhh
Confidence            99886653310       1110   1112222333333311                                       


Q ss_pred             -----------------CCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          202 -----------------DKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       202 -----------------~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                                       ...++|+|+.|.|||++.++.+-|+||+.+.
T Consensus       157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                             1137999999999999987667899998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.06  E-value=1.2e-05  Score=74.64  Aligned_cols=78  Identities=17%  Similarity=0.188  Sum_probs=48.3

Q ss_pred             CceecccCCeeEEEEEecCcCCCCCCCceEEEEEecC----CC---cccHHHHHHHHHHHhccC-C-C-ceeeEEEEEEe
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKPGLEAQPVAVKALDL----DG---TQGHKEWMAEIIFLGQLR-H-P-HLVKLIGYCWE  151 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~----~~---~~~~~~~~~E~~~l~~l~-h-p-nI~~~~~~~~~  151 (401)
                      .+.||.|....||++....      .++.|++|.-..    .+   .....+...|.+.|+.+. + | .+++++.+  +
T Consensus        31 ~~eig~G~~N~vfrV~~~~------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEEeCCCceEeEEEEEeCC------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence            3578999999999987654      467899996532    11   112344566888877663 2 3 45566544  4


Q ss_pred             CCeEEEEEEecCCCCh
Q 040050          152 EEYRLLVYEYMPRGSL  167 (401)
Q Consensus       152 ~~~~~lv~e~~~~~~L  167 (401)
                      +...++|||++.+..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            4556899999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.27  E-value=0.00065  Score=62.54  Aligned_cols=80  Identities=19%  Similarity=0.174  Sum_probs=51.5

Q ss_pred             CceecccCCeeEEEEEecCcCCC-CCCCceEEEEEecCCCcccHHHHHHHHHHHhccC-CCceeeEEEEEEeCCeEEEEE
Q 040050           82 SNLLGEGGFGPVYKGFVDEKLKP-GLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR-HPHLVKLIGYCWEEEYRLLVY  159 (401)
Q Consensus        82 ~~~Lg~G~~g~V~~a~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnI~~~~~~~~~~~~~~lv~  159 (401)
                      .+.|+.|-.-.+|++........ ....+.|++++.. . ........+|..+++.+. +.-..++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            36788888889999876543211 1234567777765 2 223345667898888885 4334577777642    5889


Q ss_pred             EecCCCCh
Q 040050          160 EYMPRGSL  167 (401)
Q Consensus       160 e~~~~~~L  167 (401)
                      +|++|.+|
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99977544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.17  E-value=0.0009  Score=59.79  Aligned_cols=134  Identities=14%  Similarity=0.094  Sum_probs=75.8

Q ss_pred             CeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccCCCcee--eEE-----EEEEeCCeEEEEEEec
Q 040050           90 FGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLRHPHLV--KLI-----GYCWEEEYRLLVYEYM  162 (401)
Q Consensus        90 ~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI~--~~~-----~~~~~~~~~~lv~e~~  162 (401)
                      .-.||++...+       |..|++|+.+.. .....++..|...+..|...+|.  ..+     ..+......+.+++++
T Consensus        35 EN~vy~v~~~d-------g~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~  106 (325)
T d1zyla1          35 ENRVYQFQDED-------RRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  106 (325)
T ss_dssp             SSEEEEECCTT-------CCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             cceeEEEEcCC-------CCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence            46899987654       778999998743 22346677888887777422221  111     1234466778899998


Q ss_pred             CCCChh-----H------HH---hh----h---cC-------------------CCCCH---HHHHHHHHHHHHHHHHHh
Q 040050          163 PRGSLH-----N------QL---FR----S---YS-------------------AALPW---STRMKIALGAAKGLAFLH  199 (401)
Q Consensus       163 ~~~~L~-----~------~l---~~----~---~~-------------------~~l~~---~~~~~i~~qi~~al~~LH  199 (401)
                      .|..+.     .      .+   ..    .   ..                   ..++.   ......+..++..+.-+-
T Consensus       107 ~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~  186 (325)
T d1zyla1         107 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  186 (325)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            764321     0      00   00    0   00                   11111   122233334443333321


Q ss_pred             --CCCCCeeeccCCCCcEEEcCCCcEEEEecCCCCC
Q 040050          200 --GEDKPVIYRDFKASNILLDSDYTAKLSDFGLAKD  233 (401)
Q Consensus       200 --~~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~~  233 (401)
                        ....++||+|+.+.|||+++ + ..++||+-+..
T Consensus       187 ~~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         187 REDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CSCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             cccCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence              12346899999999999974 3 45899998763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.68  E-value=0.01  Score=52.20  Aligned_cols=155  Identities=15%  Similarity=0.047  Sum_probs=80.2

Q ss_pred             cHHHHHHHhcCCCCCceec-----ccCCeeEEEEEecCcCCCCCCCceEEEEEecCCCcccHHHHHHHHHHHhccC----
Q 040050           68 TLAELRLITSNFSRSNLLG-----EGGFGPVYKGFVDEKLKPGLEAQPVAVKALDLDGTQGHKEWMAEIIFLGQLR----  138 (401)
Q Consensus        68 ~~~~~~~~~~~y~~~~~Lg-----~G~~g~V~~a~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----  138 (401)
                      +..++..+-..|.++++..     .|---+.|+.....        ..+++|+......  ...+..|+.++..+.    
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~--------g~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~   73 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK--------DPLILTLYEKRVE--KNDLPFFLGLMQHLAAKGL   73 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS--------CCEEEEEECC-----CCHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC--------CcEEEEEcCCCCC--HHHHHHHHHHHHhhhhccc
Confidence            4556666777888865543     55557789876543        3599999864322  123344565665553    


Q ss_pred             -CCceeeEE---EEEEeCCeEEEEEEecCCCChhH--------------HHhh---hcC---------------------
Q 040050          139 -HPHLVKLI---GYCWEEEYRLLVYEYMPRGSLHN--------------QLFR---SYS---------------------  176 (401)
Q Consensus       139 -hpnI~~~~---~~~~~~~~~~lv~e~~~~~~L~~--------------~l~~---~~~---------------------  176 (401)
                       .|..+...   .+.........++.++.+.....              .+..   ...                     
T Consensus        74 pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (316)
T d2ppqa1          74 SCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEE  153 (316)
T ss_dssp             CCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGG
T ss_pred             cccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHH
Confidence             22222111   01122344556666665533211              0000   000                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhC--CCCCeeeccCCCCcEEEcCCCcEEEEecCCCC
Q 040050          177 -AALPWSTRMKIALGAAKGLAFLHG--EDKPVIYRDFKASNILLDSDYTAKLSDFGLAK  232 (401)
Q Consensus       177 -~~l~~~~~~~i~~qi~~al~~LH~--~~~~iiH~Dlkp~NIlv~~~~~vkL~DfG~a~  232 (401)
                       ...........+..+...+...+.  ...|+||+|+.++||+++.+...-|+||+.+.
T Consensus       154 ~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         154 RADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence             000011112223333333343332  24579999999999999988777899999876